PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Costa, M; Cruz, E; Barton, JC; Thorstensen, K; Morais, S; da Silva, BM; Pinto, JP; Vieira, CP; Vieira, J; Acton, RT; Porto, G				Costa, Monica; Cruz, Eugenia; Barton, James C.; Thorstensen, Ketil; Morais, Sandra; da Silva, Berta M.; Pinto, Jorge P.; Vieira, Cristina P.; Vieira, Jorge; Acton, Ronald T.; Porto, Graca			Effects of Highly Conserved Major Histocompatibility Complex (MHC) Extended Haplotypes on Iron and Low CD8(+) T Lymphocyte Phenotypes in HFE C282Y Homozygous Hemochromatosis Patients from Three Geographically Distant Areas	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; HLA HAPLOTYPES; POPULATION; EXPRESSION; OVERLOAD; MUTATION; PROBANDS; NUMBERS; GENE; ASSOCIATIONS	Hereditary Hemochromatosis (HH) is a recessively inherited disorder of iron overload occurring commonly in subjects homozygous for the C282Y mutation in HFE gene localized on chromosome 6p21.3 in linkage disequilibrium with the human leukocyte antigen (HLA)-A locus. Although its genetic homogeneity, the phenotypic expression is variable suggesting the presence of modifying factors. One such genetic factor, a SNP microhaplotype named A-A-T, was recently found to be associated with a more severe phenotype and also with low CD8(+)T-lymphocyte numbers. The present study aimed to test whether the predictive value of the A-A-T microhaplotype remained in other population settings. In this study of 304 HH patients from 3 geographically distant populations (Porto, Portugal 65; Alabama, USA 57; Nord-Trondelag, Norway 182), the extended haplotypes involving A-A-T were studied in 608 chromosomes and the CD8(+)T-lymphocyte numbers were determined in all subjects. Patients from Porto had a more severe phenotype than those from other settings. Patients with A-A-T seemed on average to have greater iron stores (p = 0.021), but significant differences were not confirmed in the 3 separate populations. Low CD8(+)T-lymphocytes were associated with HLA-A*03-A-A-T in Porto and Alabama patients but not in the greater series from Nord-Trondelag. Although A-A-T may signal a more severe iron phenotype, this study was unable to prove such an association in all population settings, precluding its use as a universal predictive marker of iron overload in HH. Interestingly, the association between A-A-T and CD8(+)T-lymphocytes, which was confirmed in Porto and Alabama patients, was not observed in Nord-Trondelag patients, showing that common HLA haplotypes like A*01-B*08 or A*03-B*07 segregating with HFE/C282Y in the three populations may carry different messages. These findings further strengthen the relevance of HH as a good disease model to search for novel candidate loci associated with the genetic transmission of CD8(+)T-lymphocyte numbers.	[Costa, Monica; Cruz, Eugenia; Pinto, Jorge P.; Porto, Graca] Univ Porto, IBMC, BCRIB, P-4100 Oporto, Portugal; [Cruz, Eugenia; Porto, Graca] Ctr Hosp Porto, Santo Antonio Hosp, Oporto, Portugal; [Barton, James C.; Acton, Ronald T.] Univ Alabama Birmingham, Southern Iron Disorders Ctr, Birmingham, AL USA; [Barton, James C.; Acton, Ronald T.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Thorstensen, Ketil] St Olav Hosp, Dept Med Biochem, Trondheim, Norway; [Morais, Sandra; da Silva, Berta M.] Univ Porto, UMIB, ICBAS, P-4100 Oporto, Portugal; [Morais, Sandra] Pedro Hispano Hosp, Matosinhos, Portugal; [Vieira, Cristina P.; Vieira, Jorge] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Acton, Ronald T.] Univ Alabama Birmingham, Dept Epidemiol & Int Hlth, Birmingham, AL USA; [Porto, Graca] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Norwegian University of Science & Technology (NTNU); Universidade do Porto; Universidade do Porto; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Universidade do Porto	Porto, G (corresponding author), Univ Porto, IBMC, BCRIB, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	gporto@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Vieira, Jorge/J-7477-2013; Porto, Graca/J-7939-2013	Vieira, Cristina P./0000-0002-7139-2107; Vieira, Jorge/0000-0001-7032-5220; Porto, Graca/0000-0002-1923-4638; Cruz, Eugenia/0000-0002-4801-5047; Costa, Monica Isabel/0000-0002-6792-5687; Morais, Sandra A./0000-0001-6131-1759; Barton, James/0000-0003-2876-8276; Silva, Berta/0000-0001-6579-5068	FEDER through the program POFC-COMPETE [COMPETE "FCOMP-01-0124-FEDER-008447"]; FCT (Portuguese Foundation for Science and Technology) [PTDC/SAU-GMC/67868/2006, PIC/IC/82785/2007, SFRH/BD/69186/2010]; INOVA/APRF, USA; BIIC-Programa Roche/ICBAS/HAS; Southern Iron Disorders Center, Birmingham, Alabama; Nord-Trondelag Health Study (The HUNT Study); Cancer Foundation at St. Olav Hospital, Trondheim; Throne Holst Foundation, Oslo; Liaison Committee between the Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Norwegian Haemochromatosis Association	FEDER through the program POFC-COMPETE; FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); INOVA/APRF, USA; BIIC-Programa Roche/ICBAS/HAS; Southern Iron Disorders Center, Birmingham, Alabama; Nord-Trondelag Health Study (The HUNT Study); Cancer Foundation at St. Olav Hospital, Trondheim; Throne Holst Foundation, Oslo; Liaison Committee between the Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Norwegian Haemochromatosis Association	FEDER through the program POFC-COMPETE (COMPETE "FCOMP-01-0124-FEDER-008447") and portuguese national funds through the FCT (Portuguese Foundation for Science and Technology) grants: PTDC/SAU-GMC/67868/2006, PIC/IC/82785/2007 and SFRH/BD/69186/2010; and partly by: 2) INOVA/APRF, USA; 3) The BIIC-Programa Roche/ICBAS/HAS 2008/2010; 4) Southern Iron Disorders Center, Birmingham, Alabama; 5) Nord-Trondelag Health Study (The HUNT Study), a collaboration between HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology NTNU), Nord-Trondelag County Council and The Norwegian Institute of Public Health; 6) The Cancer Foundation at St. Olav Hospital, Trondheim; 7) The Throne Holst Foundation, Oslo; 8) The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) and 9) The Norwegian Haemochromatosis Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka RS, 1997, J MED GENET, V34, P28, DOI 10.1136/jmg.34.1.28; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Asberg A, 2002, SCAND J GASTROENTERO, V37, P719, DOI 10.1080/00365520212510; Barton EH, 2004, ETHNIC DIS, V14, P73; Barton J, 2005, FIDDLEHEAD, P34; Barton James C, 2005, BMC Blood Disord, V5, P5, DOI 10.1186/1471-2326-5-5; Barton James C, 2002, BMC Med Genet, V3, P9, DOI 10.1186/1471-2350-3-9; Barton JC, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-22; Barton JC, 1997, BLOOD CELL MOL DIS, V23, P135, DOI 10.1006/bcmd.1997.0129; Barton JC, 1996, BLOOD CELL MOL DIS, V22, P195, DOI 10.1006/bcmd.1996.0100; Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Cardoso C, 2001, HUM IMMUNOL, V62, P488, DOI 10.1016/S0198-8859(01)00233-6; CRAWFORD DHG, 1995, AM J HUM GENET, V57, P362; Cruz E, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-16; Cruz E, 2004, TISSUE ANTIGENS, V64, P25, DOI 10.1111/j.1399-0039.2004.00245.x; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Cruz E, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-97; Distante S, 2004, HUM GENET, V115, P269, DOI 10.1007/s00439-004-1152-4; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Harbo HF, 2010, TISSUE ANTIGENS, V75, P207, DOI 10.1111/j.1399-0039.2009.01425.x; Jazwinska EC, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P91; Olsson KS, 2007, EUR J HAEMATOL, V79, P429, DOI 10.1111/j.1600-0609.2007.00953.x; Olsson KS, 2010, EUR J HAEMATOL, V84, P145, DOI 10.1111/j.1600-0609.2009.01376.x; Olsson KS, 2011, EUR J HAEMATOL, V86, P75, DOI 10.1111/j.1600-0609.2010.01536.x; Picket AJ, 1851, HIST ALABAMA INCIDEN; Piperno A, 1996, HEPATOLOGY, V24, P43, DOI 10.1002/hep.510240109; Piperno A, 1998, GASTROENTEROLOGY, V114, P996, DOI 10.1016/S0016-5085(98)70319-1; PORTO G, 1994, EUR J HAEMATOL, V52, P283; Porto G, 1997, HEPATOLOGY, V25, P397, DOI 10.1002/hep.510250223; Porto G, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P51; Pratiwi R, 1999, J HEPATOL, V31, P39, DOI 10.1016/S0168-8278(99)80161-5; Raha-Chowdhury R, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P75; REIMAO R, 1991, CR ACAD SCI III-VIE, V313, P481; Ribeiro O, 1989, GEOGRAFIA PORTUGAL P; Sachot S, 2001, BLOOD CELL MOL DIS, V27, P518, DOI 10.1006/bcmd.2001.0394; Schipper RF, 1997, HUM IMMUNOL, V52, P54, DOI 10.1016/S0198-8859(96)00257-1; SIMON M, 1987, AM J HUM GENET, V41, P89; Southerland Henry DeLeon, 1989, FEDERAL ROAD GEORGIA; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; THOMSON G, 1983, TISSUE ANTIGENS, V21, P320; Thorstensen K, 2010, SCAND J CLIN LAB INV, V70, P92, DOI 10.3109/00365510903527838; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79990	10.1371/journal.pone.0079990	http://dx.doi.org/10.1371/journal.pone.0079990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282517	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500018
J	Tsukahara, T; Matsuda, Y; Haniu, H				Tsukahara, Tamotsu; Matsuda, Yoshikazu; Haniu, Hisao			Cyclic Phosphatidic Acid Stimulates cAMP Production and Inhibits Growth in Human Colon Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE; LYSOPHOSPHATIDIC ACID; TUMOR INVASION; AKT ACTIVATION; PHOSPHORYLATION; PHOSPHODIESTERASE-3; EXPRESSION; INDUCTION; RELEASE; 3B	Colon cancer is a malignancy that develops in colon and rectal tissues. The prognosis for metastatic colon cancer remains poor, and novel therapeutic options are required to reduce colon cancer mortality. Recently, intracellular cAMP levels have been suggested to influence the behavior of cancer cells. Intriguingly, cyclic phosphatidic acid (cPA) and its structural analogs inhibit growth in many cancer cell lines, and our previous work has suggested that cPA increases cAMP production. Phosphodiesterase (PDE) type 3 isoforms PDE3A and PDE3B are expressed mainly in cardiovascular tissue and adipose tissue, respectively. Moreover, increase in intracellular cAMP levels has been associated with the inhibition of growth in colon cancer cells. These findings suggest that cPA could be used in colon cancer therapy. In this study, we found that cPA inhibited the growth of HT-29 cells, which express high levels of PDE3B, but not the growth of DLD-1 cells, which express low levels of PDE3B. Furthermore, cPA inhibited the phosphorylation of Akt in HT-29 cells in a dose-dependent fashion. Our results suggest that PDE3B expression and intracellular cAMP levels are correlated with the proliferation of colon cancer cells. These findings demonstrate for the first time that cPA may serve as a useful a molecule in targeted therapy for colon cancer.	[Tsukahara, Tamotsu] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 92002, Japan; [Matsuda, Yoshikazu] Nihon Pharmaceut Univ, Clin Pharmacol Educ Ctr, Ina, Saitama, Japan; [Haniu, Hisao] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 390, Japan	Kanazawa Medical University; Shinshu University	Haniu, H (corresponding author), Shinshu Univ, Sch Med, Dept Orthopaed Surg, 3-1-1 Asahi, Matsumoto, Nagano 390, Japan.	ttamotsu@kanazawa-med.ac.jp	Tsukahara, Tamotsu/ABB-3631-2021	Tsukahara, Tamotsu/0000-0001-6469-920X	Japan Society for the Promotion of Science [22591482]; Takeda Science Foundation; Astellas foundation for research on metabolic disorders; Nagano Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas foundation for research on metabolic disorders; Nagano Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research (C) 22591482 (to TT) from the Japan Society for the Promotion of Science, Grant-in-Aid from Takeda Science Foundation (to TT), Astellas foundation for research on metabolic disorders (to TT) and Nagano Society for the Promotion of Science (to TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; Hanson MS, 2010, EXP BIOL MED, V235, P256, DOI 10.1258/ebm.2009.009206; HORVATH JE, 1995, P NATL ACAD SCI USA, V92, P1856, DOI 10.1073/pnas.92.6.1856; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Liu XJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-684; Marfella-Scivittaro C, 2002, AM J PHYSIOL-CELL PH, V282, pC693, DOI 10.1152/ajpcell.00122.2001; Minami M, 2010, CIRC J, V74, P1779, DOI 10.1253/circj.CJ-10-0632; Mukai M, 2000, FEBS LETT, V484, P69, DOI 10.1016/S0014-5793(00)02129-3; Mukai M, 1999, INT J CANCER, V81, P918, DOI 10.1002/(SICI)1097-0215(19990611)81:6<918::AID-IJC13>3.0.CO;2-E; Murakami-Murofushi K, 2002, BBA-MOL CELL BIOL L, V1582, P1, DOI 10.1016/S1388-1981(02)00131-2; Nagaoka T, 1998, DIABETES, V47, P1135, DOI 10.2337/diabetes.47.7.1135; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pende M, 1997, J NEUROSCI, V17, P1291; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Savai R, 2010, EXPERT OPIN INV DRUG, V19, P117, DOI 10.1517/13543780903485642; Shafer SH, 1998, BIOCHEM PHARMACOL, V56, P1229, DOI 10.1016/S0006-2952(98)00260-3; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tsukahara T, 2011, BIOCHEM BIOPH RES CO, V404, P109, DOI 10.1016/j.bbrc.2010.11.076; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Vasko V, 2004, J MED GENET, V41, P161, DOI 10.1136/jmg.2003.015339	30	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81139	10.1371/journal.pone.0081139	http://dx.doi.org/10.1371/journal.pone.0081139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282571	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500073
J	Zhao, Q; Azeria, ET; Le Blanc, ML; Lemaitre, J; Fortin, D				Zhao, Qing; Azeria, Ermias T.; Le Blanc, Melanie-Louise; Lemaitre, Jerome; Fortin, Daniel			Landscape-Scale Disturbances Modified Bird Community Dynamics in Successional Forest Environment	PLOS ONE			English	Article							BOREAL FOREST; MANAGEMENT GUIDELINES; NATURAL DISTURBANCE; SPECIES RICHNESS; CONSERVATION; BIODIVERSITY; QUEBEC; FIRE; ASSEMBLAGES; DIVERSITY	Ecosystem-based forest management strives to develop silvicultural practices that best emulate natural disturbances such as wildfire to conserve biodiversity representative of natural forest ecosystems. Yet, current logging practices alter forest structure and reduce the proportion of old-growth forest and, consequently, can exert long-term effects on the dynamics of forest biota. The stand-and landscape-scale factors driving bird community dynamics in post-disturbance environment remain poorly understood. In this study, we examined bird community dynamics along successional gradients in boreal ecosystems originating from fire and logging in landscapes dominated by old-growth forest. We tested if bird species richness and community compositions in clear-cutting stands became comparable to those in natural stands after 70 years, and identified the relative contributions of stand-and landscape-scale forest attributes in bird community dynamics. Based on records of bird occurrences at 185 field sites in natural and clearcutting stands, we demonstrate that (1) both forest structures and bird communities underwent evident changes along successional gradients in post-clearcutting environment; (2) bird species richness and community composition in 60-to 70-years-old clearcutting stands still differed from those in 50-to 79-years-old natural stands, in spite of the fact that most forest attributes of clearcutting stands became comparable to those of natural stands after 40 years; and (3) landscape disturbances contributed more than stand characteristics in explaining the lack of convergence of mature forest species, residents, and short-distance migrants in post-clearcutting environment. Our study points out that more regards should be paid to improve the landscape configuration of the managed forests, and implies that old-growth forest retention within logged areas, combined with selection cutting and prolonged logging rotations, can better emulate fire and alleviate forest harvesting effects on bird community assemblages typical of natural boreal ecosystem.	[Zhao, Qing; Le Blanc, Melanie-Louise; Lemaitre, Jerome; Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Azeria, Ermias T.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Laval University; University of Alberta	Zhao, Q (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	whitelangur@gmail.com	Zhao, Qing/K-3486-2015; Fortin, Daniel/ABG-3554-2020; Lemaître, Jérôme/S-1337-2017	Zhao, Qing/0000-0003-2759-1114; Lemaître, Jérôme/0000-0001-7736-111X	Natural Sciences and Engineering Research Council of Canada (NSERC)-Laval University Industrial Research Chair in Silviculture and Wildlife	Natural Sciences and Engineering Research Council of Canada (NSERC)-Laval University Industrial Research Chair in Silviculture and Wildlife(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Laval University Industrial Research Chair in Silviculture and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2004, PERMDISP FORTRAN COM; Azeria ET, 2011, GLOBAL ECOL BIOGEOGR, V20, P119, DOI 10.1111/j.1466-8238.2010.00580.x; Azeria ET, 2009, DIVERS DISTRIB, V15, P958, DOI 10.1111/j.1472-4642.2009.00613.x; Azeria ET, 2009, GLOBAL ECOL BIOGEOGR, V18, P333, DOI 10.1111/j.1466-8238.2009.00454.x; BARRETT S, 1988, INCREMENT BORER METH; Bawa KS, 1998, CONSERV BIOL, V12, P46, DOI 10.1046/j.1523-1739.1998.96480.x; Bergeron Y, 1999, FOREST CHRON, V75, P49, DOI 10.5558/tfc75049-1; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Blanc M-LL, 2010, ECOSCIENCE, V17, P334; Bouchard M, 2008, CAN J FOREST RES, V38, P1621, DOI 10.1139/X07-201; Boucher D, 2003, FOREST CHRON, V79, P318, DOI 10.5558/tfc79318-2; Buddle CM, 2006, BIOL CONSERV, V128, P346, DOI 10.1016/j.biocon.2005.10.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; DRAKE JA, 1990, J THEOR BIOL, V147, P213, DOI 10.1016/S0022-5193(05)80053-0; Drapeau P, 2000, ECOL MONOGR, V70, P423, DOI 10.1890/0012-9615(2000)070[0423:LSDACI]2.0.CO;2; Edenius L, 1997, ECOGRAPHY, V20, P425, DOI 10.1111/j.1600-0587.1997.tb00410.x; Fleishman E, 2006, ECOL INDIC, V6, P543, DOI 10.1016/j.ecolind.2005.07.005; Gauthier S, 1996, FOREST DYNAMICS MODE; Hobson KA, 1999, ECOL APPL, V9, P849, DOI 10.1890/1051-0761(1999)009[0849:CIBCIB]2.0.CO;2; Hutto RL, 2006, CONSERV BIOL, V20, P984, DOI 10.1111/j.1523-1739.2006.00494.x; Imbeau L, 1999, CAN J ZOOL, V77, P1850, DOI 10.1139/cjz-77-12-1850; Imbeau L, 2001, CONSERV BIOL, V15, P1151, DOI 10.1046/j.1523-1739.2001.0150041151.x; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Lemaitre J, 2012, BIODIVERS CONSERV, V21, P3355, DOI 10.1007/s10531-012-0366-3; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; McRae D. J., 2001, Environmental Reviews, V9, P223, DOI 10.1139/a01-010; Morissette JL, 2002, CAN J FOREST RES, V32, P2169, DOI 10.1139/X02-134; Pham AT, 2004, CAN J FOREST RES, V34, P353, DOI 10.1139/X03-265; Poole A., 2005, BIRDS N AM ONLINE; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Verner J., 1985, Current Ornithology, V2, P247; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; Youngblood A, 1996, FOREST CHRON, V72, P31, DOI 10.5558/tfc72031-1	40	8	8	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81358	10.1371/journal.pone.0081358	http://dx.doi.org/10.1371/journal.pone.0081358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282585	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500087
J	Rami, L; Auguste, P; Thebaud, NB; Bareille, R; Daculsi, R; Ripoche, J; Bordenave, L				Rami, Lila; Auguste, Patrick; Thebaud, Noelie B.; Bareille, Reine; Daculsi, Richard; Ripoche, Jean; Bordenave, Laurence			IQ Domain GTPase-Activating Protein 1 is Involved in Shear Stress-Induced Progenitor-Derived Endothelial Cell Alignment	PLOS ONE			English	Article							ADHERENS JUNCTIONS; VE-CADHERIN; IQGAP1; MIGRATION; RAC1; ADHESION; CDC42; CYTOSKELETON; COMPLEXES; BINDING	Shear stress is one of mechanical constraints which are exerted by blood flow on endothelial cells (ECs). To adapt to shear stress, ECs align in the direction of flow through adherens junction (AJ) remodeling. However, mechanisms regulating ECs alignment under shear stress are poorly understood. The scaffold protein IQ domain GTPase activating protein 1 (IQGAP1) is a scaffold protein which couples cell signaling to the actin and microtubule cytoskeletons and is involved in cell migration and adhesion. IQGAP1 also plays a role in AJ organization in epithelial cells. In this study, we investigated the potential IQGAP1 involvement in the endothelial cells alignment under shear stress. Progenitor-derived endothelial cells (PDECs), transfected (or not) with IQGAP1 small interfering RNA, were exposed to a laminar shear stress (1.2 N/m(2)) and AJ proteins (VE-cadherin and beta-catenin) and IQGAP1 were labeled by immunofluorescence. We show that IQGAP1 is essential for ECs alignment under shear stress. We studied the role of IQGAP1 in AJs remodeling of PDECs exposed to shear stress by studying cell localization and IQGAP1 interactions with VE-cadherin and beta-catenin by immunofluorescence and Proximity Ligation Assays. In static conditions, IQGAP1 interacts with VE-cadherin but not with beta-catenin at the cell membrane. Under shear stress, IQGAP1 lost its interaction from VE-cadherin to beta-catenin. This "switch'' was concomitant with the loss of beta catenin/VE-cadherin interaction at the cell membrane. This work shows that IQGAP1 is essential to ECs alignment under shear stress and that AJ remodeling represents one of the mechanisms involved. These results provide a new approach to understand ECs alignment under to shear stress.	[Rami, Lila; Thebaud, Noelie B.; Bareille, Reine; Daculsi, Richard; Ripoche, Jean; Bordenave, Laurence] Univ Bordeaux, U1026, F-33000 Bordeaux, France; [Rami, Lila; Thebaud, Noelie B.; Bareille, Reine; Daculsi, Richard; Ripoche, Jean; Bordenave, Laurence] INSERM, U1026, Bordeaux, France; [Auguste, Patrick] Univ Bordeaux, LAMC, UMR 1029, Talence, France; [Auguste, Patrick] INSERM, LAMC, UMR 1029, Talence, France; [Bordenave, Laurence] CHU Bordeaux, CIC IT BioDiMI, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Rami, L (corresponding author), Univ Bordeaux, U1026, F-33000 Bordeaux, France.	lila.rami@inserm.fr	Auguste, Patrick/J-9901-2014; HERAULT, EMILIE/M-3701-2014	Auguste, Patrick/0000-0003-1485-0295	ANR [ANR2010-TECS017]	ANR(French National Research Agency (ANR))	The authors thank ANR for funding the TECSAN collaborative research program ChitoArt (ANR2010-TECS017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; Chien Shu, 2008, Molecular & Cellular Biomechanics, V5, P1; Daculsi R, ACTA BIOMATER, V6, P1437; David S, 2011, ARTERIOSCL THROM VAS, V31, P2643, DOI 10.1161/ATVBAHA.111.233189; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dickinson DJ, 2012, DEV CELL, V23, P533, DOI 10.1016/j.devcel.2012.06.008; Fuchs S, 2006, CELL TISSUE RES, V326, P79, DOI 10.1007/s00441-006-0222-4; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Hage B, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-23; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; McCue S, 2004, TRENDS CARDIOVAS MED, V14, P143, DOI 10.1016/j.tcm.2004.02.003; Nakhaei-Nejad M, 2010, EUR J IMMUNOL, V40, P204, DOI 10.1002/eji.200839214; Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pelikan-Conchaudron A, 2011, J BIOL CHEM, V286, P35119, DOI 10.1074/jbc.M111.258772; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Sacks DB, CELL MICROBIOL, V14, P1415; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Thebaud NB, J TISSUE ENG REGEN M, V4, P473; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	30	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79919	10.1371/journal.pone.0079919	http://dx.doi.org/10.1371/journal.pone.0079919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278215	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700021
J	Miyagawa, Y; Ogawa, J; Iwata, Y; Koizumi, N; Mishiba, KI				Miyagawa, Yosuke; Ogawa, Jun; Iwata, Yuji; Koizumi, Nozomu; Mishiba, Kei-ichiro			An Attempt to Detect siRNA-Mediated Genomic DNA Modification by Artificially Induced Mismatch siRNA in Arabidopsis	PLOS ONE			English	Article							ACETOLACTATE SYNTHASE GENE; PLANT GENETICS; SMALL RNAS; METHYLATION; SITE; TRANSFORMATION; TRANSGENES; RESISTANT; DICER; TOOL	Although tremendous progress has been made in recent years in identifying molecular mechanisms of small interfering RNA (siRNA) functions in higher plants, the possibility of direct interaction between genomic DNA and siRNA remains an enigma. Such an interaction was proposed in the 'RNA cache' hypothesis, in which a mutant allele is restored based on template-directed gene conversion. To test this hypothesis, we generated transgenic Arabidopsis thaliana plants conditionally expressing a hairpin dsRNA construct of a mutated acetolactate synthase (mALS) gene coding sequence, which confers chlorsulfuron resistance, in the presence of dexamethasone (DEX). In the transgenic plants, suppression of the endogenous ALS mRNA expression as well as 21-nt mALS siRNA expression was detected after DEX treatment. After screening >100,000 progeny of the mALS siRNA-induced plants, no chlorsulfuron-resistant progeny were obtained. Further experiments using transgenic calli also showed that DEX-induced expression of mALS siRNA did not affect the number of chlorsulfuron-resistant calli. No trace of cytosine methylation of the genomic ALS region corresponding to the dsRNA region was observed in the DEX-treated calli. These results do not necessarily disprove the 'RNA cache' hypothesis, but indicate that an RNAi machinery for ALS mRNA suppression does not alter the ALS locus, either genetically or epigenetically.	[Miyagawa, Yosuke; Ogawa, Jun; Iwata, Yuji; Koizumi, Nozomu; Mishiba, Kei-ichiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan	Osaka Metropolitan University	Mishiba, KI (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan.	mishiba@plant.osakafu-u.ac.jp	Mishiba, Kei-ichiro/A-5844-2013	Mishiba, Kei-ichiro/0000-0002-3827-1020; Iwata, Yuji/0000-0003-4187-6570	Japan Society for the Promotion of Science [23780027]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grant-in-Aid for Young Scientists(B)(No. 23780027) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; CHALEFF RS, 1984, SCIENCE, V224, P1443, DOI 10.1126/science.224.4656.1443; Chaudhury A, 2005, NATURE, V437, pE1, DOI 10.1038/nature04062; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Comai L, 2005, PLANT CELL, V17, P2856, DOI 10.1105/tpc.105.036293; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Endo M, 2006, PLANT CELL PHYSIOL, V47, P372, DOI 10.1093/pcp/pcj003; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Goto K, 2003, PLANT MOL BIOL REP, V21, P51, DOI 10.1007/BF02773396; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Hopkins Marianne T, 2013, F1000Res, V2, P5, DOI 10.12688/f1000research.2-5.v1; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Kochevenko A, 2003, PLANT PHYSIOL, V132, P174, DOI 10.1104/pp.102.016857; Krishnaswamy L, 2007, PLANT BIOLOGY, V9, P30, DOI 10.1055/s-2006-924563; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; MAZUR BJ, 1987, PLANT PHYSIOL, V85, P1110, DOI 10.1104/pp.85.4.1110; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercier R, 2008, GENETICS, V180, P2295, DOI 10.1534/genetics.108.095208; Mishiba K, 2005, PLANT J, V44, P541, DOI 10.1111/j.1365-313X.2005.02556.x; Mishiba K, 2005, PLANT CELL REP, V24, P297, DOI 10.1007/s00299-005-0938-8; Mishiba K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009670; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Nowacki M, 2011, ANNU REV GENOM HUM G, V12, P367, DOI 10.1146/annurev-genom-082410-101420; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Peng P, 2006, NATURE, V443, pE8, DOI 10.1038/nature05251; Ray A, 2005, NATURE, V437, pE1, DOI 10.1038/nature04063; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wielopolska A, 2005, PLANT BIOTECHNOL J, V3, P583, DOI 10.1111/j.1467-7652.2005.00149.x; Wierzbicki AT, 2012, CURR OPIN PLANT BIOL, V15, P517, DOI 10.1016/j.pbi.2012.08.008; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768	48	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81326	10.1371/journal.pone.0081326	http://dx.doi.org/10.1371/journal.pone.0081326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278423	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800122
J	Santos, SM; Lourenco, R; Mira, A; Beja, P				Santos, Sara M.; Lourenco, Rui; Mira, Antonio; Beja, Pedro			Relative Effects of Road Risk, Habitat Suitability, and Connectivity on Wildlife Roadkills: The Case of Tawny Owls (Strix aluco)	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CONSERVATION BIOLOGY; VEHICLE COLLISIONS; LOCATIONS; PATTERNS; ECOLOGY; PERFORMANCE; REGRESSION; MOVEMENT; HIGHWAY	Background: Despite its importance for reducing wildlife-vehicle collisions, there is still incomplete understanding of factors responsible for high road mortality. In particular, few empirical studies examined the idea that spatial variation in roadkills is influenced by a complex interplay between road-related factors, and species-specific habitat quality and landscape connectivity. Methodology/Principal Findings: In this study we addressed this issue, using a 7-year dataset of tawny owl (Strix aluco) roadkills recorded along 37 km of road in southern Portugal. We used a multi-species roadkill index as a surrogate of intrinsic road risk, and we used a Maxent distribution model to estimate habitat suitability. Landscape connectivity was estimated from least-cost paths between tawny owl territories, using habitat suitability as a resistance surface. We defined 10 alternative scenarios to compute connectivity, based on variation in potential movement patterns according to territory quality and dispersal distance thresholds. Hierarchical partitioning of a regression model indicated that independent variation in tawny owl roadkills was explained primarily by the roadkill index (70.5%) and, to a much lesser extent, by landscape connectivity (26.2%), while habitat suitability had minor effects (3.3%). Analysis of connectivity scenarios suggested that owl roadkills were primarily related to short range movements (<5 km) between high quality territories. Tawny owl roadkills were spatially autocorrelated, but the introduction of spatial filters in the regression model did not change the type and relative contribution of environmental variables. Conclusions: Overall, results suggest that road-related factors may have a dominant influence on roadkill patterns, particularly in areas like ours where habitat quality and landscape connectivity are globally high for the study species. Nevertheless, the study supported the view that functional connectivity should be incorporated whenever possible in roadkill models, as it may greatly increase their power to predict the location of roadkill hotspots.	[Santos, Sara M.; Mira, Antonio] Univ Evora, CIBIO Res Ctr Biodivers & Genet Resources, Evora, Portugal; [Lourenco, Rui] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran, LabOr Lab Ornithol, Evora, Portugal; [Beja, Pedro] Univ Porto, CIBIO Res Ctr Biodivers & Genet Resources, EDP Biodivers Chair, Vairao, Portugal	University of Evora; University of Evora; Universidade do Porto	Santos, SM (corresponding author), Univ Evora, CIBIO Res Ctr Biodivers & Genet Resources, Evora, Portugal.	saramlsantos@yahoo.com	Santos, Sara/AAU-4738-2020; Lourenço, Rui/AAB-6030-2020; Mira, Antonio/E-5715-2010; Lourenço, Rui/B-7148-2012; Beja, Pedro/A-7851-2008	Lourenço, Rui/0000-0001-7694-0478; Mira, Antonio/0000-0001-6152-0454; Lourenço, Rui/0000-0001-7694-0478; Beja, Pedro/0000-0001-8164-0760; Santos, Sara/0000-0003-4931-1080	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/70124/2010, SFRH/BPD/78241/2011]; integrated program "CIBIO-UE: Biodiversity and Climate change" [ALENT-07-0224-FEDER-001755]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); integrated program "CIBIO-UE: Biodiversity and Climate change"	S.M. Santos and R. Lourenco were supported by Post-doctoral grants of Fundacao para a Ciencia e Tecnologia (FCT; SFRH/BPD/70124/2010 and SFRH/BPD/78241/2011, respectively). The creation of the vertebrate mortality database was partially funded by the integrated program "CIBIO-UE: Biodiversity and Climate change" founded by INALENTEJO with the ref. ALENT-07-0224-FEDER-001755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Baudvin Hugues, 2003, Alauda, V71, P221; Bissonette John A., 2008, Human-Wildlife Conflicts, V2, P122; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campioni L, 2010, IBIS, V152, P569, DOI 10.1111/j.1474-919X.2010.01030.x; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Delgado MD, 2009, BEHAV ECOL SOCIOBIOL, V64, P35, DOI 10.1007/s00265-009-0815-5; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; EP, 2005, REC TRAF EV; Equipa Atlas, 2008, ATL AV NID PORT 1999; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; Fahrig L, 2009, ECOL SOC, V14; Gomes L, 2009, ECOL RES, V24, P355, DOI 10.1007/s11284-008-0515-z; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Grilo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043811; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; HIRONS G J M, 1985, Journal of Zoology Series B, V1, P21; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; Huijser MP, 2009, ECOL SOC, V14; Jaarsma CF, 2007, ECOL INFORM, V2, P73, DOI 10.1016/j.ecoinf.2007.04.004; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Colino-Rabanal VJ, 2011, EUR J WILDLIFE RES, V57, P399, DOI 10.1007/s10344-010-0446-1; Kolowski JM, 2008, BIOL CONSERV, V141, P1119, DOI 10.1016/j.biocon.2008.02.011; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Litvaitis JA, 2008, ENVIRON MANAGE, V42, P688, DOI 10.1007/s00267-008-9108-4; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Mac Nally R, 1996, AUST J ECOL, V21, P224; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Martin G., 1990, BIRDS NIGHT; Martinez JA, 2002, RAPACES NOCTURNAS GU; Mikkola H., 1983, P1; Minor ES, 2008, CONSERV BIOL, V22, P297, DOI 10.1111/j.1523-1739.2007.00871.x; Neumann W, 2012, BIOL CONSERV, V145, P70, DOI 10.1016/j.biocon.2011.10.011; O'Brien D, 2006, BIOL CONSERV, V130, P70, DOI 10.1016/j.biocon.2005.12.014; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Pereira M, 2011, GEOFOCUS, V11, P70; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2016, R FDN STAT COMP; Ramp D, 2005, BIOL CONSERV, V126, P474, DOI 10.1016/j.biocon.2005.07.001; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; REDPATH SM, 1994, BIRD STUDY, V41, P192, DOI 10.1080/00063659409477219; Roger E, 2009, DIVERS DISTRIB, V15, P222, DOI 10.1111/j.1472-4642.2008.00523.x; Santens S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025429, 10.1371/journal.pone.0025383]; Seiler A, 2005, J APPL ECOL, V42, P371, DOI 10.1111/j.1365-2664.2005.01013.x; Seiler A, 2001, INTRODUTORY RES ESSA, V9, P1; Silva CC, 2012, ACTA ORNITHOL, V47, P47, DOI 10.3161/000164512X653917; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Sunde P, 2004, J ZOOL, V263, P65, DOI 10.1017/S0952836904004881; Sunde P, 2011, ECOLOGY CONSERVATION; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; Walsh C., 2008, HIER PART PACKAGE HI; Wang YH, 2008, LANDSCAPE ECOL, V23, P989, DOI 10.1007/s10980-008-9262-3; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zuberogoitia I, 2003, ATLAS AVES REPRODUCT, P320; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	70	47	50	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79967	10.1371/journal.pone.0079967	http://dx.doi.org/10.1371/journal.pone.0079967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278226	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800040
J	Xi, ZX; Rest, JS; Davis, CC				Xi, Zhenxiang; Rest, Joshua S.; Davis, Charles C.			Phylogenomics and Coalescent Analyses Resolve Extant Seed Plant Relationships	PLOS ONE			English	Article							ESTIMATING SPECIES TREES; LAND PLANTS; PHYLOGENETIC ANALYSIS; MULTIGENE PHYLOGENY; CHLOROPLAST DNA; INVERTED REPEAT; SISTER GROUP; ORIGIN; GENE; GYMNOSPERMS	The extant seed plants include more than 260,000 species that belong to five main lineages: angiosperms, conifers, cycads, Ginkgo, and gnetophytes. Despite tremendous effort using molecular data, phylogenetic relationships among these five lineages remain uncertain. Here, we provide the first broad coalescent-based species tree estimation of seed plants using genome-scale nuclear and plastid data By incorporating 305 nuclear genes and 47 plastid genes from 14 species, we identify that i) extant gymnosperms (i. e., conifers, cycads, Ginkgo, and gnetophytes) are monophyletic, ii) gnetophytes exhibit discordant placements within conifers between their nuclear and plastid genomes, and iii) cycads plus Ginkgo form a clade that is sister to all remaining extant gymnosperms. We additionally observe that the placement of Ginkgo inferred from coalescent analyses is congruent across different nucleotide rate partitions. In contrast, the standard concatenation method produces strongly supported, but incongruent placements of Ginkgo between slow- and fast-evolving sites. Specifically, fast-evolving sites yield relationships in conflict with coalescent analyses. We hypothesize that this incongruence may be related to the way in which concatenation methods treat sites with elevated nucleotide substitution rates. More empirical and simulation investigations are needed to understand this potential weakness of concatenation methods.	[Xi, Zhenxiang; Davis, Charles C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rest, Joshua S.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Davis, CC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu		Rest, Joshua/0000-0002-9582-1041	United States National Science Foundation [DEB-1120243]; Direct For Biological Sciences [1120243] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by a grant from the United States National Science Foundation DEB-1120243 to C. C. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Brenner ED, 2003, TRENDS PLANT SCI, V8, P446, DOI 10.1016/S1360-1385(03)00190-0; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Burleigh JG, 2007, INT J PLANT SCI, V168, P111, DOI 10.1086/509586; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chaw SM, 1997, MOL BIOL EVOL, V14, P56, DOI 10.1093/oxfordjournals.molbev.a025702; Cibrian-Jaramillo A, 2010, GENOME BIOL EVOL, V2, P225, DOI 10.1093/gbe/evq012; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; de la Torre-Barcena JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005764; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; FRIEDMAN WE, 1993, TRENDS ECOL EVOL, V8, P15, DOI 10.1016/0169-5347(93)90125-9; Goremykin V, 1996, MOL BIOL EVOL, V13, P383, DOI 10.1093/oxfordjournals.molbev.a025597; Goremykin VV, 2010, J MOL EVOL, V71, P319, DOI 10.1007/s00239-010-9398-z; Graham SW, 2009, AM J BOT, V96, P216, DOI 10.3732/ajb.0800320; Gribaldo S, 2002, THEOR POPUL BIOL, V61, P391, DOI 10.1006/tpbi.2002.1593; Gugerli F, 2001, MOL PHYLOGENET EVOL, V21, P167, DOI 10.1006/mpev.2001.1004; Hajibabaei M, 2006, MOL PHYLOGENET EVOL, V40, P208, DOI 10.1016/j.ympev.2006.03.006; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2010, BIOINFORMATICS, V26, P962, DOI 10.1093/bioinformatics/btq062; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Liu QP, 2005, J GENET, V84, P55, DOI 10.1007/BF02715890; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Mathews S, 2010, PHILOS T R SOC B, V365, P383, DOI 10.1098/rstb.2009.0233; Mathews S, 2009, AM J BOT, V96, P228, DOI 10.3732/ajb.0800178; MEDGYESY P, 1985, P NATL ACAD SCI USA, V82, P6960, DOI 10.1073/pnas.82.20.6960; Mossel E, 2005, SCIENCE, V309, P2207, DOI 10.1126/science.1115493; Nickrent DL, 2000, MOL BIOL EVOL, V17, P1885, DOI 10.1093/oxfordjournals.molbev.a026290; Norstog KJ, 2004, BOT REV, V70, P5, DOI 10.1663/0006-8101(2004)070[0005:CDOTSO]2.0.CO;2; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; OLSEN GJ, 1987, COLD SPRING HARB SYM, V52, P825, DOI 10.1101/SQB.1987.052.01.090; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Philippe H, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-91; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; Qiu YL, 2007, INT J PLANT SCI, V168, P691, DOI 10.1086/513474; Qiu YL, 2006, TAXON, V55, P837, DOI 10.2307/25065680; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Qiu YL, 2000, INT J PLANT SCI, V161, pS3, DOI 10.1086/317584; Rai HS, 2008, BOTANY, V86, P658, DOI 10.1139/B08-062; RAJORA OP, 1995, THEOR APPL GENET, V90, P331, DOI 10.1007/BF00221973; Ran JH, 2010, MOL PHYLOGENET EVOL, V54, P136, DOI 10.1016/j.ympev.2009.09.011; Regina TMR, 2010, PLANT PHYSIOL BIOCH, V48, P646, DOI 10.1016/j.plaphy.2010.05.003; Rosenberg NA, 2008, SYST BIOL, V57, P131, DOI 10.1080/10635150801905535; ROTHWELL GW, 1989, BOT GAZ, V150, P170, DOI 10.1086/337763; Rudall PJ, 2010, PHILOS T R SOC B, V365, P397, DOI 10.1098/rstb.2009.0234; Rydin C, 2002, INT J PLANT SCI, V163, P197, DOI 10.1086/338321; Samigullin TK, 1999, J MOL EVOL, V49, P310, DOI 10.1007/PL00006553; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Wang L, 2011, J SYST EVOL, V49, P353, DOI 10.1111/j.1759-6831.2011.00123.x; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2013, GENOME BIOL EVOL, V5, P243, DOI 10.1093/gbe/evt001; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zhong BJ, 2011, GENOME BIOL EVOL, V3, P1340, DOI 10.1093/gbe/evr105; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170	92	56	59	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80870	10.1371/journal.pone.0080870	http://dx.doi.org/10.1371/journal.pone.0080870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278335	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800087
J	Zhang, L; Zhu, BY; Dai, RX; Zhao, GP; Ding, XM				Zhang, Lin; Zhu, Binyan; Dai, Ruixue; Zhao, Guoping; Ding, Xiaoming			Control of Directionality in Streptomyces Phage phi BT1 Integrase-Mediated Site-Specific Recombination	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; BACTERIOPHAGE-LAMBDA; PHI-C31 INTEGRASE; HETEROLOGOUS EXPRESSION; CENTRAL DINUCLEOTIDE; SERINE RECOMBINASE; PROPHAGE EXCISION; DNA COMPLEX; ATT-SITE; PROTEIN	Streptomyces phage phi BT1 integrates its genome into the attB site of the host chromosome with the attP site to generate attL and attR. The phi BT1 integrase belongs to the large serine recombinase subfamily which directly binds to target sites to initiate double strand breakage and exchange. A recombination directionality factor (RDF) is commonly required for switching integration to excision. Here we report the characterization of the RDF protein for phi BT1 recombination. The RDF, is a phage-encoded gp3 gene product (28 KDa), which allows efficient active excision between attL and attR, and inhibits integration between attB and attP; Gp3 can also catalyze topological relaxation with the integrase of supercoiled plasmids containing a single excision site. Further study showed that Gp3 could form a dimer and interact with the integrase whether it bound to the substrate or not. The synapse formation of attL or attR alone with integrase and Gp3 showed that synapsis did not discriminate between the two sites, indicating that complementarity of central dinucleotides is the sole determinant of outcome in correct excision synapses. Furthermore, both in vitro and in vivo evidence support that the RDFs of phi BT1 and phi C31 were fully exchangeable, despite the low amino acid sequence identity of the two integrases.	[Zhang, Lin; Zhu, Binyan; Dai, Ruixue; Zhao, Guoping; Ding, Xiaoming] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China; [Zhang, Lin; Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Gen, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China.	gpzhao@sibs.ac.cn; xmding74@fudan.edu.cn		Zhang, Lin/0000-0001-5431-5006; Dai, Ruixue/0000-0002-3703-0153; Zhao, Guo-Ping/0000-0002-7621-6620	National Basic Research Program of China (973 Program) [2012CB721102]; National Natural Science Foundation of China [30830002]; China Postdoctoral Science Foundation funded project [2012T50444, 2012M520947]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation)	This work was supported by National Basic Research Program of China (973 Program) (2012CB721102), National Natural Science Foundation of China (30830002), and the China Postdoctoral Science Foundation funded project (2012T50444 and 2012M520947). Websites: National Basic Research Program of China (http://www.973.gov.cn/English/Index.aspx), National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_ nsfc/desktop/zn/0101.htm), China Postdoctoral Science Foundation (http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbani MA, 2007, P NATL ACAD SCI USA, V104, P2109, DOI 10.1073/pnas.0607820104; ABREMSKI K, 1981, J MOL BIOL, V153, P67, DOI 10.1016/0022-2836(81)90527-1; Alexander DC, 2010, APPL ENVIRON MICROB, V76, P6877, DOI 10.1128/AEM.01248-10; Bai H, 2011, P NATL ACAD SCI USA, V108, P7419, DOI [10.1073/pnas.1018436108, 10.1073/pnas.10184361]; Baltz RH, 2012, J IND MICROBIOL BIOT, V39, P661, DOI 10.1007/s10295-011-1069-6; Bibb LA, 2005, MOL MICROBIOL, V55, P1896, DOI 10.1111/j.1365-2958.2005.04517.x; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; BOOCOCK MR, 1995, EMBO J, V14, P5129, DOI 10.1002/j.1460-2075.1995.tb00195.x; Breuner A, 1999, J BACTERIOL, V181, P7291; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Ghosh P, 2008, P NATL ACAD SCI USA, V105, P3238, DOI 10.1073/pnas.0711649105; Ghosh P, 2006, PLOS BIOL, V4, P964, DOI 10.1371/journal.pbio.0040186; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; HSU PL, 1984, NATURE, V311, P721, DOI 10.1038/311721a0; HSU PL, 1980, NATURE, V285, P85, DOI 10.1038/285085a0; Johnson RC, 2011, STRUCTURE, V19, P751, DOI 10.1016/j.str.2011.05.007; Khaleel T, 2011, MOL MICROBIOL, V80, P1450, DOI 10.1111/j.1365-2958.2011.07696.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KIKUCHI Y, 1979, P NATL ACAD SCI USA, V76, P3760, DOI 10.1073/pnas.76.8.3760; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Liu H, 2009, J NAT PROD, V72, P389, DOI 10.1021/np8006149; Morita K, 2009, MOL GENET GENOMICS, V282, P607, DOI 10.1007/s00438-009-0490-2; Morita K, 2009, FEMS MICROBIOL LETT, V297, P234, DOI 10.1111/j.1574-6968.2009.01683.x; Olorunniji FJ, 2012, P NATL ACAD SCI USA, V109, P19661, DOI 10.1073/pnas.1210964109; Rajeev L, 2009, MICROBIOL MOL BIOL R, V73, P300, DOI 10.1128/MMBR.00038-08; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; Savinov A, 2012, GENE, V495, P42, DOI 10.1016/j.gene.2011.12.003; Smith MCA, 2004, MOL MICROBIOL, V51, P1719, DOI 10.1111/j.1365-2958.2003.03942.x; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Stark WM, 2011, MOL MICROBIOL, V80, P1417, DOI 10.1111/j.1365-2958.2011.07699.x; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Xu Z, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1123; Zhang L, 2008, J BACTERIOL, V190, P6392, DOI 10.1128/JB.00777-08; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; [张霖 Zhang Lin], 2010, [中国科学：生命科学, Scientia Sinica Vitae], V40, P1090; Zhang L, 2010, J MOL CELL BIOL, V2, P264, DOI 10.1093/jmcb/mjq025	42	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80434	10.1371/journal.pone.0080434	http://dx.doi.org/10.1371/journal.pone.0080434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278283	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800073
J	Dowling, AR; Nedorezov, LB; Qiu, XL; Marino, JS; Hill, JW				Dowling, Abigail R.; Nedorezov, Laura B.; Qiu, Xiaoliang; Marino, Joseph S.; Hill, Jennifer W.			Genetic Factors Modulate the Impact of Pubertal Androgen Excess on Insulin Sensitivity and Fertility	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; LUTEINIZING-HORMONE RECEPTOR; IMPAIRED GLUCOSE-TOLERANCE; HUMAN GRANULOSA-CELLS; FAMILY-BASED ANALYSIS; 4 INBRED STRAINS; ATHEROSCLEROSIS SUSCEPTIBILITY; ANOVULATORY WOMEN; FASTING GLUCOSE; CANDIDATE GENES	Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive age women. The syndrome is caused by a combination of environmental influences and genetic predisposition. Despite extensive efforts, the heritable factors contributing to PCOS development are not fully understood. The objective of this study was to test the hypothesis that genetic background contributes to the development of a PCOS-like reproductive and metabolic phenotype in mice exposed to excess DHEA during the pubertal transition. We tested whether the PCOS phenotype would be more pronounced on the diabetes-prone C57BL/6 background than the previously used strain, BALB/cByJ. In addition, we examined strain-dependent upregulation of the expression of ovarian and extra-ovarian candidate genes implicated in human PCOS, genes containing known strain variants, and genes involved with steroidogenesis or insulin sensitivity. These studies show that there are significant strain-related differences in metabolic response to excess androgen exposure during puberty. Additionally, our results suggest the C57BL/6J strain provides a more robust and uniform experimental platform for PCOS research than the BALB/cByJ strain.	[Dowling, Abigail R.; Nedorezov, Laura B.; Qiu, Xiaoliang; Hill, Jennifer W.] Univ Toledo, Med Ctr, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA; [Hill, Jennifer W.] Univ Toledo, Med Ctr, Dept Obstet Gynecol, Toledo, OH 43606 USA; [Marino, Joseph S.] Univ N Carolina, Dept Kinesiol, Charlotte, NC 28223 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Charlotte	Hill, JW (corresponding author), Univ Toledo, Med Ctr, Dept Physiol & Pharmacol, Ctr Diabet & Endocrine Res, 2801 W Bancroft St, Toledo, OH 43606 USA.	JenniferW.Hill@utoledo.edu	Qiu, Xiaoliang/O-6171-2019; Qiu, Xiaoliang/C-5905-2016; Hill, Jennifer/AAD-8415-2019	Hill, Jennifer/0000-0001-7482-9215; Marino, Joseph/0000-0002-6207-5986	National Institute of Health (NICHD) [R00HD056491, R21HD071529]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071529] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD056491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institute of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Health (NICHD) awarded to JWH: R00HD056491 and R21HD071529 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Belgorosky D, 2010, REPROD BIOMED ONLINE, V20, P797, DOI 10.1016/j.rbmo.2010.02.012; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; Biyasheva A, 2009, J CLIN ENDOCR METAB, V94, P2617, DOI 10.1210/jc.2008-1664; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; Botcherby M, 2002, COMPAR FUNCT GENOM, V3, P319, DOI 10.1002/cfg.198; Broekmans FJ, 2006, BJOG-INT J OBSTET GY, V113, P1210, DOI 10.1111/j.1471-0528.2006.01008.x; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Calogero AE, 2011, J ENDOCRINOL INVEST, V34, P630, DOI 10.3275/7746; Chua S, 2002, DIABETOLOGIA, V45, P976, DOI 10.1007/s00125-002-0880-z; CLAYTON RN, 1992, CLIN ENDOCRINOL, V37, P127, DOI 10.1111/j.1365-2265.1992.tb02296.x; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; CUNLIFFEBEAMER TL, 1976, LAB ANIM SCI, V26, P895; Das M, 2008, J CLIN ENDOCR METAB, V93, P881, DOI 10.1210/jc.2007-1650; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; EDWARDS DA, 1971, PHYSIOL BEHAV, V6, P223, DOI 10.1016/0031-9384(71)90030-8; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Franks S, 1999, ENDOCRIN METAB CLIN, V28, P361, DOI 10.1016/S0889-8529(05)70074-8; Fueger PT, 2004, DIABETES, V53, P306, DOI 10.2337/diabetes.53.2.306; Gearhart S, 2004, COMPARATIVE MED, V54, P418; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Goodarzi MO, 2008, HUM REPROD, V23, P2842, DOI 10.1093/humrep/den324; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Hughesdon P E, 1982, Obstet Gynecol Surv, V37, P59, DOI 10.1097/00006254-198202000-00001; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; ITO Y, 1993, P NATL ACAD SCI USA, V90, P11673, DOI 10.1073/pnas.90.24.11673; Jakimiuk AJ, 2001, J CLIN ENDOCR METAB, V86, P1318, DOI 10.1210/jc.86.3.1318; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Kahsar-Miller MD, 2001, FERTIL STERIL, V75, P53, DOI 10.1016/S0015-0282(00)01662-9; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; KAMIJO T, 1994, LIFE SCI, V55, P527, DOI 10.1016/0024-3205(94)00745-4; Karakas SE, 2010, DIABETES CARE, V33, P887, DOI 10.2337/dc09-1525; KEISLER LW, 1991, BIOL REPROD, V44, P707, DOI 10.1095/biolreprod44.4.707; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; KRYSHKINA VP, 1975, GENETIKA+, V11, P68; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Liu NN, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luchetti CG, 2004, J REPROD IMMUNOL, V64, P59, DOI 10.1016/j.jri.2004.04.002; Maciel GAR, 2004, J CLIN ENDOCR METAB, V89, P5321, DOI 10.1210/jc.2004-0643; MAHESH VB, 1964, RECENT PROG HORM RES, V20, P341; MAHESH VB, 1962, J CLIN ENDOCR METAB, V22, P441, DOI 10.1210/jcem-22-4-441; Elia EM, 2009, MOL HUM REPROD, V15, P421, DOI 10.1093/molehr/gap033; MASON HD, 1994, J CLIN ENDOCR METAB, V79, P1355, DOI 10.1210/jc.79.5.1355; McNeilly AS, 2013, MOL CELL ENDOCRINOL, V373, P2, DOI 10.1016/j.mce.2012.10.007; Motta AB, 2010, J STEROID BIOCHEM, V119, P105, DOI 10.1016/j.jsbmb.2010.02.015; Munir I, 2004, ENDOCRINOLOGY, V145, P175, DOI 10.1210/en.2003-0329; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; PAIGEN B, 1987, BIOCHEM GENET, V25, P881, DOI 10.1007/BF00502607; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Pan ZX, 2012, MOL BIOL REP, V39, P10823, DOI 10.1007/s11033-012-1976-2; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; POLSON DW, 1988, LANCET, V1, P870; Qiu J, 2001, ENDOCRINOLOGY, V142, P3421, DOI 10.1210/en.142.8.3421; Rice S, 2005, HUM REPROD, V20, P373, DOI 10.1093/humrep/deh609; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; ROY S, 1962, NATURE, V196, P42, DOI 10.1038/196042a0; Sander V, 2005, NEUROIMMUNOMODULAT, V12, P285, DOI 10.1159/000087106; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Shim J, 2011, ARTERIOSCL THROM VAS, V31, P1814, DOI 10.1161/ATVBAHA.111.229674; Solano ME, 2011, J REPROD IMMUNOL, V92, P33, DOI 10.1016/j.jri.2011.09.003; STENERVICTORIN E, 2013, MOL CELL ENDOCRINOL; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; SURWIT RS, 1991, DIABETES, V40, P82, DOI 10.2337/diabetes.40.1.82; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Urbanek M, 2007, NAT CLIN PRACT ENDOC, V3, P103, DOI 10.1038/ncpendmet0400; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wang H, 2011, MOL HUM REPROD, V17, P386, DOI 10.1093/molehr/gar007; Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422; Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8; Willis D, 1996, J CLIN ENDOCR METAB, V81, P302, DOI 10.1210/jc.81.1.302; WILLIS D, 1995, J CLIN ENDOCR METAB, V80, P3788, DOI 10.1210/jc.80.12.3788; Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984; Xita N, 2010, FERTIL STERIL, V94, P250, DOI 10.1016/j.fertnstert.2009.01.147; Zhao H, 2012, HUM REPROD, V27, P294, DOI 10.1093/humrep/der379	81	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79849	10.1371/journal.pone.0079849	http://dx.doi.org/10.1371/journal.pone.0079849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278193	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100056
J	Yu, Y; Li, HT; Gao, MX; Zhang, F; Gu, CX				Yu, Yang; Li, Hai-tao; Gao, Ming-xin; Zhang, Fan; Gu, Cheng-xiong			Outcomes of Middle Cardiac Vein Arterialization via Internal Mammary/Thoracic Artery Anastomosis	PLOS ONE			English	Article							SELECTIVE ARTERIALIZATION; CORONARY VEINS; PERFUSION; DISEASE; MODEL; FLOW	Objective: Cardiac vein arterialization is seldom applied for treating right coronary artery disease. This study aimed to improve outcomes of cardiac vein arterialization in a porcine model using intramammary artery anastomosis. Methods: A chronic, stenotic coronary artery model was established in 12 of 14 Chinese experimental miniature pigs of either sex, which were randomly divided into equal control (n = 6) and experimental (n = 6) groups. In experimental animals, blood flow was reconstructed in the right coronary artery using intramammary artery. Arterialization involved dissection of right internal mammary artery from bifurcation to apex of thorax followed by end-to-side anastomosis of internal mammary artery and middle cardiac vein plus posterior descending branch of right coronary artery. Intraoperative heart rate was maintained at 110 beats/min. Graft flow assessment and echocardiography were performed when blood pressure and heart rate normalized. Results: The experimental group had significantly higher mean endocardial and epicardial blood flow postoperatively than control group (mean endocardial blood flow: 0.37 vs. 0.14 ml/(g*min), p<0.001; mean epicardial blood flow: 0.29 vs. 0.22, p = 0.014). Transmural blood flow was also higher in experimental group than in control group (0.33 vs. 0.19, p<0.001); ejection fraction increased from 0.46% at baseline to 0.51% (p = 0.0038) at 6 hours postoperatively, and mean blood flow of internal mammary artery was 44.50, perfusion index 0.73 at postoperative 6 months, 43.33 and 0.80 at 3 months. Conclusion: Successful cardiac vein arterialization via intramammary artery in a porcine model suggests that this may be a viable method for reconstructing blood flow in chronic, severe coronary artery disease.	[Yu, Yang; Li, Hai-tao; Gao, Ming-xin; Zhang, Fan; Gu, Cheng-xiong] Capital Med Univ, Beijing An Zhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Gu, CX (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	anzhengu@sina.com	yu, yang/HGC-6679-2022	Yu, Yang/0000-0002-8482-4626	National Natural Science Foundation of China [81170191]; Beijing NOVA Program [2008B61]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (No. 81170191) and the Beijing NOVA Program (No. 2008B61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vila JHA, 2011, SAO PAULO MED J, V129, P186; AREALIS EG, 1973, CHEST, V63, P462, DOI 10.1378/chest.63.3.462; Beller GA, 2011, J CARDIOVASC TRANSL, V4, P416, DOI 10.1007/s12265-011-9290-2; BHAYANA JN, 1974, J THORAC CARDIOV SUR, V67, P125; Chowdhry MF, 2005, J CARDIAC SURG, V20, P326, DOI 10.1111/j.1540-8191.2005.200489.x; Fitzgerald, 1999, Curr Interv Cardiol Rep, V1, P127; Galinanes M, 2005, REV ESP CARDIOL, V58, P1459, DOI 10.1016/S0300-8932(05)74076-8; GARDNER RS, 1974, J THORAC CARDIOV SUR, V68, P273; Harig F, 2011, COMPARATIVE MED, V61, P150; HOCHBERG MS, 1980, ANN THORAC SURG, V29, P578, DOI 10.1016/S0003-4975(10)61712-2; HOCHBERG MS, 1979, J THORAC CARDIOV SUR, V77, P1; Hochberg MS, 2002, CLIN CSI, P195; Ido A, 2001, AM J PHYSIOL-HEART C, V280, pH1361, DOI 10.1152/ajpheart.2001.280.3.H1361; Ielasi A, 2012, REV ESP CARDIOL; Isner JM, 2002, NATURE, V415, P234, DOI 10.1038/415234a; Kassab GS, 2008, J APPL PHYSIOL, V104, P1266, DOI 10.1152/japplphysiol.00063.2008; MARCO JD, 1977, ANN THORAC SURG, V23, P449, DOI 10.1016/S0003-4975(10)64165-3; Moeller CH, 2008, HEART SURG FORUM, V11; OKADA M, 1991, THORAC CARDIOV SURG, V39, P1, DOI 10.1055/s-2007-1013921; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Raake P, 2005, EUR HEART J, V26, P1228, DOI 10.1093/eurheartj/ehi136; Resetar ME, 2007, J THORAC CARDIOV SUR, V133, P1252, DOI 10.1016/j.jtcvs.2006.12.037; Sadaba JR, 2004, ANN THORAC SURG, V78, P1458, DOI 10.1016/S0003-4975(03)01654-0; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Sundt TM, 1999, ANN THORAC SURG, V68, P1272, DOI 10.1016/S0003-4975(99)00693-1; Trana C, 2011, Rev Med Suisse, V7, P1182; Yamane M, 2012, REV ESP CARDIOL, V65, P265, DOI [10.1016/j.rec.2011.12.001, 10.1016/j.recesp.2011.10.026]; Yu Y, 2011, CHINESE MED J-PEKING, V124, P3017, DOI 10.3760/cma.j.issn.0366-6999.2011.19.012	28	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80963	10.1371/journal.pone.0080963	http://dx.doi.org/10.1371/journal.pone.0080963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278355	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100130
J	Yuan, HC; Zhuang, Y; Xiong, J; Zhi, W; Liu, LR; Wei, Q; Han, P				Yuan, Haichao; Zhuang, Yue; Xiong, Ju; Zhi, Wei; Liu, Liangren; Wei, Qiang; Han, Ping			Human Umbilical Mesenchymal Stem Cells-Seeded Bladder Acellular Matrix Grafts for Reconstruction of Bladder Defects in a Canine Model	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SMALL-INTESTINAL SUBMUCOSA; BONE-MARROW; URINARY-BLADDER; STROMAL CELLS; CLINICAL-APPLICATIONS; TISSUE; CORD; DIFFERENTIATION; REGENERATION	Background: The goal of this study was to explore the feasibility of utilizing human umbilical mesenchymal stem cells (HUMSCs)-seeded Bladder acellular matrix graft (BAMG) for bladder reconstruction in a canine model. Methodology/Principal Findings: HUMSCs were isolated from newborn umbilical cords and identified by flow cytometry. Partial cystectomy was performed in the experimental and control group. Bladder defects were repaired with HUMSCs-BAMG in the experimental group and repaired with unseeded-BAMG in control group. The implanted grafts were harvested after surgery. H&E and immunohistochemistry staining were performed to evaluate the regeneration of the bladder defect. Primary cultured HUMSCs displayed typical fibroblast morphology with spindle-shaped. Flow cytometry indicated that these cells were positive for CD105 (97.3%) and CD44 (99%), but negative for CD34 (2.8%), CD31 (2.1%), and CD45 (1.7%). Immunohistochemistry staining showed that a multilayered urothelium and well-developed smooth muscle were observed at 12 weeks in experiment group. In contrast, multilayered urothelial tissues were also observed at 12 weeks in group B, but well-developed smooth muscle bundles were observed. Conclusions/Significance: Our preliminary results demonstrate that UMSC-seeded BAMGs are superior to unseeded BAMGs to promote the regeneration of bladder defects. Our findings indicated that HUMSCs may be a potential cell source for bladder tissue engineering.	[Yuan, Haichao; Liu, Liangren; Wei, Qiang; Han, Ping] Sichuan Univ, West China Hosp, Dept Urol, Chengdu 610064, Sichuan, Peoples R China; [Zhuang, Yue] Sichuan Univ, West China Hosp, Dept Rheumatol, Chengdu 610064, Sichuan, Peoples R China; [Xiong, Ju] Sichuan Univ, West China Hosp 2, Dept Gynaecol, Chengdu 610064, Sichuan, Peoples R China; [Zhi, Wei] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610064, Sichuan, Peoples R China; [Zhi, Wei] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Han, P (corresponding author), Sichuan Univ, West China Hosp, Dept Urol, Chengdu 610064, Sichuan, Peoples R China.	hanpinghxyy@163.com			National Natural Science Foundation of China [81200551, 81270841]; foundation of Sichuan province [2013SZ0034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Sichuan province	This research was supported by a grant from National Natural Science Foundation of China (81200551, 81270841) and foundation of Sichuan province (2013SZ0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Batsali AK, 2013, CURR STEM CELL RES T, V8, P144; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020; Chung SY, 2006, LANCET, V367, P1215, DOI 10.1016/S0140-6736(06)68481-X; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Duel BP, 1996, J UROLOGY, V156, P1798, DOI 10.1016/S0022-5347(01)65540-X; Fan CG, 2011, STEM CELL REV REP, V7, P195, DOI 10.1007/s12015-010-9168-8; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; GOLOMB J, 1989, UROLOGY, V34, P329, DOI 10.1016/0090-4295(89)90435-4; Han Ping, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P1009; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0; Karahuseyinoglu S, 2008, STEM CELLS, V26, P682, DOI 10.1634/stemcells.2007-0738; Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028; Liao W, 2013, TRANSPL P, V45, P730, DOI 10.1016/j.transproceed.2012.08.023; Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Orabi H, 2013, EUR UROL, V63, P531, DOI 10.1016/j.eururo.2012.07.041; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; RUBINSTEIN P, 1993, BLOOD, V81, P1679; Salem SA, 2013, J BIOMED MATER RES A, DOI [10.1002/jbm.a.34518, DOI 10.1002/JBM.A.34518)]; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Wang LM, 2009, J TISSUE ENG REGEN M, V3, P398, DOI 10.1002/term.176; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Yokoyama T, 2001, UROLOGY, V57, P826, DOI 10.1016/S0090-4295(00)01083-9; Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang H, 2012, CELL BIOCHEM FUNCT, V30, P643, DOI 10.1002/cbf.2843; Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835; Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	39	30	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80959	10.1371/journal.pone.0080959	http://dx.doi.org/10.1371/journal.pone.0080959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278354	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100129
J	Andersen, JM; Skern-Mauritzen, M; Boehme, L; Wiersma, YF; Rosing-Asvid, A; Hammill, MO; Stenson, GB				Andersen, Julie M.; Skern-Mauritzen, Mette; Boehme, Lars; Wiersma, Yolanda F.; Rosing-Asvid, Aqqalu; Hammill, Mike O.; Stenson, Garry B.			Investigating Annual Diving Behaviour by Hooded Seals (Cystophora cristata) within the Northwest Atlantic Ocean	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; DRIFT ICE WATERS; SEX-DIFFERENCES; FORAGING BEHAVIOR; LIKELIHOOD-ESTIMATION; MAXIMUM-LIKELIHOOD; SEASONAL-VARIATION; MIROUNGA-LEONINA; BODY-COMPOSITION; MARINE PREDATOR	With the exception of relatively brief periods when they reproduce and moult, hooded seals, Cystophora cristata, spend most of the year in the open ocean where they undergo feeding migrations to either recover or prepare for the next fasting period. Valuable insights into habitat use and diving behaviour during these periods have been obtained by attaching Satellite Relay Data Loggers (SRDLs) to 51 Northwest (NW) Atlantic hooded seals (33 females and 18 males) during icebound fasting periods (200422008). Using General Additive Models (GAMs) we describe habitat use in terms of First Passage Time (FPT) and analyse how bathymetry, seasonality and FPT influence the hooded seals' diving behaviour described by maximum dive depth, dive duration and surface duration. Adult NW Atlantic hooded seals exhibit a change in diving activity in areas where they spend >20 h by increasing maximum dive depth, dive duration and surface duration, indicating a restricted search behaviour. We found that male and female hooded seals are spatially segregated and that diving behaviour varies between sexes in relation to habitat properties and seasonality. Migration periods are described by increased dive duration for both sexes with a peak in May, October and January. Males demonstrated an increase in dive depth and dive duration towards May (post-breeding/pre-moult) and August-October (post-moult/pre-breeding) but did not show any pronounced increase in surface duration. Females dived deepest and had the highest surface duration between December and January (post-moult/pre-breeding). Our results suggest that the smaller females may have a greater need to recover from dives than that of the larger males. Horizontal segregation could have evolved as a result of a resource partitioning strategy to avoid sexual competition or that the energy requirements of males and females are different due to different energy expenditure during fasting periods.	[Andersen, Julie M.; Wiersma, Yolanda F.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Skern-Mauritzen, Mette] Inst Marine Res, Marine Mammal Res Dept, N-5024 Bergen, Norway; [Boehme, Lars] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Rosing-Asvid, Aqqalu] Greenland Inst Nat Resources, Nuuk, Greenland; [Hammill, Mike O.] Inst Maurice Lamontang, Dept Fisheries & Oceans, Sci Branch, Mont Joli, PQ, Canada; [Stenson, Garry B.] Northwest Atlantic Fisheries Ctr, Dept Fisheries & Oceans, Sci Branch, St John, NF, Canada	Memorial University Newfoundland; Institute of Marine Research - Norway; University of St Andrews; Greenland Institute of Natural Resources; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Andersen, JM (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	jmandersen77@gmail.com	Rosing-Asvid, Aqqalu/GRN-7660-2022; Boehme, Lars/B-6567-2009; Skern-Mauritzen, Mette/ABA-8173-2020	Boehme, Lars/0000-0003-3513-6816; Wiersma, Yolanda/0000-0003-4604-9240	Atlantic Seal Research Programme, International Governance Programme (DFO); Greenland Institute of Natural Resources; CFI; Marine Alliance for Science and Technology for Scotland (MASTS) pooling initiative; Scottish Funding Council [HR09011]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Atlantic Seal Research Programme, International Governance Programme (DFO); Greenland Institute of Natural Resources; CFI(Canada Foundation for Innovation); Marine Alliance for Science and Technology for Scotland (MASTS) pooling initiative; Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded through the Atlantic Seal Research Programme, International Governance Programme (DFO), the Greenland Institute of Natural Resources, and a CFI grant to YFW. The authors also acknowledge the support of the Marine Alliance for Science and Technology for Scotland (MASTS) pooling initiative in the completion of this study. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JM, 2013, ICES J MAR SCI, V70, P173, DOI 10.1093/icesjms/fss133; Andersen Julie M., 2009, Journal of Northwest Atlantic Fishery Science, V42, P1; Anderson D. R., 2008, MODEL BASED INFERENC; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bajzak CE, 2009, MAR ECOL PROG SER, V385, P285, DOI 10.3354/meps08015; Beck CA, 2003, J ANIM ECOL, V72, P979, DOI 10.1046/j.1365-2656.2003.00761.x; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2003, J ANIM ECOL, V72, P280, DOI 10.1046/j.1365-2656.2003.00704.x; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013816; Boily P, 1996, AM J PHYSIOL-REG I, V270, pR1051, DOI 10.1152/ajpregu.1996.270.5.R1051; BOWEN WD, 1985, CAN J ZOOL, V63, P2841, DOI 10.1139/z85-424; BOYD I, 1993, PHYSIOL ZOOL, V66, P43, DOI 10.1086/physzool.66.1.30158286; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns JM, 2007, J COMP PHYSIOL B, V177, P687, DOI 10.1007/s00360-007-0167-2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; DFO, 2006, 2006018 DFO; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Folkow LP, 1996, POLAR BIOL, V16, P179, DOI 10.1007/BF02329206; Folkow LP, 1999, POLAR BIOL, V22, P61, DOI 10.1007/s003000050391; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Grist JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048204; Hammill M.O., 2000, Journal of Northwest Atlantic Fishery Science, V26, P1, DOI 10.2960/J.v26.a1; Haug T, 2004, POLAR RES, V23, P35, DOI 10.1111/j.1751-8369.2004.tb00127.x; Haug T, 2007, MAR BIOL RES, V3, P123, DOI 10.1080/17451000701358531; Heerah K, 2013, DEEP-SEA RES PT II, V88-89, P23, DOI 10.1016/j.dsr2.2012.08.025; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; HINDELL MA, 1994, POLAR BIOL, V14, P275; Hindell M, 2008, J ANIM ECOL, V77, P847, DOI 10.1111/j.1365-2656.2008.01441.x; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kovacs KM, 1996, CAN J ZOOL, V74, P1521, DOI 10.1139/z96-166; KOVACS KM, 1992, CAN J ZOOL, V70, P1315, DOI 10.1139/z92-184; KRAMER DL, 1988, CAN J ZOOL, V66, P89, DOI 10.1139/z88-012; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lavigne D.M., 1988, HARPS HOODS ICE BREE; Le Boeuf B.J., 1993, Symposia of the Zoological Society of London, V66, P149; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; LEBOEUF BJ, 1989, CAN J ZOOL, V67, P2514; McIntyre T, 2010, POLAR BIOL, V33, P1037, DOI 10.1007/s00300-010-0782-3; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; Pepin P, 2013, DEEP-SEA RES PT I, V75, P119, DOI 10.1016/j.dsr.2013.01.012; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Potelov V, 2000, NAMMCO SCI PUBL, V2, P40, DOI 10.7557/3.2970; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; SCOTT J S, 1982, Journal of Northwest Atlantic Fishery Science, V3, P29; Sergeant D.E., 1974, Polarforschung, V44, P1; SERGEANT D E, 1976, Biological Conservation, V10, P95, DOI 10.1016/0006-3207(76)90055-0; *SERV ARG, 1996, US MAN; Shriner SA, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P529; Smyth GK, 1996, J ROY STAT SOC B MET, V58, P565; Thordarson G, 2007, POLAR BIOL, V30, P379, DOI 10.1007/s00300-006-0194-6; Thums M, 2013, J ANIM ECOL, V82, P72, DOI 10.1111/j.1365-2656.2012.02021.x; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Thums M, 2008, MAR ECOL PROG SER, V370, P249, DOI 10.3354/meps07613; Trillmich F, 2006, BEHAV ECOL SOCIOBIOL, V60, P137, DOI 10.1007/s00265-005-0150-4; Tucker S, 2009, MAR ECOL PROG SER, V384, P287, DOI 10.3354/meps08000; WOLOCK DM, 1995, WATER RESOUR RES, V31, P1315, DOI 10.1029/95WR00471; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	70	8	9	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80438	10.1371/journal.pone.0080438	http://dx.doi.org/10.1371/journal.pone.0080438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282541	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500042
J	Bilandzija, H; Ma, L; Parkhurst, A; Jeffery, WR				Bilandzija, Helena; Ma, Li; Parkhurst, Amy; Jeffery, William R.			A Potential Benefit of Albinism in Astyanax Cavefish: Downregulation of the oca2 Gene Increases Tyrosine and Catecholamine Levels as an Alternative to Melanin Synthesis	PLOS ONE			English	Article							PINK-EYED-DILUTION; REGRESSIVE EVOLUTION; BLIND CAVEFISH; PIGMENTATION; TRANSPORT; FISH; DEGENERATION; CONVERGENCE; POPULATIONS; MELANOCYTES	Albinism, the loss of melanin pigmentation, has evolved in a diverse variety of cave animals but the responsible evolutionary mechanisms are unknown. In Astyanax mexicanus, which has a pigmented surface dwelling form (surface fish) and several albino cave-dwelling forms (cavefish), albinism is caused by loss of function mutations in the oca2 gene, which operates during the first step of the melanin synthesis pathway. In addition to albinism, cavefish have evolved differences in behavior, including feeding and sleep, which are under the control of the catecholamine system. The catecholamine and melanin synthesis pathways diverge after beginning with the same substrate, L-tyrosine. Here we describe a novel relationship between the catecholamine and melanin synthesis pathways in Astyanax. Our results show significant increases in L-tyrosine, dopamine, and norepinephrine in pre-feeding larvae and adult brains of Pachon cavefish relative to surface fish. In addition, norepinephrine is elevated in cavefish adult kidneys, which contain the teleost homologs of catecholamine synthesizing adrenal cells. We further show that the oca2 gene is expressed during surface fish development but is downregulated in cavefish embryos. A key finding is that knockdown of oca2 expression in surface fish embryos delays the development of pigmented melanophores and simultaneously increases L-tyrosine and dopamine. We conclude that a potential evolutionary benefit of albinism in Astyanax cavefish may be to provide surplus L-tyrosine as a precursor for the elevated catecholamine synthesis pathway, which could be important for adaptation to the challenging cave environment.	[Bilandzija, Helena] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Bilandzija, Helena; Ma, Li; Parkhurst, Amy; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Rudjer Boskovic Institute; University System of Maryland; University of Maryland College Park	Jeffery, WR (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	Jeffery@umd.edu	Bilandzija, Helena/HHS-5554-2022	Bilandzija, Helena/0000-0002-4922-0149	NIH [R01-EY014619]; NSF [IBN-0542384]; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	NIH (R01-EY014619) and NSF (IBN-0542384) grants to WRJ supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDUS KL, 1986, J NEUROCHEM, V47, P484; Baldwin E, 1941, J EXP BIOL, V18, P136; Bilandzija H, 2012, EVOL DEV, V14, P196, DOI 10.1111/j.1525-142X.2012.00535.x; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; BOROWSKY R, 2008, EMERGING MODEL ORGAN, V1, P469; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Duboue ER, 2012, BRAIN BEHAV EVOLUT, V80, P233, DOI 10.1159/000341403; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Felice V, 2008, NEOTROP ICHTHYOL, V6, P657, DOI 10.1590/S1679-62252008000400015; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gallo ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041443; Gallo VP, 2003, INT REV CYTOL, V230, P89; GRAHAM DG, 1978, J INVEST DERMATOL, V70, P113, DOI 10.1111/1523-1747.ep12541249; Gross JB, 2013, HEREDITY, V111, P122, DOI 10.1038/hdy.2013.26; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hirobe T, 2002, J CELL PHYSIOL, V191, P162, DOI 10.1002/jcp.10085; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Huppop K., 1987, International Journal of Speleology, V16, P59; Jeffery WR, 2006, ISR J ECOL EVOL, V52, P405, DOI 10.1560/IJEE_52_3-4_405; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; Jeffery WR, 2000, DEV GENES EVOL, V210, P223, DOI 10.1007/s004270050308; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; McCauley DW, 2004, EVOL DEV, V6, P209, DOI 10.1111/j.1525-142X.2004.04026.x; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Mitchell R., 1977, MEXICAN EYELESS CHAR, P89; MONS N, 1987, J NEUROCHEM, V48, P1826, DOI 10.1111/j.1471-4159.1987.tb05743.x; MURPHY JF, 1992, J IMMUNOL METHODS, V154, P89, DOI 10.1016/0022-1759(92)90216-G; Nichkova M, 2013, J NEUROCHEM, V125, P724, DOI 10.1111/jnc.12248; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Ouyang M, 2004, J NEUROPHYSIOL, V92, P2071, DOI 10.1152/jn.00226.2004; Potterf SB, 1998, EXP CELL RES, V244, P319, DOI 10.1006/excr.1998.4173; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2012, WIRES DEV BIOL, V1, P823, DOI 10.1002/wdev.61; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Protas ME, 2011, P NATL ACAD SCI USA, V108, P5702, DOI 10.1073/pnas.1013850108; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SADOGLU P, 1957, EXPERIENTIA, V13, P394, DOI 10.1007/BF02161111; SCHEMMEL CHRISTIAN, 1967, Z MORPHOL TIERE, V61, P255, DOI 10.1007/BF00400988; SLOMINSKI A, 1988, J CELL SCI, V89, P287; Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x; Stoehr AM, 2006, FUNCT ECOL, V20, P276, DOI 10.1111/j.1365-2435.2006.01090.x; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; STRICKER EM, 1984, INT J OBESITY, V8, P39; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Strickler AG, 2011, GENETICA, V139, P383, DOI 10.1007/s10709-011-9557-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Toyofuku K, 2002, PIGM CELL RES, V15, P217, DOI 10.1034/j.1600-0749.2002.02007.x; Varatharasan N, 2009, DEV DYNAM, V238, P3056, DOI 10.1002/dvdy.22144; WILKENS H, 1988, EVOL BIOL, V23, P271; Yamamoto Y, 2009, DEV BIOL, V330, P200, DOI 10.1016/j.ydbio.2009.03.003; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	63	75	76	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80823	10.1371/journal.pone.0080823	http://dx.doi.org/10.1371/journal.pone.0080823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282555	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500057
J	Dimitrov, D; Boily, MC; Brown, ER; Hallett, TB				Dimitrov, Dobromir; Boily, Marie-Claude; Brown, Elizabeth R.; Hallett, Timothy B.			Analytic Review of Modeling Studies of ARV Based PrEP Interventions Reveals Strong Influence of Drug-Resistance Assumptions on the Population-Level Effectiveness	PLOS ONE			English	Review							TENOFOVIR DISOPROXIL FUMARATE; PREEXPOSURE PROPHYLAXIS; HIV-1 INFECTION; VAGINAL MICROBICIDES; POTENTIAL IMPACT; SEXUAL-BEHAVIOR; UNITED-STATES; AFRICA; TRANSMISSION; MEN	Background: Four clinical trials have shown that oral and topical pre-exposure prophylaxis (PrEP) based on tenofovir may be effective in preventing HIV transmission. The expected reduction in HIV transmission and the projected prevalence of drug resistance due to PrEP use vary significantly across modeling studies as a result of the broad spectrum of assumptions employed. Our goal is to quantify the influence of drug resistance assumptions on the predicted population-level impact of PrEP. Methods: All modeling studies which evaluate the impact of oral or topical PrEP are reviewed and key assumptions regarding mechanisms of generation and spread of drug-resistant HIV are identified. A dynamic model of the HIV epidemic is developed to assess and compare the impact of oral PrEP using resistance assumptions extracted from published studies. The benefits and risks associated with ten years of PrEP use are evaluated under identical epidemic, behavioral and intervention conditions in terms of cumulative fractions of new HIV infections prevented, resistance prevalence among those infected with HIV, and fractions of infections in which resistance is transmitted. Results: Published models demonstrate enormous variability in resistance-generating assumptions and uncertainty in parameter values. Depending on which resistance parameterization is used, a resistance prevalence between 2% and 44% may be expected if 50% efficacious oral PrEP is used consistently by 50% of the population over ten years. We estimated that resistance may be responsible for up to a 10% reduction or up to a 30% contribution to the fraction of prevented infections predicted in different studies. Conclusions: Resistance assumptions used in published studies have a strong influence on the projected impact of PrEP. Modelers and virologists should collaborate toward clarifying the set of resistance assumptions biologically relevant to the PrEP products which are already in use or soon to be added to the arsenal against HIV.	[Dimitrov, Dobromir; Brown, Elizabeth R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Boily, Marie-Claude; Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London, England; [Dimitrov, Dobromir] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dimitrov, D (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dobromir@scharp.org		Hallett, Timothy/0000-0002-9681-0424; Dimitrov, Dobromir/0000-0002-2842-5436; Boily, Marie-Claude/0000-0003-3919-006X	HIV Modeling Consortium; Bill and Melinda Gates Foundation; NIH [5 U01 AI068615-03]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068615, UM1AI068615] Funding Source: NIH RePORTER	HIV Modeling Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project is funded by the HIV Modeling Consortium which is supported by a grant from Bill and Melinda Gates Foundation. DD and ERB are also supported by NIH grant (5 U01 AI068615-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abbas UL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018165; ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baggaley RF, 2011, CURR OPIN HIV AIDS, V6, P131, DOI 10.1097/COH.0b013e328343ad03; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Bekker L. G., 2012, Southern African Journal of HIV Medicine, V13, P40; Boily MC, 2011, SEX TRANSM INFECT, V87, P646, DOI 10.1136/sextrans-2011-050184; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Breban R, 2006, MATH BIOSCI ENG, V3, P459; Chen FH, 2006, AIDS, V20, P1551, DOI 10.1097/01.aids.0000237372.38939.5d; Cox AP, 2011, SEX TRANSM INFECT, V87, P635, DOI 10.1136/sti.2010.046227; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dimitrov DT, 2011, J THEOR BIOL, V288, P9, DOI 10.1016/j.jtbi.2011.08.001; Dimitrov DT, 2010, STAT COMMUNICATIONS, V2; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Jeanne Marrazzo GR, 2013, C RETR OPP INF ATL G; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Karmon E, 2003, JAIDS-J ACQ IMM DEF, V34, P71, DOI 10.1097/00126334-200309010-00011; Louie M, 2003, AIDS, V17, P1151, DOI 10.1097/00002030-200305230-00006; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Prada N, 2008, JAIDS-J ACQ IMM DEF, V49, P117, DOI 10.1097/QAI.0b013e3181869a9b; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Statistics South Africa, 2010, MID POP EST; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; The HIV Modelling Consortium, 2011, POT SPREAD DRUG RES; Todd J, 2009, SEX TRANSM INFECT, V85, pI72, DOI 10.1136/sti.2008.033985; UNAIDS/WHO, 2009, AIDS EP UPD NOV 2009; Vickerman P, 2008, JAIDS-J ACQ IMM DEF, V48, P460, DOI 10.1097/QAI.0b013e31817aebd6; Vickerman P, 2006, SEX TRANSM DIS, V33, P397, DOI 10.1097/01.olq.0000218974.77208.cc; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; Williams BG, 2011, JAIDS-J ACQ IMM DEF, V58, P207, DOI 10.1097/QAI.0b013e3182253c19; Wilson DP, 2008, P NATL ACAD SCI USA, V105, P9835, DOI 10.1073/pnas.0711813105	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80927	10.1371/journal.pone.0080927	http://dx.doi.org/10.1371/journal.pone.0080927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282559	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500061
J	Salvadori, MR; Lepre, LF; Ando, RA; do Nascimento, CAO; Correa, B				Salvadori, Marcia R.; Lepre, Luiz F.; Ando, Romulo A.; Oller do Nascimento, Claudio A.; Correa, Benedito			Biosynthesis and Uptake of Copper Nanoparticles by Dead Biomass of Hypocrea lixii Isolated from the Metal Mine in the Brazilian Amazon Region	PLOS ONE			English	Article							BIOSORPTION; ADSORPTION; REMOVAL; IONS; BIOSORBENT; CADMIUM; FUNGUS; ZINC	A biological system for the biosynthesis of nanoparticles (NPs) and uptake of copper from wastewater, using dead biomass of Hypocrea lixii was analyzed and described for the first time. The equilibrium and kinetics investigation of the biosorption of copper onto dead, dried and live biomass of fungus were performed as a function of initial metal concentration, pH, temperature, agitation and inoculum volume. The high biosorption capacity was observed for dead biomass, completed within 60 min of contact, at pH 5.0, temperature of 40 degrees C and agitation speed of 150 rpm with a maximum copper biosorption of 19.0 mg g(-1). The equilibrium data were better described using the Langmuir isotherm and kinetic analysis indicated that copper biosorption follows a pseudo-second-order model. The average size, morphology and location of NPs biosynthesized by the fungus were determined by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS) and transmission electron microscopy (TEM). NPs were mainly spherical, with an average size of 24.5 nm, and were synthesized extracellularly. The X-ray diffraction (XRD) analysis confirms the presence of metallic copper particles. Infrared spectroscopy (FTIR) study revealed that the amide groups interact with the particles, which was accountable for the stability of NPs. This method further confirmed the presence of proteins as stabilizing and capping agents surrounding the copper NPs. These studies demonstrate that dead biomass of Hypocrea lixii provides an economic and technically feasible option for bioremediation of wastewater and is a potential candidate for industrial-scale production of copper NPs.	[Salvadori, Marcia R.; Correa, Benedito] Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, Sao Paulo, Brazil; [Lepre, Luiz F.; Ando, Romulo A.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil; [Oller do Nascimento, Claudio A.] Univ Sao Paulo, Dept Engn Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Salvadori, MR (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed 2, Dept Microbiol, Sao Paulo, Brazil.	mrsal@usp.br	Ando, Romulo Augusto/C-9665-2012; Nascimento, Claudio A.O./G-8565-2014	Ando, Romulo Augusto/0000-0002-3872-8094; Nascimento, Claudio A.O./0000-0001-6110-0249; Salvadori, Marcia Regina/0000-0001-6771-5447; Correa, Benedito/0000-0003-4314-0751	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/52305-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grant 2010/52305-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Iqbal, 2006, Indian J Exp Biol, V44, P73; Aizpurua J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057401; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Arland P, 2006, BIORESOURCE TECHNOL, V97, P1018, DOI 10.1016/j.biortech.2005.04.046; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; DEROME L, 1987, APPL MICROBIOL BIOT, V26, P84, DOI 10.1007/BF00282153; Du AX, 2009, WATER AIR SOIL POLL, V201, P99, DOI 10.1007/s11270-008-9930-6; Faryal R, 2006, PAK J BOT, V38, P817; FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002; Guo ZH, 2007, COMPOS SCI TECHNOL, V67, P2036, DOI 10.1016/j.compscitech.2006.11.017; Hasan SS, 2008, J NANOSCI NANOTECHNO, V8, P3191, DOI 10.1166/jnn.2008.095; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Honary S, 2012, DIG J NANOMATER BIOS, V7, P999; Kumar BN, 2011, SEP SCI TECHNOL, V46, P997, DOI 10.1080/01496395.2010.537727; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Li YM, 2008, MATER RES BULL, V43, P2380, DOI 10.1016/j.materresbull.2007.07.045; Liu YG, 2006, T NONFERR METAL SOC, V16, P681, DOI 10.1016/S1003-6326(06)60121-0; Ramanathan R, 2013, NANOSCALE, V5, P2300, DOI 10.1039/c2nr32887a; Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989; Singh AV, 2010, CURR NANOSCI, V6, P365; Srivastava S, 2006, BIORESOURCE TECHNOL, V97, P1167, DOI 10.1016/j.biortech.2005.05.012; Srivastava SK, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-70; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; Varshney R., 2012, NANO BIOMED ENG, V4, P99, DOI [10.5101/nbe.v4i2.p99-106, DOI 10.5101/NBE.V4I2.P99-106]; Veit MT, 2005, PROCESS BIOCHEM, V40, P3303, DOI 10.1016/j.procbio.2005.03.029; Vigneshwaran N, 2007, LANGMUIR, V23, P7113, DOI 10.1021/la063627p; Volesky B, 2003, HYDROMETALLURGY, V71, P179, DOI 10.1016/S0304-386X(03)00155-5; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2	30	41	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80519	10.1371/journal.pone.0080519	http://dx.doi.org/10.1371/journal.pone.0080519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282549	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500050
J	Taylor, RW; Williams, SM; Farmer, VL; Taylor, BJ				Taylor, Rachael W.; Williams, Sheila M.; Farmer, Victoria L.; Taylor, Barry J.			Changes in Physical Activity over Time in Young Children: A Longitudinal Study Using Accelerometers	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PRESCHOOL-CHILDREN; OBJECTIVE MEASUREMENT; ACTIVITY GUIDELINES; CALIBRATION; VALIDATION; TRACKING; LEVEL	Previous research has suggested that marked declines in physical activity occur during the preschool years, and across the transition into school. However, longitudinal studies using objective measures of activity have been limited by sample size and length of follow-up. The aims of this study were to determine how overall activity and time in different intensities of activity change in children followed from 3 to 7 years. Children (n = 242) wore Actical accelerometers at 3, 4, 5, 5.5, 6.5 and 7 years of age during all waking and sleeping hours for a minimum of 5 days. Time in sedentary (S), light (L), moderate (M), and vigorous (V) physical activity was determined using available cut points. Data were analyzed using a mixed model and expressed as counts per minute (cpm, overall activity) and the ratio of active time to sedentary time (LMV:S), adjusted for multiple confounders including sex, age, time worn, and weather. At 5 years, physical activity had declined substantially to around half that observed at 3 years. Although starting school was associated with a further short-term (6-month) decline in activity (cpm) in both boys (difference; 95% CI: -98; -149, -46) and girls (-124; -174, -74, both P<0.001), this proved to be relatively transient; activity levels were similar at 6-7 years as they were just prior to starting school. Boys were more physically active than girls as indicated by an overall 12% (95% CI: 2, 22%) higher ratio of active to sedentary time (P = 0.014), but the pattern of this difference did not change from 3 to 7 years. Time worn and weather variables were significant predictors of activity. In conclusion, both boys and girls show a marked decline in activity from 3 to 4 years of age, a decrease that is essentially maintained through to 7 years of age. Factors driving this marked decrease need to be determined to enable the development of targeted interventions.	[Taylor, Rachael W.; Farmer, Victoria L.] Univ Otago, Edgar Natl Ctr Diabet & Obes Res, Dept Med, Dunedin, New Zealand; [Williams, Sheila M.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Taylor, Barry J.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Taylor, RW (corresponding author), Univ Otago, Edgar Natl Ctr Diabet & Obes Res, Dept Med, Dunedin, New Zealand.	rachael.taylor@otago.ac.nz	Taylor, Barry j/G-1410-2010; Williams, Sheila/L-4028-2019	Taylor, Barry/0000-0002-6450-8677	University of Otago; Child Health Research Foundation; Dean's Bequest - AAW Jones Trust	University of Otago; Child Health Research Foundation; Dean's Bequest - AAW Jones Trust	Funding was obtained from the University of Otago, the Child Health Research Foundation, and the Dean's Bequest - AAW Jones Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph AL, 2012, J PHYS ACT HEALTH, V9, P944, DOI 10.1123/jpah.9.7.944; Aitchison J., 2003, STAT ANAL COMPOSITIO; Ball K, 2009, J PHYS ACT HEALTH, V6, P289, DOI 10.1123/jpah.6.3.289; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Bland JM, 1996, BRIT MED J, V312, P770; Bornstein DB, 2011, J SCI MED SPORT, V14, P504, DOI 10.1016/j.jsams.2011.05.007; Bornstein DB, 2011, J SCI MED SPORT, V14, P404, DOI 10.1016/j.jsams.2011.03.013; Carson V, 2010, RES Q EXERCISE SPORT, V81, P392; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; De Craemer M, 2012, OBES REV, V13, P13, DOI 10.1111/j.1467-789X.2011.00941.x; ESLIGER DW, 2005, J PHYS ACT HEALTH, V3, P366; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Jackson DM, 2003, OBES RES, V11, P420, DOI 10.1038/oby.2003.57; Janz KF, 2005, AM J PREV MED, V29, P171, DOI 10.1016/j.amepre.2005.06.001; Jauregui A, 2011, SALUD PUBLICA MEXICO, V53, P228; Kelly LA, 2007, PEDIATR EXERC SCI, V19, P51, DOI 10.1123/pes.19.1.51; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lambourne K, 2011, PEDIATR CLIN N AM, V58, P1481, DOI 10.1016/j.pcl.2011.09.004; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McKee DP, 2012, MED SCI SPORT EXER, V44, P1318, DOI 10.1249/MSS.0b013e3182464db5; McKenzie TL, 1997, RES Q EXERCISE SPORT, V68, P195, DOI 10.1080/02701367.1997.10607998; Metcalf BS, 2008, ARCH DIS CHILD, V93, P772, DOI 10.1136/adc.2007.135012; Pagels P, 2011, ACTA PAEDIATR, V100, P116, DOI 10.1111/j.1651-2227.2010.01962.x; Pate RR, 2004, PEDIATRICS, V114, P1258, DOI 10.1542/peds.2003-1088-L; Penpraze V, 2006, PEDIATR EXERC SCI, V18, P483, DOI 10.1123/pes.18.4.483; Pfeiffer KA, 2006, MED SCI SPORT EXER, V38, P152, DOI 10.1249/01.mss.0000183219.44127.e7; Pfeiffer KA, 2009, PEDIATR EXERC SCI, V21, P196, DOI 10.1123/pes.21.2.196; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Reilly JJ, 2003, OBES RES, V11, P1155, DOI 10.1038/oby.2003.158; Sigmund E, 2009, CHILD CARE HLTH DEV, V35, P376, DOI 10.1111/j.1365-2214.2009.00945.x; Skouteris H, 2012, MED J AUSTRALIA, V196, P174, DOI 10.5694/mja11.11015; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vale S, 2011, INT J PEDIATR OBES, V6, P37, DOI 10.3109/17477166.2011.613663; Vale S, 2010, J SPORT SCI, V28, P603, DOI 10.1080/02640411003702694; Yamamoto S, 2011, PREV MED, V52, P126, DOI 10.1016/j.ypmed.2010.11.014	40	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81567	10.1371/journal.pone.0081567	http://dx.doi.org/10.1371/journal.pone.0081567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282607	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500110
J	Lango-Scholey, L; Brachmann, AO; Bode, HB; Clarke, DJ				Lango-Scholey, Lea; Brachmann, Alexander O.; Bode, Helge B.; Clarke, David J.			The Expression of stlA in Photorhabdus luminescens Is Controlled by Nutrient Limitation	PLOS ONE			English	Article							GENERAL STRESS-RESPONSE; ESCHERICHIA-COLI; ANTIBIOTIC BIOSYNTHESIS; STATIONARY-PHASE; METABOLIC SWITCH; GLOBAL REGULATOR; TYRR PROTEIN; LRP; PATHOGENICITY; RESVERATROL	Photorhabdus is a genus of Gram-negative entomopathogenic bacteria that also maintain a mutualistic association with nematodes from the family Heterorhabditis. Photorhabdus has an extensive secondary metabolism that is required for the interaction between the bacteria and the nematode. A major component of this secondary metabolism is a stilbene molecule, called ST. The first step in ST biosynthesis is the non-oxidative deamination of phenylalanine resulting in the production of cinnamic acid. This reaction is catalyzed by phenylalanine-ammonium lyase, an enzyme encoded by the stlA gene. In this study we show, using a stlA-gfp transcriptional fusion, that the expression of stlA is regulated by nutrient limitation through a regulatory network that involves at least 3 regulators. We show that TyrR, a LysR-type transcriptional regulator that regulates gene expression in response to aromatic amino acids in E. coli, is absolutely required for stlA expression. We also show that stlA expression is modulated by sigma(S) and Lrp, regulators that are implicated in the regulation of the response to nutrient limitation in other bacteria. This work is the first that describes pathway-specific regulation of secondary metabolism in Photorhabdus and, therefore, our study provides an initial insight into the complex regulatory network that controls secondary metabolism, and therefore mutualism, in this model organism.	[Lango-Scholey, Lea; Clarke, David J.] Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Brachmann, Alexander O.; Bode, Helge B.] Goethe Univ, Inst Mol Biosci, Frankfurt, Germany	University College Cork; Goethe University Frankfurt	Clarke, DJ (corresponding author), Univ Coll Cork, Dept Microbiol, Cork, Ireland.	david.clarke@ucc.ie	Clarke, David J/I-7859-2014; Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909; Clarke, David/0000-0001-9082-0501; Brachmann, Alexander/0000-0002-9878-9550	Science Foundation Ireland through Research Frontiers Programme [RFP/07/GENF546]	Science Foundation Ireland through Research Frontiers Programme(Science Foundation Ireland)	This work was supported by Science Foundation Ireland with an award through the Research Frontiers Programme (RFP/07/GENF546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brachmann AO, 2012, ANGEW CHEM INT EDIT, V51, P12086, DOI 10.1002/anie.201205384; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; Chalabaev S, 2008, APPL ENVIRON MICROB, V74, P1717, DOI 10.1128/AEM.02589-07; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Ciche Todd, 2007, WormBook, P1; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Cowles KN, 2007, CELL MICROBIOL, V9, P1311, DOI 10.1111/j.1462-5822.2006.00873.x; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; EYDALLIN G, 2013, ENVIRON MICROBIOL, P15253, DOI DOI 10.1111/1462-2920.12208.PUBMED:23889812; Gaudriault S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r117; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hu K, 2000, FEMS MICROBIOL LETT, V189, P219, DOI 10.1111/j.1574-6968.2000.tb09234.x; Hu KJ, 2006, BIOORGAN MED CHEM, V14, P4677, DOI 10.1016/j.bmc.2006.01.025; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Joyce SA, 2011, ADV APPL MICROBIOL, V76, P1, DOI 10.1016/B978-0-12-387048-3.00001-5; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; Koyanagi T, 2009, BIOSCI BIOTECH BIOCH, V73, P1221, DOI 10.1271/bbb.90019; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Lango L, 2010, MOL MICROBIOL, V77, P1394, DOI 10.1111/j.1365-2958.2010.07300.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; McCann J, 2003, APPL ENVIRON MICROB, V69, P5928, DOI 10.1128/AEM.69.10.5928-5934.2003; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Polen I, 2005, J BIOTECHNOL, V115, P221, DOI 10.1016/j.jbiotec.2004.08.017; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Somvanshi VS, 2012, SCIENCE, V337, P88, DOI 10.1126/science.1216641; Spira B, 2008, MICROBIOL-SGM, V154, P2887, DOI 10.1099/mic.0.2008/018457-0; Takeuchi K, 2012, MOL PLANT MICROBE IN, V25, P1440, DOI 10.1094/MPMI-02-12-0034-R; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Traxler MF, 2011, MOL MICROBIOL, V79, P830, DOI 10.1111/j.1365-2958.2010.07498.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Watson RJ, 2005, MOL MICROBIOL, V56, P763, DOI 10.1111/j.1365-2958.2005.04574.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; XU J, 1990, APPL ENVIRON MICROB, V56, P815, DOI 10.1128/AEM.56.3.815-818.1990; Yang J, 2004, MOL MICROBIOL, V52, P243, DOI 10.1111/j.1365-2958.2003.03965.x; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	55	20	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82152	10.1371/journal.pone.0082152	http://dx.doi.org/10.1371/journal.pone.0082152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278476	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700076
J	Saastamoinen, M; Rantala, MJ				Saastamoinen, Marjo; Rantala, Markus J.			Influence of Developmental Conditions on Immune Function and Dispersal-Related Traits in the Glanville Fritillary (Melitaea cinxia) Butterfly	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; METABOLIC-RATE; DEFENSE; CRICKET; STRESS; RESTRICTION; PARASITOIDS; TEMPERATURE; RESISTANCE; MIGRATION	Organisms in the wild are constantly faced with a wide range of environmental variability, such as fluctuation in food availability. Poor nutritional conditions influence life-histories via individual resource allocation patterns, and trade-offs between competing traits. In this study, we assessed the influence of food restriction during development on the energetically expensive traits flight metabolic rate (proxy of dispersal ability), encapsulation rate (proxy of immune defence), and lifespan using the Glanville fritillary butterfly, Melitaea cinxia, as a model organism. Additionally, we examined the direct costs of flight on individual immune function, and whether those costs increase under restricted environmental conditions. We found that nutritional restriction during development enhanced adult encapsulations rate, but reduced both resting and flight metabolic rates. However, at the individual level metabolic rates were not associated with encapsulation rate. Interestingly, individuals that were forced to fly prior to the immune assays had higher encapsulation rates than individuals that had not flown, suggesting that flying itself enhances immune response. Finally, in the control group encapsulation rate correlated positively with lifespan, whereas in the nutritional restriction group there was no relationship between these traits, suggesting that the association between encapsulation rate on adult lifespan was condition-dependent. Thus stressful events during both larval development (food limitation) and adulthood (forced flight) induce increased immune response in the adult butterflies, which may allow individuals to cope with stressful events later on in life.	[Saastamoinen, Marjo] Univ Helsinki, Dept Biol Sci, Helsinki, Finland; [Rantala, Markus J.] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Helsinki; University of Turku	Saastamoinen, M (corresponding author), Univ Helsinki, Dept Biol Sci, Helsinki, Finland.	marjo.saastamoinen@helsinki.fi	Saastamoinen, Marjo/F-6576-2012	Saastamoinen, Marjo/0000-0001-7009-2527	Academy of Finland [132697, 273098]; Kone Foundation [35-3181]	Academy of Finland(Academy of Finland); Kone Foundation	The research was funded by the grants from the Academy of Finland (132697 and 273098) and Kone Foundation (35-3181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2008, J EXP BIOL, V211, P531, DOI 10.1242/jeb.013136; Adamo SA, 2006, ANIM BEHAV, V72, P235, DOI 10.1016/j.anbehav.2006.01.011; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Catalan TP, 2012, J INSECT PHYSIOL, V58, P310, DOI 10.1016/j.jinsphys.2011.10.001; Chaput-Bardy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010694; De Coster G, 2011, NATURWISSENSCHAFTEN, V98, P1049, DOI 10.1007/s00114-011-0863-3; Debeffe L, 2012, J ANIM ECOL, V81, DOI 10.1111/j.1365-2656.2012.02014.x; Downs CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2636; Fellowes MDE, 2000, HEREDITY, V84, P1, DOI 10.1046/j.1365-2540.2000.00685.x; Franke K, 2013, J EVOLUTION BIOL, V26, P517, DOI 10.1111/jeb.12064; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gupta AP, 2001, IMMUNOLOGY OF INVERT; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hanski I., 1999, METAPOPULATION ECOLO; Hanski IA, 2011, P NATL ACAD SCI USA, V108, P14397, DOI 10.1073/pnas.1110020108; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Keil S, 2001, ECOL ENTOMOL, V26, P495, DOI 10.1046/j.1365-2311.2001.00346.x; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Koella JC, 2002, EVOLUTION, V56, P1074, DOI 10.1111/j.0014-3820.2002.tb01419.x; KONIG C, 1995, P ROY SOC B-BIOL SCI, V260, P225, DOI 10.1098/rspb.1995.0084; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Laurentz M, 2012, J CHEM ECOL, V38, P116, DOI 10.1007/s10886-012-0066-1; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattila A, HERITABILITY OF FLIG; Mestre L, 2012, BEHAV ECOL, V23, P759, DOI 10.1093/beheco/ars024; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Meylan S, 2002, HORM BEHAV, V42, P319, DOI 10.1006/hbeh.2002.1827; Meylan S, 2009, J EXP ZOOL PART A, V311A, P377, DOI 10.1002/jez.533; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Nieminen M, 2004, ON THE WINGS OF CHECKERSPOTS: A MODEL SYSTEM FOR POPULATION BIOLOGY, P63; Niitepold K, 2010, J EXP BIOL, V213, P1042, DOI 10.1242/jeb.034132; Niitepold K, 2009, ECOLOGY, V90, P2223, DOI 10.1890/08-1498.1; Payne CA, 1991, MEASUREMENTS ON INSE, P201; Prokkola J, 2013, HEREDITY, V111, P89, DOI 10.1038/hdy.2013.20; Rantala MJ, 2003, BIOL J LINN SOC, V79, P503, DOI 10.1046/j.1095-8312.2003.00202.x; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Rantala MJ, 2003, FUNCT ECOL, V17, P534, DOI 10.1046/j.1365-2435.2003.00764.x; Rantala MJ, 2004, OIKOS, V107, P479, DOI 10.1111/j.0030-1299.2004.12776.x; Roff Derek, 2002, pi; Saastamoinen M, 2008, HEREDITY, V100, P39, DOI 10.1038/sj.hdy.6801056; Saastamoinen M, 2013, OECOLOGIA, V171, P93, DOI 10.1007/s00442-012-2412-y; Saastamoinen M, 2012, J EVOLUTION BIOL, V25, P2264, DOI 10.1111/j.1420-9101.2012.02602.x; Saastamoinen M, 2010, AM NAT, V176, P686, DOI 10.1086/657038; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Srygley RB, 2011, ANIM BEHAV, V81, P395, DOI 10.1016/j.anbehav.2010.11.006; Suhonen J, 2010, OECOLOGIA, V162, P541, DOI 10.1007/s00442-009-1470-2; Valtonen TM, 2010, EVOL BIOL, V37, P49, DOI 10.1007/s11692-009-9078-3; van den Heuvel J, 2013, AM NAT, V181, pE28, DOI 10.1086/668818; van Nouhuys Saskya, 2012, Insects, V3, P1236, DOI 10.3390/insects3041236; van Ooik T, 2008, CHEMOSPHERE, V71, P1840, DOI 10.1016/j.chemosphere.2008.02.014; Vilmos P, 1998, IMMUNOL LETT, V62, P59, DOI 10.1016/S0165-2478(98)00023-6; Washburn JO, 1996, NATURE, V383, P767, DOI 10.1038/383767a0; Wilson AJ, 2010, TRENDS ECOL EVOL, V25, P207, DOI 10.1016/j.tree.2009.10.002; Yang SY, 2007, ANN ZOOL FENN, V44, P89; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	62	23	23	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81289	10.1371/journal.pone.0081289	http://dx.doi.org/10.1371/journal.pone.0081289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278412	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700055
J	Breen, J; Wicker, T; Shatalina, M; Frenkel, Z; Bertin, I; Philippe, R; Spielmeyer, W; Simkova, H; Safar, J; Cattonaro, F; Scalabrin, S; Magni, F; Vautrin, S; Berges, H; Paux, E; Fahima, T; Dolezel, J; Korol, A; Feuillet, C; Keller, B				Breen, James; Wicker, Thomas; Shatalina, Margarita; Frenkel, Zeev; Bertin, Isabelle; Philippe, Romain; Spielmeyer, Wolfgang; Simkova, Hana; Safar, Jan; Cattonaro, Federica; Scalabrin, Simone; Magni, Federica; Vautrin, Sonia; Berges, Helene; Paux, Etienne; Fahima, Tzion; Dolezel, Jaroslav; Korol, Abraham; Feuillet, Catherine; Keller, Beat		Int Wheat Genome Sequencing Consor	A Physical Map of the Short Arm of Wheat Chromosome 1A	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; WEIGHT GLUTENIN LOCI; HEXAPLOID WHEAT; BARE-1 RETROTRANSPOSON; BIN MAP; GENE; GENOME; EVOLUTION; SEQUENCE; BARLEY	Bread wheat (Triticum aestivum) has a large and highly repetitive genome which poses major technical challenges for its study. To aid map-based cloning and future genome sequencing projects, we constructed a BAC-based physical map of the short arm of wheat chromosome 1A (1AS). From the assembly of 25,918 high information content (HICF) fingerprints from a 1AS-specific BAC library, 715 physical contigs were produced that cover almost 99% of the estimated size of the chromosome arm. The 3,414 BAC clones constituting the minimum tiling path were end-sequenced. Using a gene microarray containing similar to 40 K NCBI UniGene EST clusters, PCR marker screening and BAC end sequences, we arranged 160 physical contigs (97 Mb or 35.3% of the chromosome arm) in a virtual order based on synteny with Brachypodium, rice and sorghum. BAC end sequences and information from microarray hybridisation was used to anchor 3.8 Mbp of Illumina sequences from flow-sorted chromosome 1AS to BAC contigs. Comparison of genetic and synteny-based physical maps indicated that similar to 50% of all genetic recombination is confined to 14% of the physical length of the chromosome arm in the distal region. The 1AS physical map provides a framework for future genetic mapping projects as well as the basis for complete sequencing of chromosome arm 1AS.	[Breen, James; Wicker, Thomas; Shatalina, Margarita; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Frenkel, Zeev; Fahima, Tzion; Korol, Abraham] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Bertin, Isabelle; Philippe, Romain; Paux, Etienne; Feuillet, Catherine] INRA, UMR 1095, Clermont Ferrand, France; [Spielmeyer, Wolfgang] CSIRO Plant Ind, Canberra, ACT, Australia; [Simkova, Hana; Safar, Jan; Dolezel, Jaroslav] Inst Expt Bot, Ctr Region Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Cattonaro, Federica; Scalabrin, Simone; Magni, Federica] Ist Genom Applicata, Udine, Italy; [Vautrin, Sonia; Berges, Helene] INRA, CNRGV, Castanet Tolosan, France	University of Zurich; University of Haifa; INRAE; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; INRAE	Keller, B (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	bkeller@botinst.uzh.ch	Safar, Jan/G-1038-2014; Simkova, Hana/F-7734-2014; Dolezel, Jaroslav/B-7716-2008; Wicker, Thomas/Z-1978-2019; Spielmeyer, Wolfgang/M-3254-2018; philippe, romain/AAG-4932-2021; Breen, Jimmy/HHZ-1361-2022; Keller, Beat/K-3093-2019; Frenkel, Zeev/A-5589-2019	Simkova, Hana/0000-0003-4159-7619; Dolezel, Jaroslav/0000-0002-6263-0492; Spielmeyer, Wolfgang/0000-0002-5115-7820; Keller, Beat/0000-0003-2379-9225; BERGES, Helene/0000-0002-5492-1062; Paux, Etienne/0000-0002-3094-7129; , Thomas/0000-0002-6777-7135; Fahima, Tzion/0000-0001-5555-0040; Frenkel, Zeev/0000-0003-0211-6966; Breen, James/0000-0001-6184-0925	University of Zurich; European Community [FP7-212019]	University of Zurich; European Community(European Commission)	The research leading to these results received funding from the University of Zurich and the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement FP7-212019 (Triticeae Genome). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Breen J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-98; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Ding Y, 2001, GENOMICS, V74, P142, DOI 10.1006/geno.2001.6547; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; DUBCOVSKY J, 1995, P NATL ACAD SCI USA, V92, P6645, DOI 10.1073/pnas.92.14.6645; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Frenkel Z, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-584; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; GILL KS, 1991, GENETICS, V129, P257; Gill KS, 1996, GENETICS, V143, P1001; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Janda J, 2006, PLANT J, V47, P977, DOI 10.1111/j.1365-313X.2006.02840.x; Kalavacharla V, 2006, GENETICS, V173, P1089, DOI 10.1534/genetics.106.056481; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Lazo GR, 2004, GENETICS, V168, P585, DOI 10.1534/genetics.104.034777; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; McFadden HG, 2006, THEOR APPL GENET, V113, P987, DOI 10.1007/s00122-006-0358-3; Middleton CP, 2012, PLANT J; NELSON JC, 1995, GENETICS, V141, P721; Nelson W, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp034; Nelson WM, 2005, PLANT PHYSIOL, V139, P27, DOI 10.1104/pp.105.061978; Ozdemir N, 2005, GENOME, V48, P401, DOI 10.1139/G05-005; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Paux E, 2008, FUNCT INTEGR GENOMIC, V8, P29, DOI 10.1007/s10142-007-0068-1; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Peng JH, 2004, GENETICS, V168, P609, DOI 10.1534/genetics.104.034793; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Ronin Y, 2012, G3-GENES GENOM GENET, V2, P537, DOI 10.1534/g3.112.002428; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Rustenholz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-714; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Scalabrin S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-127; Shatalina M, 2013, PLANT BIOTECHNOL J, V11, P23, DOI 10.1111/pbi.12003; Simkova H, 2003, BIOL PLANTARUM, V46, P369, DOI 10.1023/A:1024322001786; Simkova H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/302543; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; Soleimani VD, 2006, GENOME, V49, P389, DOI 10.1139/G05-119; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Spielmeyer W, 2004, THEOR APPL GENET, V109, P1303, DOI 10.1007/s00122-004-1745-2; Vicient CM, 1999, GENETICA, V107, P53, DOI 10.1023/A:1003929913398; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vrana J, 2000, GENETICS, V156, P2033; Wang ZN, 2010, FUNCT INTEGR GENOMIC, V10, P241, DOI 10.1007/s10142-009-0150-y; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2001, PLANT J, V26, P307, DOI 10.1046/j.1365-313X.2001.01028.x; Wicker T, 2007, GENETICS, V177, P1207, DOI 10.1534/genetics.107.077354; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Xue SL, 2008, THEOR APPL GENET, V117, P181, DOI 10.1007/s00122-008-0764-9; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494	70	26	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80272	10.1371/journal.pone.0080272	http://dx.doi.org/10.1371/journal.pone.0080272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278269	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327539800070
J	Burress, ED; Duarte, A; Serra, WS; Loueiro, M; Gangloff, MM; Siefferman, L				Burress, Edward D.; Duarte, Alejandro; Serra, Wilson S.; Loueiro, Marcelo; Gangloff, Michael M.; Siefferman, Lynn			Functional Diversification within a Predatory Species Flock	PLOS ONE			English	Article							CICHLID FISHES; SYMPATRIC SPECIATION; TELEOSTEI CICHLIDAE; STABLE-ISOTOPES; SELECTION; DIFFERENTIATION; CONVERGENCE; DIVERGENCE; LIKELIHOOD; MORPHOLOGY	Ecological speciation is well-known from adaptive radiations in cichlid fishes inhabiting lentic ecosystems throughout the African rift valley and Central America. Here, we investigate the ecological and morphological diversification of a recently discovered lotic predatory Neotropical cichlid species flock in subtropical South America. We document morphological and functional diversification using geometric morphometrics, stable C and N isotopes, stomach contents and character evolution. This species flock displays species-specific diets and skull and pharyngeal jaw morphology. Moreover, this lineage appears to have independently evolved away from piscivory multiple times and derived forms are highly specialized morphologically and functionally relative to ancestral states. Ecological speciation played a fundamental role in this radiation and our data reveal novel conditions of ecological speciation including a species flock that evolved: 1) in a piscivorous lineage, 2) under lotic conditions and 3) with pronounced morphological novelties, including hypertrophied lips that appear to have evolved rapidly.	[Burress, Edward D.; Gangloff, Michael M.; Siefferman, Lynn] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Duarte, Alejandro; Serra, Wilson S.; Loueiro, Marcelo] Fac Ciencias, Dept Ecol & Evoluc, Secc Zool Vertebrados, Montevideo, Uruguay; [Serra, Wilson S.; Loueiro, Marcelo] Museo Nacl Hist Nat, Dept Zool, Secc Ictiol, Montevideo, Uruguay	University of North Carolina; Appalachian State University; Universidad de la Republica, Uruguay	Burress, ED (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	edb0014@auburn.edu	; Serra Alanis, Wilson Sebastian/B-9857-2017	Gangloff, Michael/0000-0003-4689-1120; Serra Alanis, Wilson Sebastian/0000-0003-0032-9335	Paul V. Loiselle Conservation Fund; Office of Student Research at Appalachian State University; Sigma Xi	Paul V. Loiselle Conservation Fund; Office of Student Research at Appalachian State University; Sigma Xi	This research was funded by the Paul V. Loiselle Conservation Fund, the Office of Student Research at Appalachian State University, and Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bethea F, 2007, BUNTBARSCHE B, V239, P4; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Burress ED, 2013, J FISH BIOL, V82, P1904, DOI 10.1111/jfb.12117; Burress ED, 2013, ECOL FRESHW FISH, V22, P66, DOI 10.1111/eff.12002; Burress ED, 2013, HYDROBIOLOGIA, V702, P5, DOI 10.1007/s10750-012-1290-y; Collar DC, 2009, EVOLUTION, V63, P1557, DOI 10.1111/j.1558-5646.2009.00626.x; Coyne J.A., 2004, SPECIATION; de Lucena CAS, 2007, NEOTROP ICHTHYOL, V5, P449, DOI 10.1590/S1679-62252007000400004; Elmer KR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-60; Geiger MF, 2010, MOL PHYLOGENET EVOL, V56, P1011, DOI 10.1016/j.ympev.2010.05.015; Gibran F. Z., 2001, BIOTA NEOTROP, V1, P1, DOI DOI 10.1590/S1676-06032001000100007; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Horstkotte J, 2005, BIOL J LINN SOC, V85, P125, DOI 10.1111/j.1095-8312.2005.00476.x; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Johansson J, 2004, OIKOS, V105, P595, DOI 10.1111/j.0030-1299.2004.12938.x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kullander SO, 2010, J ZOOL SYST EVOL RES, V10, P439; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Lopez-Fernandez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033997; LOWE-MCCONNELL R H, 1969, Zoological Journal of the Linnean Society, V48, P255, DOI 10.1111/j.1096-3642.1969.tb00714.x; LUCENA CAS, 1992, ICHTHYOL EXPLOR FRES, V3, P97; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin RA, 2009, AM NAT, V174, P268, DOI 10.1086/600090; MITTELBACH GG, 1984, ECOLOGY, V65, P499, DOI 10.2307/1941412; Montana CG, 2013, BIOL J LINN SOC, V109, P146, DOI 10.1111/bij.12021; Montana CG, 2009, NEOTROP ICHTHYOL, V7, P267, DOI 10.1590/S1679-62252009000200019; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pialek L, 2012, MOL PHYLOGENET EVOL, V62, P46, DOI 10.1016/j.ympev.2011.09.006; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; REIS R E, 1988, Revista Brasileira de Zoologia, V4, P259; Rohlf F.J., 2010, TPSRELW THIN PLATE S; Roy D, 2007, MOL ECOL, V16, P35, DOI 10.1111/j.1365-294X.2006.03106.x; Rudnick D, 2005, FRESHWATER BIOL, V50, P1323, DOI 10.1111/j.1365-2427.2005.01398.x; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; Schliewen Uli, 2005, P58; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Serra Wilson S., 2011, Check List, V7, P357; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919	50	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80929	10.1371/journal.pone.0080929	http://dx.doi.org/10.1371/journal.pone.0080929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278349	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800092
J	Fuhrer, R; Hofmann, S; Hild, N; Vetsch, JR; Herrmann, IK; Grass, RN; Stark, WJ				Fuhrer, Roland; Hofmann, Sandra; Hild, Nora; Vetsch, Jolanda R.; Herrmann, Inge K.; Grass, Robert N.; Stark, Wendelin J.			Pressureless Mechanical Induction of Stem Cell Differentiation Is Dose and Frequency Dependent	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; BONE-MARROW; TISSUE; CHONDROGENESIS; THERAPY; GROWTH; REPAIR; FATE; NANOPARTICLES; ARCHITECTURE	Movement is a key characteristic of higher organisms. During mammalian embryogenesis fetal movements have been found critical to normal tissue development. On the single cell level, however, our current understanding of stem cell differentiation concentrates on inducing factors through cytokine mediated biochemical signaling. In this study, human mesenchymal stem cells and chondrogenesis were investigated as representative examples. We show that pressureless, soft mechanical stimulation precipitated by the cyclic deformation of soft, magnetic hydrogel scaffolds with an external magnetic field, can induce chondrogenesis in mesenchymal stem cells without any additional chondrogenesis transcription factors (TGF-beta 1 and dexamethasone). A systematic study on the role of movement frequency revealed a classical dose-response relationship for human mesenchymal stem cells differentiation towards cartilage using mere mechanical stimulation. This effect could even be synergistically amplified when exogenous chondrogenic factors and movement were combined.	[Fuhrer, Roland; Hild, Nora; Grass, Robert N.; Stark, Wendelin J.] Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland; [Hofmann, Sandra; Vetsch, Jolanda R.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Herrmann, Inge K.] Univ Zurich Hosp, Inst Anaesthesiol, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Stark, WJ (corresponding author), Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	wendelin.stark@chem.ethz.ch	Hofmann, Sandra/F-2832-2010; Stark, Wendelin J./A-8680-2008; Herrmann, Inge/H-6318-2018	Hofmann, Sandra/0000-0002-2568-8388; Herrmann, Inge/0000-0002-3018-6796; Vetsch, Jolanda Rita/0000-0003-4134-2691; Grass, Robert N/0000-0001-6968-0823	ETH Zurich	ETH Zurich(ETH Zurich)	Financial support by ETH Zurich is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008; Finger AR, 2007, TISSUE ENG, V13, P1151, DOI 10.1089/ten.2006.0290; Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091; Galle J, 2010, CURR MED CHEM, V17, P2274, DOI 10.2174/092986710791331095; Gong Z, 2009, TISSUE ENG PT A, V15, P319, DOI 10.1089/ten.tea.2008.0161; Grass RN, 2006, J MATER CHEM, V16, P1825, DOI 10.1039/b601013j; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Grossi A, 2007, J BIOMECH, V40, P3354, DOI 10.1016/j.jbiomech.2007.05.007; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Herrmann IK, 2010, SMALL, V6, P1388, DOI 10.1002/smll.201000438; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Langelaan MLP, 2011, J TISSUE ENG REGEN M, V5, P529, DOI 10.1002/term.345; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Li Z, 2010, TISSUE ENG PT A, V16, P575, DOI [10.1089/ten.tea.2009.0262, 10.1089/ten.TEA.2009.0262]; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002; Masuda T, 2008, J BIOTECHNOL, V133, P231, DOI 10.1016/j.jbiotec.2007.08.007; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; Mayer-Wagner S, 2011, BIOELECTROMAGNETICS, V32, P283, DOI 10.1002/bem.20633; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; Michalopoulos E, 2012, TISSUE ENG PART C-ME, V18, P252, DOI [10.1089/ten.tec.2011.0347, 10.1089/ten.TEC.2011.0347]; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Nagel-Heyer S, 2005, BIOPROC BIOSYST ENG, V27, P273, DOI 10.1007/s00449-005-0419-z; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; OHTA A, 1987, J RHEUMATOL, V14, P1139; Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Potier E, 2010, J BIOMECH, V43, P807, DOI 10.1016/j.jbiomech.2009.11.019; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Reger Roxanne L., 2008, V449, P93, DOI 10.1007/978-1-60327-169-1_7; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Rogers BA, 2006, J BONE JOINT SURG BR, V88B, P1670, DOI 10.1302/0301-620X.88B12.18132; ROODENBURG PJ, 1991, EARLY HUM DEV, V25, P19, DOI 10.1016/0378-3782(91)90203-F; SCHILLING F, 1973, Z RHEUMAFORSCH, V32, P375; Shintani N, 2011, Eur Cell Mater, V22, P302; Snow WB, 1943, NEW ENGL J MED, V229, P959; Toyoda T, 1998, CLIN ORTHOP RELAT R, P247; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Vunjak-Novakovic G, 2011, CELL STEM CELL, V8, P252, DOI 10.1016/j.stem.2011.02.014; Weber W, 2009, J BIOTECHNOL, V141, P118, DOI 10.1016/j.jbiotec.2009.02.023	53	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81362	10.1371/journal.pone.0081362	http://dx.doi.org/10.1371/journal.pone.0081362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278427	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800125
J	Alam, FM; Bateman, C; Turner, CE; Wiles, S; Sriskandan, S				Alam, Faraz M.; Bateman, Colin; Turner, Claire E.; Wiles, Siouxsie; Sriskandan, Shiranee			Non-Invasive Monitoring of Streptococcus pyogenes Vaccine Efficacy Using Biophotonic Imaging	PLOS ONE			English	Article							LYMPHOID-TISSUE; EXPRESSION; SPYCEP; IMMUNIZATIONS; INFECTION; PROTEINS; SYSTEM; GROWTH	Streptococcus pyogenes infection of the nasopharynx represents a key step in the pathogenic cycle of this organism and a major focus for vaccine development, requiring robust models to facilitate the screening of potentially protective antigens. One antigen that may be an important target for vaccination is the chemokine protease, SpyCEP, which is cell surface-associated and plays a role in pathogenesis. Biophotonic imaging (BPI) can non-invasively characterize the spatial location and abundance of bioluminescent bacteria in vivo. We have developed a bioluminescent derivative of a pharyngeal S. pyogenes strain by transformation of an emm75 clinical isolate with the luxABCDE operon. Evaluation of isogenic recombinant strains in vitro and in vivo confirmed that bioluminescence conferred a growth deficit that manifests as a fitness cost during infection. Notwithstanding this, bioluminescence expression permitted non-invasive longitudinal quantitation of S. pyogenes within the murine nasopharynx albeit with a detection limit corresponding to approximately 105 bacterial colony forming units (CFU) in this region. Vaccination of mice with heat killed streptococci, or with SpyCEP led to a specific IgG response in the serum. BPI demonstrated that both vaccine candidates reduced S. pyogenes bioluminescence emission over the course of nasopharyngeal infection. The work suggests the potential for BPI to be used in the non-invasive longitudinal evaluation of potential S. pyogenes vaccines.	[Alam, Faraz M.; Bateman, Colin; Turner, Claire E.; Wiles, Siouxsie; Sriskandan, Shiranee] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Wiles, Siouxsie] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	Imperial College London; University of Auckland	Wiles, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.	s.wiles@auckland.ac.nz; s.sriskandan@imperial.ac.uk	Wiles, Siouxsie/E-1690-2011; Turner, Claire/H-8142-2019	Wiles, Siouxsie/0000-0002-0467-0015; Turner, Claire/0000-0002-4458-9748; Sriskandan, Shiranee/0000-0002-5214-4941; Alam, Faraz/0000-0003-3738-0409	National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs); Biotechnology and Biological Sciences Research Council (BBSRC) via the Centre for Integrative Mammalian Physiology and Pharmacology; UK CRC; BBSRC [BB/E52708X/1] Funding Source: UKRI; MRC [G0800777] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; Medical Research Council [G0800777] Funding Source: researchfish; National Centre for the Replacement [G0800720/1] Funding Source: researchfish	National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Biotechnology and Biological Sciences Research Council (BBSRC) via the Centre for Integrative Mammalian Physiology and Pharmacology(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK CRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by the National Centre for Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and the Biotechnology and Biological Sciences Research Council (BBSRC) via the Centre for Integrative Mammalian Physiology and Pharmacology. SS and CET acknowledge the UK CRC for additional funding to the Centre for Infection Prevention and Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061655; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Beard SJ, 2002, ANTIMICROB AGENTS CH, V46, P538, DOI 10.1128/AAC.46.2.538-542.2002; Bensi G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015693; Beyer-Sehlmeyer G, 2005, INT J MED MICROBIOL, V295, P161, DOI 10.1016/j.ijmm.2005.02.010; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; La Rosa SL, 2012, APPL ENVIRON MICROB, V78, P7003, DOI 10.1128/AEM.02018-12; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Park HS, 2005, INFECT IMMUN, V73, P7878, DOI 10.1128/IAI.73.12.7878-7886.2005; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Riedel CU, 2007, APPL ENVIRON MICROB, V73, P3091, DOI 10.1128/AEM.02940-06; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Russell WMS., 1959, MED J AUSTRALIA; Schulze K, 2003, VACCINE, V21, P1958, DOI 10.1016/S0264-410X(02)00803-4; Sheel M, 2010, CLIN VACCINE IMMUNOL, V17, P127, DOI 10.1128/CVI.00256-09; Sriskandan S, 1999, MOL MICROBIOL, V33, P778, DOI 10.1046/j.1365-2958.1999.01525.x; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Turner CE, 2009, VACCINE, V27, P4923, DOI 10.1016/j.vaccine.2009.06.042; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; van der Meer JR, 2004, ENVIRON MICROBIOL, V6, P1005, DOI 10.1111/j.1462-2920.2004.00655.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	30	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e82123	10.1371/journal.pone.0082123	http://dx.doi.org/10.1371/journal.pone.0082123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278474	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327313100167
J	Buriankova, I; Brablcova, L; Mach, V; Dvorak, P; Chaudhary, PP; Rulik, M				Buriankova, Iva; Brablcova, Lenka; Mach, Vaclav; Dvorak, Petr; Chaudhary, Prem Prashant; Rulik, Martin			Identification of Methanogenic archaea in the Hyporheic Sediment of Sitka Stream	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; A MCRA GENES; COMMUNITY STRUCTURE; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; METHANE PRODUCTION; ORGANIC-CARBON; GRAVEL BAR; DIVERSITY; BACTERIAL	Methanogenic archaea produce methane as a metabolic product under anoxic conditions and they play a crucial role in the global methane cycle. In this study molecular diversity of methanogenic archaea in the hyporheic sediment of the lowland stream Sitka (Olomouc, Czech Republic) was analyzed by PCR amplification, cloning and sequencing analysis of the methyl coenzyme M reductase alpha subunit (mcrA) gene. Sequencing analysis of 60 clones revealed 24 different mcrA phylotypes from hyporheic sedimentary layers to a depth of 50 cm. Phylotypes were affiliated with Methanomicrobiales, Methanosarcinales and Methanobacteriales orders. Only one phylotype remains unclassified. The majority of the phylotypes showed higher affiliation with uncultured methanogens than with known methanogenic species. The presence of relatively rich assemblage of methanogenic archaea confirmed that methanogens may be an important component of hyporheic microbial communities and may affect CH4 cycling in rivers.	[Buriankova, Iva; Brablcova, Lenka; Mach, Vaclav; Chaudhary, Prem Prashant; Rulik, Martin] Palacky Univ, Fac Sci, Lab Aquat Microbial Ecol, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic; [Dvorak, Petr] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Buriankova, I (corresponding author), Palacky Univ, Fac Sci, Lab Aquat Microbial Ecol, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic.	ivaburiankova@seznam.cz	Dvorak, Petr/AAC-7610-2020	Dvorak, Petr/0000-0003-0101-9566; Chaudhary, Prem Prashant/0000-0002-3467-8608	Czech Grant Agency [526/09/1639]	Czech Grant Agency(Grant Agency of the Czech Republic)	This work was supported by the Czech Grant Agency grant 526/09/1639 (http://www.gacr.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff F, 2010, CHEMOSPHERE, V80, P286, DOI 10.1016/j.chemosphere.2010.04.004; Amalfitano S, 2008, J MICROBIOL METH, V75, P237, DOI 10.1016/j.mimet.2008.06.004; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Biderre-Petit C, 2011, FEMS MICROBIOL ECOL, V77, P533, DOI 10.1111/j.1574-6941.2011.01134.x; Bjerkan G, 2009, ACTA ORTHOP, V80, P245, DOI 10.3109/17453670902947457; BRETSCHKO G, 1986, STYGOLOGIA, V2, P297; Buriankova I, 2012, FUND APPL LIMNOL, V181, P87, DOI 10.1127/1863-9135/2012/0283; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; Chan OC, 2005, ENVIRON MICROBIOL, V7, P1139, DOI 10.1111/j.1462-2920.2005.00790.x; Chaudhary PP, 2013, APPL MICROBIOL BIOT, V97, P7553, DOI 10.1007/s00253-013-5102-8; Chaudhary PP, 2012, GENE, V493, P13, DOI 10.1016/j.gene.2011.11.041; Chaudhary PP, 2011, J MICROBIOL, V49, P558, DOI 10.1007/s12275-011-1052-y; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P2341; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V1, P61; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; Conrad R, 2008, GLOBAL CHANGE BIOL, V14, P657, DOI 10.1111/j.1365-2486.2007.01516.x; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Dhillon A, 2005, APPL ENVIRON MICROB, V71, P4592, DOI 10.1128/AEM.71.8.4592-4601.2005; Earl J, 2003, MICROBIAL ECOL, V46, P270, DOI 10.1007/s00248-003-2003-x; Fazi S, 2005, ENVIRON MICROBIOL, V7, P1633, DOI 10.1111/j.1462-2920.2005.00857.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenchel T, 1998, BACTERIAL BIOCH ECOP; Ganzert L, 2007, FEMS MICROBIOL ECOL, V59, P476, DOI 10.1111/j.1574-6941.2006.00205.x; GARCIA JL, 1990, FEMS MICROBIOL LETT, V87, P297, DOI 10.1111/j.1574-6968.1990.tb04928.x; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hedderich R, 2005, PROKARYOTES EVOLVING, P1050; Hlavacova E, 2006, ARCH HYDROBIOL, V165, P339, DOI 10.1127/0003-9136/2006/0165-0339; Hlavacova E, 2005, RIVER RES APPL, V21, P1003, DOI 10.1002/rra.866; Hunger S, 2011, APPL ENVIRON MICROB, V77, P3773, DOI 10.1128/AEM.00282-11; Jeanthon C, 1999, INT J SYST BACTERIOL, V49, P583, DOI 10.1099/00207713-49-2-583; Jones JB, 1995, BIOGEOCHEMISTRY, V31, P155, DOI 10.1007/BF00004047; Juottonen H, 2006, RES MICROBIOL, V157, P914, DOI 10.1016/j.resmic.2006.08.006; Juottonen H, 2012, APPL ENVIRON MICROB, V78, P6386, DOI 10.1128/AEM.00261-12; Jupraputtasri W, 2005, J MICROBIOL METH, V61, P95, DOI 10.1016/j.mimet.2004.11.017; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Kemnitz D, 2004, ENVIRON MICROBIOL, V6, P449, DOI 10.1111/j.1462-2920.2004.00573.x; Kobabe S, 2004, FEMS MICROBIOL ECOL, V50, P13, DOI 10.1016/j.femsec.2004.05.003; Kotsyurbenko OR, 2007, APPL ENVIRON MICROB, V73, P2344, DOI 10.1128/AEM.02413-06; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Leichtfried M, 1988, VERH INT VEREIN LIMN, V23, P1325, DOI DOI 10.1080/03680770.1987.11898016-; Lin CZ, 1997, FEMS MICROBIOL ECOL, V22, P281, DOI 10.1111/j.1574-6941.1997.tb00380.x; Lu Z, 2012, J BACTERIOL, V194, P2398, DOI 10.1128/JB.00207-12; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; MEYER JL, 1981, ARCH HYDROBIOL, V91, P28; Milferstedt K, 2004, ENVIRON MICROBIOL, V6, P449, DOI [10.1111/j.1462-2920.2004.00573.x, DOI 10.1111/J.1462-2920.2004.00573.X.PUBMED:15049918]; Miyamoto K., 1997, FAO AGR SERVICES B, P128; Nogaro G, 2010, FRESHWATER BIOL, V55, P1288, DOI 10.1111/j.1365-2427.2009.02352.x; Noll M, 2010, FEMS MICROBIOL ECOL, V73, P215, DOI 10.1111/j.1574-6941.2010.00883.x; Paul K, 2012, APPL ENVIRON MICROB, V78, P8245, DOI 10.1128/AEM.02193-12; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; Rastogi G, 2008, BIORESOURCE TECHNOL, V99, P5317, DOI 10.1016/j.biortech.2007.11.024; Rastogi G, 2011, MICROB ECOL, V62, P1, DOI 10.1007/s00248-011-9810-2; Rulik M, 2004, SOIL BIOL BIOCHEM, V36, P1653, DOI 10.1016/j.soilbio.2004.07.005; Rulik M, 2013, BIOMASS NOW CULTIVAT, P395, DOI DOI 10.5772/3437; Rulik Martin, 2000, Limnologica, V30, P359, DOI 10.1016/S0075-9511(00)80029-8; Sanders IA, 2007, FRESHWATER BIOL, V52, P1176, DOI 10.1111/j.1365-2427.2007.01745.x; Santmire JA, 2006, ARCH HYDROBIOL, V166, P491, DOI 10.1127/0003-9136/2006/0166-0491; Schindler JE, 1998, BIOGEOCHEMISTRY, V43, P157, DOI 10.1023/A:1006005311257; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Sheppard SK, 2005, APPL SOIL ECOL, V28, P147, DOI 10.1016/j.apsoil.2004.07.004; Smith JM, 2007, APPL ENVIRON MICROB, V73, P4135, DOI 10.1128/AEM.02557-06; Steinberg LM, 2009, APPL ENVIRON MICROB, V75, P4435, DOI 10.1128/AEM.02858-08; Stolyar S, 1999, MICROBIOL-UK, V145, P1235, DOI 10.1099/13500872-145-5-1235; SUGIMOTO A, 1995, GEOCHIM COSMOCHIM AC, V59, P1329, DOI 10.1016/0016-7037(95)00047-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trulleyova S, 2003, ARCH HYDROBIOL, V158, P407, DOI 10.1127/0003-9136/2003/0158-0407; Wilcock RJ, 2008, WATER AIR SOIL POLL, V188, P155, DOI 10.1007/s11270-007-9532-8; Zhang GS, 2008, ENVIRON MICROBIOL, V10, P1850, DOI 10.1111/j.1462-2920.2008.01606.x	74	21	21	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80804	10.1371/journal.pone.0080804	http://dx.doi.org/10.1371/journal.pone.0080804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278322	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100113
J	de Hevia, MD; Spelke, ES				de Hevia, Maria Dolores; Spelke, Elizabeth S.			Not All Continuous Dimensions Map Equally: Number-Brightness Mapping in Human Infants	PLOS ONE			English	Article							6-MONTH-OLD INFANTS; REPRESENTATION; DISCRIMINATION; MAGNITUDE; SPACE; TIME; MODEL; SIZE	Evidence for spontaneous mappings between the dimensions of number and length, time and length, and number and time, has been recently described in preverbal infants. It is unclear, however, whether these abilities reflect the existence of privileged mappings between certain quantitative dimensions, like number, space and time, or instead the existence of a magnitude system underlying the representation of any quantitative dimension, and allowing mappings across those dimensions. Four experiments, using the same methods from previous research that revealed a number-length mapping in eight-month-old infants, investigated whether infants of the same age establish mappings between number and a different, non-spatial continuous dimension: level of brightness. We show that infants are able to learn and productively use mappings between brightness and number when they are positively related, i.e., larger numbers paired with brighter or higher contrast levels, and fail when they are inversely related, i.e., smaller numbers paired with brighter or higher contrast levels, suggesting that they are able to learn this mapping in a specific direction. However, infants not only do not show any baseline preference for any direction of the number-brightness mapping, but fail at transferring the discrimination from one dimension (number) to the other (brightness). Although infants can map multiple dimensions to one another, the number-length mapping may be privileged early in development, as it is for adults.	[de Hevia, Maria Dolores] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France; [de Hevia, Maria Dolores] INSERM, Cognit NeuroImaging Unit, U992, NeuroSpin, Gif Sur Yvette, France; [Spelke, Elizabeth S.] Harvard Univ, Lab Dev Studies, Cambridge, MA 02138 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Harvard University	de Hevia, MD (corresponding author), Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France.	dehevialola@gmail.com			NIH [HD 23103]; Marie Curie Intra-European Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023103] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023103] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie Intra-European Fellowship(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH grant HD 23103 to ESS. MDdH was supported by a Marie Curie Intra-European Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKS WP, 1977, J EXP PSYCHOL HUMAN, V3, P278, DOI 10.1037/0096-1523.3.2.278; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Brannon EM, 2006, DEVELOPMENTAL SCI, V9, pF59, DOI 10.1111/j.1467-7687.2006.00530.x; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Castronovo J, 2007, Q J EXP PSYCHOL, V60, P101, DOI 10.1080/17470210600598635; Kadosh RC, 2006, EXP PSYCHOL, V53, P87, DOI 10.1027/1618-3769.53.2.87; de Hevia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035530; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Deroy O, 2013, NEUROSCI BIOBEHAV R, V37, P1240, DOI 10.1016/j.neubiorev.2013.04.001; Fias W, 2001, COGNITIVE BRAIN RES, V12, P415, DOI 10.1016/S0926-6410(01)00078-7; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fiser J, 2002, P NATL ACAD SCI USA, V99, P15822, DOI 10.1073/pnas.232472899; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gebuis T, 2011, ATTEN PERCEPT PSYCHO, V73, P259, DOI 10.3758/s13414-010-0002-9; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Girelli L, 2000, J EXP CHILD PSYCHOL, V76, P104, DOI 10.1006/jecp.2000.2564; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; JOHNSON DM, 1939, ARCH PSYCHOL, V34, P1; Lammertyn J., 2002, CORTEX, V38, P878, DOI [DOI 10.1016/S0010-9452(08)70061-3, 10.1016/S0010-9452(08)70061-3]; LEVIN I, 1977, CHILD DEV, V48, P435, DOI 10.2307/1128636; LEWKOWICZ DJ, 1980, DEV PSYCHOL, V16, P597; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nunez R, 2011, COGNITION, V120, P225, DOI 10.1016/j.cognition.2011.05.001; Piaget J., 1969, CHILDS CONCEPTION TI; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; Stevens JC, 1965, P NATL ACAD SCI USA, V54, P407; STEVENS SS, 1959, J EXP PSYCHOL, V57, P201, DOI 10.1037/h0048957; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	40	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81241	10.1371/journal.pone.0081241	http://dx.doi.org/10.1371/journal.pone.0081241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278402	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100148
J	Dwivedi, VD				Dwivedi, Veena D.			Interpreting Quantifier Scope Ambiguity: Evidence of Heuristic First, Algorithmic Second Processing	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; LANGUAGE COMPREHENSION; EYE-MOVEMENTS; BRAIN POTENTIALS; RESOLUTION; SENTENCES; UNDERSPECIFICATION; INFORMATION; ROLES; ERP	The present work suggests that sentence processing requires both heuristic and algorithmic processing streams, where the heuristic processing strategy precedes the algorithmic phase. This conclusion is based on three self-paced reading experiments in which the processing of two-sentence discourses was investigated, where context sentences exhibited quantifier scope ambiguity. Experiment 1 demonstrates that such sentences are processed in a shallow manner. Experiment 2 uses the same stimuli as Experiment 1 but adds questions to ensure deeper processing. Results indicate that reading times are consistent with a lexical-pragmatic interpretation of number associated with context sentences, but responses to questions are consistent with the algorithmic computation of quantifier scope. Experiment 3 shows the same pattern of results as Experiment 2, despite using stimuli with different lexical-pragmatic biases. These effects suggest that language processing can be superficial, and that deeper processing, which is sensitive to structure, only occurs if required. Implications for recent studies of quantifier scope ambiguity are discussed.	[Dwivedi, Veena D.] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Dwivedi, Veena D.] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada	Brock University; Brock University	Dwivedi, VD (corresponding author), Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada.	vdwivedi@brocku.ca		Dwivedi, Veena D./0000-0003-2316-3673	Social Sciences and Humanities Research Council of Canada [410-2006-1748]; Brock University	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Brock University	This work was partially supported by Social Sciences and Humanities Research Council of Canada award #410-2006-1748 (http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx), as well as seed grants from Brock University (www.brocku.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, GEN QUANTIFIERS NATU, DOI DOI 10.1515/9783110867909.45; BARTON SB, 1993, MEM COGNITION, V21, P477, DOI 10.3758/BF03197179; BOCK K, 1992, PSYCHOL REV, V99, P150, DOI 10.1037/0033-295X.99.1.150; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; CARAMAZZA A, 1976, BRAIN LANG, V3, P572, DOI 10.1016/0093-934X(76)90048-1; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Christianson K, 2010, J EXP PSYCHOL LEARN, V36, P538, DOI 10.1037/a0018027; Chwilla DJ, 2005, COGNITIVE BRAIN RES, V25, P589, DOI 10.1016/j.cogbrainres.2005.08.011; Clark DG, 2011, J NEUROLINGUIST, V24, P401, DOI 10.1016/j.jneuroling.2011.01.002; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cole Peter, 1978, SYNTAX SEMANTICS, V9, P221; Daneman M, 2007, LANG COGNITIVE PROC, V22, P83, DOI 10.1080/01690960500372725; Diesing Molly., 1992, INDEFINITES; Dwivedi V, 2012, ANN M CAN LING ASS 2; Dwivedi V. D., 2013, 20 ANN M COGN NEUR S; Dwivedi VD, 1996, MCGILL WORKING PAPER, P17; Dwivedi VD, 2003, 39 ANN M CHIC LING S, P32; Dwivedi VD, 2006, BRAIN RES, V1117, P135, DOI 10.1016/j.brainres.2006.07.048; Dwivedi VD, 2010, NEUROREPORT, V21, P791, DOI 10.1097/WNR.0b013e32833cae0d; Dwivedi VD, 2010, BRAIN RES, V1311, P93, DOI 10.1016/j.brainres.2009.09.102; FERREIRA F, 1986, J MEM LANG, V25, P348, DOI 10.1016/0749-596X(86)90006-9; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Filik R, 2004, PSYCHON B REV, V11, P953, DOI 10.3758/BF03196727; Filik R, 2008, J COGNITIVE NEUROSCI, V20, P1315, DOI 10.1162/jocn.2008.20090; Fodor J. D., 1982, PROCESSES BELIEFS QU, P129, DOI DOI 10.1007/978-94-015-7668-0_5; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Frazier L., 1996, CONSTRUAL; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Garrod S, 2000, J MEM LANG, V42, P526, DOI 10.1006/jmla.1999.2694; Gigerenzer G., 2000, ADAPTIVE THINKING RA; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hannon B, 2001, MEM COGNITION, V29, P449, DOI 10.3758/BF03196396; Hoeks JCJ, 2004, COGNITIVE BRAIN RES, V19, P59, DOI 10.1016/j.cogbrainres.2003.10.022; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kemtes K. A., 1999, J GERONTOL B-PSYCHOL, V54, P350, DOI [10.1093/geronb/54B.6.P350, DOI 10.1093/GERONB/54B.6.P350, 10.1093/geronb/54b.6.p350, DOI 10.1093/GER0NB/54B.6.P350.PUBMED:10625963]; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; Kim A, 2011, BRAIN LANG, V118, P15, DOI 10.1016/j.bandl.2011.03.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2003, J COGNITIVE NEUROSCI, V15, P272, DOI 10.1162/089892903321208204; KURTZMAN HS, 1993, COGNITION, V48, P243, DOI 10.1016/0010-0277(93)90042-T; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1982, NEUROPSYCHOLOGIA, V20, P579, DOI 10.1016/0028-3932(82)90031-8; Kutas M, 2006, METAPHOR SYMBOL, V21, P285, DOI 10.1207/s15327868ms2104_5; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; May Robert., 1985, LOGICAL FORM ITS STR; Partee BH, 1991, DOMAINS QUANTIFICATI, P3; Paterson KB, 2008, Q J EXP PSYCHOL, V61, P459, DOI 10.1080/17470210701255317; Patson ND, 2010, J EXP PSYCHOL LEARN, V36, P782, DOI 10.1037/a0018783; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2006, DISCOURSE PROCESS, V42, P131, DOI 10.1207/s15326950dp4202_3; Postal Paul, 1966, MOD STUD ENGL, P201; Raffray CN, 2010, PSYCHOL SCI, V21, P1090, DOI 10.1177/0956797610375446; RUCHKIN DS, 1988, PSYCHOPHYSIOLOGY, V25, P339, DOI 10.1111/j.1469-8986.1988.tb01253.x; Rumelhart D.E., 1980, THEORETICAL ISSUES R, P33, DOI [10.4324/9781315107493-4, DOI 10.4324/9781315107493-4]; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Sanford AJ, 1994, HDB PSYCHOLINGUISTIC, P699; Sanford AJ, 2006, DISCOURSE PROCESS, V42, P99, DOI 10.1207/s15326950dp4202_1; Schank RC., 1977, SCRIPTS PLANS GOALS; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Swets B, 2008, MEM COGNITION, V36, P201, DOI 10.3758/MC.36.1.201; Townsend D.J., 2001, SENTENCE COMPREHENSI; Traxler MJ, 1998, J MEM LANG, V39, P558, DOI 10.1006/jmla.1998.2600; TRUESWELL JC, 1994, J MEM LANG, V33, P285, DOI 10.1006/jmla.1994.1014; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; van Herten M, 2006, J COGNITIVE NEUROSCI, V18, P1181, DOI 10.1162/jocn.2006.18.7.1181	68	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81461	10.1371/journal.pone.0081461	http://dx.doi.org/10.1371/journal.pone.0081461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278439	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100157
J	Gu, J; Xuan, ZY				Gu, Jin; Xuan, Zhenyu			Inferring the Perturbed microRNA Regulatory Networks in Cancer Using Hierarchical Gene Co-Expression Signatures	PLOS ONE			English	Article							HUMAN LUNG ADENOCARCINOMA; SET ENRICHMENT ANALYSIS; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GROWTH-FACTOR; EXPRESSION; TARGETS; HSA-MIR-125A-5P; IDENTIFICATION; METASTASIS	MicroRNAs (miRNAs), a class of endogenous small regulatory RNAs, play important roles in many biological and physiological processes. The perturbations of some miRNAs, which are usually called as onco-microRNAs (onco-miRs), are significantly associated with multiple stages of cancer. Although hundreds of miRNAs have been discovered, the perturbed miRNA regulatory networks and their functions are still poorly understood in cancer. Analyzing the expression patterns of miRNA target genes is a very useful strategy to infer the perturbed miRNA networks. However, due to the complexity of cancer transcriptome, current methods often encounter low sensitivity and report few onco-miR candidates. Here, we developed a new method, named miRHiC (enrichment analysis of miRNA targets in Hierarchical gene Co-expression signatures), to infer the perturbed miRNA regulatory networks by using the hierarchical co-expression signatures in large-scale cancer gene expression datasets. The method can infer onco-miR candidates and their target networks which are only linked to sub-clusters of the differentially expressed genes at fine scales of the co-expression hierarchy. On two real datasets of lung cancer and hepatocellular cancer, miRHiC uncovered several known onco-miRs and their target genes (such as miR-26, miR-29, miR-124, miR-125 and miR-200) and also identified many new candidates (such as miR-149, which is inferred in both types of cancers). Using hierarchical gene co-expression signatures, miRHiC can greatly increase the sensitivity for inferring the perturbed miRNA regulatory networks in cancer. All Perl scripts of miRHiC and the detailed documents are freely available on the web at http://bioinfo.au.tsinghua.edu.cn/member/jgu/miRHiC/.	[Gu, Jin] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Gu, Jin] Tsinghua Univ, Bioinformat Div, Ctr Synthet & Syst Biol, Tsinghua Natl Lab Informat Sci & Technol,Dept Aut, Beijing 100084, Peoples R China; [Xuan, Zhenyu] Univ Texas Dallas, Dept Mol & Cell Biol, Ctr Syst Biol, Richardson, TX 75083 USA	Tsinghua University; Tsinghua University; University of Texas System; University of Texas Dallas	Gu, J (corresponding author), Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jgu@tsinghua.edu.cn		Xuan, Zhenyu/0000-0001-9344-8493	National Basic Research Program of China [2012CB316503]; National Natural Science Foundation of China [61005040, 61370035]; National Institute of Health [U01 ES017166]; Tsinghua National Laboratory for Information Science and Technology Cross-discipline Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tsinghua National Laboratory for Information Science and Technology Cross-discipline Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by National Basic Research Program of China [2012CB316503], National Natural Science Foundation of China [61005040, 61370035], National Institute of Health [U01 ES017166] and Tsinghua National Laboratory for Information Science and Technology Cross-discipline Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Ahn DH, 2012, MOL CARCINOG; Alpini G, 2011, J HEPATOL, V55, P1339, DOI 10.1016/j.jhep.2011.04.015; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Cho WCS, 2009, EUR J CANCER, V45, P2197, DOI 10.1016/j.ejca.2009.04.039; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Dang XM, 2012, CANCER GENET-NY, V205, P113, DOI 10.1016/j.cancergen.2012.01.002; Dekker C, 2010, FEBS LETT, V584, P477, DOI 10.1016/j.febslet.2009.11.088; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Gong J., 2012, ONCOGENE; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Jiang LL, 2011, EXP LUNG RES, V37, P387, DOI 10.3109/01902148.2010.492068; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Lee SC, 2012, CANCER GENOM PROTEOM, V9, P101; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Plaisier C. L., 2012, GENOME RES; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Ulitsky I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq570; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang F, 2012, J PATHOL; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wong N, 2003, J HEPATOL, V38, P298, DOI 10.1016/S0168-8278(02)00412-9; Yin R, 2011, ONCOL REP, V25, P1747, DOI 10.3892/or.2011.1252; Zhang MW, 2012, MOL CARCINOGEN, V51, pE21, DOI 10.1002/mc.20863; Zhang Shuai, 2011, Zhongguo Fei Ai Za Zhi, V14, P317, DOI 10.3779/j.issn.1009-3419.2011.04.03; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682; Zhu W, 2012, CANCER CHEMOTH PHARM, V69, P723, DOI 10.1007/s00280-011-1752-3	57	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81032	10.1371/journal.pone.0081032	http://dx.doi.org/10.1371/journal.pone.0081032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278370	gold, Green Published			2022-12-27	WOS:000327313100137
J	Hoque, MT; Windus, LCE; Lovitt, CJ; Avery, VM				Hoque, Md Tamjidul; Windus, Louisa C. E.; Lovitt, Carrie J.; Avery, Vicky M.			PCaAnalyser: A 2D-Image Analysis Based Module for Effective Determination of Prostate Cancer Progression in 3D Culture	PLOS ONE			English	Article							BONE-MARROW STROMA; CELL-ADHESION; DIFFERENTIAL EXPRESSION; ANDROGEN RECEPTOR; INTEGRIN; ACTIVATION; MOLECULES; PATHWAY; ALPHA-2; IMAGE	Three-dimensional (3D) in vitro cell based assays for Prostate Cancer (PCa) research are rapidly becoming the preferred alternative to that of conventional 2D monolayer cultures. 3D assays more precisely mimic the microenvironment found in vivo, and thus are ideally suited to evaluate compounds and their suitability for progression in the drug discovery pipeline. To achieve the desired high throughput needed for most screening programs, automated quantification of 3D cultures is required. Towards this end, this paper reports on the development of a prototype analysis module for an automated high-content-analysis (HCA) system, which allows for accurate and fast investigation of in vitro 3D cell culture models for PCa. The Java based program, which we have named PCaAnalyser, uses novel algorithms that allow accurate and rapid quantitation of protein expression in 3D cell culture. As currently configured, the PCaAnalyser can quantify a range of biological parameters including: nuclei-count, nuclei-spheroid membership prediction, various function based classification of peripheral and non-peripheral areas to measure expression of biomarkers and protein constituents known to be associated with PCa progression, as well as defining segregate cellular-objects effectively for a range of signal-to-noise ratios. In addition, PCaAnalyser architecture is highly flexible, operating as a single independent analysis, as well as in batch mode; essential for High-Throughput-Screening (HTS). Utilising the PCaAnalyser, accurate and rapid analysis in an automated high throughput manner is provided, and reproducible analysis of the distribution and intensity of well-established markers associated with PCa progression in a range of metastatic PCa cell-lines (DU145 and PC3) in a 3D model demonstrated.	[Hoque, Md Tamjidul] Univ New Orleans, New Orleans, LA 70148 USA; [Windus, Louisa C. E.; Lovitt, Carrie J.; Avery, Vicky M.] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia	University of Louisiana System; University of New Orleans; Griffith University	Avery, VM (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld 4111, Australia.	v.avery@griffith.edu.au	Windus, Louisa/C-1296-2014; Avery, Vicky M/A-5449-2010	Windus, Louisa/0000-0002-7186-459X; Avery, Vicky M/0000-0003-4914-2299; Hoque, Md Tamjidul/0000-0002-0110-2194	Prostate Cancer Foundation of Australia; Louisiana Board of Regents through the Board of Regents Support Fund [LEQSF(2013-16)-RD-A-19]; Australian Postgraduate Award	Prostate Cancer Foundation of Australia; Louisiana Board of Regents through the Board of Regents Support Fund; Australian Postgraduate Award(Australian Government)	This work was supported by a grant from the Prostate Cancer Foundation of Australia awarded to VMA. TH acknowledges the Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF(2013-16)-RD-A-19 partially for preparing the final manuscript. CJL was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AIHW Website, 2008, CANC AUSTR OV; BONKHOFF H, 1993, HUM PATHOL, V24, P243, DOI 10.1016/0046-8177(93)90033-D; Clendenon JL, 2006, MICROSCOPIC IMAGING, V103, P50; Garlick DS, 2012, AM J TRANSL RES, V4, P165; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hatzoglou A, 2005, J CLIN ENDOCR METAB, V90, P893, DOI 10.1210/jc.2004-0801; Howe G, 2012, CELL ADH MIGR, V6; JCuda, 2010, JCUDA IMAGEJ; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kampa M, 2002, FASEB J, V16, P1429, DOI 10.1096/fj.02-0131fje; King TE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003535; KNOX JD, 1994, AM J PATHOL, V145, P167; Knudsen BS, 2006, J CELL BIOCHEM, V99, P345, DOI 10.1002/jcb.20934; Kunzelmann K-H, 2012, DEBUGGING IMAGEJ PLU; Lang SH, 1997, CLIN EXP METASTAS, V15, P218, DOI 10.1023/A:1018465213641; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; LOCI, 2012, BIOF; MBF, 2012, MBF IMAGEJ; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murant SJ, 1997, EUR J CANCER, V33, P263, DOI 10.1016/S0959-8049(96)00418-2; Okera M, 2011, BJU INT, V108, pE51, DOI 10.1111/j.1464-410X.2010.09884.x; Papakonstanti EA, 2003, MOL ENDOCRINOL, V17, P870, DOI 10.1210/me.2002-0253; PCaAnalyser, 2013, PCAANALYSER 2D IM AN; PerkinElmer, 2012, OPERA; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Rasband W., 2006, IMAGEJ; Schmelz M, 2002, NEOPLASIA, V4, P243, DOI 10.1038/sj.neo.7900223; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Taichman RS, 2002, CANCER RES, V62, P1832; Tamburrino L, STEROIDS; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544	41	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79865	10.1371/journal.pone.0079865	http://dx.doi.org/10.1371/journal.pone.0079865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278197	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000327313100060
J	Kiyoshima, T; Yoshida, H; Wada, H; Nagata, K; Fujiwara, H; Kihara, M; Hasegawa, K; Someya, H; Sakai, H				Kiyoshima, Tamotsu; Yoshida, Hisato; Wada, Hiroko; Nagata, Kengo; Fujiwara, Hiroaki; Kihara, Makiko; Hasegawa, Kana; Someya, Hirotaka; Sakai, Hidetaka			Chemoresistance to Concanamycin A1 in Human Oral Squamous Cell Carcinoma Is Attenuated by an HDAC Inhibitor Partly via Suppression of Bcl-2 Expression	PLOS ONE			English	Article							VACUOLAR-H+-ATPASE; HISTONE DEACETYLASE INHIBITOR; V-ATPASE; EXTRACELLULAR PH; CANCER; CISPLATIN; APOPTOSIS; VORINOSTAT; ACTIVATION; INDUCTION	V-ATPase is involved in the acidification of the microenvironment around/in solid tumors, such as oral squamous cell carcinoma (OSCC). V-ATPase is thought to induce tumor invasion and multi-drug resistance in several malignant tumors, and it also contributes to maintaining the intracellular pH under an acidic microenvironment by inducing proton extrusion into the extracellular medium. However, there is little information regarding the effects of V-ATPase inhibitors on OSCCs. In this study, the effects of a V-ATPase inhibitor, concanamycin A1 (CMA), on the proliferation and apoptosis of OSCC were investigated in vitro. We used four OSCC cell lines, MISK81-5, SAS, HSC-4 and SQUU-B. Acridine orange staining revealed that the red fluorescence was reduced in all of the low concentration CMA-treated OSCC cells, indicating that the acidification of vesicular organelles in the OSCCs was prevented by the treatment with low-concentration of CMA. CMA treatment induced apoptosis in MISK81-5, SAS and HSC-4 cells, but not in SQUU-B cells. The p-p38 expression was not altered in CMA-treated SQUU-B cells, but their levels were increased in the other cells. The Bax/Bcl-2 ratio in CMA-treated SQUU-B cells was dramatically decreased in comparison with that in the other cell lines treated with CMA. However, when the SQUU-B cells were treated with CMA and a histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), the SQUU-B cells became more susceptible to the CMA-induced apoptosis. SAHA treatment led to a significantly decrease in the Bcl-2 expression in CMA-treated SQUU-B cells, resulting in a dramatically increased Bax/Bcl-2 ratio in comparison with that observed in the SQUU-B cells treated with CMA alone. These findings suggest that CMA could have an anti-tumor effect on OSCCs. In addition, combination of CMA with other agents, such as SAHA, could help improve the pro-apoptotic effects of CMA even in CMA-resistant OSCC cells.	[Kiyoshima, Tamotsu; Yoshida, Hisato; Wada, Hiroko; Nagata, Kengo; Fujiwara, Hiroaki; Kihara, Makiko; Hasegawa, Kana; Someya, Hirotaka; Sakai, Hidetaka] Kyushu Univ, Lab Oral Pathol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci, Fukuoka 812, Japan; [Kihara, Makiko] Kyushu Univ, Dept Orthodont, Div Oral Hlth Growth & Dev, Fac Dent Sci, Fukuoka 812, Japan; [Hasegawa, Kana] Kyushu Univ, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fac Dent Sci, Fukuoka 812, Japan; [Someya, Hirotaka] Kyushu Univ, Dept Removable Prosthodont, Div Rehabil, Fac Dent Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Kiyoshima, T (corresponding author), Kyushu Univ, Lab Oral Pathol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci, Fukuoka 812, Japan.	kiyo@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25463124, 25670779]; Grants-in-Aid for Scientific Research [25670779] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was support by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nos. 25463124 (to TK) and 25670779 (to H. Sakai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2004, CANCER RES, V64, P7867, DOI 10.1158/0008-5472.CAN-04-0648; Aiko K, 2002, CELL SIGNAL, V14, P717, DOI 10.1016/S0898-6568(02)00016-5; Andersson CX, 2007, J BIOL CHEM, V282, P9430, DOI 10.1074/jbc.M609980200; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Chauhan SS, 2003, BRIT J CANCER, V88, P1327, DOI 10.1038/sj.bjc.6600861; Chidzonga MM, 2006, ORAL ONCOL, V42, P177, DOI 10.1016/j.oraloncology.2005.07.003; Chidzonga MM, 2006, ORAL ONCOL, V42, P184, DOI 10.1016/j.oraloncology.2005.07.011; Choi HJ, 2012, BBA-MOL CELL RES, V1823, P1082, DOI 10.1016/j.bbamcr.2012.03.015; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; Dong G, 2008, J PHARMACOL EXP THER, V325, P978, DOI 10.1124/jpet.108.137398; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Garcia-Garcia A, 2012, BIOTECH HISTOCHEM, V87, P133, DOI 10.3109/10520295.2011.574647; Hashioka S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-113; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Karube K, 2013, CANCER LETT, V333, P47, DOI 10.1016/j.canlet.2012.12.022; KATO Y, 1992, J BIOL CHEM, V267, P11424; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kraus M, 1996, TUMOR BIOL, V17, P133, DOI 10.1159/000217977; Kumar P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-206; Licitra L, 2003, J CLIN ONCOL, V21, P327, DOI 10.1200/JCO.2003.06.146; Lioni M, 2008, MOL CANCER THER, V7, P2866, DOI 10.1158/1535-7163.MCT-08-0391; Liu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046624; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Ma J, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-67; MA LD, 1992, BIOCHEM BIOPH RES CO, V182, P675, DOI 10.1016/0006-291X(92)91785-O; Manero F, 2006, CANCER RES, V66, P2757, DOI 10.1158/0008-5472.CAN-05-2097; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MATSUO K, 1994, JPN J CANCER RES, V85, P1257, DOI 10.1111/j.1349-7006.1994.tb02938.x; MIYAZAKI K, 1990, CANCER RES, V50, P4522; Morifuji M, 2000, AM J PATHOL, V156, P1317, DOI 10.1016/S0002-9440(10)65002-X; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Naher L, 2012, INT J ONCOL, V41, P1577, DOI 10.3892/ijo.2012.1594; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Nyhan MJ, 2012, BRIT J CANCER, V106, P711, DOI 10.1038/bjc.2011.604; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Ookuma YF, 2013, HISTOCHEM CELL BIOL, V139, P355, DOI 10.1007/s00418-012-1033-1; Otero-Rey EM, 2008, ORAL ONCOL, V44, P193, DOI 10.1016/j.oraloncology.2007.02.011; Ouar Z, 2003, BIOCHEM J, V370, P185, DOI 10.1042/BJ20021411; Petrangolini G, 2006, J PHARMACOL EXP THER, V318, P939, DOI 10.1124/jpet.106.103481; Rikiishi H, 2007, INT J ONCOL, V30, P1181; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Rouette A, 2012, INT J CANCER, V130, P1755, DOI 10.1002/ijc.26183; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Takahashi K, 1989, J JPN STOMATOL SOC, V38, P20, DOI DOI 10.11277/stomatology1952.38.20; Uehara N, 2012, CANCER LETT, V315, P112, DOI 10.1016/j.canlet.2011.07.032; Wahl ML, 2000, GEN PHARMACOL-VASC S, V35, P277, DOI 10.1016/S0306-3623(01)00115-X; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Xiao YT, 2008, INT J BIOCHEM CELL B, V40, P2002, DOI 10.1016/j.biocel.2007.08.006; Yang L, 2008, CELL MOL BIOL LETT, V13, P119, DOI 10.2478/s11658-007-0042-x; Yoshimoto Y, 2002, BIOORG MED CHEM LETT, V12, P3525, DOI 10.1016/S0960-894X(02)00806-5	56	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80998	10.1371/journal.pone.0080998	http://dx.doi.org/10.1371/journal.pone.0080998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278362	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100133
J	Qian, J; You, HZ; Zhu, QY; Ma, S; Zhou, Y; Zheng, Y; Liu, JF; Kuang, DW; Gu, Y; Hao, CM; Ding, F				Qian, Jing; You, Huaizhou; Zhu, Qiuyu; Ma, Shuai; Zhou, Ying; Zheng, Ying; Liu, Junfeng; Kuang, Dingwei; Gu, Yong; Hao, Chuanming; Ding, Feng			Nitrotyrosine Level Was Associated with Mortality in Patients with Acute Kidney Injury	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; OXIDANT MECHANISMS; NITRIC-OXIDE; PEROXYNITRITE; NITRATION; MYELOPEROXIDASE; SUPEROXIDE; TYROSINE	Background: To examine the characteristics of oxidative stress in patients with acute kidney injury (AKI) and investigate the association between plasma nitrotyrosine levels and 90-day mortality in patients with AKI. Methodology/Principal Findings: 158 patients with hospital-acquired AKI were recruited to this prospective cohort study according to RIFLE (Risk, Injury, Failure, Lost or End Stage Kidney) criteria. Twelve critically ill patients without AKI and 15 age and gender-matched healthy subjects served as control. Plasma 3-nitrotyrosine was analyzed in relation to 90-day all cause mortality of patients with AKI. The patients with AKI were followed up for 90 days and grouped according to median plasma 3-nitrotyrosine concentrations. Highest 3-NT/Tyr was detected in patients with AKI compared with healthy subjects, and critically ill patients without AKI (ANOVA p<0.001). The 90-day survival curves of patients with high 3-NT/Tyr showed significant differences compared with the curves of individuals with low 3-NT/Tyr (p = 0.001 by log rank test). Multivariate analysis (Cox regression) revealed that 3-NT/Tyr (p = 0.025) was independently associated with mortality after adjustment for age, gender, sepsis and Acute Physiology and Chronic Health Evaluation (APACHE) II score. Conclusions/Significance: There is excess plasma protein oxidation in patients with AKI, as evidenced by increased nitrotyrosine content. 3-NT/Tyr level was associated with mortality of AKI patients independent of the severity of illness.	[Qian, Jing; You, Huaizhou; Zhu, Qiuyu; Ma, Shuai; Zhou, Ying; Zheng, Ying; Liu, Junfeng; Kuang, Dingwei; Gu, Yong; Hao, Chuanming; Ding, Feng] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China	Fudan University	Ding, F (corresponding author), Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China.	dingfeng@fudan.edu.cn			National Natural Science Foundation of China [81070609, 81270850]; Science and Technology Commission of Shanghai Municipality [11441901401]; National Science and Technology Support Program [2011BAI10B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science and Technology Support Program	This study was supported, in part, by grants from the National Natural Science Foundation of China (No: 81070609, 81270850), the Science and Technology Commission of Shanghai Municipality (No: 11441901401), and the National Science and Technology Support Program (No: 2011BAI10B08) (to F. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga R, 1997, AM J KIDNEY DIS, V29, P465, DOI 10.1016/S0272-6386(97)90212-2; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BONVENTRE JV, 1993, KIDNEY INT, V43, P1160, DOI 10.1038/ki.1993.163; Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3; Descamps-Latscha B, 2001, SEMIN DIALYSIS, V14, P193, DOI 10.1046/j.1525-139X.2001.00052.x; GAILIT J, 1993, AM J PHYSIOL, V264, pF149, DOI 10.1152/ajprenal.1993.264.1.F149; GRAHAM A, 1993, FEBS LETT, V330, P181, DOI 10.1016/0014-5793(93)80269-Z; Gutteridge JMC, 1999, BRIT MED BULL, V55, P49, DOI 10.1258/0007142991902295; Hazen SL, 1999, CIRC RES, V85, P950; Heinecke JW, 2002, FREE RADICAL BIO MED, V32, P1090, DOI 10.1016/S0891-5849(02)00792-X; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Himmelfarb J, 2001, FREE RADICAL BIO MED, V31, P1163, DOI 10.1016/S0891-5849(01)00697-9; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; OHSHIMA H, 1990, FOOD CHEM TOXICOL, V28, P647, DOI 10.1016/0278-6915(90)90173-K; OSSWALD H, 1977, PFLUG ARCH EUR J PHY, V371, P45, DOI 10.1007/BF00580771; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Zager RA, 1997, SEMIN NEPHROL, V17, P3; Zhang WZ, 2007, BIOMED CHROMATOGR, V21, P273, DOI 10.1002/bmc.750	24	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79962	10.1371/journal.pone.0079962	http://dx.doi.org/10.1371/journal.pone.0079962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278225	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100069
J	DeChaine, EG; Forester, BR; Schaefer, H; Davis, CC				DeChaine, Eric G.; Forester, Brenna R.; Schaefer, Hanno; Davis, Charles C.			Deep Genetic Divergence between Disjunct Refugia in the Arctic-Alpine King's Crown, Rhodiola integrifolia (Crassulaceae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NORTH-AMERICAN CONIFER; LAST GLACIAL MAXIMUM; CLIMATE-CHANGE; MITOCHONDRIAL-DNA; CHLOROPLAST DNA; POPULATION-STRUCTURE; POSTGLACIAL RECOLONIZATION; PHYLOGEOGRAPHIC STRUCTURE; CONSERVING BIODIVERSITY	Despite the strength of climatic variability at high latitudes and upper elevations, we still do not fully understand how plants in North America that are distributed between Arctic and alpine areas responded to the environmental changes of the Quaternary. To address this question, we set out to resolve the evolutionary history of the King's Crown, Rhodiola integrifolia using multi-locus population genetic and phylogenetic analyses in combination with ecological niche modeling. Our population genetic analyses of multiple anonymous nuclear loci revealed two major clades within R. integrifolia that diverged from each other similar to 700 kya: one occurring in Beringia to the north (including members of subspecies leedyi and part of subspecies integrifolia), and the other restricted to the Southern Rocky Mountain refugium in the south (including individuals of subspecies neomexicana and part of subspecies integrifolia). Ecological niche models corroborate our hypothesized locations of refugial areas inferred from our phylogeographic analyses and revealed some environmental differences between the regions inhabited by its two subclades. Our study underscores the role of geographic isolation in promoting genetic divergence and the evolution of endemic subspecies in R. integrifolia. Furthermore, our phylogenetic analyses of the plastid spacer region trnL-F demonstrate that among the native North American species, R. integrifolia and R. rhodantha are more closely related to one another than either is to R. rosea. An understanding of these historic processes lies at the heart of making informed management decisions regarding this and other Arctic-alpine species of concern in this increasingly threatened biome.	[DeChaine, Eric G.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Forester, Brenna R.] Western Washington Univ, Dept Environm Sci, Bellingham, WA 98225 USA; [Schaefer, Hanno; Davis, Charles C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Western Washington University; Western Washington University; Harvard University	DeChaine, EG (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	dechainelab@gmail.com		Forester, Brenna/0000-0002-1608-1904	National Science Foundation, Arctic Natural Sciences Award [0714232]	National Science Foundation, Arctic Natural Sciences Award	Funding was provided by the National Science Foundation (www.nsf.gov), Arctic Natural Sciences Award 0714232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Albach DC, 2006, MOL ECOL, V15, P3269, DOI 10.1111/j.1365-294X.2006.02980.x; Allen GA, 2012, ECOL EVOL, V2, P649, DOI 10.1002/ece3.213; Amano Makoto, 1995, Journal of Japanese Botany, V70, P334; [Anonymous], 1967, BERING LAND BRIDGE; [Anonymous], 2004, K 1 COUPL GCM MIROC; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beatty GE, 2010, MOL ECOL, V19, P5009, DOI 10.1111/j.1365-294X.2010.04859.x; Benson L, 1996, PALAEOGEOGR PALAEOCL, V122, P45, DOI 10.1016/0031-0182(95)00099-2; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Brubaker LB, 2005, J BIOGEOGR, V32, P833, DOI 10.1111/j.1365-2699.2004.01203.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burke R.M., 1983, LATE QUATERNARY ENV, P3; Calonje M, 2009, PLANT SYST EVOL, V282, P257, DOI 10.1007/s00606-008-0031-1; Chung M, 2004, MOL ECOL, V13, P3657, DOI 10.1111/j.1365-294X.2004.02360.x; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; CLAUSEN R T, 1975, P742; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dawe JC, 1979, TAXON, V28, P267; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; DeChaine EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069814, DOI 10.1371/J0URNAL.P0NE.0069814.PUBMED:23922810]; DeChaine EG, 2006, EVOLUTION, V60, P1004; DeChaine EG, 2008, PLANT ECOL DIVERS, V1, P197, DOI 10.1080/17550870802328660; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyke AS, 2003, 1574 GEOL SURV CAN; Edwards ME, 2000, J BIOGEOGR, V27, P521, DOI 10.1046/j.1365-2699.2000.00426.x; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; ESRI, 2010, ARCMAP; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Forester BR, 2013, DIVERS DISTRIB, V19, P1480, DOI 10.1111/ddi.12098; FU YX, 1993, GENETICS, V133, P693; Galbreath KE, 2011, EVOLUTION, V65, P1879, DOI 10.1111/j.1558-5646.2011.01287.x; Gallagher ML, 1985, TAXON, V34, P159; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Guest H, 2009, THESIS VICTORIA U VI, P120; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hartley TG, 1966, NAT HIST, V21, P87; Hedges TG, 1972, B PERYGLACJALNY, V21, P87; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hulten E, 1937, THESIS LUND U STOCKH; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Jennings WB, 2005, EVOLUTION, V59, P2033; Kejnovsky E, 2009, TRENDS ECOL EVOL, V24, P572, DOI 10.1016/j.tree.2009.04.010; Kiefer C, 2009, MOL PHYLOGENET EVOL, V52, P303, DOI 10.1016/j.ympev.2009.03.016; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; Lei Y., 2004, J GENET MOL BIOL, V15, P190; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Levsen ND, 2008, BIOL J LINN SOC, V95, P815, DOI 10.1111/j.1095-8312.2008.01097.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martin AP, 2002, SYST BIOL, V51, P570, DOI 10.1080/10635150290069995; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Mayuzumi S, 2004, SYST BOT, V29, P587, DOI 10.1600/0363644041744329; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Moran R., 2000, Cactus and Succulent Journal, V72, P137; Moran RV, 2005, FLORA N AM N MEXICO, V8, P164; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Noonan GR, 2001, ANN ENTOMOL SOC AM, V94, P301, DOI 10.1603/0013-8746(2001)094[0301:SACOTN]2.0.CO;2; Oberle B, 2011, P NATL ACAD SCI USA, V108, P5655, DOI 10.1073/pnas.1012302108; Ohba H., 1999, J JAP BOT, V74, P61; Olfelt JP, 2001, AM J BOT, V88, P401, DOI 10.2307/2657104; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Phillips FM, 1996, SCIENCE, V274, P749, DOI 10.1126/science.274.5288.749; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pielou EC, 1991, ICE AGE RETURN LIFE; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Porter S., 1983, LATE QUATERNARY ENV, V1, P71; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pusateri William P., 1993, Journal of the Iowa Academy of Science, V100, P29; R Development Core Team, 2012, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 5; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Richmond G. M., 1965, QUATERNARY GLACIATIO, P99; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Rozen S, 2000, Methods Mol Biol, V132, P365; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Shackleton NJ., 1976, GEOLOGICAL SOC AM ME, P449, DOI DOI 10.1130/MEM145-P449; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sher AV, 2005, QUATERNARY SCI REV, V24, P533, DOI 10.1016/j.quascirev.2004.09.007; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis DE, 1997, PLANT SYST EVOL, V206, P353, DOI 10.1007/BF00987957; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P597; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; UHL CH, 1952, EVOLUTION, V6, P81, DOI 10.2307/2405505; Van Ham RCHJ, 1998, AM J BOT, V85, P123, DOI 10.2307/2446561; Wakeley J, 1997, GENETICS, V145, P847; Waltari E, 2007, J BIOGEOGR, V34, P561, DOI 10.1111/j.1365-2699.2007.01705.x; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; WEBER R, 1979, THESIS U NO IOWA CED; Winkler M, 2012, MOL ECOL, V21, P4618, DOI 10.1111/j.1365-294X.2012.05705.x; Xiang QY, 2008, MOL PHYLOGENET EVOL, V49, P327, DOI 10.1016/j.ympev.2008.07.010; Zwickl DJ, 2006, THESIS U TEXAS AUSTI	123	13	14	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79451	10.1371/journal.pone.0079451	http://dx.doi.org/10.1371/journal.pone.0079451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24282505	Green Published, gold, Green Submitted			2022-12-27	WOS:000326499300085
J	Picatoste, B; Ramirez, E; Caro-Vadillo, A; Iborra, C; Egido, J; Tunon, J; Lorenzo, O				Picatoste, Belen; Ramirez, Elisa; Caro-Vadillo, Alicia; Iborra, Cristian; Egido, Jesus; Tunon, Jose; Lorenzo, Oscar			Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MYOCARDIAL-INFARCTION; DPP-4 INHIBITION; GENE-EXPRESSION; ACTIVATION; RECEPTOR; CELLS; IMPROVES; HEART; RAT	Background: Myocardial fibrosis is a key process in diabetic cardiomyopathy. However, their underlying mechanisms have not been elucidated, leading to a lack of therapy. The glucagon-like peptide-1 (GLP-1) enhancer, sitagliptin, reduces hyperglycemia but may also trigger direct effects on the heart. Methods: Goto-Kakizaki (GK) rats developed type-II diabetes and received sitagliptin, an anti-hyperglycemic drug (metformin) or vehicle (n=10, each). After cardiac structure and function assessment, plasma and left ventricles were isolated for biochemical studies. Cultured cardiomyocytes and fibroblasts were used for in vitro assays. Results: Untreated GK rats exhibited hyperglycemia, hyperlipidemia, plasma GLP-1 decrease, and cardiac cell-death, hypertrophy, fibrosis and prolonged deceleration time. Moreover, cardiac pro-apoptotic/necrotic, hypertrophic and fibrotic factors were up-regulated. Importantly, both sitagliptin and metformin lessened all these parameters. In cultured cardiomyocytes and cardiac fibroblasts, high-concentration of palmitate or glucose induced cell-death, hypertrophy and fibrosis. Interestingly, GLP-1 and its insulinotropic-inactive metabolite, GLP-1(9-36), alleviated these responses. In addition, despite a specific GLP-1 receptor was only detected in cardiomyocytes, GLP-1 isoforms attenuated the pro-fibrotic expression in cardiomyocytes and fibroblasts. In addition, GLP-1 receptor signalling may be linked to PPAR delta activation, and metformin may also exhibit anti-apoptotic/necrotic and anti-fibrotic direct effects in cardiac cells. Conclusions: Sitagliptin, via GLP-1 stabilization, promoted cardioprotection in type-II diabetic hearts primarily by limiting hyperglycemia e hyperlipidemia. However, GLP-1 and GLP-1(9-36) promoted survival and anti-hypertrophic/fibrotic effects on cultured cardiac cells, suggesting cell-autonomous cardioprotective actions.	[Picatoste, Belen; Ramirez, Elisa; Iborra, Cristian; Egido, Jesus; Tunon, Jose; Lorenzo, Oscar] Fdn Jimenez Diaz, Inst Invest Sanitarias, E-28040 Madrid, Spain; [Caro-Vadillo, Alicia] Univ Complutense Madrid, Sch Vet, Madrid, Spain	Fundacion Jimenez Diaz; Complutense University of Madrid	Lorenzo, O (corresponding author), Fdn Jimenez Diaz, Inst Invest Sanitarias, E-28040 Madrid, Spain.	olorenzo@fjd.es	Tuñón, José L/R-3037-2016; Lorenzo, Oscar/L-2526-2013; Tunon, Jose/ABA-8847-2020	Tuñón, José L/0000-0003-2220-180X; Lorenzo, Oscar/0000-0001-5515-6078; Tunon, Jose/0000-0002-1373-0999; Picatoste Botija, Maria Belen/0000-0001-5752-2051	Ministerio de Educacion y Ciencia [SAF2009-08367]; Comunidad de Madrid [CCG10-UAM/BIO-5289]; Merck/MSD	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Merck/MSD(Merck & Company)	This work was supported by national funding from Ministerio de Educacion y Ciencia (SAF2009-08367), Comunidad de Madrid (CCG10-UAM/BIO-5289), and a unrestricted grant from by Merck/MSD. These grants were used to provide consumables and animals required. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Ares-Carrasco S, 2012, J PROTEOMICS, V75, P1816, DOI 10.1016/j.jprot.2011.12.023; Ares-Carrasco S, 2009, AM J PHYSIOL-HEART C, V297, pH2109, DOI 10.1152/ajpheart.00157.2009; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chen S, 2000, J MOL CELL CARDIOL, V32, P1621, DOI 10.1006/jmcc.2000.1197; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cobble M, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-8; D'Souza A, 2011, EXP PHYSIOL, V96, P875, DOI 10.1113/expphysiol.2011.058271; Dhillon S, 2010, DRUGS, V70, P489, DOI 10.2165/11203790-000000000-00000; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Escudero Eduardo Manuel, 2004, Eur J Echocardiogr, V5, P169, DOI 10.1016/j.euje.2003.11.004; Fan SC, 2010, HORM METAB RES, V42, P637, DOI 10.1055/s-0030-1253373; Glauser DA, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-54; Gros R, 2003, ENDOCRINOLOGY, V144, P2242, DOI 10.1210/en.2003-0007; Hickson-Bick DLM, 2002, AM J PHYSIOL-HEART C, V282, pH656, DOI 10.1152/ajpheart.00726.2001; Hui HX, 2010, PANCREAS, V39, P315, DOI 10.1097/MPA.0b013e3181bc30dd; Ishibashi Y, 2011, HORM METAB RES, V43, P731, DOI 10.1055/s-0031-1284383; Ishibashi Y, 2012, MICROVASC RES, V84, P395, DOI 10.1016/j.mvr.2012.06.008; Kim HJ, 2009, CIRC RES, V105, P16, DOI 10.1161/CIRCRESAHA.108.189159; Lenski M, 2011, J MOL CELL CARDIOL, V51, P906, DOI 10.1016/j.yjmcc.2011.08.001; Lorell BH, 2000, CIRCULATION, V102, P470; Martin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041545; Mellitzer G, 2011, CURR OPIN LIPIDOL, V22, P171, DOI 10.1097/MOL.0b013e32834622a2; Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824; Mizushige K, 2000, CIRCULATION, V101, P899, DOI 10.1161/01.CIR.101.8.899; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Mudaliar S, 2012, DIABETOLOGIA, V55, P1865, DOI 10.1007/s00125-012-2561-x; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okerson T, 2010, CARDIOVASC THER; ORSKOV C, 1987, SCAND J CLIN LAB INV, V47, P165; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; Piteau S, 2007, BIOCHEM BIOPH RES CO, V362, P1007, DOI 10.1016/j.bbrc.2007.08.115; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Ravassa S, 2011, AM J PHYSIOL-HEART C, V300, pH1361, DOI 10.1152/ajpheart.00885.2010; Read PA, 2010, CIRC-CARDIOVASC IMAG, V3, P195, DOI 10.1161/CIRCIMAGING.109.899377; REGAN TJ, 1983, ANNU REV MED, V34, P161, DOI 10.1146/annurev.me.34.020183.001113; Rendell M, 2012, EXPERT OPIN PHARMACO, V13, P553, DOI 10.1517/14656566.2012.656088; Rosenstock J, 2008, DIABETES OBES METAB, V10, P376, DOI 10.1111/j.1463-1326.2008.00876.x; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Tahara A, 2009, PHARMACOL REP, V61, P899, DOI 10.1016/S1734-1140(09)70147-1; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang XF, 2011, CHINESE MED J-PEKING, V124, P1876, DOI 10.3760/cma.j.issn.0366-6999.2011.12.020; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Ye YM, 2010, AM J PHYSIOL-HEART C, V298, pH1454, DOI 10.1152/ajpheart.00867.2009; Zhang HJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P25, DOI 10.1016/j.abb.2007.01.028	55	71	75	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e78330	10.1371/journal.pone.0078330	http://dx.doi.org/10.1371/journal.pone.0078330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24302978	gold, Green Published			2022-12-27	WOS:000326032600096
J	Bertagnolli, NM; Drake, JA; Tennessen, JM; Alter, O				Bertagnolli, Nicolas M.; Drake, Justin A.; Tennessen, Jason M.; Alter, Orly			SVD Identifies Transcript Length Distribution Functions from DNA Microarray Data and Reveals Evolutionary Forces Globally Affecting GBM Metabolism	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; GENE-EXPRESSION; ALTERNATIVE CLEAVAGE; RNA LENGTH; CANCER; PROTEIN; PHOSPHORYLATION; REPLICATION; INITIATION; DISCOVERY	To search for evolutionary forces that might act upon transcript length, we use the singular value decomposition (SVD) to identify the length distribution functions of sets and subsets of human and yeast transcripts from profiles of mRNA abundance levels across gel electrophoresis migration distances that were previously measured by DNA microarrays. We show that the SVD identifies the transcript length distribution functions as ``asymmetric generalized coherent states'' from the DNA microarray data and with no a-priori assumptions. Comparing subsets of human and yeast transcripts of the same gene ontology annotations, we find that in both disparate eukaryotes, transcripts involved in protein synthesis or mitochondrial metabolism are significantly shorter than typical, and in particular, significantly shorter than those involved in glucose metabolism. Comparing the subsets of human transcripts that are overexpressed in glioblastoma multiforme (GBM) or normal brain tissue samples from The Cancer Genome Atlas, we find that GBM maintains normal brain overexpression of significantly short transcripts, enriched in transcripts that are involved in protein synthesis or mitochondrial metabolism, but suppresses normal overexpression of significantly longer transcripts, enriched in transcripts that are involved in glucose metabolism and brain activity. These global relations among transcript length, cellular metabolism and tumor development suggest a previously unrecognized physical mode for tumor and normal cells to differentially regulate metabolism in a transcript length-dependent manner. The identified distribution functions support a previous hypothesis from mathematical modeling of evolutionary forces that act upon transcript length in the manner of the restoring force of the harmonic oscillator.	[Bertagnolli, Nicolas M.; Drake, Justin A.; Tennessen, Jason M.; Alter, Orly] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT 84108 USA; [Bertagnolli, Nicolas M.; Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Tennessen, Jason M.; Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Alter, O (corresponding author), Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT 84108 USA.	orly@sci.utah.edu	Tennessen, Jason/I-1937-2019	Tennessen, Jason/0000-0002-3527-5683; Alter, Orly/0000-0002-0418-1078; Drake, Justin/0000-0001-8966-3027	Utah Science, Technology and Research Initiative; National Human Genome Research Institute [HG-004302]; National Science Foundation CAREER Award [DMS-0847173]; National Institute of General Medical Sciences [GM-101341]; Direct For Mathematical & Physical Scien [0847173] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM101341] Funding Source: NIH RePORTER	Utah Science, Technology and Research Initiative; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Utah Science, Technology and Research Initiative, National Human Genome Research Institute R01 Grant HG-004302 and National Science Foundation CAREER Award DMS-0847173 (to OA), and National Institute of General Medical Sciences K99/R00 Pathway to Independence Award GM-101341 (to JMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; ALTER O, 2001, QUANTUM MEASUREMENT; Alter O, 2004, MIAM NAT BIOT WINT S; Alter O, 2006, P NATL ACAD SCI USA, V103, P11828, DOI 10.1073/pnas.0604756103; Alter O, 2006, P NATL ACAD SCI USA, V103, P16063, DOI 10.1073/pnas.0607650103; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Hur V, 2013, CELL REP, V3, P103, DOI 10.1016/j.celrep.2012.11.020; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DAUBECHIES I, 1988, IEEE T INFORM THEORY, V34, P605, DOI 10.1109/18.9761; De Gennes P.-G., 1979, SCALING CONCEPTS POL; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Drake JA, 2009, RAO C INT STAT SCI D; DUKE TAJ, 1992, PHYS REV LETT, V68, P542, DOI 10.1103/PhysRevLett.68.542; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; Golub G. H., 2012, MATRIX COMPUTATIONS; Griguer CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061035; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herbert A, 1999, NAT GENET, V21, P265, DOI 10.1038/6780; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hurowitz EH, 2004, GENOME BIOL, V5; Hurowitz EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000460; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; LERMAN LS, 1982, BIOPOLYMERS, V21, P995, DOI 10.1002/bip.360210511; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Luria SE, 1943, GENETICS, V28, P491; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schiff L.I., 1968, QUANTUM MECH; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SLATER GW, 1993, ELECTROPHORESIS, V14, P1, DOI 10.1002/elps.1150140102; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tinland B, 1998, BIOPOLYMERS, V46, P201, DOI 10.1002/(SICI)1097-0282(19981005)46:4<201::AID-BIP2>3.0.CO;2-T; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Wong TZ, 2002, NEUROIMAG CLIN N AM, V12, P615, DOI 10.1016/S1052-5149(02)00033-3; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e78913	10.1371/journal.pone.0078913	http://dx.doi.org/10.1371/journal.pone.0078913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282503	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500008
J	de-Freitas, JCM; Carvalho, S; Dias, AM; Oliveira, P; Cabral, J; Seruca, R; Oliveira, C; Morgado-Diaz, JA; Reis, CA; Pinho, SS				Madureira de-Freitas-Junior, Julio Cesar; Carvalho, Sandra; Dias, Ana M.; Oliveira, Patricia; Cabral, Joana; Seruca, Raquel; Oliveira, Carla; Morgado-Diaz, Jose Andres; Reis, Celso A.; Pinho, Salome S.			Insulin/IGF-I Signaling Pathways Enhances Tumor Cell Invasion through Bisecting GlcNAc N-glycans Modulation. An Interplay with E-Cadherin	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ACETYLGLUCOSAMINYLTRANSFERASE-III; GASTRIC-CANCER; BREAST-CANCER; UP-REGULATION; GROWTH; IGF; INHIBITION; RECEPTOR; GLYCOSYLATION	Changes in glycosylation are considered a hallmark of cancer, and one of the key targets of glycosylation modifications is E-cadherin. We and others have previously demonstrated that E-cadherin has a role in the regulation of bisecting GlcNAc N-glycans expression, remaining to be determined the E-cadherin-dependent signaling pathway involved in this N-glycans expression regulation. In this study, we analysed the impact of E-cadherin expression in the activation profile of receptor tyrosine kinases such as insulin receptor (IR) and IGF-I receptor (IGF-IR). We demonstrated that exogenous E-cadherin expression inhibits IR, IGF-IR and ERK 1/2 phosphorylation. Stimulation with insulin and IGF-I in MDA-MD-435 cancer cells overexpressing E-cadherin induces a decrease of bisecting GlcNAc N-glycans that was accompanied with alterations on E-cadherin cellular localization. Concomitantly, IR/IGFIR signaling activation induced a mesenchymal-like phenotype of cancer cells together with an increased tumor cell invasion capability. Altogether, these results demonstrate an interplay between E-cadherin and IR/IGF-IR signaling as major networking players in the regulation of bisecting N-glycans expression, with important effects in the modulation of epithelial characteristics and tumor cell invasion. Here we provide new insights into the role that Insulin/IGF-I signaling play during cancer progression through glycosylation modifications.	[Madureira de-Freitas-Junior, Julio Cesar; Morgado-Diaz, Jose Andres] Brazilian Natl Canc Inst, Div Cellular Biol, Rio De Janeiro, RJ, Brazil; [Carvalho, Sandra; Dias, Ana M.; Oliveira, Patricia; Cabral, Joana; Seruca, Raquel; Oliveira, Carla; Reis, Celso A.; Pinho, Salome S.] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Carvalho, Sandra; Reis, Celso A.; Pinho, Salome S.] Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Seruca, Raquel; Oliveira, Carla; Reis, Celso A.] Univ Porto, Fac Med, P-4100 Oporto, Portugal	National Cancer Institute (Inca); Universidade do Porto; Universidade do Porto; Universidade do Porto	Morgado-Diaz, JA (corresponding author), Brazilian Natl Canc Inst, Div Cellular Biol, Rio De Janeiro, RJ, Brazil.	jmorgado@inca.gov.br; celsor@ipatimup.pt; salomep@ipatimup.pt	Oliveira, Patrícia JMF/J-9447-2013; Morgado-Diaz, Jose A./A-9649-2010; de Freitas Junior, Julio Cesar/M-5754-2013; Carvalho, Sandra/ABA-8715-2020; Dias, Ana/AAE-8828-2020; Carvalho, Sandra S/K-1724-2016; REIS, Celso A/B-9969-2008; Oliveira, Carla/F-8188-2011; Pinho, Salome/F-1764-2011	Oliveira, Patrícia JMF/0000-0002-3078-2950; de Freitas Junior, Julio Cesar/0000-0002-2070-1432; Carvalho, Sandra/0000-0003-3647-3582; Carvalho, Sandra S/0000-0003-3647-3582; REIS, Celso A/0000-0002-0286-6639; Oliveira, Carla/0000-0001-8340-2264; Seruca, Raquel/0000-0002-8851-4166; Pinho, Salome/0000-0002-3484-5162; Dias, Ana/0000-0003-0060-2872; Cabral, Joana/0000-0002-3496-5463	Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [6155/11-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao para a Ciencia e Tecnologia, FCT [SFRH/BPD/63094/2009]; Luso-American Foundation (FLAD); bilateral protocol between FCT/CAPES; FCT; Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/111358/2009, PIC/IC/82716/2007, PTDC/SAU-GMG/110785/2009];  [SFRH/BPD/89764/2012]	Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao para a Ciencia e Tecnologia, FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Luso-American Foundation (FLAD); bilateral protocol between FCT/CAPES; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); 	Financial support from Brazil: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Student grant - process number: 6155/11-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Financial support from Portugal: SSP acknowledges Fundacao para a Ciencia e Tecnologia, FCT [SFRH/BPD/63094/2009], the Luso-American Foundation (FLAD), and the bilateral protocol between FCT/CAPES 2013-2015. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT. This work was supported by grants from the Portuguese Foundation for Science and Technology (FCT), project grants [PTDC/CVT/111358/2009; PIC/IC/82716/2007; PTDC/SAU-GMG/110785/2009)], Post-Doc grant to PO [SFRH/BPD/89764/2012]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Carvalho J, 2012, J PATHOL, V228, P31, DOI 10.1002/path.4032; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Feng Y, 2008, CURR OPIN DRUG DISC, V11, P178; Ferreira AC, 2012, HUM MOL GENET, V21, P334, DOI 10.1093/hmg/ddr469; Granovsky M, 2000, NAT MED, V6, P306; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Ji QS, 2007, MOL CANCER THER, V6, P2158, DOI 10.1158/1535-7163.MCT-07-0070; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; de Freitas JCM, 2011, CANCER CHEMOTH PHARM, V68, P227, DOI 10.1007/s00280-010-1477-8; McKinley ET, 2011, CLIN CANCER RES, V17, P3332, DOI 10.1158/1078-0432.CCR-10-2274; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Oliveira C, 2009, GASTROENTEROLOGY, V136, P2137, DOI 10.1053/j.gastro.2009.02.065; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Paye JMD, 2007, CELL COMMUN ADHES, V14, P85, DOI 10.1080/15419060701463116; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033191; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Walsh LA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-10; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhao H, 2012, MOL CANCER THER, V11, P503, DOI 10.1158/1535-7163.MCT-11-0327; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	36	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81579	10.1371/journal.pone.0081579	http://dx.doi.org/10.1371/journal.pone.0081579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282611	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500114
J	Rodriguez, ME; Loyd, CM; Ding, XD; Karim, AF; McDonald, DJ; Canaday, DH; Rojas, RE				Rodriguez, Myriam E.; Loyd, Candace M.; Ding, Xuedong; Karim, Ahmad F.; McDonald, David J.; Canaday, David H.; Rojas, Roxana E.			Mycobacterial Phosphatidylinositol Mannoside 6 (PIM6) Up-Regulates TCR-Triggered HIV-1 Replication in CD4(+) T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INFECTED MACROPHAGES; DENDRITIC CELLS; IN-VITRO; TUBERCULOSIS; EXPRESSION; ACTIVATION; INTEGRIN	Tuberculosis (TB) is the leading cause of mortality among those infected with human immunodeficiency virus (HIV-1) worldwide. HIV-1 load and heterogeneity are increased both locally and systemically in active TB. Mycobacterium tuberculosis (MTB) infection supports HIV-1 replication through dysregulation of host cytokines, chemokines, and their receptors. However the possibility that mycobacterial molecules released from MTB infected macrophages directly interact with CD4(+) T cells triggering HIV-1 replication has not been fully explored. We studied the direct effect of different MTB molecules on HIV-1 replication (R5-tropic strain Bal) in anti-CD3-stimulated CD4(+) T cells from healthy donors in an antigen presenting cell (APC)-free system. PIM6, a major glycolipid of the mycobacterial cell wall, induced significant increases in the percent of HIV-1 infected T cells and the viral production in culture supernatants. In spite of structural relatedness, none of the other three major MTB cell wall glycolipids had significant impact on HIV-1 replication in T cells. Increased levels of IFN-gamma in culture supernatants from cells treated with PIM6 indicate that HIV-1 replication is likely dependent on enhanced T cell activation. In HEK293 cells transfected with TLR2, PIM6 was the strongest TLR2 agonist among the cell wall associated glycolipids tested. PIM6 increased the percentage of HIV infected cells and viral particles in the supernatant in a T-cell-based reporter cell line (JLTRg-R5) transfected with TLR1 and TLR2 but not in the cells transfected with the empty vector (which lack TLR2 expression) confirming that PIM6-induced HIV-1 replication depends at least partially on TLR2 signaling.	[Rodriguez, Myriam E.; Loyd, Candace M.; Ding, Xuedong; Karim, Ahmad F.; Canaday, David H.; Rojas, Roxana E.] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [McDonald, David J.; Rojas, Roxana E.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [McDonald, David J.; Rojas, Roxana E.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Canaday, David H.] Cleveland VA MedicalCtr, Cleveland, VA USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	Rojas, RE (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.	rxr38@case.edu	ismail, hanafi/AAH-9159-2020; Ismail, Hanafi/A-3564-2009		National Institute of Health [P30 AI036219, AI080313, AI027243, HL106798, AI099494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027243, R01AI087511, R21AI099494, P30AI036219, R01AI080313] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Health grants P30 AI036219 (CWRU/UH Center for AIDS Research, Case-CFAR), AI080313, AI027243, HL106798 and AI099494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; [Anonymous], TB HIV FACTS 2011; Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Collins KR, 2002, J VIROL, V76, P1697, DOI 10.1128/JVI.76.4.1697-1706.2002; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Ding J, 2012, J IMMUNOL, V188, P992, DOI 10.4049/jimmunol.1102098; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/518667; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461; Goletti D, 1996, J IMMUNOL, V157, P1271; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kabelitz D, 2007, CURR OPIN IMMUNOL, V19, P39, DOI 10.1016/j.coi.2006.11.007; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lancioni CL, 2011, INFECT IMMUN, V79, P663, DOI 10.1128/IAI.00806-10; Lancioni CL, 2009, J IMMUNOL METHODS, V344, P15, DOI 10.1016/j.jim.2009.02.005; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Li Q, 2012, J LEUKOCYTE BIOL, V91, P311, DOI 10.1189/jlb.0711364; MAGUIRE JE, 1995, J EXP MED, V182, P2079, DOI 10.1084/jem.182.6.2079; Mahon RN, 2012, CELL IMMUNOL, V275, P98, DOI 10.1016/j.cellimm.2012.02.009; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; Neri F, 2011, J GEN VIROL, V92, P141, DOI 10.1099/vir.0.026005-0; Neto EH, 2007, BBA-MOL CELL RES, V1773, P176, DOI 10.1016/j.bbamcr.2006.09.026; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Ramachandra L, 2010, INFECT IMMUN, V78, P5116, DOI 10.1128/IAI.01089-09; Rojas RE, 2006, J IMMUNOL, V177, P2959, DOI 10.4049/jimmunol.177.5.2959; Sundstrom JB, 2004, J IMMUNOL, V172, P4391, DOI 10.4049/jimmunol.172.7.4391; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Thayil SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041093; Thibault S, 2007, J IMMUNOL, V179, P4357, DOI 10.4049/jimmunol.179.7.4357; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Torre VS, 2000, J VIROL, V74, P4868, DOI 10.1128/JVI.74.10.4868-4876.2000; *UNAIDS, 2008, UNAIDS REP GLOB AIDS; van Seventer GA, 1998, EUR J IMMUNOL, V28, P3867, DOI 10.1002/(SICI)1521-4141(199811)28:11<3867::AID-IMMU3867>3.3.CO;2-B; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125	57	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80938	10.1371/journal.pone.0080938	http://dx.doi.org/10.1371/journal.pone.0080938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282561	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500063
J	Zhou, DX; Ji, ZX; Jiang, XM; Dunphy, DR; Brinker, J; Keller, AA				Zhou, Dongxu; Ji, Zhaoxia; Jiang, Xingmao; Dunphy, Darren R.; Brinker, Jeffrey; Keller, Arturo A.			Influence of Material Properties on TiO2 Nanoparticle Agglomeration	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; AGGREGATION KINETICS; OXIDE NANOPARTICLES; HUMIC-ACID; SURFACE; RUTILE; SIZE; NANOMATERIALS; MONOVALENT; PARTICLES	Emerging nanomaterials are being manufactured with varying particle sizes, morphologies, and crystal structures in the pursuit of achieving outstanding functional properties. These variations in these key material properties of nanoparticles may affect their environmental fate and transport. To date, few studies have investigated this important aspect of nanoparticles' environmental behavior. In this study, the aggregation kinetics of ten different TiO2 nanoparticles (5 anatase and 5 rutile each with varying size) was systematically evaluated. Our results show that, as particle size increases, the surface charge of both anatase and rutile TiO2 nanoparticles shifts toward a more negative value, and, accordingly, the point of zero charge shifts toward a lower value. The colloidal stability of anatase sphere samples agreed well with DLVO theoretical predictions, where an increase in particle size led to a higher energy barrier and therefore greater critical coagulation concentration. In contrast, the critical coagulation concentration of rutile rod samples correlated positively with the specific surface area, i.e., samples with higher specific surface area exhibited higher stability. Finally, due to the large innate negative surface charge of all the TiO2 samples at the pH value (pH = 8) tested, the addition of natural organic matter was observed to have minimal effect on TiO2 aggregation kinetics, except for the smallest rutile rods that showed decreased stability in the presence of natural organic matter.	[Zhou, Dongxu; Keller, Arturo A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Zhou, Dongxu; Ji, Zhaoxia; Keller, Arturo A.] Univ Calif Los Angeles, Ctr Environm Implicat Nanotechnol, Los Angeles, CA USA; [Jiang, Xingmao; Dunphy, Darren R.; Brinker, Jeffrey] Univ New Mexico, Ctr Microengn Mat, Albuquerque, NM 87131 USA; [Jiang, Xingmao; Dunphy, Darren R.; Brinker, Jeffrey] Univ New Mexico, Dept Chem Engn, Albuquerque, NM 87131 USA; [Brinker, Jeffrey] Sandia Natl Labs, Albuquerque, NM USA	University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories	Keller, AA (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu			National Science Foundation; US Environmental Protection Agency [DBI-0830117]; US Public Health Service [U19 ES019528]; Sandia National Laboratory LDRD program; Los Alamos National Laboratory IMMS program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019528] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency(United States Environmental Protection Agency); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sandia National Laboratory LDRD program(United States Department of Energy (DOE)); Los Alamos National Laboratory IMMS program(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Foundation and the US Environmental Protection Agency under Cooperative Agreement Number DBI-0830117. CJB, XJ, and DD acknowledge support from US Public Health Service Grants, U19 ES019528 (UCLA Center for Nanobiology and Predictive Toxicology) and the Sandia National Laboratory LDRD program. We also gratefully acknowledge partial funding from the Los Alamos National Laboratory IMMS program for Dongxu Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2008, J PHYS CHEM C, V112, P5715, DOI 10.1021/jp709667u; Abe T, 2011, COLLOID SURFACE A, V379, P21, DOI 10.1016/j.colsurfa.2010.11.052; Buettner KM, 2010, COLLOID SURFACE A, V366, P74, DOI 10.1016/j.colsurfa.2010.05.024; Chen GX, 2012, ENVIRON SCI TECHNOL, V46, P7142, DOI 10.1021/es204010g; Chen KL, 2007, J COLLOID INTERF SCI, V309, P126, DOI 10.1016/j.jcis.2007.01.074; Chen KL, 2006, ENVIRON SCI TECHNOL, V40, P1516, DOI 10.1021/es0518068; Christian P, 2008, ECOTOXICOLOGY, V17, P326, DOI 10.1007/s10646-008-0213-1; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Elimelech M., 1995, PARTICLE DEPOSITION, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]; FOISSY A, 1982, COLLOID SURFACE, V5, P363, DOI 10.1016/0166-6622(82)80046-2; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; GIACOMELLI CE, 1995, LANGMUIR, V11, P3483, DOI 10.1021/la00009a034; Guerrero-Garcia GI, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656763; Guzman KAD, 2006, ENVIRON SCI TECHNOL, V40, P7688, DOI 10.1021/es060847g; Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0; He YT, 2008, J NANOPART RES, V10, P321, DOI 10.1007/s11051-007-9255-1; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4; Johnson AC, 2011, SCI TOTAL ENVIRON, V409, P2503, DOI 10.1016/j.scitotenv.2011.03.040; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Keller AA, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1692-4; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kobayashi M, 2005, LANGMUIR, V21, P5761, DOI 10.1021/la046829z; Lead J.R., 2009, WILEY, V7, P132; Liu XY, 2011, J COLLOID INTERF SCI, V363, P84, DOI 10.1016/j.jcis.2011.06.085; Liu XY, 2010, J COLLOID INTERF SCI, V348, P101, DOI 10.1016/j.jcis.2010.04.036; McBride MB, 2002, SOIL SCI SOC AM J, V66, P1207, DOI 10.2136/sssaj2002.1207; Mulvihill MJ, 2010, CHEM MATER, V22, P5251, DOI 10.1021/cm101262s; Perron H, 2007, THEOR CHEM ACC, V117, P565, DOI 10.1007/s00214-006-0189-y; Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h; RAMAMOORTHY M, 1994, PHYS REV B, V49, P16721, DOI 10.1103/PhysRevB.49.16721; Saleh NB, 2008, ENVIRON SCI TECHNOL, V42, P7963, DOI 10.1021/es801251c; Stone V, 2010, SCI TOTAL ENVIRON, V408, P1745, DOI 10.1016/j.scitotenv.2009.10.035; Suttiponparnit K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9772-1; Thio BJR, 2012, ENVIRON SCI TECHNOL, V46, P6985, DOI 10.1021/es203596w; Thio BJR, 2011, J HAZARD MATER, V189, P556, DOI 10.1016/j.jhazmat.2011.02.072; Wang DW, 2011, ACS NANO, V5, P530, DOI 10.1021/nn1025252; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Zhou DX, 2012, ENVIRON SCI TECHNOL, V46, P7520, DOI 10.1021/es3004427; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025	42	82	85	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81239	10.1371/journal.pone.0081239	http://dx.doi.org/10.1371/journal.pone.0081239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282573	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500075
J	Ahn, M; Cho, H; Ahn, S; Jun, SC				Ahn, Minkyu; Cho, Hohyun; Ahn, Sangtae; Jun, Sung Chan			High Theta and Low Alpha Powers May Be Indicative of BCI-Illiteracy in Motor Imagery	PLOS ONE			English	Article							DEFAULT MODE; BRAIN; ATTENTION; OSCILLATIONS; CORTEX; DESYNCHRONIZATION; SYNCHRONIZATION; INFORMATION; BIOFEEDBACK; DYNAMICS	In most brain computer interface (BCI) systems, some target users have significant difficulty in using BCI systems. Such target users are called 'BCI-illiterate'. This phenomenon has been poorly investigated, and a clear understanding of the BCI-illiteracy mechanism or a solution to this problem has not been reported to date. In this study, we sought to demonstrate the neurophysiological differences between two groups (literate, illiterate) with a total of 52 subjects. We investigated recordings under non-task related state (NTS) which is collected during subject is relaxed with eyes open. We found that high theta and low alpha waves were noticeable in the BCI-illiterate relative to the BCI-literate people. Furthermore, these high theta and low alpha wave patterns were preserved across different mental states, such as NTS, resting before motor imagery (MI), and MI states, even though the spatial distribution of both BCI-illiterate and BCI-literate groups did not differ. From these findings, an effective strategy for pre-screening subjects for BCI illiteracy has been determined, and a performance factor that reflects potential user performance has been proposed using a simple combination of band powers. Our proposed performance factor gave an r = 0.59 (r(2) = 0.34) in a correlation analysis with BCI performance and yielded as much as r = 0.70 (r(2) = 0.50) when seven outliers were rejected during the evaluation of whole data (N = 61), including BCI competition datasets (N = 9). These findings may be directly applicable to online BCI systems.	[Ahn, Minkyu; Cho, Hohyun; Ahn, Sangtae; Jun, Sung Chan] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea; [Jun, Sung Chan] New York State Hlth Dept, Wadsworth Ctr, Albany, NY USA	Gwangju Institute of Science & Technology (GIST); Wadsworth Center	Jun, SC (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	scjun@gist.ac.kr	JUN, SUNG/AAJ-2677-2020	JUN, SUNG/0000-0001-5357-4436; Ahn, Sangtae/0000-0001-9487-5649; Ahn, Minkyu/0000-0001-6512-0167; Cho, Hohyun/0000-0003-1512-0622	National Research Foundation of Korea (NRF); Korea government (MEST) [2010-0006135]; Korea Research Council of Fundamental Science and Technology (KRCF) through the Basic Research Project	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research Council of Fundamental Science and Technology (KRCF) through the Basic Research Project	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2010-0006135) and the Korea Research Council of Fundamental Science and Technology (KRCF) through the Basic Research Project managed by KRISS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, J NEUROSCI METH, V204, P168, DOI 10.1016/j.jneumeth.2011.11.002; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blankertz B, 2008, ACM SIGCHI P; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064; Cruikshank LC, 2012, J NEUROPHYSIOL, V107, P65, DOI 10.1152/jn.00893.2010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Erfani A, 2004, P ANN INT IEEE EMBS, V26, P239; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Gibbons JD, 2011, NONPARAMETRIC STAT I, V1, P977, DOI 10.1007/978-3-642-04898-2_420; Grosse-Wentrup M, 2011, 5 INT BCI C P, V172-175; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2011, RECENT ADV BRAIN COM; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hoshi E, 2000, NATURE, V408, P466, DOI 10.1038/35044075; Hwang HJ, 2009, J NEUROSCI METH, V179, P150, DOI 10.1016/j.jneumeth.2009.01.015; Inanaga K, 1998, PSYCHIAT CLIN NEUROS, V52, P555, DOI 10.1046/j.1440-1819.1998.00452.x; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; KURATA K, 1994, BEHAV BRAIN RES, V61, P135, DOI 10.1016/0166-4328(94)90154-6; Leeb R, 2007, IEEE T NEUR SYS REH, V15, P473, DOI 10.1109/TNSRE.2007.906956; Linden M, 1996, BIOFEEDBACK SELF-REG, V21, P35, DOI 10.1007/BF02214148; McCartney H, 2004, HIPPOCAMPUS, V14, P684, DOI 10.1002/hipo.20019; Monastra VJ, 2005, APPL PSYCHOPHYS BIOF, V30, P95, DOI 10.1007/s10484-005-4305-x; Muller-Putz GR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00034; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sannelli C, 2008, ESTIMATING NOISE DIM; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sokolov A, 2004, NEUROIMAGE, V22, P521, DOI 10.1016/j.neuroimage.2004.01.045; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; van Gerven M, 2009, NEURAL NETWORKS, V22, P1271, DOI 10.1016/j.neunet.2009.06.004; Varkuti B, 2011, 5 INT BCI C P, P104; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Volosyak I, 2010, IEEE ENG MED BIO, P4201, DOI 10.1109/IEMBS.2010.5627390; Vukovic A., 2010, P 2010 3 INT S APPL, P1	49	116	121	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80886	10.1371/journal.pone.0080886	http://dx.doi.org/10.1371/journal.pone.0080886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278339	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700036
J	Khathi, A; Serumula, MR; Myburg, RB; Van Heerden, FR; Musabayane, CT				Khathi, Andile; Serumula, Metse R.; Myburg, Rene B.; Van Heerden, Fanie R.; Musabayane, Cephas T.			Effects of Syzygium aromaticum-Derived Triterpenes on Postprandial Blood Glucose in Streptozotocin-Induced Diabetic Rats Following Carbohydrate Challenge	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE; OLEANOLIC ACID; AMYLASE; EXTRACT; INSULIN; INHIBITION; ACARBOSE; GLYCOGEN	Purpose: Recent reports suggest that the hypoglycaemic effects of the triterpenes involve inhibition of glucose transport in the small intestine. Therefore, the effects of Syzygium spp-derived triterpenes oleanolic acid (OA) and maslinic acid (MA) were evaluated on carbohydrate hydrolyzing enzymes in STZ-induced diabetic rats and consequences on postprandial hyperglycaemia after carbohydrate loading. Methods: We determined using Western blot analysis the expressions of alpha-amylase and alpha-glucosidase and glucose transporters SGLT1 and GLUT2 in the small intestine intestines isolated from diabetic rats treated with OA/MA for 5 weeks. In vitro assays were used to assess the inhibitory activities of OA and MA against alpha-amylase, alpha-glucosidase and sucrase. Results: OA and MA ameliorated postprandial hyperglycemia in carbohydrate loaded diabetic rats as indicated by the significantly small glucose area under the curve (AUC) in treated diabetic animals compared with that in untreated diabetic rats. Western blotting showed that OA and MA treatment not only down-regulated the increase of SGLT1 and GLUT2 expressions in the small intestine of STZ-induced diabetic rats, but also inhibited small intestine alpha-amylase, sucrase and alpha-glucosidase activity. IC50 values of OA against alpha-amylase (3.60 +/- 0.18 mmol/L), alpha-glucosidase (12.40 +/- 0.11 mmol/L) and sucrase (11.50 +/- 0.13 mmol/L) did not significantly differ from those of OA and acarbose. Conclusions: The results of suggest that OA and MA may be used as potential supplements for treating postprandial hyperglycemia. Novelty of the Work: The present observations indicate that besides improving glucose homeostasis in diabetes, OA and MA suppress postprandial hyperglycaemia mediated in part via inhibition of carbohydrate hydrolysis and reduction of glucose transporters in the gastrointestinal tract. Inhibition of alpha-glucosidase and alpha-amylase can significantly decrease the postprandial hyperglycaemia after a mixed carbohydrate diet and therefore can be an important strategy in the management of postprandial blood glucose levels in NIDDM patients.	[Khathi, Andile; Serumula, Metse R.; Myburg, Rene B.; Musabayane, Cephas T.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Van Heerden, Fanie R.] Univ KwaZulu Natal, Sch Chem & Phys, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Musabayane, CT (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa.	musabayanec@ukzn.ac.za	Van Heerden, Fanie R/A-5685-2008; Khathi, Andile/S-9664-2019	Van Heerden, Fanie R/0000-0002-5710-7525; Khathi, Andile/0000-0002-2246-0038; Khan, Rene/0000-0002-3589-6869	NRF South Africa; University of KwaZulu-Natal, Research Division	NRF South Africa(National Research Foundation - South Africa); University of KwaZulu-Natal, Research Division	The authors are grateful to the NRF South Africa and the University of KwaZulu-Natal, Research Division for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari MR, 2008, FOOD CHEM, V106, P247, DOI 10.1016/j.foodchem.2007.05.077; Brayer GD, 2000, BIOCHEMISTRY-US, V39, P4778, DOI 10.1021/bi9921182; Ceriello A, 2006, CURR OPIN LIPIDOL, V17, P510, DOI 10.1097/01.mol.0000245256.17764.fb; Charpentier G, 2000, DIABETES METAB, V26, P73; Deshpande MC, 2009, INT J PHARMACEUT, V380, P16, DOI 10.1016/j.ijpharm.2009.06.024; Diaz-Gutierrez FL, 1998, AM J GASTROENTEROL, V93, P481, DOI 10.1111/j.1572-0241.1998.481_1.x; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Dyer J., 1997, Biochemical Society Transactions, V25, p479S; Eggermont E, 1969, EUR J BIOCH, V9; Fred-Jaiyesimi A, 2009, FOOD CHEM, V116, P285, DOI 10.1016/j.foodchem.2009.02.047; Gao H, 2008, BIOORG MED CHEM LETT, V18, P812, DOI 10.1016/j.bmcl.2007.11.032; Garcia-Granados A, 2000, J CHEM RES SYNOP, V2; Gowri PM, 2007, PHYTOTHER RES, V21, P796, DOI 10.1002/ptr.2176; Hanefeld M, 1998, J DIABETES COMPLICAT, V12, P228, DOI 10.1016/S1056-8727(97)00123-2; HARA Y, 1990, AGR BIOL CHEM TOKYO, V54, P1939, DOI 10.1080/00021369.1990.10870239; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Hussain S.A., 2012, J DIABETES MELLITUS, V02, P82, DOI [10.4236/jdm.2012.21013, DOI 10.4236/JDM.2012.21013]; Inoue I, 1997, DIABETES RES CLIN PR, V36, P143, DOI 10.1016/S0168-8227(97)00045-4; Jo S.-H., 2009, INT J APPL RES NAT P, V2, P52; Khathi A, 2013, J DIABETES, V5, P80, DOI 10.1111/j.1753-0407.2012.00230.x; Kim GN, 2009, FOOD CHEM, V117, P35, DOI 10.1016/j.foodchem.2009.03.072; Kwon YI, 2007, J MED FOOD, V10, P266, DOI 10.1089/jmf.2006.234; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Meinild AK, 1998, J PHYSIOL-LONDON, V508, P15, DOI 10.1111/j.1469-7793.1998.015br.x; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; Musabayane CT, 2005, RENAL FAILURE, V27, P763, DOI 10.1080/08860220500244807; Musabayane CT, 2005, J ETHNOPHARMACOL, V97, P485, DOI 10.1016/j.jep.2004.12.005; Ortiz-Andrade RR, 2007, J ETHNOPHARMACOL, V109, P48, DOI 10.1016/j.jep.2006.07.002; Parkin CG, 2002, CLIN DIABETES, V20, P71, DOI DOI 10.2337/DIACLIN.20.2.71; Raptis SA, 2001, EXP CLIN ENDOCR DIAB, V109, pS265, DOI 10.1055/s-2001-18588; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Uddin GHW, 2011, J SCI RES, V8, P85; van de Laar FA, 2005, DIABETES CARE, V28, P154, DOI 10.2337/diacare.28.1.154; Yoshikawa M, 2002, J NUTR, V132, P1819, DOI 10.1093/jn/132.7.1819	35	51	53	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81632	10.1371/journal.pone.0081632	http://dx.doi.org/10.1371/journal.pone.0081632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278452	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700069
J	Lim, SH; Park, E; You, B; Jung, Y; Park, AR; Park, SG; Lee, JR				Lim, So-Hee; Park, Eunha; You, Boram; Jung, Youngseob; Park, A-Reum; Park, Sung Goo; Lee, Jae-Ran			Neuronal Synapse Formation Induced by Microglia and Interleukin 10	PLOS ONE			English	Article							CLASS-I MHC; NEUROTROPHIC FACTOR; BRAIN; RECEPTOR; CELLS; CNS; EXPRESSION; ACTIVATION; PROTEIN; IL-10	Recently, it was found that microglia regulated synaptic remodeling of the developing brain, but their mechanisms have not been well understood. In this study, the action of microglia on neuronal synapse formation was investigated, and the primary target of microglial processes was discovered. When the developing microglia were applied to cultured hippocampal neurons without direct contact, the numbers of dendritic spines and excitatory and inhibitory synapses significantly increased. In order to find out the main factor for synaptic formation, the effects of cytokines released from microglia were examined. When recombinant proteins of cytokines were applied to neuronal culture media, interleukin 10 increased the numbers of dendritic spines in addition to excitatory and inhibitory synapses. Interestingly, without external stimuli, the amount of interleukin 10 released from the intact microglia appeared to be sufficient for the induction of synaptic formation. The neutralizing antibodies of interleukin 10 receptors attenuated the induction of the synaptic formation by microglia. The expression of interleukin 10 receptor was newly found in the hippocampal neurons of early developmental stage. When interleukin 10 receptors on the hippocampal neurons were knocked down with specific shRNA, the induction of synaptic formation by microglia and interleukin 10 disappeared. Pretreatment with lipopolysaccharide inhibited microglia from inducing synaptic formation, and interleukin 1 beta antagonized the induction of synaptic formation by interleukin 10. In conclusion, the developing microglia regulated synaptic functions and neuronal development through the interactions of the interleukin 10 released from the microglia with interleukin 10 receptors expressed on the hippocampal neurons.	[Lim, So-Hee; Park, Eunha; You, Boram; Jung, Youngseob; Park, A-Reum; Park, Sung Goo; Lee, Jae-Ran] Korea Res Inst Bioscience & Biotechnol, Biomed Prote Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, JR (corresponding author), Korea Res Inst Bioscience & Biotechnol, Biomed Prote Res Ctr, Taejon, South Korea.	leejr@kribb.re.kr			National Research Foundation of Korea (NRF) grant; Korea government [2012R1A2A2A02014520, 2009-0087354]; KRIBB research initiative program	National Research Foundation of Korea (NRF) grant; Korea government(Korean Government); KRIBB research initiative program	National Research Foundation of Korea (NRF) grant funded by the Korea government (2012R1A2A2A02014520 and 2009-0087354 to J.R.L.) and a grant from KRIBB research initiative program (to J.R.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachis A, 2001, J NEUROSCI, V21, P3104, DOI 10.1523/JNEUROSCI.21-09-03104.2001; Balasingam V, 1996, J NEUROSCI, V16, P2945; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; de Bilbao F, 2009, J NEUROCHEM, V110, P12, DOI 10.1111/j.1471-4159.2009.06098.x; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hocke AC, 2006, CYTOKINE, V33, P199, DOI 10.1016/j.cyto.2006.01.007; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; JI K, 2013, PLOS ONE, V8, P15253, DOI DOI 10.1371/J0URNAL.P0NE.0056293.PUBMED:23393609; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; KAUR C, 1987, J ANAT, V152, P13; Kelly A, 2001, J BIOL CHEM, V276, P45564, DOI 10.1074/jbc.M108757200; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Ledeboer A, 2002, EUR J NEUROSCI, V16, P1175, DOI 10.1046/j.1460-9568.2002.02200.x; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; Park KW, 2007, EXP MOL MED, V39, P812, DOI 10.1038/emm.2007.88; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Silva SL, 2012, NEUROPHARMACOLOGY, V62, P2398, DOI 10.1016/j.neuropharm.2012.02.002; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TODD KJ, 2005, J PHYSL, V99, P75; Wu LJ, 2008, J NEUROPHYSIOL, V99, P2026, DOI 10.1152/jn.01210.2007; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	50	126	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81218	10.1371/journal.pone.0081218	http://dx.doi.org/10.1371/journal.pone.0081218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278397	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700052
J	Balogun, KA; Albert, CJ; Ford, DA; Brown, RJ; Cheema, SK				Balogun, Kayode A.; Albert, Carolyn J.; Ford, David A.; Brown, Robert J.; Cheema, Sukhinder K.			Dietary Omega-3 Polyunsaturated Fatty Acids Alter the Fatty Acid Composition of Hepatic and Plasma Bioactive Lipids in C57BL/6 Mice: A Lipidomic Approach	PLOS ONE			English	Article							ESSENTIAL PHOSPHOLIPIDS; INFLAMMATORY RESPONSE; DOCOSAHEXAENOIC ACID; RECEPTOR-ALPHA; LYSOPHOSPHATIDYLCHOLINE; METABOLISM; MODULATION; EXPRESSION; MECHANISM; LYSOPHOSPHOLIPIDS	Background: Omega (n)-3 polyunsaturated fatty acids (PUFA) are converted to bioactive lipid components that are important mediators in metabolic and physiological pathways; however, which bioactive compounds are metabolically active, and their mechanisms of action are still not clear. We investigated using lipidomic techniques, the effects of diets high in n-3 PUFA on the fatty acid composition of various bioactive lipids in plasma and liver. Methodology and Principal Findings: Female C57BL/6 mice were fed semi-purified diets (20% w/w fat) containing varying amounts of n-3 PUFA before mating, during gestation and lactation, and until weaning. Male offspring were continued on their mothers' diets for 16 weeks. Hepatic and plasma lipids were extracted in the presence of non-naturally occurring internal standards, and tandem electrospray ionization mass spectrometry methods were used to measure the fatty acyl compositions. There was no significant difference in total concentrations of phospholipids in both groups. However, there was a significantly higher concentration of eicosapentaenoic acid containing phosphatidylcholine (PC), lysophosphatidylcholine (LPC), and cholesteryl esters (CE) (p < 0.01) in the high n-3 PUFA group compared to the low n-3 PUFA group in both liver and plasma. Plasma and liver from the high n-3 PUFA group also had a higher concentration of free n-3 PUFA (p < 0.05). There were no significant differences in plasma concentrations of different fatty acyl species of phosphatidylethanolamine, triglycerides, sphingomyelin and ceramides. Conclusions/Significance: Our findings reveal for the first time that a diet high in n-3 PUFA caused enrichment of n-3 PUFA in PC, LPC, CE and free fatty acids in the plasma and liver of C57BL/6 mice. PC, LPC, and unesterified free n-3 PUFA are important bioactive lipids, thus altering their fatty acyl composition will have important metabolic and physiological roles.	[Balogun, Kayode A.; Brown, Robert J.; Cheema, Sukhinder K.] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Ctr Cardiovasc Res, St Louis, MO 63103 USA	Memorial University Newfoundland; Saint Louis University; Saint Louis University	Cheema, SK (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	skaur@mun.ca	Ford, David/D-1819-2018	Ford, David/0000-0002-0029-1560; Brown, Robert/0000-0002-1875-1537	Natural Sciences and Engineering Research Council (SKC); Research & Development Corporation of Newfoundland and Labrador; National Institutes of Health [HL-074214, HL-111906]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111906, R01HL074214] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (SKC); Research & Development Corporation of Newfoundland and Labrador; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by funds from the Natural Sciences and Engineering Research Council (SKC), an Ignite R&D grant from the Research & Development Corporation of Newfoundland and Labrador (RJB), and National Institutes of Health Grants HL-074214 and HL-111906 (DAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Banni S, 2010, MOL NUTR FOOD RES, V54, P82, DOI 10.1002/mnfr.200900516; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Block RC, 2010, PROSTAG LEUKOTR ESS, V82, P87, DOI 10.1016/j.plefa.2009.12.005; Browning LM, 2012, AM J CLIN NUTR, V96, P748, DOI 10.3945/ajcn.112.041343; Bunea Ruxandra, 2004, Altern Med Rev, V9, P420; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chechi K, 2010, PROSTAG LEUKOTR ESS, V83, P97, DOI 10.1016/j.plefa.2010.06.001; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Colles SM, 2000, J LIPID RES, V41, P1188; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fuchs B, 2005, CLIN BIOCHEM, V38, P925, DOI 10.1016/j.clinbiochem.2005.06.006; Fuentes L, 2002, CIRC RES, V91, P681, DOI 10.1161/01.RES.0000038341.34243.64; Galli C, 2012, BRIT J CLIN PHARMACO, V74, P60, DOI 10.1111/j.1365-2125.2012.04174.x; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Gundermann KJ, 2011, PHARMACOL REP, V63, P643, DOI 10.1016/S1734-1140(11)70576-X; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Hayashi K, 2001, CIRC RES, V89, P251, DOI 10.1161/hh1501.094265; Hirafuji M, 2003, J PHARMACOL SCI, V92, P308; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; HOLUB BJ, 1978, J BIOL CHEM, V253, P691; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Huwiler A, 2009, PHARMACOL THERAPEUT, V124, P96, DOI 10.1016/j.pharmthera.2009.06.008; JUMP DB, 1994, J LIPID RES, V35, P1076; Klimov AN, 1995, CARDIOVASC DRUG THER, V9, P779, DOI 10.1007/BF00879871; Knopp RH, 1997, J CLIN ENDOCR METAB, V82, P3952, DOI 10.1210/jc.82.12.3952; Knopp Robert H, 2005, Curr Atheroscler Rep, V7, P472, DOI 10.1007/s11883-005-0065-6; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; Lagarde M, 2001, J MOL NEUROSCI, V16, P201, DOI 10.1385/JMN:16:2-3:201; Lamaziere A, 2013, PROSTAG LEUKOTR ESS, V88, P149, DOI 10.1016/j.plefa.2012.12.001; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; Lucas A, 2008, METABOLISM, V57, P233, DOI 10.1016/j.metabol.2007.09.006; Ma J, 1997, AM J CLIN NUTR, V65, P551, DOI 10.1093/ajcn/65.2.551; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Morise A, 2009, EUR J NUTR, V48, P465, DOI 10.1007/s00394-009-0037-7; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Hung DN, 2011, INFLAMMATION, V34, P147, DOI 10.1007/s10753-010-9218-z; Nguyen DH, 2011, BRIT J PHARMACOL, V162, P1119, DOI 10.1111/j.1476-5381.2010.01117.x; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Park CH, 2009, LIPIDS, V44, P425, DOI 10.1007/s11745-009-3286-6; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; PLUCKTHUN A, 1982, BIOCHEMISTRY-US, V21, P1743; PORTMAN OW, 1969, J LIPID RES, V10, P158; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Schmidt EB, 2005, THROMB RES, V115, P163, DOI 10.1016/j.thromres.2004.09.006; Schmitz G, 2010, ATHEROSCLEROSIS, V208, P10, DOI 10.1016/j.atherosclerosis.2009.05.029; Schuchardt JP, 2011, PROSTAG LEUKOTR ESS, V85, P381, DOI 10.1016/j.plefa.2011.07.006; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Tang X, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-70; Taylor LA, 2010, SUPPORT CARE CANCER, V18, P159, DOI 10.1007/s00520-009-0640-4; THIES F, 1992, J NEUROCHEM, V59, P1110, DOI 10.1111/j.1471-4159.1992.tb08353.x; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Treede I, 2007, J BIOL CHEM, V282, P27155, DOI 10.1074/jbc.M704408200; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; von Schacky Clemens, 2003, Curr Atheroscler Rep, V5, P139, DOI 10.1007/s11883-003-0086-y; VONSCHACKY C, 1985, J CLIN INVEST, V76, P1626, DOI 10.1172/JCI112147; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Wu WT, 2005, ENDOCRINOLOGY, V146, P3387, DOI 10.1210/en.2004-1654; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200	80	35	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e82399	10.1371/journal.pone.0082399	http://dx.doi.org/10.1371/journal.pone.0082399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278481	Green Accepted, Green Published, gold			2022-12-27	WOS:000327539800148
J	Hsin, LJ; Kao, HK; Chen, IH; Tsang, NM; Hsu, CL; Liu, SC; Chang, YS; Chang, KP				Hsin, Li-Jen; Kao, Huang-Kai; Chen, I-How; Tsang, Ngan-Ming; Hsu, Cheng-Lung; Liu, Shiau-Chin; Chang, Yu-Sun; Chang, Kai-Ping			Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-LYMPHOCYTES; EXPRESSION; CELLS; INFILTRATION; RADIOTHERAPY; CHEMOKINES; PLASMA; CANCER; DNA	Objectives: The aim of this cohort study was to examine the role of the chemokine (C-X-C motif) ligand 9 (CXCL9) on nasopharyngeal carcinoma (NPC). Materials & Methods: Sera from 205 NPC patients and 231 healthy individuals, and 86 NPC tumor samples were enrolled. CXCL9 expression in tissue samples was analyzed by quantitative real-time PCR and immunohistochemistry. CXCL9 serum concentrations were measured by enzyme-linked immunosorbent assay. Results: CXCL9 expression was significantly higher in tumors than in normal epithelium. CXCL9 serum concentrations were also significantly higher in NPC patients compared to those in healthy individuals (516.8 +/- 617.6 vs. 170.7 +/- 375.0 pg/mL, P<0.0001). Serum CXCL9 levels were significantly higher in NPC patients with higher tumor stages, nodal stages, and overall stages (P<0.001, P = 0.001, and P<0.001, respectively). We found a statistically significant correlation between the concentrations of CXCL9 and EBV DNA load in the NPC patients (Spearman's correlation analysis; r = 0.473, P<0.001; 95% confidence interval, 0.346-0.582). Moreover, NPC patients with higher CXCL9 levels (>290 pg/mL, median) before treatment had worse prognoses for overall survival and disease-free survival (P = 0.045 and P = 0.008, respectively). Multivariate logistic regression analyses also indicated that higher CXCL9 serum levels were an independent prognostic factor for disease-free survival (P = 0.015). Conclusion: Our study demonstrated that CXCL9 is associated with tumor burden and aggressiveness of NPC tumors and the serum level of this ligand may be useful as a prognostic indicator.	[Hsin, Li-Jen; Chen, I-How; Liu, Shiau-Chin; Chang, Kai-Ping] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Kao, Huang-Kai] Chang Gung Mem Hosp Lin Kou, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan; [Tsang, Ngan-Ming] Chang Gung Mem Hosp Lin Kou, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hsu, Cheng-Lung] Chang Gung Mem Hosp Lin Kou, Dept Internal Med, Div Hematol & Oncol, Tao Yuan, Taiwan; [Chang, Yu-Sun; Chang, Kai-Ping] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Chen, I-How; Chang, Kai-Ping] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chen, IH (corresponding author), Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan.	egawa@ms27.hinet.net; dr.kpchang@gmail.com			National Science Council [NSC99-2314-B-182A-051-MY3]; Department of Health [DOH99-TD-C-111-006]; Chang Gung University [CMRPG32090, CMRPG360213, CMRPG381113, CMRPG390643]; Chang Gung Memorial Hospital, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Chang Gung University; Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by the grant (NSC99-2314-B-182A-051-MY3) from the National Science Council, the grant (DOH99-TD-C-111-006) from the Department of Health, and by grants (CMRPG32090, CMRPG360213, CMRPG381113, CMRPG390643) from Chang Gung University and Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgos JS, 2005, MED ONCOL, V22, P113, DOI 10.1385/MO:22:2:113; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang KP, 2008, CLIN CANCER RES, V14, P6979, DOI 10.1158/1078-0432.CCR-08-0090; Chang KP, 2012, J NUCL MED, V53, P21, DOI 10.2967/jnumed.111.090696; Chang KP, 2011, CLIN CHIM ACTA, V412, P980, DOI 10.1016/j.cca.2011.02.002; Chang KP, 2011, HEAD NECK-J SCI SPEC, V33, P886, DOI 10.1002/hed.21557; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Chang KP, 2010, ANN SURG ONCOL, V17, P1945, DOI 10.1245/s10434-010-0926-2; Chang KP, 2006, LARYNGOSCOPE, V116, P541, DOI 10.1097/01.mlg.0000201993.53410.40; Cheng SH, 2000, INT J RADIAT ONCOL, V48, P1323, DOI 10.1016/S0360-3016(00)00779-3; HO HC, 1976, BRIT J CANCER, V34, P655, DOI 10.1038/bjc.1976.228; Hu JY, 2005, CLIN CANCER RES, V11, P4658, DOI 10.1158/1078-0432.CCR-04-1798; Kunz M, 1999, J PATHOL, V189, P552, DOI 10.1002/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I; Lai HC, 2010, VIROLOGY, V405, P464, DOI 10.1016/j.virol.2010.06.037; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lo YMD, 1999, CANCER RES, V59, P1188; Lu X, 2011, EUR J CANCER, V47, P339, DOI 10.1016/j.ejca.2010.09.025; Ma BBY, 2006, INT J RADIAT ONCOL, V66, P714, DOI 10.1016/j.ijrobp.2006.05.064; Miura M, 2001, J IMMUNOL, V167, P3494, DOI 10.4049/jimmunol.167.6.3494; Murphy PM, 2000, PHARMACOL REV, V52, P145; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Ohshima K, 2003, LEUKEMIA LYMPHOMA, V44, P329, DOI 10.1080/1042819031000060546; Oppenheim JJ, 1997, CLIN CANCER RES, V3, P2682; Ou DL, 2006, J PATHOL, V210, P363, DOI 10.1002/path.2053; Parsonage G, 2012, AM J PATHOL, V180, P1215, DOI 10.1016/j.ajpath.2011.11.032; Ruiz-Garcia E, 2010, BRIT J CANCER, V102, P462, DOI 10.1038/sj.bjc.6605511; Tang KF, 2001, HUM PATHOL, V32, P42, DOI 10.1053/hupa.2001.20886; Venetz D, 2010, INT J CANCER, V127, P2300, DOI 10.1002/ijc.25236; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Whiting D, 2004, J IMMUNOL, V172, P7417, DOI 10.4049/jimmunol.172.12.7417; Wolff HA, 2011, RADIAT ENVIRON BIOPH, V50, P145, DOI 10.1007/s00411-010-0341-x	31	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80052	10.1371/journal.pone.0080052	http://dx.doi.org/10.1371/journal.pone.0080052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278236	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800046
J	Lankester, J; Patel, C; Cullen, MR; Ley, C; Parsonnet, J				Lankester, Joanna; Patel, Chirag; Cullen, Mark R.; Ley, Catherine; Parsonnet, Julie			Urinary Triclosan is Associated with Elevated Body Mass Index in NHANES	PLOS ONE			English	Article							GUT MICROBIOTA; BISPHENOL-A; ENVIRONMENTAL EXPOSURE; ANDROGENIC ACTIVITY; OBESITY; ESTROGEN; TOOTHPASTE; TOXICITY; CHILDREN; PLASMA	Background: Triclosan-a ubiquitous chemical in toothpastes, soaps, and household cleaning supplies-has the potential to alter both gut microbiota and endocrine function and thereby affect body weight. Methods: We investigated the relationship between triclosan and body mass index (BMI) using National Health and Nutrition Examination Surveys (NHANES) from 2003-2008. BMI and spot urinary triclosan levels were obtained from adults. Using two different exposure measures-either presence vs. absence or quartiles of triclosan-we assessed the association between triclosan and BMI. We also screened all NHANES serum and urine biomarkers to identify correlated factors that might confound observed associations. Results: Compared with undetectable triclosan, a detectable level was associated with a 0.9-point increase in BMI (p<0.001). In analysis by quartile, compared to the lowest quartile, the 2nd, 3rd and 4th quartiles of urinary triclosan were associated with BMI increases of 1.5 (p<0.001), 1.0 (p = 0.002), and 0.3 (p = 0.33) respectively. The one strong correlate of triclosan identified in NHANES was its metabolite, 2,4-dichlorophenol (r = 0.4); its association with BMI, however, was weaker than that of triclosan. No other likely confounder was identified. Conclusions: Triclosan exposure is associated with increased BMI. Stronger effect at moderate than high levels suggests a complex mechanism of action.	[Lankester, Joanna] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Lankester, Joanna; Patel, Chirag; Cullen, Mark R.; Ley, Catherine; Parsonnet, Julie] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Patel, Chirag] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Parsonnet, Julie] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Lankester, J (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.	Lankester@stanfordalumni.org		Lankester, Joanna/0000-0003-0709-6722; Parsonnet, Julie/0000-0001-7342-5366; cullen, mark/0000-0001-7996-1864	National Institutes of Health [R01 HD063142]; Stanford University Innovation in Population Science Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University Innovation in Population Science Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the National Institutes of Health [grant number R01 HD063142] and from a Stanford University Innovation in Population Science Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afflitto J, 1989, Am J Dent, V2 Spec No, P207; Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Allmyr M, 2009, BASIC CLIN PHARMACOL, V105, P339, DOI 10.1111/j.1742-7843.2009.00455.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; CDC NCHS, 2007, ENV PEST DESCR LAB M; CDC NCHS, 2007, URM ALB URM CREAT DE; CDC NCHS, 2007, SER CONT UR TOT NNAL; CDC NCHS, 2007, ENV PHEN DESCR LAB M; Center for Disease Control, 2012, NAT HLTH NUTR EX SUR; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168; Crofton KM, 2007, ENVIRON TOXICOL PHAR, V24, P194, DOI 10.1016/j.etap.2007.04.008; Cullinan MP, 2012, SCI TOTAL ENVIRON, V416, P75, DOI 10.1016/j.scitotenv.2011.11.063; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Flint HJ, 2012, NAT REV GASTROENTERO; Foran CM, 2000, MAR ENVIRON RES, V50, P153, DOI 10.1016/S0141-1136(00)00080-5; Gee RH, 2008, J APPL TOXICOL, V28, P78, DOI 10.1002/jat.1316; HAIGHT TH, 1955, J NUTR, V56, P151; Hundt K, 2000, APPL ENVIRON MICROB, V66, P4157, DOI 10.1128/AEM.66.9.4157-4160.2000; Jarvis MJ, 2008, ADDICTION, V103, P1553, DOI 10.1111/j.1360-0443.2008.02297.x; Jung EM, 2012, TOXICOL LETT, V208, P142, DOI 10.1016/j.toxlet.2011.10.017; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Kumar V, 2009, REPROD TOXICOL, V27, P177, DOI 10.1016/j.reprotox.2008.12.002; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li ZY, 2012, TOXICOL IN VITRO, V26, P769, DOI 10.1016/j.tiv.2012.05.017; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Niederman Richard, 2005, Evid Based Dent, V6, P33, DOI 10.1038/sj.ebd.6400318; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Paul KB, 2012, TOXICOLOGY, V300, P31, DOI 10.1016/j.tox.2012.05.023; PERKINS KA, 1992, J APPL PHYSIOL, V72, P401, DOI 10.1152/jappl.1992.72.2.401; Pirard C, 2012, ENVIRON INT, V48, P78, DOI 10.1016/j.envint.2012.07.003; Rodricks JV, 2010, CRIT REV TOXICOL, V40, P422, DOI 10.3109/10408441003667514; Rodriguez PEA, 2010, J TOXICOL ENV HEAL A, V73, P1678, DOI 10.1080/15287394.2010.516241; Saleh S, 2011, LETT APPL MICROBIOL, V52, P87, DOI 10.1111/j.1472-765X.2010.02976.x; Sandborgh-Englund G, 2006, J TOXICOL ENV HEAL A, V69, P1861, DOI 10.1080/15287390600631706; Sankoda K, 2011, B ENVIRON CONTAM TOX, V86, P470, DOI 10.1007/s00128-011-0249-4; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P453, DOI 10.1016/j.jaci.2012.05.006; Stoker TE, 2010, TOXICOL SCI, V117, P45, DOI 10.1093/toxsci/kfq180; Tehrani AB, 2012, NEUROGASTROENT MOTIL, V24, P305, DOI 10.1111/j.1365-2982.2012.01895.x; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; TULP MTM, 1979, XENOBIOTICA, V9, P65, DOI 10.3109/00498257909038708; Upadhyay V, 2012, NAT IMMUNOL; Veetil PGP, 2012, APPL BIOCHEM BIOTECH, V167, P1603, DOI 10.1007/s12010-012-9573-3; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	52	68	68	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80057	10.1371/journal.pone.0080057	http://dx.doi.org/10.1371/journal.pone.0080057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278238	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800048
J	Low, VL; Chen, CD; Lee, HL; Tan, TK; Chen, CF; Leong, CS; Lim, YAL; Lim, PE; Norma-Rashid, Y; Sofian-Azirun, M				Low, Van Lun; Chen, Chee Dhang; Lee, Han Lim; Tan, Tiong Kai; Chen, Chin Fong; Leong, Cherng Shii; Lim, Yvonne Ai Lian; Lim, Phaik Eem; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd			Enzymatic Characterization of Insecticide Resistance Mechanisms in Field Populations of Malaysian Culex quinquefasciatus Say (Diptera: Culicidae)	PLOS ONE			English	Article							PERMETHRIN RESISTANCE; ALBOPICTUS SKUSE; MICROPLATE ASSAY; KUALA-LUMPUR; ANOPHELES; SUSCEPTIBILITY; MOSQUITOS; PIPIENS; DDT; ORGANOPHOSPHORUS	Background: There has been no comprehensive study on biochemical characterization of insecticide resistance mechanisms in field populations of Malaysian Culex quinquefasciatus. To fill this void in the literature, a nationwide investigation was performed to quantify the enzyme activities, thereby attempting to characterize the potential resistance mechanisms in Cx. quinquefasciatus in residential areas in Malaysia. Methodology/Principal Findings: Culex quinquefasciatus from 14 residential areas across 13 states and one federal territory were subjected to esterases, mixed function oxidases, glutathione-S-transferase and insensitive acetylcholinesterase assays. Enzyme assays revealed that alpha-esterases and beta-esterases were elevated in 13 populations and 12 populations, respectively. Nine populations demonstrated elevated levels of mixed function oxidases and glutathione-S-transferase. Acetylcholinesterase was insensitive to propoxur in all 14 populations. Activity of alpha-esterases associated with malathion resistance was found in the present study. In addition, an association between the activity of alpha-esterases and beta-esterases was also demonstrated. Conclusions/Significance: The present study has characterized the potential biochemical mechanisms in contributing towards insecticide resistance in Cx. quinquefasciatus field populations in Malaysia. Identification of mechanisms underlying the insecticide resistance will be beneficial in developing effective mosquito control programs in Malaysia.	[Low, Van Lun; Chen, Chee Dhang; Chen, Chin Fong; Leong, Cherng Shii; Lim, Phaik Eem; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Lee, Han Lim] Inst Med Res, WHO Collaborating Ctr Vectors, Med Entomol Unit, Kuala Lumpur, Malaysia; [Tan, Tiong Kai; Lim, Yvonne Ai Lian] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Lim, Phaik Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Malaya; Universiti Malaya	Low, VL (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	lucaslow24@gmail.com	LIM, Phaik Eem/B-5331-2010; Tan, Tiong Kai/F-6565-2013; Low, Van Lun/C-8045-2013; Chen, Chee Dhang/C-6482-2011; LIM, YVONNE AL/B-5276-2010; Chen, Chee Dhang/ABD-9353-2021; Norma-Rashid, Y/B-8028-2010; AZIRUN, MOHD SOFIAN/B-9127-2010	LIM, Phaik Eem/0000-0001-9186-1487; Tan, Tiong Kai/0000-0003-0297-1727; Low, Van Lun/0000-0002-4299-5339; LIM, YVONNE AL/0000-0003-4050-6332; Norma-Rashid, Y/0000-0002-1450-1995; 	University of Malaya [RG164/12SUS]	University of Malaya(Universiti Malaya)	This study was supported by the University of Malaya Research Grant (RG164/12SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Bourguet D, 1996, J ECON ENTOMOL, V89, P1060, DOI 10.1093/jee/89.5.1060; BREWER KK, 1989, PESTIC SCI, V26, P29, DOI 10.1002/ps.2780260105; BROGDON WG, 1989, PARASITOL TODAY, V5, P56, DOI 10.1016/0169-4758(89)90192-0; BROGDON WG, 1988, J AM MOSQUITO CONTR, V4, P152; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; Chen CD, 2013, TROP BIOMED, V30, P220; Chen CD, 2008, P ASEAN C TROP MED P, V3, P6; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Fonseca-Gonzalez I, 2009, MEM I OSWALDO CRUZ, V104, P18, DOI 10.1590/S0074-02762009000100003; GJULLIN C. M., 1952, MOSQUITO NEWS, V12, P1; HEMINGWAY J, 1991, PESTIC BIOCHEM PHYS, V39, P49, DOI 10.1016/0048-3575(91)90213-6; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hollingworth RM, 2008, GLOBAL PESTICIDE RES, P68; Lee H. L., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P458; Lee H.L., 1996, Tropical Biomedicine, V13, P137; Lee H. L., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P164; Lee H.L., 1990, Tropical Biomedicine, V7, P21; Lee H. L., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P371; Low VL, 2013, PESTIC BIOCHEM PHYS, V107, P127, DOI 10.1016/j.pestbp.2013.06.004; Low VL, 2013, J MED ENTOMOL, V50, P103, DOI 10.1603/ME12068; Low V, 2013, PEST MANAG SCI, V69, P1362, DOI 10.1002/ps.3512; Low VL, 2012, J AM MOSQUITO CONTR, V28, P160, DOI 10.2987/12-6235R.1; Mendoza F, 2008, B ENTOMOL RES, V98, P323, DOI 10.1017/S0007485308005701; Nazni W.A., 2000, Tropical Biomedicine, V17, P69; Nazni W A, 2005, Trop Biomed, V22, P63; Nazni W. A., 2004, Tropical Biomedicine, V21, P67; Nazni W. A., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P849; Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x; PEIRIS HTR, 1993, B ENTOMOL RES, V83, P127, DOI 10.1017/S0007485300041869; Pethuan S, 2007, TROP BIOMED, V24, P7; Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1; REID J A, 1955, Bull World Health Organ, V12, P705; Sarkar M, 2009, MED VET ENTOMOL, V23, P122, DOI 10.1111/j.1365-2915.2009.00805.x; Sarkar M, 2009, TROP MED INT HEALTH, V14, P1097, DOI 10.1111/j.1365-3156.2009.02323.x; Selvi S, 2007, TROP BIOMED, V24, P63; STONE BF, 1969, B WORLD HEALTH ORGAN, V40, P401; THOMAS V, 1962, B WORLD HEALTH ORGAN, V27, P595; Wan-Norafikah O., 2008, P ASEAN C TROP MED P, V3, P69; Wan-Norafikah O, 2013, ASIAN BIOMED, V7, P51, DOI 10.5372/1905-7415.0701.150; Wan-Norafikah O, 2013, SAUDI J BIOL SCI, V20, P241, DOI 10.1016/j.sjbs.2013.02.001; Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003; WHARTON R H, 1958, Bull World Health Organ, V18, P684; WHO, 1998, TECHNIQUES DETECT IN; WHO, 2009, GUID EFF TEST INS IN; Yap H, 2000, ASM SCI J, P73; Zayed ABB, 2006, J AM MOSQUITO CONTR, V22, P473, DOI 10.2987/8756-971X(2006)22[473:UOBAMA]2.0.CO;2	49	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79928	10.1371/journal.pone.0079928	http://dx.doi.org/10.1371/journal.pone.0079928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278220	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327539800036
J	Mowles, SL; King, BH; Linforth, RST; Hardy, ICW				Mowles, Sophie L.; King, Bethia H.; Linforth, Robert S. T.; Hardy, Ian C. W.			A Female-Emitted Pheromone Component Is Associated with Reduced Male Courtship in the Parasitoid Wasp Spalangia endius	PLOS ONE			English	Article							SEXUAL CONFLICT; BEHAVIOR; COSTS; HYMENOPTERA; COPULATION; MECHANISMS; HARASSMENT; DROSOPHILA; CHOICE; DEATH	During courtship interactions, the courted individual may not always be prepared to mate. For example, mating or courtship may be detrimental to its fitness and resistance is expected under these circumstances. As such, various resistance strategies have evolved, from physically fending off courting individuals to producing behavioural signals of unreceptivity. In the parasitoid wasp Spalangia endius, females rarely re-mate and mated females are avoided by males in favour of virgin females. Further, mated females appear to advertise their mating status by the release of a pheromone component (methyl 6-methylsalicylate), but direct evidence of the nature of this release is lacking. Here we used real-time chemical analysis to track the emission of the pheromone component during courtship interactions between virgin males and either virgin or mated females. We found that females actively release methyl 6-methylsalicylate when courted and that significantly greater concentrations are released by previously mated females. Further, high concentrations of this component are associated with both the prevention and termination of courtship.	[Mowles, Sophie L.; Linforth, Robert S. T.; Hardy, Ian C. W.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [King, Bethia H.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	University of Nottingham; Northern Illinois University	Mowles, SL (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	sophie.mowles@nottingham.ac.uk		Linforth, Robert/0000-0003-1946-6540	University of Nottingham Anne McLaren Fellowship	University of Nottingham Anne McLaren Fellowship	SLM was funded by a University of Nottingham Anne McLaren Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNQVIST G, 1992, ANIM BEHAV, V43, P559, DOI 10.1016/S0003-3472(05)81016-4; Arnqvist Goran, 2005, pUnpaginated; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Briffa M, 2013, ANIMAL CONTESTS, P47; Carazo P, 2004, ANIM BEHAV, V68, P123, DOI 10.1016/j.anbehav.2003.10.014; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Cordero A, 1999, J INSECT BEHAV, V12, P27, DOI 10.1023/A:1020972913683; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Fischer CR, 2012, BEHAVIOUR, V149, P153, DOI 10.1163/156853912X631974; Goubault M, 2006, P ROY SOC B-BIOL SCI, V273, P2853, DOI 10.1098/rspb.2006.3655; Harari AR, 2011, EVOLUTION, V65, P1572, DOI 10.1111/j.1558-5646.2011.01252.x; HOLLEY AJF, 1984, NATURE, V309, P549, DOI 10.1038/309549a0; Johansson BG, 2005, ANIM BEHAV, V69, P851, DOI 10.1016/j.anbehav.2004.08.007; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Kamimura Y, 2007, BIOL LETTERS, V3, P401, DOI 10.1098/rsbl.2007.0192; Kemp DJ, 2012, BEHAV ECOL, V23, P191, DOI 10.1093/beheco/arr173; King BH, 2008, ANN ENTOMOL SOC AM, V101, P229, DOI 10.1603/0013-8746(2008)101[229:ABSOPM]2.0.CO;2; King BH, 2010, BEHAVIOUR, V147, P85, DOI 10.1163/000579509X12483520922241; King BH, 2010, BEHAV ECOL SOCIOBIOL, V64, P607, DOI 10.1007/s00265-009-0878-3; King BH, 2005, J INSECT PHYSIOL, V51, P1340, DOI 10.1016/j.jinsphys.2005.08.004; King BH, 2005, BEHAV ECOL SOCIOBIOL, V57, P350, DOI 10.1007/s00265-004-0863-9; LEBOEUF BJ, 1991, BEHAVIOUR, V116, P143, DOI 10.1163/156853990X00400; Marshall DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004185; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; McLain DK, 1999, BEHAV ECOL SOCIOBIOL, V46, P164, DOI 10.1007/s002650050606; Mowles SL, 2012, ANIM BEHAV, V84, P295, DOI 10.1016/j.anbehav.2012.05.015; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Nichols WJ, 2010, J CHEM ECOL, V36, P1140, DOI 10.1007/s10886-010-9855-6; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; Rowe L, 1996, BEHAV ECOL, V7, P474, DOI 10.1093/beheco/7.4.474; Schulz S, 2008, J CHEM ECOL, V34, P82, DOI 10.1007/s10886-007-9393-z; Shine R, 2004, BEHAV ECOL, V15, P654, DOI 10.1093/beheco/arh058; Shine R, 2001, EVOLUTION, V55, P598, DOI 10.1554/0014-3820(2001)055[0598:BITSDE]2.0.CO;2; STONE GN, 1995, ANIM BEHAV, V50, P405, DOI 10.1006/anbe.1995.0255; Tram U, 1998, P NATL ACAD SCI USA, V95, P4051, DOI 10.1073/pnas.95.7.4051; Wedell N, 2006, ANIM BEHAV, V71, P999, DOI 10.1016/j.anbehav.2005.06.023; Wedell N, 2010, BEHAV ECOL SOCIOBIOL, V64, P1385, DOI 10.1007/s00265-010-0953-9	39	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e82010	10.1371/journal.pone.0082010	http://dx.doi.org/10.1371/journal.pone.0082010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278468	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100165
J	Sarig, R; Slon, V; Abbas, J; May, H; Shpack, N; Vardimon, AD; Hershkovitz, I				Sarig, Rachel; Slon, Viviane; Abbas, Janan; May, Hila; Shpack, Nir; Vardimon, Alexander Dan; Hershkovitz, Israel			Malocclusion in Early Anatomically Modern Human: A Reflection on the Etiology of Modern Dental Misalignment	PLOS ONE			English	Article							QAFZEH; MEDIEVAL; CHILDREN; MIDDLE; FORCE	Malocclusions are common in modern populations. Yet, as the study of occlusion requires an almost intact dentition in both the maxilla and mandible, searching for the ultimate cause of malocclusion is a challenge: relatively little ancient material is available for research on occlusal states. The Qafzeh 9 skull is unique, as its preserved dentition allowed us to investigate the presence and manifestations of malocclusion. The aim of this study was thus to examine the occlusal condition in the Qafzeh 9 specimen in light of modern knowledge regarding the etiology of malocclusion. We revealed a pathologic occlusion in the Qafzeh 9 skull that probably originated in the early developmental stage of the dentition, and was aggravated by forces applied by mastication. When arch continuity is interrupted due to misalignment of teeth as in this case, force transmission is not equal on both sides, causing intra-arch outcomes such as mesialization of the teeth, midline deviation, rotations and the aggravation of crowding. All are evident in the Qafzeh 9 skull: the midline deviates to the left; the incisors rotate mesio-buccally; the left segment is constricted; the left first molar is buccally positioned and the left premolars palatally tilted. The inter-arch evaluation revealed anterior cross bite with functional shift that might affect force transmission and bite force. In conclusion, the findings of the current study suggest that malocclusion of developmental origin was already present in early anatomically modern humans (AMH) (the present case being the oldest known case, dated to ca. 100,000 years); that there is no basis to the notion that early AMH had a better adjustment between teeth and jaw size; and that jaw-teeth size discrepancy could be found in prehistoric populations and is not a recent phenomenon.	[Sarig, Rachel; Shpack, Nir; Vardimon, Alexander Dan] Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Orthodont, IL-69978 Tel Aviv, Israel; [Sarig, Rachel; Slon, Viviane; Abbas, Janan; May, Hila; Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Sarig, R (corresponding author), Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Orthodont, IL-69978 Tel Aviv, Israel.	sarigrac@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020	Hershkovitz, Israel/0000-0001-5841-6090; Sarig, Rachel/0000-0002-9323-5014	Dan David Foundation; Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine	Dan David Foundation; Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine	The study was supported by Dan David Foundation and the Tassia and Dr. Joseph Meychan Chair for the History and Philosophy of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JA, 2000, AM J ORTHOD DENTOFAC, V118, P328, DOI 10.1067/mod.2000.103252; Andradea AD, 2009, ANGLE ORTHOD, V79, P380, DOI 10.2319/030708-137.1; ANDREWS LF, 1972, AMER J ORTHODONTICS, V62, P296, DOI 10.1016/S0002-9416(72)90268-0; ANDRIK P, 1963, J OROFAC ORTHOP, V24, P12, DOI DOI 10.1007/BF02257681; Bayrak Sule, 2008, Eur J Dent, V2, P303; BEGG PR, 1954, AM J ORTHOD DENTOFAC, V40, P298, DOI 10.1016/0002-9416(54)90092-5; Benazzi S, 2013, AM J PHYS ANTHROPOL, V150, P324, DOI 10.1002/ajpa.22225; BISHARA SE, 1994, ANGLE ORTHOD, V64, P89; Bruzek J., 1997, AM J PHYS ANTHROPOL, V24, P84; CORRUCCINI RS, 1984, AM J ORTHOD DENTOFAC, V86, P419, DOI 10.1016/S0002-9416(84)90035-6; Couqueugniot H, 2000, INT J OSTEOARCHAEOL, V10, P426; Dastugue J., 1981, PALEORIENT, V7, P135, DOI [DOI 10.3406/PALE0.1981.4292, 10.3406/paleo.1981.4292, DOI 10.3406/PALEO.1981.4292]; Dorfer CE, 2000, EUR J ORAL SCI, V108, P368, DOI 10.1034/j.1600-0722.2000.108005368.x; Evensen JP, 2007, AM J ORTHOD DENTOFAC, V131, P710, DOI 10.1016/j.ajodo.2005.08.037; GRABER TM, 1988, ORTHODONTICS PRINCIP; Guatelli-Steinberg D, 2010, AM J PHYS ANTHROPOL, V141, P152, DOI 10.1002/ajpa.21158; HANNUKSELA A, 1987, AM J ORTHOD DENTOFAC, V92, P299, DOI 10.1016/0889-5406(87)90330-1; HARPER C, 1994, EUR J ORTHODONT, V16, P163, DOI 10.1093/ejo/16.3.163; HEIKINHEIMO K, 1987, EUR J ORTHODONT, V9, P151; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; HUNT EE, 1961, AM J ORTHOD DENTOFAC, V47, P406, DOI 10.1016/0002-9416(61)90220-2; Jung YG, 2000, J DENT RES, V79, P722, DOI 10.1177/00220345000790020501; Kecik D, 2007, AM J ORTHOD DENTOFAC, V131, P202, DOI 10.1016/j.ajodo.2005.03.030; KILIARIDIS S, 1985, EUR J ORTHODONT, V7, P273, DOI 10.1093/ejo/7.4.273; LAVELLE CLB, 1976, COMMUNITY DENT ORAL, V4, P38, DOI 10.1111/j.1600-0528.1976.tb00967.x; LOMBARDI AV, 1982, AM J ORTHOD DENTOFAC, V81, P38, DOI 10.1016/0002-9416(82)90286-X; LUNDSTROM ANDERS, 1953, ACTA ODONTOL SCAND, V11, P111, DOI 10.3109/00016355308993918; Lysell L., 1958, ODONTOL TIDSKR, V6, P161; Major P W, 1992, J Can Dent Assoc, V58, P574; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; MCEVOY SA, 1983, CLIN REPORTS PEDIAT, V5, P280; McKeever A, 2012, BRIT DENT J, V212, P527, DOI 10.1038/sj.bdj.2012.465; MELLQUIST C, 1939, ODONTOL TIDSKR S, V38; Mockers O, 2004, EUR J ORTHODONT, V26, P151, DOI 10.1093/ejo/26.2.151; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Niewoehner WA, 2001, P NATL ACAD SCI USA, V98, P2979, DOI 10.1073/pnas.041588898; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Proffit W.R., 2000, CONT ORTHODONTICS, V3rd, P435; RAK Y, 1990, AM J PHYS ANTHROPOL, V81, P323, DOI 10.1002/ajpa.1330810302; Rak Y, 2002, AM J PHYS ANTHROPOL, V119, P199, DOI 10.1002/ajpa.10131; Rougier H, 2006, PERIOD BIOL, V108, P269; Sarig R, 2013, CLIN ORAL INVEST, V17, P731, DOI 10.1007/s00784-012-0759-4; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; SMYTH KC, 1934, DENT REC, V54, P1; SOFAER JA, 1971, EVOLUTION, V25, P509, DOI 10.1111/j.1558-5646.1971.tb01910.x; Sonnesen L, 2001, EUR J ORTHODONT, V23, P741, DOI 10.1093/ejo/23.6.741; SOUTHARD TE, 1990, AM J ORTHOD DENTOFAC, V97, P41, DOI 10.1016/S0889-5406(05)81707-X; Tillier A-m., 1999, CAHIERS PALEOANTHROP; TILLIER AM, 2006, DIOGENE, V214, P132; TRINKAUS E, 1993, J HUM EVOL, V25, P393, DOI 10.1006/jhev.1993.1058; Trinkaus R, 2000, J ANAT, V196, P473, DOI 10.1046/j.1469-7580.2000.19630473.x; Valencia R, 2004, AM J ORTHOD DENTOFAC, V125, P537, DOI 10.1016/j.ajodo.2003.05.009; Valentine F, 1970, ASDC J Dent Child, V37, P420; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; Vandermeersch B., 1981, HOMMES FOSSILES QAFZ; Vardimon AD, 2003, AM J DENT, V16, p20A; Vodanovic M, 2012, ARCH ORAL BIOL, V57, P401, DOI 10.1016/j.archoralbio.2011.09.006; Yokoyama Y, 1997, CR ACAD SCI II A, V324, P773	62	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80771	10.1371/journal.pone.0080771	http://dx.doi.org/10.1371/journal.pone.0080771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278319	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100111
J	Sun, HL; Guan, LX; Zhu, ZL; Li, H				Sun, Hongli; Guan, Lixia; Zhu, Zhongliang; Li, Hui			Reduced Levels of NR1 and NR2A with Depression-Like Behavior in Different Brain Regions in Prenatally Stressed Juvenile Offspring	PLOS ONE			English	Article							NMDA RECEPTOR COMPLEX; CHRONIC MILD STRESS; SUBUNIT MESSENGER-RNA; RAT-BRAIN; ANTICONVULSANT MK-801; SUCROSE PREFERENCE; PREFRONTAL CORTEX; EXPRESSION; GLUTAMATE; MODEL	Adolescence is a time of continued brain maturation, particularly in limbic and cortical regions, which undoubtedly plays a role in the physiological and emotional changes. Juvenile rats repeatedly exposed to prenatal stress (PS) exhibit behavioral features often observed in neuropsychiatric disorders including depression. However, to date the underlying neurological mechanisms are still unclear. In the current study, juvenile offspring rats whose mothers were exposed to PS were evaluated for depression-related behaviors in open field and sucrose preference test. NMDA receptor subunits NR1 and NR2A in the hippocampus, frontal cortex and striatum were assayed by western blotting. The results indicated that PS resulted in several behavioral anomalies in the OFT and sucrose preference test. Moreover, reduced levels of NMDA receptor subunits NR1 and NR2A in the hippocampus, and NR1 in prefrontal cortex and striatum of prenatally stressed juvenile offspring were found. Treatment with MK-801 to pregnant dams could prevent all those changes in the juvenile offspring. Collectivity, these data support the argument that PS to pregnant dams could induce depression-like behavior, which may be involved with abnormal expression of NR1 and NR2A in specific brain regions, and MK-801 may have antidepressant-like effects on the juvenile offspring.	[Sun, Hongli; Guan, Lixia; Zhu, Zhongliang] Xi An Jiao Tong Univ, Coll Med, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Guan, Lixia] Liuzhou Municipal Liutie Cent Hosp, Dept Pharm, Guangxi, Peoples R China; [Zhu, Zhongliang] Northwest Univ, Coll Life Sci, Shaanxi Prov Biomed Key Lab, Xian, Shaanxi, Peoples R China; [Li, Hui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neonatol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Northwest University Xi'an; Xi'an Jiaotong University	Li, H (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neonatol, Xian, Shaanxi, Peoples R China.	zlzhu@mail.xjtu.edu.cn; huili@mail.xjtu.edu.cn			National Natural Science Foundation of China [30970952, 18110059, 81271497]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (No. 30970952, 18110059, 81271497) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Almeida RF, 2010, NEUROCHEM RES, V35, P1164, DOI 10.1007/s11064-010-0169-4; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Chen G, 2010, BIOL PSYCHIAT, V67, P1007, DOI 10.1016/j.biopsych.2010.03.027; CHERMAT R, 1986, J PHARMACOL-PARIS, V17, P348; Chutabhakdikul N, 2013, INT J DEV NEUROSCI, V31, P560, DOI 10.1016/j.ijdevneu.2013.06.011; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dang HX, 2009, PROG NEURO-PSYCHOPH, V33, P1417, DOI 10.1016/j.pnpbp.2009.07.020; Decollogne S, 1997, PHARMACOL BIOCHEM BE, V58, P261, DOI 10.1016/S0091-3057(96)00555-2; Deussing J.M., 2006, DRUG DISCO TODAY DIS, V3, P375, DOI [DOI 10.1016/J.DDM0D.2006.11.003, 10.1016/J.DDMOD.2006.11.003, DOI 10.1016/J.DDMOD.2006.11.003]; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; GUAN L, 2013, BRAIN RES B; GUPTA BD, 1971, EUR J PHARMACOL, V13, P341, DOI 10.1016/0014-2999(71)90224-X; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Jia N, 2010, DEV NEUROBIOL, V70, P114, DOI 10.1002/dneu.20766; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Koehl M, 1999, J NEUROBIOL, V40, P302, DOI 10.1002/(SICI)1097-4695(19990905)40:3<302::AID-NEU3>3.0.CO;2-7; KULKARNI SK, 1973, PSYCHOPHARMACOLOGIA, V33, P333, DOI 10.1007/BF00437510; Lachamp P, 2005, J PHYSIOL-LONDON, V564, P751, DOI 10.1113/jphysiol.2005.084517; Law AJ, 2001, NEUROREPORT, V12, P2971, DOI 10.1097/00001756-200109170-00043; LAYER RT, 1995, PHARMACOL BIOCHEM BE, V52, P621, DOI 10.1016/0091-3057(95)00155-P; Maj J, 1992, Eur Neuropsychopharmacol, V2, P37, DOI 10.1016/0924-977X(92)90034-6; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; MCDONALD JW, 1989, BRAIN RES, V490, P33, DOI 10.1016/0006-8993(89)90427-7; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MOREAU JL, 1994, J PSYCHIATR NEUROSCI, V19, P51; MORLEYFLETCHER S, 2013, BEHAV NEUROENDOCRINE, P175; MUSCAT R, 1991, PHARMACOL BIOCHEM BE, V40, P209, DOI 10.1016/0091-3057(91)90541-9; NOWAK G, 1995, BRAIN RES, V675, P157, DOI 10.1016/0006-8993(95)00057-W; OZYURT E, 1988, J CEREBR BLOOD F MET, V8, P138, DOI 10.1038/jcbfm.1988.18; PAPP M, 1994, EUR J PHARMACOL, V263, P1, DOI 10.1016/0014-2999(94)90516-9; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rice F, 2007, ACTA PSYCHIAT SCAND, V115, P171, DOI 10.1111/j.1600-0447.2006.00895.x; RIVA MA, 1994, MOL BRAIN RES, V25, P209, DOI 10.1016/0169-328X(94)90155-4; Ryan B, 2009, INT J NEUROPSYCHOPH, V12, P553, DOI 10.1017/S1461145708009607; Schwabe L, 2012, J NEUROSCI, V32, P11042, DOI 10.1523/JNEUROSCI.1484-12.2012; Shiotani M, 2011, J TOXICOL SCI, V36, P131, DOI 10.2131/jts.36.131; Smolders I, 2008, NEUROPHARMACOLOGY, V54, P1017, DOI 10.1016/j.neuropharm.2008.02.006; Song DK, 1996, EUR J PHARMACOL, V316, P165, DOI 10.1016/S0014-2999(96)00666-8; Szewczyk B, 2012, EXPERT OPIN INV DRUG, V21, P91, DOI 10.1517/13543784.2012.638916; Taniguchi S, 2009, EMBO J, V28, P3717, DOI 10.1038/emboj.2009.300; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Wang DY, 2007, BEHAV BRAIN RES, V178, P262, DOI 10.1016/j.bbr.2007.01.003; Wenzel A, 1997, J NEUROCHEM, V68, P469; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wilson MA, 1998, DEV BRAIN RES, V109, P211, DOI 10.1016/S0165-3806(98)00084-4; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xu SZ, 2006, NEUROTOXICOLOGY, V27, P169, DOI 10.1016/j.neuro.2005.08.005; Zhang XH, 2013, NEUROSCIENCE, V250, P333, DOI 10.1016/j.neuroscience.2013.04.031; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S; Zuo DY, 2006, LIFE SCI, V78, P2172, DOI 10.1016/j.lfs.2005.09.022	59	36	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81775	10.1371/journal.pone.0081775	http://dx.doi.org/10.1371/journal.pone.0081775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278457	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100161
J	Zofou, D; Tematio, EL; Ntie-Kang, F; Tene, M; Ngemenya, MN; Tane, P; Titanji, VPK				Zofou, Denis; Tematio, Esther Laure; Ntie-Kang, Fidele; Tene, Mathieu; Ngemenya, Moses N.; Tane, Pierre; Titanji, Vincent P. K.			New Antimalarial Hits from Dacryodes edulis (Burseraceae) - Part I: Isolation, In Vitro Activity, In Silico "drug-likeness" and Pharmacokinetic Profiles	PLOS ONE			English	Article							NATURAL-PRODUCTS	The aims of the present study were to identify the compounds responsible for the anti-malarial activity of Dacryoedes edulis (Burseraceae) and to investigate their suitability as leads for the treatment of drug resistant malaria. Five compounds were isolated from ethyl acetate and hexane extracts of D. edulis stem bark and tested against 3D7 (chloroquine-susceptible) and Dd2 (multidrug-resistant) strains of Plasmodium falciparum, using the parasite lactate dehydrogenase method. Cytotoxicity studies were carried out on LLC-MK2 monkey kidney epithelial cell-line. In silico analysis was conducted by calculating molecular descriptors using the MOE software running on a Linux workstation. The "drug-likeness" of the isolated compounds was assessed using Lipinski criteria, from computed molecular properties of the geometry optimized structures. Computed descriptors often used to predict absorption, distribution, metabolism, elimination and toxicity (ADMET) were used to assess the pharmacokinetic profiles of the isolated compounds. Antiplasmodial activity was demonstrated for the first time in five major natural products previously identified in D. edulis, but not tested against malaria parasites. The most active compound identified was termed DES4. It had IC50 values of 0.37 and 0.55 mu g/mL, against 3D7 and Dd2 respectively. In addition, this compound was shown to act in synergy with quinine, satisfied all criteria of "Drug-likeness" and showed considerable probability of providing an antimalarial lead. The remaining four compounds also showed antiplasmodial activity, but were less effective than DES4. None of the tested compounds was cytotoxicity against LLC-MK2 cells, suggesting their selective activities on malaria parasites. Based on the high in vitro activity, low toxicity and predicted "Drug-likeness" DES4 merits further investigation as a possible drug lead for the treatment of malaria.	[Zofou, Denis; Ngemenya, Moses N.; Titanji, Vincent P. K.] Univ Buea, Biotechnol Unit, Fac Sci, Buea, Cameroon; [Tematio, Esther Laure; Tene, Mathieu; Tane, Pierre] Univ Dschang, Lab Nat Prod Chem, Dschang, Cameroon; [Ntie-Kang, Fidele] Univ Douala, CEPAMOQ, Douala, Cameroon; [Ntie-Kang, Fidele] Univ Buea, Chem & Bioact Informat Ctr, Fac Sci, Buea, Cameroon		Zofou, D (corresponding author), Univ Buea, Biotechnol Unit, Fac Sci, Buea, Cameroon.	zofden@yahoo.com	Ngemenya, Moses Njutain/GPW-7189-2022; Ntie-Kang, Fidele/B-5877-2013; Zofou, Denis/D-3538-2013	Ntie-Kang, Fidele/0000-0003-0795-394X; Zofou, Denis/0000-0002-3421-7609	International Foundation for Science, Stockholm, Sweden / Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) [F/5122-1]	International Foundation for Science, Stockholm, Sweden / Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW)	This work was financially supported by a research grant awarded to Dr. Denis Zofou by the International Foundation for Science, Stockholm, Sweden / Organisation for the Prohibition of Chemical Weapons, The Hague, The Netherlands (IFS/OPCW) grant (number F/5122-1) (www.ifs.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibesin K. K., 2011, Research Journal of Medicinal Plant, V5, P32, DOI 10.3923/rjmp.2011.32.41; [Anonymous], 2005, ABSTRACT ACTA TROP S; Arhoghro E.M., 2009, EUR J SCI RES, V226, P122; Atawodi SE, 2009, J MED FOOD, V12, P1321, DOI 10.1089/jmf.2008.0215; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Chemical Computing Group Inc, 2010, MOL OP ENV SOFTW; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Darvas Ferenc, 2002, Current Topics in Medicinal Chemistry, V2, P1287, DOI 10.2174/1568026023392841; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DESARR SO, 2011, MALARIA J, V10, P85, DOI DOI 10.1186/1475-2875-10-85.PUBMED:21481272; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Efange S. M. N., 2002, Ethnomedicine and drug discovery, P61; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Grabowski K, 2008, NAT PROD REP, V25, P892, DOI 10.1039/b715668p; Hanson I., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1561; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; LHUILLIER MA, 2007, THESIS I NATL POLYTE; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Malebo H M, 2009, Tanzan J Health Res, V11, P226; Mpiana PT, 2007, PHYTOMEDICINE, V14, P192, DOI 10.1016/j.phymed.2006.05.008; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; NOEDL H, 2002, HN NONLIN V1 1; Ntie-Kang F, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-88; Okwu D., 2006, INT J MOL MED ADV SC, V1, P1; Okwu D, 2005, INT J MOL MED ADV SC, V1, P375; Okwu DE, 2008, AFR J TRADIT COMPLEM, V5, P194; Okwu D. E., 2004, Journal of Sustainable Agriculture and the Environment, V6, P30; Omonhinmin C. A., 2012, Ethnobotany Research and Applications, V10, P175; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Ramiarantsoa H., 2008, J SOC OUEST AFRICAIN, V26, P99; Schneider G, 2002, CURR MED CHEM, V9, P2095, DOI 10.2174/0929867023368755; SCHRODINGER P, 2011, QIK PROP 3 4; STEWART JJP, 1993, MOPAC MANUAL; Tane P, 2005, FITOTERAPIA, V76, P656, DOI 10.1016/j.fitote.2005.08.018; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; TL O, 2002, J COMPUT AID MOL DES, V16, P325; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vivas L, 2007, J ANTIMICROB CHEMOTH, V59, P658, DOI 10.1093/jac/dkl563; WALKER AR, 1961, PLANTES UTILES GABON, P19; WATERMAN PG, 1987, PHYTOCHEMISTRY, V26, P1189, DOI 10.1016/S0031-9422(00)82376-6; Wetzel S, 2007, CHIMIA, V61, P355, DOI 10.2533/chimia.2007.355; Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156; ZOFOU D, 2011, IN VITRO ANTIPLASMOD; Zofou D, 2013, NAT PROD REP, V30, P1098, DOI 10.1039/c3np70030e; Zofou D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-167; Zofou D, 2011, PARASITOL RES, V108, P1383, DOI 10.1007/s00436-011-2363-y	48	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79544	10.1371/journal.pone.0079544	http://dx.doi.org/10.1371/journal.pone.0079544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24282507	Green Submitted, Green Published, gold			2022-12-27	WOS:000327216200074
J	Bayraktarov, E; Pizarro, V; Eidens, C; Wilke, T; Wild, C				Bayraktarov, Elisa; Pizarro, Valeria; Eidens, Corvin; Wilke, Thomas; Wild, Christian			Bleaching Susceptibility and Recovery of Colombian Caribbean Corals in Response to Water Current Exposure and Seasonal Upwelling	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; SCLERACTINIAN CORALS; REEF CORALS; EL-NINO; FLOW; STRESS; VARIABILITY; DIVERSITY	Coral bleaching events are globally occurring more frequently and with higher intensity, mainly caused by increases in seawater temperature. In Tayrona National Natural Park (TNNP) in the Colombian Caribbean, local coral communities are subjected to seasonal wind-triggered upwelling events coinciding with stronger water currents depending on location. This natural phenomenon offers the unique opportunity to study potential water current-induced mitigation mechanisms of coral bleaching in an upwelling influenced region. Therefore, coral bleaching susceptibility and recovery patterns were compared during a moderate and a mild bleaching event in December 2010 and 2011, and at the end of the subsequent upwelling periods at a water current-exposed and -sheltered site of an exemplary bay using permanent transect and labeling tools. This was accompanied by parallel monitoring of key environmental variables. Findings revealed that in 2010 overall coral bleaching before upwelling was significantly higher at the sheltered (34%) compared to the exposed site (8%). Whereas 97% of all previously bleached corals at the water current-exposed site had recovered from bleaching by April 2011, only 77% recovered at the sheltered site, but 12% had died there. In December 2011, only mild bleaching (< 10% at both sites) was observed, but corals recovered significantly at both sites in the course of upwelling. No differences in water temperatures between sites occurred, but water current exposure and turbidity were significantly higher at the exposed site, suggesting that these variables may be responsible for the observed site-specific mitigation of coral bleaching. This indicates the existence of local resilience patterns against coral bleaching in Caribbean reefs.	[Bayraktarov, Elisa; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Pizarro, Valeria] Ctr Excellence Marine Sci CEMarin, Santa Marta, Magdalena, Colombia; [Eidens, Corvin; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, D-35390 Giessen, Hessen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Justus Liebig University Giessen	Bayraktarov, E (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany.	elisa.bayraktarov@zmt-bremen.de	Wilke, Thomas/G-1517-2012	Wilke, Thomas/0000-0001-8263-7758	German Academic Research Service (DAAD) through the German-Colombian Center of Excellence in Marine Sciences (CEMarin); German Research Foundation (DFG) [Wi 2677/6-1]	German Academic Research Service (DAAD) through the German-Colombian Center of Excellence in Marine Sciences (CEMarin); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Academic Research Service (DAAD; https://www.daad.de/en/) through the German-Colombian Center of Excellence in Marine Sciences (CEMarin; http://www.cemarin.org/) and by the German Research Foundation (DFG; http://www.dfg.de/en/) grant Wi 2677/6-1 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrade CA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001549; Andrade CA, 2005, CONT SHELF RES, V25, P1003, DOI 10.1016/j.csr.2004.12.012; Atkinson M. J., 1994, Pacific Science, V48, P296; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bastidas C, 2012, REV BIOL TROP, V60, P29; Bayraktarov E, 2012, P 12 INT COR REEF A; BERKELMANS R, 2001, THESIS J COOK U TOWN; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bonilla HR, 2001, B MAR SCI, V69, P251; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Cano M, 1991, TIPOS DISTRIBUCION E; CARICOMP, 1997, P 8 INT COR REEF S, P673; Chollett I, 2010, MAR ECOL PROG SER, V416, P47, DOI 10.3354/meps08775; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; del Monaco C, 2012, REV BIOL TROP, V60, P527; Diaz-Pulido G, 2002, BOT MAR, V45, P284, DOI 10.1515/BOT.2002.028; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; DOTY MS, 1971, BOT MAR, V14, P32, DOI 10.1515/botm.1971.14.1.32; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Garay J., 2003, MANUAL TECNICAS ANAL; Garzon-Ferreira J, 1998, COAST REG SM ISL PA, P115; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Gleeson MW, 1994, CORRELATION CORAL BL; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 1997, REV BIOL TROP, V45, P1033; Glynn PW, 2001, B MAR SCI, V69, P31; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Gutierrez JL, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P53; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, SCIENCE, V334, P1494, DOI 10.1126/science.334.6062.1494-b; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; Invemar, 2012, SIST INF AMB MAR COL; Jimenez C, 2001, B MAR SCI, V69, P151; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Lranco-Herrera A, 2007, 12 C LAT CIENC MAR; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McField MD, 1999, B MAR SCI, V64, P155; Meesters EH, 2002, MAR ECOL PROG SER, V227, P233, DOI 10.3354/meps227233; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Nakamura T, 2003, MAR ECOL PROG SER, V256, P287, DOI 10.3354/meps256287; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; Navas-Camacho R, 2010, REV BIOL TROP, V58, P95; Paramo J, 2011, REV BIOL MAR OCEANOG, V46, P421, DOI 10.4067/S0718-19572011000300011; Podesta GP, 1997, J GEOPHYS RES-OCEANS, V102, P15749, DOI 10.1029/96JC03557; Reyes-Bonilla H, 2002, CORAL REEFS, V21, P368, DOI 10.1007/s00338-002-0255-4; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Roder C, 2010, MAR ECOL PROG SER, V412, P113, DOI 10.3354/meps08707; Rodriguez-Ramirez A, 2008, STATUS CARIBBEAN COR, P105; Rodriguez-Ramirez A, 2010, REV BIOL TROP, V58, P45; Rodriguez-Ramirez A, 2010, REV BIOL TROP, V58, P107; Rueda-Roa DT, 2013, DEEP-SEA RES PT I, V78, P102, DOI 10.1016/j.dsr.2013.04.008; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Salzwedel H., 1983, B MAR COAST RES, V13, P67, DOI [10.25268/bimc.invemar.1983.13.0.483, DOI 10.25268/BIMC.INVEMAR.1983.13.0.483]; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Tosic M, 2012, JOINT ICTP TWAS WORK; Vega-Sequeda Johanna, 2008, Bol. Invest. Mar. Cost., V37, P87; Wall M, 2012, THESIS U BREMEN; Watson A.L., 1976, Proceedings of the New Zealand Ecological Society, V23, P45; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Werding B., 1989, Medio Ambiente, V10, P61; West J, 2003, COMMENTARY, V115, P17; Wild C, 2012, AQUAT ECOL, V46, P335, DOI 10.1007/s10452-012-9404-1; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilkinson C, 2008, STATUS CARIBBEAN COR	80	24	28	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80536	10.1371/journal.pone.0080536	http://dx.doi.org/10.1371/journal.pone.0080536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282551	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500052
J	Cook, DA; Sorensen, KJ; Hersh, W; Berger, RA; Wilkinson, JM				Cook, David A.; Sorensen, Kristi J.; Hersh, William; Berger, Richard A.; Wilkinson, John M.			Features of Effective Medical Knowledge Resources to Support Point of Care Learning: A Focus Group Study	PLOS ONE			English	Article							CLINICAL QUESTIONS; PATIENT-CARE; INFORMATION PRODUCTS; ONLINE; PHYSICIANS; UPTODATE; DOCTORS; TEXTBOOKS; RESIDENTS; BEHAVIOR	Objective: Health care professionals access various information sources to quickly answer questions that arise in clinical practice. The features that favorably influence the selection and use of knowledge resources remain unclear. We sought to better understand how clinicians select among the various knowledge resources available to them, and from this to derive a model for an effective knowledge resource. Methods: We conducted 11 focus groups at an academic medical center and outlying community sites. We included a purposive sample of 50 primary care and subspecialist internal medicine and family medicine physicians. We transcribed focus group discussions and analyzed these using a constant comparative approach to inductively identify features that influence the selection of knowledge resources. Results: We identified nine features that influence users' selection of knowledge resources, namely efficiency (with sub-features of comprehensiveness, searchability, and brevity), integration with clinical workflow, credibility, user familiarity, capacity to identify a human expert, reflection of local care processes, optimization for the clinical question (e. g., diagnosis, treatment options, drug side effect), currency, and ability to support patient education. No single existing resource exemplifies all of these features. Conclusion: The influential features identified in this study will inform the development of knowledge resources, and could serve as a framework for future research in this field.	[Cook, David A.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Off Educ Res, Rochester, MN 55905 USA; [Cook, David A.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN USA; [Cook, David A.; Sorensen, Kristi J.] Mayo Clin, Knowledge Delivery Ctr, Rochester, MN USA; [Hersh, William] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Berger, Richard A.] Mayo Clin, Coll Med, Sch Continuous Profess Dev, Rochester, MN USA; [Berger, Richard A.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA; [Wilkinson, John M.] Mayo Clin, Coll Med, Dept Family Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Oregon Health & Science University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Cook, DA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Off Educ Res, Rochester, MN 55905 USA.	cook.david33@mayo.edu	Hersh, William/AAH-6106-2019	Hersh, William/0000-0002-4114-5148				Ahmadi SF, 2011, MED TEACH, V33, P724, DOI 10.3109/0142159X.2010.531155; Alper BS, 2004, J MED LIBR ASSOC, V92, P429; Alper BS, 2001, J FAM PRACTICE, V50, P960; Banzi R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5856; Banzi R, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1288; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Bennett NL, 2006, J CONTIN EDUC HEALTH, V26, P120, DOI 10.1002/chp.60; Bennett Nancy L, 2004, J Contin Educ Health Prof, V24, P31, DOI 10.1002/chp.1340240106; Bernstam EV, 2005, INT J MED INFORM, V74, P13, DOI 10.1016/j.ijmedinf.2004.10.001; Bonis PA, 2008, INT J MED INFORM, V77, P745, DOI 10.1016/j.ijmedinf.2008.04.002; Buscaglia Jonathan, 2011, Therap Adv Gastroenterol, V4, P283, DOI 10.1177/1756283X11412240; Campbell R, 2006, J MED LIBR ASSOC, V94, P435; Cao YG, 2011, J BIOMED INFORM, V44, P277, DOI 10.1016/j.jbi.2011.01.004; Cook DA, 2013, JAMA INTERN MED, DOI [10.1001/jamainternmed.2013.10103, DOI 10.1001/JAMAINTERNMED.2013.10103)]; Coumou HCH, 2006, J MED LIBR ASSOC, V94, P55; Davies K, 2007, HEALTH INFO LIBR J, V24, P78, DOI 10.1111/j.1471-1842.2007.00713.x; Dicenso Alba, 2009, Evid Based Nurs, V12, P99, DOI 10.1136/ebn.12.4.99-b; Duran-Nelson A, 2013, ACAD MED, V88, P788, DOI 10.1097/ACM.0b013e31828ffdb7; Ely JW, 2007, J AM MED INFORM ASSN, V14, P407, DOI 10.1197/jamia.M2398; Ely JW, 2005, J AM MED INFORM ASSN, V12, P217, DOI 10.1197/jamia.M1608; Ely JW, 2002, BRIT MED J, V324, P710, DOI 10.1136/bmj.324.7339.710; Ensan LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023487; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Green ML, 2005, ACAD MED, V80, P176, DOI 10.1097/00001888-200502000-00016; Hoogendam A, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1012; Isaac T, 2012, J HOSP MED, V7, P85, DOI 10.1002/jhm.944; Jeffery R, 2012, J MED INTERNET RES, V14, P431, DOI 10.2196/jmir.2105; Ketchum AM, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1539; Koonce TY, 2004, J MED LIBR ASSOC, V92, P407; Lobach David, 2012, Evid Rep Technol Assess (Full Rep), P1; Manian FA, 1996, JAMA-J AM MED ASSOC, V275, P145; McDonald FS, 2007, J GEN INTERN MED, V22, P962, DOI 10.1007/s11606-007-0206-4; McGowan JJ, 2004, ACAD MED, V79, P236, DOI 10.1097/00001888-200403000-00007; McKibbon KA, 2006, J AM MED INFORM ASSN, V13, P653, DOI 10.1197/jamia.M2087; Prorok JC, 2012, J CLIN EPIDEMIOL, V65, P1289, DOI 10.1016/j.jclinepi.2012.05.003; Reed DA, 2012, J GEN INTERN MED, V27, P917, DOI 10.1007/s11606-012-2017-5; Revere D, 2007, J BIOMED INFORM, V40, P410, DOI 10.1016/j.jbi.2006.12.008; Shariff SZ, 2011, J NEPHROL, V24, P723, DOI 10.5301/JN.2011.6373; Smith R, 1996, BRIT MED J, V313, P1062; Tang HW, 2006, BRIT MED J, V333, P1143, DOI 10.1136/bmj.39003.640567.AE; Thiele RH, 2010, POSTGRAD MED J, V86, P459, DOI 10.1136/pgmj.2010.098053	41	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80318	10.1371/journal.pone.0080318	http://dx.doi.org/10.1371/journal.pone.0080318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282535	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500036
J	Darmanis, S; Cui, T; Drobin, K; Li, SC; Oberg, K; Nilsson, P; Schwenk, JM; Giandomenico, V				Darmanis, Spyros; Cui, Tao; Drobin, Kimi; Li, Su-Chen; Oberg, Kjell; Nilsson, Peter; Schwenk, Jochen M.; Giandomenico, Valeria			Identification of Candidate Serum Proteins for Classifying Well-Differentiated Small Intestinal Neuroendocrine Tumors	PLOS ONE			English	Article							GROWTH-FACTOR; CELLS; EXPRESSION; BIOMARKERS; RESISTANCE; PROFILES; ARRAYS; HEAT; IGF1	Background: Patients with well-differentiated small intestine neuroendocrine tumors (WD-SI-NETs) are most often diagnosed at a metastatic stage of disease, which reduces possibilities for a curative treatment. Thus new approaches for earlier detection and improved monitoring of the disease are required. Materials and Methods: Suspension bead arrays targeting 124 unique proteins with antibodies from the Human Protein Atlas were used to profile biotinylated serum samples. Discoveries from a cohort of 77 individuals were followed up in a cohort of 132 individuals both including healthy controls as well as patients with untreated primary WD-SI-NETs, lymph node metastases and liver metastases. Results: A set of 20 antibodies suggested promising proteins for further verification based on technically verified statistical significance. Proceeding, we assessed the classification performance in an independent cohort of patient serum, achieving, classification accuracy of up to 85% with different subsets of antibodies in respective pairwise group comparisons. The protein profiles of nine targets, namely IGFBP2, IGF1, SHKBP1, ETS1, IL1 alpha, STX2, MAML3, EGR3 and XIAP were verified as significant contributors to tumor classification. Conclusions: We propose new potential protein biomarker candidates for classifying WD-SI-NETs at different stage of disease. Further evaluation of these proteins in larger sample sets and with alternative approaches is needed in order to further improve our understanding of their functional relation to WD-SI-NETs and their eventual use in diagnostics.	[Darmanis, Spyros] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Cui, Tao; Li, Su-Chen; Oberg, Kjell; Giandomenico, Valeria] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Oberg, Kjell] Univ Uppsala Hosp, Clin Endocrine Oncol, Uppsala, Sweden; [Drobin, Kimi; Nilsson, Peter; Schwenk, Jochen M.] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Darmanis, Spyros; Oberg, Kjell; Giandomenico, Valeria] Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; Royal Institute of Technology	Schwenk, JM (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden.	jochen.schwenk@scilifelab.se; valeria.giandomenico@medsci.uu.se	Schwenk, Jochen/AAS-4164-2021; Oberg, Kjell/AAG-7118-2019; Nilsson, Peter/E-4547-2010; Darmanis, Spyros/ABG-4670-2020; Schwenk, Jochen M/F-1730-2010	Schwenk, Jochen/0000-0001-8141-8449; Nilsson, Peter/0000-0002-4657-8532; Darmanis, Spyros/0000-0003-4002-8158; Schwenk, Jochen M/0000-0001-8141-8449; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Science for Life Laboratory Stockholm; ProNova VINN Excellence Centre for Protein Technology (VINNOVA); Knut and Alice Wallenberg Foundation	Science for Life Laboratory Stockholm; ProNova VINN Excellence Centre for Protein Technology (VINNOVA)(Vinnova); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was funded by grants from Science for Life Laboratory Stockholm (http://www.scilifelab.se/), ProNova VINN Excellence Centre for Protein Technology (VINNOVA) (http://www.vinnova.se/) and the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/). The authors certify that no individuals employed or contracted by the funders (other than the named authors) had any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund A, 2012, PROTEOMICS, V12, P2067, DOI 10.1002/pmic.201100504; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cui T, 2012, EUR J ENDOCRINOL; Cui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016010; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Ewing GP, 2010, CLIN COLORECTAL CANC, V9, P219, DOI 10.3816/CCC.2010.n.032; Haggmark A, 2012, NEW BIOTECHNOL, V29, P564, DOI 10.1016/j.nbt.2011.10.005; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kaltsas GA, 2011, ENDOCR-RELAT CANCER, V18, P61, DOI 10.1677/ERC-10-0026; Kato BS, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-73; Khan MS, 2011, CLIN CANCER RES, V17, P337, DOI 10.1158/1078-0432.CCR-10-1776; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; LI SC, 2012, PLOS ONE, V96, P7, DOI DOI 10.1371/JOURNAL.PONE.0048411; Li SC, 2013, MOD PATHOL; Lindholm DP, 2011, HORM METAB RES, V43, P832, DOI 10.1055/s-0031-1287794; Modlin IM, 2008, JNCI-J NATL CANCER I, V100, P1282, DOI 10.1093/jnci/djn275; Mole D, 2011, ENDOCR-RELAT CANCER, V18, P439, DOI 10.1530/ERC-11-0055; Neiman M, 2011, J PROTEOME RES, V10, P4925, DOI 10.1021/pr200286c; Oberg K, 2011, ENDOCR-RELAT CANCER, V18, pS17, DOI 10.1530/ERC-10-0280; Poetz O, 2010, MOL CELL PROTEOMICS, V9, P2474, DOI 10.1074/mcp.M110.002709; Ripley B. D., 1996, PATTERN RECOGNITION; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Sjoberg R, 2011, NEW BIOTECHNOLOGY; Tsugane S, 2010, CANCER SCI, V101, P1073, DOI 10.1111/j.1349-7006.2010.01521.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Venables W., 2013, MODERN APPL STAT S, V53, P86	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81712	10.1371/journal.pone.0081712	http://dx.doi.org/10.1371/journal.pone.0081712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282616	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500120
J	dos Reis, TF; Menino, JF; Bom, VLP; Brown, NA; Colabardini, AC; Savoldi, M; Goldman, MHS; Rodrigues, F; Goldman, GH				dos Reis, Thaila Fernanda; Menino, Joao Filipe; Pedro Bom, Vinicius Leite; Brown, Neil Andrew; Colabardini, Ana Cristina; Savoldi, Marcela; Goldman, Maria Helena S.; Rodrigues, Fernando; Goldman, Gustavo Henrique			Identification of Glucose Transporters in Aspergillus nidulans	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; INDIVIDUAL HEXOSE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; HXT GENES; MONOSACCHARIDE TRANSPORTER; TRANSCRIPTIONAL RESPONSE; YEAST; EXPRESSION; RGT1; STARVATION	To characterize the mechanisms involved in glucose transport, in the filamentous fungus Aspergillus nidulans, we have identified four glucose transporter encoding genes hxtB-E. We evaluated the ability of hxtB-E to functionally complement the Saccharomyces cerevisiae EBY. VW4000 strain that is unable to grow on glucose, fructose, mannose or galactose as single carbon source. In S. cerevisiae HxtB-E were targeted to the plasma membrane. The expression of HxtB, HxtC and HxtE was able to restore growth on glucose, fructose, mannose or galactose, indicating that these transporters accept multiple sugars as a substrate through an energy dependent process. A tenfold excess of unlabeled maltose, galactose, fructose, and mannose were able to inhibit glucose uptake to different levels (50 to 80 %) in these s. cerevisiae complemented strains. Moreover, experiments with cyanide-mchlorophenylhydrazone (CCCP), strongly suggest that hxtB, -C, and -E mediate glucose transport via active proton symport. The A. nidulans Delta hxtB, Delta hxtC or Delta hxtE null mutants showed similar to 2.5-fold reduction in the affinity for glucose, while Delta hxtB and -C also showed a 2-fold reduction in the capacity for glucose uptake. The Delta hxtD mutant had a 7.8-fold reduction in affinity, but a 3-fold increase in the capacity for glucose uptake. However, only the Delta hxtB mutant strain showed a detectable decreased rate of glucose consumption at low concentrations and an increased resistance to 2-deoxyglucose.	[Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [dos Reis, Thaila Fernanda; Pedro Bom, Vinicius Leite; Brown, Neil Andrew; Colabardini, Ana Cristina; Savoldi, Marcela; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Goldman, Maria Helena S.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil; [Rodrigues, Fernando] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Minho	Goldman, GH (corresponding author), Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	ggoldman@usp.br	Colabardini, Ana/P-1791-2015; dos Reis, Thaila F/N-6237-2014; Rodrigues, Fernando/T-5299-2018; Goldman, Maria Helena S./D-1424-2012; Goldman, Gustavo Henrique/F-1848-2013; Rodrigues, Fernando/A-3123-2011	Colabardini, Ana/0000-0002-2131-7969; dos Reis, Thaila F/0000-0002-7776-977X; Rodrigues, Fernando/0000-0001-8436-9398; Goldman, Maria Helena S./0000-0002-6786-9320; Goldman, Gustavo Henrique/0000-0002-2986-350X; Menino, Joao/0000-0003-3778-1747; Brown, Neil/0000-0002-3555-5765; Leite Pedro Bom, Vinicius/0000-0002-3083-2524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054701; Amillis S, 2004, MOL MICROBIOL, V52, P205, DOI 10.1046/j.1365-2958.2003.03956.x; BAILEY C, 1975, EUR J BIOCHEM, V51, P573, DOI 10.1111/j.1432-1033.1975.tb03958.x; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Delgado-Jarana J, 2003, EUKARYOT CELL, V2, P708, DOI 10.1128/EC.2.4.708-717.2003; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Fekete E, 2012, FUNGAL GENET BIOL, V49, P415, DOI 10.1016/j.fgb.2012.03.001; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Forment JV, 2006, J BIOL CHEM, V281, P8339, DOI 10.1074/jbc.M508198200; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Hector RE, 2011, J IND MICROBIOL BIOT, V38, P1193, DOI 10.1007/s10295-010-0896-1; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; HIRAYAMA T, 1995, MOL GEN GENET, V249, P127, DOI 10.1007/BF00290358; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Kruckeberg AL, 1998, BIOESSAYS, V20, P972, DOI 10.1002/(SICI)1521-1878(199812)20:12<972::AID-BIES2>3.0.CO;2-M; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Leandro MJ, 2008, MICROBIOL-SGM, V154, P1646, DOI 10.1099/mic.0.2007/015511-0; Lingner U, 2011, J BIOL CHEM, V286, P20913, DOI 10.1074/jbc.M110.213678; Luyten K, 2002, YEAST, V19, P713, DOI 10.1002/yea.869; MacCabe AP, 2003, MICROBIOL-SGM, V149, P2129, DOI 10.1099/mic.0.26349-0; Madi L, 1997, GENETICS, V146, P499; MARSHALLCARLSON L, 1990, MOL CELL BIOL, V10, P1105, DOI 10.1128/MCB.10.3.1105; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nehls U, 1998, MOL PLANT MICROBE IN, V11, P167, DOI 10.1094/MPMI.1998.11.3.167; NEIGEBORN L, 1986, MOL CELL BIOL, V6, P3569, DOI 10.1128/MCB.6.11.3569; OKAZAWA H, 2007, PROTEIN REV, V6, P451, DOI DOI 10.1007/978-0-387-36534-3_; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Polidori E, 2007, FUNGAL GENET BIOL, V44, P187, DOI 10.1016/j.fgb.2006.08.001; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Sambrook J., 2001, MOL CLONING LAB MANU; SCARBOROUGH GA, 1970, J BIOL CHEM, V245, P3985; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schussler A, 2006, NATURE, V444, P933, DOI 10.1038/nature05364; Semighini CP, 2002, APPL ENVIRON MICROB, V68, P1351, DOI 10.1128/AEM.68.3.1351-1357.2002; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Tazebay UH, 1997, MOL MICROBIOL, V24, P105, DOI 10.1046/j.1365-2958.1997.3201689.x; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; THEODORIS G, 1994, GENETICS, V137, P957; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wei HJ, 2004, FUNGAL GENET BIOL, V41, P148, DOI 10.1016/j.fgb.2003.10.006; WENDELL DL, 1993, J BACTERIOL, V175, P7689, DOI 10.1128/JB.175.23.7689-7696.1993; WENDELL DL, 1994, J BACTERIOL, V176, P3730, DOI 10.1128/JB.176.12.3730-3737.1994; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie X, 2004, FUNGAL GENET BIOL, V41, P1104, DOI 10.1016/j.fgb.2004.08.009; Young E, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-24; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	66	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81412	10.1371/journal.pone.0081412	http://dx.doi.org/10.1371/journal.pone.0081412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282591	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500093
J	Ikai, H; Odashima, Y; Kanno, T; Nakamura, K; Shirato, M; Sasaki, K; Niwano, Y				Ikai, Hiroyo; Odashima, Yu; Kanno, Taro; Nakamura, Keisuke; Shirato, Midori; Sasaki, Keiichi; Niwano, Yoshimi			In Vitro Evaluation of the Risk of Inducing Bacterial Resistance to Disinfection Treatment with Photolysis of Hydrogen Peroxide	PLOS ONE			English	Article							ANTIMICROBIAL PHOTODYNAMIC THERAPY; SYSTEM	In The purpose of the present study was to evaluate the risk of inducing bacterial resistance to disinfection treatment with photolysis of H2O2 and comparing this with existing antibacterial agents. We tested seven antibacterial agents, including amoxicillin, cefepime hydrochloride, erythromycin, ofloxacin, clindamycin hydrochloride, ciprofloxacin hydrochloride, and minocycline hydrochloride, as positive controls for validation of the assay protocol. For all of the agents tested, at least one of the four bacterial species (Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Streptococcus salivarius) was resistant to these agents by repeated exposure to subinhibitory concentrations of the agents up to 10 times. In contrast, antibacterial activity against any of the bacterial species tested (S. aureus, E. faecalis, E. coli, S. salivarius, Pseudomonas aeruginosa, Streptococcus mutans, and Aggregatibacter actinomycetemcomitans) was not affected by repeated exposure to the disinfection treatment up to 40 times. This finding suggested that the risk of inducing bacterial resistance by disinfection treatment was low. The active ingredient of this disinfection treatment is hydroxyl radicals generated by photolysis of H2O2. Therefore, hydroxyl radicals interact with several cell structures and different metabolic pathways in microbial cells, probably resulting in a lack of development of bacterial resistance. In conclusion, disinfection treatment with photolysis of H2O2 appears to be a potential alternative for existing antimicrobial agents in terms of a low risk of inducing bacterial resistance.	[Ikai, Hiroyo; Odashima, Yu; Kanno, Taro; Nakamura, Keisuke; Shirato, Midori; Sasaki, Keiichi; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan	Tohoku University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 980, Japan.	niwano@m.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Education, Science, Sports and Culture, Japan [23590144]; Grants-in-Aid for Scientific Research [25893019] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 23590144, 2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM SOC MICR, 1995, REP ASM TASK FORC AN; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Clinical and Laboratory Standards (CLSI), 2009, METHODS DILUTION ANT, Veighth; Eick S, 2004, J ANTIMICROB CHEMOTH, V54, P553, DOI 10.1093/jac/dkh354; FAD, 2003, 03127835 FAD FR; Fujita K, 2010, RINSHO IYAKU, V26, P483; Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09; Hayashi E, 2012, J BIOSCI BIOENG, V114, P193, DOI 10.1016/j.jbiosc.2012.03.020; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Mallik D, 2013, CURR MICROBIOL; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Pedigo LA, 2009, P SPIE, V7380; Russell AD, 1996, MICROBIOS, V85, P45; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; WATANAKUNAKORN C, 1988, J ANTIMICROB CHEMOTH, V22, P321, DOI 10.1093/jac/22.3.321	18	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81316	10.1371/journal.pone.0081316	http://dx.doi.org/10.1371/journal.pone.0081316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282582	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500084
J	Giardina, G; Paiardini, A; Fernicola, S; Franceschini, S; Rinaldo, S; Stelitano, V; Cutruzzola, F				Giardina, Giorgio; Paiardini, Alessandro; Fernicola, Silvia; Franceschini, Stefano; Rinaldo, Serena; Stelitano, Valentina; Cutruzzola, Francesca			Investigating the Allosteric Regulation of YfiN from Pseudomonas aeruginosa: Clues from the Structure of the Catalytic Domain	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; DI-GMP; STRUCTURE PREDICTION; BIOFILM FORMATION; PROTEIN; RESISTANCE; DNA; EXOPOLYSACCHARIDE; DETERMINANTS; PERSISTENCE	Pseudomonas aeruginosa is responsible for a plethora of biofilm mediated chronic infections among which cystic fibrosis pneumonia is the most frightening. The long-term survival strategy of P. aeruginosa in the patients lungs is based on a fine balance of virulence vs dormant states and on genetic adaptation, in order to select persistent phenotypes as the small colony variants (SCVs), which strongly correlate with antibiotic resistance and poor lung function. Recent studies have coupled SCV with increased levels of the signaling molecule cyclic di-GMP, and demonstrated the central role of the diguanylate cyclase YfiN, part of the tripartite signaling module YifBNR, in c-di-GMP dependent SCV regulation. YfiN, also called TpbB, is a multi-domain membrane enzyme connecting periplasmic stimuli to cytosolic c-di-GMP production by an allosteric inside-out signaling mechanism that, due to the lack of structural data, is still largely hypothetical. We have solved the crystal structure of the catalytic domain (GGDEF), and measured the enzymatic activity of the cytosolic portion in real-time by means of a newly developed method. Based on these results we demonstrate that, unlike other diguanylate cyclase, YfiN does not undergo product feedback inhibition, and that the presence of the HAMP domain is required for dimerization and catalysis. Coupling our structural and kinetic data with an in silico study we are now able to propose a model for the allosteric regulation of YfiN.	[Giardina, Giorgio; Paiardini, Alessandro; Fernicola, Silvia; Franceschini, Stefano; Rinaldo, Serena; Stelitano, Valentina; Cutruzzola, Francesca] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Giardina, Giorgio; Fernicola, Silvia; Franceschini, Stefano; Rinaldo, Serena; Stelitano, Valentina; Cutruzzola, Francesca] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dept Biochem Sci, I-00185 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Cutruzzola, F (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy.	francesca.cutruzzola@uniroma1.it	Giardina, Giorgio/M-8882-2019; Giardina, Giorgio/C-7529-2009; Cutruzzola', Francesca/G-4052-2011; rinaldo, serena/O-6989-2014	Giardina, Giorgio/0000-0002-0802-1370; Giardina, Giorgio/0000-0002-0802-1370; Cutruzzola', Francesca/0000-0002-4621-2135; rinaldo, serena/0000-0003-0682-023X; Paiardini, Alessandro/0000-0001-9078-7545	Ministero della Universita e Ricerca of Italy [RBRN07BMCT, 20094BJ9R7, RBFR10LHD1]; Sapienza University of Rome; Fondazione Italiana Fibrosi Cistica [13/2009-]; Sapienza University of Rome [C26A10NXKK]	Ministero della Universita e Ricerca of Italy; Sapienza University of Rome; Fondazione Italiana Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Sapienza University of Rome	Funding: Ministero della Universita e Ricerca of Italy [RBRN07BMCT and 20094BJ9R7 to FC, RBFR10LHD1 to SR]; Sapienza University of Rome to FC and AP; Fondazione Italiana Fibrosi Cistica [13/2009- with the contribution of Delegazione Novara and Delegazione Cosenza2 to FC]. VS acknowledges a Post-doctoral fellowship on the project C26A10NXKK funded by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola MV, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001479; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chi CN, 2012, BIOCHEMISTRY-US, V51, P8971, DOI 10.1021/bi300792h; Chua SL, 2013, ANTIMICROB AGENTS CH, V57, P2066, DOI 10.1128/AAC.02499-12; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giardina G, 2011, BIOCHEM SOC T, V39, P294, DOI 10.1042/BST0390294; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Malone JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002760; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; McDonald MJ, 2009, GENETICS, V183, P1041, DOI 10.1534/genetics.109.107110; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Paiardini A, 2005, NUCLEIC ACIDS RES, V33, pW50, DOI 10.1093/nar/gki416; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Reinhardt A, 2007, ANTIMICROB AGENTS CH, V51, P1341, DOI 10.1128/AAC.01278-06; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rooman M, 2002, J MOL BIOL, V319, P67, DOI 10.1016/S0022-2836(02)00263-2; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sathyapriya R, 2004, NUCLEIC ACIDS RES, V32, P4109, DOI 10.1093/nar/gkh733; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Stelitano V, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vorobiev Sergey M., 2012, Journal of Structural and Functional Genomics, V13, P177, DOI 10.1007/s10969-012-9136-4; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Yang CY, 2011, ACTA CRYSTALLOGR D, V67, P997, DOI 10.1107/S090744491104039X	60	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81324	10.1371/journal.pone.0081324	http://dx.doi.org/10.1371/journal.pone.0081324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278422	Green Submitted, gold, Green Published			2022-12-27	WOS:000327541700059
J	Makowsky, MD; Rubin, J				Makowsky, Michael D.; Rubin, Jared			An Agent-Based Model of Centralized Institutions, Social Network Technology, and Revolution	PLOS ONE			English	Article							EAST EUROPEAN REVOLUTION; COLLECTIVE ACTION; INFORMATIONAL CASCADES; BEHAVIOR; CONTAGION; NORMS	This paper sheds light on the general mechanisms underlying large-scale social and institutional change. We employ an agent-based model to test the impact of authority centralization and social network technology on preference falsification and institutional change. We find that preference falsification is increasing with centralization and decreasing with social network range. This leads to greater cascades of preference revelation and thus more institutional change in highly centralized societies and this effect is exacerbated at greater social network ranges. An empirical analysis confirms the connections that we find between institutional centralization, social radius, preference falsification, and institutional change.	[Makowsky, Michael D.] Johns Hopkins Univ, Ctr Adv Modeling, Dept Emergency Med, Baltimore, MD 21218 USA; [Rubin, Jared] Chapman Univ, Dept Econ, Orange, CA USA	Johns Hopkins University; Chapman University System; Chapman University	Makowsky, MD (corresponding author), Johns Hopkins Univ, Ctr Adv Modeling, Dept Emergency Med, Baltimore, MD 21218 USA.	mikemakowsky@gmail.com	Makowsky, Michael/K-9641-2013	Makowsky, Michael/0000-0002-5558-0490; Rubin, Jared/0000-0002-3133-7947	Office of the Director, National Institutes of Health [DP1OD003874]; Johns Hopkins University Libraries	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University Libraries(Johns Hopkins University)	MM was supported, in part, by Pioneer Award Number DP1OD003874 awarded to J. M. Epstein by the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, National Institutes of Health or the National Institutes of Health, or the Office of Naval Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries.	Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; [Anonymous], FOREIGN AFFAIRS, V90, P28; [Anonymous], 2012, POLITY 4 PROJECT POL; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; BERNHEIM BD, 1994, J POLIT ECON, V102, P841, DOI 10.1086/261957; Bicchieri C., 2006, GRAMMAR SOC NATURE D, pXVI; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Callander S, 2007, REV ECON STUD, V74, P653, DOI 10.1111/j.1467-937X.2007.00441.x; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Delre SA, 2007, J BUS RES, V60, P826, DOI 10.1016/j.jbusres.2007.02.002; Ellis CJ, 2011, ECON J, V121, P763, DOI 10.1111/j.1468-0297.2010.02401.x; Epstein JM, 2002, P NATL ACAD SCI USA, V99, P7243, DOI 10.1073/pnas.092080199; Epstein JM, 1996, GROWING ARTIFICIAL S, Vxv; Epstein JM, 2006, GENERATIVE SOCIAL SC, Vxx; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Goldstone J., 2011, FOREIGN AFFAIRS, V90; Golub B., 2012, O J EC, V127, P1287; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; KURAN T, 1995, AM J SOCIOL, V100, P1528, DOI 10.1086/230671; KURAN T, 1991, AM ECON REV, V81, P121; KURAN T, 1991, WORLD POLIT, V44, P7, DOI 10.2307/2010422; KURAN T, 1989, PUBLIC CHOICE, V61, P41, DOI 10.1007/BF00116762; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; KURAN T, 1987, ECON J, V97, P642, DOI 10.2307/2232928; Kuran T., 1995, PRIVATE TRUTHS PUBLI; Kuran T, 2008, REV ECON STUD, V75, P201, DOI 10.1111/j.1467-937X.2007.00469.x; Lee IH, 2000, REV ECON STUD, V67, P47, DOI 10.1111/1467-937X.00120; LOHMANN S, 1994, WORLD POLIT, V47, P42, DOI 10.2307/2950679; Luke S, 2005, SIMUL-T SOC MOD SIM, V81, P517, DOI 10.1177/0037549705058073; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; MACY MW, 1991, AM SOCIOL REV, V56, P730, DOI 10.2307/2096252; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MOROZOV EVGENY, 2011, NET DELUSION DARK SI, p[xvii, 100]; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; OLIVER P, 1985, AM J SOCIOL, V91, P522, DOI 10.1086/228313; Press WH, 2002, NUMERICAL RECIPES C, VXXVIII; Rubin J, 2013, 32364 MPRA U LIB MUN; Schelling T., 1978, MICROMOTIVES MACROBE; Shirky C., 2011, POLITICAL POWER SOCI; Siegel DA, 2009, AM J POLIT SCI, V53, P122, DOI 10.1111/j.1540-5907.2008.00361.x; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Willer R, 2009, AM J SOCIOL, V115, P451, DOI 10.1086/599250; Wright G, 1999, J ECON HIST, V59, P267, DOI 10.1017/S002205070002283X; Yin CC, 1998, PUBLIC CHOICE, V97, P535, DOI 10.1023/A:1004921725560; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778	48	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80380	10.1371/journal.pone.0080380	http://dx.doi.org/10.1371/journal.pone.0080380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278280	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800071
J	Pereira, DIA; Mergler, BI; Faria, N; Bruggraber, SFA; Aslam, MF; Poots, LK; Prassmayer, L; Lonnerdal, B; Brown, AP; Powell, JJ				Pereira, Dora I. A.; Mergler, Bianca I.; Faria, Nuno; Bruggraber, Sylvaine F. A.; Aslam, Mohamad F.; Poots, Lynsey K.; Prassmayer, Laura; Loennerdal, Bo; Brown, Andy P.; Powell, Jonathan J.			Caco-2 Cell Acquisition of Dietary Iron(III) Invokes a Nanoparticulate Endocytic Pathway	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SIZE-DEPENDENT ENDOCYTOSIS; INTESTINAL IRON-ABSORPTION; HUMAN GASTRIC-JUICE; EPITHELIAL-CELLS; BINDING GLYCOPROTEIN; PLASMA-MEMBRANE; TRANSPORT; FERRITIN; CULTURE	Dietary non-heme iron contains ferrous [Fe(II)] and ferric [Fe(III)] iron fractions and the latter should hydrolyze, forming Fe(III) oxo-hydroxide particles, on passing from the acidic stomach to less acidic duodenum. Using conditions to mimic the in vivo hydrolytic environment we confirmed the formation of nanodisperse fine ferrihydrite-like particles. Synthetic analogues of these (similar to 10 nm hydrodynamic diameter) were readily adherent to the cell membrane of differentiated Caco-2 cells and internalization was visualized using transmission electron microscopy. Moreover, Caco-2 exposure to these nanoparticles led to ferritin formation (i.e., iron utilization) by the cells, which, unlike for soluble forms of iron, was reduced (p=0.02) by inhibition of clathrin-mediated endocytosis. Simulated lysosomal digestion indicated that the nanoparticles are readily dissolved under mildly acidic conditions with the lysosomal ligand, citrate. This was confirmed in cell culture as monensin inhibited Caco-2 utilization of iron from this source in a dose dependent fashion (p<0.05) whilet soluble iron was again unaffected. Our findings reveal the possibility of an endocytic pathway for acquisition of dietary Fe(III) by the small intestinal epithelium, which would complement the established DMT-1 pathway for soluble Fe(II).	[Pereira, Dora I. A.; Mergler, Bianca I.; Faria, Nuno; Bruggraber, Sylvaine F. A.; Aslam, Mohamad F.; Poots, Lynsey K.; Prassmayer, Laura; Powell, Jonathan J.] MRC HNR, Elsie Widdowson Lab, Cambridge, England; [Loennerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Brown, Andy P.] Univ Leeds, Inst Mat Res, Sch Proc Environm & Mat Engn, Leeds, W Yorkshire, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of California System; University of California Davis; University of Leeds	Powell, JJ (corresponding author), MRC HNR, Elsie Widdowson Lab, Cambridge, England.	jonathan.powell@mrc-hnr.cam.ac.uk	Pereira, Dora I A/D-4634-2012	Pereira, Dora I A/0000-0001-5688-4448; Lederer, Bianca/0000-0002-4512-2226; Brown, Andy/0000-0001-9692-2154	UK Medical Research Council (MRC) [U105960399]; MRC Technology Development Gap Fund (DGF); Action Medical Research [SP4528]; WellChild; Medical Research Council [MC_U105960399] Funding Source: researchfish; MRC [MC_U105960399] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Technology Development Gap Fund (DGF); Action Medical Research; WellChild; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (MRC) (U105960399), MRC Technology Development Gap Fund (DGF), Action Medical Research (SP4528) and WellChild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; ALVAREZHERNANDEZ X, 1991, BIOCHIM BIOPHYS ACTA, V1070, P205, DOI 10.1016/0005-2736(91)90165-5; Anderson GJ, 2005, BIOMETALS, V18, P339, DOI 10.1007/s10534-005-3708-8; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; AWAAD A, 2011, NANOMEDICINE; BERNER LA, 1986, J NUTR, V116, P259, DOI 10.1093/jn/116.2.259; Bravo SA, 2004, EUR J PHARM SCI, V21, P77, DOI 10.1016/S0928-0987(03)00205-7; CARPENTER CE, 1995, NUTR RES, V15, P1129, DOI 10.1016/0271-5317(95)00072-Q; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; CONRAD ME, 1991, GASTROENTEROLOGY, V100, P129, DOI 10.1016/0016-5085(91)90592-9; Conte MP, 1996, J MED MICROBIOL, V44, P418, DOI 10.1099/00222615-44-6-418; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; DAVIS PS, 1969, BIOCHEM BIOPH RES CO, V37, P532, DOI 10.1016/0006-291X(69)90948-6; DELLER DJ, 1969, AUSTRALAS ANN MED, V18, P36; DOREY C, 1993, BRIT J NUTR, V70, P157, DOI 10.1079/BJN19930113; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; Ekmekcioglu C, 1998, IN VITRO CELL DEV-AN, V34, P674; Field FJ, 1998, J LIPID RES, V39, P333; FLYNN CM, 1984, CHEM REV, V84, P31, DOI 10.1021/cr00059a003; Garcia MN, 1996, J NUTR, V126, P251, DOI 10.1093/jn/126.1.251; Glahn RP, 2006, FASEB J, V20, pA130; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glahn RP, 1996, J NUTR, V126, P332, DOI 10.1093/jn/126.1.332; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Guignot J, 2001, INFECT IMMUN, V69, P1856, DOI 10.1128/IAI.69.3.1856-1868.2001; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harvey RSJ, 1998, ALIMENT PHARM THERAP, V12, P845, DOI 10.1046/j.1365-2036.1998.00380.x; Hoppler M, 2008, J NUTR, V138, P878, DOI 10.1093/jn/138.5.878; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jambor JL, 1998, CHEM REV, V98, P2549, DOI 10.1021/cr970105t; Janney DE, 2000, AM MINERAL, V85, P1180, DOI 10.2138/am-2000-8-910; Kalgaonkar S, 2008, J NUTR BIOCHEM, V19, P33, DOI 10.1016/j.jnutbio.2007.02.001; Kalgaonkar S, 2009, J NUTR BIOCHEM, V20, P304, DOI 10.1016/j.jnutbio.2008.04.003; Kemp SJ, 2008, AM J RESP CELL MOL, V39, P591, DOI 10.1165/rcmb.2007-0334OC; LATUNDEDADA GO, 1986, J FOOD TECHNOL, V21, P255; Leitch GJ, 2005, INFECT IMMUN, V73, P7697, DOI 10.1128/IAI.73.11.7697-7704.2005; LUKE CG, 1967, LANCET, V1, P926; Mackenzie B, 2005, AM J PHYSIOL-GASTR L, V289, pG981, DOI 10.1152/ajpgi.00363.2005; Martin CDS, 2008, J NUTR, V138, P659, DOI 10.1093/jn/138.4.659; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; MERGLER BI, 2012, THESIS U CAMBRIDGE U; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MULTANI JS, 1970, BIOCHEMISTRY-US, V9, P3970, DOI 10.1021/bi00822a015; Oh JM, 2009, CHEM-ASIAN J, V4, P67, DOI 10.1002/asia.200800290; Pan YH, 2010, ULTRAMICROSCOPY, V110, P1020, DOI 10.1016/j.ultramic.2010.01.008; Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001; POHLMANN R, 1984, BIOCHEM J, V217, P649, DOI 10.1042/bj2170649; POWELL J, 2008, LIGAND MODIFIED POLY; Powell JJ, 1999, P NUTR SOC, V58, P147, DOI 10.1079/PNS19990020; Powell JJ, 1999, J INORG BIOCHEM, V75, P167, DOI 10.1016/S0162-0134(99)00094-X; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; RUDZKI Z, 1973, DIGESTION, V8, P35, DOI 10.1159/000197299; RUDZKI Z, 1973, DIGESTION, V8, P53, DOI 10.1159/000197300; SAERMARK T, 1986, BIOCHEM J, V233, P643, DOI 10.1042/bj2330643; Sharp PA, 2010, INT J VITAM NUTR RES, V80, P231, DOI 10.1024/0300-9831/a000029; Simovich M, 2003, AM J HEMATOL, V74, P32, DOI 10.1002/ajh.10383; SIMPSON RJ, 1990, BRIT J NUTR, V63, P79, DOI 10.1079/BJN19900093; Skotland T, 2002, J PHARMACEUT BIOMED, V28, P323, DOI 10.1016/S0731-7085(01)00592-1; Smith PJ, 2012, INT J NANOMED, V7, P2045, DOI 10.2147/IJN.S29334; Subramanian VS, 2009, AM J PHYSIOL-CELL PH, V296, pC663, DOI 10.1152/ajpcell.00396.2008; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212; Theil EC, 2012, J NUTR, V142, P478, DOI 10.3945/jn.111.145854; Vanden Broeck D, 2006, BIOTECHNIQUES, V41, P475, DOI 10.2144/000112265; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wang SH, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-33; WEBB J, 1973, BIOCHEMISTRY-US, V12, P265, DOI 10.1021/bi00726a014; Yamauchi KE, 2000, INFECT IMMUN, V68, P6496, DOI 10.1128/IAI.68.11.6496-6504.2000; Yang HS, 2007, J FOOD SCI, V72, pR65, DOI 10.1111/j.1750-3841.2007.00346.x; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393; Zhang YH, 2010, ANTIOXID REDOX SIGN, V13, P999, DOI 10.1089/ars.2010.3129	76	52	54	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81250	10.1371/journal.pone.0081250	http://dx.doi.org/10.1371/journal.pone.0081250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278403	Green Published, gold			2022-12-27	WOS:000327539800112
J	Edwards, KR; Goyal, J; Plavina, T; Czerkowicz, J; Goelz, S; Ranger, A; Cadavid, D; Browning, JL				Edwards, Keith R.; Goyal, Jaya; Plavina, Tatiana; Czerkowicz, Julie; Goelz, Susan; Ranger, Ann; Cadavid, Diego; Browning, Jeffrey L.			Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis	PLOS ONE			English	Article							B-CELL FOLLICLES; CEREBROSPINAL-FLUID; INTERFERON-BETA; PROGNOSTIC MARKER; DISEASE-ACTIVITY; MOLECULAR-BASIS; BRAIN-BARRIER; CXCL13; INFLAMMATION; NEUROINFLAMMATION	Meningeal inflammation, including the presence of semi-organized tertiary lymphoid tissue, has been associated with cortical pathology at autopsy in secondary progressive multiple sclerosis (SPMS). Accessible and robust biochemical markers of cortical inflammation for use in SPMS clinical trials are needed. Increased levels of chemokines in the cerebrospinal fluid (CSF) can report on inflammatory processes occurring in the cerebral cortex of MS patients. A multiplexed chemokine array that included BAFF, a high sensitivity CXCL13 assay and composite chemokine scores were developed to explore differences in lymphoid (CXCL12, CXCL13, CCL19 and CCL21) and inflammatory (CCL2, CXCL9, CXCL10 and CXCL11) chemokines in a small pilot study. Paired CSF and serum samples were obtained from healthy controls (n=12), relapsing-remitting MS (RRMS) (n=21) and SPMS (N=12). A subset of the RRMS patients (n = 9) was assessed upon disease exacerbation and 1 month later following iv methylprednisone. SPMS patients were sampled twice to ascertain stability. Both lymphoid and inflammatory chemokines were elevated in RRMS and SPMS with the highest levels found in the active RRMS group. Inflammatory and lymphoid chemokine signatures were defined and generally correlated with each other. This small exploratory clinical study shows the feasibility of measuring complex and potentially more robust chemokine signatures in the CSF of MS patients during clinical trials. No differences were found between stable RRMS and SPMS. Future trials with larger patient cohorts with this chemokine array are needed to further characterize the differences, or the lack thereof, between stable RRMS and SPMS.	[Edwards, Keith R.] Multiple Sclerosis Ctr NE New York, Latham, NY USA; [Edwards, Keith R.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Goyal, Jaya; Plavina, Tatiana] Biogen Idec Inc, Dept Translat Med, Cambridge, MA USA; [Czerkowicz, Julie; Ranger, Ann; Browning, Jeffrey L.] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA; [Goelz, Susan; Cadavid, Diego] Biogen Idec Inc, Dept Neurol Clin Dev, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Biogen; Biogen; Biogen	Browning, JL (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	browninj@bu.edu			Biogen Idec	Biogen Idec(Biogen)	The clinical aspects of this study were funded by Biogen Idec and all but one author is/was an employee of this company. Biogen Idec and the authors conceived and initiated the study, generated the study protocol in conjunction with Dr. K Edwards, did all the data collection and analysis, decision to publish, and preparation of the manuscript. Dr. Keith Edwards was the PI on the clinical study and he is not a Biogen Idec employee. All patients were accrued through his practice and he received funding to run the study and obtain patient samples.	Aloisi F, 2008, J NEUROIMMUNOL, V198, P106, DOI 10.1016/j.jneuroim.2008.04.025; Alvarez E, 2013, MULT SCLER J, V19, P1204, DOI 10.1177/1352458512473362; Antonelli A, 2011, CYTOKINE, V55, P288, DOI 10.1016/j.cyto.2011.04.022; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bushnell SE, 2012, NEUROLOGY, V79, P531, DOI 10.1212/WNL.0b013e318259e123; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Cross AH, 2012, THER ADV NEUROL DISO, V5, P311, DOI 10.1177/1756285612461165; Cross AH, 2011, BBA-MOL BASIS DIS, V1812, P231, DOI 10.1016/j.bbadis.2010.07.020; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Fischer L, 2009, CLIN CANCER RES, V15, P5968, DOI 10.1158/1078-0432.CCR-09-0108; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; Hedegaard CJ, 2011, MULT SCLER J, V17, P567, DOI 10.1177/1352458510393771; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Magraner MJ, 2012, NEURORADIOLOGY, V54, P5, DOI 10.1007/s00234-011-0841-7; Kalinowska-Lyszczarz A, 2011, J NEUROL SCI, V300, P81, DOI 10.1016/j.jns.2010.09.026; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kuerten S, 2012, ACTA NEUROPATHOL, V124, P861, DOI 10.1007/s00401-012-1023-3; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Linden M, 2013, MULT SCLER J, V19, P863, DOI 10.1177/1352458512463482; Lovato L, 2011, BRAIN, V134, P534, DOI 10.1093/brain/awq350; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Mahad DJ, 2002, J NEUROL NEUROSUR PS, V72, P498; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Moreira MA, 2006, BRAZ J MED BIOL RES, V39, P441, DOI 10.1590/S0100-879X2006000400003; Nelson TE, 2011, BRAIN BEHAV IMMUN, V25, pS106, DOI 10.1016/j.bbi.2011.02.013; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; Piccio L, 2010, ARCH NEUROL-CHICAGO, V67, P707, DOI 10.1001/archneurol.2010.99; Politis M, 2012, NEUROLOGY, V79, P523, DOI 10.1212/WNL.0b013e3182635645; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reynolds R, 2011, ACTA NEUROPATHOL, V122, P155, DOI 10.1007/s00401-011-0840-0; Scarpini E, 2002, J NEUROL SCI, V195, P41, DOI 10.1016/S0022-510X(01)00680-3; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Sorensen TL, 2001, EUR J NEUROL, V8, P665, DOI 10.1046/j.1468-1331.2001.00327.x; Szczucinski A, 2011, NEUROIMMUNOMODULAT, V18, P67, DOI 10.1159/000317394; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; Villar LM, 2012, ARCH NEUROL-CHICAGO, V69, P191, DOI 10.1001/archneurol.2011.971	52	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81007	10.1371/journal.pone.0081007	http://dx.doi.org/10.1371/journal.pone.0081007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278364	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100134
J	Kang, MK; Lim, SS; Lee, JY; Yeo, KM; Kang, YH				Kang, Min-Kyung; Lim, Soon Sung; Lee, Jae-Yong; Yeo, Kyung Mok; Kang, Young-Hee			Anthocyanin-Rich Purple Corn Extract Inhibit Diabetes-Associated Glomerular Angiogenesis	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ENDOTHELIAL-CELLS; RENAL ALTERATIONS; NEPHROPATHY; HYPOXIA; ANGIOPOIETINS; MICE; REGULATOR; FIBROSIS; DISEASE	Diabetic nephropathy (DN) is one of the major diabetic complications and the leading cause of end-stage renal disease. Abnormal angiogenesis results in new vessels that are often immature and play a pathological role in DN, contributing to renal fibrosis and disrupting glomerular failure. Purple corn has been utilized as a daily food and exerts disease-preventive activities. This study was designed to investigate whether anthocyanin-rich purple corn extract (PCE) prevented glomerular angiogenesis under hyperglycemic conditions. Human endothelial cells were cultured in conditioned media of mesangial cells exposed to 33 mM high glucose (HG-HRMC-CM). PCE decreased endothelial expression of vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF)-1 alpha induced by HG-HRMC-CM. Additionally, PCE attenuated the induction of the endothelial marker of platelet endothelial cell adhesion molecule (PECAM)-1 and integrin beta 3 enhanced in HG-HRMC-CM. Endothelial tube formation promoted by HG-HRMC-CM was disrupted in the presence of PCE. In the in vivo study employing db/db mice treated with 10 mg/kg PCE for 8 weeks, PCE alleviated glomerular angiogenesis of diabetic kidneys by attenuating the induction of VEGF and HIF-1 alpha. Oral administration of PCE retarded the endothelial proliferation in db/db mouse kidneys, evidenced by its inhibition of the induction of vascular endothelium-cadherin, PECAM-1 and Ki-67. PCE diminished the mesangial and endothelial induction of angiopoietin (Angpt) proteins under hypeglycemic conditions. The induction and activation of VEGF receptor 2 (VEGFR2) were dampened by treating PCE to db/db mice. These results demonstrate that PCE antagonized glomerular angiogenesis due to chronic hyperglycemia and diabetes through disturbing the Angpt-Tie-2 ligand-receptor system linked to renal VEGFR2 signaling pathway. Therefore, PCE may be a potent therapeutic agent targeting abnormal angiogenesis in DN leading to kidney failure.	[Kang, Min-Kyung; Lim, Soon Sung; Kang, Young-Hee] Hallym Univ, Dept Food & Nutr, Chunchon, South Korea; [Kang, Min-Kyung; Lim, Soon Sung; Kang, Young-Hee] Hallym Univ, Ctr Aging & Healthcare, Chunchon, South Korea; [Lee, Jae-Yong] Hallym Univ, Sch Med, Dept Biochem, Chunchon, South Korea; [Yeo, Kyung Mok] S&D Co Ltd, Chunchon, South Korea	Hallym University; Hallym University; Hallym University	Kang, YH (corresponding author), Hallym Univ, Dept Food & Nutr, Chunchon, South Korea.	yhkang@hallym.ac.kr			National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation [2012-01-A-05-003-12-010100]; Ministry for Food, Agriculture, Forestry and Fisheries through the Korea Institute of Planning and Evaluation for Technology of Food, Agriculture, Forestry and Fisheries [109163-03-1-SB030]	National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation(National Research Foundation of Korea); Ministry for Food, Agriculture, Forestry and Fisheries through the Korea Institute of Planning and Evaluation for Technology of Food, Agriculture, Forestry and Fisheries	This study was supported by the National Research Foundation of Korea through the Human Resource Training Project for Regional Innovation (2012-01-A-05-003-12-010100) and by a grant from the Ministry for Food, Agriculture, Forestry and Fisheries through the Korea Institute of Planning and Evaluation for Technology of Food, Agriculture, Forestry and Fisheries (109163-03-1-SB030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2012, SEMIN NEPHROL, V32, P199, DOI 10.1016/j.semnephrol.2012.02.006; Ballermann BJ, 2007, NEPHRON PHYSIOL, V106, P19, DOI 10.1159/000101796; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Choi S, 2013, NUTR RES PRACT, V7, P9, DOI 10.4162/nrp.2013.7.1.9; Costa PZ, 2013, LIFE SCI, V92, P1037, DOI 10.1016/j.lfs.2013.04.001; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Dessapt-Baradez C, 2013, J AM SOC NEPHROL; Favot L, 2003, CARDIOVASC RES, V59, P479, DOI 10.1016/S0008-6363(03)00433-4; Fernandez PM, 2004, SEMIN THROMB HEMOST, V30, P31; Gu HF, 2013, DIABETES CARE, V36, P415, DOI 10.2337/dc12-1125; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Ichinose K, 2006, DIABETES, V55, P1232, DOI 10.2337/db05-1367; Kang MK, 2012, AM J PHYSIOL-RENAL, V303, pF1060, DOI 10.1152/ajprenal.00106.2012; Khoury CC, 2011, CONTRIB NEPHROL, V170, P83, DOI 10.1159/000324950; Kim TH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/727143; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Li J, 2012, EUR J NUTR, V51, P961, DOI 10.1007/s00394-011-0274-4; Li J, 2012, J NUTR BIOCHEM, V23, P320, DOI 10.1016/j.jnutbio.2010.12.008; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Long N, 2013, CANCER SCI, V104, P298, DOI 10.1111/cas.12078; Maeshima Yohei, 2005, Clin Exp Nephrol, V9, P271, DOI 10.1007/s10157-005-0388-1; Matsunaga N, 2010, PHYTOTHER RES, V24, pS42, DOI 10.1002/ptr.2895; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Nguyen Dung V, 2012, Front Endocrinol (Lausanne), V3, P170, DOI 10.3389/fendo.2012.00170; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Satchell SC, 2003, J NEPHROL, V16, P168; SAVAGE COS, 1994, KIDNEY INT, V45, P314, DOI 10.1038/ki.1994.40; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Siddiqui IA, 2008, ONCOGENE, V27, P2055, DOI 10.1038/sj.onc.1210840; Sivaskandarajah GA, 2012, DIABETES, V61, P2958, DOI 10.2337/db11-1655; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Tait CR, 2004, J PATHOL, V204, P1, DOI 10.1002/path.1618; Tanaka J, 2012, PHYTOTHER RES, V26, P214, DOI 10.1002/ptr.3533; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Westra J, 2010, CURR MED CHEM, V17, P254, DOI 10.2174/092986710790149783; Willard AL, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/209538; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243; Zent R, 2007, SEMIN NEPHROL, V27, P161, DOI 10.1016/j.semnephrol.2007.01.007	41	89	94	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79823	10.1371/journal.pone.0079823	http://dx.doi.org/10.1371/journal.pone.0079823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278186	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100051
J	Wong, MKS; Takei, Y				Wong, Marty Kwok-Shing; Takei, Yoshio			Lack of Plasma Kallikrein-Kinin System Cascade in Teleosts	PLOS ONE			English	Article							CARDIOVASCULAR ACTIVITY; RENIN-ANGIOTENSIN; MOLECULAR-WEIGHT; PURIFICATION; BRADYKININ; CLONING	The kallikrein-kinin system (KKS) consists of two major cascades in mammals: "plasma KKS" consisting of high molecular-weight (HMW) kininogen (KNG), plasma kallikrein (KLKB1), and bradykinin (BK); and "tissue KKS" consisting of low molecular-weight (LMW) KNG, tissue kallikreins (KLKs), and [Lys(0)]-BK. Some components of the KKS have been identified in the fishes, but systematic analyses have not been performed, thus this study aims to define the KKS components in teleosts and pave a way for future physiological and evolutionary studies. Through a combination of genomics, molecular, and biochemical methods, we showed that the entire plasma KKS cascade is absent in teleosts. Instead of two KNGs as found in mammals, a single molecular weight KNG was found in various teleosts, which is homologous to the mammalian LMW KNG. Results of molecular phylogenetic and synteny analyses indicated that the all current teleost genomes lack KLKB1, and its unique protein structure, four apple domains and one trypsin domain, could not be identified in any genome or nucleotide databases. We identified some KLK-like proteins in teleost genomes by synteny and conserved domain analyses, which could be the orthologs of tetrapod KLKs. A radioimmunoassay system was established to measure the teleost BK and we found that [Arg(0)]-BK is the major circulating form instead of BK, which supports that the teleost KKS is similar to the mammalian tissue KKS. Coincidently, coelacanths are the earliest vertebrate that possess both HMW KNG and KLKB1, which implies that the plasma KKS could have evolved in the early lobe-finned fish and descended to the tetrapod lineage. The co-evolution of HMW KNG and KLKB1 in lobe-finned fish and early tetrapods may mark the emergence of the plasma KKS and a contact activation system in blood coagulation, while teleosts may have retained a single KKS cascade.	[Wong, Marty Kwok-Shing; Takei, Yoshio] Univ Tokyo, Physiol Lab, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Wong, MKS (corresponding author), Univ Tokyo, Physiol Lab, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	martywong@aori.u-tokyo.ac.jp	Wong, Marty KS/M-5689-2016	Wong, Marty KS/0000-0002-3615-2087	CREST by Japanese Science and Technology Agency;  [23247010]; Grants-in-Aid for Scientific Research [23247010] Funding Source: KAKEN	CREST by Japanese Science and Technology Agency; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work is supported by Grant-in-Aid for Basic Research A (23247010) awarded to YT. MW is supported by CREST funding by Japanese Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balment RJ, 2002, COMP BIOCHEM PHYS A, V131, P467, DOI 10.1016/S1095-6433(01)00486-X; Blais C, 2000, PEPTIDES, V21, P1903, DOI 10.1016/S0196-9781(00)00348-X; Campbell DJ, 2003, INT J BIOCHEM CELL B, V35, P784, DOI 10.1016/S1357-2725(02)00262-5; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; COLMAN RW, 1994, BRAZ J MED BIOL RES, V27, P1839; Conlon JM, 1996, PEPTIDES, V17, P531, DOI 10.1016/0196-9781(96)00024-1; Doolittle RF, 2011, J INNATE IMMUN, V3, P9, DOI 10.1159/000321005; FERRE J, 1985, J CHROMATOGR, V350, P389, DOI 10.1016/S0021-9673(01)93544-7; Golias Ch, 2007, Hippokratia, V11, P124; Hilgenfeldt U, 1998, AM J PHYSIOL-RENAL, V275, pF88, DOI 10.1152/ajprenal.1998.275.1.F88; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Lalmanach G, 2010, BIOCHIMIE, V92, P1568, DOI 10.1016/j.biochi.2010.03.011; Li ZH, 1998, PEPTIDES, V19, P635, DOI 10.1016/S0196-9781(97)00479-8; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Olson KR, 1997, AM J PHYSIOL-REG I, V272, pR1112, DOI 10.1152/ajpregu.1997.272.4.R1112; Pathak M, 2013, THROMB HAEMOSTASIS, V109; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Platzack B, 1997, AM J PHYSIOL-REG I, V272, pR710, DOI 10.1152/ajpregu.1997.272.2.R710; Schmaier AH, 2003, AM J PHYSIOL-REG I, V285, pR1, DOI 10.1152/ajpregu.00535.2002; Shen B, 2006, BIOL CHEM, V387, P145, DOI 10.1515/BC.2006.019; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Takano M, 1997, BBA-GENE STRUCT EXPR, V1352, P222, DOI 10.1016/S0167-4781(97)00018-3; Takei Y, 2001, AM J PHYSIOL-REG I, V281, pR1090, DOI 10.1152/ajpregu.2001.281.4.R1090; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsutsui S, 2011, GLYCOBIOLOGY, V21, P1580, DOI 10.1093/glycob/cwr070; Wong MKS, 2012, GEN COMP ENDOCR, V178, P250, DOI 10.1016/j.ygcen.2012.06.007; Ylonen A, 2002, EUR J BIOCHEM, V269, P2639, DOI 10.1046/j.1432-1033.2002.02927.x; ZHOU GX, 1992, J BIOL CHEM, V267, P25873; Zhou LW, 2008, GENOMICS, V91, P129, DOI 10.1016/j.ygeno.2007.10.007; Zhou LW, 2009, J GENET GENOMICS, V36, P109, DOI 10.1016/S1673-8527(08)60097-1; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	34	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81057	10.1371/journal.pone.0081057	http://dx.doi.org/10.1371/journal.pone.0081057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278376	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100141
J	Grimaud, O; Lapostolle, A; Berr, C; Helmer, C; Dufouil, C; Kihal, W; Alperovitch, A; Chauvin, P				Grimaud, Olivier; Lapostolle, Annabelle; Berr, Claudine; Helmer, Catherine; Dufouil, Carole; Kihal, Wahida; Alperovitch, Annick; Chauvin, Pierre			Gender Differences in the Association between Socioeconomic Status and Subclinical Atherosclerosis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ISCHEMIC-HEART-DISEASE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; NEIGHBORHOOD DEPRIVATION; RISK-FACTORS; WOMEN; PROGRESSION; HEALTH; MEN	Objectives: This study explored the pattern of associations between socioeconomic status (SES) and atherosclerosis progression (as indicated by carotid intima media thickness, CIMT) across gender. Design: Cross-sectional analysis of a sample of 5474 older persons (mean age 73 years) recruited between 1999 and 2001 in the 3C study (France). We fitted linear regression models including neighborhood SES, individual SES and cardiovascular risk factors. Results: CIMT was on average 24 mm higher in men (95% CI: 17 to 31). Neighborhood SES was inversely associated with CIMT in women only (highest versus lowest tertiles: -12.2 mu m, 95% CI -22 to -2.4). This association persisted when individual SES and risk factors were accounted for. High individual education was associated with lower CIMT in men (-21.4 mm 95% CI -37.5 to -5.3) whereas high professional status was linked to lower CIMT among women (-15.7 mu m 95% CI: -29.2 to -2.2). Adjustment for cardiovascular risk factors resulted in a slightly more pronounced reduction of the individual SES-CIMT association observed in men than in women. Conclusion: In this sample, neighborhood and individual SES displayed different patterns of associations with subclinical atherosclerosis across gender. This suggests that the causal pathways leading to SES variations in atherosclerosis may differ among men and women.	[Grimaud, Olivier; Kihal, Wahida] French Sch Publ Hlth, Rennes, France; [Lapostolle, Annabelle; Chauvin, Pierre] INSERM, U707, Paris, France; [Berr, Claudine] INSERM, U1061, Montpellier, France; [Helmer, Catherine] INSERM, U897, Bordeaux, France; [Dufouil, Carole; Alperovitch, Annick] Univ Bordeaux Segalen, Bordeaux, France; [Dufouil, Carole; Alperovitch, Annick] Inst Natl Sante & Rech Med 708, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Grimaud, O (corresponding author), French Sch Publ Hlth, Rennes, France.	olivier.grimaud@ehesp.fr	berr, Claudine/D-5238-2014; Chauvin, Pierre/G-1095-2015; Dufouil, Carole/F-5751-2014; HELMER, Catherine/I-6581-2015; HELMER, Catherine/AAG-5126-2021; Chauvin, Pierre/S-2981-2019; Dufouil, Carole/J-4968-2012	berr, Claudine/0000-0001-5254-7655; Chauvin, Pierre/0000-0002-9183-6406; Dufouil, Carole/0000-0003-2442-4476; HELMER, Catherine/0000-0002-5169-7421; Chauvin, Pierre/0000-0002-9183-6406; 	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	The Three-City Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Victor Segalen - Bordeaux II University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." The funding organizations played no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in preparation, review, or approval of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Carson AP, 2007, ANN EPIDEMIOL, V17, P296, DOI 10.1016/j.annepidem.2006.07.009; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Deans Kevin A, 2009, BMJ, V339, pb4170, DOI 10.1136/bmj.b4170; Deguen S, 2010, EPIDEMIOLOGY, V21, P459, DOI 10.1097/EDE.0b013e3181e09925; DIEZROUX AV, 1995, AM J EPIDEMIOL, V141, P960, DOI 10.1093/oxfordjournals.aje.a117363; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Grimaud O, 2011, STROKE, V42, P1201, DOI 10.1161/STROKEAHA.110.596429; Inagami S, 2007, SOC SCI MED, V65, P1779, DOI 10.1016/j.socscimed.2007.05.051; Lamont D, 2000, BMJ-BRIT MED J, V320, P273, DOI 10.1136/bmj.320.7230.273; Larsen SB, 2012, EUR J EPIDEMIOL, V27, P837, DOI 10.1007/s10654-012-9739-x; Lemelin ET, 2009, SOC SCI MED, V68, P444, DOI 10.1016/j.socscimed.2008.10.038; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lynch J, 1997, ARTERIOSCL THROM VAS, V17, P513, DOI 10.1161/01.ATV.17.3.513; LYNCH J, 1995, CIRCULATION, V92, P1786, DOI 10.1161/01.CIR.92.7.1786; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Murray Emily T, 2010, Am J Epidemiol, V171, P1099, DOI 10.1093/aje/kwq044; Nash SD, 2011, PREV MED, V52, P208, DOI 10.1016/j.ypmed.2010.12.009; Nordstrom CK, 2004, SOC SCI MED, V59, P2139, DOI 10.1016/j.socscimed.2004.03.017; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Petticrew M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027939; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Plichart M, 2011, ATHEROSCLEROSIS, V219, P917, DOI 10.1016/j.atherosclerosis.2011.09.024; Ranjit N, 2006, ARTERIOSCL THROM VAS, V26, P411, DOI 10.1161/01.ATV.0000198245.16342.3d; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Sutton CJ, 2010, J EPIDEMIOL COMMUN H, V64, P523, DOI 10.1136/jech.2008.086785; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394; Wang HX, 2007, J INTERN MED, V261, P245, DOI 10.1111/j.1365-2796.2006.01759.x; Zureik M, 2004, STROKE, V35, P2770, DOI 10.1161/01.STR.0000147968.48379.c3	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80195	10.1371/journal.pone.0080195	http://dx.doi.org/10.1371/journal.pone.0080195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282522	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500023
J	Kapaki, E; Paraskevas, GP; Emmanouilidou, E; Vekrellis, K				Kapaki, Elisabeth; Paraskevas, George P.; Emmanouilidou, Evangelia; Vekrellis, Kostas			The Diagnostic Value of CSF alpha-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; BIOMARKERS; RECOMMENDATIONS; DISCRIMINATE; TAU	The detection of alpha-synuclein (alpha-syn) in the cerebrospinal fluid (CSF) of patients with synucleinopathy has yielded promising but inconclusive results. The aim of the present study was to determine the diagnostic value of a-syn as a biological marker for Dementia with Lewy bodies (DLB) vs. normal subjects and patients with Alzheimer's disease (AD), after strict control of several recognized confounders. Sixteen patients with DLB, 18 patients with AD and 22 age- and sex-matched normal controls (CTRL) were recruited. The levels of total a-syn in CSF were measured using a novel enzyme-linked immunosorbent assay. There was a significant increase of CSF a-syn levels in DLB patients as compared to the CTRL and AD groups (P= 0.049 and 0.01 respectively). ROC analysis revealed that increased asyn was 81.8% specific for the discrimination of DLB vs. CTRL and 90% vs. AD. However, sensitivity was lower (56.2 % and 50% respectively). These findings provide evidence for a possible diagnostic role of a-syn as a surrogate biomarker for DLB.	[Kapaki, Elisabeth; Paraskevas, George P.] Univ Athens, Sch Med, Eginit Hosp, Dept Neurol 1, Athens 11528, Greece; [Emmanouilidou, Evangelia; Vekrellis, Kostas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Academy of Athens	Kapaki, E (corresponding author), Univ Athens, Sch Med, Eginit Hosp, Dept Neurol 1, Athens 11528, Greece.	ekapaki@med.uoa.gr	Emmanouilidou, Evangelia/ACP-6562-2022		MJF Foundation	MJF Foundation	The project presented here is part of the BIOMARKAPD Project in the frame of the Joint Programming Neurodegenerative Disease. This work was partly funded by a grant from the MJF Foundation to EE and KV. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Kasuga K, 2012, INT J ALZHEIMERS DIS, DOI [10.1155/2012/437025, DOI 10.1155/2012/437025]; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2012, J NEURAL TRANSM, V119, P739, DOI 10.1007/s00702-012-0784-0; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; MURRAY AM, 1995, ANN NEUROL, V37, P300, DOI 10.1002/ana.410370306; Noguchi-Shinohara M, 2009, BRAIN RES, V1251, P1, DOI 10.1016/j.brainres.2008.11.055; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Paraskevas GP, 2009, EUR J NEUROL, V16, P205, DOI 10.1111/j.1468-1331.2008.02387.x; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Rinne JO, 1998, NEUROLOGY, V50, P152, DOI 10.1212/WNL.50.1.152; SantaCruz KS, 2001, AM FAM PHYSICIAN, V63, P703; Spies PE, 2009, J ALZHEIMERS DIS, V16, P363, DOI 10.3233/JAD-2009-0955; Tapiola T, 1997, NEUROREPORT, V8, P3961, DOI 10.1097/00001756-199712220-00022; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Teunissen CE, 2002, NEUROBIOL AGING, V23, P485, DOI 10.1016/S0197-4580(01)00328-1; TIRABOSCHI P, 2010, OPEN NUCL MED J, V2, P58, DOI DOI 10.2174/1876388X01002020058; van Geel WJA, 2008, J NEUROSCI METH, V168, P182, DOI 10.1016/j.jneumeth.2007.09.021; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Wennstrom M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053250, 10.1371/journal.pone.0109387]	35	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81654	10.1371/journal.pone.0081654	http://dx.doi.org/10.1371/journal.pone.0081654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282614	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500117
J	Senese, VP; De Falco, S; Bornstein, MH; Caria, A; Buffolino, S; Venuti, P				Senese, Vincenzo Paolo; De Falco, Simona; Bornstein, Marc H.; Caria, Andrea; Buffolino, Simona; Venuti, Paola			Human Infant Faces Provoke Implicit Positive Affective Responses in Parents and Non-Parents Alike	PLOS ONE			English	Article							ASSOCIATION TEST; MOTHERS; BRAIN; COGNITION; CHILDREN; YOUNG; RESPONSIVENESS; DETERMINANTS; PSYCHOLOGY; LANGUAGE	Human infants' complete dependence on adult caregiving suggests that mechanisms associated with adult responsiveness to infant cues might be deeply embedded in the brain. Behavioural and neuroimaging research has produced converging evidence for adults' positive disposition to infant cues, but these studies have not investigated directly the valence of adults' reactions, how they are moderated by biological and social factors, and if they relate to child caregiving. This study examines implicit affective responses of 90 adults toward faces of human and non-human (cats and dogs) infants and adults. Implicit reactions were assessed with Single Category Implicit Association Tests, and reports of childrearing behaviours were assessed by the Parental Style Questionnaire. The results showed that human infant faces represent highly biologically relevant stimuli that capture attention and are implicitly associated with positive emotions. This reaction holds independent of gender and parenthood status and is associated with ideal parenting behaviors.	[Senese, Vincenzo Paolo; Buffolino, Simona] Univ Naples 2, Dept Psychol, Psychometr Lab, Caserta, Italy; [De Falco, Simona; Venuti, Paola] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy; [Bornstein, Marc H.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, US Dept HHS, Bethesda, MD USA; [Caria, Andrea] Univ Tubingen, Inst Med Psychol & Behav Neurobiol Eberhard Karls, Tubingen, Germany	Universita della Campania Vanvitelli; University of Trento; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Eberhard Karls University of Tubingen	Senese, VP (corresponding author), Univ Naples 2, Dept Psychol, Psychometr Lab, Caserta, Italy.	vincenzopaolo.senese@unina2.it	Senese, V. P./Z-4550-2019; Venuti, Paola/J-8540-2014	Senese, V. P./0000-0003-2299-6040; Venuti, Paola/0000-0002-1827-0549; Caria, Andrea/0000-0003-2017-7084; De Falco, Simona/0000-0001-9137-2958	NIH, NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001119] Funding Source: NIH RePORTER	NIH, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was partially supported by the Intramural Research Program of the NIH, NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Babchishin KM, 2013, ARCH SEX BEHAV, V42, P487, DOI 10.1007/s10508-012-0022-8; Barnow S, 2005, AGGRESSIVE BEHAV, V31, P24, DOI 10.1002/ab.20033; Beck JE, 2005, J CHILD PSYCHOL PSYC, V46, P35, DOI 10.1111/j.1469-7610.2004.00336.x; Belsky J, 2006, DEV PSYCHOPATHOL, V3, P38, DOI DOI 10.1002/9780470939406.CH2; BERMAN PW, 1980, PSYCHOL BULL, V88, P668, DOI 10.1037/0033-2909.88.3.668; Bornstein M.H., 2013, INFANT MIND ORIGINS, P266; Bornstein M. H., 2002, HDB PARENTING CHILDR; Bornstein M. H., 2010, HDB CULTURAL DEV SCI, P259, DOI 10.4324/9780203805497; Bornstein MH, 2008, DEV PSYCHOL, V44, P867, DOI 10.1037/0012-1649.44.3.867; Bornstein MH, 2013, DEV NEUROPSYCHOL, V38, P365, DOI 10.1080/87565641.2013.804923; BORNSTEIN MH, 1989, DEV REV, V9, P171, DOI 10.1016/0273-2297(89)90028-2; Bornstein MH, 2003, MON PARENT, P29; Bornstein MH, 1996, INT J BEHAV DEV, V19, P347; Bornstein MH, 1989, INTERACTION HUMAN DE, P197; BOWLBY J, 1969, ATTACHMENT LOSS, DOI DOI 10.1177/000306518403200125; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Carver CS, 2009, CURR DIR PSYCHOL SCI, V18, P195, DOI 10.1111/j.1467-8721.2009.01635.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conrey FR, 2007, SOC COGNITION, V25, P718, DOI 10.1521/soco.2007.25.5.718; Darwin C., 1872, P374; Di Conza A, 2010, PSICOL SOC, V2, P301; Eibl-Eibesfeldt I., 1970, ETHOLOGY BIOL BEHAV; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Frick PJ, 2006, CHILD ADOL PSYCH CL, V15, P311, DOI 10.1016/j.chc.2005.11.003; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; FRODI AM, 1978, DEV PSYCHOL, V14, P490, DOI 10.1037/0012-1649.14.5.490; FRODI AM, 1980, CHILD DEV, V51, P238, DOI 10.2307/1129612; FRODI AM, 1984, SEX ROLES, V10, P639; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Goodnow J.J., 1990, DEV ACCORDING PARENT, DOI 10.4324/9781315785103; GREEN JA, 1987, DEV PSYCHOL, V23, P370, DOI 10.1037/0012-1649.23.3.370; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; GREENWALD AG, 1992, AM PSYCHOL, V47, P766, DOI 10.1037/0003-066X.47.6.766; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grogan-Kaylor A, 2005, CHILD MALTREATMENT, V10, P283, DOI 10.1177/1077559505277803; Grusec JE, 2006, ENCY EARLY CHILDHOOD; Hoff E., 2002, HDB PARENTING BIOL E, VVolume 2, P231, DOI DOI 10.4324/9780429401459-13; Holden G. W., 2002, HDB PARENTING, V3, P537; Holden G.W., 2010, PARENTING DYNAMIC PE; Hrdy S. B., 1999, MOTHER NATURE HIST M; Rodrigo MJ, 2011, DEV PSYCHOPATHOL, V23, P163, DOI 10.1017/S0954579410000714; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Kihlstrom J. F., 1990, HDB PERSONALITY THEO, P445; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lorenz K, 1971, STUDIES ANIMAL HUMAN, VII; MILLER SA, 1988, CHILD DEV, V59, P259, DOI 10.1111/j.1467-8624.1988.tb01467.x; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Papousek H., 2002, HDB PARENTING, P183; Parke R.D., 2002, HDB PARENTING, P27; Plutchik R, 1987, EMPATHY ITS DEV, P3; Prinzie P, 2009, J PERS SOC PSYCHOL, V97, P351, DOI 10.1037/a0015823; Raine A, 1996, ARCH GEN PSYCHIAT, V53, P544; Sander LW, 2000, INF MENTAL HLTH J, V21, P5, DOI 10.1002/(SICI)1097-0355(200001/04)21:1/2<5::AID-IMHJ2>3.0.CO;2-S; Sanefuji W, 2007, J ETHOL, V25, P249, DOI 10.1007/s10164-006-0018-8; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Senese VP, 2012, INFANT BEHAV DEV, V35, P479, DOI 10.1016/j.infbeh.2012.02.006; Sigel I. E., 2002, BEING BECOMING PAREN, P485; Smith ER, 2000, PERS SOC PSYCHOL REV, V4, P108, DOI 10.1207/S15327957PSPR0402_01; Sroufe LA, 2000, INFANT MENT HEALTH J, V21, P67, DOI 10.1002/(SICI)1097-0355(200001/04)21:1/2<67::AID-IMHJ8>3.0.CO;2-2; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Strathearn L., 2007, DEV SCI PSYCHOANALYS, P117; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; Swain JE, 2011, PROG NEURO-PSYCHOPH, V35, P1242, DOI 10.1016/j.pnpbp.2010.10.017; Thornberry TP, 2003, J ABNORM CHILD PSYCH, V31, P171, DOI 10.1023/A:1022574208366; Trevarthen C, 2001, J CHILD PSYCHOL PSYC, V42, P3, DOI 10.1111/1469-7610.00701; Tronick E., 2005, EMOTIONAL DEV RECENT, P293; Uziel L, 2010, PERSPECT PSYCHOL SCI, V5, P243, DOI 10.1177/1745691610369465; VAN IJZENDOORN MH, 1995, SOC DEV, V4, P115; Venuti P., 2007, G ITAL PSICOL, VXXXIV, P677; WEISNER TS, 1977, CURR ANTHROPOL, V18, P169, DOI 10.1086/201883	77	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80379	10.1371/journal.pone.0080379	http://dx.doi.org/10.1371/journal.pone.0080379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282537	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500038
J	Ueno, S; Nishiguchi, KM; Tanioka, H; Enomoto, A; Yamanouchi, T; Kondo, M; Yasuma, TR; Yasuda, S; Kuno, N; Takahashi, M; Terasaki, H				Ueno, Shinji; Nishiguchi, Koji M.; Tanioka, Hidetoshi; Enomoto, Atsushi; Yamanouchi, Takashi; Kondo, Mineo; Yasuma, Testuhiro R.; Yasuda, Shunsuke; Kuno, Noriyuki; Takahashi, Masahide; Terasaki, Hiroko			Degeneration of Retinal ON Bipolar Cells Induced by Serum Including Autoantibody against TRPM1 in Mouse Model of Paraneoplastic Retinopathy	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; ELECTRORETINOGRAM; ANTIBODIES; MUTATIONS; RECEPTOR; NEURONS; ERG; COMPONENTS; ALPHA; GLUR3	The paraneoplastic retinopathies (PRs) are a group of eye diseases characterized by a sudden and progressive dysfunction of the retina caused by an antibody against a protein in a neoplasm. Evidence has been obtained that the transient receptor potential melastatin 1 (TRPM1) protein was one of the antigens for the autoantibody against the ON bipolar cells in PR patients. However, it has not been determined how the autoantibody causes the dysfunction of the ON bipolar cells. We hypothesized that the antibody against TRPM1 in the serum of patients with PR causes a degeneration of retinal ON bipolar cells. To test this hypothesis, we injected the serum from the PR patient, previously shown to contain anti-TRPM1 antibodies by westerblot, intravitreally into mice and examined the effects on the retina. We found that the electroretinograms (ERGs) of the mice were altered acutely after the injection, and the shape of the ERGs resembled that of the patient with PR. Immunohistochemical analysis of the eyes injected with the serum showed immunoreactivity against bipolar cells only in wild-type animals and not in TRPM1 knockout mice, consistent with the serum containing anti-TRPM1 antibodies. Histology also showed that some of the bipolar cells were apoptotic by 5 hours after the injection in wild type mice, but no bipolar cell death was found in TRPM1 knockout mice,. At 3 months, the inner nuclear layer was thinner and the amplitudes of the ERGs were still reduced. These results indicate that the serum of a patient with PR contained an antibody against TRPM1 caused an acute death of retinal ON bipolar cells of mice.	[Ueno, Shinji; Nishiguchi, Koji M.; Kondo, Mineo; Yasuma, Testuhiro R.; Yasuda, Shunsuke; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Tanioka, Hidetoshi; Yamanouchi, Takashi; Kuno, Noriyuki] Santen Pharmaceut Co Ltd, Ctr Res & Dev, Ikoma, Japan; [Enomoto, Atsushi; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan	Nagoya University; Santen Pharmaceutical Co Ltd; Nagoya University	Ueno, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan.	ueno@med.nagoya-u.ac.jp	Enomoto, Atsushi/I-7272-2014; Ueno, Shinji/M-5063-2014; TAKAHASHI, Masahide/I-7244-2014; Terasaki, Hiroko/M-5054-2014; Takahashi, Masahide/AAN-4770-2020	Enomoto, Atsushi/0000-0002-9206-6116; Takahashi, Masahide/0000-0002-2803-2683	Ministry of Education, Culture, Sports, Science and Technology [23791977]; Grants-in-Aid for Scientific Research [23592603] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research (B)(#23791977) from the Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; BERSON EL, 1988, AM J OPHTHALMOL, V106, P307, DOI 10.1016/0002-9394(88)90366-2; Brown K T, 1969, UCLA Forum Med Sci, V8, P319; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Gittinger JW, 1999, AM J OPHTHALMOL, V127, P612, DOI 10.1016/S0002-9394(98)00431-0; Goetgebuer G, 2008, DOC OPHTHALMOL, V116, P49, DOI 10.1007/s10633-007-9074-9; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; Heckenlively JR, 2008, SEMIN IMMUNOPATHOL, V30, P127, DOI 10.1007/s00281-008-0114-7; Hisatomi T, 2003, AM J PATHOL, V162, P1869, DOI 10.1016/S0002-9440(10)64321-0; ICHIKAWA M, 1985, BRAIN RES, V345, P87, DOI 10.1016/0006-8993(85)90839-X; Jacobson DM, 2001, AM J OPHTHALMOL, V131, P806, DOI 10.1016/S0002-9394(00)00925-9; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Keltner JL, 2001, J NEURO-OPHTHALMOL, V21, P173, DOI 10.1097/00041327-200109000-00004; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; KOLB H, 1993, VISUAL NEUROSCI, V10, P341, DOI 10.1017/S0952523800003734; KONDO M, 2011, PLOS ONE; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; LEONG SK, 1989, J ANAT, V164, P1; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; MILAM AH, 1993, INVEST OPHTH VIS SCI, V34, P91; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Ruether K, 2010, INVEST OPHTH VIS SCI, V51, P6051, DOI 10.1167/iovs.09-4704; SAWYER RA, 1976, AM J OPHTHALMOL, V81, P606, DOI 10.1016/0002-9394(76)90125-2; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; THIRKILL CE, 1992, INVEST OPHTH VIS SCI, V33, P2768; Ueno S, 2005, EXP EYE RES, V81, P751, DOI 10.1016/j.exer.2005.04.013; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Vardi N, 1998, J COMP NEUROL, V395, P43; Whitney KD, 2000, J NEUROSCI, V20, P7307; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1007/s11068-004-4209-3	41	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81507	10.1371/journal.pone.0081507	http://dx.doi.org/10.1371/journal.pone.0081507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282602	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500105
J	Wahlberg, N; Wheat, CW; Pena, C				Wahlberg, Niklas; Wheat, Christopher W.; Pena, Carlos			Timing and Patterns in the Taxonomic Diversification of Lepidoptera (Butterflies and Moths)	PLOS ONE			English	Article							SPECIES-DIVERSITY; PHYLOGENY; RADIATION; EVOLUTION; INSIGHTS; FOSSILS; ORIGIN	The macroevolutionary history of the megadiverse insect order Lepidoptera remains little-known, yet coevolutionary dynamics with their angiospermous host plants are thought to have influenced their diversification significantly. We estimate the divergence times of all higher-level lineages of Lepidoptera, including most extant families. We find that the diversification of major lineages in Lepidoptera are approximately equal in age to the crown group of angiosperms and that there appear to have been three significant increases in diversification rates among Lepidoptera over evolutionary time: 1) at the origin of the crown group of Ditrysia about 150 million years ago (mya), 2) at the origin of the stem group of Apoditrysia about 120 mya and finally 3) a spectacular increase at the origin of the stem group of the quadrifid noctuoids about 70 mya. In addition, there appears to be a significant increase in diversification rate in multiple lineages around 90 mya, which is concordant with the radiation of angiosperms. Almost all extant families appear to have begun diversifying soon after the Cretaceous/Paleogene event 65.51 mya.	[Wahlberg, Niklas; Pena, Carlos] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Wheat, Christopher W.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	University of Turku; Stockholm University	Wahlberg, N (corresponding author), Univ Turku, Dept Biol, SF-20500 Turku, Finland.	niklas.wahlberg@utu.fi	Wahlberg, Niklas/B-7765-2008	Wahlberg, Niklas/0000-0002-1259-3363	Kone Foundation; Academy of Finland	Kone Foundation; Academy of Finland(Academy of Finland)	This study has been funded by Kone Foundation (NW and CP) and the Academy of Finland (CWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Grimaldi David, 2005, pi; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Janz N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-4; Kozlov M.V., 1988, P16; Kristensen NP, 1998, HDB ZOOLOGY, V4; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; Malm T, 2013, SYST ENTOMOL, V38, P459, DOI 10.1111/syen.12016; McInnes L, 2011, P ROY SOC B-BIOL SCI, V278, P3294, DOI 10.1098/rspb.2011.0241; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nieukerken EJv, 2011, ANIMAL BIODIVERSITY, P212; Pennell MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043348; Powell Jerry A., 1999, Handbuch der Zoologie (Berlin), V4, P403; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, 2010, LANG ENV STAT COMP; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ross Andrew, 2010, P208; SCOBLE M. J., 1992, LEPIDOPTERA FORM FUN; SOHN JC, 2012, ZOOTAXA 0430, P1; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; WHALLEY P, 1978, Annals of the Transvaal Museum, V31, P71; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x	36	165	173	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80875	10.1371/journal.pone.0080875	http://dx.doi.org/10.1371/journal.pone.0080875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282557	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500059
J	Yu, F; Li, MJ; Xu, CY; Wang, ZJ; Zhou, H; Yang, M; Chen, YX; Tang, L; He, JH				Yu, Feng; Li, Minjun; Xu, Chunyan; Wang, Zhijun; Zhou, Huan; Yang, Min; Chen, Yaxing; Tang, Lin; He, Jianhua			Structural Insights into the Mechanism for Recognizing Substrate of the Cytochrome P450 Enzyme TxtE	PLOS ONE			English	Article							NITRIC-OXIDE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; THAXTOMIN-A; PHYTOTOXIN; NITRATION; BIOSYNTHESIS; P450CAM	Thaxtomins, a family of phytotoxins produced by Streptomyces spp., can cause dramatic plant cell hypertrophy and seedling stunting. Thaxtomin A is the dominant form from Streptomyces scabies and has demonstrated herbicidal action. TxtE, a cytochrome P450 enzyme from Streptomyces scabies 87.22, catalyzes direct nitration of the indolyl moiety of L-tryptophan to L-4-nitrotryptophan using nitric oxide, dioxygen and NADPH. The crystal structure of TxtE was determined at 2.1 angstrom resolution and described in this work. A clearly defined substrate access channel is observed and can be classified as channel 2a, which is common in bacteria cytochrome P450 enzymes. A continuous hydrogen bond chain from the active site to the external solvent is observed. Compared with other cytochrome P450 enzymes, TxtE shows a unique proton transfer pathway which crosses the helix I distortion. Polar contacts of Arg59, Tyr89, Asn293, Thr296, and Glu394 with L-tryptophan are seen using molecular docking analysis, which are potentially important for substrate recognition and binding. After mutating Arg59, Asn293, Thr296 or Glu394 to leucine, the substrate binding ability of TxtE was lost or decreased significantly. Based on the docking and mutation results, a possible mechanism for substrate recognition and binding is proposed.	[Yu, Feng; Li, Minjun; Xu, Chunyan; Wang, Zhijun; Zhou, Huan; Yang, Min; Chen, Yaxing; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China; [Tang, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yu, F (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China.	yufeng@sinap.ac.cn; hejh@sinap.ac.cn	zhou, huan/GYJ-4398-2022		National Natural Science Foundation [31100529, 31100528]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (Grant No. 31100529 and 31100528, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Barry SM, 2012, METHOD ENZYMOL, V516, P171, DOI 10.1016/B978-0-12-394291-3.00001-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fry BA, 2002, PHYSIOL MOL PLANT P, V60, P1, DOI 10.1006/pmpp.2001.0371; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Healy FG, 2000, MOL MICROBIOL, V38, P794, DOI 10.1046/j.1365-2958.2000.02170.x; Healy FG, 2002, J BACTERIOL, V184, P2019, DOI 10.1128/JB.184.7.2019-2029.2002; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Johnson EG, 2009, MOL MICROBIOL, V73, P409, DOI 10.1111/j.1365-2958.2009.06780.x; Joshi MV, 2007, MOL MICROBIOL, V66, P633, DOI 10.1111/j.1365-2958.2007.05942.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mccoy JG, 2009, PROTEINS, V74, P50, DOI 10.1002/prot.22131; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pikuleva IA, 2013, J BIOL CHEM, V288, P17091, DOI 10.1074/jbc.R112.431916; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sala A, 2004, EUR J BIOCHEM, V271, P2841, DOI 10.1111/j.1432-1033.2004.04219.x; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schrodinger L, 2012, PYMOL MOL GRAPHICS S; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shoun H, 2012, PHILOS T R SOC B, V367, P1186, DOI 10.1098/rstb.2011.0335; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200; Zocher G, 2011, J AM CHEM SOC, V133, P2292, DOI 10.1021/ja110146z	34	13	13	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81526	10.1371/journal.pone.0081526	http://dx.doi.org/10.1371/journal.pone.0081526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282603	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500106
J	Zaharieva, IT; Calissano, M; Scoto, M; Preston, M; Cirak, S; Feng, L; Collins, J; Kole, R; Guglieri, M; Straub, V; Bushby, K; Ferlini, A; Morgan, JE; Muntoni, F				Zaharieva, Irina T.; Calissano, Mattia; Scoto, Mariacristina; Preston, Mark; Cirak, Sebahattin; Feng, Lucy; Collins, James; Kole, Ryszard; Guglieri, Michela; Straub, Volker; Bushby, Kate; Ferlini, Alessandra; Morgan, Jennifer E.; Muntoni, Francesco			Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							EXPRESSION; PROLIFERATION; REGENERATION; MICRORNAS; AUTOPHAGY; CANCER; MOUSE	Duchenne muscular Dystrophy (DMD) is an inherited disease caused by mutations in the dystrophin gene that disrupt the open reading frame, while in frame mutations result in Becker muscular dystrophy (BMD). Ullrich congenital muscular dystrophy (UCMD) is due to mutations affecting collagen VI genes. Specific muscle miRNAs (dystromirs) are potential non-invasive biomarkers for monitoring the outcome of therapeutic interventions and disease progression. We quantified miR-1, miR-133a,b, miR-206 and miR-31 in serum from patients with DMD, BMD, UCMD and healthy controls. MiR-1, miR-133a, b and miR-206 were upregulated in DMD, but unchanged in UCMD compared to controls. Milder DMD patients had higher levels of dystromirs than more severely affected patients. Patients with low forced vital capacity (FVC) values, indicating respiratory muscle weakness, had low levels of serum miR-1 and miR-133b. There was no significant difference in the level of the dystromirs in BMD compared to controls. We also assessed the effect of dystrophin restoration on the expression of the five dystromirs in serum of DMD patients treated systemically for 12 weeks with antisense oligomer eteplirsen that induces skipping of exon 51 in the dystrophin gene. The dystromirs were also analysed in muscle biopsies of DMD patients included in a single dose intramuscular eteplirsen clinical trial. Our analysis detected a trend towards normalization of these miRNA between the pre- and post-treatment samples of the systemic trial, which however failed to reach statistical significance. This could possibly be due to the small number of patients and the short duration of these clinical trials. Although longer term studies are needed to clarify the relationship between dystrophin restoration following therapeutic intervention and the level of circulating miRNAs, our results indicate that miR-1 and miR-133 can be considered as exploratory biomarkers for monitoring the progression of muscle weakness and indirectly the remaining muscle mass in DMD.	[Zaharieva, Irina T.; Calissano, Mattia; Scoto, Mariacristina; Cirak, Sebahattin; Feng, Lucy; Morgan, Jennifer E.; Muntoni, Francesco] UCL, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England; [Preston, Mark] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England; [Cirak, Sebahattin] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Collins, James] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Neurol, Cincinnati, OH 45229 USA; [Kole, Ryszard] Sarepta Therapeut, Cambridge, MA USA; [Guglieri, Michela; Straub, Volker; Bushby, Kate] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ferlini, Alessandra] Univ Ferrara, Dept Med Sci, I-44100 Ferrara, Italy	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Children's National Health System; Cincinnati Children's Hospital Medical Center; Newcastle University - UK; University of Ferrara	Muntoni, F (corresponding author), UCL, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England.	f.muntoni@ucl.ac.uk	Cirak, Sebahattin/AAX-9593-2020; Cirak, Sebahattin/AAZ-6829-2020; Preston, Mark D/P-1429-2015	Preston, Mark D/0000-0002-6506-3104; Straub, Volker/0000-0001-9046-3540; FERLINI, ALESSANDRA/0000-0001-8385-9870	European Commission [HEALTH-2009-2.4.4-1]; MRC [MR/K000608/1] Funding Source: UKRI; Medical Research Council [MR/K000608/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10036] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the European Commission FP7 funded grant "Bio-NMD: Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders" (HEALTH-2009-2.4.4-1: Rare neurological diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Bourke SC, 2002, EUR RESPIR J, V19, P1194, DOI 10.1183/09031936.02.01302001a; BUSHBY KMD, 1991, LANCET, V337, P1022, DOI 10.1016/0140-6736(91)92671-N; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI, P293; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Manzur AY, 2008, ARCH DIS CHILD, V93, P986, DOI 10.1136/adc.2007.118141; Markham LW, 2005, PEDIATR CARDIOL, V26, P768, DOI 10.1007/s00246-005-0909-4; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Vignier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055281; Wang CH, 2010, J CHILD NEUROL, V25, P1559, DOI 10.1177/0883073810381924	37	101	106	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80263	10.1371/journal.pone.0080263	http://dx.doi.org/10.1371/journal.pone.0080263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282529	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500030
J	Wang, HL; Geng, Y; Han, B; Qiang, J; Li, XL; Sun, MY; Wang, Q; Wang, MW				Wang, Hualong; Geng, Yuan; Han, Bing; Qiang, Jing; Li, Xiaoli; Sun, Meiyu; Wang, Qian; Wang, Mingwei			Repetitive Transcranial Magnetic Stimulation Applications Normalized Prefrontal Dysfunctions and Cognitive-Related Metabolic Profiling in Aged Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CHROMATOGRAPHY/MASS SPECTROMETRY; RESONANCE-SPECTROSCOPY; SYNAPTIC PLASTICITY; AVOIDANCE-RESPONSE; BRAIN; RAT; CHOLESTEROL; HIPPOCAMPAL	Chronic high-frequency repetitive transcranial magnetic stimulation (rTMS) is a noninvasive brain stimulation technique that has recently received increasing interests as a therapeutic procedure for neurodegenerative diseases. To identify the metabolism mechanism underlying the improving effects of rTMS, we observed that high frequency (25Hz) rTMS for 14 days could reverse the decline of the performance of the passive avoidance task in aged mice. We further investigated the metabolite profiles in the prefrontal cortex (PFC) in those mice and found that rTMS could also reverse the metabolic abnormalities of gamma-aminobutyric acid, N-acetyl aspartic, and cholesterol levels to the degree similar to the young mice. These data suggested that the rTMS could ameliorate the age-related cognitive impairment and improving the metabolic profiles in PFC, and potentially can be used to improve cognitive decline in the elderly.	[Wang, Hualong; Han, Bing; Qiang, Jing; Li, Xiaoli; Sun, Meiyu; Wang, Qian; Wang, Mingwei] Hebei Med Univ, Hosp 1, Dept Neurol, Shijiazhuang, Hebei, Peoples R China; [Geng, Yuan; Wang, Mingwei] Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University	Wang, MW (corresponding author), Hebei Med Univ, Hosp 1, Dept Neurol, Shijiazhuang, Hebei, Peoples R China.	wmwsjz@163.com	Li, Xiaoli/GYQ-7384-2022		973 special preliminary projects [2010CB535005]	973 special preliminary projects	This work was supported by grants from 973 special preliminary projects (2010CB535005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MA, 2012, J NEUROL, V259, P83, DOI 10.1007/s00415-011-6128-4; Ahmed Z, 2006, BIOELECTROMAGNETICS, V27, P288, DOI 10.1002/bem.20211; Angelie E, 2001, AM J NEURORADIOL, V22, P119; Chen GH, 2004, PHYSIOL BEHAV, V83, P531, DOI 10.1016/j.physbeh.2004.09.012; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Eckert GP, 2007, NEUROSCI LETT, V423, P47, DOI 10.1016/j.neulet.2007.05.063; Foster TC, 2012, PROG NEUROBIOL, V96, P283, DOI 10.1016/j.pneurobio.2012.01.007; Giovannini MG, 2005, NEUROSCIENCE, V136, P15, DOI 10.1016/j.neuroscience.2005.07.046; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hellmann J, 2012, EUR ARCH PSY CLIN N, V262, P87, DOI 10.1007/s00406-011-0217-3; Hirsch-Reinshagen V, 2009, MOL CELL BIOCHEM, V326, P121, DOI 10.1007/s11010-008-0012-2; Hooijmans CR, 2008, EUR J PHARMACOL, V585, P176, DOI 10.1016/j.ejphar.2007.11.081; Jansen D, 2012, J ALZHEIMERS DIS, V31, P813, DOI 10.3233/JAD-2012-120298; Jia LW, 2007, J PHARMACEUT BIOMED, V43, P646, DOI 10.1016/j.jpba.2006.07.040; Jonsson P, 2005, ANALYST, V130, P701, DOI 10.1039/b501890k; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; Kellert M, 2008, CHEM RES TOXICOL, V21, P761, DOI 10.1021/tx7004212; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SH, 2012, NEUROSCI RES, V74, P256, DOI 10.1016/j.neures.2012.08.008; Lasarge CL, 2009, NEUROSCIENCE, V164, P941, DOI 10.1016/j.neuroscience.2009.08.055; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Marjanska M, 2013, MOVEMENT DISORD, V28, P201, DOI 10.1002/mds.25279; Meng JR, 2012, ANAL CHIM ACTA, V710, P125, DOI 10.1016/j.aca.2011.09.033; Michael N, 2003, EUR J NEUROSCI, V17, P2462, DOI 10.1046/j.1460-9568.2003.02683.x; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Paban V, 2010, EUR J NEUROSCI, V31, P1063, DOI 10.1111/j.1460-9568.2010.07126.x; Romanova GA, 2010, B EXP BIOL MED+, V149, P289, DOI 10.1007/s10517-010-0929-9; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; Toman RE, 2000, J NEUROTRAUM, V17, P891, DOI 10.1089/neu.2000.17.891; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wang Y, 2008, ANAL CHEM, V80, P4680, DOI 10.1021/ac8002402; Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039; Yao H, 2010, MOL BIOSYST, V6, P1061, DOI 10.1039/b925612a; Yin PY, 2008, J CHROMATOGR B, V871, P322, DOI 10.1016/j.jchromb.2008.05.043; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004	41	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81482	10.1371/journal.pone.0081482	http://dx.doi.org/10.1371/journal.pone.0081482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278445	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700065
J	Ajrezo, L; Wiener-Vacher, S; Bucci, MP				Ajrezo, Layla; Wiener-Vacher, Sylvette; Bucci, Maria Pia			Saccades Improve Postural Control: A Developmental Study in Normal Children	PLOS ONE			English	Article							EYE-MOVEMENTS; GAZE BEHAVIOR; DUAL-TASK; SWAY; CHILDHOOD; COORDINATION; ACTIVATION; PARAMETERS; STABILITY; ATTENTION	Introduction: Dual-task performance is known to affect postural stability in children. This study focused on the effect of oculomotor tasks like saccadic eye movements on postural stability, studied in a large population of children by recording simultaneously their eye movements and posture. Materials and Methods: Ninety-five healthy children from 5.8 to 17.6 years old were examined. All children were free of any vestibular, neurological, ophtalmologic and orthoptic abnormalities. Postural control was measured with a force platform TechnoConcept (R), and eye movements with video oculography (MobilEBTH (R)). Children performed two oculomotor tasks: fixation of a stable central target and horizontal saccades. We measured the saccade latency and the number of saccades during fixation as well as the surface, length and mean velocity of the center of pressure. Results: During postural measurement, we observed a correlation between the age on the one hand and a decrease in saccade latency as well as an improvement in the quality of fixation on the other. Postural sway decreases with age and is reduced in the dual task (saccades) in comparison with a simple task of fixation. Discussion - Conclusion: These results suggest a maturation of neural circuits controlling posture and eye movements during childhood. This study also shows the presence of an interaction between the oculomotor system and the postural system. Engaging in oculomotor tasks results in a reduction of postural sway.	[Ajrezo, Layla; Wiener-Vacher, Sylvette] 75019 Robert Debre Paediat Hosp, ORL Dept, Vestibular & Oculomotor Evaluat Unit, Paris, France; [Ajrezo, Layla; Wiener-Vacher, Sylvette; Bucci, Maria Pia] Univ Paris 07, INSERM, UMR 676, Hop Robert Debre, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 07, INSERM, UMR 676, Hop Robert Debre, Paris, France.	mariapia.bucci@gmail.com			APHP (Assistance Publique Hopitaux de Paris)	APHP (Assistance Publique Hopitaux de Paris)	Authors have no financial and personal relationships with other people or organizations that could inappropriately influence or bias their work in this study. The authors are grateful to the APHP (Assistance Publique Hopitaux de Paris) for their financial support (PHRC Regional). No current external funding sources for this study.	ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante C, 2012, NEUROPHYSIOL CLIN, V42, P43, DOI 10.1016/j.neucli.2011.09.002; Baumberger B, 2004, EXP BRAIN RES, V159, P33, DOI 10.1007/s00221-004-1930-1; BELEN'KII V. E., 1967, BIOFIZIKA, V12, P135; Blanchard Yvette, 2005, Pediatr Phys Ther, V17, P189, DOI 10.1097/01.PEP.0000176578.57147.5d; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Campos JJ, 2000, INFANCY, V1, P149, DOI 10.1207/S15327078IN0102_1; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P706, DOI 10.1017/S0140525X99552151; FISCHER B, 1987, REV PHYSIOL BIOCH P, V106, P1, DOI 10.1007/BFb0027574; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gagey PM, 2004, POSTUROLOGIE REGULAT; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Glasauer S, 2005, NEUROLOGY, V65, P1291, DOI 10.1212/01.wnl.0000175132.01370.fc; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hong SL, 2008, DEV PSYCHOBIOL, V50, P502, DOI 10.1002/dev.20310; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Krekelberg B, 2011, CURR BIOL, V21, pR416, DOI 10.1016/j.cub.2011.03.037; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Laufer Y, 2008, GAIT POSTURE, V27, P347, DOI 10.1016/j.gaitpost.2007.04.013; Laurens J, 2010, GAIT POSTURE, V31, P37, DOI 10.1016/j.gaitpost.2009.08.241; Legrand A, 2013, EXP BRAIN RES, V227, P397, DOI 10.1007/s00221-013-3519-z; Legrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035301; Legrand A, 2011, NEUROSCI LETT, V501, P96, DOI 10.1016/j.neulet.2011.06.056; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lions C, 2013, GRAEF ARCH CLIN EXP, V251, P2219, DOI 10.1007/s00417-013-2372-x; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Olivier I, 2008, EXP BRAIN RES, V185, P341, DOI 10.1007/s00221-008-1271-6; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Palluel E, 2010, BRAIN RES, V1358, P151, DOI 10.1016/j.brainres.2010.08.051; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rougier P, 2007, MOTOR CONTROL, V11, P213, DOI 10.1123/mcj.11.3.213; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; Scharli AM, 2013, EXP BRAIN RES, V227, P523, DOI 10.1007/s00221-013-3528-y; Scharli AM, 2012, GAIT POSTURE, V36, P78, DOI 10.1016/j.gaitpost.2012.01.008; Schmid M, 2007, EXP BRAIN RES, V179, P375, DOI 10.1007/s00221-006-0795-x; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Stoffregen TA, 2007, MOTOR CONTROL, V11, P86; Stoffregen TA, 2006, ECOL PSYCHOL, V18, P191, DOI 10.1207/s15326969eco1803_3; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tse YYF, 2013, MED SCI MONITOR, V19, P175, DOI 10.12659/MSM.883824; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; Von Noorden GK, 2002, BINOCULAR VISION OCU, V14, P252; Vuillerme N, 2008, NEUROSCIENCE, V155, P291, DOI 10.1016/j.neuroscience.2008.05.018; WHITE KD, 1980, SCIENCE, V208, P621, DOI 10.1126/science.7367888; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	53	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81066	10.1371/journal.pone.0081066	http://dx.doi.org/10.1371/journal.pone.0081066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278379	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800098
J	Barreto-Ortiz, SF; Zhang, SM; Davenport, M; Fradkin, J; Ginn, B; Mao, HQ; Gerecht, S				Barreto-Ortiz, Sebastian F.; Zhang, Shuming; Davenport, Matthew; Fradkin, Jamie; Ginn, Brian; Mao, Hai-Quan; Gerecht, Sharon			A Novel In Vitro Model for Microvasculature Reveals Regulation of Circumferential ECM Organization by Curvature	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; CAPILLARY LUMEN FORMATION; BLOOD-VESSELS; 3-DIMENSIONAL COLLAGEN; VASCULAR NETWORKS; TUBE FORMATION; FINE STRUCTURE; ANGIOGENESIS; DIAMETER; MATRIX	In microvascular vessels, endothelial cells are aligned longitudinally whereas several components of the extracellular matrix (ECM) are organized circumferentially. While current three-dimensional (3D) in vitro models for microvasculature have allowed the study of ECM-regulated tubulogenesis, they have limited control over topographical cues presented by the ECM and impart a barrier for the high-resolution and dynamic study of multicellular and extracellular organization. Here we exploit a 3D fibrin microfiber scaffold to develop a novel in vitro model of the microvasculature that recapitulates endothelial alignment and ECM deposition in a setting that also allows the sequential co-culture of mural cells. We show that the microfibers' nanotopography induces longitudinal adhesion and alignment of endothelial colony-forming cells (ECFCs), and that these deposit circumferentially organized ECM. We found that ECM wrapping on the microfibers is independent of ECFCs' actin and microtubule organization, but it is dependent on the curvature of the microfiber. Microfibers with smaller diameters (100-400 mm) guided circumferential ECM deposition, whereas microfibers with larger diameters (450 mm) failed to support wrapping ECM. Finally, we demonstrate that vascular smooth muscle cells attached on ECFC-seeded microfibers, depositing collagen I and elastin. Collectively, we establish a novel in vitro model for the sequential control and study of microvasculature development and reveal the unprecedented role of the endothelium in organized ECM deposition regulated by the microfiber curvature.	[Barreto-Ortiz, Sebastian F.; Davenport, Matthew; Fradkin, Jamie; Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Barreto-Ortiz, Sebastian F.; Davenport, Matthew; Fradkin, Jamie; Gerecht, Sharon] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Zhang, Shuming; Ginn, Brian; Mao, Hai-Quan; Gerecht, Sharon] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Zhang, Shuming; Ginn, Brian; Mao, Hai-Quan] Johns Hopkins Sch Med, Translat Tissue Engn Ctr, Baltimore, MD USA; [Fradkin, Jamie; Mao, Hai-Quan] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Mao, Hai-Quan/0000-0002-4262-9988	Cancer and Nanotechnology Training Center at Johns Hopkins University - Institute of NanoBioTechnology [R25CA153952]; National Institute of Health [R01HL107938, U54CA143868]; American Heart Association Scientist Development grant; National Science Foundation [DMR-0748340]; NATIONAL CANCER INSTITUTE [R25CA153952, U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107938] Funding Source: NIH RePORTER	Cancer and Nanotechnology Training Center at Johns Hopkins University - Institute of NanoBioTechnology; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development grant(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SFBO acknowledges the support from the Cancer and Nanotechnology Training Center at Johns Hopkins University - Institute of NanoBioTechnology under the grant number R25CA153952; This research was partially funded by National Institute of Health grants R01HL107938 and U54CA143868, and an American Heart Association Scientist Development grant (to SG) and National Science Foundation Career Award grant number DMR-0748340 (to H-Q M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI [10.1089/ten.tea.2009.0708, 10.1089/ten.TEA.2009.0708]; Alberts B., 2002, MOL BIOL CELL, V4th; Aper T, 2007, EUR J VASC ENDOVASC, V33, P33, DOI 10.1016/j.ejvs.2006.08.008; Baranski JD, 2013, P NATL ACAD SCI US; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Bayless KJ, 2002, J CELL SCI, V115, P1123; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; CANHAM PB, 1989, CARDIOVASC RES, V23, P973, DOI 10.1093/cvr/23.11.973; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h; Dickinson LE, 2010, SOFT MATTER, V6, P5109, DOI 10.1039/c0sm00233j; FERNANDO NEIL V. P., 1964, EXP MOL PATHOL, V3, P1, DOI 10.1016/0014-4800(64)90013-9; FINLAY HM, 1995, J VASC RES, V32, P301, DOI 10.1159/000159104; Fioretta ES, 2012, MACROMOL BIOSCI, V12, P577, DOI 10.1002/mabi.201100315; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Grant DS, 1989, 2 DIFFERENT LAMININ, P933; Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589; Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]; HALLORAN BG, 1995, J SURG RES, V59, P17, DOI 10.1006/jsre.1995.1126; Hanjaya-Putra D, 2009, J CELL MOL MED; Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x; HIBBS RG, 1958, AM HEART J, V56, P662, DOI 10.1016/0002-8703(58)90209-6; Hielscher AC, 2012, CANCER RES, V72, P6089, DOI 10.1158/0008-5472.CAN-12-2773; Hielscher AC, 2012, AM J PHYSIOL-CELL PH, V302, pC1243, DOI 10.1152/ajpcell.00011.2012; Huynh TN, 2010, ANN BIOMED ENG, V38, P2226, DOI 10.1007/s10439-010-0045-z; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kantarjian HM, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2738.2738; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Lee AA, 2002, J BIOMECH ENG-T ASME, V124, P37, DOI 10.1115/1.1427697; Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108; Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060; Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Marieb EN, 2010, HUMAN ANATOMY PHYSL; Melchiorri AJ, 2012, TISSUE ENG B; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Meyer GT, 1997, ANAT REC, V249, P327; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; MOORE DH, 1957, J BIOPHYS BIOCHEM CY, V3, P457, DOI 10.1083/jcb.3.3.457; MOVAT H Z, 1963, Exp Mol Pathol, V2, P549, DOI 10.1016/0014-4800(63)90032-7; Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Ranjan A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/30/305102; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Schriefl AJ, 2012, J R SOC INTERFACE, V9, P1275, DOI 10.1098/rsif.2011.0727; SCHWARTZ SM, 1972, AM J PATHOL, V66, P241; Soucy PA, 2011, ACTA BIOMATER, V7, P96, DOI 10.1016/j.actbio.2010.07.021; Soucy PA, 2009, MATRIX BIOL, V28, P273, DOI 10.1016/j.matbio.2009.04.005; Standring S, 2008, GRAYS ANATOMY; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821; Yee D, 2011, TISSUE ENG PT A, V17, P1351, DOI [10.1089/ten.TEA.2010.0481, 10.1089/ten.tea.2010.0481]; Yoder MC, 2009, J THROMB HAEMOST, V7, P49, DOI 10.1111/j.1538-7836.2009.03407.x; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang SL, 2013, CREATING POLYM UNPUB; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	83	20	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81061	10.1371/journal.pone.0081061	http://dx.doi.org/10.1371/journal.pone.0081061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278378	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800097
J	Hofmann, M; Kohler, B; Leichsenring, F; Kruse, J				Hofmann, Mareike; Koehler, Birgit; Leichsenring, Falk; Kruse, Johannes			Depression as a Risk Factor for Mortality in Individuals with Diabetes: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							COMORBID DEPRESSION; ALL-CAUSE; TYPE-2; ASSOCIATION; ADULTS; PREVALENCE; SYMPTOMS; DISEASE; WOMEN; LIFE	Objective: To quantify the impact of depression measured by self-reports and depression measured by clinical interview on all-cause mortality in individuals with diabetes and to analyze the strength of both associations, the influence of covariates, and possible differences between studies assessing self-rated depressive symptoms and those using a clinical interview to measure depression as predictors of mortality. Research Design and Methods: PUBMED and PsycINFO were searched up to July 2013 for prospective studies assessing depression, diabetes and mortality. The pooled hazard ratios were calculated using random-effects models. Results: Sixteen studies met the inclusion criteria. After adjustment for demographic variables depression measured by self-reports was associated with an increased all-cause mortality risk (pooled HR = 2.56, 95% CI 1.89-3.47), and the mortality risk remained high after additional adjustment for diabetes complications (HR = 1.76, 95% CI 1.45-2.14,). Six studies reporting adjusted HRs for depression measured by clinical interviews supported the results of the other models (HR = 1.49, 95% CI 1.15-1.93). Conclusions: Both depression measured by self-report and depression measured by clinical interview have an unfavorable impact on mortality in individuals with diabetes. The results, however, are limited by the heterogeneity of the primary studies. It remains unclear whether self-reports or clinical interviews for depression are the more precise predictor.	[Hofmann, Mareike; Koehler, Birgit; Leichsenring, Falk; Kruse, Johannes] Univ Giessen, Dept Psychosomat Med & Psychotherapy, D-35390 Giessen, Germany; [Kruse, Johannes] Univ Marburg, Dept Psychosomat Med & Psychotherapy, Marburg, Germany	Justus Liebig University Giessen; Philipps University Marburg	Hofmann, M (corresponding author), Univ Giessen, Dept Psychosomat Med & Psychotherapy, D-35390 Giessen, Germany.	mareike.hofmann@psycho.med.uni-giessen.de			department of Psychosomatic Medicine and Psychotherapy, University of Giessen	department of Psychosomatic Medicine and Psychotherapy, University of Giessen	The work was funded by grants of the department of Psychosomatic Medicine and Psychotherapy, University of Giessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola AJ, 2012, DIABETOLOGIA, V55, P73, DOI 10.1007/s00125-011-2347-6; Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822; Bot M, 2012, DIABETES CARE, V35, P503, DOI 10.2337/dc11-1749; Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mapppsy LKR, 2008, DIABETES CARE, V31, P880, DOI 10.2337/dc07-2215; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Pieper L, 2011, BUNDESGESUNDHEITSBLA, V54, P98, DOI 10.1007/s00103-010-1181-1; Rosenthal MJ, 1998, DIABETES CARE, V21, P231, DOI 10.2337/diacare.21.2.231; Scherrer JF, 2011, DIABETES CARE, V34, P1729, DOI 10.2337/dc11-0031; Strine TW, 2008, GEN HOSP PSYCHIAT, V30, P127, DOI 10.1016/j.genhosppsych.2007.12.008; Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791; Ting RZW, 2013, J AFFECT DISORDERS, V149, P129, DOI 10.1016/j.jad.2013.01.012; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Winkley K, 2012, DIABETOLOGIA, V55, P303, DOI 10.1007/s00125-011-2359-2; Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089	34	65	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79809	10.1371/journal.pone.0079809	http://dx.doi.org/10.1371/journal.pone.0079809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278183	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800025
J	Ramos-Rodriguez, JJ; Molina-Gil, S; Rey-Brea, R; Berrocoso, E; Garcia-Alloza, M				Jose Ramos-Rodriguez, Juan; Molina-Gil, Sara; Rey-Brea, Raquel; Berrocoso, Esther; Garcia-Alloza, Monica			Specific Serotonergic Denervation Affects tau Pathology and Cognition without Altering Senile Plaques Deposition in APP/PS1 Mice	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; ALZHEIMERS-DISEASE; MOUSE MODEL; TRANSGENIC MICE; RAT-BRAIN; AMYLOID DEPOSITION; COMBINED LESIONS; IN-VIVO; 5,7-DIHYDROXYTRYPTAMINE; DEGENERATION	Senile plaques and neurofibrillary tangles are major neuropathological features of Alzheimer's Disease (AD), however neuronal loss is the alteration that best correlates with cognitive impairment in AD patients. Underlying neurotoxic mechanisms are not completely understood although specific neurotransmission deficiencies have been observed in AD patients and, in animal models, cholinergic and noradrenergic denervation may increase amyloid-beta deposition and tau phosphorylation in denervated areas. On the other hand brainstem neurodegeneration has been suggested as an initial event in AD, and serotonergic dysfunction, as well as reductions in raphe neurones density, have been reported in AD patients. In this study we addressed whether specific serotonergic denervation, by administering 5,7-dihydroxitriptamine (5,7-DHT) in the raphe nuclei, could also worsen central pathology in APPswe/PS1dE9 mice or interfere with learning and memory activities. In our hands specific serotonergic denervation increased tau phosphorylation in denervated cortex, without affecting amyloid-beta (A beta) pathology. We also observed that APPswe/PS1dE9 mice lesioned with 5,7-DHT were impaired in the Morris water maze test, supporting a synergistic effect of the serotonergic denervation and the presence of APP/PS1 transgenes on learning and memory impairment. Altogether our data suggest that serotonergic denervation may interfere with some pathological aspects observed in AD, including tau phosphorylation or cognitive impairment, without affecting A beta pathology, supporting a differential role of specific neurotransmitter systems in AD.	[Jose Ramos-Rodriguez, Juan; Molina-Gil, Sara; Garcia-Alloza, Monica] Univ Cadiz, Sch Med, Div Physiol, Cadiz, Spain; [Rey-Brea, Raquel; Berrocoso, Esther] Univ Cadiz, Sch Med, Dept Neurosci, Cadiz, Spain; [Rey-Brea, Raquel; Berrocoso, Esther] Inst Salud Carlos III, Ctr Invest Biomed & Red Salud Mental, Madrid, Spain	Universidad de Cadiz; Universidad de Cadiz; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Garcia-Alloza, M (corresponding author), Univ Cadiz, Sch Med, Div Physiol, Cadiz, Spain.	monica.garcia@uca.es	Garcia-Alloza, Monica/F-3313-2016; Berrocoso, Esther/H-9958-2015; Garcia-Alloza, Monica/AAN-9799-2021; Ramos-Rodriguez, Juan Jose/B-7459-2017	Garcia-Alloza, Monica/0000-0003-1610-4114; Berrocoso, Esther/0000-0003-0208-7472; Garcia-Alloza, Monica/0000-0003-1610-4114; Ramos-Rodriguez, Juan Jose/0000-0001-9081-5366; Molina-Gil, Sara/0000-0003-0352-6449	Ramon y Cajal program [RYC-2008-02333]; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Junta de Andalucia, Proyectos de Excelencia [P11-CTS-7847]; Instituto de Salud Carlos III; FEDER (European Union); Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" [PI12/00675]	Ramon y Cajal program(Spanish Government); ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion; Junta de Andalucia, Proyectos de Excelencia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER (European Union)(European Commission); Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa"	MG-A was supported by Ramon y Cajal program RYC-2008-02333, ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion. Junta de Andalucia, Proyectos de Excelencia (P11-CTS-7847), Instituto de Salud Carlos III and FEDER (European Union), cofinanced by Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" PI12/00675. Fundacion Dr. Eugenio Rodriguez Pascual. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Buhot HC, 2000, ANN MED, V32, P210, DOI 10.3109/07853890008998828; Chen CPLH, 2000, NEUROPATH APPL NEURO, V26, P347, DOI 10.1046/j.1365-2990.2000.00254.x; Cirrito JR, 2011, P NATL ACAD SCI USA, V108, P14968, DOI 10.1073/pnas.1107411108; Cowen P, 2013, J PSYCHOPHARMACOL; Cuadrado-Tejedor M, 2011, BRIT J PHARMACOL, V164, P2029, DOI 10.1111/j.1476-5381.2011.01517.x; de Almeida RMM, 2001, PSYCHOPHARMACOLOGY, V157, P131, DOI 10.1007/s002130100778; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Diez-Ariza M, 2002, BRAIN RES, V956, P81, DOI 10.1016/S0006-8993(02)03483-2; Gutierrez-Guzman BE, 2012, EUR J PHARMACOL, V682, P99, DOI 10.1016/j.ejphar.2012.02.024; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V407, P730, DOI 10.1016/j.bbrc.2011.03.091; Garcia-Alloza M, 2004, NEUROPSYCHOPHARMACOL, V29, P410, DOI 10.1038/sj.npp.1300330; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcia-Alloza M, 2011, BRAIN, V134, P3694, DOI 10.1093/brain/awr300; Gil-Bea FJ, 2004, NEUROPHARMACOLOGY, V47, P225, DOI 10.1016/j.neuropharm.2004.03.014; Grinberg LT, 2009, NEUROPATH APPL NEURO, V35, P406, DOI [10.1111/j.1365-2990.2009.00997.x, 10.1111/j.1365-2990.2008.00997.x]; Harkany T, 2000, NEUROSCIENCE, V101, P101, DOI 10.1016/S0306-4522(00)00296-7; He Y, 2012, BIOCHEM BIOPH RES CO, V429, P125, DOI 10.1016/j.bbrc.2012.10.129; HEAL DJ, 1985, NEUROPHARMACOLOGY, V24, P1201, DOI 10.1016/0028-3908(85)90155-8; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Hochgrafe K, 2013, FEBS J; Hohmann CF, 2007, BRAIN RES, V1139, P163, DOI 10.1016/j.brainres.2006.12.095; Hohmann Christine F., 2000, Neural Plasticity, V7, P213, DOI 10.1155/NP.2000.213; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jeltsch-David H, 2008, BEHAV BRAIN RES, V195, P86, DOI 10.1016/j.bbr.2008.02.037; Jha S, 2006, BRAIN RES, V1075, P48, DOI 10.1016/j.brainres.2005.12.110; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Ramos-Rodriguez JJ, 2013, J NEUROPATH EXP NEUR, V72, P272, DOI 10.1097/NEN.0b013e318288a8dd; Jost BC, 1996, J AM GERIATR SOC, V44, P1078, DOI 10.1111/j.1532-5415.1996.tb02942.x; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kalinin S, 2007, NEUROBIOL AGING, V28, P1206, DOI 10.1016/j.neurobiolaging.2006.06.003; Lehmann O, 2000, EUR J NEUROSCI, V12, P67, DOI 10.1046/j.1460-9568.2000.00881.x; Lehmann O, 2002, PHARMACOL BIOCHEM BE, V72, P899, DOI 10.1016/S0091-3057(02)00752-9; Lieben CKJ, 2006, BEHAV BRAIN RES, V168, P197, DOI 10.1016/j.bbr.2005.11.003; Menuet C, 2011, RESP PHYSIOL NEUROBI, V178, P290, DOI 10.1016/j.resp.2011.06.030; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURTHA SJE, 1994, BRAIN RES, V651, P16, DOI 10.1016/0006-8993(94)90676-9; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Orejana L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.018; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Piechal A, 2012, PHARMACOL REP, V64, P266, DOI 10.1016/S1734-1140(12)70764-8; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pum ME, 2009, BEHAV NEUROSCI, V123, P449, DOI 10.1037/a0014478; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shen F, 2011, NEUROPHARMACOLOGY, V61, P69, DOI 10.1016/j.neuropharm.2011.02.026; Simic G, 2009, NEUROPATH APPL NEURO, V35, P532, DOI 10.1111/j.1365-2990.2009.01038.x; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Xu YQ, 2012, PROG NEUROBIOL, V97, P1, DOI 10.1016/j.pneurobio.2012.02.002; Yalcin I, 2008, PSYCHOPHARMACOLOGY, V200, P497, DOI 10.1007/s00213-008-1227-3; Yen YC, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00103	58	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79947	10.1371/journal.pone.0079947	http://dx.doi.org/10.1371/journal.pone.0079947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278223	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800038
J	Niederkofler, EE; Phillips, DA; Krastins, B; Kulasingam, V; Kiernan, UA; Tubbs, KA; Peterman, SM; Prakash, A; Diamandis, EP; Lopez, MF; Nedelkov, D				Niederkofler, Eric E.; Phillips, David A.; Krastins, Bryan; Kulasingam, Vathany; Kiernan, Urban A.; Tubbs, Kemmons A.; Peterman, Scott M.; Prakash, Amol; Diamandis, Eleftherios P.; Lopez, Mary F.; Nedelkov, Dobrin			Targeted Selected Reaction Monitoring Mass Spectrometric Immunoassay for Insulin-like Growth Factor 1	PLOS ONE			English	Article							IGF-I ASSAYS; HORMONE ABUSE; QUANTIFICATION; PLASMA; RADIOIMMUNOASSAY; REPRODUCIBILITY; EXTRACTION; BIOMARKERS; PROTEINS; PEPTIDE	Insulin-like growth factor 1 (IGF1) is an important biomarker of human growth disorders that is routinely analyzed in clinical laboratories. Mass spectrometry-based workflows offer a viable alternative to standard IGF1 immunoassays, which utilize various pre-analytical preparation strategies. In this work we developed an assay that incorporates a novel sample preparation method for dissociating IGF1 from its binding proteins. The workflow also includes an immunoaffinity step using antibody-derivatized pipette tips, followed by elution, trypsin digestion, and LC-MS/MS separation and detection of the signature peptides in a selected reaction monitoring (SRM) mode. The resulting quantitative mass spectrometric immunoassay (MSIA) exhibited good linearity in the range of 1 to 1,500 ng/mL IGF1, intra-and inter-assay precision with CVs of less than 10%, and lowest limits of detection of 1 ng/mL. The linearity and recovery characteristics of the assay were also established, and the new method compared to a commercially available immunoassay using a large cohort of human serum samples. The IGF1 SRM MSIA is well suited for use in clinical laboratories.	[Niederkofler, Eric E.; Phillips, David A.; Kiernan, Urban A.; Tubbs, Kemmons A.; Nedelkov, Dobrin] Thermo Fisher Sci, Tempe, AZ USA; [Krastins, Bryan; Peterman, Scott M.; Prakash, Amol; Lopez, Mary F.] Thermo Fisher Sci, BRIMS, Cambridge, MA USA; [Kulasingam, Vathany; Diamandis, Eleftherios P.] Univ Hlth Network, Toronto, ON, Canada; [Kulasingam, Vathany; Diamandis, Eleftherios P.] Univ Toronto, Toronto, ON, Canada	Thermo Fisher Scientific; Thermo Fisher Scientific; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Nedelkov, D (corresponding author), Thermo Fisher Sci, Tempe, AZ USA.	dnedelkov@populationproteomics.org	Nedelkov, Dobrin/I-3603-2013	Kulasingam, Vathany/0000-0001-5610-873X; Diamandis, Eleftherios/0000-0002-1589-820X				Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620; Barton C, 2010, J PROTEOME RES, V9, P333, DOI 10.1021/pr900658d; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bobin S, 2001, ANALYST, V126, P1996, DOI 10.1039/b105022m; Bredehoft M, 2008, RAPID COMMUN MASS SP, V22, P477, DOI 10.1002/rcm.3388; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Brugts MP, 2009, EUR J ENDOCRINOL, V161, P561, DOI 10.1530/EJE-09-0316; Brun V, 2007, MOL CELL PROTEOMICS, V6, P2139, DOI 10.1074/mcp.M700163-MCP200; Burns C, 2009, GROWTH HORM IGF RES, V19, P457, DOI 10.1016/j.ghir.2009.02.002; Bystrom C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043457; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z; Cox HD, 2013, ANAL BIOANAL CHEM, V405, P1949, DOI 10.1007/s00216-012-6626-y; DAUGHADAY WH, 1980, J CLIN ENDOCR METAB, V51, P781, DOI 10.1210/jcem-51-4-781; de Kock SS, 2001, RAPID COMMUN MASS SP, V15, P1191, DOI 10.1002/rcm.363; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Kay RG, 2009, RAPID COMMUN MASS SP, V23, P3173, DOI 10.1002/rcm.4237; Kay R, 2013, CLIN ENDOCRINOL, V78, P424, DOI 10.1111/cen.12085; Kirsch S, 2007, J CHROMATOGR A, V1153, P300, DOI 10.1016/j.chroma.2007.03.058; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Kuhn E, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013854; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lopez MF, 2010, CLIN CHEM, V56, P281, DOI 10.1373/clinchem.2009.137323; Nedelkov D, 2012, EXPERT REV MOL DIAGN, V12, P235, DOI [10.1586/ERM.12.15, 10.1586/erm.12.15]; Nelson RW, 2004, J PROTEOME RES, V3, P851, DOI 10.1021/pr0499388; Niederkofler EE, 2001, ANAL CHEM, V73, P3294, DOI 10.1021/ac010143j; Niederkofler EE, 2008, CIRC-HEART FAIL, V1, P258, DOI 10.1161/CIRCHEARTFAILURE.108.790774; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Prakash A, 2012, J PROTEOME RES, V11, P3986, DOI 10.1021/pr300014s; Soldin OP, 2008, CLIN BIOCHEM, V41, P937, DOI 10.1016/j.clinbiochem.2008.04.025; Thomas A, 2011, ANALYST, V136, P1003, DOI 10.1039/c0an00632g; Trenchevska O, 2010, J PROTEOME RES, V9, P5969, DOI 10.1021/pr1007587; Tubbs KA, 2001, ANAL BIOCHEM, V289, P26, DOI 10.1006/abio.2000.4921; Whiteaker JR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005645; Zapf J, 1999, CONT ENDOCRINOLOGY	37	36	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81125	10.1371/journal.pone.0081125	http://dx.doi.org/10.1371/journal.pone.0081125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278387	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800103
J	Hossain, MJ; Waldbieser, GC; Sun, DW; Capps, NK; Hemstreet, WB; Carlisle, K; Griffin, MJ; Khoo, L; Goodwin, AE; Sonstegard, TS; Schroeder, S; Hayden, K; Newton, JC; Terhune, JS; Liles, MR				Hossain, Mohammad J.; Waldbieser, Geoffrey C.; Sun, Dawei; Capps, Nancy K.; Hemstreet, William B.; Carlisle, Kristen; Griffin, Matt J.; Khoo, Lester; Goodwin, Andrew E.; Sonstegard, Tad S.; Schroeder, Steven; Hayden, Karl; Newton, Joseph C.; Terhune, Jeffery S.; Liles, Mark R.			Implication of Lateral Genetic Transfer in the Emergence of Aeromonas hydrophila Isolates of Epidemic Outbreaks in Channel Catfish	PLOS ONE			English	Article							O-ANTIGEN; CAMPYLOBACTER-JEJUNI; VIRULENCE GENES; IDENTIFICATION; BIOSYNTHESIS; PROTEIN; METHYLTRANSFERASE; CLUSTER; GENOME; TRANSPORTERS	To investigate the molecular basis of the emergence of Aeromonas hydrophila responsible for an epidemic outbreak of motile aeromonad septicemia of catfish in the Southeastern United States, we sequenced 11 A. hydrophila isolates that includes five reference and six recent epidemic isolates. Comparative genomics revealed that recent epidemic A. hydrophila isolates are highly clonal, whereas reference isolates are greatly diverse. We identified 55 epidemic-associated genetic regions with 313 predicted genes that are present in epidemic isolates but absent from reference isolates and 35% of these regions are located within genomic islands, suggesting their acquisition through lateral gene transfer. The epidemic-associated regions encode predicted prophage elements, pathogenicity islands, metabolic islands, fitness islands and genes of unknown functions, and 34 of the genes encoded in these regions were predicted as virulence factors. We found two pilus biogenesis gene clusters encoded within predicted pathogenicity islands. A functional metabolic island that encodes a complete pathway for myo-inositol catabolism was evident by the ability of epidemic A. hydrophila isolates to use myo-inositol as a sole carbon source. Testing of A. hydrophila field isolates found a consistent correlation between myo-inositol utilization as a sole carbon source and the presence of an epidemic-specific genetic marker. All epidemic isolates and one reference isolate shared a novel O-antigen cluster. Altogether we identified four different O-antigen biosynthesis gene clusters within the 11 sequenced A. hydrophila genomes. Our study reveals new insights into the evolutionary changes that have resulted in the emergence of recent epidemic A. hydrophila strains.	[Hossain, Mohammad J.; Capps, Nancy K.; Carlisle, Kristen; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Waldbieser, Geoffrey C.] USDA, Catfish Genet Res Unit, Stoneville, MS USA; [Sun, Dawei; Hayden, Karl; Terhune, Jeffery S.] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA; [Hemstreet, William B.] Alabama Fish Farming Ctr, Greensboro, AL USA; [Griffin, Matt J.; Khoo, Lester] Mississippi State Univ, Coll Vet Med, Stoneville, MS USA; [Goodwin, Andrew E.] Univ Arkansas Pine Bluff, Aquaculture & Fisheries Ctr, Pine Bluff, AR USA; [Sonstegard, Tad S.; Schroeder, Steven] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA; [Newton, Joseph C.] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA	Auburn University System; Auburn University; United States Department of Agriculture (USDA); Auburn University System; Auburn University; Mississippi State University; University of Arkansas System; University Arkansas Pine Bluff; United States Department of Agriculture (USDA); Auburn University System; Auburn University	Liles, MR (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	lilesma@auburn.edu	Sun, Dawei/T-4355-2019; Hossain, Mohammad J/I-1542-2014	Sun, Dawei/0000-0001-6925-2001; Hossain, Mohammad J/0000-0003-3848-9035; Griffin, Matt/0000-0002-7920-3446; Schroeder, Steven/0000-0001-9103-5150	Alabama Agricultural Experiment Station (Hatch project) [ALA021-1-09005]; Alabama EPSCoR program	Alabama Agricultural Experiment Station (Hatch project); Alabama EPSCoR program	The Alabama Agricultural Experiment Station (Hatch project #ALA021-1-09005) provided research funding and the Alabama EPSCoR program provided stipend support for the first author MJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 1996, MED MICROBIOL LETT, V5, P156; ANDERSON WA, 1971, J BIOL CHEM, V246, P5662; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Beatson SA, 2011, J BACTERIOL, V193, P1286, DOI 10.1128/JB.01337-10; Bebawy John F, 2011, Anesthesiology, V114, P1486, DOI 10.1097/ALN.0b013e3181fe3cea; Bellstein F, 2008, VIROLOGY, V373, P25, DOI 10.1016/j.virol.2007.11.016; Boutte CC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000310; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; BURTLE GJ, 1989, CAN J FISH AQUAT SCI, V46, P218, DOI 10.1139/f89-030; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cordero-Alba M, 2012, J BACTERIOL, V194, P4226, DOI 10.1128/JB.00173-12; DOOLEY JSG, 1988, J BACTERIOL, V170, P499, DOI 10.1128/jb.170.2.499-506.1988; Duthy TG, 1999, J BACTERIOL, V181, P5847, DOI 10.1128/JB.181.18.5847-5851.1999; Eck RV, 1996, ATLAS PROTEIN SEQUEN; Erova TE, 2006, INFECT IMMUN, V74, P410, DOI 10.1128/IAI.74.1.410-424.2006; FORD LA, 1991, J WILDLIFE DIS, V27, P557, DOI 10.7589/0090-3558-27.4.557; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Griffin MJ, 2013, J VET DIAGN INVEST, V25, P473, DOI 10.1177/1040638713494210; Guo HJ, 2005, APPL ENVIRON MICROB, V71, P7995, DOI 10.1128/AEM.71.12.7995-8001.2005; Hemstreet B, 2010, CATFISH J, V24, P4; Holt J., 1994, BERGEYS MANUAL DETER; Hossain MJ, 2012, MICROBIOL-SGM, V158, P474, DOI 10.1099/mic.0.054866-0; HULL RA, 1978, J VIROL, V27, P513, DOI 10.1128/JVI.27.3.513-518.1978; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kim JS, 2008, J BACTERIOL, V190, P6524, DOI 10.1128/JB.00765-08; Krings E, 2006, J BACTERIOL, V188, P8054, DOI 10.1128/JB.00935-06; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Le Roux F, 2011, ENVIRON MICROBIOL, V13, P296, DOI 10.1111/j.1462-2920.2010.02329.x; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Li J, 2011, J APPL MICROBIOL, V110, P823, DOI 10.1111/j.1365-2672.2011.04944.x; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; McLaughlin HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042205; Mooi FR, 1997, TRENDS MICROBIOL, V5, P161, DOI 10.1016/S0966-842X(96)10086-X; Parks AR, 2007, J BACTERIOL, V189, P2170, DOI 10.1128/JB.01536-06; Pepe CM, 1996, MOL MICROBIOL, V19, P857, DOI 10.1046/j.1365-2958.1996.431958.x; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Pridgeon JW, 2011, VET MICROBIOL, V152, P117, DOI 10.1016/j.vetmic.2011.04.008; Pridgeon JW, 2011, DIS AQUAT ORGAN, V94, P249, DOI 10.3354/dao02332; Pullinger GD, 2004, MOL MICROBIOL, V51, P255, DOI 10.1046/j.1365-2958.2003.03829.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; RODRIGUEZ LA, 1992, MICROB PATHOGENESIS, V13, P17, DOI 10.1016/0882-4010(92)90028-M; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SANTOS Y, 1988, INFECT IMMUN, V56, P3285, DOI 10.1128/IAI.56.12.3285-3293.1988; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Snipen L, 2010, STAND GENOMIC SCI, V2, P135, DOI 10.4056/sigs.38923; Stahl M, 2011, P NATL ACAD SCI USA, V108, P7194, DOI 10.1073/pnas.1014125108; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEKEDAR HC, 2013, GENOME ANNOUNC, V1; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THUNE RL, 1982, T AM FISH SOC, V111, P404, DOI 10.1577/1548-8659(1982)111&lt;404:EPAEFA&gt;2.0.CO;2; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Wang YN, 2011, EUKARYOT CELL, V10, P618, DOI 10.1128/EC.00327-10; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Xue CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002869; Xue CY, 2010, MBIO, V1, DOI 10.1128/mBio.00084-10; Yanez MA, 2003, INT J SYST EVOL MICR, V53, P875, DOI 10.1099/ijs.0.02443-0; YOSHIDA K, 1994, MICROBIOL-UK, V140, P2289, DOI 10.1099/13500872-140-9-2289; Yoshida KI, 2008, J BIOL CHEM, V283, P10415, DOI 10.1074/jbc.M708043200; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Yu HB, 2005, APPL ENVIRON MICROB, V71, P4469, DOI 10.1128/AEM.71.8.4469-4477.2005; Zhang DH, 2013, VET MICROBIOL, V165, P478, DOI 10.1016/j.vetmic.2013.04.023; Zhang YL, 2002, INFECT IMMUN, V70, P2326, DOI 10.1128/IAI.70.5.2326-2335.2002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, P14, DOI DOI 10.1093/NAR/GKQ1122.PUBMED:21672955	74	72	78	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80943	10.1371/journal.pone.0080943	http://dx.doi.org/10.1371/journal.pone.0080943			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278351	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100128
J	Newman, AJ; Selkoe, D; Dettmer, U				Newman, Andrew J.; Selkoe, Dennis; Dettmer, Ulf			A New Method for Quantitative Immunoblotting of Endogenous alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; WILD-TYPE; BRAIN; MUTATION; TETRAMER; PROTEIN; CELLS; FORMS; DJ-1	beta-Sheet-rich aggregates of alpha-synuclein (alpha Syn) are the hallmark neuropathology of Parkinson's disease and related synucleinopathies, whereas the principal native structure of alpha Syn in healthy cells - unfolded monomer or alpha-helically folded oligomer - is under debate. Our recent crosslinking analysis of alpha Syn in intact cells showed that a large portion of endogenous alpha Syn can be trapped as oligomers, most notably as apparent tetramers. One challenge in such studies is accurately quantifying alpha Syn Western blot signals among samples, as crosslinked alpha Syn trends toward increased immunoreactivity. Here, we analyzed this phenomenon in detail and found that treatment with the reducible amine-reactive crosslinker DSP strongly increased alpha Syn immunoreactivity even after cleavage with the reducing agent beta-mercaptoethanol. The effect was observed with all alpha Syn antibodies tested and in all sample types from human brain homogenates to untransfected neuroblastoma cells, permitting easy detection of endogenous alpha Syn in the latter, which had long been considered impossible. Coomassie staining of blots before and after several hours of washing revealed complete retention of alpha Syn after DSP/beta-mercaptoethanol treatment, in contrast to a marked loss of alpha Syn without this treatment. The treatment also enhanced immunodetection of the homologs beta- and gamma-synuclein and of histones, another group of small, lysine-rich proteins. We conclude that by neutralizing positive charges and increasing protein hydrophobicity, amine crosslinker treatment promotes adhesion of alpha Syn to blotting membranes. These data help explain the recent report of fixing alpha Syn blots with paraformaldehyde after transfer, which we find produces similar but weaker effects. DSP/beta-mercaptoethanol treatment of Western blots should be particularly useful to quantify low-abundance alpha Syn forms such as extracellular and post-translationally modified alpha Syn and splice variants.	[Dettmer, Ulf] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dettmer, U (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	ulf_dettmer@harvard.edu		Dettmer, Ulf/0000-0001-6676-0107	Fidelity Biosciences Research Initiative; Michael J Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845] Funding Source: NIH RePORTER	Fidelity Biosciences Research Initiative; Michael J Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a research grant from the Fidelity Biosciences Research Initiative (www.fidelitybiosciences.com) to DS and a research grant from the Michael J Fox Foundation (www.michaeljfox.org) to UD and DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2013, NATURE, V498, pE6, DOI 10.1038/nature12126; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Starita-Geribaldi M, 1990, Bioseparation, V1, P111; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	24	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81314	10.1371/journal.pone.0081314	http://dx.doi.org/10.1371/journal.pone.0081314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278419	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100151
J	Nieszner, I; Vronka, M; Indikova, I; Szostak, MP				Nieszner, Isolde; Vronka, Martin; Indikova, Ivana; Szostak, Michael P.			Development of a Site-Directed Integration Plasmid for Heterologous Gene Expression in Mycoplasma gallisepticum	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; REPLICATION ORIGIN; ESCHERICHIA-COLI; ORIC PLASMIDS; STRAIN-R; CONSTRUCTION; VECTORS; CLONING; SYSTEM; TN916	Deciphering the molecular basis of the interactions between the parasite Mycoplasma gallisepticum and its avian hosts suffers from the lack of genetic tools available for the pathogen. In the absence of well established methods for targeted disruption of relevant M. gallisepticum genes, we started to develop suicide vectors and equipped them with a short fragment of M. gallisepticum origin or replication (oriC(MG)). We failed to create a disruption vector, although by adding a further short fragment of the M. gallisepticum tufB upstream region we created a "Trojan horse" plasmid. This is fully integrated into the genomic DNA of M. gallisepticum, always at the same site, oriC(MG), and is able to carry and express any gene of interest in the genetic background of M. gallisepticum. Successful expression of a heterologous gene was shown with the lacZ gene of E. coli. When used for gene complementation or expression of hybrid genes in M. gallisepticum, a site-specific combined integration/expression vector constitutes an improvement on randomly integrating transposons, which might have unexpected effects on the expression of chromosomal genes.	[Nieszner, Isolde; Vronka, Martin; Indikova, Ivana; Szostak, Michael P.] Univ Vet Med Vienna, Dept Pathobiol, Inst Bacteriol Mycol & Hyg, Vienna, Austria	University of Veterinary Medicine Vienna	Szostak, MP (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Inst Bacteriol Mycol & Hyg, Vienna, Austria.	michael.szostak@vetmeduni.ac.at			Austrian Science Fund FWF [P20712]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by grant P20712 from the Austrian Science Fund FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAO J, 1994, J BACTERIOL, V176, P4459, DOI 10.1128/jb.176.14.4459-4462.1994; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Delaney NF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002511; DYBVIG K, 1994, MOL MICROBIOL, V12, P547, DOI 10.1111/j.1365-2958.1994.tb01041.x; GAWRONBURKE C, 1984, J BACTERIOL, V159, P214, DOI 10.1128/JB.159.1.214-221.1984; Hahn TW, 1998, J BACTERIOL, V180, P1270, DOI 10.1128/JB.180.5.1270-1276.1998; HOLT SJ, 1958, PROC R SOC SER B-BIO, V148, P495, DOI 10.1098/rspb.1958.0041; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; Jechlinger W, 1999, FEMS MICROBIOL LETT, V173, P347, DOI 10.1111/j.1574-6968.1999.tb13524.x; KNUDTSON KL, 1993, GENE, V137, P217, DOI 10.1016/0378-1119(93)90009-R; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Miller JH., 1972, EXPT MOL GENETICS; Panicker IS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-138; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Papazisi L, 2000, INFECT IMMUN, V68, P6643, DOI 10.1128/IAI.68.12.6643-6649.2000; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Stipkovits L, 1996, REV SCI TECH OIE, V15, P1495, DOI 10.20506/rst.15.4.986; Voelker LL, 1996, J BACTERIOL, V178, P6078, DOI 10.1128/jb.178.20.6078-6081.1996; Winner F, 2003, INFECT IMMUN, V71, P1265, DOI 10.1128/IAI.71.3.1265-1273.2003; WISE KS, 1983, INFECT IMMUN, V41, P1332, DOI 10.1128/IAI.41.3.1332-1339.1983; YE FC, 1994, CURR MICROBIOL, V29, P23, DOI 10.1007/BF01570187	22	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81481	10.1371/journal.pone.0081481	http://dx.doi.org/10.1371/journal.pone.0081481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278444	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100159
J	Xu, XY; Shi, Y; Cai, Y; Zhang, QQ; Yang, F; Chen, H; Gu, Y; Zhang, M; Yu, LP; Yang, T				Xu, Xinyu; Shi, Yun; Cai, Yun; Zhang, Qingqing; Yang, Fan; Chen, Heng; Gu, Yong; Zhang, Mei; Yu, Liping; Yang, Tao			Inhibition of Increased Circulating Tfh Cell by Anti-CD20 Monoclonal Antibody in Patients with Type 1 Diabetes	PLOS ONE			English	Article							HELPER T-CELLS; GERMINAL CENTER B; INCREASED FREQUENCY; DIRECTED THERAPIES; AUTOIMMUNE-DISEASE; FH CELLS; RESPONSES; IL-21; DIFFERENTIATION; EXPRESSION	Objectives: Follicular helper T (Tfh) cells exert an important role in autoimmune diseases. Whether it might be involved in type 1 diabetes (T1D) is unknown. Our aim was to investigate the role of Tfh cells in patients with T1D and the effect of anti-CD20 monoclonal antibody (rituximab) on Tfh cells from T1D patients. Patients and Methods: Fifty-four patients with T1D and 37 healthy controls were enrolled in the current study. 20 of those patients were treated with rituximab. The frequencies of circulating CD4(+)CXCR5(+)ICOS(+)T cells were analyzed by flow cytometry. The serum autoantibodies were detected by radioligand assay. The levels of IL-21, IL-6 and BCL-6 were assessed using ELISA and/or real-time PCR. Results: Increased frequencies of circulating Tfh cells together with enhanced expression of IL-21 were detected in patients. The correlation between the frequencies of circulating Tfh cells and the serum autoantibodies or C-peptide level was comfirmed. After rituximab therapy, follow-up analysis demonstrated that the frequencies of circulating Tfh cell and serum IA2A were decreased. The levels of IL-21, IL-6 and Bcl-6 mRNA were decreased after treatment. Furthermore, beta cell function in 10 of 20 patients was improved. Conclusions: These data indicate Tfh cells may participate in the T1D-relatede immune responses and B cells might play a role in the development of Tfh responses in the disease progression.	[Xu, Xinyu; Shi, Yun; Cai, Yun; Zhang, Qingqing; Yang, Fan; Chen, Heng; Gu, Yong; Zhang, Mei; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Yu, Liping] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Nanjing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn	zhang, qingqing/GXF-2381-2022	Yang, Tao/0000-0001-6375-3622	National Natural Science Foundation of China [30971405, 81270897]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by grants from the National Natural Science Foundation of China (number 30971405, 81270897) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; FORSGREN S, 1991, SCAND J IMMUNOL, V34, P445, DOI 10.1111/j.1365-3083.1991.tb01567.x; Fox CJ, 1998, DIABETES, V47, P331, DOI 10.2337/diabetes.47.3.331; Geerlings SE, 2000, EUR J CLIN INVEST, V30, P995, DOI 10.1046/j.1365-2362.2000.00745.x; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Harjutsalo V, 2006, DIABETES, V55, P1517, DOI 10.2337/db05-1296; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kendall PL, 2007, J IMMUNOL, V178, P5643, DOI 10.4049/jimmunol.178.9.5643; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P13, DOI 10.1016/j.jaci.2007.11.030; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linterman MA, 2012, IMMUNOL REV, V247, P143, DOI 10.1111/j.1600-065X.2012.01121.x; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liossis SNC, 2008, CLIN IMMUNOL, V127, P280, DOI 10.1016/j.clim.2008.01.011; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Marino E, 2011, TRENDS IMMUNOL, V32, P287, DOI 10.1016/j.it.2011.03.006; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Noorchashm H, 1997, DIABETES, V46, P941, DOI 10.2337/diabetes.46.6.941; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Okada T, 2012, IMMUNOL REV, V247, P120, DOI 10.1111/j.1600-065X.2012.01120.x; Silva DG, 2011, DIABETES, V60, P2102, DOI 10.2337/db10-1344; Silveira PA, 2006, TRENDS ENDOCRIN MET, V17, P128, DOI 10.1016/j.tem.2006.03.006; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Szabo K, 2013, CLIN IMMUNOL, V147, P95, DOI 10.1016/j.clim.2013.02.024; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu LP, 2011, DIABETES, V60, P2560, DOI 10.2337/db11-0674; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	41	52	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79858	10.1371/journal.pone.0079858	http://dx.doi.org/10.1371/journal.pone.0079858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278195	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100058
J	Trobec, K; Kos, MK; von Haehling, S; Springer, J; Anker, SD; Lainscak, M				Trobec, Katja; Kos, Mojca Kerec; von Haehling, Stephan; Springer, Jochen; Anker, Stefan D.; Lainscak, Mitja			Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review	PLOS ONE			English	Review							HIV-INFECTED PATIENTS; LEAN BODY-MASS; LIPID-METABOLISM; CACHEXIA; CHILDREN; DIARRHEA; DISPOSITION; NEVIRAPINE; RIFABUTIN; EXPOSURE	Cachexia is a weight-loss process caused by an underlying chronic disease such as cancer, chronic heart failure, chronic obstructive pulmonary disease, or rheumatoid arthritis. It leads to changes in body structure and function that may influence the pharmacokinetics of drugs. Changes in gut function and decreased subcutaneous tissue may influence the absorption of orally and transdermally applied drugs. Altered body composition and plasma protein concentration may affect drug distribution. Changes in the expression and function of metabolic enzymes could influence the metabolism of drugs, and their renal excretion could be affected by possible reduction in kidney function. Because no general guidelines exist for drug dose adjustments in cachectic patients, we conducted a systematic search to identify articles that investigated the pharmacokinetics of drugs in cachectic patients.	[Trobec, Katja] Univ Clin Resp & Allerg Dis Golnik, Dept Pharm, Golnik, Slovenia; [Kos, Mojca Kerec] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [von Haehling, Stephan; Springer, Jochen; Lainscak, Mitja] Campus Virchow Klinikum, Charite Med Sch, Dept Cardiol, Berlin, Germany; [von Haehling, Stephan; Springer, Jochen] Campus Virchow Klinikum, Charite Med Sch, Ctr Cardiovasc Res, Berlin, Germany; [Springer, Jochen] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy; [Lainscak, Mitja] Univ Clin Resp & Allerg Dis Golnik, Div Cardiol, Golnik, Slovenia	University Clinic Golnik; University of Ljubljana; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of East Anglia; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University Clinic Golnik	Lainscak, M (corresponding author), Campus Virchow Klinikum, Charite Med Sch, Dept Cardiol, Berlin, Germany.	mitja.lainscak@guest.arnes.si						Agustsson T, 2012, NUTRITION, V28, P851, DOI 10.1016/j.nut.2011.11.026; Araujo JP, 2011, INT J CARDIOL, V146, P359, DOI 10.1016/j.ijcard.2009.07.042; Arutyunov GP, 2008, INT J CARDIOL, V125, P240, DOI 10.1016/j.ijcard.2007.11.103; Baracos VE, 2011, J CACHEXIA SARCOPENI, V2, P71, DOI 10.1007/s13539-011-0031-9; BARRY RE, 1974, GUT, V15, P562, DOI 10.1136/gut.15.7.562; Brantley Richard K., 2003, Braz J Infect Dis, V7, P16, DOI 10.1590/S1413-86702003000100003; *BRIST MYERS SQUIB, 2011, ZER STAV HARD CAPS O; CALDWELL J, 1995, TOXICOL PATHOL, V23, P102, DOI 10.1177/019262339502300202; Cederholm T, 1997, AM J CLIN NUTR, V65, P876, DOI 10.1093/ajcn/65.3.876; Chien JY, 2011, J PHARM SCI-US, V100, P53, DOI 10.1002/jps.22253; Christensen HM, 2013, ENDOCRINE, V43, P626, DOI 10.1007/s12020-012-9836-3; *CLIN, 2000, GOLN IMP BOD COMP CH; Durham WJ, 2009, CURR OPIN CLIN NUTR, V12, P72, DOI 10.1097/MCO.0b013e32831cef61; EDEN E, 1985, SURGERY, V97, P176; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FEARON KCH, 1990, INFUSIONSTHERAPIE, V17, P63; Gatti G, 1999, BRIT J CLIN PHARMACO, V48, P704; Gatti G, 1998, ANTIMICROB AGENTS CH, V42, P2017, DOI 10.1128/AAC.42.8.2017; *GEN INC, 2012, INV SAQ MES CAPS TAB; George J, 1996, J GASTROEN HEPATOL, V11, P33, DOI 10.1111/j.1440-1746.1996.tb00007.x; Gusella M, 2002, BRIT J CLIN PHARMACO, V54, P131, DOI 10.1046/j.1365-2125.2002.01598.x; Heiskanen T, 2009, PAIN, V144, P218, DOI 10.1016/j.pain.2009.04.012; Herrington JD, 2005, CANCER CHEMOTH PHARM, V57, P241, DOI 10.1007/s00280-005-0012-9; HOLROYDE CP, 1984, CANCER RES, V44, P5910; Jacques KA, 2010, AM J HEALTH-SYST PH, V67, P1948, DOI 10.2146/ajhp100226; Kemik O, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-85; King D, 1996, AGE AGEING, V25, P144, DOI 10.1093/ageing/25.2.144; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuester K, 2009, CLIN PHARMACOKINET, V48, P477, DOI 10.2165/11313400-000000000-00000; KUMAR RV, 1987, CHEMOTHERAPY, V33, P234, DOI 10.1159/000238500; Liu WP, 2012, PLATIN MET REV, V56, P248, DOI 10.1595/147106712X654204; Marier JF, 2007, J CLIN PHARMACOL, V47, P1381, DOI 10.1177/0091270007307572; Marzo A, 1997, PHARMACOL RES, V36, P425, DOI 10.1006/phrs.1997.0254; McLeay SC, 2012, CLIN PHARMACOKINET, V51, P319, DOI 10.2165/11598930-000000000-00000; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MORGAN DJ, 1994, CLIN PHARMACOKINET, V26, P292, DOI 10.2165/00003088-199426040-00005; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Mouly S, 2001, BRIT J CLIN PHARMACO, V51, P557, DOI 10.1046/j.0306-5251.2001.01389.x; Mouly S, 2000, J ACQ IMMUN DEF SYND, V24, P344; MULLIGAN HD, 1992, BRIT J CANCER, V66, P57, DOI 10.1038/bjc.1992.216; Murry DJ, 1998, INT J CANCER, V78, P48; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Naito T, 2012, EUR J CLIN PHARMACOL, V68, P1411, DOI 10.1007/s00228-012-1266-x; Nawaratne S, 1998, BRIT J CLIN PHARMACO, V46, P447, DOI 10.1046/j.1365-2125.1998.00812.x; Oshikoya KA, 2010, EUR J CLIN PHARMACOL, V66, P1025, DOI 10.1007/s00228-010-0851-0; Patel SS, 2013, J CACHEXIA SARCOPENI, V4, P19, DOI 10.1007/s13539-012-0079-1; Pichard C, 1998, Curr Opin Clin Nutr Metab Care, V1, P357, DOI 10.1097/00075197-199807000-00008; Pollock L, 2009, J ANTIMICROB CHEMOTH, V64, P1251, DOI 10.1093/jac/dkp358; Prado CMM, 2011, CANCER CHEMOTH PHARM, V67, P93, DOI 10.1007/s00280-010-1288-y; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; *ROCH PROD LTD, 2011, CYM GANC POWD INTR I; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Sandek A, 2011, INT J CARDIOL, V146, P277, DOI 10.1016/j.ijcard.2010.10.083; Seelaender MCL, 1996, BIOCHEM MOL BIOL INT, V39, P1037; Tepsuwan Thitipong, 2009, Asian Cardiovasc Thorac Ann, V17, P617, DOI 10.1177/0218492309349093; Trobec K, 2012, LUNG CANCER, V76, P397, DOI 10.1016/j.lungcan.2011.11.016; Trout H, 2004, ANTIMICROB AGENTS CH, V48, P538, DOI 10.1128/AAC.48.2.538-545.2004; Valentova M, 2013, NUTRITION, V29, P370, DOI 10.1016/j.nut.2012.06.002; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6	60	68	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79603	10.1371/journal.pone.0079603	http://dx.doi.org/10.1371/journal.pone.0079603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24282510	Green Submitted, Green Published, gold			2022-12-27	WOS:000327216200080
J	Ganin, IP; Shishkin, SL; Kaplan, AY				Ganin, Ilya P.; Shishkin, Sergei L.; Kaplan, Alexander Y.			A P300-based Brain-Computer Interface with Stimuli on Moving Objects: Four-Session Single-Trial and Triple-Trial Tests with a Game-Like Task Design	PLOS ONE			English	Article							SMOOTH-PURSUIT; P300 SPELLER; EVOKED-POTENTIALS; BCI; ATTENTION; PERFORMANCE; ALLOCATION; PARADIGM; WHEELCHAIR; AMPLITUDE	Brain-computer interfaces (BCIs) are tools for controlling computers and other devices without using muscular activity, employing user-controlled variations in signals recorded from the user's brain. One of the most efficient noninvasive BCIs is based on the P300 wave of the brain's response to stimuli and is therefore referred to as the P300 BCI. Many modifications of this BCI have been proposed to further improve the BCI's characteristics or to better adapt the BCI to various applications. However, in the original P300 BCI and in all of its modifications, the spatial positions of stimuli were fixed relative to each other, which can impose constraints on designing applications controlled by this BCI. We designed and tested a P300 BCI with stimuli presented on objects that were freely moving on a screen at a speed of 5.4 degrees/s. Healthy participants practiced a game-like task with this BCI in either single-trial or triple-trial mode within four sessions. At each step, the participants were required to select one of nine moving objects. The mean online accuracy of BCI-based selection was 81% in the triple-trial mode and 65% in the single-trial mode. A relatively high P300 amplitude was observed in response to targets in most participants. Self-rated interest in the task was high and stable over the four sessions (the medians in the 1st/4th sessions were 79/84% and 76/71% in the groups practicing in the single-trial and triple-trial modes, respectively). We conclude that the movement of stimulus positions relative to each other may not prevent the efficient use of the P300 BCI by people controlling their gaze, e. g., in robotic devices and in video games.	[Ganin, Ilya P.; Shishkin, Sergei L.; Kaplan, Alexander Y.] Moscow MV Lomonosov State Univ, Fac Biol, Lab Neurophysiol & Neurocomp Interfaces, Moscow, Russia; [Shishkin, Sergei L.] Natl Res Ctr, Ctr Converging Nano Bio Informat Cognit & Social, Lab Neuroergon & Brain Comp Interfaces, NBICS Ctr,Kurchatov Inst, Moscow, Russia	Lomonosov Moscow State University; National Research Centre - Kurchatov Institute	Kaplan, AY (corresponding author), Moscow MV Lomonosov State Univ, Fac Biol, Lab Neurophysiol & Neurocomp Interfaces, Moscow, Russia.	akaplan@mail.ru	Shishkin, Sergei L./A-3461-2013; Ganin, Ilya P/D-6923-2018; Kaplan, Alexander/L-5832-2017	Shishkin, Sergei L./0000-0002-3257-1022; Kaplan, Alexander/0000-0002-3912-4639	Skolkovo Foundation [1110034]	Skolkovo Foundation	This study was supported by funding from the Skolkovo Foundation (project #1110034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2011, P 5 INT BCI C 2011 2, P236; Allison BZ, 2006, INT J PSYCHOPHYSIOL, V59, P127, DOI 10.1016/j.ijpsycho.2005.02.007; Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Aloise F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025025; Arico P, 2011, P 5 INT BCI C 22 24, P240; Bayliss JD, 2003, IEEE T NEUR SYS REH, V11, P113, DOI 10.1109/TNSRE.2003.814438; Bayliss JD, 2000, IEEE T REHABIL ENG, V8, P188, DOI 10.1109/86.847811; Beer AL, 2004, COGNITIVE BRAIN RES, V18, P205, DOI 10.1016/j.cogbrainres.2003.10.004; Bell CJ, 2008, J NEURAL ENG, V5, P214, DOI 10.1088/1741-2560/5/2/012; Bensch Michael, 2007, Comput Intell Neurosci, P71863, DOI 10.1155/2007/71863; Bianchi L, 2010, BRAIN TOPOGR, V23, P180, DOI 10.1007/s10548-010-0143-0; Bieger J, 2010, TN201000315 KON PHIL, P1; Bos DPO, 2010, HUM-COMPUT INT-SPRIN, P149, DOI 10.1007/978-1-84996-272-8_10; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cinel C., 2004, BIOMED TECH, V49, P39; Citi L, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056006; Congedo M., 2011, P 5 INT BRAIN COMP I, P280; Datta A, 2007, COMPUT INTEL NEUROSC, P93968, DOI DOI 10.1155/2007/93968; DONCHIN E, 1967, ELECTROEN CLIN NEURO, V22, P537, DOI 10.1016/0013-4694(67)90061-2; Donnerer M, 2010, PRESENCE-TELEOP VIRT, V19, P12, DOI 10.1162/pres.19.1.12; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Escolano C, 2012, IEEE T SYST MAN CY B, V42, P793, DOI 10.1109/TSMCB.2011.2177968; Eskandari P, 2008, IEEE ENG MED BIO, P662, DOI 10.1109/IEMBS.2008.4649239; Fard MM, 2009, ADV NEURAL INF PROCE, V21, p[665, 1065]; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Fazel-Rezai R, 2009, CAN J ELECT COMPUT E, V34, P81, DOI 10.1109/CJECE.2009.5443854; Finke A, 2011, P 2011 INT UKIERI WO, P16; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Frenzel S, 2010, ARXIV10063688V1; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; Frye GE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025024; Ganin I. P., 2012, Human Physiology, V38, P121, DOI 10.1134/S0362119712020041; Ganin I. P., 2011, P 5 INT BCI C 2011, P308; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Groenegress C, 2010, PRESENCE-TELEOP VIRT, V19, P1, DOI 10.1162/pres.19.1.1; Guan C., 2004, P IEEE INT WORKSH BI; Guan JN, 2005, 2005 FIRST INTERNATIONAL CONFERENCE ON NEURAL INTERFACE AND CONTROL PROCEEDINGS, P45; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Hakvoort G, 2011, THESIS U TWENTE; Hawkins GE, 2013, BEHAV RES METHODS, V45, P301, DOI 10.3758/s13428-012-0264-3; Heinen SJ, 2011, J VISION, V11, DOI 10.1167/11.2.9; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Jin J, 2012, J NEUROSCI METH, V205, P265, DOI 10.1016/j.jneumeth.2012.01.004; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Kaplan A. J., 2009, RU Patent, Patent No. [2406554, 2406554 C1]; Kaplan AY, 2013, IEEE T COMP INTEL AI, V5, P141, DOI 10.1109/TCIAIG.2012.2237517; Kaplan AY, 2005, INT J NEUROSCI, V115, P781, DOI 10.1080/00207450590881975; Khan AZ, 2010, J VISION, V10, DOI 10.1167/10.13.7; KHURANA B, 1987, VISION RES, V27, P1603, DOI 10.1016/0042-6989(87)90168-4; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER AF, 1983, HUM FACTORS, V25, P597, DOI 10.1177/001872088302500601; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Lakey CE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025019; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Liu T, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036003; Long JY, 2012, IEEE T NEUR SYS REH, V20, P720, DOI 10.1109/TNSRE.2012.2197221; Lovejoy LP, 2009, VISION RES, V49, P1275, DOI 10.1016/j.visres.2009.01.011; Luck S.J., 2005, INTRO EVENT RELATED; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; Michalski A, 1999, ACTA NEUROBIOL EXP, V59, P123; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Muhl C, 2009, 5 INT SUMM WORKSH MU, P41; Nijholt A, 2009, ENTERTAIN COMPUT, V1, P85, DOI 10.1016/j.entcom.2009.09.007; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Onose G, 2012, SPINAL CORD, V50, P599, DOI 10.1038/sc.2012.14; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Pires G, 2012, CLIN NEUROPHYSIOL, V123, P1168, DOI 10.1016/j.clinph.2011.10.040; Pires G, 2008, IEEE ENG MED BIO, P658, DOI 10.1109/IEMBS.2008.4649238; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rebsamen B, 2010, IEEE T NEUR SYS REH, V18, P590, DOI 10.1109/TNSRE.2010.2049862; ROGER M, 1981, PSYCHOPHYSIOLOGY, V18, P477, DOI 10.1111/j.1469-8986.1981.tb02485.x; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; SEKULER R, 1977, SCIENCE, V198, P60, DOI 10.1126/science.897682; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Shishkin SL, 2011, NEUROSCI LETT, V496, P95, DOI 10.1016/j.neulet.2011.03.089; Shishkin SL, 2009, J INTEGR NEUROSCI, V8, P471, DOI 10.1142/S0219635209002320; Silvoni S, 2011, P 5 INT BCI C AUSTR, P324; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; SOMMER W, 1992, BIOL PSYCHOL, V33, P37, DOI 10.1016/0301-0511(92)90004-E; Suchow JW, 2011, CURR BIOL, V21, P140, DOI 10.1016/j.cub.2010.12.019; Tonin L., 2009, INT J BIOELECTROMAGN, V11, P97; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Townsend G, 2012, NEUROSCI LETT, V531, P63, DOI 10.1016/j.neulet.2012.08.041; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yu TY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036012; Yuksel B, 2010, P SIGCHI C HUM FACT, P855; Yuksel BF, 2011, P 5 INT BCI C 2011 2, P288; Zhang D, 2013, NEUROIMAGE, V71, P30, DOI 10.1016/j.neuroimage.2012.12.069; Zhang HH, 2008, IEEE T BIO-MED ENG, V55, P1754, DOI 10.1109/TBME.2008.919128	104	21	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77755	10.1371/journal.pone.0077755	http://dx.doi.org/10.1371/journal.pone.0077755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24302977	Green Published, gold, Green Submitted			2022-12-27	WOS:000326373800007
J	Wagener, AH; Zwinderman, AH; Luiten, S; Fokkens, WJ; Bel, EH; Sterk, PJ; van Drunen, CM				Wagener, Ariane H.; Zwinderman, Aeilko H.; Luiten, Silvia; Fokkens, Wytske J.; Bel, Elisabeth H.; Sterk, Peter J.; van Drunen, Cornelis M.			The Impact of Allergic Rhinitis and Asthma on Human Nasal and Bronchial Epithelial Gene Expression	PLOS ONE			English	Article							AIRWAY; INFLAMMATION; CELLS; COLLABORATION; DISCOVERY; DISEASE; UPDATE; SPINK5; ROLES; SHOWS	Background: The link between upper and lower airways in patients with both asthma and allergic rhinitis is still poorly understood. As the biological complexity of these disorders can be captured by gene expression profiling we hypothesized that the clinical expression of rhinitis and/or asthma is related to differential gene expression between upper and lower airways epithelium. 3Objective: Defining gene expression profiles of primary nasal and bronchial epithelial cells from the same individuals and examining the impact of allergic rhinitis with and without concomitant allergic asthma on expression profiles. Methods: This cross-sectional study included 18 subjects (6 allergic asthma and allergic rhinitis; 6 allergic rhinitis; 6 healthy controls). The estimated false discovery rate comparing 6 subjects per group was approximately 5%. RNA was extracted from isolated and cultured epithelial cells from bronchial brushings and nasal biopsies, and analyzed by microarray (Affymetrix U133+ PM Genechip Array). Data were analysed using R and Bioconductor Limma package. For gene ontology GeneSpring GX12 was used. Results: The study was successfully completed by 17 subjects (6 allergic asthma and allergic rhinitis; 5 allergic rhinitis; 6 healthy controls). Using correction for multiple testing, 1988 genes were differentially expressed between healthy lower and upper airway epithelium, whereas in allergic rhinitis with or without asthma this was only 40 and 301 genes, respectively. Genes influenced by allergic rhinitis with or without asthma were linked to lung development, remodeling, regulation of peptidases and normal epithelial barrier functions. Conclusions: Differences in epithelial gene expression between the upper and lower airway epithelium, as observed in healthy subjects, largely disappear in patients with allergic rhinitis with or without asthma, whilst new differences emerge. The present data identify several pathways and genes that might be potential targets for future drug development.	[Wagener, Ariane H.; Bel, Elisabeth H.; Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1012 WX Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1012 WX Amsterdam, Netherlands; [Luiten, Silvia; Fokkens, Wytske J.; van Drunen, Cornelis M.] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Wagener, AH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1012 WX Amsterdam, Netherlands.	a.h.wagener@amc.uva.nl	Sterk, P.J./AAK-8175-2020; Fokkens, Wytske WJ/ABF-2185-2020	van Drunen, Cornelis M/0000-0001-5503-066X	Academic Medical Center (AMC), University of Amsterdam	Academic Medical Center (AMC), University of Amsterdam	The work was financially supported by the Academic Medical Center (AMC), University of Amsterdam. No grant was involved in this study. The funders (University of Amsterdam) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Benjamini Y, 2001, ANN STAT, V29, P1165; Birben E, 2012, RESP MED, V106, P349, DOI 10.1016/j.rmed.2011.11.007; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bourdin A, 2009, THORAX, V64, P999, DOI 10.1136/thx.2008.112862; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2004, J ALLERGY CLIN IMMUN, V113, P43, DOI 10.1016/j.jaci.2003.09.047; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ferreira JA, 2006, STAT APPL GENET MOL, V5; Global Strategy for Asthma Management and Prevention, 2006, GLOB STRAT ASTHM MAN; Golebski K, 2013, ALLERGY, V68, P152, DOI 10.1111/all.12080; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hiemstra PS, 2002, BIOCHEM SOC T, V30, P116, DOI 10.1042/BST0300116; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; KAMB A, 1995, TRENDS GENET, V11, P136, DOI 10.1016/S0168-9525(00)89027-7; Li Q, 2010, MOL BIOL REP, V37, P2981, DOI 10.1007/s11033-009-9865-z; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maeda Y, 2011, AM J RESP CRIT CARE, V184, P421, DOI 10.1164/rccm.201101-0106OC; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Moffatt MF, 2004, CLIN EXP ALLERGY, V34, P325, DOI 10.1111/j.1365-2222.2004.01915.x; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Park SW, 2009, AM J RESP CRIT CARE, V180, P603, DOI 10.1164/rccm.200811-1768OC; Pegorier S, 2007, J ALLERGY CLIN IMMUN, V120, P1301, DOI 10.1016/j.jaci.2007.09.023; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Reinartz SM, 2005, ALLERGY, V60, P1301, DOI 10.1111/j.1398-9995.2005.00911.x; Roschmann KIL, 2011, CLIN EXP ALLERGY, V41, P830, DOI 10.1111/j.1365-2222.2011.03713.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sridhar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-259; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Vroling AB, 2008, ALLERGY, V63, P1110, DOI 10.1111/j.1398-9995.2008.01785.x; Vroling AB, 2007, ALLERGY, V62, P1310, DOI 10.1111/j.1398-9995.2007.01495.x; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yang IV, 2012, AM J RESP CRIT CARE, V185, P620, DOI 10.1164/rccm.201108-1503OC; Zhang XL, 2010, PHYSIOL GENOMICS, V41, P1, DOI 10.1152/physiolgenomics.00167.2009	49	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80257	10.1371/journal.pone.0080257	http://dx.doi.org/10.1371/journal.pone.0080257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282527	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500028
J	Zhang, SY; Blount, AC; McNicholas, CM; Skinner, DF; Chestnut, M; Kappes, JC; Sorscher, EJ; Woodworth, BA				Zhang, Shaoyan; Blount, Angela C.; McNicholas, Carmel M.; Skinner, Daniel F.; Chestnut, Michael; Kappes, John C.; Sorscher, Eric J.; Woodworth, Bradford A.			Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; HEALTH-CARE UTILIZATION; CHRONIC RHINOSINUSITIS; INTERFACE CULTURES; CHLORIDE TRANSPORT; ION-TRANSPORT; IN-VITRO; CHANNEL; MUCOCILIARY; MULTICENTER	Background: Chronic rhinosinusitis engenders enormous morbidity in the general population, and is often refractory to medical intervention. Compounds that augment mucociliary clearance in airway epithelia represent a novel treatment strategy for diseases of mucus stasis. A dominant fluid and electrolyte secretory pathway in the nasal airways is governed by the cystic fibrosis transmembrane conductance regulator (CFTR). The objectives of the present study were to test resveratrol, a strong potentiator of CFTR channel open probability, in preparation for a clinical trial of mucociliary activators in human sinus disease. Methods: Primary sinonasal epithelial cells, immortalized bronchoepithelial cells (wild type and F508del CFTR), and HEK293 cells expressing exogenous human CFTR were investigated by Ussing chamber as well as patch clamp technique under non-phosphorylating conditions. Effects on airway surface liquid depth were measured using confocal laser scanning microscopy. Impact on CFTR gene expression was measured by quantitative reverse transcriptase polymerase chain reaction. Results: Resveratrol is a robust CFTR channel potentiator in numerous mammalian species. The compound also activated temperature corrected F508del CFTR and enhanced CFTR-dependent chloride secretion in human sinus epithelium ex vivo to an extent comparable to the recently approved CFTR potentiator, ivacaftor. Using inside out patches from apical membranes of murine cells, resveratrol stimulated an similar to 8 picosiemens chloride channel consistent with CFTR. This observation was confirmed in HEK293 cells expressing exogenous CFTR. Treatment of sinonasal epithelium resulted in a significant increase in airway surface liquid depth (in mu m: 8.08+/-1.68 vs. 6.11+/-0.47, control, p<0.05). There was no increase CFTR mRNA. Conclusion: Resveratrol is a potent chloride secretagogue from the mucosal surface of sinonasal epithelium, and hydrates airway surface liquid by increasing CFTR channel open probability. The foundation for a clinical trial utilizing resveratrol as a therapeutic intervention to increase mucociliary transport and airway surface liquid hydration in sinus disease is strongly supported by these findings.	[Zhang, Shaoyan; Blount, Angela C.; Skinner, Daniel F.; Chestnut, Michael; Woodworth, Bradford A.] Univ Alabama Birmingham, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA; [McNicholas, Carmel M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kappes, John C.; Sorscher, Eric J.; Woodworth, Bradford A.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Kappes, John C.; Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Woodworth, BA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA.	bwoodwo@hotmail.com		Sorscher, Eric J./0000-0001-9341-3354; McNicholas-Bevensee, Carmel/0000-0002-7013-8764	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [1K08HL107142-03]; MD - NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5P30DK072482-03]; PhD - NIH/National Institute of Allergy and Infectious Diseases [P30-AI-27767]; NIH/NIDDK [R24DK-64400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R24DK064400] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MD - NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); PhD - NIH/National Institute of Allergy and Infectious Diseases; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided to BAW, MD - National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (1K08HL107142-03); EJS, MD - NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5P30DK072482-03), JCK, PhD - NIH/National Institute of Allergy and Infectious Diseases (P30-AI-27767) and NIH/NIDDK (R24DK-64400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Alexander NS, 2012, LARYNGOSCOPE, V122, P1193, DOI 10.1002/lary.23278; Alexander NS, 2011, LARYNGOSCOPE, V121, P1313, DOI 10.1002/lary.21798; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bhargave G, 2008, AM J RHINOL, V22, P7, DOI 10.2500/ajr.2008.22.3125; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Blount A, 2011, LARYNGOSCOPE, V121, P1929, DOI 10.1002/lary.21921; Cohen NA, 2009, LARYNGOSCOPE, V119, P2269, DOI 10.1002/lary.20223; Donnelly LE, 2004, AM J PHYSIOL-LUNG C, V287, pL774, DOI 10.1152/ajplung.00110.2004; Fischer H, 2008, CELL PHYSIOL BIOCHEM, V22, P685, DOI 10.1159/000185552; GLIKLICH RE, 1995, OTOLARYNG HEAD NECK, V113, P104, DOI 10.1016/S0194-5998(95)70152-4; Hamdaoui N, 2011, BRIT J PHARMACOL, V163, P876, DOI 10.1111/j.1476-5381.2011.01289.x; Lee M, 2009, INT IMMUNOPHARMACOL, V9, P418, DOI 10.1016/j.intimp.2009.01.005; Leung PS, 1998, J REPROD FERTIL, P15; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Moller W, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-10; Murphy MP, 2002, OTOLARYNG HEAD NECK, V127, P367, DOI 10.1067/mhn.2002.129815; Noone PG, 2001, PEDIATR PULM, V32, P122, DOI 10.1002/ppul.1098.abs; Ruddy J, 2013, J AEROSOL MED PULM D, V26, P69, DOI 10.1089/jamp.2011.0942; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Virgin FW, 2010, LARYNGOSCOPE, V120, P1465, DOI 10.1002/lary.20930; Woodworth BA, 2008, AM J RHINOL, V22, P235, DOI 10.2500/ajr.2008.22.3178; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang SY, 2009, AM J RHINOL ALLERGY, V23, P149, DOI 10.2500/ajra.2009.23.3285	30	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81589	10.1371/journal.pone.0081589	http://dx.doi.org/10.1371/journal.pone.0081589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282612	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500115
J	Hansen, A; Alston, L; Tulk, SE; Schenck, LP; Grassie, ME; Alhassan, BF; Veermalla, AT; Al-Bashir, S; Gendron, FP; Altier, C; MacDonald, JA; Beck, PL; Hirota, SA				Hansen, Ashleigh; Alston, Laurie; Tulk, Sarah E.; Schenck, L. Patrick; Grassie, Michael E.; Alhassan, Basmah F.; Veermalla, Arun Teja; Al-Bashir, Samir; Gendron, Fernand-Pierre; Altier, Christophe; MacDonald, Justin A.; Beck, Paul L.; Hirota, Simon A.			The P2Y(6) Receptor Mediates Clostridium difficile Toxin-Induced CXCL8/IL-8 Production and Intestinal Epithelial Barrier Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; A-INDUCED ENTERITIS; IN-VITRO; INTERLEUKIN-8 PRODUCTION; NEUTROPHIL MIGRATION; EXTRACELLULAR NUCLEOTIDES; MONOCLONAL-ANTIBODIES; KINASE ACTIVATION; CL-SECRETION; MOUSE MODEL	C. difficile is a Gram-positive spore-forming anaerobic bacterium that is the leading cause of nosocomial diarrhea in the developed world. The pathogenesis of C. difficile infections (CDI) is driven by toxin A (TcdA) and toxin B (TcdB), secreted factors that trigger the release of inflammatory mediators and contribute to disruption of the intestinal epithelial barrier. Neutrophils play a key role in the inflammatory response and the induction of pseudomembranous colitis in CDI. TcdA and TcdB alter cytoskeletal signaling and trigger the release of CXCL8/IL-8, a potent neutrophil chemoattractant, from intestinal epithelial cells; however, little is known about the surface receptor(s) that mediate these events. In the current study, we sought to assess whether toxin-induced CXCL8/IL-8 release and barrier dysfunction are driven by the activation of the P2Y(6) receptor following the release of UDP, a danger signal, from intoxicated Caco-2 cells. Caco-2 cells express a functional P2Y(6) receptor and release measurable amounts of UDP upon exposure to TcdA/B. Toxin-induced CXCL8/IL-8 production and release were attenuated in the presence of a selective P2Y(6) inhibitor (MRS2578). This was associated with inhibition of TcdA/B-induced activation of NF kappa B. Blockade of the P2Y(6) receptor also attenuated toxin-induced barrier dysfunction in polarized Caco-2 cells. Lastly, pretreating mice with the P2Y(6) receptor antagonists (MSR2578) attenuated TcdA/B-induced inflammation and intestinal permeability in an intrarectal toxin exposure model. Taken together these data outline a novel role for the P2Y(6) receptor in the induction of CXCL8/IL-8 production and barrier dysfunction in response to C. difficile toxin exposure and may provide a new therapeutic target for the treatment of CDI.	[Hansen, Ashleigh; Alston, Laurie; Veermalla, Arun Teja; Altier, Christophe; Hirota, Simon A.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Hansen, Ashleigh; Alston, Laurie; Hirota, Simon A.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Schenck, L. Patrick; Grassie, Michael E.; Alhassan, Basmah F.; MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Alhassan, Basmah F.; Beck, Paul L.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Al-Bashir, Samir] Jordan Univ Sci & Technol, Dept Pathol & Lab Med, Irbid, Jordan; [Gendron, Fernand-Pierre] Univ Sherbrooke, Dept Anat & Cell Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Jordan University of Science & Technology; University of Sherbrooke	Hirota, SA (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.	simon.hirota@ucalgary.ca	Gendron, Fernand-Pierre/AAN-2965-2021	Al Bashir, Samir/0000-0001-8637-2136; MacDonald, Justin/0000-0002-9238-8473	Canadian Institutes of Health Research (CIHR); Alberta Health Innovates (AIHS); Canada Research Chair; AIHS; CIHR [MOP-98004]; Snyder Institute for Chronic Diseases, University of Calgary	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Health Innovates (AIHS); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); AIHS; CIHR(Canadian Institutes of Health Research (CIHR)); Snyder Institute for Chronic Diseases, University of Calgary	This work was supported by Canadian Institutes of Health Research (CIHR - www.cihr-irsc.gc.ca) and Alberta Health Innovates (AIHS - www.ahfmr.ab.ca) fellowships (SAH), Canada Research Chair (CA & JAM) and AIHS Senior Scholar (JAM) and AIHS Clinical Investigator (PLB) and grants from CIHR (CA, PLB & JAM - MOP-98004). All investigators receive support from the Snyder Institute for Chronic Diseases, University of Calgary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; Cavalcante IC, 2006, INFECT IMMUN, V74, P2606, DOI 10.1128/IAI.74.5.2606-2612.2006; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; D HE, 2000, GASTROENTEROLOGY, V119, P139, DOI 10.1053/gast.2000.8526; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Dulong S, 2007, CELL PHYSIOL BIOCHEM, V20, P483, DOI 10.1159/000107532; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Grbic DM, 2012, INFLAMM BOWEL DIS, V18, P1456, DOI 10.1002/ibd.21931; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Hasegawa M, 2011, J IMMUNOL, V186, P4872, DOI 10.4049/jimmunol.1003761; He D, 2002, GASTROENTEROLOGY, V122, P1048, DOI 10.1053/gast.2002.32386; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Hirota SA, 2012, INFECT IMMUN, V80, P4474, DOI 10.1128/IAI.00933-12; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Hull MW, 2004, CAN FAM PHYSICIAN, V50, P1536; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; KETLEY JM, 1987, J MED MICROBIOL, V24, P41, DOI 10.1099/00222615-24-1-41; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Korcok J, 2005, J BIOL CHEM, V280, P16909, DOI 10.1074/jbc.M410764200; Kucharzik T, 2002, PATHOBIOLOGY, V70, P143, DOI 10.1159/000068146; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Lapointe TK, 2010, CELL MICROBIOL, V12, P692, DOI 10.1111/j.1462-5822.2010.01429.x; Lau WKH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022363; Lee JY, 2007, J MOL MED-JMM, V85, P1393, DOI 10.1007/s00109-007-0237-7; Lee JY, 2009, J MOL MED, V87, P169, DOI 10.1007/s00109-008-0415-2; Lica M, 2011, N-S ARCH PHARMACOL, V383, P275, DOI 10.1007/s00210-010-0595-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahida YR, 1996, GUT, V38, P337, DOI 10.1136/gut.38.3.337; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Matarrese P, 2007, J BIOL CHEM, V282, P9029, DOI 10.1074/jbc.M607614200; Matte I, 2009, INFECT IMMUN, V77, P5400, DOI 10.1128/IAI.00485-09; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Momotani K, 2011, CIRC RES, V109, P993, DOI 10.1161/CIRCRESAHA.111.248898; Mueller C, 2012, DIGEST DIS, V30, P40, DOI 10.1159/000342600; Na X, 2005, GASTROENTEROLOGY, V128, P1002, DOI 10.1053/j.gastro.2005.01.053; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Pittman K, 2013, J INNATE IMMUN; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Relvas LJM, 2009, INVEST OPHTH VIS SCI, V50, P1241, DOI 10.1167/iovs.08-1902; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Robinson KS, 2010, MICROBIOL-SGM, V156, P1815, DOI 10.1099/mic.0.037259-0; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schenck LP, 2013, NEUROGASTROENT MOTIL, V25, pe441, DOI 10.1111/nmo.12139; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Steiner TS, 1997, CLIN DIAGN LAB IMMUN, V4, P719, DOI 10.1128/CDLI.4.6.719-722.1997; Junqueira AFTD, 2011, INFECT IMMUN, V79, P653, DOI 10.1128/IAI.01159-10; TRIADAFILOPOULOS G, 1987, GASTROENTEROLOGY, V93, P273, DOI 10.1016/0016-5085(87)91014-6; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Warny M, 2000, J CLIN INVEST, V105, P1147, DOI 10.1172/JCI7545; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Warren CA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-13; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Zemljic M, 2010, ANAEROBE, V16, P527, DOI 10.1016/j.anaerobe.2010.06.010; Zemskov Evgeny, 2011, J Cardiovasc Dis Res, V2, P14, DOI 10.4103/0975-3583.78582; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946	69	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81491	10.1371/journal.pone.0081491	http://dx.doi.org/10.1371/journal.pone.0081491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278446	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700066
J	Tugume, AK; Amayo, R; Weinheimer, I; Mukasa, SB; Rubaihayo, PR; Valkonen, JPT				Tugume, Arthur K.; Amayo, Robert; Weinheimer, Isabel; Mukasa, Settumba B.; Rubaihayo, Patrick R.; Valkonen, Jari P. T.			Genetic Variability and Evolutionary Implications of RNA Silencing Suppressor Genes in RNA1 of Sweet Potato Chlorotic Stunt Virus Isolates Infecting Sweetpotato and Related Wild Species	PLOS ONE			English	Article							IPOMOEA-BATATAS L.; DISEASE SPVD; SELECTION PRESSURE; RIBONUCLEASE-III; COAT PROTEIN; EAST-AFRICA; SEQUENCE; RECOMBINATION; DIVERSITY; DIVERSIFICATION	Background: The bipartite single-stranded RNA genome of Sweet potato chlorotic stunt virus (SPCSV, genus Crinivirus; Closteroviridae) encodes a Class 1 RNase III (RNase3), a putative hydrophobic protein (p7) and a 22-kDa protein (p22) from genes located in RNA1. RNase3 and p22 suppress RNA silencing, the basal antiviral defence mechanism in plants. RNase3 is sufficient to render sweetpotato (Ipomoea batatas) virus-susceptible and predisposes it to development of severe diseases following infection with unrelated virus. The incidence, strains and gene content of SPCSV infecting wild plant species have not been studied. Methodology/Principal Findings: Thirty SPCSV isolates were characterized from 10 wild Ipomoea species, Hewittia sublobata or Lepistemon owariensis (family Convolvulaceae) in Uganda and compared with 34 local SPCSV isolates infecting sweetpotatoes. All isolates belonged to the East African (EA) strain of SPCSV and contained RNase3 and p7, but p22 was not detected in six isolates. The three genes showed only limited genetic variability and the proteins were under purifying selection. SPCSV isolates lacking p22 synergized with Sweet potato feathery mottle virus (SPFMV, genus potyvirus; Potyviridae) and caused severe symptoms in co-infected sweetpotato plants. One SPCSV isolate enhanced accumulation of SPFMV, but no severe symptoms developed. A new whitefly-transmitted virus (KML33b) encoding an RNase3 homolog (<56% identity to SPCSV RNase3) able to suppresses sense-mediated RNA silencing was detected in I. sinensis. Conclusions/Significance: SPCSV isolates infecting wild species and sweetpotato in Uganda were genetically undifferentiated, suggesting inter-species transmission of SPCSV. Most isolates in Uganda contained p22, unlike SPCSV isolates characterized from other countries and continents. Enhanced accumulation of SPFMV and increased disease severity were found to be uncoupled phenotypic outcomes of RNase3-mediated viral synergism in sweetpotato. A second virus encoding an RNase3-like RNA silencing suppressor was detected. Overall, results provided many novel and important insights into evolutionary biology of SPCSV.	[Tugume, Arthur K.; Amayo, Robert; Weinheimer, Isabel; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Tugume, Arthur K.] Makerere Univ, Dept Biol Sci, Sch Biosci, Coll Nat Sci, Kampala, Uganda; [Amayo, Robert] NARO NaSARRI, Serere, Soroti, Uganda; [Amayo, Robert; Mukasa, Settumba B.; Rubaihayo, Patrick R.] Makerere Univ, Coll Agr & Environm Sci, Dept Agr, Kampala, Uganda	University of Helsinki; Makerere University; Makerere University	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	jari.valkonen@helsinki.fi	Amayo, Robert/ABE-9959-2020	Amayo, Robert/0000-0001-8343-6261; Valkonen, Jari/0000-0002-3704-9911; Tugume, Arthur/0000-0003-3689-6745	Academy of Finland [1110797, 1134335]; Viikki Graduate Programme in Molecular Biosciences	Academy of Finland(Academy of Finland); Viikki Graduate Programme in Molecular Biosciences	Financial support from the Academy of Finland (grants #1110797 and 1134335 to JPTV) and Viikki Graduate Programme in Molecular Biosciences (to IW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRANOVSKY AA, 1991, J GEN VIROL, V72, P15, DOI 10.1099/0022-1317-72-1-15; Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Alicai T, 1999, PLANT PATHOL, V48, P718, DOI 10.1046/j.1365-3059.1999.00402.x; Alzhanova DV, 2000, VIROLOGY, V268, P192, DOI 10.1006/viro.1999.0155; Aritua V, 2008, J PHYTOPATHOL, V156, P181, DOI 10.1111/j.1439-0434.2007.01338.x; BLUNDEL M, 1992, COLLINS PHOTO GUIDE; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CAREY EE, 1999, CIP PROGRAM REPORT, P1997; Chanfreau G, 2003, EUKARYOT CELL, V2, P901, DOI 10.1128/EC.2.5.901-909.2003; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; COHEN J, 1992, ANN APPL BIOL, V121, P257, DOI 10.1111/j.1744-7348.1992.tb03438.x; Conrad C, 2002, INT J BIOCHEM CELL B, V34, P116, DOI 10.1016/S1357-2725(01)00112-1; Cuellar WJ, 2008, J GEN VIROL, V89, P573, DOI 10.1099/vir.0.83471-0; Cuellar WJ, 2011, VIRUS RES, V157, P111, DOI 10.1016/j.virusres.2011.01.010; Cuellar WJ, 2009, P NATL ACAD SCI USA, V106, P10354, DOI 10.1073/pnas.0806042106; Dawson W O, 1990, Adv Virus Res, V38, P307, DOI 10.1016/S0065-3527(08)60865-9; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Dolja VV, 2006, VIRUS RES, V117, P38, DOI 10.1016/j.virusres.2006.02.002; Fenby NS, 2002, TROP AGRIC, V79, P26; Gamarra HA, 2010, PLANT DIS, V94, P510, DOI 10.1094/PDIS-94-5-0510; Gibson RW, 1998, PLANT PATHOL, V47, P95, DOI 10.1046/j.1365-3059.1998.00196.x; Gutierrez DL, 2003, PLANT DIS, V87, P297, DOI [10.1094/PDIS.2003.87.3.297, 10.1094/PDIS.2003.87.1.98C]; Hoyer U, 1996, PHYTOPATHOLOGY, V86, P744, DOI 10.1094/Phyto-86-744; IsHak JA, 2003, ARCH VIROL, V148, P2449, DOI 10.1007/s00705-003-0187-5; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Karyeija RF, 2000, VIROLOGY, V269, P26, DOI 10.1006/viro.1999.0169; Karyeija RF, 1998, ANN APPL BIOL, V133, P39, DOI 10.1111/j.1744-7348.1998.tb05800.x; Kashif M, 2012, PLANT DIS, V96, P1430, DOI 10.1094/PDIS-03-12-0268-RE; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kreuze JF, 2008, MOL PLANT PATHOL, V9, P589, DOI 10.1111/J.1364-3703.2008.00480.X; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kreuze JF, 2002, J VIROL, V76, P9260, DOI 10.1128/JVI.76.18.9260-9270.2002; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin S, 2009, J GEN VIROL, V90, P1527, DOI 10.1099/vir.0.008193-0; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; Qin YH, 2013, ARCH VIROL, V158, P491, DOI 10.1007/s00705-012-1503-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sim J., 2000, Plant Disease, V84, P1250, DOI 10.1094/PDIS.2000.84.11.1250C; Sivparsad BJ, 2012, CROP PROT, V41, P49, DOI 10.1016/j.cropro.2012.04.020; Tairo F, 2005, MOL PLANT PATHOL, V6, P199, DOI 10.1111/j.1364-3703.2005.00267.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traore O, 2005, MOL ECOL, V14, P2097, DOI 10.1111/j.1365-294X.2005.02578.x; Tugume AK, 2008, PHYTOPATHOLOGY, V98, P640, DOI 10.1094/PHYTO-98-6-0640; Tugume AK, 2010, MOL ECOL, V19, P3139, DOI 10.1111/j.1365-294X.2010.04682.x; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Valverde RA, 2004, PLANT DIS, V88, P428, DOI 10.1094/PDIS.2004.88.4.428B; Verdcourt B., 1963, FLORA TROPICAL E AFR; VETTEN HJ, 1996, PHYTOPATHOLOGY S, V100; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	59	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81479	10.1371/journal.pone.0081479	http://dx.doi.org/10.1371/journal.pone.0081479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278443	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700064
J	Kukita, Y; Uchida, J; Oba, S; Nishino, K; Kumagai, T; Taniguchi, K; Okuyama, T; Imamura, F; Kato, K				Kukita, Yoji; Uchida, Junji; Oba, Shigeyuki; Nishino, Kazumi; Kumagai, Toru; Taniguchi, Kazuya; Okuyama, Takako; Imamura, Fumio; Kato, Kikuya			Quantitative Identification of Mutant Alleles Derived from Lung Cancer in Plasma Cell-Free DNA via Anomaly Detection Using Deep Sequencing Data	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CIRCULATING TUMOR DNA; ACQUIRED-RESISTANCE; RARE MUTATIONS; EGFR MUTATIONS; QUANTIFICATION; GEFITINIB	The detection of rare mutants using next generation sequencing has considerable potential for diagnostic applications. Detecting circulating tumor DNA is the foremost application of this approach. The major obstacle to its use is the high read error rate of next-generation sequencers. Rather than increasing the accuracy of final sequences, we detected rare mutations using a semiconductor sequencer and a set of anomaly detection criteria based on a statistical model of the read error rate at each error position. Statistical models were deduced from sequence data from normal samples. We detected epidermal growth factor receptor (EGFR) mutations in the plasma DNA of lung cancer patients. Single-pass deep sequencing (>100,000 reads) was able to detect one activating mutant allele in 10,000 normal alleles. We confirmed the method using 22 prospective and 155 retrospective samples, mostly consisting of DNA purified from plasma. A temporal analysis suggested potential applications for disease management and for therapeutic decision making to select epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI).	[Kukita, Yoji; Taniguchi, Kazuya; Kato, Kikuya] Osaka Med Ctr Canc & Cardiovasc Dis, Res Inst, Osaka, Japan; [Uchida, Junji; Nishino, Kazumi; Kumagai, Toru; Okuyama, Takako; Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; [Oba, Shigeyuki] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Oba, Shigeyuki] JST, PRESTO, Uji, Kyoto, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kyoto University; Japan Science & Technology Agency (JST)	Kato, K (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Res Inst, Osaka, Japan.	katou-ki@mc.pref.osaka.jp		Kukita, Yoji/0000-0003-3523-2816	Osaka Medical Center for Cancer and Cardiovascular Diseases	Osaka Medical Center for Cancer and Cardiovascular Diseases	This work was supported by grants from Osaka Medical Center for Cancer and Cardiovascular Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Giaccone G, 2011, CANCER TREAT REV, V37, P456, DOI 10.1016/j.ctrv.2011.01.003; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lynch TJ, 2006, CLIN CANCER RES, V12, p4365S, DOI 10.1158/1078-0432.CCR-06-1005; Marchetti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042164; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712	28	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81468	10.1371/journal.pone.0081468	http://dx.doi.org/10.1371/journal.pone.0081468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278442	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800133
J	Martins, C; Azevedo, LF; Ribeiro, O; Sa, L; Santos, P; Couto, L; Costa-Pereira, A; Hespanhol, AP				Martins, Carlos; Azevedo, Luis F.; Ribeiro, Orquidea; Sa, Luisa; Santos, Paulo; Couto, Luciana; Costa-Pereira, Altamiro; Hespanhol, Alberto P.			A Population-Based Nationwide Cross-Sectional Study on Preventive Health Services Utilization in Portugal-What Services (and Frequencies) Are Deemed Necessary by Patients?	PLOS ONE			English	Article							BENEFITS; VIEWS	Background: Most of the strategies to induce a more rational use of preventive health services are oriented to the medical side of the doctor-patient relationship. However, the consultation model has changed, and patients now have a more important role in medical consultation. The aim of this study was to assess which healthcare services are deemed necessary, and with what frequency, by adults from the general Portuguese population. Methods: Design: Population-based nationwide cross-sectional study Setting: Portuguese population Participants: One thousand Portuguese adults, surveyed by computer-assisted telephone interviewing and selected by a stratified cluster sampling design. Measurements: Proportions and population prevalence estimates were determined for each healthcare service, taking into account whether respondents considered them necessary, and with what frequency. Results: Respondent ages ranged between 18 and 97 years, and 520 of 1000 (52%) respondents were women. Among Portuguese adults, 99.2% (95% confidence interval (CI): 98.5 to 99.6) believe that they should undergo general routine blood and urine tests, to be repeated every 12.0 months on average (95% CI: 11.4 to 12.6); 87.4% (95% CI: 85.3 to 89.3) of the respondents reported having actually performed these tests. Of the 15 services surveyed, 14 were considered periodically necessary by more than 60% of respondents. Among the respondents, 37.7% (95% CI: 34.5 to 41.1) reported using healthcare services by their own initiative. Conclusions: The majority of Portuguese adults believe that they should utilize a great number of healthcare services, on a nearly annual basis; most actually follow this schedule. Our findings indicate a tendency towards the overuse of resources. Adequate patient-oriented strategies regarding the use of medical tests and preventive interventions-with appropriate information and discussion of risks and harms-are urgently needed, and crucial for achieving a more rational use of healthcare services and for preventing the consequences of over-testing.	[Martins, Carlos; Sa, Luisa; Santos, Paulo; Couto, Luciana; Hespanhol, Alberto P.] Fac Med Porto, Social Sci & Hlth Dept, Family Med Unit, Oporto, Portugal; [Azevedo, Luis F.; Ribeiro, Orquidea; Costa-Pereira, Altamiro] Univ Porto, Fac Med, Informat Sci & Decis Hlth Dept CIDES, Ctr Res Hlth Technol & Informat Syst CINTESIS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Martins, C (corresponding author), Fac Med Porto, Social Sci & Hlth Dept, Family Med Unit, Oporto, Portugal.	carlosmartins20@gmail.com	Santos, Paulo/C-5923-2013; Martins, Carlos/C-3924-2013; Azevedo, Luís/J-7819-2012; Costa-Pereira, Altamiro/I-5987-2012	Santos, Paulo/0000-0002-2362-5527; Martins, Carlos/0000-0001-8561-5167; Azevedo, Luís/0000-0002-8421-2937; Costa-Pereira, Altamiro/0000-0001-8467-6398				Brotons C, 2005, PREV MED, V40, P595, DOI 10.1016/j.ypmed.2004.07.020; Brotons C, 2012, FAM PRACT, V29, pi168, DOI 10.1093/fampra/cmr102; da Saude Ministerio, 2007, NAT PLAN PREV CONTR; Domenighetti G, 2003, INT J EPIDEMIOL, V32, P816, DOI 10.1093/ije/dyg257; Elwyn Glyn, 2004, Eur J Gen Pract, V10, P93; Fialho AS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-274; Gervas J, 2008, LANCET, V372, P1997, DOI 10.1016/S0140-6736(08)61843-7; Getz L, 2003, BMJ-BRIT MED J, V327, P498, DOI 10.1136/bmj.327.7413.498; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; GROVES R, 1988, TELEPHONE SURVEY MET; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hudson B, 2012, ANN FAM MED, V10, P495, DOI 10.1370/afm.1407; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; O'Toole J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-71; Pisco L, 2008, REFORM PRIMARY HLTH; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Statistics Portugal Instituto Nacional de Estatistica (INE), 2001, PORT CENS	20	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81256	10.1371/journal.pone.0081256	http://dx.doi.org/10.1371/journal.pone.0081256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278405	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800113
J	Pinho, AJ; Garcia, SP; Pratas, D; Ferreira, PJSG				Pinho, Armando J.; Garcia, Sara P.; Pratas, Diogo; Ferreira, Paulo J. S. G.			DNA Sequences at a Glance	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; DIPLOID GENOME SEQUENCE; COMPLEXITY-MEASURES; FORMAL THEORY; COMPRESSION; ALGORITHM; PROFILES; PATTERNS; MODEL	Data summarization and triage is one of the current top challenges in visual analytics. The goal is to let users visually inspect large data sets and examine or request data with particular characteristics. The need for summarization and visual analytics is also felt when dealing with digital representations of DNA sequences. Genomic data sets are growing rapidly, making their analysis increasingly more difficult, and raising the need for new, scalable tools. For example, being able to look at very large DNA sequences while immediately identifying potentially interesting regions would provide the biologist with a flexible exploratory and analytical tool. In this paper we present a new concept, the "information profile", which provides a quantitative measure of the local complexity of a DNA sequence, independently of the direction of processing. The computation of the information profiles is computationally tractable: we show that it can be done in time proportional to the length of the sequence. We also describe a tool to compute the information profiles of a given DNA sequence, and use the genome of the fission yeast Schizosaccharomyces pombe strain 972 h 2 and five human chromosomes 22 for illustration. We show that information profiles are useful for detecting large-scale genomic regularities by visual inspection. Several discovery strategies are possible, including the standalone analysis of single sequences, the comparative analysis of sequences from individuals from the same species, and the comparative analysis of sequences from different organisms. The comparison scale can be varied, allowing the users to zoom-in on specific details, or obtain a broad overview of a long segment. Software applications have been made available for non-commercial use at http://bioinformatics.ua.pt/software/dna-at-glance.	[Pinho, Armando J.; Garcia, Sara P.; Pratas, Diogo; Ferreira, Paulo J. S. G.] Univ Aveiro, IEETA DETI, Signal Proc Lab, P-3800 Aveiro, Portugal	Universidade de Aveiro	Pinho, AJ (corresponding author), Univ Aveiro, IEETA DETI, Signal Proc Lab, P-3800 Aveiro, Portugal.	ap@ua.pt	Pratas, Diogo/AAG-8710-2020; Pinho, Armando J/A-2309-2012	Pratas, Diogo/0000-0003-1176-552X; Ferreira, Paulo/0000-0002-5147-0948; Pinho, Armando/0000-0002-9164-0016; Garcia, Sara/0000-0003-3312-6454	European Fund for Regional Development (FEDER) through the Operational Program Competitiveness Factors (COMPETE); Portuguese Foundation for Science and Technology (FCT) [FCOMP-01-0124-FEDER-010099, PTDC/EIA-EIA/103099/2008, FCOMP-01-0124-FEDER-022682, PEst-C/EEI/UI0127/2011]; European Social Fund; Portuguese Ministry of Education and Science	European Fund for Regional Development (FEDER) through the Operational Program Competitiveness Factors (COMPETE); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Portuguese Ministry of Education and Science(Portuguese Foundation for Science and Technology)	Supported by the European Fund for Regional Development (FEDER) through the Operational Program Competitiveness Factors (COMPETE) and by the Portuguese Foundation for Science and Technology (FCT) in the context of projects FCOMP-01-0124-FEDER-010099 (FCT reference PTDC/EIA-EIA/103099/2008) and FCOMP-01-0124-FEDER-022682 (FCT reference PEst-C/EEI/UI0127/2011). SPG acknowledges funding from the European Social Fund and the Portuguese Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Allison L, 2000, COMPUT CHEM, V24, P43, DOI 10.1016/S0097-8485(99)00046-7; Behzadi B, 2005, LECT NOTES COMPUT SC, V3537, P190; Cao MD, 2007, IEEE DATA COMPR CONF, P43; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Chen, 1999, Genome Inform Ser Workshop Genome Inform, V10, P51; Chen X, 2001, IEEE ENG MED BIOL, V20, P61, DOI 10.1109/51.940049; CLIFT B, 1986, NUCLEIC ACIDS RES, V14, P141, DOI 10.1093/nar/14.1.141; Crochemore M, 1999, COMPUT CHEM, V23, P275, DOI 10.1016/S0097-8485(99)00009-1; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Dix TI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S10; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Fertil B, 2005, NUCLEIC ACIDS RES, V33, pW512, DOI 10.1093/nar/gki489; GOLDMAN N, 1993, NUCLEIC ACIDS RES, V21, P2487, DOI 10.1093/nar/21.10.2487; Gordon G, 2003, J BIOMOL STRUCT DYN, V20, P747, DOI 10.1080/07391102.2003.10506891; Grumbach S., 1993, DCC '93. Data Compression Conference (Cat. No.93TH0536-3), P340, DOI 10.1109/DCC.1993.253115; Gusev VD, 1999, BIOINFORMATICS, V15, P994; Hiraoka Y, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P191; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Korodi G, 2005, ACM T INFORM SYST, V23, P3, DOI 10.1145/1055709.1055711; Korodi G, 2007, IEEE DATA COMPR CONF, P33; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; LEVIN HL, 1990, MOL CELL BIOL, V10, P6791, DOI 10.1128/MCB.10.12.6791; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Manzini G, 2004, SOFTWARE PRACT EXPER, V34, P1397, DOI 10.1002/spe.619; Matsumoto T, 2000, Genome Inform Ser Workshop Genome Inform, V11, P43; Nan F, 2004, P IEEE COMP SYST BIO; OLIVER JL, 1993, J THEOR BIOL, V160, P457, DOI 10.1006/jtbi.1993.1030; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Pinho A. J., 2008, P 16 EUR SIGN PROC C; Pinho AJ, 2011, P IEEE WORKSH STAT S; Pinho AJ, 2006, IEEE T BIO-MED ENG, V53, P2148, DOI 10.1109/TBME.2006.879477; Pinho AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021588; Pinho AJ, 2009, INT CONF ACOUST SPEE, P1693, DOI 10.1109/ICASSP.2009.4959928; Pirhaji L, 2008, J THEOR BIOL, V251, P380, DOI 10.1016/j.jtbi.2007.11.021; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Rivals E, 1997, COMPUT APPL BIOSCI, V13, P131; Rivals E, 1996, DCC '96 - DATA COMPRESSION CONFERENCE, PROCEEDINGS, P453, DOI 10.1109/DCC.1996.488385; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SOLOMONOFF RJ, 1964, INFORM CONTROL, V7, P224, DOI 10.1016/S0019-9958(64)90131-7; SOLOMONOFF RJ, 1964, INFORM CONTROL, V7, P1, DOI 10.1016/S0019-9958(64)90223-2; Stern L, 2001, MOL BIOCHEM PARASIT, V118, P175, DOI 10.1016/S0166-6851(01)00388-7; Sugawara N, 1989, THESIS HARVARD U CAM; Troyanskaya OG, 2002, BIOINFORMATICS, V18, P679, DOI 10.1093/bioinformatics/18.5.679; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinga S, 2007, BMC BIOINFORMATICS, V8; WALLACE CS, 1968, COMPUT J, V11, P185, DOI 10.1093/comjnl/11.2.185; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wong PC, 2012, IEEE COMPUT GRAPH, V32, P63, DOI 10.1109/MCG.2012.87; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2006, TOP CURR GENET, V15, P233, DOI 10.1007/4735_97	55	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79922	10.1371/journal.pone.0079922	http://dx.doi.org/10.1371/journal.pone.0079922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278218	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800035
J	Wilhelmsson, P; Lindblom, P; Fryland, L; Ernerudh, J; Forsberg, P; Lindgren, PE				Wilhelmsson, Peter; Lindblom, Pontus; Fryland, Linda; Ernerudh, Jan; Forsberg, Pia; Lindgren, Per-Eric			Prevalence, Diversity, and Load of Borrelia species in Ticks That Have Fed on Humans in Regions of Sweden and angstrom land Islands, Finland with Different Lyme Borreliosis Incidences	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; SOUTH-CENTRAL SWEDEN; TRANSMISSION; ASSOCIATION; INFECTION; MIYAMOTOI; IXODIDAE; EUROPE; ACARI	The incidence of Lyme borreliosis (LB) in a region may reflect the prevalence of Borrelia in the tick population. Our aim was to investigate if regions with different LB incidences can be distinguished by studying the prevalence and diversity of Borrelia species in their respective tick populations. The Borrelia load in a feeding tick increases with the duration of feeding, which may facilitate a transmission of Borrelia Spirochetes from tick to host. Therefore, we also wanted to investigate how the Borrelia load in ticks that have fed on humans varies with the duration of tick feeding. During 2008 and 2009, ticks that had bitten humans were collected from four regions of Sweden and Finland, regions with expected differences in LB incidence. The duration of tick feeding was estimated and Borrelia were detected and quantified by a quantitative PCR assay followed by species determination. Out of the 2,154 Ixodes ricinus ticks analyzed, 26% were infected with Borrelia and seven species were identified. B. spielmanii was detected for the first time in the regions. The tick populations collected from the four regions exhibited only minor differences in both prevalence and diversity of Borrelia species, indicating that these variables alone cannot explain the regions' different LB incidences. The number of Borrelia cells in the infected ticks ranged from fewer than ten to more than a million. We also found a lower number of Borrelia cells in adult female ticks that had fed for more than 36 hours, compared to the number of Borrelia cells found in adult female ticks that had fed for less than 36 hours.	[Wilhelmsson, Peter; Lindblom, Pontus; Lindgren, Per-Eric] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden; [Fryland, Linda; Ernerudh, Jan] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Clin Immunol, Linkoping, Sweden; [Forsberg, Pia] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Infect Dis, Linkoping, Sweden; [Forsberg, Pia] Cty Council Ostergotland, Clin Infect Dis, Linkoping, Sweden; [Lindgren, Per-Eric] Ryhov Cty Hosp, Dept Microbiol, Med Serv, Jonkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland	Wilhelmsson, P (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Med Microbiol, Linkoping, Sweden.	peter.wilhelmsson@liu.se		Wilhelmsson, Peter/0000-0002-9200-2964	Medical Research Council of South-East Sweden [FORSS-8967, FORSS-12573, FORSS-29021, FORSS-86911]; Swedish Research Council (Medicine) [2011-345]; County Council of Ostergotland; Wilhelm and Else Stockmanns Foundation; Angstromlands Kuturstiftelse; EU Interreg IV A [167226]	Medical Research Council of South-East Sweden; Swedish Research Council (Medicine)(Swedish Research Council); County Council of Ostergotland; Wilhelm and Else Stockmanns Foundation; Angstromlands Kuturstiftelse; EU Interreg IV A	The Medical Research Council of South-East Sweden (grant no. FORSS-8967, FORSS-12573, FORSS-29021, FORSS-86911) The Swedish Research Council (Medicine) (grant no. 2011-345) ALF Grants from the County Council of Ostergotland (www.lio.se) Wilhelm and Else Stockmanns Foundation (www.stockmanngroup.fi) angstrom lands Kuturstiftelse (www.kulturstiftelsen.ax) angstrom lands Sjalvstyrelses 75-ars Jubileumsfond (www.lagtinget.ax) An EU Interreg IV A supported ScandTick (grant no. 167226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Bennet L, 2006, EUR J CLIN MICROBIOL, V25, P426, DOI 10.1007/s10096-006-0167-2; BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Cadenas FM, 2007, J MED ENTOMOL, V44, P1109, DOI 10.1603/0022-2585(2007)44[1109:IOHBSA]2.0.CO;2; Carlsson SA, 1998, SCAND J INFECT DIS, V30, P501, DOI 10.1080/00365549850161520; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Estrada-Pena A, 2011, APPL ENVIRON MICROB, V77, P3838, DOI 10.1128/AEM.00067-11; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gern L, 2008, PARASITE, V15, P244, DOI 10.1051/parasite/2008153244; Gray J, 2005, INT J MED MICROBIOL, V295, P567, DOI 10.1016/j.ijmm.2005.05.008; GRAY JS, 1991, REV MED VET ENTOMOL, V79, P232; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; Huegli D, 2011, TICKS TICK-BORNE DIS, V2, P129, DOI 10.1016/j.ttbdis.2011.05.002; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Kjelland V, 2010, SCAND J INFECT DIS, V42, P579, DOI 10.3109/00365541003716526; KURTENBACH K, 1995, J MED ENTOMOL, V32, P807, DOI 10.1093/jmedent/32.6.807; Kurtenbach K, 2002, INT J MED MICROBIOL, V291, P152, DOI 10.1016/S1438-4221(02)80029-7; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; Maiwald M, 1998, EPIDEMIOL INFECT, V121, P103, DOI 10.1017/S0950268898008929; MEJLON HA, 1993, SCAND J INFECT DIS, V25, P449, DOI 10.3109/00365549309008526; NYMAN D, 2002, FINSKA LAKARESALLSKA, V162, P26; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Ornstein K, 2006, VECTOR-BORNE ZOONOT, V6, P103, DOI 10.1089/vbz.2006.6.103; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Talleklint L, 1996, J MED ENTOMOL, V33, P592, DOI 10.1093/jmedent/33.4.592; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tijsse-Klasen E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-17; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	39	52	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81433	10.1371/journal.pone.0081433	http://dx.doi.org/10.1371/journal.pone.0081433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278437	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800130
J	Einhorn, J; Li, A; Hazan, R; Knikou, M				Einhorn, Jonathan; Li, Alan; Hazan, Royi; Knikou, Maria			Cervicothoracic Multisegmental Transpinal Evoked Potentials in Humans	PLOS ONE			English	Article							SPINAL-CORD STIMULATION; ELECTRICAL-STIMULATION; MAGNETIC STIMULATION; H-REFLEX; HOMOSYNAPTIC DEPRESSION; PRESYNAPTIC INHIBITION; EPIDURAL STIMULATION; ROOT STIMULATION; VERTEBRAL COLUMN; HEALTHY-SUBJECTS	The objectives of this study were to establish the neurophysiological properties of the transpinal evoked potentials (TEPs) following transcutaneous electric stimulation of the spine (tsESS) over the cervicothoracic region, changes in the amplitude of the TEPs preceded by median nerve stimulation at group I threshold, and the effects of tsESS on the flexor carpi radialis (FCR) H-reflex in thirteen healthy human subjects while seated. Two re-usable self-adhering electrodes, connected to function as one electrode (cathode), were placed bilaterally on the clavicles. A re-usable electrode (anode) was placed on the cervicothoracic region covering from Cervical 4 - Thoracic 2 and held under constant pressure throughout the experiment. TEPs were recorded bilaterally from major arm muscles with subjects seated at stimulation frequencies of 1.0, 0.5, 0.33, 0.2, 0.125, and 0.1 Hz, and upon double tsESS pulses delivered at an inter-stimulus interval of 40 ms. TEPs from the arm muscles were also recorded following median nerve stimulation at the conditioning-test (C-T) intervals of 2, 3, 5, 8, and 10 ms. The FCR H-reflex was evoked and recorded according to conventional methods following double median nerve pulses at 40 ms, and was also conditioned by tsESS at C-T intervals that ranged from -10 to +50 ms. The arm TEPs amplitude was not decreased at low-stimulation frequencies and upon double tsESS pulses in all but one subject. Ipsilateral and contralateral arm TEPs were facilitated following ipsilateral median nerve stimulation, while the FCR H-reflex was depressed by double pulses and following tsESS at short and long C-T intervals. Non-invasive transpinal stimulation can be used as a therapeutic modality to decrease spinal reflex hyper-excitability in neurological disorders and when combined with peripheral nerve stimulation to potentiate spinal output.	[Einhorn, Jonathan; Li, Alan; Hazan, Royi; Knikou, Maria] CUNY, Grad Ctr, New York, NY 10021 USA; [Knikou, Maria] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Knikou, Maria] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA	City University of New York (CUNY) System; Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Knikou, M (corresponding author), CUNY, Grad Ctr, New York, NY 10021 USA.	Maria.Knikou@csi.cuny.edu	Knikou, Maria/E-5568-2015	Knikou, Maria/0000-0002-6277-236X	Graduate Center of the City University of New York	Graduate Center of the City University of New York	This work was supported by the Graduate Center of the City University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2011, J PHYSIOL-LONDON, V589, P4981, DOI 10.1113/jphysiol.2011.214189; Ahmed Z, 2012, J APPL PHYSIOL, V112, P1576, DOI 10.1152/japplphysiol.00967.2011; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Brinkworth RSA, 2003, J NEUROSCI METH, V122, P179, DOI 10.1016/S0165-0270(02)00321-7; Butson CR, 2005, CLIN NEUROPHYSIOL, V116, P2490, DOI 10.1016/j.clinph.2005.06.023; CHOKROVERTY S, 1991, ELECTROEN CLIN NEURO, V81, P359, DOI 10.1016/0168-5597(91)90025-S; Courtine GG, 2007, J PHYSIOL-LONDON, V582, P1125, DOI 10.1113/jphysiol.2007.128447; CROS D, 1990, NEUROLOGY, V40, P1751, DOI 10.1212/WNL.40.11.1751; DENOORDHOUT AM, 1988, J NEUROL NEUROSUR PS, V51, P174, DOI 10.1136/jnnp.51.2.174; ERTEKIN C, 1976, ACTA NEUROL SCAND, V53, P3, DOI 10.1111/j.1600-0404.1976.tb04321.x; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; HALONEN JP, 1989, ELECTROEN CLIN NEURO, V74, P161, DOI 10.1016/0013-4694(89)90002-3; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Hofstoetter US, 2008, ARTIF ORGANS, V32, P644, DOI 10.1111/j.1525-1594.2008.00616.x; Hultborn H, 1996, EXP BRAIN RES, V108, P450; HUNTER JP, 1994, J PHYSIOL-LONDON, V474, P407, DOI 10.1113/jphysiol.1994.sp020032; ILLIS LS, 1976, LANCET, V1, P1383; Jessop T, 2013, EUR J APPL PHYSIOL, V113, P273, DOI 10.1007/s00421-012-2438-1; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P630, DOI 10.1002/bem.21808; Knikou M, 2013, BIOELECTROMAGNETICS, V34, P200, DOI 10.1002/bem.21768; Kohn AF, 1997, EXP BRAIN RES, V116, P375, DOI 10.1007/PL00005765; Kuhn A, 2009, MED BIOL ENG COMPUT, V47, P279, DOI 10.1007/s11517-008-0422-z; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; LLOYD DPC, 1957, J GEN PHYSIOL, V40, P409, DOI 10.1085/jgp.40.3.409; MAGLADERY JW, 1952, B JOHNS HOPKINS HOSP, V91, P219; MAGLADERY JW, 1950, B JOHNS HOPKINS HOSP, V86, P265; MASTAGLIA FL, 1985, J NEUROL NEUROSUR PS, V48, P182, DOI 10.1136/jnnp.48.2.182; MILLS KR, 1986, ELECTROEN CLIN NEURO, V63, P582, DOI 10.1016/0013-4694(86)90145-8; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; PAILLARD J, 1955, Pflugers Arch Gesamte Physiol Menschen Tiere, V260, P448, DOI 10.1007/BF00363666; Sabbahi MA, 2012, SPINAL CORD, V50, P432, DOI 10.1038/sc.2011.166; Sabbahi MA, 2011, SPINAL CORD, V49, P741, DOI 10.1038/sc.2010.165; Turker KS, 2005, TRENDS NEUROSCI, V28, P379, DOI 10.1016/j.tins.2005.05.007; UGAWA Y, 1989, J NEUROL NEUROSUR PS, V52, P1025, DOI 10.1136/jnnp.52.9.1025; UGAWA Y, 1995, CAN J NEUROL SCI, V22, P36, DOI 10.1017/S0317167100040476; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P392, DOI 10.1016/j.clinph.2005.10.011; YIANNIKAS C, 1988, J NEUROL NEUROSUR PS, V51, P499, DOI 10.1136/jnnp.51.4.499	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76940	10.1371/journal.pone.0076940	http://dx.doi.org/10.1371/journal.pone.0076940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24282479	Green Published, gold			2022-12-27	WOS:000325501300108
J	Ma, P; Varela, F; Magoch, M; Silva, AR; Rosario, AL; Brito, J; Oliveira, TF; Nogly, P; Pessanha, M; Stelter, M; Kletzin, A; Henderson, PJF; Archer, M				Ma, Pikyee; Varela, Filipa; Magoch, Malgorzata; Silva, Ana Rita; Rosario, Ana Lucia; Brito, Jose; Oliveira, Tania Filipa; Nogly, Przemyslaw; Pessanha, Miguel; Stelter, Meike; Kletzin, Arnulf; Henderson, Peter J. F.; Archer, Margarida			An Efficient Strategy for Small-Scale Screening and Production of Archaeal Membrane Transport Proteins in Escherichia coli	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; STRUCTURAL GENOMICS; SACCHAROMYCES-CEREVISIAE; EXPRESSION SYSTEMS; EFFLUX PROTEINS; OVEREXPRESSION; PURIFICATION; TOPOLOGY; THROUGHPUT; ORGANISMS	Background: Membrane proteins play a key role in many fundamental cellular processes such as transport of nutrients, sensing of environmental signals and energy transduction, and account for over 50% of all known drug targets. Despite their importance, structural and functional characterisation of membrane proteins still remains a challenge, partially due to the difficulties in recombinant expression and purification. Therefore the need for development of efficient methods for heterologous production is essential. Methodology/Principal Findings: Fifteen integral membrane transport proteins from Archaea were selected as test targets, chosen to represent two superfamilies widespread in all organisms known as the Major Facilitator Superfamily (MFS) and the 5-Helix Inverted Repeat Transporter superfamily (5HIRT). These proteins typically have eleven to twelve predicted transmembrane helices and are putative transporters for sugar, metabolite, nucleobase, vitamin or neurotransmitter. They include a wide range of examples from the following families: Metabolite-H+-symporter; Sugar Porter; Nucleobase-Cation-Symporter-1; Nucleobase-Cation-Symporter-2; and neurotransmitter-sodium-symporter. Overproduction of transporters was evaluated with three vectors (pTTQ18, pET52b, pWarf) and two Escherichia coli strains (BL21 Star and C43 (DE3)). Thirteen transporter genes were successfully expressed; only two did not express in any of the tested vector-strain combinations. Initial trials showed that seven transporters could be purified and six of these yielded quantities of >= 0.4 mg per litre suitable for functional and structural studies. Size-exclusion chromatography confirmed that two purified transporters were almost homogeneous while four others were shown to be non-aggregating, indicating that they are ready for up-scale production and crystallisation trials. Conclusions/Significance: Here, we describe an efficient strategy for heterologous production of membrane transport proteins in E. coli. Small-volume cultures (10 mL) produced sufficient amount of proteins to assess their purity and aggregation state. The methods described in this work are simple to implement and can be easily applied to many more membrane proteins.	[Ma, Pikyee; Varela, Filipa; Magoch, Malgorzata; Silva, Ana Rita; Rosario, Ana Lucia; Brito, Jose; Oliveira, Tania Filipa; Nogly, Przemyslaw; Pessanha, Miguel; Stelter, Meike; Archer, Margarida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kletzin, Arnulf] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany; [Henderson, Peter J. F.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Biomed Sci, Leeds, W Yorkshire, England	Universidade Nova de Lisboa; Technical University of Darmstadt; University of Leeds	Archer, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	archer@itqb.unl.pt	Varela, Filipa Alexandra Pereira Rosa/V-8718-2019; Pessanha, Miguel/HGD-8721-2022; Kletzin, Arnulf/AAO-7366-2020; Nogly, Przemyslaw M/B-8278-2012; Henderson, Peter JF/Q-1907-2018; Santos Silva, Ana Rita/ABD-5857-2020; Nogly, Przemyslaw/GQZ-7032-2022; Brito, Jose A./A-5605-2011; Nogly, Przemyslaw/N-3590-2019	Nogly, Przemyslaw M/0000-0002-8040-7753; Santos Silva, Ana Rita/0000-0001-5819-9065; Nogly, Przemyslaw/0000-0002-8040-7753; Brito, Jose A./0000-0002-8307-2282; Nogly, Przemyslaw/0000-0002-8040-7753; Rebelo do Rosario, Ana Lucia/0000-0003-2342-1978; Henderson, Peter/0000-0002-9187-0938; Kletzin, Arnulf/0000-0002-4500-2232; Archer, Margarida/0000-0001-8419-5420; Ma, Pikyee/0000-0003-4080-2908; Oliveira, Tania/0000-0003-0843-7541	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-PRO/103718/2008, PTDC/SAU-NEU/103720/2008, PTDC/BIA-PRO/118535/2010, SFRH/BDP/79243/2011, SFRH/BPD/72179/2010, SFRH/BPD/79224/2011, PEst-OE/EQB/LA0004/2011]; European community [211800]; European Membrane Protein consortium [E-MeP LSGH-CT-2004-504601]; European Drug Initiative for Channels and Transporters (EDICT grant) [201924]; Biotechnology and Biological Sciences Research Council [BB/D524832/1] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European community(European Commission); European Membrane Protein consortium; European Drug Initiative for Channels and Transporters (EDICT grant); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by Fundacao para a Ciencia e a Tecnologia (FCT) through grants PTDC/BIA-PRO/103718/2008, PTDC/SAU-NEU/103720/2008 and PTDC/BIA-PRO/118535/2010, and fellowships SFRH/BDP/79243/2011 (PM), SFRH/BPD/72179/2010 (TO) and SFRH/BPD/79224/2011 (JB); PEst-OE/EQB/LA0004/2011; European community's Seven Framework Programme (Marie Curie) FP7/2007-2013 under grant agreement 211800 to PM, PN and MA. Work done in the PJFH laboratory by PM, JB, MP and MS was supported by the European Membrane Protein consortium (E-MeP LSGH-CT-2004-504601) and European Drug Initiative for Channels and Transporters (EDICT grant number 201924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boer HA, 1983, P NATL ACAD SCI USA, V80, P21, DOI [10.1073/pnas.80.1.21, DOI 10.1073/PNAS.80.1.21.PUBMED:6337371]; Chakravarty S, 2002, BIOCHEMISTRY-US, V41, P8152, DOI 10.1021/bi025523t; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Fan JP, 2011, PROTEIN EXPRES PURIF, V78, P6, DOI 10.1016/j.pep.2011.02.010; Hammon J, 2009, PROTEIN SCI, V18, P121, DOI 10.1002/pro.18; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; Jenney FE, 2008, EXTREMOPHILES, V12, P39, DOI 10.1007/s00792-007-0087-9; Kang HJ, 2013, INT J BIOCHEM CELL B, V45, P636, DOI 10.1016/j.biocel.2012.12.018; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Ma PK, 2008, MOL MEMBR BIOL, V25, P449, DOI 10.1080/09687680802359885; Mancia F, 2011, CURR OPIN STRUC BIOL, V21, P517, DOI 10.1016/j.sbi.2011.07.001; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Ravna AW, 2009, TOP MED CHEM SER, V4, P15, DOI 10.1007/7355_2008_023; Saidijam M, 2003, FEBS LETT, V555, P170, DOI 10.1016/S0014-5793(03)01148-7; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schlegel S, 2010, MICROB BIOTECHNOL, V3, P403, DOI 10.1111/j.1751-7915.2009.00148.x; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suzuki S, 2006, J BACTERIOL, V188, P3329, DOI 10.1128/JB.188.9.3329-3336.2006; Szakonyi G, 2007, J ANTIMICROB CHEMOTH, V59, P1265, DOI 10.1093/jac/dkm036; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; WARD A, 2000, MEMBRANE TRANSPORT P; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weyand S, 2010, HDB METALLOPROTEINS, DOI DOI 10.1002/0470028637.MET268/ABSTRACT.[; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]	47	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76913	10.1371/journal.pone.0076913	http://dx.doi.org/10.1371/journal.pone.0076913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232NS	24282478	Green Published, gold, Green Submitted			2022-12-27	WOS:000325501300105
J	Cohen, M; Ribaux, P; Epiney, M; Irion, O				Cohen, Marie; Ribaux, Pascale; Epiney, Manuella; Irion, Olivier			Role of Prostate Apoptosis Response 4 in Translocation of GRP78 from the Endoplasmic Reticulum to the Cell Surface of Trophoblastic Cells	PLOS ONE			English	Article							GLUCOSE-REGULATED PROTEIN; CANCER-CELLS; STRESS-PROTEIN; EXPRESSION; RESISTANCE; OVEREXPRESSION; INDUCTION; RECEPTOR; PAR-4	Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum (ER) molecular chaperone that belongs to the heat shock protein 70 family. GRP78 is also present on the cell surface membrane of trophoblastic cells, where it is associated with invasive or fusion properties of these cells. Impaired mechanism of GRP78 relocation from ER to the cell surface was observed in preeclamptic cytotrophoblastic cells (CTB) and could take part in the pathogenesis of preeclampsia. In this study, we have investigated whether prostate apoptosis response 4 (Par-4), a protein identified as a partner of GRP78 relocation to the cell surface in prostate cancer cells, is present in trophoblastic cells and is involved in the translocation of GRP78 to the cell surface of CTB. Par-4 is indeed present in trophoblastic cells and its expression correlates with expression of membrane GRP78. Moreover, overexpression of Par-4 led to an increase of cell surface expression of GRP78 and decreased Par-4 gene expression reduced cell surface localization of GRP78 confirming a role of Par-4 in relocation of GRP78 from ER to the cell surface. Accordingly, invasive property was modified in these cells. In conclusion, we show that Par-4 is expressed in trophoblastic cells and is involved in transport of GRP78 to the cell surface and thus regulates invasive property of extravillous CTB.				marie.cohen@hcuge.ch		cohen, marie/0000-0003-4621-5464	Swiss National Foundation [31003_127392]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was funded by Swiss National Foundation (31003_127392). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Arnaudeau S, 2009, PROTEOMICS, V9, P5316, DOI 10.1002/pmic.200800865; Bischof P, 1995, Early Pregnancy, V1, P263; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; CHATTERJEE S, 1994, CANCER RES, V54, P4405; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fradet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040596; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Hebbar N, 2012, J CELL PHYSIOL, V227, P3715, DOI 10.1002/jcp.24098; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Laverriere A, 2009, MOL HUM REPROD, V15, P569, DOI 10.1093/molehr/gap037; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; PATIERNO SR, 1987, CANCER RES, V47, P6220; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Potgens AJG, 2004, HUM REPROD UPDATE, V10, P487, DOI 10.1093/humupd/dmh039; Shrestha-Bhattarai T, 2010, ONCOGENE, V29, P3873, DOI 10.1038/onc.2010.141; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yun J, 1995, ONCOL RES, V7, P583; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80231	10.1371/journal.pone.0080231	http://dx.doi.org/10.1371/journal.pone.0080231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282526	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500027
J	de Araujo, FT; Bolanos-Garcia, VM; Pereira, CT; Sanches, M; Oshiro, EE; Ferreira, RCC; Chigardze, DY; Barbosa, JAG; Ferreira, LCD; Benedetti, CE; Blundell, TL; Balan, A				de Araujo, Fabiano Tofoli; Bolanos-Garcia, Victor M.; Pereira, Cristiane T.; Sanches, Mario; Oshiro, Elisa E.; Ferreira, Rita C. C.; Chigardze, Dimitri Y.; Goncalves Barbosa, Joao Alexandre; de Souza Ferreira, Luis Carlos; Benedetti, Celso E.; Blundell, Tom L.; Balan, Andrea			Structural and Physiological Analyses of the Alkanesulphonate-Binding Protein (SsuA) of the Citrus Pathogen Xanthomonas citri	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; GENE-CLUSTER; SULFUR; SULFATE; CANKER; METABOLISM; TAURINE	Background: The uptake of sulphur-containing compounds plays a pivotal role in the physiology of bacteria that live in aerobic soils where organosulfur compounds such as sulphonates and sulphate esters represent more than 95% of the available sulphur. Until now, no information has been available on the uptake of sulphonates by bacterial plant pathogens, particularly those of the Xanthomonas genus, which encompasses several pathogenic species. In the present study, we characterised the alkanesulphonate uptake system (Ssu) of Xanthomonas axonopodis pv. citri 306 strain (X. citri), the etiological agent of citrus canker. Methodology/Principal Findings: A single operon-like gene cluster (ssuEDACB) that encodes both the sulphur uptake system and enzymes involved in desulphurisation was detected in the genomes of X. citri and of the closely related species. We characterised X. citri SsuA protein, a periplasmic alkanesulphonate-binding protein that, together with SsuC and SsuB, defines the alkanesulphonate uptake system. The crystal structure of SsuA bound to MOPS, MES and HEPES, which is herein described for the first time, provides evidence for the importance of a conserved dipole in sulphate group coordination, identifies specific amino acids interacting with the sulphate group and shows the presence of a rather large binding pocket that explains the rather wide range of molecules recognised by the protein. Isolation of an isogenic ssuA-knockout derivative of the X. citri 306 strain showed that disruption of alkanesulphonate uptake affects both xanthan gum production and generation of canker lesions in sweet orange leaves. Conclusions/Significance: The present study unravels unique structural and functional features of the X. citri SsuA protein and provides the first experimental evidence that an ABC uptake system affects the virulence of this phytopathogen.	[de Araujo, Fabiano Tofoli; Oshiro, Elisa E.; Ferreira, Rita C. C.; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Dept Microbiol, Sao Paulo, Brazil; [Bolanos-Garcia, Victor M.; Chigardze, Dimitri Y.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Pereira, Cristiane T.; Benedetti, Celso E.; Balan, Andrea] Ctr Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Sanches, Mario] Mt Sinai Hosp, Toronto, ON, Canada; [Goncalves Barbosa, Joao Alexandre] Univ Catolica Brasilia, Dept Genet, Brasilia, DF, Brazil	Universidade de Sao Paulo; University of Cambridge; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Universidade Catolica de Brasilia	Balan, A (corresponding author), Ctr Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	andrea.balan@lnbio.cnpem.br	Balan, Andrea/D-1891-2014; Barbosa, João Alexandre/E-2261-2012; Barbosa, João/GVT-7916-2022; Bolanos-Garcia, Victor M./AAN-8575-2020; Ferreira, Rita/AFO-9971-2022; Ferreira, Luis/M-3954-2014	Balan, Andrea/0000-0001-6199-3198; Barbosa, João Alexandre/0000-0002-0534-481X; Bolanos-Garcia, Victor M./0000-0003-2700-1479; Benedetti, Celso/0000-0002-4602-0256; Ferreira, Luis/0000-0002-4883-1693	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Pesquisas	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisas	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Conselho Nacional de Pesquisas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTRY AR, 1990, BIOL FERT SOILS, V10, P50; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baldini RL, 1999, PLASMID, V42, P126, DOI 10.1006/plas.1999.1404; Beale J, 2010, ACTA CRYSTALLOGR F, V66, P391, DOI 10.1107/S1744309110006226; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Cook AM, 1998, TENSIDE SURFACT DET, V35, P52; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eichhorn E, 2000, J BACTERIOL, V182, P2687, DOI 10.1128/JB.182.10.2687-2695.2000; GOTTWALD TR, 1993, PLANT DIS, V77, P1004, DOI 10.1094/PD-77-1004; Guo YP, 2010, APPL ENVIRON MICROB, V76, P2234, DOI 10.1128/AEM.02897-09; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kahnert A, 2000, J BACTERIOL, V182, P2869, DOI 10.1128/JB.182.10.2869-2878.2000; Kemp BP, 2004, PHYSIOL MOL PLANT P, V64, P209, DOI 10.1016/j.pmpp.2004.08.007; Kertesz MA, 2001, RES MICROBIOL, V152, P279, DOI 10.1016/S0923-2508(01)01199-8; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oshiro EE, 2006, J MICROBIOL METH, V65, P171, DOI 10.1016/j.mimet.2005.07.005; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Polikarpov I, 1998, NUCL INSTRUM METH A, V405, P159, DOI 10.1016/S0168-9002(97)01202-3; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Ploeg JR, 1998, MICROBIOL-SGM, V144, P2555, DOI 10.1099/00221287-144-9-2555; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; van der Ploeg JR, 1999, J BIOL CHEM, V274, P29358, DOI 10.1074/jbc.274.41.29358; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; VANDERSLICE RW, 1989, BIOMEDICAL AND BIOTECHNOLOGICAL ADVANCES IN INDUSTRIAL POLYSACCHARIDES, P145; Vojnov AA, 1998, MICROBIOL-UK, V144, P1487, DOI 10.1099/00221287-144-6-1487; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519	43	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80083	10.1371/journal.pone.0080083	http://dx.doi.org/10.1371/journal.pone.0080083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282519	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500020
J	Schovancova, K; Pomajbikova, K; Prochazka, P; Modry, D; Bolechova, P; Petrzelkova, KJ				Schovancova, Katerina; PomajbiKova, Katerina; Prochazka, Petr; Modry, David; Bolechova, Petra; Petrzelkova, Klara J.			Preliminary Insights into the Impact of Dietary Starch on the Ciliate, Neobalantidium coli, in Captive Chimpanzees	PLOS ONE			English	Article							BALANTIDIUM-COLI; RESISTANT STARCH; CARBOHYDRATE; PARASITES; WILD	Infections caused by the intestinal ciliate Neobalantidium coli are asymptomatic in most hosts. In humans and captive African great apes clinical infections occasionally occur, manifested mainly by dysentery; however, factors responsible for development of clinical balantidiasis have not been fully clarified. We studied the effect of dietary starch on the intensities of infection by N. coli in two groups of captive chimpanzees. Adult chimpanzees infected by N. coli from the Hodonin Zoo and from the Brno Zoo, Czech Republic, were fed with a high starch diet (HSD) (average 14.7% of starch) for 14 days, followed by a five-day transition period and subsequently with a period of low starch diet (LoSD) (average 0.1% of starch) for another 14 days. We collected fecal samples during the last seven days of HSD and LoSD and fixed them in 10% formalin. We quantified trophozoites of N. coli using the FLOTAC method. The numbers of N. coli trophozoites were higher during the HSD (mean +/- SD: 49.0 +/- 134.7) than during the LoSD (3.5 +/- 6.8). A generalized linear mixed-effects model revealed significantly lower numbers of the N. coli trophozoites in the feces during the LoSD period in comparison to the HSD period (treatment contrast LoSD vs. HSD: 2.7 +/- 0.06 (SE), z = 47.7; p<<0.001). We conclude that our data provide a first indication that starch-rich diet might be responsible for high intensities of infection of N. coli in captive individuals and might predispose them for clinically manifested balantidiasis. We discuss the potential nutritional modifications to host diets that can be implemented in part to control N. coli infections.	[Schovancova, Katerina] Masaryk Univ, Inst Bot & Zool, Brno, Czech Republic; [PomajbiKova, Katerina; Modry, David; Petrzelkova, Klara J.] Univ Vet & Pharmaceut Sci, Dept Pathol & Parasitol, Brno, Czech Republic; [Prochazka, Petr; Petrzelkova, Klara J.] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [PomajbiKova, Katerina; Modry, David; Petrzelkova, Klara J.] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Modry, David] Cent European Inst Technol, Brno, Czech Republic; [Bolechova, Petra] CULS, Dept Husb & Ethol Anim, Prague, Czech Republic; [Bolechova, Petra; Petrzelkova, Klara J.] Liberec Zoo, Liberec, Czech Republic	Masaryk University Brno; University of Veterinary Sciences Brno; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Pomajbikova, K (corresponding author), Univ Vet & Pharmaceut Sci, Dept Pathol & Parasitol, Brno, Czech Republic.	kpomajbik@gmail.com	Petrzelkova, Klara Judita/G-7111-2014; Prochazka, Petr/A-9727-2008; Jirků (Pomajbíková), Katerina/G-9858-2014; Modry, David/G-7815-2014; Bolechova, Petra/Z-1214-2018	Prochazka, Petr/0000-0001-9385-4547; Jirků (Pomajbíková), Katerina/0000-0001-5411-6082; Modry, David/0000-0001-9649-6255; Bolechova, Petra/0000-0001-9007-1213	project "CEITEC'' - Central European Institute of Technology" from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Grant Agency of the Czech Republic [206/09/0927]; Institute of Vertebrate Biology Academy of Sciences of the Czech Republic [RVO:68081766]; OPVK 2.3 project - Development of Scientific Team and Laboratory for Infectious Diseases Common to Humans and Great Apes [CZ.1.07/2.3.00/20.0300]	project "CEITEC'' - Central European Institute of Technology" from the European Regional Development Fund; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Vertebrate Biology Academy of Sciences of the Czech Republic; OPVK 2.3 project - Development of Scientific Team and Laboratory for Infectious Diseases Common to Humans and Great Apes	This work was supported by the project "CEITEC'' - Central European Institute of Technology" (grant no. CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund, by grant from the Grant Agency of the Czech Republic (grant no. 206/09/0927), and by institutional support of Institute of Vertebrate Biology Academy of Sciences of the Czech Republic (grant no. RVO:68081766) and by OPVK 2.3 project - Development of Scientific Team and Laboratory for Infectious Diseases Common to Humans and Great Apes (CZ.1.07/2.3.00/20.0300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anargyrou K, 2003, AM J HEMATOL, V73, P180, DOI 10.1002/ajh.10336; Association of Zoos and Aquariums (AZA) Ape TAG, 2010, CHIMP PAN TROGL CAR; Bates D., 2008, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; CHAPMAN RW, 1985, AM J CLIN NUTR, V41, P1244, DOI 10.1093/ajcn/41.6.1244; Clyti E, 1998, B SOC PATHOL EXOT, V91, P309; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Das G, 2011, VET PARASITOL, V178, P121, DOI 10.1016/j.vetpar.2010.12.027; DORFMAN S, 1984, T ROY SOC TROP MED H, V78, P833, DOI 10.1016/0035-9203(84)90036-1; Ferry T, 2004, EUR J CLIN MICROBIOL, V23, P393, DOI 10.1007/s10096-004-1126-4; Fujita S, 2007, J MED PRIMATOL, V36, P25, DOI 10.1111/j.1600-0684.2006.00191.x; Germeno JR, 2003, AIDS, V17, P941; Greene JL, 1923, J AMER MED ASSOC, V81, P291, DOI 10.1001/jama.1923.02650040031010; Hockings KJ, 2010, J HUM EVOL, V58, P227, DOI 10.1016/j.jhevol.2009.11.004; Houdijk JGM, 2012, VET PARASITOL, V186, P38, DOI 10.1016/j.vetpar.2011.11.044; Isidoro M, 2013, J COMP PATHOL, V148, P87, DOI 10.1016/j.jcpa.2012.11.165; KIM JCS, 1978, LAB ANIM, V12, P231, DOI 10.1258/002367778781088620; Kisidayova S, 2009, AM J PRIMATOL, V71, P548, DOI 10.1002/ajp.20687; Lankester F, 2008, J MED PRIMATOL, V37, P297, DOI 10.1111/j.1600-0684.2008.00287.x; Latimer G.W., 2019, OFFICIAL METHODS ANA, V21; LEE RV, 1990, REV INFECT DIS, V12, P1052; Levecke B, 2007, VET PARASITOL, V148, P236, DOI 10.1016/j.vetpar.2007.06.020; McCleary BV, 2002, J AOAC INT, V85, P1103; MCGEACHIN RL, 1982, COMP BIOCHEM PHYS A, V72, P267, DOI 10.1016/0300-9629(82)90045-7; National Research Council US, 2003, NUTR REQ NONH PRIM; Nelson EC, 1933, AM J HYG, V18, P185, DOI 10.1093/oxfordjournals.aje.a117943; NISBET W. O., 1920, Southern Medical Journal, V13, P403, DOI 10.1097/00007611-192006000-00003; Oftedal Olav T., 1996, P148; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Petrzelkova KJ, 2012, AM J PRIMATOL, V74, P669, DOI 10.1002/ajp.22021; Pinheiro M C, 1991, Rev Soc Bras Med Trop, V24, P173, DOI 10.1590/S0037-86821991000300009; Pomajbikova K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002140; Pomajbikova K, 2010, J PARASITOL, V96, P1139, DOI 10.1645/GE-2433.1; PRITZE FELIX, 1928, ZEITSCHR WISS BIOL ABT F PARASITENK, V1, P345, DOI 10.1007/BF02120381; R Core Team, 2016, R FDN STAT COMP; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Ruzicova M, 2012, THESIS U VET PHARM S, P51; Schmidt D.A., 2000, C P APES CHALLENGES, P177; Schovancova K, 2011, THESIS MASARYK U BRN, P57; Schumaker E, 1931, AM J HYG, V13, P576, DOI 10.1093/oxfordjournals.aje.a117137; Schumaker E, 1930, AM J EPIDEMIOL, V25, P384; Schuster FL, 2008, CLIN MICROBIOL REV, V21, P626, DOI 10.1128/CMR.00021-08; Schwitzer C., 2009, ZOO ANIMAL NUTR 4, P131; Solaymani-Mohammadi S, 2006, VET PARASITOL, V140, P189, DOI 10.1016/j.vetpar.2006.05.012; Steen PH, 1921, UGESKRIFT LAEGER, V83, P662; STEPHEN AM, 1983, GASTROENTEROLOGY, V85, P589; TEARE JA, 1982, J AM VET MED ASSOC, V181, P1345; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Zaman V., 1978, P633	49	9	9	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81374	10.1371/journal.pone.0081374	http://dx.doi.org/10.1371/journal.pone.0081374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282589	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500091
J	Fu, XT; Dou, JZ; Mao, JX; Su, HL; Jiao, WQ; Zhang, LL; Hu, XL; Huang, XT; Wang, S; Bao, ZM				Fu, Xiaoteng; Dou, Jinzhuang; Mao, Junxia; Su, Hailin; Jiao, Wenqian; Zhang, Lingling; Hu, Xiaoli; Huang, Xiaoting; Wang, Shi; Bao, Zhenmin			RADtyping: An Integrated Package for Accurate De Novo Codominant and Dominant RAD Genotyping in Mapping Populations	PLOS ONE			English	Article								Genetic linkage maps are indispensable tools in genetic, genomic and breeding studies. As one of genotyping-by-sequencing methods, RAD-Seq (restriction-site associated DNA sequencing) has gained particular popularity for construction of high-density linkage maps. Current RAD analytical tools are being predominantly used for typing codominant markers. However, no genotyping algorithm has been developed for dominant markers (resulting from recognition site disruption). Given their abundance in eukaryotic genomes, utilization of dominant markers would greatly diminish the extensive sequencing effort required for large-scale marker development. In this study, we established, for the first time, a novel statistical framework for de novo dominant genotyping in mapping populations. An integrated package called RADtyping was developed by incorporating both de novo codominant and dominant genotyping algorithms. We demonstrated the superb performance of RADtyping in achieving remarkably high genotyping accuracy based on simulated and real mapping datasets. The RADtyping package is freely available at http://www2.ouc.edu.cn/mollusk/detailen.asp?id = 727.	[Fu, Xiaoteng; Dou, Jinzhuang; Mao, Junxia; Su, Hailin; Jiao, Wenqian; Zhang, Lingling; Hu, Xiaoli; Huang, Xiaoting; Wang, Shi; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China	Ocean University of China	Wang, S (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Qingdao, Shandong, Peoples R China.	swang@ouc.edu.cn; zmbao@ouc.edu.cn	zhang, lingling/HDM-2189-2022; Su, Hailin/D-1352-2017	Su, Hailin/0000-0002-0284-2071	National Natural Science Foundation of China [31322055, 31130054]; National Basic Research Program of China [2010CB126406]; National High Technology Research and Development Program of China [2012AA10A402, 2012AA10A405]; Natural Science Foundation for Distinguished Young Scholars of Shandong Province [JQ201308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation for Distinguished Young Scholars of Shandong Province	This work was supported by National Natural Science Foundation of China (31322055 & 31130054), National Basic Research Program of China (2010CB126406), National High Technology Research and Development Program of China (2012AA10A402, 2012AA10A405) and Natural Science Foundation for Distinguished Young Scholars of Shandong Province (JQ201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Dou JZ, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-17; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jiao W, 2013, DNA RES IN PRESS, DOI [10.1093/dnares/dst043, DOI 10.1093/DNARES/DST043)]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346	14	72	88	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79960	10.1371/journal.pone.0079960	http://dx.doi.org/10.1371/journal.pone.0079960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278224	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800039
J	Geng, S; Matsushima, H; Okamoto, T; Yao, Y; Lu, R; Takashima, A				Geng, Shuo; Matsushima, Hironori; Okamoto, Takashi; Yao, Yi; Lu, Ran; Takashima, Akira			Reciprocal Regulation of Development of Neutrophil-Dendritic Cell Hybrids in Mice by IL-4 and Interferon-Gamma	PLOS ONE			English	Article							COMPLEX CLASS-II; MHC CLASS-II; POLYMORPHONUCLEAR NEUTROPHILS; IFN-GAMMA; WEGENERS-GRANULOMATOSIS; MACROPHAGE ACTIVATION; RHEUMATOID-ARTHRITIS; BACTERIAL-INFECTIONS; UP-REGULATION; T-CELLS	Neutrophils contribute to innate host immunity by functioning as professional phagocytes, whereas dendritic cells (DCs) are prototypic antigen presenting cells (APCs) responsible for the induction of adaptive immune responses. We have demonstrated recently that neutrophils trans-differentiate into a unique population, termed "neutrophil-DC hybrids," expressing surface markers of both neutrophils and DCs and exhibiting dual functionality of both phagocytes and APCs. Although the hybrid cells emerged in significant numbers in murine bone marrow (BM) culture in the presence of GM-CSF, mechanisms regulating their development remained mostly unknown. In this study, we tested a total of 61 cytokines for their potentials to regulate neutrophil-DC hybrid formation using a newly developed BM micro-culture system combined with semi-automated FACS analysis. Several cytokines including GM-CSF were found to promote the generation of neutrophil-DC hybrids defined by the phenotype of CD11c(+)/MHC II+/Ly6G(+). When tested in the presence of GM-CSF, hybrid cell development was enhanced by IL-4 and suppressed by interferon-gamma (IFN gamma) in dose-dependent fashions. We next determined in vivo impacts of IL-4 and IFN gamma on the development of neutrophil-DC hybrids in thioglycollate-induced peritonitis lesions. Intraperitoneal administrations of IL-4/anti-IL-4 antibody complex (IL-4C) significantly increased the number of hybrids recovered from the lesions. By contract, recovery of hybrids was reduced by recombinant IFN gamma. With regard to function, those hybrid cells recovered from IL-4C-treated mice and IFN gamma-treated mice showed potent abilities to capture E. coli. These observations imply that emergence of neutrophil-DC hybrids in inflammatory sites is tightly regulated by local cytokine milieus.	[Geng, Shuo; Matsushima, Hironori; Okamoto, Takashi; Yao, Yi; Lu, Ran; Takashima, Akira] Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Takashima, A (corresponding author), Univ Toledo, Coll Med, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Akira.Takashima@UToledo.edu	lu, ran/HHC-8613-2022; Geng, Shuo/J-3735-2013		NIH; Bill and Melinda Gates Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the NIH and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam BKAH, 2008, J MICROBIOL IMMUNOL, V41, P462; Andina N, 2009, CELL DEATH DIFFER, V16, P1248, DOI 10.1038/cdd.2009.50; Araki H, 2004, BLOOD, V103, P2973, DOI 10.1182/blood-2003-08-2742; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cross A, 2003, ARTHRITIS RHEUM, V48, P2796, DOI 10.1002/art.11253; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Hansch GM, 1999, KIDNEY INT, V55, P1811, DOI 10.1046/j.1523-1755.1999.00446.x; Iking-Konert C, 2002, CLIN EXP IMMUNOL, V130, P501, DOI 10.1046/j.1365-2249.2002.02008.x; Iking-Konert C, 2001, J MOL MED, V79, P464, DOI 10.1007/s001090100237; Iking-Konert C, 2001, KIDNEY INT, V60, P2247, DOI 10.1046/j.1523-1755.2001.00068.x; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Matsushima H, 2013, BLOOD, V121, P1677, DOI 10.1182/blood-2012-07-445189; Mayuzumi N, 2009, EUR J IMMUNOL, V39, P3331, DOI 10.1002/eji.200939472; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; Morris SC, 2006, J IMMUNOL, V176, P5299, DOI 10.4049/jimmunol.176.9.5299; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Oehler L, 1998, J EXP MED, V187, P1019, DOI 10.1084/jem.187.7.1019; Ostanin DV, 2012, J IMMUNOL, V188, P1491, DOI 10.4049/jimmunol.1102296; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pliyev BK, 2011, CELL IMMUNOL, V271, P214, DOI 10.1016/j.cellimm.2011.08.020; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; REED SG, 1988, J IMMUNOL, V140, P4342; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Xue M, 2013, INT IMMUNOPHARMACOL, pS1567; Yamashiro S, 2000, BLOOD, V96, P3958, DOI 10.1182/blood.V96.12.3958.h8003958_3958_3963	35	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e82929	10.1371/journal.pone.0082929	http://dx.doi.org/10.1371/journal.pone.0082929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278484	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800149
J	Yan, HC; Liu, JH; Li, J; He, BX; Yang, L; Qiu, J; Li, L; Ding, DP; Shi, L; Zhao, SJ				Yan, Hua-Cheng; Liu, Jun-Hua; Li, Jian; He, Bao-Xia; Yang, Liang; Qiu, Jian; Li, Liang; Ding, Da-Peng; Shi, Lei; Zhao, Shu-Jin			Association between the CYP4A11 T8590C Variant and Essential Hypertension: New Data from Han Chinese and a Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; 20-HYDROXYEICOSATETRAENOIC ACID; ARACHIDONIC-ACID; POLYMORPHISM; GENE; CYP4F2; POPULATION; MEN; AMERICANS	Objective: CYP4A11 oxidizes endogenous arachidonic acid to 20-hydroxyeicosatetraenoic acid, a renal vasoconstrictor and natriuretic in humans. Previous studies demonstrated an association between a functional variant (T8590C) of CYP4A11 and essential hypertension, though with conflicting results. To elucidate this relationship, a case-control study and meta-analysis were performed to assess the possible association of essential hypertension with CYP4A11 genetic variations. Methods: Associations between the T8590C polymorphism and essential hypertension were examined in 328 unrelated cases and 297 age-matched controls in Han Chinese individuals. High-resolution melting was used to identify the CYP4A11 variant. To further investigate the association, we conducted a meta-analysis including eight studies published previously in July 2012. Results: The frequency of the CYP4A11 T8590C polymorphism showed no significant difference between cases and controls (all P>0.05). However, the meta-analysis showed that the CYP4A11 T8590C polymorphism may increase the risk of essential hypertension in an additive model (OR: 1.15, 95% CI: 1.02-1.29, P = 0.02), a dominant model (OR: 1.06, 95% CI: 1.01-1.32, P = 0.03), a recessive model (OR: 1.52, 95% CI: 1.15-2.02, P = 0.003) and a homozygote contrast (OR: 1.38, 95% CI: 1.07-1.78, P = 0.01). Also, a significant relationship was observed among Caucasians in the additive model, the homozygote contrast, the recessive model and the dominant model (all P<0.05). However, no association was observed in an Asian population (all P>0.05). Conclusions: This meta-analysis suggests there is a significant association between the CYP4A11 T8590C variant and essential hypertension, especially in Caucasians. The case-control study did not find a significant association among the Han Chinese population, but the controls were poorly matched and meaningful conclusions cannot therefore be made. Further large-scale studies are needed to clarify whether the CYP4A11 T8590C polymorphism is associated with hypertension risk in Asians or has a gender-specific effect.	[Yan, Hua-Cheng; Liu, Jun-Hua; Li, Jian; He, Bao-Xia; Shi, Lei; Zhao, Shu-Jin] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Yang, Liang; Qiu, Jian] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [He, Bao-Xia] Henan Canc Hosp, Dept Pharm, Zhengzhou, Peoples R China; [Li, Liang] Southern Med Univ, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Ding, Da-Peng] Southern Med Univ, Inst Genet Engn, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital; Zhengzhou University; Southern Medical University - China; Southern Medical University - China	Shi, L (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Pharm, Guangzhou, Guangdong, Peoples R China.	lucyshi622._921@163.com; gzzsjzhs@163.com	li, liang/F-2165-2011		National Natural Science Foundation of China [81100945]; China Postdoctoral Science Foundation [201150M1577]; Science and Technology Planning Project of Guangdong Province [2009B080701105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Planning Project of Guangdong Province	This work was supported by grants from the National Natural Science Foundation of China (No. 81100945), the China Postdoctoral Science Foundation (No. 201150M1577), and the Science and Technology Planning Project of Guangdong Province (No. 2009B080701105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood LD, 1997, HYPERTENSION, V30, P326, DOI 10.1161/01.HYP.30.3.326; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Cho BH, 2005, J HUM GENET, V50, P259, DOI 10.1007/s10038-005-0245-9; Ding H, 2010, PHARMACOGENET GENOM, V20, P187, DOI 10.1097/FPC.0b013e328336eefe; Fan ChunHong, 2011, Chinese Preventive Medicine, V12, P662; Fava C, 2008, HYPERTENSION, V52, P373, DOI 10.1161/HYPERTENSIONAHA.108.114199; Fava C, 2012, PROSTAG OTH LIPID M, V98, P75, DOI 10.1016/j.prostaglandins.2011.11.007; Fu Z, 2008, J XINJIANG MED U, V31, P511; Fu Z, 2008, J HYPERTENS, V26, P453, DOI 10.1097/HJH.0b013e3282f2f10c; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; Gainer JV, 2000, AM J HYPERTENS, V13, P1268, DOI 10.1016/S0895-7061(00)01215-2; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Ito O, 2006, MOL CELL BIOCHEM, V284, P141, DOI 10.1007/s11010-005-9038-x; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Mayer B, 2006, J HYPERTENS, V24, P1965, DOI 10.1097/01.hjh.0000244944.34546.8e; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Sarkis A, 2004, CURR OPIN NEPHROL HY, V13, P205, DOI 10.1097/00041552-200403000-00009; Stokes 3rd J, 1989, HYPERTENSION S1, V13, pI13; Sugimoto K, 2008, HYPERTENSION, V52, P1142, DOI 10.1161/HYPERTENSIONAHA.108.114082; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Wells G.A., NEWCASTLE OTTAWA SCA; Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Zhang R, 2011, HYPERTENS RES, V34, P645, DOI 10.1038/hr.2011.8; Zordoky BNM, 2010, PHARMACOL THERAPEUT, V125, P446, DOI 10.1016/j.pharmthera.2009.12.002	30	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80072	10.1371/journal.pone.0080072	http://dx.doi.org/10.1371/journal.pone.0080072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278241	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800051
J	Yang, HJ; Zhang, B; Zhu, JL; Liu, D; Guan, FL; He, XJ				Yang, Haojie; Zhang, Bo; Zhu, Jialin; Liu, Dan; Guan, Fanglin; He, Xijing			4q22.1 Contributes to Bone Mineral Density and Osteoporosis Susceptibility in Postmenopausal Women of Chinese Han Population	PLOS ONE			English	Article							HAPLOTYPE ANALYSIS; LRP5 GENE; ASSOCIATION; FRACTURES; AGE; POLYMORPHISMS; EPIDEMIOLOGY; MUTATIONS; PROGRAMS; DISEASE	Osteoporosis is a multifactorial disease in which genetic determinants are modulated by hormonal, environmental and nutritional factors. An important clinical risk factor in the pathogenesis of osteoporosis is the presence of genetics polymorphism in/around susceptibility genes/regions. This study explored whether the region of 4q22.1, which confers risk of developing osteoporosis in some populations, associated with bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese. We investigated 32 SNPs with minor allele frequencies >= 0.05 between 20 kb upstream and 20 kb downstream (40 kb window) of rs6532023, mapping in the 4q22.1 region, which was reported to be significantly associated with osteoporosis in previous studies. We found that rs6532023 was significantly associated with bone mineral density and osteoporosis (corrected p = 0.015) in our sample, including 440 cases and 640 controls, and allele G was supposed as a risk factor while T worked as a protective factor. Further genotype association analyses suggested a similar pattern (corrected p = 0.040). Additionally, analyses by haplotypes indicated that a haplotype block rs7683315-rs6532023-rs1471400-rs1471403 in the region associated with bone mineral density and osteoporosis (global p = 0.032), and risk haplotype A-G-G-C had almost 1.5-fold increased in the cases. To our knowledge, this is the first report to examine 4q22.1 region polymorphisms and osteoporosis in Han Chinese. Our results provide further evidence for an effect of the region of 4q22.1 on the etiology of osteoporosis and suggest that 4q22.1 may be a genetic risk factor for bone mineral density and osteoporosis.	[Yang, Haojie; Zhang, Bo] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Peoples R China; [Yang, Haojie; Zhu, Jialin; He, Xijing] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped 2, Xian 710049, Peoples R China; [Liu, Dan] Fifth Hosp Xian, Xian, Peoples R China; [Guan, Fanglin] Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Peoples R China; [Guan, Fanglin] Inst Human Genom & Forens Sci, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Guan, FL (corresponding author), Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Peoples R China.	fanglingguan@163.com; xijing_h@vip.tom.com	He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376	China Postdoctoral Science Foundation Funded Project [M532029]; Fundamental Research Funds for the Central Universities [08142024, 08143003]	China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was totally supported by China Postdoctoral Science Foundation Funded Project (M532029) and Fundamental Research Funds for the Central Universities (08142024 and 08143003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueda L, 2008, J BONE MINER RES, V23, P1954, DOI [10.1359/jbmr.080806, 10.1359/JBMR.080806]; Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cheung CL, 2010, NAT REV RHEUMATOL, V6, P507, DOI 10.1038/nrrheum.2010.106; Chung BD, 2009, HUM MUTAT, V30, P641, DOI 10.1002/humu.20916; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Curtis D, 2006, ANN HUM GENET, V70, P277, DOI 10.1111/j.1529-8817.2005.00225.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Feng ZP, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-39; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Gammage KL, 2012, J AM COLL HEALTH, V60, P58, DOI 10.1080/07448481.2011.570399; Garcia-Unzueta MT, 2008, HORM METAB RES, V40, P219, DOI 10.1055/s-2008-1046793; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Hartikka H, 2005, J BONE MINER RES, V20, P783, DOI 10.1359/JBMR.050101; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Korostishevsky M, 2004, BIOL PSYCHIAT, V56, P169, DOI 10.1016/j.biopsych.2004.04.006; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; Li YF, 2012, MOL BIOL REP, V39, P5709, DOI 10.1007/s11033-011-1380-3; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Omasu F, 2003, J HUM GENET, V48, P342, DOI 10.1007/s10038-003-0035-1; Ozbas H, 2012, MOL BIOL REP, V39, P11289, DOI 10.1007/s11033-012-2038-5; Parsons CA, 2005, HUM MOL GENET, V14, P3141, DOI 10.1093/hmg/ddi346; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Prockop DJ, 1998, NEW ENGL J MED, V338, P1061, DOI 10.1056/NEJM199804093381510; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; ROUSSET F, 1995, GENETICS, V140, P1413; SEEMAN E, 1994, J BONE MINER RES, V9, P739; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zhang W, 2012, CURR OSTEOPOROS REP, V10, P93, DOI 10.1007/s11914-011-0086-8; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694; Zhao JH, 2003, COMPUT METH PROG BIO, V70, P1, DOI 10.1016/S0169-2607(01)00193-6; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zhao L, 2011, MENOPAUSE, V18, P1018, DOI 10.1097/gme.0b013e318213545a; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	38	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80165	10.1371/journal.pone.0080165	http://dx.doi.org/10.1371/journal.pone.0080165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278256	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800061
J	De Stefani, E; Innocenti, A; De Marco, D; Gentilucci, M				De Stefani, Elisa; Innocenti, Alessandro; De Marco, Doriana; Gentilucci, Maurizio			Concatenation of Observed Grasp Phases with Observer's Distal Movements: A Behavioural and TMS Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOUTH; IMITATION; GESTURES; SPEECH; HAND	The present study aimed at determining how actions executed by two conspecifics can be coordinated with each other, or more specifically, how the observation of different phases of a reaching-grasping action is temporary related to the execution of a movement of the observer. Participants observed postures of initial finger opening, maximal finger aperture, and final finger closing of grasp after observation of an initial hand posture. Then, they opened or closed their right thumb and index finger (experiments 1, 2 and 3). Response times decreased, whereas acceleration and velocity of actual finger movements increased when observing the two late phases of grasp. In addition, the results ruled out the possibility that this effect was due to salience of the visual stimulus when the hand was close to the target and confirmed an effect of even hand postures in addition to hand apparent motion due to the succession of initial hand posture and grasp phase. In experiments 4 and 5, the observation of grasp phases modulated even foot movements and pronunciation of syllables. Finally, in experiment 6, transcranial magnetic stimulation applied to primary motor cortex 300 ms post-stimulus induced an increase in hand motor evoked potentials of opponens pollicis muscle when observing the two late phases of grasp. These data suggest that the observation of grasp phases induced simulation which was stronger during observation of finger closing. This produced shorter response times, greater acceleration and velocity of the successive movement. In general, our data suggest best concatenation between two movements (one observed and the other executed) when the observed (and simulated) movement was to be accomplished. The mechanism joining the observation of a conspecific's action with our own movement may be precursor of social functions. It may be at the basis for interactions between conspecifics, and related to communication between individuals.	[De Stefani, Elisa; Innocenti, Alessandro; De Marco, Doriana; Gentilucci, Maurizio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] IIT Ist Italiano Tecnol, RTM Rete Tecnol Multidisciplinare, Parma, Italy; [Gentilucci, Maurizio] Univ Parma, I-43100 Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Gentilucci, M (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	maurizio.gentilucci@unipr.it	De Marco, Doriana/J-5744-2018; De Stefani, Elisa/C-3154-2018	De Marco, Doriana/0000-0003-2700-2252; De Stefani, Elisa/0000-0003-4492-3926	MIUR (Ministero dell'Istruzione, Universita e Ricerca)	MIUR (Ministero dell'Istruzione, Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR))	The work was supported by funds MIUR (Ministero dell'Istruzione, Universita e Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri F, 2009, BRAIN LANG, V110, P1, DOI 10.1016/j.bandl.2009.01.002; Bernardis P, 2006, NEUROPSYCHOLOGIA, V44, P178, DOI 10.1016/j.neuropsychologia.2005.05.007; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Campione GC, 2011, BEHAV BRAIN RES, V225, P201, DOI 10.1016/j.bbr.2011.07.025; Campione GC, 2010, BEHAV BRAIN RES, V207, P343, DOI 10.1016/j.bbr.2009.10.018; CASTIELLO U, 2002, COMMON MECH PERCEPTI, P314; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gentilucci M, 1997, EXP BRAIN RES, V115, P116, DOI 10.1007/PL00005671; Gentilucci M, 2004, NEUROPSYCHOLOGIA, V42, P1554, DOI 10.1016/j.neuropsychologia.2004.03.002; Gentilucci M, 2004, EUR J NEUROSCI, V19, P190, DOI 10.1111/j.1460-9568.2004.03104.x; Gentilucci M, 2003, EXP BRAIN RES, V153, P260, DOI 10.1007/s00221-003-1600-8; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gentilucci M, 2006, J COGNITIVE NEUROSCI, V18, P1059, DOI 10.1162/jocn.2006.18.7.1059; Gentilucci M, 2012, BEHAV BRAIN RES, V233, P130, DOI 10.1016/j.bbr.2012.04.036; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; Gentilucci M, 2009, NEUROPSYCHOLOGIA, V47, P3190, DOI 10.1016/j.neuropsychologia.2009.07.020; Gianelli C, 2008, BRAIN RES, V1218, P166, DOI 10.1016/j.brainres.2008.04.046; Johnson-Frey SH, 2004, VIS COGN, V11, P371, DOI 10.1080/13506280344000329; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; MATURI FAP, 2002, MANUALE FONETICA, P172; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81197	10.1371/journal.pone.0081197	http://dx.doi.org/10.1371/journal.pone.0081197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278395	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100144
J	Ervasti, J; Vahtera, J; Pentti, J; Oksanen, T; Ahola, K; Kivimaki, M; Virtanen, M				Ervasti, Jenni; Vahtera, Jussi; Pentti, Jaana; Oksanen, Tuula; Ahola, Kirsi; Kivimaki, Mika; Virtanen, Marianna			Depression-Related Work Disability: Socioeconomic Inequalities in Onset, Duration and Recurrence	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; PSYCHOSOCIAL FACTORS; SICKNESS ABSENCE; POPULATION; MORTALITY; RETURN; INCOME; RISK; CARE	Objective: Depression is a major cause of disability in working populations and the reduction of socioeconomic inequalities in disability is an important public health challenge. We examined work disability due to depression with four indicators of socioeconomic status. Methods: A prospective cohort study of 125 355 Finnish public sector employees was linked to national register data on work disability (>9 days) due to depressive disorders (International Classification of Diseases, codes F32-F34) from January 2005 to December 2011. Primary outcomes were the onset of work disability due to depressive disorders and, among those with such disability, return to work after and recurrent episodes of work disability due to depression. Results: We found a consistent inverse socioeconomic gradient in work disability due to depression. Lower occupational position, lower educational level, smaller residence size, and rented (vs. owner-occupied) residence were all associated with an increased risk of work disability. Return to work was slower for employees with basic education (cumulative odds ratio = 1.21, 95% CI: 1.05-1.39) compared to those with higher education. Recurrent work disability episodes due to depression were less common among upper-grade non-manual workers (the highest occupational group) than among lower-grade non-manual (hazard ratio = 1.16, 95% CI: 1.07-1.25) and manual (hazard ratio = 1.14, 95% CI: 1.02-1.26) workers. Conclusions: These data from Finnish public sector employees show persistent socioeconomic inequalities in work disability due to depression from 2005 to 2011 in terms of onset, recovery and recurrence.	[Ervasti, Jenni; Vahtera, Jussi; Pentti, Jaana; Oksanen, Tuula; Ahola, Kirsi; Virtanen, Marianna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika] Univ Helsinki, Dept Behav Sci, Helsinki, Finland	Finnish Institute of Occupational Health; University of Turku; University of Turku; University of London; University College London; University of Helsinki	Ervasti, J (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	jenni.ervasti@ttl.fi	Kivimaki, Mika/B-3607-2012; Ervasti, Jenni/AAN-1856-2021; Oksanen, Tuula/AAK-5599-2021	Kivimaki, Mika/0000-0002-4699-5627; Ervasti, Jenni/0000-0001-9113-2428; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [265174, 258598, 264944]; UK Economic and Social Research Council; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Academy of Finland: JE received funding from project number 265174, MV received funding from project number 258598, and JV received funding from project number 264944. MK was supported by a professorial fellowship from the UK Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DA, 2006, AM J PSYCHIAT, V163, P1569, DOI 10.1176/appi.ajp.163.9.1569; Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; [Anonymous], 2001, CLASS OCC; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Briffault X, 2008, SOC PSYCH PSYCH EPID, V43, P165, DOI 10.1007/s00127-007-0281-1; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Halonen JI, 2012, ENVIRON HEALTH PERSP, V120, P1391, DOI 10.1289/ehp.1205026; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hees Hiske L, 2012, J Clin Psychiatry, V73, pe1048, DOI 10.4088/JCP.12m07699; Huijts T, 2010, SOC SCI MED, V71, P1964, DOI 10.1016/j.socscimed.2010.09.021; Institute for Health Metrics and Evaluation, GBD ARR DIAGR; Jain FA, 2013, DEPRESS ANXIETY, V30, P624, DOI 10.1002/da.22045; Jokela M, 2013, BRIT J PSYCHIAT, V202, P115, DOI 10.1192/bjp.bp.111.098863; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2009, INT J EPIDEMIOL, V38, P1265, DOI 10.1093/ije/dyn373; Kivimaki M, 2007, PSYCHOL MED, V37, P373, DOI 10.1017/S0033291706009457; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Moustgaard H, 2013, J AFFECT DISORDERS, V148, P278, DOI 10.1016/j.jad.2012.12.008; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nielsen MBD, 2012, DISABIL REHABIL, V34, P1311, DOI 10.3109/09638288.2011.641664; Nieuwenhuijsen K, 2006, SCAND J WORK ENV HEA, V32, P67, DOI 10.5271/sjweh.978; Nieuwenhuijsen K, 2013, J OCCUP REHABIL, V23, P290, DOI 10.1007/s10926-012-9389-6; Population Register Center, 2010, POP INF SYST; Pulkki-Raback L, 2012, EUR J PUBLIC HEALTH, V22, P327, DOI 10.1093/eurpub/ckr127; Roelen CAM, 2012, J OCCUP REHABIL, V22, P409, DOI 10.1007/s10926-012-9363-3; Suoyrjo H, 2007, J REHABIL MED, V39, P198, DOI 10.2340/16501977-0035; Taimela S, 2013, OCCUP ENVIRON MED, V70, P521, DOI 10.1136/oemed-2013-101376; Virtanen M, 2008, OCCUP ENVIRON MED, V65, P171, DOI 10.1136/oem.2007.033159; Virtanen M, 2011, OCCUP ENVIRON MED, V68, P791, DOI 10.1136/oem.2010.061101; Vlasveld MC, 2013, OCCUP ENVIRON MED, V70, P223, DOI 10.1136/oemed-2012-100793; World Health Organization, 1994, INT STAT CLASS DIS R	35	44	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79855	10.1371/journal.pone.0079855	http://dx.doi.org/10.1371/journal.pone.0079855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278194	Green Published, gold			2022-12-27	WOS:000327313100057
J	You, QS; Peng, XY; Chen, CX; Xu, L; Jonas, JB				You, Qi Sheng; Peng, Xiao Yan; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.			Peripapillary Intrachoroidal Cavitations. The Beijing Eye Study	PLOS ONE			English	Article							OPTIC DISC; DETACHMENT; DEPTH; MYOPIA	Purpose: To assess prevalence, size and location of peripapillary intrachoroidal cavitations (PICCs) and their associations in a population-based sample.. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years (range: 50-93 years). A detailed ophthalmic examination included enhanced depth imaging of the choroid by spectral-domain optical coherence tomography and fundus photography. PICCs were defined as triangular thickening of the choroid with the base at the optic disc border and a distance between Bruch's membrane and sclera of >= 200 mu m. Parapapillary large choroidal vessels were excluded. Results: Out of 94 subjects with high myopia (refractive error <-6.0 diopters or axial length >26.5mm in right eyes), OCT images were available for 89 (94.7%) participants. A PICC was detected in 15 out of these 89 highly myopic subjects (prevalence: 16.9 +/- 4.0%) and in none of hyperopic, emmetropic or medium myopic subgroups each consisting of 100 randomly selected subjects. Mean PICC width was 4.2 +/- 2.3 hours (30 degrees) of disc circumference and mean length was 1363 +/- 384 mu m. PICCs were located most frequently (40%) at the inferior disc border. On fundus photos, a typical yellow-orange lesion was found in 8 (53%) eyes with PICCs. In binary regression analysis, presence of PICCs was significantly associated with optic disc tilting (P=0.04) and presence of posterior staphylomata (P=0.046). Conclusions: Prevalence of PICCs in the adult Chinese population was 16.9 +/- 4.0% in the highly myopic group, with no PICCs detected in non-highly myopic eyes. PICCs were located most frequently at the inferior optic disc border. Only half of the PICCs detected on OCT images showed a yellow-orange lesion on fundus photos. Presence of PICC was significantly associated only with an increased optic disc tilting and presence of posterior staphylomata, while it was not associated with axial length, refractive error or other ocular or systemic parameters.	[You, Qi Sheng; Peng, Xiao Yan; Chen, Chang Xi; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing Tongren Hosp,Beijing Ophthalmol & Visual, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/A-3619-2014; You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320	state natural sciences fund [81170890]; Beijing Nova Program [2010B032]; Beijing Beijing Ophthalmology and Visual Science Key Lab Fund [201210]; National Key Technology R&D Program of the Ministry of Science and Technology [2011BAH15B08, 2012BAH05F05]	state natural sciences fund(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Beijing Ophthalmology and Visual Science Key Lab Fund; National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	Supported by state natural sciences fund (81170890); Beijing Nova Program (2010B032), Beijing 2013 Beijing Ophthalmology and Visual Science Key Lab Fund (No. 201210) and National Key Technology R&D Program of the Ministry of Science and Technology (No. 2011BAH15B08 and 2012BAH05F05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Forte R, 2008, EYE, V22, P158, DOI 10.1038/sj.eye.6702666; Freund KB, 2011, ARCH OPHTHALMOL-CHIC, V129, P1096, DOI 10.1001/archophthalmol.2011.208; Freund KB, 2003, ARCH OPHTHALMOL-CHIC, V121, P197; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Ohno-Matsui K, 2013, EYE, V27, P630, DOI 10.1038/eye.2013.16; Ohno-Matsui K, 2012, AM J OPHTHALMOL, V154, P382, DOI 10.1016/j.ajo.2012.02.010; Panda-Jonas S, 2013, ACTA OPHTHALMOL, DOI [10.1111/j. 1755-3768.2012.02570.x, DOI 10.1111/J.1755-3768.2012.02570.X.[]; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Shimada N, 2006, ARCH OPHTHALMOL-CHIC, V124, P46, DOI 10.1001/archopht.124.1.46; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1037, DOI 10.1097/IAE.0b013e318242b9c0; Toranzo J, 2005, AM J OPHTHALMOL, V140, P731, DOI 10.1016/j.ajo.2005.03.063; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Wei YH, 2009, EYE, V23, P141, DOI 10.1038/sj.eye.6702961; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yeh SI, 2013, OPHTHALMOLOGY, V120, P544, DOI 10.1016/j.ophtha.2012.08.028; You QS, 2013, OPHTHALMOLOGY, V120, P2013, DOI [10.1016/j.ophtha.2013.06.013, DOI 10.1016/J.0PHTHA.2013.06.013.PUBMED:23706949.[]	21	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78743	10.1371/journal.pone.0078743	http://dx.doi.org/10.1371/journal.pone.0078743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302981	gold, Green Published, Green Submitted			2022-12-27	WOS:000326152300081
J	Peterburs, J; Suchan, B; Bellebaum, C				Peterburs, Jutta; Suchan, Boris; Bellebaum, Christian			You Do the Math: Coding of Bets and Outcomes in a Gambling Task in the Feedback-Related Negativity and P300 in Healthy Adults	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; MEDIAL FRONTAL-CORTEX; TIME-ESTIMATION TASK; REWARD PREDICTION; BRAIN POTENTIALS; BAD OUTCOMES; NEAR-MISS; MAGNITUDE; RESPONSES; COMPONENT	The feedback-related negativity (FRN) is an event-related potential (ERP) component associated with processing of performance feedback, with more negative amplitudes for losses relative to wins. The amplitude of the FRN following near misses, i.e. the experience of coming close to winning, is between the amplitude elicited by losses and wins. In gambling, however, outcome value may not always be obvious since initially placed bets need to be taken into account when evaluating wins or losses. It is still unclear if initial bet size is reflected in the FRN or the later P300 component. The present study applied a virtual card gambling task to investigate the sensitivity of FRN and P300 to the manipulation of outcome magnitude as implemented through the presence or absence of initial bets, resulting in wins, losses or ambivalent outcomes, with the latter representing losses with and wins without bets. The FRN was larger for trials with bets compared to trials without bets. Wins were associated with a smaller FRN than losses or ambivalent outcomes, while losses and ambivalent outcomes did not differ. P300 amplitudes were larger for trials without bets, and wins were associated with a larger P300 than losses or ambivalent outcomes. Crucially, P300 amplitudes were also smaller for ambivalent outcomes compared to losses. Thus, the different dimensions determining outcome value appear to be integrated in early and late stages of feedback processing. However, only at later stages reflected in the P300 were ambivalent outcomes with and without bet clearly distinguished from other outcomes.	[Peterburs, Jutta] Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany; [Peterburs, Jutta; Suchan, Boris; Bellebaum, Christian] Ruhr Univ Bochum, Fac Psychol, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany	University of Munster; Ruhr University Bochum	Peterburs, J (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany.	jutta.peterburs@uni-muenster.de	Suchan, Boris/G-6068-2017; Suchan, Boris/ABE-2512-2020; Peterburs, Jutta/R-2352-2019	Peterburs, Jutta/0000-0003-3571-126X; Suchan, Boris/0000-0003-2934-0263	Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; MIWF) [334-4]	Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; MIWF)	This research was funded by the Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; MIWF; grant number 334-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER DE, 1980, PSYCHOPHYSIOLOGY, V17, P385, DOI 10.1111/j.1469-8986.1980.tb00168.x; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bellebaum C, 2011, BEHAV NEUROSCI, V125, P241, DOI 10.1037/a0022536; Bellebaum C, 2010, NEUROPSYCHOLOGIA, V48, P3343, DOI 10.1016/j.neuropsychologia.2010.07.023; Cote Denis, 2003, J Gambl Stud, V19, P433, DOI 10.1023/A:1026384011003; Dixon MJ, 2010, ADDICTION, V105, P1819, DOI 10.1111/j.1360-0443.2010.03050.x; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; GRIFFITHS M, 1991, J PSYCHOL, V125, P347, DOI 10.1080/00223980.1991.10543298; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; KARIS D, 1983, PSYCHOPHYSIOLOGY, V20, P260, DOI 10.1111/j.1469-8986.1983.tb02153.x; Kassinove JI, 2001, PSYCHOL ADDICT BEHAV, V15, P155, DOI 10.1037/0893-164X.15.2.155; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Li P, 2009, NEUROREPORT, V20, P788, DOI 10.1097/WNR.0b013e32832b7fac; Long Y, 2012, NEUROSCIENCE, V200, P50, DOI 10.1016/j.neuroscience.2011.10.035; Luo QL, 2011, NEUROREPORT, V22, P989, DOI 10.1097/WNR.0b013e32834da8ae; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Santesso DL, 2012, SOC COGN AFFECT NEUR, V7, P794, DOI 10.1093/scan/nsr054; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; Toyomaki A, 2005, NEUROREPORT, V16, P1865, DOI 10.1097/01.wnr.0000185962.96217.36; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004	31	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81262	10.1371/journal.pone.0081262	http://dx.doi.org/10.1371/journal.pone.0081262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282577	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500079
J	Velentzas, PD; Velentzas, AD; Pantazi, AD; Mpakou, VE; Zervas, CG; Papassideri, IS; Stravopodis, DJ				Velentzas, Panagiotis D.; Velentzas, Athanassios D.; Pantazi, Asimina D.; Mpakou, Vassiliki E.; Zervas, Christos G.; Papassideri, Issidora S.; Stravopodis, Dimitrios J.			Proteasome, but Not Autophagy, Disruption Results in Severe Eye and Wing Dysmorphia: A Subunit- and Regulator-Dependent Process in Drosophila	PLOS ONE			English	Article							FAT-FACETS GENE; DEUBIQUITINATING ENZYME; CELL-DEATH; NEURODEGENERATIVE DISEASE; SIGNALING PATHWAY; VEIN DEVELOPMENT; LIQUID FACETS; MELANOGASTER; ENDOCYTOSIS; MECHANISMS	Proteasome-dependent and autophagy-mediated degradation of eukaryotic cellular proteins represent the two major proteostatic mechanisms that are critically implicated in a number of signaling pathways and cellular processes. Deregulation of functions engaged in protein elimination frequently leads to development of morbid states and diseases. In this context, and through the utilization of GAL4/UAS genetic tool, we herein examined the in vivo contribution of proteasome and autophagy systems in Drosophila eye and wing morphogenesis. By exploiting the ability of GAL4-ninaE. GMR and P{GawB}Bx(MS1096) genetic drivers to be strongly and preferentially expressed in the eye and wing discs, respectively, we proved that proteasomal integrity and ubiquitination proficiency essentially control fly's eye and wing development. Indeed, subunit-and regulator-specific patterns of severe organ dysmorphia were obtained after the RNAi-induced downregulation of critical proteasome components (Rpn1, Rpn2, alpha 5, beta 5 and beta 6) or distinct protein-ubiquitin conjugators (UbcD6, but not UbcD1 and UbcD4). Proteasome deficient eyes presented with either rough phenotypes or strongly dysmorphic shapes, while transgenic mutant wings were severely folded and carried blistered structures together with loss of vein differentiation. Moreover, transgenic fly eyes overexpressing the UBP2-yeast deubiquitinase enzyme were characterized by an eyeless-like phenotype. Therefore, the proteasome/ubiquitin proteolytic activities are undoubtedly required for the normal course of eye and wing development. In contrast, the RNAi-mediated downregulation of critical Atg (1, 4, 7, 9 and 18) autophagic proteins revealed their non-essential, or redundant, functional roles in Drosophila eye and wing formation under physiological growth conditions, since their reduced expression levels could only marginally disturb wing's, but not eye's, morphogenetic organization and architecture. However, Atg9 proved indispensable for the maintenance of structural integrity of adult wings in aged flies. In toto, our findings clearly demonstrate the gene-specific fundamental contribution of proteasome, but not autophagy, in invertebrate eye and wing organ development.	[Velentzas, Panagiotis D.; Velentzas, Athanassios D.; Pantazi, Asimina D.; Mpakou, Vassiliki E.; Papassideri, Issidora S.; Stravopodis, Dimitrios J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece; [Zervas, Christos G.] Acad Athens, Div Genet, Ctr Basic Res 2, Biomed Res Fdn, Athens, Greece	National & Kapodistrian University of Athens; Academy of Athens	Stravopodis, DJ (corresponding author), Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece.	dstravop@biol.uoa.gr	Velentzas, Panagiotis/AFK-2270-2022; Velentzas, Athanassios D/C-1261-2011	Velentzas, Panagiotis/0000-0001-9552-8403; Velentzas, Athanassios D/0000-0002-9755-395X; Mpakou, Vassiliki/0000-0002-8850-884X; Zervas, Christos/0000-0003-0531-9515; Stravopodis, Dimitrios/0000-0002-9535-2134				Arnone MI, 1997, DEVELOPMENT, V124, P1851; Bajpe PK, 2008, MOL CELL BIOL, V28, P1606, DOI 10.1128/MCB.01567-07; Bier E, 2000, CURR OPIN GENET DEV, V10, P393, DOI 10.1016/S0959-437X(00)00102-7; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Comstock JH, 1918, WINGS INSECTS; Dang TPT, 2012, CELL TISSUE RES, V348, P453, DOI 10.1007/s00441-012-1404-x; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Du J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024168; Egoz-Matia N, 2011, DEV BIOL, V351, P99, DOI 10.1016/j.ydbio.2010.12.039; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Freeman M, 1997, DEVELOPMENT, V124, P261; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hess MW, 2006, MICROSC RES TECHNIQ, V69, P93, DOI 10.1002/jemt.20268; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Hwang S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003412; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Juhasz G, 2008, AUTOPHAGY, V4, P357, DOI 10.4161/auto.5572; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kanao T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030958; Kim YI, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-9; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Li WZ, 2012, GENET MOL RES, V11, P1997, DOI 10.4238/2012.August.6.4; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842; Marygold SJ, 2011, FLY, V5, P291, DOI 10.4161/fly.5.4.18276; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Muller D, 2006, J CELL SCI, V119, P250, DOI 10.1242/jcs.02743; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ou CY, 2003, TRENDS GENET, V19, P382, DOI 10.1016/S0168-9525(03)00146-X; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Reggiori F, 2012, J CELL BIOL, V198, P151, DOI 10.1083/jcb.201206119; Rubinsztein DC, 2007, NEURON, V54, P854, DOI 10.1016/j.neuron.2007.06.005; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Stark J, 1999, ANNU REV ENTOMOL, V44, P97, DOI 10.1146/annurev.ento.44.1.97; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tang HW, 2011, AUTOPHAGY, V7, P778, DOI 10.4161/auto.7.7.15537; Thumm M, 2001, MOL GENET GENOMICS, V266, P657, DOI 10.1007/s004380100585; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Velentzas PD, 2013, CELL BIOL TOXICOL, V29, P13, DOI 10.1007/s10565-012-9235-9; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Yamaguchi O, 2012, J CARDIOVASC PHARM, V60, P242, DOI 10.1097/FJC.0b013e31824cc31c; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780	75	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80530	10.1371/journal.pone.0080530	http://dx.doi.org/10.1371/journal.pone.0080530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282550	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500051
J	Zhang, XY; Brunet, YR; Logger, L; Douzi, B; Cambillau, C; Journet, L; Cascales, E				Zhang, Xiang Y.; Brunet, Yannick R.; Logger, Laureen; Douzi, Badreddine; Cambillau, Christian; Journet, Laure; Cascales, Eric			Dissection of the TssB-TssC Interface during Type VI Secretion Sheath Complex Formation	PLOS ONE			English	Article							BACTERIAL 2-HYBRID SYSTEM; ENTEROAGGREGATIVE ESCHERICHIA-COLI; TRYPTOPHAN-SCANNING MUTAGENESIS; VIBRIO-CHOLERAE; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; TARGET-CELLS; TAIL; EFFECTOR; COMPONENT	The Type VI secretion system (T6SS) is a versatile machine that delivers toxins into either eukaryotic or bacterial cells. At a molecular level, the T6SS is composed of a membrane complex that anchors a long cytoplasmic tubular structure to the cell envelope. This structure is thought to resemble the tail of contractile bacteriophages. It is composed of the Hcp protein that assembles into hexameric rings stacked onto each other to form a tube similar to the phage tail tube. This tube is proposed to be wrapped by a structure called the sheath, composed of two proteins, TssB and TssC. It has been shown using fluorescence microscopy that the TssB and TssC proteins assemble into a tubular structure that cycles between long and short conformations suggesting that, similarly to the bacteriophage sheath, the T6SS sheath undergoes elongation and contraction events. The TssB and TssC proteins have been shown to interact and a specific alpha-helix of TssB is required for this interaction. Here, we confirm that the TssB and TssC proteins interact in enteroaggregative E. coli. We further show that this interaction requires the N-terminal region of TssC and the conserved alpha-helix of TssB. Using site-directed mutagenesis coupled to phenotypic analyses, we demonstrate that an hydrophobic motif located in the N-terminal region of this helix is required for interaction with TssC, sheath assembly and T6SS function.	[Zhang, Xiang Y.; Brunet, Yannick R.; Logger, Laureen; Journet, Laure; Cascales, Eric] Aix Marseille Univ, CNRS, IMM, LISM,UMR 7255, Marseille, France; [Douzi, Badreddine; Cambillau, Christian] Aix Marseille Univ, CNRS, UMR 6098, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), Aix Marseille Univ, CNRS, IMM, LISM,UMR 7255, Marseille, France.	cascales@imm.cnrs.fr	CASCALES, ERIC/G-7420-2011; douzi, Badreddine/Z-5707-2019; Douzi, Badreddine/ABA-4540-2021	CASCALES, ERIC/0000-0003-0611-9179; Douzi, Badreddine/0000-0003-3140-4713; Journet, Laure/0000-0002-5847-2962	Centre National de la Recherche Scientifique (CNRS); Aix-Marseille Universite; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; CNRS	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	Work in E. C. laboratory is supported by the Centre National de la Recherche Scientifique (CNRS), the Aix-Marseille Universite and a grant from the Agence Nationale de la Recherche (ANR-10-JCJC-1303-03) to E. C. Work in C. C. laboratory is supported by the CNRS, the Aix-Marseille Universite , the Plateforme Technologique de Recherche en Sciences Biologiques (IBiSA) and a grant from the Fondation pour la Recherche Medicale (FRM DEQ2011-0421282). X.Y.Z. was supported by the ANR-10-JCJC-1303-03 grant, Y.R.B by a doctoral fellowship from the French Ministere de la Recherche, and B. D. by the FRM-DEQ2011-0421282 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broms JE, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-96; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Gueguen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066615; Gueguen E, 2013, APPL ENVIRON MICROB, V79, P32, DOI 10.1128/AEM.02504-12; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kapitein N, 2013, MOL MICROBIOL, V87, P1013, DOI 10.1111/mmi.12147; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karna SLR, 2010, BIOTECHNIQUES, V49, P831, DOI 10.2144/000113539; Leiman PG, 2012, ADV EXP MED BIOL, V726, P93, DOI 10.1007/978-1-4614-0980-9_5; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao VA, 2011, ACTA CRYSTALLOGR D, V67, P1065, DOI 10.1107/S0907444911046300; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; SHARP LL, 1995, BIOCHEMISTRY-US, V34, P9166, DOI 10.1021/bi00028a028; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	64	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81074	10.1371/journal.pone.0081074	http://dx.doi.org/10.1371/journal.pone.0081074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282569	gold, Green Published			2022-12-27	WOS:000327543500071
J	Zhang, XJ; Lu, LH; Wang, RR; Wang, YP; Luo, RH; Lai, CC; Yang, LM; He, YP; Zheng, YT				Zhang, Xing-Jie; Lu, Li-He; Wang, Rui-Rui; Wang, Yue-Ping; Luo, Rong-Hua; Lai, Christopher Cong; Yang, Liu-Meng; He, Yan-Ping; Zheng, Yong-Tang			DB-02, a C-6-Cyclohexylmethyl Substituted Pyrimidinone HIV-1 Reverse Transcriptase Inhibitor with Nanomolar Activity, Displays an Improved Sensitivity against K103N or Y181C Than S-DABOs	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRUCTURE-BASED DESIGN; IN-VITRO SELECTION; DRUG-RESISTANCE; NONNUCLEOSIDE INHIBITORS; BIOLOGICAL EVALUATION; WILD-TYPE; POTENT; DISCOVERY; STRAIN	6-(cyclohexylmethyl)-5-ethyl-2-((2-oxo-2-phenylethyl)thio)pyrimidin-4(3H)-one (DB-02) is a member of the newly reported synthetic anti-HIV-1 compounds dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines, S-DACOs. In vitro anti-HIV-1 activity and resistance profile studies have suggested that DB-02 has very low cytotoxicity (CC50>1mM) to cell lines and peripheral blood mononuclear cells (PBMCs). It displays potent anti-HIV-1 activity against laboratory adapted strains and primary isolated strains including different subtypes and tropism strains (EC(50)s range from 2.40 to 41.8 nM). Studies on site-directed mutagenesis, genotypic resistance profiles revealed that V106A was the major resistance contributor for the compound. Molecular docking analysis showed that DB-02 located in the hydrophobic pocket with interactions of Lys101, Val106, Leu234, His235. DB-02 also showed non-antagonistic effects to four approved antiretroviral drugs. All studies indicated that DB-02 would be a potential NNRTI with low cytotoxicity and improved activity.	[Zhang, Xing-Jie; Wang, Rui-Rui; Luo, Rong-Hua; Yang, Liu-Meng; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Zhang, Xing-Jie; Wang, Rui-Rui; Luo, Rong-Hua; Yang, Liu-Meng; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Zhang, Xing-Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Li-He; Wang, Yue-Ping; He, Yan-Ping] Yunnan Univ, Sch Chem Sci & Technol, Key Lab Med Chem Nat Resource, Minist Educ, Kunming, Yunnan, Peoples R China; [Lai, Christopher Cong] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	He, YP (corresponding author), Yunnan Univ, Sch Chem Sci & Technol, Key Lab Med Chem Nat Resource, Minist Educ, Kunming, Yunnan, Peoples R China.	yphe@ynu.edu.cn; zhengyt@mail.kiz.ac.cn	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		973 Program [2009CB522306]; Key Scientific and Technological Program of China Yunnan Province [2012ZX10001-006, 2012ZX10001-007, 2012ZX09103-101-068, 2009BC018, 2010GA001, Y103951111]; National Science Foundation of China [21262044, 30560179, 30960459, 81001462, 81102483]; Chinese Academy of Sciences [W8090303]	973 Program(National Basic Research Program of China); Key Scientific and Technological Program of China Yunnan Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by grants from the 973 Program (2009CB522306), the Key Scientific and Technological Program of China (2012ZX10001-006; 2012ZX10001-007, 2012ZX09103-101-068) and of Yunnan Province (2009BC018, 2010GA001, Y103951111), the National Science Foundation of China (21262044, 30560179, 30960459, 81001462, 81102483) and the Chinese Academy of Sciences (W8090303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2004, ANTIMICROB AGENTS CH, V48, P4680, DOI 10.1128/AAC.48.12.4680-4686.2004; Chen WM, 2012, CURR PHARM DESIGN, V18, P4165, DOI 10.2174/138161212802430440; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Conway B, 2001, AIDS, V15, P1269, DOI 10.1097/00002030-200107060-00008; Das K, 2004, J MED CHEM, V47, P2550, DOI 10.1021/jm030558s; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; He YP, 2011, BIOORG MED CHEM LETT, V21, P694, DOI 10.1016/j.bmcl.2010.12.003; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; Li L, 2010, AIDS RES HUM RETROV, V26, P711, DOI 10.1089/aid.2010.0001; Liu GJ, 2007, CELL MOL IMMUNOL, V4, P203; Liu Si-yang, 2010, Yaoxue Xuebao, V45, P241; Long Jing, 2010, Yaoxue Xuebao, V45, P228; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; Mai A, 1997, J MED CHEM, V40, P1447, DOI 10.1021/jm960802y; Mai A, 1999, J MED CHEM, V42, P619, DOI 10.1021/jm980260f; MAI A, 1995, J MED CHEM, V38, P3258, DOI 10.1021/jm00017a010; Mai A, 2001, J MED CHEM, V44, P2544, DOI 10.1021/jm010853h; Manetti F, 2005, J MED CHEM, V48, P8000, DOI 10.1021/jm050744t; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Marcellin F, 2013, EXPERT REV ANTI-INFE, V11, P239, DOI [10.1586/ERI.13.8, 10.1586/eri.13.8]; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Mugnaini C, 2007, J MED CHEM, V50, P6580, DOI 10.1021/jm0708230; Nawrozkij MB, 2008, J MED CHEM, V51, P4641, DOI 10.1021/jm800340w; Ordonez P, 2012, ANTIMICROB AGENTS CH, V56, P2581, DOI 10.1128/AAC.06307-11; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Radi M, 2012, CHEMMEDCHEM, V7, P883, DOI 10.1002/cmdc.201200056; Radi M, 2009, J MED CHEM, V52, P840, DOI 10.1021/jm801330n; Ren JS, 2008, VIRUS RES, V134, P157, DOI 10.1016/j.virusres.2007.12.018; UNAIDS, 2012, WORLD AIDS DAY REP R; Vingerhoets J, 2005, J VIROL, V79, P12773, DOI 10.1128/JVI.79.20.12773-12782.2005; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057; Wang YP, 2008, BIOORGAN MED CHEM, V16, P3887, DOI 10.1016/j.bmc.2008.01.039; Yang SQ, 2012, CURR MED CHEM, V19, P152, DOI 10.2174/092986712803414169; Yu MY, 2011, CHEMMEDCHEM, V6, P826, DOI 10.1002/cmdc.201000555; Yu MY, 2011, CURR MED CHEM, V18, P10; Zhang J, 2011, BIOORGAN MED CHEM, V19, P4366, DOI 10.1016/j.bmc.2011.05.024	41	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81489	10.1371/journal.pone.0081489	http://dx.doi.org/10.1371/journal.pone.0081489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282600	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500102
J	Deschamps, K; Matricali, GA; Roosen, P; Desloovere, K; Bruyninckx, H; Spaepen, P; Nobels, F; Tits, J; Flour, M; Staes, F				Deschamps, Kevin; Matricali, Giovanni Arnoldo; Roosen, Philip; Desloovere, Kaat; Bruyninckx, Herman; Spaepen, Pieter; Nobels, Frank; Tits, Jos; Flour, Mieke; Staes, Filip			Classification of Forefoot Plantar Pressure Distribution in Persons with Diabetes: A Novel Perspective for the Mechanical Management of Diabetic Foot?	PLOS ONE			English	Article							CLUSTER-ANALYSIS; WALKING SPEED; TOE DEFORMITY; GAIT PATTERN; RISK-FACTORS; ULCERATION; ADULTS; DISEASE; PREVALENCE; CHILDREN	Background: The aim of this study was to identify groups of subjects with similar patterns of forefoot loading and verify if specific groups of patients with diabetes could be isolated from non-diabetics. Methodology/Principal Findings: Ninety-seven patients with diabetes and 33 control participants between 45 and 70 years were prospectively recruited in two Belgian Diabetic Foot Clinics. Barefoot plantar pressure measurements were recorded and subsequently analysed using a semi-automatic total mapping technique. Kmeans cluster analysis was applied on relative regional impulses of six forefoot segments in order to pursue a classification for the control group separately, the diabetic group separately and both groups together. Cluster analysis led to identification of three distinct groups when considering only the control group. For the diabetic group, and the computation considering both groups together, four distinct groups were isolated. Compared to the cluster analysis of the control group an additional forefoot loading pattern was identified. This group comprised diabetic feet only. The relevance of the reported clusters was supported by ANOVA statistics indicating significant differences between different regions of interest and different clusters. Conclusion/s Significance: There seems to emerge a new era in diabetic foot medicine which embraces the classification of diabetic patients according to their biomechanical profile. Classification of the plantar pressure distribution has the potential to provide a means to determine mechanical interventions for the prevention and/or treatment of the diabetic foot.	[Deschamps, Kevin; Roosen, Philip; Desloovere, Kaat; Staes, Filip] Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium; [Deschamps, Kevin; Desloovere, Kaat] Univ Hosp Leuven, Lab Clin Mot Anal, Pellenberg, Belgium; [Deschamps, Kevin; Matricali, Giovanni Arnoldo; Flour, Mieke] Univ Hosp Leuven, Multidisciplinary Diabet Foot Clin, Louvain, Belgium; [Matricali, Giovanni Arnoldo] Katholieke Univ Leuven, Dept Dev & Regenerat, Louvain, Belgium; [Bruyninckx, Herman; Spaepen, Pieter] Katholieke Univ Leuven, Dept Mech Engn, Louvain, Belgium; [Nobels, Frank; Tits, Jos] Onze Lieve Vrouw Ziekenhuis Aalst, Dept Internal Med Endocrinol, Aalst, Belgium; [Flour, Mieke] Univ Hosp Leuven, Dept Dermatol, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Deschamps, K (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium.	kevin.deschamps@uz.kuleuven.ac.be	Desloovere, Kaat/F-3240-2014	Desloovere, Kaat/0000-0002-8507-5276; Staes, Filip/0000-0002-1569-6333	Agency for Innovation by Science and Technology Flanders [080659]	Agency for Innovation by Science and Technology Flanders	This scientific work was carried out under the financial support of the Agency for Innovation by Science and Technology Flanders (GRANT: 080659) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Bennetts CJ, 2013, J BIOMECH, V46, P19, DOI 10.1016/j.jbiomech.2012.09.007; Birch I, 2006, DIABETIC FOOT, V9, P102; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; Burnfield JM, 2004, CLIN BIOMECH, V19, P78, DOI 10.1016/j.clinbiomech.2003.09.007; Bus SA, 2005, J BIOMECH, V38, P1918, DOI 10.1016/j.jbiomech.2004.07.034; Bus SA, 2004, DIABETES CARE, V27, P2376, DOI 10.2337/diacare.27.10.2376; CAVANAGH P, 2001, DIABETIC FOOT, P125; Cavanagh PR, 2010, J AM PODIAT MED ASSN, V100, P360, DOI 10.7547/1000360; Chung MJ, 2012, ERGONOMICS, V55, P194, DOI 10.1080/00140139.2011.583359; Dahmen R, 2001, DIABETES CARE, V24, P705, DOI 10.2337/diacare.24.4.705; De Cock A, 2006, GAIT POSTURE, V23, P339, DOI 10.1016/j.gaitpost.2005.04.011; De Cock A, 2005, GAIT POSTURE, V21, P432, DOI 10.1016/j.gaitpost.2004.05.004; Deschamps K, 2013, GAIT POSTURE, DOI [10.1016/j.gaitpost.2013.04.003, DOI 10.1016/J.GAITP0ST.2013.04.003]; Dinh Thanh L, 2005, Int J Low Extrem Wounds, V4, P154, DOI 10.1177/1534734605280130; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Giacomozzi C, 2006, GAIT POSTURE, V23, P464, DOI 10.1016/j.gaitpost.2005.06.006; HENNIG EM, 1994, FOOT ANKLE, V15, P35, DOI 10.1177/107110079401500107; Kastenbauer T, 2001, J AM PODIAT MED ASSN, V91, P343; KUMAR S, 1994, DIABETIC MED, V11, P480, DOI 10.1111/j.1464-5491.1994.tb00310.x; Lavery LA, 2003, DIABETES CARE, V26, P1069, DOI 10.2337/diacare.26.4.1069; MEYERSRICE B, 1994, J AM PODIAT MED ASSN, V84, P499, DOI 10.7547/87507315-84-10-499; Mulroy S, 2003, GAIT POSTURE, V18, P114, DOI 10.1016/S0966-6362(02)00165-0; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Phethean J, 2012, GAIT POSTURE, V36, P287, DOI 10.1016/j.gaitpost.2012.03.012; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sawacha Zimi, 2010, J Diabetes Sci Technol, V4, P1127; Schaper NC, 2004, DIABETES-METAB RES, V20, pS90, DOI 10.1002/dmrr.464; Segal A, 2004, FOOT ANKLE INT, V25, P926, DOI 10.1177/107110070402501215; Van Gheluwe B, 2006, J AM PODIAT MED ASSN, V96, P428, DOI 10.7547/0960428; van Schie C H M, 2005, Int J Low Extrem Wounds, V4, P160; Waldecker Ute, 2012, Foot Ankle Surg, V18, P42, DOI 10.1016/j.fas.2011.03.004; Wrobel James S, 2010, J Diabetes Sci Technol, V4, P833; York RM, 2009, PM&R, V1, P434, DOI 10.1016/j.pmrj.2009.03.001	38	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79924	10.1371/journal.pone.0079924	http://dx.doi.org/10.1371/journal.pone.0079924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278219	Green Published, gold			2022-12-27	WOS:000327541700022
J	Fortuna, M; Teixeira, S; Machado, S; Velasques, B; Bittencourt, J; Peressutti, C; Budde, H; Cagy, M; Nardi, AE; Piedade, R; Ribeiro, P; Arias-Carrion, O				Fortuna, Marina; Teixeira, Silmar; Machado, Sergio; Velasques, Bruna; Bittencourt, Juliana; Peressutti, Caroline; Budde, Henning; Cagy, Mauricio; Nardi, Antonio E.; Piedade, Roberto; Ribeiro, Pedro; Arias-Carrion, Oscar			Cortical Reorganization after Hand Immobilization: The beta qEEG Spectral Coherence Evidences	PLOS ONE			English	Article							DECISION-MAKING; EEG COHERENCE; MOTOR CORTEX; MOVEMENT; INTEGRATION; DYNAMICS; OSCILLATIONS; INHIBITION; MECHANISMS; EXECUTION	There is increasing evidence that hand immobilization is associated with various changes in the brain. Indeed, beta band coherence is strongly related to motor act and sensitive stimuli. In this study we investigate the electrophysiological and cortical changes that occur when subjects are submitted to hand immobilization. We hypothesized that beta coherence oscillations act as a mechanism underlying inter-and intra-hemispheric changes. As a methodology for our study fifteen healthy individuals between the ages of 20 and 30 years were subjected to a right index finger task before and after hand immobilization while their brain activity pattern was recorded using quantitative electroencephalography. This analysis revealed that hand immobilization caused changes in frontal, central and parietal areas of the brain. The main findings showed a lower beta-2 band in frontal regions and greater cortical activity in central and parietal areas. In summary, the coherence increased in the frontal, central and parietal cortex, due to hand immobilization and it adjusted the brains functioning, which had been disrupted by the procedure. Moreover, the brain adaptation upon hand immobilization of the subjects involved inter-and intra-hemispheric changes.	[Fortuna, Marina; Teixeira, Silmar; Velasques, Bruna; Bittencourt, Juliana; Peressutti, Caroline; Piedade, Roberto; Ribeiro, Pedro] Univ Fed Rio de Janeiro, Inst Psychiat, IPUB, Rio De Janeiro, Brazil; [Ribeiro, Pedro] Univ Fed Rio de Janeiro, Sch Phys Educ, Dept Biosci, EEFD, Rio de Janeiro, Brazil; [Cagy, Mauricio] Univ Fed Fluminense, Inst Hlth Community, Div Epidemiol & Biostat, Rio De Janeiro, Brazil; [Teixeira, Silmar; Velasques, Bruna; Ribeiro, Pedro] INA, Rio De Janeiro, Brazil; [Teixeira, Silmar] Veiga Almeida Univ, Lab Phys Therapy, Rio De Janeiro, Brazil; [Teixeira, Silmar] State Univ Rio De Janeiro UERJ, Phys Therapy Dept, Piquet Carneiro Policlin, Rio De Janeiro, Brazil; [Machado, Sergio; Nardi, Antonio E.] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil; [Machado, Sergio] Natl Inst Translat Med INCT TM, Rio De Janeiro, Brazil; [Machado, Sergio] Cent Univ, Fac Hlth Sci, Quiropraxia Program, Santiago, Chile; [Machado, Sergio] Salgado Oliveira Univ, Phys Activ Sci Postgrad Program, Niteroi, RJ, Brazil; [Machado, Sergio] Univ Fed Uberlandia, Inst Phylosophy, IFILO, Rio De Janeiro, Brazil; [Budde, Henning] Univ Appl Sci & Med Univ, Med Sch Hamburg, Hamburg, Germany; [Arias-Carrion, Oscar] Hosp Gen Dr Manuel Gea Gonzalez, Movement Disorders & Transcranial Magnet Stimulat, Mexico City, DF, Mexico; [Arias-Carrion, Oscar] Hosp Gen Ajusco Medio, Dept Neurol, Mexico City, DF, Mexico	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Veiga de Almeida (UVA); Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidad Central de Chile; Universidade Salgado de Oliveira; Universidade Federal de Uberlandia; University of Hamburg; University Medical Center Hamburg-Eppendorf	Arias-Carrion, O (corresponding author), Hosp Gen Dr Manuel Gea Gonzalez, Movement Disorders & Transcranial Magnet Stimulat, Mexico City, DF, Mexico.	arias@ciencias.unam.mx	Teixeira, Silmar/G-8881-2011; Budde, Henning/AFB-9845-2022; Machado, Sergio/M-9384-2013; Nardi, Antonio E/A-7335-2014; Cagy, Mauricio/AAF-2989-2019; Arias-Carrion, Oscar/A-4248-2018; Teixeira, Silmar/L-5846-2019	Teixeira, Silmar/0000-0002-9240-1228; Budde, Henning/0000-0003-3526-0569; Machado, Sergio/0000-0001-8946-8467; Nardi, Antonio E/0000-0002-2152-4669; Cagy, Mauricio/0000-0002-6488-842X; Arias-Carrion, Oscar/0000-0002-9982-7571; 				Anghinah R, 2005, ARQ NEURO-PSIQUIAT, V63, P83, DOI 10.1590/S0004-282X2005000100015; Bastos VH, 2005, ARQ NEURO-PSIQUIAT, V63, P443, DOI 10.1590/S0004-282X2005000300015; Bender S, 2004, COGNITIVE BRAIN RES, V21, P49, DOI 10.1016/j.cogbrainres.2004.05.004; BROWN P, 1991, BRAIN, V114, P2333, DOI 10.1093/brain/114.5.2333; Bucci P, 2004, CLIN NEUROPHYSIOL, V115, P1340, DOI 10.1016/j.clinph.2003.12.031; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Chen R, 1998, J NEUROSCI, V18, P3443; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; dos Santos S.G., 2009, REV BRAS CINEANTROPO, V11, P326, DOI [10.5007/1980-0037.2009v11n3p326, DOI 10.5007/1980-0037.2009V11N3P326]; Fuster JM, 2009, J COGNITIVE NEUROSCI, V21, P2047, DOI 10.1162/jocn.2009.21280; Hamzei F, 2006, NEUROIMAGE, V31, P710, DOI 10.1016/j.neuroimage.2005.12.035; Hanajima R, 2001, CLIN NEUROPHYSIOL, V112, P623, DOI 10.1016/S1388-2457(01)00477-1; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kim YH, 2004, YONSEI MED J, V45, P241, DOI 10.3349/ymj.2004.45.2.241; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; Mano Y, 2003, J ELECTROMYOGR KINES, V13, P57, DOI 10.1016/S1050-6411(02)00086-X; Minc D, 2010, NEUROSCI LETT, V469, P145, DOI 10.1016/j.neulet.2009.11.062; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Polato D, 2008, REV BRAS MED ESPORTE, V14, P221, DOI 10.1590/S1517-86922008000300012; Portella CE, 2007, ARQ NEURO-PSIQUIAT, V65, P63, DOI 10.1590/S0004-282X2007000100014; Preston AR, 2002, LEARN MEMORY, V9, P215, DOI 10.1101/lm.54702; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Rowlands AV, 2012, J BIOMECH, V45, P448, DOI 10.1016/j.jbiomech.2011.12.006; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Schack B, 1999, CLIN NEUROPHYSIOL, V110, P1410, DOI 10.1016/S1388-2457(99)00111-X; Schaechter JD, 2002, NEUROREHAB NEURAL RE, V16, P326, DOI 10.1177/154596830201600403; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Serrien DJ, 2004, EXP BRAIN RES, V155, P204, DOI 10.1007/s00221-003-1720-1; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Smith ME, 1999, COGNITIVE BRAIN RES, V7, P389, DOI 10.1016/S0926-6410(98)00043-3; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Szurhaj W, 2005, EUR J NEUROSCI, V21, P1223, DOI 10.1111/j.1460-9568.2005.03966.x; Szurhaj W, 2003, CLIN NEUROPHYSIOL, V114, P107, DOI 10.1016/S1388-2457(02)00333-4; Thickbroom GW, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-4; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Velasques B, 2007, NEUROSCI LETT, V426, P155, DOI 10.1016/j.neulet.2007.08.061; Wada Y, 1996, CLIN ELECTROENCEPHAL, V27, P84, DOI 10.1177/155005949602700207; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; Weiss T, 2000, EXP BRAIN RES, V134, P199, DOI 10.1007/s002210000456; Wittenberg GF, 2009, CURRENT O NEUROL, V22, P1	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79912	10.1371/journal.pone.0079912	http://dx.doi.org/10.1371/journal.pone.0079912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278213	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700020
J	Ledouit, S; Casanova, R; Zaal, FTJM; Bootsma, RJ				Ledouit, Simon; Casanova, Remy; Zaal, Frank T. J. M.; Bootsma, Reinoud J.			Prospective Control in Catching: The Persistent Angle-of-Approach Effect in Lateral Interception	PLOS ONE			English	Article							HITTING MOVING TARGETS; VAN WIERINGEN 1990; MANUAL INTERCEPTIONS; HAND MOVEMENTS; VISUAL CONTROL; BALL; MODEL; INFORMATION; TIME; VARIABLES	In lateral interception tasks balls converging onto the same interception location via different trajectories give rise to systematic differences in the kinematics of hand movement. While it is generally accepted that this angle-of-approach effect reflects the prospective (on-line) control of movement, controversy exists with respect to the information used to guide the hand to the future interception location. Based on the pattern of errors observed in a task requiring visual extrapolation of line segments to their intersection with a second line, angle-of-approach effects in lateral interception have been argued to result from perceptual biases in the detection of information about the ball's future passing distance along the axis of hand movement. Here we demonstrate that this account does not hold under experimental scrutiny: The angle-of-approach effect still emerged when participants intercepted balls moving along trajectories characterized by a zero perceptual bias with respect to the ball's future arrival position (Experiment 4). Designing and validating such bias-controlled trajectories were done using the line-intersection extrapolation task (Experiments 2 and 3). The experimental set-up used in the present series of experiments was first validated for the lateral interception and the line-intersection extrapolation tasks: In Experiment 1 we used rectilinear ball trajectories to replicate the angle-of-approach effect in lateral interception of virtual balls. Using line segments extracted from these rectilinear ball trajectories, in Experiment 2 we replicated the reported pattern of errors in the estimated locus of intersection with the axis of hand movement. We used these errors to develop a set of bias-free trajectories. Experiment 3 confirmed that the perceptual biases had been corrected for successfully. We discuss the implications on the information-based regulation of hand movement of our finding that the angle-of-approach effect in lateral interception cannot not explained by perceptual biases in information about the ball's future passing distance.	[Ledouit, Simon; Casanova, Remy; Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Zaal, Frank T. J. M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9700 AB Groningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Groningen	Bootsma, RJ (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France.	reinoud.bootsma@univ-amu.fr	casanova, rémy/AGK-6933-2022; Bootsma, Reinoud/B-1254-2008; Zaal, Frank TJM/A-5578-2008; casanova, remy/U-3603-2017; Casanova, Remy/GSO-3393-2022	casanova, rémy/0000-0002-7101-8043; Bootsma, Reinoud/0000-0002-3719-7586; Zaal, Frank TJM/0000-0003-2697-3612; casanova, remy/0000-0002-7101-8043; 	French-Dutch collaborative travel grant [PHC Van Gogh 29353PF]	French-Dutch collaborative travel grant	Support provided by French-Dutch collaborative travel grant (PHC Van Gogh 29353PF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzamarski R, 2007, EXP BRAIN RES, V177, P312, DOI 10.1007/s00221-006-0671-8; Bastin J, 2010, EXP BRAIN RES, V201, P763, DOI 10.1007/s00221-009-2092-y; Bootsma RJ, 2010, J EXP PSYCHOL HUMAN, V36, P1056, DOI 10.1037/a0019327; Bootsma RJ, 2009, PERCEPTION, V38, P851; BOOTSMA RJ, 1991, INT J SPORT PSYCHOL, V22, P271; Bootsma RJ, 1997, J EXP PSYCHOL HUMAN, V23, P1282; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brouwer AM, 2005, EXP BRAIN RES, V165, P28, DOI 10.1007/s00221-005-2277-y; Chardenon A, 2005, J MOTOR BEHAV, V37, P52, DOI 10.3200/JMBR.37.1.52-62; Chardenon A, 2004, EXP BRAIN RES, V158, P100, DOI 10.1007/s00221-004-1880-7; Craig CM, 2009, ATTEN PERCEPT PSYCHO, V71, P515, DOI 10.3758/APP.71.3.515; Dessing JC, 2005, J COGNITIVE NEUROSCI, V17, P668, DOI 10.1162/0898929053467604; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dessing JC, 2009, EXP BRAIN RES, V196, P511, DOI 10.1007/s00221-009-1882-6; Fajen BR, 2007, EXP BRAIN RES, V180, P303, DOI 10.1007/s00221-007-0859-6; Fayt V, 1997, J SPORT SCI, V15, P581, DOI 10.1080/026404197367010; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Gray R, 2009, J EXP PSYCHOL-APPL, V15, P91, DOI 10.1037/a0015591; Jacobs DM, 2006, J EXP PSYCHOL HUMAN, V32, P443, DOI 10.1037/0096-1523.32.2.443; LANCHESTER BS, 1975, J EXP BIOL, V63, P627; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; McLeod P, 1996, J EXP PSYCHOL HUMAN, V22, P531; McLeod P, 2003, NATURE, V426, P244, DOI 10.1038/426244a; Michaels CF, 2006, J EXP PSYCHOL HUMAN, V32, P459, DOI 10.1037/0096-1523.32.2.459; Michaels Claire F., 1992, Ecological Psychology, V4, P199, DOI 10.1207/s15326969eco0404_1; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Olberg RM, 2012, CURR OPIN NEUROBIOL, V22, P267, DOI 10.1016/j.conb.2011.11.015; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1994, VISION RES, V34, P163, DOI 10.1016/0042-6989(94)90329-8; Shaffer DM, 2004, PSYCHOL SCI, V15, P437, DOI 10.1111/j.0956-7976.2004.00698.x; Tresilian JR, 2006, EXP BRAIN RES, V171, P421, DOI 10.1007/s00221-005-0286-5; Tresilian JR, 2005, PERCEPT PSYCHOPHYS, V67, P129, DOI 10.3758/BF03195017; van Soest AJ, 2010, J EXP PSYCHOL HUMAN, V36, P1040, DOI 10.1037/a0016890; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003	37	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80827	10.1371/journal.pone.0080827	http://dx.doi.org/10.1371/journal.pone.0080827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278324	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700034
J	Federighi, G; Traina, G; Macchi, M; Ciampini, C; Bernardi, R; Baldi, E; Bucherelli, C; Brunelli, M; Scuri, R				Federighi, Giuseppe; Traina, Giovanna; Macchi, Monica; Ciampini, Cristina; Bernardi, Rodolfo; Baldi, Elisabetta; Bucherelli, Corrado; Brunelli, Marcello; Scuri, Rossana			Modulation of Gene Expression in Contextual Fear Conditioning in the Rat	PLOS ONE			English	Article							ACETYL-L-CARNITINE; LONG-TERM-MEMORY; PROTEIN-SYNTHESIS; SYNAPTIC PLASTICITY; BINDING PROTEIN; RNA-SYNTHESIS; CONSOLIDATION; STATHMIN; PROFILIN; AMYGDALA	In contextual fear conditioning (CFC) a single training leads to long-term memory of context-aversive electrical foot-shocks association. Mid-temporal regions of the brain of trained and naive rats were obtained 2 days after conditioning and screened by two-directional suppression subtractive hybridization. A pool of differentially expressed genes was identified and some of them were randomly selected and confirmed with qRT-PCR assay. These transcripts showed high homology for rat gene sequences coding for proteins involved in different cellular processes. The expression of the selected transcripts was also tested in rats which had freely explored the experimental apparatus (exploration) and in rats to which the same number of aversive shocks had been administered in the same apparatus, but temporally compressed so as to make the association between painful stimuli and the apparatus difficult (shock-only). Some genes resulted differentially expressed only in the rats subjected to CFC, others only in exploration or shock-only rats, whereas the gene coding for translocase of outer mitochondrial membrane 20 protein and nardilysin were differentially expressed in both CFC and exploration rats. For example, the expression of stathmin 1 whose transcripts resulted up regulated was also tested to evaluate the transduction and protein localization after conditioning.	[Federighi, Giuseppe; Ciampini, Cristina; Scuri, Rossana] Univ Pisa, Dipartimento Ric Traslazionale & Nuove Tecnol Med, Unit Fisiol, Pisa, Italy; [Traina, Giovanna] Univ Perugia, Dipartimento Sci Econ Estimat Alimenti, Sez Chim Bromatol Biochim Fisiol & Nutr, I-06100 Perugia, Italy; [Macchi, Monica; Brunelli, Marcello] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Bernardi, Rodolfo] Univ Pisa, Dipartimento Sci Agr Genet Alimentari & Agroambie, Pisa, Italy; [Baldi, Elisabetta; Bucherelli, Corrado] Univ Florence, Dipartimento Sci Fisiol, Florence, Italy	University of Pisa; University of Perugia; University of Pisa; University of Pisa; University of Florence	Scuri, R (corresponding author), Univ Pisa, Dipartimento Ric Traslazionale & Nuove Tecnol Med, Unit Fisiol, Pisa, Italy.	r.scuri@dsf.unipi.it	baldi, elisabetta/AAA-6629-2019; Traina, Giovanna/AAR-2179-2020	Traina, Giovanna/0000-0001-9996-3584	Ateneo	Ateneo	This work was supported by grants from Ateneo 2011-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Alberini CM, 2008, NEUROBIOL LEARN MEM, V89, P234, DOI 10.1016/j.nlm.2007.08.007; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; AMAT JA, 1991, DEV BRAIN RES, V60, P205, DOI 10.1016/0165-3806(91)90049-O; Antonov I, 2001, J NEUROSCI, V21, P6413, DOI 10.1523/JNEUROSCI.21-16-06413.2001; Arguello AA, 2013, J NEUROSCI, V33, P3646, DOI 10.1523/JNEUROSCI.1635-12.2013; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Beeman CL, 2013, LEARN MEMORY, V20, P336, DOI 10.1101/lm.031161.113; Bergstrom HC, 2012, BRAIN STRUCT FUNCT, P1; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Byrne J. H., 2009, MOL NETWORKS INTRO C; Canales JJ, 2007, EUR ARCH PSY CLIN N, V257, P261, DOI 10.1007/s00406-007-0730-6; Chen X, 2013, NEUROSCIENCE, DOI [10.1016/j.neuroscience.2013.08.054, DOI 10.1016/J.NEUR0SCIENCE.2013.08.054]; Da Silva WC, 2008, HIPPOCAMPUS, V18, P29, DOI 10.1002/hipo.20362; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Ehlis AC, 2011, AM J MED GENET B, V156B, P291, DOI 10.1002/ajmg.b.31161; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Gold PE, 2008, NEUROBIOL LEARN MEM, V89, P201, DOI 10.1016/j.nlm.2007.10.006; Gover TD, 2009, NEUROBIOL LEARN MEM, V92, P155, DOI 10.1016/j.nlm.2009.03.006; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Hernandez-Rabaza V, 2008, NEUROBIOL LEARN MEM, V90, P553, DOI 10.1016/j.nlm.2008.06.008; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Kawaai K, 2010, J NEUROSCI RES, V88, P2911, DOI 10.1002/jnr.22457; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Meunier B, 2009, EUR J CELL BIOL, V88, P91, DOI 10.1016/j.ejcb.2008.08.006; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Murk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034167; NEALE JH, 1973, SCIENCE, V179, P1243, DOI 10.1126/science.179.4079.1243; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Pedreira ME, 1996, PHARMACOL BIOCHEM BE, V54, P611; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; PESCHANSKI M, 1993, J COMP NEUROL, V337, P655, DOI 10.1002/cne.903370410; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Sacchetti B, 1999, ARCH ITAL BIOL, V137, P235; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1970, NATURE, V225, P649, DOI 10.1038/225649a0; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Traina G, 2004, MOL BRAIN RES, V132, P57, DOI 10.1016/j.molbrainres.2004.09.006; Traina G, 2008, NEUROCHEM INT, V53, P244, DOI 10.1016/j.neuint.2008.08.001; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967	57	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80037	10.1371/journal.pone.0080037	http://dx.doi.org/10.1371/journal.pone.0080037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278235	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800045
J	Hughes, AD; Grottoli, AG				Hughes, Adam D.; Grottoli, Andrea G.			Heterotrophic Compensation: A Possible Mechanism for Resilience of Coral Reefs to Global Warming or a Sign of Prolonged Stress?	PLOS ONE			English	Article							BLEACHING EVENT; CLIMATE-CHANGE; STABLE CARBON; TEMPERATURE; ZOOXANTHELLAE; TISSUE; MORTALITY; RECOVERY; BIOMASS; ZOOPLANKTON	Thermally induced bleaching has caused a global decline in corals and the frequency of such bleaching events will increase. Thermal bleaching severely disrupts the trophic behaviour of the coral holobiont, reducing the photosynthetically derived energy available to the coral host. In the short term this reduction in energy transfer from endosymbiotic algae results in an energy deficit for the coral host. If the bleaching event is short-lived then the coral may survive this energy deficit by depleting its lipid reserves, or by increasing heterotrophic energy acquisition. We show for the first time that the coral animal is capable of increasing the amount of heterotrophic carbon incorporated into its tissues for almost a year following bleaching. This prolonged heterotrophic compensation could be a sign of resilience or prolonged stress. If the heterotrophic compensation is in fact an acclimatization response, then this physiological response could act as a buffer from future bleaching by providing sufficient heterotrophic energy to compensate for photoautotrophic energy losses during bleaching, and potentially minimizing the effect of subsequent elevated temperature stresses. However, if the elevated incorporation of zooplankton is a sign that the effects of bleaching continue to be stressful on the holobiont, even after 11 months of recovery, then this physiological response would indicate that complete coral recovery requires more than 11 months to achieve. If coral bleaching becomes an annual global phenomenon by mid-century, then present temporal refugia will not be sufficient to allow coral colonies to recover between bleaching events and coral reefs will become increasingly less resilient to future climate change. If, however, increasing their sequestration of zooplankton-derived nutrition into their tissues over prolonged periods of time is a compensating mechanism, the impacts of annual bleaching may be reduced. Thus, some coral species may be better equipped to face repeated bleaching stress than previously thought.	[Hughes, Adam D.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Grottoli, Andrea G.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA	UHI Millennium Institute; University System of Ohio; Ohio State University	Hughes, AD (corresponding author), Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	adam.hughes@sams.ac.uk	Hughes, Adam D/J-7867-2013; Hughes, Adam D/L-1088-2016		NSF Biological Oceanography Program [0542415]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Emerging Frontiers [1041124] Funding Source: National Science Foundation	NSF Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Major funding for this research was provided by NSF Biological Oceanography Program grant number 0542415 to A. G. A. H. received funding during the preparation of this manuscript from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Bachar A, 2007, J EXP MAR BIOL ECOL, V349, P295, DOI 10.1016/j.jembe.2007.05.030; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox EF, 2007, CORAL REEFS, V26, P721, DOI 10.1007/s00338-007-0251-9; Edmonson CH, 1928, BISHOP MUSEUM B, V45; Edmunds PJ, 2003, CORAL REEFS, V22, P54, DOI 10.1007/s00338-003-0278-5; EDMUNDS PJ, 1994, MAR BIOL, V121, P137, DOI 10.1007/BF00349482; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GLYNN PW, 1973, MAR BIOL, V22, P1, DOI 10.1007/BF00388905; GLYNN PW, 1983, ENVIRON CONSERV, V10, P149, DOI 10.1017/S0376892900012248; GOREAU TF, 1971, BIOL BULL, V141, P247, DOI 10.2307/1540115; GOREAU TJ, 1990, CORAL REEFS, V8, P211, DOI 10.1007/BF00265013; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hill R, 2004, MAR BIOL, V144, P633, DOI 10.1007/s00227-003-1226-1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Hueerkamp C, 2001, B MAR SCI, V69, P215; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Montano S, 2010, HYDROBIOLOGIA, V655, P99, DOI 10.1007/s10750-010-0407-4; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Ortiz JC, 2009, CORAL REEFS, V28, P999, DOI 10.1007/s00338-009-0546-0; Palardy JE, 2008, J EXP MAR BIOL ECOL, V367, P180, DOI 10.1016/j.jembe.2008.09.015; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; Piontkovski SA, 2009, HYDROBIOLOGIA, V632, P365, DOI 10.1007/s10750-009-9854-1; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Quinn NJ, 1999, B MAR SCI, V65, P201; Reynaud S, 2002, MAR ECOL PROG SER, V238, P81, DOI 10.3354/meps238081; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodrigues LJ, 2006, GEOCHIM COSMOCHIM AC, V70, P2781, DOI 10.1016/j.gca.2006.02.014; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; Tada K, 2003, J PLANKTON RES, V25, P991, DOI 10.1093/plankt/25.8.991; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Wilkinson C, 1999, AMBIO, V28, P188	49	82	85	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81172	10.1371/journal.pone.0081172	http://dx.doi.org/10.1371/journal.pone.0081172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278392	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800107
J	Wang, Z; Myers, KG; Guo, YM; Ocampo, MA; Pang, RD; Jakowec, MW; Holschneider, DP				Wang, Zhuo; Myers, Kalisa G.; Guo, Yumei; Ocampo, Marco A.; Pang, Raina D.; Jakowec, Michael W.; Holschneider, Daniel P.			Functional Reorganization of Motor and Limbic Circuits after Exercise Training in a Rat Model of Bilateral Parkinsonism	PLOS ONE			English	Article							UNILATERAL DOPAMINE DEPLETION; RANDOMIZED CONTROLLED-TRIAL; CEREBRAL BLOOD-FLOW; BASAL GANGLIA; SENSORIMOTOR CORTEX; TREADMILL EXERCISE; BRAIN-FUNCTION; 6-HYDROXYDOPAMINE LESIONS; INDICATOR FRACTIONATION; DIFFERENTIAL-DIAGNOSIS	Exercise training is widely used for neurorehabilitation of Parkinson's disease (PD). However, little is known about the functional reorganization of the injured brain after long-term aerobic exercise. We examined the effects of 4 weeks of forced running wheel exercise in a rat model of dopaminergic deafferentation (bilateral, dorsal striatal 6-hydroxydopamine lesions). One week after training, cerebral perfusion was mapped during treadmill walking or at rest using [C-14]-iodoantipyrine autoradiography. Regional cerebral blood flow-related tissue radioactivity (rCBF) was analyzed in three-dimensionally reconstructed brains by statistical parametric mapping. In non-exercised rats, lesions resulted in persistent motor deficits. Compared to sham-lesioned rats, lesioned rats showed altered functional brain activation during walking, including: 1. hypoactivation of the striatum and motor cortex; 2. hyperactivation of non-lesioned areas in the basal ganglia-thalamocortical circuit; 3. functional recruitment of the red nucleus, superior colliculus and somatosensory cortex; 4. hyperactivation of the ventrolateral thalamus, cerebellar vermis and deep nuclei, suggesting recruitment of the cerebellar-thalamocortical circuit; 5. hyperactivation of limbic areas (amygdala, hippocampus, ventral striatum, septum, raphe, insula). These findings show remarkable similarities to imaging findings reported in PD patients. Exercise progressively improved motor deficits in lesioned rats, while increasing activation in dorsal striatum and rostral secondary motor cortex, attenuating a hyperemia of the zona incerta and eliciting a functional reorganization of regions participating in the cerebellar-thalamocortical circuit. Both lesions and exercise increased activation in mesolimbic areas (amygdala, hippocampus, ventral striatum, laterodorsal tegmental n., ventral pallidum), as well as in related paralimbic regions (septum, raphe, insula). Exercise, but not lesioning, resulted in decreases in rCBF in the medial prefrontal cortex (cingulate, prelimbic, infralimbic). Our results in this PD rat model uniquely highlight the breadth of functional reorganizations in motor and limbic circuits following lesion and long-term, aerobic exercise, and provide a framework for understanding the neural substrates underlying exercise-based neurorehabilitation.	[Wang, Zhuo; Myers, Kalisa G.; Guo, Yumei; Ocampo, Marco A.; Pang, Raina D.; Holschneider, Daniel P.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90089 USA; [Jakowec, Michael W.; Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA; [Holschneider, Daniel P.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Holschneider, DP (corresponding author), Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90089 USA.	holschne@usc.edu		Wang, Zhuo/0000-0003-1531-8065; Jakowec, Michael/0000-0002-3318-0197; Holschneider, Daniel/0000-0002-4297-8280	United States National Institute of Child Health & Human Development (NICHD) [1R01HD060630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060630] Funding Source: NIH RePORTER	United States National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported by a United States National Institute of Child Health & Human Development (NICHD) grant 1R01HD060630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Al-Jarrah M, 2007, NEUROSCIENCE, V149, P28, DOI 10.1016/j.neuroscience.2007.07.038; Alberts JL, 2011, EXERC SPORT SCI REV, V39, P177, DOI 10.1097/JES.0b013e31822cc71a; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; BASSO MA, 1993, EXP BRAIN RES, V94, P88; Bays PM, 2005, EXP BRAIN RES, V163, P400, DOI 10.1007/s00221-005-2299-5; Beall EB, 2013, BRAIN CONNECT; Bello O, 2008, MOVEMENT DISORD, V23, P1243, DOI 10.1002/mds.22069; Blandini F, 2007, EUR J NEUROSCI, V25, P397, DOI 10.1111/j.1460-9568.2006.05285.x; Blonder LX, 2011, BEHAV NEUROL, V24, P201, DOI [10.1155/2011/143857, 10.3233/BEN-2011-0329]; Boecker H, 1999, BRAIN, V122, P1651, DOI 10.1093/brain/122.9.1651; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Brosse AL, 2002, SPORTS MED, V32, P741, DOI 10.2165/00007256-200232120-00001; Brownell AL, 2003, NEUROIMAGE, V20, P1064, DOI 10.1016/S1053-8119(03)00348-3; Buot A, 2012, REV NEUROL-FRANCE, V168, P569, DOI 10.1016/j.neurol.2012.06.015; Butson CR, 2007, NEUROIMAGE, V34, P661, DOI 10.1016/j.neuroimage.2006.09.034; CADET JL, 1991, BRAIN RES BULL, V26, P707, DOI 10.1016/0361-9230(91)90164-F; Cakit BD, 2007, CLIN REHABIL, V21, P698, DOI 10.1177/0269215507077269; Ceballos-Baumann AO, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1103-1; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chen L, 2011, BRAIN RES BULL, V85, P329, DOI 10.1016/j.brainresbull.2011.05.009; Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008; Dagher A, 2007, MOL IMAGING BIOL, V9, P234, DOI 10.1007/s11307-007-0089-0; DAHLGREN N, 1981, BRAIN RES, V230, P221, DOI 10.1016/0006-8993(81)90403-0; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; Eckert T, 2005, NEUROIMAGE, V26, P912, DOI 10.1016/j.neuroimage.2005.03.012; Eckert T, 2007, EUR J NUCL MED MOL I, V34, P496, DOI 10.1007/s00259-006-0261-9; Erro ME, 2001, HISTOCHEM CELL BIOL, V115, P447; Feigin A, 2002, MOVEMENT DISORD, V17, P1265, DOI 10.1002/mds.10270; Foley TE, 2008, NEUROMOL MED, V10, P67, DOI 10.1007/s12017-008-8032-3; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Garifoli A, 2003, ARCH ITAL BIOL, V141, P181; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; Greenwood BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046118; Groenewegen HJ, 2004, RAT NERVOUS SYSTEM, P407, DOI [10.1016/B978-012547638-6/50018-3, DOI 10.1016/B978-012547638-6/50018-3]; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Herman T, 2007, ARCH PHYS MED REHAB, V88, P1154, DOI 10.1016/j.apmr.2007.05.015; Hermer-Vazquez L, 2004, BEHAV BRAIN RES, V150, P93, DOI 10.1016/S0166-4328(03)00226-2; Hesse S, 2001, NEUROREHABILITATION, V16, P133; Holschneider DP, 2008, METHODS, V45, P255, DOI 10.1016/j.ymeth.2008.04.006; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; Hoschneider DP, 2007, BRAIN RES, V1184, P96, DOI 10.1016/j.brainres.2007.09.081; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Howells FM, 2005, BEHAV BRAIN RES, V165, P210, DOI 10.1016/j.bbr.2005.06.044; ICHITANI Y, 1994, EXP NEUROL, V130, P269, DOI 10.1006/exnr.1994.1205; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; KARSON CN, 1984, NEUROLOGY, V34, P677, DOI 10.1212/WNL.34.5.677; KELLY PAT, 1982, BRAIN RES, V233, P157, DOI 10.1016/0006-8993(82)90937-4; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Lee T, 2012, J COMP NEUROL, V520, P1021, DOI 10.1002/cne.22767; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Lewis GN, 2002, BRAIN, V125, P2089, DOI 10.1093/brain/awf200; Lin TW, 2012, NEUROBIOL LEARN MEM, V97, P140, DOI 10.1016/j.nlm.2011.10.006; LINDVALL O, 1981, BRAIN RES, V211, P211, DOI 10.1016/0006-8993(81)90086-X; Luft AR, 2008, STROKE, V39, P3341, DOI 10.1161/STROKEAHA.108.527531; Ma YL, 2007, J CEREBR BLOOD F MET, V27, P597, DOI 10.1038/sj.jcbfm.9600358; Ma YL, 2009, NEUROIMAGE, V45, P260, DOI 10.1016/j.neuroimage.2008.09.052; Mabandla MV, 2009, METAB BRAIN DIS, V24, P525, DOI 10.1007/s11011-009-9161-6; McCloskey DP, 2001, BRAIN RES, V891, P168, DOI 10.1016/S0006-8993(00)03200-5; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Metz GA, 2004, BRAIN RES, V1026, P126, DOI 10.1016/j.brainres.2004.08.025; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miyai I, 2002, ARCH PHYS MED REHAB, V83, P1370, DOI 10.1053/apmr.2002.34603; Moore RY, 2008, NEUROBIOL DIS, V29, P381, DOI 10.1016/j.nbd.2007.09.004; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nakao N, 1998, J NEUROSCI, V18, P1806; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Niethammer M, 2012, ANN NEUROL, V72, P635, DOI 10.1002/ana.23631; Nikfekr E, 2002, MOVEMENT DISORD, V17, P274, DOI 10.1002/mds.10073; Nuckolls AL, 2012, BEHAV BRAIN RES, V234, P343, DOI 10.1016/j.bbr.2012.07.003; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Dell SJ, 2007, NEUROSCIENCE, V144, P1141, DOI 10.1016/j.neuroscience.2006.10.042; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; Panzer S, 2006, J MOTOR BEHAV, V38, P60, DOI 10.3200/JMBR.38.1.60-70; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Paxinos G., 2007, RAT BRAIN STEREOTACT; Pelled G, 2002, EUR J NEUROSCI, V15, P389, DOI 10.1046/j.0953-816x.2001.01866.x; Perier C, 2000, EXP NEUROL, V162, P215, DOI 10.1006/exnr.1999.7331; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; PORTER RHP, 1994, J NEUROSCI, V14, P7192; Rane P, 2011, NEUROSCIENCE, V181, P189, DOI 10.1016/j.neuroscience.2011.03.001; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; ROBERTS DCS, 1975, BRAIN RES, V93, P441, DOI 10.1016/0006-8993(75)90182-1; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Rowe JB, 2012, NEUROIMAGE, V61, P464, DOI 10.1016/j.neuroimage.2011.12.042; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Sampedro-Piquero P, 2013, BRAIN RES, V1502, P20, DOI 10.1016/j.brainres.2012.12.036; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SCHALLERT T, 1988, ANN NY ACAD SCI, V515, P108, DOI 10.1111/j.1749-6632.1988.tb32972.x; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; SCHALLERT T, 1988, BEHAV BRAIN RES, V30, P15, DOI 10.1016/0166-4328(88)90003-4; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; Small GW, 2006, AM J GERIAT PSYCHIAT, V14, P538, DOI 10.1097/01.JGP.0000219279.72210.ca; Stumpf WE, 1995, AUTORADIOGRAPHY CORR, P67; Tashiro M, 2008, METHODS, V45, P300, DOI 10.1016/j.ymeth.2008.05.001; Toma Keiichiro, 2002, Magn Reson Med Sci, V1, P109, DOI 10.2463/mrms.1.109; TRUGMAN JM, 1987, J NEUROSCI, V7, P2927; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; van Eimeren T, 2006, CURR OPIN NEUROL, V19, P412, DOI 10.1097/01.wco.0000236623.68625.54; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wachter T, 2010, EXP BRAIN RES, V200, P319, DOI 10.1007/s00221-009-2027-7; Wang Z, 2012, FUNCTIONAL BRAIN MAP; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023; Yang J, 2007, NEUROIMAGE, V36, P755, DOI 10.1016/j.neuroimage.2007.03.010; Yoon MC, 2007, NEUROSCI LETT, V423, P12, DOI 10.1016/j.neulet.2007.06.031; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zheng H, 2006, BEHAV BRAIN RES, V168, P47, DOI 10.1016/j.bbr.2005.10.007	124	44	44	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80058	10.1371/journal.pone.0080058	http://dx.doi.org/10.1371/journal.pone.0080058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278239	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800049
J	Cho, A; Haruyama, N; Hall, B; Danton, MJS; Zhang, L; Arany, P; Mooney, DJ; Harichane, Y; Goldberg, M; Gibson, CW; Kulkarni, AB				Cho, Andrew; Haruyama, Naoto; Hall, Bradford; Danton, Mary Jo S.; Zhang, Lu; Arany, Praveen; Mooney, David J.; Harichane, Yassine; Goldberg, Michel; Gibson, Carolyn W.; Kulkarni, Ashok B.			TGF-beta Regulates Enamel Mineralization and Maturation through KLK4 Expression	PLOS ONE			English	Article							AMELOGENESIS IMPERFECTA PHENOTYPE; MATRIX-METALLOPROTEINASE 20; MICE DISPLAY; NULL MICE; AMELOBLASTS; APOPTOSIS; DEFECTS; TOOTH; GENE; DIFFERENTIATION	Transforming growth factor-beta (TGF-beta) signaling plays an important role in regulating crucial biological processes such as cell proliferation, differentiation, apoptosis, and extracellular matrix remodeling. Many of these processes are also an integral part of amelogenesis. In order to delineate a precise role of TGF-beta signaling during amelogenesis, we developed a transgenic mouse line that harbors bovine amelogenin promoter-driven Cre recombinase, and bred this line with TGF-beta receptor II floxed mice to generate ameloblast-specific TGF-beta receptor II conditional knockout (cKO) mice. Histological analysis of the teeth at postnatal day 7 (P7) showed altered enamel matrix composition in the cKO mice as compared to the floxed mice that had enamel similar to the wild-type mice. The mu CT and SEM analyses revealed decreased mineral content in the cKO enamel concomitant with increased attrition and thinner enamel crystallites. Although the mRNA levels remained unaltered, immunostaining revealed increased amelogenin, ameloblastin, and enamelin localization in the cKO enamel at the maturation stage. Interestingly, KLK4 mRNA levels were significantly reduced in the cKO teeth along with a slight increase in MMP-20 levels, suggesting that normal enamel maturation is regulated by TGF-beta signaling through the expression of KLK4. Thus, our study indicates that TGF-beta signaling plays an important role in ameloblast functions and enamel maturation.	[Cho, Andrew; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Gene Transfer Core, NIH, Bethesda, MD USA; [Cho, Andrew; Haruyama, Naoto; Hall, Bradford; Danton, Mary Jo S.; Zhang, Lu; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Haruyama, Naoto] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan; [Arany, Praveen; Mooney, David J.] Harvard Univ, Cambridge, MA 02138 USA; [Harichane, Yassine; Goldberg, Michel] Univ Paris 05, Paris, France; [Gibson, Carolyn W.] Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tokyo Medical & Dental University (TMDU); Harvard University; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, Gene Transfer Core, NIH, Bethesda, MD USA.	ak40m@nih.gov	Arany, Praveen/S-5329-2019; Haruyama, Naoto/D-1993-2011	Arany, Praveen/0000-0002-6116-2340; Haruyama, Naoto/0000-0001-6225-5816; Mooney, David/0000-0001-6299-1194	Division of Intramural Research, NIDCR, NIH; System Consortium on Organ Design and Engineering [R01DE019023-01]; JSPS KAKENHI [22792040]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000741, ZIADE000664] Funding Source: NIH RePORTER	Division of Intramural Research, NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); System Consortium on Organ Design and Engineering; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Division of Intramural Research, NIDCR, NIH (ABK), System Consortium on Organ Design and Engineering (DJM, R01DE019023-01), and JSPS KAKENHI (#22792040 to NH). The funders had no role in study, data collection and analysis, decision to publish, or preparation of the abstract.	Bartlett JD, 2011, EUR J ORAL SCI, V119, P199, DOI 10.1111/j.1600-0722.2011.00864.x; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chai Y, 1999, MECH DEVELOP, V86, P63, DOI 10.1016/S0925-4773(99)00112-4; CHEN EH, 1994, DEV DYNAM, V199, P189, DOI 10.1002/aja.1001990304; Cho Andrew, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1911s42; Chun YHP, 2010, J DENT RES, V89, P1414, DOI 10.1177/0022034510379223; DSOUZA RN, 1990, ARCH ORAL BIOL, V35, P957, DOI 10.1016/0003-9969(90)90015-3; DSOUZA RN, 1998, INT J ORAL BIOL, V23, P119; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gao YG, 2009, ANAT REC, V292, P885, DOI 10.1002/ar.20901; Gibson CW, 2008, CRIT REV EUKAR GENE, V18, P345, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.30; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Harichane Y, 2011, EUR J ORAL SCI, V119, P177, DOI 10.1111/j.1600-0722.2011.00908.x; Haruyama N, 2006, EUR J ORAL SCI, V114, P30, DOI 10.1111/j.1600-0722.2006.00276.x; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu YY, 2011, EUR J ORAL SCI, V119, P217, DOI 10.1111/j.1600-0722.2011.00859.x; Kim SG, 2004, MOL BIOL CELL, V15, P420, DOI 10.1091/mbc.E03-04-0201; Klopcic B, 2007, EUR J CELL BIOL, V86, P781, DOI 10.1016/j.ejcb.2007.03.005; Kulkarni Ashok B., 2002, Current Molecular Medicine (Hilversum), V2, P303; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Prime SS, 2004, CRIT REV ORAL BIOL M, V15, P324, DOI 10.1177/154411130401500602; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Smith CE, 2011, J BIOL CHEM, V286, P18149, DOI 10.1074/jbc.M110.194258; Sreenath TL, 2003, GENESIS, V35, P94, DOI 10.1002/gene.10170; Torres-Quintana Maria Angelica, 2005, J Oral Sci, V47, P27, DOI 10.2334/josnusd.47.27; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P206, DOI 10.1111/j.1600-0722.2011.00866.x; Yokozeki M, 2003, BIOCHEM BIOPH RES CO, V305, P684, DOI 10.1016/S0006-291X(03)00806-4	35	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e82267	10.1371/journal.pone.0082267	http://dx.doi.org/10.1371/journal.pone.0082267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278477	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100168
J	Ruddock, K; August, PV; Damon, C; LaBash, C; Rubinoff, P; Robadue, D				Ruddock, Kevin; August, Peter V.; Damon, Christopher; LaBash, Charles; Rubinoff, Pamela; Robadue, Donald			Conservation in the Context of Climate Change: Practical Guidelines for Land Protection at Local Scales	PLOS ONE			English	Article							GEOMORPHOLOGICAL HETEROGENEITY; BIODIVERSITY; FUTURE; REPRESENTATION; STRATEGIES; MOUNTAINS; UNITS; AREA	Climate change will affect the composition of plant and animal communities in many habitats and geographic settings. This presents a dilemma for conservation programs - will the portfolio of protected lands we now have achieve a goal of conserving biodiversity in the future when the ecological communities occurring within them change? Climate change will significantly alter many plant communities, but the geophysical underpinnings of these landscapes, such as landform, elevation, soil, and geological properties, will largely remain the same. Studies show that extant landscapes with a diversity of geophysical characteristics support diverse plant and animal communities. Therefore, geophysically diverse landscapes will likely support diverse species assemblages in the future, although which species and communities will be present is not altogether clear. Following protocols advanced in studies spanning large regions, we developed a down-scaled, high spatial resolution measure of geophysical complexity based on Ecological Land Units (ELUs) and examined the relationship between plant species richness, ecological community richness, and ELU richness (number of different ELU types). We found that extant landscapes with high ELU richness had a greater variety of ecological community types and high species richness of trees, shrubs, and herbaceous plants. We developed a spatial representation of diverse ELU landscapes to inform local conservation practitioners, such as land trusts, of potential conservation targets that will likely support diverse faunas and floras despite the impact of climate change.	[Ruddock, Kevin] Nature Conservancy, Rhode Isl Chapter, Providence, RI USA; [August, Peter V.; Damon, Christopher; LaBash, Charles] Univ Rhode Isl, Dept Nat Resources Sci, Environm Data Ctr, Kingston, RI 02881 USA; [Rubinoff, Pamela; Robadue, Donald] Univ Rhode Isl, Grad Sch Oceanog, Coastal Resources Ctr, Narragansett, RI 02882 USA	University of Rhode Island; University of Rhode Island	August, PV (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Environm Data Ctr, Kingston, RI 02881 USA.	pete@edc.uri.edu			US Department of Agriculture Renewable Resource Extension Act; Sea Grant College Program of Rhode Island; Rhode Island Coastal Resources Management Council; US Department of Commerce National Oceanic and Atmospheric Administration	US Department of Agriculture Renewable Resource Extension Act; Sea Grant College Program of Rhode Island; Rhode Island Coastal Resources Management Council; US Department of Commerce National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This research was supported by grants from the US Department of Agriculture Renewable Resource Extension Act, the Sea Grant College Program of Rhode Island, the Rhode Island Coastal Resources Management Council, and the US Department of Commerce National Oceanic and Atmospheric Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; ANDERSON MG, 1999, THESIS U NEW HAMPSHI; August P, ENCY NATURAL RESOURC; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Burnett MR, 1998, CONSERV BIOL, V12, P363, DOI 10.1046/j.1523-1739.1998.96238.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Fels JE, 1996, P 3 NCGIA INT C WORK; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Franklin J, 2003, FOREST SCI, V49, P354; Frumhoff PC, 2007, CONFRONTING CLIMATE; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hjort J, 2012, BIODIVERS CONSERV, V21, P3487, DOI 10.1007/s10531-012-0376-1; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Huston M. A., 1994, BIOL DIVERSITY; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Kintsch JA, 2002, CONSERV BIOL, V16, P936, DOI 10.1046/j.1523-1739.2002.00542.x; Langpap C, 2012, J ENVIRON ECON MANAG, V64, P1, DOI 10.1016/j.jeem.2012.02.002; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Maune D.F., 2007, DIGITAL ELEVATION MO; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nichols W, 1996, THESIS U RHODE ISLAN; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Notaro M, 2012, ECOL APPL, V22, P1365, DOI 10.1890/11-1269.1; Olson D, 2009, NAT AREA J, V29, P394, DOI 10.3375/043.029.0406; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; R Core Team, 2021, R LANGUAGE ENV STAT; Rapacciuolo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040212; Shellito BA, 2011, INTRO GEOSPATIAL TEC; Strager MP, 2007, J ENVIRON MANAGE, V82, P290, DOI 10.1016/j.jenvman.2006.01.007; Theobald DM, 2002, CONSERV ECOL, V6; Vacher KA, 2007, LANDSCAPE ECOL, V22, P821, DOI 10.1007/s10980-007-9087-5; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Zimmerman CL, 2010, NAT AREA J, V30, P27, DOI 10.3375/043.030.0104	43	2	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80874	10.1371/journal.pone.0080874	http://dx.doi.org/10.1371/journal.pone.0080874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278336	Green Published, gold			2022-12-27	WOS:000327313100121
J	Sarrafchi, A; Odhammer, AME; Salazar, LTH; Laska, M				Sarrafchi, Amir; Odhammer, Anna M. E.; Hernandez Salazar, Laura Teresa; Laska, Matthias			Olfactory Sensitivity for Six Predator Odorants in CD-1 Mice, Human Subjects, and Spider Monkeys	PLOS ONE			English	Article							ATELES-GEOFFROYI; NONHUMAN-PRIMATES; DISCRIMINATION ABILITY; VOLATILE COMPONENTS; ALIPHATIC-ALDEHYDES; SULFUR-COMPOUNDS; ORAL MALODOR; FECAL SCENTS; RESPONSES; RECEPTOR	Using a conditioning paradigm, we assessed the olfactory sensitivity of six CD-1 mice (Mus musculus) for six sulfur-containing odorants known to be components of the odors of natural predators of the mouse. With all six odorants, the mice discriminated concentrations <0.1 ppm (parts per million) from the solvent, and with five of the six odorants the best-scoring animals were even able to detect concentrations <1 ppt (parts per trillion). Four female spider monkeys (Ateles geoffroyi) and twelve human subjects (Homo sapiens) tested in parallel were found to detect the same six odorants at concentrations <0.01 ppm, and with four of the six odorants the best-scoring animals and subjects even detected concentrations <10 ppt. With all three species, the threshold values obtained here are generally lower than (or in the lower range of) those reported for other chemical classes tested previously, suggesting that sulfur-containing odorants may play a special role in olfaction. Across-species comparisons showed that the mice were significantly more sensitive than the human subjects and the spider monkeys with four of the six predator odorants. However, the human subjects were significantly more sensitive than the mice with the remaining two odorants. Human subjects and spider monkeys significantly differed in their sensitivity with only two of the six odorants. These comparisons lend further support to the notion that the number of functional olfactory receptor genes or the relative or absolute size of the olfactory bulbs are poor predictors of a species' olfactory sensitivity. Analysis of odor structure-activity relationships showed that in both mice and human subjects the type of alkyl rest attached to a thietane and the type of oxygen moiety attached to a thiol significantly affected olfactory sensitivity.	[Sarrafchi, Amir; Odhammer, Anna M. E.; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Hernandez Salazar, Laura Teresa] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico	Linkoping University; Universidad Veracruzana	Laska, M (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	malas@ifm.liu.se	Salazar, Laura Teresa Hernández/E-7378-2012	Salazar, Laura Teresa Hernández/0000-0001-7567-8068; Laska, Matthias/0000-0001-5583-2697	CONACYT Mexico [J-51435-IV]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was financially supported by a grant (J-51435-IV) from CONACYT Mexico (www.conacyt.mx) to LTHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MH, 2002, CHEM SENSES, V27, P95, DOI 10.1093/chemse/27.2.95; Anderson KK, 1980, NATURAL SULFUR COMPO, P399; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Belton LE, 2007, AFR ZOOL, V42, P135, DOI 10.3377/1562-7020(2007)42[135:DCGSXI]2.0.CO;2; Blank I., 2002, HETEROATOMIC AROMA C, P25; Blumstein DT, 2008, ETHOLOGY, V114, P1135, DOI 10.1111/j.1439-0310.2008.01563.x; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bramley GN, 2000, J CHEM ECOL, V26, P705, DOI 10.1023/A:1005432322861; Brechuhl J, 2013, P NATL ACAD SCI USA, V110, P4762, DOI 10.1073/pnas.1214249110; BRINCK C, 1983, J CHEM ECOL, V9, P727, DOI 10.1007/BF00988779; BUCHANANSMITH HM, 1993, ANIM WELFARE, V2, P17; CAINE NG, 1989, BIOTROPICA, V21, P186, DOI 10.2307/2388709; Conover M. R., 2007, PREDATOR PREY DYNAMI; Duan XF, 2012, P NATL ACAD SCI USA, V109, P3492, DOI 10.1073/pnas.1111297109; Dykyi J., 2001, LANDOLT BORNSTEIN C, V20; EPPLE G, 1995, ECOL APPL, V5, P1163, DOI 10.2307/2269363; Erwin, 1988, COMP PRIMATE BIOL, V4, P1; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Guven SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034301; Hacquemand R, 2013, BEHAV BRAIN RES, V238, P227, DOI 10.1016/j.bbr.2012.10.014; Jaeger SR, 2010, FOOD QUAL PREFER, V21, P121, DOI 10.1016/j.foodqual.2009.08.011; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; JORGENSON JW, 1978, SCIENCE, V199, P796, DOI 10.1126/science.199.4330.796; Joshi D, 2006, CHEM SENSES, V31, P655, DOI 10.1093/chemse/bjl006; KAMIYA A, 1984, J CHROMATOGR, V292, P383, DOI 10.1016/S0021-9673(01)83617-7; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kjeldmand L, 2011, J COMP PHYSIOL A, V197, P15, DOI 10.1007/s00359-010-0580-y; Krespi YP, 2006, OTOLARYNG HEAD NECK, V135, P671, DOI 10.1016/j.otohns.2005.09.036; Laidre ME, 2009, J COMP PSYCHOL, V123, P34, DOI 10.1037/a0013129; Larsson L, 2011, NEUROSCI RES, V71, P355, DOI 10.1016/j.neures.2011.08.009; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laska M, 2006, AM J PHYS ANTHROPOL, V129, P112, DOI 10.1002/ajpa.20252; Laska M, 2005, CHEM SENSES, V30, P505, DOI 10.1093/chemse/bji043; Laska M, 2005, PHYSIOL BEHAV, V84, P211, DOI 10.1016/j.physbeh.2004.11.006; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Laska M, 2004, CHEM SENSES, V29, P143, DOI 10.1093/chemse/bjh019; Laska M, 2004, CHEM SENSES, V29, P101, DOI 10.1093/chemse/bjh010; Laska M, 2003, PHYSIOL BEHAV, V78, P321, DOI 10.1016/S0031-9384(02)00976-9; Laska M, 2007, J EXP BIOL, V210, P4169, DOI 10.1242/jeb.012237; Laska M, 2006, J CHEM ECOL, V32, P1317, DOI 10.1007/s10886-006-9090-3; Laska M, 2006, J COMP PSYCHOL, V120, P106, DOI 10.1037/0735-7036.120.2.106; Laska M, 2010, ATTEN PERCEPT PSYCHO, V72, P806, DOI 10.3758/APP.72.3.806; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; LEONARDOS G, 1969, Journal of the Air Pollution Control Association, V19, P91; Liborio RA, 2013, STUD NEOTROP FAUNA E, V48, P81, DOI 10.1080/01650521.2013.789724; Lotvedt PK, 2012, PHARMACOL BIOCHEM BE, V101, P450, DOI 10.1016/j.pbb.2012.02.013; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; MATTINA MJI, 1991, J CHEM ECOL, V17, P451, DOI 10.1007/BF00994344; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; NOLTE DL, 1994, J CHEM ECOL, V20, P1505, DOI 10.1007/BF02059876; Porter SR, 2006, BMJ-BRIT MED J, V333, P632, DOI 10.1136/bmj.38954.631968.AE; Salazar LTH, 2003, BEHAV NEUROSCI, V117, P1142, DOI 10.1037/0735-7044.117.6.1142; Sbarbati A, 2006, CELLS TISSUES ORGANS, V183, P206, DOI 10.1159/000096511; Sundermann D, 2008, J COMP PSYCHOL, V122, P146, DOI 10.1037/0735-7036.122.2.146; SULLIVAN TP, 1984, J CHEM ECOL, V10, P1809, DOI 10.1007/BF00987363; TONZETICH J, 1978, J INT MED RES, V6, P245, DOI 10.1177/030006057800600313; Van Gemert L. J.., 2011, ODOUR THRESHOLDS COM, V2nd; Wallen H, 2012, AMINO ACIDS, V42, P1475, DOI 10.1007/s00726-011-0951-x; Wang JY, 2003, P NATL ACAD SCI USA, V100, P3035, DOI 10.1073/pnas.262792899; Weast RC., 1987, HDB CHEM PHYS, V68; Wood WF, 2002, J CHEM ECOL, V28, P1865, DOI 10.1023/A:1020573404341; WOOLHOUSE AD, 1995, J CHEM ECOL, V21, P1571, DOI 10.1007/BF02035153; Zhang JX, 2002, J CHEM ECOL, V28, P1287, DOI 10.1023/A:1016246120479	65	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80621	10.1371/journal.pone.0080621	http://dx.doi.org/10.1371/journal.pone.0080621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278296	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100096
J	Mitsuishi, T; Ohsawa, I; Kato, T; Egawa, N; Kiyono, T				Mitsuishi, Tsuyoshi; Ohsawa, Ikuroh; Kato, Toshihiko; Egawa, Nagayasu; Kiyono, Tohru			Molecular Cloning and Characterisation of a Novel Type of Human Papillomavirus 160 Isolated from a Flat Wart of an Immunocompetent Patient	PLOS ONE			English	Article							E6; PROTEIN; INACTIVATION; ONCOPROTEIN; BINDING; DOMAIN	More than 150 types of Human papillomaviruses (HPVs) have been isolated from numerous cutaneous and/or mucosal lesions. Flat wart samples on the face from 36 immunocompetent patients were collected and screened for HPV. From one sample, we cloned a putative novel genotype. The novel type consisted of 7779 bp in length with a GC content of 47.1%, containing open reading frames for putative early proteins (E1, E2, E4, E6, and E7) and two late proteins (L1 and L2). Homology searches and phylogenetic analyses indicated that it belonged to Alphapapillomavirus (Alpha-PV) species 2 and most closely resembled HPV 3. The virus fulfilled the definition of a novel type, and was named HPV 160 by the Reference Center for Papillomaviruses. The putative E7 protein of HPV 160 as well as HPV 29, 77, and 78 contained the Leu-X-Cys-X-Glu pRB-binding motif but other Alpha-PV species 2 (HPV 3, 10, 28, 94, 117, and 125) did not have this conserved motif.	[Mitsuishi, Tsuyoshi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Dermatol, Yachiyo City, Chiba, Japan; [Ohsawa, Ikuroh] Tokyo Metropolitan Inst Gerontol, Dept Biol Proc Aging, Tokyo, Japan; [Kato, Toshihiko] Nippon Med Sch, Res Inst Vaccine Therapy Tumours & Infect Dis, Tokyo 113, Japan; [Egawa, Nagayasu; Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 104, Japan	Tokyo Women's Medical University; Tokyo Metropolitan Institute of Gerontology; Nippon Medical School; National Cancer Center - Japan	Mitsuishi, T (corresponding author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Dermatol, Yachiyo City, Chiba, Japan.	tmitsu@tymc.twmu.ac.jp; tkiyono@ncc.go.jp			Grants-in-Aid for Scientific Research [24500882] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Boulet G, 2007, INT J BIOCHEM CELL B, V39, P2006, DOI 10.1016/j.biocel.2007.07.004; Cardoso JC, 2011, ACTA DERMATOVEN ALP, V20, P145; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V13, DOI [10.1016/j.virol.2013.04.023, DOI 10.1016/J.VIR0L.2013.04.023.[]; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022529; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; MORAN E, 1993, CURR OPIN GENET DEV, V3, P63, DOI 10.1016/S0959-437X(05)80342-9; Narechania A, 2004, J GEN VIROL, V85, P1243, DOI 10.1099/vir.0.19765-0; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Sasagawa T, 2012, J MED VIROL, V84, P138, DOI 10.1002/jmv.22195; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueno T, 2006, ONCOGENE, V25, P4155, DOI 10.1038/sj.onc.1209445; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	23	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e79592	10.1371/journal.pone.0079592	http://dx.doi.org/10.1371/journal.pone.0079592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24282509	Green Submitted, gold, Green Published			2022-12-27	WOS:000327216200079
J	Diez-Leon, M; Bowman, J; Bursian, S; Filion, H; Galicia, D; Kanefsky, J; Napolitano, A; Palme, R; Schulte-Hostedde, A; Scribner, K; Mason, G				Diez-Leon, Maria; Bowman, Jeff; Bursian, Steve; Filion, Helene; Galicia, David; Kanefsky, Jeannette; Napolitano, Angelo; Palme, Rupert; Schulte-Hostedde, Albrecht; Scribner, Kim; Mason, Georgia			Environmentally Enriched Male Mink Gain More Copulations than Stereotypic, Barren-Reared Competitors	PLOS ONE			English	Article							FERRETS MUSTELA-NIGRIPES; INFLUENCING REPRODUCTIVE SUCCESS; FLUCTUATING ASYMMETRY; MATE CHOICE; AILUROPODA-MELANOLEUCA; SPECIES-DIFFERENCES; BREEDING SUCCESS; FEMALE CHOICE; STRESS; BEHAVIOR	Wild carnivores in zoos, conservation breeding centres, and farms commonly live in relatively small, unstimulating enclosures. Under these captive conditions, in a range of species including giant pandas, black-footed ferrets, and European mink, male reproductive abilities are often poor. Such problems have long been hypothesized to be caused by these animals' housing conditions. We show for the first time that rearing under welfare-improving (i.e., highly valued and stress-reducing) environmental enrichments enhances male carnivores' copulatory performance: in mate choice competitions, enriched male American mink (Neovison vison) mated more often than non-enriched males. We screened for several potential mediators of this effect. First was physiological stress and its impact on reproductive physiology; second, stress-mediated changes in morphology and variables related to immunocompetence that could influence male attractiveness; and third, behavioural changes likely to affect social competence, particularly autistic-like excessive routine and repetition ('perseveration') as is reflected in the stereotypies common in captive animals. Consistent with physiological stress, excreted steroid metabolites revealed that non-enriched males had higher cortisol levels and lower androgen levels than enriched conspecifics. Their os penises (bacula) also tended to be less developed. Consistent with reduced attractiveness, non-enriched males were lighter, with comparatively small spleens and a trend to greater fluctuating asymmetry. Consistent with impaired social competence, non-enriched males performed more stereotypic behaviour (e. g., pacing) in their home cages. Of all these effects, the only significant predictor of copulation number was stereotypy (a trend suggesting that low bodyweights may also be influential): highly stereotypic males gained the fewest copulations. The neurophysiological changes underlying stereotypy thus handicap males sexually. We hypothesise that such males are abnormally perseverative when interacting with females. Investigating similar problems in other taxa would be worthwhile, since many vertebrates, wild and domestic, live in conditions that cause stereotypic behaviour and/or impair neurological development.	[Diez-Leon, Maria; Mason, Georgia] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Bowman, Jeff] Trent Univ, Wildlife Res & Dev Sect, Ontario Minist Nat Resources, Peterborough, ON K9J 7B8, Canada; [Bursian, Steve; Napolitano, Angelo] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Filion, Helene; Schulte-Hostedde, Albrecht] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada; [Galicia, David] Univ Navarra, Dept Zool & Ecol, E-31080 Pamplona, Spain; [Kanefsky, Jeannette; Scribner, Kim] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Palme, Rupert] Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria	University of Guelph; Ministry of Natural Resources & Forestry; Trent University; Michigan State University; Laurentian University; University of Navarra; Michigan State University; University of Veterinary Medicine Vienna	Mason, G (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	gmason@uoguelph.ca	Palme, Rupert/A-3499-2008; Schulte-Hostedde, Albrecht/C-2007-2009; Bowman, Jeff/B-4147-2009; Galicia, David/H-7718-2012	Palme, Rupert/0000-0001-9466-3662; Bowman, Jeff/0000-0002-1892-4469; Galicia, David/0000-0002-2585-9888; Diez Leon, Maria/0000-0002-0105-7039	Basque Government; Natural Science and Engineering Research Council of Canada; Ontario Ministry of Natural Resources; Canadian Mink Breeders Association; Mink Farmers Research Foundation	Basque Government(Basque Government); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Natural Resources; Canadian Mink Breeders Association; Mink Farmers Research Foundation	The sources of funding that have supported this work are: the Basque Government, the Natural Science and Engineering Research Council of Canada, the Ontario Ministry of Natural Resources, the Canadian Mink Breeders Association and the Mink Farmers Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Ismail UA, 2011, LAB ANIM-UK, V45, P145, DOI 10.1258/la.2011.010149; Badyaev AV, 2005, AM NAT, V166, P382, DOI 10.1086/432559; Badyaev AV, 2000, ECOLOGY, V81, P336, DOI 10.1890/0012-9658(2000)081[0336:SADSVR]2.0.CO;2; Barbato A, 2004, QUAL LIFE RES, V13, P969, DOI 10.1023/B:QURE.0000025601.05350.7c; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berejikian BA, 2001, CAN J FISH AQUAT SCI, V58, P804, DOI 10.1139/cjfas-58-4-804; Bhui K, 1997, SOC PSYCH PSYCH EPID, V32, P459; Biggins DE, 2003, CR BIOL, V326, pS104, DOI 10.1016/S1631-0691(03)00046-5; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; BLANCHARD DC, 1995, PSYCHONEUROENDOCRINO, V20, P117, DOI 10.1016/0306-4530(94)E0045-B; Bogartz RS, 2005, POOLING ERROR TERMS; Boogert NJ, 2011, BEHAV ECOL, V22, P447, DOI 10.1093/beheco/arq173; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Branvold HA, 2003, ZOO BIOL, V22, P1, DOI 10.1002/zoo.10066; Bronson E, 2007, J ZOO WILDLIFE MED, V38, P169, DOI 10.1638/1042-7260(2007)038[0169:MOCBFM]2.0.CO;2; Broom D. M., 2007, Domestic animal behaviour and welfare, DOI 10.1079/9781845932879.0000; Buob M, 2013, APPL ANIM BEHAV SCI, V147, P194, DOI 10.1016/j.applanim.2013.05.004; Campbell DLM, 2013, BEHAV BRAIN RES, V239, P177, DOI 10.1016/j.bbr.2012.11.004; Carlstead K, 2005, ZOO BIOL, V24, P215, DOI 10.1002/zoo.20050; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Carvalho AFU, 2009, BRAZ J BIOL, V69, P153, DOI 10.1590/S1519-69842009000100020; Cauchard L, 2013, ANIM BEHAV, V85, P19, DOI 10.1016/j.anbehav.2012.10.005; CHENOWETH PJ, 1979, THERIOGENOLOGY, V12, P223, DOI 10.1016/0093-691X(79)90006-2; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; COLLIER RJ, 1982, J DAIRY SCI, V65, P2213, DOI 10.3168/jds.S0022-0302(82)82484-3; Cooper J, 1998, VET REC, V143, P359, DOI 10.1136/vr.143.13.359; Corbin E, 2008, MAMMAL REV, V38, P108, DOI 10.1111/j.1365-2907.2007.00112.x; Dallaire JA, 2012, APPL ANIM BEHAV SCI, V142, P98, DOI 10.1016/j.applanim.2012.09.012; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Diaz-Fleischer F, 2009, J EXP BIOL, V212, P2119, DOI 10.1242/jeb.027342; Dodzi MS, 2011, APPL ANIM BEHAV SCI, V133, P11, DOI 10.1016/j.applanim.2011.04.014; Doncaster CP, 2007, ANALYSIS OF VARIANCE AND COVARIANCE: HOW TO CHOOSE AND CONSTRUCT MODELS FOR THE LIFE SCIENCES, P1, DOI 10.1017/CBO9780511611377; Dukas R, 2003, ANIM BEHAV, V66, P741, DOI 10.1006/anbe.2002.2261; Dunstone N., 1993, MINK; ELDER WH, 1951, J MAMMAL, V32, P43, DOI 10.2307/1375411; Fleming MA, 1999, MOL ECOL, V8, P1352, DOI 10.1046/j.1365-294X.1999.00701_2.x; Galicia Paredes D, 2006, ANALISIS ASIMETRIA F; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Garner JP, 1999, AETIOLOGY STEREOTYPY; GIBSON RM, 1982, BEHAVIOUR, V80, P9, DOI 10.1163/156853982X00418; GILBERT FF, 1969, J MAMMAL, V50, P625, DOI 10.2307/1378797; Ginsberg J. R., 1994, P365; Gotz AA, 2008, PHYSIOL BEHAV, V93, P1055, DOI 10.1016/j.physbeh.2008.01.009; Grafen A., 2002, MODERN STAT LIFE SCI; Gronli J, 2005, PHYSIOL BEHAV, V84, P571, DOI 10.1016/j.physbeh.2005.02.007; Hansen SW, 2007, ANIM WELFARE, V16, P63; Hardy MP, 2002, BIOL REPROD, V67, P1750, DOI 10.1095/biolreprod.102.006312; Hellstedt P, 2005, J ZOOL, V266, P37, DOI 10.1017/S0952836905006618; Herrick JR, 2010, BIOL REPROD, V82, P552, DOI 10.1095/biolreprod.109.081034; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Howard J., 2007, ZOO WILD ANIMAL MED, V6th, pp272; Jeppesen LL, 2000, APPL ANIM BEHAV SCI, V68, P85, DOI 10.1016/S0168-1591(00)00099-X; Jones RSP, 1999, BEHAV INTERVENT, V14, P45, DOI 10.1002/(SICI)1099-078X(199901/03)14:1<45::AID-BIN27>3.0.CO;2-0; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kiik K, 2013, ZOO BIOL, V32, P387, DOI 10.1002/zoo.21062; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Lam KSL, 2008, J CHILD PSYCHOL PSYC, V49, P1193, DOI 10.1111/j.1469-7610.2008.01944.x; LATORRE JC, 1968, EXP NEUROL, V22, P493, DOI 10.1016/0014-4886(68)90144-1; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Levine TR, 2002, COMMUN MONOGR, V69, P132, DOI 10.1080/714041709; Lindburg DG, 2001, STEREOTYPED BEHAV GI, P189; Loeffler K, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P323, DOI 10.1016/B978-1-4377-7813-7.00018-5; Lombardo Michael P., 2009, International Studies on Sparrows, V33, P5; Loyau A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1043, DOI 10.1007/s00265-006-0337-3; Ludwig W., 1932, RECHTS LINKS PROBLEM; Malmkvist J, 2011, STRESS, V14, P312, DOI 10.3109/10253890.2010.547640; Martin MS, 2012, CONSERV BIOL, V26, P649, DOI 10.1111/j.1523-1739.2012.01880.x; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; MASON GJ, 1993, BEHAVIOUR, V127, P191, DOI 10.1163/156853993X00029; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Meagher R, 2011, WELFARE SIGNIFICANCE; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Minitab, 2008, MINITAB REL 14 1; Mitchell WA, 2006, BIOGERONTOLOGY, V7, P461, DOI 10.1007/s10522-006-9061-7; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; MOLLER AP, 1993, J EVOLUTION BIOL, V6, P481, DOI 10.1046/j.1420-9101.1993.6040481.x; Moller AP, 1997, ASYMMETRY DEV STABIL; Morais RN, 2002, THERIOGENOLOGY, V57, P2027, DOI 10.1016/S0093-691X(02)00707-0; Morato RG, 2001, REPRODUCTION, V122, P745, DOI 10.1530/reprod/122.5.745; Muehlmann AM, 2012, J INTELL DISABIL RES, V56, P427, DOI 10.1111/j.1365-2788.2011.01519.x; Murphy B.D., 1974, Dissertation Abstr lnt, V34, P5255; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nowicki S, 2005, AUK, V122, P1, DOI 10.1642/0004-8038(2005)122[0001:SAMCIB]2.0.CO;2; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 1994, BIOTIN STREPTAVIDIN; Peng JJ, 2007, APPL ANIM BEHAV SCI, V104, P151, DOI 10.1016/j.applanim.2006.04.029; Poessel SA, 2011, GEN COMP ENDOCR, V172, P526, DOI 10.1016/j.ygcen.2011.04.018; Polak M., 2003, DEV INSTABILITY CAUS, DOI DOI 10.1016/S0165-5876(03)00095-8; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; Prokosch MD, 2009, EVOL HUM BEHAV, V30, P11, DOI 10.1016/j.evolhumbehav.2008.07.004; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Roberts M, 1989, RED PANDA BIOL; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Roed KH, 2007, P ROY SOC B-BIOL SCI, V274, P727, DOI 10.1098/rspb.2006.0214; Rohlf FJ, 2004, TPSDIG V 2 0; ROSENZWEIG MR, 1968, PHYSIOL BEHAV, V3, P819, DOI 10.1016/0031-9384(68)90161-3; Santymire RM, 2007, REPROD FERT DEVELOP, V19, P652, DOI 10.1071/RD06096; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Sorensen DB, 2005, SCAND J LAB ANIM SCI, V32, P117; Spencer KA, 2011, BEHAV ECOL, V22, P1, DOI 10.1093/beheco/arq068; Stevenson JC, 2006, AM J HUM BIOL, V18, P402, DOI 10.1002/ajhb.20507; Suarez M, 1996, ARCH PHYSIOL BIOCHEM, V104, P351, DOI 10.1076/apab.104.3.351.12903; SUNDQVIST C, 1989, J REPROD FERTIL, V85, P413, DOI 10.1530/jrf.0.0850413; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Tanimura Y, 2008, BEHAV BRAIN RES, V189, P250, DOI 10.1016/j.bbr.2008.01.001; Thom MD, 2004, ANIM BEHAV, V67, P975, DOI 10.1016/j.anbehav.2003.09.008; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Torpy DJ, 1996, BAILLIERE CLIN RHEUM, V10, P181; Tuyttens FAM, 2005, J ANIM SCI, V83, P2645; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; VANVALEN L, 1962, EVOLUTION, V16, P125; Vickery S, 2004, ZOO BIOL, V23, P409, DOI 10.1002/zoo.20027; Vickery SS, 2005, APPL ANIM BEHAV SCI, V91, P247, DOI 10.1016/j.applanim.2005.01.005; Waitt C, 2006, INT J PRIMATOL, V27, P133, DOI 10.1007/s10764-005-9015-y; WEGNER TN, 1971, J DAIRY SCI, V54, P798; WEGNER TN, 1976, J DAIRY SCI, V59, P949, DOI 10.3168/jds.S0022-0302(76)84303-2; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Widholzer F.L., 1978, International Zoo Yearbook, V18, P122, DOI 10.1111/j.1748-1090.1978.tb00240.x; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Wildt D, 2009, SEX REPROD MENOPAUSE, V7, P21; Williams B, 2009, MOL ECOL, V19, P227; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wisely SM, 2005, ANIM CONSERV, V8, P321, DOI 10.1017/S1367943005002283; Wisely SM, 2002, CAN J ZOOL, V80, P1562, DOI 10.1139/Z02-160; Wolf KN, 2000, ZOO BIOL, V19, P517, DOI 10.1002/1098-2361(2000)19:6<517::AID-ZOO4>3.3.CO;2-M; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Workman JL, 2010, PHYSIOL BEHAV, V99, P638, DOI 10.1016/j.physbeh.2010.01.029; WRIGHT PL, 1950, P SOC EXP BIOL MED, V75, P820; Wurbel H, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P86, DOI 10.1079/9780851990040.0086; Zhang GQ, 2004, ZOO BIOL, V23, P15, DOI 10.1002/zoo.10118; Zhu XJ, 2001, J ZOOL, V253, P141, DOI 10.1017/S0952836901000139	139	30	31	4	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80494	10.1371/journal.pone.0080494	http://dx.doi.org/10.1371/journal.pone.0080494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282547	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500048
J	Zhang, XF; Hagen, J; Muniz, VP; Smith, T; Coombs, GS; Eischen, CM; Mackie, DI; Roman, DL; Van Rheeden, R; Darbro, B; Tompkins, VS; Quelle, DE				Zhang, Xuefeng; Hagen, Jussara; Muniz, Viviane P.; Smith, Tarik; Coombs, Gary S.; Eischen, Christine M.; Mackie, Duncan I.; Roman, David L.; Van Rheeden, Richard; Darbro, Benjamin; Tompkins, Van S.; Quelle, Dawn E.			RABL6A, a Novel RAB-Like Protein, Controls Centrosome Amplification and Chromosome Instability in Primary Fibroblasts	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; TUMOR-SUPPRESSOR; CELL-CYCLE; ROCK-II; ARF; P53; CANCER; MDM2; GENE; DUPLICATION	RABL6A (RAB-like 6 isoform A) is a novel protein that was originally identified based on its association with the Alternative Reading Frame (ARF) tumor suppressor. ARF acts through multiple p53-dependent and p53-independent pathways to prevent cancer. How RABL6A functions, to what extent it depends on ARF and p53 activity, and its importance in normal cell biology are entirely unknown. We examined the biological consequences of RABL6A silencing in primary mouse embryo fibroblasts (MEFs) that express or lack ARF, p53 or both proteins. We found that RABL6A depletion caused centrosome amplification, aneuploidy and multinucleation in MEFs regardless of ARF and p53 status. The centrosome amplification in RABL6A depleted p53-/- MEFs resulted from centrosome reduplication via Cdk2-mediated hyperphosphorylation of nucleophosmin (NPM) at threonine-199. Thus, RABL6A prevents centrosome amplification through an ARF/p53-independent mechanism that restricts NPM-T199 phosphorylation. These findings demonstrate an essential role for RABL6A in centrosome regulation and maintenance of chromosome stability in non-transformed cells, key processes that ensure genomic integrity and prevent tumorigenesis.	[Zhang, Xuefeng; Hagen, Jussara; Smith, Tarik; Quelle, Dawn E.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Muniz, Viviane P.; Quelle, Dawn E.] Univ Iowa, Mol & Cellular Biol Grad Program, Iowa City, IA USA; [Coombs, Gary S.] Waldorf Coll, Dept Biol, Forest City, IA USA; [Eischen, Christine M.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Mackie, Duncan I.; Roman, David L.] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA USA; [Van Rheeden, Richard; Darbro, Benjamin] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Tompkins, Van S.; Quelle, Dawn E.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Vanderbilt University; University of Iowa; University of Iowa; University of Iowa	Quelle, DE (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	dawn-quelle@uiowa.edu	Tompkins, Van/A-5757-2018; Roman, David/G-2637-2010	Tompkins, Van/0000-0003-1279-8075; Darbro, Benjamin/0000-0001-9279-356X; Mackie, Duncan/0000-0001-5299-9475; Quelle, Dawn/0000-0001-8776-0122; Roman, David/0000-0002-8250-0337	NIH/NCI [CA090367, CA127031]; NATIONAL CANCER INSTITUTE [R01CA090367, R21CA127031] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grants to DEQ. (CA090367 and CA127031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Adon AM, 2010, MOL CELL BIOL, V30, P694, DOI 10.1128/MCB.00253-09; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Cheng XL, 2008, J BIOL CHEM, V283, P5888, DOI 10.1074/jbc.M708145200; Cui YP, 2003, WORLD J GASTROENTERO, V9, P1892, DOI 10.3748/wjg.v9.i9.1892; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; di Tommaso A, 2009, EXP CELL RES, V315, P1326, DOI 10.1016/j.yexcr.2009.01.010; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Fukasawa Kenji, 2011, Hormones & Cancer, V2, P104, DOI 10.1007/s12672-010-0060-4; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hanashiro K, 2011, ONCOGENE, V30, P2188, DOI 10.1038/onc.2010.607; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Li YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071764; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Matijasevic Z, 2008, MOL CELL BIOL, V28, P1265, DOI 10.1128/MCB.01108-07; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Melo Alexia N, 2012, Genes Cancer, V3, P283, DOI 10.1177/1947601912454139; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; Muniz Viviane P, 2013, Genes Cancer, V4, P273, DOI 10.1177/1947601913501074; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pihan GA, 2003, CANCER RES, V63, P1398; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; QUELLE DE, 1995, CELL, V83, P993; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tompkins V, 2006, CELL CYCLE, V5, P641; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253	54	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80228	10.1371/journal.pone.0080228	http://dx.doi.org/10.1371/journal.pone.0080228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282525	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500026
J	Binder, C; Cashman, SM; Kumar-Singh, R				Binder, Christina; Cashman, Siobhan M.; Kumar-Singh, Rajendra			Extended Duration of Transgene Expression from Pegylated POD Nanoparticles Enables Attenuation of Photoreceptor Degeneration	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; CELL-PENETRATING PEPTIDE; GENE-TRANSFER; RETINAL DEGENERATION; TYROSINE-HYDROXYLASE; FUNCTIONAL RESCUE; IN-VIVO; DELIVERY; VECTOR; THERAPY	Retinitis pigmentosa (RP) is the most genetically heterogeneous disorder known to cause blindness, involving over 50 different genes. Previously, we have described nanoparticles (NPs) 150 nm in size, comprised of a 3.5 kD peptide (POD) complexed to PEG and DNA (PEGPOD DNA). These NPs expressing GDNF enabled rescue of photoreceptor degeneration in mice up to 11 days post injection. In the current study we examine use of scaffold/matrix attachment regions (S/MARs), CpG depletion and titration of DNA content of PEGPOD DNA NPs to extend the duration of transgene expression. S/MARs and CpGs did not significantly influence the duration of transgene expression, but did influence its stability. These parameters enabled us to extend transgene expression from 48 hours to 10 weeks. At 77 days post injection, we observed a 76% rescue of the thickness of the retinal outer nuclear layer (ONL) and at 37 days post injection we observed 53% and 55% rescue of the A and B wave ERG amplitudes respectively and 60% rescue of the ONL. Our studies suggest that PEGPOD DNA NPs have potential as gene delivery vectors for the retina.	[Binder, Christina; Cashman, Siobhan M.; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Kumar-Singh, R (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	Rajendra.Kumar-Singh@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	National Institute of Health/NEI [EY021805, EY013837]; Ellison Foundation; Department of Defense/TATRC; Lions Eye Foundation; Research to Prevent Blindness; National Institute On Aging of the National Institutes of Health [F30AG040956]; NATIONAL EYE INSTITUTE [R01EY013837, R01EY021805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040956] Funding Source: NIH RePORTER	National Institute of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ellison Foundation(Lawrence Ellison Foundation); Department of Defense/TATRC(United States Department of Defense); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institute On Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants to R. K. S from The National Institute of Health/NEI (EY021805 and EY013837), The Ellison Foundation, The Department of Defense/TATRC and grants to the Department of Ophthalmology at Tufts University School of Medicine from the Lions Eye Foundation and Research to Prevent Blindness. Research reported in this publication was also supported by the National Institute On Aging of the National Institutes of Health under Award Number F30AG040956. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeo K, 2000, PIGM CELL RES, V13, P80, DOI 10.1034/j.1600-0749.2000.130206.x; Anand V, 2002, MOL THER, V5, P125, DOI 10.1006/mthe.2002.0525; Argyros O, 2011, EXPERT OPIN BIOL TH, V11, P1177, DOI 10.1517/14712598.2011.582035; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cim A, 2012, J ENDOCRINOL, V214, P277, DOI 10.1530/JOE-12-0033; Daiger SP, 2013, CLIN GENET, V84, P132, DOI 10.1111/cge.12203; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Doonan F, 2012, EXP CELL RES, V318, P1278, DOI 10.1016/j.yexcr.2012.02.003; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fletcher AM, 2011, NEUROSCIENCE, V194, P220, DOI 10.1016/j.neuroscience.2011.07.072; Georgievska B, 2004, J NEUROSCI, V24, P6437, DOI 10.1523/JNEUROSCI.1122-04.2004; Haase R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-20; Han ZC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052189; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hattori K, 2010, J IMMUNOL, V184, P2729, DOI 10.4049/jimmunol.0900215; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Johnson LN, 2008, MOL THER, V16, P107, DOI 10.1038/sj.mt.6300324; Johnson LN, 2010, VISION RES, V50, P686, DOI 10.1016/j.visres.2009.08.028; Klausner EA, 2012, J GENE MED, V14, P100, DOI 10.1002/jgm.1634; Koirala A, 2013, HUM MOL GENET, V22, P1632, DOI 10.1093/hmg/ddt013; Koirala A, 2011, BIOMATERIALS, V32, P9483, DOI 10.1016/j.biomaterials.2011.08.062; Komaromy AM, 2013, MOL THER, V21, P1131, DOI 10.1038/mt.2013.50; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Miyazaki H, 2000, EUR J NEUROSCI, V12, P2032, DOI 10.1046/j.1460-9568.2000.00092.x; Perez VL, 2013, J AUTOIMMUN, V45, P7, DOI 10.1016/j.jaut.2013.06.011; Piechaczek C, 1999, NUCLEIC ACIDS RES, V27, P426, DOI 10.1093/nar/27.2.426; Read SP, 2010, MOL THER, V18, P1917, DOI 10.1038/mt.2010.167; Read SP, 2010, J GENE MED, V12, P86, DOI 10.1002/jgm.1415; Roffler-Tarlov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057184; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Touchard E, 2012, GENE THER, V19, P886, DOI 10.1038/gt.2011.154; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wu JM, 1999, GRAEF ARCH CLIN EXP, V237, P855, DOI 10.1007/s004170050323; Yew NS, 2000, MOL THER, V1, P255, DOI 10.1006/mthe.2000.0036; Yurek DM, 2011, MOL IMAGING, V10, P327, DOI 10.2310/7290.2010.00053; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	48	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82295	10.1371/journal.pone.0082295	http://dx.doi.org/10.1371/journal.pone.0082295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278479	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700078
J	Capredon, M; Brucato, N; Tonasso, L; Choesmel-Cadamuro, V; Ricaut, FX; Razafindrazaka, H; Rakotondrabe, AB; Ratolojanahary, MA; Randriamarolaza, LP; Champion, B; Dugoujon, JM				Capredon, Melanie; Brucato, Nicolas; Tonasso, Laure; Choesmel-Cadamuro, Valerie; Ricaut, Francois-Xavier; Razafindrazaka, Harilanto; Rakotondrabe, Andriamihaja Bakomalala; Ratolojanahary, Mamisoa Adelta; Randriamarolaza, Louis-Paul; Champion, Bernard; Dugoujon, Jean-Michel			Tracing Arab-Islamic Inheritance in Madagascar: Study of the Y-chromosome and Mitochondrial DNA in the Antemoro	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; BANTU EXPANSIONS; SLAVE-TRADE; MTDNA; RESOLUTION; DIVERSITY; AFRICA; EAST; MALAGASY; ASIA	Madagascar is located at the crossroads of the Asian and African worlds and is therefore of particular interest for studies on human population migration. Within the large human diversity of the Great Island, we focused our study on a particular ethnic group, the Antemoro. Their culture presents an important Arab-Islamic influence, but the question of an Arab biological inheritance remains unresolved. We analyzed paternal (n=129) and maternal (n=135) lineages of this ethnic group. Although the majority of Antemoro genetic ancestry comes from sub-Saharan African and Southeast Asian gene pools, we observed in their paternal lineages two specific haplogroups (J1 and T1) linked to Middle Eastern origins. This inheritance was restricted to some Antemoro sub-groups. Statistical analyses tended to confirm significant Middle Eastern genetic contribution. This study gives a new perspective to the large human genetic diversity in Madagascar.	[Capredon, Melanie; Tonasso, Laure; Choesmel-Cadamuro, Valerie; Ricaut, Francois-Xavier; Razafindrazaka, Harilanto; Dugoujon, Jean-Michel] CNRS, Lab Anthropol Mol & Imagerie Synth, Toulouse, France; [Capredon, Melanie; Tonasso, Laure; Choesmel-Cadamuro, Valerie; Ricaut, Francois-Xavier; Razafindrazaka, Harilanto; Dugoujon, Jean-Michel] Univ Toulouse 3, UMR5288, F-31062 Toulouse, France; [Capredon, Melanie; Champion, Bernard] Univ La Reunion, Dept Ethnol, Ctr Rech Litteraire & Hist Ocean Indien, St Denis, France; [Capredon, Melanie] Univ Montreal, Fac Med, CHU St Justine, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Brucato, Nicolas] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Rakotondrabe, Andriamihaja Bakomalala; Ratolojanahary, Mamisoa Adelta; Randriamarolaza, Louis-Paul] Univ Antananarivo, Lab Anthropol Patrimoine Transformat Sociales Tra, Antananarivo, Madagascar	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of La Reunion; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Max Planck Society; University Antananarivo	Capredon, M (corresponding author), CNRS, Lab Anthropol Mol & Imagerie Synth, Toulouse, France.	m.capredon@yahoo.fr	Ricaut, Francois Xavier/G-1206-2010; RAZAFINDRAZAKA, Harilanto/AAB-6818-2022	RICAUT, Francois-Xavier/0000-0001-7609-7898; RAZAFINDRAZAKA, HARILANTO/0000-0001-5209-4780	CNRS; University Paul Sabatier Toulouse 3; University of La Reunion; European Union; La Region Reunion	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier Toulouse 3; University of La Reunion; European Union(European Commission); La Region Reunion	Data collection and laboratory work were funded by the CNRS, the University Paul Sabatier Toulouse 3, the University of La Reunion, La Region Reunion and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; ADELAAR K, 2009, COMP HDB, P15253; ALLIBERT C, 2007, E FLACOURT HIST GRAN, P712; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; BEAUJARD P, 2007, MADAGASCAR AFRIQUE I, P481; Beaujard P, 2003, ETUDES OCEAN INDIEN, V35-36, P59; BEAUJARD P, 1991, ISLAMISES SYSTEMES R, P235; BEAUJARD P, 1988, MANUSCRITS ARABICOMA, P15253; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; BRUCATO N, 2010, GENETIC DIVERSITY DY, P15253; Brucato N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-314; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Capredon M, 2012, INT J IMMUNOGENET, V39, P161, DOI 10.1111/j.1744-313X.2011.01069.x; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; DALH CO, 1991, LOANWORDS MALAY MALA, P14; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; DESCHAMPS H, 1972, HIST MADAGASCAR, P358; DESCHAMPS H, 1959, PEUPLES MALGACHES MA, P15253; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FERRAND G, 1891, MUSULMANS MADAGASCAR, P15253; Friedlaender JS, 2002, HUM BIOL, V74, P453, DOI 10.1353/hub.2002.0029; Fuller D. Q., 2009, TUDES OC AN INDIEN, V42, P13, DOI DOI 10.4000/OCEANINDIEN.698; Gomes V, 2010, FORENSIC SCI INT-GEN, V4, pE83, DOI 10.1016/j.fsigen.2009.07.001; Hammer MF, 1997, GENETICS, V145, P787; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; LOMBARD J, 1988, ROYAUME SAKALAVA MEN, P15253; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Mendez FL, 2011, HUM BIOL, V83, P39, DOI 10.3378/027.083.0103; Msaidie S, 2011, EUR J HUM GENET, V19, P89, DOI 10.1038/ejhg.2010.128; Nei M., 1987, MOL EVOLUTIONARY GEN; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; RAZAFINDRAZAKA H, 2010, PEUPLEMENT HUMAIN MA, P15253; Razafindrazaka H, 2010, EUR J HUM GENET, V18, P575, DOI 10.1038/ejhg.2009.222; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Ricaut FX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-605; ROLLAND D, 2007, GLISSEMENT TERRAIN E, P15253; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Tofanelli S, 2009, EUR J HUM GENET, V17, P1520, DOI 10.1038/ejhg.2009.58; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Wang JL, 2003, GENETICS, V164, P747; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	63	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80932	10.1371/journal.pone.0080932	http://dx.doi.org/10.1371/journal.pone.0080932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278350	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700038
J	Couturier, M; Feliu, J; Bozonnet, S; Roussel, A; Berrin, JG				Couturier, Marie; Feliu, Julia; Bozonnet, Sophie; Roussel, Alain; Berrin, Jean-Guy			Molecular Engineering of Fungal GH5 and GH26 Beta-(1,4)-Mannanases toward Improvement of Enzyme Activity	PLOS ONE			English	Article							PROTEIN EXPRESSION; PICHIA-PASTORIS; MANNANASES; EVOLUTION; HYDROLYSIS; SYSTEM; FAMILY	Microbial mannanases are biotechnologically important enzymes since they target the hydrolysis of hemicellulosic polysaccharides of softwood biomass into simple molecules like manno-oligosaccharides and mannose. In this study, we have implemented a strategy of molecular engineering in the yeast Yarrowia lipolytica to improve the specific activity of two fungal endo-mannanases, PaMan5A and PaMan26A, which belong to the glycoside hydrolase (GH) families GH5 and GH26, respectively. Following random mutagenesis and two steps of high-throughput enzymatic screening, we identified several PaMan5A and PaMan26A mutants that displayed improved kinetic constants for the hydrolysis of galactomannan. Examination of the three-dimensional structures of PaMan5A and PaMan26A revealed which of the mutated residues are potentially important for enzyme function. Among them, the PaMan5A-G311S single mutant, which displayed an impressive 8.2-fold increase in k(cat)/K-M due to a significant decrease of K-M, is located within the core of the enzyme. The PaMan5A-K139R/Y223H double mutant revealed modification of hydrolysis products probably in relation to an amino-acid substitution located nearby one of the positive subsites. The PaMan26A-P140L/D416G double mutant yielded a 30% increase in k(cat)/K-M compared to the parental enzyme. It displayed a mutation in the linker region (P140L) that may confer more flexibility to the linker and another mutation (D416G) located at the entrance of the catalytic cleft that may promote the entrance of the substrate into the active site. Taken together, these results show that the directed evolution strategy implemented in this study was very pertinent since a straightforward round of random mutagenesis yielded significantly improved variants, in terms of catalytic efiiciency (k(cat)/K-M).	[Couturier, Marie; Feliu, Julia; Berrin, Jean-Guy] INRA, Polytech Marseille, Lab Biotechnol Champignons Filamenteux, UMR1163, Marseille, France; [Couturier, Marie; Feliu, Julia; Berrin, Jean-Guy] Aix Marseille Univ, Polytech Marseille, Marseille, France; [Bozonnet, Sophie] Univ Toulouse, Toulouse, France; [Bozonnet, Sophie] INSA, UPS, INP, Toulouse, France; [Bozonnet, Sophie] LISBP, Toulouse, France; [Bozonnet, Sophie] INRA, UMR792, Ingn Syst Biol & Procedes, F-31931 Toulouse, France; [Bozonnet, Sophie] CNRS, UMR5504, Toulouse, France; [Roussel, Alain] Aix Marseille Univ, CNRS, UMR7257, Marseille, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Berrin, JG (corresponding author), INRA, Polytech Marseille, Lab Biotechnol Champignons Filamenteux, UMR1163, Marseille, France.	jean-guy.berrin@univ-amu.fr	BERRIN, Jean-Guy/AAF-3107-2021; BERRIN, Jean-Guy/E-1460-2014; Couturier, Marie/ABB-1893-2021	BERRIN, Jean-Guy/0000-0001-7570-3745; Bozonnet, Sophie/0000-0001-5091-2209; Couturier, Marie/0000-0002-0032-1280	Region Midi-Pyrenees; European Regional Development Fund; Institut National de la Recherche Agronomique (INRA); OSEO Innovation	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); Institut National de la Recherche Agronomique (INRA); OSEO Innovation	ICEO is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund and the Institut National de la Recherche Agronomique (INRA). This work was carried out as part of the FUTUROL PROJECT and the authors want to thank OSEO Innovation for its financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200; Boonvitthya N, 2013, MOL BIOTECHNOL, V54, P158, DOI 10.1007/s12033-012-9557-0; Bordes F, 2007, J MICROBIOL METH, V70, P493, DOI 10.1016/j.mimet.2007.06.008; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; Chen YQ, 2012, APPL BIOCHEM BIOTECH, V168, P638, DOI 10.1007/s12010-012-9806-5; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; Duquesne S, 2012, METHODS MOL BIOL, V861, P301, DOI 10.1007/978-1-61779-600-5_18; Emond S, 2010, APPL ENVIRON MICROB, V76, P2684, DOI [10.1128/AEM.03057-09, 10.1128/AEM.0305-09]; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Hekmat O, 2010, BIOCHEMISTRY-US, V49, P4884, DOI 10.1021/bi100097f; Himmel EM, 2008, BIOMASS RECALCITRANC, P1; LEDALL MT, 1994, CURR GENET, V26, P38, DOI 10.1007/BF00326302; Liang CN, 2011, J BIOTECHNOL, V154, P46, DOI 10.1016/j.jbiotec.2011.03.025; Lin L, 2009, APPL MICROBIOL BIOT, V82, P671, DOI 10.1007/s00253-008-1789-3; MARGEOT A, 2009, CURR OPIN BIOTECH, V20, P1; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Montiel MD, 1999, APPL MICROBIOL BIOT, V52, P240, DOI 10.1007/s002530051515; Navarro D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-58; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Sachslehner A, 2000, J BIOTECHNOL, V80, P127, DOI 10.1016/S0168-1656(00)00253-4; Salmen L, 2004, CR BIOL, V327, P873, DOI 10.1016/j.crvi.2004.03.010; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Song LT, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-3; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Pham TA, 2010, J BIOTECHNOL, V148, P163, DOI 10.1016/j.jbiotec.2010.05.012; Wang XJ, 2012, APPL MICROBIOL BIOT, V95, P1469, DOI 10.1007/s00253-011-3799-9; Wiedenhoeft AC, 2005, HANDBOOK OF WOOD CHEMISTRY AND WOOD COMPOSITES, P9	32	23	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79800	10.1371/journal.pone.0079800	http://dx.doi.org/10.1371/journal.pone.0079800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278180	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700015
J	Snitsarev, V; Young, MN; Miller, RMS; Rotella, DP				Snitsarev, Vladislav; Young, Michael N.; Miller, Ross M. S.; Rotella, David P.			The Spectral Properties of (-)-Epigallocatechin 3-O-Gallate (EGCG) Fluorescence in Different Solvents: Dependence on Solvent Polarity	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; HSP90 INHIBITORS; CANCER; CATECHINS; CAFFEINE	(-)-Epigallocatechin 3-O-gallate (EGCG) a molecule found in green tea and known for a plethora of bioactive properties is an inhibitor of heat shock protein 90 (HSP90), a protein of interest as a target for cancer and neuroprotection. Determination of the spectral properties of EGCG fluorescence in environments similar to those of binding sites found in proteins provides an important tool to directly study protein-EGCG interactions. The goal of this study is to examine the spectral properties of EGCG fluorescence in an aqueous buffer (AB) at pH=7.0, acetonitrile (AN) (a polar aprotic solvent), dimethylsulfoxide (DMSO) (a polar aprotic solvent), and ethanol (EtOH) (a polar protic solvent). We demonstrate that EGCG is a highly fluorescent molecule when excited at approximately 275 nm with emission maxima between 350 and 400 nm depending on solvent. Another smaller excitation peak was found when EGCG is excited at approximately 235 nm with maximum emission between 340 and 400 nm. We found that the fluorescence intensity (FI) of EGCG in AB at pH=7.0 is significantly quenched, and that it is about 85 times higher in an aprotic solvent DMSO. The Stokes shifts of EGCG fluorescence were determined by solvent polarity. In addition, while the emission maxima of EGCG fluorescence in AB, DMSO, and EtOH follow the Lippert-Mataga equation, its fluorescence in AN points to non-specific solvent effects on EGCG fluorescence. We conclude that significant solvent-dependent changes in both fluorescence intensity and fluorescence emission shifts can be effectively used to distinguish EGCG in aqueous solutions from EGCG in environments of different polarity, and, thus, can be used to study specific EGCG binding to protein binding sites where the environment is often different from aqueous in terms of polarity.	[Snitsarev, Vladislav; Young, Michael N.; Miller, Ross M. S.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA; [Rotella, David P.] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ USA; [Rotella, David P.] Margaret & Herman Sokol Inst Pharmaceut Life Sci, Montclair, NJ USA	Montclair State University; Montclair State University; Montclair State University	Snitsarev, V (corresponding author), Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA.	SnitsarevV@mail.montclair.edu	Snitsarev, Vladislav/AAP-5599-2020	Snitsarev, Vladislav/0000-0001-5518-5899	Margaret and Herman Sokol Fellows Program; Sokol Endowment fund	Margaret and Herman Sokol Fellows Program; Sokol Endowment fund	This work was supported by the Margaret and Herman Sokol Fellows Program to VS, and by the Sokol Endowment fund to DPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x; Bark KM, 2011, B KOREAN CHEM SOC, V32, P3443, DOI 10.5012/bkcs.2011.32.9.3443; Jhaveri K, 2012, ADV PHARMACOL, V65, P471, DOI 10.1016/B978-0-12-397927-8.00015-4; KHAN SG, 1992, CANCER RES, V52, P4050; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V205, P235; Maiti TK, 2006, PROTEINS, V64, P355, DOI 10.1002/prot.20995; Matsuo N, 1997, ALLERGY, V52, P58, DOI 10.1111/j.1398-9995.1997.tb02546.x; MIURA S, 1995, BIOL PHARM BULL, V18, P1; Nagaoka H, 2002, ANAL SCI, V18, P951, DOI 10.2116/analsci.18.951; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; polewski K., 2002, CURR TOP BIOPHYS, V26, P217; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Shiozaki T, 1997, YAKUGAKU ZASSHI, V117, P448, DOI 10.1248/yakushi1947.117.7_448; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Valcic S, 1996, ANTI-CANCER DRUG, V7, P461, DOI 10.1097/00001813-199606000-00011; WANG ZY, 1989, MUTAT RES, V223, P273, DOI 10.1016/0165-1218(89)90120-1; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Yin ZY, 2009, BIOCHEMISTRY-US, V48, P336, DOI 10.1021/bi801637q	21	20	20	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79834	10.1371/journal.pone.0079834	http://dx.doi.org/10.1371/journal.pone.0079834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278192	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700017
J	Schusser, B; Yi, H; Collarini, EJ; Izquierdo, SM; Harriman, WD; Etches, RJ; Leighton, PA				Schusser, Benjamin; Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley Mettler; Harriman, William D.; Etches, Robert J.; Leighton, Philip A.			Harnessing Gene Conversion in Chicken B Cells to Create a Human Antibody Sequence Repertoire	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; LIGHT-CHAIN GENE; SOMATIC HYPERMUTATION; PHI-C31 INTEGRASE; CD-HIT; GENERATION; ANTIGEN; PROTEIN; LYMPHOMA; REGION	Transgenic chickens expressing human sequence antibodies would be a powerful tool to access human targets and epitopes that have been intractable in mammalian hosts because of tolerance to conserved proteins. To foster the development of the chicken platform, it is beneficial to validate transgene constructs using a rapid, cell culture-based method prior to generating fully transgenic birds. We describe a method for the expression of human immunoglobulin variable regions in the chicken DT40 B cell line and the further diversification of these genes by gene conversion. Chicken V-L and V-H loci were knocked out in DT40 cells and replaced with human V-K and V-H genes. To achieve gene conversion of human genes in chicken B cells, synthetic human pseudogene arrays were inserted upstream of the functional human V-K and V-H regions. Proper expression of chimeric IgM comprised of human variable regions and chicken constant regions is shown. Most importantly, sequencing of DT40 genetic variants confirmed that the human pseudogene arrays contributed to the generation of diversity through gene conversion at both the Igl and Igh loci. These data show that engineered pseudogene arrays produce a diverse pool of human antibody sequences in chicken B cells, and suggest that these constructs will express a functional repertoire of chimeric antibodies in transgenic chickens.	[Schusser, Benjamin] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley Mettler; Harriman, William D.; Etches, Robert J.; Leighton, Philip A.] Crystal Biosci Inc, Emeryville, CA USA	University of California System; University of California Davis	Leighton, PA (corresponding author), Crystal Biosci Inc, Emeryville, CA USA.	pal@crystalbioscience.com	Schusser, Benjamin/AAI-1189-2019	Schusser, Benjamin/0000-0002-9990-1890	German Research Foundation [Schu2446/2-1]; National Institute of General Medical Sciences SBIR [R43 GM090626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM090626] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Institute of General Medical Sciences SBIR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Research Foundation (www.dfg.de; grant Schu2446/2-1 to BS), and the National Institute of General Medical Sciences [www.nigms.nih.gov; SBIR grant R43 GM090626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Bousquet J, 2005, ALLERGY, V60, P302, DOI 10.1111/j.1398-9995.2004.00770.x; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GREENMAN L, 1994, NEW STATESMAN SOC, V7, P13, DOI 10.1038/ng0594-13; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kanayama N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj013; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; Knight DM, 1995, MOL IMMUNOL, V32, P1271, DOI 10.1016/0161-5890(95)00085-2; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kothapalli N, 2008, J IMMUNOL, V180, P2019, DOI 10.4049/jimmunol.180.4.2019; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Mohammed SM, 1998, IMMUNOTECHNOLOGY, V4, P115, DOI 10.1016/S1380-2933(98)00013-X; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; NADLER LM, 1980, CANCER RES, V40, P3147; Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; RITZ J, 1982, BLOOD, V59, P1; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Seo H, 2005, NAT BIOTECHNOL, V23, P731, DOI 10.1038/nbt1092; STEPLEWSKI Z, 1990, FRONT RADIAT THER ON, V24, P69; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Yabuki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036032; Yang SY, 2006, J EXP MED, V203, P2919, DOI 10.1084/jem.20061835	39	22	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80108	10.1371/journal.pone.0080108	http://dx.doi.org/10.1371/journal.pone.0080108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278246	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800054
J	Dukers-Muijrers, NHTM; Speksnijder, AGCL; Morre, SA; Wolffs, PFG; van der Sande, MAB; Brink, AATP; van den Broek, IVF; Werner, MILS; Hoebe, CJPA				Dukers-Muijrers, Nicole H. T. M.; Speksnijder, Arjen G. C. L.; Morre, Servaas A.; Wolffs, Petra F. G.; van der Sande, Marianne A. B.; Brink, Antoinette A. T. P.; van den Broek, Ingrid V. F.; Werner, Marita I. L. S.; Hoebe, Christian J. P. A.			Detection of Anorectal and Cervicovaginal Chlamydia Trachomatis Infections following Azithromycin Treatment: Prospective Cohort Study with Multiple Time-Sequential Measures of rRNA, DNA, Quantitative Load and Symptoms	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE INFECTIONS; NONGONOCOCCAL URETHRITIS; ANTIMICROBIAL RESISTANCE; DOUBLE-BLIND; MEN; SEX	Background: Determination of Chlamydia trachomatis (Ct) treatment success is hampered by current assessment methods, which involve a single post-treatment measurement only. Therefore, we evaluated Ct detection by applying multiple laboratory measures on time-sequential post-treatment samples. Methods: A prospective cohort study was established with azithromycin-treated (1000 mg) Ct patients (44 cervicovaginal and 15 anorectal cases). Each patient provided 18 self-taken samples pre-treatment and for 8 weeks post-treatment (response: 96%; 1,016 samples). Samples were tested for 16S rRNA (TMA), bacterial load (quantitative PCR; Chlamydia plasmid DNA) and type (serovar and multilocus sequence typing). Covariates (including behavior, pre-treatment load, anatomic site, symptoms, age, and menstruation) were tested for their potential association with positivity and load at 3-8 weeks using regression analyses controlling for repeated measures. Findings: By day 9, Ct positivity decreased to 20% and the median load to 0.3 inclusion-forming units (IFU) per ml (pre-treatment: 170 IFU/ml). Of the 35 cases who reported no sex, sex with a treated partner or safe sex with a new partner, 40% had detection, i.e. one or more positive samples from 3-8 weeks (same Ct type over time), indicating possible antimicrobial treatment failure. Cases showed intermittent positive detection and the number of positive samples was higher in anorectal cases than in cervicovaginal cases. The highest observed bacterial load between 3-8 weeks post-treatment was 313 IFU/ml, yet the majority (65%) of positive samples showed a load of <= 2 IFU/ml. Pre-treatment load was found to be associated with later load in anorectal cases. Conclusions: A single test at 3-8 weeks post-treatment frequently misses Ct. Detection reveals intermittent low loads, with an unknown risk of later complications or transmission. These findings warrant critical re-evaluation of the clinical management of single dose azithromycin-treated Ct patients and fuel the debate on defining treatment failure. Clinicaltrials.gov Identifier: NCT01448876.	[Dukers-Muijrers, Nicole H. T. M.; Werner, Marita I. L. S.; Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Wolffs, Petra F. G.; Brink, Antoinette A. T. P.; Hoebe, Christian J. P. A.] Maastricht Univ, Dept Med Microbiol, Sch Publ Hlth & Primary Care CAPHRI, Med Ctr, Maastricht, Netherlands; [Speksnijder, Arjen G. C. L.] Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [Morre, Servaas A.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Inst Publ Hlth Genom, Dept Genet & Cell Biol, Res Inst GROW,Fac Hlth Med & Life Sci, Maastricht, Netherlands; [van der Sande, Marianne A. B.; van den Broek, Ingrid V. F.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; Maastricht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Dukers-Muijrers, NHTM (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	nicole.dukers@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014; Speksnijder, Arjen/M-3406-2017	Speksnijder, Arjen/0000-0002-1966-7265; Hoebe, Christian/0000-0003-1815-0974; van der Sande, Marianne AB/0000-0002-4778-6739; Wolffs, Petra/0000-0002-5326-3985; Dukers-Muijrers, Nicole/0000-0003-4896-758X	Dutch National Institute for Environment and Health, Center for Infectious Diseases Control [3900051587]	Dutch National Institute for Environment and Health, Center for Infectious Diseases Control	This work was supported by the Dutch National Institute for Environment and Health, Center for Infectious Diseases Control [3900051587]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; British Association for Sexual Health and HIV (BASHH), 2010, CHLAM TRACH UK TEST; Catsburg A, 2006, 11 INT S HUM CHLAM I, P521; Centers for Disease Control and Prevention, 2010, MMWR RECOMM REP, V59, P1484; Drummond F, 2011, INT J STD AIDS, V22, P478, DOI 10.1258/ijsa.2011.010490; Dukers-Muijrers NHTM, 2013, SEX TRANSM INFECT, V89, P25, DOI 10.1136/sextrans-2011-050467; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Geisler WM, 2012, CLIN INFECT DIS, V55, P82, DOI 10.1093/cid/cis291; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Handsfield H, 2011, SEX TRANS DIS, V38, DOI [10.1097/OLQ.0b013e318227a366, DOI 10.1097/0LQ.0B013E318227A366]; Hathorn E, 2012, SEX TRANSM INFECT, V88, P352, DOI 10.1136/sextrans-2011-050466; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Horner P, 2006, SEX TRANSM INFECT, V82, P340, DOI 10.1136/sti.2005.019158; Horner PJ, 2012, SEX TRANSM INFECT, V88, P154, DOI 10.1136/sextrans-2011-050385; Kissinger PJ, 2009, SEX TRANSM DIS, V36, P498, DOI 10.1097/OLQ.0b013e3181a4d147; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; Quint KD, 2007, J MOL DIAGN, V9, P631, DOI 10.2353/jmoldx.2007.070011; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Stamm WE, 2007, SEX TRANSM DIS, V34, P545, DOI 10.1097/01.olq.0000253348.44308.8c; Steedman NM, 2009, INT J STD AIDS, V20, P16, DOI 10.1258/ijsa.2008.008211; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Liere GAFS, 2013, SEX TRANSM DIS, V40, P285, DOI 10.1097/OLQ.0b013e31828098f8; Wang SA, 2005, J INFECT DIS, V191, P917, DOI 10.1086/428290	27	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81236	10.1371/journal.pone.0081236	http://dx.doi.org/10.1371/journal.pone.0081236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278400	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100146
J	Rushton, JO; Kolodziejek, J; Tichy, A; Nowotny, N; Nell, B				Rushton, James O.; Kolodziejek, Jolanta; Tichy, Alexander; Nowotny, Norbert; Nell, Barbara			Clinical Course of Ophthalmic Findings and Potential Influence Factors of Herpesvirus Infections: 18 Month Follow-Up of a Closed Herd of Lipizzaners	PLOS ONE			English	Article							VIRUS TYPE-2 EHV-2; EQUINE; KERATOCONJUNCTIVITIS; PREVALENCE; HORSES; SWABS; DNA	Background: To date the influence of herpesviruses on the development of equine ocular diseases has not been clearly determined. Objective: The purpose of this study was to illustrate the course of equine ocular findings over a period of 18 months at 6 month intervals, in correlation with the results of herpesvirus detection. Methods: 266 Lipizzaners in 3 federal states of Austria underwent complete ophthalmologic examination 4 times. Blood samples, nasal-and conjunctival swabs were obtained at the same time and used for the detection of the equid gammaherpesviruses EHV-2 and EHV-5 using consensus herpesvirus PCR and type-specific qPCRs. Ophthalmic findings and results of herpesvirus PCRs were recorded and statistically analysed using one-way ANOVA, and multiple logistic regression analysis to determine the influence of herpesvirus infections and other contributing factors on the presence of ophthalmic findings. Results: In the first, second, third and fourth examination period 266, 261, 249 and 230 horses were included, respectively. Ophthalmic findings consistent with herpesvirus infections included conjunctival-and corneal pathologies. Statistical analysis revealed that the probability of positive herpesvirus PCR results decreased with progressing age; however the presence of corneal findings increased over time. At the time of each examination 45.1%, 41.8%, 43.0%, and 57.0% of horses with conjunctival or corneal findings, respectively, were positive for EHV-2 and/or EHV-5. However, 31.6%, 17.6%, 20.1%, and 13.0% of clinically sound horses were positive for these herpesviruses at each examination period, too. Conclusion: Based on the results of our study there is a significant influence of young age on EHV-2 and/or EHV-5 infection. Corneal pathologies increased over time and with progressing age. Whether the identified findings were caused by herpesviruses could not be unequivocally determined.	[Rushton, James O.; Nell, Barbara] Univ Vet Med Vienna, Dept Compan Anim & Horses, Clin Surg Dent & Ophthalmol, Vienna, Austria; [Rushton, James O.; Kolodziejek, Jolanta; Nowotny, Norbert] Univ Vet Med Vienna, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Inst Virol, Vienna, Austria; [Tichy, Alexander] Univ Vet Med Vienna, Dept Biomed Sci, Inst Populat Genet, Vienna, Austria; [Nowotny, Norbert] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Sultan Qaboos University	Nowotny, N (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Viral Zoonoses Emerging & Vector Borne Infect Grp, Inst Virol, Vienna, Austria.	norbert.nowotny@vetmeduni.ac.at	Nowotny, Norbert/A-5474-2019	Nowotny, Norbert/0000-0002-3548-571X	Spanish Riding School - Federal stud Piber; University of Veterinary Medicine Vienna	Spanish Riding School - Federal stud Piber; University of Veterinary Medicine Vienna	This study was funded by the Spanish Riding School - Federal stud Piber and the University of Veterinary Medicine Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers K, 1998, VIRUS RES, V55, P101, DOI 10.1016/S0168-1702(98)00028-8; Borchers K, 1997, ARCH VIROL, V142, P917, DOI 10.1007/s007050050128; Borchers K, 2006, VET MICROBIOL, V118, P260, DOI 10.1016/j.vetmic.2006.07.024; BURKI F, 1991, J VET MED B, V38, P432, DOI 10.1111/j.1439-0450.1991.tb00892.x; BURKI F, 1984, WIEN TIERARZTL MONAT, V71, P312; COLLINSON PN, 1994, J AM VET MED ASSOC, V205, P329; Dunowska M, 2001, RES VET SCI, V71, P111, DOI 10.1053/rvsc.2001.0493; Fetsch A, 2007, TIERAERZTL PRAX G N, V35, P356, DOI 10.1055/s-0037-1621643; Fortier G, 2010, VET J, V186, P148, DOI 10.1016/j.tvjl.2009.08.017; Kershaw O, 2001, VIRUS RES, V80, P93, DOI 10.1016/S0168-1702(01)00299-4; Kono Y., 1964, National Institute of Animal Health Quarterly, V4, P10; Krudewagen EM, 2001, PFERDEHEILKUNDE, V17, P444; Marenzoni ML, 2010, VET RES COMMUN, V34, P703, DOI 10.1007/s11259-010-9443-9; Matthews AG., 2004, EQUINE OPHTHALMOLOGY, P211; PLUMMER G, 1963, VIROLOGY, V19, P412, DOI 10.1016/0042-6822(63)90083-7; Posch U, 2002, THESIS U VET MED VIE; Richter N, 2009, PFERDEHEILKUNDE, V25, P38; Rushton J, 2013, EQUINE VET J, V45, P209, DOI 10.1111/j.2042-3306.2012.00630.x; Rushton JO, 2013, VET MICROBIOL, V164, P139, DOI 10.1016/j.vetmic.2013.01.035; Sonderegger F, 2011, THESIS U ZURICH; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; von Oppen T, 2001, TIERARZTL PRAX G N, V29, P227; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849	23	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79888	10.1371/journal.pone.0079888	http://dx.doi.org/10.1371/journal.pone.0079888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278206	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100066
J	Walter, S; Glymour, MM; Koenen, K; Liang, LM; Tchetgen, EJT; Cornelis, M; Chang, SC; Rimm, E; Kawachi, I; Kubzansky, LD				Walter, Stefan; Glymour, M. Maria; Koenen, Karestan; Liang, Liming; Tchetgen, Eric J. Tchetgen; Cornelis, Marilyn; Chang, Shun-Chiao; Rimm, Eric; Kawachi, Ichiro; Kubzansky, Laura D.			Performance of Polygenic Scores for Predicting Phobic Anxiety	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; GENERALIZED ANXIETY; CANDIDATE GENE; LIFE-STYLE; RISK; METAANALYSIS; COMORBIDITY; DISORDERS; TWIN	Context: Anxiety disorders are common, with a lifetime prevalence of 20% in the U. S., and are responsible for substantial burdens of disability, missed work days and health care utilization. To date, no causal genetic variants have been identified for anxiety, anxiety disorders, or related traits. Objective: To investigate whether a phobic anxiety symptom score was associated with 3 alternative polygenic risk scores, derived from external genome-wide association studies of anxiety, an internally estimated agnostic polygenic score, or previously identified candidate genes. Design: Longitudinal follow-up study. Using linear and logistic regression we investigated whether phobic anxiety was associated with polygenic risk scores derived from internal, leave-one out genome-wide association studies, from 31 candidate genes, and from out-of-sample genome-wide association weights previously shown to predict depression and anxiety in another cohort. Setting and Participants: Study participants (n = 11,127) were individuals from the Nurses' Health Study and Health Professionals Follow-up Study. Main Outcome Measure: Anxiety symptoms were assessed via the 8-item phobic anxiety scale of the Crown Crisp Index at two time points, from which a continuous phenotype score was derived. Results: We found no genome-wide significant associations with phobic anxiety. Phobic anxiety was also not associated with a polygenic risk score derived from the genome-wide association study beta weights using liberal p-value thresholds; with a previously published genome-wide polygenic score; or with a candidate gene risk score based on 31 genes previously hypothesized to predict anxiety. Conclusion: There is a substantial gap between twin-study heritability estimates of anxiety disorders ranging between 20-40% and heritability explained by genome-wide association results. New approaches such as improved genome imputations, application of gene expression and biological pathways information, and incorporating social or environmental modifiers of genetic risks may be necessary to identify significant genetic predictors of anxiety.	[Walter, Stefan; Glymour, M. Maria; Chang, Shun-Chiao; Kawachi, Ichiro; Kubzansky, Laura D.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Walter, Stefan; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Koenen, Karestan] Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Liang, Liming; Tchetgen, Eric J. Tchetgen; Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming; Tchetgen, Eric J. Tchetgen] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cornelis, Marilyn; Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Walter, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	swalter@hsph.harvard.edu	Tchetgen, Eric Tchetgen/AAF-6160-2021; Koenen, Karestan/K-5402-2014	Koenen, Karestan/0000-0003-3293-4281; Glymour, M. Maria/0000-0001-9644-3081; Walter, Stefan/0000-0002-6010-7550	NIH/NIMH [MH092707-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC4MH092707] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors gratefully acknowledge funding from NIH/NIMH (MH092707-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stefan Walter had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Albert CM, 2005, CIRCULATION, V111, P480, DOI 10.1161/01.CIR.0000153813.64165.5D; Arnold Paul D, 2004, Curr Psychiatry Rep, V6, P243, DOI 10.1007/s11920-004-0073-1; Calboli FCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011504; Chu NF, 2001, INT J OBESITY, V25, P106, DOI 10.1038/sj.ijo.0801468; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; CROWN S, 1966, BRIT J PSYCHIAT, V112, P917, DOI 10.1192/bjp.112.490.917; Demirkan A, 2011, MOL PSYCHIATR, V16, P773, DOI 10.1038/mp.2010.65; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Ernst C, 2011, BIOL PSYCHIAT, V69, P604, DOI 10.1016/j.biopsych.2010.10.008; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; HAINES AP, 1987, BRIT MED J, V295, P297, DOI 10.1136/bmj.295.6593.297; Hamilton Steven P., 2009, V23, P165; Hettema JM, 2005, ARCH GEN PSYCHIAT, V62, P182, DOI 10.1001/archpsyc.62.2.182; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hettema JM, 2001, J NERV MENT DIS, V189, P413, DOI 10.1097/00005053-200107000-00001; Hettema JM, 2009, PSYCHIAT GENET, V19, P213, DOI 10.1097/YPG.0b013e32832cec22; KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Machiela MJ, 2011, GENET EPIDEMIOL, V35, P506, DOI 10.1002/gepi.20600; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Monsees GM, 2009, GENET EPIDEMIOL, V33, P717, DOI 10.1002/gepi.20424; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Organization WH, 1992, COMP INT DIAGN INT C; Otowa T, 2010, J HUM GENET, V55, P91, DOI 10.1038/jhg.2009.127; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Scherrer JF, 2000, J AFFECT DISORDERS, V57, P25, DOI 10.1016/S0165-0327(99)00031-2; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; Smoller JW, 2008, AM J MED GENET C, V148C, P118, DOI 10.1002/ajmg.c.30174; Smoller JW, 2008, DEPRESS ANXIETY, V25, P368, DOI 10.1002/da.20492; Smoller JW, 2011, BIOL PSYCHIAT, V69, P506, DOI 10.1016/j.biopsych.2011.01.020; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; YOUNG JPR, 1971, BRIT J PSYCHIAT, V119, P393, DOI 10.1192/bjp.119.551.393	41	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80326	10.1371/journal.pone.0080326	http://dx.doi.org/10.1371/journal.pone.0080326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278274	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100083
J	Wei, SJ; Joseph, T; Chee, S; Li, L; Yurlova, L; Zolghadr, K; Brown, C; Lane, D; Verma, C; Ghadessy, F				Wei, Siau Jia; Joseph, Thomas; Chee, Sharon; Li, Ling; Yurlova, Larisa; Zolghadr, Kourosh; Brown, Christopher; Lane, David; Verma, Chandra; Ghadessy, Farid			Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides	PLOS ONE			English	Article							N-TERMINAL DOMAIN; P53 PEPTIDE; WILD-TYPE; PROTEIN INTERACTIONS; IN-VIVO; MDM2; PATHWAY; BINDING; CANCER; DESIGN	Pharmacological modulation of p53 activity is an attractive therapeutic strategy in cancers with wild-type p53. Presently in clinical trials, the small molecule Nutlin-3A competitively binds to HDM2, a key negative regulator of p53 and blocks its activity. We have described resistance mutations in HDM2 that selectively reduce affinity for Nutlin but not p53. In the present communication, we show that stapled peptides targeting the same region of HDM2 as Nutlin are refractory to these mutations, and display reduced discrimination between the wild-type and mutant HDM2s with regards to functional abrogation of interaction with p53. The larger interaction footprint afforded by stapled peptides suggests that this class of ligands may prove comparatively more resilient to acquired resistance in a clinical setting.	[Wei, Siau Jia; Chee, Sharon; Li, Ling; Brown, Christopher; Lane, David; Ghadessy, Farid] Agcy Sci Technol & Res, P53Lab, Singapore, Singapore; [Joseph, Thomas; Verma, Chandra] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Yurlova, Larisa; Zolghadr, Kourosh] ChromoTek GmbH, Planegg Martinsried, Germany; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Verma, C (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg; fghadessy@p53Lab.a-star.edu.sg	Joseph, Thomas/J-9736-2017	Joseph, Thomas/0000-0002-7911-4988; Ghadessy, Farid/0000-0001-8559-903X; Lane, David/0000-0003-0551-3545				Allen JG, 2009, J MED CHEM, V52, P7044, DOI 10.1021/jm900681h; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Balius TE, 2009, BIOCHEMISTRY-US, V48, P8435, DOI 10.1021/bi900729a; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bottger V, 1996, ONCOGENE, V13, P2141; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Brown CJ, 2013, ACS CHEM BIOL, V8, P506, DOI 10.1021/cb3005148; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Case D, 2010, AMBER, V11; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2012, CELL CYCLE, V11, P2239, DOI 10.4161/cc.20333; DeLano WL, 2002, PYMOL MOL GRAPHICS S; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ElSawy KM, 2013, CELL CYCLE, V12, P394, DOI 10.4161/cc.23511; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hernychova L, 2013, PROTEOMICS, V13, P2512, DOI 10.1002/pmic.201300029; Higueruelo AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051742; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lai ZH, 2000, ARCH BIOCHEM BIOPHYS, V381, P278, DOI 10.1006/abbi.2000.1998; Liu G, 2010, DIS ESOPHAGUS, V23, P36, DOI 10.1111/j.1442-2050.2009.00960.x; LUNA RMD, 1995, NATURE, V378, P203; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Michelsen K, 2012, J AM CHEM SOC, V134, P17059, DOI 10.1021/ja305839b; Miyazaki M, 2013, BIOORGAN MED CHEM, V21, P4319, DOI 10.1016/j.bmc.2013.04.056; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nair AC, 2002, J MOL GRAPH MODEL, V21, P171, DOI 10.1016/S1093-3263(02)00149-3; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Secchiero P, 2011, CURR PHARM DESIGN, V17, P569, DOI 10.2174/138161211795222586; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; TAKAHASHI T, 1992, CANCER RES, V52, P2340; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Verkhivker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040897; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062564; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	60	24	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81068	10.1371/journal.pone.0081068	http://dx.doi.org/10.1371/journal.pone.0081068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278380	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100142
J	Brozoski, TJ; Wisner, KW; Odintsov, B; Bauer, CA				Brozoski, Thomas J.; Wisner, Kurt W.; Odintsov, Boris; Bauer, Carol A.			Local NMDA Receptor Blockade Attenuates Chronic Tinnitus and Associated Brain Activity in an Animal Model	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; UNIPOLAR BRUSH CELLS; INFERIOR COLLICULUS; RAT; DEGENERATION; CONNECTIONS; CEREBELLUM; PLASTICITY; LESIONS; SYSTEM	Chronic tinnitus has no broadly effective treatment. Identification of specific markers for tinnitus should facilitate the development of effective therapeutics. Recently it was shown that glutamatergic blockade in the cerebellar paraflocculus, using an antagonist cocktail was successful in reducing chronic tinnitus. The present experiment examined the effect of selective N-methyl d-aspartate (NMDA) receptor blockade on tinnitus and associated spontaneous brain activity in a rat model. The NMDA antagonist, D(-)-2-amino-5-phosphonopentanoic acid (D-AP5) (0.5 mM), was continuously infused for 2 weeks directly to the ipsilateral paraflocculus of rats with tinnitus induced months prior by unilateral noise exposure. Treated rats were compared to untreated normal controls without tinnitus, and to untreated positive controls with tinnitus. D-AP5 significantly decreased tinnitus within three days of beginning treatment, and continued to significantly reduce tinnitus throughout the course of treatment and for 23 days thereafter, at which time testing was halted. At the conclusion of psychophysical testing, neural activity was assessed using manganese enhanced magnetic resonance imaging (MEMRI). In agreement with previous research, untreated animals with chronic tinnitus showed significantly elevated bilateral activity in their paraflocculus and brainstem cochlear nuclei, but not in mid or forebrain structures. In contrast, D-AP5-treated-tinnitus animals showed significantly less bilateral parafloccular and dorsal cochlear nucleus activity, as well as significantly less contralateral ventral cochlear nucleus activity. It was concluded that NMDA-mediated glutamatergic transmission in the paraflocculus appears to be a necessary component of chronic noise-induced tinnitus in a rat model. Additionally, it was confirmed that in this model, elevated spontaneous activity in the cerebellar paraflocculus and auditory brainstem is associated with tinnitus.	[Brozoski, Thomas J.; Wisner, Kurt W.; Bauer, Carol A.] So Illinois Univ, Sch Med, Div Otolaryngol, Springfield, IL USA; [Odintsov, Boris] Univ Illinois, Beckman Inst Adv Sci & Technol, Biomed Imaging Ctr, Urbana, IL 61801 USA	Southern Illinois University System; Southern Illinois University; University of Illinois System; University of Illinois Urbana-Champaign	Brozoski, TJ (corresponding author), So Illinois Univ, Sch Med, Div Otolaryngol, Springfield, IL USA.	tbrozoski@siumed.edu			National Institute on Deafness and Other Communication Disorders [1R01DC009669-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009669] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by the National Institute on Deafness and Other Communication Disorders, # 1R01DC009669-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Andreia A, 2005, Braz J Otorhinolaryngol, V71, P618; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, PLOSONE IN PRESS; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Bauer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064726; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Brozoski T, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00009; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Brozoski TJ, 2010, HEARING RES, V270, P71, DOI 10.1016/j.heares.2010.09.006; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Bukowska D, 2002, CELLS TISSUES ORGANS, V170, P61, DOI 10.1159/000047921; CONLEE JW, 1982, NEUROSCIENCE, V7, P161, DOI 10.1016/0306-4522(82)90158-0; Dino MR, 2008, NEUROSCIENCE, V154, P29, DOI 10.1016/j.neuroscience.2008.01.035; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Ito M, 1984, THE CEREBELLUM AND N; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Lobarinas E, 2006, ACTA OTO-LARYNGOL, V126, P13, DOI 10.1080/03655230600895408; Manohar S, 2012, NEUROSCIENCE, V202, P169, DOI 10.1016/j.neuroscience.2011.12.013; Morest DK, 1997, HEARING RES, V103, P151, DOI 10.1016/S0378-5955(96)00172-4; Muehlmeier G, 2011, AUDIOL NEURO-OTOL, V16, P388, DOI 10.1159/000322641; MUGNAINI E, 1994, SYNAPSE, V16, P284, DOI 10.1002/syn.890160406; MUGNAINI E, 1980, J NEUROCYTOL, V9, P537, DOI 10.1007/BF01204841; Mugnaini E, 2011, BRAIN RES REV, V66, P220, DOI 10.1016/j.brainresrev.2010.10.001; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Odintsov B, 2011, V2010/0012483 A1, Patent No. 20100012483; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Rasmussen G., 1990, RES NOTEBOOKS HIST M, P1; Rousseau CV, 2012, J NEUROSCI, V32, P4632, DOI 10.1523/JNEUROSCI.5122-11.2012; Salembier L, 2006, ACTA OTO-LARYNGOL, V126, P93, DOI 10.1080/03655230600895242; Sharma DK, 2012, INDIAN J PHARMACOL, V44, P93, DOI 10.4103/0253-7613.91876; Shulman, 1997, Int Tinnitus J, V3, P77; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Wang HN, 2011, HEARING RES, V279, P111, DOI 10.1016/j.heares.2011.04.004; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; YOUNG ED, 1976, J NEUROPHYSIOL, V39, P282, DOI 10.1152/jn.1976.39.2.282; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zheng Yiwen, 2012, Front Neurol, V3, P127; Zhou J, 2010, J ASSOC RES OTOLARYN	47	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77674	10.1371/journal.pone.0077674	http://dx.doi.org/10.1371/journal.pone.0077674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24282480	Green Published, Green Submitted, gold			2022-12-27	WOS:000326032600039
J	Burston, JJ; Sagar, DR; Shao, P; Bai, MF; King, E; Brailsford, L; Turner, JM; Hathway, GJ; Bennett, AJ; Walsh, DA; Kendall, DA; Lichtman, A; Chapman, V				Burston, James J.; Sagar, Devi Rani; Shao, Pin; Bai, Mingfeng; King, Emma; Brailsford, Louis; Turner, Jenna M.; Hathway, Gareth J.; Bennett, Andrew J.; Walsh, David A.; Kendall, David A.; Lichtman, Aron; Chapman, Victoria			Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint	PLOS ONE			English	Article							MONOSODIUM IODOACETATE MODEL; PERIPHERAL-NERVE INJURY; NEUROPATHIC PAIN; ENDOCANNABINOID SYSTEM; MECHANICAL ALLODYNIA; SENSORY INNERVATION; ARTICULAR-CARTILAGE; INFLAMMATORY PAIN; BRAIN-REGIONS; SPINAL-CORD	Osteoarthritis (OA) of the joint is a prevalent disease accompanied by chronic, debilitating pain. Recent clinical evidence has demonstrated that central sensitization contributes to OA pain. An improved understanding of how OA joint pathology impacts upon the central processing of pain is crucial for the identification of novel analgesic targets/new therapeutic strategies. Inhibitory cannabinoid 2 (CB2) receptors attenuate peripheral immune cell function and modulate central neuro-immune responses in models of neurodegeneration. Systemic administration of the CB2 receptor agonist JWH133 attenuated OA-induced pain behaviour, and the changes in circulating pro-and anti-inflammatory cytokines exhibited in this model. Electrophysiological studies revealed that spinal administration of JWH133 inhibited noxious-evoked responses of spinal neurones in the model of OA pain, but not in control rats, indicating a novel spinal role of this target. We further demonstrate dynamic changes in spinal CB2 receptor mRNA and protein expression in an OA pain model. The expression of CB2 receptor protein by both neurones and microglia in the spinal cord was significantly increased in the model of OA. Hallmarks of central sensitization, significant spinal astrogliosis and increases in activity of metalloproteases MMP-2 and MMP-9 in the spinal cord were evident in the model of OA pain. Systemic administration of JWH133 attenuated these markers of central sensitization, providing a neurobiological basis for analgesic effects of the CB2 receptor in this model of OA pain. Analysis of human spinal cord revealed a negative correlation between spinal cord CB2 receptor mRNA and macroscopic knee chondropathy. These data provide new clinically relevant evidence that joint damage and spinal CB2 receptor expression are correlated combined with converging pre-clinical evidence that activation of CB2 receptors inhibits central sensitization and its contribution to the manifestation of chronic OA pain. These findings suggest that targeting CB2 receptors may have therapeutic potential for treating OA pain.	[Burston, James J.; Sagar, Devi Rani; Walsh, David A.; Chapman, Victoria] Univ Nottingham, Arthrit Res UK Pain Ctr, Nottingham NG7 2RD, England; [Burston, James J.; Sagar, Devi Rani; King, Emma; Brailsford, Louis; Turner, Jenna M.; Hathway, Gareth J.; Bennett, Andrew J.; Kendall, David A.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Shao, Pin; Bai, Mingfeng] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Bai, Mingfeng] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Lichtman, Aron] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA	University of Nottingham; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University	Chapman, V (corresponding author), Univ Nottingham, Arthrit Res UK Pain Ctr, Nottingham NG7 2RD, England.	victoria.chapman@nottingham.ac.uk	Hanmer, Jenna Mary/ABB-4884-2021	Hanmer, Jenna Mary/0000-0002-7652-6098; bennett, andrew/0000-0003-3829-0309; Chapman, Victoria/0000-0002-7969-2788; Walsh, David/0000-0002-6316-5692; Hathway, Gareth/0000-0003-4347-9667	Arthritis Research U.K. [18769]; National Institutes of Health [P50DA005274, 5P01DA009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005274, P01DA009789] Funding Source: NIH RePORTER; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; MRC [MR/K00414X/1] Funding Source: UKRI	Arthritis Research U.K.(Versus Arthritis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Arthritis Research U.K. Grant number 18769 (D. W. Walsh and V. Chapman) and National Institutes of Health grants: P50DA005274 (P. I. Bill Dewey) and 5P01DA009789 (P. I. Aron Lichtman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Ayral X, 1996, J RHEUMATOL, V23, P698; Bajaj P, 2001, PAIN, V93, P107, DOI 10.1016/S0304-3959(01)00300-1; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berenbaum F, 2011, OSTEOARTHR CARTILAGE, V19, P361, DOI 10.1016/j.joca.2011.01.019; Berrendero F, 1998, BBA-MOL BASIS DIS, V1407, P205, DOI 10.1016/S0925-4439(98)00042-8; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; DOUGADOS M, 1994, ARTHROSCOPY, V10, P69, DOI 10.1016/S0749-8063(05)80295-6; Dray A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2178; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; FAN F, 1994, J PHARMACOL EXP THER, V271, P1383; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kobayashi K, 2003, J VET MED SCI, V65, P1195, DOI 10.1292/jvms.65.1195; La Porta C, 2013, PAIN, V154, P160, DOI 10.1016/j.pain.2012.10.009; Lee Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-39; Luongo L, 2010, NEUROBIOL DIS, V37, P177, DOI 10.1016/j.nbd.2009.09.021; Malan TP, 2003, CURR OPIN PHARMACOL, V3, P62, DOI 10.1016/S1471-4892(02)00004-8; Miller TR, 2012, EUR J PAIN; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Okine BN, 2012, BRIT J PHARMACOL, V167, P627, DOI 10.1111/j.1476-5381.2012.02028.x; Orita S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-134; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Sagar DR, 2012, PHILOS T R SOC B, V367, P3300, DOI 10.1098/rstb.2011.0390; Sagar DR, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-88; Sagar DR, 2010, ARTHRITIS RHEUM-US, V62, P3666, DOI 10.1002/art.27698; Sagar DR, 2005, EUR J NEUROSCI, V22, P371, DOI 10.1111/j.1460-9568.2005.04206.x; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Soderstrom K, 2000, BRAIN RES, V857, P151, DOI 10.1016/S0006-8993(99)02393-8; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Takeshita M, 2012, RHEUMATOLOGY, V51, P1790, DOI 10.1093/rheumatology/kes173; Walsh DA, 2009, OSTEOARTHR CARTILAGE, V17, P304, DOI 10.1016/j.joca.2008.07.016; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	47	66	69	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80440	10.1371/journal.pone.0080440	http://dx.doi.org/10.1371/journal.pone.0080440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282543	Green Accepted, gold, Green Published			2022-12-27	WOS:000327543500044
J	Labuda, D; Yotova, V; Lefebvre, JF; Moreau, C; Utermann, G; Williams, SM				Labuda, Damian; Yotova, Vania; Lefebvre, Jean-Francois; Moreau, Claudia; Utermann, Gerd; Williams, Scott M.			X-Linked MTMR8 Diversity and Evolutionary History of Sub-Saharan Populations	PLOS ONE			English	Article							DISTRIBUTED HUMAN-POPULATIONS; WHOLE-GENOME SEQUENCES; MODERN HUMAN ORIGINS; OUT-OF-AFRICA; MODERN HUMANS; MUTATION-RATES; Y-CHROMOSOME; DNA POLYMORPHISM; SOUTHERN AFRICA; LINKAGE DISEQUILIBRIUM	The genetic diversity within an 11 kb segment of the MTMR8 gene in a sample of 111 sub-Saharan and 49 non-African X chromosomes was investigated to assess the early evolutionary history of sub-Saharan Africans and the out-of-Africa expansion. The analyses revealed a complex genetic structure of the Africans that contributed to the emergence of modern humans. We observed partitioning of two thirds of old lineages among southern, west/central and east African populations indicating ancient population stratification predating the out of Africa migration. Age estimates of these lineages, older than coalescence times of uniparentally inherited markers, raise the question whether contemporary humans originated from a single population or as an amalgamation of different populations separated by years of independent evolution, thus suggesting a greater antiquity of our species than generally assumed. While the oldest sub-Saharan lineages,,500 thousand years, are found among Khoe-San from southern-Africa, a distinct haplotype found among Biaka is likely due to admixture from an even older population. An East African population that gave rise to non-Africans underwent a selective sweep affecting the subcentromeric region where MTMR8 is located. This and similar sweeps in four other regions of the X chromosome, documented in the literature, effectively reduced genetic diversity of non-African chromosomes and therefore may have exacerbated the effect of the demographic bottleneck usually ascribed to the out of Africa migration. Our data is suggestive, however, that a bottleneck, occurred in Africa before range expansion.	[Labuda, Damian; Yotova, Vania; Lefebvre, Jean-Francois; Moreau, Claudia] Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Utermann, Gerd] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Williams, Scott M.] Dartmouth Coll, Dept Genet, Geisel Sch Med, Hanover, NH 03755 USA	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Medical University of Innsbruck; Dartmouth College	Labuda, D (corresponding author), Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada.	damian.labuda@umontreal.ca	Williams, Scott/Q-4812-2019	Williams, Scott/0000-0002-4835-9544	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by the National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Alves I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002837; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Cann HM, 2002, SCIENCE, V296, P261; Casto AM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r10; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Emery LS, 2010, AM J HUM GENET, V87, P848, DOI 10.1016/j.ajhg.2010.10.021; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fay JC, 2000, GENETICS, V155, P1405; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Forster P, 1996, AM J HUM GENET, V59, P935; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hawks J, 2012, P NATL ACAD SCI USA, V109, P15531, DOI 10.1073/pnas.1212718109; Hayakawa T, 2006, GENETICS, V172, P1139, DOI 10.1534/genetics.105.046995; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Jaruzelska J, 1999, GENETICS, V152, P1091; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kitano T, 2003, MOL BIOL EVOL, V20, P1281, DOI 10.1093/molbev/msg134; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Labuda D, 2000, GENETICS, V156, P799; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Labuda D, 2010, AM J HUM GENET, V86, P980, DOI 10.1016/j.ajhg.2010.05.013; Labuda D, 2010, AM J HUM GENET, V86, P353, DOI 10.1016/j.ajhg.2010.01.029; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lambert CA, 2010, AM J HUM GENET, V86, P34, DOI 10.1016/j.ajhg.2009.12.002; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovell A, 2005, ANN HUM GENET, V69, P275, DOI 10.1046/j.1529-8817.2005.00152.x; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Matsumura S, 2008, P ROY SOC B-BIOL SCI, V275, P1501, DOI 10.1098/rspb.2007.1724; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nachman MW, 2004, GENETICS, V167, P423, DOI 10.1534/genetics.167.1.423; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Relethford JH, 1999, AM J PHYS ANTHROPOL, V108, P251; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schlebusch CM, 2012, HUM BIOL, V84, P695, DOI 10.3378/027.084.0603; Schlebusch CM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-56; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen GJ, 2013, J HUM EVOL, V65, P162, DOI 10.1016/j.jhevol.2013.05.002; Shimada MK, 2007, MOL BIOL EVOL, V24, P687, DOI 10.1093/molbev/msl196; Sjodin P, 2012, MOL BIOL EVOL, V29, P1851, DOI 10.1093/molbev/mss061; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Yotova V, 2007, HUM GENET, V122, P431, DOI 10.1007/s00439-007-0413-4; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777; Zietkiewicz E, 1997, GENE, V205, P161; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371; ZOUROS E, 1979, GENETICS, V92, P623	110	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80710	10.1371/journal.pone.0080710	http://dx.doi.org/10.1371/journal.pone.0080710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282552	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500054
J	Maier, D; Praxenthaler, H; Schulz, A; Preiss, A				Maier, Dieter; Praxenthaler, Heiko; Schulz, Adriana; Preiss, Anette			Gain of Function Notch Phenotypes Associated with Ectopic Expression of the Su(H) C-Terminal Domain Illustrate Separability of Notch and Hairless-Mediated Activities	PLOS ONE			English	Article							SENSORY ORGAN DEVELOPMENT; ALTERNATIVE CELL FATES; DROSOPHILA-MELANOGASTER; SIGNALING PATHWAY; SUBCELLULAR-LOCALIZATION; BRISTLE DEVELOPMENT; CRYSTAL-STRUCTURE; SUPPRESSOR; COMPLEX; PROTEIN	The Notch signaling pathway is instrumental for cell fate decisions. Signals from the Notch receptor are transduced by CSL-type DNA-binding proteins. In Drosophila, this protein is named Suppressor of Hairless [Su(H)]. Together with the intracellular domain of the activated Notch receptor ICN, Su(H) assembles a transcriptional activator complex on Notch target genes. Hairless acts as the major antagonist of the Notch signaling pathway in Drosophila by means of the formation of a repressor complex together with Su(H) and several co-repressors. Su(H) is characterized by three domains, the N-terminal domain NTD, the beta-trefoil domain BTD and the C-terminal domain CTD. NTD and BTD bind to the DNA, whereas BTD and CTD bind to ICN. Hairless binds to the CTD, however, to sites different from ICN. In this work, we have addressed the question of competition and availability of Su(H) for ICN and Hairless binding in vivo. To this end, we overexpressed the CTD during fly development. We observed a strong activation of Notch signaling processes in various tissues, which may be explained by an interference of CTD with Hairless corepressor activity. Accordingly, a combined overexpression of CTD together with Hairless ameliorated the effects, unlike Su(H) which strongly enhances repression when overexpressed concomitantly with Hairless. Interestingly, in the combined overexpression CTD accumulated in the nucleus together with Hairless, whereas it is predominantly cytoplasmic on its own.	[Maier, Dieter; Praxenthaler, Heiko; Schulz, Adriana; Preiss, Anette] Univ Hohenheim, Inst Genet 240, Stuttgart, Germany	University Hohenheim	Maier, D (corresponding author), Univ Hohenheim, Inst Genet 240, Stuttgart, Germany.	dieter.maier@uni-hohenheim.de			German Science Foundation [DFG MA 1328/10-1]; National Science Foundation; National Institutes of Health [OD010949-10]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a German Research Foundation-grant from the German Science Foundation to DM (DFG MA 1328/10-1). Some of the antisera used in this study were obtained from Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology, Iowa City, Iowa 52242. Some Drosophila fly stocks were obtained from the Bloomington Drosophila Stock Center BDSC, funded by the National Science Foundation (http://flystocks.bio.indiana.edu/Inst/funding.htm). The development of FlyC31 system (http://www.frontiers-in-genetics.org/flyc31/) used in this study was funded by the The National Centre of Competence in Research Frontiers-in-Genetics program (http://www.frontiers-in-genetics.org/page.php?id=home_en).SchneiderS2 cells were obtained from the Drosophila Genomic Resource Center, supported by National Institutes of Health grant OD010949-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray S, 2005, DEV CELL, V8, P279, DOI 10.1016/j.devcel.2004.11.020; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Couturier L, 2012, NAT CELL BIOL, V14, P131, DOI 10.1038/ncb2419; DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632; Djiane A, 2013, EMBO J, V32, P60, DOI 10.1038/emboj.2012.326; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; Go MJ, 1998, DEVELOPMENT, V125, P2031; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Kurth P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027986; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LYMAN DF, 1995, GENETICS, V141, P1491; MAIER D, 1992, MECH DEVELOP, V38, P143, DOI 10.1016/0925-4773(92)90006-6; Maier D, 1999, MECH DEVELOP, V89, P195, DOI 10.1016/S0925-4773(99)00208-7; Maier D, 1997, MECH DEVELOP, V67, P97, DOI 10.1016/S0925-4773(97)00117-2; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Maier D, 2011, MOL BIOL CELL, V22, P3242, DOI 10.1091/mbc.E11-05-0420; Maier D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-175; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Miller DT, 1998, DEVELOPMENT, V125, P2327; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Muller D, 2006, J CELL SCI, V119, P250, DOI 10.1242/jcs.02743; Nagel AC, 2000, MECH DEVELOP, V94, P3, DOI 10.1016/S0925-4773(00)00319-1; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; Parks AL, 1997, MECH DEVELOP, V63, P61, DOI 10.1016/S0925-4773(97)00675-8; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; Protzer CE, 2008, J CELL SCI, V121, P3167, DOI 10.1242/jcs.035014; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SAKAI T, 1995, J BIOCHEM-TOKYO, V118, P621, DOI 10.1093/oxfordjournals.jbchem.a124955; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Schweisguth F, 1996, DEV GENET, V18, P28, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;28::AID-DVG4&gt;3.0.CO;2-3; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; VASSIN H, 1985, J NEUROGENET, V2, P291, DOI 10.3109/01677068509102325; Wacker SA, 2011, EMBO J, V30, P43, DOI 10.1038/emboj.2010.289; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Zhou SF, 2001, MOL CELL BIOL, V21, P6222, DOI 10.1128/MCB.21.18.6222-6232.2001	69	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81578	10.1371/journal.pone.0081578	http://dx.doi.org/10.1371/journal.pone.0081578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282610	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500113
J	Smith, DJ; Nicholl, BI; Cullen, B; Martin, D; Ul-Haq, Z; Evans, J; Gill, JMR; Roberts, B; Gallacher, J; Mackay, D; Hotopf, M; Deary, I; Craddock, N; Pell, JP				Smith, Daniel J.; Nicholl, Barbara I.; Cullen, Breda; Martin, Daniel; Ul-Haq, Zia; Evans, Jonathan; Gill, Jason M. R.; Roberts, Beverly; Gallacher, John; Mackay, Daniel; Hotopf, Matthew; Deary, Ian; Craddock, Nick; Pell, Jill P.			Prevalence and Characteristics of Probable Major Depression and Bipolar Disorder within UK Biobank: Cross-Sectional Study of 172,751 Participants	PLOS ONE			English	Article							WEEKLY SYMPTOMATIC STATUS; SPECTRUM DISORDER; NATURAL-HISTORY; MENTAL-HEALTH; LIFE EVENTS; NEUROTICISM; ASSOCIATION; DEPRIVATION; POPULATION; SEX	Objectives: UK Biobank is a landmark cohort of over 500,000 participants which will be used to investigate genetic and non-genetic risk factors for a wide range of adverse health outcomes. This is the first study to systematically assess the prevalence and validity of proposed criteria for probable mood disorders within the cohort (major depression and bipolar disorder). Methods: This was a descriptive epidemiological study of 172,751 individuals assessed for a lifetime history of mood disorder in relation to a range of demographic, social, lifestyle, personality and health-related factors. The main outcomes were prevalence of a probable lifetime (single) episode of major depression, probable recurrent major depressive disorder (moderate), probable recurrent major depressive disorder (severe), probable bipolar disorder and no history of mood disorder (comparison group). Outcomes were compared on age, gender, ethnicity, socioeconomic status, educational attainment, functioning, self-reported health status, current depressive symptoms, neuroticism score, smoking status and alcohol use. Results: Prevalence rates for probable single lifetime episode of major depression (6.4%), probable recurrent major depression (moderate) (12.2%), probable recurrent major depression (severe) (7.2%) and probable bipolar disorder (1.3%) were comparable to those found in other population studies. The proposed diagnostic criteria have promising validity, with a gradient in evidence from no mood disorder through major depression and probable bipolar disorder in terms of gender distribution, socioeconomic status, self-reported health rating, current depressive symptoms and smoking. Significance: The validity of our proposed criteria for probable major depression and probable bipolar disorder within this cohort are supported by these cross-sectional analyses. Our findings are likely to prove useful as a framework for a wide range of future genetic and non-genetic studies.	[Smith, Daniel J.; Cullen, Breda; Martin, Daniel; Evans, Jonathan] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing Res Grp, Glasgow, Lanark, Scotland; [Roberts, Beverly; Deary, Ian] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Hotopf, Matthew] Kings Coll London, Inst Psychiat, London, England; [Gallacher, John; Craddock, Nick] Cardiff Univ, Inst Neurosci & Mental Hlth, Natl Ctr Mental Hlth, Cardiff CF10 3AX, S Glam, Wales; [Nicholl, Barbara I.] Univ Glasgow, Inst Hlth & Wellbeing Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Ul-Haq, Zia; Gill, Jason M. R.; Mackay, Daniel; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Glasgow; University of Edinburgh; University of London; King's College London; Cardiff University; University of Glasgow; University of Glasgow	Smith, DJ (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing Res Grp, Glasgow, Lanark, Scotland.	daniel.smith@glasgow.ac.uk	Cullen, Breda/N-3449-2019; Deary, Ian J/C-6297-2009; Cullen, Breda/C-9154-2012; Ul Haq, Zia/GZM-0053-2022; Nicholl, Barbara/AAY-3598-2020; Hotopf, Matthew/E-4971-2010	Cullen, Breda/0000-0002-7259-9505; Deary, Ian J/0000-0002-1733-263X; Cullen, Breda/0000-0002-7259-9505; Nicholl, Barbara/0000-0001-5639-0130; ul haq, zia/0000-0001-5124-2171; Pell, Jill/0000-0002-8898-7035; Hotopf, Matthew/0000-0002-3980-4466; Smith, Daniel/0000-0002-2267-1951	Welsh Assembly Government; British Heart Foundation; Medical Research Council [MC_qA137853, G0700704, MR/K026992/1] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Welsh Assembly Government; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted using the UK Biobank resource. UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has also had funding from the Welsh Assembly Government and the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SPSS WIND VERS 11 5; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; Duggan C, 1995, J AFFECT DISORDERS, V35, P139, DOI 10.1016/0165-0327(95)00062-3; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; First M. D., 1996, USERS GUIDE STRUCTUR; Ghaemi SN, 2003, BIPOLAR DISORD, V5, P421, DOI 10.1046/j.1399-5618.2003.00074.x; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Ivkovic V, 2007, PERS INDIV DIFFER, V42, P123, DOI 10.1016/j.paid.2006.06.025; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; KATZ R, 1987, PSYCHOL MED, V17, P155, DOI 10.1017/S0033291700013052; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; Kirkbride JB, 2012, SCHIZOPHRENIA B; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Luciano M, 2012, AM J MED GENET B, V159B, P684, DOI 10.1002/ajmg.b.32072; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Merikangas KR, 2012, ARCH GEN PSYCHIAT AR, V2012, P2038; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Robins L.N., 1991, PSYCHIAT DISORDERS A; RUSH AJ, 1987, J CLIN PSYCHIAT, V48, P246; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Srireddy P, 2012, EPIDEMIOL PSYCH SCI, V21, P311, DOI 10.1017/S2045796012000352; STATA Software, 2011, VERS REL 12 1 2011; Swanson JM, 2012, LANCET, V380, P110, DOI 10.1016/S0140-6736(12)61179-9; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; UK Biobank, 2012, PROT LARG SCAL PROSP; UK Biobank, 2012, TOUCHSCR QUEST; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van Os J, 2001, BRIT J PSYCHIAT, V178, pS72, DOI 10.1192/bjp.178.40.s72; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zobel A, 2004, ACTA PSYCHIAT SCAND, V109, P392, DOI 10.1111/j.1600-0447.2004.00313.x	37	161	162	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e75362	10.1371/journal.pone.0075362	http://dx.doi.org/10.1371/journal.pone.0075362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282498	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000327543500004
J	Ogura, Y; Yabuki, S; Iida, A; Kou, I; Nakajima, M; Kano, H; Shiina, M; Kikuchi, S; Toyama, Y; Ogata, K; Nakamura, M; Matsumoto, M; Ikegawa, S				Ogura, Yoji; Yabuki, Shoji; Iida, Aritoshi; Kou, Ikuyo; Nakajima, Masahiro; Kano, Hiroki; Shiina, Masaaki; Kikuchi, Shinichi; Toyama, Yoshiaki; Ogata, Kazuhiro; Nakamura, Masaya; Matsumoto, Morio; Ikegawa, Shiro			FOXC2 Mutations in Familial and Sporadic Spinal Extradural Arachnoid Cyst	PLOS ONE			English	Article							LYMPHEDEMA-DISTICHIASIS SYNDROME; TRUNCATING MUTATIONS; TRANSCRIPTION FACTOR; MISSENSE MUTATION; CORD COMPRESSION; GENE; MFH-1; DISEASE	Spinal extradural arachnoid cyst (SEDAC) is a cyst in the spinal canal that protrudes into the epidural space from a defect in the dura mater. Most cases are sporadic; however, three familial SEDAC cases have been reported, suggesting genetic etiological factors. All familial cases are associated with lymphedema-distichiasis syndrome (LDS), whose causal gene is FOXC2. However, FOXC2 mutation analysis has been performed in only 1 family, and no mutation analysis has been performed on sporadic (non-familial) SEDACs. We recruited 17 SEDAC subjects consisting of 2 familial and 7 sporadic cases and examined FOXC2 mutations by Sanger sequencing and structural abnormalities by TaqMan copy number assay. We identified 2 novel FOXC2 mutations in 2 familial cases. Incomplete LDS penetrance was noted in both families. Four subjects presented with SEDACs only. Thus, SEDAC caused by the heterozygous FOXC2 loss-of-function mutation should be considered a feature of LDS, although it often manifests as the sole symptom. Seven sporadic SEDAC subjects had no FOXC2 mutations, no symptoms of LDS, and showed differing clinical characteristics from those who had FOXC2 mutations, suggesting that other gene(s) besides FOXC2 are likely to be involved in SEDAC.	[Ogura, Yoji; Iida, Aritoshi; Kou, Ikuyo; Nakajima, Masahiro; Kano, Hiroki; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Yabuki, Shoji; Kikuchi, Shinichi] Fukushima Med Univ, Dept Orthopaed Surg, Fukushima, Japan; [Ogura, Yoji; Toyama, Yoshiaki; Nakamura, Masaya; Matsumoto, Morio] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 232, Japan	RIKEN; Fukushima Medical University; Keio University; Yokohama City University	Ikegawa, S (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ogura, Yoji/V-2740-2019; Iida, Aritoshi/CAA-1373-2022; Ikegawa, Shiro/N-6895-2015; Matsumoto, Morio M/L-6227-2013; Toyama, Yoshiaki/K-5743-2013; Nakamura, Masaya/K-4111-2013	Iida, Aritoshi/0000-0001-7538-1651; Ikegawa, Shiro/0000-0003-0316-2147; 				BERGLAND RM, 1968, J NEUROSURG, V28, P495, DOI 10.3171/jns.1968.28.5.0495; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Brooks BP, 2003, J AAPOS, V7, P354, DOI 10.1016/S1091-8531(03)00144-7; Butler MG, 2012, AM J MED GENET A, V158A, P839, DOI 10.1002/ajmg.a.35229; Chang IC, 2004, PEDIATR NEUROSURG, V40, P70, DOI 10.1159/000078911; CHYNN KY, 1967, AMER J ROENTGENOL RA, V101, P204, DOI 10.2214/ajr.101.1.204; CILLUFFO JM, 1981, MAYO CLIN PROC, V56, P93; CORBETT CRR, 1982, LYMPHOLOGY, V15, P85; Dellinger MT, 2008, LYMPHOLOGY, V41, P98; Erickson RP, 2001, LYMPHOLOGY, V34, P1; Erickson RP, 2001, J MED GENET, V38, P761, DOI 10.1136/jmg.38.11.761; Fabretto A, 2010, OPHTHALMIC GENET, V31, P98, DOI 10.3109/13816811003620517; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fauret AL, 2010, LYMPHOLOGY, V43, P14; Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185; Iascone M, 2012, CLIN GENET, V81, P542, DOI 10.1111/j.1399-0004.2011.01674.x; Iida K, 1997, DEVELOPMENT, V124, P4627; Johnson SM, 1999, ARCH DERMATOL, V135, P347, DOI 10.1001/archderm.135.3.347; KAESTNER KH, 1993, P NATL ACAD SCI USA, V90, P7628, DOI 10.1073/pnas.90.16.7628; Kriederman BM, 2003, HUM MOL GENET, V12, P1179, DOI 10.1093/hmg/ddg123; Mellor RH, 2011, J VASC RES, V48, P397, DOI 10.1159/000323484; Michelini S, 2012, LYMPHOLOGY, V45, P3; Miravet E, 2002, J CHILD NEUROL, V17, P770, DOI 10.1177/08830738020170101802; Myles LM, 1999, J NEUROSURG, V91, P116, DOI 10.3171/spi.1999.91.1.0116; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Sanchez-Carpintero R, 2010, GENET MED, V12, P532, DOI 10.1097/GIM.0b013e3181e5c7ea; SCHWARTZ JF, 1980, ANN NEUROL, V7, P340, DOI 10.1002/ana.410070410; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sutkowska E, 2012, GENE, V498, P96, DOI 10.1016/j.gene.2012.01.098; Verstraeten VLRM, 2009, J INVEST DERMATOL, V129, P509, DOI 10.1038/jid.2008.246; Yabuki S, 2007, AM J MED GENET A, V143A, P884, DOI 10.1002/ajmg.a.31669; Yanga XL, 2000, FEBS LETT, V470, P29, DOI 10.1016/S0014-5793(00)01285-0	32	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80548	10.1371/journal.pone.0080548	http://dx.doi.org/10.1371/journal.pone.0080548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278289	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700030
J	Boardman, LA; Johnson, RA; Viker, KB; Hafner, KA; Jenkins, RB; Riegert-Johnson, DL; Smyrk, TC; Litzelman, K; Seo, S; Gangnon, RE; Engelman, CD; Rider, DN; Vanderboom, RJ; Thibodeau, SN; Petersen, GM; Skinner, HG				Boardman, Lisa A.; Johnson, Ruth A.; Viker, Kimberly B.; Hafner, Kari A.; Jenkins, Robert B.; Riegert-Johnson, Douglas L.; Smyrk, Thomas C.; Litzelman, Kristin; Seo, Songwon; Gangnon, Ronald E.; Engelman, Corinne D.; Rider, David N.; Vanderboom, Russell J.; Thibodeau, Stephen N.; Petersen, Gloria M.; Skinner, Halcyon G.			Correlation of Chromosomal Instability, Telomere Length and Telomere Maintenance in Microsatellite Stable Rectal Cancer: A Molecular Subclass of Rectal Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; CARCINOMA; CELLS; DYSFUNCTION; FREQUENCY; SUBSET; BREAST	Introduction: Colorectal cancer (CRC) tumor DNA is characterized by chromosomal damage termed chromosomal instability (CIN) and excessively shortened telomeres. Up to 80% of CRC is microsatellite stable (MSS) and is historically considered to be chromosomally unstable (CIN+). However, tumor phenotyping depicts some MSS CRC with little or no genetic changes, thus being chromosomally stable (CIN-). MSS CIN-tumors have not been assessed for telomere attrition. Experimental Design: MSS rectal cancers from patients <= 50 years old with Stage II (B2 or higher) or Stage III disease were assessed for CIN, telomere length and telomere maintenance mechanism (telomerase activation [TA]; alternative lengthening of telomeres [ALT]). Relative telomere length was measured by qPCR in somatic epithelial and cancer DNA. TA was measured with the TRAPeze assay, and tumors were evaluated for the presence of C-circles indicative of ALT. p53 mutation status was assessed in all available samples. DNA copy number changes were evaluated with Spectral Genomics aCGH. Results: Tumors were classified as chromosomally stable (CIN-) and chromosomally instable (CIN+) by degree of DNA copy number changes. CIN-tumors (35%; n=6) had fewer copy number changes (<17% of their clones with DNA copy number changes) than CIN+ tumors (65%; n=13) which had high levels of copy number changes in 20% to 49% of clones. Telomere lengths were longer in CIN-compared to CIN+ tumors (p=0.0066) and in those in which telomerase was not activated (p=0.004). Tumors exhibiting activation of telomerase had shorter tumor telomeres (p=0.0040); and tended to be CIN+ (p=0.0949). Conclusions: MSS rectal cancer appears to represent a heterogeneous group of tumors that may be categorized both on the basis of CIN status and telomere maintenance mechanism. MSS CIN-rectal cancers appear to have longer telomeres than those of MSS CIN+ rectal cancers and to utilize ALT rather than activation of telomerase.	[Boardman, Lisa A.; Riegert-Johnson, Douglas L.] Mayo Clin, Dept Internal Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Johnson, Ruth A.; Viker, Kimberly B.; Hafner, Kari A.; Jenkins, Robert B.; Smyrk, Thomas C.; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Expt Pathol, Rochester, MN USA; [Litzelman, Kristin; Gangnon, Ronald E.; Engelman, Corinne D.; Skinner, Halcyon G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Seo, Songwon; Gangnon, Ronald E.; Skinner, Halcyon G.] Univ Wisconsin, Carbone Canc Ctr, Dept Biostat & Med Informat, Madison, WI USA; [Rider, David N.; Petersen, Gloria M.] Mayo Clin, Rochester, MN USA; [Vanderboom, Russell J.] Mayo Clin, Mayo Clin Canc Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic	Boardman, LA (corresponding author), Mayo Clin, Dept Internal Med, Div Gastroenterol & Hepatol, Rochester, MN USA.	boardman.lisa@mayo.edu	Litzelman, Kristin/H-5343-2019	Litzelman, Kristin/0000-0002-5542-6434; Gangnon, Ronald/0000-0003-2587-6714	National Cancer Institute [R01 CA132718, P50 CA102701]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK084567]; Lustgarten Foundation for Pancreatic Cancer; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA132718, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Lustgarten Foundation for Pancreatic Cancer; Mayo Clinic Center for Individualized Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Cancer Institute (R01 CA132718 and P50 CA102701 Mayo Clinic SPORE in Pancreatic Cancer); the National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK084567 Mayo Clinic Center for Cell Signaling in Gastroenterology); the Lustgarten Foundation for Pancreatic Cancer; and by the Mayo Clinic Center for Individualized Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Boardman LA, 2007, CLIN CANCER RES, V13, P2323, DOI 10.1158/1078-0432.CCR-06-2739; Boland CR, 1998, CANCER RES, V58, P5248; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Christodoulidou A, 2013, NEOPLASIA, V15, P156, DOI 10.1593/neo.121398; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; DECACERES II, 2004, CANCER BIOL THER, V3, P289, DOI DOI 10.4161/CBT.3.3.695.PUBMED:14726659; FRIDLYAND J, 2010, ACGH CLASSES FUNCTIO; Georgiades IB, 1999, ONCOGENE, V18, P7933, DOI 10.1038/sj.onc.1203368; Giaretti W, 2003, GENE CHROMOSOME CANC, V37, P207, DOI 10.1002/gcc.10203; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hakin-Smith V, 2003, LANCET, V361, P836, DOI 10.1016/S0140-6736(03)12681-5; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hawkins NJ, 2001, BRIT J CANCER, V84, P232, DOI 10.1054/bjoc.2000.1554; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Plentz RR, 2003, GUT, V52, P1304, DOI 10.1136/gut.52.9.1304; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Yi BQ, 2011, HEPATO-GASTROENTEROL, V58, P785	36	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80015	10.1371/journal.pone.0080015	http://dx.doi.org/10.1371/journal.pone.0080015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278232	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800044
J	Caliman, IF; Lamas, AZ; Dalpiaz, PLM; Medeiros, ARS; Abreu, GR; Figueiredo, SG; Gusmao, LN; Andrade, TU; Bissoli, NS				Caliman, Izabela Facco; Lamas, Aline Zandonadi; Meireles Dalpiaz, Polyana Lima; Santos Medeiros, Ana Raquel; Abreu, Glaucia Rodrigues; Figueiredo, Suely Gomes; Gusmao, Lara Nascimento; Andrade, Tadeu Uggere; Bissoli, Nazare Souza			Endothelial Relaxation Mechanisms and Oxidative Stress Are Restored by Atorvastatin Therapy in Ovariectomized Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SPONTANEOUSLY HYPERTENSIVE-RATS; COA REDUCTASE INHIBITORS; NF-KAPPA-B; POSTMENOPAUSAL WOMEN; FEMALE RATS; MESENTERIC-ARTERIES; TNF-ALPHA; CARDIOVASCULAR-DISEASE; HYPERPOLARIZING FACTOR	The studies on hormone replacement therapy (HRT) in females with estrogen deficiency are not conclusive. Thus, non-estrogen therapies, such as atorvastatin (ATO), could be new strategies to substitute or complement HRT. This study evaluated the effects of ATO on mesenteric vascular bed (MVB) function from ovariectomized (OVX) female rats. Female rats were divided into control SHAM, OVX, and OVX treated with 17 beta-estradiol (EST) or ATO groups. The MVB reactivity was determined in organ chambers, vascular oxidative stress by dihydroethidine staining, and the expression of target proteins by western blot. The reduction in acetylcholine-induced relaxation in OVX rats was restored by ATO or EST treatment. The endothelium-dependent nitric oxide (NO) component was reduced in OVX rats, whereas the endothelium-derived hyperpolarizing factor (EDHF) component or prostanoids were not altered in the MVBs. Endothelial dysfunction in OVX rats was associated with oxidative stress, an up-regulation of iNOS and NADPH oxidase expression and a down-regulation of eNOS expression. Treatment with ATO or EST improved the NO component of the relaxation and normalized oxidative stress and the expression of those signaling pathways enzymes. Thus, the protective effect of ATO on endothelial dysfunction caused by estrogen deficiency highlights a significant therapeutic benefit for statins independent of its effects on cholesterol, thus providing evidence that non-estrogen therapy could be used for cardiovascular benefit in an estrogen-deficient state, such as menopause.	[Caliman, Izabela Facco; Lamas, Aline Zandonadi; Meireles Dalpiaz, Polyana Lima; Abreu, Glaucia Rodrigues; Figueiredo, Suely Gomes; Gusmao, Lara Nascimento; Bissoli, Nazare Souza] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Santos Medeiros, Ana Raquel] Univ Fed Espirito Santo, Vitoria, ES, Brazil; [Andrade, Tadeu Uggere] Univ Ctr Vila Velha, Dept Pharm, Vila Velha, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Bissoli, NS (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	naza@npd.ufes.br	Bissoli, Nazare/ABA-2679-2021; Andrade, Tadeu U/M-4616-2016; dalpiaz, Polyana/AFK-3054-2022	Andrade, Tadeu U/0000-0001-6387-7895; Caliman, Izabela/0000-0002-6357-1375	CNPq Casadinho/Procad [552623/2011]	CNPq Casadinho/Procad	CNPq Casadinho/Procad, 552623/2011-; http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbacanne MA, 1999, CARDIOVASC RES, V41, P672, DOI 10.1016/S0008-6363(98)00254-5; Bhuiyan S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1606, DOI 10.1152/ajpendo.00246.2007; Binko J, 1998, AM J PHYSIOL-HEART C, V274, pH853, DOI 10.1152/ajpheart.1998.274.3.H853; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Briones AM, 2009, HYPERTENSION, V54, P142, DOI 10.1161/HYPERTENSIONAHA.109.133710; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; Chataigneau T, 2004, MENOPAUSE, V11, P255, DOI 10.1097/01.GME.0000097847.95550.E3; Chatterjee A, 2008, VASC PHARMACOL, V49, P134, DOI 10.1016/j.vph.2008.06.008; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Dalpiaz PLM, 2013, BRAZ J MED BIOL RES, V46, P171, DOI 10.1590/1414-431X20122472; Dantas APV, 2004, J CARDIOVASC PHARM, V43, P48, DOI 10.1097/00005344-200401000-00008; de Kleijn MJJ, 2002, AM J EPIDEMIOL, V155, P339, DOI 10.1093/aje/155.4.339; Demir BC, 2013, J OBSTET GYNAECOL RE, V39, P229, DOI 10.1111/j.1447-0756.2012.01969.x; Endres M, 2004, STROKE, V35, P2708, DOI 10.1161/01.STR.0000143319.73503.38; Feletou M, 2009, CLIN SCI, V117, P139, DOI 10.1042/CS20090096; Feng L, 2008, J ENDOCRINOL, V199, P95, DOI 10.1677/JOE-08-0026; Florian M, 2004, STEROIDS, V69, P779, DOI 10.1016/j.steroids.2004.09.008; Fukuchi M, 1998, CIRCULATION, V98, P132, DOI 10.1161/01.CIR.98.2.132; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; Gonzales RJ, 2001, AM J PHYSIOL-LUNG C, V280, pL555, DOI 10.1152/ajplung.2001.280.3.L555; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Igase M, 2012, MENOPAUSE, V19, P1294, DOI 10.1097/gme.0b013e318259c04e; Issa MH, 2012, J STEROID BIOCHEM, V128, P139, DOI 10.1016/j.jsbmb.2011.11.001; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Khodja NI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032039; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Koh KK, 2011, INT J CARDIOL, V146, P319, DOI 10.1016/j.ijcard.2009.07.002; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Kurumazuka D, 2006, EUR J PHARMACOL, V553, P263, DOI 10.1016/j.ejphar.2006.09.036; Lam KK, 2006, MENOPAUSE, V13, P294, DOI 10.1097/01.gme.0000182806.99137.5e; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005; Liu MY, 2002, J CARDIOVASC PHARM, V40, P938, DOI 10.1097/00005344-200212000-00016; Liu MY, 2001, BRIT J PHARMACOL, V132, P1035, DOI 10.1038/sj.bjp.0703899; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Loyer X, 2007, ENDOCRINOLOGY, V148, P4579, DOI 10.1210/en.2007-0228; Mandosi E, 2010, J ATHEROSCLER THROMB, V17, P539, DOI 10.5551/jat.2956; Martorell A, 2009, CARDIOVASC RES, V84, P300, DOI 10.1093/cvr/cvp214; MCGREGOR DD, 1965, J PHYSIOL-LONDON, V177, P21, DOI 10.1113/jphysiol.1965.sp007572; Nachtigal P, 2008, LIFE SCI, V82, P708, DOI 10.1016/j.lfs.2008.01.006; Nawate S, 2005, BRIT J PHARMACOL, V144, P178, DOI 10.1038/sj.bjp.0706091; Park JK, 2000, KIDNEY INT, V58, P1420, DOI 10.1046/j.1523-1755.2000.00304.x; Perez-Guerrero C, 2003, J CARDIOVASC PHARM, V42, P204, DOI 10.1097/00005344-200308000-00008; Perez-Torres I, 2008, CAN J PHYSIOL PHARM, V86, P25, DOI [10.1139/Y07-113, 10.1139/y07-113]; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; Puntawangkoon C, 2010, MENOPAUSE, V17, P114, DOI 10.1097/gme.0b013e3181b63c4d; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Rush JWE, 2007, EXP BIOL MED, V232, P814; Sakuma I, 2002, BRIT J PHARMACOL, V135, P48, DOI 10.1038/sj.bjp.0704444; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Santos RL, 2004, BRAZ J MED BIOL RES, V37, P569, DOI 10.1590/S0100-879X2004000400014; Shuto H, 2011, EUR J PHARMACOL, V651, P234, DOI 10.1016/j.ejphar.2010.10.084; Simoncini T, 2000, J CLIN ENDOCR METAB, V85, P2966, DOI 10.1210/jc.85.8.2966; Suh JW, 2010, J KOREAN MED SCI, V25, P16, DOI 10.3346/jkms.2010.25.1.16; Sun YM, 2009, BIOCHEM BIOPH RES CO, V382, P336, DOI 10.1016/j.bbrc.2009.03.019; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Urso ML, 2005, ARTERIOSCL THROM VAS, V25, P2560, DOI 10.1161/01.ATV.0000190608.28704.71; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Virdis A, 2000, CIRCULATION, V101, P2258, DOI 10.1161/01.CIR.101.19.2258; Virdis A, 2009, HYPERTENSION, V53, P1008, DOI 10.1161/HYPERTENSIONAHA.109.132258; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; Wagner AH, 2002, BRIT J PHARMACOL, V136, P143, DOI 10.1038/sj.bjp.0704678; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wong CM, 2006, VASC PHARMACOL, V44, P290, DOI 10.1016/j.vph.2005.12.005; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH343, DOI 10.1152/ajpheart.01350.2007; Yin H, 2012, EUR J PHARMACOL, V674, P200, DOI 10.1016/j.ejphar.2011.11.024; Yung LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017437	73	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80892	10.1371/journal.pone.0080892	http://dx.doi.org/10.1371/journal.pone.0080892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278341	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800088
J	de Val, BP; Vidal, E; Villarreal-Ramos, B; Gilbert, SC; Andaluz, A; Moll, X; Martin, M; Nofrarias, M; McShane, H; Vordermeier, HM; Domingo, M				Perez de Val, Bernat; Vidal, Enric; Villarreal-Ramos, Bernardo; Gilbert, Sarah C.; Andaluz, Anna; Moll, Xavier; Martin, Maite; Nofrarias, Miquel; McShane, Helen; Vordermeier, H. Martin; Domingo, Mariano			A Multi-Antigenic Adenoviral-Vectored Vaccine Improves BCG-Induced Protection of Goats against Pulmonary Tuberculosis Infection and Prevents Disease Progression	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; PRIME-BOOST IMMUNIZATION; CATTLE; CAPRAE; MUCOSAL; MODEL; RESPONSES; CELLS; REACTIVATION; STRATEGIES	The "One world, one health" initiative emphasizes the need for new strategies to control human and animal tuberculosis (TB) based on their shared interface. A good example would be the development of novel universal vaccines against Mycobacterium tuberculosis complex (MTBC) infection. This study uses the goat model, a natural TB host, to assess the protective effectiveness of a new vaccine candidate in combination with Bacillus Calmette-Guerin (BCG) vaccine. Thirty-three goat kids were divided in three groups: Group 1) vaccinated with BCG (week 0), Group 2) vaccinated with BCG and boosted 8 weeks later with a recombinant adenovirus expressing the MTBC antigens Ag85A, TB10.4, TB9.8 and Acr2 (AdTBF), and Group 3) unvaccinated controls. Later on, an endobronchial challenge with a low dose of M. caprae was performed (week 15). After necropsy (week 28), the pulmonary gross pathology was quantified using high resolution Computed Tomography. Small granulomatous pulmonary lesions (< 0.5 cm diameter) were also evaluated through a comprehensive qualitative histopathological analysis. M. caprae CFU were counted from pulmonary lymph nodes. The AdTBF improved the effects of BCG reducing gross lesion volume and bacterial load, as well as increasing weight gain. The number of Ag85A-specific gamma interferon-producing memory T-cells was identified as a predictor of vaccine efficacy. Specific cellular and humoral responses were measured throughout the 13-week post-challenge period, and correlated with the severity of lesions. Unvaccinated goats exhibited the typical pathological features of active TB in humans and domestic ruminants, while vaccinated goats showed only very small lesions. The data presented in this study indicate that multi-antigenic adenoviral vectored vaccines boosts protection conferred by vaccination with BCG.	[Perez de Val, Bernat; Vidal, Enric; Martin, Maite; Nofrarias, Miquel; Domingo, Mariano] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Bellaterra, Catalonia, Spain; [Villarreal-Ramos, Bernardo; Vordermeier, H. Martin] Agcy Weybridge, Anim Hlth & Vet Labs, TB Res Grp, Addlestone, Surrey, England; [Gilbert, Sarah C.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Andaluz, Anna; Moll, Xavier] Univ Autonoma Barcelona, Dept Med & Cirugia Anim, Bellaterra, Catalonia, Spain; [Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Catalonia, Spain	Autonomous University of Barcelona; IRTA; University of Oxford; Jenner Institute; Autonomous University of Barcelona; Autonomous University of Barcelona	de Val, BP (corresponding author), Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim, Campus Univ Autonoma Barcelona, Bellaterra, Catalonia, Spain.	bernat.perez@cresa.uab.cat	Gilbert, Sarah C./H-2857-2019; Moll, Xavier/H-3203-2018; Vidal, Enric/P-2901-2019; DE VAL, BERNAT PÉREZ/G-6865-2012; Vordermeier, H Martin/C-6936-2011; Domingo, Mariano/A-1015-2009; Vidal, Enric/I-1679-2014	Gilbert, Sarah C./0000-0002-6823-9750; Moll, Xavier/0000-0002-2992-9361; Vidal, Enric/0000-0002-4965-3286; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Domingo, Mariano/0000-0002-9623-4826; Vidal, Enric/0000-0002-4965-3286; Andaluz, Anna/0000-0001-8097-8110; Nofrarias Espadamala, Miquel/0000-0002-7983-1389; McShane, Helen/0000-0002-2126-5142	European Community [FP7-KBBE-2007-1-3-04: TB-STEP, 212414]	European Community(European Commission)	The study was funded by the European Community's 7th Framework Programme (FP7-KBBE-2007-1-3-04: TB-STEP project under grant agreement 212414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; BUDDLE BM, 1995, VACCINE, V13, P1123, DOI 10.1016/0264-410X(94)00055-R; Buddle BM, 2005, TUBERCULOSIS, V85, P19, DOI 10.1016/j.tube.2004.09.003; Canetti G., 1955, TUBERCLE BACILLUS PU; Daniel R, 2009, VET REC, V165, P335, DOI 10.1136/vr.165.12.335; Dean GS, 2008, TUBERCULOSIS, V88, P586, DOI 10.1016/j.tube.2008.01.004; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Domingo M, 2009, SCAND J IMMUNOL, V69, P500, DOI 10.1111/j.1365-3083.2009.02251.x; Domogalla J, 2013, J CLIN MICROBIOL; Erler W, 2004, J CLIN MICROBIOL, V42, P2234, DOI 10.1128/JCM.42.5.2234-2238.2004; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Garcia-Jimenez WL, 2013, TRANSBOUND EMERG DIS, V60, P102, DOI 10.1111/j.1865-1682.2012.01321.x; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Hewinson RG, 2003, TUBERCULOSIS, V83, P119, DOI 10.1016/S1472-9792(02)00062-8; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Krebs J., 1997, PB3423 HMSO; Kubica T, 2003, J CLIN MICROBIOL, V41, P3070, DOI 10.1128/JCM.41.7.3070-3077.2003; Kyd JM, 2001, VACCINE, V19, P2527, DOI 10.1016/S0264-410X(00)00484-9; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lyashchenko K, 2004, INFECT IMMUN, V72, P2462, DOI 10.1128/IAI.72.5.2462-2467.2004; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; Napp S, 2013, VET REC, V172, DOI 10.1136/vr.101347; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; de Val BP, 2012, CLIN VACCINE IMMUNOL, V19, P1339, DOI 10.1128/CVI.00275-12; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Plopper CG, 2005, RESP SYTEM ITS USE R, V30, P503; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Rodriguez S, 2011, EMERG INFECT DIS, V17, P532, DOI 10.3201/eid1703.100618; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Shuralev E, 2012, VET MICROBIOL, V154, P292, DOI 10.1016/j.vetmic.2011.07.028; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Vordermeier M, 2012, METHODS MOL BIOL, V792, P219, DOI 10.1007/978-1-61779-325-7_17; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Whelan A, 2012, VACCINE, V30, P6294, DOI 10.1016/j.vaccine.2012.07.086; *WHO, 2009, GLOB TUB CONTR SHORT; Xing Z, 2007, EXPERT REV VACCINES, V6, P539, DOI 10.1586/14760584.6.4.539; Xing Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005856	46	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81317	10.1371/journal.pone.0081317	http://dx.doi.org/10.1371/journal.pone.0081317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278420	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800121
J	Zhang, D; Chen, CF; Zhao, BB; Gong, LL; Jin, WJ; Liu, JJ; Wang, JF; Wang, TT; Yuan, XH; He, YW				Zhang, Ding; Chen, Cai-Feng; Zhao, Bin-Bin; Gong, Lu-Lu; Jin, Wen-Jing; Liu, Jing-Jun; Wang, Jing-Fei; Wang, Tian-Tian; Yuan, Xiao-Hui; He, You-Wen			A Novel Antibody Humanization Method Based on Epitopes Scanning and Molecular Dynamics Simulation	PLOS ONE			English	Article							THERAPEUTIC MONOCLONAL-ANTIBODIES; ADENOVIRUS TYPE-3 HEXON; DENDRITIC CELLS; VARIABLE DOMAINS; HLA-DR; RECEPTOR; PROTEIN; MOUSE; IMMUNOGLOBULIN; DEC-205	1-17-2 is a rat anti-human DEC-205 monoclonal antibody that induces internalization and delivers antigen to dendritic cells (DCs). The potentially clinical application of this antibody is limited by its murine origin. Traditional humanization method such as complementarity determining regions (CDRs) graft often leads to a decreased or even lost affinity. Here we have developed a novel antibody humanization method based on computer modeling and bioinformatics analysis. First, we used homology modeling technology to build the precise model of Fab. A novel epitope scanning algorithm was designed to identify antigenic residues in the framework regions (FRs) that need to be mutated to human counterpart in the humanization process. Then virtual mutation and molecular dynamics (MD) simulation were used to assess the conformational impact imposed by all the mutations. By comparing the root-mean-square deviations (RMSDs) of CDRs, we found five key residues whose mutations would destroy the original conformation of CDRs. These residues need to be back-mutated to rescue the antibody binding affinity. Finally we constructed the antibodies in vitro and compared their binding affinity by flow cytometry and surface plasmon resonance (SPR) assay. The binding affinity of the refined humanized antibody was similar to that of the original rat antibody. Our results have established a novel method based on epitopes scanning and MD simulation for antibody humanization.	[Zhang, Ding; Chen, Cai-Feng; Zhao, Bin-Bin; Gong, Lu-Lu; Jin, Wen-Jing; Liu, Jing-Jun; Yuan, Xiao-Hui; He, You-Wen] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhang, Ding; Chen, Cai-Feng; Zhao, Bin-Bin; Gong, Lu-Lu; Jin, Wen-Jing; Liu, Jing-Jun; Yuan, Xiao-Hui; He, You-Wen] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Jing-Fei] Chinese Acad Agr Sci, Harbin Vet Res Inst, Harbin, Peoples R China; [He, You-Wen] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Wang, Tian-Tian] Chinese Peoples Armed Police Forces, Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Duke University	Yuan, XH (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	yuanhui1024@gmail.com; youwen.he@duke.edu	Xiaohui, Yuan/D-7374-2016		National Grand Program on Key Infectious Diseases from the Ministry of Health of China [2012ZX10002-006]; Institute of Pathology Biology, Chinese Academy of Medical Sciences [2008IPB115-2, 2009IPB108]	National Grand Program on Key Infectious Diseases from the Ministry of Health of China; Institute of Pathology Biology, Chinese Academy of Medical Sciences	This study is funded by the National Grand Program on Key Infectious Diseases (No. 2012ZX10002-006) from the Ministry of Health of China and the Institute of Pathology Biology (No.2008IPB115-2, No.2009IPB108), Chinese Academy of Medical Sciences. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Brady JL, 2006, J IMMUNOL METHODS, V315, P61, DOI 10.1016/j.jim.2006.07.002; Calvo B, 2012, CURR MED CHEM, V19, P4445, DOI 10.2174/092986712803251485; Caravella JA, 2010, CURR COMPUT AIDED DR; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Chatterjee S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841127; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Cheng Xiaolin, 2012, Methods Mol Biol, V929, P243; Coutsias EA, 2004, J COMPUT CHEM, V25, P1849, DOI 10.1002/jcc.20110; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Friedman R, 2013, BIOCH BIOPHYS ACTA; Hackett J, 1998, J CLIN MICROBIOL, V36, P1277, DOI 10.1128/JCM.36.5.1277-1284.1998; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kennedy GA, 2002, BRIT J HAEMATOL, V119, P412, DOI 10.1046/j.1365-2141.2002.03843.x; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; Mo SL, 2012, CURR PHARM BIOTECHNO, V13, P1640, DOI 10.2174/138920112800958779; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nurisso Alessandra, 2012, Methods Mol Biol, V857, P137, DOI 10.1007/978-1-61779-588-6_6; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; PEDERSEN JT, 1994, J MOL BIOL, V235, P959, DOI 10.1006/jmbi.1994.1050; POLJAK RJ, 1974, P NATL ACAD SCI USA, V71, P3440, DOI 10.1073/pnas.71.9.3440; Presta LG, 2006, ADV DRUG DELIVER REV, V58, P640, DOI 10.1016/j.addr.2006.01.026; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Roguska MA, 1996, PROTEIN ENG, V9, P895, DOI 10.1093/protein/9.10.895; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Southwood S, 1998, J IMMUNOL, V160, P3363; Spassov VZ, 2008, PROTEIN ENG DES SEL, V21, P91, DOI 10.1093/protein/gzm083; Suyama M, 1997, J MOL EVOL, V44, pS163, DOI 10.1007/PL00000065; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; TJANDRA JJ, 1990, IMMUNOL CELL BIOL, V68, P367, DOI 10.1038/icb.1990.50; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Vyas VK, 2012, INDIAN J PHARM SCI, V74, P1, DOI 10.4103/0250-474X.102537; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yuan XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032938; Yuan XH, 2011, CHEM J CHINESE U, V32, P1838; Yuan XH, 2009, CHEM J CHINESE U, V30, P1636; Yuan XH, 2009, VACCINE, V27, P5103, DOI 10.1016/j.vaccine.2009.06.041; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	51	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80636	10.1371/journal.pone.0080636	http://dx.doi.org/10.1371/journal.pone.0080636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278299	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800078
J	Aghajani, M; Mahdavi, MRV; Najafabadi, MK; Ghazanfari, T; Azimi, A; Soleymani, SA; Dust, SM				Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Najafabadi, Mohsen Khalili; Ghazanfari, Tooba; Azimi, Armin; Soleymani, Saeid Arbab; Dust, Shirin Mahdi			Effects of Dominant/Subordinate Social Status on Formalin-Induced Pain and Changes in Serum Proinflammatory Cytokine Concentrations in Mice	PLOS ONE			English	Article							STRESS-INDUCED HYPERALGESIA; AGGRESSIVE-BEHAVIOR; GLUCOCORTICOID RESISTANCE; DEFEAT; BRAIN; MODULATION; EXPRESSION; SEROTONIN; INCREASES; RELEVANCE	Current investigations regarding social stress primarily focus on the health consequences of being in stressful social hierarchies. The repetitive nature of social conflicts seems to favor an induction of hyperalgesia or hypoalgesia, both in rodents and humans. Additionally, social conflicts may affect the immune system. In order to better establish the pain and immune responses to stress, the present study implemented a sensory contact model on 32 male BALB/c mice. Subsequent to establishing a dominance/submissive social relationship, each mouse was injected with formalin (20 mu l, 2%) and their pain behavior was scored and serum concentrations of proinflammatory cytokines IL-1 and IL-6, and corticosterone were also measured. Test results revealed that subordinate mice were hypoalgesic during chronic phase of formalin test compared to control and dominant mice (P<0.05). On the other hand, subordinate mice were hyperalgesic compared to dominant mice during the whole acute phase of formalin test (P<0.05). Corticosterone, IL-1 and IL-6 concentrations were much higher in serum of dominant and subordinate mice than in the control group (p<0.05). The results indicated that, although both dominant and subordinate animals displayed an increase in serum corticosterone and proinflammatory cytokines during social interactions, their response to pain perception differently was affected with the social status.	[Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Najafabadi, Mohsen Khalili; Azimi, Armin; Soleymani, Saeid Arbab; Dust, Shirin Mahdi] Shahed Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Aghajani, Marjan; Mahdavi, Mohammad Reza Vaez; Ghazanfari, Tooba] Shahed Univ, Equ & Hlth Res Dept, Tehran, Iran; [Ghazanfari, Tooba] Shahed Univ, Fac Med Sci, Dept Immunol, Tehran, Iran; [Mahdavi, Mohammad Reza Vaez] Shahed Univ, Tradit Med Clin Trial Res Ctr, Tehran, Iran; [Aghajani, Marjan] Tehran Med Univ, Fac Med Sci, Dept Physiol, Tehran, Iran	Shahed University; Shahed University; Shahed University; Shahed University; Tehran University of Medical Sciences	Mahdavi, MRV (corresponding author), Shahed Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.	vaezmahdavi@shahed.ac.ir	Vaez-Mahdavi, Mohammad-Reza/I-8185-2016; Khalili, Mohsen/H-2622-2016	Vaez-Mahdavi, Mohammad-Reza/0000-0002-1490-4364; Khalili, Mohsen/0000-0002-7154-676X; , marjan/0000-0002-7617-271X; azimi, armin/0000-0001-9544-9828	Shahed Medical University [87/14/A/P]	Shahed Medical University	This research was provided by financial support and supervision of Shahed Medical University (grant number: 87/14/A/P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 2009, PAIN, V141, P292, DOI 10.1016/j.pain.2008.12.007; Andre J, 2005, J NEUROSCI, V25, P7896, DOI 10.1523/JNEUROSCI.0743-05.2005; Arregi A, 2006, AGGRESS VIOLENT BEH, V11, P394, DOI 10.1016/j.avb.2006.01.005; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; Audet MC, 2011, BRAIN BEHAV IMMUN, V25, P1197, DOI 10.1016/j.bbi.2011.03.010; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Avitsur R, 2003, J LEUKOCYTE BIOL, V74, P507, DOI 10.1189/jlb.0303090; Azpiroz A, 2003, AGGRESS VIOLENT BEH, V8, P433, DOI 10.1016/S1359-1789(02)00066-6; Barnum CJ, 2008, BRAIN BEHAV IMMUN, V22, P517, DOI 10.1016/j.bbi.2007.10.004; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Biondi M., 2001, PSYCHONEUROIMMUNOLOG, P189; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Colas DC, 2011, THESIS; Danielle CC, 2010, THESIS NEWBRUNSWICK; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Farmer AD, 2013, BRIT J PAIN, V7, P39, DOI 10.1177/2049463713479229; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Gioiosa L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004143; Glynn P, 1999, THORAX, V54, P51, DOI 10.1136/thx.54.1.51; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Heidary F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003705; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Hoff J, 2000, LAB ANIMAL, V29, P47; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; Institute for Laboratory Animal Research, 2009, REC ASS PAIN, P47; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Langford DJ, 2011, J PAIN, V12, P125, DOI 10.1016/j.jpain.2010.06.003; Liebregts T, 2007, EUR J PAIN, V11, P216, DOI 10.1016/j.ejpain.2006.02.007; Marini F, 2006, BRAIN RES, V1067, P25, DOI 10.1016/j.brainres.2005.10.002; Martenson ME, 2009, PAIN, V142, P236, DOI 10.1016/j.pain.2009.01.011; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Miranda HC, 2011, BRAZ ARCH BIOL TECHN, V54, P717, DOI 10.1590/S1516-89132011000400010; Mojarab S., 2010, World Applied Sciences Journal, V8, P680; Moles A, 2006, PSYCHONEUROENDOCRINO, V31, P623, DOI 10.1016/j.psyneuen.2006.01.004; Morin P, 2003, BIOL BASIS BEHAV, P1; Munhoz CD, 2008, BRAZ J MED BIOL RES, V41, P1037, DOI 10.1590/S0100-879X2008001200001; Nevison CM, 1999, ANIM WELFARE, V8, P361; Nevison CM, 2000, P ROY SOC B-BIOL SCI, V267, P687, DOI 10.1098/rspb.2000.1057; O'Connor TM, 2000, QJM-INT J MED, V93, P323, DOI 10.1093/qjmed/93.6.323; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pan YL, 2010, HORM BEHAV, V58, P478, DOI 10.1016/j.yhbeh.2010.05.001; Pavlidis M, 2011, BEHAV BRAIN RES, V225, P529, DOI 10.1016/j.bbr.2011.08.022; Raber P, 2002, PAIN, V97, P139, DOI 10.1016/S0304-3959(02)00013-1; Rabin B.S., 1999, STRESS IMMUNE FUNCTI; Razzoli M, 2011, BEHAV BRAIN RES, V216, P100, DOI 10.1016/j.bbr.2010.07.014; Rettich Andreas, 2006, Journal of Applied Animal Welfare Science, V9, P277, DOI 10.1207/s15327604jaws0904_3; Richebe P, 2011, ANESTHESIOLOGY, V114, P1280, DOI 10.1097/ALN.0b013e31821c112b; Rittner HL, 2005, J LEUKOCYTE BIOL, V78, P1215, DOI 10.1189/jlb.0405223; Rivat C, 2010, PAIN, V150, P358, DOI 10.1016/j.pain.2010.05.031; Rivers J.J., 2010, DOMIN HLTH, P87; Rohde P, 2001, J AFFECT DISORDERS, V65, P221, DOI 10.1016/S0165-0327(00)00219-6; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1993, RECENT PROG HORM RES, V48, P437; Savignac HM, 2011, BEHAV BRAIN RES, V216, P576, DOI 10.1016/j.bbr.2010.08.049; Seo YJ, 2006, BRAIN RES BULL, V71, P279, DOI 10.1016/j.brainresbull.2006.09.012; Stark JL, 2001, AM J PHYSIOL-REG I, V280, pR1799, DOI 10.1152/ajpregu.2001.280.6.R1799; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; van Erp AMM, 2000, J NEUROSCI, V20, P9320; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80650	10.1371/journal.pone.0080650	http://dx.doi.org/10.1371/journal.pone.0080650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278302	Green Published, gold			2022-12-27	WOS:000327313100098
J	Gao, B; Ju, XT; Su, F; Gao, FB; Cao, QS; Oenema, O; Christie, P; Chen, XP; Zhang, FS				Gao, Bing; Ju, Xiaotang; Su, Fang; Gao, Fengbin; Cao, Qingsen; Oenema, Oene; Christie, Peter; Chen, Xinping; Zhang, Fusuo			Comparison of Soil Respiration in Typical Conventional and New Alternative Cereal Cropping Systems on the North China Plain	PLOS ONE			English	Article							CARBON-DIOXIDE; WATER-CONTENT; TEMPERATURE; NITROGEN; DEPENDENCE; ECOSYSTEM; TILLAGE; FOREST; MANAGEMENT; MOISTURE	We monitored soil respiration (Rs), soil temperature (T) and volumetric water content (VWC%) over four years in one typical conventional and four alternative cropping systems to understand Rs in different cropping systems with their respective management practices and environmental conditions. The control was conventional double-cropping system (winter wheat and summer maize in one year - Con. W/M). Four alternative cropping systems were designed with optimum water and N management, i.e. optimized winter wheat and summer maize (Opt. W/M), three harvests every two years (first year, winter wheat and summer maize or soybean; second year, fallow then spring maize - W/M-M and W/S-M), and single spring maize per year (M). Our results show that Rs responded mainly to the seasonal variation in T but was also greatly affected by straw return, root growth and soil moisture changes under different cropping systems. The mean seasonal CO2 emissions in Con. W/M were 16.8 and 15.1 Mg CO2 ha(-1) for summer maize and winter wheat, respectively, without straw return. They increased significantly by 26 and 35% in Opt. W/M, respectively, with straw return. Under the new alternative cropping systems with straw return, W/M-M showed similar Rs to Opt. W/M, but total CO2 emissions of W/S-M decreased sharply relative to Opt. W/M when soybean was planted to replace summer maize. Total CO2 emissions expressed as the complete rotation cycles of W/S-M, Con. W/M and M treatments were not significantly different. Seasonal CO2 emissions were significantly correlated with the sum of carbon inputs of straw return from the previous season and the aboveground biomass in the current season, which explained 60% of seasonal CO2 emissions. T and VWC% explained up to 65% of Rs using the exponential-power and double exponential models, and the impacts of tillage and straw return must therefore be considered for accurate modeling of Rs in this geographical region.	[Gao, Bing; Ju, Xiaotang; Su, Fang; Gao, Fengbin; Cao, Qingsen; Christie, Peter; Chen, Xinping; Zhang, Fusuo] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Oenema, Oene] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands	China Agricultural University; Wageningen University & Research	Ju, XT (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	juxt@cau.edu.cn	Gao, Bing/AAV-1324-2021; Zhang, Fusuo/AAV-4517-2021; Christie, Peter/B-7919-2008	Christie, Peter/0000-0002-1939-7277; Ju, Xiaotang/0000-0003-2593-9500	National Natural Science Foundation of China [41230856, 31172033]; Special Fund for the Agricultural Profession [201103039]; '973' Project [2009CB118606, 2012CB417105]; Innovation Group Grant of the National Natural Science Foundation of China [31121062]; China Postdoctoral Science Foundation [2013M 530778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for the Agricultural Profession; '973' Project(National Basic Research Program of China); Innovation Group Grant of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by the National Natural Science Foundation of China (41230856, 31172033), the Special Fund for the Agricultural Profession (201103039), the '973' Project (2009CB118606) and the Innovation Group Grant of the National Natural Science Foundation of China (31121062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] into [This work was funded by the '973' Project (2012CB417105, 2009CB118606), the National Natural Science Foundation of China (41230856, 31172033), the Special Fund for the Agricultural Profession (201103039), China Postdoctoral Science Foundation (2013M 530778), and the Innovation Group Grant of the National Natural Science Foundation of China (31121062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kaisi MM, 2005, J ENVIRON QUAL, V34, P437, DOI 10.2134/jeq2005.0437; Alluvione F, 2009, J ENVIRON QUAL, V38, P2023, DOI 10.2134/jeq2008.0517; Bavin TK, 2009, AGR ECOSYST ENVIRON, V134, P234, DOI 10.1016/j.agee.2009.07.005; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Carlisle EA, 2006, J ENVIRON QUAL, V35, P1396, DOI 10.2134/jeq2005.0155; Conant RT, 2004, SOIL BIOL BIOCHEM, V36, P945, DOI 10.1016/j.soilbio.2004.02.013; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; Guo RY, 2010, ENVIRON POLLUT, V158, P2218, DOI 10.1016/j.envpol.2010.02.014; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; HOWARD DM, 1993, SOIL BIOL BIOCHEM, V25, P1537, DOI 10.1016/0038-0717(93)90008-Y; Hu C, 2005, J SOIL WATER CONSERV, V60, P80; Huang T, 2013, BIOGEOSCIENCES DISCU, V10, P13191; Huang Y, 2006, CHINESE SCI BULL, V51, P1785, DOI 10.1007/s11434-006-2056-6; Iqbal J, 2009, GEODERMA, V152, P63, DOI 10.1016/j.geoderma.2009.05.011; Jackson LE, 2003, GEODERMA, V114, P305, DOI 10.1016/S0016-7061(03)00046-6; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; Li HJ, 2008, THESIS SHANXI U SHAN; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lohila A, 2003, PLANT SOIL, V251, P303, DOI 10.1023/A:1023004205844; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Melling L, 2005, TELLUS B, V57, P1, DOI 10.1111/j.1600-0889.2005.00129.x; [孟凡乔 MENG Fanqiao], 2006, [环境科学学报, Acta Scientiae Circumstantiae], V26, P992; Meng QF, 2012, AGR ECOSYST ENVIRON, V146, P93, DOI 10.1016/j.agee.2011.10.015; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; [牛灵安 NIU Lingan], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P1054; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Willmott CJ, 1982, AM METEOROL SOC B, V63, P1309; Xiao M, 2006, EFFECT LONG TERM FER; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; [张庆忠 ZHANG QingZhong], 2005, [生态学报, Acta Ecologica Sinica], V25, P2883	40	4	6	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80887	10.1371/journal.pone.0080887	http://dx.doi.org/10.1371/journal.pone.0080887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278340	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100124
J	Kopeikina, KJ; Wegmann, S; Pitstick, R; Carlson, GA; Bacskai, BJ; Betensky, RA; Hyman, BT; Spires-Jones, TL				Kopeikina, Katherine J.; Wegmann, Susanne; Pitstick, Rose; Carlson, George A.; Bacskai, Brian J.; Betensky, Rebecca A.; Hyman, Bradley T.; Spires-Jones, Tara L.			Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; AXONAL-TRANSPORT; CASPASE ACTIVATION; TANGLE FORMATION; SPINE LOSS; MITOCHONDRIA; PATHOGENESIS; NEURONS; CA2+	Neurofibrillary tangles (NFTs) of tau are one of the defining hallmarks of Alzheimer's disease (AD), and are closely associated with neuronal degeneration. Although it has been suggested that calcium dysregulation is important to AD pathogenesis, few studies have probed the link between calcium homeostasis, synapse loss and pathological changes in tau. Here we test the hypothesis that pathological changes in tau are associated with changes in calcium by utilizing in vivo calcium imaging in adult rTg4510 mice that exhibit severe tau pathology due to over-expression of human mutant P301L tau. We observe prominent dendritic spine loss without disruptions in calcium homeostasis, indicating that tangles do not disrupt this fundamental feature of neuronal health, and that tau likely induces spine loss in a calcium-independent manner.	[Kopeikina, Katherine J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kopeikina, Katherine J.; Wegmann, Susanne; Bacskai, Brian J.; Hyman, Bradley T.; Spires-Jones, Tara L.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Wegmann, Susanne; Bacskai, Brian J.; Hyman, Bradley T.; Spires-Jones, Tara L.] Harvard Univ, Sch Med, Boston, MA USA; [Pitstick, Rose; Carlson, George A.] McLaughlin Res Inst, Great Falls, MT USA; [Betensky, Rebecca A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Spires-Jones, Tara L.] Univ Edinburgh, Ctr Cognit & Neural Syst, Edinburgh, Midlothian, Scotland	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; McLaughlin Research Institute for Biomedical Sciences, Inc.; Harvard University; Harvard T.H. Chan School of Public Health; University of Edinburgh	Spires-Jones, TL (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	tara.spires-jones@ed.ac.uk	Bacskai, Brian/AAE-9583-2021; Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598	National Institutes of Health [T32AG000277, AG026249, AG08487, R00AG33670, P50AG05134]; Alzheimer's Association; Harvard Catalyst; Harvard Neurodiscovery Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026249, R01AG008487, R00AG033670, P50AG005134, T32AG000277, R29AG008487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Harvard Catalyst; Harvard Neurodiscovery Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by National Institutes of HealthGrants T32AG000277, AG026249, AG08487, R00AG33670 and P50AG05134 as well as the Alzheimer's Association Zenith Award. Further support came from Harvard Catalyst and the Harvard Neurodiscovery Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Attems J, 2011, J NEURAL TRANSM, V118, P737, DOI 10.1007/s00702-011-0626-5; Bacskai BJ, 2002, J CEREBR BLOOD F MET, V22, P1035, DOI 10.1097/00004647-200209000-00001; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Chakroborty S, 2011, SCI CHINA LIFE SCI, V54, P752, DOI 10.1007/s11427-011-4205-7; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Crimins JL, 2012, ACTA NEUROPATHOL, V124, P777, DOI 10.1007/s00401-012-1038-9; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Dubey M, 2008, CELL MOTIL CYTOSKEL, V65, P89, DOI 10.1002/cm.20243; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Furukawa K, 2003, J NEUROCHEM, V87, P427, DOI 10.1046/j.1471-4159.2003.02020.x; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Green KN, 2009, J CELL MOL MED, V13, P2787, DOI 10.1111/j.1582-4934.2009.00861.x; Hermes M, 2010, J CELL MOL MED, V14, P30, DOI 10.1111/j.1582-4934.2009.00976.x; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kopeikina KJ, 2013, J COMP NEUROL, V521, P1334, DOI 10.1002/cne.23234; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Meyer-Luehmann M, 2009, J NEUROSCI, V29, P12636, DOI 10.1523/JNEUROSCI.1948-09.2009; Muresan V, 2009, FUTUR NEUROL, V4, P761, DOI 10.2217/FNL.09.54; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones T, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/319836; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; TAI HC, 2012, SYSTEM AM J PATHOL; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	54	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80834	10.1371/journal.pone.0080834	http://dx.doi.org/10.1371/journal.pone.0080834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278327	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100117
J	Lebedeva, EV; Hatzenpichler, R; Pelletier, E; Schuster, N; Hauzmayer, S; Bulaev, A; Grigor'eva, NV; Galushko, A; Schmid, M; Palatinszky, M; Le Paslier, D; Daims, H; Wagner, M				Lebedeva, Elena V.; Hatzenpichler, Roland; Pelletier, Eric; Schuster, Nathalie; Hauzmayer, Sandra; Bulaev, Aleksandr; Grigor'eva, Nadezhda V.; Galushko, Alexander; Schmid, Markus; Palatinszky, Marton; Le Paslier, Denis; Daims, Holger; Wagner, Michael			Enrichment and Genome Sequence of the Group I. 1a Ammonia-Oxidizing Archaeon "Ca. Nitrosotenuis uzonensis" Representing a Clade Globally Distributed in Thermal Habitats	PLOS ONE			English	Article							CANDIDATUS NITROSOPUMILUS-MARITIMUS; GLYCEROL TETRAETHER LIPIDS; HOT-SPRINGS; AMOA GENES; CELL-DIVISION; RIBOSOMAL-RNA; BACTERIA; MARINE; DIVERSITY; OXIDATION	The discovery of ammonia-oxidizing archaea (AOA) of the phylum Thaumarchaeota and the high abundance of archaeal ammonia monooxygenase subunit A encoding gene sequences in many environments have extended our perception of nitrifying microbial communities. Moreover, AOA are the only aerobic ammonia oxidizers known to be active in geothermal environments. Molecular data indicate that in many globally distributed terrestrial high-temperature habits a thaumarchaeotal lineage within the Nitrosopumilus cluster (also called "marine" group I. 1a) thrives, but these microbes have neither been isolated from these systems nor functionally characterized in situ yet. In this study, we report on the enrichment and genomic characterization of a representative of this lineage from a thermal spring in Kamchatka. This thaumarchaeote, provisionally classified as "Candidatus Nitrosotenuis uzonensis", is a moderately thermophilic, non-halophilic, chemolithoautotrophic ammonia oxidizer. The nearly complete genome sequence (assembled into a single scaffold) of this AOA confirmed the presence of the typical thaumarchaeotal pathways for ammonia oxidation and carbon fixation, and indicated its ability to produce coenzyme F-420 and to chemotactically react to its environment. Interestingly, like members of the genus Nitrosoarchaeum, "Candidatus N. uzonensis" also possesses a putative artubulin-encoding gene. Genome comparisons to related AOA with available genome sequences confirmed that the newly cultured AOA has an average nucleotide identity far below the species threshold and revealed a substantial degree of genomic plasticity with unique genomic regions in "Ca. N. uzonensis", which potentially include genetic determinants of ecological niche differentiation.	[Lebedeva, Elena V.; Bulaev, Aleksandr; Grigor'eva, Nadezhda V.] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow, Russia; [Hatzenpichler, Roland; Schuster, Nathalie; Hauzmayer, Sandra; Galushko, Alexander; Schmid, Markus; Palatinszky, Marton; Daims, Holger; Wagner, Michael] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Pelletier, Eric; Le Paslier, Denis] Commissariat Energie Atom, Evry, France; [Pelletier, Eric; Le Paslier, Denis] CNRS, Evry, France; [Pelletier, Eric; Le Paslier, Denis] Univ Evry Val dEssonne, Evry, France	Research Center of Biotechnology RAS; Russian Academy of Sciences; University of Vienna; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Wagner, M (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria.	wagner@microbial-ecology.net	Palatinszky, Marton/HGB-7938-2022; Palatinszky, Marton/D-9876-2011; Hatzenpichler, Roland/E-7538-2011; Palatinszky, Márton/ABB-2723-2020; Bulaev, Aleksandr/O-2455-2013; Galushko, Alexander/I-4980-2015; Schmid, Markus C/D-2669-2012; Wagner, Michael/A-7801-2011; Daims, Holger/I-8410-2012	Palatinszky, Marton/0000-0002-3627-085X; Palatinszky, Marton/0000-0002-3627-085X; Bulaev, Aleksandr/0000-0001-7914-9817; Galushko, Alexander/0000-0002-0387-7997; Wagner, Michael/0000-0002-9778-7684; Daims, Holger/0000-0002-4195-0913; Hatzenpichler, Roland/0000-0002-5489-3444; Le Paslier, Denis/0000-0003-4335-9956; Pelletier, Eric/0000-0003-4228-1712; Valeeva, Aygul V./0000-0002-9968-9586	Austrian Academy of Sciences; Austrian Science Fund (FWF) [J 3162-B20]; Vienna Science and Technology Fund (WWTF) [LS09-040]; European Research Council [294343]; Russian Foundation for Basic Research [09-04-00502]	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); European Research Council(European Research Council (ERC)European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the Austrian Academy of Sciences via a DOC fellowship to RH, a Erwin Schrodinger postdoctoral fellowship by the Austrian Science Fund (FWF), J 3162-B20 to RH, by the Vienna Science and Technology Fund (WWTF) via grant LS09-040 to HD, the European Research Council [Advanced Grant Nitrification Reloaded (NITRICARE) 294343 to MW] and by the Russian Foundation for Basic Research No. 09-04-00502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair KL, 2008, MICROB ECOL, V56, P420, DOI 10.1007/s00248-007-9360-9; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Bartossek R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00208; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bollmann A, 2011, METHOD ENZYMOL, V486, P55, DOI [10.1016/S0076-6879(11)86003-9, 10.1016/B978-0-12-381294-0.00003-1]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Deppenmeier U, 2002, CELL MOL LIFE SCI, V59, P1513, DOI 10.1007/s00018-002-8526-3; Dodsworth JA, 2012, FEMS MICROBIOL ECOL, V81, P446, DOI 10.1111/j.1574-6941.2012.01369.x; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Ellen AF, 2010, ARCHAEA, V2010, DOI 10.1155/2010/608243; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hasan MR, 2010, J BIOL CHEM, V285, P19135, DOI 10.1074/jbc.M109.074310; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Jeanthon C, 1999, INT J SYST BACTERIOL, V49, P583, DOI 10.1099/00207713-49-2-583; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Kim BK, 2011, J BACTERIOL, V193, P5539, DOI 10.1128/JB.05717-11; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; KOOPS HP, 2003, PROCARYOTES EVOLVING; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lebedeva EV, 2011, FEMS MICROBIOL ECOL, V75, P195, DOI 10.1111/j.1574-6941.2010.01006.x; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nakagawa T, 2007, MICROBES ENVIRON, V22, P365, DOI 10.1264/jsme2.22.365; Ng KH, 2013, ARCHAEA, V2013, DOI 10.1155/2013/104147; Offre P, 2011, ENV MICROBIOL REP, V3, P245, DOI 10.1111/j.1758-2229.2010.00217.x; Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7; Pearson A, 2004, APPL ENVIRON MICROB, V70, P5229, DOI 10.1128/AEM.70.9.5229-5237.2004; Pearson A, 2008, APPL ENVIRON MICROB, V74, P3523, DOI 10.1128/AEM.02450-07; Pelve EA, 2011, MOL MICROBIOL, V82, P555, DOI 10.1111/j.1365-2958.2011.07834.x; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pitcher A, 2011, APPL ENVIRON MICROB, V77, P3468, DOI 10.1128/AEM.02758-10; Pitcher A, 2010, ISME J, V4, P542, DOI 10.1038/ismej.2009.138; Pitcher A, 2009, APPL ENVIRON MICROB, V75, P4443, DOI 10.1128/AEM.02591-08; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; REYNOLDS PJ, 1987, J MICROBIOL METH, V7, P115, DOI 10.1016/0167-7012(87)90032-7; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schouten S, 2008, APPL ENVIRON MICROB, V74, P2433, DOI 10.1128/AEM.01709-07; Schouten S, 2007, APPL ENVIRON MICROB, V73, P6181, DOI 10.1128/AEM.00630-07; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Spear JR, 2007, APPL ENVIRON MICROB, V73, P6172, DOI 10.1128/AEM.00393-07; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wang SF, 2009, APPL ENVIRON MICROB, V75, P4216, DOI 10.1128/AEM.01761-08; Weidler GW, 2008, APPL ENVIRON MICROB, V74, P5934, DOI 10.1128/AEM.02602-07; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yakimov MM, 2009, DEEP-SEA RES PT II, V56, P748, DOI 10.1016/j.dsr2.2008.07.024; YUTIN N, 2012, BIOL DIRECT, V7, DOI DOI 10.1186/1745-6150-1187-1110; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107; Zhang T, 2009, J APPL MICROBIOL, V107, P970, DOI 10.1111/j.1365-2672.2009.04283.x; Zhao WD, 2011, GEOMICROBIOL J, V28, P149, DOI 10.1080/01490451003753076	83	61	65	4	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80835	10.1371/journal.pone.0080835	http://dx.doi.org/10.1371/journal.pone.0080835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278328	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100118
J	Li, SS; Li, GF; Liu, L; Jiang, X; Zhang, B; Liu, ZG; Li, XL; Weng, LD; Zuo, T; Liu, Q				Li, Sha-Sha; Li, Guo-Feng; Liu, Li; Jiang, Xiao; Zhang, Bin; Liu, Zhi-Gang; Li, Xue-Ling; Weng, Li-Dong; Zuo, Ting; Liu, Qiang			Evaluation of Paeonol Skin-Target Delivery from Its Microsponge Formulation: In Vitro Skin Permeation and In Vivo Microdialysis	PLOS ONE			English	Article							TOPICAL DELIVERY; SIGNALING PATHWAYS; BENZOYL PEROXIDE; TNF-ALPHA; KAPPA-B; SYSTEM; RELEASE; PENETRATION; DESIGN; MODEL	The aim of the present study was to design a novel topical skin-target drug-delivery system, the paeonol microsponge, and to investigate its drug-release patterns in dosage form, both in vitro and in vivo. Paeonol microsponges were prepared using the quasi-emulsion solvent-diffusion method. In vitro release studies were carried out using Franz diffusion cells, while in vivo studies were investigated by microdialysis after the paeonol microsponges were incorporated into a cream base. In vitro release studies showed that the drug delivered via microsponges increased the paeonol permeation rate. Ex vivo drug-deposition studies showed that the microsponge formulation improved drug residence in skin. In addition, in vivo microdialysis showed that the values for the area under the concentration versus time curve (AUC) for the paeonol microsponge cream was much higher than that of paeonol cream without microsponges. Maximum time (T-max) was 220 min for paeonol microsponge cream and 480 min for paeonol cream, while the half-life (t(1/2)) of paeonol microsponge cream (935.1 min) was almost twice that of paeonol cream (548.6 min) in the skin (n = 3). Meanwhile, in the plasma, the AUC value for paeonol microsponge cream was half that of the paeonol cream. Based on these results, paeonol-loaded microsponge formulations could be a better alternative for treating skin disease, as the formulation increases drug bioavailability by lengthening the time of drug residence in the skin and should reduce side-effects because of the lower levels of paeonol moving into the circulation.	[Li, Sha-Sha; Li, Guo-Feng] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Li; Jiang, Xiao; Zhang, Bin; Liu, Zhi-Gang; Li, Xue-Ling; Weng, Li-Dong; Zuo, Ting; Liu, Qiang] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liu, Q (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China.	gzlq2002@163.com	Li, Sha-Sha/AHA-4810-2022; Li, Sha-Sha/AHA-2014-2022	Li, Sha-Sha/0000-0003-4346-7535; 	Guangdong Technology Research Center for Chinese Herbs Cosmetic of China [GCZX-A1007]	Guangdong Technology Research Center for Chinese Herbs Cosmetic of China	This project was supported by Guangdong Technology Research Center for Chinese Herbs Cosmetic of China (No. GCZX-A1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrutiya N, 2009, AAPS PHARMSCITECH, V10, P402, DOI 10.1208/s12249-009-9220-7; Chadawar V, 2007, AAPS PHARMSCITECH, V4, P402; Desai PR, 2012, PHARM RES-DORDR, V29, P2587, DOI 10.1007/s11095-012-0789-2; Embil K, 1996, J MICROENCAPSUL, V13, P575, DOI 10.3109/02652049609026042; Fang JY, 1999, INT J PHARM, V180, P137, DOI 10.1016/S0378-5173(98)00287-7; Himaya SWA, 2012, TOXICOL IN VITRO, V26, P878, DOI 10.1016/j.tiv.2012.04.022; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Incecayir T, 2011, PHARM RES-DORDR, V28, P2165, DOI 10.1007/s11095-011-0444-3; Jain V, 2010, J PHARM SCI, P1545; Jain V, 2011, ARCH PHARM RES, V34, P733, DOI 10.1007/s12272-011-0506-4; Jalon EGd, 2001, J CONTROL RELEASE, P191; Jalon EGd, 2001, J CONTROL RELEASE, V75, P197; Jelvehgari M, 2006, INT J PHARM, V308, P124, DOI 10.1016/j.ijpharm.2005.11.001; Kim SH, 2004, INT IMMUNOPHARMACOL, V4, P279, DOI 10.1016/j.intimp.2003.12.013; Li YJ, 2010, VASC PHARMACOL, V53, P169, DOI 10.1016/j.vph.2010.07.001; Ma YL, 2006, EUR J PHARMACOL, V545, P87, DOI 10.1016/j.ejphar.2006.06.064; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Nokhodchi A, 2007, MICRON, V38, P834, DOI 10.1016/j.micron.2007.06.012; Orlu M, 2006, INT J PHARMACEUT, V318, P103, DOI 10.1016/j.ijpharm.2006.03.025; Pan LL, 2009, PHYTOMEDICINE, V16, P1027, DOI 10.1016/j.phymed.2009.04.003; Rishabh S, 2012, INT J PHARMACEUT, V427, P153; Rizkalla CMZ, 2011, AAPS PHARMSCITECH, V12, P989, DOI 10.1208/s12249-011-9663-5; Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Schnetz E, 2001, EUR J PHARM SCI, V12, P165, DOI 10.1016/S0928-0987(00)00155-X; Simonsen L, 2004, EUR J PHARM SCI, V21, P379, DOI 10.1016/j.ejps.2003.11.004; Sun GP, 2008, EUR J PHARMACOL, V584, P246, DOI 10.1016/j.ejphar.2008.02.016; Tsai YH, 2010, FOOD CHEM, V120, P837, DOI 10.1016/j.foodchem.2009.11.024; Tsao JY, 2010, INT J PHARMACEUT, V402, P123, DOI 10.1016/j.ijpharm.2010.09.033; Wu JB, 2008, J NEUROL SCI, V264, P50, DOI 10.1016/j.jns.2007.06.057; Wu RG, 2012, INT J PHARMACEUT, V438, P91, DOI 10.1016/j.ijpharm.2012.08.052; Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008	31	26	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79881	10.1371/journal.pone.0079881	http://dx.doi.org/10.1371/journal.pone.0079881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278204	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100065
J	Soto-Azat, C; Valenzuela-Sanchez, A; Clarke, BT; Busse, K; Ortiz, JC; Barrientos, C; Cunningham, AA				Soto-Azat, Claudio; Valenzuela-Sanchez, Andres; Clarke, Barry T.; Busse, Klaus; Carlos Ortiz, Juan; Barrientos, Carlos; Cunningham, Andrew A.			Is Chytridiomycosis Driving Darwin's Frogs to Extinction?	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; AMPHIBIAN POPULATION DECLINES; CHYTRID FUNGUS; MORTALITY; DIVERSITY; AUSTRALIA; AREAS	Darwin's frogs (Rhinoderma darwinii and R. rufum) are two species of mouth brooding frogs from Chile and Argentina that have experienced marked population declines. Rhinoderma rufum has not been found in the wild since 1980. We investigated historical and current evidence of Batrachochytrium dendrobatidis (Bd) infection in Rhinoderma spp. to determine whether chytridiomycosis is implicated in the population declines of these species. Archived and live specimens of Rhinoderma spp., sympatric amphibians and amphibians at sites where Rhinoderma sp. had recently gone extinct were examined for Bd infection using quantitative real-time PCR. Six (0.9%) of 662 archived anurans tested positive for Bd (4/289 R. darwinii; 1/266 R. rufum and 1/107 other anurans), all of which had been collected between 1970 and 1978. An overall Bd-infection prevalence of 12.5% was obtained from 797 swabs taken from 369 extant individuals of R. darwinii and 428 individuals representing 18 other species of anurans found at sites with current and recent presence of the two Rhinoderma species. In extant R. darwinii, Bd-infection prevalence (1.9%) was significantly lower than that found in other anurans (7.3%). The prevalence of infection (30%) in other amphibian species was significantly higher in sites where either Rhinoderma spp. had become extinct or was experiencing severe population declines than in sites where there had been no apparent decline (3.0%; x(2) = 106.407, P<0.001). This is the first report of widespread Bd presence in Chile and our results are consistent with Rhinoderma spp. declines being due to Bd infection, although additional field and laboratory investigations are required to investigate this further.	[Soto-Azat, Claudio; Valenzuela-Sanchez, Andres] Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Santiago, Chile; [Soto-Azat, Claudio; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Clarke, Barry T.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Busse, Klaus] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Carlos Ortiz, Juan; Barrientos, Carlos] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Concepcion, Chile	Universidad Andres Bello; Zoological Society of London; Natural History Museum London; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universidad de Concepcion	Soto-Azat, C (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Santiago, Chile.	csoto@unab.cl	Cunningham, Andrew A/E-7536-2010; Ortiz Cuellar, Juan carlos/GQZ-3899-2022; Valenzuela-Sánchez, Andrés/AAG-2762-2019	Valenzuela-Sánchez, Andrés/0000-0002-0445-9156; Azat, Claudio/0000-0001-9201-7886	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme, Wildlife Health Fund, Wildlife Conservation Society; Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme, Wildlife Health Fund, Wildlife Conservation Society; Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award(Royal Society of London)	This research was funded by the Institute of Zoology, Zoological Society of London (ZSL) and the ZSL EDGE Fellowship Programme; the Direccion General de Investigacion y Doctorados, Universidad Andres Bello; the Field Veterinary Programme, Wildlife Health Fund, Wildlife Conservation Society; and a Fundacion Futuro Scholarship. AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bishop PJ, 2009, DIS AQUAT ORGAN, V84, P9, DOI 10.3354/dao02028; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bourke J, 2011, DIS AQUAT ORGAN, V95, P259, DOI 10.3354/dao02369; Bourke J, 2010, DIS AQUAT ORGAN, V92, P217, DOI 10.3354/dao02239; Bourke J, 2012, NORTH-WEST J ZOOL, V8, P99; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Burger O, 1905, NEOMELIA RHINDOERMA; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Gascon C, 2007, P IUCN SSC AMPH CONS; GOICOECHEA O, 1986, J HERPETOL, V20, P168, DOI 10.2307/1563941; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Jimenez de la Espada DM, 1872, AN SOC HIST NAT MADR, V1, P139; Jorquera B, 1981, MEDIO AMBIENTE, V5, P58; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; PENNA M, 1990, J HERPETOL, V24, P23, DOI 10.2307/1564285; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; Shaw SD, 2010, DIS AQUAT ORGAN, V92, P159, DOI 10.3354/dao02227; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Soto-Azat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066957; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; ubeda C., 2010, IUCN RED LIST THREAT; Valdovinos C., 2005, HIST BIODIVERSIDAD E, P452; Veloso A., 2010, IUCN RED LIST THREAT; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Werning H, 2009, IRCF REPTILES AMPHIB, V16, P247	49	27	30	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79862	10.1371/journal.pone.0079862	http://dx.doi.org/10.1371/journal.pone.0079862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278196	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100059
J	Yeghiazarian, L; Cumberland, WG; Yang, OO				Yeghiazarian, Lilit; Cumberland, William G.; Yang, Otto O.			A Stochastic Multi-Scale Model of HIV-1 Transmission for Decision-Making: Application to a MSM Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; VIRAL LOAD; SENSITIVITY ANALYSIS; SEXUAL TRANSMISSION; PROTEASE INHIBITOR; SPREAD; MARKERS	Background: In the absence of an effective vaccine against HIV-1, the scientific community is presented with the challenge of developing alternative methods to curb its spread. Due to the complexity of the disease, however, our ability to predict the impact of various prevention and treatment strategies is limited. While ART has been widely accepted as the gold standard of modern care, its timing is debated. Objectives: To evaluate the impact of medical interventions at the level of individuals on the spread of infection across the whole population. Specifically, we investigate the impact of ART initiation timing on HIV-1 spread in an MSM (Men who have Sex with Men) population. Design and Methods: A stochastic multi-scale model of HIV-1 transmission that integrates within a single framework the in-host cellular dynamics and their outcomes, patient health states, and sexual contact networks. The model captures disease state and progression within individuals, and allows for simulation of therapeutic strategies. Results: Early ART initiation may substantially affect disease spread through a population. Conclusions: Our model provides a multi-scale, systems-based approach to evaluate the broader implications of therapeutic strategies.	[Yeghiazarian, Lilit] Univ Cincinnati, Dept Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA; [Cumberland, William G.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Microbiol, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Immunol, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA	University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Yeghiazarian, L (corresponding author), Univ Cincinnati, Dept Biomed Chem & Environm Engn, Cincinnati, OH 45221 USA.	yeghialt@ucmail.uc.edu			Ruth Kirchstein National Service Award (NIH); NIAID [AI043203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203, T32AI007370, P30AI028697] Funding Source: NIH RePORTER	Ruth Kirchstein National Service Award (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by the Ruth Kirchstein National Service Award (NIH) and the NIAID grant AI043203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Alvarez FP, 2007, METHOD INFORM MED, V46, P19; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; ARIAS E, 2007, US LIFE TABLES 2004; BAILEY, 1975, MATH THEORY INFECT D; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Breban R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046110; *CDC, 2011, NEW HOP STOPP HIV; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; CLARK SJ, 1994, J INFECT DIS, V170, P194, DOI 10.1093/infdis/170.1.194; De Cock KM, 2008, LANCET, V371, P2068, DOI 10.1016/S0140-6736(08)60732-1; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; FOUST E, 2001, MMWR-MORBID MORTAL W, V52, P1181; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Halloran ME, 2002, SCIENCE, V298, P1428, DOI 10.1126/science.1074674; Handcock MS, 2006, THEOR POPUL BIOL, V70, P125, DOI 10.1016/j.tpb.2006.02.004; Handcock MS, 2004, THEOR POPUL BIOL, V65, P413, DOI 10.1016/j.tpb.2003.09.006; Hendriks JCM, 1996, AIDS, V10, P649, DOI 10.1097/00002030-199606000-00011; HETHCOTE HW, 1982, MATH BIOSCI, V58, P93, DOI 10.1016/0025-5564(82)90053-0; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kassutto S, 2006, CLIN INFECT DIS, V42, P1024, DOI 10.1086/500410; Kaufmann DE, 2004, PLOS MED, V1, P137, DOI 10.1371/journal.pmed.0010036; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lafeuillade A, 2003, J INFECT DIS, V188, P1426, DOI 10.1086/379251; LONGINI IM, 1980, MATH BIOSCI, V50, P85, DOI 10.1016/0025-5564(80)90123-6; Lori F, 1999, J INFECT DIS, V180, P1827, DOI 10.1086/315113; Losina E, 2004, CLIN INFECT DIS, V38, P1613, DOI 10.1086/420930; Louzoun Y, 2012, J THEOR BIOL, V310, P3, DOI 10.1016/j.jtbi.2012.06.020; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Newman M.E.J., 2002, PHYS REV E, V66; *OARAC, 2006, GUID US ANT AG HIV 1; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pincus JM, 2003, CLIN INFECT DIS, V37, P1699, DOI 10.1086/379772; Potterat JJ, 2002, SEX TRANSM INFECT, V78, pI159, DOI 10.1136/sti.78.suppl_1.i159; Riddler SA, 1997, AIDS, V11, pS141; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1999, NEW ENGL J MED, V340, P969, DOI 10.1056/NEJM199903253401217; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; Shirreff G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002185; Smith DE, 2004, AIDS, V18, P709, DOI 10.1097/00002030-200403260-00001; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Tattevin P, 2007, CLIN INFECT DIS, V44, pE28, DOI 10.1086/510683; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tuckwell HC, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041918; Tuckwell HC, 2007, BIOSYSTEMS, V90, P546, DOI 10.1016/j.biosystems.2006.12.006; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Yang OO, 2002, AIDS RES HUM RETROV, V18, P1051, DOI 10.1089/08892220260235416; Youm Y, 2002, SEX TRANSM DIS, V29, P689, DOI 10.1097/00007435-200211000-00012	88	7	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e70578	10.1371/journal.pone.0070578	http://dx.doi.org/10.1371/journal.pone.0070578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302983	Green Published, Green Submitted, gold			2022-12-27	WOS:000327546400001
J	Ayllon, D; Nicola, GG; Elvira, B; Parra, I; Almodovar, A				Ayllon, Daniel; Nicola, Graciela G.; Elvira, Benigno; Parra, Irene; Almodovar, Ana			Thermal Carrying Capacity for a Thermally-Sensitive Species at the Warmest Edge of Its Range	PLOS ONE			English	Article							TROUT SALMO-TRUTTA; CLIMATE-CHANGE; EVOLUTIONARY RESCUE; DENSITY-DEPENDENCE; RESPONSES; TEMPERATURE; EXTINCTION; FISH; POPULATIONS; PERSISTENCE	Anthropogenic environmental change is causing unprecedented rates of population extirpation and altering the setting of range limits for many species. Significant population declines may occur however before any reduction in range is observed. Determining and modelling the factors driving population size and trends is consequently critical to predict trajectories of change and future extinction risk. We tracked during 12 years 51 populations of a cold-water fish species (brown trout Salmo trutta) living along a temperature gradient at the warmest thermal edge of its range. We developed a carrying capacity model in which maximum population size is limited by physical habitat conditions and regulated through territoriality. We first tested whether population numbers were driven by carrying capacity dynamics and then targeted on establishing (1) the temperature thresholds beyond which population numbers switch from being physical habitat-to temperature-limited; and (2) the rate at which carrying capacity declines with temperature within limiting thermal ranges. Carrying capacity along with emergent density-dependent responses explained up to 76% of spatio-temporal density variability of juveniles and adults but only 50% of young-of-the-year's. By contrast, young-of-the-year trout were highly sensitive to thermal conditions, their performance declining with temperature at a higher rate than older life stages, and disruptions being triggered at lower temperature thresholds. Results suggest that limiting temperature effects were progressively stronger with increasing anthropogenic disturbance. There was however a critical threshold, matching the incipient thermal limit for survival, beyond which realized density was always below potential numbers irrespective of disturbance intensity. We additionally found a lower threshold, matching the thermal limit for feeding, beyond which even unaltered populations declined. We predict that most of our study populations may become extinct by 2100, depicting the gloomy fate of thermally-sensitive species occurring at thermal range margins under limited potential for adaptation and dispersal.	[Ayllon, Daniel; Elvira, Benigno; Parra, Irene; Almodovar, Ana] Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain; [Nicola, Graciela G.] Univ Castilla La Mancha, Dept Environm Sci, Toledo, OH USA	Complutense University of Madrid	Almodovar, A (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain.	aalmodovar@bio.ucm.es	Almodóvar, Ana/L-5400-2014; G. Nicola, Graciela/ABE-5362-2021; Ayllon, Daniel/K-6862-2019; Elvira, Benigno/A-9273-2009; G. NICOLA, GRACIELA/R-8768-2017	Almodóvar, Ana/0000-0003-1465-3857; Ayllon, Daniel/0000-0001-7539-5287; Elvira, Benigno/0000-0002-6127-5302; G. NICOLA, GRACIELA/0000-0002-6898-307X	Government of Navarra; Spanish Ministry of Science and Innovation [CGL2008-04257/BOS]; Government of Madrid; European Social Fund (ESF)	Government of Navarra; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Madrid; European Social Fund (ESF)(European Social Fund (ESF))	This study was funded by the Government of Navarra and the Spanish Ministry of Science and Innovation through the research project CGL2008-04257/BOS. I. Parra was funded by a postgraduate contract from the Government of Madrid and the European Social Fund (ESF). Fisheries staff of the Regional Service of Navarra (Wildlife Service) carried out the fish surveys. The funders had not any other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Ayllon D, 2010, RIVER RES APPL, V26, P1090, DOI 10.1002/rra.1315; Ayllon D, 2010, ECOL FRESHW FISH, V19, P420, DOI 10.1111/j.1600-0633.2010.00426.x; Ayllon D, 2012, FISH RES, V134, P95, DOI 10.1016/j.fishres.2012.08.004; Ayllon D, 2012, ECOL INDIC, V20, P295, DOI 10.1016/j.ecolind.2012.02.028; Bates D, 2012, IME4 LINEAR MIXED EF; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brunet M, 2009, REGIONAL CLIMATE CHA; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; del Monte-Luna P, 2004, GLOBAL ECOL BIOGEOGR, V13, P485, DOI 10.1111/j.1466-822X.2004.00131.x; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Einum S, 2008, EVOL APPL, V1, P239, DOI 10.1111/j.1752-4571.2008.00021.x; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Eros T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036462; Filipe AF, 2013, DIVERS DISTRIB, V19, P1059, DOI 10.1111/ddi.12086; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Griffen BD, 2009, P ROY SOC B-BIOL SCI, V276, P1361, DOI 10.1098/rspb.2008.1558; Haldane J. B. S., 1953, New Biol, VNo. 15, P9; Halpern BS, 2005, AM NAT, V165, P82, DOI 10.1086/426672; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hayes JW, 2007, ECOL MODEL, V207, P171, DOI 10.1016/j.ecolmodel.2007.04.032; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R., 2012, QUANTREG QUANTILE RE; Lande R., 2003, OXFORD SERIES ECOLOG; Lassalle G, 2009, GLOBAL CHANGE BIOL, V15, P1072, DOI 10.1111/j.1365-2486.2008.01794.x; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; Lopez-Sepulcre A, 2005, AM NAT, V166, P317, DOI 10.1086/432560; Milhous RT, 1989, 26 US FISH WILDL SER; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Morrill JC, 2005, J ENVIRON ENG, V131, P139, DOI 10.1061/(ASCE)0733-9372(2005)131:1(139); Morris DW, 2007, ECOLOGY, V88, P597, DOI 10.1890/06-0389; Nicola GG, 2009, OECOLOGIA, V160, P515, DOI 10.1007/s00442-009-1317-x; Osmond MM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0085; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parra I, 2012, CAN J FISH AQUAT SCI, V69, P821, DOI 10.1139/F2012-025; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Piou C, 2013, GLOBAL CHANGE BIOL, V19, P711, DOI 10.1111/gcb.12085; Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; PUCKETT KJ, 1985, BEHAVIOUR, V92, P97, DOI 10.1163/156853985X00398; R Core Team, 2021, R LANGUAGE ENV STAT; Renwick AR, 2012, DIVERS DISTRIB, V18, P121, DOI 10.1111/j.1472-4642.2011.00827.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Samhouri JF, 2009, ECOLOGY, V90, P1009, DOI 10.1890/07-1161.1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Seber G.A.F., 1982, P1; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sibly RM, 2003, WILDLIFE POPULATION; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Waddle TJ, 2012, 2001340 US GEOL SURV; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; ZIPPIN C, 1956, BIOMETRICS, V12, P163, DOI 10.2307/3001759	71	17	18	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81354	10.1371/journal.pone.0081354	http://dx.doi.org/10.1371/journal.pone.0081354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282584	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500086
J	Christensen, JM; Brat, GA; Johnson, KE; Chen, YP; Buretta, KJ; Cooney, DS; Brandacher, G; Lee, WPA; Li, XD; Sacks, JM				Christensen, Joani M.; Brat, Gabriel A.; Johnson, Kristine E.; Chen, Yongping; Buretta, Kate J.; Cooney, Damon S.; Brandacher, Gerald; Lee, W. P. Andrew; Li, Xingde; Sacks, Justin M.			Monocytes Loaded with Indocyanine Green as Active Homing Contrast Agents Permit Optical Differentiation of Infectious and Non-Infectious Inflammation	PLOS ONE			English	Article							ADOPTIVE IMMUNOTHERAPY; BLOOD MONOCYTES; MURINE MODEL; ARTHRITIS; FLOW	Distinguishing cutaneous infection from sterile inflammation is a diagnostic challenge and currently relies upon subjective interpretation of clinical parameters, microbiological data, and nonspecific imaging. Assessing characteristic variations in leukocytic infiltration may provide more specific information. In this study, we demonstrate that homing of systemically administered monocytes tagged using indocyanine green (ICG), an FDA-approved near infrared dye, may be assessed non-invasively using clinically-applicable laser angiography systems to investigate cutaneous inflammatory processes. RAW 264.7 mouse monocytes co-incubated with ICG fluoresce brightly in the near infrared range. In vitro, the loaded cells retained the ability to chemotax toward monocyte chemotactic protein-1. Following intravascular injection of loaded cells into BALB/c mice with induced sterile inflammation (Complete Freund's Adjuvant inoculation) or infection (Group A Streptococcus inoculation) of the hind limb, non-invasive whole animal imaging revealed local fluorescence at the inoculation site. There was significantly higher fluorescence of the inoculation site in the infection model than in the inflammation model as early as 2 hours after injection (p<0.05). Microscopic examination of bacterial inoculation site tissue revealed points of near infrared fluorescence, suggesting the presence of ICG-loaded cells. Development of a non-invasive technique to rapidly image inflammatory states without radiation may lead to new tools to distinguish infectious conditions from sterile inflammatory conditions at the bedside.	[Christensen, Joani M.; Brat, Gabriel A.; Buretta, Kate J.; Cooney, Damon S.; Brandacher, Gerald; Lee, W. P. Andrew; Sacks, Justin M.] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA; [Johnson, Kristine E.] Johns Hopkins Bayview Med Ctr, Dept Med, Div Infect Dis, Baltimore, MD USA; [Chen, Yongping; Li, Xingde] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Sacks, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21218 USA.	jmsacks@jhmi.edu	Cooney, Damon/J-4762-2014; Li, Xingde/F-7663-2012; Brandacher, Gerald/L-7540-2016	Cooney, Damon/0000-0002-2786-287X; Brandacher, Gerald/0000-0001-7790-441X	Novadaq Corporation; Infectious Diseases Society of America Medical Scholars Program; NATIONAL CANCER INSTITUTE [U54CA151838] Funding Source: NIH RePORTER	Novadaq Corporation; Infectious Diseases Society of America Medical Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an unrestricted educational grant from Novadaq Corporation (www.novadaq.com) and by funding provided by the Infectious Diseases Society of America Medical Scholars Program [to JMC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN R, 1991, CANCER DETECT PREV, V15, P413; AUDRAN R, 1995, NUCL MED BIOL, V22, P817, DOI 10.1016/0969-8051(95)00013-N; BAHMANI B, 2010, P SPIE, V7576; Bisno AL, 1997, INFECT IMMUN, V65, P4926, DOI 10.1128/IAI.65.12.4926-4930.1997; Boddington SE, 2010, CELL TRANSPLANT, V19, P55, DOI [10.3727/096368909X478579, 10.3727/096368909X]; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; BUNCE C, 1992, INFECT IMMUN, V60, P2636, DOI 10.1128/IAI.60.7.2636-2640.1992; Draube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018801; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; Eisenblatter M, 2009, J NUCL MED, V50, P1676, DOI 10.2967/jnumed.108.060707; Falagas ME, 2005, ANN INTERN MED, V142, P47, DOI 10.7326/0003-4819-142-1-200501040-00011; FARADJI A, 1994, J IMMUNOL METHODS, V174, P297, DOI 10.1016/0022-1759(94)90033-7; FLOWER RW, 1973, INVEST OPHTH VISUAL, V12, P248; Imai T, 1997, ANESTHESIOLOGY, V87, P816, DOI 10.1097/00000542-199710000-00015; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; LARSON AA, 1986, PHARMACOL BIOCHEM BE, V24, P49, DOI 10.1016/0091-3057(86)90043-2; LEEVY CM, 1962, J CLIN INVEST, V41, P1169, DOI 10.1172/JCI104570; Lisy MR, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2409310; LOPEZ M, 1992, J IMMUNOTHER, V11, P209, DOI 10.1097/00002371-199204000-00008; Meier R, 2010, ARTHRITIS RHEUM-US, V62, P2322, DOI 10.1002/art.27542; Menendez L, 2004, LIFE SCI, V74, P3235, DOI 10.1016/j.lfs.2003.11.019; MILLER E, 1962, J LAB CLIN MED, V59, P345; Simon GH, 2006, EUR J NUCL MED MOL I, V33, P998, DOI 10.1007/s00259-006-0081-y; Werner SG, 2012, ANN RHEUM DIS, V71, P504, DOI 10.1136/annrheumdis-2010-148288; YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81430	10.1371/journal.pone.0081430	http://dx.doi.org/10.1371/journal.pone.0081430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282595	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500097
J	Ko, HC; Liu, TC; Lee, LA; Chao, WC; Tsou, YT; Ng, SH; Wu, CM				Ko, Hui-Chen; Liu, Tien-Chen; Lee, Li-Ang; Chao, Wei-Chieh; Tsou, Yung-Ting; Ng, Shu-Hang; Wu, Che-Ming			Timing of Surgical Intervention with Cochlear Implant in Patients with Large Vestibular Aqueduct Syndrome	PLOS ONE			English	Article							TERM SPEECH-PERCEPTION; HEARING-LOSS; CHILDREN; INTELLIGIBILITY; SLC26A4; AGE	Objectives: (1) To report the speech perception and intelligibility results of Mandarin-speaking patients with large vestibular aqueduct syndrome (LVAS) after cochlear implantation (CI); (2) to compare their performance with a group of CI users without LVAS; (3) to understand the effects of age at implantation and duration of implant use on the CI outcomes. The obtained data may be used to guide decisions about CI candidacy and surgical timing. Methods: Forty-two patients with LVAS participating in this study were divided into two groups: the early group received CI before 5 years of age and the late group after 5. Open-set speech perception tests (on Mandarin tones, words and sentences) were administered one year after implantation and at the most recent follow-up visit. Categories of auditory perception (CAP) and Speech Intelligibility Rating (SIR) scale scores were also obtained. Results: The patients with LVAS with more than 5 years of implant use (18 cases) achieved a mean score higher than 80% on the most recent speech perception tests and reached the highest level on the CAP/SIR scales. The early group developed speech perception and intelligibility steadily over time, while the late group had a rapid improvement during the first year after implantation. The two groups, regardless of their age at implantation, reached a similar performance level at the most recent follow-up visit. Conclusion: High levels of speech performance are reached after 5 years of implant use in patients with LVAS. These patients do not necessarily need to wait until their hearing thresholds are higher than 90 dB HL or PB word score lower than 40% to receive CI. They can do it "earlier" when their speech perception and/or speech intelligibility do not reach the performance level suggested in this study.	[Ko, Hui-Chen; Lee, Li-Ang; Chao, Wei-Chieh; Tsou, Yung-Ting; Wu, Che-Ming] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan; [Liu, Tien-Chen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Ng, Shu-Hang] Chang Gung Univ, Mol Imaging Ctr, Linkou, Taiwan; [Ng, Shu-Hang] Chang Gung Univ, Dept Diagnost Radiol, Linkou, Taiwan; [Ng, Shu-Hang] Chang Gung Univ, Dept Med Imaging, Linkou, Taiwan; [Ng, Shu-Hang] Chang Gung Univ, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University	Wu, CM (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan.	bobwu506@hotmail.com	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; CHE-MING, WU/0000-0001-5245-0482; TSOU, YUNG-TING/0000-0001-6557-5153				Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Allen MC, 1998, AM J OTOL, V19, P742; Archbold S, 1998, BRIT J AUDIOL, V32, P7, DOI 10.3109/03005364000000045; Aschendorff A, 1997, AM J OTOL, V18, pS57; Asma A, 2010, INT J PEDIATR OTORHI, V74, P474, DOI 10.1016/j.ijporl.2010.01.023; Au G, 1999, AM J OTOL, V20, P183; Berrettini S, 2005, AM J OTOLARYNG, V26, P363, DOI 10.1016/j.amjoto.2005.02.013; Bichey BG, 2002, OTOL NEUROTOL, V23, P323, DOI 10.1097/00129492-200205000-00016; Chen XM, 2010, ELECTROCHEMISTRY FOR THE ENVIRONMENT, P263, DOI 10.1007/978-0-387-68318-8_11; Chen XQ, 2011, INT J PEDIATR OTORHI, V75, P943, DOI 10.1016/j.ijporl.2011.04.015; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; EMMETT JR, 1985, AM J OTOL, V6, P387; Fahy CP, 2001, INT J PEDIATR OTORHI, V59, P207, DOI 10.1016/S0165-5876(01)00487-6; Gopen Q, 2011, LARYNGOSCOPE, V121, P1971, DOI 10.1002/lary.22083; Govaerts PJ, 1999, INT J PEDIATR OTORHI, V51, P157, DOI 10.1016/S0165-5876(99)00268-2; Harker LA, 1999, ANN OTO RHINOL LARYN, V108, P39, DOI 10.1177/00034894991080S409; JACKLER RK, 1989, LARYNGOSCOPE, V99, P1238; Kirk KI, 2002, ANN OTO RHINOL LARYN, V111, P69, DOI 10.1177/00034894021110S515; Lai CC, 2004, LARYNGOSCOPE, V114, P832, DOI 10.1097/00005537-200405000-00008; Lin CY, 2005, AURIS NASUS LARYNX, V32, P99, DOI 10.1016/j.anl.2004.11.001; Liu TC, 2004, ACTA OTO-LARYNGOL, V124, P1149, DOI 10.1080/00016480410017846; Miyamoto RT, 2002, LARYNGOSCOPE, V112, P1178, DOI 10.1097/00005537-200207000-00006; Morris LG, 2007, OTOL NEUROTOL, V28, P25, DOI 10.1097/01.mao.0000244365.24449.00; PHELPS PD, 1992, J LARYNGOL OTOL, V106, P967, DOI 10.1017/S0022215100121486; Reyes S, 2009, OTOLARYNG HEAD NECK, V141, P502, DOI 10.1016/j.otohns.2009.07.004; Sampaio Andre L L, 2011, Int J Otolaryngol, V2011, P573968, DOI 10.1155/2011/573968; SILVERMAN S R, 1955, Ann Otol Rhinol Laryngol, V64, P1234; Snik AFM, 1997, INT J PEDIATR OTORHI, V41, P121, DOI 10.1016/S0165-5876(97)00058-X; Temple RH, 1999, CLIN OTOLARYNGOL, V24, P301, DOI 10.1046/j.1365-2273.1999.00260.x; VALVASSORI GE, 1978, LARYNGOSCOPE, V88, P723; WANG LT, 1979, J TAIWAN OTOLARYNGOL, V14; Wu CM, 2008, CLIN OTOLARYNGOL, V33, P472, DOI 10.1111/j.1749-4486.2008.01713.x; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; ZALZAL GH, 1995, ARCH OTOLARYNGOL, V121, P23	34	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81568	10.1371/journal.pone.0081568	http://dx.doi.org/10.1371/journal.pone.0081568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282608	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500111
J	Larose, C; Prestat, E; Cecillon, S; Berger, S; Malandain, C; Lyon, D; Ferrari, C; Schneider, D; Dommergue, A; Vogel, TM				Larose, Catherine; Prestat, Emmanuel; Cecillon, Sebastien; Berger, Sibel; Malandain, Cedric; Lyon, Delina; Ferrari, Christophe; Schneider, Dominique; Dommergue, Aurelien; Vogel, Timothy M.			Interactions between Snow Chemistry, Mercury Inputs and Microbial Population Dynamics in an Arctic Snowpack	PLOS ONE			English	Article							CO-INERTIA ANALYSIS; BACTERIAL COMMUNITIES; DIMETHYL SULFIDE; GEN. NOV.; SEA-ICE; DIVERSITY; SULFUR; RESISTANCE; DIMETHYLSULFONIOPROPIONATE; CYANOBACTERIA	We investigated the interactions between snowpack chemistry, mercury (Hg) contamination and microbial community structure and function in Arctic snow. Snowpack chemistry (inorganic and organic ions) including mercury (Hg) speciation was studied in samples collected during a two-month field study in a high Arctic site, Svalbard, Norway (79 degrees N). Shifts in microbial community structure were determined by using a 16S rRNA gene phylogenetic microarray. We linked snowpack and meltwater chemistry to changes in microbial community structure by using co-inertia analyses (CIA) and explored changes in community function due to Hg contamination by q-PCR quantification of Hg-resistance genes in metagenomic samples. Based on the CIA, chemical and microbial data were linked (p=0.006) with bioavailable Hg (BioHg) and methylmercury (MeHg) contributing significantly to the ordination of samples. Mercury was shown to influence community function with increases in merA gene copy numbers at low BioHg levels. Our results show that snowpacks can be considered as dynamic habitats with microbial and chemical components responding rapidly to environmental changes.	[Larose, Catherine; Prestat, Emmanuel; Cecillon, Sebastien; Berger, Sibel; Lyon, Delina; Vogel, Timothy M.] Univ Lyon, Ecole Cent Lyon, CNRS, Lab Ampere, Ecully, France; [Malandain, Cedric] ENOVEO, Lyon, France; [Ferrari, Christophe; Dommergue, Aurelien] Univ Grenoble 1, CNRS, LGGE, St Martin Dheres, France; [Schneider, Dominique] Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganismes, Grenoble, France; [Schneider, Dominique] CNRS, UMR 5163, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Larose, C (corresponding author), Univ Lyon, Ecole Cent Lyon, CNRS, Lab Ampere, Ecully, France.	catherine.larose@ec-lyon.fr	Schneider, Dominique/M-6019-2014; Berger, Sibel/AGE-5766-2022; Lyon, Delina/ABD-7121-2021; Dommergue, Aurélien/AAC-6823-2019; Dommergue, Aurelien/A-2829-2009	Berger, Sibel/0000-0003-3668-3598; Dommergue, Aurélien/0000-0002-8185-9604; Dommergue, Aurelien/0000-0002-8185-9604; Lyon, Delina/0000-0002-2291-9048; Vogel, Timothy/0000-0002-9542-3246; Prestat, Emmanuel/0000-0002-9965-2134; Malandain, Cedric/0000-0001-9576-3040	Institut Polar Emile Victor [CHIMERPOL 399]; EC2CO (INSU/CNRS); FQRNT (Le Fonds Quebecois de la Recherche sur la Nature et les Technologies)	Institut Polar Emile Victor; EC2CO (INSU/CNRS); FQRNT (Le Fonds Quebecois de la Recherche sur la Nature et les Technologies)(FQRNT)	The authors would like to thank the Institut Polar Emile Victor (CHIMERPOL 399) for financing the field campaign. They also thank Alan Le Tressoler, Nicolas Soumis and Nicolas Marusczak for their invaluable assistance in the field, and M. De Angelis for analytical support. This research was supported by grants from EC2CO (INSU/CNRS) and CL acknowledges the FQRNT (Le Fonds Quebecois de la Recherche sur la Nature et les Technologies) for a PhD research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amoroso A, 2010, ENVIRON SCI TECHNOL, V44, P714, DOI 10.1021/es9027309; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bowman J.P., 2006, PROKARYOTES, P677, DOI DOI 10.1007/0-387-30747-8_26; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; Carre-Mlouka A, 2006, J BIOL CHEM, V281, P24462, DOI 10.1074/jbc.M602973200; Christner BC, 2001, ENVIRON MICROBIOL, V3, P570, DOI 10.1046/j.1462-2920.2001.00226.x; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Coppee JY, 2001, MICROBIOL-SGM, V147, P1631, DOI 10.1099/00221287-147-6-1631; Cowan DA, 2004, ANNU REV MICROBIOL, V58, P649, DOI 10.1146/annurev.micro.57.030502.090811; Daly GL, 2004, ENVIRON SCI TECHNOL, V38, P4176, DOI 10.1021/es035105r; David MM, 2008, J MICROBIOL METH, V73, P73, DOI 10.1016/j.mimet.2008.01.001; DAVID MM, 2009, ENV SCI TECHNO UNPUB; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Dommergue A, 2010, ENVIRON SCI TECHNOL, V44, P901, DOI 10.1021/es902579m; Douglas TA, 2012, ENVIRON CHEM, V9, P321, DOI 10.1071/EN11140; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duran R, 2008, ENVIRON POLLUT, V156, P951, DOI 10.1016/j.envpol.2008.05.007; Ferrari CP, 2000, FRESEN J ANAL CHEM, V366, P433, DOI 10.1007/s002160050088; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Ginzburg B, 1998, ENVIRON SCI TECHNOL, V32, P2130, DOI 10.1021/es9709076; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Gray ND, 1999, APPL ENVIRON MICROB, V65, P5089; GU BH, 1993, APPL ENVIRON MICROB, V59, P422, DOI 10.1128/AEM.59.2.422-430.1993; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hell K, 2013, ISME J; Hinkler J, 2008, ADV ECOL RES, V40, P175, DOI 10.1016/S0065-2504(07)00008-6; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jones HG, 1999, HYDROL PROCESS, V13, P2135, DOI 10.1002/(SICI)1099-1085(199910)13:14/15&lt;2135::AID-HYP862&gt;3.0.CO;2-Y; Karsten U, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P143; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kuhn M, 2001, AQUAT SCI, V63, P150, DOI 10.1007/PL00001348; Kumar PA, 2007, INT J SYST EVOL MICR, V57, P1261, DOI 10.1099/ijs.0.64753-0; Labrenz M, 1999, INT J SYST BACTERIOL, V49, P137, DOI 10.1099/00207713-49-1-137; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Larose C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035004; Larose C, 2011, ENVIRON SCI TECHNOL, V45, P2150, DOI 10.1021/es103016x; Larose C, 2010, EXTREMOPHILES, V14, P205, DOI 10.1007/s00792-009-0299-2; Larose C, 2010, GEOCHIM COSMOCHIM AC, V74, P6263, DOI 10.1016/j.gca.2010.08.043; Lauber CL, 2009, APPL ENV MICROBIOLOG; Liu YQ, 2006, FEMS MICROBIOL LETT, V265, P98, DOI 10.1111/j.1574-6968.2006.00477.x; Liu YQ, 2009, EXTREMOPHILES, V13, P89, DOI 10.1007/s00792-008-0200-8; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Maron PA, 2007, MICROB ECOL, V53, P426, DOI 10.1007/s00248-006-9121-1; Mindlin S, 2005, RES MICROBIOL, V156, P994, DOI 10.1016/j.resmic.2005.05.011; Moller AK, 2011, FEMS MICROBIOL ECOL, V75, P390, DOI 10.1111/j.1574-6941.2010.01016.x; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Muir D, 1999, SCI TOTAL ENVIRON, V230, P83, DOI 10.1016/S0048-9697(99)00037-6; Murray AE, 2012, P NATL ACAD SCI USA, V109, P20626, DOI 10.1073/pnas.1208607109; Ntougias S, 2001, INT J SYST EVOL MICR, V51, P1161, DOI 10.1099/00207713-51-3-1161; Olson JB, 1998, MICROBIAL ECOL, V36, P231, DOI 10.1007/s002489900110; Oregaard G, 2007, ISME J, V1, P453, DOI 10.1038/ismej.2007.56; Poulain AJ, 2007, APPL ENVIRON MICROB, V73, P2230, DOI 10.1128/AEM.02701-06; PRISCU JC, 2004, MICROBIAL DIVERSITY, P130, DOI DOI 10.1128/9781555817770.CH13; Rasmussen LD, 2001, FEMS MICROBIOL ECOL, V36, P1, DOI 10.1111/j.1574-6941.2001.tb00820.x; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schimel JP, 1998, GLOBAL CHANGE BIOL, V4, P745, DOI 10.1046/j.1365-2486.1998.00195.x; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Steen AO, 2009, ATMOS ENVIRON, V43, P5604, DOI 10.1016/j.atmosenv.2009.07.069; THIOULOUSE J, 1995, COMPUT APPL BIOSCI, V11, P321; THOMAS WH, 1995, ARCTIC ALPINE RES, V27, P389, DOI 10.2307/1552032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Tranter M, 2002, HYDROL PROCESS, V16, P959, DOI 10.1002/hyp.309; Vezina S, 1997, POLAR BIOL, V17, P523, DOI 10.1007/s003000050151; VISSCHER PT, 1991, APPL ENVIRON MICROB, V57, P3237, DOI 10.1128/AEM.57.11.3237-3242.1991; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/w11-004, 10.1139/W11-004]	79	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79972	10.1371/journal.pone.0079972	http://dx.doi.org/10.1371/journal.pone.0079972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282515	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500016
J	Ashoor, R; Yafawi, R; Jessen, B; Lu, SY				Ashoor, Roshan; Yafawi, Rolla; Jessen, Bart; Lu, Shuyan			The Contribution of Lysosomotropism to Autophagy Perturbation	PLOS ONE			English	Article							CELL-DEATH; GENE-EXPRESSION; MECHANISM; LYSOSOME; ENHANCE; DRUGS; INHIBITORS; TOXICITY; PATHWAY; NRF2	Autophagy refers to the catabolic process in eukaryotic cells that delivers cytoplasmic material to lysosomes for degradation. This highly conserved process is involved in the clearance of long-lived proteins and damaged organelles. Consequently, autophagy is important in providing nutrients to maintain cellular function under starvation, maintaining cellular homeostasis, and promoting cell survival under certain conditions. Several pathways, including mTOR, have been shown to regulate autophagy. However, the impact of lysosomal function impairment on the autophagy process has not been fully explored. Basic lipophilic compounds can accumulate in lysosomes via pH partitioning leading to perturbation of lysosomal function. Our hypothesis is that these types of compounds can disturb the autophagy process. Eleven drugs previously shown to accumulate in lysosomes were selected and evaluated for their effects on cytotoxicity and autophagy using ATP depletion and LC3 assessment, respectively. All eleven drugs induced increased staining of endogenous LC3 and exogenous GFP-LC3, even at non toxic dose levels. In addition, an increase in the abundance of SQSTM1/p62 by all tested compounds denotes that the increase in LC3 is due to autophagy perturbation rather than enhancement. Furthermore, the gene expression profile resulting from in vitro treatment with these drugs revealed the suppression of plentiful long-lived proteins, including structural cytoskeletal and associated proteins, and extracellular matrix proteins. This finding indicates a retardation of protein turnover which further supports the notion of autophagy inhibition. Interestingly, upregulation of genes containing antioxidant response elements, e. g. glutathione S transferase and NAD(P)H dehydrogenase quinone 1 was observed, suggesting activation of Nrf2 transcription factor. These gene expression changes could be related to an increase in SQSTM1/p62 resulting from autophagy deficiency. In summary, our data indicate that lysosomal accumulation due to the basic lipophilic nature of xenobiotics could be a general mechanism contributing to the perturbation of the autophagy process.	[Ashoor, Roshan; Yafawi, Rolla; Jessen, Bart; Lu, Shuyan] Pfizer Inc, Drug Safety Res & Dev, San Diego, CA USA	Pfizer	Lu, SY (corresponding author), Pfizer Inc, Drug Safety Res & Dev, San Diego, CA USA.	shuyan.lu@pfizer.com						Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Amaravadi RK, 2012, AUTOPHAGY, V8, P1383, DOI 10.4161/auto.20958; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bezprozvanny I, 2010, DRUG NEWS PERSPECT, V23, P518, DOI 10.1358/dnp.2010.23.8.1500435; Bharadwaj PR, 2012, J ALZHEIMERS DIS, V32, P949, DOI 10.3233/JAD-2012-120178; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen Y, 2013, EXP CELL RES, V319, P142, DOI 10.1016/j.yexcr.2012.09.004; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cloonan SM, 2011, INT J CANCER, V128, P1712, DOI 10.1002/ijc.25477; de Medina P, 2009, AUTOPHAGY, V5, P1066, DOI 10.4161/auto.5.7.9820; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; GRABNER R, 1987, BIOCHEM PHARMACOL, V36, P1063, DOI 10.1016/0006-2952(87)90415-1; Hopkins CR, 2010, ACS CHEM NEUROSCI, V1, P587, DOI 10.1021/cn1000588; Hu WY, 2012, TOXICOL SCI, V129, P188, DOI 10.1093/toxsci/kfs192; Ihanamaki T, 2001, EXP EYE RES, V72, P423, DOI 10.1006/exer.2000.0972; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V377, P268, DOI 10.1016/j.bbrc.2008.09.121; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jeon SH, 2011, BIOCHEM BIOPH RES CO, V413, P311, DOI 10.1016/j.bbrc.2011.08.093; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kieburtz K, 2013, JAMA NEUROL, V70, P25, DOI 10.1001/2013.jamaneurol.382; Kitareewan S, 2007, J NATL CANCER I, V99, P41, DOI 10.1093/jnci/djk004; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; KOSTROMINOVA TY, 2013, AGE DORDR, P15253; KUBO M, 1985, BIOCHEMISTRY-US, V24, P6515, DOI 10.1021/bi00344a031; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lau A, 2013, MOL CELL BIOL, V33, P2436, DOI 10.1128/MCB.01748-12; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lu SY, 2012, TOXICOL IN VITRO, V26, P613, DOI 10.1016/j.tiv.2012.01.025; Mannerstrom M, 2001, PHARMACOL TOXICOL, V88, P27, DOI 10.1034/j.1600-0773.2001.088001027.x; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; MYERS BM, 1995, HEPATOLOGY, V22, P1519, DOI 10.1016/0270-9139(95)90160-4; Nadanaciva S, 2011, TOXICOL IN VITRO, V25, P715, DOI 10.1016/j.tiv.2010.12.010; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ndolo RA, 2010, J PHARMACOL EXP THER, V333, P120, DOI 10.1124/jpet.109.160226; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Qiu HY, 2007, PHYSIOL GENOMICS, V29, P169, DOI 10.1152/physiolgenomics.00229.2006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shin SY, 2013, CARCINOGENESIS, V34, P2080, DOI 10.1093/carcin/bgt169; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Wang XK, 2010, CURR GENOMICS, V11, P618, DOI 10.2174/138920210793360943; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zschocke J, 2011, NEUROPSYCHOPHARMACOL, V36, P1754, DOI 10.1038/npp.2011.57	58	46	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82481	10.1371/journal.pone.0082481	http://dx.doi.org/10.1371/journal.pone.0082481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278483	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700080
J	Ender, M; Andreoni, F; Zinkernagel, AS; Schuepbach, RA				Ender, Miriam; Andreoni, Federica; Zinkernagel, Annelies Sophie; Schuepbach, Reto Andreas			Streptococcal SpeB Cleaved PAR-1 Suppresses ERK Phosphorylation and Blunts Thrombin-Induced Platelet Aggregation	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; GROUP-A STREPTOCOCCUS; PYROGENIC EXOTOXIN B; COAGULATION; RECEPTOR-1; PYOGENES; CONTRIBUTES; APOPTOSIS; ENDOTOXEMIA; MORTALITY	Background: The family of 4 related protease-activated receptors (PAR-1, 2, 3 & 4) expressed by mammalian cells allow to sense for and react to extracellular proteolytic activity. Since major human bacterial pathogens secret a wide array of protease(-s) we investigated whether they interfere with human PAR function. Methodology/Principal Findings: Supernatants from cultures of major human bacterial pathogens were assayed for the presence of protease(-s) capable to cleave overexpressed human PAR-1, 2, 3 and 4 reporter constructs. Group A streptococcus (GAS) was found to secret a PAR-1-cleaving protease. Experiments involving genetical and pharmacological gain and loss of function identified streptococcal pyrogenic exotoxin B SpeB as the protease responsible. On the host's side analysis of overexpressed PAR-1 carrying alanine substitutions and deletions showed the amino acid residue leucine(44) on PAR-1's extracellular N-terminus to be the only cleavage site. Complementary studies on endogenously expressed PAR-1 using PAR-1 blocking antibodies further supported our conclusion. Through PAR-1 cleavage SpeB efficiently blunted thrombin-induced induction of the ERK-pathway in endothelial cells and prevented platelets aggregation in response to thrombin. Conclusions/Significance: Our results identify a novel function of the streptococcal virulence factor SpeB. By cleaving human PAR-1 at the N-terminal amino acid residue leucine(44) SpeB rendered endothelial cells unresponsive to thrombin and prevented human platelets from thrombin-induced aggregation. These results suggest that by blunting PAR-1 signaling, SpeB modulates various innate host responses directed against invasive GAS potentially helping the invasive bacteria to escape. This may allow to tailor additional treatments in the future since upon invasion of the blood stream endothelial cells as well as platelets and mononuclear cells respond to PAR-1 agonists aiming to prevent further bacterial dissemination.	[Ender, Miriam; Schuepbach, Reto Andreas] Univ Zurich, Univ Zurich Hosp, Div Surg Intens Care Med, Zurich, Switzerland; [Andreoni, Federica; Zinkernagel, Annelies Sophie] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Schuepbach, RA (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Surg Intens Care Med, Zurich, Switzerland.	reto.schuepbach@usz.ch	Schuepbach, Reto A/J-9737-2012; Schuepbach, Reto/AAO-6360-2020; Zinkernagel, Annelies S/F-1780-2017	Schuepbach, Reto A/0000-0002-7058-4377; Schuepbach, Reto/0000-0002-7058-4377; Zinkernagel, Annelies S/0000-0003-4700-1118	Hartmann Stiftung, Zurich, Switzerland; Anna Feddersen-Wagner-Fonds; Olga Mayenfisch Fonds; Ida-de Pottere-Leupold-Fonds; Huggenberger-Bischoff_Fonds; Swiss National Foundation [PZ00P3_136639, 31-130748]; Faculty of Medicine; Zentrum fur Klinische Forschung of the University of Zurich, Switzerland	Hartmann Stiftung, Zurich, Switzerland; Anna Feddersen-Wagner-Fonds; Olga Mayenfisch Fonds; Ida-de Pottere-Leupold-Fonds; Huggenberger-Bischoff_Fonds; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Faculty of Medicine; Zentrum fur Klinische Forschung of the University of Zurich, Switzerland	This work was made possible by grants from the Hartmann Stiftung, Zurich, Switzerland (to RAS), the Anna Feddersen-Wagner-Fonds (to RAS), the Olga Mayenfisch Fonds (to RAS), the Ida-de Pottere-Leupold-Fonds (to RAS), the Huggenberger-Bischoff_Fonds (to RAS), as well as the Swiss National Foundation (grant# PZ00P3_136639 [to RAS] and grant # 31-130748 [to ASZ]) and support from the Faculty of Medicine and the Zentrum fur Klinische Forschung of the University of Zurich, Switzerland (to RAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PCJ, 2009, THROMB HAEMOSTASIS, V102, P772, DOI 10.1160/TH09-04-0215; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; HONDAOGAWA M, 2013, J BIOL CHEM, P15253; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kastrup CJ, 2008, NAT CHEM BIOL, V4, P742, DOI 10.1038/nchembio.124; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Lourbakos A, 2001, BLOOD, V97, P3790, DOI 10.1182/blood.V97.12.3790; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Schouten M, 2012, CRIT CARE, V16, DOI 10.1186/cc11910; Schuepbach RA, 2010, J THROMB HAEMOST, V8, P379, DOI 10.1111/j.1538-7836.2009.03682.x; SCHUEPBACH RA, 2012, J THROMB HAEMOST, P15253; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Steck N, 2012, GUT, V61, P1610, DOI 10.1136/gutjnl-2011-300775; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; UCHIYAMA S, 2013, J MOL MED BERL, P5829; Viera NT, 2001, KIDNEY INT, V59, P950, DOI 10.1046/j.1523-1755.2001.059003950.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com	49	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81298	10.1371/journal.pone.0081298	http://dx.doi.org/10.1371/journal.pone.0081298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278414	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000327541700056
J	Holter, SM; Stromberg, M; Kovalenko, M; Garrett, L; Glasl, L; Lopez, E; Guide, J; Gotz, A; Hans, W; Becker, L; Rathkolb, B; Rozman, J; Schrewed, A; Klingenspor, M; Klopstock, T; Schulz, H; Wolf, E; Wursta, W; Gillis, T; Wakimoto, H; Seidman, J; MacDonald, ME; Cotman, S; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Lee, JM; Wheeler, VC				Hoelter, Sabine M.; Stromberg, Mary; Kovalenko, Marina; Garrett, Lillian; Glasl, Lisa; Lopez, Edith; Guide, Jolene; Goetz, Alexander; Hans, Wolfgang; Becker, Lore; Rathkolb, Birgit; Rozman, Jan; Schrewed, Anja; Klingenspor, Martin; Klopstock, Thomas; Schulz, Holger; Wolf, Eckhard; Wursta, Wolfgang; Gillis, Tammy; Wakimoto, Hiroko; Seidman, Jonathan; MacDonald, Marcy E.; Cotman, Susan; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Lee, Jong-Min; Wheeler, Vanessa C.			A Broad Phenotypic Screen Identifies Novel Phenotypes Driven by a Single Mutant Allele in Huntington's Disease CAG Knock-In Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; REPEAT INSTABILITY; GLUCOSE-TOLERANCE; BEHAVIORAL ABNORMALITIES; POLYGLUTAMINE INCLUSIONS; OLFACTORY DISCRIMINATION; HIPPOCAMPAL NEUROGENESIS; ASYMPTOMATIC CARRIERS; LONGITUDINAL ANALYSIS; BONE-DENSITY	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of a CAG trinucleotide repeat in the HTT gene encoding huntingtin. The disease has an insidious course, typically progressing over 10-15 years until death. Currently there is no effective disease-modifying therapy. To better understand the HD pathogenic process we have developed genetic HTT CAG knock-in mouse models that accurately recapitulate the HD mutation in man. Here, we describe results of a broad, standardized phenotypic screen in 10-46 week old heterozygous HdhQ111 knock-in mice, probing a wide range of physiological systems. The results of this screen revealed a number of behavioral abnormalities in HdhQ111/+ mice that include hypoactivity, decreased anxiety, motor learning and coordination deficits, and impaired olfactory discrimination. The screen also provided evidence supporting subtle cardiovascular, lung, and plasma metabolite alterations. Importantly, our results reveal that a single mutant HTT allele in the mouse is sufficient to elicit multiple phenotypic abnormalities, consistent with a dominant disease process in patients. These data provide a starting point for further investigation of several organ systems in HD, for the dissection of underlying pathogenic mechanisms and for the identification of reliable phenotypic endpoints for therapeutic testing.	[Hoelter, Sabine M.; Garrett, Lillian; Glasl, Lisa] Helmholtz Zentrum Munchen, Inst Dev Genet, German Mouse Clin, Neuherberg, Germany; [Stromberg, Mary; Kovalenko, Marina; Lopez, Edith; Guide, Jolene; Gillis, Tammy; MacDonald, Marcy E.; Cotman, Susan; Lee, Jong-Min; Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Goetz, Alexander] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Neuherberg, Germany; [Hans, Wolfgang; Becker, Lore; Rathkolb, Birgit; Rozman, Jan; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Schrewed, Anja] Heidelberg Univ, Dept Med 3, Div Cardiol, Heidelberg, Germany; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-80290 Munich, Germany; [Klingenspor, Martin] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, D-80290 Munich, Germany; [Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Klopstock, Thomas] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [Schulz, Holger] Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wolf, Eckhard] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Wursta, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wursta, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Wakimoto, Hiroko; Seidman, Jonathan] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Harvard Medical School	Wheeler, VC (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	Wheeler@chgr.mgh.harvard.edu	Becker, Lore/E-3717-2010; Hölter, Sabine M./N-5868-2014; Klingenspor, Martin/D-6930-2011; Fuchs, Helmut/M-7347-2014; Schulz, Holger/J-5643-2015; Klingenspor, Martin/K-5033-2019; Rozman, Jan/A-2540-2010; Gailus-Durner, Valerie/M-7337-2014; de Angelis, Martin Hrabe/F-5531-2012; Becker, Lore/AAJ-1203-2020	Hölter, Sabine M./0000-0003-4878-5241; Klingenspor, Martin/0000-0002-4502-6664; Fuchs, Helmut/0000-0002-5143-2677; Schulz, Holger/0000-0002-1157-200X; Rozman, Jan/0000-0002-8035-8904; de Angelis, Martin Hrabe/0000-0002-7898-2353; Becker, Lore/0000-0002-6890-4984; Garrett, Lillian/0000-0003-4880-7076	National Institutes of Health [R01NS049206, R01NS073813]; CHDI Foundation; German Federal Ministry of Education and Research [01GS0850, 01GS0851, 01KX1012]; German Center for Vertigo and Balance Disorders [01 EO 0901]; Helmholtz Alliance for Mental Health in an Ageing Society [HA-215]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206, R01NS073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; Helmholtz Alliance for Mental Health in an Ageing Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health R01NS049206, R01NS073813 and the CHDI Foundation. GMC researchers were funded by the German Federal Ministry of Education and Research by grants to the GMC (NGFN-Plus grants No. 01GS0850; 01GS0851; Infrafrontier grant 01KX1012), to the German Center for Diabetes Research (DZD e.V.), the German Center for Vertigo and Balance Disorders (grant 01 EO 0901), and by the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2006, CURR NEUROL NEUROSCI, V6, P379, DOI 10.1007/s11910-996-0018-7; Alonso M, 2012, NAT NEUROSCI, V15, P897, DOI 10.1038/nn.3108; Andrich J, 2002, J NEUROL NEUROSUR PS, V72, P726, DOI 10.1136/jnnp.72.6.726; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Aziz NA, 2010, EUR J NEUROL, V17, P1068, DOI 10.1111/j.1468-1331.2010.02973.x; Bar KJ, 2008, EUR J NEUROL, V15, P869, DOI 10.1111/j.1468-1331.2008.02173.x; Barrios FA, 2007, NEUROREPORT, V18, P73, DOI 10.1097/WNR.0b013e3280102302; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P171, DOI 10.1016/j.brainresbull.2011.03.013; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Boesgaard TW, 2009, J NEUROENDOCRINOL, V21, P770, DOI 10.1111/j.1365-2826.2009.01898.x; BOLT JMW, 1973, Q J MED, V42, P151; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Brooks S., 2010, BRAIN RES B, DOI 10.106/j.brainresbull.2010.05.003; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks S, 2012, BRAIN RES BULL, V88, P148, DOI 10.1016/j.brainresbull.2010.05.003; Brooks SP, 2006, BRAIN RES BULL, V69, P452, DOI 10.1016/j.brainresbull.2006.02.011; Bylsma FW, 1997, J NEUROPSYCH CLIN N, V9, P598; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; CHIU E, 1982, MED J AUSTRALIA, V1, P153, DOI 10.5694/j.1326-5377.1982.tb132224.x; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; FARRER LA, 1985, CLIN GENET, V27, P62; File SE, 1998, BRAIN RES, V805, P234, DOI 10.1016/S0006-8993(98)00736-7; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Fossale E, 2011, HUM MOL GENET, V20, P4258, DOI 10.1093/hmg/ddr355; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Gines S, 2006, EUR J NEUROSCI, V23, P649, DOI 10.1111/j.1460-9568.2006.04590.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Goodman A.O., 2011, PLOS CURR, P3; Hamilton JM, 1999, J INT NEUROPSYCH SOC, V5, P609, DOI 10.1017/S1355617799577035; Harper PS, 1999, PHILOS T ROY SOC B, V354, P957, DOI 10.1098/rstb.1999.0446; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Heng MY, 2010, AUTOPHAGY, V6, P1206, DOI 10.4161/auto.6.8.13617; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Ho AK, 2003, NEUROLOGY, V61, P1702, DOI 10.1212/01.WNL.0000098878.47789.BD; Holter SM, 2011, NEUROMETHODS, V61, P109, DOI 10.1007/978-1-61779-298-4_7; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Josefsen K, 2008, J NEUROENDOCRINOL, V20, P165, DOI 10.1111/j.1365-2826.2007.01629.x; Josefsen K, 2010, NEUROBIOL DIS, V40, P656, DOI 10.1016/j.nbd.2010.08.009; Kc P, 2010, RESP PHYSIOL NEUROBI, V174, P55, DOI 10.1016/j.resp.2010.08.001; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Kobal J, 2004, EUR J NEUROL, V11, P842, DOI 10.1111/j.1468-1331.2004.00894.x; Kobal J, 2010, ACTA NEUROL SCAND, V121, P392, DOI 10.1111/j.1600-0404.2009.01251.x; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; Larsson M, 2006, J CLIN EXP NEUROPSYC, V28, P1373, DOI 10.1080/13803390500473746; Lawrence AD, 1996, BRAIN, V119, P1633, DOI 10.1093/brain/119.5.1633; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Lazic SE, 2007, BRAIN RES, V1151, P219, DOI 10.1016/j.brainres.2007.03.018; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023647; Lemiere J, 2004, J NEUROL, V251, P935, DOI 10.1007/s00415-004-0461-9; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Lorincz MT, 2009, MOL CELL NEUROSCI, V40, P1, DOI 10.1016/j.mcn.2008.06.004; Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364; Loskutova N, 2009, J ALZHEIMERS DIS, V18, P777, DOI 10.3233/JAD-2009-1185; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; Melik Z, 2012, J NEUROL, V259, P921, DOI 10.1007/s00415-011-6279-3; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; Montoya A, 2006, NEUROPSYCHOLOGIA, V44, P1984, DOI 10.1016/j.neuropsychologia.2006.01.015; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Noack J, 2010, NEUROBIOL LEARN MEM, V94, P568, DOI 10.1016/j.nlm.2010.09.013; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; Renoir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022133; Ribeiro FM, 2010, J NEUROSCI, V30, P316, DOI 10.1523/JNEUROSCI.4974-09.2010; Rising AC, 2011, EXP NEUROL, V228, P173, DOI 10.1016/j.expneurol.2010.12.017; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHROEDER AM, 2011, PLOS CURR, V3, P15253; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Sharma KR, 1999, ARCH NEUROL-CHICAGO, V56, P1248, DOI 10.1001/archneur.56.10.1248; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Stuwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e; Thorens B, 2011, DIABETES OBES METAB, V13, P82, DOI 10.1111/j.1463-1326.2011.01453.x; Tkac I, 2012, J CEREBR BLOOD F MET, V32, P1977, DOI 10.1038/jcbfm.2012.104; Trueman RC, 2012, BRAIN RES BULL, V88, P163, DOI 10.1016/j.brainresbull.2011.10.019; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Trueman RC, 2008, BEHAV BRAIN RES, V189, P317, DOI 10.1016/j.bbr.2008.01.020; Trueman RC, 2007, EUR J NEUROSCI, V25, P551, DOI 10.1111/j.1460-9568.2007.05307.x; Valenza M, 2011, TRENDS NEUROSCI, V34, P474, DOI 10.1016/j.tins.2011.06.005; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wesson DW, 2011, NEUROSCI BIOBEHAV R, V35, P655, DOI 10.1016/j.neubiorev.2010.08.004; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404	116	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80923	10.1371/journal.pone.0080923	http://dx.doi.org/10.1371/journal.pone.0080923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278347	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700037
J	Kruger, S; Sokolov, AN; Enck, P; Krageloh-Mann, I; Pavlova, MA				Krueger, Samuel; Sokolov, Alexander N.; Enck, Paul; Kraegeloh-Mann, Ingeborg; Pavlova, Marina A.			Emotion through Locomotion: Gender Impact	PLOS ONE			English	Article							POINT-LIGHT DISPLAYS; SEX-DIFFERENCES; BODY EXPRESSIONS; MOTION; PERCEPTION; BRAIN; EPIDEMIOLOGY; CUES; RECOGNITION; IMPRESSIONS	Body language reading is of significance for daily life social cognition and successful social interaction, and constitutes a core component of social competence. Yet it is unclear whether our ability for body language reading is gender specific. In the present work, female and male observers had to visually recognize emotions through point-light human locomotion performed by female and male actors with different emotional expressions. For subtle emotional expressions only, males surpass females in recognition accuracy and readiness to respond to happy walking portrayed by female actors, whereas females exhibit a tendency to be better in recognition of hostile angry locomotion expressed by male actors. In contrast to widespread beliefs about female superiority in social cognition, the findings suggest that gender effects in recognition of emotions from human locomotion are modulated by emotional content of actions and opposite actor gender. In a nutshell, the study makes a further step in elucidation of gender impact on body language reading and on neurodevelopmental and psychiatric deficits in visual social cognition.	[Krueger, Samuel; Kraegeloh-Mann, Ingeborg; Pavlova, Marina A.] Univ Tubingen, Sch Med, Dept Pediat Neurol & Dev Med, Childrens Hosp, Tubingen, Germany; [Sokolov, Alexander N.; Enck, Paul] Univ Tubingen, Sch Med, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Sokolov, Alexander N.] Univ Tubingen, Sch Med, Ctr Pediat Clin Studies, Tubingen, Germany; [Kraegeloh-Mann, Ingeborg] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Pavlova, Marina A.] Univ Tubingen, Inst Womens Hlth Baden Wurttemberg, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Pavlova, MA (corresponding author), Univ Tubingen, Sch Med, Dept Pediat Neurol & Dev Med, Childrens Hosp, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Else Kroner Fresenius Foundation [P2010_92, P2013_127]; Werner Reichardt Center for Integrative Neuroscience, CIN [2009-24]; Deutsche Forschungsgemeinschaft (DFG); Reinhold Beitlich Foundation; Heidehof Foundation; Berthold Leibinger Foundation;  [EXC 307]	Else Kroner Fresenius Foundation; Werner Reichardt Center for Integrative Neuroscience, CIN; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Reinhold Beitlich Foundation; Heidehof Foundation; Berthold Leibinger Foundation; 	This work was supported by the Else Kroner Fresenius Foundation (Grants P2010_92 and P2013_127), the Werner Reichardt Center for Integrative Neuroscience, CIN (pool project 2009-24), EXC 307 funded by Deutsche Forschungsgemeinschaft (DFG), the Reinhold Beitlich Foundation, the Heidehof Foundation, and the Berthold Leibinger Foundation to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support toward open access publishing by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Ball WS, 2012, CEREB CORTEX, V22, P1, DOI 10.1093/cercor/bhr018; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Billino J, 2008, VISION RES, V48, P1254, DOI 10.1016/j.visres.2008.02.014; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; BLANCK PD, 1981, J PERS SOC PSYCHOL, V41, P391, DOI 10.1037/0022-3514.41.2.391; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Brown J, 2010, ANIM COGN, V13, P555, DOI 10.1007/s10071-009-0306-0; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Calvo-Merino B, 2010, PSYCHOL RES-PSYCH FO, V74, P400, DOI 10.1007/s00426-009-0262-y; Chou KH, 2011, NEUROIMAGE, V54, P725, DOI 10.1016/j.neuroimage.2010.07.010; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; Craske M.G., 2003, ORIGINS PHOBIAS ANXI, DOI 10.1016/B978-0-08-044032-3.X5000-X; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Hugill N, 2010, EVOL PSYCHOL-US, V8, P66; Ikeda H, 2009, PERCEPTION, V38, P1002, DOI 10.1068/p6250; Johnson KL, 2011, COGNITION, V119, P265, DOI 10.1016/j.cognition.2011.01.016; Kim J, 2008, DEPRESS ANXIETY, V25, P601, DOI 10.1002/da.20345; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00028; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Ma YL, 2006, BEHAV RES METHODS, V38, P134, DOI 10.3758/BF03192758; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Miura M, 2012, ANIM COGN, V15, P871, DOI 10.1007/s10071-012-0514-x; MONTEPARE JM, 1988, J PERS SOC PSYCHOL, V55, P547, DOI 10.1037/0022-3514.55.4.547; Nackaerts E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044473; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Pavlova M, 2006, NEUROPSYCHOLOGIA, V44, P586, DOI 10.1016/j.neuropsychologia.2005.06.016; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pollick FE, 2002, VISION RES, V42, P2345, DOI 10.1016/S0042-6989(02)00196-7; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Roether CL, 2009, J VISION, V9, DOI 10.1167/9.6.15; Rose D, 2009, PERCEPTION, V38, P153, DOI 10.1068/p6279; Ross PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044815; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Sinigaglia C, 2011, CONSCIOUS COGN, V20, P64, DOI 10.1016/j.concog.2010.11.012; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; Taylor NM, 2009, NEUROPSYCHOLOGIA, V47, P2766, DOI 10.1016/j.neuropsychologia.2009.06.001; Thoresen JC, 2012, COGNITION, V124, P261, DOI 10.1016/j.cognition.2012.05.018; Virji-Babul Naznin, 2006, Downs Syndr Res Pract, V10, P74, DOI 10.3104/reports.308; WALK RD, 1984, B PSYCHONOMIC SOC, V22, P437	61	30	31	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81716	10.1371/journal.pone.0081716	http://dx.doi.org/10.1371/journal.pone.0081716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259QP	24278456	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700070
J	Yan, Y; Zhang, L; Xu, T; Zhou, JX; Qin, R; Chen, C; Zou, YX; Fu, D; Hu, GH; Chen, JX; Lu, YC				Yan, Yong; Zhang, Lei; Xu, Tao; Zhou, Jinxu; Qin, Rong; Chen, Chao; Zou, Yongxiang; Fu, Da; Hu, Guohan; Chen, Juxiang; Lu, Yicheng			SAMSN1 Is Highly Expressed and Associated with a Poor Survival in Glioblastoma Multiforme	PLOS ONE			English	Article							HISTONE DEACETYLASE; HUMAN LEUKEMIA; PROTEIN; CELLS; FUSION; CANCER; GENE; TEL; OVEREXPRESSION; KINASE	Objectives: To study the expression pattern and prognostic significance of SAMSN1 in glioma. Methods: Affymetrix and Arrystar gene microarray data in the setting of glioma was analyzed to preliminarily study the expression pattern of SAMSN1 in glioma tissues, and Hieratical clustering of gene microarray data was performed to filter out genes that have prognostic value in malignant glioma. Survival analysis by Kaplan-Meier estimates stratified by SAMSN1 expression was then made based on the data of more than 500 GBM cases provided by The Cancer Genome Atlas (TCGA) project. At last, we detected the expression of SAMSN1 in large numbers of glioma and normal brain tissue samples using Tissue Microarray (TMA). Survival analysis by Kaplan-Meier estimates in each grade of glioma was stratified by SAMSN1 expression. Multivariate survival analysis was made by Cox proportional hazards regression models in corresponding groups of glioma. Results: With the expression data of SAMSN1 and 68 other genes, high-grade glioma could be classified into two groups with clearly different prognoses. Gene and large sample tissue microarrays showed high expression of SAMSN1 in glioma particularly in GBM. Survival analysis based on the TCGA GBM data matrix and TMA multi-grade glioma dataset found that SAMSN1 expression was closely related to the prognosis of GBM, either PFS or OS (P<0.05). Multivariate survival analysis with Cox proportional hazards regression models confirmed that high expression of SAMSN1 was a strong risk factor for PFS and OS of GBM patients. Conclusion: SAMSN1 is over-expressed in glioma as compared with that found in normal brains, especially in GBM. High expression of SAMSN1 is a significant risk factor for the progression free and overall survival of GBM.	[Yan, Yong; Zhang, Lei; Xu, Tao; Qin, Rong; Chen, Chao; Zou, Yongxiang; Hu, Guohan; Chen, Juxiang; Lu, Yicheng] Second Mil Med Univ, Changzheng Hosp, Neurosurg Res Inst Shanghai, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Jinxu] 101st Hosp PLA, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Fu, Da] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JX (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosurg Res Inst Shanghai, Dept Neurosurg, Shanghai, Peoples R China.	Lyc305@126.com; juxiangchen.cz@gmail.com	Fu, Da/GXF-2656-2022		National "863" High Technique Project [2007AA02Z483]; National Natural Science Foundation of China [30930094, 81101908, 81272781, 30973076]; Program for academic leaders in health sciences [XBR2011030]; "Shu Guang" project in Shanghai [11SG37]	National "863" High Technique Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for academic leaders in health sciences; "Shu Guang" project in Shanghai	This study was supported by the National "863" High Technique Project (2007AA02Z483), National Natural Science Foundation of China (30930094, 81101908, 81272781, 30973076), Program for academic leaders in health sciences (No. XBR2011030) and "Shu Guang" project (No. 11SG37) in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Brandt S, 2010, INT J BIOCHEM CELL B, V42, P1472, DOI 10.1016/j.biocel.2010.05.004; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Gao F, 2012, DIG DIS SCI; Gitton Y, 2002, NATURE, V420, P586, DOI 10.1038/nature01178; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Laver T., 2009, CNS CANC MODELS MARK, P1011; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Uchida T, 2001, BIOCHEM BIOPH RES CO, V288, P137, DOI 10.1006/bbrc.2001.5722; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Watanabe T, 2011, CLIN COLORECTAL CANC, V10, P134, DOI 10.1016/j.clcc.2011.03.011; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xie HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034265; Xu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048415; Xu XM, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-33; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang X, 2011, NEUROSURGERY, V68; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	29	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81905	10.1371/journal.pone.0081905	http://dx.doi.org/10.1371/journal.pone.0081905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278465	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700071
J	Acosta-Cabronero, J; Williams, GB; Cardenas-Blanco, A; Arnold, RJ; Lupson, V; Nestor, PJ				Acosta-Cabronero, Julio; Williams, Guy B.; Cardenas-Blanco, Arturo; Arnold, Robert J.; Lupson, Victoria; Nestor, Peter J.			In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease	PLOS ONE			English	Article							TRANSVERSE RELAXATION RATE; ENABLED DIPOLE INVERSION; BRAIN IRON CONCENTRATION; MAGNETIC-FIELD; CLINICAL-APPLICATIONS; PHASE-CONTRAST; FERRITIN IRON; MRI; ORIENTATION; MULTIPLE	Background: This study explores the magnetostatic properties of the Alzheimer's disease brain using a recently proposed, magnetic resonance imaging, postprocessed contrast mechanism. Quantitative susceptibility mapping (QSM) has the potential to monitor in vivo iron levels by reconstructing magnetic susceptibility sources from field perturbations. However, with phase data acquired at a single head orientation, the technique relies on several theoretical approximations and requires fast-evolving regularisation strategies. Methods: In this context, the present study describes a complete methodological framework for magnetic susceptibility measurements with a review of its theoretical foundations. Findings and Significance: The regional and whole-brain cross-sectional comparisons between Alzheimer's disease subjects and matched controls indicate that there may be significant magnetic susceptibility differences for deep brain nuclei particularly the putamen - as well as for posterior grey and white matter regions. The methodology and findings described suggest that the QSM method is ready for larger-scale clinical studies.	[Acosta-Cabronero, Julio; Cardenas-Blanco, Arturo; Nestor, Peter J.] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Acosta-Cabronero, Julio; Arnold, Robert J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 2QQ, England; [Williams, Guy B.; Lupson, Victoria] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; [Arnold, Robert J.] Univ Cambridge, Dept Psychiat, Cambridge, England	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Acosta-Cabronero, J (corresponding author), German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany.	julio.acosta@dzne.de	Acosta-Cabronero, Julio/C-8225-2014; Nestor, Peter/Y-6106-2018	Acosta-Cabronero, Julio/0000-0003-1174-5983; Nestor, Peter/0000-0002-5860-5921; Cardenas-Blanco, Arturo/0000-0001-8683-8741; Williams, Guy/0000-0001-5223-6654	Alzheimer's Research UK [REF: ART-RF2010-1]; Cambridge Biomedical Research Centre, UK	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Cambridge Biomedical Research Centre, UK	Alzheimer's Research UK (to JAC, REF: ART-RF2010-1) and Cambridge Biomedical Research Centre, UK (to PJN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049072; Bakker CJG, 2012, MAGN RESON IMAGING, V30, P601, DOI 10.1016/j.mri.2011.12.023; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; Bartzokis G, 2007, NEUROBIOL AGING, V28, P414, DOI 10.1016/j.neurobiolaging.2006.02.005; Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Benedictus MR, 2013, NEUROBIOL AGING, V34, P2488, DOI 10.1016/j.neurobiolaging.2013.04.023; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Bianciardi M, 2014, HUM BRAIN MAPP, V35, P2191, DOI 10.1002/hbm.22320; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Boyd S., 2004, CONVEX OPTIMIZATION, P464; Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Collingwood J, 2006, J ALZHEIMERS DIS, V10, P215; CONNOR JR, 1995, J NEUROCHEM, V65, P717; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; CONTURO TE, 1990, MAGN RESON MED, V15, P420, DOI 10.1002/mrm.1910150308; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; DEDMAN DJ, 1992, BIOCHEM J, V287, P509, DOI 10.1042/bj2870509; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; FLEMING J, 1987, P NATL ACAD SCI USA, V84, P7866, DOI 10.1073/pnas.84.22.7866; FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukunaga M, 2010, P NATL ACAD SCI USA, V107, P3834, DOI 10.1073/pnas.0911177107; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; GRUNDKEIQBAL I, 1990, ACTA NEUROPATHOL, V81, P105, DOI 10.1007/BF00334497; GUTTERIDGE JMC, 1992, ANN NEUROL, V32, pS16, DOI 10.1002/ana.410320705; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; He X, 2009, P NATL ACAD SCI USA, V106, P13558, DOI 10.1073/pnas.0904899106; HENNIG J, 1988, MAGN RESON IMAGING, V6, P391, DOI 10.1016/0730-725X(88)90475-4; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Koch KM, 2006, PHYS MED BIOL, V51, P6381, DOI 10.1088/0031-9155/51/24/007; Kressler B, 2010, IEEE T MED IMAGING, V29, P273, DOI 10.1109/TMI.2009.2023787; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Lee J, 2010, P NATL ACAD SCI USA, V107, P5130, DOI 10.1073/pnas.0910222107; Lee J, 2010, NEUROIMAGE, V49, P193, DOI 10.1016/j.neuroimage.2009.07.017; Leskovjan AC, 2011, NEUROIMAGE, V55, P32, DOI 10.1016/j.neuroimage.2010.11.073; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; Li L, 2004, MAGN RESON MED, V51, P1077, DOI 10.1002/mrm.20054; Li L, 2001, J MAGN RESON, V148, P442, DOI 10.1006/jmre.2000.2267; Li W, 2012, NEUROIMAGE, V59, P2088, DOI 10.1016/j.neuroimage.2011.10.038; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Li X, 2012, NEUROIMAGE, V62, P314, DOI 10.1016/j.neuroimage.2012.04.042; Lim IAL, 2013, NEUROIMAGE, V82, P449, DOI 10.1016/j.neuroimage.2013.05.127; Liu CL, 2012, NEUROIMAGE, V59, P1290, DOI 10.1016/j.neuroimage.2011.07.096; Liu CL, 2010, MAGN RESON MED, V63, P1471, DOI 10.1002/mrm.22482; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Luo J, 2012, NEUROIMAGE, V60, P1073, DOI 10.1016/j.neuroimage.2012.01.108; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mitsumori F, 2009, MAGN RESON MED, V62, P1326, DOI 10.1002/mrm.22097; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park JH, 2013, ANN NEUROL, V73, P584, DOI 10.1002/ana.23845; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pengas G, 2009, J NEUROIMAGING, V19, P37, DOI 10.1111/j.1552-6569.2008.00246.x; Pereira JMS, 2010, NEUROIMAGE, V49, P2205, DOI 10.1016/j.neuroimage.2009.10.068; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Popescu BFG, 2009, PHYS MED BIOL, V54, P651, DOI 10.1088/0031-9155/54/3/012; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schenck JF, 2004, NMR BIOMED, V17, P433, DOI 10.1002/nbm.922; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schenck John F, 2006, Top Magn Reson Imaging, V17, P41, DOI 10.1097/01.rmr.0000245455.59912.40; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; TAYLOR HL, 1979, GEOPHYSICS, V44, P39, DOI 10.1190/1.1440921; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tropp JA, 2006, IEEE T INFORM THEORY, V52, P1030, DOI 10.1109/TIT.2005.864420; Tropp JA, 2009, IEEE T INFORM THEORY, V55, P917, DOI 10.1109/TIT.2008.2009806; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Walsh AJ, 2011, NEUROIMAGE, V57, P452, DOI 10.1016/j.neuroimage.2011.04.017; Wang S, 2013, IEEE T BIO-MED ENG, V60, P3441, DOI 10.1109/TBME.2013.2266795; Wen YW, 2012, IEEE T IMAGE PROCESS, V21, P1770, DOI 10.1109/TIP.2011.2181401; Wharton S, 2010, NEUROIMAGE, V53, P515, DOI 10.1016/j.neuroimage.2010.06.070; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wharton S, 2012, P NATL ACAD SCI USA, V109, P18559, DOI 10.1073/pnas.1211075109; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Xu YB, 2006, MAGN RESON IMAGING, V24, P155, DOI 10.1016/j.mri.2005.10.030; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022	124	171	176	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81093	10.1371/journal.pone.0081093	http://dx.doi.org/10.1371/journal.pone.0081093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278382	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800100
J	Brown, LE; Johnston, K; Palmer, SM; Aspray, KL; Holden, J				Brown, Lee E.; Johnston, Kerrylyn; Palmer, Sheila M.; Aspray, Katie L.; Holden, Joseph			River Ecosystem Response to Prescribed Vegetation Burning on Blanket peatland	PLOS ONE			English	Article							MACROINVERTEBRATE ASSEMBLAGES; SOIL-WATER; LAND-USE; STREAM; FIRE; MANAGEMENT; COMMUNITIES; PH; BIODIVERSITY; CATCHMENT	Catchment-scale land-use change is recognised as a major threat to aquatic biodiversity and ecosystem functioning globally. In the UK uplands rotational vegetation burning is practised widely to boost production of recreational game birds, and while some recent studies have suggested burning can alter river water quality there has been minimal attention paid to effects on aquatic biota. We studied ten rivers across the north of England between March 2010 and October 2011, five of which drained burned catchments and five from unburned catchments. There were significant effects of burning, season and their interaction on river macroinvertebrate communities, with rivers draining burned catchments having significantly lower taxonomic richness and Simpson's diversity. ANOSIM revealed a significant effect of burning on macroinvertebrate community composition, with typically reduced Ephemeroptera abundance and diversity and greater abundance of Chironomidae and Nemouridae. Grazer and collector-gatherer feeding groups were also significantly less abundant in rivers draining burned catchments. These biotic changes were associated with lower pH and higher Si, Mn, Fe and Al in burned systems. Vegetation burning on peatland therefore has effects beyond the terrestrial part of the system where the management intervention is being practiced. Similar responses of river macroinvertebrate communities have been observed in peatlands disturbed by forestry activity across northern Europe. Finally we found river ecosystem changes similar to those observed in studies of wild and prescribed forest fires across North America and South Africa, illustrating some potentially generic effects of fire on aquatic ecosystems.	[Brown, Lee E.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Water Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Brown, LE (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	l.brown@leeds.ac.uk		Brown, Lee/0000-0002-2420-0088; Holden, Joseph/0000-0002-1108-4831	UK's Natural Environment Research Council [NE/G00224X/1]; Yorkshire Water; Natural Environment Research Council [NE/G00224X/1] Funding Source: researchfish; NERC [NE/G00224X/1] Funding Source: UKRI	UK's Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Yorkshire Water; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was conducted as part of the EMBER (Effects of Moorland Burning on the Ecohydrology of River basins) project funded by the UK's Natural Environment Research Council (NE/G00224X/1). Yorkshire Water provided additional project funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson R.C., 1989, FIRE N AM TALLGRASS; Arkle RS, 2010, FOREST ECOL MANAG, V259, P893, DOI 10.1016/j.foreco.2009.11.029; ARMITAGE PD, 1975, FRESHWATER BIOL, V5, P479, DOI 10.1111/j.1365-2427.1975.tb00150.x; Beche LA, 2005, FOREST ECOL MANAG, V218, P37, DOI 10.1016/j.foreco.2005.06.010; BRITTON D L, 1991, Southern African Journal of Aquatic Sciences, V17, P51; Clay GD, 2012, J HYDROL, V448, P139, DOI 10.1016/j.jhydrol.2012.04.048; Clay GD, 2010, J HYDROL, V380, P135, DOI 10.1016/j.jhydrol.2009.10.030; Clay GD, 2009, J HYDROL, V376, P486, DOI 10.1016/j.jhydrol.2009.07.055; DAVIS EA, 1989, FOREST ECOL MANAG, V26, P189, DOI 10.1016/0378-1127(89)90120-5; Evans M., 2007, GEOMORPHOLOGY UPLAND, DOI 10.1002/9780470798003; FIANCE SB, 1978, OIKOS, V31, P332, DOI 10.2307/3543659; Finn DS, 2011, J N AM BENTHOL SOC, V30, P963, DOI 10.1899/11-012.1; Freckleton RP, 2004, J APPL ECOL, V41, P599, DOI 10.1111/j.0021-8901.2004.00941.x; Glaves DJ, 2013, NATURAL ENGLAND EVID; Grant M. C., 2012, COSTS BENEFITS GROUS; Heal KV, 2001, SCI TOTAL ENVIRON, V265, P169, DOI 10.1016/S0048-9697(00)00657-4; HERRMANN J, 1986, WATER AIR SOIL POLL, V30, P703, DOI 10.1007/BF00303335; HILDREW AG, 1984, FRESHWATER BIOL, V14, P323, DOI 10.1111/j.1365-2427.1984.tb00045.x; Holden J, 2012, J ENVIRON MANAGE, V101, P92, DOI 10.1016/j.jenvman.2012.02.002; Holden J, 2014, HYDROL PROCESS, V28, P2868, DOI 10.1002/hyp.9875; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Ledger ME, 1998, FRESHWATER BIOL, V40, P655, DOI 10.1046/j.1365-2427.1998.00364.x; Ledger ME, 2000, FRESHWATER BIOL, V43, P545, DOI 10.1046/j.1365-2427.2000.00534.x; Legendre P., 2012, NUMERICAL ECOLOGY; Limited WE, 2010, ASSEMBLING UK WIDE D; Meyers L. S., 2006, APPL MULTIVARIATE RE; MIHUC TB, 1995, ECOLOGY, V76, P2361, DOI 10.2307/2265813; Minshall GW, 1997, CAN J FISH AQUAT SCI, V54, P2509, DOI 10.1139/cjfas-54-11-2509; Minshall GW, 2003, FOREST ECOL MANAG, V178, P155, DOI 10.1016/S0378-1127(03)00059-8; Minshall GW, 2001, CAN J FISH AQUAT SCI, V58, P1077, DOI 10.1139/cjfas-58-6-1077; Moog O., 1995, FAUNA AQUATICA AUSTR; Nyberg P, 1995, WATER AIR SOIL POLL, V85, P333, DOI 10.1007/BF00476851; Oksanen J., 2005, VEGAN R FUNCTIONS VE; ORMEROD SJ, 1993, J APPL ECOL, V30, P13, DOI 10.2307/2404266; ORMEROD SJ, 1987, FRESHWATER BIOL, V17, P533, DOI 10.1111/j.1365-2427.1987.tb01074.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pawley S., 2011, GUIDE BRIT FRESHWATE; Ramchunder SJ, 2009, PROG PHYS GEOG, V33, P49, DOI 10.1177/0309133309105245; Ramchunder SJ, 2013, J APPL ECOL, V50, P636, DOI 10.1111/1365-2664.12082; Ramchunder SJ, 2012, J APPL ECOL, V49, P182, DOI 10.1111/j.1365-2664.2011.02075.x; Ramchunder SJ, 2011, ECOHYDROLOGY, V4, P577, DOI 10.1002/eco.189; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SUTCLIFFE D W, 1973, Freshwater Biology, V3, P437, DOI 10.1111/j.1365-2427.1973.tb00933.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; TALLIS JH, 1987, J ECOL, V75, P1099, DOI 10.2307/2260317; Tucker G, 2003, REV IMPACTS HEATHER, V550, P1; Urban MC, 2006, DIVERS DISTRIB, V12, P337, DOI 10.1111/j.1366-9516.2005.00226.x; Verble RM, 2013, ANN ENTOMOL SOC AM, V106, P198, DOI 10.1603/AN12108; Vieira NKM, 2011, WEST N AM NATURALIST, V71, P257, DOI 10.3398/064.071.0213; Vieira NKM, 2004, FRESHWATER BIOL, V49, P1243, DOI 10.1111/j.1365-2427.2004.01261.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vuori KM, 1998, AQUAT CONSERV, V8, P745, DOI 10.1002/(SICI)1099-0755(1998110)8:6<745::AID-AQC310>3.3.CO;2-O; WEATHERLEY NS, 1987, ENVIRON POLLUT, V46, P223, DOI 10.1016/0269-7491(87)90079-0; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Woodward G. B. T.-A.in E. R., 2010, ADV ECOL RES, P265, DOI [10.1016/B978-0-12-381363-3.00005-8, DOI 10.1016/S0065-2504(10)42005-X]; Worrall F, 2008, HYDROL PROCESS, V22, P2531, DOI 10.1002/hyp.6848; Worrall F, 2007, J HYDROL, V339, P1, DOI 10.1016/j.jhydrol.2006.12.025; Yallop AR, 2006, J APPL ECOL, V43, P1138, DOI 10.1111/j.1365-2664.2006.01222.x; Yibarbuk D, 2001, J BIOGEOGR, V28, P325, DOI 10.1046/j.1365-2699.2001.00555.x	60	19	20	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81023	10.1371/journal.pone.0081023	http://dx.doi.org/10.1371/journal.pone.0081023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278367	Green Published, gold			2022-12-27	WOS:000327539800095
J	Joshi, MR; Yao, NH; Myers, KA; Li, ZY				Joshi, Michelle R.; Yao, Nianhuan; Myers, Kenneth A.; Li, Zhiyu			Human Serum Albumin and p53-Activating Peptide Fusion Protein Is Able to Promote Apoptosis and Deliver Fatty Acid-Modified Molecules	PLOS ONE			English	Article							P53 PATHWAY; BOUND PACLITAXEL; MDM2 ONCOPROTEIN; TUMOR-SUPPRESSOR; IN-VIVO; ACTIVATION; BINDING; GENES; METHOTREXATE; INHIBITION	Therapeutic peptides offer a high degree of specificity, potency, and low toxicity; making them promising candidates for cancer therapy. Despite these advantages, a number of hurdles, such as poor serum stability and inefficient cellular penetration, must be overcome. Fusing a therapeutic peptide to human serum albumin (HSA) is a common approach to extend the serum stability of a peptide that binds to extracellular receptors. However, no study has shown that this approach can be applied to target intracellular proteins. Here we demonstrate the feasibility of using a recombinant human serum albumin (rHSA) fusion protein to simultaneously deliver two types of molecules: a peptide capable of binding an intracellular target, as well as fatty acid (FA)-modified FITC (FA-FITC). Two peptides reported to disrupt the intracellular p53 and MDM2/MDMX interaction were fused to the C-terminal of HSA. Cellular and biochemical studies indicate that rHSA fusion proteins were efficiently taken up by SJSA-1 cells and retained MDM2-and MDMX-binding activity. By inducing the accumulation of p53, both fusion proteins promoted efficient cytotoxicity in SJSA-1 cells via caspase activation. Long chain fatty acid (LCFA) transportation is an essential endogenous function of HSA. This study also demonstrates that rHSA fusion proteins formed highly stable complexes with FA-FITC via non-covalent interactions. FA-FITC complexed with HSA could be internalized efficiently and rHSA-P53i and rHSA-PMI retained apoptotic activity as complex components. It is expected that such an approach can ultimately be used to facilitate intracellular delivery of two anticancer therapeutics, each with distinct but complimentary mechanisms, to achieve synergistic efficacy.	[Joshi, Michelle R.; Yao, Nianhuan; Li, Zhiyu] Univ Sci, Philadelphia Coll Pharm, Dept Pharmaceut Sci, Philadelphia, PA USA; [Myers, Kenneth A.] Univ Sci, Misher Coll Arts & Sci, Dept Biol Sci, Philadelphia, PA USA		Li, ZY (corresponding author), Univ Sci, Philadelphia Coll Pharm, Dept Pharmaceut Sci, Philadelphia, PA USA.	zh.li@usciences.edu			University of the Sciences in Philadelphia Start-up Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL113069] Funding Source: NIH RePORTER	University of the Sciences in Philadelphia Start-up Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	University of the Sciences in Philadelphia Start-up Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Boratynski J, 2000, CANCER LETT, V148, P189, DOI 10.1016/S0304-3835(99)00334-1; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; CHEN RF, 1967, J BIOL CHEM, V242, P173; Chuang VTG, 2002, PHARMACEUT RES, V19, P569; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; Kratz F, 2008, CHEMMEDCHEM, V3, P20, DOI 10.1002/cmdc.200700159; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kuo ML, 2003, CANCER RES, V63, P1046; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Peterson GE, 2006, CURR MED RES OPIN, V22, P2613, DOI 10.1185/030079906X154178; Pignatello R, 2004, BIOORGAN MED CHEM, V12, P2951, DOI 10.1016/j.bmc.2004.03.040; Rinn JL, 2011, TRENDS CELL BIOL, V21, P344, DOI 10.1016/j.tcb.2011.04.002; Rustgi VK, 2009, CURR MED RES OPIN, V25, P991, DOI 10.1185/03007990902779186 ; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Singh Y, 2008, CURR MED CHEM, V15, P1802, DOI 10.2174/092986708785132997; SPECTOR AA, 1975, J LIPID RES, V16, P165; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; TRAVIS J, 1976, BIOCHEM J, V157, P301, DOI 10.1042/bj1570301; Tzefos M, ANN PHARMACOTHER, V44, P1294, DOI [10.1345/aph.1P047, DOI 10.1345/APH.1P047.PUBMED:20530705]; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Zhang XX, 2012, J CONTROL RELEASE, V159, P2, DOI 10.1016/j.jconrel.2011.10.023	43	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80926	10.1371/journal.pone.0080926	http://dx.doi.org/10.1371/journal.pone.0080926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278348	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800091
J	Poropat, SF; Kear, BP				Poropat, Stephen F.; Kear, Benjamin P.			Photographic Atlas and Three-Dimensional Reconstruction of the Holotype Skull of Euhelopus zdanskyi with Description of Additional Cranial Elements	PLOS ONE			English	Article							TAZOUDASAURUS-NAIMI DINOSAURIA; BASAL SAUROPOD DINOSAUR; PHYLOGENETIC-RELATIONSHIPS; BONITASAURA-SALGADOI; CAMARASAURUS-LENTUS; EARLY EVOLUTION; PATAGONIA; ANATOMY; MOROCCO; REDESCRIPTION	Background: Euhelopus zdanskyi is one of relatively few sauropod taxa known from an almost complete skull and mandible. Recent phylogenetic analyses suggest that Euhelopus is a somphospondylan titanosauriform, and that it is a member of the clade (Euhelopodidae) which is the sister taxon to the hugely successful, dominantly Cretaceous sauropod group Titanosauria. Methodology/Principal Findings: The skull elements of Euhelopus were CT scanned at Uppsala Akademiska Sjukhuset. Three-dimensional models of the elements were constructed from the DICOM data using Mimics 14.0, InVesalius 3.0, and GeoMagic Studio 2012, the skull was rearticulated in Rhinoceros 4.0, and the final version was rendered in GeoMagic Studio 2012. Conclusions/Significance: The fact that relatively complete sauropod skulls are so rare in the fossil record, particularly among titanosauriforms, means that the skulls that are known should be as thoroughly described and well-illustrated as possible. This contribution supplements previous descriptions of the cranial elements of Euhelopus, one of the few euhelopodid taxa for which cranial material is known, by presenting a comprehensive photographic atlas of the skull elements to facilitate a better understanding of their morphology. We describe several elements which have been overlooked in past studies of Euhelopus, and also provide as accurate a reconstruction of the skull as possible (in the absence of the braincase), the most significant components of which are the articulations of the palate and the mandible.	[Poropat, Stephen F.; Kear, Benjamin P.] Uppsala Univ, Dept Earth Sci, Uppsala, Sweden; [Poropat, Stephen F.] Australian Age Dinosaurs Nat Hist Museum, Winton, Qld, Australia	Uppsala University	Poropat, SF (corresponding author), Uppsala Univ, Dept Earth Sci, Uppsala, Sweden.	stephen.poropat@geo.uu.se	Poropat, Stephen F/M-1959-2016	Poropat, Stephen F/0000-0002-4909-1666	Australian Research Council [LP100100339]; Department of Earth Sciences, Uppsala University	Australian Research Council(Australian Research Council); Department of Earth Sciences, Uppsala University	Australian Research Council Grant LP100100339 awarded to B. P. Kear as Chief Investigator: http://www.arc.gov.au/. Department of Earth Sciences, Uppsala University: http://www.geo.uu.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2004, CR PALEVOL, V3, P199, DOI 10.1016/j.crpv.2004.03.001; Allain R, 2008, GEODIVERSITAS, V30, P345; [Anonymous], 1984, J CHENGDU COLL GEOL; Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Bai Z.-Q., 1990, YUXIWENBO, V1, P14; Balanoff AM, 2010, AM MUS NOVIT, P1, DOI 10.1206/591.1; Bannikov A. F, 1983, PALEONTOL J+, V17, P91; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Berman D. S., 1978, B CARNEGIE MUS NAT H, V8, P1; Berman DS, 1994, DINOFEST, P83; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P325; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Calvo Jorge O., 1995, Gaia, V11, P13; Chatterjee S, 2002, ZOOL J LINN SOC-LOND, V136, P145, DOI 10.1046/j.1096-3642.2002.00037.x; Chatterjee S, 2005, LIFE O PAST, P199; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; COOPER M R, 1984, Palaeontologia Africana, V25, P203; Cope ED, 1877, PALAEONTOLOGICAL B, V27, P5; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Gallina PA, 2011, ACTA PALAEONTOL POL, V56, P45, DOI 10.4202/app.2010.0011; Gilmore GW, 1925, MEM CARNEGIE MUS, V10, P347; Hatcher JB., 1903, MEM CARNEGIE MUS, V2, P1; HATCHER JB, 1903, P BIOL SOC WASH, V16, P100; Hatcher JB, 1903, P BIOL SOC WASH, V16, P1; Haughton S. H., 1924, Annals of the South African Museum, V12, P323; He XL, 1988, SAUROPOD DINOSAURS O, P1; Holland W. J., 1924, Memoirs of the Carnegie Museum, V9, P379; HOLLAND WJ, 1915, ANN CARNEGIE MUS, V9, P273; Janensch W., 1914, ARCH BIONTOLOGIE, V3, P81; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; Madsen James H. Jr, 1995, Bulletin of Carnegie Museum of Natural History, V31, P1; Mannion P, 2013, ZOOLOGICAL J LINNEAN; Marsh O. C., 1884, AM J SCI 3, V158, P161, DOI DOI 10.2475/AJS.S3-27.158.161; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Mateer NJ., 1985, B GEOL I UPSALA NEW, V11, P124; McIntosh J.S., 1990, P345; McIntosh John S., 1996, Bulletin of Gunma Museum of Natural History, V1, P1; MCINTOSH JS, 1975, J PALEONTOL, V49, P187; McIntosh JS, 1988, KIRTLANDIA, V43, P2; Nowinski A., 1971, Palaeontologia Polonica, VNo. 25, P57; Osborn H. F., 1921, Memoirs from the American Museum of Natural History New York NS, V3, P247; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Peyer K, 2010, HIST BIOL, V22, P134, DOI 10.1080/08912960903562317; Pi L, 1996, 30 INT GEOL C, P87; Poropat SF, 2013, C WIMANS SAUROPODS U; RAATH M A, 1972, Arnoldia (Rhodesia), V5, P1; Rauhut OWM, 2003, AMEGHINIANA, V40, P425; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Romer A, 1956, OSTEOLOGY REPTILES; Royo-Torres R, 2012, J SYST PALAEONTOL, V10, P553, DOI 10.1080/14772019.2011.598577; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; Salgado L, 2004, J VERTEBR PALEONTOL, V24, P903, DOI 10.1671/0272-4634(2004)024[0903:LCRSFC]2.0.CO;2; SALGADO L, 1991, Ameghiniana, V28, P333; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Salgado Leonardo, 1992, Ameghiniana, V29, P337; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Tang F., 2001, COMPLETE SAUROPOD JI, P128; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch P, 1994, ASPECTS SAUROPOD PAL, P249; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; WHITE TE, 1958, J PALEONTOL, V32, P477; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; YOUNG C. C., 1935, BULL GEOL SOC CHINA, V14, P519; Young MT, 2010, MORPHOMETRICS NONMOR, V124, P259; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zhang Y, 1984, J CHENGDU COLL GEOLO, V2, P1; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; Zheng Z, 1996, CRANIAL ANATOMY SHUN; Zheng Zhong, 1991, Vertebrata Palasiatica, V29, P108	85	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79932	10.1371/journal.pone.0079932	http://dx.doi.org/10.1371/journal.pone.0079932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278222	Green Published, gold			2022-12-27	WOS:000327539800037
J	Sadis, C; Detienne, S; Vokaer, B; Charbonnier, LM; Lemaitre, P; Spilleboudt, C; Delbauve, S; Kubjak, C; Flamand, V; Field, KA; Goldman, M; Benghiat, FS; Le Moine, A				Sadis, Claude; Detienne, Sophie; Vokaer, Benoit; Charbonnier, Louis-Marie; Lemaitre, Philippe; Spilleboudt, Chloe; Delbauve, Sandrine; Kubjak, Carole; Flamand, Veronique; Field, Kenneth A.; Goldman, Michel; Benghiat, Fleur S.; Le Moine, Alain			The Cholinergic Anti-Inflammatory Pathway Delays TLR-Induced Skin Allograft Rejection in Mice: Cholinergic Pathway Modulates Alloreactivity	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; CD4(+) T-CELLS; LISTERIA-MONOCYTOGENES; BACTERIAL-INFECTIONS; GRAFT-REJECTION; TOLERANCE; INFLAMMATION; IMMUNITY; PERSPECTIVES; RECRUITMENT	Activation of innate immunity through Toll-like receptors (TLR) can abrogate transplantation tolerance by revealing hidden T cell alloreactivity. Separately, the cholinergic anti-inflammatory pathway has the capacity to dampen macrophage activation and cytokine release during endotoxemia and ischemia reperfusion injury. However, the relevance of the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR)-dependent anti-inflammatory pathway in the process of allograft rejection or maintenance of tolerance remains unknown. The aim of our study is to investigate whether the cholinergic pathway could impact T cell alloreactivity and transplant outcome in mice. For this purpose, we performed minor-mismatched skin allografts using donor/recipient combinations genetically deficient for the alpha 7nAChR. Minor-mismatched skin grafts were not rejected unless the mice were housed in an environment with endogenous pathogen exposure or the graft was treated with direct application of imiquimod (a TLR7 ligand). The alpha 7nAChR-deficient recipient mice showed accelerated rejection compared to wild type recipient mice under these conditions of TLR activation. The accelerated rejection was associated with enhanced IL-17 and IFN-gamma production by alloreactive T cells. An alpha 7nAChR-deficiency in the donor tissue facilitated allograft rejection but not in recipient mice. In addition, adoptive T cell transfer experiments in skin-grafted lymphopenic animals revealed a direct regulatory role for the alpha 7nAChR on T cells. Taken together, our data demonstrate that the cholinergic pathway regulates alloreactivity and transplantation tolerance at multiple levels. One implication suggested by our work is that, in an organ transplant setting, deliberate alpha 7nAChR stimulation of brain dead donors might be a valuable approach for preventing donor tissue inflammation prior to transplant.	[Sadis, Claude] Univ Libre Brussels, Erasme Hosp, Dept Anaesthesiol, B-1050 Brussels, Belgium; [Sadis, Claude; Detienne, Sophie; Vokaer, Benoit; Charbonnier, Louis-Marie; Lemaitre, Philippe; Spilleboudt, Chloe; Delbauve, Sandrine; Kubjak, Carole; Flamand, Veronique; Goldman, Michel; Benghiat, Fleur S.; Le Moine, Alain] Inst Med Immunol, Gosselies, Belgium; [Field, Kenneth A.] Bucknell Univ, Dept Biol, Cell Biol Biochem Program, Lewisburg, PA 17837 USA	Universite Libre de Bruxelles; Bucknell University	Sadis, C (corresponding author), Univ Libre Brussels, Erasme Hosp, Dept Anaesthesiol, B-1050 Brussels, Belgium.	csadis@ulb.ac.be; alemoine@ulb.ac.be		Charbonnier, Louis-Marie/0000-0002-4594-7893; Flamand, Veronique/0000-0002-8906-3758; Field, Kenneth/0000-0001-7417-4386	Walloon Region; FNRS (Fonds National de la Recherche Scientifique - Belgium); FNRS; Fonds Erasme (Universite Libre de Bruxelles-Belgium)	Walloon Region; FNRS (Fonds National de la Recherche Scientifique - Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme (Universite Libre de Bruxelles-Belgium)	The Institute for Medical Immunology is funded by research grants of the Walloon Region and the FNRS (Fonds National de la Recherche Scientifique - Belgium). Claude Sadis is a doctoral researcher funded by the FNRS and the Fonds Erasme (Universite Libre de Bruxelles-Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EB, 2011, AM J TRANSPLANT, V11, P936, DOI 10.1111/j.1600-6143.2011.03476.x; Ahmed EB, 2011, TRANSPLANT REV-ORLAN, V25, P27, DOI 10.1016/j.trre.2010.10.003; Alegre ML, 2008, TRANSPLANTATION, V86, P1, DOI 10.1097/TP.0b013e31817c11e6; Alegre ML, 2009, TRANSPLANTATION, V87, pS77, DOI 10.1097/TP.0b013e3181a2b90f; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Benghiat FS, 2008, TRANSPLANTATION, V85, P943, DOI 10.1097/TP.0b013e31816a5ae7; BILLINGHAM RE, 1954, PROC R SOC SER B-BIO, V143, P43, DOI 10.1098/rspb.1954.0053; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Chen L, 2009, J IMMUNOL, V182, P6217, DOI 10.4049/jimmunol.0803842; Chen Y, 2003, J IMMUNOL, V171, P6510, DOI 10.4049/jimmunol.171.12.6510; Chong AS, 2012, NAT REV IMMUNOL, V12, P459, DOI 10.1038/nri3215; Curtis BJ, 2012, J INVEST DERMATOL, V132, P28, DOI 10.1038/jid.2011.264; Goldman M, 2009, CLIN EXP IMMUNOL, V156, P185, DOI 10.1111/j.1365-2249.2009.03887.x; McKisic M, 1998, TRANSPLANTATION, V65, P1436, DOI 10.1097/00007890-199806150-00005; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Norman GJ, 2011, J NEUROSCI, V31, P3446, DOI 10.1523/JNEUROSCI.4558-10.2011; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; Nouri-Shirazi M, 2012, J IMMUNOL, V188, P2359, DOI 10.4049/jimmunol.1102552; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Richards DM, 2004, J IMMUNOL, V172, P3469, DOI 10.4049/jimmunol.172.6.3469; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Scott DW, 2010, CLIN IMMUNOL; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Waldmann H, 2010, NAT REV NEPHROL, V6, P569, DOI 10.1038/nrneph.2010.108; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang T, 2010, AM J TRANSPLANT, V10, P1524, DOI 10.1111/j.1600-6143.2010.03066.x; Wang TM, 2008, J IMMUNOL, V180, P5991, DOI 10.4049/jimmunol.180.9.5991; Westman M, 2010, CLIN EXP IMMUNOL, V162, P62, DOI 10.1111/j.1365-2249.2010.04204.x; Zafar SY, 2008, ONCOLOGIST, V13, P769, DOI 10.1634/theoncologist.2007-0251	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79984	10.1371/journal.pone.0079984	http://dx.doi.org/10.1371/journal.pone.0079984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278228	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800042
J	Uckun, FM; Ma, H; Ishkhanian, R; Arellano, M; Shahidzadeh, A; Termuhlen, A; Gaynon, PS; Qazi, S				Uckun, Fatih M.; Ma, Hong; Ishkhanian, Rita; Arellano, Martha; Shahidzadeh, Anoush; Termuhlen, Amanda; Gaynon, Paul S.; Qazi, Sanjive			Constitutive Function of the Ikaros Transcription Factor in Primary Leukemia Cells from Pediatric Newly Diagnosed High-Risk and Relapsed B-precursor ALL Patients	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; COPY NUMBER VARIATION; DELETION; GENE; IKZF1; PCR; SYK	We examined the constitutive function of the Ikaros (IK) transcription factor in blast cells from pediatric B-precursor acute lymphoblastic leukemia (BPL) patients using multiple assay platforms and bioinformatics tools. We found no evidence of diminished IK expression or function for primary cells from high-risk BPL patients including a Philadelphia chromosome (Ph)(+) subset. Relapse clones as well as very aggressive in vivo clonogenic leukemic B-cell precursors isolated from spleens of xenografted NOD/SCID mice that developed overt leukemia after inoculation with primary leukemic cells of patients with BPL invariably and abundantly expressed intact IK protein. These results demonstrate that a lost or diminished IK function is not a characteristic feature of leukemic cells in Ph+ or Ph-high-risk BPL.	[Uckun, Fatih M.; Ma, Hong; Ishkhanian, Rita; Arellano, Martha; Shahidzadeh, Anoush; Qazi, Sanjive] Childrens Hosp Los Angeles, Syst Immunobiol Lab, Los Angeles, CA 90027 USA; [Uckun, Fatih M.; Ma, Hong; Ishkhanian, Rita; Arellano, Martha; Shahidzadeh, Anoush; Qazi, Sanjive] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Dev Therapeut Program, Los Angeles, CA 90027 USA; [Uckun, Fatih M.; Termuhlen, Amanda; Gaynon, Paul S.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Uckun, Fatih M.] USC Norris Comprehens Canc Ctr, Dev Therapeut Program, Los Angeles, CA USA; [Termuhlen, Amanda] Miller Childrens Hosp, Jonathan Jaques Canc Ctr, Long Beach, CA USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Uckun, FM (corresponding author), Childrens Hosp Los Angeles, Syst Immunobiol Lab, Los Angeles, CA 90027 USA.	fmuckun@chla.usc.edu		Uckun, Fatih M./0000-0001-9334-183X	DHHS grants from the National Cancer Institute [P30CA014089, U01-CA-151837, R01CA-154471, R21-CA-164098]; Children's Hospital Los Angeles Institutional Endowment and Special Funds; Ronald McDonald House Charities of Southern California; Couples Against Leukemia Foundation; William Lawrence & Blanche Hughes Foundation; Nautica Triathalon; Children's Hospital Los Angeles Stem Cell Core Facility; CIRM; NATIONAL CANCER INSTITUTE [R01CA154471, P30CA014089, R21CA164098, U01CA151837] Funding Source: NIH RePORTER	DHHS grants from the National Cancer Institute; Children's Hospital Los Angeles Institutional Endowment and Special Funds; Ronald McDonald House Charities of Southern California; Couples Against Leukemia Foundation; William Lawrence & Blanche Hughes Foundation; Nautica Triathalon; Children's Hospital Los Angeles Stem Cell Core Facility; CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported in part by DHHS grants P30CA014089, U01-CA-151837, R01CA-154471 and R21-CA-164098 (FMU) from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This work was supported in part by Children's Hospital Los Angeles Institutional Endowment and Special Funds (FMU), Ronald McDonald House Charities of Southern California (FMU), Couples Against Leukemia Foundation (FMU), a William Lawrence & Blanche Hughes Foundation grant (FMU), Nautica Triathalon and its producer Michael Epstein (FMU). This work was supported by the Children's Hospital Los Angeles Stem Cell Core Facility. The Stem Cell Core is a CIRM funded shared laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Dorge P, 2013, HAEMATOLOGICA, V98, P428, DOI 10.3324/haematol.2011.056135; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Eckel-Passow JE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-220; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hong HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044483; Iacobucci I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040934; Ivakhno S, 2010, BIOINFORMATICS, V26, P1395, DOI 10.1093/bioinformatics/btq145; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kim Soon-Young, 2012, Genomics & Informatics, V10, P194, DOI 10.5808/GI.2012.10.3.194; Ma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071302; Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ouillette Peter D, 2013, Methods Mol Biol, V973, P99, DOI 10.1007/978-1-62703-281-0_7; Ozer Z, 2013, INT J MOL MED SCI, V3, DOI [10.5376/ijmms.2013.03.0007,2013, DOI 10.5376/IJMMS.2013.03.0007]; Palmi C., 2013, HAEMATOLOGICA; Qazi S, 2013, INT J MOL MED SCI, V3, DOI [10.5376/ijmms.2013.03.0009, DOI 10.5376/IJMMS.2013.03.0009]; Qazi S, 2013, HAEMATOLOGI IN PRESS; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Uckun FM, 2013, BLOOD, V121, P4348, DOI 10.1182/blood-2012-11-470633; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Yang HC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-100; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80732	10.1371/journal.pone.0080732	http://dx.doi.org/10.1371/journal.pone.0080732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278314	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100106
J	Beaven, CM; Ekstrom, J				Beaven, C. Martyn; Ekstrom, Johan			A Comparison of Blue Light and Caffeine Effects on Cognitive Function and Alertness in Humans	PLOS ONE			English	Article							EVENING EXPOSURE; BRAIN RESPONSES; HUMAN MELATONIN; PERFORMANCE; MOOD; SENSITIVITY; SLEEPINESS; MEMORY; RED; SUPPRESSION	The alerting effects of both caffeine and short wavelength (blue) light have been consistently reported. The ability of blue light to enhance alertness and cognitive function via non-image forming neuropathways have been suggested as a non-pharmacological countermeasure for drowsiness across a range of occupational settings. Here we compare and contrast the alerting and psychomotor effects of 240 mg of caffeine and a 1-h dose of similar to 40 lx blue light in a non-athletic population. Twenty-one healthy subjects performed a computer-based psychomotor vigilance test before and after each of four randomly assigned trial conditions performed on different days: white light/placebo; white light/240 mg caffeine; blue light/placebo; blue light/240 mg caffeine. The Karolinska Sleepiness Scale was used to assess subjective measures of alertness. Both the caffeine only and blue light only conditions enhanced accuracy in a visual reaction test requiring a decision and an additive effect was observed with respect to the fastest reaction times. However, in a test of executive function, where a distraction was included, caffeine exerted a negative effect on accuracy. Furthermore, the blue light only condition consistently outperformed caffeine when both congruent and incongruent distractions were presented. The visual reactions in the absence of a decision or distraction were also enhanced in the blue light only condition and this effect was most prominent in the blue-eyed participants. Overall, blue light and caffeine demonstrated distinct effects on aspects of psychomotor function and have the potential to positively influence a range of settings where cognitive function and alertness are important. Specifically, despite the widespread use of caffeine in competitive sporting environments, the possible impact of blue light has received no research attention.	[Beaven, C. Martyn] Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden; [Ekstrom, Johan] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Mid-Sweden University; Mid-Sweden University	Beaven, CM (corresponding author), Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden.	Martyn.Beaven@miun.se	Beaven, Christopher/Q-3109-2016	Beaven, Christopher/0000-0003-2900-7460				AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; ARNOLD ME, 1987, PHYSIOL BEHAV, V41, P25, DOI 10.1016/0031-9384(87)90126-0; BARON RA, 1992, MOTIV EMOTION, V16, P1, DOI 10.1007/BF00996485; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Cajochen C, 2006, EUR J NEUROSCI, V23, P1082, DOI 10.1111/j.1460-9568.2006.04613.x; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Childs E, 2006, PSYCHOPHARMACOLOGY, V185, P514, DOI 10.1007/s00213-006-0341-3; Cook CJ, 2011, J INT SOC SPORT NUTR, V8, DOI 10.1186/1550-2783-8-2; Duncan MJ, 2011, J STRENGTH COND RES, V25, P178, DOI 10.1519/JSC.0b013e318201bddb; Elliman NA, 2010, APPETITE, V55, P355, DOI 10.1016/j.appet.2010.03.016; Figueiro MG, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/829351; Figueiro MG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-105; FINE BJ, 1994, PSYCHOPHARMACOLOGY, V114, P233, DOI 10.1007/BF02244842; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Glickman G, 2006, BIOL PSYCHIAT, V59, P502, DOI 10.1016/j.biopsych.2005.07.006; GOLDSTEIN A, 1965, J PHARMACOL EXP THER, V149, P156; Heatherley SV, 2005, PSYCHOPHARMACOLOGY, V178, P461, DOI 10.1007/s00213-005-2159-9; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnson RF, 1996, PROCEEDINGS OF THE HUMAN FACTORS AND ERGONOMICS SOCIETY - 40TH ANNUAL MEETING, VOLS 1 AND 2, P1217, DOI 10.1177/154193129604002315; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Lazarus M, 2011, J NEUROSCI, V31, P10067, DOI 10.1523/JNEUROSCI.6730-10.2011; Lehrl S, 2007, J NEURAL TRANSM, V114, P457, DOI 10.1007/s00702-006-0621-4; Lockley S.W, 2008, J HUM ENV SYST, V11, P43; Munch M, 2012, BEHAV NEUROSCI, V126, P196, DOI 10.1037/a0026702; Munch M, 2006, AM J PHYSIOL-REG I, V290, pR1421, DOI 10.1152/ajpregu.00478.2005; Peeling P, 2007, ADV PHYSIOL EDUC, V31, P332, DOI 10.1152/advan.00003.2007; Plitnick B, 2010, LIGHTING RES TECHNOL, V42, P449, DOI 10.1177/1477153509360887; Rautkyla E, 2012, LIGHTING RES TECHNOL, V44, P238, DOI 10.1177/1477153511409294; Rogers PJ, 2007, NUTR BULL, V32, P84, DOI 10.1111/j.1467-3010.2007.00607.x; Ruberg FL, 1996, J CLIN ENDOCR METAB, V81, P2980, DOI 10.1210/jc.81.8.2980; Sahin L, 2013, PHYSIOL BEHAV, V116, P1, DOI 10.1016/j.physbeh.2013.03.014; Sicard BA, 1996, AVIAT SPACE ENVIR MD, V67, P859; Smith A, 2003, J PSYCHOPHARMACOL, V17, P283, DOI 10.1177/02698811030173010; Smith A, 2009, HUM PSYCHOPHARM CLIN, V24, P239, DOI 10.1002/hup.1020; Tonnessen E, 2013, J STRENGTH COND RES, V27, P885, DOI 10.1519/JSC.0b013e31826520c3; Uchida Y, 2012, J STRENGTH COND RES; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Warburton DM, 2001, PSYCHOPHARMACOLOGY, V158, P322, DOI 10.1007/s002130100884; West KE, 2011, J APPL PHYSIOL, V110, P619, DOI 10.1152/japplphysiol.01413.2009; Wood B, 2013, APPL ERGON, V44, P237, DOI 10.1016/j.apergo.2012.07.008; Wright KP, 1997, J SLEEP RES, V6, P26, DOI 10.1046/j.1365-2869.1997.00022.x	50	33	34	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2013	8	10							e76707	10.1371/journal.pone.0076707	http://dx.doi.org/10.1371/journal.pone.0076707			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232NS	24282477	gold, Green Published, Green Submitted			2022-12-27	WOS:000325501300082
J	Lawrence, J; Chang, YMR; Szladovits, B; Davison, LJ; Garden, OA				Lawrence, Jennifer; Chang, Yu-Mei Ruby; Szladovits, Balazs; Davison, Lucy J.; Garden, Oliver A.			Breed-Specific Hematological Phenotypes in the Dog: A Natural Resource for the Genetic Dissection of Hematological Parameters in a Mammalian Species	PLOS ONE			English	Article							REFERENCE INTERVALS; BLOOD-CELL; LOCI; HEALTHY; VALUES; MODEL; AGE; ASSOCIATION; DISEASES; BEAGLE	Remarkably little has been published on hematological phenotypes of the domestic dog, the most polymorphic species on the planet. Information on the signalment and complete blood cell count of all dogs with normal red and white blood cell parameters judged by existing reference intervals was extracted from a veterinary database. Normal hematological profiles were available for 6046 dogs, 5447 of which also had machine platelet concentrations within the reference interval. Seventy-five pure breeds plus a mixed breed control group were represented by 10 or more dogs. All measured parameters except mean corpuscular hemoglobin concentration (MCHC) varied with age. Concentrations of white blood cells (WBCs), neutrophils, monocytes, lymphocytes, eosinophils and platelets, but not red blood cell parameters, all varied with sex. Neutering status had an impact on hemoglobin concentration, mean corpuscular hemoglobin (MCH), MCHC, and concentrations of WBCs, neutrophils, monocytes, lymphocytes and platelets. Principal component analysis of hematological data revealed 37 pure breeds with distinctive phenotypes. Furthermore, all hematological parameters except MCHC showed significant differences between specific individual breeds and the mixed breed group. Twenty-nine breeds had distinctive phenotypes when assessed in this way, of which 19 had already been identified by principal component analysis. Tentative breed-specific reference intervals were generated for breeds with a distinctive phenotype identified by comparative analysis. This study represents the first large-scale analysis of hematological phenotypes in the dog and underlines the important potential of this species in the elucidation of genetic determinants of hematological traits, triangulating phenotype, breed and genetic predisposition.	[Lawrence, Jennifer; Garden, Oliver A.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory Cell Lab T, London, England; [Chang, Yu-Mei Ruby] Univ London Royal Vet Coll, Res Off, London, England; [Szladovits, Balazs] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England; [Davison, Lucy J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford, England; [Davison, Lucy J.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Oxford; University of Cambridge	Garden, OA (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory Cell Lab T, Camden Campus,Royal Coll St, London, England.	ogarden@rvc.ac.uk			Wellcome Trust Veterinary Postdoctoral Fellowship	Wellcome Trust Veterinary Postdoctoral Fellowship	We would like to thank Mr Roger Bishop for his help in accessing the Diagnostic Laboratory database in the course of this study and the many clinicians, both past and present, who managed canine patients from which blood samples were submitted for hematological analysis. LJD is supported by a Wellcome Trust Veterinary Postdoctoral Fellowship.	Aroch I, 2007, VET CLIN PATH, V36, P40, DOI 10.1111/j.1939-165X.2007.tb00180.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Beale H, 2012, CURR BIOL, V22, pR315, DOI 10.1016/j.cub.2012.02.013; Bourges-Abella N, 2011, VET CLIN PATH, V40, P303, DOI 10.1111/j.1939-165X.2011.00333.x; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Brockus C. W., 2011, Duncan & Prasse's veterinary laboratory medicine: clinical pathology, P3; Campora C, 2011, J SMALL ANIM PRACT, V52, P301, DOI 10.1111/j.1748-5827.2011.01070.x; Chase K, 2009, J HERED, V100, pS37, DOI 10.1093/jhered/esp011; Chen JC, 2002, BLOOD, V99, P561, DOI 10.1182/blood.V99.2.561; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Choi SY, 2011, LAB ANIM RES, P283; Christopher MJ, 2007, CURR OPIN HEMATOL, V14, P3, DOI 10.1097/00062752-200701000-00003; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI [10.1016/j.jepa.2009.10.011, 10.1016/j.jcpa.2009.10.011]; DEGEN M, 1987, J AM VET MED ASSOC, V190, P541; Downs LM, 2013, ANIM GENET, V44, P169, DOI 10.1111/j.1365-2052.2012.02379.x; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gookin JL, 1998, J AM VET MED ASSOC, V212, P1258; Greeley EH, 1996, VET IMMUNOL IMMUNOP, V55, P1, DOI 10.1016/S0165-2427(96)05563-8; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Harper EJ, 2003, J AM VET MED ASSOC, V223, P1436, DOI 10.2460/javma.2003.223.1436; Head E, 2013, BBA-MOL BASIS DIS, V1832, P1384, DOI 10.1016/j.bbadis.2013.03.016; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Lilliehook I, 2000, J SMALL ANIM PRACT, V41, P248, DOI 10.1111/j.1748-5827.2000.tb03934.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LUMSDEN JH, 1979, CAN J COMP MED, V43, P125; Lund C, 2000, BERL MUNCH TIERARZTL, V113, P447; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nielsen L, 2010, VET CLIN PATH, V39, P20, DOI 10.1111/j.1939-165X.2009.00186.x; Okada Y, 2012, J HUM GENET, V57, P161, DOI 10.1038/jhg.2012.2; Pedersen HD, 2002, J VET INTERN MED, V16, P169, DOI 10.1892/0891-6640(2002)016&lt;0169:IATICK&gt;2.3.CO;2; Petkova SB, 2008, PHYSIOL GENOMICS, V34, P304, DOI 10.1152/physiolgenomics.00185.2007; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Qadir S, 2011, J HELMINTHOL, V85, P401, DOI 10.1017/S0022149X10000726; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; SAROR DI, 1979, J SMALL ANIM PRACT, V20, P243, DOI 10.1111/j.1748-5827.1979.tb06714.x; Schalm O. W., 1976, Canine Practice, V3, P55; Shiel RE, 2007, VET CLIN PATH, V36, P274, DOI 10.1111/j.1939-165X.2007.tb00223.x; SHIFRINE M, 1973, LAB ANIM SCI, V23, P894; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Starr JM, 2011, MATURITAS, V69, P373, DOI 10.1016/j.maturitas.2011.05.007; STRASSER A, 1993, J VET MED A, V40, P720, DOI 10.1111/j.1439-0442.1993.tb00689.x; Swanson KS, 2004, J ANIM SCI, V82, P1713; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; Tsai KL, 2007, MAMM GENOME, V18, P444, DOI 10.1007/s00335-007-9037-1; Vajdovich P, 1997, VET RES COMMUN, V21, P463, DOI 10.1023/A:1005929801735; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525	52	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81288	10.1371/journal.pone.0081288	http://dx.doi.org/10.1371/journal.pone.0081288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282579	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500081
J	Meeuwsen, E; Melis, R; van der Aa, G; Goluke-Willemse, G; de Leest, B; van Raak, F; Scholzel-Dorenbos, C; Verheijen, D; Verhey, F; Visser, M; Wolfs, C; Adang, E; Rikkert, MO				Meeuwsen, Els; Melis, Rene; van der Aa, Geert; Goluke-Willemse, Gertie; de Leest, Benoit; van Raak, Frank; Scholzel-Dorenbos, Carla; Verheijen, Desiree; Verhey, Frans; Visser, Marieke; Wolfs, Claire; Adang, Eddy; Rikkert, Marcel Olde			Cost-Effectiveness of One Year Dementia Follow-Up Care by Memory Clinics or General Practitioners: Economic Evaluation of a Randomised Controlled Trial	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; STRATEGY; VALUATIONS; EUROQOL; UTILITY; TARIFF; STATE	Objective: To evaluate the cost-effectiveness of post-diagnosis dementia treatment and coordination of care by memory clinics compared to general practitioners' care. Methods: A multicentre randomised trial with 175 community dwelling patients newly diagnosed with mild to moderate dementia, and their informal caregivers, with twelve months' follow-up. Cost-effectiveness was evaluated from a societal point of view and presented as incremental cost per quality adjusted life year. To establish cost-effectiveness, a cost-utility analysis was conducted using utilities based on the EQ-5D. Uncertainty surrounding the incremental cost-effectiveness ratio (difference in costs divided by difference in effects) was calculated by bootstrapping from the original data. Results: Compared to general practitioners' care, treatment by the memory clinics was on average (sic)1024 (95% CI: -(sic)7723 to (sic)5674) cheaper, and showed a non-significant decrease of 0.025 (95% CI: -0.114 to 0.064) quality adjusted life years. The incremental cost-effectiveness point estimate from the bootstrap simulation was (sic) 41 442 per QALY lost if one would use memory clinic care instead of general practitioner care. Conclusion: No evidence was found that memory clinics were more cost-effective compared to general practitioners with regard to post-diagnosis treatment and coordination of care of patients with dementia in the first year after diagnosis.	[Meeuwsen, Els; Melis, Rene; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr, Nijmegen, Netherlands; [van der Aa, Geert] Catharina Hosp, Dept Geriatr, Eindhoven, Netherlands; [Goluke-Willemse, Gertie] Rijnstate Hosp, Dept Geriatr, Arhem, Netherlands; [de Leest, Benoit] Elkerliek Hosp, Dept Geriatr, Helmond, Netherlands; [van Raak, Frank] Ctr Land van Cuijk, Mental Hlth Org Oost Brabant, Boxmeer, Netherlands; [Scholzel-Dorenbos, Carla] Slingeland Hosp, Dept Geriatr, Doetinchem, Netherlands; [Verheijen, Desiree] Gelderse Vallei Hosp, Dept Geriatr, Ede, Netherlands; [Verhey, Frans; Wolfs, Claire] Maastricht Univ Med Ctr, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Visser, Marieke] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam, Netherlands; [Adang, Eddy] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, Nijmegen, Netherlands	Radboud University Nijmegen; Catharina Hospital; Rijnstate Hospital; Gelderse Vallei Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Meeuwsen, E (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Radboud Alzheimer Ctr, Dept Geriatr, Nijmegen, Netherlands.	Els.Meeuwsen@radboudumc.nl	Melis, René/J-5943-2012; Rikkert, M.G.M. Olde/H-8078-2014; Adang, E.M.M./L-4169-2015; Rikkert, Marcel Olde/D-9773-2012	Melis, René/0000-0002-7863-4738; Rikkert, M.G.M. Olde/0000-0003-1397-1677; 	ZonMw (Netherlands Organization for Health Research and Development) [945-07-703]; Radboud University Nijmegen Medical Centre	ZonMw (Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and Development); Radboud University Nijmegen Medical Centre	This work was supported by ZonMw (Netherlands Organization for Health Research and Development; grant no 945-07-703) and by the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; BOOMSMA LJ, 2005, HUISARTS WET, V48, P124; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b931; Cahill S, 2010, INT J GERIATR PSYCH, V25, P912, DOI 10.1002/gps.2597; Craig D., 2004, PSYCHIAT B, V28, P375, DOI [10.1192/pb.28.10.375, DOI 10.1192/PB.28.10.375]; Department of Health, 2009, LIVING WELL DEMENTIA; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Eriksson S, 2010, INT J GERIATR PSYCH, V25, P885, DOI 10.1002/gps.2592; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graff MJL, 2008, BMJ-BRIT MED J, V336, P134, DOI 10.1136/bmj.39408.481898.BE; Jolley SD, 2006, POSTGRAD MED J, V82, P199, DOI 10.1136/pgmj.2005.040592; Jonsson L, 2006, ALZ DIS ASSOC DIS, V20, P49; Jonsson L, 2009, PHARMACOECONOMICS, V27, P391, DOI 10.2165/00019053-200927050-00004; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Krol M, 2006, PHARMACOECONOMICS, V24, P401, DOI 10.2165/00019053-200624040-00009; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Meeuwsen EJ, 2009, J NUTR HEALTH AGING, V13, P242, DOI 10.1007/s12603-009-0066-1; Meeuwsen EJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3086; Melis RJF, 2009, J ROY SOC MED, V102, P456, DOI 10.1258/jrsm.2009.090259; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Nederlands Huisartsen Genootschap, 2003, NHG STAND DEM; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Ramakers IHGB, 2011, AGING MENT HEALTH, V15, P34, DOI 10.1080/13607863.2010.519321; Richtlijn CBO, 2005, DIAGNOSTIEK MEDICAME; U.S.Department of Health and Human Services, 2012, ALZHEIMERS DEMENT, V8, P234; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Wimo A, 2007, ARCH GERONTOL GERIAT, V44, P71, DOI 10.1016/j.archger.2006.03.001; Wolfs CAG, 2009, ARCH GEN PSYCHIAT, V66, P313, DOI 10.1001/archgenpsychiatry.2008.544; World Health Organization, 2012, WHO ALZH DIS INT DEM	32	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79797	10.1371/journal.pone.0079797	http://dx.doi.org/10.1371/journal.pone.0079797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282511	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500012
J	Zhang, C; Chi, FL; Xie, TH; Zhou, YH				Zhang, Chi; Chi, Feng-Ling; Xie, Tian-Hao; Zhou, Yu-Hao			Effect of B-vitamin Supplementation on Stroke: a Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							FOLIC-ACID; PLASMA HOMOCYSTEINE; CARDIOVASCULAR EVENTS; RISK-FACTOR; PREVENTION; FOLATE; DISEASE	Background: B vitamins have been extensively used to reduce homocysteine levels; however, it remains uncertain whether B vitamins are associated with a reduced risk of stroke. Our aim was to evaluate the effects of B vitamins on stroke. Methodology and Principal findings: We systematically searched PubMed, EmBase, and the Cochrane Central Register of Controlled Trials to identify studies for our analysis. Relative risk (RR) was used to measure the effect of B-vitamin supplementation on the risk of stroke. The analysis was further stratified based on factors that could affect the treatment effects. Of the 13,124 identified articles, we included 18 trials reporting data on 57,143 individuals and 2,555 stroke events. B-vitamin supplementation was not associated with a significant reduction in the risk of stroke (RR, 0.91, 95%CI: 0.82-1.01, P = 0.075; RD, -0.003, 95%CI: -0.007-0.001, P = 0.134). Subgroup analyses suggested that B-vitamin supplementation might reduce the risk of stroke if included trials had a man/woman ratio of more than 2 or subjects received dose of folic acid less than 1 mg. Furthermore, in a cumulative meta-analysis for stroke, the originally proposed nonsignificant B-vitamin effect was refuted by the evidence accumulated up to 2006. There is a small effect with borderline statistical significance based on data gathered since 2007. Conclusions/Significance: Our study indicates that B-vitamin supplementation is not associated with a lower risk of stroke based on relative and absolute measures of association. Subgroup analyses suggested that B-vitamin supplementation can effectively reduce the risk of stroke if included trials had a man/woman ratio of more than 2 or subjects received dose of folic acid less than 1 mg.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Xie, Tian-Hao] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China	Naval Medical University	Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com						Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Al-Delaimy WK, 2004, STROKE, V35, P1259, DOI 10.1161/01.STR.0000127813.12854.9c; Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRATTSTROM LE, 1984, STROKE, V15, P1012, DOI 10.1161/01.STR.15.6.1012; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Heinz J, 2010, CIRCULATION, V121, P1432, DOI 10.1161/CIRCULATIONAHA.109.904672; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Huang T, 2012, CLIN NUTR, V31, P448, DOI 10.1016/j.clnu.2011.01.003; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc; Larsson SC, 2008, AM J EPIDEMIOL, V167, P954, DOI 10.1093/aje/kwm395; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Saposnik G, 2009, STROKE, V40, P1365, DOI 10.1161/STROKEAHA.108.529503; Spence JD, 2011, JAMA-J AM MED ASSOC, V306, P2610, DOI 10.1001/jama.2011.1834; The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators, 2006, N ENGL J MED, V354; The Linxian Nutrition Intervention Trial Group, 1996, AM J EPIDEMIOL, V143, P658, DOI [10.1093/oxfordjournals.aje.a008798, DOI 10.1093/0XF0RDJ0URNALS.AJE.A008798.PUBMED:8651227]; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	42	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81577	10.1371/journal.pone.0081577	http://dx.doi.org/10.1371/journal.pone.0081577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282609	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500112
J	Feng, Y; Mao, HY; Xu, CP; Jiang, JM; Chen, Y; Yan, JY; Gao, J; Li, Z; Xia, SC; Lu, YY				Feng, Yan; Mao, Haiyan; Xu, Changping; Jiang, Jianmin; Chen, Yin; Yan, Juying; Gao, Jian; Li, Zhen; Xia, Shichang; Lu, Yiyu			Origin and Characteristics of Internal Genes Affect Infectivity of the Novel Avian-Origin Influenza A (H7N9) Virus	PLOS ONE			English	Article							HONG-KONG; H9N2 VIRUSES; H5N1; TRANSMISSION; EVOLUTION; POULTRY; EPIDEMIOLOGY; SUBTYPE; CHINA	Background: Human infection with a novel avian-origin influenza A (H7N9) virus occurred continuously in China during the first half of 2013, with high infectivity and pathogenicity to humans. In this study, we investigated the origin of internal genes of the novel H7N9 virus and analyzed the relationship between internal genes and infectivity of the virus. Methodology and Principal findings: We tested the environmental specimens using real-time RT-PCR assays and isolated five H9N2 viruses from specimens that were positive for both H7 and H9. Results of recombination and phylogeny analysis, performed based on the entire sequences of 221 influenza viruses, showed that one of the Zhejiang avian H9N2 isolates, A/environment/Zhejiang/16/2013, shared the highest identities on the internal genes with the novel H7N9 virus A/Anhui/1/2013, ranging from 98.98% to 100%. Zhejiang avian H9N2 isolates were all reassortant viruses, by acquiring NS gene from A/chicken/Dawang/1/2011-like viruses and other five internal genes from A/brambling/Beijing/16/2012-like viruses. Compared to A/Anhui/1/2013 (H7N9), the homology on the NS gene was 99.16% with A/chicken/Dawang/1/2011, whereas only 94.27-97.61% with A/bramnling/Beijing/16/2012-like viruses. Analysis on the relationship between internal genes and the infectivity of novel H7N9 viruses were performed by comparing amino acid sequences with the HPAI H5N1 viruses, the H9N2 and the earlier H7N9 avian influenza viruses. There were nine amino acids on the internal genes found to be possibly associated with the infectivity of the novel H7N9 viruses. Conclusions: These findings indicate that the internal genes, sharing the highest similarities with A/environment/Zhejiang/16/2013-like (H9N2) viruses, may affect the infectivity of the novel H7N9 viruses.	[Feng, Yan; Mao, Haiyan; Xu, Changping; Jiang, Jianmin; Chen, Yin; Yan, Juying; Gao, Jian; Li, Zhen; Xia, Shichang; Lu, Yiyu] Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Lu, YY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Key Lab Emergency Detect Publ Hlth Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	luyiyuzjh@163.com			Key Medical Subjects Construction Project of Zhejiang Province [XKQ-009-003]	Key Medical Subjects Construction Project of Zhejiang Province	This work was supported by the Key Medical Subjects Construction Project of Zhejiang Province (XKQ-009-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen Hualan, 2008, V27; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Food and Agriculture Organization of the United Nations (FAO), FOOD AGR ORG UN FAO; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hadipour MM, 2011, J ANIM VET ADV, V10, P832, DOI 10.3923/javaa.2011.832.834; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kou Z, 2008, CHINESE SCI BULL, V53, P2002, DOI 10.1007/s11434-008-0236-2; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Kwon TY, 2011, VET MICROBIOL, V153, P393, DOI 10.1016/j.vetmic.2011.06.011; Li Chuan-hua, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P213; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu LQ, 2011, BIOMED ENVIRON SCI, V24, P530, DOI 10.3967/0895-3988.2011.05.012; Lu XH, 2001, J VIROL, V75, P4896, DOI 10.1128/JVI.75.10.4896-4901.2001; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pickett BE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-165; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shortridge KF, 2000, VET MICROBIOL, V74, P141, DOI 10.1016/S0378-1135(00)00174-7; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; *WHO, WHO NUMB CONF HUM CA, P15253; *WHO, 2003, WHO CUM NUMB CONF HU, P15253; Xiong CL, 2013, CLIN INFECT DIS, V57, P622, DOI 10.1093/cid/cit294; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang Y, 2013, SCIENCE, V340, P1459, DOI 10.1126/science.1229455	35	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81136	10.1371/journal.pone.0081136	http://dx.doi.org/10.1371/journal.pone.0081136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278391	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700051
J	Daly, KC; Kalwar, F; Hatfield, M; Staudacher, E; Bradley, SP				Daly, Kevin C.; Kalwar, Faizan; Hatfield, Mandy; Staudacher, Erich; Bradley, Samual P.			Odor Detection in Manduca sexta Is Optimized when Odor Stimuli Are Pulsed at a Frequency Matching the Wing Beat during Flight	PLOS ONE			English	Article							INDUCED AIR-FLOW; PHEROMONE PLUMES; OPTOMOTOR ANEMOTAXIS; PROJECTION NEURONS; FLYING INSECTS; UPWIND FLIGHT; MOTH; DISCRIMINATION; RESOLUTION; RESPONSES	Sensory systems sample the external world actively, within the context of self-motion induced disturbances. Mammals sample olfactory cues within the context of respiratory cycles and have adapted to process olfactory information within the time frame of a single sniff cycle. In plume tracking insects, it remains unknown whether olfactory processing is adapted to wing beating, which causes similar physical effects as sniffing. To explore this we first characterized the physical properties of our odor delivery system using hotwire anemometry and photo ionization detection, which confirmed that odor stimuli were temporally structured. Electroantennograms confirmed that pulse trains were tracked physiologically. Next, we quantified odor detection in moths in a series of psychophysical experiments to determine whether pulsing odor affected acuity. Moths were first conditioned to respond to a target odorant using Pavlovian olfactory conditioning. At 24 and 48 h after conditioning, moths were tested with a dilution series of the conditioned odor. On separate days odor was presented either continuously or as 20 Hz pulse trains to simulate wing beating effects. We varied pulse train duty cycle, olfactometer outflow velocity, pulsing method, and odor. Results of these studies, established that detection was enhanced when odors were pulsed. Higher velocity and briefer pulses also enhanced detection. Post hoc analysis indicated enhanced detection was the result of a significantly lower behavioral response to blank stimuli when presented as pulse trains. Since blank responses are a measure of false positive responses, this suggests that the olfactory system makes fewer errors (i.e. is more reliable) when odors are experienced as pulse trains. We therefore postulate that the olfactory system of Manduca sexta may have evolved mechanisms to enhance odor detection during flight, where the effects of wing beating represent the norm. This system may even exploit temporal structure in a manner similar to sniffing.	[Daly, Kevin C.; Kalwar, Faizan; Hatfield, Mandy; Staudacher, Erich; Bradley, Samual P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Daly, KC (corresponding author), W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	kevin.daly@mail.wvu.edu			NIH [DC009417]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant DC009417 to KCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN ED, 1951, J PHYSL, V114, P61801; ALCORTA E, 1991, J NEUROPHYSIOL, V65, P702, DOI 10.1152/jn.1991.65.3.702; BAKER TC, 1984, PHYSIOL ENTOMOL, V9, P365, DOI 10.1111/j.1365-3032.1984.tb00777.x; BAKER TC, 1985, PHYSIOL ENTOMOL, V10, P257, DOI 10.1111/j.1365-3032.1985.tb00045.x; Barrozo RB, 2002, J INSECT PHYSIOL, V48, P825, DOI 10.1016/S0022-1910(02)00109-9; Bau J, 2005, CHEM SENSES, V30, P771, DOI 10.1093/chemse/bji069; Bau J, 2002, J INSECT PHYSIOL, V48, P433, DOI 10.1016/S0022-1910(02)00062-8; BELL CC, 1989, J NEUROSCI, V9, P1029; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BORST A, 1984, IDENTIFICATION DIFFE; Carde RT, 1996, CIBA F SYMP, V200, P54; Christensen TA, 1998, J NEUROSCI, V18, P5999; Daly KC, 2000, J EXP BIOL, V203, P2025; Daly KC, 2001, J INSECT PHYSIOL, V47, P375, DOI 10.1016/S0022-1910(00)00117-7; Daly KC, 2008, CHEM SENSES, V33, P95, DOI 10.1093/chemse/bjm068; Daly KC, 2007, BEHAV NEUROSCI, V121, P794, DOI 10.1037/0735-7044.121.4.794; Fadamiro HY, 1998, J INSECT BEHAV, V11, P549, DOI 10.1023/A:1022367430354; Goldman JA, 2002, J EXP BIOL, V205, P3891; Heinbockel T, 1999, J COMP NEUROL, V409, P1; HOMBERG U, 1991, J COMP NEUROL, V307, P647, DOI 10.1002/cne.903070410; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Justus KA, 2002, PHYSIOL ENTOMOL, V27, P58, DOI 10.1046/j.1365-3032.2002.00269.x; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; KAISSLING KE, 2013, J COMP PHYSL A; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Khan AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1712; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Lei H, 1999, J NEUROPHYSIOL, V81, P1113, DOI 10.1152/jn.1999.81.3.1113; Lemon WC, 1997, J EXP BIOL, V200, P1809; Loudon C, 2000, J EXP BIOL, V203, P2977; MCLEAN JH, 1987, J NEUROSCI, V7, P3029; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Reisenman CE, 2009, ANN NY ACAD SCI, V1170, P462, DOI 10.1111/j.1749-6632.2009.03875.x; Reisenman CE, 2005, J NEUROSCI, V25, P8017, DOI 10.1523/JNEUROSCI.1314-05.2005; Reisenman CE, 2004, J NEUROSCI, V24, P2602, DOI 10.1523/JNEUROSCI.5192-03.2004; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Sane SP, 2006, J EXP BIOL, V209, P32, DOI 10.1242/jeb.01957; Sane SP, 2006, J EXP BIOL, V209, P43, DOI 10.1242/jeb.01958; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; SMITH BH, 1994, J EXP BIOL, V195, P91; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tripathy SJ, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/neuro.03.001.2010; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; WILLEMSE LPM, 1994, J MED ENTOMOL, V31, P775, DOI 10.1093/jmedent/31.6.775; WILLIS MA, 1984, PHYSIOL ENTOMOL, V9, P341, DOI 10.1111/j.1365-3032.1984.tb00715.x; Willis MA, 2013, J COMP PHYSIOL A, V199, P1015, DOI 10.1007/s00359-013-0856-0; Willmott AP, 1997, J EXP BIOL, V200, P2705; Zhou Y, 2012, J NEUROPHYSIOL, V108, P2051, DOI 10.1152/jn.01146.2011	52	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81863	10.1371/journal.pone.0081863	http://dx.doi.org/10.1371/journal.pone.0081863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278463	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800144
J	Rubin, MA; Jones, M; Leecaster, M; Khader, K; Ray, W; Huttner, A; Huttner, B; Toth, D; Sablay, T; Borotkanics, RJ; Gerding, DN; Samore, MH				Rubin, Michael A.; Jones, Makoto; Leecaster, Molly; Khader, Karim; Ray, Willy; Huttner, Angela; Huttner, Benedikt; Toth, Damon; Sablay, Theodore; Borotkanics, Robert J.; Gerding, Dale N.; Samore, Matthew H.			A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HAND HYGIENE; CONTACT ISOLATION; INTENSIVE-CARE; IMPACT; COLONIZATION; DIAGNOSIS; ACQUISITION; GUIDELINES; ADMISSIONS	Background: Clostridium difficile is one of the most common and important nosocomial pathogens, causing severe gastrointestinal disease in hospitalized patients. Although "bundled" interventions have been proposed and promoted, optimal control strategies remain unknown. Methods: We designed an agent-based computer simulation of nosocomial C. difficile transmission and infection, which included components such as: patients and health care workers, and their interactions; room contamination via C. difficile shedding; C. difficile hand carriage and removal via hand hygiene; patient acquisition of C. difficile via contact with contaminated rooms or health care workers; and patient antimicrobial use. We then introduced six interventions, alone and "bundled" together: aggressive C. difficile testing; empiric isolation and treatment of symptomatic patients; improved adherence to hand hygiene and contact precautions; improved use of soap and water for hand hygiene; and improved environmental cleaning. All interventions were tested using values representing base-case, typical intervention, and optimal intervention scenarios. Findings: In the base-case scenario, C. difficile infection rates ranged from 8-21 cases/10,000 patient-days, with a case detection fraction between 32%-50%. Implementing the "bundle" at typical intervention levels had a large impact on C. difficile acquisition and infection rates, although intensifying the intervention to optimal levels had much less additional impact. Most of the impact came from improved hand hygiene and empiric isolation and treatment of suspected C. difficile cases. Conclusion: A "bundled" intervention is likely to reduce nosocomial C. difficile infection rates, even under typical implementation conditions. Real-world implementation of the "bundle" should focus on those components of the intervention that are likely to produce the greatest impact on C. difficile infection rates, such as hand hygiene and empiric isolation and treatment of suspected cases.	[Rubin, Michael A.; Jones, Makoto; Leecaster, Molly; Khader, Karim; Ray, Willy; Toth, Damon; Sablay, Theodore; Samore, Matthew H.] Vet Affairs Med Ctr, Dept Internal Med, George E Wahlen Dept, Salt Lake City, UT 84148 USA; [Rubin, Michael A.; Jones, Makoto; Leecaster, Molly; Sablay, Theodore; Samore, Matthew H.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Huttner, Angela; Huttner, Benedikt] Univ Hosp Geneva, Infect Control Program, Geneva, Switzerland; [Borotkanics, Robert J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Gerding, Dale N.] Vet Affairs Hosp, Dept Internal Med, Edward Hines Jr Dept, Hines, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rubin, MA (corresponding author), Vet Affairs Med Ctr, Dept Internal Med, George E Wahlen Dept, Salt Lake City, UT 84148 USA.	Michael.Rubin@hsc.utah.edu	Huttner, Benedikt/M-5616-2014; Huttner, Angela/AAM-1197-2020	Huttner, Benedikt/0000-0002-1749-9464; Huttner, Angela/0000-0002-8380-368X	GOJO Industries, Inc.; VA Health Services Research and Development Service [REA 08-264, VA HSR CDA 10-030-2]; U.S. Centers for Disease Control and Prevention (VA Epicenter) [CDC 07FED706506]	GOJO Industries, Inc.; VA Health Services Research and Development Service(US Department of Veterans Affairs); U.S. Centers for Disease Control and Prevention (VA Epicenter)	This study was supported with funding from GOJO Industries, Inc. (http://www.gojo.com/), the VA Health Services Research and Development Service (REA 08-264 and VA HSR CDA 10-030-2), and the U.S. Centers for Disease Control and Prevention (VA Epicenter, CDC 07FED706506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbett SK, 2009, INFECT CONT HOSP EP, V30, P1062, DOI 10.1086/644757; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Beggs CB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-64; BETTIN K, 1994, INFECT CONT HOSP EP, V15, P697; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cohen B, 2012, JT COMM J QUAL PATIE, V38, P560, DOI 10.1016/S1553-7250(12)38073-2; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Curry S, 2010, CLIN LAB MED, V30, P329, DOI 10.1016/j.cll.2010.04.001; D'Agata EMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030170; Duggan JM, 2008, INFECT CONT HOSP EP, V29, P534, DOI 10.1086/588164; Eckstein BC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-61; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Golan Y, 2006, CLIN INFECT DIS, V42, P370, DOI 10.1086/498906; Grima DT, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/605861; Hacek DM, 2010, AM J INFECT CONTROL, V38, P350, DOI 10.1016/j.ajic.2009.11.003; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; Hsu J, 2010, AM J GASTROENTEROL, V105, P2327, DOI 10.1038/ajg.2010.254; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kachrimanidou M, 2011, CRIT REV MICROBIOL, V37, P178, DOI 10.3109/1040841X.2011.556598; Kho AN, 2008, INT J MED INFORM, V77, P194, DOI 10.1016/j.ijmedinf.2007.02.005; Kundrapu S, 2012, CLIN INFECT DIS, V55, P1527, DOI 10.1093/cid/cis707; Lee BY, 2010, AM J PREV MED, V38, P247, DOI 10.1016/j.amepre.2009.11.009; McArdle FI, 2006, J HOSP INFECT, V62, P304, DOI 10.1016/j.jhin.2005.09.019; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McGlone SM, 2012, CLIN MICROBIOL INFEC, V18, P282, DOI 10.1111/j.1469-0691.2011.03571.x; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Perez J, 2005, AM J INFECT CONTROL, V33, P320, DOI 10.1016/j.ajic.2005.04.240; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Planche T, 2008, LANCET INFECT DIS, V8, P777, DOI 10.1016/S1473-3099(08)70233-0; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupp ME, 2008, INFECT CONT HOSP EP, V29, P8, DOI 10.1086/524333; Saint S, 2009, AM J INFECT CONTROL, V37, P306, DOI 10.1016/j.ajic.2008.08.004; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Speight S, 2011, J HOSP INFECT, V79, P18, DOI 10.1016/j.jhin.2011.05.016; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Sunenshine RH, 2006, CLEV CLIN J MED, V73, P187, DOI 10.3949/ccjm.73.2.187; Vonberg RP, 2008, J HOSP INFECT, V70, P15, DOI 10.1016/j.jhin.2008.05.004; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Wilcox MH, 1996, J HOSP INFECT, V34, P23, DOI 10.1016/S0195-6701(96)90122-X	53	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80671	10.1371/journal.pone.0080671	http://dx.doi.org/10.1371/journal.pone.0080671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278304	Green Published, gold			2022-12-27	WOS:000327539800080
J	Beck, I; Jochner, S; Gilles, S; McIntyre, M; Buters, JTM; Schmidt-Weber, C; Behrendt, H; Ring, J; Menzel, A; Traidl-Hoffmann, C				Beck, Isabelle; Jochner, Susanne; Gilles, Stefanie; McIntyre, Mareike; Buters, Jeroen T. M.; Schmidt-Weber, Carsten; Behrendt, Heidrun; Ring, Johannes; Menzel, Annette; Traidl-Hoffmann, Claudia			High Environmental Ozone Levels Lead to Enhanced Allergenicity of Birch Pollen	PLOS ONE			English	Article							AIR-POLLUTION; RELEASE; TEMPERATURE	Background: Evidence is compelling for a positive correlation between climate change, urbanisation and prevalence of allergic sensitisation and diseases. The reason for this association is not clear to date. Some data point to a pro-allergenic effect of anthropogenic factors on susceptible individuals. Objectives: To evaluate the impact of urbanisation and climate change on pollen allergenicity. Methods: Catkins were sampled from birch trees from different sites across the greater area of Munich, pollen were isolated and an urbanisation index, NO2 and ozone exposure were determined. To estimate pollen allergenicity, allergen content and pollen-associated lipid mediators were measured in aqueous pollen extracts. Immune stimulatory and modulatory capacity of pollen was assessed by neutrophil migration assays and the potential of pollen to inhibit dendritic cell interleukin-12 response. In vivo allergenicity was assessed by skin prick tests. Results: The study revealed ozone as a prominent environmental factor influencing the allergenicity of birch pollen. Enhanced allergenicity, as assessed in skin prick tests, was mirrored by enhanced allergen content. Beyond that, ozone induced changes in lipid composition and chemotactic and immune modulatory potential of the pollen. Higher ozone-exposed pollen was characterised by less immune modulatory but higher immune stimulatory potential. Conclusion: It is likely that future climate change along with increasing urbanisation will lead to rising ozone concentrations in the next decades. Our study indicates that ozone is a crucial factor leading to clinically relevant enhanced allergenicity of birch pollen. Thus, with increasing temperatures and increasing ozone levels, also symptoms of pollen allergic patients may increase further.	[Beck, Isabelle; Gilles, Stefanie; Buters, Jeroen T. M.; Schmidt-Weber, Carsten; Behrendt, Heidrun; Traidl-Hoffmann, Claudia] Tech Univ Munich, Helmholtz Ctr, ZAUM Ctr Allergy & Environm, D-80290 Munich, Germany; [Jochner, Susanne; Menzel, Annette] Tech Univ Munich, Dept Ecol & Ecosyst Management, Freising Weihenstephan, Germany; [McIntyre, Mareike; Ring, Johannes; Traidl-Hoffmann, Claudia] Tech Univ Munich, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Gilles, Stefanie; Behrendt, Heidrun; Traidl-Hoffmann, Claudia] Christine Kuhne Ctr Allergy Res & Educ CK Care, Davos, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich	Traidl-Hoffmann, C (corresponding author), Tech Univ Munich, Helmholtz Ctr, ZAUM Ctr Allergy & Environm, D-80290 Munich, Germany.	claudia.traidl-hoffmann@lrz.tu-muenchen.de	Gilles-Stein, Stefanie/AAA-3741-2021; Jochner-Oette, Susanne/D-4201-2017; Ring, Johannes/GLN-4341-2022; BUTERS, JEROEN/AAF-6949-2020; Schmidt-Weber, Carsten B./AAU-1621-2021; Buters, Jeroen T/G-5070-2011; Menzel, Annette/B-1105-2013	Gilles-Stein, Stefanie/0000-0002-5159-2558; Ring, Johannes/0000-0001-8236-3152; Schmidt-Weber, Carsten B./0000-0002-3203-8084; Menzel, Annette/0000-0002-7175-2512; Buters, Jeroen/0000-0003-3581-5472; Traidl-Hoffmann, Claudia/0000-0001-5085-5179; Jochner-Oette, Susanne/0000-0002-5371-9516	German Research Council (Deutsche Forschunsgemeinschaft, DFG) [TR467/5-1, ME 179/3-1]; Technische Universitat Munchen; CK Care, Christine Kuhne Center for Allergy Research and Education	German Research Council (Deutsche Forschunsgemeinschaft, DFG); Technische Universitat Munchen; CK Care, Christine Kuhne Center for Allergy Research and Education	The study was supported by a grant of the German Research Council (Deutsche Forschunsgemeinschaft, DFG, TR467/5-1 and ME 179/3-1) (CTH and AM), the HWP grant from of the Technische Universitat Munchen (SG), and CK Care, Christine Kuhne Center for Allergy Research and Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1995, BRIT J PHARMACOL, V116, P2903, DOI 10.1111/j.1476-5381.1995.tb15943.x; Behrendt H, 1997, INT ARCH ALLERGY IMM, V113, P69, DOI 10.1159/000237511; Behrendt H, 2002, NEW TRENDS IN ALLERGY V, P3; Behrendt H, 2001, INT ARCH ALLERGY IMM, V124, P121, DOI 10.1159/000053688; Behrendt H, 1995, PROG ALLER CLIN IMM, V3, P83; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Buters JTM, 2008, INT ARCH ALLERGY IMM, V145, P122, DOI 10.1159/000108137; Darbah JNT, 2007, THESCIENTIFICWORLDJO, V7, P240, DOI 10.1100/tsw.2007.42; Diaz-Sanchez D, 2005, AM J PHYSIOL-LUNG C, V289, pL722, DOI 10.1152/ajplung.00217.2005; Eckl-Dorna J, 2010, J ALLERGY CLIN IMMUN, V126, P1315, DOI 10.1016/j.jaci.2010.06.012; Gilles S, 2012, CURRENT PHARM DESIGN; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Gilles Stefanie, 2009, Allergy Asthma Clin Immunol, V5, P3, DOI 10.1186/1710-1492-5-3; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Health Effects Institute B MA, 2010, 17 HEI; Heinrich J, 2004, CURR OPIN ALLERGY CL, V4, P341, DOI 10.1097/00130832-200410000-00003; Helander ML, 1997, ALLERGY, V52, P1207, DOI 10.1111/j.1398-9995.1997.tb02525.x; Hjelmroos M, 1995, INT ARCH ALLERGY APP, V108; Jochner SC, 2011, CLIM RES, V49, P101, DOI 10.3354/cr01022; Kanter U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061518; Kramer U, 2000, EPIDEMIOLOGY, V11, P64, DOI 10.1097/00001648-200001000-00014; Meier U., 2001, BBCH MONOGRAPH, P165; PALMES ED, 1976, AM IND HYG ASSOC J, V37, P570, DOI 10.1080/0002889768507522; Ring J, 2001, ANN ALLERG ASTHMA IM, V87, P2, DOI 10.1016/S1081-1206(10)62332-0; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Sillman S, 1999, ATMOSPHERIC ENV, V33; Stathopoulou E, 2008, J EARTH SYST SCI, V117, P227, DOI 10.1007/s12040-008-0027-9; Strachan DP, 1999, LANCET, V353, P1457, DOI 10.1016/S0140-6736(99)90038-7; Tashpulatov AS, 2004, INT ARCH ALLERGY IMM, V134, P1, DOI 10.1159/000077527; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Traidl-Hoffmann C, 2002, J ALLERGY CLIN IMMUN, V109, P831, DOI 10.1067/mai.2002.124655; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	33	85	87	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80147	10.1371/journal.pone.0080147	http://dx.doi.org/10.1371/journal.pone.0080147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278250	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100076
J	Raschi, E; Poluzzi, E; Godman, B; Koci, A; Moretti, U; Kalaba, M; Bennie, M; Barbui, C; Wettermark, B; Sturkenboom, M; De Ponti, F				Raschi, Emanuel; Poluzzi, Elisabetta; Godman, Brian; Koci, Ariola; Moretti, Ugo; Kalaba, Marija; Bennie, Marion; Barbui, Corrado; Wettermark, Bjorn; Sturkenboom, Miriam; De Ponti, Fabrizio			Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe	PLOS ONE			English	Article							TORSADES-DE-POINTES; ATYPICAL ANTIPSYCHOTICS; PSYCHIATRIC DRUGS; TRENDS; SCHIZOPHRENIA; PATTERNS; SYSTEM; PRESCRIPTION; MEDICATIONS; COUNTRIES	Background: Antipsychotics (APs) have been associated with risk of torsade de Pointes (TdP). This has important public health implications. Therefore, (a) we exploited the public FDA Adverse Event Reporting System (FAERS) to characterize their torsadogenic profile; (b) we collected drug utilization data from 12 European Countries to assess the population exposure over the 2005-2010 period. Methods: FAERS data (2004-2010) were analyzed based on the following criteria: (1) >= 4 cases of TdP/QT abnormalities; (2) Significant Reporting Odds Ratio, ROR [Lower Limit of the 95% confidence interval>1], for TdP/QT abnormalities, adjusted and stratified (Arizona CERT drugs as effect modifiers); (3) >= 4 cases of ventricular arrhythmia/sudden cardiac death (VA/SCD); (4) Significant ROR for VA/SCD; (5) Significant ROR, combined by aggregating TdP/QT abnormalities with VA and SCD. Torsadogenic signals were characterized in terms of signal strength: from Group A (very strong torsadogenic signal: all criteria fulfilled) to group E (unclear/uncertain signal: only 2/5 criteria). Consumption data were retrieved from 12 European Countries and expressed as defined daily doses per 1,000 inhabitants per day (DID). Results: Thirty-five antipsychotics met at least one criterium: 9 agents were classified in Group A (amisulpride, chlorpromazine, clozapine, cyamemazine, haloperidol, olanzapine, quetiapine, risperidone, ziprasidone). In 2010, the overall exposure to antipsychotics varied from 5.94 DID (Estonia) to 13.99 (France, 2009). Considerable increment of Group A agents was found in several Countries (+3.47 in France): the exposure to olanzapine increased across all Countries (+1.84 in France) and peaked 2.96 in Norway; cyamemazine was typically used only in France (2.81 in 2009). Among Group B drugs, levomepromazine peaked 3.78 (Serbia); fluphenazine 1.61 (Slovenia). Conclusions: This parallel approach through spontaneous reporting and drug utilization analyses highlighted drug- and Country-specific scenarios requiring potential regulatory consideration: levomepromazine (Serbia), fluphenazine (Slovenia), olanzapine (across Europe), cyamemazine (France). This synergy should be encouraged to support future pharmacovigilance activities.	[Raschi, Emanuel; Poluzzi, Elisabetta; Koci, Ariola; De Ponti, Fabrizio] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Godman, Brian; Wettermark, Bjorn] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden; [Godman, Brian; Bennie, Marion] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Moretti, Ugo] Univ Verona, Clin Pharmacol Unit, I-37100 Verona, Italy; [Kalaba, Marija] Republ Inst Hlth Insurance, Belgrade, Serbia; [Bennie, Marion] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Barbui, Corrado] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med, Sect Psychiat, I-37100 Verona, Italy; [Wettermark, Bjorn] Karolinska Univ Hosp, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Sturkenboom, Miriam] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	University of Bologna; Karolinska Institutet; University of Strathclyde; University of Verona; NHS National Services Scotland; University of Verona; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	De Ponti, F (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.	fabrizio.deponti@unibo.it	Godman, Brian/R-8897-2019; De Ponti, Fabrizio/H-8701-2019; Raschi, Emanuel/H-8821-2019	De Ponti, Fabrizio/0000-0002-0367-9595; Raschi, Emanuel/0000-0003-0487-7996; POLUZZI, ELISABETTA/0000-0002-7209-0426	European Community [241679]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241679 - the ARITMO project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2012, DRUG SAFETY, V35, P1171, DOI 10.2165/11631940-000000000-00000; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Anderson N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025221; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bennie M, 2013, INT J CLIN PRACT, V67, P170, DOI 10.1111/ijcp.12100; Bret MC, 2007, PHARM WORLD SCI, V29, P551, DOI 10.1007/s11096-007-9107-1; Cha DS, 2012, EXPERT OPIN PHARMACO, V13, P1587, DOI 10.1517/14656566.2012.656590; Comer JS, 2011, AM J PSYCHIAT, V168, P1057, DOI 10.1176/appi.ajp.2011.11010087; Diatta T, 2007, FUND CLIN PHARMACOL, V21, P371, DOI 10.1111/j.1472-8206.2007.00492.x; Divac N, 2006, PHARMACOEPIDEM DR S, V15, P835, DOI 10.1002/pds.1316; Dorsey ER, 2010, ARCH INTERN MED, V170, P96, DOI 10.1001/archinternmed.2009.456; Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; Fourrier A, 2000, BRIT J CLIN PHARMACO, V49, P80, DOI 10.1046/j.1365-2125.2000.00108.x; Furst J, 2003, PHARMACOEPIDEM DR S, V12, P399, DOI 10.1002/pds.826; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Godman B, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00198; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Hartling L, 2012, ANN INTERN MED, V157, P498, DOI 10.7326/0003-4819-157-7-201210020-00525; Hauben M, 2009, DRUG DISCOV TODAY, V14, P343, DOI 10.1016/j.drudis.2008.12.012; Hochberg AM, 2009, CLIN PHARMACOL THER, V85, P600, DOI 10.1038/clpt.2009.26; Hoffman KB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042866, DOI 10.1371/J0URNAL.P0NE.0042866.PUBMED:22936996]; Jolly K, 2009, BRIT J CLIN PHARMACO, V68, P743, DOI 10.1111/j.1365-2125.2009.03496.x; Kalaba M, 2012, J COMP EFFECT RES, V1, P539, DOI [10.2217/CER.12.62, 10.2217/cer.12.62]; Kales HC, 2011, ARCH GEN PSYCHIAT, V68, P190, DOI 10.1001/archgenpsychiatry.2010.200; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mann Eva, 2009, BMC Geriatr, V9, P18, DOI 10.1186/1471-2318-9-18; Meyer-Massetti C, 2011, INT J CLIN PHARM-NET, V33, P806, DOI 10.1007/s11096-011-9541-y; Meyer-Massetti Carla, 2010, J Hosp Med, V5, pE8, DOI 10.1002/jhm.691; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Muzyk AJ, 2012, DRUG SAFETY, V35, P725, DOI 10.2165/11631460-000000000-00000; Muzyk AJ, 2012, DRUG SAFETY, V35, P547, DOI 10.2165/11599960-000000000-00000; NICE (National Institute for Health and Clinical Excellence), 2009, NICE CLIN GUID 82; Nose M, 2008, INT CLIN PSYCHOPHARM, V23, P287, DOI 10.1097/YIC.0b013e328303ac75; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Poluzzi E, 2013, DRUG SAFETY, V36, P467, DOI 10.1007/s40264-013-0032-z; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Poluzzi E, 2009, PHARMACOEPIDEM DR S, V18, P512, DOI 10.1002/pds.1746; Raschi E, 2013, ACTA DIABETOL, V50, P569, DOI 10.1007/s00592-011-0340-7; Raschi E, 2013, J PHARMACOVIGIL, V1, DOI [DOI 10.4172/2329-6887.1000104, 10.4172/2329-6887.1000104]; Raschi E, 2009, BRIT J CLIN PHARMACO, V67, P88, DOI 10.1111/j.1365-2125.2008.03319.x; Ravera S, 2009, EUR J CLIN PHARMACOL, V65, P1139, DOI 10.1007/s00228-009-0695-7; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Richter T, 2012, COCHRANE DB SYST REV, V12; Roden DM, 1998, PACE, V21, P1029, DOI 10.1111/j.1540-8159.1998.tb00148.x; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Srba J, 2012, EUR J CLIN PHARMACOL, V68, P1057, DOI 10.1007/s00228-012-1219-4; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Stephenson WP, 2007, PHARMACOEPIDEM DR S, V16, P359, DOI 10.1002/pds.1323; Titier K, 2005, DRUG SAFETY, V28, P35, DOI 10.2165/00002018-200528010-00003; Valiyeva E, 2008, CAN MED ASSOC J, V179, P438, DOI 10.1503/cmaj.071540; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Wettermark B, 2008, DRUG UTILIZATION RES, P159; WHO, 2003, INTR DRUG UT RES; Wladysiuk M, 2011, APPL HEALTH ECON HEA, V9, P101, DOI 10.2165/11318840-000000000-00000	57	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81208	10.1371/journal.pone.0081208	http://dx.doi.org/10.1371/journal.pone.0081208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278396	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327313100145
J	Shimada, Y; Kinoshita, M; Harada, K; Mizutani, M; Masahata, K; Kayama, H; Takeda, K				Shimada, Yosuke; Kinoshita, Makoto; Harada, Kazuo; Mizutani, Masafumi; Masahata, Kazunori; Kayama, Hisako; Takeda, Kiyoshi			Commensal Bacteria-Dependent Indole Production Enhances Epithelial Barrier Function in the Colon	PLOS ONE			English	Article							GUT MICROBIOTA; TIGHT-JUNCTION; TRANSCRIPTION FACTOR; INDOXYL SULFATE; MUCOSAL BARRIER; GERM-FREE; INFLAMMATION; CELLS; SULFOTRANSFERASES; 7-HYDROXYINDOLE	Microbiota have been shown to have a great influence on functions of intestinal epithelial cells (ECs). The role of indole as a quorum-sensing (QS) molecule mediating intercellular signals in bacteria has been well appreciated. However, it remains unknown whether indole has beneficial effects on maintaining intestinal barriers in vivo. In this study, we analyzed the effect of indole on ECs using a germ free (GF) mouse model. GF mice showed decreased expression of junctional complex molecules in colonic ECs. The feces of specific pathogen-free (SPF) mice contained a high amount of indole; however the amount was significantly decreased in the feces of GF mice by 27-fold. Oral administration of indole-containing capsules resulted in increased expression of both tight junction (TJ)- and adherens junction (AJ)-associated molecules in colonic ECs in GF mice. In accordance with the increased expression of these junctional complex molecules, GF mice given indole-containing capsules showed higher resistance to dextran sodium sulfate (DSS)-induced colitis. A similar protective effect of indole on DSS-induced epithelial damage was also observed in mice bred in SPF conditions. These findings highlight the beneficial role of indole in establishing an epithelial barrier in vivo.	[Shimada, Yosuke; Kinoshita, Makoto; Masahata, Kazunori; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Lab Immune Regulat, Osaka, Japan; [Shimada, Yosuke; Kinoshita, Makoto; Masahata, Kazunori; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Mucosal Immunol, Osaka, Japan; [Kinoshita, Makoto; Kayama, Hisako; Takeda, Kiyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Harada, Kazuo] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Mizutani, Masafumi] Morishita Jintan Co Ltd, Osaka Techno Ctr, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Takeda, K (corresponding author), Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Lab Immune Regulat, Osaka, Japan.	ktakeda@ongene.med.osaka-u.ac.jp	MASAHATA, KAZUNORI/AAU-4482-2021; Takeda, Kiyoshi/C-9331-2009	HARADA, Kazuo/0000-0002-9348-1629; Takeda, Kiyoshi/0000-0002-1778-6332; Masahata, Kazunori/0000-0002-8539-8235	Ministry of Education, Culture, Sports, Science and Technology [24390120]; Ministry of Health, Labour and Welfare; Osaka Foundation for the Promotion of Clinical Immunology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Osaka Foundation for the Promotion of Clinical Immunology	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (24390120); the Ministry of Health, Labour and Welfare; and the Osaka Foundation for the Promotion of Clinical Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoglu E, 2002, EUR J DRUG METAB PH, V27, P135, DOI 10.1007/BF03190428; Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chen J, 2008, MOL BIOL CELL, V19, P3701, DOI 10.1091/mbc.E08-02-0175; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kim MH, 2013, GASTROENTEROLOGY; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Konishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2297, DOI 10.1271/bbb.67.2297; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee J, 2007, APPL ENVIRON MICROB, V73, P4100, DOI 10.1128/AEM.00360-07; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Li N, 2009, J NUTR, V139, P710, DOI 10.3945/jn.108.101485; Lukas F, 2008, FOLIA MICROBIOL, V53, P221, DOI 10.1007/s12223-008-0030-1; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; ROSENBERG DW, 1994, CARCINOGENESIS, V15, P73, DOI 10.1093/carcin/15.1.73; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879; Smith P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030273; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Taki K, 2005, J RENAL NUTR, V15, P77, DOI 10.1053/j.jrn.2004.09.028; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Teubner W, 2007, BIOCHEM J, V404, P207, DOI 10.1042/BJ20061431; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	41	99	104	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80604	10.1371/journal.pone.0080604	http://dx.doi.org/10.1371/journal.pone.0080604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278294	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100094
J	Khanna, RC; Murthy, GVS; Giridhar, P; Krishnaiah, S; Pant, HB; Shantha, GPS; Chakrabarti, S; Gilbert, C; Rao, GN				Khanna, Rohit C.; Murthy, Gudlavalleti V. S.; Giridhar, Pyda; Krishnaiah, Sannapaneni; Pant, Hira B.; Shantha, Ghanshyam Palamaner Subash; Chakrabarti, Subhabrata; Gilbert, Clare; Rao, Gullapalli N.			Cataract, Visual Impairment and Long-Term Mortality in a Rural Cohort in India: The Andhra Pradesh Eye Disease Study	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; LENS OPACITIES; POPULATION; SURVIVAL; RISK; ASSOCIATION; BLINDNESS; CLASSIFICATION; INPATIENT; SYSTEM	Background: A large-scale prevalence survey of blindness and visual impairment (The Andhra Pradesh Eye Diseases Study [APEDS1]) was conducted between 1996-2000 on 10,293 individuals of all ages in three rural and one urban clusters in Andhra Pradesh, Southern India. More than a decade later (June 2009-March 2010), APEDS1 participants in rural clusters were traced (termed APEDS2) to determine ocular risk factors for mortality in this longitudinal cohort. Methods and Findings: Mortality hazard ratio (HR) analysis was performed for those aged >= 30 years at APEDS1, using Cox proportional hazard regression models to identify associations between ocular exposures and risk of mortality. Blindness and visual impairment (VI) were defined using Indian definitions. 799/4,188 (19.1%) participants had died and 308 (7.3%) had migrated. Mortality was higher in males than females (p<0.001). In multivariable analysis, after adjusting for age, gender, diabetes, hypertension, body mass index, smoking and education status the mortality HR was 1.9 (95% CI: 1.5-2.5) for blindness; 1.4 (95% CI: 1.2-1.7) for VI; 1.8 (95% CI: 1.4-2.3) for pure nuclear cataract, 1.5 (95% CI: 1.1-2.1) for pure cortical cataract; 1.96 (95% CI: 1.6-2.4) for mixed cataract, 2.0 (95% CI: 1.4-2.9) for history of cataract surgery, and 1.58 (95% CI: 1.3-1.9) for any cataract. When all these factors were included in the model, the HRs were attenuated, being 1.5 (95% CI: 1.1-2.0) for blindness and 1.2 (95% CI: 0.9-1.5) for VI. For lens type, the HRs were as follows: pure nuclear cataract, 1.6 (95% CI: 1.3-2.1); pure cortical cataract, 1.5 (95% CI: 1.1-2.1); mixed cataract, 1.8 (95% CI: 1.4-2.2), and history of previous cataract surgery, 1.8 (95% CI: 1.3-2.6). Conclusions: All types of cataract, history of cataract surgery and VI had an increased risk of mortality that further suggests that these could be potential markers of ageing.	[Khanna, Rohit C.; Giridhar, Pyda; Krishnaiah, Sannapaneni; Rao, Gullapalli N.] LV Prasad Eye Inst, Int Ctr Adv Rural Eye care, Allen Foster Res Ctr Community Eye Hlth, Hyderabad, Andhra Pradesh, India; [Khanna, Rohit C.; Giridhar, Pyda; Krishnaiah, Sannapaneni; Chakrabarti, Subhabrata; Rao, Gullapalli N.] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Murthy, Gudlavalleti V. S.; Gilbert, Clare] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England; [Murthy, Gudlavalleti V. S.; Pant, Hira B.] Indian Inst Publ Hlth, Hyderabad, Andhra Pradesh, India; [Shantha, Ghanshyam Palamaner Subash] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Shantha, Ghanshyam Palamaner Subash] Wright Ctr Grad Med Educ, Dept Internal Med, Scranton, PA USA	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanna, RC (corresponding author), LV Prasad Eye Inst, Int Ctr Adv Rural Eye care, Allen Foster Res Ctr Community Eye Hlth, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org	Chakrabarti, Subhabrata/F-2468-2015	Chakrabarti, Subhabrata/0000-0003-3717-4963	Sightsavers International	Sightsavers International	The work was supported by Sightsavers International. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BENSON WH, 1988, OPHTHALMOLOGY, V95, P1288; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Borger PH, 2003, OPHTHALMOLOGY, V110, P1292, DOI 10.1016/S0161-6420(03)00450-0; Buch H, 2005, OPHTHALMOLOGY, V112, P305, DOI 10.1016/j.ophtha.2004.08.025; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; COX DR, 1972, J R STAT SOC B, V34, P187; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Dandona L, 1998, LANCET, V351, P1312, DOI 10.1016/S0140-6736(97)09509-3; Dandona L, 1999, OPHTHALMOLOGY, V106, P497, DOI 10.1016/S0161-6420(99)90107-0; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dandona Rakhi, 1997, Indian Journal of Ophthalmology, V45, P251; Foong AWP, 2008, OPHTHALMOLOGY, V115, P802, DOI 10.1016/j.ophtha.2007.04.066; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hennis A, 2001, OPHTHALMOLOGY, V108, P498, DOI 10.1016/S0161-6420(00)00542-X; HIRSCH RP, 1983, ARCH OPHTHALMOL-CHIC, V101, P1034; Hu FB, 2001, AM J EPIDEMIOL, V153, P875, DOI 10.1093/aje/153.9.875; Klein BEK, 2005, ARCH GERONTOL GERIAT, V41, P141, DOI 10.1016/j.archger.2005.01.002; Klein BEK, 1998, OPHTHALMOLOGY, V105, P160, DOI 10.1016/S0161-6420(98)91911-X; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P333, DOI 10.1001/archopht.1995.01100030089026; Knudsen EB, 1999, ACTA OPHTHALMOL SCAN, V77, P99, DOI 10.1034/j.1600-0420.1999.770122.x; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Krishnaiah S, 2007, CLIN OPHTHALMOL, V1, P475; Li ZJ, 2011, OPHTHAL EPIDEMIOL, V18, P54, DOI 10.3109/09286586.2010.545503; McCarty CA, 2001, BRIT J OPHTHALMOL, V85, P322, DOI 10.1136/bjo.85.3.322; Meddings DR, 1999, EPIDEMIOLOGY, V10, P288, DOI 10.1097/00001648-199905000-00017; MINASSIAN DC, 1984, LANCET, V1, P751; NinnPedersen K, 1995, BRIT J OPHTHALMOL, V79, P1115, DOI 10.1136/bjo.79.12.1115; Nucci C, 2004, GRAEF ARCH CLIN EXP, V242, P289, DOI 10.1007/s00417-003-0837-z; Pathai S, 2013, AGEING RES REV, V12, P490, DOI 10.1016/j.arr.2012.11.002; PODGOR MJ, 1985, NEW ENGL J MED, V313, P1438, DOI 10.1056/NEJM198512053132303; Reidy A, 2002, BRIT J OPHTHALMOL, V86, P424, DOI 10.1136/bjo.86.4.424; Rumsfeld JS, 2005, AM HEART J, V150, P961, DOI 10.1016/j.ahj.2005.02.036; StataCorp, 2021, STATA STAT SOFTWARE; STREET DA, 1992, AM J OPHTHALMOL, V113, P263, DOI 10.1016/S0002-9394(14)71577-6; Taylor H R, 1988, Yan Ke Xue Bao, V4, P14; TAYLOR HR, 1991, B WORLD HEALTH ORGAN, V69, P335; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Thiagarajan M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1397, DOI 10.1001/archopht.123.10.1397; THOMPSON JR, 1993, ARCH OPHTHALMOL-CHIC, V111, P675, DOI 10.1001/archopht.1993.01090050109039; Wang JJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1186, DOI 10.1001/archopht.119.8.1186; Wang JJ, 1999, INVEST OPHTH VIS SCI, V40, P12; West SK, 2000, ARCH OPHTHALMOL-CHIC, V118, P393, DOI 10.1001/archopht.118.3.393; Williams SL, 2002, AM J EPIDEMIOL, V156, P127, DOI 10.1093/aje/kwf012; World Health Organization, 2006, GLOB DAT BOD MASS IN; Xu L, 2009, OPHTHALMOLOGY, V116, P732, DOI 10.1016/j.ophtha.2008.11.003	49	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e78002	10.1371/journal.pone.0078002	http://dx.doi.org/10.1371/journal.pone.0078002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24282482	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326155400067
J	Barrett, B; Waheed, W; Farrelly, S; Birchwood, M; Dunn, G; Flach, C; Henderson, C; Leese, M; Lester, H; Marshall, M; Rose, D; Sutherby, K; Szmukler, G; Thornicroft, G; Byford, S				Barrett, Barbara; Waheed, Waquas; Farrelly, Simone; Birchwood, Max; Dunn, Graham; Flach, Clare; Henderson, Claire; Leese, Morven; Lester, Helen; Marshall, Max; Rose, Diana; Sutherby, Kim; Szmukler, George; Thornicroft, Graham; Byford, Sarah			Randomised Controlled Trial of Joint Crisis Plans to Reduce Compulsory Treatment for People with Psychosis: Economic Outcomes	PLOS ONE			English	Article							DECISION-MAKING APPROACH; COST-EFFECTIVENESS; ETHNIC-DIFFERENCES; BLACK-PEOPLE; HEALTH; COMMUNITY; COERCION; DISEASE; ILLNESS; GUIDE	Background: Compulsory admission to psychiatric hospitals may be distressing, disruptive to patients and families, and associated with considerable cost to the health service. Improved patient experience and cost reductions could be realised by providing cost-effective crisis planning services. Methods: Economic evaluation within a multi-centre randomised controlled trial comparing Joint Crisis Plans (JCP) plus treatment as usual (TAU) to TAU alone for patients aged over 16, with at least one psychiatric hospital admission in the previous two years and on the Enhanced Care Programme Approach register. JCPs, containing the patient's treatment preferences for any future psychiatric emergency, are a form of crisis intervention that aim to mitigate the negative consequences of relapse, including hospital admission and use of coercion. Data were collected at baseline and 18-months after randomisation. The primary outcome was admission to hospital under the Mental Health Act. The economic evaluation took a service perspective (health, social care and criminal justice services) and a societal perspective (additionally including criminal activity and productivity losses). Findings: The addition of JCPs to TAU had no significant effect on compulsory admissions or total societal cost per participant over 18-months follow-up. From the service cost perspective, however, evidence suggests a higher probability (80%) of JCPs being the more cost-effective option. Exploration by ethnic group highlights distinct patterns of costs and effects. Whilst the evidence does not support the cost-effectiveness of JCPs for White or Asian ethnic groups, there is at least a 90% probability of the JCP intervention being the more cost-effective option in the Black ethnic group. Interpretation: The results by ethnic group are sufficiently striking to warrant further investigation into the potential for patient gain from JCPs among black patient groups.	[Barrett, Barbara; Farrelly, Simone; Henderson, Claire; Leese, Morven; Rose, Diana; Sutherby, Kim; Szmukler, George; Thornicroft, Graham; Byford, Sarah] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London, England; [Waheed, Waquas; Marshall, Max] Univ Manchester, Sch Med, Div Psychiat, Manchester, Lancs, England; [Birchwood, Max] Univ Birmingham, Dept Psychol, Birmingham, W Midlands, England; [Dunn, Graham; Flach, Clare] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Lester, Helen] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of London; King's College London; University of Manchester; University of Birmingham; University of Manchester; University of Birmingham	Barrett, B (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London, England.	barbara.m.barrett@kcl.ac.uk	Thornicroft, Graham/B-4027-2010; Rose, Diana S/D-1387-2010; Rose, Diana/HGE-8574-2022; Birchwood, Max/E-3474-2017; Barrett, Barbara M/F-7606-2010; Henderson, Claire/E-4664-2010; Byford, Sarah/D-1699-2010	Thornicroft, Graham/0000-0003-0662-0879; Rose, Diana S/0000-0002-6393-6389; Birchwood, Max/0000-0002-7476-0171; Barrett, Barbara M/0000-0002-0270-6256; Henderson, Claire/0000-0002-6998-5659; Byford, Sarah/0000-0001-7084-1495; Flach, Clare/0000-0002-3128-0952; Flach, Clare/0000-0001-7836-1744; Farrelly, Simone/0000-0001-8991-6178	UK Medical Research Council; National Institute for Health Research (NIHR); NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry; King's College London; King's College South London; Maudsley NHS Foundation Trust; Guy's and St Thomas's Charitable Trust; Big Lottery Fund; Comic Relief; National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC); Medical Research Council (MRC); Medical Research Council [G0601660] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10053] Funding Source: researchfish; MRC [G0601660] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry; King's College London; King's College South London; Maudsley NHS Foundation Trust; Guy's and St Thomas's Charitable Trust; Big Lottery Fund; Comic Relief; National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC)(National Institute for Health Research (NIHR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council (www.mrc.ac.uk). Excess treatment costs were provided by the National Institute for Health Research. GT, DR, and CH are funded in relation to a National Institute for Health Research (NIHR) Applied Programme grant awarded to the South London and Maudsley NHS Foundation Trust (GT), and in relation to the NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London, and the South London and Maudsley NHS Foundation Trust. CH is funded by a grant from Guy's and St Thomas's Charitable Trust and a grant from the Big Lottery Fund and Comic Relief. MB is partially-funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC-BBC). This report is independent research funded by the Medical Research Council (MRC) and managed by the NIHR on behalf of the MRC-NIHR partnership. The views expressed in this publication are those of the authors and not necessarily those of the MRC, National Health Service, NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afuwape SA, 2010, J AFFECT DISORDERS, V127, P370, DOI 10.1016/j.jad.2010.05.017; [Anonymous], 2008, GUID METH TECHN APPR; [Anonymous], MENT HLTH RES REV; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Bedfordshire Police Authority, 2011, 2011 2012 FEES CHARG; Bennewith O, 2010, BRIT J PSYCHIAT, V196, P75, DOI 10.1192/bjp.bp.109.068890; Bhugra D, 2011, EPIDEMIOL PSYCH SCI, V20, P83, DOI 10.1017/S2045796011000151; Byford S, 2000, BRIT J PSYCHIAT, V176, P537, DOI 10.1192/bjp.176.6.537; Byford S, 2003, PSYCHOL MED, V33, P977, DOI 10.1017/S0033291703008183; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health, 1991, CAR PROGR APPROACH; Department of Health, 2011, REF COSTS 2010; Department of Health, 2012, DEP HLTH INF CTR STA; Drummond MF, 2015, METHODS EC EVALUATIO; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Flood C, 2006, BRIT MED J, V333, P729, DOI 10.1136/bmj.38929.653704.55; Henderson C, 2004, BRIT MED J, V329, P136, DOI 10.1136/bmj.38155.585046.63; Henderson C, 2009, SOC PSYCH PSYCH EPID, V44, P369, DOI 10.1007/s00127-008-0442-x; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Kisely S, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004101.pub2, 10.1002/14651858.CD004408.pub2]; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Koopmanschap MA, 1996, PHARMACOECONOMICS, V10, P460, DOI 10.2165/00019053-199610050-00003; Lawlor C, 2012, INT J SOC PSYCHIATR, V58, P3, DOI 10.1177/0020764010382369; Lawton-Smith M, 2008, COST MENTAL HLTH CAR; Mohseni M, 2008, ETHNIC HEALTH, V13, P417, DOI 10.1080/13557850802009603; Parkman S, 1997, BRIT J PSYCHIAT, V171, P260, DOI 10.1192/bjp.171.3.260; Royal Pharmaceutical Society of Great Britain, 2010, BRIT NAT FORM 60; Sutherby K, 1999, ACTA PSYCHIAT SCAND, V100, P56, DOI 10.1111/j.1600-0447.1999.tb10914.x; Sutherby K, 1998, PSYCHIAT B, V22, P4; Thornicroft G, 2013, LANCET, V381, P1634, DOI 10.1016/S0140-6736(13)60105-1; Thornicroft G, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-102; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505	35	20	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e74210	10.1371/journal.pone.0074210	http://dx.doi.org/10.1371/journal.pone.0074210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282495	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500001
J	Harris, GM; Shazly, T; Jabbarzadeh, E				Harris, Greg M.; Shazly, Tarek; Jabbarzadeh, Ehsan			Deciphering the Combinatorial Roles of Geometric, Mechanical, and Adhesion Cues in Regulation of Cell Spreading	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; MICROPATTERNED SURFACES; FOCAL ADHESIONS; STIFFNESS; DIFFERENTIATION; SHAPE; HYDROGELS; FORCE; MECHANOTRANSDUCTION	Significant effort has gone towards parsing out the effects of surrounding microenvironment on macroscopic behavior of stem cells. Many of the microenvironmental cues, however, are intertwined, and thus, further studies are warranted to identify the intricate interplay among the conflicting downstream signaling pathways that ultimately guide a cell response. In this contribution, by patterning adhesive PEG (polyethylene glycol) hydrogels using Dip Pen Nanolithography (DPN), we demonstrate that substrate elasticity, subcellular elasticity, ligand density, and topography ultimately define mesenchymal stem cells (MSCs) spreading and shape. Physical characteristics are parsed individually with 7 kilopascal (kPa) hydrogel islands leading to smaller, spindle shaped cells and 105 kPa hydrogel islands leading to larger, polygonal cell shapes. In a parallel effort, a finite element model was constructed to characterize and confirm experimental findings and aid as a predictive tool in modeling cell microenvironments. Signaling pathway inhibition studies suggested that RhoA is a key regulator of cell response to the cooperative effect of the tunable substrate variables. These results are significant for the engineering of cell-extra cellular matrix interfaces and ultimately decoupling matrix bound cues presented to cells in a tissue microenvironment for regenerative medicine.	[Harris, Greg M.; Jabbarzadeh, Ehsan] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA; [Shazly, Tarek] Univ S Carolina, Dept Mech Engn, Columbia, SC 29208 USA; [Shazly, Tarek; Jabbarzadeh, Ehsan] Univ S Carolina, Dept Biomed Engn, Columbia, SC 29208 USA; [Jabbarzadeh, Ehsan] Univ S Carolina, Dept Orthopaed Surg, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Jabbarzadeh, E (corresponding author), Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.	jabbarza@cec.sc.edu	Harris, Greg M./R-3910-2017	Harris, Greg M./0000-0001-5594-9780	National Institute of Health [NIH P20 GM103641]; National Science Foundation [EPS-0903795]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support from the National Institute of Health (Grant NIH P20 GM103641) and National Science Foundation (Grant EPS-0903795). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodovar J, 2013, LAB CHIP, V13, P1562, DOI 10.1039/c3lc41407h; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Collins JM, 2011, ANAL BIOCHEM, V419, P339, DOI 10.1016/j.ab.2011.08.021; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curran JM, 2010, LAB CHIP, V10, P1662, DOI 10.1039/c004149a; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2009, EUR CELLS MATER, V18, P1; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Ghafar-Zadeh E, 2011, LAB CHIP, V11, P3031, DOI 10.1039/c1lc20284g; Glucksmann A, 1942, J ANAT, V76, P231; Gray DS, 2008, EXP CELL RES, V314, P2846, DOI 10.1016/j.yexcr.2008.06.023; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grevesse T, 2013, LAB CHIP, V13, P777, DOI 10.1039/c2lc41168g; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Harris J. M., 1992, POLYETHYLENE GLYCOL; Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B; Huang T, 2007, ADV MAT, V19, P1622; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jegadesan S, 2007, J NANOSCI NANOTECHNO, V7, P2172, DOI 10.1166/jnn.2007.789; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7; Kim D, 2009, REPROD FERT DEVELOP, V21, P237, DOI 10.1071/RDv21n1Ab280; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Lanniel M, 2011, SOFT MATTER, V7, P6501, DOI 10.1039/c1sm05167a; Lim JH, 2003, ANGEW CHEM INT EDIT, V42, P2309, DOI 10.1002/anie.200351256; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mareschi K, 2001, BONE MARROW TRANSPL, V27, pS322; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Murtuza B, 2009, TISSUE ENG PART B-RE, V15, P443, DOI [10.1089/ten.teb.2009.0006, 10.1089/ten.TEB.2009.0006]; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Palsson B., 2004, TISSUE ENG, P74; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Previtera ML, 2011, ANN BIOMEDICAL ENG; Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3; Sistiabudi R, 2008, ADV MAT, V20, P3678; Sochol RD, 2011, MICRO NANO LETT, V6, P323, DOI 10.1049/mnl.2011.0020; Sochol RD, 2011, SOFT MATTER, V7, P4606, DOI 10.1039/c1sm05163f; Song W, 2011, J NANOMATER, V2011, DOI 10.1155/2011/265251; Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8; Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tinazli A, 2007, NAT NANOTECHNOL, V2, P220, DOI 10.1038/nnano.2007.63; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; YOSHITAKE S, 1982, J BIOCHEM-TOKYO, V92, P1413, DOI 10.1093/oxfordjournals.jbchem.a134065; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zamir E, 2001, J CELL SCI, V114, P3583; Zhao Y, 2007, CELL MOTIL CYTOSKEL, V64, P718, DOI 10.1002/cm.20218; Zheng Z, 2008, ANGEW CHEM INT EDIT, V47, P9951, DOI 10.1002/anie.200803834	81	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81113	10.1371/journal.pone.0081113	http://dx.doi.org/10.1371/journal.pone.0081113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282570	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500072
J	Li, PH; Wang, S; Kim, J; Xiong, HK; Ohno-Machado, L; Jiang, XQ				Li, Pinghao; Wang, Shuang; Kim, Jihoon; Xiong, Hongkai; Ohno-Machado, Lucila; Jiang, Xiaoqian			DNA-COMPACT: DNA COMpression Based on a Pattern-Aware Contextual Modeling Technique	PLOS ONE			English	Article							GENOMIC SEQUENCE; ALGORITHM; READS	Genome data are becoming increasingly important for modern medicine. As the rate of increase in DNA sequencing outstrips the rate of increase in disk storage capacity, the storage and data transferring of large genome data are becoming important concerns for biomedical researchers. We propose a two-pass lossless genome compression algorithm, which highlights the synthesis of complementary contextual models, to improve the compression performance. The proposed framework could handle genome compression with and without reference sequences, and demonstrated performance advantages over best existing algorithms. The method for reference-free compression led to bit rates of 1.720 and 1.838 bits per base for bacteria and yeast, which were approximately 3.7% and 2.6% better than the state-of-the-art algorithms. Regarding performance with reference, we tested on the first Korean personal genome sequence data set, and our proposed method demonstrated a 189-fold compression rate, reducing the raw file size from 2986.8 MB to 15.8 MB at a comparable decompression cost with existing algorithms. DNAcompact is freely available at https://sourceforge.net/projects/dnacompact/for research purpose.	[Li, Pinghao; Wang, Shuang; Kim, Jihoon; Ohno-Machado, Lucila; Jiang, Xiaoqian] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA; [Li, Pinghao; Xiong, Hongkai] Shanghai Jiao Tong Univ, Dept Elect Engn, Shanghai 200030, Peoples R China	University of California System; University of California San Diego; Shanghai Jiao Tong University	Li, PH (corresponding author), Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA.	pinghaoli1989@gmail.com		Ohno-Machado, Lucila/0000-0002-8005-7327; Xiong, Hongkai/0000-0003-4552-0029; Wang, Shuang/0000-0001-6420-983X; Jiang, Xiaoqian/0000-0001-9933-2205	National Library of Medicine [K99LM011392, R01HS019913]; NHLBI [U54HL108460, UH2HL108785, UL1TR00010003]; NSFC [U1201255, 61271218, 61228101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460, UH2HL108785, UH3HL108785] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM011392, R00LM011392] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	XJ, SW, JK, and LOM were funded in part by the National Library of Medicine (http://www.nlm.nih.gov/) (K99LM011392, R01HS019913) and NHLBI (http://www.nhlbi.nih.gov/) (U54HL108460, UH2HL108785) and UL1TR00010003. HX was funded in part by the NSFC (http://www.nsfc.gov.cn/) under grants U1201255, 61271218, and 61228101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Behzadi B, 2005, LECT NOTES COMPUT SC, V3537, P190; Cao MD, 2007, IEEE DATA COMPR CONF, P43; Chen X, 2002, BIOINFORMATICS, V18, P1696, DOI 10.1093/bioinformatics/18.12.1696; Chen X, 2001, IEEE ENG MED BIOL, V20, P61, DOI 10.1109/51.940049; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Dai WR, 2008, DCC: 2008 DATA COMPRESSION CONFERENCE, PROCEEDINGS, P172, DOI 10.1109/DCC.2008.6; Deorowicz S, 2011, BIOINFORMATICS, V27, P860, DOI 10.1093/bioinformatics/btr014; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Grumbach S., 1993, DCC '93. Data Compression Conference (Cat. No.93TH0536-3), P340, DOI 10.1109/DCC.1993.253115; GRUMBACH S, 1994, INFORM PROCESS MANAG, V30, P875, DOI 10.1016/0306-4573(94)90014-0; Hach F, 2012, BIOINFORMATICS, V28, P3051, DOI 10.1093/bioinformatics/bts593; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jones DC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks754; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Korodi G, 2007, IEEE DATA COMPR CONF, P33; Kozanitis C, 2011, J COMPUT BIOL, V18, P401, DOI 10.1089/cmb.2010.0253; Kuruppu S, 2010, LECT NOTES COMPUT SC, V6393, P201, DOI 10.1007/978-3-642-16321-0_20; Mahoney M. V., 2000, FLAIRS-2000. Proceedings of the Thirteenth International Florida Artificial Intelligence Research Society Conference, P230; Manzini G, 2004, SOFTWARE PRACT EXPER, V34, P1397, DOI 10.1002/spe.619; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Matsumoto T, 2000, Genome Inform Ser Workshop Genome Inform, V11, P43; Minka T., 2000, BAYESIAN MODEL AVERA; Pinho AJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1124; Pinho AJ, 2011, 2011 IEEE STATISTICAL SIGNAL PROCESSING WORKSHOP (SSP), P125, DOI 10.1109/SSP.2011.5967637; Pinho AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021588; Pinho AJ, 2009, INT CONF ACOUST SPEE, P1693, DOI 10.1109/ICASSP.2009.4959928; Popitsch N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks939; Pratas D, 2011, ADV INTEL SOFT COMPU, V93, P213; Sakib MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028251; Tembe W, 2010, BIOINFORMATICS, V26, P2192, DOI 10.1093/bioinformatics/btq346; Wang CM, 2011, NUCLEIC ACIDS RES, V39, pE45, DOI 10.1093/nar/gkr009; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WILLEMS FMJ, 1995, IEEE T INFORM THEORY, V41, P653, DOI 10.1109/18.382012; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	41	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80377	10.1371/journal.pone.0080377	http://dx.doi.org/10.1371/journal.pone.0080377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282536	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500037
J	Wilson, JJ; Sing, KW; Sofian-Azirun, M				Wilson, John-James; Sing, Kong-Wah; Sofian-Azirun, Mohd			Building a DNA Barcode Reference Library for the True Butterflies (Lepidoptera) of Peninsula Malaysia: What about the Subspecies?	PLOS ONE			English	Article							BIOGEOGRAPHY; PHYLOGENY; TAXONOMY	The objective of this study was to build a DNA barcode reference library for the true butterflies of Peninsula Malaysia and assess the value of attaching subspecies names to DNA barcode records. A new DNA barcode library was constructed with butterflies from the Museum of Zoology, University of Malaya collection. The library was analysed in conjunction with publicly available DNA barcodes from other Asia-Pacific localities to test the ability of the DNA barcodes to discriminate species and subspecies. Analyses confirmed the capacity of the new DNA barcode reference library to distinguish the vast majority of species (92%) and revealed that most subspecies possessed unique DNA barcodes (84%). In some cases conspecific subspecies exhibited genetic distances between their DNA barcodes that are typically seen between species, and these were often taxa that have previously been regarded as full species. Subspecies designations as shorthand for geographically and morphologically differentiated groups provide a useful heuristic for assessing how such groups correlate with clustering patterns of DNA barcodes, especially as the number of DNA barcodes per species in reference libraries increases. Our study demonstrates the value in attaching subspecies names to DNA barcode records as they can reveal a history of taxonomic concepts and expose important units of biodiversity.	[Wilson, John-James; Sing, Kong-Wah] Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur, Malaysia; [Wilson, John-James; Sofian-Azirun, Mohd] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Wilson, JJ (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Museum Zool, Kuala Lumpur, Malaysia.	johnwilson@um.edu.my	SING, KONG WAH/E-1008-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; Wilson, John-James/C-4656-2012	SING, KONG WAH/0000-0002-2151-5551; Wilson, John-James/0000-0002-3583-3550	University of Malaya [RG158/12SUS]; Canadian Centre for DNA Barcoding under the iBOL program	University of Malaya(Universiti Malaya); Canadian Centre for DNA Barcoding under the iBOL program	This study was supported by University of Malaya Research Grant RG158/12SUS and also through subsidised analyticals costs at the Canadian Centre for DNA Barcoding under the iBOL program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Poku K, 2009, MOL PHYLOGENET EVOL, V53, P463, DOI 10.1016/j.ympev.2009.06.021; Basset Yves, 2011, Journal of Research on the Lepidoptera, V44, P17; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Braby MF, 2007, SYST ENTOMOL, V32, P2, DOI 10.1111/j.1365-3113.2006.00349.x; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Cleary DFR, 2004, J ECON ENTOMOL, V97, P429, DOI 10.1603/0022-0493-97.2.429; Corbet A. S., 1937, Proceedings of the Royal Entomological Society of London (B), V6, P96; Corbet A.S., 1992, BUTTERFLIES MALAY PE; Corbet AS, 1941, J NATURAL HIST SERIE, V11, P507; Corbet AS, 1934, BUTTERFLIES MALAY PE; Corbet AS, 1956, BUTTERFLIES MALAY PE; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Distant WL, 1882, RHOPALOCERA MALAYANA; Eliot J.N., 1986, Bulletin of the British Museum (Natural History) Entomology, V53, P1; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Gaikwad SS, 2012, MOL BIOL REP, V39, P2375, DOI 10.1007/s11033-011-0988-7; Haig SM, 2006, CONSERV BIOL, V20, P1584, DOI 10.1111/j.1523-1739.2006.00530.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hayashi H, 1976, T LEP SOC JAPAN, V47, P1; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Inayoshi Y, 2012, CHECK LIST BUTTERFLI; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kato K, 2005, GUIDE BUTTERFLIES LA, P319; Kim MI, 2010, MOL CELLS, V30, P409, DOI 10.1007/s10059-010-0141-9; Kodandaramaiah U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041058; Koscinski D, 2009, ECOLOGICAL ENTOMOLOG, V36, P301; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Narita S, 2007, GENETICA, V131, P241, DOI 10.1007/s10709-006-9134-1; Nazari V, 2006, E H STRICKLAND ENTOM; Ohshima I, 2010, MOL PHYLOGENET EVOL, V57, P1026, DOI 10.1016/j.ympev.2010.09.018; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Prado BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027776; Quek KC, 1999, RAFFLES B ZOOL, P271; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; SANDS D P A, 1977, Journal of the Australian Entomological Society, V16, P81; Savela M, 2013, LEPIDOPTERA SOME OTH; Scheermeyer E., 1999, Monographs on Australian Lepidoptera, V6, P191; Smith DAS, 2005, ZOOL J LINN SOC-LOND, V144, P191, DOI 10.1111/j.1096-3642.2005.00169.x; Smith VS, 2011, ZOOKEYS, P53, DOI 10.3897/zookeys.150.2193; Sofian-Azirun M, 2009, MALAYSIAN J SCI, V28, P415; Sofian-Azirun M, 2005, FORESTS BIODIVERSITY, P169; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Tsao WC, 2008, ZOOL STUD, V47, P633; Vane-Wright R.I., 2003, Zoologische Verhandelingen (Leiden), V343, P3; Vane-Wright R.I., 2003, Systematics and Biodiversity, V1, P3, DOI 10.1017/S1477200003001063; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Wang H.Y., 1991, Journal of the Lepidopterists' Society, V44, P216; Wilson JJ, 2013, BUTTERFLIES PENINSUL; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Wilson John James, 2011, Terrestrial Arthropod Reviews, V4, P221, DOI 10.1163/187498311X591111; Wilson John James, 2011, BMC Ecology, V11, P18, DOI 10.1186/1472-6785-11-18; Yata O, 2010, SYST ENTOMOL, V35, P764, DOI 10.1111/j.1365-3113.2010.00535.x	59	18	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79969	10.1371/journal.pone.0079969	http://dx.doi.org/10.1371/journal.pone.0079969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282514	gold, Green Accepted, Green Published			2022-12-27	WOS:000327543500015
J	Harvey, ES; Cappo, M; Kendrick, GA; McLean, DL				Harvey, Euan S.; Cappo, Mike; Kendrick, Gary A.; McLean, Dianne L.			Coastal Fish Assemblages Reflect Geological and Oceanographic Gradients Within An Australian Zootone	PLOS ONE			English	Article							NELUSETTA-AYRAUDI QUOY; LEEUWIN CURRENT; DEMERSAL FISH; HABITAT ASSOCIATIONS; REPRODUCTIVE-BIOLOGY; DIETARY COMPOSITIONS; SOUTHERN AUSTRALIA; TEMPORAL VARIATION; SEAGRASS HABITATS; SPECIES RICHNESS	Distributions of mobile animals have been shown to be heavily influenced by habitat and climate. We address the historical and contemporary context of fish habitats within a major zootone: the Recherche Archipelago, southern western Australia. Baited remote underwater video systems were set in nine habitat types within three regions to determine the species diversity and relative abundance of bony fishes, sharks and rays. Constrained ordinations and multivariate prediction and regression trees were used to examine the effects of gradients in longitude, depth, distance from islands and coast, and epibenthic habitat on fish assemblage composition. A total of 90 species from 43 families were recorded from a wide range of functional groups. Ordination accounted for 19% of the variation in the assemblage composition when constrained by spatial and epibenthic covariates, and identified redundancy in the use of distance from the nearest emergent island as a predictor. A spatial hierarchy of fourteen fish assemblages was identified using multivariate prediction and regression trees, with the primary split between assemblages on macroalgal reefs, and those on bare or sandy habitats supporting seagrass beds. The characterisation of indicator species for assemblages within the hierarchy revealed important faunal break in fish assemblages at 122.30 East at Cape Le Grand and subtle niche partitioning amongst species within the labrids and monacanthids. For example, some species of monacanthids were habitat specialists and predominantly found on seagrass (Acanthaluteres vittiger, Scobinichthys granulatus), reef (Meuschenia galii, Meuschenia hippocrepis) or sand habitats (Nelusetta ayraudi). Predatory fish that consume molluscs, crustaceans and cephalopods were dominant with evidence of habitat generalisation in reef species to cope with local disturbances by wave action. Niche separation within major genera, and a sub-regional faunal break, indicate future zootone mapping should recognise both cross-shelf and longshore environmental gradients.	[Harvey, Euan S.; Kendrick, Gary A.; McLean, Dianne L.] Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Perth, WA 6009, Australia; [Harvey, Euan S.; Kendrick, Gary A.; McLean, Dianne L.] Univ Western Australia, Fac Nat & Agr Sci, Sch Plant Biol, Perth, WA 6009, Australia; [Cappo, Mike] Australian Inst Marine Sci, Mc, Qld, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science	Harvey, ES (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, UWA Oceans Inst, Perth, WA 6009, Australia.	euan.harvey@uwa.edu.au	McLean, Dianne/H-2449-2012; Kendrick, Gary Andrew/B-3460-2011; Harvey, Euan/B-2896-2011	McLean, Dianne/0000-0002-0306-8348; Kendrick, Gary Andrew/0000-0002-0276-6064; Harvey, Euan/0000-0002-9069-4581	Fisheries Research and Development Corporation [FRDC 2001/060]; New Zealand Foundation for Research, Science and Technology; University of Western Australia	Fisheries Research and Development Corporation; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); University of Western Australia	The project 'Characterising the Fish Habitats in the Recherche Archipelago, Western Australia' was funded by the Fisheries Research and Development Corporation [FRDC 2001/060] to Drs Kendrick, Harvey, Pattiaratchi, Shortis, and Cappo. Additional funding was provided by M.G. Kailis, Esperance Port Authority, Black Swan Nickel. Harvey was supported by Postdoctoral Fellowships from the New Zealand Foundation for Research, Science and Technology and The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhir MFM, 2009, THESIS U W AUSTR; AYVAZIAN SG, 1995, MAR BIOL, V122, P527, DOI 10.1007/BF00350675; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; BARRETT NS, 1995, MAR FRESHWATER RES, V46, P853, DOI 10.1071/MF9950853; Bender MG, 2013, ORYX, V47, P259, DOI 10.1017/S003060531100144X; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Cappo Mike, 2011, Journal of the Royal Society of Western Australia, V94, P303; Chatfield BS, 2010, J BIOGEOGR, V37, P593, DOI 10.1111/j.1365-2699.2009.02246.x; Coleman MA, 2007, MAR FRESHWATER RES, V58, P589, DOI 10.1071/MF06216; Colton MA, 2012, MAR FRESHWATER RES, V63, P218, DOI 10.1071/MF10322; Connell S. D., 2007, MARINE ECOLOGY; Connell SD, 1999, ESTUAR COAST SHELF S, V48, P483, DOI 10.1006/ecss.1998.0438; Connell SD, 2013, MAR BIOL, V160, P491, DOI 10.1007/s00227-012-2161-9; Cossington S, 2010, J FISH BIOL, V77, P600, DOI 10.1111/j.1095-8649.2010.02706.x; Coulson PG, 2010, MAR FRESHWATER RES, V61, P104, DOI 10.1071/MF08341; Coulson PG, 2009, FISH B-NOAA, V107, P57; Crawley KR, 2009, MAR ECOL PROG SER, V376, P33, DOI 10.3354/meps07810; Cresswell GR, 2004, MAR FRESHWATER RES, V55, P267, DOI 10.1071/MF03115; Davis JP, 2012, MAR ECOL PROG SER, V446, P207, DOI 10.3354/meps09452; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar GJ, 2004, ENVIRON BIOL FISH, V70, P273, DOI 10.1023/B:EBFI.0000033342.89719.39; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P83, DOI 10.1016/0022-0981(95)00084-4; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P53, DOI 10.1016/0022-0981(95)00083-6; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P107, DOI 10.1016/0022-0981(95)00085-2; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fernandes L, 2009, OCEAN COAST MANAGE, V52, P439, DOI 10.1016/j.ocecoaman.2009.06.004; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Gartner A, 2013, J EXP MAR BIOL ECOL, V439, P143, DOI 10.1016/j.jembe.2012.11.009; Goldberg NA, 2004, J PHYCOL, V40, P631, DOI 10.1111/j.1529-8817.2004.03212.x; Gunderson DR, 2008, FISHERIES, V33, P172, DOI 10.1577/1548-8446-33.4.172; Hamilton SL, 2011, MAR ECOL PROG SER, V429, P227, DOI 10.3354/meps09086; Hilborn R, 2004, MAR ECOL PROG SER, V274, P275; Hindell JS, 2006, MAR FRESHWATER RES, V57, P121, DOI 10.1071/MF05082; Hutchins J. Barry, 2001, Records of the Western Australian Museum, V20, P247; HUTCHINS JB, 1994, RECORDS W AUSTR MU S, V46, P1; HUTCHINS JB, 2005, MARINE FLORA FAUNA E, P425; Hutchins JB, 1999, SO SEAS ECOLOGY AUST, P194; Hyndes GA, 2005, ESTUAR COAST SHELF S, V63, P633, DOI 10.1016/j.ecss.2005.01.008; Hyndes GA, 2013, ESTUAR COAST SHELF S, V119, P176, DOI 10.1016/j.ecss.2012.12.015; JONES GP, 1988, NEW ZEAL J MAR FRESH, V22, P445, DOI 10.1080/00288330.1988.9516315; Jones GP, 1999, SO SEAS ECOLOGY AUST, P180; Kendrick G. A., 2009, Journal of the Royal Society of Western Australia, V92, P211; Kendrick GA, 2005, 2001060 FRDC; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Last PR, 2005, J MARINE RES; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Lek E, 2011, J FISH BIOL, V78, P1913, DOI 10.1111/j.1095-8649.2011.02961.x; Leleu K, 2012, BIOL CONSERV, V155, P193, DOI 10.1016/j.biocon.2012.05.009; LINDHOLM R, 1984, AUST J MAR FRESH RES, V35, P597; Lowry M.B., 1999, SO SEAS ECOLOGY AUST, P172; MacArthur LD, 2007, J EXP MAR BIOL ECOL, V340, P247, DOI 10.1016/j.jembe.2006.09.017; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; McAuley R., 2003, 146 W AUSTR DEP FISH; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Miller ME, 2010, ENVIRON BIOL FISH, V88, P263, DOI 10.1007/s10641-010-9639-4; Monk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034558; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore SE, 2007, J FISH BIOL, V71, P1407, DOI 10.1111/j.1095-8649.2007.01614.x; Phillips JA, 2001, BIODIVERS CONSERV, V10, P1555, DOI 10.1023/A:1011813627613; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Platell ME, 2010, J FISH BIOL, V76, P1255, DOI [10.1111/j.1095-8649.2010.02537.x, 10.1111/j.1095-8649.2010.02537.X]; Poore Gary C.B., 2007, P177; Powter DM, 2010, MAR FRESHWATER RES, V61, P74, DOI 10.1071/MF09021; R Core Team, 2018, R LANG ENV STAT COMP; Ryan DA, 2007, ESTUAR COAST SHELF S, V72, P379, DOI 10.1016/j.ecss.2006.10.008; Shepherd SA, 2008, T ROY SOC SOUTH AUST, V132, P147, DOI 10.1080/03721426.2008.10887100; Simpfendorfer CA, 2001, MAR FRESHWATER RES, V52, P975, DOI 10.1071/MF01017; SINCLAIR M, 1989, J CONSEIL, V45, P165; Smith TM, 2008, MAR ECOL PROG SER, V359, P203, DOI 10.3354/meps07348; Sommerville E, 2011, MAR FRESHWATER RES, V62, P54, DOI 10.1071/MF10164; Tuya F, 2011, J FISH BIOL, V79, P217, DOI 10.1111/j.1095-8649.2011.03015.x; Vanderklift MA, 2010, MAR ECOL PROG SER, V403, P53, DOI 10.3354/meps08484; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010	83	29	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80955	10.1371/journal.pone.0080955	http://dx.doi.org/10.1371/journal.pone.0080955			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278353	gold, Green Submitted, Green Published			2022-12-27	WOS:000327541700039
J	Li, M; Zhang, L; Wu, N; Huang, WT; Lv, N				Li, Meng; Zhang, Li; Wu, Ning; Huang, Wenting; Lv, Ning			Imaging Findings of Primary Splenic Lymphoma: A Review of 17 Cases in Which Diagnosis Was Made at Splenectomy	PLOS ONE			English	Article							MALIGNANT-LYMPHOMA; EXTRANODAL INVOLVEMENT; SPLEEN; CT	Purpose: This study sought to characterize the imaging features of primary splenic lymphoma (PSL). Materials and Methods: Pathological and imaging data from 17 patients with primary splenic lymphoma initially diagnosed at splenectomy were retrospectively analyzed. Pretreatment computed tomography (CT) imaging was available for 16 patients, and magnetic resonance imaging (MRI) data were available for 4 patients. Splenic lymphoma imaging data were categorized based on the gross pathological presentation in the following manner: type 1, homogeneous enlargement; type 2, miliary nodules; type 3, multifocal masses of varying size; and type 4, solitary large mass. Results: Of the 17 patients with PSL, 16 cases were non-Hodgkin lymphoma, and of these, 9 cases were diffuse large B cell lymphomas (DLBCL) and 4 cases were splenic marginal zone B-cell lymphoma (SMZL). Imaging showed the following types of PSL presentation: 1 case of type 1, 0 cases of type 2, 4 cases of type 3, and 12 cases of type 4. There was evidence of necrosis in 12 cases (70.6%), and there was evidence of mild enhancement in enhanced CT in 14 cases and in enhanced MRI in 3 cases. Prior to surgery, PSL was considered possible in 8 patients. Conclusion: The most frequent histological subtype was DLBCL, followed by SMZL. In both CT and MRI, PSL generally presents as a solitary mass or masses rather than as splenomegaly. In addition, necrosis and mild enhancement are commonly observed, and splenectomy may be required to confirm the diagnosis.	[Li, Meng; Zhang, Li; Wu, Ning] Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100730, Peoples R China; [Wu, Ning] Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, PET CT Ctr, Beijing 100730, Peoples R China; [Huang, Wenting; Lv, Ning] Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wu, N (corresponding author), Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Dept Diagnost Radiol, Beijing 100730, Peoples R China.	cjr.wuning@vip.163.com	Lv, Ning/V-5706-2019; meng, li/GVT-2063-2022					AHMANN DL, 1966, CANCER-AM CANCER SOC, V19, P461, DOI 10.1002/1097-0142(196604)19:4<461::AID-CNCR2820190402>3.0.CO;2-X; Ambulkar I, 2006, LEUKEMIA LYMPHOMA, V47, P135, DOI 10.1080/10428190500277142; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Dachman AH, 1998, CLIN RADIOL, V53, P137, DOI 10.1016/S0009-9260(98)80061-5; DASGUPTA T, 1965, SURG GYNECOL OBSTETR, V120, P947; Elsayes KM, 2005, RADIOGRAPHICS, V25, P967, DOI 10.1148/rg.254045154; Fenchel S, 2003, EUR J RADIOL, V45, pS59, DOI 10.1016/S0720-048X(02)00363-7; Giovagnoni Andrea, 2005, Cancer Imaging, V5, P73, DOI 10.1102/1470-7330.2005.0002; GOH KO, 1984, AM J MED SCI, V288, P48, DOI 10.1097/00000441-198407000-00013; Humphries PD, 2007, RADIOLOGY, V245, P848, DOI 10.1148/radiol.2452061535; KEHOE J, 1988, CANCER, V62, P1433, DOI 10.1002/1097-0142(19881001)62:7<1433::AID-CNCR2820620731>3.0.CO;2-V; Kirshtein B, 2008, J LAPAROENDOSC ADV S, V18, P42, DOI 10.1089/lap.2007.0085; KRAEMER BB, 1984, CANCER-AM CANCER SOC, V54, P1606, DOI 10.1002/1097-0142(19841015)54:8<1606::AID-CNCR2820540823>3.0.CO;2-5; Leite NP, 2007, RADIOGRAPHICS, V27, P1613, DOI 10.1148/rg.276065170; MOREL P, 1993, CANCER-AM CANCER SOC, V71, P207, DOI 10.1002/1097-0142(19930101)71:1<207::AID-CNCR2820710132>3.0.CO;2-0; Nakashima A, 1994, Radiat Med, V12, P42; Paes FM, 2010, RADIOGRAPHICS, V30, P269, DOI 10.1148/rg.301095088; Rini JN, 2003, J NUCL MED, V44, P1072; Stephane V, 2013, EUR J RADIO IN PRESS; SUMIMURA J, 1992, SURG TODAY, V22, P371, DOI 10.1007/BF00308749; Swerdlow SH, 2008, WHO CLASSIFICATION T	21	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80264	10.1371/journal.pone.0080264	http://dx.doi.org/10.1371/journal.pone.0080264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278265	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800067
J	Matos, DA; Whitney, IP; Harrington, MJ; Hazen, SP				Matos, Dominick A.; Whitney, Ian P.; Harrington, Michael J.; Hazen, Samuel P.			Cell Walls and the Developmental Anatomy of the Brachypodium distachyon Stem Internode	PLOS ONE			English	Article							TRACHEARY ELEMENT DIFFERENTIATION; CELLULOSE SYNTHESIS; LIGNIN; PLANT; GENES; DEATH; IDENTIFICATION; LIGNIFICATION; EXPRESSION; SYSTEM	While many aspects of plant cell wall polymer structure are known, their spatial and temporal distribution within the stem are not well understood. Here, we studied vascular system and fiber development, which has implication for both biofuel feedstock conversion efficiency and crop yield. The subject of this study, Brachypodium distachyon, has emerged as a grass model for food and energy crop research. Here, we conducted our investigation using B. distachyon by applying various histological approaches and Fourier transform infrared spectroscopy to the stem internode from three key developmental stages. While vascular bundle size and number did not change over time, the size of the interfascicular region increased dramatically, as did cell wall thickness. We also describe internal stem internode anatomy and demonstrate that lignin deposition continues after crystalline cellulose and xylan accumulation ceases. The vascular bundle anatomy of B. distachyon appears to be highly similar to domesticated grasses. While the arrangement of bundles within the stem is highly variable across grasses, B. distachyon appears to be a suitable model for the rind of large C-4 grass crops. A better understanding of growth and various anatomical and cell wall features of B. distachyon will further our understanding of plant biomass accumulation processes.	[Matos, Dominick A.; Whitney, Ian P.; Harrington, Michael J.; Hazen, Samuel P.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Matos, Dominick A.; Whitney, Ian P.] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hazen, SP (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	hazen@bio.umass.edu		Hazen, Samuel/0000-0001-9131-8994	Office of Science (BER) Department of Energy [DE-FG02-08ER64700DE, DE-SC0006621]	Office of Science (BER) Department of Energy(United States Department of Energy (DOE))	This work was supported by Office of Science (BER) Department of Energy Grants DE-FG02-08ER64700DE and DE-SC0006621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Barcelo AR, 2005, PLANTA, V220, P747, DOI 10.1007/s00425-004-1394-3; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bollhoner B, 2012, J EXP BOT, V63, P1081, DOI 10.1093/jxb/err438; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chen L, 2002, J AGR FOOD CHEM, V50, P5558, DOI 10.1021/jf020516x; Chesson A, 1997, J SCI FOOD AGR, V73, P10, DOI [10.1002/(SICI)1097-0010(199701)73:1<10::AID-JSFA697>3.0.CO;2-E, 10.1002/(SICI)1097-0010(199701)73:1&lt;10::AID-JSFA697&gt;3.0.CO;2-E]; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Esau K., 1977, ANATOMY SEED PLANTS; Faix O., 1992, METHODS LIGNIN CHEM, P83, DOI DOI 10.1007/978-3-642-74065-7_7; Groover A, 1999, PLANT PHYSIOL, V119, P375, DOI 10.1104/pp.119.2.375; Harris D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002897; Hosokawa M, 2001, PLANT CELL PHYSIOL, V42, P959, DOI 10.1093/pcp/pce124; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kiesselbach TA, 1949, STRUCTURE REPORDUCTI; KIM JB, 1992, PLANT PHYSIOL, V98, P646, DOI 10.1104/pp.98.2.646; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Leroux O, 2012, ANN BOT-LONDON, V110, P1083, DOI 10.1093/aob/mcs186; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Marchessault R.H., 1962, PURE APPL CHEM, V5, P107, DOI [10.1351/pac196205010107, DOI 10.1351/PAC196205010107]; McCann MC, 2007, PLANT PHYSIOL, V143, P1314, DOI 10.1104/pp.106.093054; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nelson M.L., 1964, J APPL POLYM SCI, V8, P1325, DOI [10.1002/app.1964.070080323, DOI 10.1002/APP.1964.070080323]; Nelson M.L., 1964, J APPL POLYM SCI, V8, P1325, DOI [DOI 10.1002/APP.1964.070080322, 10.1002/app.1964.070080323]; Obara K, 2001, PLANT PHYSIOL, V125, P615, DOI 10.1104/pp.125.2.615; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760; PATRICK JW, 1972, AUST J BOT, V20, P49, DOI 10.1071/BT9720049; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sills DL, 2012, BIOTECHNOL BIOENG, V109, P353, DOI 10.1002/bit.23314; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STEWART CM, 1966, SCIENCE, V153, P1068, DOI 10.1126/science.153.3740.1068; Tu Y, 2010, PLANT CELL, V22, P3357, DOI 10.1105/tpc.109.072827; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406; Ye ZH, 2002, INT REV CYTOL, V220, P225; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245	47	27	27	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80640	10.1371/journal.pone.0080640	http://dx.doi.org/10.1371/journal.pone.0080640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278300	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800079
J	Tian, XY; Hu, TY; He, LJ; Zhang, H; Huang, XZ; Poelmann, RE; Liu, WB; Yang, Z; Yan, Y; Pu, WT; Zhou, B				Tian, Xueying; Hu, Tianyuan; He, Lingjuan; Zhang, Hui; Huang, Xiuzhen; Poelmann, Robert E.; Liu, Weibo; Yang, Zhen; Yan, Yan; Pu, William T.; Zhou, Bin			Peritruncal Coronary Endothelial Cells Contribute to Proximal Coronary Artery Stems and Their Aortic Orifices in the Mouse Heart	PLOS ONE			English	Article							EPICARDIAL PROGENITORS; ANOMALOUS ORIGIN; SINUS; FORM; OUTGROWTH; PATTERNS; LINEAGE; VESSEL	Avian embryo experiments proved an ingrowth model for the coronary artery connections with the aorta. However, whether a similar mechanism applies to the mammalian heart still remains unclear. Here we analyzed how the main coronary arteries and their orifices form during murine heart development. Apelin (Apln) is expressed in coronary vascular endothelial cells including peritruncal endothelial cells. By immunostaining, however, we did not find Apln expression in endothelial cells of the aorta during the period of coronary vessel development (E10.5 to E15.5). As a result of this unique expression difference, Apln(CreERT2/+) genetically labels nascent coronary vessels forming on the heart, but not the aorta endothelium when pulse activated by tamoxifen injection at E10.5. This allowed us to define the temporal contribution of these distinct endothelial cell populations to formation of the murine coronary artery orifice. We found that the peritruncal endothelial cells were recruited to form the coronary artery orifices. These cells penetrate the wall of aorta and take up residence in the aortic sinus of valsalva. In conclusion, main coronary arteries and their orifices form through the recruitment and vascular remodeling of peritruncal endothelial cells in mammalian heart.	[Tian, Xueying; Hu, Tianyuan; He, Lingjuan; Zhang, Hui; Huang, Xiuzhen; Zhou, Bin] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China; [Poelmann, Robert E.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Liu, Weibo] Ningbo 2nd Hosp, Ningbo, Zhejiang, Peoples R China; [Yang, Zhen; Yan, Yan] Fu Dan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai, Peoples R China; [Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fudan University; Harvard University; Boston Children's Hospital	Yan, Y (corresponding author), Fu Dan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai, Peoples R China.	yan.yan@zs-hospital.sh.cn; zhoubin@sibs.ac.cn	Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079; Zhou, Bin/0000-0001-5278-5522	Chinese Ministry of Science and Technology [2012CB945102, 2013CB945302]; Chinese Academy of Sciences [874, KSCX2- EW-R-09]; Shanghai PuJiang grant [11PJ1411400]; National Natural Science Foundation of China [31271552, 31222038]; SA-SIBS Scholarship Program; SIBS-Postdoc Fund [2013KIP311]; China Postdoc Science Fund [2013M541561]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai PuJiang grant(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SA-SIBS Scholarship Program; SIBS-Postdoc Fund; China Postdoc Science Fund	This work was supported by the Chinese Ministry of Science and Technology grant 2012CB945102, 2013CB945302, Chinese Academy of Sciences No. 874 and KSCX2- EW-R-09, and Shanghai PuJiang grant 11PJ1411400, National Natural Science Foundation of China 31271552 and 31222038. SA-SIBS Scholarship Program, SIBS-Postdoc Fund (2013KIP311), China Postdoc Science Fund (2013M541561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2004, CIRC RES, V94, P346, DOI 10.1161/01.RES.0000112963.79064.09; Arima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2258; Bennett HS, 1936, AM J ANAT, V60, P27, DOI 10.1002/aja.1000600103; BOGERS AJJC, 1989, ANAT EMBRYOL, V180, P437, DOI 10.1007/BF00305118; BOGERS AJJC, 1988, INT J CARDIOL, V20, P117, DOI 10.1016/0167-5273(88)90321-X; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Epstein JA, 2010, NEW ENGL J MED, V363, P1638, DOI 10.1056/NEJMra1003941; Eralp I, 2005, CIRC RES, V96, P526, DOI 10.1161/01.RES.0000158965.34647.4e; HUTCHINS GM, 1988, CIRCULATION, V77, P1250, DOI 10.1161/01.CIR.77.6.1250; Ishii Y, 2010, DEV CELL, V19, P307, DOI 10.1016/j.devcel.2010.07.017; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Ou P, 2006, EUR J CARDIO-THORAC, V29, P610, DOI 10.1016/j.ejcts.2005.12.031; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; SMITH A, 1986, INT J CARDIOL, V12, P295, DOI 10.1016/0167-5273(86)90265-2; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wann S, 2006, NEW ENGL J MED, V355, pE8, DOI 10.1056/NEJMicm050051; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007	25	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80857	10.1371/journal.pone.0080857	http://dx.doi.org/10.1371/journal.pone.0080857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278332	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800086
J	Zehendner, CM; Wedler, HE; Luhmann, HJ				Zehendner, Christoph M.; Wedler, Hannah E.; Luhmann, Heiko J.			A Novel In Vitro Model to Study Pericytes in the Neurovascular Unit of the Developing Cortex	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SYSTEMIC INFLAMMATION; NEURONAL APOPTOSIS; CEREBRAL-CORTEX; WHITE-MATTER; INJURY; CNS; SCHIZOPHRENIA; EXPRESSION	Cortical function is impaired in various disorders of the central nervous system including Alzheimer's disease, autism and schizophrenia. Some of these disorders are speculated to be associated with insults in early brain development. Pericytes have been shown to regulate neurovascular integrity in development, health and disease. Hence, precisely controlled mechanisms must have evolved in evolution to operate pericyte proliferation, repair and cell fate within the neurovascular unit (NVU). It is well established that pericyte deficiency leads to NVU injury resulting in cognitive decline and neuroinflammation in cortical layers. However, little is known about the role of pericytes in pathophysiological processes of the developing cortex. Here we introduce an in vitro model that enables to precisely study pericytes in the immature cortex and show that moderate inflammation and hypoxia result in caspase-3 mediated pericyte loss. Using heterozygous EYFP-NG2 mouse mutants we performed live imaging of pericytes for several days in vitro. In addition we show that pericytes maintain their capacity to proliferate which may allow cell-based therapies like reprogramming of pericytes into induced neuronal cells in the presented approach.	[Zehendner, Christoph M.; Wedler, Hannah E.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Saarstr 21, Mainz, Germany.	Zehendner@uni-mainz.de	Luhmann, Heiko J./N-8797-2019	Luhmann, Heiko J./0000-0002-7934-8661	University Medical Center of the Johannes Gutenberg-University of Mainz; DFG	University Medical Center of the Johannes Gutenberg-University of Mainz; DFG(German Research Foundation (DFG))	CMZ was supported by a Stage 1 grant of the University Medical Center of the Johannes Gutenberg-University of Mainz. This work was supported by DFG grants to HJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Brochu ME, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-55; Brown AS, 2012, DEV NEUROBIOL, V72, P1272, DOI 10.1002/dneu.22024; Chauvier D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.87; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Darnall RA, 2006, CLIN PERINATOL, V33, P883, DOI 10.1016/j.clp.2006.10.004; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Guedel E, 1937, AM J MED SCI; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hagg T, 1997, BRAIN RES, V764, P17, DOI 10.1016/S0006-8993(97)00419-8; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hansel CM, 2012, P NATL ACAD SCI USA, V109, P12621, DOI 10.1073/pnas.1203885109; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; Indredavik MS, 2010, J DEV BEHAV PEDIATR, V31, P286, DOI 10.1097/DBP.0b013e3181d7b1d3; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kovacs R, 2011, CARDIOVASC PSYCHIAT, V2011, P1, DOI [DOI 10.1155/2011/646958, 10.1155/2011/646958]; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nimmervoll B, 2011, GLYCINE RECEPTORS IN; Nimmervoll B, 2013, CEREB CORTEX, V23, P1742, DOI 10.1093/cercor/bhs156; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Osborn DA, 2003, PEDIATRICS, V112, P33, DOI 10.1542/peds.112.1.33; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; SCHONK DM, 1989, HUM GENET, V83, P297, DOI 10.1007/BF00285178; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Volpe JJ, 2011, ANN NEUROL, V70, P525, DOI 10.1002/ana.22533; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Wen W, 2011, CURR OPIN PSYCHIATR, V24, P219, DOI 10.1097/YCO.0b013e32834591f8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81637	10.1371/journal.pone.0081637	http://dx.doi.org/10.1371/journal.pone.0081637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278454	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800138
J	Lagarde, J; Valabregue, R; Corvol, JC; Pineau, F; Le Ber, I; Vidailhet, M; Dubois, B; Levy, R				Lagarde, Julien; Valabregue, Romain; Corvol, Jean-Christophe; Pineau, Fanny; Le Ber, Isabelle; Vidailhet, Marie; Dubois, Bruno; Levy, Richard			Are Frontal Cognitive and Atrophy Patterns Different in PSP and bvFTD? A Comparative Neuropsychological and VBM Study	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; FRONTOTEMPORAL LOBAR DEGENERATION; RICHARDSON-OLSZEWSKI SYNDROME; REGIONAL CEREBRAL ATROPHY; SUBCORTICAL DEMENTIA; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; BRAIN ATROPHY; CORTEX	Progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration (FTD) are two clinicohistological entities that share a severe prefrontal syndrome. To what extent do the cognitive syndrome and the location of the underlying brain atrophy unify or segregate these entities? Here, we examined the clinical and radiological patterns of frontal involvement and the neural bases of the cognitive dysfunctions observed in the Richardson form of PSP and the behavioral variant of FTD (bvFTD). The cognitive profile and grey and white matter volume of PSP (n = 19) and bvFTD (n = 16) patients and control participants (n = 18) were compared using a standard battery of neuropsychological tests and voxel-based morphometry (VBM), respectively. Analyses of correlations between neuropsychological and morphometric data were additionally performed. The severity and qualitative pattern of cognitive dysfunction was globally similar between the two patient groups. Grey matter volume was decreased in widespread frontal areas and in the temporal uncus in bvFTD, while it was decreased in the frontal and temporal lobes as well as in the thalamus in PSP. We also found an unexpected involvement of the frontal rectal gyrus in PSP patients compared to controls. Correlation analyses yielded different results in the two groups, with no area showing significant correlations in PSP patients, while several frontal and some temporal areas did so in bvFTD patients. In spite of minor neuropsychological and morphological differences, this study shows that the patterns of cognitive dysfunction and atrophy are very similar in PSP and bvFTD. However, executive dysfunction in these diseases may stem from partially divergent cortical and subcortical neural circuits.	[Lagarde, Julien; Corvol, Jean-Christophe; Pineau, Fanny; Le Ber, Isabelle; Vidailhet, Marie; Dubois, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurol, F-75634 Paris, France; [Levy, Richard] Hop St Antoine, AP HP, Dept Neurol, F-75571 Paris, France; [Valabregue, Romain] Grp Hosp Pitie Salpetriere, Ctr NeuroImagerie Rech CENIR, F-75634 Paris, France; [Lagarde, Julien; Valabregue, Romain; Corvol, Jean-Christophe; Le Ber, Isabelle; Vidailhet, Marie; Dubois, Bruno; Levy, Richard] CNRS, INSERM, UMR 975, UMR 7225, Paris, France; [Valabregue, Romain; Corvol, Jean-Christophe; Le Ber, Isabelle; Vidailhet, Marie; Dubois, Bruno; Levy, Richard] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere ICM, UMR S975, Paris, France; [Corvol, Jean-Christophe; Pineau, Fanny] Grp Hosp Pitie Salpetriere, INSERM, Ctr Invest Clin, CIC 9503, F-75634 Paris, France; [Le Ber, Isabelle; Dubois, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Natl Reference Ctr Rare Dementias, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Levy, R (corresponding author), Hop St Antoine, AP HP, Dept Neurol, F-75571 Paris, France.	richard.levy@sat.aphp.fr	Corvol, Jean-Christophe/F-2124-2017; valabregue, romain/GWQ-7484-2022; Levy, Richard/D-8411-2011; corvol, jean-christophe/I-6387-2012	Corvol, Jean-Christophe/0000-0001-7325-0199; valabregue, romain/0000-0002-1814-9570; corvol, jean-christophe/0000-0001-7325-0199; Lagarde, Julien/0000-0002-2018-261X	JNLF; INSERM	JNLF; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the JNLF (for Julien Lagarde), and the INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; Ashburner J, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P92, DOI 10.1016/B978-012372560-8/50007-3; Bak TH, 2010, J NEUROL NEUROSUR PS, V81, P1057, DOI 10.1136/jnnp.2008.157974; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BLIN J, 1990, ARCH NEUROL-CHICAGO, V47, P747, DOI 10.1001/archneur.1990.00530070035009; Brenneis C, 2004, J NEUROL NEUROSUR PS, V75, P246; BRUSA A, 1980, ITAL J NEUROL SCI, V1, P205; CAMBIER J, 1985, REV NEUROL, V141, P528; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Cordato NJ, 2005, BRAIN, V128, P1259, DOI 10.1093/brain/awh508; Cordato NJ, 2000, ANN NEUROL, V47, P718, DOI 10.1002/1531-8249(200006)47:6<718::AID-ANA4>3.0.CO;2-J; DANTONA R, 1985, BRAIN, V108, P785, DOI 10.1093/brain/108.3.785; DAVIS PH, 1985, ANN NEUROL, V17, P337, DOI 10.1002/ana.410170406; de Souza LC, 2013, J ALZHEIMERS DIS, V36, P57, DOI 10.3233/JAD-122293; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dubois B, 2005, NEUROLOGY, V64, P2132, DOI 10.1212/01.WNL.0000165977.38272.15; DUBOIS B, 1988, ARCH NEUROL-CHICAGO, V45, P1194, DOI 10.1001/archneur.1988.00520350032011; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Jeong Y, 2005, J NUCL MED, V46, P233; Josephs KA, 2008, ANN NEUROL, V64, P4, DOI 10.1002/ana.21426; Josephs KA, 2011, MOVEMENT DISORD, V26, P493, DOI 10.1002/mds.23471; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Kim C, 2011, HUM BRAIN MAPP, V32, P304, DOI 10.1002/hbm.21020; Kramer J.H., 2007, HUMAN FRONTAL LOBES, P279; Le Ber I, 2006, BRAIN, V129, P3051, DOI 10.1093/brain/awl288; Litvan I, 1996, NEUROLOGY, V47, P1184, DOI 10.1212/WNL.47.5.1184; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Litvan I, 1997, BRAIN, V120, P65, DOI 10.1093/brain/120.1.65; McMurtray AM, 2006, NEUROLOGY, V66, P517, DOI 10.1212/01.wnl.0000197983.39436.e7; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Pasquier F, 1999, DEMENT GERIATR COGN, V10, P10, DOI 10.1159/000051206; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Sha S, 2006, NAT CLIN PRACT NEURO, V2, P658, DOI 10.1038/ncpneuro0357; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Van Balken I, 2007, HUMAN FRONTAL LOBES, P422; Verny M, 1996, BRAIN, V119, P1123, DOI 10.1093/brain/119.4.1123; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0	42	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80353	10.1371/journal.pone.0080353	http://dx.doi.org/10.1371/journal.pone.0080353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278277	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100086
J	Smith, JR; Syre, PP; Oake, SA; Nicholson, KJ; Weisshaar, CL; Cruz, K; Bucki, R; Baumann, BC; Janmey, PA; Winkelstein, BA				Smith, Jenell R.; Syre, Peter P.; Oake, Shaina A.; Nicholson, Kristen J.; Weisshaar, Christine L.; Cruz, Katrina; Bucki, Robert; Baumann, Bethany C.; Janmey, Paul A.; Winkelstein, Beth A.			Salmon and Human Thrombin Differentially Regulate Radicular Pain, Glial-Induced Inflammation and Spinal Neuronal Excitability through Protease-Activated Receptor-1	PLOS ONE			English	Article							NERVE ROOT COMPRESSION; GENE-RELATED PEPTIDE; NEUROPATHIC PAIN; BEHAVIORAL SENSITIVITY; CYTOKINE EXPRESSION; DORSAL-HORN; NECK PAIN; FIBRIN; BRAIN; MECHANISMS	Chronic neck pain is a major problem with common causes including disc herniation and spondylosis that compress the spinal nerve roots. Cervical nerve root compression in the rat produces sustained behavioral hypersensitivity, due in part to the early upregulation of pro-inflammatory cytokines, the sustained hyperexcitability of neurons in the spinal cord and degeneration in the injured nerve root. Through its activation of the protease-activated receptor-1 (PAR1), mammalian thrombin can enhance pain and inflammation; yet at lower concentrations it is also capable of transiently attenuating pain which suggests that PAR1 activation rate may affect pain maintenance. Interestingly, salmon-derived fibrin, which contains salmon thrombin, attenuates nerve root-induced pain and inflammation, but the mechanisms of action leading to its analgesia are unknown. This study evaluates the effects of salmon thrombin on nerve root-mediated pain, axonal degeneration in the root, spinal neuronal hyperexcitability and inflammation compared to its human counterpart in the context of their enzymatic capabilities towards coagulation substrates and PAR1. Salmon thrombin significantly reduces behavioral sensitivity, preserves neuronal myelination, reduces macrophage infiltration in the injured nerve root and significantly decreases spinal neuronal hyperexcitability after painful root compression in the rat; whereas human thrombin has no effect. Unlike salmon thrombin, human thrombin upregulates the transcription of IL-1 beta and TNF-alpha and the secretion of IL-6 by cortical cultures. Salmon and human thrombins cleave human fibrinogen-derived peptides and form clots with fibrinogen with similar enzymatic activities, but salmon thrombin retains a higher enzymatic activity towards coagulation substrates in the presence of antithrombin III and hirudin compared to human thrombin. Conversely, salmon thrombin activates a PAR1-derived peptide more weakly than human thrombin. These results are the first to demonstrate that salmon thrombin has unique analgesic, neuroprotective and anti-inflammatory capabilities compared to human thrombin and that PAR1 may contribute to these actions.	[Smith, Jenell R.; Syre, Peter P.; Oake, Shaina A.; Nicholson, Kristen J.; Weisshaar, Christine L.; Baumann, Bethany C.; Janmey, Paul A.; Winkelstein, Beth A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Cruz, Katrina; Bucki, Robert; Janmey, Paul A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Winkelstein, Beth A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Winkelstein, BA (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	winkelst@seas.upenn.edu		Baumann, Bethany/0000-0003-4144-5690; Bucki, Robert/0000-0001-7664-9226	Department of Defense [W81XWH-10-1-1002]; Cervical Spine Research Society; Ashton Fellowship;  [T32-AR007132]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007132] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Cervical Spine Research Society; Ashton Fellowship; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Grant support for this work was provided by the Department of Defense (W81XWH-10-1-1002), the Cervical Spine Research Society and fellowships provided by the Ashton Fellowship and an institutional training grant (T32-AR007132). The authors also thank Sea Run Holdings for providing reagents and other support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbed KM, 2007, NEUROSURGERY, V60, P28, DOI 10.1227/01.NEU.0000249223.51871.C2; ARNER S, 1988, PAIN, V33, P11, DOI 10.1016/0304-3959(88)90198-4; Asfaha S, 2007, BRIT J PHARMACOL, V150, P176, DOI 10.1038/sj.bjp.0706975; Asfaha S, 2002, BRIT J PHARMACOL, V135, P1101, DOI 10.1038/sj.bjp.0704568; Boven LA, 2003, J IMMUNOL, V170, P2638, DOI 10.4049/jimmunol.170.5.2638; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Caridi John M, 2011, HSS J, V7, P265; Chang YW, 2011, J NEUROTRAUM, V28, P2429, DOI 10.1089/neu.2011.1918; Chang YW, 2010, J PAIN, V11, P119, DOI 10.1016/j.jpain.2009.06.009; Choi MS, 2008, BRAIN RES BULL, V76, P368, DOI 10.1016/j.brainresbull.2008.02.031; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crosby ND, 2013, NEUROSCI LETT, V542, P102, DOI 10.1016/j.neulet.2013.03.019; Dale C, 2008, J RECEPT SIG TRANSD, V28, P29, DOI [10.1080/10799890801941913, 10.1080/10799890801941913 ]; DeLeo JA, 2006, J BONE JOINT SURG AM, V88A, P58, DOI 10.2106/JBJS.E.01286; Dong L, 2013, J NEUROTRAUM, V30, P818, DOI 10.1089/neu.2012.2600; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Fan YY, 2005, J SURG RES, V129, P196, DOI 10.1016/j.jss.2005.07.041; Fang M, 2003, J PHYSIOL-LONDON, V549, P903, DOI 10.1113/jphysiol.2002.036384; Gao Yong-Jing, 2009, Open Pain J, V2, P11; Garcia PS, 2010, THROMB HAEMOSTASIS, V103, P1145, DOI 10.1160/TH09-12-0848; Gosalia DN, 2005, PROTEOMICS, V5, P1292, DOI 10.1002/pmic.200401011; Haldeman S, 2008, SPINE, V33, pS5; Hubbard RD, 2008, EXP NEUROL, V212, P482, DOI 10.1016/j.expneurol.2008.04.042; Hubbard RD, 2008, STAPP CAR C, V52, P33; Hubbard RD, 2005, SPINE, V30, P1924, DOI 10.1097/01.brs.0000176239.72928.00; Ignjatovic Vera, 2013, Methods Mol Biol, V992, P131, DOI 10.1007/978-1-62703-339-8_10; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; KANGRGA I, 1990, J NEUROSCI, V10, P2026; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Ma L, 2012, SEMIN IMMUNOPATHOL, V34, P63, DOI 10.1007/s00281-011-0281-9; Manseth E, 2004, J BIOCHEM BIOPH METH, V60, P39, DOI 10.1016/j.jbbm.2004.04.016; Martin L, 2009, PAIN, V146, P121, DOI 10.1016/j.pain.2009.07.016; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; McNicol E, J PAIN, V4, P231; Melzack R, 1994, TXB PAIN; Michaud SE, 2002, THROMB RES, V107, P245, DOI 10.1016/S0049-3848(02)00333-X; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Neigo B, 2011, BRAIN RES, V1381, P31; Nicholson KJ, 2014, J NEUROSCI RES, V92, P116, DOI 10.1002/jnr.23295; Nicholson KJ, 2012, NEUROSCIENCE, V209, P187, DOI 10.1016/j.neuroscience.2012.02.027; Nicholson Kristen J, 2011, Stapp Car Crash J, V55, P1; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; Pompili E, 2011, J HISTOCHEM CYTOCHEM, V59, P302, DOI 10.1369/0022155410397996; Quinn KP, 2010, PAIN, V151, P414, DOI 10.1016/j.pain.2010.07.034; Rothman SM, 2007, BRAIN RES, V1181, P30, DOI 10.1016/j.brainres.2007.08.064; Rothman SM, 2010, ANN BIOMED ENG, V38, P2563, DOI 10.1007/s10439-010-0012-8; Rothman SM, 2009, J PAIN, V10, P90, DOI 10.1016/j.jpain.2008.07.008; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016; Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x; Simmons S, 2013, NEUROREPORT, V24, P36, DOI 10.1097/WNR.0b013e32835c1de4; SMULLIN DH, 1990, PAIN, V42, P93, DOI 10.1016/0304-3959(90)91095-Z; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; Uibo R, 2009, BBA-MOL CELL RES, V1793, P924, DOI 10.1016/j.bbamcr.2009.01.007; Vallejo R, 2010, PAIN PRACT, V10, P167, DOI 10.1111/j.1533-2500.2010.00367.x; Vellani V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-61; Vergnolle N, 1999, BRIT J PHARMACOL, V126, P1262, DOI 10.1038/sj.bjp.0702408; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vranken Jan H., 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P71; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Weisshaar CL, 2011, BIOMATERIALS, V32, P9738, DOI 10.1016/j.biomaterials.2011.09.021; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382; Winkelstein BA, 2002, BRAIN RES, V956, P294, DOI 10.1016/S0006-8993(02)03560-6; Winkelstein BA, 2001, J COMP NEUROL, V439, P127; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	79	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80006	10.1371/journal.pone.0080006	http://dx.doi.org/10.1371/journal.pone.0080006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278231	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100071
J	Srinivasan, S; Morgan, MT; Liu, CZ; Matsen, FA; Hoffman, NG; Fiedler, TL; Agnew, KJ; Marrazzo, JM; Fredricks, DN				Srinivasan, Sujatha; Morgan, Martin T.; Liu, Congzhou; Matsen, Frederick A.; Hoffman, Noah G.; Fiedler, Tina L.; Agnew, Kathy J.; Marrazzo, Jeanne M.; Fredricks, David N.			More Than Meets the Eye: Associations of Vaginal Bacteria with Gram Stain Morphotypes Using Molecular Phylogenetic Analysis	PLOS ONE			English	Article							METRONIDAZOLE THERAPY; VAGINOSIS; BACTEROIDES; GENUS; IDENTIFICATION; MICROFLORA; MOBILUNCUS; PREVOTELLA; SEQUENCES; PROPOSAL	Bacterial vaginosis (BV) is a highly prevalent condition associated with adverse health outcomes. Gram stain analysis of vaginal fluid is the standard for confirming the diagnosis of BV, wherein abundances of key bacterial morphotypes are assessed. These Lactobacillus, Gardnerella, Bacteroides, and Mobiluncus morphotypes were originally linked to particular bacterial species through cultivation studies, but no studies have systematically investigated associations between uncultivated bacteria detected by molecular methods and Gram stain findings. In this study, 16S-rRNA PCR/pyrosequencing was used to examine associations between vaginal bacteria and bacterial morphotypes in 220 women with and without BV. Species-specific quantitative PCR (qPCR) and fluorescence in Situ hybridization (FISH) methods were used to document concentrations of two bacteria with curved rod morphologies: Mobiluncus and the fastidious BV-associated bacterium-1 (BVAB1). Rank abundance of vaginal bacteria in samples with evidence of curved gram-negative rods showed that BVAB1 was dominant (26.1%), while Mobiluncus was rare (0.2% of sequence reads). BVAB1 sequence reads were associated with Mobiluncus morphotypes (p<0.001). Among women with curved rods, mean concentration of BVAB1 DNA was 2 log units greater than Mobiluncus (p<0.001) using species-specific quantitative PCR. FISH analyses revealed that mean number of BVAB1 cells was 2 log units greater than Mobiluncus cells in women with highest Nugent score (p<0.001). Prevotella and Porphyromonas spp. were significantly associated with the "Bacteroides morphotype," whereas Bacteroides species were rare. Gram-negative rods designated Mobiluncus morphotypes on Gram stain are more likely BVAB1. These findings provide a clearer picture of the bacteria associated with morphotypes on vaginal Gram stain.	[Srinivasan, Sujatha; Liu, Congzhou; Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Morgan, Martin T.; Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Agnew, Kathy J.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Marrazzo, Jeanne M.; Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fhcrc.org; dfredric@fhcrc.org		Fredricks, David/0000-0003-2735-6800; Marrazzo, Jeanne/0000-0002-9277-7364; Morgan, Martin/0000-0002-5874-8148	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH) [R01 AI061628]; National Human Genome Research Institute (NHGRI), division of NIH [R01 HG005966-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), division of National Institutes of Health (NIH); National Human Genome Research Institute (NHGRI), division of NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded with grants R01 AI061628 to Dr. DNF from National Institute of Allergy and Infectious Diseases (NIAID) (www3.niaid.nih.gov), division of National Institutes of Health (NIH) and R01 HG005966-01 to Dr. DNF and Dr. FAM (co-PIs) from National Human Genome Research Institute (NHGRI) (www.genome.gov), division of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; BINGEN E, 1990, EUR J CLIN MICROBIOL, V9, P278, DOI 10.1007/BF01968060; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Holst E, 1984, Scand J Urol Nephrol Suppl, V86, P117; Hummelen R, 2010, PLOS ONE, V5; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; Morgan M, 2012, DIRICHLET MULTINOMIA; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7; PASTER BJ, 1994, J BACTERIOL, V176, P725, DOI 10.1128/jb.176.3.725-732.1994; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBERTS MC, 1985, J INFECT DIS, V152, P74, DOI 10.1093/infdis/152.1.74; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwebke JR, 2007, CLIN INFECT DIS, V44, P213, DOI 10.1086/509577; SHAH HN, 1989, INT J SYST BACTERIOL, V39, P85, DOI 10.1099/00207713-39-1-85; SHAH HN, 1988, INT J SYST BACTERIOL, V38, P128, DOI 10.1099/00207713-38-1-128; SHAH HN, 1990, INT J SYST BACTERIOL, V40, P205, DOI 10.1099/00207713-40-2-205; Sobel J, 2001, Infect Dis Obstet Gynecol, V9, P9, DOI 10.1155/S1064744901000035; SPIEGEL CA, 1980, NEW ENGL J MED, V303, P601, DOI 10.1056/NEJM198009113031102; SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983; Srinivasan S, 2012, PLOS ONE, V7; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thoma ME, 2011, SEX TRANSM DIS, V38, P1040, DOI 10.1097/OLQ.0b013e3182275499; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	39	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78633	10.1371/journal.pone.0078633	http://dx.doi.org/10.1371/journal.pone.0078633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302980	Green Published, gold, Green Submitted			2022-12-27	WOS:000326152300075
J	Chakravarthy, VS				Chakravarthy, V. Srinivasa			Do Basal Ganglia Amplify Willed Action by Stochastic Resonance? A Model	PLOS ONE			English	Article							PRECEDING VOLUNTARY MOVEMENT; SUPPLEMENTARY MOTOR AREA; SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; NOISE; SYSTEM; CORTEX; CIRCUITS; MECHANORECEPTORS; OSCILLATIONS	Basal ganglia are usually attributed a role in facilitating willed action, which is found to be impaired in Parkinson's disease, a pathology of basal ganglia. We hypothesize that basal ganglia possess the machinery to amplify will signals, presumably weak, by stochastic resonance. Recently we proposed a computational model of Parkinsonian reaching, in which the contributions from basal ganglia aid the motor cortex in learning to reach. The model was cast in reinforcement learning framework. We now show that the above basal ganglia computational model has all the ingredients of stochastic resonance process. In the proposed computational model, we consider the problem of moving an arm from a rest position to a target position: the two positions correspond to two extrema of the value function. A single kick (a half-wave of sinusoid, of sufficiently low amplitude) given to the system in resting position, succeeds in taking the system to the target position, with high probability, only at a critical noise level. But for suboptimal noise levels, the model arm's movements resemble Parkinsonian movement symptoms like akinetic rigidity (low noise) and dyskinesias (high noise).	Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Chakravarthy, VS (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	schakra@iitm.ac.in		Chakravarthy, Srinivasa/0000-0002-2453-1637				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashby FG, 2007, PSYCHOL REV, V114, P632, DOI 10.1037/0033-295X.114.3.632; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Baunez C, 2007, EUR J NEUROSCI, V25, P1187, DOI 10.1111/j.1460-9568.2007.05373.x; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Clark DL, 2005, BRAIN AND BEHAVIOR: AN INTRODUCTION TO BEHAVIORAL NEUROANATOMY, P1, DOI 10.1017/CBO9780511543661; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; CRITCHLEY EMR, 1981, J NEUROL NEUROSUR PS, V44, P751, DOI 10.1136/jnnp.44.9.751; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; Damasio A, 1980, NEUROLOGY, V30, P1983; Deecke L., 2003, BEREITSCHAFTSPOTENTI, P283, DOI [10.1007/978-1-4615-0189-3_17, DOI 10.1007/978-1-4615-0189-3_17]; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Frith C D, 1991, Br J Psychiatry Suppl, P26; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hikosaka O, 2002, EXP BRAIN RES, V147, P494, DOI 10.1007/s00221-002-1258-7; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; Jahanshahi M, 1998, COGN NEUROPSYCHOL, V15, P483, DOI 10.1080/026432998381005; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Kalva SK, 2012, NEURAL NETWORKS, V32, P65, DOI 10.1016/j.neunet.2012.02.031; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Krishnan R, 2011, NEURAL NETWORKS, V24, P801, DOI 10.1016/j.neunet.2011.06.002; LANG W, 1991, EXP BRAIN RES, V87, P688; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Magdoom KN, 2011, NEURAL COMPUT, V23, P477, DOI 10.1162/NECO_a_00073; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mejias JF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228102; Mejias JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017255; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; Norman D.A., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pinamonti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051170; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schurger A, 2012, P NATL ACAD SCI USA, V109, pE2904, DOI 10.1073/pnas.1210467109; Sridharan D, 2006, INT J NEURAL SYST, V16, P111, DOI 10.1142/S0129065706000548; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tessone CJ, 2007, PHYSICA A, V374, P46, DOI 10.1016/j.physa.2006.06.026; Todorov E, 2005, NEURAL COMPUT, V17, P1084, DOI 10.1162/0899766053491887; Torres JJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053014; Townsend BR, 2006, J NEUROPHYSIOL, V96, P2578, DOI 10.1152/jn.01086.2005; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858, DOI 10.1152/jn.2001.85.5.1858; Yasuda H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118103; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	68	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e75657	10.1371/journal.pone.0075657	http://dx.doi.org/10.1371/journal.pone.0075657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24302984	gold, Green Published, Green Submitted			2022-12-27	WOS:000327546400002
J	Geng, Y; Li, L; Dong, YY; Liu, X; Li, XH; Ning, W				Geng, Yan; Li, Lian; Dong, Yingying; Liu, Xue; Li, Xiao-He; Ning, Wen			Impaired Elastin Deposition in Fstl1(-/-) Lung Allograft under the Renal Capsule	PLOS ONE			English	Article							FOLLISTATIN-LIKE 1; HUMAN FETAL LUNG; DEFICIENT MICE; SURFACE-AREA; DISTAL LUNG; MOUSE LUNG; CELL; GENE; PROTEIN; MORPHOGENESIS	Lung alveolar development in late gestation is a process important to postnatal survival. Follistatin-like 1 (Fstl1) is a matricellular protein of the Bmp antagonist class, which is involved in the differentiation/maturation of alveolar epithelial cells during saccular stage of lung development. This study investigates the role of Fstl1 on elastin deposition in mesenchyme and subsequent secondary septation in the late gestation stage of terminal saccular formation. To this aim, we modified the renal capsule allograft model for lung organ culture by grafting diced E15.5 distal lung underneath the renal capsule of syngeneic host and cultured up to 7 days. The saccular development of the diced lung allografts, as indicated by the morphology, epithelial and vascular developments, occurred in a manner similar to that in utero. Fstl1 deficiency caused atelectatic phenotype companied by impaired epithelial differentiation in D3 Fstl1(-/-) lung allografts, which is similar to that of E18.5 Fstl1(-/-) lungs, supporting the role of Fstl1 during saccular stage. Inhibition of Bmp signaling by intraperitoneal injection of dorsomorphin in the host mice rescued the pulmonary atelectasis of D3 Fstl1(-/-) allografts. Furthermore, a marked reduction in elastin expression and deposition was observed in walls of air sacs of E18.5 Fstl1(-/-) lungs and at the tips of the developing alveolar septae of D7 Fstl1(-/-) allografts. Thus, in addition to its role on alveolar epithelium, Fstl1 is crucial for elastin expression and deposition in mesenchyme during lung alveologenesis. Our data demonstrates that the modified renal capsule allograft model for lung organ culture is a robust and efficient technique to increase our understanding of saccular stage of lung development.	[Geng, Yan; Li, Lian; Dong, Yingying; Liu, Xue; Li, Xiao-He; Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Geng, Yan] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi, Peoples R China	Nankai University; Jiangnan University	Ning, W (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	ningwen108@nankai.edu.cn	Geng, Yan/ABH-7789-2022; Liu, Xue/ABC-1127-2021	Liu, Xue/0000-0002-2104-9335; Geng, Yan/0000-0001-8861-7686	Ministry of Science and Technology of China [2009CB522101]; National Natural Science Foundation of China [30771130, 31271559, 31201020]; 111 project [B08011]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the Ministry of Science and Technology of China (2009CB522101) http://www.most.gov.cn/; the National Natural Science Foundation of China (30771130, 31271559, and 31201020) http://www.nsfc.gov.cn/Portal0/default152.htm; and the 111 project (B08011) http://www.moe.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JT, 2009, DEV BIOL, V335, P407, DOI 10.1016/j.ydbio.2009.09.021; BLANCO LN, 1991, AM J PHYSIOL, V261, pL370, DOI 10.1152/ajplung.1991.261.6.L370; BOLENDER RP, 1993, AM J PHYSIOL, V265, pL521, DOI 10.1152/ajplung.1993.265.6.L521; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Cardoso Wellington V, 2008, Proc Am Thorac Soc, V5, P767, DOI 10.1513/pats.200803-026HR; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chinoy MR, 2005, J SURG RES, V124, P14, DOI 10.1016/j.jss.2004.09.022; Clutter SD, 2009, J IMMUNOL, V182, P234, DOI 10.4049/jimmunol.182.1.234; COBB LM, 1975, THORAX, V30, P357, DOI 10.1136/thx.30.3.357; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; De Paepe ME, 2012, PEDIATR PULM, V47, P1192, DOI 10.1002/ppul.22617; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Ehara Y, 2004, CLIN EXP RHEUMATOL, V22, P707; Esterberg R, 2008, DEVELOPMENT, V135, P3891, DOI 10.1242/dev.029264; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; GIOVANELLA BC, 1985, ADV CANCER RES, V44, P69, DOI 10.1016/S0065-230X(08)60026-3; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; HOWETT MK, 1990, INTERVIROLOGY, V31, P109, DOI 10.1159/000150144; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063578; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Mandeville I, 2006, AM J PATHOL, V169, P1312, DOI 10.2353/ajpath.2006.051333; Massaro GD, 1996, ANNU REV PHYSIOL, V58, P73; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murakami K, 2012, FEBS LETT, V586, P319, DOI 10.1016/j.febslet.2012.01.010; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Pavlovic J, 2008, EARLY HUM DEV, V84, P181, DOI 10.1016/j.earlhumdev.2007.04.002; Robertson Nathan J, 2007, Methods Mol Biol, V380, P347; Sanchez-Esteban J, 2001, J APPL PHYSIOL, V91, P589, DOI 10.1152/jappl.2001.91.2.589; Schwarz MA, 2000, AM J PHYSIOL-LUNG C, V278, pL1000, DOI 10.1152/ajplung.2000.278.5.L1000; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shimano M, 2011, P NATL ACAD SCI USA, V108, pE899, DOI 10.1073/pnas.1108559108; Snyder JM, 2005, PEDIATR RES, V57, P384, DOI 10.1203/01.PDR.0000151315.81106.D3; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 1998, INT IMMUNOL, V10, P1305, DOI 10.1093/intimm/10.9.1305; Towers P, 1999, DEV BIOL, V214, P298, DOI 10.1006/dbio.1999.9421; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Vu TH, 2003, MECH DEVELOP, V120, P305, DOI 10.1016/S0925-4773(02)00451-3; Weinstein DC, 1998, NATURE, V394, P904, DOI 10.1038/29808; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Wilkinson GA, 2008, DEV DYNAM, V237, P2220, DOI 10.1002/dvdy.21643; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Zhao Li qing, 2004, Shi Yan Sheng Wu Xue Bao, V37, P303; Zhou JL, 2006, GENE, V372, P191, DOI 10.1016/j.gene.2005.12.020	54	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81368	10.1371/journal.pone.0081368	http://dx.doi.org/10.1371/journal.pone.0081368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282586	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500088
J	Smith, RJ; Jeffries, TC; Adetutu, EM; Fairweather, PG; Mitchell, JG				Smith, Renee. J.; Jeffries, Thomas C.; Adetutu, Eric M.; Fairweather, Peter G.; Mitchell, James G.			Determining the Metabolic Footprints of Hydrocarbon Degradation Using Multivariate Analysis	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; DEGRADING BACTERIA; CONTAMINATED SOIL; CRUDE-OIL; BIOREMEDIATION; DYNAMICS; BIODEGRADATION; MICROORGANISMS; METAGENOMICS; ECOSYSTEMS	The functional dynamics of microbial communities are largely responsible for the clean-up of hydrocarbons in the environment. However, knowledge of the distinguishing functional genes, known as the metabolic footprint, present in hydrocarbon-impacted sites is still scarcely understood. Here, we conducted several multivariate analyses to characterise the metabolic footprints present in a variety of hydrocarbon-impacted and non-impacted sediments. Non-metric multi-dimensional scaling (NMDS) and canonical analysis of principal coordinates (CAP) showed a clear distinction between the two groups. A high relative abundance of genes associated with cofactors, virulence, phages and fatty acids were present in the non-impacted sediments, accounting for 45.7 % of the overall dissimilarity. In the hydrocarbon-impacted sites, a high relative abundance of genes associated with iron acquisition and metabolism, dormancy and sporulation, motility, metabolism of aromatic compounds and cell signalling were observed, accounting for 22.3 % of the overall dissimilarity. These results suggest a major shift in functionality has occurred with pathways essential to the degradation of hydrocarbons becoming overrepresented at the expense of other, less essential metabolisms.	[Smith, Renee. J.; Adetutu, Eric M.; Fairweather, Peter G.; Mitchell, James G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Jeffries, Thomas C.] Univ Technol Sydney, Sydney, NSW 2007, Australia	Flinders University South Australia; University of Technology Sydney	Smith, RJ (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	renee.smith@flinders.edu.au	Jeffries, Thomas/D-4270-2018; Jeffries, Thomas/E-8679-2013	Mitchell, Jim/0000-0002-8445-0935; Jeffries, Thomas/0000-0001-6479-0353; Fairweather, Peter/0000-0001-5927-3044	Australian Research Council (ARC) [LP0776478]	Australian Research Council (ARC)(Australian Research Council)	Funding for this manuscrip was provided by the Australian Research Council (ARC linkage grant LP0776478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Anderson TH, 2003, AGR ECOSYST ENVIRON, V98, P285, DOI 10.1016/S0167-8809(03)00088-4; Avidano L, 2005, APPL SOIL ECOL, V30, P21, DOI 10.1016/j.apsoil.2005.01.003; Baker KL, 2009, SOIL BIOL BIOCHEM, V41, P2292, DOI 10.1016/j.soilbio.2009.08.010; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bastias BA, 2006, SOIL BIOL BIOCHEM, V38, P3492, DOI 10.1016/j.soilbio.2006.06.007; BELLER HR, 1992, APPL ENVIRON MICROB, V58, P786, DOI 10.1128/AEM.58.3.786-793.1992; Bonjoch X, 2004, APPL ENVIRON MICROB, V70, P3171, DOI 10.1128/AEM.70.5.3171-3175.2004; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buyer JS, 1997, J MICROBIOL METH, V30, P3, DOI 10.1016/S0167-7012(97)00038-9; Chakraborty R, 2012, CURR OPIN BIOTECH, V23, P483, DOI 10.1016/j.copbio.2012.01.015; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chikere CB, 2011, 3 BIOTECH, V1, P117, DOI 10.1007/s13205-011-0014-8; Clarke A, 2006, PRIMER V6 USER MANUL; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cookson WR, 2007, SOIL BIOL BIOCHEM, V39, P744, DOI 10.1016/j.soilbio.2006.09.022; Delille D, 2000, MAR ENVIRON RES, V49, P403, DOI 10.1016/S0141-1136(99)00080-X; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fernandez-Luqueno F, 2011, ENVIRON SCI POLLUT R, V18, P12, DOI 10.1007/s11356-010-0371-6; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hamamura N, 2006, APPL ENVIRON MICROB, V72, P6316, DOI 10.1128/AEM.01015-06; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Henriques IDS, 2007, ENVIRON SCI TECHNOL, V41, P3945, DOI 10.1021/es062796t; Hernesmaa A, 2005, SOIL BIOL BIOCHEM, V37, P777, DOI 10.1016/j.soilbio.2004.10.010; Jeffries TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025173; Karl DM, 2002, TRENDS MICROBIOL, V10, P410, DOI 10.1016/S0966-842X(02)02430-7; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Langworthy DE, 1998, APPL ENVIRON MICROB, V64, P3422; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Liang YT, 2009, CHEMOSPHERE, V75, P193, DOI 10.1016/j.chemosphere.2008.12.007; Maila MP, 2005, INT BIODETER BIODEGR, V55, P1, DOI 10.1016/j.ibiod.2004.10.003; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mohan S. Venkata, 2006, Reviews in Environmental Science and Bio/Technology, V5, P347, DOI 10.1007/s11157-006-0004-1; Ortega-Calvo JJ, 2003, FEMS MICROBIOL ECOL, V44, P373, DOI 10.1016/S0168-6496(03)00092-8; Pelz O, 1999, ENVIRON MICROBIOL, V1, P167, DOI 10.1046/j.1462-2920.1999.00023.x; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Ron EZ, 2002, CURR OPIN BIOTECH, V13, P249, DOI 10.1016/S0958-1669(02)00316-6; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Singh AK, 2011, APPL MICROBIOL MOL B, P199, DOI [10.1007/978-90-481-9252-6_24, DOI 10.1007/978-90-481-9252-6_]; SINGLETON I, 1994, J CHEM TECHNOL BIOT, V59, P9, DOI 10.1002/jctb.280590104; Smith RJ, 2012, ENVIRON MICROBIOL, V14, P240, DOI 10.1111/j.1462-2920.2011.02614.x; Steube C, 2009, HYDROGEOL J, V17, P23, DOI 10.1007/s10040-008-0346-6; Suenaga H, 2007, ENVIRON MICROBIOL, V9, P2289, DOI 10.1111/j.1462-2920.2007.01342.x; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Walworth J, 2007, COLD REG SCI TECHNOL, V48, P84, DOI 10.1016/j.coldregions.2006.07.001; Watanabe K, 2001, CURR OPIN BIOTECH, V12, P237, DOI 10.1016/S0958-1669(00)00205-6; WILLIAMS BK, 1988, ECOLOGY, V69, P1275, DOI 10.2307/1941283; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4; Wu YC, 2008, BIODEGRADATION, V19, P247, DOI 10.1007/s10532-007-9131-9; Xu R, 2003, WORLD J MICROB BIOT, V19, P719, DOI 10.1023/A:1025116421986; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09; [No title captured], DOI DOI 10.1023/A:1009971414055	67	11	11	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81910	10.1371/journal.pone.0081910	http://dx.doi.org/10.1371/journal.pone.0081910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282619	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500123
J	Tsuchimine, S; Yasui-Furukori, N; Kaneda, A; Kaneko, S				Tsuchimine, Shoko; Yasui-Furukori, Norio; Kaneda, Ayako; Kaneko, Sunao			Differential Effects of the Catechol-O-Methyltransferase Val158Met Genotype on the Cognitive Function of Schizophrenia Patients and Healthy Japanese Individuals	PLOS ONE			English	Article							VAL(158)MET POLYMORPHISM; WORKING-MEMORY; GENE POLYMORPHISM; MESSENGER-RNA; COMT; PERFORMANCE; ASSOCIATIONS; METAANALYSIS; VARIANTS; DOPAMINE	Background: The functional polymorphism Val158Met in the catechol-O-methyltransferase (COMT) gene has been associated with differences in prefrontal cognitive functions in patients with schizophrenia and healthy individuals. Several studies have indicated that the Met allele is associated with better performance on measures of cognitive function. We investigated whether the COMT Val158Met genotype was associated with cognitive function in 149 healthy controls and 118 patients with schizophrenia. Methods: Cognitive function, including verbal memory, working memory, motor speed, attention, executive function and verbal fluency, was assessed by the Brief Assessment of Cognition in Schizophrenia (BACS-J). We employed a one-way analysis of variance (ANOVA) and a multiple regression analysis to determine the associations between the COMT Val158Met genotype and the BACS-J measurements. Results: The one-way ANOVA revealed a significant difference in the scores on the Tower of London, a measure of executive function, between the different Val158Met genotypes in the healthy controls (p = 0.023), and a post-hoc analysis showed significant differences between the scores on the Tower of London in the val/val genotype group (18.6 +/- 2.4) compared to the other two groups (17.6 +/- 2.7 for val/met and 17.1 +/- 3.2 for met/met; p = 0.027 and p = 0.024, respectively). Multiple regression analyses revealed that executive function was significantly correlated with the Val158Met genotype (p = 0.003). However, no evidence was found for an effect of the COMT on any cognitive domains of the BACS-J in the patients with schizophrenia. Conclusion: These data support the hypothesis that the COMT Val158Met genotype maintains an optimal level of dopamine activity. Further studies should be performed that include a larger sample size and include patients on and off medication, as these patients would help to confirm our findings.	[Tsuchimine, Shoko; Yasui-Furukori, Norio; Kaneda, Ayako; Kaneko, Sunao] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan	Hirosaki University	Yasui-Furukori, N (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	yasufuru@cc.hirosaki-u.ac.jp			Japan Society for the Promotion of Research (JSPS) [24590652]; Mitsubishi Pharma Research Foundation; Hirosaki Research Institute for Neurosciences; Astra; Dainippon; Eli Lilly; GSK; Janssen-Pharma; Meiji; Mochida; MSD; Otsuka; Pfizer; Takada; Yoshitomi	Japan Society for the Promotion of Research (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Pharma Research Foundation; Hirosaki Research Institute for Neurosciences(Hirosaki Research Institute for Neurosciences); Astra; Dainippon; Eli Lilly(Eli Lilly); GSK(GlaxoSmithKline); Janssen-Pharma; Meiji; Mochida; MSD; Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Takada; Yoshitomi(Mitsubishi Tanabe Pharma Corporation)	This study was funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research (JSPS, # 24590652), Mitsubishi Pharma Research Foundation. Asteras Schizophrenia Research Foundation and a grant from the Hirosaki Research Institute for Neurosciences. Norio Yasui-Furukori has received grant/research support or honoraria from, and been on the speakers of Astra, Dainippon, Eli Lilly, GSK, Janssen-Pharma, Meiji. Mochida, MSD, Otsuka, Pfizer, Takada and Yoshitomi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil M, 2003, J NEUROSCI, V23, P2008; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Crocker A. D., 1994, AUST PRESCR, V17, P17; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Dickerson FB, 2007, SCHIZOPHR RES, V96, P87, DOI 10.1016/j.schres.2007.05.021; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; First M. B., 1997, STRUCTURED CLIN INTE; Galderisi S, 2005, NEUROPSYCHOBIOLOGY, V52, P83, DOI 10.1159/000087096; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Leung Winnie W, 2007, Neuropsychiatr Dis Treat, V3, P925; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Moron JA, 2002, J NEUROSCI, V22, P389, DOI 10.1523/JNEUROSCI.22-02-00389.2002; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Carroll R., 2000, ADV PSYCHIAT TREAT, V6, P161, DOI [10.1192/apt.6.3.161, DOI 10.1192/APT.6.3.161]; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prata DP, 2009, BIOL PSYCHIAT, V65, P473, DOI 10.1016/j.biopsych.2008.09.027; Saito S, 2001, J HUM GENET, V46, P529, DOI 10.1007/s100380170035; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Stefanis NC, 2004, BIOL PSYCHIAT, V56, P510, DOI 10.1016/j.biopsych.2004.06.038; Szoke A, 2006, AM J MED GENET B, V141B, P504, DOI 10.1002/ajmg.b.30352; Tsai SJ, 2003, NEUROSCI LETT, V338, P123, DOI 10.1016/S0304-3940(02)01396-4; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e76763	10.1371/journal.pone.0076763	http://dx.doi.org/10.1371/journal.pone.0076763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282499	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500005
J	Liu, CB; Mou, SH; Cai, YQ				Liu, Chibo; Mou, Sihua; Cai, Yangqun			FTO Gene Variant and Risk of Overweight and Obesity among Children and Adolescents: a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; FAT MASS; EARLY-ONSET; RS9939609 POLYMORPHISM; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; DIETARY-INTAKE; ADULT OBESITY; ENERGY-INTAKE	Objective: The fat mass and obesity associated gene (FTO) polymorphisms have been implicated in the susceptibility of overweight/obesity in children and adolescents. However, the results have been inconsistent. In this study, we performed a meta-analysis to clarify the association of FTO gene polymorphisms with overweight/obesity risk among children and adolescents. Methods: PubMed and Embase were used to search for eligible published literatures. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-or fixed-effect models. Results: A total of 21 articles containing 23 studies (11208cases and 35015controls) were included in our analysis. The results indicated that variant in FTO gene was significantly associated with increased risk of overweight/obesity in children and adolescents (OR=1.35; 95% CI: 1.27-1.44; P<0.001). The overall pooled ORs for risk obesity and overweight were 1.34 (95% CI: 1.21-1.48) and 1.35 (95% CI: 1.25-1.47), respectively. Subgroup analyses also showed similar trends in most subgroups of adjustment for covariates and unadjustment, different ethnicities (Caucasians, Asians, and Amerindians), and each of three investigated polymorphisms (rs9939609, rs1421085, and rs1558902). Conclusions: The present meta-analysis suggested a positive association between FTO gene polymorphism and overweight/obesity risk among children and adolescents. Further prospective studies should be recommended to confirm the observed association, and underlying mechanism should be investigated to clarify the association of FTO gene polymorphism with overweight/obesity.	[Liu, Chibo; Mou, Sihua; Cai, Yangqun] Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Zhejiang, Peoples R China	Taizhou University	Liu, CB (corresponding author), Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Zhejiang, Peoples R China.	chibo_liu@163.com						Albuquerque D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054370; Almen MS, 2013, INT J OBESITY, V37, P424, DOI 10.1038/ijo.2012.57; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Dwivedi OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047772; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elks CE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000284; Fang HY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-136; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gonzalez JR, 2012, OBESITY, V20, P909, DOI 10.1038/oby.2011.325; Goran MI, 2001, AM J CLIN NUTR, V73, P158; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Lauria F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048876; Lee HJ, 2010, CLIN CHIM ACTA, V411, P1716, DOI 10.1016/j.cca.2010.07.010; Liu GF, 2011, EUR J EPIDEMIOL, V26, P463, DOI 10.1007/s10654-011-9583-4; Luczynski W, 2012, J PHYSIOL PHARMACOL, V63, P241; Mangge H, 2011, J OBES, V2011, DOI 10.1155/2011/186368; Mantel N, 2004, CHALLENGE EPIDEMIOLO, V1, P533; Mejia-Benitez A, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-21; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moleres A, 2012, BRIT J NUTR, V107, P533, DOI 10.1017/S0007114511003424; Muller TD, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-85; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Ntalla I, 2013, ANN HUM GENET, V77, P268, DOI 10.1111/ahg.12012; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Okuda M, 2011, PEDIATR DIABETES, V12, P494, DOI 10.1111/j.1399-5448.2010.00727.x; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Riffo B, 2012, PEDIATR DIABETES, V13, P392, DOI 10.1111/j.1399-5448.2011.00834.x; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Xi Bo, 2012, PLoS One, V7, pe45731, DOI 10.1371/journal.pone.0045731; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Zavattari P, 2011, ANN HUM GENET, V75, P648, DOI 10.1111/j.1469-1809.2011.00674.x; Zhao JH, 2011, J OBES, V2011, DOI 10.1155/2011/845148	54	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82133	10.1371/journal.pone.0082133	http://dx.doi.org/10.1371/journal.pone.0082133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278475	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700075
J	Donaldson, AE; Lamont, IL				Donaldson, Andrea E.; Lamont, Iain L.			Biochemistry Changes That Occur after Death: Potential Markers for Determining Post-Mortem Interval	PLOS ONE			English	Article							URIC-ACID LEVELS; INTESTINAL MICROBIOTA; FORMIC-ACID; HYPOXANTHINE; XANTHINE; FORMATE; PLASMA; BLOOD; INDICATOR; EVOLUTION	Death is likely to result in very extensive biochemical changes in all body tissues due to lack of circulating oxygen, altered enzymatic reactions, cellular degradation, and cessation of anabolic production of metabolites. These biochemical changes may provide chemical markers for helping to more accurately determine the time since death (post-mortem interval), which is challenging to establish with current observation-based methodologies. In this study blood pH and changes in concentration of six metabolites (lactic acid, hypoxanthine, uric acid, ammonia, NADH and formic acid) were examined post-mortem over a 96 hour period in blood taken from animal corpses (rat and pig) and blood from rats and humans stored in vitro. The pH and the concentration of all six metabolites changed post-mortem but the extent and rate of change varied. Blood pH in corpses fell from 7.4 to 5.1. Concentrations of hypoxanthine, ammonia, NADH and formic acid all increased with time and these metabolites may be potential markers for postmortem interval. The concentration of lactate increased and then remained at an elevated level and changes in the concentration were different in the rat compared to the human and pig. This is the first systematic study of multiple metabolic changes post-mortem and demonstrates the nature and extent of the changes that occur, in addition to identifying potential markers for estimating post-mortem interval.	[Donaldson, Andrea E.; Lamont, Iain L.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago	Donaldson, AE (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	andrea.donaldson@otago.ac.nz; iain.lamont@otago.ac.nz	Donaldson, Andrea/AAY-4477-2020	Donaldson, Andrea/0000-0002-8548-4221; Lamont, Iain/0000-0002-7601-6354	Ministry of Science and innovation, Wellington, New Zealand [UOOX0916]	Ministry of Science and innovation, Wellington, New Zealand	This research was supported by a Te Tipu Putaiao PhD scholarship from the Ministry of Science and innovation, Wellington, New Zealand, Grant Number - UOOX0916 (http://www.msi.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHALIDI UA, 1965, BIOCHEM J, V97, P318, DOI 10.1042/bj0970318; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; BOULIEU R, 1983, ANAL BIOCHEM, V129, P398, DOI 10.1016/0003-2697(83)90568-7; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; BROOKS GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI DOI 10.1113/JPHYSI0L.2009.178350; BUCHAN MJ, 2001, CANADIAN SOC FORENSI, V34, P1, DOI DOI 10.1080/00085030.2001.10757514; BUTTERY JE, 1988, J ANAL TOXICOL, V12, P292, DOI 10.1093/jat/12.5.292; Cook RJ, 2001, ARCH BIOCHEM BIOPHYS, V393, P192, DOI 10.1006/abbi.2001.2485; Cotran RS, 1994, ROBBINS PATHOLOGIC B, P4; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; EGOROV AM, 1979, EUR J BIOCHEM, V99, P569, DOI 10.1111/j.1432-1033.1979.tb13289.x; Gawehn K, 1974, METHODS ENZYMATIC AN; HARKNESS RA, 1988, J CHROMATOGR-BIOMED, V429, P255, DOI 10.1016/S0378-4347(00)83873-6; Inoue R, 2005, J GEN APPL MICROBIOL, V51, P257, DOI 10.2323/jgam.51.257; Inoue R, 2003, FEMS MICROBIOL ECOL, V45, P147, DOI 10.1016/S0168-6496(03)00134-X; Jetter W., 1959, J FORENSIC SCI, V4, P330; KRAEMER RJ, 1968, J BIOL CHEM, V243, P6402; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; LIESIVUORI J, 1991, PHARMACOL TOXICOL, V69, P157, DOI 10.1111/j.1600-0773.1991.tb01290.x; Marieb E, 2000, ESSENTIALS HUMAN ANA, V6th ed.; MOLE RH, 1948, J PATHOL BACTERIOL, V60, P413, DOI 10.1002/path.1700600308; Murray R, 2006, HARPERS ILLUSTRATED; NICHOLLS P, 1976, BIOCHIM BIOPHYS ACTA, V430, P13, DOI 10.1016/0005-2728(76)90218-8; Parkinson RA, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P379, DOI 10.1007/978-1-4020-9204-6_24; PENTTILA A, 1981, FORENSIC SCI INT, V17, P121, DOI 10.1016/0379-0738(81)90004-9; POULSEN JP, 1990, PEDIATR RES, V28, P477, DOI 10.1203/00006450-199011000-00012; POULSEN JP, 1990, PEDIATR RES, V28, P482, DOI 10.1203/00006450-199011000-00013; Powers RH, 2005, FORENSIC SCI MED, P3, DOI 10.1385/1-59259-897-8:003; ROGNUM TO, 1991, FORENSIC SCI INT, V51, P139, DOI 10.1016/0379-0738(91)90214-4; SAUGSTAD OD, 1988, PEDIATR RES, V23, P143, DOI 10.1203/00006450-198802000-00001; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; SAWYER WR, 1988, J FORENSIC SCI, V33, P1439; Schleyer F, 1963, METHODS FORENSIC SCI, V2, P253; TAKEICHI S, 1985, AM J FOREN MED PATH, V6, P25, DOI 10.1097/00000433-198503000-00006; TAKEICHI S, 1984, AM J FOREN MED PATH, V5, P223, DOI 10.1097/00000433-198409000-00006; TAKEICHI S, 1986, AM J FOREN MED PATH, V7, P35, DOI 10.1097/00000433-198603000-00007; Thibodeau GA, 2007, FLUID ELECTROLYTE BA, P1067; TRIEBIG G, 1980, CLIN CHIM ACTA, V108, P355, DOI 10.1016/0009-8981(80)90341-1; Viinamaki J, 2011, FORENSIC SCI INT, V208, P42, DOI 10.1016/j.forsciint.2010.10.026; Villas-Boas SG., 2007, METABOLOME ANAL INTR, DOI [10.1002/0470105518, DOI 10.1002/0470105518]; Yeom Su-Cheong, 2012, Lab Anim Res, V28, P245, DOI 10.5625/lar.2012.28.4.245; Zhu Bao-Li, 2007, Legal Medicine, V9, P115, DOI 10.1016/j.legalmed.2006.10.002	43	110	115	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e82011	10.1371/journal.pone.0082011	http://dx.doi.org/10.1371/journal.pone.0082011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278469	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000327539800145
J	Hinsinger, DD; Basak, J; Gaudeul, M; Cruaud, C; Bertolino, P; Frascaria-Lacoste, N; Bousquet, J				Hinsinger, Damien Daniel; Basak, Jolly; Gaudeul, Myriam; Cruaud, Corinne; Bertolino, Paola; Frascaria-Lacoste, Nathalie; Bousquet, Jean			The Phylogeny and Biogeographic History of Ashes (Fraxinus, Oleaceae) Highlight the Roles of Migration and Vicariance in the Diversification of Temperate Trees	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; RETICULATE EVOLUTION; NORTHERN-HEMISPHERE; SEQUENCES; EASTERN; LIKELIHOOD; PATTERNS; ANGIOSPERMS; POLLINATION; DIVERSITY	The cosmopolitan genus Fraxinus, which comprises about 40 species of temperate trees and shrubs occupying various habitats in the Northern Hemisphere, represents a useful model to study speciation in long-lived angiosperms. We used nuclear external transcribed spacers (nETS), phantastica gene sequences, and two chloroplast loci (trnH-psbA and rpl32-trnL) in combination with previously published and newly obtained nITS sequences to produce a time-calibrated multi-locus phylogeny of the genus. We then inferred the biogeographic history and evolution of floral morphology. An early dispersal event could be inferred from North America to Asia during the Oligocene, leading to the diversification of the section Melioides sensus lato. Another intercontinental dispersal originating from the Eurasian section of Fraxinus could be dated from the Miocene and resulted in the speciation of F. nigra in North America. In addition, vicariance was inferred to account for the distribution of the other Old World species (sections Sciadanthus, Fraxinus and Ornus). Geographic speciation likely involving dispersal and vicariance could also be inferred from the phylogenetic grouping of geographically close taxa. Molecular dating suggested that the initial divergence of the taxonomical sections occurred during the middle and late Eocene and Oligocene periods, whereas diversification within sections occurred mostly during the late Oligocene and Miocene, which is consistent with the climate warming and accompanying large distributional changes observed during these periods. These various results underline the importance of dispersal and vicariance in promoting geographic speciation and diversification in Fraxinus. Similarities in life history, reproductive and demographic attributes as well as geographical distribution patterns suggest that many other temperate trees should exhibit similar speciation patterns. On the other hand, the observed parallel evolution and reversions in floral morphology would imply a major influence of environmental pressure. The phylogeny obtained and its biogeographical implications should facilitate future studies on the evolution of complex adaptive characters, such as habitat preference, and their possible roles in promoting divergent evolution in trees.	[Hinsinger, Damien Daniel; Bertolino, Paola; Frascaria-Lacoste, Nathalie] AgroParisTech, Lab Ecol Systemat & Evolut, Unite Mixte Rech 8079, Orsay, France; [Hinsinger, Damien Daniel; Bertolino, Paola; Frascaria-Lacoste, Nathalie] CNRS, Lab Ecol Systemat & Evolut, Unite Mixte Rech 8079, F-91405 Orsay, France; [Hinsinger, Damien Daniel; Basak, Jolly; Bertolino, Paola; Frascaria-Lacoste, Nathalie] Univ Paris 11, Lab Ecol Systemat & Evolut, Unite Mixte Rech 8079, Orsay, France; [Hinsinger, Damien Daniel; Bousquet, Jean] Univ Laval, Ctr Forest Res, Canada Res Chair Forest & Environm Gen, Quebec City, PQ G1K 7P4, Canada; [Hinsinger, Damien Daniel; Bousquet, Jean] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ G1K 7P4, Canada; [Gaudeul, Myriam] Museum Natl Hist Naturelle, Unite Mixte Rech Origine 7205, Paris, France; [Cruaud, Corinne] Genoscope, Ctr Natl Sequencage, Evry, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Laval University; Laval University; Museum National d'Histoire Naturelle (MNHN); CEA; UDICE-French Research Universities; Universite Paris Saclay	Hinsinger, DD (corresponding author), AgroParisTech, Lab Ecol Systemat & Evolut, Unite Mixte Rech 8079, Orsay, France.	damien.hinsinger@u-psud.fr	Hinsinger, Damien/V-5892-2019	Hinsinger, Damien/0000-0001-7459-7610; Frascaria-Lacoste, Nathalie/0000-0002-3425-7838; Cruaud, Corinne/0000-0002-4752-7278	Ministere des Affaires Etrangeres (Bourse Lavoisier); French Ministry of Education and the Universite Paris-Sud 11 (Orsay); Consortium National de Recherche en Genomique; "Service de Systematique Moleculaire'' of the Museum National d'Histoire Naturelle [(IFR 101]; Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of Life' [2005/67]	Ministere des Affaires Etrangeres (Bourse Lavoisier); French Ministry of Education and the Universite Paris-Sud 11 (Orsay); Consortium National de Recherche en Genomique(General Electric); "Service de Systematique Moleculaire'' of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS)); Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of Life'	D.D. Hinsinger is the recipient of a fellowship from the Ministere des Affaires Etrangeres (Bourse Lavoisier) and received financial support from the French Ministry of Education and the Universite Paris-Sud 11 (Orsay). This work was supported by the "Consortium National de Recherche en Genomique", and the "Service de Systematique Moleculaire'' of the Museum National d'Histoire Naturelle (IFR 101). It is part of agreement no. 2005/67 between Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of Life'', directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Besnard G, 2009, ANN BOT-LONDON, V104, P143, DOI 10.1093/aob/mcp105; Bouille M, 2005, AM J BOT, V92, P63, DOI 10.3732/ajb.92.1.63; CALL VB, 1992, REV PALAEOBOT PALYNO, V74, P249, DOI 10.1016/0034-6667(92)90010-E; Chen CH, 2009, BOT STUD, V50, P425; Culley TM, 2002, TRENDS ECOL EVOL, V17, P361, DOI 10.1016/S0169-5347(02)02540-5; de Heredia UL, 2007, TAXON, V56, P1209, DOI 10.2307/25065912; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Donoghue MJ, 2001, INT J PLANT SCI, V162, pS41, DOI 10.1086/323278; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fernandez-Manjarres JF, 2006, MOL ECOL, V15, P3245, DOI 10.1111/j.1365-294X.2006.02975.x; GIELLY L, 1994, CR ACAD SCI III-VIE, V317, P685; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Havill NP, 2008, SYST BOT, V33, P478, DOI 10.1600/036364408785679770; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Jeandroz S, 1997, MOL PHYLOGENET EVOL, V7, P241, DOI 10.1006/mpev.1996.0393; Jung SH, 2009, ACTA GEOL SIN-ENGL, V83, P845, DOI 10.1111/j.1755-6724.2009.00113.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li JH, 2002, SYST BOT, V27, P592; Maddison WP, 2011, MESQUITE MODULAR SYS; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Miller GN, 1955, GENUS FRAXINUS ASHES; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morand-Prieur ME, 2003, AM J BOT, V90, P949, DOI 10.3732/ajb.90.6.949; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NAKAIKE T, 1972, Bulletin of the National Science Museum (Tokyo), V15, P475; Nesom GL, 2010, PHYTONEURON, V32, P1; Nesom GL, 2010, PHYTONEURON, V33, P1; Nesom GL, 2010, PHYTONEURON, V37, P1; Nesom GL, 2010, PHYTONEURON, V38, P1; Nesom GL, 2010, PHYTONEURON, V34, P1; Nesom GL, 2010, PHYTONEURON, V17, P1; Nesom GL, 2010, PHYTONEURON, V39, P1; Nesom GL, 2010, PHYTONEURON, V51, P1; NICKRENT DL, 1994, AM J BOT, V81, P1149, DOI 10.2307/2445477; Nie ZL, 2006, AM J BOT, V93, P1343, DOI 10.3732/ajb.93.9.1343; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; PALAMAREV E, 1989, PLANT SYST EVOL, V162, P93, DOI 10.1007/BF00936912; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rambaut A, 2005, TRACER V1 5; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rambaut A, 2009, FIGTREE V1 3 1; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REGAL PJ, 1982, ANNU REV ECOL SYST, V13, P497, DOI 10.1146/annurev.es.13.110182.002433; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SANTAMOUR FRANK S., 1962, BULL TORREY BOT CLUB, V89, P228, DOI 10.2307/2483198; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Vamosi JC, 2004, EVOLUTION, V58, P723, DOI 10.1111/j.0014-3820.2004.tb00405.x; Via S, 2002, AM NAT, V159, pS1, DOI 10.1086/338368; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Wallander E, 2000, AM J BOT, V87, P1827, DOI 10.2307/2656836; Wallander E, 2008, PLANT SYST EVOL, V273, P25, DOI 10.1007/s00606-008-0005-3; Wang Q, 2010, PALAEOGEOGR PALAEOCL, V295, P323, DOI 10.1016/j.palaeo.2010.06.010; Wei Z, 1996, FLORA CHINA, P273; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; WOJCIECHOWSKI MF, 1993, AM J BOT, V80, P711, DOI 10.2307/2445441; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Yihong W, 1995, J FOR RES, V6, P61; Yonekura Koji, 2005, Journal of Japanese Botany, V80, P323; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	81	48	51	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80431	10.1371/journal.pone.0080431	http://dx.doi.org/10.1371/journal.pone.0080431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278282	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800072
J	Miotto, P; Mwangoka, G; Valente, IC; Norbis, L; Sotgiu, G; Bosu, R; Ambrosi, A; Codecasa, LR; Goletti, D; Matteelli, A; Ntinginya, EN; Aloi, F; Heinrich, N; Reither, K; Cirillo, DM				Miotto, Paolo; Mwangoka, Grace; Valente, Ilaria C.; Norbis, Luca; Sotgiu, Giovanni; Bosu, Roberta; Ambrosi, Alessandro; Codecasa, Luigi R.; Goletti, Delia; Matteelli, Alberto; Ntinginya, Elias N.; Aloi, Francesco; Heinrich, Norbert; Reither, Klaus; Cirillo, Daniela M.			miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							HIGH BREAKDOWN-POINT; CIRCULATING MICRORNAS; BIOMARKERS; INFECTION; DIAGNOSIS; RESPONSES; IDENTIFY; CELLS; NEEDS	Several studies showed that assessing levels of specific circulating microRNAs (miRNAs) is a non-invasive, rapid, and accurate method for diagnosing diseases or detecting alterations in physiological conditions. We aimed to identify a serum miRNA signature to be used for the diagnosis of tuberculosis (TB). To account for variations due to the genetic makeup, we enrolled adults from two study settings in Europe and Africa. The following categories of subjects were considered: healthy (H), active pulmonary TB (PTB), active pulmonary TB, HIV co-infected (PTB/ HIV), latent TB infection (LTBI), other pulmonary infections (OPI), and active extra-pulmonary TB (EPTB). Sera from 10 subjects of the same category were pooled and, after total RNA extraction, screened for miRNA levels by TaqMan low-density arrays. After identification of "relevant miRNAs'', we refined the serum miRNA signature discriminating between H and PTB on individual subjects. Signatures were analyzed for their diagnostic performances using a multivariate logistic model and a Relevance Vector Machine (RVM) model. A leaveone- out-cross-validation (LOOCV) approach was adopted for assessing how both models could perform in practice. The analysis on pooled specimens identified selected miRNAs as discriminatory for the categories analyzed. On individual serum samples, we showed that 15 miRNAs serve as signature for H and PTB categories with a diagnostic accuracy of 82% (CI 70.2-90.0), and 77% (CI 64.2-85.9) in a RVM and a logistic classification model, respectively. Considering the different ethnicity, by selecting the specific signature for the European group (10 miRNAs) the diagnostic accuracy increased up to 83% (CI 68.1-92.1), and 81% (65.0-90.3), respectively. The African-specific signature (12 miRNAs) increased the diagnostic accuracy up to 95% (CI 76.4-99.1), and 100% (83.9-100.0), respectively. Serum miRNA signatures represent an interesting source of biomarkers for TB disease with the potential to discriminate between PTB and LTBI, but also among the other categories.	[Miotto, Paolo; Valente, Ilaria C.; Norbis, Luca; Cirillo, Daniela M.] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Mwangoka, Grace; Reither, Klaus] Ifakara Hlth Inst, Bagamoyo Res & Training Ctr, Bagamoyo, Tanzania; [Sotgiu, Giovanni; Bosu, Roberta] Univ Sassari, Dept Biomed Sci, Clin Epidemiol & Med Stat Unit, I-07100 Sassari, Italy; [Sotgiu, Giovanni; Bosu, Roberta] AOU Sassari, Res Med Educ & Profess Dev Unit, Sassari, Italy; [Ambrosi, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Codecasa, Luigi R.] Osped Niguarda Ca Granda, Reg Reference Ctr TB Villa Marelli, Milan, Italy; [Goletti, Delia] Natl Inst Infect Dis L Spallanzani, Translat Res Unit, Rome, Italy; [Matteelli, Alberto] Univ Brescia, WHO, Collaborating Ctr TB HIV Coinfect, Inst Infect & Trop Dis, Brescia, Italy; [Ntinginya, Elias N.] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania; [Aloi, Francesco] St Francis Nsambya Hosp AISPO, Kampala, Uganda; [Aloi, Francesco] Italian Assoc Solidar People AISPO NGO, Kampala, Uganda; [Heinrich, Norbert] Univ Munich, Div Infect Dis & Trop Med, Munich, Germany; [Reither, Klaus] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Reither, Klaus] Univ Basel, Basel, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Ifakara Health Institute; University of Sassari; Vita-Salute San Raffaele University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Lazzaro Spallanzani; University of Brescia; World Health Organization; National Institute of Medical Research; University of Munich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Cirillo, DM (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	ambrosi, alessandro/H-4424-2011; Cirillo, Daniela Maria/AAB-3646-2019; codecasa, luigi/K-2693-2018; N, Heinrich/B-3750-2014; goletti, delia/AAM-6577-2020; Matteelli, Alberto/M-8784-2015; Miotto, Paolo/E-3940-2017; Sotgiu, Giovanni/N-1032-2017	ambrosi, alessandro/0000-0003-1976-5663; Cirillo, Daniela Maria/0000-0001-6415-1535; codecasa, luigi/0000-0001-6825-2050; N, Heinrich/0000-0001-9252-7106; Matteelli, Alberto/0000-0001-5109-9248; Miotto, Paolo/0000-0003-4610-2427; Sotgiu, Giovanni/0000-0002-1600-4474; Goletti, Delia/0000-0001-8360-4376; Reither, Klaus/0000-0001-6195-8237	European Community [FP7-223681]; EDCTP TB CHILD project [IP.2009.32040.007]	European Community(European Commission); EDCTP TB CHILD project	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681 to DMC (http://www.tbpannet.org/) and by the EDCTP TB CHILD project (IP.2009.32040.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Ajit SK, 2012, SENSORS-BASEL, V12, P3359, DOI 10.3390/s120303359; Amanatidou V, 2012, EUR J CLIN MICROBIOL, V31, P1285, DOI 10.1007/s10096-011-1524-3; Benjamini Y, 2001, ANN STAT, V29, P1165; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braun AC, 2012, IEEE J-STARS, V5, P436, DOI 10.1109/JSTARS.2012.2190266; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Good P, 2005, PERMUTATION PARAMETR; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lapedriza A, 2008, PATTERN ANAL APPL, V11, P299, DOI 10.1007/s10044-008-0130-1; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Norbis L, 2013, NEW MICROBIOL, V36, P111; Olivier I, 2012, J MICROBIOL METH, V88, P419, DOI 10.1016/j.mimet.2012.01.012; Pearce EC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/401896; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; R Core Team, 2016, R FDN STAT COMP; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Salibian-Barrera M, 2008, ANN STAT, V36, P118, DOI 10.1214/009053607000000794; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Zou KH, 1997, STAT MED, V16, P2143; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	49	60	64	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80149	10.1371/journal.pone.0080149	http://dx.doi.org/10.1371/journal.pone.0080149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278252	Green Published, gold, Green Accepted			2022-12-27	WOS:000327539800058
J	Zheng, ZK; Wang, JJ; Huang, X; Jiang, K; Nie, J; Qiao, XW; Li, JS				Zheng, Zhikun; Wang, Jianjun; Huang, Xia; Jiang, Ke; Nie, Jun; Qiao, Xinwei; Li, Jinsong			Improvements of the Surgical Technique on the Established Mouse Model of Orthotopic Single Lung Transplantation	PLOS ONE			English	Article							CUFF TECHNIQUE; RAT	Background: A wide range of knockout and transgenic murine models for the study of nonimmune and immune mechanisms in lung transplants are available nowadays, but the microsurgical techniques are difficult to learn. We describe methods to simplify techniques and facilitate learning. Methods: Traditional procedures were implemented to perform lung transplants in 30 cases (group 1). Improved techniques which included cuff without tail, broadening of the cuff diameter for bronchus, establishment of one tunnel between three structures, innovative technology of the vascular anastomosis and placement of the chest tube post-operation were used to perform lung transplants in 30 cases (group 2). Results: The improved techniques considerably shorten operative times (96.75 +/- 6.16 min and 85.32 +/- 6.98 min in groups 1 and 2, respectively). The survival rates in the recipient animals were 86.7% and 96.7% in groups 1 and 2, respectively. Chest X-rays and macroscopic changes of transplanted recipients showed that grafts were well inflated on postoperative day 30. There was no significant difference of the arterial oxygen tension (PaO2) between two groups (115.9 +/- 7.11 mm Hg and 116.3 +/- 6.87 mm Hg in groups 1 and 2, respectively). Histologically, no lung injury was seen in grafts. Conclusions: We described the modified procedures of orthotopic left lung transplants in mice, which could shorten operative time and increase survival rate.	[Zheng, Zhikun; Wang, Jianjun; Jiang, Ke; Nie, Jun; Qiao, Xinwei; Li, Jinsong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430074, Hubei Province, Peoples R China; [Huang, Xia] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Organ Transplantat, Minist Educ,Key Lab Organ Transplantat, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, JS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430074, Hubei Province, Peoples R China.	lijinsong67@hotmail.com			Hubei Provincial Department of Health Research Fund [JX4B08]	Hubei Provincial Department of Health Research Fund	This work was supported by the Hubei Provincial Department of Health Research Fund (Grant No. JX4B08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASIMACOP.PJ, 1971, TRANSPLANT P, V3, P583; [龚勇泉 Gong Yongquan], 2012, [中华器官移植杂志, Chinese Journal of Organ Transplantation], V33, P303; Goto T, 2012, ANN THORAC SURG, V93, P2078, DOI 10.1016/j.athoracsur.2012.01.096; Guo HZ, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-1; Jungraithmayr W, 2012, AM J TRANSPLANT, V12, P1624, DOI 10.1111/j.1600-6143.2011.03980.x; Jungraithmayr WM, 2009, J THORAC CARDIOV SUR, V137, P486, DOI 10.1016/j.jtcvs.2008.10.007; Li J, 2006, J HUAZHONG U SCI TEC, V26, P100, DOI [10.1007/BF02828050, DOI 10.1007/BF02828050.PUBMED:16711018]; Lin X, 2012, J THORAC DIS, V4, P247, DOI 10.3978/j.issn.2072-1439.2012.06.02; MIZUTA T, 1989, J THORAC CARDIOV SUR, V97, P578; Okazaki M, 2007, AM J TRANSPLANT, V7, P1672, DOI 10.1111/j.1600-6143.2007.01819.x; Zhai W, 2008, J INVEST SURG, V21, P33, DOI 10.1080/08941930701834114; Zhang QC, 2008, TRANSPL INT, V21, P1090, DOI 10.1111/j.1432-2277.2008.00747.x	12	49	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81000	10.1371/journal.pone.0081000	http://dx.doi.org/10.1371/journal.pone.0081000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278363	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800094
J	Zhu, JY; Li, YH; Yang, S; Li, QW				Zhu, Jia-Ying; Li, Yong-He; Yang, Song; Li, Qin-Wen			De novo Assembly and Characterization of the Global Transcriptome for Rhyacionia leptotubula Using Illumina Paired-End Sequencing	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR-CLONING; MICROSATELLITE LOCI; FAMILY PROTEINS; GENES; EXPRESSION; CHAPERONE; GENOME; HSP105; HSP70	Background: The pine tip moth, Rhyacionia leptotubula (Lepidoptera: Tortricidae) is one of the most destructive forestry pests in Yunnan Province, China. Despite its importance, less is known regarding all aspects of this pest. Understanding the genetic information of it is essential for exploring the specific traits at the molecular level. Thus, we here sequenced the transcriptome of R. leptotubula with high-throughput Illumina sequencing. Methodology/Principal Findings: In a single run, more than 60 million sequencing reads were generated. De novo assembling was performed to generate a collection of 46,910 unigenes with mean length of 642 bp. Based on Blastx search with an E-value cut-off of 10(-5), 22,581 unigenes showed significant similarities to known proteins from National Center for Biotechnology Information (NCBI) non-redundant (Nr) protein database. Of these annotated unigenes, 10,360, 6,937 and 13,894 were assigned to Gene Ontology (GO), Clusters of Orthologous Group (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases, respectively. A total of 5,926 unigenes were annotated with domain similarity derived functional information, of which 55 and 39 unigenes respectively encoding the insecticide resistance related enzymes, cytochrome P450 and carboxylesterase. Using the transcriptome data, 47 unigenes belonging to the typical "stress" genes of heat shock protein (Hsp) family were retrieved. Furthermore, 1,450 simple sequence repeats (SSRs) were detected; 3.09% of the unigenes contained SSRs. Large numbers of SSR primer pairs were designed and out of randomly verified primer pairs 80% were successfully yielded amplicons. Conclusions/Significance: A large of putative R. leptotubula transcript sequences has been obtained from the deep sequencing, which extensively increases the comprehensive and integrated genomic resources of this pest. This large-scale transcriptome dataset will be an important information platform for promoting our investigation of the molecular mechanisms from various aspects in this species.	[Zhu, Jia-Ying; Li, Yong-He; Yang, Song; Li, Qin-Wen] Southwest Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China	Southwest Forestry University - China	Li, YH (corresponding author), Southwest Forestry Univ, Key Lab Forest Disaster Warning & Control Yunnan, Kunming, Peoples R China.	swfclyh@126.com			National Nature Science Foundation of China [30960316]; Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China [2008PY021]; Key Grant of Southwest Forestry University [110931]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China; Key Grant of Southwest Forestry University	This work was supported by the National Nature Science Foundation of China (30960316), Science Foundation for the Excellent Youth Academic and Technological Scholars of Yunnan Province of China (2008PY021), and the Key Grant of Southwest Forestry University (110931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BORK P, 1992, TRENDS BIOCHEM SCI, V17, P129, DOI 10.1016/0968-0004(92)90319-5; Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gething MJ, 1997, GUIDEBOOK MOL CHAPER, P384; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2012, INSECT MOL BIOL, V21, P535, DOI 10.1111/j.1365-2583.2012.01158.x; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Karatolos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031077; Karlin S, 1998, J MOL EVOL, V47, P565, DOI 10.1007/PL00006413; Keyghobadi N, 2002, HEREDITAS, V136, P247, DOI 10.1034/j.1601-5223.2002.1360311.x; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liang C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-146; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Liu ZH, 2012, CELL STRESS CHAPERON, V17, P539, DOI 10.1007/s12192-012-0330-x; Manjunatha HB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20401; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Saito Y, 2007, EXP CELL RES, V313, P3707, DOI 10.1016/j.yexcr.2007.06.009; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toursel C, 2000, MOL BIOCHEM PARASIT, V111, P319, DOI 10.1016/S0166-6851(00)00324-8; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Wang H, 2012, ARCH INSECT BIOCHEM, V79, P247, DOI 10.1002/arch.21013; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wu XP, 2008, J SW FOREST COLL, V28, P58; Wu Y, 2000, MOL BIOCHEM PARASIT, V107, P155, DOI 10.1016/S0166-6851(99)00227-3; Xu PJ, 2010, MOL BIOL REP, V37, P2265, DOI 10.1007/s11033-009-9715-z; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamagishi N, 2003, FEBS LETT, V555, P390, DOI 10.1016/S0014-5793(03)01292-4; Yang S, 2012, FOREST PEST DIS, V31, P41; Yang Song, 2012, Zhongguo Senlin Bingchong, V31, P20; Yasuda K, 1999, BIOCHEM BIOPH RES CO, V256, P75, DOI 10.1006/bbrc.1999.0283; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhao X, 2002, GENE, V488, P52; Zhou J, 2010, J INVERTEBR PATHOL, V103, P170, DOI 10.1016/j.jip.2009.12.006; Zhu JY, 2013, INSECT SCI, V20, P183, DOI 10.1111/j.1744-7917.2011.01494.x; Zhu Jia-Ying, 2013, PLoS ONE, V8, pe54411, DOI 10.1371/journal.pone.0054411; Zhu JY, 2012, MITOCHONDR DNA, V23, P376, DOI 10.3109/19401736.2012.696632; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zhu JY, 2011, AFR J MICROBIOL RES, V5, P4026	68	10	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81096	10.1371/journal.pone.0081096	http://dx.doi.org/10.1371/journal.pone.0081096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278383	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800101
J	Bagneux, V; Thomassin, N; Gonthier, C; Roulin, JL				Bagneux, Virginie; Thomassin, Noemylle; Gonthier, Corentin; Roulin, Jean-Luc			Working Memory in the Processing of the Iowa Gambling Task: An Individual Differences Approach	PLOS ONE			English	Article							SHORT-TERM-MEMORY; DECISION-MAKING; EXECUTIVE FUNCTIONS; SOMATIC MARKERS; EMOTION; DAMAGE; CONSEQUENCES; INTELLIGENCE; CAPACITY	The Iowa Gambling Task (IGT) is a sequential learning task in which participants develop a tendency towards advantageous options arising from the outcomes associated with their previous decisions. The role of working memory in this complex task has been largely debated in the literature. On one hand, low working memory resources lead to a decrease in the number of advantageous decisions and make a significant part of participants unable to report explicitly which options are the most profitable. On the other hand, several studies have shown no contribution of working memory to the IGT decision patterns. In order to investigate this apparent incompatibility of results, we used an individual differences approach, which has proven an effective method to investigate the role of working memory in cognition. We compared the IGT decision patterns of participants as a function of their working memory capacity (WMC). As expected, contrary to low WMC participants, high WMC participants developed a tendency towards advantageous decisions. These findings lead us to discuss the role of WMC in decision making tasks.	[Bagneux, Virginie] Univ Savoy, Lab Interuniv Psychol, Chambery, France; [Thomassin, Noemylle; Gonthier, Corentin; Roulin, Jean-Luc] Univ Savoy, Lab Psychol & NeuroCognit, Chambery, France		Bagneux, V (corresponding author), Univ Savoy, Lab Interuniv Psychol, Chambery, France.	virginie.bagneux@gmail.com	Gonthier, Corentin/AAD-5483-2020	Gonthier, Corentin/0000-0001-8573-0413				Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Bagneux V, 2013, MOTIV EMOTION, V37, P818, DOI 10.1007/s11031-013-9346-5; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; de Vries M, 2008, JUDGM DECIS MAK, V3, P42; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Dretsch MN, 2008, BRAIN COGNITION, V66, P83, DOI 10.1016/j.bandc.2007.05.006; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Fein G, 2007, J INT NEUROPSYCH SOC, V13, P480, DOI 10.1017/S135561770707052X; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Gozzi M, 2011, PSYCHOL RES-PSYCH FO, V75, P188, DOI 10.1007/s00426-010-0296-1; Gupta R, 2009, NEUROPSYCHOLOGIA, V47, P1686, DOI 10.1016/j.neuropsychologia.2009.02.007; Hinson JM, 2002, COGN AFFECT BEHAV NE, V2, P341, DOI 10.3758/CABN.2.4.341; Jameson TL, 2004, PSYCHON B REV, V11, P515, DOI 10.3758/BF03196604; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Pecchinenda A, 2006, EXP PSYCHOL, V53, P191, DOI 10.1027/1618-3169.53.3.191; St Clair-Thompson HL, 2010, EUR J COGN PSYCHOL, V22, P286, DOI 10.1080/09541440902771299; STOCCO A, 2006, P 28 ANN C COGN SCI, P2192; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; Turnbull OH, 2005, BRAIN COGNITION, V57, P244, DOI 10.1016/j.bandc.2004.08.053; Turnbull OH, 2003, BRAIN COGNITION, V53, P389, DOI 10.1016/S0278-2626(03)00151-9; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; Upton DJ, 2011, PERS INDIV DIFFER, V50, P492, DOI 10.1016/j.paid.2010.11.013; Wagar BM, 2006, COGN AFFECT BEHAV NE, V6, P277, DOI 10.3758/CABN.6.4.277; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI [10.1002/9780470996652.ch20, DOI 10.1002/9780470996652.CH20]	34	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81498	10.1371/journal.pone.0081498	http://dx.doi.org/10.1371/journal.pone.0081498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278447	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100160
J	Bushara, K; Bower, M; Liu, JL; McFarland, KN; Landrian, I; Hutter, D; Teive, HAG; Rasmussen, A; Mulligan, CJ; Ashizawa, T				Bushara, Khalaf; Bower, Matthew; Liu, Jilin; McFarland, Karen N.; Landrian, Ivette; Hutter, Diane; Teive, Helio A. G.; Rasmussen, Astrid; Mulligan, Connie J.; Ashizawa, Tetsuo			Expansion of the Spinocerebellar Ataxia Type 10 (SCA10) Repeat in a Patient with Sioux Native American Ancestry	PLOS ONE			English	Article							ATTCT REPEAT; REDUCED PENETRANCE; FREQUENCY-ANALYSIS; FAMILIES; POPULATION; DISEASE; ORIGIN; MODEL	Spinocerebellar ataxia type 10 (SCA10), an autosomal dominant cerebellar ataxia, is caused by the expansion of the non-coding ATTCT pentanucleotide repeat in the ATAXIN 10 gene. To date, all cases of SCA10 are restricted to patients with ancestral ties to Latin American countries. Here, we report on a SCA10 patient with Sioux Native American ancestry and no reported Hispanic or Latino heritage. Neurological exam findings revealed impaired gait with mild, age-consistent cerebellar atrophy and no evidence of epileptic seizures. The age at onset for this patient, at 83 years of age, is the latest documented for SCA10 patients and is suggestive of a reduced penetrance allele in his family. Southern blot analysis showed an SCA10 expanded allele of 1400 repeats. Established SNPs surrounding the SCA10 locus showed a disease haplotype consistent with the previously described "SCA10 haplotype". This case suggests that the SCA10 expansion represents an early mutation event that possibly occurred during the initial peopling of the Americas.	[Bushara, Khalaf; Hutter, Diane] Univ Minnesota, Dept Neurol, Med Ctr, Minneapolis, MN 55455 USA; [Bower, Matthew] Univ Minnesota, Inst Human Genet, Med Ctr, Minneapolis, MN 55455 USA; [Liu, Jilin; McFarland, Karen N.; Landrian, Ivette; Ashizawa, Tetsuo] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA; [Liu, Jilin; McFarland, Karen N.; Landrian, Ivette; Ashizawa, Tetsuo] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Teive, Helio A. G.] Univ Fed Parana, Movement Disorders Unit, Neurol Serv, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Rasmussen, Astrid] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Mulligan, Connie J.] Univ Florida, Genet Inst, Gainesville, FL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Federal do Parana; Oklahoma Medical Research Foundation; State University System of Florida; University of Florida; State University System of Florida; University of Florida	McFarland, KN (corresponding author), Univ Florida, Dept Neurol, Gainesville, FL 32610 USA.	karen.mcfarland@neurology.ufl.edu	Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948	National Institutes of Health [NS041547, NS068897, NS083564]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083564, RC1NS068897, R01NS041547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS041547, NS068897 and NS083564 to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004553; Alonso I, 2006, NEUROLOGY, V66, P1602, DOI 10.1212/01.wnl.0000216266.30177.bb; Ashizawa Tetsuo, 2012, Handb Clin Neurol, V103, P507, DOI 10.1016/B978-0-444-51892-7.00032-2; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Fujigasaki H, 2002, ANN NEUROL, V51, P408, DOI 10.1002/ana.10126; GALLARDO M, 2009, MOVEMENT DISORD S1, V24, pS12; Gatto EM, 2007, NEUROLOGY, V69, P216, DOI 10.1212/01.wnl.0000265596.72492.89; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grewal RP, 2002, ARCH NEUROL-CHICAGO, V59, P1285, DOI 10.1001/archneur.59.8.1285; Jiang H, 2005, CHINESE MED J-PEKING, V118, P837; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 2006, AM J HUM GENET, V78, P125, DOI 10.1086/498654; McFarland KN, 2013, EUR J HUM GENET 0227, DOI [10.1038/ejhg.2013.32, DOI 10.1038/EJHG.2013.32:]; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Raskin S, 2007, ARCH NEUROL-CHICAGO, V64, P591, DOI 10.1001/archneur.64.4.591; Rasmussen A, 2002, ANN NEUROL, V51, P408, DOI 10.1002/ana.10127; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Roxburgh RH, 2013, J NEUROL SCI, V324, P176, DOI 10.1016/j.jns.2012.09.030; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; Sulek-Piatkowska A, 2010, NEUROL NEUROCHIR POL, V44, P238; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Teive HAG, 2004, NEUROLOGY, V63, P1509; Teive HAG, 2011, PARKINSONISM RELAT D, V17, P655, DOI 10.1016/j.parkreldis.2011.04.001; Vale J, 2010, EUR J NEUROL, V17, P124, DOI 10.1111/j.1468-1331.2009.02757.x; Wakamiya M, 2006, NEUROLOGY, V67, P607, DOI 10.1212/01.wnl.0000231140.26253.eb; Wang Jun-ling, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P501, DOI 10.3760/cma.j.issn.1003-9406.2010.05.006; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Xie Qiu-you, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P71	30	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81342	10.1371/journal.pone.0081342	http://dx.doi.org/10.1371/journal.pone.0081342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278426	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100153
J	Krcmery, J; Gupta, R; Sadleir, RW; Ahrens, MJ; Misener, S; Kamide, C; Fitchev, P; Losordo, DW; Crawford, SE; Simon, HG				Krcmery, Jennifer; Gupta, Rajesh; Sadleir, Rudyard W.; Ahrens, Molly J.; Misener, Sol; Kamide, Christine; Fitchev, Philip; Losordo, Douglas W.; Crawford, Susan E.; Simon, Hans-Georg			Loss of the Cytoskeletal Protein Pdlim7 Predisposes Mice to Heart Defects and Hemostatic Dysfunction	PLOS ONE			English	Article							LIM-DOMAIN PROTEIN; SUBCELLULAR-LOCALIZATION; VALVE DEVELOPMENT; SEVERE FORM; TBX5; CYPHER; ORGANIZATION; FIBROBLASTS; DISRUPTION; DEFICIENCY	The actin-associated protein Pdlim7 is essential for heart and fin development in zebrafish; however, the expression and function of this PDZ-LIM family member in the mammal has remained unclear. Here, we show that Pdlim7 predominantly localizes to actin-rich structures in mice including the heart, vascular smooth muscle, and platelets. To test the requirement for Pdlim7 in mammalian development and function, we analyzed a mouse strain with global genetic inactivation of Pdlim7. We demonstrate that Pdlim7 loss-of-function leads to significant postnatal mortality. Inactivation of Pdlim7 does not disrupt cardiac development, but causes mild cardiac dysfunction in adult mice. Adult Pdlim7(-/-) mice displayed increased mitral and tricuspid valve annulus to body weight ratios. These structural aberrations in Pdlim7(-/-) mice were supported by three-dimensional reconstructions of adult cardiac valves, which revealed increased surface area to volume ratios for the mitral and tricuspid valve leaflets. Unexpectedly, we found that loss of Pdlim7 triggers systemic venous and arterial thrombosis, leading to significant mortality shortly after birth in Pdlim7(+/-) (11/60) and Pdlim7(-/-) (19/35) mice. In line with a prothrombotic phenotype, adult Pdlim7(-/-) mice exhibit dramatically decreased tail bleed times compared to controls. These findings reveal a novel and unexpected function for Pdlim7 in maintaining proper hemostasis in neonatal and adult mice.	[Krcmery, Jennifer; Sadleir, Rudyard W.; Ahrens, Molly J.; Simon, Hans-Georg] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Krcmery, Jennifer; Sadleir, Rudyard W.; Ahrens, Molly J.; Simon, Hans-Georg] Ann & Robert H Lurie Childrens Hosp Chicago Res C, Chicago, IL USA; [Gupta, Rajesh; Misener, Sol; Kamide, Christine; Losordo, Douglas W.] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA; [Fitchev, Philip; Crawford, Susan E.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Saint Louis University	Simon, HG (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	hgsimon@northwestern.edu		Gupta, Rajesh/0000-0001-7428-7671; Losordo, Douglas/0000-0002-6857-7506	National Heart, Lung, and Blood Institute [F31HL090031]; Children's Research Fund; Lurie Children's Hospital of Chicago Research Center; Family of Michael P. Polsky; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL090031] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Research Fund; Lurie Children's Hospital of Chicago Research Center; Family of Michael P. Polsky; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (Grant F31HL090031), the Children's Research Fund (to J. Krcmery), the Lurie Children's Hospital of Chicago Research Center Pilot Grant and The Family of Michael P. Polsky (to H.G. Simon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Bauer K, 2000, BLOOD, V96, P4236; Bearer EL, 2002, INT REV CYTOL, V217, P137; Bimber B, 2007, DEV BIOL, V302, P230, DOI 10.1016/j.ydbio.2006.09.023; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Camarata T, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-104; Camarata T, 2010, DEV BIOL, V337, P233, DOI 10.1016/j.ydbio.2009.10.039; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cui JS, 2000, BLOOD, V96, P4222, DOI 10.1182/blood.V96.13.4222.h8004222_4222_4226; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Franco D, 2001, EUR J MORPHOL, V39, P169, DOI 10.1076/ejom.39.3.169.4670; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Gupta S, 2012, CIRC RES, V111, P1410, DOI 10.1161/CIRCRESAHA.112.264754; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; KINSELLA MG, 1980, SCIENCE, V207, P1359, DOI 10.1126/science.7355294; Krause A, 2004, DEV BIOL, V273, P106, DOI 10.1016/j.ydbio.2004.05.024; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kruithof BPT, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.003; Kujovich JL, 2005, CRIT CARE CLIN, V21, P563, DOI 10.1016/j.ccc.2005.03.002; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Northup PG, 2008, J THROMB HAEMOST, V6, P2; Ott EB, 2008, DEV DYNAM, V237, P3940, DOI 10.1002/dvdy.21807; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Passier R, 2000, MECH DEVELOP, V92, P277, DOI 10.1016/S0925-4773(99)00330-5; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Tei C, 1995, J Cardiol, V26, P135; Tei C, 1995, J Cardiol, V26, P357; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; Ward AD, 2007, ACAD RADIOL, V14, P1229, DOI 10.1016/j.acra.2007.06.014; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	58	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80809	10.1371/journal.pone.0080809	http://dx.doi.org/10.1371/journal.pone.0080809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278323	gold, Green Published			2022-12-27	WOS:000327313100114
J	Liu, HY; Chen, K; Feng, WQ; Wu, XX; Li, H				Liu, Hongya; Chen, Kai; Feng, Wenqiang; Wu, Xinxing; Li, Hui			TLR4-MyD88/Mal-NF-kB Axis Is Involved in Infection of HSV-2 in Human Cervical Epithelial Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; DENDRITIC CELLS; TYPE-2; ADAPTER; INDUCTION; RESPONSES; TOLL-LIKE-RECEPTOR-4	We have established an in vitro HSV-2 acute infection model with Human cervical epithelial (HCE cells, the primary target and natural host cells for HSV-2) to investigate the role of TLRs-mediated innate immune response to HSV-2. In current study, we found that HSV-2 infection induced activity of NF-kB reporter and expression of cytokines are TLR4-dependent using approaches with shRNA and TLR4 antagonist. Knockdown experiments demonstrated that the adaptor molecules MyD88 and Mal of the TLRs signaling pathway are required in the HSV-2 induced TLR4-dependent NF-kB activation in HCE cells. Western blot assay suggested that knockdown of TLR4 decreased the phosphorylation of IRAK1 and inhibitor of NF-kB (IkB-alpha) upon HSV-2 infection. Finally, decreased expression of either TLR4 or MyD88/Mal alone or both significantly abolished productions of IL-6 and IFN-beta by ELISA analysis. Taken together, our results from the in vitro infection model reveal for the first time that there exists the pathway via TLR4-Mal/MyD88-IRAK1-NF-kB axis in human cervical epithelial cells in response to HSV-2 infection.	[Liu, Hongya; Chen, Kai; Feng, Wenqiang; Wu, Xinxing; Li, Hui] Wuhan Univ, Sch Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Liu, Hongya; Chen, Kai; Feng, Wenqiang; Li, Hui] Wuhan Univ, Shenzhen Inst, State Key Lab Virol, Shengzhen R&D Ctr, Shenzhen, Guandong, Peoples R China	Wuhan University; Wuhan University	Li, H (corresponding author), Wuhan Univ, Sch Med, Inst Med Virol, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	somhli@whu.edu.cn			National Natural Science Foundation of China [30810103052, 81072419]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (30810103052, 81072419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen JM, 2006, BIOL REPROD, V74, P824, DOI 10.1095/biolreprod.105.048629; Baege AC, 2002, AM J PATHOL, V160, P1251, DOI 10.1016/S0002-9440(10)62552-7; Chan T, 2011, J REPROD IMMUNOL, V88, P210, DOI 10.1016/j.jri.2011.01.001; Corey Lawrence, 2007, Herpes, V14 Suppl 1, p5A; Finberg RW, 2005, VIRAL IMMUNOL, V18, P457, DOI 10.1089/vim.2005.18.457; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koelle DM, 2006, CURR OPIN INVEST DR, V7, P136; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kurt-Jones EA, 2005, J INFECT DIS, V191, P746, DOI 10.1086/427339; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li H, 2009, BIOCHEM BIOPH RES CO, V379, P686, DOI 10.1016/j.bbrc.2008.12.150; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Miller J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003284; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Paz-Bailey G, 2007, SEX TRANSM INFECT, V83, P16, DOI 10.1136/sti.2006.020966; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Schacker T, 2001, Herpes, V8, P46; Sin WX, 2012, IMMUNOL RES, V53, P25, DOI 10.1007/s12026-012-8293-7; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Thon JN, 2012, J CELL BIOL, V198, P561, DOI 10.1083/jcb.201111136; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Whitley Richard J, 2002, Semin Pediatr Infect Dis, V13, P6, DOI 10.1053/spid.2002.29752; WHITLEY RJ, 1991, DRUGS, V42, P406, DOI 10.2165/00003495-199142030-00005; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Yasuda K, 2009, J IMMUNOL, V183, P3109, DOI 10.4049/jimmunol.0900399; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	42	6	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80327	10.1371/journal.pone.0080327	http://dx.doi.org/10.1371/journal.pone.0080327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278275	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100084
J	Oberfeld, D; Kuta, M; Jesteadt, W				Oberfeld, Daniel; Kuta, Martha; Jesteadt, Walt			Factors Limiting Performance in a Multitone Intensity-Discrimination Task: Disentangling Non-Optimal Decision Weights and Increased Internal Noise	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; PSYCHOMETRIC FUNCTIONS; SAMPLE DISCRIMINATION; MULTIPLE OBSERVATIONS; BROAD-BAND; LEVEL; MASKING; PERCEPTION; TUTORIAL; SIGNALS	To identify factors limiting performance in multitone intensity discrimination, we presented sequences of five pure tones alternating in level between loud (85 dB SPL) and soft (30, 55, or 80 dB SPL). In the "overall-intensity task", listeners detected a level increment on all of the five tones. In the "masking task", the level increment was imposed only on the soft tones, rendering the soft tones targets and loud tones task-irrelevant maskers. Decision weights quantifying the importance of the five tone levels for the decision were estimated using methods of molecular psychophysics. Compatible with previous studies, listeners placed higher weights on the loud tones than on the soft tones in the overall-intensity condition. In the masking task, the decisions were systematically influenced by the to-be-ignored loud tones (maskers). Using a maximum-likelihood technique, we estimated the internal noise variance and tested whether the internal noise was higher in the alternating-level five-tone sequences than in sequences presenting only the soft or only the loud tones. For the overall-intensity task, we found no evidence for increased internal noise, but listeners applied suboptimal decision weights. These results are compatible with the hypothesis that the presence of the loud tones does not impair the precision of the representation of the intensity of the soft tones available at the decision stage, but that this information is not used in an optimal fashion due to a difficulty in attending to the soft tones. For the masking task, in some cases our data indicated an increase in internal noise. Additionally, listeners applied suboptimal decision weights. The maximum-likelihood analyses we developed should also be useful for other tasks or other sensory modalities.	[Oberfeld, Daniel; Kuta, Martha] Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany; [Jesteadt, Walt] Boys Town Natl Res Hosp, Psychoacoust Lab, Omaha, NE 68131 USA	Johannes Gutenberg University of Mainz; Boys Town National Research Hospital	Oberfeld, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany.	oberfeld@uni-mainz.de	Oberfeld, Daniel/A-7997-2008	Oberfeld, Daniel/0000-0002-6710-3309	Deutsche Forschungsgemeinschaft (DFG) [OB 346/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from Deutsche Forschungsgemeinschaft (DFG) to Daniel Oberfeld (OB 346/4-1: Temporal aspects of auditory intensity processing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received.	AGRESTI A, 1989, PSYCHOL BULL, V105, P290, DOI 10.1037/0033-2909.105.2.290; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Alexander JM, 2004, J ACOUST SOC AM, V116, P2234, DOI 10.1121/1.1784437; Alexander JM, 2008, J ACOUST SOC AM, V123, P241, DOI 10.1121/1.2816415; [Anonymous], 1970, 318 IEC; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P362, DOI 10.1080/14640746608400055; BEKESY GEORG v., 1947, ACTA OTO LARYNGOL [STOCKHOLM], V35, P411, DOI 10.3109/00016484709123756; BERG BG, 1989, J ACOUST SOC AM, V86, P1743, DOI 10.1121/1.398605; BERG BG, 1990, J ACOUST SOC AM, V88, P149, DOI 10.1121/1.399962; Berg BG, 2004, J ACOUST SOC AM, V115, P822, DOI 10.1121/1.1639904; BERG BG, 1987, J ACOUST SOC AM, V81, pS33, DOI 10.1121/1.2024197; BRAIDA LD, 1972, J ACOUST SOC AM, V51, P483, DOI 10.1121/1.1912868; BUUS S, 1991, J ACOUST SOC AM, V90, P1371, DOI 10.1121/1.401928; Chen Z, 2012, ATTEN PERCEPT PSYCHO, V74, P784, DOI 10.3758/s13414-012-0322-z; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAMER H., 1946, Mathematical methods of statistics.; Dittrich K, 2009, J ACOUST SOC AM, V126, P3168, DOI 10.1121/1.3238233; DURLACH NI, 1986, J ACOUST SOC AM, V80, P63, DOI 10.1121/1.394084; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Ellermeier W, 2000, FECHNER DAY 2000, P169; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; GREEN DM, 1958, J ACOUST SOC AM, V30, P904, DOI 10.1121/1.1909400; GREEN DM, 1966, PSYCHOL BULL, V66, P228, DOI 10.1037/h0023645; GREEN DM, 1986, J ACOUST SOC AM, V79, P760, DOI 10.1121/1.393465; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hartmann W. M., 2005, SIGNALS SOUND SENSAT; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Iverson G, 1997, CHOICE DECISION MEAS, pxv; Kahneman D., 1981, PERCEPTUAL ORG, P181; KESELMAN HJ, 1994, J EDUC STAT, V19, P127, DOI 10.3102/10769986019002127; LESHOWITZ B, 1973, J ACOUST SOC AM, V54, P882, DOI 10.1121/1.1914342; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUTFI RA, 1989, J ACOUST SOC AM, V86, P934, DOI 10.1121/1.398728; Lutfi RA, 2006, J ACOUST SOC AM, V120, P3853, DOI 10.1121/1.2361184; Lutfi RA, 2011, J ACOUST SOC AM, V130, pEL329, DOI 10.1121/1.3645968; Macmillan NA, 2004, PERCEPT PSYCHOPHYS, V66, P406, DOI 10.3758/BF03194889; Macmillan NA, 2005, DETECTION THEORY USE, VXIX; MASSARO DW, 1975, J ACOUST SOC AM, V58, P1059, DOI 10.1121/1.380765; Maxwell S. E., 2004, DESIGNING EXPT ANAL; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; Moore BCJ, 1999, J ACOUST SOC AM, V106, P3539, DOI 10.1121/1.428207; Nachmias J, 2006, VISION RES, V46, P2456, DOI 10.1016/j.visres.2006.01.029; Oberfeld D, 2008, CAN J EXP PSYCHOL, V62, P24, DOI 10.1037/1196-1961.62.1.24; Oberfeld D, 2008, J ACOUST SOC AM, V123, P1571, DOI 10.1121/1.2837284; Oberfeld D, 2013, BEHAV RES METHODS, V45, P792, DOI 10.3758/s13428-012-0281-2; Oberfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050184; Oberfeld D, 2012, HEARING RES, V294, P1, DOI 10.1016/j.heares.2012.09.004; Oberfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048054; Oberfeld D, 2011, ATTEN PERCEPT PSYCHO, V73, P189, DOI 10.3758/s13414-010-0011-8; Oberfeld D, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P99, DOI 10.1007/978-1-4419-5686-6_10; Oberfeld D, 2009, J ACOUST SOC AM, V125, P294, DOI 10.1121/1.3021296; Pedersen B, 2008, J ACOUST SOC AM, V123, P963, DOI 10.1121/1.2822883; PLACK CJ, 1995, J ACOUST SOC AM, V97, P1141, DOI 10.1121/1.412227; PLACK CJ, 1992, J ACOUST SOC AM, V92, P3097, DOI 10.1121/1.404205; Plank T, 2005, THESIS U REGENSBURG; Rennies J, 2009, J ACOUST SOC AM, V126, P951, DOI 10.1121/1.3192348; Sorkin R. D., 1987, Proceedings of the Human Factors Society 31st Annual Meeting: Rising to New Heights with Technology, P1184; SWETS JA, 1959, J ACOUST SOC AM, V31, P514, DOI 10.1121/1.1907745; SWETS JA, 1986, PSYCHOL BULL, V99, P181, DOI 10.1037/0033-2909.99.2.181; SWETS JA, 1986, PSYCHOL BULL, V99, P100, DOI 10.1037/0033-2909.99.1.100; Tang Z, 2005, J ACOUST SOC AM, V117, P2597; TANNER WP, 1958, J ACOUST SOC AM, V30, P922, DOI 10.1121/1.1909408; TURNER CW, 1992, J ACOUST SOC AM, V92, P3102, DOI 10.1121/1.404206; Turner MD, 2007, J ACOUST SOC AM, V121, P1848, DOI 10.1121/1.2710345; ZENG FG, 1992, J ACOUST SOC AM, V92, P782, DOI 10.1121/1.403947; ZENG FG, 1991, HEARING RES, V55, P223, DOI 10.1016/0378-5955(91)90107-K; Zwillinger D, 2003, CRC STANDARD MATH TA	70	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79830	10.1371/journal.pone.0079830	http://dx.doi.org/10.1371/journal.pone.0079830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278190	Green Published, gold			2022-12-27	WOS:000327313100055
J	Zhang, XQ; Duan, AG; Zhang, JG				Zhang, Xiongqing; Duan, Aiguo; Zhang, Jianguo			Tree Biomass Estimation of Chinese fir (Cunninghamia lanceolata) Based on Bayesian Method	PLOS ONE			English	Article							VOLUME EQUATIONS; DISTRIBUTIONS; GROWTH; PREDICTION; ALLOMETRY; MORTALITY; INFERENCE; FORESTS; MODELS	Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) is the most important conifer species for timber production with huge distribution area in southern China. Accurate estimation of biomass is required for accounting and monitoring Chinese forest carbon stocking. In the study, allometric equation W=a((DH)-H-2)(b) was used to analyze tree biomass of Chinese fir. The common methods for estimating allometric model have taken the classical approach based on the frequency interpretation of probability. However, many different biotic and abiotic factors introduce variability in Chinese fir biomass model, suggesting that parameters of biomass model are better represented by probability distributions rather than fixed values as classical method. To deal with the problem, Bayesian method was used for estimating Chinese fir biomass model. In the Bayesian framework, two priors were introduced: non-informative priors and informative priors. For informative priors, 32 biomass equations of Chinese fir were collected from published literature in the paper. The parameter distributions from published literature were regarded as prior distributions in Bayesian model for estimating Chinese fir biomass. Therefore, the Bayesian method with informative priors was better than non-informative priors and classical method, which provides a reasonable method for estimating Chinese fir biomass.	[Zhang, Xiongqing; Duan, Aiguo; Zhang, Jianguo] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat, State Forestry Adm,Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, JG (corresponding author), Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat, State Forestry Adm,Res Inst Forestry, Beijing, Peoples R China.	zhangjg@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	Research Institute of Forestry, Chinese Academy of Forestry [RIF2013-09]; National Natural Science Foundation of China [31300537, 31370629]	Research Institute of Forestry, Chinese Academy of Forestry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was sponsored by the Research Institute of Forestry, Chinese Academy of Forestry (No. RIF2013-09) and National Natural Science Foundation of China (No. 31300537, No. 31370629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt BR, 2000, ECOLOGY, V81, P3509, DOI 10.2307/177510; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; BERGER JO, 1988, AM SCI, V76, P159; Bi HQ, 2010, FOREST ECOL MANAG, V259, P2301, DOI 10.1016/j.foreco.2010.03.003; Bullock BP, 2007, FOREST ECOL MANAG, V242, P127, DOI 10.1016/j.foreco.2007.01.024; Case BS, 2008, CAN J FOREST RES, V38, P878, DOI 10.1139/X07-212; Chambers JQ, 2001, FOREST ECOL MANAG, V152, P73, DOI 10.1016/S0378-1127(00)00591-0; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Clark JS, 2007, ECOL APPL, V17, P1942, DOI 10.1890/06-1039.1; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Edwards D, 1996, ECOL APPL, V6, P1090, DOI 10.2307/2269593; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Gelman A., 2004, BAYESIAN DATA ANAL; GREEN EJ, 1994, BIOMETRICS, V50, P254, DOI 10.2307/2533217; Green EJ, 1998, FOREST SCI, V44, P134; Green EJ, 1996, FOREST SCI, V42, P456; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HOLBROOK NM, 1989, AM J BOT, V76, P1740, DOI 10.2307/2444473; HUI G, 1989, SCI SILV SIN, V25, P564; Jaynes E.T., 2003, PROBABILITY THEORY L; Jenkins JC, 2003, FOREST SCI, V49, P12; KING DA, 1991, TREE PHYSIOL, V9, P369, DOI 10.1093/treephys/9.3.369; Lehtonen A, 2004, FOREST ECOL MANAG, V188, P211, DOI 10.1016/j.foreco.2003.07.008; Lei J, 2005, CHINESE FOREST RESOU; Li RX, 2012, FORESTRY, V85, P17, DOI 10.1093/forestry/cpr050; Li SS, 2007, CHINESE PHYS, V16, P1, DOI 10.1088/1009-1963/16/1/001; Lin S-M, 1991, J ZHEJIANG FORESTRY, V8, P288; [刘雯雯 Liu Wenwen], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P7; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; Metcalf CJE, 2009, CAN J FOREST RES, V39, P1677, DOI 10.1139/X09-083; Nystrom K, 2001, SILVA FENN, V35, P185, DOI 10.14214/sf.595; PETRUS J, 1994, J TROP ECOL, V10, P207; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Tian D.L., 1998, J CENT S FOR U, V18, P159; Wang B, 2012, SCAND J FOREST RES, V27, P545, DOI 10.1080/02827581.2012.672585; Wu Z., 1984, CHINESE FIR; Wyckoff PH, 2000, CAN J FOREST RES, V30, P156, DOI 10.1139/cjfr-30-1-156; Zapata-Cuartas M, 2012, FOREST ECOL MANAG, V277, P173, DOI 10.1016/j.foreco.2012.04.030; Zianis D., 2005, Silva Fennica Monographs, P1	41	31	36	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79868	10.1371/journal.pone.0079868	http://dx.doi.org/10.1371/journal.pone.0079868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278198	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100061
J	Zheng, S; Pan, T; Fan, LG; Qiu, QS				Zheng, Sheng; Pan, Ting; Fan, Ligang; Qiu, Quan-Sheng			A Novel AtKEA Gene Family, Homolog of Bacterial K+/H+ Antiporters, Plays Potential Roles in K+ Homeostasis and Osmotic Adjustment in Arabidopsis	PLOS ONE			English	Article							GATED POTASSIUM EFFLUX; PLASMA-MEMBRANE; SALT TOLERANCE; NA+/H+ EXCHANGER; NA+(K+)/H+ EXCHANGER; ESCHERICHIA-COLI; SODIUM-TRANSPORT; ION HOMEOSTASIS; MORNING GLORY; PLANT-GROWTH	AtKEAs, homologs of bacterial KefB/KefC, are predicted to encode K+/H+ antiporters in Arabidopsis. The AtKEA family contains six genes forming two subgroups in the cladogram: AtKEA1-3 and AtKEA4-6. AtKEA1 and AtKEA2 have a long N-terminal domain; the full-length AtKEA1 was inactive in yeast. The transport activity was analyzed by expressing the AtKEA genes in yeast mutants lacking multiple ion carriers. AtKEAs conferred resistance to high K+ and hygromycin B but not to salt and Li+ stress. AtKEAs expressed in both the shoot and root of Arabidopsis. The expression of AtKEA1, -3 and -4 was enhanced under low K+ stress, whereas AtKEA2 and AtKEA5 were induced by sorbitol and ABA treatments. However, osmotic induction of AtKEA2 and AtKEA5 was not observed in aba2-3 mutants, suggesting an ABA regulated mechanism for their osmotic response. AtKEAs' expression may not be regulated by the SOS pathway since their expression was not affected in sos mutants. The GFP tagging analysis showed that AtKEAs distributed diversely in yeast. The Golgi localization of AtKEA3 was demonstrated by both the stably transformed seedlings and the transient expression in protoplasts. Overall, AtKEAs expressed and localized diversely, and may play roles in K+ homeostasis and osmotic adjustment in Arabidopsis.	[Zheng, Sheng; Pan, Ting; Fan, Ligang; Qiu, Quan-Sheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn			National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31070222]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 project, 2013CB429904 to QSQ), the National Natural Science Foundation of China (NSFC) (31070222 to QSQ), and the Fundamental Research Funds for the Central Universities (lzujbky-2013-k10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Choe S, 2002, NAT REV NEUROSCI, V3, P115, DOI 10.1038/nrn727; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DaSilva LLP, 2004, PLANT CELL, V16, P1753, DOI 10.1105/tpc.022673; FANG ZW, 1995, PLANT PHYSIOL, V108, P1725, DOI 10.1104/pp.108.4.1725; Ferguson GP, 1997, J BACTERIOL, V179, P1007, DOI 10.1128/jb.179.4.1007-1012.1997; Flis K, 2005, BIOCHEM J, V390, P655, DOI 10.1042/BJ20050480; Fujisawa M, 2007, P NATL ACAD SCI USA, V104, P13289, DOI 10.1073/pnas.0703709104; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Guo Q, 2004, ENDOCRINOLOGY, V145, P1640, DOI 10.1210/en.2003-1270; Hall D, 2006, AM POETRY REV, V35, P57; Jiang XY, 2010, PLANT SIGNAL BEHAV, V5, P792, DOI 10.4161/psb.5.7.11767; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Maresova L, 2006, YEAST, V23, P1167, DOI 10.1002/yea.1424; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mei Y, 2012, CELL RES, V22, P581, DOI 10.1038/cr.2011.150; Miller S, 1997, J BIOL CHEM, V272, P24942, DOI 10.1074/jbc.272.40.24942; Miller S, 2000, J BACTERIOL, V182, P6536, DOI 10.1128/JB.182.22.6536-6540.2000; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Aranda-Sicilia MN, 2012, BBA-BIOMEMBRANES, V1818, P2362, DOI 10.1016/j.bbamem.2012.04.011; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; ROBINSON SP, 1985, PLANT PHYSIOL, V79, P996, DOI 10.1104/pp.79.4.996; Roosild TP, 2010, P NATL ACAD SCI USA, V107, P19784, DOI 10.1073/pnas.1012716107; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Song CP, 2004, P NATL ACAD SCI USA, V101, P10211, DOI 10.1073/pnas.0403709101; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; WANG XC, 1993, P NATL ACAD SCI USA, V90, P4981, DOI 10.1073/pnas.90.11.4981; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida K, 2005, PLANT CELL PHYSIOL, V46, P407, DOI 10.1093/pcp/pci057; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhao J, 2008, PLANT PHYSIOL, V148, P796, DOI 10.1104/pp.108.124248; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	76	34	47	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81463	10.1371/journal.pone.0081463	http://dx.doi.org/10.1371/journal.pone.0081463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278440	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100158
J	Lam, T; Thomas, LM; White, CA; Li, GD; Pone, EJ; Xu, ZM; Casali, P				Lam, Tonika; Thomas, Lisa M.; White, Clayton A.; Li, Guideng; Pone, Egest J.; Xu, Zhenming; Casali, Paolo			Scaffold Functions of 14-3-3 Adaptors in B Cell Immunoglobulin Class Switch DNA Recombination	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVATION-INDUCED DEAMINASE; PROTEIN-KINASE-A; SOMATIC HYPERMUTATION; CYCLE ARREST; HIV-1 VPR; HIV-1-INFECTED PATIENTS; LIVING CELLS; FC-RECEPTOR	Class switch DNA recombination (CSR) of the immunoglobulin heavy chain (IgH) locus crucially diversifies antibody biological effector functions. CSR involves the induction of activation-induced cytidine deaminase (AID) expression and AID targeting to switch (S) regions by 14-3-3 adaptors. 14-3-3 adaptors specifically bind to 5'-AGCT-3' repeats, which make up for the core of all IgH locus S regions. They selectively target the upstream and downstream S regions that are set to undergo S-S DNA recombination. We hypothesized that 14-3-3 adaptors function as scaffolds to stabilize CSR enzymatic elements on S regions. Here we demonstrate that all seven 14-3-3 beta, 14-3-3 epsilon, 14-3-3 gamma, 14-3-3 eta, 14-3-3 sigma, 14-3-3 tau and 14-3-3 zeta adaptors directly interacted with AID, PKA-C alpha (catalytic subunit) and PKA-RI alpha (regulatory inhibitory subunit) and uracil DNA glycosylase (Ung). 14-3-3 adaptors, however, did not interact with AID C-terminal truncation mutant AID Delta(180-198) or AIDF193A and AIDL196A point-mutants (which have been shown not to bind to S region DNA and fail to mediate CSR). 14-3-3 adaptors colocalized with AID and replication protein A (RPA) in B cells undergoing CSR. 14-3-3 and AID binding to S region DNA was disrupted by viral protein R (Vpr), an accessory protein of human immunodeficiency virus type-1 (HIV-1), which inhibited CSR without altering AID expression or germline I-H-C-H transcription. Accordingly, we demonstrated that 14-3-3 directly interact with Vpr, which in turn, also interact with AID, PKA-C alpha and Ung. Altogether, our findings suggest that 14-3-3 adaptors play important scaffold functions and nucleate the assembly of multiple CSR factors on S regions. They also show that such assembly can be disrupted by a viral protein, thereby allowing us to hypothesize that small molecule compounds that specifically block 14-3-3 interactions with AID, PKA and/or Ung can be used to inhibit unwanted CSR.	[Lam, Tonika; Thomas, Lisa M.; White, Clayton A.; Li, Guideng; Pone, Egest J.; Xu, Zhenming; Casali, Paolo] Univ Calif Irvine, Sch Med, Inst Immunol, Irvine, CA 92717 USA; [Lam, Tonika; Thomas, Lisa M.; White, Clayton A.; Li, Guideng; Pone, Egest J.; Xu, Zhenming; Casali, Paolo] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92717 USA; [Lam, Tonika; Xu, Zhenming; Casali, Paolo] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio	Casali, P (corresponding author), Univ Calif Irvine, Sch Med, Inst Immunol, Irvine, CA 92717 USA.	pcasali@uci.edu			United States National Institutes of Health [AI 079705, AI 10105813, AI 060573];  [AI 060573 T32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105813, R01AI079705, T32AI060573, R56AI079705] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States National Institutes of Health grants AI 079705, AI 10105813 and AI 060573 ( to P. C.), and T. Lam is supported by the AI 060573 T32 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SD, 2012, DNA REPAIR, V11, P267, DOI 10.1016/j.dnarep.2011.11.007; Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Begum NA, 2009, P NATL ACAD SCI USA, V106, P2752, DOI 10.1073/pnas.0813252106; Bolton DL, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-17; Casali P, 2013, LEWINS GENES; Casali P., 2009, LEWINS GENES, P570; Casali P, 2006, TRENDS IMMUNOL, V27, P313, DOI 10.1016/j.it.2006.05.001; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Conticello SG, 2007, NAT STRUCT MOL BIOL, V14, P7, DOI 10.1038/nsmb0107-7; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Diaz M, 2013, AUTOIMMUNITY, V46, P115, DOI 10.3109/08916934.2012.750303; Doi T, 2009, P NATL ACAD SCI USA, V106, P2758, DOI 10.1073/pnas.0813253106; Engels K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001367; Forthal DN, 2005, J VIROL, V79, P2042, DOI 10.1128/JVI.79.4.2042-2049.2005; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Han L, 2012, P NATL ACAD SCI US; Han L, 2011, P NATL ACAD SCI USA, V108, P11584, DOI 10.1073/pnas.1018726108; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Kellner WA, 2012, GENOME RES, V22, P1081, DOI 10.1101/gr.136929.111; Kenter AL, 2012, SEMIN IMMUNOL, V24, P281, DOI 10.1016/j.smim.2012.06.001; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim EC, 2004, J BIOL CHEM, V279, P42258, DOI 10.1074/jbc.M407496200; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Kino T, 2005, DIABETES, V54, P23, DOI 10.2337/diabetes.54.1.23; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Li G, 2013, TRENDS IMMUNOL; Li G, 2013, CELL REP, V5, DOI [10.1016/j.cellrep.2013.1009.1031., DOI 10.1016/J.CELLREP.2013.1009.1031]; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Mai T, 2010, J BIOL CHEM, V285, P37797, DOI 10.1074/jbc.M110.169086; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Oakley GG, 2009, BIOCHEMISTRY-US, V48, P7473, DOI 10.1021/bi900694p; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Park SR, 2009, NAT IMMUNOL, V10, P540, DOI 10.1038/ni.1725; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pone EJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1769; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stavnezer J, 2011, TRENDS IMMUNOL, V32, P194, DOI 10.1016/j.it.2011.03.003; Stoiber H, 2003, VACCINE, V21, pS77, DOI 10.1016/S0264-410X(03)00203-2; Storck S, 2011, CURR OPIN IMMUNOL, V23, P337, DOI 10.1016/j.coi.2011.02.002; Tungaturthi PK, 2003, BIOMED PHARMACOTHER, V57, P20, DOI 10.1016/S0753-3322(02)00328-1; Unniraman S, 2006, DNA REPAIR, V5, P1259, DOI 10.1016/j.dnarep.2006.05.019; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wecker K, 2002, EUR J BIOCHEM, V269, P3779, DOI 10.1046/j.1432-1033.2002.03067.x; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Xu ZM, 2005, ANN NY ACAD SCI, V1050, P146, DOI 10.1196/annals.1313.119; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zan H, 2013, AUTOIMMUNITY, V46, P83, DOI 10.3109/08916934.2012.749244; Zan H, 2012, CELL REP, V2, P1220, DOI 10.1016/j.celrep.2012.09.029; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhao J, 2011, P NATL ACAD SCI USA, V108, P16212, DOI 10.1073/pnas.1100012108	73	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80414	10.1371/journal.pone.0080414	http://dx.doi.org/10.1371/journal.pone.0080414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282540	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500041
J	Nehete, PN; Hanley, PW; Nehete, BP; Yang, GJ; Ruiz, JC; Williams, L; Abee, CR; Sastry, KJ				Nehete, Pramod N.; Hanley, Patrick W.; Nehete, Bharti P.; Yang, Guojun; Ruiz, Julio C.; Williams, Lawrence; Abee, Christian R.; Sastry, K. Jagannadha			Phenotypic and Functional Characterization of Lymphocytes from Different Age Groups of Bolivian Squirrel Monkeys (Saimiri boliviensis boliviensis)	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MACAQUES MACACA-MULATTA; PEPTIDE COCKTAIL VACCINE; NONHUMAN PRIMATE MODELS; CD4(+)CD8(+) T-CELLS; HEMATOLOGY VARIABLES; IMMUNE-RESPONSES; PLASMODIUM-VIVAX; BLOOD-CHEMISTRY; BONE-MARROW	Due to many physiological and genetic characteristic similarities to humans, squirrel monkeys provide an ideal animal model specifically for studying malaria, and transmissible spongiform encephalopathies (Creutzfeldt-Jacob disease). While squirrel monkeys three years and older are generally considered adult subjects suitable for use in medical research studies, little is known about the functional properties of lymphocytes in relation to the age of these animals, which could significantly impact the quality and quantity of innate and adaptive immune responses. In this study, we investigated differences in the phenotype and function of lymphocytes subsets of young (3-4 years), adult (8-10 years) and aged (16-19 years) squirrel monkeys. In general, animals in all three age groups exhibited comparable numbers of different lymphocyte subsets except for CD20+ B cells that were significantly lower in aged relative to young animals and T cells subsets expressing both CD4 and CD8 (double positive) were significantly higher in aged relative to young animals. With increasing age, phenotypic differences in central and effector memory T cells subsets were observed, that were more pronounced for the CD8+ T cells. Despite equal proportions of CD3+ T cells among the three age groups, responses of peripheral blood mononuclear cells to T cell mitogens PHA and Con A showed lower IFN-gamma producing cells in the aged group than that in the young group. Furthermore, aged animals showed significantly higher plasma levels of inflammatory cytokines IL-6, IFN-gamma, TNF-alpha, IL-10 and IL-12. These findings suggest that while the squirrel monkeys in general share phenotypic and functional similarities of lymphocyte subsets with humans in relation to age, specific differences exist in immune function of lymphocytes between young and old animals that could potentially impact experimental outcomes for which the measurement of immunologic endpoints are critical.	[Nehete, Pramod N.; Hanley, Patrick W.; Nehete, Bharti P.; Ruiz, Julio C.; Williams, Lawrence; Abee, Christian R.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA; [Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr Houston, Dept Immunol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Nehete, PN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA.	pnehete@mdanderson.org	Williams, Lawrence/AAD-6685-2020	Williams, Lawrence/0000-0003-2267-9918; Sastry, Jagannadha/0000-0002-6987-4422; Hanley, Patrick/0000-0003-2300-1818; Nehete, Pramod/0000-0002-2815-2677	NCCR [P40-001254RR]; Cattleman for Cancer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001254] Funding Source: NIH RePORTER	NCCR(Swiss National Science Foundation (SNSF)); Cattleman for Cancer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NCCR: grant (P40-001254RR) to C.A. and Cattleman for Cancer Foundation to P.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonafe M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.3.CO;2-O; BONOMO A, 1994, J IMMUNOL, V152, P1509; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; COBLEIGH MA, 1980, CLIN IMMUNOL IMMUNOP, V15, P162, DOI 10.1016/0090-1229(80)90028-8; Collins WE, 2000, AM J TROP MED HYG, V62, P491, DOI 10.4269/ajtmh.2000.62.491; Collins WE, 2009, AM J TROP MED HYG, V80, P228, DOI 10.4269/ajtmh.2009.80.228; Contamin H, 2005, J IMMUNOL METHODS, V297, P61, DOI 10.1016/j.jim.2004.11.019; Damania B, 2001, PHILOS T ROY SOC B, V356, P535, DOI 10.1098/rstb.2000.0782; De Bruin TGM, 2000, VIRAL IMMUNOL, V13, P511; Dennett NS, 2002, EXP GERONTOL, V37, P271, DOI 10.1016/S0531-5565(01)00193-0; DEPAOLI P, 1988, CLIN IMMUNOL IMMUNOP, V48, P290, DOI 10.1016/0090-1229(88)90022-0; FACCHINI A, 1987, CLIN EXP IMMUNOL, V68, P340; Frahm MA, 2012, J IMMUNOL, V188, P4289, DOI 10.4049/jimmunol.1103701; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Haberthur K, 2010, EXP GERONTOL, V45, P655, DOI 10.1016/j.exger.2010.06.001; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; Heraud JM, 2002, IMMUNOGENETICS, V54, P20, DOI 10.1007/s00251-002-0443-y; Hong MS, 2004, MECH AGEING DEV, V125, P615, DOI 10.1016/j.mad.2004.07.001; Inadera H, 1999, J INTERF CYTOK RES, V19, P1179, DOI 10.1089/107999099313127; Jankovic V, 2003, BLOOD, V102, P3244, DOI 10.1182/blood-2003-03-0927; Jiang J, 2007, MECH AGEING DEV, V128, P332, DOI 10.1016/j.mad.2007.02.002; Jimenez E, 2002, J IMMUNOL, V168, P5005, DOI 10.4049/jimmunol.168.10.5005; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Kovaiou RD, 2005, INT IMMUNOL, V17, P1359, DOI 10.1093/intimm/dxh314; Lane MA, 2000, EXP GERONTOL, V35, P533, DOI 10.1016/S0531-5565(00)00102-9; Lee WW, 2003, IMMUNOLOGY, V109, P217, DOI 10.1046/j.1365-2567.2003.01646.x; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; MILLER RA, 1995, NUTR REV, V53, pS8; MURASKO DM, 1987, CLIN EXP IMMUNOL, V70, P440; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Nehete PN, 2005, VACCINE, V23, P2154, DOI 10.1016/j.vaccine.2005.01.052; Nehete PN, 2003, J MED PRIMATOL, V32, P67, DOI 10.1034/j.1600-0684.2003.00011.x; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Potestio M, 1999, EXP GERONTOL, V34, P659, DOI 10.1016/S0531-5565(99)00041-8; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; SALA P, 1993, BLOOD, V82, P1546; Schapiro SJ, 2000, APPL ANIM BEHAV SCI, V68, P67, DOI 10.1016/S0168-1591(00)00090-3; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sharma PM, 2007, J MED VIROL, V79, P1199, DOI 10.1002/jmv.20909; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Smucny DA, 2004, J MED PRIMATOL, V33, P48, DOI 10.1111/j.1600-0684.2003.00052.x; Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Verschoor EJ, 2008, J GEN VIROL, V89, P130, DOI 10.1099/vir.0.83287-0; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Williams L, 2007, J GEN VIROL, V88, P688, DOI 10.1099/vir.0.81957-0; Williams Lawrence E., 2002, Primatologie, V5, P303; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; ZLOTNIK I, 1974, LANCET, V2, P435; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79836	10.1371/journal.pone.0079836	http://dx.doi.org/10.1371/journal.pone.0079836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282512	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500013
J	Porat-Shliom, N; Weigert, R; Donaldson, JG				Porat-Shliom, Natalie; Weigert, Roberto; Donaldson, Julie G.			Endosomes Derived from Clathrin-Independent Endocytosis Serve as Precursors for Endothelial Lumen Formation	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE INDUCER; HAMSTER OVARY CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MOLECULAR-MECHANISMS; RECYCLING PATHWAY; BIOLOGICAL TUBES; ZEBRAFISH EMBRYO; UNIQUE PLATFORM; ARF6 RECRUITS; POLARITY	Clathrin-independent endocytosis (CIE) is a form of bulk plasma membrane (PM) endocytosis that allows cells to sample and evaluate PM composition. Once in endosomes, the internalized proteins and lipids can be recycled back to the PM or delivered to lysosomes for degradation. Endosomes arising from CIE contain lipid and signaling molecules suggesting that they might be involved in important biological processes. During vasculogenesis, new blood vessels are formed from precursor cells in a process involving internalization and accumulation of endocytic vesicles. Here, we found that CIE has a role in endothelial lumen formation. Specifically, we found that human vascular endothelial cells (HUVECs) utilize CIE for internalization of distinct cargo molecules and that in three-dimensional cultures CIE membranes are delivered to the newly formed lumen.	[Porat-Shliom, Natalie; Donaldson, Julie G.] NHLBI, NIH, Cell Biol & Physiol Ctr, Bethesda, MD 20892 USA; [Porat-Shliom, Natalie; Weigert, Roberto] Natl Inst Dent & Craniofacial Res, NIH, Intracellular Membrane Trafficking Unit, Oral & Pharyngeal Canc Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Donaldson, JG (corresponding author), NHLBI, NIH, Cell Biol & Physiol Ctr, Bldg 10, Bethesda, MD 20892 USA.	donaldsonj@helix.nih.gov		Porat-Shliom, Natalie/0000-0003-2676-8483	Intramural Research Program National Heart, Lung, and Blood Institute, National Institutes of Health [HL006060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000717] Funding Source: NIH RePORTER	Intramural Research Program National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by the Intramural Research Program (HL006060) of the National Heart, Lung, and Blood Institute, National Institutes of Health. http://www.nhlbi.nih.gov/research/intramural/researchers/pi/donaldson-julie/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2006, MOL BIOL CELL, V17, P711, DOI 10.1091/mbc.E05-05-0382; Ang SF, 2012, ESSAYS BIOCHEM, V53, P29, DOI [10.1042/BSE0530029, 10.1042/bse0530029]; Bach AS, 2010, MOL BIOL CELL, V21, P2412, DOI 10.1091/mbc.E09-12-1063; Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Chies R, 2003, J CELL SCI, V116, P987, DOI 10.1242/jcs.00326; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Ellertsdottir E, 2010, DEV BIOL, V341, P56, DOI 10.1016/j.ydbio.2009.10.035; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guo HM, 1997, J BIOL CHEM, V272, P24; Helker CSM, 2013, DEVELOPMENT, V140, P2776, DOI 10.1242/dev.091876; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jose M, 2013, J CELL BIOL, V200, P407, DOI 10.1083/jcb.201206081; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Le Roy C, 2005, DEV CELL, V9, P167, DOI 10.1016/j.devcel.2005.07.007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Mostov K, 2006, NATURE, V442, P363, DOI 10.1038/442363a; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Song J, 1998, J CELL SCI, V111, P2257; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Yang JM, 2003, MOL CANCER RES, V1, P420; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	51	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81987	10.1371/journal.pone.0081987	http://dx.doi.org/10.1371/journal.pone.0081987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282620	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500124
J	Sampson, C; Kirk, WDJ				Sampson, Clare; Kirk, William D. J.			Can Mass Trapping Reduce Thrips Damage and Is It Economically Viable? Management of the Western Flower Thrips in Strawberry	PLOS ONE			English	Article							FRANKLINIELLA-OCCIDENTALIS PERGANDE; AGGREGATION PHEROMONE; PEST-MANAGEMENT; ONION THRIPS; PALMI KARNY; IN-FIELD; THYSANOPTERA; CROPS; COLOR; CAPTURE	The western flower thrips Frankliniella occidentalis (Pergande) (Thysanoptera: Thripidae) is a cosmopolitan, polyphagous insect pest that causes bronzing to fruit of strawberry (Fragaria x ananassa). The main aim of this study was to test whether mass trapping could reduce damage and to predict whether this approach would be economically viable. In semi-protected strawberry crops, mass trapping of F. occidentalis using blue sticky roller traps reduced adult thrips numbers per flower by 61% and fruit bronzing by 55%. The addition of the F. occidentalis aggregation pheromone, neryl (S)-2-methylbutanoate, to the traps doubled the trap catch, reduced adult thrips numbers per flower by 73% and fruit bronzing by 68%. The factors affecting trapping efficiency through the season are discussed. Damage that would result in downgrading of fruit to a cheaper price occurred when bronzing affected about 10% of the red fruit surface. Cost-benefit analysis using this threshold showed that mass trapping of thrips using blue sticky roller traps can be cost-effective in high-value crops. The addition of blue sticky roller traps to an integrated pest management programme maintained thrips numbers below the damage threshold and increased grower returns by a conservative estimate of 2.2k pound per hectare. Further work is required to develop the F. occidentalis aggregation pheromone for mass trapping and to determine the best timing for trap deployment. Mass trapping of thrips is likely to be cost-effective in other countries and other high-value crops affected by F. occidentalis damage, such as cucumber and cut flowers.	[Sampson, Clare; Kirk, William D. J.] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Newcastle Under Lyme, Staffs, England	Keele University	Sampson, C (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Newcastle Under Lyme, Staffs, England.	a.c.sampson@keele.ac.uk		Kirk, William/0000-0001-8586-4518	Horticulture LINK programme in the U.K. [HL01107]	Horticulture LINK programme in the U.K.	This research was co-funded through the Horticulture LINK programme in the U.K. (project HL01107) by the Department for Environment, Food and Rural Affairs (http://www.defra.gov.uk/), together with a consortium of industrial companies (Agriculture and Horticulture Development Board, Bayer CropScience Ltd, Belchim Crop Protection Ltd, Berryworld Ltd, Berry Gardens Growers Ltd, Certis Europe BV, CPM Retail Ltd, East Malling Ltd, KG Growers Ltd, Russell IPM Ltd, Syngenta Bioline Ltd and Tesco Stores Ltd). The funders had no role in study design, data collection and analysis or preparation of the manuscript. The funders could object to publication if it was prejudicial to intellectual property, security or confidentiality. No objections were raised.	BRODSGAARD HF, 1989, J APPL ENTOMOL, V107, P136, DOI 10.1111/j.1439-0418.1989.tb00240.x; BRODSGAARD HF, 1990, IOBC WPRS B, V13, P36; Broughton S, 2012, CROP PROT, V42, P156, DOI 10.1016/j.cropro.2012.05.004; Byers JA, 2012, ENTOMOL EXP APPL, V145, P228, DOI 10.1111/eea.12006; Coll M, 2007, ENTOMOL EXP APPL, V122, P59, DOI 10.1111/j.1570-7458.2006.00488.x; Covaci A. D., 2012, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, V69, P333; CRESPI BJ, 1990, AM NAT, V135, P48, DOI 10.1086/285031; Davidson M. M., 2007, New Zealand Plant Protection, V60, P56; Davidson MM, 2006, J INSECT PHYSIOL, V52, P729, DOI 10.1016/j.jinsphys.2006.03.013; Department for Environment Food and Rural Affairs, 2013, AGR UK 2012; Dublon I. A. N., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P249, DOI 10.1556/APhyt.43.2008.2.6; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; FREY JE, 1994, BIOCONTROL SCI TECHN, V4, P177, DOI 10.1080/09583159409355325; Gomez M., 2006, IOBC-WPRS Bulletin, V29, P153; Gonzalez-Zamora JE, 2003, J APPL ENTOMOL, V127, P516, DOI 10.1046/j.0931-2048.2003.00783.x; Hamilton JGC, 2005, J CHEM ECOL, V31, P1369, DOI 10.1007/s10886-005-1351-z; Howse P.E., 1998, INSECT PHEROMONES TH, P280, DOI [10.1007/978-94-011-5344-7_10, DOI 10.1007/978-94-011-5344-7_10]; KAWAI A, 1990, JARQ-JPN AGR RES Q, V24, P43; KAWAI A, 1990, APPL ENTOMOL ZOOL, V25, P161, DOI 10.1303/aez.25.161; Kirk W. D. J., 2004, Acta Phytopathologica et Entomologica Hungarica, V39, P131, DOI 10.1556/APhyt.39.2004.1-3.13; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Koike ST, 2009, HORTSCIENCE, V44, P1588; Lim UT, 2013, J ASIA-PAC ENTOMOL, V16, P143, DOI 10.1016/j.aspen.2012.12.007; Lim UT, 2009, CROP PROT, V28, P1098, DOI 10.1016/j.cropro.2009.07.012; Martins AS, 1997, FISH RES, V30, P217, DOI 10.1016/S0165-7836(96)00566-8; MORENO DS, 1984, ENVIRON ENTOMOL, V13, P935, DOI 10.1093/ee/13.4.935; Natwick ET, 2007, SOUTHWEST ENTOMOL, V32, P229, DOI 10.3958/0147-1724-32.4.229; Nondillo A, 2010, CIENC RURAL, V40, P820, DOI 10.1590/S0103-84782010005000050; O'Leary AT, 2005, THESIS KEELE U; Sampson C., 2012, IOBC/WPRS Bulletin, V80, P313; Sampson Clare, 2012, Acta Phytopathologica et Entomologica Hungarica, V47, P133, DOI 10.1556/APhyt.47.2012.1.17; Shakya S, 2010, J ECON ENTOMOL, V103, P1086, DOI 10.1603/EC09373; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; Steiner MY, 2005, AUST J ENTOMOL, V44, P175, DOI 10.1111/j.1440-6055.2005.00467.x; Teulon DAJ, 1999, ENTOMOL EXP APPL, V93, P9, DOI 10.1023/A:1003893905051; Teulon DAJ, 2007, J AGR FOOD CHEM, V55, P6198, DOI 10.1021/jf070389a; Trdan S, 2005, Z PFLANZENK PFLANZEN, V112, P173; Whittaker MS, 2004, ENTOMOL EXP APPL, V111, P209, DOI 10.1111/j.0013-8703.2004.00167.x; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y	39	44	52	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80787	10.1371/journal.pone.0080787	http://dx.doi.org/10.1371/journal.pone.0080787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282554	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500056
J	Whitehead, CL; Teh, WT; Walker, SP; Leung, C; Larmour, L; Tong, S				Whitehead, Clare L.; Teh, Wan Tinn; Walker, Susan P.; Leung, Cheryl; Larmour, Luke; Tong, Stephen			Circulating MicroRNAs in Maternal Blood as Potential Biomarkers for Fetal Hypoxia In-Utero	PLOS ONE			English	Article							GROWTH RESTRICTION; HUMAN PLACENTAS; EXPRESSION; MIR-210; PREECLAMPSIA; PREGNANCIES; UPDATE; CELLS	Stillbirth affects 1 in 200 pregnancies and commonly arises due to a lack of oxygen supply to the fetus. Current tests to detect fetal hypoxia in-utero lack the sensitivity to identify many babies at risk. Emerging evidence suggests that microRNAs derived from the placenta circulate in the maternal blood during pregnancy and may serve as non-invasive biomarkers for pregnancy complications. In this study, we examined the expression of miRs known to be regulated by hypoxia in two clinical settings of significant fetal hypoxia: 1) labour and 2) fetal growth restriction. Six miRs (miR 210, miR 21, miR 424, miR 199a, miR 20b, and miR 373) were differentially expressed in pregnancies complicated by fetal hypoxia. In healthy term pregnancies there was a 4.2 fold increase in miR 210 (p<0.01), 2.7 fold increase in miR 424 (p<0.05), 2.6 fold increase in miR 199a (p<0.01) and 2.3 fold increase in miR 20b (p<0.05) from prior to labour to delivery of the fetus. Furthermore, the combined expression of miR 21 and miR 20b correlated with the degree of fetal hypoxia at birth determined by umbilical cord lactate delivery (r = 0.79, p = 0.03). In pregnancies complicated by severe preterm fetal growth restriction there was upregulation of the hypoxia-regulated miRs compared to gestation-matched controls: 3.6 fold in miR 210 (p<0.01), 3.6 fold in miR 424 (p<0.05), 5.9 fold in miR 21 (p<0.01), 3.8 fold in miR 199a (p<0.01) and 3.7 fold in miR 20b (p<0.01). Interestingly, the expression of miR 373 in gestation matched controls was very low, but was very highly expressed in FGR (p<0.0001). Furthermore, the expression increased in keeping with the degree of in-utero hypoxia estimated by fetal Doppler velocimetry. We conclude quantifying hypoxia-regulated miRs in the maternal blood may identify pregnancies at risk of fetal hypoxia, enabling early intervention to improve perinatal outcomes.	[Whitehead, Clare L.; Tong, Stephen] Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia; [Teh, Wan Tinn] Univ Melbourne, Royal Hosp Women, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia; [Walker, Susan P.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Heidelberg, Vic, Australia; [Leung, Cheryl; Larmour, Luke] Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia	University of Melbourne; University of Melbourne; Monash University	Whitehead, CL (corresponding author), Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic, Australia.	clarew@unimelb.edu.au	Teh, Wan Tinn/AGQ-1270-2022	Teh, Wan Tinn/0000-0001-9808-1141; Tong, Stephen/0000-0002-2319-0586; Walker, Susan Phillipa/0000-0001-9075-4655	Royal Australian and New Zealand College of Obstetricians and Gynaecologists Arthur Wilson Scholarship; William Buckland Foundation Grant; Medical Research Foundation; NHMRC [1028521]	Royal Australian and New Zealand College of Obstetricians and Gynaecologists Arthur Wilson Scholarship; William Buckland Foundation Grant; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding sources for this work included the Royal Australian and New Zealand College of Obstetricians and Gynaecologists Arthur Wilson Scholarship, a William Buckland Foundation Grant, a Medical Research Foundation For Women and Babies Grant, and a NHMRC Project Grant (#1028521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACKE B, 1993, BRIT J OBSTET GYNAEC, V100, P727, DOI 10.1111/j.1471-0528.1993.tb14263.x; Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008; Baschat AA, 2006, HIGH RISK PREGNANCY, P240; Baschat AA, 2010, J PERINAT MED, V38, P239, DOI [10.1515/JPM.2010.041, 10.1515/jpm.2010.041]; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chernausek SD, 2012, J CLIN ENDOCR METAB, V97, P689, DOI 10.1210/jc.2011-2741; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Enquobahrie DA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.004; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Froen JF, 2004, ACTA OBSTET GYN SCAN, V83, P801, DOI 10.1111/j.0001-6349.2004.00602.x; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Ishibashi O, 2012, HYPERTENSION, V59, P265, DOI 10.1161/HYPERTENSIONAHA.111.180232; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee DC, 2011, AM J PATHOL, V179, P590, DOI 10.1016/j.ajpath.2011.04.035; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395; Marsal K, 2009, BEST PRACT RES CL OB, V23, P857, DOI 10.1016/j.bpobgyn.2009.08.011; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; OUNSTED M, 1981, EARLY HUM DEV, V5, P367, DOI 10.1016/0378-3782(81)90017-7; Paiva P, 2011, J CLIN ENDOCR METAB, V96, pE1807, DOI 10.1210/jc.2011-1233; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Shen J, 2013, CANCER LETT, V329, P125, DOI 10.1016/j.canlet.2012.11.001; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; White CRH, 2012, J MATERN-FETAL NEO M, V25, P1653, DOI 10.3109/14767058.2011.653421; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x	40	62	68	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e78487	10.1371/journal.pone.0078487	http://dx.doi.org/10.1371/journal.pone.0078487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282500	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500006
J	Goodall, S; Gibson, AS; Voller, B; Lomarev, M; Howatson, G; Dang, N; Hortobagyi, T; Hallett, M				Goodall, Stuart; Gibson, Alan St Clair; Voller, Bernhard; Lomarev, Mike; Howatson, Glyn; Nguyet Dang; Hortobagyi, Tibor; Hallett, Mark			Repetitive Transcranial Magnetic Stimulation Attenuates the Perception of Force Output Production in Non-Exercised Hand Muscles after Unilateral Exercise	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; THETA-BURST STIMULATION; CENTRAL-NERVOUS-SYSTEM; CROSS-LIMB TRANSFER; LOW-FREQUENCY; EVOKED-POTENTIALS; POSTEXERCISE DEPRESSION; PERFORMANCE GAINS; FATIGUE; MECHANISMS	We examined whether unilateral exercise creates perception bias in the non-exercised limb and ascertained whether rTMS applied to the primary motor cortex (M1) interferes with this perception. All participants completed 4 interventions: 1) 15-min learning period of intermittent isometric contractions at 35% MVC with the trained hand (EX), 2) 15-min learning period of intermittent isometric contractions at 35% MVC with the trained hand whilst receiving rTMS over the contralateral M1 (rTMS+EX); 3) 15-min of rTMS over the 'trained' M1 (rTMS) and 4) 15-min rest (Rest). Pre and post-interventions, the error of force output production, the perception of effort (RPE), motor evoked potentials (MEPs) and compound muscle action potentials (CMAPs) were measured in both hands. EX did not alter the error of force output production in the trained hand (Delta 3%; P>0.05); however, the error of force output production was reduced in the untrained hand (Delta 12%; P<0.05). rTMS+EX and rTMS alone did not show an attenuation in the error of force output production in either hand. EX increased RPE in the trained hand (9.1 +/- 0.5 vs. 11.3 +/- 0.7; P<0.01) but not the untrained hand (8.8 +/- 0.6 vs. 9.2 +/- 0.6; P>0.05). RPE was significantly higher after rTMS+EX in the trained hand (9.2 +/- 0.5 vs. 10.7 +/- 0.7; P<0.01) but ratings were unchanged in the untrained hand (8.5 +/- 0.6 vs. 9.2 +/- 0.5; P>0.05). The novel finding was that exercise alone reduced the error in force output production by over a third in the untrained hand. Further, when exercise was combined with rTMS the transfer of force perception was attenuated. These data suggest that the contralateral M1 of the trained hand might, in part, play an essential role for the transfer of force perception to the untrained hand.	[Goodall, Stuart; Gibson, Alan St Clair; Howatson, Glyn] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Voller, Bernhard] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Lomarev, Mike] Bekhterev Neuropsychol Inst, St Petersburg, Russia; [Howatson, Glyn] Northwest Univ, Sch Environm Sci & Dev, Water Res Grp, Potchefstroom, South Africa; [Nguyet Dang; Hallett, Mark] NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA; [Hortobagyi, Tibor] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	Northumbria University; Medical University of Vienna; V.M. Bekhterev National Research Medical Center Psychiatry & Neurology; North West University - South Africa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Groningen	Goodall, S (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	stuart.goodall@northumbria.ac.uk	Howatson, Glyn/AAE-9508-2021	Howatson, Glyn/0000-0001-8494-2043; Goodall, Stuart/0000-0001-9029-2171	National Institutes of Health; Northumbria University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northumbria University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was completed with funding from a National Institutes of Health Fogarty International Travelling Fellowship Award and the Strategic Investment Fund and Visiting Professors Fund at Northumbria University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Bagnato S, 2005, EXP BRAIN RES, V160, P368, DOI 10.1007/s00221-004-2020-0; Baraduc P, 2004, CURR BIOL, V14, P252, DOI 10.1016/j.cub.2004.01.033; Bawa P, 2009, J NEUROPHYSIOL, V102, P2265, DOI 10.1152/jn.00278.2009; Blennerhassett JM, 2007, NEUROREHAB NEURAL RE, V21, P263, DOI 10.1177/1545968306295560; Borg G., 1998, BORGS PERCEIVED EXER; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; CAFARELLI E, 1986, MED SCI SPORT EXER, V18, P516; Camus M, 2009, CLIN NEUROPHYSIOL, V120, P1859, DOI 10.1016/j.clinph.2009.08.013; Carroll TJ, 2008, J APPL PHYSIOL, V104, P1656, DOI 10.1152/japplphysiol.01351.2007; Carson RG, 2002, J PHYSIOL-LONDON, V539, P913, DOI 10.1113/jphysiol.2001.013385; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Cincotta M, 2006, EXP BRAIN RES, V171, P490, DOI 10.1007/s00221-005-0296-3; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; Daskalakis ZJ, 2006, EXP BRAIN RES, V174, P403, DOI 10.1007/s00221-006-0472-0; Di Lazzaro V, 2010, CLIN NEUROPHYSIOL, V121, P464, DOI 10.1016/j.clinph.2009.11.007; Farthing JP, 2009, EXERC SPORT SCI REV, V37, P179, DOI 10.1097/JES.0b013e3181b7e882; Fowles JR, 2002, J APPL PHYSIOL, V92, P1585, DOI 10.1152/japplphysiol.00668.2001; GANDEVIA SC, 1978, J PHYSIOL-LONDON, V283, P493; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Helmholtz H, 2009, TREATISE PHYSL OPTIC; Hinder MR, 2011, J APPL PHYSIOL, V110, P166, DOI 10.1152/japplphysiol.00958.2010; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hortobagyi T, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1384096; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; Hortobagyi T, 2009, J APPL PHYSIOL, V106, P403, DOI 10.1152/japplphysiol.90701.2008; Houdayer E, 2008, EXP BRAIN RES, V187, P207, DOI 10.1007/s00221-008-1294-z; Howatson G, 2011, EUR J NEUROSCI, V33, P978, DOI 10.1111/j.1460-9568.2010.07567.x; JONES LA, 1983, EXP NEUROL, V81, P640, DOI 10.1016/0014-4886(83)90332-1; Latash M.L., 2008, NEUROPHYSIOLOGICAL B, V3rd ed.; Lee M, 2007, SPORTS MED, V37, P1, DOI 10.2165/00007256-200737010-00001; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Martin PG, 2006, J NEUROSCI, V26, P4796, DOI 10.1523/JNEUROSCI.5487-05.2006; McCloskey D I, 1983, Adv Neurol, V39, P151; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pal PK, 2005, J NEUROPHYSIOL, V94, P1668, DOI 10.1152/jn.01306.2004; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Riek S, 2012, NEUROPSYCHOLOGIA, V50, P2515, DOI 10.1016/j.neuropsychologia.2012.06.024; Romero JR, 2002, CLIN NEUROPHYSIOL, V113, P101, DOI 10.1016/S1388-2457(01)00693-9; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Samii A, 1997, ELECTROMYOGR MOTOR C, V105, P352, DOI 10.1016/S0924-980X(97)00033-7; Selvanayagam VS, 2011, J APPL PHYSIOL, V111, P367, DOI 10.1152/japplphysiol.00064.2011; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Siebner HR, 2000, NEUROLOGY, V54, P956, DOI 10.1212/WNL.54.4.956; Smith JL, 2007, J APPL PHYSIOL, V103, P560, DOI 10.1152/japplphysiol.00220.2007; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Spraker MB, 2009, CEREB CORTEX, V19, P2640, DOI 10.1093/cercor/bhp015; Suzuki M, 2012, BRAIN RES, V1473, P114, DOI 10.1016/j.brainres.2012.07.043; TAYLOR HG, 1980, CORTEX, V16, P587, DOI 10.1016/S0010-9452(80)80006-2; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2007, J AFFECT DISORDERS, V97, P271, DOI 10.1016/j.jad.2006.06.027; Taylor JL, 2010, J APPL PHYSIOL, V108, P466, DOI 10.1152/japplphysiol.01388.2009; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Teixeira LA, 2003, EXP BRAIN RES, V149, P312, DOI 10.1007/s00221-002-1363-7; Therrien AS, 2011, NEUROPSYCHOLOGIA, V49, P2941, DOI 10.1016/j.neuropsychologia.2011.06.023; Trompetto C, 2004, EXP BRAIN RES, V158, P133, DOI 10.1007/s00221-004-1881-6; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Voss M, 2007, NEUROPSYCHOLOGIA, V45, P2712, DOI 10.1016/j.neuropsychologia.2007.04.008; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807	68	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80202	10.1371/journal.pone.0080202	http://dx.doi.org/10.1371/journal.pone.0080202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278259	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700025
J	Liebeke, M; Garcia-Perez, I; Anderson, CJ; Lawlor, AJ; Bennett, MH; Morris, CA; Kille, P; Svendsen, C; Spurgeon, DJ; Bundy, JG				Liebeke, Manuel; Garcia-Perez, Isabel; Anderson, Craig J.; Lawlor, Alan J.; Bennett, Mark H.; Morris, Ceri A.; Kille, Peter; Svendsen, Claus; Spurgeon, David J.; Bundy, Jacob G.			Earthworms Produce phytochelatins in Response to Arsenic	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; HEAVY-METAL DETOXIFICATION; CAENORHABDITIS-ELEGANS; ENVIRONMENTAL METABOLOMICS; BIOMARKER CANDIDATES; EISENIA-FOETIDA; CADMIUM; SYNTHASE; TOXICITY; IDENTIFICATION	Phytochelatins are small cysteine-rich non-ribosomal peptides that chelate soft metal and metalloid ions, such as cadmium and arsenic. They are widely produced by plants and microbes; phytochelatin synthase genes are also present in animal species from several different phyla, but there is still little known about whether these genes are functional in animals, and if so, whether they are metal-responsive. We analysed phytochelatin production by direct chemical analysis in Lumbricus rubellus earthworms exposed to arsenic for a 28 day period, and found that arsenic clearly induced phytochelatin production in a dose-dependent manner. It was necessary to measure the phytochelatin metabolite concentrations directly, as there was no upregulation of phytochelatin synthase gene expression after 28 days: phytochelatin synthesis appears not to be transcriptionally regulated in animals. A further untargetted metabolomic analysis also found changes in metabolites associated with the transsulfuration pathway, which channels sulfur flux from methionine for phytochelatin synthesis. There was no evidence of biological transformation of arsenic (e. g. into methylated species) as a result of laboratory arsenic exposure. Finally, we compared wild populations of earthworms sampled from the field, and found that both arsenic-contaminated and cadmium-contaminated mine site worms had elevated phytochelatin concentrations.	[Liebeke, Manuel; Garcia-Perez, Isabel; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Anderson, Craig J.; Svendsen, Claus; Spurgeon, David J.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Anderson, Craig J.; Morris, Ceri A.; Kille, Peter] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Lawlor, Alan J.] Ctr Ecol & Hydrol, Lancaster, England; [Bennett, Mark H.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); Cardiff University; UK Centre for Ecology & Hydrology (UKCEH); Imperial College London	Bundy, JG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	j.bundy@imperial.ac.uk	Bundy, Jacob G/C-2131-2008; Svendsen, Claus/A-1250-2009; Garcia-Perez, Isabel/AAA-4552-2021; Anderson, Craig/K-2050-2013; Kille, Peter/A-4337-2010; morris, ceri/GXV-8603-2022; Spurgeon, David J/E-9466-2010; Liebeke, Manuel/F-3559-2012	Bundy, Jacob G/0000-0002-1164-8465; Svendsen, Claus/0000-0001-7281-647X; Anderson, Craig/0000-0002-2832-9313; Kille, Peter/0000-0001-6023-5221; Spurgeon, David/0000-0003-3264-8760; Morris, Ceri/0000-0002-3293-5260; Liebeke, Manuel/0000-0002-2339-1409	Natural Environment Research Council (NERC), UK [NE/H00973/1, NE/G010145/1, NE/G523571/1]; NERC [NE/H009973/1, NE/G010145/1, NE/H005382/1] Funding Source: UKRI; Natural Environment Research Council [NE/H005382/1, NE/G010145/1, NE/H009973/1] Funding Source: researchfish	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Natural Environment Research Council (NERC), UK, under grants NE/H00973/1, NE/G010145/1, and NE/G523571/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson CJ, 2013, ENVIRON POLLUT, V172, P200, DOI 10.1016/j.envpol.2012.09.005; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bernard F, 2010, ECOTOX ENVIRON SAFE, V73, P1034, DOI 10.1016/j.ecoenv.2010.01.010; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Brulle F, 2011, SCI TOTAL ENVIRON, V409, P5470, DOI 10.1016/j.scitotenv.2011.08.040; Bundy JG, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-25; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Bundy JG, 2002, ENVIRON TOXICOL CHEM, V21, P1966, DOI 10.1897/1551-5028(2002)021&lt;1966:MAOTOF&gt;2.0.CO;2; Button M, 2011, CHEMOSPHERE, V85, P1277, DOI 10.1016/j.chemosphere.2011.07.026; Button M, 2009, J ENVIRON MONITOR, V11, P1484, DOI 10.1039/b904104d; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Clemens S, 2001, EUR J BIOCHEM, V268, P3640, DOI 10.1046/j.1432-1327.2001.02293.x; Clemens S, 2009, PLANT SCI, V177, P266, DOI 10.1016/j.plantsci.2009.06.008; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Hall J, 2012, TOXICOL SCI, V128, P418, DOI 10.1093/toxsci/kfs166; Hirata K, 2005, J BIOSCI BIOENG, V100, P593, DOI 10.1263/jbb.100.593; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Langdon CJ, 2009, ENVIRON POLLUT, V157, P3114, DOI 10.1016/j.envpol.2009.05.027; Langdon CJ, 1999, SOIL BIOL BIOCHEM, V31, P1963, DOI 10.1016/S0038-0717(99)00118-2; Langdon CJ, 2003, ENVIRON POLLUT, V124, P361, DOI 10.1016/S0269-7491(03)00047-2; Lankadurai BP, 2013, ENVIRON REV, V21, P180, DOI 10.1139/er-2013-0011; Liebeke M, 2013, BIOCHEM BIOPH RES CO, V430, P1306, DOI 10.1016/j.bbrc.2012.12.049; Liebeke M, 2012, METABOLOMICS, V8, P819, DOI 10.1007/s11306-011-0377-1; Morecroft MD, 2009, BIOL CONSERV, V142, P2814, DOI 10.1016/j.biocon.2009.07.004; Novais SC, 2012, ECOTOXICOLOGY, V21, P213, DOI 10.1007/s10646-011-0780-4; Park BY, 2011, APPL SOIL ECOL, V51, P17, DOI 10.1016/j.apsoil.2011.08.006; Ray D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001168; Rea PA, 2004, PLANT PHYSIOL, V136, P2463, DOI 10.1104/pp.104.048579; Rea PA, 2012, PHYSIOL PLANTARUM, V145, P154, DOI 10.1111/j.1399-3054.2012.01571.x; Rigouin C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002037; ROOTS BI, 1956, J EXP BIOL, V33, P29; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith R, 2005, SOIL USE MANAGE, V21, P527, DOI 10.1079/SUM2005345; SPURGEON DJ, 1995, ECOTOXICOLOGY, V4, P190, DOI 10.1007/BF00116481; Sturzenbaum SR, 2001, J BIOL CHEM, V276, P34013, DOI 10.1074/jbc.M103605200; Sturzenbaum SR, 1999, BBA-GENE STRUCT EXPR, V1489, P467, DOI 10.1016/S0167-4781(99)00209-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Watts MJ, 2008, J ENVIRON MONITOR, V10, P753, DOI 10.1039/b800567b; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x	49	24	24	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81271	10.1371/journal.pone.0081271	http://dx.doi.org/10.1371/journal.pone.0081271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278409	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000327541700054
J	Arezes, J; Costa, M; Vieira, I; Dias, V; Kong, XL; Fernandes, R; Vos, M; Carlsson, A; Rikers, Y; Porto, G; Rangel, M; Hider, RC; Pinto, JP				Arezes, Joao; Costa, Monica; Vieira, Ines; Dias, Vera; Kong, Xiao L.; Fernandes, Rui; Vos, Matthijn; Carlsson, Anna; Rikers, Yuri; Porto, Graca; Rangel, Maria; Hider, Robert C.; Pinto, Jorge P.			Non-Transferrin-Bound Iron (NTBI) Uptake by T Lymphocytes: Evidence for the Selective Acquisition of Oligomeric Ferric Citrate Species	PLOS ONE			English	Article							HEPATIC IRON; RAT-LIVER; CELLULAR UPTAKE; SERUM-ALBUMIN; OVERLOAD; CELLS; MICE; HEMOCHROMATOSIS; HEPATOCYTES; PLASMA	Iron is an essential nutrient in several biological processes such as oxygen transport, DNA replication and erythropoiesis. Plasma iron normally circulates bound to transferrin. In iron overload disorders, however, iron concentrations exceed transferrin binding capacity and iron appears complexed with low molecular weight molecules, known as non-transferrin-bound iron (NTBI). NTBI is responsible for the toxicity associated with iron-overload pathologies but the mechanisms leading to NTBI uptake are not fully understood. Here we show for the first time that T lymphocytes are able to take up and accumulate NTBI in a manner that resembles that of hepatocytes. Moreover, we show that both hepatocytes and T lymphocytes take up the oligomeric Fe3Cit3 preferentially to other iron-citrate species, suggesting the existence of a selective NTBI carrier. These results provide a tool for the identification of the still elusive ferric-citrate cellular carrier and may also open a new pathway towards the design of more efficient iron chelators for the treatment of iron overload disorders.	[Arezes, Joao; Costa, Monica; Vieira, Ines; Dias, Vera; Porto, Graca; Pinto, Jorge P.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Kong, Xiao L.; Hider, Robert C.] Kings Coll London, Pharmaceut Sci Res Div, London, England; [Fernandes, Rui] Univ Porto, IBMC, ATAF, P-4100 Oporto, Portugal; [Vos, Matthijn; Carlsson, Anna; Rikers, Yuri] FEI, Europe NanoPort, Eindhoven, Netherlands; [Porto, Graca] Santo Antonio Gen Hosp, CHP HSA, Oporto, Portugal; [Porto, Graca] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Rangel, Maria] Univ Porto, ICBAS, REQUIMTE, P-4100 Oporto, Portugal	Universidade do Porto; University of London; King's College London; Universidade do Porto; Universidade do Porto; Universidade do Porto	Arezes, J (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	joao.arezes@ibmc.up.pt	Carlsson, Anna/M-9708-2018; Fernandes, Rui/S-4508-2017; Rangel, Maria/B-3732-2012; Porto, Graca/J-7939-2013; Rangel, Maria/B-3732-2012	Carlsson, Anna/0000-0002-8554-0895; Fernandes, Rui/0000-0002-9535-368X; Rangel, Maria/0000-0002-0998-1437; Porto, Graca/0000-0002-1923-4638; Costa, Monica Isabel/0000-0002-6792-5687; Rangel, Maria/0000-0002-2423-3154; Hider, Robert/0000-0003-1330-5797; Arezes, Joao/0000-0003-4214-7337	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-015823(PTDC/SAU-MET/113011/2009), FCOMP-01-0124-FEDER-007046(PTDC/BIA-BCM/66818/2006), FCOMP-01-0124-FEDER-007506(PTDC/SAU-GMG/67868/2006)]; INOVA Foundation; Programa Ciencia; POPH-QREN; MCTES; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/66818/2006, SFRH/BD/128863/2017, PTDC/SAU-GMG/67868/2006, PTDC/SAU-MET/113011/2009] Funding Source: FCT	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); INOVA Foundation; Programa Ciencia(Spanish Government); POPH-QREN; MCTES; Fundação para a Ciência e a Tecnologia	This work is funded by FEDER funds through the Operational Competitiveness Programme - COMPETE, by national funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-015823(PTDC/SAU-MET/113011/2009), FCOMP-01-0124-FEDER-007046(PTDC/BIA-BCM/66818/2006) FCOMP-01-0124-FEDER-007506(PTDC/SAU-GMG/67868/2006) and by the INOVA Foundation. JA, IV, MC and VD are recipients of FCT fellowships (www.fct.pt). JPP is supported by Programa Ciencia (sponsored by POPH-QREN (4.2), with match-funding from the European Social Fund and Portuguese funds from the MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Bates R.G., 1973, J ELECTROCHEM SOC, V120, p263C, DOI [10.1149/1.2403829, DOI 10.1149/1.2403829]; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; BRISSOT P, 1985, J CLIN INVEST, V76, P1463, DOI 10.1172/JCI112125; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Cao H, 2011, HEPATOLOGY, V54, P1819, DOI 10.1002/hep.24572; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Cardoso EMP, 2001, EUR J CLIN INVEST, V31, P45, DOI 10.1046/j.1365-2362.2001.00744.x; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; DESOUSA M, 1994, IMMUNOL LETT, V39, P105, DOI 10.1016/0165-2478(94)90094-9; DORNER MH, 1980, SCIENCE, V209, P1019, DOI 10.1126/science.6967622; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Evans RW, 2008, J BIOL INORG CHEM, V13, P57, DOI 10.1007/s00775-007-0297-8; FALLER B, 1994, J AM CHEM SOC, V116, P3860, DOI 10.1021/ja00088a022; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; JORDAN I, 1994, BIOCHEM J, V302, P875, DOI 10.1042/bj3020875; Lane DJR, 2008, ANAL BIOCHEM, V373, P287, DOI 10.1016/j.ab.2007.09.009; LINK G, 1985, J LAB CLIN MED, V106, P147; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; LOVSTAD RA, 1993, INT J BIOCHEM, V25, P1015, DOI 10.1016/0020-711X(93)90115-U; MAY PM, 1977, J CHEM SOC DALTON, P588, DOI 10.1039/dt9770000588; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; NECKERS LM, 1983, P NATL ACAD SCI-BIOL, V80, P3494, DOI 10.1073/pnas.80.11.3494; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Peters T, 1996, ALL ALBUMI BIOCH GEN; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Pinto JP, 2010, IMMUNOLOGY, V130, P217, DOI 10.1111/j.1365-2567.2009.03226.x; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; Santos MM, 2000, AM J PATHOL, V157, P1883, DOI 10.1016/S0002-9440(10)64827-4; Silva AMN, 2009, DALTON T, P8616, DOI 10.1039/b910970f; Silva AMN, 2009, BBA-PROTEINS PROTEOM, V1794, P1449, DOI 10.1016/j.bbapap.2009.06.003; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; Trinder D, 1998, AM J PHYSIOL-GASTR L, V275, pG279, DOI 10.1152/ajpgi.1998.275.2.G279; VANDERHEUL C, 1972, CLIN CHIM ACTA, V38, P347, DOI 10.1016/0009-8981(72)90125-8; Wang CY, 2013, HEPATOLOGY, V58, P788, DOI 10.1002/hep.26401; Wood JC, 2005, ANN NY ACAD SCI, V1054, P386, DOI 10.1196/annals.1345.047; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; WRIGHT TL, 1988, J BIOL CHEM, V263, P1842; ZDOLSEK JM, 1993, FREE RADICAL BIO MED, V15, P1, DOI 10.1016/0891-5849(93)90120-J; ZIMELMAN AP, 1977, GASTROENTEROLOGY, V72, P129	52	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79870	10.1371/journal.pone.0079870	http://dx.doi.org/10.1371/journal.pone.0079870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278199	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800027
J	da Silva, MS; Monteiro, JP; Nunes, VS; Vasconcelos, EJ; Perez, AM; Freitas, LD; Elias, MC; Cano, MIN				da Silva, Marcelo Santos; Monteiro, Jomar Patricio; Nunes, Vinicius Santana; Vasconcelos, Elton Jose; Perez, Arina Marina; Freitas-Junior, Lucio de Holanda; Elias, Maria Carolina; Nogueira Cano, Maria Isabel			Leishmania amazonensis Promastigotes Present Two Distinct Modes of Nucleus and Kinetoplast Segregation during Cell Cycle	PLOS ONE			English	Article							MORPHOLOGICAL EVENTS; REPLICATION; CYTOKINESIS; BIOLOGY; PARASITES; GENOMICS	Here, we show the morphological events associated with organelle segregation and their timing in the cell cycle of a reference strain of Leishmania (L.) amazonensis promastigotes, the main causative agent of Tegumentary leishmaniasis in the Americas. We show evidences that during the cell cycle, L. amazonensis promastigotes present two distinct modes of nucleus and kinetoplast segregation, which occur in different temporal order in different proportions of cells. We used DAPI-staining and EdU-labeling to monitor the segregation of DNA-containing organelles and DNA replication in wild-type parasites. The emergence of a new flagellum was observed using a specific monoclonal antibody. The results show that L. amazonensis cell cycle division is peculiar, with 65% of the dividing cells duplicating the kinetoplast before the nucleus, and the remaining 35% doing the opposite or duplicating both organelles concomitantly. In both cases, the new flagellum appeared during S to G2 phase in 1N1K cells and thus before the segregation of both DNA-containing organelles; however, we could not determine the exact timing of flagellar synthesis. Most of these results were confirmed by the synchronization of parasites using hydroxyurea. Altogether, our data show that during the cell cycle of L. amazonensis promastigotes, similarly to L. donovani, the segregation of nucleus and kinetoplast do not follow a specific order, especially when compared to other trypanosomatids, reinforcing the idea that this characteristic seems to be species-specific and may represent differences in cellular biology among members of the Leishmania genus.	[da Silva, Marcelo Santos; Nunes, Vinicius Santana; Perez, Arina Marina; Nogueira Cano, Maria Isabel] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Sao Paulo, Brazil; [da Silva, Marcelo Santos] Univ Estadual Campinas UNICAMP, Sao Paulo, Brazil; [Monteiro, Jomar Patricio] Empresa Brasileira Pesquisa Agr Embrapa Caprinos, Sobral, Ceara, Brazil; [Vasconcelos, Elton Jose] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Freitas-Junior, Lucio de Holanda] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias LNBio, Sao Paulo, Brazil; [Elias, Maria Carolina] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling CeTIC, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Center for Infectious Disease Research; Instituto Butantan	Cano, MIN (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Sao Paulo, Brazil.	micano@ibb.unesp.br	Monteiro, Jomar Patricio/ABF-7207-2021; Elias, Maria Carolina/E-9197-2015; Nunes, Vinicius/W-7200-2019; Cano, Maria Isabel/A-4020-2008; Cano, Maria Isabel/M-7691-2019; da Silva, Marcelo Santos/N-4145-2014; Elias, Maria QB/AAW-9284-2021; Freitas-Junior, Lucio H/C-8677-2011; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Vasconcelos, Elton/O-5593-2014	Monteiro, Jomar Patricio/0000-0002-5979-0305; Elias, Maria Carolina/0000-0002-0501-8280; Nunes, Vinicius/0000-0002-1400-0680; Cano, Maria Isabel/0000-0001-9798-6627; da Silva, Marcelo Santos/0000-0003-4203-9299; Freitas-Junior, Lucio H/0000-0002-8904-7897; Vasconcelos, Elton/0000-0001-5130-6622	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/50263-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [4744252010-0]; FAPESP; CNPq [PDE 202223/2012-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2012/50263-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 4744252010-0). MSS, AMP receive doctoral and VSN receive post-doctoral fellowships from FAPESP and EJV receive a financial support from CNPq (PDE 202223/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Borges VM, 2005, PARASITOL RES, V95, P90, DOI 10.1007/s00436-004-1248-8; Breniere SF, 1999, ACTA TROP, V73, P283, DOI 10.1016/S0001-706X(99)00025-X; Cupolillo E, 2000, PARASITOL TODAY, V16, P142, DOI 10.1016/S0169-4758(99)01609-9; Cuvillier A, 2003, CELL MICROBIOL, V5, P717, DOI 10.1046/j.1462-5822.2003.00316.x; Cuvillier A, 2000, J CELL SCI, V113, P2065; da Silva M.S., 2012, DNA REPLICATION MUTA; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Elias MC, 2007, PROTIST, V158, P147, DOI 10.1016/j.protis.2006.10.002; Fraga J, 2010, INFECT GENET EVOL, V10, P238, DOI 10.1016/j.meegid.2009.11.007; Gluenz E, 2011, MOL CELL BIOL, V31, P1012, DOI 10.1128/MCB.01176-10; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Gull K, 2001, INT J PARASITOL, V31, P443, DOI 10.1016/S0020-7519(01)00154-0; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; Johnston DA, 1999, BIOESSAYS, V21, P131, DOI 10.1002/(SICI)1521-1878(199902)21:2<131::AID-BIES7>3.0.CO;2-I; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Minocha N, 2011, J EUKARYOT MICROBIOL, V58, P249, DOI 10.1111/j.1550-7408.2011.00539.x; Noyes HA, 2000, MEM I OSWALDO CRUZ, V95, P575, DOI 10.1590/S0074-02762000000400021; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; Selvapandiyan A, 2006, INDIAN J MED RES, V123, P455; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Simpson AGB, 2004, PROTIST, V155, P407, DOI 10.1078/1434461042650389; SIMPSON L, 1970, J PROTOZOOL, V17, P511, DOI 10.1111/j.1550-7408.1970.tb04719.x; Soto M, 2004, BIOCHEM J, V379, P617, DOI 10.1042/BJ20031522; Tyers M, 2004, CURR OPIN CELL BIOL, V16, P602, DOI 10.1016/j.ceb.2004.09.013; Da Silveira RDV, 2013, PARASITOLOGY, V140, P547, DOI 10.1017/S0031182012002028; Wheeler RJ, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-1; Wheeler RJ, 2011, MOL MICROBIOL, V79, P647, DOI 10.1111/j.1365-2958.2010.07479.x; Williams F. M., 1971, SYSTEMS ANAL SIMULAT, V1, P247; WOODWARD R, 1990, J CELL SCI, V95, P49	38	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81397	10.1371/journal.pone.0081397	http://dx.doi.org/10.1371/journal.pone.0081397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278433	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800128
J	Maglietti, F; Michinski, S; Olaiz, N; Castro, M; Suarez, C; Marshall, G				Maglietti, Felipe; Michinski, Sebastian; Olaiz, Nahuel; Castro, Marcelo; Suarez, Cecilia; Marshall, Guillermo			The Role of Ph Fronts in Tissue Electroporation Based Treatments	PLOS ONE			English	Article							IN-VIVO; ELECTRIC PULSES; ELECTROCHEMICAL TREATMENT; DNA ELECTROTRANSFER; GENE-THERAPY; ELECTROCHEMOTHERAPY; DELIVERY; BLEOMYCIN; TUMORS; CELLS	Treatments based on electroporation (EP) induce the formation of pores in cell membranes due to the application of pulsed electric fields. We present experimental evidence of the existence of pH fronts emerging from both electrodes during treatments based on tissue EP, for conditions found in many studies, and that these fronts are immediate and substantial. pH fronts are indirectly measured through the evanescence time (ET), defined as the time required for the tissue buffer to neutralize them. The ET was measured through a pH indicator imaged at a series of time intervals using a four-cluster hard fuzzy-c-means algorithm to segment pixels corresponding to the pH indicator at every frame. The ET was calculated as the time during which the number of pixels was 10% of those in the initial frame. While in EP-based treatments such as reversible (ECT) and irreversible electroporation (IRE) the ET is very short (though enough to cause minor injuries) due to electric pulse characteristics and biological buffers present in the tissue, in gene electrotransfer (GET), ET is much longer, enough to denaturate plasmids and produce cell damage. When any of the electric pulse parameters is doubled or tripled the ET grows and, remarkably, when any of the pulse parameters in GET is halved, the ET drops significantly. Reducing pH fronts has relevant implications for GET treatment efficiency, due to a substantial reduction of plasmid damage and cell loss.	[Maglietti, Felipe; Michinski, Sebastian; Olaiz, Nahuel; Suarez, Cecilia; Marshall, Guillermo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn CONICET, Dept Computac,Lab Sistemas Complejos, Buenos Aires, DF, Argentina; [Michinski, Sebastian] Inst Tecnol Buenos Aires, Buenos Aires, DF, Argentina; [Castro, Marcelo] Univ Tecnol Nacl, Fac Reg Buenos Aires, CONICET, Grp Invest & Desarrollo Bioingn, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Marshall, G (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn CONICET, Dept Computac,Lab Sistemas Complejos, Buenos Aires, DF, Argentina.	marshalg@retina.ar	, Cecilia/I-5244-2016	, Cecilia/0000-0003-0134-8618; Maglietti, Felipe Horacio/0000-0002-0860-6854; Michinski, Sebastian Diego/0000-0002-9408-0819; Castro, Marcelo/0000-0003-3450-0989	CONICET [PIP 1087/09]; Universidad de Buenos Aires [UBACyT X132/08]; ITBACyT; Argentina-Slovenia Scientific Collaboration Project [SLO0802/2008]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); ITBACyT; Argentina-Slovenia Scientific Collaboration Project	This work was supported by grants from: CONICET (PIP 1087/09), Universidad de Buenos Aires (UBACyT X132/08), ITBACyT and Argentina-Slovenia Scientific Collaboration Project (SLO0802/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; Andre F, 2004, GENE THER, V11, pS33, DOI 10.1038/sj.gt.3302367; Arena CB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-102; Becker SM, 2006, J BIOMECH ENG-T ASME, V128, P76, DOI 10.1115/1.2132375; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Cadossi R, 2007, IFMBE P, V13, P8; Colombo L, 2007, BIOELECTROCHEMISTRY, V71, P223, DOI 10.1016/j.bioelechem.2007.07.001; CROWLEY JM, 1973, BIOPHYS J, V13, P711, DOI 10.1016/S0006-3495(73)86017-5; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; De Vry J, 2010, MOL THER, V18, P1183, DOI 10.1038/mt.2010.62; Dubey RK, 2005, INDIAN J BIOCHEM BIO, V42, P301; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Finch JG, 2002, CLIN SCI, V102, P389, DOI 10.1042/cs1020389; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Gothelf A, 2010, CURR GENE THER, V10, P287, DOI 10.2174/156652310791823443; Haberl S, 2013, IEEE ELECTR INSUL M, V29, P29, DOI 10.1109/MEI.2013.6410537; Hofmann GA, 1999, IEEE T BIO-MED ENG, V46, P752, DOI 10.1109/10.764952; Jaichandran S, 2006, HUM GENE THER, V17, P362, DOI 10.1089/hum.2006.17.362; Kee ST, 2006, CLIN ASPECTS ELECTRO; KINOSITA K, 1977, P NATL ACAD SCI USA, V74, P1923; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; LANDO DY, 1994, J BIOMOL STRUCT DYN, V12, P355, DOI 10.1080/07391102.1994.10508745; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Marshall G, 1999, PHYS REV E, V59, P2157, DOI 10.1103/PhysRevE.59.2157; Maxim PG, 2004, RADIAT RES, V162, P185, DOI 10.1667/RR3200; Miklavcic D, 2005, BIOELECTROCHEMISTRY, V65, P121, DOI 10.1016/j.bioelechem.2004.07.004; Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005; Mir LM, 2009, MOL BIOTECHNOL, V43, P167, DOI 10.1007/s12033-009-9192-6; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Nanda GS, 1998, ANTICANCER RES, V18, P999; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; Olaiz N, 2010, ELECTROCHIM ACTA, V55, P6010, DOI 10.1016/j.electacta.2010.05.057; Olaiz N, 2010, ELECTROCHEM COMMUN, V12, P94, DOI 10.1016/j.elecom.2009.10.044; ORLOWSKI S, 1993, BIOCHIM BIOPHYS ACTA, V1154, P51, DOI 10.1016/0304-4157(93)90016-H; Pliquett UF, 2002, BIOELECTROCHEMISTRY, V57, P65, DOI 10.1016/S1567-5394(01)00177-3; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Saulis G, 2005, BIOELECTROCHEMISTRY, V67, P101, DOI 10.1016/j.bioelechem.2005.03.001; Saulis G, 2007, BIOELECTROCHEMISTRY, V70, P519, DOI 10.1016/j.bioelechem.2006.12.003; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2006, EJC SUPPL, V4, P3; Sersa G, 2006, EJC SUPPL, V4, P52, DOI 10.1016/j.ejcsup.2006.08.007; Soden DM, 2006, CANCER LETT, V232, P300, DOI 10.1016/j.canlet.2005.03.057; Turjanski P, 2009, ELECTROCHIM ACTA, V54, P6199, DOI 10.1016/j.electacta.2009.05.062; Turjanski P, 2011, PLOS ONE, DOI [10.1371/journal.-pone.0017303, DOI 10.1371/J0URNAL.-P0NE.0017303]; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V10, P86; WEAVER JC, 1993, J CELL BIOCHEM, V51, P426, DOI 10.1002/jcb.2400510407; Wells DJ, 2004, GENE THER, V11, P1363, DOI 10.1038/sj.gt.3302337; WONG TK, 1982, BIOCHEM BIOPH RES CO, V107, P584, DOI 10.1016/0006-291X(82)91531-5; Xin Y L, 1994, Eur J Surg Suppl, P25; Zhou R, 2007, GENE THER, V14, P775, DOI 10.1038/sj.gt.3302936; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4; Zupanic A, 2007, NEOPLASMA, V54, P246	57	42	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80167	10.1371/journal.pone.0080167	http://dx.doi.org/10.1371/journal.pone.0080167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278257	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800062
J	Naughton, BJ; Duncan, FJ; Murrey, D; Ware, T; Meadows, A; McCarty, DM; Fu, HY				Naughton, Bartholomew J.; Duncan, F. Jason; Murrey, Darren; Ware, Tierra; Meadows, Aaron; McCarty, Douglas M.; Fu, Haiyan			Amyloidosis, Synucleinopathy, and Prion Encephalopathy in a Neuropathic Lysosomal Storage Disease: The CNS-Biomarker Potential of Peripheral Blood	PLOS ONE			English	Article							SYNDROME TYPE-B; MOUSE MODEL; MUCOPOLYSACCHARIDOSIS-IIIB; PARKINSONS-DISEASE; BRAIN; GLYCOSAMINOGLYCANS; DELIVERY; NEURONS; ACCUMULATION; PATHOGENESIS	Mucopolysaccharidosis (MPS) IIIB is a devastating neuropathic lysosomal storage disease with complex pathology. This study identifies molecular signatures in peripheral blood that may be relevant to MPS IIIB pathogenesis using a mouse model. Genome-wide gene expression microarrays on pooled RNAs showed dysregulation of 2,802 transcripts in blood from MPS IIIB mice, reflecting pathological complexity of MPS IIIB, encompassing virtually all previously reported and as yet unexplored disease aspects. Importantly, many of the dysregulated genes are reported to be tissue-specific. Further analyses of multiple genes linked to major pathways of neurodegeneration demonstrated a strong brain-blood correlation in amyloidosis and synucleinopathy in MPS IIIB. We also detected prion protein (Prnp) deposition in the CNS and Prnp dysregulation in the blood in MPS IIIB mice, suggesting the involvement of Prnp aggregation in neuropathology. Systemic delivery of trans-BBB-neurotropic rAAV9-hNAGLU vector mediated not only efficient restoration of functional alpha-N-acetylglucosaminidase and clearance of lysosomal storage pathology in the central nervous system (CNS) and periphery, but also the correction of impaired neurodegenerative molecular pathways in the brain and blood. Our data suggest that molecular changes in blood may reflect pathological status in the CNS and provide a useful tool for identifying potential CNS-specific biomarkers for MPS IIIB and possibly other neurological diseases.	[Naughton, Bartholomew J.; Duncan, F. Jason; Murrey, Darren; Ware, Tierra; Meadows, Aaron; McCarty, Douglas M.; Fu, Haiyan] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [McCarty, Douglas M.; Fu, Haiyan] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Fu, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.	haiyan.fu@nationwidechildrens.org		Naughton, Bart/0000-0002-9121-7445	NIH/NINDS [U01NS069626]; Sanfilippo Research Foundation	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sanfilippo Research Foundation	This research was supported by a translational research grant from NIH/NINDS (U01NS069626), and support from families and friends of MPS III patients through Ben's Dream - the Sanfilippo Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Beesley CE, 2009, MOL GENET METAB, V96, P218, DOI 10.1016/j.ymgme.2008.12.002; Byrne BJ, 2012, HUM GENE THER, V23, P808, DOI 10.1089/hum.2012.140; DEJONG JGN, 1989, CLIN CHEM, V35, P1472; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fu H, 2007, GENE THER, V14, P1065, DOI 10.1038/sj.gt.3302961; Fu H, 2002, MOL THER, V5, P42, DOI 10.1006/mthe.2001.0514; Fu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045992; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Ginsberg SD, 1999, J NEUROPATH EXP NEUR, V58, P815, DOI 10.1097/00005072-199908000-00004; Hamano K, 2008, ACTA NEUROPATHOL, V115, P547, DOI 10.1007/s00401-007-0325-3; Henchcliffe C, 2011, PROG NEUROBIOL, V95, P601, DOI 10.1016/j.pneurobio.2011.09.002; High KA, 2011, METHODS MOL BIOL, V807, P429, DOI 10.1007/978-1-61779-370-7_18; Hu W, 2008, J NEUROL SCI, V264, P1, DOI 10.1016/j.jns.2007.06.019; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Kurihara M, 1996, PEDIATR NEUROL, V14, P317, DOI 10.1016/0887-8994(96)00083-5; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Mougeot JLC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-74; Naughton BJ, 2012, NEUROREPORT, V23, P1, DOI 10.1097/WNR.0b013e32834d2216; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ohmi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027461; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Panaro MA, 2012, CURR PHARM DESIGN, V18, P200; Randall DR, 2008, MOL GENET METAB, V94, P456, DOI 10.1016/j.ymgme.2008.05.001; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Ruzo A, 2012, HUM GENE THER; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; TAMAGAWA K, 1985, BRAIN DEV-JPN, V7, P599, DOI 10.1016/S0387-7604(85)80008-5; Thompson J. N., 1991, TECHNIQUES DIAGNOSTI, P567; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Villani GRD, 2009, BRAIN RES, V1279, P99, DOI 10.1016/j.brainres.2009.03.071; Warburton EC, 2001, J NEUROSCI, V21, P7323, DOI 10.1523/JNEUROSCI.21-18-07323.2001; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Winder-Rhodes SE, 2012, MOVEMENT DISORD, V27, P312, DOI 10.1002/mds.24029; Yogalingam G, 2001, HUM MUTAT, V18, P264, DOI 10.1002/humu.1189; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zou WQ, 2011, PRION, V5, P172, DOI 10.4161/pri.5.3.16894	50	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80142	10.1371/journal.pone.0080142	http://dx.doi.org/10.1371/journal.pone.0080142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278249	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800056
J	Vaiyapuri, S; Vaiyapuri, R; Ashokan, R; Ramasamy, K; Nattamaisundar, K; Jeyaraj, A; Chandran, V; Gajjeraman, P; Baksh, MF; Gibbins, JM; Hutchinson, EG				Vaiyapuri, Sakthivel; Vaiyapuri, Rajendran; Ashokan, Rajesh; Ramasamy, Karthikeyan; Nattamaisundar, Kameshwaran; Jeyaraj, Anburaj; Chandran, Viswanathan; Gajjeraman, Prabu; Baksh, M. Fazil; Gibbins, Jonathan M.; Hutchinson, E. Gail			Snakebite and Its Socio-Economic Impact on the Rural Population of Tamil Nadu, India	PLOS ONE			English	Article							BITE; MORTALITY	Background: Snakebite represents a significant health issue worldwide, affecting several million people each year with as many as 95,000 deaths. India is considered to be the country most affected, but much remains unknown about snakebite incidence in this country, its socio-economic impact and how snakebite management could be improved. Methods/Principal Findings: We conducted a study within rural villages in Tamil Nadu, India, which combines a household survey (28,494 people) of snakebite incidence with a more detailed survey of victims in order to understand the health and socio-economic effects of the bite, the treatments obtained and their views about future improvements. Our survey suggests that snakebite incidence is higher than previously reported. 3.9% of those surveyed had suffered from snakebite and the number of deaths corresponds to 0.45% of the population. The socio-economic impact of this is very considerable in terms of the treatment costs and the long-term effects on the health and ability of survivors to work. To reduce this, the victims recommended improvements to the accessibility and affordability of antivenom treatment. Conclusions: Snakebite has a considerable and disproportionate impact on rural populations, particularly in South Asia. This study provides an incentive for researchers and the public to work together to reduce the incidence and improve the outcomes for snake bite victims and their families.	[Vaiyapuri, Sakthivel; Gibbins, Jonathan M.; Hutchinson, E. Gail] Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England; [Vaiyapuri, Rajendran] Univ Reading, Sch Chem Food & Pharm, Reading, Berks, England; [Ashokan, Rajesh; Ramasamy, Karthikeyan; Nattamaisundar, Kameshwaran; Jeyaraj, Anburaj; Chandran, Viswanathan; Gajjeraman, Prabu] Karpagam Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Baksh, M. Fazil] Univ Reading, Sch Math & Phys Sci, Dept Math & Stat, Reading, Berks, England	University of Reading; University of Reading; Karpagam Academy of Higher Education (KAHE); University of Reading	Vaiyapuri, S (corresponding author), Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England.	s.vaiyapuri@reading.ac.uk	Jeyaraj, Anburaj/C-6416-2018; Gajjeraman, Prabu/B-5999-2015	Jeyaraj, Anburaj/0000-0002-7671-0362; Gajjeraman, Prabu/0000-0002-6326-9379; Baksh, M. Fazil/0000-0003-3107-8815; Gibbins, Jonathan/0000-0002-0372-5352; Vaiyapuri, Sakthivel/0000-0002-6006-6517	Felix trust, London	Felix trust, London	This study was funded by the Felix trust, London (www.felixscholarship.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; [Anonymous], 1981, WHO Offset Publ, P1; BLAYLOCK RSM, 1994, S AFR MED J, V84, P826; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P513; Fox S, 2006, T ROY SOC TROP MED H, V100, P693, DOI 10.1016/j.trstmh.2005.09.003; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Harris JB, 2010, T ROY SOC TROP MED H, V104, P320, DOI 10.1016/j.trstmh.2009.12.006; Joseph JK, 2007, T ROY SOC TROP MED H, V101, P85, DOI 10.1016/j.trstmh.2006.03.008; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kochar DK, 2007, WILD ENVIRON MED, V18, P75, DOI 10.1580/06-WEME-OR-078R.1; Levy P., 1991, SAMPLING POPULATIONS; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Mohapatra B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001018; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; Sharma LR, 2008, WILD ENVIRON MED, V19, P195, DOI 10.1580/07-WEME-CR-175.1; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; Simpson ID, 2007, WILD ENVIRON MED, V18, P2, DOI 10.1580/06-WEME-CO-023R1.1; SUTHERLAND SK, 1979, LANCET, V1, P183, DOI 10.1016/S0140-6736(79)90580-4; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; White J, 2000, THER DRUG MONIT, V22, P65, DOI 10.1097/00007691-200002000-00014; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, 2010, GUIDELINES MANAGEMEN	22	71	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80090	10.1371/journal.pone.0080090	http://dx.doi.org/10.1371/journal.pone.0080090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278244	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800053
J	Ala-Mursula, L; Buxton, JL; Ek, E; Koiranen, M; Taanila, A; Blakemore, AIF; Jarvelin, MR				Ala-Mursula, Leena; Buxton, Jessica L.; Ek, Ellen; Koiranen, Markku; Taanila, Anja; Blakemore, Alexandra I. F.; Jarvelin, Marjo-Riitta			Long-Term Unemployment Is Associated with Short Telomeres in 31-Year-Old Men: An Observational Study in the Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							LIFE STRESS; FOLLOW-UP; LENGTH; EMPLOYMENT; BIOMARKER; DISEASE; HEALTH; CANCER; WORK; AGE	Objective: Life stress resulting from early-life experiences and domestic stress is linked with shorter leukocyte telomere length (LTL), but evidence on employment-related stress is scarce. We explored whether unemployment in early adulthood is associated with shorter LTL, a potential biomarker of premature aging. Methods: We used data from 5620 men and women belonging to the Northern Finland Birth Cohort 1966. Individually registered unemployment days in 1995-97 were compared with data on biological, behavioral and socioeconomic health predictors and existing medical conditions obtained by surveys and clinical examinations at follow-up in 1997-98. Mean LTL at follow-up was measured by multiplex quantitative real-time PCR. We calculated odds ratios and their 95% confidence intervals (CI) of belonging to the sex-stratified shortest decile of standardized relative mean LTL according to the categories of: 0, <260, <500 and over 500 unemployment days, representing 0, <1, <2 and over 2 calendar years. Results: Among men, unemployment exceeding 500 days during three years was associated with having shorter LTL at follow-up, compared to being continuously employed. The corresponding odds ratio was 2.61 (95% CI 1.16 to 5.85) in the fully adjusted model. Such an association was not found among women in this study. Conclusions: Long-term unemployment in early adulthood is associated with shorter LTL among men.	[Ala-Mursula, Leena; Ek, Ellen; Koiranen, Markku; Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Buxton, Jessica L.; Blakemore, Alexandra I. F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Div Diabet Endocrinol & Metab, Sect Invest Med, London, England; [Taanila, Anja; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland	University of Oulu; Imperial College London; University of Oulu; Imperial College London; University of Oulu; Finland National Institute for Health & Welfare	Ala-Mursula, L (corresponding author), Univ Oulu, Inst Hlth Sci, Oulu, Finland.	leena.ala-mursula@oulu.fi	Buxton, Jessica/L-9849-2019; Blakemore, Alexandra I F/D-2253-2009; Buxton, Jessica L/I-4033-2014	Blakemore, Alexandra I F/0000-0003-0661-564X; Buxton, Jessica L/0000-0002-0918-9335; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Wellcome Trust [WT088431MA]; Academy of Finland [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; Medical Research Council, UK [G0500539, G0600705]; Academy of Finland; Biocentrum Helsinki; MRC [MR/K014536/1, G0600705] Funding Source: UKRI; Medical Research Council [G0600705, MR/K014536/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Finland(Academy of Finland); Biocentrum Helsinki; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JLB was supported by a Wellcome Trust fellowship grant (WT088431MA), which funded all telomere measurements. The Northern Finland Birth Cohort (NFBC1966) study received financial support from the Academy of Finland (project grants 104781, 120315, 129269, 1114194 and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), and the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE). The DNA extractions, sample quality controls, biobank up-keeping and aliquotting were performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2007, AGING CELL, V6, P125, DOI 10.1111/j.1474-9726.2006.00258.x; Ahola K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040186; ARMITAGE P, 1974, STAT METHODS MED RES, P72; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Blackburn EH, 2012, NATURE, V490, P169, DOI 10.1038/490169a; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Coggon D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6305; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Davila EP, 2010, J OCCUP ENVIRON MED, V52, P501, DOI 10.1097/JOM.0b013e3181d5e371; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P228, DOI 10.1002/ajhb.21126; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; *EUR WEBS, EUR COMM UN STAT; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fujishiro K, 2013, OCCUP ENVIRON MED, V70, P552, DOI 10.1136/oemed-2012-101296; Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034; HAAPEA M, 2010, ACTA U OULUENSIS M D, V1049; Isohanni I, 1998, PSYCHOL MED, V28, P967, DOI 10.1017/S0033291798006928; Julkunen R., 1999, MODERNIZATION WORKIN; Ludlow AT, 2011, J AGING RES, DOI DOI 10.4061/2011/790378; Macdonald EB, 2010, J OCCUP ENVIRON MED, V52, P1273, DOI 10.1097/JOM.0b013e3181f7cbf0; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; Parks CG, 2011, OCCUP ENVIRON MED, V68, P582, DOI 10.1136/oem.2010.063214; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; *STAT FINL, 1998, STAT YB FINL; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Strandberg TE, 2012, EUR J EPIDEMIOL, V27, P815, DOI 10.1007/s10654-012-9728-0; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WADDELL G, 2006, IS WORK GOOD YOUR HL, P3694; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005	43	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80094	10.1371/journal.pone.0080094	http://dx.doi.org/10.1371/journal.pone.0080094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278245	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327313100074
J	Kong, YN; Yang, L; Tang, HL; Lv, N; Xie, XH; Li, J; Guo, JL; Li, LS; Wu, MQ; Gao, J; Yang, HJ; Tang, ZH; He, JJ; Zhang, B; Li, H; Qiao, YL; Xie, XM				Kong, Yanan; Yang, Lu; Tang, Hailin; Lv, Ning; Xie, Xinhua; Li, Jing; Guo, Jiaoli; Li, Laisheng; Wu, Minqin; Gao, Jie; Yang, Hongjian; Tang, Zhonghua; He, Jianjun; Zhang, Bin; Li, Hui; Qiao, Youlin; Xie, Xiaoming			A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999-2008	PLOS ONE			English	Article							DCIS; MAMMOGRAPHY; RISK; OVERDIAGNOSIS; RADIOTHERAPY; DISEASE	Background: Compared with invasive breast cancer, breast cancer in situ (BCIS) is seldom life threatening. However, an increasing incidence has been observed in recent years over the world. The purpose of our study is to investigate the epidemiological, clinical and pathological profiles of BCIS in Chinese women from 1999-2008. Methods: Four thousand and two hundred-eleven female breast cancer (BC) patients were enrolled in this hospital-based nation-wide and multi-center retrospective study. Patients were randomly selected from seven hospitals in seven representative geographical regions of China between 1999 and 2008. The epidemiological, clinical and pathological data were collected based on the designed case report form (CRF). Results: There were one hundred and forty-three BCIS cases in four thousand and two hundred-eleven BC patients (3.4%). The mean age at diagnosis was 48.3 years and BCIS peaked in age group 40-49 yrs (39.9%). The most common subtype was ductal carcinoma in situ (DCIS) (88.0%). 53.8% were positive for estrogen receptor (ER). Human epidermal growth factor receptor 2 (HER2) positive status was observed in 23.8% of patients. All patients underwent surgeries and 14.7% of them had breast conservation therapies (BCT) (21/143), but 41.9% accepted chemotherapy (64/143). Much less patients underwent radiotherapy (16.0%, 23/143) and among patients who had BCT, 67% accepted radiotherapy (14/21). Endocrine therapy was taken in 44.1% patients (63/143). Conclusions: The younger age of BCIS among Chinese women than Western countries and increasing number of cases pose a great challenge. BCT and endocrine therapy are under great needs.	[Kong, Yanan; Yang, Lu; Tang, Hailin; Xie, Xinhua; Guo, Jiaoli; Li, Laisheng; Wu, Minqin; Gao, Jie; Xie, Xiaoming] Sun Yat Sen Univ, Dept Breast Oncol, State Key Lab Oncol South China, Canc Ctr,Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Lv, Ning] Sun Yat Sen Univ, Dept Med Imaging & Intervent Radiol, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Li, Jing; Qiao, Youlin] Chinese Acad Med Sci, Dept Canc Epidemiol, Canc Inst & Hosp, Beijing, Peoples R China; [Li, Jing; Qiao, Youlin] Peking Union Med Coll, Beijing, Peoples R China; [Yang, Hongjian] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China; [Tang, Zhonghua] Xiangya Sencod Hosp, Dept Breast Thyroid Surg, Changsha, Hunan, Peoples R China; [Zhang, Bin] Liaoning Canc Hosp, Dept Breast Surg, Liaoning, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang Cancer Hospital	Qiao, YL (corresponding author), Chinese Acad Med Sci, Dept Canc Epidemiol, Canc Inst & Hosp, Beijing, Peoples R China.	Qiaoy@cicams.ac.cn; xiexm@sysucc.org.cn	Lv, Ning/V-5706-2019; Qiao, You-Lin/B-4139-2012	Qiao, You-Lin/0000-0001-6380-0871; Kong, Yanan/0000-0002-3145-5492; Xie, Xiaoming/0000-0003-0687-4238	Key Program of National Natural Science Foundation of China [31030061]; Natural Science Foundation of Guangdong Province, China [9151008901000124]; Science and Technology Planning Project of Guangzhou, China [10C32060205]; China Postdoctoral Science Foundation [2012M520075]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Key Program of National Natural Science Foundation of China (31030061); Natural Science Foundation of Guangdong Province, China (9151008901000124); Science and Technology Planning Project of Guangzhou, China (10C32060205); China Postdoctoral Science Foundation (2012M520075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado R, 2012, ANN SURG ONCOL, V19, P3777, DOI 10.1245/s10434-012-2413-4; [Anonymous], 1982, ANN PATHOL, V2, P91; Autier P, 2012, JNCI-J NATL CANCER I, V104, P1080, DOI 10.1093/jnci/djs272; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Bleyer A, 2013, NEW ENGL J MED, V368, P679, DOI 10.1056/NEJMc1215494; Bocker W, 2002, VERH DEUT G, V86, P116; Brenin DR, 1998, ANN SURG ONCOL, V5, P719, DOI 10.1007/BF02303483; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Clarke CA, 2012, JNCI-J NATL CANCER I, V104, P1094, DOI 10.1093/jnci/djs264; Cunnick GH, 2003, LANCET, V362, P1154, DOI 10.1016/S0140-6736(03)14475-3; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Di Saverio S, 2008, BREAST CANCER RES TR, V109, P405, DOI 10.1007/s10549-007-9668-7; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Falk RS, 2013, INT J CANCER, V133, P705, DOI 10.1002/ijc.28052; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; HUANG J, 2006, CHINESE J DIFFICULT, V5, P139; JIANG Y, 2008, CLIN ANAL 123 CASES; Johnson RH, 2013, JAMA-J AM MED ASSOC, V309, P800, DOI 10.1001/jama.2013.776; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; LE X, 2005, JIANGXI MED J, V40, P541; LI J, 2009, CLIN MED CHINA, V25, P971; Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364; LI W, 2003, LINGNAN MODERN CLIN, V3, P288; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Nekhlyudov L, 2012, JNCI-J NATL CANCER I, V104, P614, DOI 10.1093/jnci/djs167; Punglia RS, 2012, CANCER-AM CANCER SOC, V118, P603, DOI 10.1002/cncr.26293; QIAN X, 2006, J MED SCI, V26, P861; Scribner KC, 2013, ONCOGENE, V32, P2631, DOI 10.1038/onc.2012.286; Smith Robert A, 2012, N Engl J Med, V367, pe31, DOI 10.1056/NEJMclde1212888; Sumner WE, 2007, ANN SURG ONCOL, V14, P1638, DOI 10.1245/s10434-006-9316-1; Verkooijen HM, 2002, ANN ONCOL, V13, P1236, DOI 10.1093/annonc/mdf194; Virnig Beth A, 2009, Evid Rep Technol Assess (Full Rep), P1; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; von Minckwitz G, 2012, BREAST CANCER RES TR, V132, P863, DOI 10.1007/s10549-011-1621-0; Wallis MG, 2012, BRIT J CANCER, V106, P1611, DOI 10.1038/bjc.2012.151; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; YU Y, 2003, J TIANJIN MED U, V9, P180; ZHANG X, 2011, J CLIN SURG, V19, P142; ZHAO W, 2004, J SURG CONCEPTS PRAC, V9, P428; 1997, CANCER, V80, P1798, DOI DOI 10.1002/(SICI)1097-0142(19971101)80:9	42	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81055	10.1371/journal.pone.0081055	http://dx.doi.org/10.1371/journal.pone.0081055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278375	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100140
J	Sun, B; Zhang, XF; Cheng, XS; Zhang, Y; Chen, L; Shi, LH; Liu, ZY; Qian, HH; Wu, MC; Yin, ZF				Sun, Bin; Zhang, Xiaofeng; Cheng, Xianshuo; Zhang, Yu; Chen, Lei; Shi, Lehua; Liu, Zhenyu; Qian, Haihua; Wu, Mengchao; Yin, Zhengfeng			Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma	PLOS ONE			English	Article							SMOOTH-MUSCLE ACTIN; CIRCULATING TUMOR-CELLS; STROMAL CELLS; HUMAN LIVER; PROGRESSION; EXPRESSION; MICROENVIRONMENT; SUBPOPULATIONS; APOPTOSIS	Hepatic stellate cells (HSCs), a specialized stromal cytotype in the liver, have been demonstrated to actively contribute to hepatocellular carcinoma (HCC) development. However, the previous studies were performed using HSC cell lines, and the prognostic value of intratumoral HSCs (tHSCs) was unclear. Here we isolated tHSCs from fresh human HCC tissues, and analyzed the abilities of tHSCs to promote HCC progression by using in vitro assays for cell viability, migration and invasion as well as epithelial-mesenchymal transition (EMT) phenotype. 252 HCC patients who underwent hepatectomy were enrolled for analysis of tHSCs and E-cadherin expression in tumor tissues, and 55 HCC patients for analysis of tHSCs in tumor tissues and circulating tumor cells (CTCs) in blood. Prognostic factors were then identified. The results showed that coculture of tHSCs with HCC cells had a stronger effect on HCC cell viability, migration and invasion, accompanied with the acquisition of epithelial-mesenchymal transition (EMT) phenotype. In vivo cotransplantation of HCC cells with tHSCs into nude mice more efficiently promoted tumor formation and growth. Icaritin, a known apoptosis inducer of HSCs, was demonstrated to effectively inhibit tHSC proliferation in vitro and tHSC-induced HCC-promoting effects in vivo. Clinical evidence indicated that tHSCs were rich in 45% of the HCC specimens, tHSC-rich subtypes were negatively correlated either with E-cadherin expression in tumor tissues (r = -0.256, p < 0.001) or with preoperative CTCs in blood (r = -0.287, p = 0.033), and were significantly correlated with tumor size (p = 0.027), TNM staging (p = 0.018), and vascular invasion (p = 0.008). Overall and recurrence-free survival rates of tHSC-rich patients were significantly worse than those for tHSC-poor patients. Multivariate analysis revealed tHSC-rich as an independent factor for overall and recurrence-free survival. In conclusion, tHSCs provide a promising prognostic biomarker and a new treatment target for HCC.	[Sun, Bin; Cheng, Xianshuo; Zhang, Yu; Chen, Lei; Qian, Haihua; Wu, Mengchao; Yin, Zhengfeng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Mol Oncol Lab, Shanghai, Peoples R China; [Zhang, Xiaofeng; Shi, Lehua; Liu, Zhenyu; Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yin, ZF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Mol Oncol Lab, Shanghai, Peoples R China.	yinzfk@aliyun.com	sun, bin/GLR-1711-2022	sun, bin/0000-0002-5082-3326	China National Key Projects for Infectious Disease [2012ZX10002012-010]; National Nature Science Foundation of China [81172207, 81272669, 81272668]	China National Key Projects for Infectious Disease; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Grant from China National Key Projects for Infectious Disease (No. 2012ZX10002012-010) and National Nature Science Foundation of China (No. 81172207, 81272669, 81272668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Atzori L, 2009, INT J BIOCHEM CELL B, V41, P1639, DOI 10.1016/j.biocel.2009.03.001; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Cao L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-71; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; ENZAN H, 1994, HEPATOLOGY, V19, P895, DOI 10.1016/0270-9139(94)90289-5; Faouzi S, 1999, LAB INVEST, V79, P485; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; FRIEDMAN SL, 1992, HEPATOLOGY, V15, P234, DOI 10.1002/hep.1840150211; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Johnson SJ, 1998, J GASTROEN HEPATOL, V13, P145, DOI 10.1111/j.1440-1746.1998.tb00629.x; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Leonardi GC, 2012, INT J ONCOL, V40, P1733, DOI 10.3892/ijo.2012.1408; Li J, 2011, J ETHNOPHARMACOL, V137, P714, DOI 10.1016/j.jep.2011.06.030; Li YM, 2009, APOPTOSIS, V14, P42, DOI 10.1007/s10495-008-0286-6; Liao J, 2012, BIOCHEM BIOPH RES CO, V420, P308, DOI 10.1016/j.bbrc.2012.02.155; Lugli A, 2004, AM J CLIN PATHOL, V122, P721, DOI 10.1309/KC09YTF2M4DLUY06; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Neaud V, 1997, HEPATOLOGY, V26, P1458, DOI 10.1002/hep.510260612; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; REMMELE W, 1987, PATHOLOGE, V8, P138; RubbiaBrandt L, 1997, TRANSPLANT P, V29, P2390, DOI 10.1016/S0041-1345(97)00415-6; Santamato A, 2011, CLIN SCI, V121, P159, DOI 10.1042/CS20110002; Suh YG, 2011, WORLD J GASTROENTERO, V17, P2543, DOI 10.3748/wjg.v17.i20.2543; Terada T, 1996, J HEPATOL, V24, P706; Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Xia YH, 2010, J CANCER RES CLIN, V136, P309, DOI 10.1007/s00432-009-0666-5; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu W, 2011, CLIN CANCER RES, V17, P3783, DOI 10.1158/1078-0432.CCR-10-0498; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Zhang XF, 2011, ANN SURG ONCOL, V18, P2218, DOI 10.1245/s10434-011-1613-7; Zhang Y, 2012, SEMIN ONCOL, V39, P449, DOI 10.1053/j.seminoncol.2012.05.012; Zhao WX, 2011, INT J CANCER, V129, P2651, DOI 10.1002/ijc.25920; Zhou YM, 2012, LIVER INT, V32, P1505, DOI 10.1111/j.1478-3231.2012.02846.x; Zhou YM, 2012, ANN SURG ONCOL, V19, P1700, DOI 10.1245/s10434-011-1772-6	44	11	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80212	10.1371/journal.pone.0080212	http://dx.doi.org/10.1371/journal.pone.0080212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278260	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100078
J	Ton, QV; Iovine, MK				Ton, Quynh V.; Iovine, M. Kathryn			Identification of an evx1-Dependent Joint-Formation Pathway during FIN Regeneration	PLOS ONE			English	Article							ZEBRAFISH CAUDAL FIN; GENETIC-ANALYSIS; CONNEXIN43 GJA1; GROWTH; RAYS; OSTEOBLASTS; MECHANISMS; EXPRESSION; TELEOSTS; CELLS	Joints are essential for skeletal flexibly and form, yet the process underlying joint morphogenesis is poorly understood. Zebrafish caudal fins are comprised of numerous segmented bony fin rays, where growth occurs by the sequential addition of new segments and new joints. Here, we evaluate joint gene expression during fin regeneration. First, we identify three genes that influence joint formation, evx1, dlx5a, and mmp9. We place these genes in a common molecular pathway by evaluating both their expression patterns along the distal-proximal axis (i.e. where the youngest tissue is always the most distal), and by evaluating changes in gene expression following gene knockdown. Prior studies from our lab indicate that the gap junction protein Cx43 suppresses joint formation. Remarkably, changes in Cx43 activity alter the expression of joint markers. For example, the reduced levels of Cx43 in the sof(b123) mutant causes short fin ray segments/premature joints. We also find that the expression of evx1-dlx5a-mmp9 is shifted distally in sof(b123), consistent with premature expression of these genes. In contrast, increased Cx43 in the alf (dty86) mutant leads to stochastic joint failure and stochastic loss of evx1 expression. Indeed, reducing the level of Cx43 in alf (dty86) rescues both the evx1 expression and joint formation. These results suggest that Cx43 influences the pattern of joint formation by influencing the timing of evx1 expression.	[Ton, Quynh V.; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Iovine, MK (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	mki3@lehigh.edu			NSF [IOS1145582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL124889] Funding Source: NIH RePORTER; Direct For Biological Sciences [1145582] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the NSF (IOS1145582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Borday V, 2001, DEV DYNAM, V220, P91, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1091>3.0.CO;2-J; Brown AM, 2009, DEV DYNAM, V238, P2922, DOI 10.1002/dvdy.22114; FAIELLA A, 1991, NUCLEIC ACIDS RES, V19, P6541, DOI 10.1093/nar/19.23.6541; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; LANDIS WJ, 1990, ANAT REC, V228, P383, DOI 10.1002/ar.1092280404; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; MARIBEFFA M, 1989, ANAT EMBRYOL, V180, P465, DOI 10.1007/BF00305121; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; SANTAMARIA JA, 1992, DIFFERENTIATION, V49, P143, DOI 10.1111/j.1432-0436.1992.tb00662.x; Schulte CJ, 2011, DEV DYNAM, V240, P1240, DOI 10.1002/dvdy.22534; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Singh SP, 2012, DEV CELL, V22, P879, DOI 10.1016/j.devcel.2012.03.006; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Ton QV, 2012, DEV BIOL, V366, P195, DOI 10.1016/j.ydbio.2012.03.020; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028	27	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81240	10.1371/journal.pone.0081240	http://dx.doi.org/10.1371/journal.pone.0081240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278401	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100147
J	Escrevente, C; Grammel, N; Kandzia, S; Zeiser, J; Tranfield, EM; Conradt, HS; Costa, J				Escrevente, Cristina; Grammel, Nicolas; Kandzia, Sebastian; Zeiser, Johannes; Tranfield, Erin M.; Conradt, Harald S.; Costa, Julia			Sialoglycoproteins and N-Glycans from Secreted Exosomes of Ovarian Carcinoma Cells	PLOS ONE			English	Article							TUMOR-GROWTH; GLYCOSYLATION; EXPRESSION; MIGRATION; ADHESION; L1; IDENTIFICATION; GLYCOPROTEINS; BINDING; TISSUES	Exosomes consist of vesicles that are secreted by several human cells, including tumor cells and neurons, and they are found in several biological fluids. Exosomes have characteristic protein and lipid composition, however, the results concerning glycoprotein composition and glycosylation are scarce. Here, protein glycosylation of exosomes from ovarian carcinoma SKOV3 cells has been studied by lectin blotting, NP-HPLC analysis of 2-aminobenzamide labeled glycans and mass spectrometry. An abundant sialoglycoprotein was found enriched in exosomes and it was identified by peptide mass fingerprinting and immunoblot as the galectin-3-binding protein (LGALS3BP). Exosomes were found to contain predominantly complex glycans of the di-, tri-, and tetraantennary type with or without proximal fucose and also high mannose glycans. Diantennary glycans containing bisecting N-acetylglucosamine were also detected. This work provides detailed information about glycoprotein and N-glycan composition of exosomes from ovarian cancer cells, furthermore it opens novel perspectives to further explore the functional role of glycans in the biology of exosomes.	[Escrevente, Cristina; Costa, Julia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Glycobiol, Oeiras, Portugal; [Grammel, Nicolas; Kandzia, Sebastian; Zeiser, Johannes; Conradt, Harald S.] GlycoThera GmbH, Hannover, Germany; [Tranfield, Erin M.] Inst Gulbenkian Ciencias, Electron Microscopy Facil, Oeiras, Portugal	Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia	Costa, J (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Glycobiol, Oeiras, Portugal.	jcosta@itqb.unl.pt	Costa, Júlia C/B-7131-2008; Tranfield, Erin M/AAU-4177-2020	Costa, Júlia C/0000-0001-7782-6319; Tranfield, Erin M/0000-0002-1542-7459; Zeiser, Johannes/0000-0001-5518-2137; Escrevente, Cristina/0000-0002-2183-3947	EU [JPND/0003/2011]; Fundacao para a Ciencia e Tecnologia, Portugal [Pest-OE/EQB/LA0004/2011];  [PTDC/SAU-NEU/100724/2008]; Fundação para a Ciência e a Tecnologia [PTDC/SAU-NEU/100724/2008] Funding Source: FCT	EU(European Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); ; Fundação para a Ciência e a Tecnologia	This work was funded by projects: PTDC/SAU-NEU/100724/2008 and EU Joint Programme JPND/0003/2011 and Pest-OE/EQB/LA0004/2011, Fundacao para a Ciencia e Tecnologia, Portugal. C. E. was recipient of a PhD fellowship from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Block AS, 2011, PROSTATE, V71, P711, DOI 10.1002/pros.21287; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Escrevente C, 2006, INT J ONCOL, V29, P557; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gouveia R, 2012, BBA-GEN SUBJECTS, V1820, P2007, DOI 10.1016/j.bbagen.2012.09.004; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Hellstern S, 2002, J BIOL CHEM, V277, P15690, DOI 10.1074/jbc.M200386200; ISHIBASHI K, 1989, CLIN CHIM ACTA, V185, P325, DOI 10.1016/0009-8981(89)90223-4; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Maass K, 2007, PROTEOMICS, V7, P4435, DOI 10.1002/pmic.200700253; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Michelsen U, 2009, METHOD ENZYMOL, V463, P305, DOI 10.1016/S0076-6879(09)63019-6; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nan BC, 1998, GLYCOCONJUGATE J, V15, P1033, DOI 10.1023/A:1006950311937; OSSET M, 1989, ELECTROPHORESIS, V10, P271, DOI 10.1002/elps.1150100412; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sousa VL, 2003, J BIOL CHEM, V278, P7624, DOI 10.1074/jbc.M209325200; Staubach S, 2012, J PROTEOME RES, V11, P906, DOI 10.1021/pr200711w; Tan A, 2010, INT J NANOMED, V5, DOI 10.2147/IJN.S13402; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Ullrich KJ, 1999, J AM SOC NEPHROL, V10, P1840	38	72	75	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78631	10.1371/journal.pone.0078631	http://dx.doi.org/10.1371/journal.pone.0078631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24302979	Green Submitted, Green Published, gold			2022-12-27	WOS:000326152300074
J	Kotula, E; Faigle, W; Berthault, N; Dingli, F; Loew, D; Sun, JS; Dutreix, M; Quanz, M				Kotula, Ewa; Faigle, Wolfgang; Berthault, Nathalie; Dingli, Florent; Loew, Damarys; Sun, Jian-Sheng; Dutreix, Marie; Quanz, Maria			DNA-PK Target Identification Reveals Novel Links between DNA Repair Signaling and Cytoskeletal Regulation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; INTERMEDIATE-FILAMENT PROTEINS; GROWTH-FACTOR RECEPTOR; FIBRILLARY ACIDIC PROTEIN; MATRIX ATTACHMENT REGION; INTERACTION IN-VITRO; DOUBLE-STRAND BREAKS; HEAT-SHOCK-PROTEIN; LUNG-CANCER CELLS; NF-KAPPA-B	The DNA-dependent protein kinase (DNA-PK) may function as a key signaling kinase in various cellular pathways other than DNA repair. Using a two-dimensional gel electrophoresis approach and stable DNA double-strand break-mimicking molecules (Dbait32Hc) to activate DNA-PK in the nucleus and cytoplasm, we identified 26 proteins that were highly phosphorylated following DNA-PK activation. Most of these proteins are involved in protein stability and degradation, cell signaling and the cytoskeleton. We investigated the relationship between DNA-PK and the cytoskeleton and found that the intermediate filament (IF) vimentin was a target of DNA-PK in vitro and in cells. Vimentin was phosphorylated at Ser459, by DNA-PK, in cells transfected with Dbait32Hc. We produced specific antibodies and showed that Ser459-P-vimentin was mostly located at cell protrusions. In migratory cells, the vimentin phosphorylation induced by Dbait32Hc was associated with a lower cellular adhesion and migration capacity. Thus, this approach led to the identification of downstream cytoplasmic targets of DNA-PK and revealed a connection between DNA damage signaling and the cytoskeleton.	[Kotula, Ewa; Berthault, Nathalie; Dutreix, Marie; Quanz, Maria] Univ Paris 11, INSERM, U1021, CNRS UMR3347,Inst Curie,Ctr Univ, F-91405 Orsay, France; [Kotula, Ewa; Sun, Jian-Sheng; Quanz, Maria] DNA Therapeut, Evry, France; [Faigle, Wolfgang; Dingli, Florent; Loew, Damarys] Inst Curie, Ctr Rech, Lab Prote Mass Spectrometry, Paris, France; [Faigle, Wolfgang] Univ Zurich Hosp, Dept Clin Neuroimmunol & MS Res, Paris, France; [Sun, Jian-Sheng] Museum Natl Hist Nat, USM503, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Museum National d'Histoire Naturelle (MNHN)	Dutreix, M (corresponding author), Univ Paris 11, INSERM, U1021, CNRS UMR3347,Inst Curie,Ctr Univ, F-91405 Orsay, France.	marie.dutreix@curie.fr	Quanz, Maria/AAA-4424-2020	Damarys, Loew/0000-0002-9111-8842; Faigle, Wolfgang/0000-0002-7664-8722	Institut Curie; CNRS; INSERM; Agence Nationale de la Recherche [ANR-08-Biot-009-02]; DNA Therapeutics SA; Agence Nationale de la Recherche ANRT	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); DNA Therapeutics SA; Agence Nationale de la Recherche ANRT(French National Research Agency (ANR))	This work was supported by Institut Curie, CNRS, INSERM, and the Agence Nationale de la Recherche grant ANR-08-Biot-009-02 and DNA Therapeutics SA. E. Kotula and M. Quanz were recipients of a Ph.D. fellowship cofinanced by DNA Therapeutics SA and the Agence Nationale de la Recherche ANRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2000, HISTOPATHOLOGY, V37, P45, DOI 10.1046/j.1365-2559.2000.00898.x; Athanasiou A, 2003, AM J CLIN PATHOL, V120, P699, DOI 10.1309/DL2TLDJG7JB1BQ72; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bottero V, 2001, CANCER RES, V61, P7785; Bouamrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009238; Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025; Chan DW, 1999, BIOCHEMISTRY-US, V38, P1819, DOI 10.1021/bi982584b; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Chou YH, 1996, J CELL SCI, V109, P817; Chu SJ, 2007, AM J PHYSIOL-LUNG C, V293, pL1127, DOI 10.1152/ajplung.00197.2007; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gorgoulis VG, 2001, CANCER RES, V61, P538; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hartig R, 1998, J CELL SCI, V111, P3573; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hsu FM, 2012, TRANSL CANC RES, V1; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; Kumar N, 2007, J BIOL CHEM, V282, P9244, DOI 10.1074/jbc.M605571200; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; Li GH, 2003, DNA CELL BIOL, V22, P261, DOI 10.1089/104454903321908656; Li GH, 2002, DNA CELL BIOL, V21, P163, DOI 10.1089/10445490252925422; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lopez-Egido JR, 2002, EXP CELL RES, V278, P175, DOI 10.1006/excr.2002.5575; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Marty C, 2003, MOL CELL BIOL, V23, P3847, DOI 10.1128/MCB.23.11.3847-3858.2003; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mauldin SK, 2002, NUCLEIC ACIDS RES, V30, P4075, DOI 10.1093/nar/gkf529; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Moore R, 2004, ONCOGENE, V23, P6726, DOI 10.1038/sj.onc.1207675; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Oh WK, 2003, MOL CELLS, V16, P84; OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Perunovic B, 2002, HUM PATHOL, V33, P703, DOI 10.1053/hupa.2002.125377; POWIS G, 1994, CANCER RES, V54, P2419; Prasad CK, 2008, MOL REPROD DEV, V75, P1258, DOI 10.1002/mrd.20877; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Quanz M, 2012, J BIOL CHEM, V287, P8803, DOI 10.1074/jbc.M111.320887; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Quanz M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006298; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Schlosser A, 2002, PROTEOMICS, V2, P911, DOI 10.1002/1615-9861(200207)2:7<911::AID-PROT911>3.0.CO;2-K; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; SIMONS JWIM, 1979, MUTAT RES, V59, P273, DOI 10.1016/0027-5107(79)90165-9; SINGH B, 1987, J VIROL, V61, P3625, DOI 10.1128/JVI.61.11.3625-3629.1987; SINGH B, 1989, VIROLOGY, V173, P144, DOI 10.1016/0042-6822(89)90230-4; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; Szumiel I, 2006, CELL SIGNAL, V18, P1537, DOI 10.1016/j.cellsig.2006.03.010; Takai Y, 1996, J CELL BIOL, V133, P141, DOI 10.1083/jcb.133.1.141; Thomas PA, 1999, CLIN CANCER RES, V5, P2698; Ting NSY, 2009, NUCLEIC ACIDS RES, V37, P6105, DOI 10.1093/nar/gkp636; Tolstonog GV, 2005, DNA CELL BIOL, V24, P85, DOI 10.1089/dna.2005.24.85; Tolstonog GV, 2001, DNA CELL BIOL, V20, P531, DOI 10.1089/104454901317094954; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wang Q, 2001, BIOCHEMISTRY-US, V40, P10342, DOI 10.1021/bi0108305; Wei JC, 2008, ANTICANCER RES, V28, P327; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yoon WH, 2004, CANCER LETT, V203, P99, DOI 10.1016/j.canlet.2003.08.004	95	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80313	10.1371/journal.pone.0080313	http://dx.doi.org/10.1371/journal.pone.0080313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282534	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500035
J	Nishijima, T; Kawakami, M; Kita, I				Nishijima, Takeshi; Kawakami, Masashi; Kita, Ichiro			Long-Term Exercise Is a Potent Trigger for Delta FosB Induction in the Hippocampus along the dorso-ventral Axis	PLOS ONE			English	Article							VENTRAL HIPPOCAMPUS; INDUCED NEUROGENESIS; NUCLEUS-ACCUMBENS; C-FOS; BRAIN; DORSAL; EXPRESSION; ANXIETY; RAT; DOUBLECORTIN	Physical exercise improves multiple aspects of hippocampal function. In line with the notion that neuronal activity is key to promoting neuronal functions, previous literature has consistently demonstrated that acute bouts of exercise evoke neuronal activation in the hippocampus. Repeated activating stimuli lead to an accumulation of the transcription factor Delta FosB, which mediates long-term neural plasticity. In this study, we tested the hypothesis that long-term voluntary wheel running induces Delta FosB expression in the hippocampus, and examined any potential region-specific effects within the hippocampal subfields along the dorso-ventral axis. Male C57BL/6 mice were housed with or without a running wheel for 4 weeks. Long-term wheel running significantly increased FosB/Delta FosB immunoreactivity in all hippocampal regions measured (i.e., in the DG, CA1, and CA3 subfields of both the dorsal and ventral hippocampus). Results confirmed that wheel running induced region-specific expression of FosB/Delta FosB immunoreactivity in the cortex, suggesting that the uniform increase in FosB/Delta FosB within the hippocampus is not a non-specific consequence of running. Western blot data indicated that the increased hippocampal FosB/Delta FosB immunoreactivity was primarily due to increased Delta FosB. These results suggest that long-term physical exercise is a potent trigger for Delta FosB induction throughout the entire hippocampus, which would explain why exercise can improve both dorsal and ventral hippocampus-dependent functions. Interestingly, we found that FosB/Delta FosB expression in the DG was positively correlated with the number of doublecortin-immunoreactive (i.e., immature) neurons. Although the mechanisms by which Delta FosB mediates exercise-induced neurogenesis are still uncertain, these data imply that exercise-induced neurogenesis is at least activity dependent. Taken together, our current results suggest that Delta FosB is a new molecular target involved in regulating exercise-induced hippocampal plasticity.	[Nishijima, Takeshi; Kawakami, Masashi; Kita, Ichiro] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Lab Behav Physiol, Tokyo 158, Japan	Tokyo Metropolitan University	Nishijima, T (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Lab Behav Physiol, Tokyo 158, Japan.	t-nishijima@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23700775]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TN (#23700775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2000, PHYSIOL BEHAV, V70, P425, DOI 10.1016/S0031-9384(00)00282-1; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016; Bednarczyk MR, 2009, HIPPOCAMPUS, V19, P913, DOI 10.1002/hipo.20621; Bell KFS, 2011, CURR OPIN NEUROBIOL, V21, P299, DOI 10.1016/j.conb.2011.01.002; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bjornebekk A, 2005, INT J NEUROPSYCHOPH, V8, P357, DOI 10.1017/S1461145705005122; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Clark PJ, 2011, NEUROSCIENCE, V184, P16, DOI 10.1016/j.neuroscience.2011.03.072; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Franklin K., 2007, MOUSE BRAIN STEREOTA; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Hawley DF, 2012, HIPPOCAMPUS, V22, P1338, DOI 10.1002/hipo.20970; Kaplan GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023574; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Lee MC, 2012, J APPL PHYSIOL, V113, P1260, DOI 10.1152/japplphysiol.00869.2012; Lee TH, 2003, LIFE SCI, V72, P1421, DOI 10.1016/S0024-3205(02)02406-2; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Liu JB, 2013, J PINEAL RES, V54, P222, DOI 10.1111/jpi.12023; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; MOSER E, 1993, J NEUROSCI, V13, P3916; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nishijima T, 2012, J APPL PHYSIOL, V112, P197, DOI 10.1152/japplphysiol.00763.2011; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ohnishi YN, 2011, BIOL PSYCHIAT, V70, P487, DOI 10.1016/j.biopsych.2011.04.021; Okamoto M, 2012, P NATL ACAD SCI USA, V109, P13100, DOI 10.1073/pnas.1210023109; Oladehin A, 2001, EXP BRAIN RES, V137, P26, DOI 10.1007/s002210000634; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Pitchers KK, 2013, J NEUROSCI, V33, P3434, DOI 10.1523/JNEUROSCI.4881-12.2013; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Snyder JS, 2011, NEUROBIOL AGING, V32, P1149, DOI 10.1016/j.neurobiolaging.2009.05.022; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Tulchinsky E, 2000, HISTOL HISTOPATHOL, V15, P921, DOI 10.14670/HH-15.921; Tynan RJ, 2010, BRAIN BEHAV IMMUN, V24, P1058, DOI 10.1016/j.bbi.2010.02.001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vann SD, 2000, J NEUROSCI, V20, P2711; Wallace DL, 2008, J NEUROSCI, V28, P10272, DOI 10.1523/JNEUROSCI.1531-08.2008; Werme M, 2002, J NEUROSCI, V22, P8133; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636	60	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81245	10.1371/journal.pone.0081245	http://dx.doi.org/10.1371/journal.pone.0081245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282574	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500076
J	Utz, KS; Hankeln, TMA; Jung, LN; Lammer, A; Waschbisch, A; Lee, DH; Linker, RA; Schenk, T				Utz, Kathrin S.; Hankeln, Thomas M. A.; Jung, Lena; Laemmer, Alexandra; Waschbisch, Anne; Lee, De-Hyung; Linker, Ralf A.; Schenk, Thomas			Visual Search as a Tool for a Quick and Reliable Assessment of Cognitive Functions in Patients with Multiple Sclerosis	PLOS ONE			English	Article							IMPAIRMENT; MEMORY; DYSFUNCTION; TESTS	Background: Despite the high frequency of cognitive impairment in multiple sclerosis, its assessment has not gained entrance into clinical routine yet, due to lack of time-saving and suitable tests for patients with multiple sclerosis. Objective: The aim of the study was to compare the paradigm of visual search with neuropsychological standard tests, in order to identify the test that discriminates best between patients with multiple sclerosis and healthy individuals concerning cognitive functions, without being susceptible to practice effects. Methods: Patients with relapsing remitting multiple sclerosis (n = 38) and age-and gender-matched healthy individuals (n = 40) were tested with common neuropsychological tests and a computer-based visual search task, whereby a target stimulus has to be detected amongst distracting stimuli on a touch screen. Twenty-eight of the healthy individuals were re-tested in order to determine potential practice effects. Results: Mean reaction time reflecting visual attention and movement time indicating motor execution in the visual search task discriminated best between healthy individuals and patients with multiple sclerosis, without practice effects. Conclusions: Visual search is a promising instrument for the assessment of cognitive functions and potentially cognitive changes in patients with multiple sclerosis thanks to its good discriminatory power and insusceptibility to practice effects.	[Utz, Kathrin S.; Hankeln, Thomas M. A.; Jung, Lena; Laemmer, Alexandra; Waschbisch, Anne; Lee, De-Hyung; Linker, Ralf A.; Schenk, Thomas] Univ Erlangen Nurnberg, Dept Neurol, Nurnberg, Germany	University of Erlangen Nuremberg	Utz, KS (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Nurnberg, Germany.	kathrin.utz@uk-erlangen.de	S, T/GRY-0013-2022; S, T/GXF-0648-2022; Linker, Ralf/AAD-8884-2020		Novartis Pharma GmbH	Novartis Pharma GmbH	This study was supported by Novartis Pharma GmbH (http://www.novartis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amato MP, 2013, J NEUROL, V260, P1452, DOI 10.1007/s00415-012-6678-0; Amato Maria Pia, 2008, Expert Rev Neurother, V8, P1585, DOI 10.1586/14737175.8.10.1585; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Ball K, 2010, EXP BRAIN RES, V204, P585, DOI 10.1007/s00221-010-2327-y; Ball K, 2009, NEUROPSYCHOLOGIA, V47, P1585, DOI 10.1016/j.neuropsychologia.2008.11.017; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Feinstein A, 2012, NEUROLOGY, V79, P1124, DOI 10.1212/WNL.0b013e3182698da3; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Fleischman DA, 2005, BRAIN, V128, P2006, DOI 10.1093/brain/awh559; H?rting, 2000, WECHSLER GEDACHTNIST; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lane AR, 2012, BRAIN STIMUL, V5, P11, DOI 10.1016/j.brs.2011.01.005; Langdon DW, 1999, MULT SCLER J, V5, P94, DOI 10.1177/135245859900500205; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Parmenter BA, 2006, J INT NEUROPSYCH SOC, V12, P677, DOI 10.1017/S1355617706060826; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Paul RH, 1998, MULT SCLER, V4, P433, DOI 10.1191/135245898678919438; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rao S, 1990, MANUAL BRIEF REPEATA; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Sonder JM, 2012, MULT SCLER J, V18, P196, DOI 10.1177/1352458511417827; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wechsler D., 1984, WMS R WECHSLER MEMOR; Younes M, 2007, MULT SCLER, V13, P1011, DOI 10.1177/1352458507077626; Zimmermann P, 2009, TESTBATTERIE AUFMERK	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81531	10.1371/journal.pone.0081531	http://dx.doi.org/10.1371/journal.pone.0081531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282604	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500107
J	Walden, PM; Halili, MA; Archbold, JK; Lindahl, F; Fairlie, DP; Inaba, K; Martin, JL				Walden, Patricia M.; Halili, Maria A.; Archbold, Julia K.; Lindahl, Fredrik; Fairlie, David P.; Inaba, Kenji; Martin, Jennifer L.			The alpha-Proteobacteria Wolbachia pipientis Protein Disulfide Machinery Has a Regulatory Mechanism Absent in gamma-Proteobacteria	PLOS ONE			English	Article							BOND-FORMATION; CRYSTAL-STRUCTURE; AEDES-AEGYPTI; CYTOPLASMIC INCOMPATIBILITY; REDOX PROPERTIES; DSBA; STRAIN; PREDICTION; COMPLEX; EXPRESSION	The alpha-proteobacterium Wolbachia pipientis infects more than 65% of insect species worldwide and manipulates the host reproductive machinery to enable its own survival. It can live in mutualistic relationships with hosts that cause human disease, including mosquitoes that carry the Dengue virus. Like many other bacteria, Wolbachia contains disulfide bond forming (Dsb) proteins that introduce disulfide bonds into secreted effector proteins. The genome of the Wolbachia strain wMel encodes two DsbA-like proteins sharing just 21% sequence identity to each other, alpha-DsbA1 and alpha-DsbA2, and an integral membrane protein, alpha-DsbB. alpha-DsbA1 and alpha-DsbA2 both have a Cys-X-X-Cys active site that, by analogy with Escherichia coli DsbA, would need to be oxidized to the disulfide form to serve as a disulfide bond donor toward substrate proteins. Here we show that the integral membrane protein alpha-DsbB oxidizes alpha-DsbA1, but not alpha-DsbA2. The interaction between alpha-DsbA1 and alpha-DsbB is very specific, involving four essential cysteines located in the two periplasmic loops of alpha-DsbB. In the electron flow cascade, oxidation of alpha-DsbA1 by alpha-DsbB is initiated by an oxidizing quinone cofactor that interacts with the cysteine pair in the first periplasmic loop. Oxidizing power is transferred to the second cysteine pair, which directly interacts with alpha-DsbA1. This reaction is inhibited by a non-catalytic disulfide present in alpha-DsbA1, conserved in other alpha-proteobacterial DsbAs but not in gamma-proteobacterial DsbAs. This is the first characterization of the integral membrane protein alpha-DsbB from Wolbachia and reveals that the non-catalytic cysteines of alpha-DsbA1 regulate the redox relay system in cooperation with alpha-DsbB.	[Walden, Patricia M.; Halili, Maria A.; Archbold, Julia K.; Lindahl, Fredrik; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, Brisbane, Qld, Australia; [Inaba, Kenji] Kyushu Univ, Med Inst Bioregulat, Div Prot Chem, Higashi Ku, Fukuoka 812, Japan	University of Queensland; Kyushu University	Inaba, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 980, Japan.	kinaba@tagen.tohoku.ac.jp; j.martin@imb.uq.edu.au	Fairlie, David P/F-8865-2014; Archbold, Julia/N-2884-2013; Walden, Patricia/J-8671-2014; Halili, Maria A/J-8362-2014; Martin, Jennifer L./A-6039-2010	Fairlie, David P/0000-0002-7856-8566; Archbold, Julia/0000-0002-7768-4784; Walden, Patricia/0000-0001-9400-3330; Halili, Maria A/0000-0003-4407-5269; Inaba, Kenji/0000-0001-8229-0467; Martin, Jennifer L./0000-0002-9225-8863	Australian International Postgraduate Research Scholarship; University of Queensland; NHMRC CJ Martin Postdoctoral Training Fellowship [606728]; MEXT [LS091]; Australian Research Council [FL0992138]	Australian International Postgraduate Research Scholarship; University of Queensland(University of Queensland); NHMRC CJ Martin Postdoctoral Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Australian Research Council(Australian Research Council)	This work was supported by an Australian International Postgraduate Research Scholarship (www.innovation.gov.au/RESEARCH/RESEARCHBLOCKGRANTS/Pages/InternationalPostgraduateResearchScholarships.aspx, www.uq.edu.au/grad-school/iprs-150679) to PW, a Travel Fellowship from the University of Queensland (www.uq.edu.au) to PMW, an NHMRC CJ Martin Postdoctoral Training Fellowship (ID 606728, www.nhmrc.gov.au/grants) to JKA, Next Generation World-leading Researchers funding from MEXT (LS091, www.jsps.go.jp/english/e-jisedai/life.html) to KI, and an Australian Research Council (www.arc.gov.au) Australian Laureate Fellowship (FL0992138) to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, INVEST OPHTH VIS SCI, V45, pU660; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bovicelli P, 2008, SYNTHETIC COMMUN, V38, P391, DOI 10.1080/00397910701771066; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Iturbe-Ormaetxe I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-401; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Kurz M, 2008, PROTEIN EXPRES PURIF, V59, P266, DOI 10.1016/j.pep.2008.02.008; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MARTIN JL, 1993, J MOL BIOL, V230, P1097, DOI 10.1006/jmbi.1993.1226; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; TURELLI M, 1995, GENETICS, V140, P1319; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Walker T, 2011, MEM I OSWALDO CRUZ, V106, P212, DOI 10.1590/S0074-02762011000900026; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P7032, DOI 10.1021/bi005111p; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	56	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81440	10.1371/journal.pone.0081440	http://dx.doi.org/10.1371/journal.pone.0081440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282596	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500098
J	Chien, IC; Meschke, JS; Gough, HL; Ferguson, JF				Chien, I-Chieh; Meschke, John Scott; Gough, Heidi L.; Ferguson, John F.			Characterization of Persistent Virus-Like Particles in Two Acetate-Fed Methanogenic Reactors	PLOS ONE			English	Article							ANAEROBIC-DIGESTION; CONTINUOUS CULTIVATION; MICROBIAL COMMUNITY; PROCESS STABILITY; MARINE VIRUSES; METHANOSAETA; DIVERSITY; SLUDGE; ABUNDANCE; METHANOBACTERIUM	The objective of this study was to characterize the morphology, size-distribution, concentration and genome size of virus-like particles (VLPs) in two acetate-fed Methanosaeta-dominated reactors to better understand the possible correlation between viruses and archaeal hosts. The study reactors were dominated by a single genus of acetoclastic methanogen, Methanosaeta, which was present at 6 to 13 times higher than the combined bacterial populations consisting of Proteobacteria, Firmicutes, and Bacteroidetes. Epifluorescent microscopy showed VLPs concentration of 7.1 +/- 1.5x10(7) VLPs/ml and 8.4 +/- 4.3x10(7) VLPs/ml in the two laboratory reactors. Observations of no detectable import of VLPs with the reactor feed combined long operational time since the last inocula were introduced suggests that the VLP populations were actively propagating in the reactors. Transmission electron microscopy images showed VLPs with morphology consistent with Siphoviridae in both reactors, and VLPs with morphologies consistent with Myoviridae in one of the reactors. The morphology, size-distribution and genome size of VLPs were distinct between reactors suggesting that unique viral populations inhabited each reactor, though the hosts of these VLPs remain unclear.	[Chien, I-Chieh; Meschke, John Scott; Gough, Heidi L.; Ferguson, John F.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Meschke, John Scott] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Meschke, JS (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA.	jmeschke@u.washington.edu	Gough, Heidi/ABF-5275-2021; Gough, Heidi/AAM-5528-2021	Gough, Heidi/0000-0002-2402-722X; 	National Science Foundation [CBE-0930877]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under grant number CBE-0930877. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Ackermann Hans-W., 2009, V501, P113, DOI 10.1007/978-1-60327-164-6_12; Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; Barber RD, 2011, J BACTERIOL, V193, P3668, DOI 10.1128/JB.05031-11; Carbonero F, 2010, J MICROBIOL METH, V80, P203, DOI 10.1016/j.mimet.2009.11.013; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Conklin A, 2006, WATER ENVIRON RES, V78, P486, DOI 10.2175/106143006X95393; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; DODDEMA HJ, 1978, APPL ENVIRON MICROB, V36, P752, DOI 10.1128/AEM.36.5.752-754.1978; Elberson MA, 1997, INT J SYST BACTERIOL, V47, P1258, DOI 10.1099/00207713-47-4-1258; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Janssen PH, 2003, J MICROBIOL METH, V52, P239, DOI 10.1016/S0167-7012(02)00181-1; JERIS JOHN S., 1965, J WATER POLLUT CONTR FEDERATION, V37, P178; JORDAN M, 1989, MOL GEN GENET, V220, P161, DOI 10.1007/BF00260872; Kim M, 2002, WATER RES, V36, P4369, DOI 10.1016/S0043-1354(02)00147-1; Krakat N, 2011, BIORESOURCE TECHNOL, V102, P5692, DOI 10.1016/j.biortech.2011.02.108; KROEKER EJ, 1979, J WATER POLLUT CON F, V51, P718; Lane D., 1991, NUCL ACID TECHNIQUES, V1991, P115; Leclerc M, 2004, ENVIRON MICROBIOL, V6, P809, DOI 10.1111/j.1462-2920.2004.00616.x; Limam RD, 2010, CAN J MICROBIOL, V56, P846, DOI [10.1139/w10-065, 10.1139/W10-065]; Los M, 2012, ADV VIRUS RES, V82, P339, DOI 10.1016/B978-0-12-394621-8.00019-4; McCarty PL, 2001, WATER SCI TECHNOL, V44, P149, DOI 10.2166/wst.2001.0487; MEILE L, 1989, ARCH MICROBIOL, V152, P105, DOI 10.1007/BF00456085; Mizukami S, 2006, BIOSCI BIOTECH BIOCH, V70, P828, DOI 10.1271/bbb.70.828; Nachaiyasit S, 1997, WATER RES, V31, P2737, DOI 10.1016/S0043-1354(97)00133-4; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; NOLLING J, 1993, J GEN MICROBIOL, V139, P2511, DOI 10.1099/00221287-139-10-2511; Park MO, 2007, MICROB ECOL, V53, P98, DOI 10.1007/s00248-006-9053-9; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Prangishvili D, 2005, TRENDS MICROBIOL, V13, P535, DOI 10.1016/j.tim.2005.08.013; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Prangishvili D, 2006, J MOL BIOL, V359, P1203, DOI 10.1016/j.jmb.2006.04.027; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Scholten JCM, 2000, MICROBIAL ECOL, V40, P292; Shigematsu T, 2003, J BIOSCI BIOENG, V96, P547, DOI 10.1016/S1389-1723(04)70148-6; Shigematsu T, 2006, J BIOSCI BIOENG, V102, P535, DOI 10.1263/jbb.102.535; Smith KS, 2007, TRENDS MICROBIOL, V15, P150, DOI 10.1016/j.tim.2007.02.002; SMITH PH, 1966, APPL MICROBIOL, V14, P368, DOI 10.1128/AEM.14.3.368-371.1966; Steinberg LM, 2008, APPL ENVIRON MICROB, V74, P6663, DOI 10.1128/AEM.00553-08; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tang YQ, 2005, J BIOSCI BIOENG, V99, P150, DOI 10.1263/jbb.99.150; Tapper MA, 1998, LIMNOL OCEANOGR, V43, P95, DOI 10.4319/lo.1998.43.1.0095; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; TUOMI P, 1995, FEMS MICROBIOL ECOL, V16, P123, DOI 10.1016/0168-6496(94)00076-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wu QL, 2009, WATER RES, V43, P1101, DOI 10.1016/j.watres.2008.11.039; ZEHNDER AJB, 1980, ARCH MICROBIOL, V124, P1, DOI 10.1007/BF00407022	56	13	14	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81040	10.1371/journal.pone.0081040	http://dx.doi.org/10.1371/journal.pone.0081040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278372	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700046
J	Ogura, T; Hernandez, A; Aizawa, T; Ogihara, J; Sunairi, M; Alcaino, J; Salvo-Garrido, H; Maureira-Butler, IJ				Ogura, Takahiro; Hernandez, Adrian; Aizawa, Tomoko; Ogihara, Jun; Sunairi, Michio; Alcaino, Javier; Salvo-Garrido, Haroldo; Maureira-Butler, Ivan J.			Identification of a Low Digestibility delta-Conglutin in Yellow Lupin (Lupinus luteus L.) Seed Meal for Atlantic Salmon (Salmo salar L.) by Coupling 2D-PAGE and Mass Spectrometry	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; PROTEIN DIGESTIBILITY; GEL-ELECTROPHORESIS; SUBUNIT COMPOSITION; FEED; GROWTH; INGREDIENTS; DIETS; COLLECTION	The need of quality protein in the aquaculture sector has forced the incorporation of alternative plant proteins into feeding diets. However, most plant proteins show lower digestibility levels than fish meal proteins, especially in carnivorous fishes. Manipulation of protein content by plant breeding can improve the digestibility rate of plant proteins in fish, but the identification of low digestibility proteins is essential. A reduction of low digestibility proteins will not only increase feed efficiency, but also reduce water pollution. Little is known about specific digestible protein profiles and/or molecular identification of more bioavailable plant proteins in fish diets. In this study, we identified low digestibility L. luteus seed proteins using Atlantic salmon (Salmo salar) crude digestive enzymes in an in vitro assay. Low digestibility proteins were identified by comparing SDS-PAGE banding profiles of digested and non-digested lupin seed proteins. Gel image analysis detected a major 12 kDa protein band in both lupin meal and protein isolate digested products. The 12 kDa was confirmed by 2D-PAGE gels and the extracted protein was analyzed with an ion trap mass spectrometer in tandem mass mode. The MS/MS data showed that the 12 kDa low digestibility protein was a large chain dconglutin, a common seed storage protein of yellow lupin. Comparison of the protein band profiles between lupin meal and protein isolates showed that the isolatation process did not affect the low digestibility of the 12 kDa protein.	[Ogura, Takahiro; Salvo-Garrido, Haroldo; Maureira-Butler, Ivan J.] Agriaquaculture Nutr Genom Ctr CGNA, Genom & Bioinformat Unit, Temuco, Ix Region, Chile; [Hernandez, Adrian; Alcaino, Javier] Univ Catholic Temuco, Fac Recursos Nat, Escuela Acuicultura, Nucleo Invest Prod Alimentaria, Temuco, Ix Region, Chile; [Aizawa, Tomoko; Ogihara, Jun; Sunairi, Michio] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Salvo-Garrido, Haroldo] Inst Agr Res INIA Carillanca, Temuco, Ix Region, Chile	Nihon University	Maureira-Butler, IJ (corresponding author), Agriaquaculture Nutr Genom Ctr CGNA, Genom & Bioinformat Unit, Temuco, Ix Region, Chile.	ivan.maureira@cgna.cl	Maureira-Butler, Ivan J/U-3130-2017; Arias, Adrian J. Hernandez/M-9374-2018	Maureira-Butler, Ivan J/0000-0001-7360-3580; Arias, Adrian J. Hernandez/0000-0002-8209-2994	CORFO-CHILE, INNOVA Program [07CT9 Z-83]; CONICYT Regional/GORE, Chile [AraucanA-a/CGNA/R10C1001]	CORFO-CHILE, INNOVA Program; CONICYT Regional/GORE, Chile	This research was funded by CORFO-CHILE, INNOVA Program (Project 07CT9 Z-83) and CONICYT Regional/GORE AraucanA-a/CGNA/R10C1001, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboubacar A, 2001, CEREAL CHEM, V78, P160, DOI 10.1094/CCHEM.2001.78.2.160; Blagrove RJ, 1975, FUNCTIONAL PLANT BIO, V2, P13, DOI DOI 10.1071/PP9750013; BOONVISUT S, 1976, J AGR FOOD CHEM, V24, P1130, DOI 10.1021/jf60208a033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burel C, 2000, AQUACULTURE, V188, P285, DOI 10.1016/S0044-8486(00)00337-9; Carter CG, 1999, AQUACULTURE, V179, P57, DOI 10.1016/S0044-8486(99)00152-0; CASERO P, 1983, J SCI FOOD AGR, V34, P1113, DOI 10.1002/jsfa.2740341011; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Chong ASC, 2002, AQUACULT NUTR, V8, P229, DOI 10.1046/j.1365-2095.2002.00214.x; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; DELAHIGUERA M, 1988, AQUACULTURE, V71, P37, DOI 10.1016/0044-8486(88)90271-2; Duranti M, 2008, TRENDS FOOD SCI TECH, V19, P624, DOI 10.1016/j.tifs.2008.07.002; Farhangi M, 2007, AQUAC RES, V38, P1274, DOI 10.1111/j.1365-2109.2007.01789.x; Foley RC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-59; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Glencross B, 2005, AQUACULTURE, V245, P211, DOI 10.1016/j.aquaculture.2004.11.033; Glencross B, 2004, AQUACULTURE, V235, P411, DOI 10.1016/j.aquaculture.2003.09.022; Glencross B, 2003, 6 DEP FISH GRAINS RE; Glencross BD, 2007, AQUACULT NUTR, V13, P17, DOI 10.1111/j.1365-2095.2007.00450.x; Glencross BD, 2003, AQUACULTURE, V219, P703, DOI 10.1016/S0044-8486(02)00664-6; Glencross B, 2009, AQUACULTURE, V294, P256, DOI 10.1016/j.aquaculture.2009.06.010; Hardy, 2006, AVANCES NUTR ACUICOL, P410; Hernandez AJ, 2013, AQUACULT NUTR, V19, P321, DOI 10.1111/j.1365-2095.2012.00961.x; Lemos D, 2004, AQUACULTURE, V239, P307, DOI 10.1016/j.aquaculture.2004.05.032; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; Mori T, 2012, BIOL OPEN, V1, P308, DOI 10.1242/bio2012604; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; ORIA MP, 1995, J CEREAL SCI, V22, P85, DOI 10.1016/S0733-5210(05)80010-4; Gonzalez LBP, 2010, AM J BOT, V97, pE72, DOI 10.3732/ajb.1000170; Parra-Gonzalez LB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-425; Petterson DS., 1997, CHEM COMPOSITION NUT; RESTANI P, 1981, PHYTOCHEMISTRY, V20, P2077, DOI 10.1016/0031-9422(81)80088-X; Sajjadi M, 2004, AQUACULT NUTR, V10, P135, DOI 10.1111/j.1365-2095.2003.00290.x; Salmanowicz BP, 1997, Z LEBENSM UNTERS F A, V204, P129, DOI 10.1007/s002170050049; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tai HH, 1997, J ANIM SCI, V75, P1934; Vandenberg GW, 2001, AQUACULT NUTR, V7, P237, DOI 10.1046/j.1365-2095.2001.00181.x; Wasche A, 2001, NAHRUNG, V45, P393, DOI 10.1002/1521-3803(20011001)45:6<393::AID-FOOD393>3.0.CO;2-O; YOSHIMURA KATSUJI, 1964, BULL FAC FISH HOKKAIDO UNIV, V14, P262	40	4	4	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80369	10.1371/journal.pone.0080369	http://dx.doi.org/10.1371/journal.pone.0080369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278278	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700028
J	Yang, RL; Zhao, XJ; Liu, XM				Yang, Rongling; Zhao, Xiangjie; Liu, Xueming			Novel and Highly Efficient Regioselective Route to Helicid Esters by Lipozyme TLL	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; SUGAR ESTERS; ACID-ESTERS; LIPASE; ANALOGS; ACYLATION; NUCLEOSIDES	Highly regioselective acylation of helicid with fatty acid vinyl esters catalyzed by the lipase from Thermomyces lanuginosus has been successfully performed for the first time. For the enzymatic caproylation of helicid, under the optimal conditions, initial reaction rate was 33.2 mM/h, and substrate conversion and regioselectivity were greater than 99%. In addition, the acyl recognition of the enzyme in the regioselective acylation of helicid was investigated. The results showed that although 6'-O-acyl derivatives of helicid were exclusively obtained with all the tested acyl donors, the enzymatic reaction rate varied widely with different acyl donors, presumably owing to their different interactions with the active site of the lipase. It is also interesting that the different configuration of only one hydroxyl group at C-3 in helicid couldn't affect the lipase-catalyzed esterification and helicid has the same regioselectivity as that of D-glucose and arbutin.	[Yang, Rongling; Zhao, Xiangjie; Liu, Xueming] Guangdong Acad Agr Sci, Sericulture & Agrifood Res Inst, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiangjie] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; South China University of Technology	Yang, RL (corresponding author), Guangdong Acad Agr Sci, Sericulture & Agrifood Res Inst, Guangzhou, Guangdong, Peoples R China.	ronglingyang@qq.com; xiangjiezhao@qq.com	Liu, Xueming/AAR-2243-2020; Liu, Xueming/GSD-3517-2022		Natural Science Foundation of Guangdong Province of China [S2012040008048]; President Foundation for Guangdong Academy of Agricultural Sciences [201106]; Guangzhou Science and Technology Plan Projects of China [11D84070010]	Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); President Foundation for Guangdong Academy of Agricultural Sciences; Guangzhou Science and Technology Plan Projects of China	This study was supported by the Natural Science Foundation of Guangdong Province of China (grant number S2012040008048), President Foundation for Guangdong Academy of Agricultural Sciences (number 201106), and Guangzhou Science and Technology Plan Projects of China (grant number 11D84070010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afach G, 2005, BIOSCI BIOTECH BIOCH, V69, P833, DOI 10.1271/bbb.69.833; Basri M, 2013, J MOL CATAL B-ENZYM, V85-86, P214, DOI 10.1016/j.molcatb.2012.09.013; Cauglia F, 2008, BIORESOURCE TECHNOL, V99, P4065, DOI 10.1016/j.biortech.2007.01.036; Ferrer M, 2005, ENZYME MICROB TECH, V36, P391, DOI 10.1016/j.enzmictec.2004.02.009; Gao WL, 2012, BIORESOURCE TECHNOL, V118, P82, DOI 10.1016/j.biortech.2012.04.104; Gao WL, 2011, BIOTECHNOL LETT, V33, P2233, DOI 10.1007/s10529-011-0685-6; Khor GK, 2010, BIORESOURCE TECHNOL, V101, P6558, DOI 10.1016/j.biortech.2010.03.047; Kobayashi T, 2003, BIOTECHNOL LETT, V25, P3, DOI 10.1023/A:1021799825272; Li N, 2008, J BIOTECHNOL, V133, P103, DOI 10.1016/j.jbiotec.2007.09.003; Li N, 2009, TETRAHEDRON, V65, P1063, DOI 10.1016/j.tet.2008.11.045; Lue BM, 2010, PROCESS BIOCHEM, V45, P1375, DOI 10.1016/j.procbio.2010.05.024; Martinelle M, 1996, PROTEIN ENG, V9, P519, DOI 10.1093/protein/9.6.519; RIVA S, 1988, J AM CHEM SOC, V110, P584, DOI 10.1021/ja00210a045; Salem JH, 2010, PROCESS BIOCHEM, V45, P382, DOI 10.1016/j.procbio.2009.10.012; Wang ZY, 2009, J MOL CATAL B-ENZYM, V59, P201; Wen H, 2008, EUR J MED CHEM, V43, P166, DOI 10.1016/j.ejmech.2007.03.018; Xu XB, 2000, EUR J LIPID SCI TECH, V102, P287; Yadav GD, 2004, BIOCHEM ENG J, V19, P101, DOI 10.1016/j.bej.2003.12.004; Yang RL, 2010, J MOL CATAL B-ENZYM, V67, P41, DOI 10.1016/j.molcatb.2010.07.003; Yang RL, 2010, BIORESOURCE TECHNOL, V101, P1, DOI 10.1016/j.biortech.2009.07.067; Yang XE, 2012, J BIOTECHNOL, V161, P27, DOI 10.1016/j.jbiotec.2012.05.014; Yi W, 2008, BIOORG MED CHEM LETT, V18, P6490, DOI 10.1016/j.bmcl.2008.10.056	22	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80715	10.1371/journal.pone.0080715	http://dx.doi.org/10.1371/journal.pone.0080715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278310	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700033
J	Fan, JL; Kayser, B				Fan, Jui-Lin; Kayser, Bengt			The Effect of Adding CO2 to Hypoxic Inspired Gas on Cerebral Blood Flow Velocity and Breathing during Incremental Exercise	PLOS ONE			English	Article							VENTILATORY RESPONSE; MUSCLE OXYGENATION; ANAEROBIC THRESHOLD; EXTREME ALTITUDE; NERVOUS-SYSTEM; ARTERIAL PCO2; DELIVERY; HUMANS; RAMP; HYPERVENTILATION	Hypoxia increases the ventilatory response to exercise, which leads to hyperventilation-induced hypocapnia and subsequent reduction in cerebral blood flow (CBF). We studied the effects of adding CO2 to a hypoxic inspired gas on CBF during heavy exercise in an altitude naive population. We hypothesized that augmented inspired CO2 and hypoxia would exert synergistic effects on increasing CBF during exercise, which would improve exercise capacity compared to hypocapnic hypoxia. We also examined the responsiveness of CO2 and O-2 chemoreception on the regulation ventilation ((V) over dotE) during incremental exercise. We measured middle cerebral artery velocity (MCAv; index of CBF), (V) over dotE, end-tidal PCO2, respiratory compensation threshold (RC) and ventilatory response to exercise ((V) over dotE slope) in ten healthy men during incremental cycling to exhaustion in normoxia and hypoxia (FIO2 = 0.10) with and without augmenting the fraction of inspired CO2 (FICO2). During exercise in normoxia, augmenting FICO2 elevated MCAv throughout exercise and lowered both RC onset and (V) over dotE slope below RC (P<0.05). In hypoxia, MCAv and (V) over dotE slope below RC during exercise were elevated, while the onset of RC occurred at lower exercise intensity (P<0.05). Augmenting FICO2 in hypoxia increased (V) over dotE at RC (P<0.05) but no difference was observed in RC onset, MCAv, or (V) over dot slope below RC (P>0.05). The (V) over dotE slope above RC was unchanged with either hypoxia or augmented FICO2 (P>0.05). We found augmenting FICO2 increased CBF during sub-maximal exercise in normoxia, but not in hypoxia, indicating that the 'normal' cerebrovascular response to hypercapnia is blunted during exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory reserve. This finding may explain the lack of improvement of exercise capacity in hypoxia with augmented CO2. Our data further indicate that, during exercise below RC, chemoreception is responsive, while above RC the ventilatory response to CO2 is blunted.	[Fan, Jui-Lin; Kayser, Bengt] Univ Lausanne, Inst Sports Sci, Lausanne, Switzerland; [Fan, Jui-Lin; Kayser, Bengt] Univ Lausanne, Fac Biol & Med, Dept Physiol, Lausanne, Switzerland; [Fan, Jui-Lin] Univ Lausanne, Leman Neurosci Doctoral Sch, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne	Kayser, B (corresponding author), Univ Lausanne, Inst Sports Sci, Lausanne, Switzerland.	Bengt.Kayser@unil.ch	Kayser, Bengt/M-8643-2013	Kayser, Bengt/0000-0002-9776-7501; Fan, Jui-Lin/0000-0002-4413-5615	Swiss National Science Foundation; Fondation de Reuter	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation de Reuter	This study was supported by the Swiss National Science Foundation and the Fondation de Reuter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2010, EXP PHYSIOL, V95, P251, DOI 10.1113/expphysiol.2008.045575; Amann M, 2009, HIGH ALT MED BIOL, V10, P149, DOI 10.1089/ham.2008.1105; ASMUSSEN E, 1957, ACTA PHYSIOL SCAND, V39, P27, DOI 10.1111/j.1748-1716.1957.tb01406.x; Babb TG, 1997, J APPL PHYSIOL, V82, P746, DOI 10.1152/jappl.1997.82.3.746; Babb TG, 1997, RESP PHYSIOL, V109, P15, DOI 10.1016/S0034-5687(97)84026-1; Babb TG, 2003, J APPL PHYSIOL, V94, P685, DOI 10.1152/japplphysiol.00214.2002; Babb TG, 2010, MED SCI SPORT EXER, V42, P1681, DOI 10.1249/MSS.0b013e3181d7b212; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bernardi L, 2006, EUR RESPIR J, V27, P165, DOI 10.1183/09031936.06.00015805; Boone J, 2012, SPORTS MED, V42, P511, DOI 10.2165/11599690-000000000-00000; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BRADAC GB, 1976, NEURORADIOLOGY, V10, P257, DOI 10.1007/BF00327574; CLARK JM, 1980, J APPL PHYSIOL, V48, P1065, DOI 10.1152/jappl.1980.48.6.1065; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Fan JL, 2012, RESP PHYSIOL NEUROBI, V180, P283, DOI 10.1016/j.resp.2011.12.004; Fan JL, 2010, J PHYSIOL-LONDON, V588, P539, DOI 10.1113/jphysiol.2009.184051; Forster H V, 2000, Exerc Sport Sci Rev, V28, P133; FOSTER C, 1993, MED SCI SPORT EXER, V25, P877, DOI 10.1249/00005768-199307000-00018; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Hopker JG, 2011, ANAESTHESIA, V66, P111, DOI 10.1111/j.1365-2044.2010.06604.x; HORNBEIN TF, 1989, NEW ENGL J MED, V321, P1714, DOI 10.1056/NEJM198912213212505; Ide K, 1999, J APPL PHYSIOL, V87, P1604, DOI 10.1152/jappl.1999.87.5.1604; JONES NL, 1979, J APPL PHYSIOL, V47, P954, DOI 10.1152/jappl.1979.47.5.954; KORY RC, 1961, AM J MED, V30, P243, DOI 10.1016/0002-9343(61)90096-1; LIU Z, 1995, CHEST, V107, P1218, DOI 10.1378/chest.107.5.1218; MADSEN PL, 1993, J APPL PHYSIOL, V74, P245, DOI 10.1152/jappl.1993.74.1.245; Mardimae A, 2012, PFLUG ARCH EUR J PHY, V464, P345, DOI 10.1007/s00424-012-1148-1; MATEIKA JH, 1995, EUR J APPL PHYSIOL, V71, P1, DOI 10.1007/BF00511228; MATHEW L, 1983, AVIAT SPACE ENVIR MD, V54, P121; Nybo L, 2007, EXERC SPORT SCI REV, V35, P110, DOI 10.1097/jes.0b013e3180a031ec; Ogoh S, 2008, J PHYSIOL-LONDON, V586, P4327, DOI 10.1113/jphysiol.2008.157073; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Olin JT, 2011, RESP PHYSIOL NEUROBI, V175, P176, DOI 10.1016/j.resp.2010.09.011; Palmer GS, 1996, INT J SPORTS MED, V17, P293, DOI 10.1055/s-2007-972849; Peltonen JE, 2009, RESP PHYSIOL NEUROBI, V169, P24, DOI 10.1016/j.resp.2009.08.013; Peronnet F, 2006, RESP PHYSIOL NEUROBI, V150, P4, DOI 10.1016/j.resp.2005.04.005; Poon CS, 2007, RESP PHYSIOL NEUROBI, V159, P1, DOI 10.1016/j.resp.2007.02.020; Rasmussen P, 2006, EUR J APPL PHYSIOL, V96, P299, DOI 10.1007/s00421-005-0079-3; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; ROBBINS PA, 1990, J APPL PHYSIOL, V68, P1727, DOI 10.1152/jappl.1990.68.4.1727; Rupp T, 2009, ADV EXP MED BIOL, V645, P329, DOI 10.1007/978-0-387-85998-9_49; Sato K, 2011, J PHYSIOL-LONDON, V589, P2847, DOI 10.1113/jphysiol.2010.204461; SCHOENE RB, 1982, J APPL PHYSIOL, V53, P886, DOI 10.1152/jappl.1982.53.4.886; Seifert T, 2009, ACTA PHYSIOL, V196, P295, DOI 10.1111/j.1748-1716.2008.01946.x; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Siebenmann C, 2013, RESP PHYSIOL NEUROBI, V185, P461, DOI 10.1016/j.resp.2012.08.012; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Staab JE, 2013, HIGH ALT MED BIOL, V14, P13, DOI 10.1089/ham.2012.1065; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Subudhi AW, 2011, J APPL PHYSIOL, V111, P1727, DOI 10.1152/japplphysiol.00569.2011; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Vogiatzis I, 2011, J PHYSIOL-LONDON, V589, P4027, DOI 10.1113/jphysiol.2011.210880; Ward SA, 2000, RESP PHYSIOL, V122, P149, DOI 10.1016/S0034-5687(00)00156-0; Weston SB, 2002, INT J SPORTS MED, V23, P22, DOI 10.1055/s-2002-19267; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Zuniga JM, 2012, APPL PHYSIOL NUTR ME, V37, P1110, DOI [10.1139/h2012-098, 10.1139/H2012-098]	57	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81130	10.1371/journal.pone.0081130	http://dx.doi.org/10.1371/journal.pone.0081130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278389	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800105
J	Judice, WAS; Manfredi, MA; Souza, GP; Sansevero, TM; Almeida, PC; Shida, CS; Gesteira, TF; Juliano, L; Westrop, GD; Sanderson, SJ; Coombs, GH; Tersariol, ILS				Judice, Wagner A. S.; Manfredi, Marcella A.; Souza, Gerson P.; Sansevero, Thiago M.; Almeida, Paulo C.; Shida, Claudio S.; Gesteira, Tarsis F.; Juliano, Luiz; Westrop, Gareth D.; Sanderson, Sanya J.; Coombs, Graham H.; Tersariol, Ivarne L. S.			Heparin Modulates the Endopeptidase Activity of Leishmania mexicana Cysteine Protease Cathepsin L-Like rCPB2.8	PLOS ONE			English	Article							INDIVIDUAL RATE CONSTANTS; BASIC-AMINO-ACIDS; PRE-STEADY-STATE; TRYPANOSOMA-CRUZI; SUBSTRATE-SPECIFICITY; PROTEINASE CRUZIPAIN; PROCATHEPSIN-B; GENE ARRAY; IDENTIFICATION; BINDING	Background: Cysteine protease B is considered crucial for the survival and infectivity of the Leishmania in its human host. Several microorganism pathogens bind to the heparin-like glycosaminoglycans chains of proteoglycans at host-cell surface to promote their attachment and internalization. Here, we have investigated the influence of heparin upon Leishmania mexicana cysteine protease rCPB2.8 activity. Methodology/Principal Findings: The data analysis revealed that the presence of heparin affects all steps of the enzyme reaction: (i) it decreases 3.5-fold the k(1) and 4.0-fold the k(-1), (ii) it affects the acyl-enzyme accumulation with pronounced decrease in k(2) (2.7-fold), and also decrease in k(3) (3.5-fold). The large values of triangle G = 12 kJ/mol for the association and dissociation steps indicate substantial structural strains linked to the formation/dissociation of the ES complex in the presence of heparin, which underscore a conformational change that prevents the diffusion of substrate in the rCPB2.8 active site. Binding to heparin also significantly decreases the alpha-helix content of the rCPB2.8 and perturbs the intrinsic fluorescence emission of the enzyme. The data strongly suggest that heparin is altering the ionization of catalytic (Cys(25))-S-/(His(163))-Im(+) H ion pair of the rCPB2.8. Moreover, the interaction of heparin with the N-terminal pro-region of rCPB2.8 significantly decreased its inhibitory activity against the mature enzyme. Conclusions/Significance: Taken together, depending on their concentration, heparin-like glycosaminoglycans can either stimulate or antagonize the activity of cysteine protease B enzymes during parasite infection, suggesting that this glycoconjugate can anchor parasite cysteine protease at host cell surface.	[Judice, Wagner A. S.; Manfredi, Marcella A.; Souza, Gerson P.; Sansevero, Thiago M.; Tersariol, Ivarne L. S.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil; [Almeida, Paulo C.; Tersariol, Ivarne L. S.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Shida, Claudio S.] Univ Fed Sao Paulo, Inst Ciencia & Tecnol, Sao Jose Dos Campos, Brazil; [Gesteira, Tarsis F.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Juliano, Luiz] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Westrop, Gareth D.; Sanderson, Sanya J.; Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Cincinnati Children's Hospital Medical Center; Universidade Federal de Sao Paulo (UNIFESP); University of Strathclyde	Tersariol, ILS (corresponding author), Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil.	ivarne@umc.br	Juliano, Luiz/D-7204-2012; de Almeida, Paulo C/D-8285-2014; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; DE SOUZA JUDICE, WAGNER ALVES/AAG-3225-2020; DE SOUZ A S JUDICE, WAGNER ALVES/O-1050-2013	Juliano, Luiz/0000-0002-5589-2822; de Almeida, Paulo C/0000-0002-5136-5152; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; DE SOUZ A S JUDICE, WAGNER ALVES/0000-0002-1608-9105; Westrop, Gareth/0000-0002-8011-6219; Profeta de Souza, Gerson/0000-0001-6394-2263	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/50219-6]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico [303843/2009-8]; Medical Research Council [G0700127]; MRC [G0700127] Funding Source: UKRI	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ILST acknowledges financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 2012/50219-6, and Conselho Nacional de Desenvolvimento Cientifico Tecnologico Grants acknowledges financial support from 303843/2009-8, Brazil. GHC acknowledges financial support from the Medical Research Council grant G0700127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, J IMMUNOL, V161, P6794; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Alves LC, 2001, MOL BIOCHEM PARASIT, V116, P1, DOI 10.1016/S0166-6851(01)00290-0; Alves LC, 2001, MOL BIOCHEM PARASIT, V114, P81, DOI 10.1016/S0166-6851(01)00239-0; Alves LC, 2001, MOL BIOCHEM PARASIT, V117, P137, DOI 10.1016/S0166-6851(01)00340-1; Alves LC, 2001, EUR J BIOCHEM, V268, P1206, DOI 10.1046/j.1432-1327.2001.01973.x; Ayala YM, 2000, PROTEIN SCI, V9, P1589, DOI 10.1110/ps.9.8.1589; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; BATES PA, 1994, J EUKARYOT MICROBIOL, V41, P199, DOI 10.1111/j.1550-7408.1994.tb01497.x; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; CAMPETELLA O, 1992, MOL BIOCHEM PARASIT, V50, P225, DOI 10.1016/0166-6851(92)90219-A; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Conrad H. E., 1998, HEPARIN BINDING PROT; Coombs GH, 1997, PARASITOLOGY, V114, pS61, DOI 10.1017/S003118209700111X; COOMBS GH, 1982, PARASITOLOGY, V84, P149, DOI 10.1017/S003118200005174X; Coombs Graham H., 1997, P177; Cornish-Bowden A, 1999, FUNDAMENTS ENZYME KI; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cortes LMD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-142; DelNery E, 1997, J BIOL CHEM, V272, P25713, DOI 10.1074/jbc.272.41.25713; Fairhead M, 2008, BIOCHEM BIOPH RES CO, V366, P862, DOI 10.1016/j.bbrc.2007.12.062; Gesteira TF, 2011, J BIOL CHEM, V286, P5338, DOI 10.1074/jbc.M110.100719; Graven A, 2001, J COMB CHEM, V3, P441, DOI 10.1021/cc0001102; Hilaire PMS, 2002, J MED CHEM, V45, P1971, DOI 10.1021/jm0110901; Horn M, 2011, ACS CHEM BIOL, V6, P609, DOI 10.1021/cb100411v; Hussain S, 2003, BIOCHEM J, V372, P735, DOI 10.1042/BJ20030177; Hussain S, 2011, BIOCHEMISTRY-US, V50, P10732, DOI 10.1021/bi201207z; Judice WAS, 2005, MOL BIOCHEM PARASIT, V144, P36, DOI 10.1016/j.molbiopara.2005.07.004; Judice WAS, 2001, EUR J BIOCHEM, V268, P6578, DOI 10.1046/j.0014-2956.2001.02612.x; Juliano MA, 2004, EUR J BIOCHEM, V271, P3704, DOI 10.1111/j.1432-1033.2004.04311.x; Koti ASR, 2001, J PHYS CHEM A, V105, P1767, DOI 10.1021/jp004361c; Kulkarni MM, 2008, INFECT IMMUN, V76, P1738, DOI 10.1128/IAI.01274-07; Laidler K J, 1979, Methods Enzymol, V63, P234; LEAO SD, 1995, J CELL SCI, V108, P3219; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; LOVE DC, 1993, J CELL BIOL, V123, P759, DOI 10.1083/jcb.123.3.759; MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; MOTTRAM JC, 1989, FEBS LETT, V258, P211, DOI 10.1016/0014-5793(89)81655-2; MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Nunes GLC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021525; Pimenta DC, 2002, BIOCHEM J, V366, P435, DOI 10.1042/BJ20020023; Polgar L, 1999, BIOCHEMISTRY-US, V38, P15548, DOI 10.1021/bi991767a; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; PUPKIS MF, 1984, J GEN MICROBIOL, V130, P2375; ROBERTSON CD, 1990, MOL BIOCHEM PARASIT, V42, P269, DOI 10.1016/0166-6851(90)90170-Q; ROBERTSON CD, 1992, FEMS MICROBIOL LETT, V94, P127, DOI 10.1111/j.1574-6968.1992.tb05301.x; ROBERTSON CD, 1994, MICROBIOL-SGM, V140, P417, DOI 10.1099/13500872-140-2-417; ROUGHLEY PJ, 1977, BIOCHEM J, V167, P629, DOI 10.1042/bj1670629; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sakanari JA, 1997, EXP PARASITOL, V85, P63, DOI 10.1006/expr.1996.4116; Sanderson SJ, 2000, BIOCHEM J, V347, P383, DOI 10.1042/0264-6021:3470383; Schenker P, 2010, FEBS J, V277, P2486, DOI 10.1111/j.1742-4658.2010.07663.x; Schneck JL, 2008, BIOCHEMISTRY-US, V47, P8697, DOI 10.1021/bi8007627; Shinjo SK, 2002, J BIOL CHEM, V277, P48227, DOI 10.1074/jbc.M205867200; SOUZA AE, 1992, FEBS LETT, V311, P124, DOI 10.1016/0014-5793(92)81382-V; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; St Hilaire PM, 2000, CHEMBIOCHEM, V1, P115, DOI 10.1002/1439-7633(20000818)1:2<115::AID-CBIC115>3.3.CO;2-#; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P2238, DOI 10.1021/bi00382a025; Stoka V, 1998, FEBS LETT, V429, P129, DOI 10.1016/S0014-5793(98)00532-8; TRAUBCSEKO YM, 1993, MOL BIOCHEM PARASIT, V57, P101, DOI 10.1016/0166-6851(93)90248-V; van Holde KE, 2002, BIOPHYS CHEM, V101, P249, DOI 10.1016/S0301-4622(02)00176-X; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	71	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80153	10.1371/journal.pone.0080153	http://dx.doi.org/10.1371/journal.pone.0080153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278253	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327539800059
J	Lindholm-Perry, AK; Kuehn, LA; Oliver, WT; Sexten, AK; Miles, JR; Rempel, LA; Cushman, RA; Freetly, HC				Lindholm-Perry, Amanda K.; Kuehn, Larry A.; Oliver, William T.; Sexten, Andrea K.; Miles, Jeremy R.; Rempel, Lea A.; Cushman, Robert A.; Freetly, Harvey C.			Adipose and Muscle Tissue Gene Expression of Two Genes (NCAPG and LCORL) Located in a Chromosomal Region Associated with Cattle Feed Intake and Gain	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; GROWTH; CARCASS; PCR	A region on bovine chromosome 6 has been implicated in cattle birth weight, growth, and length. Non-SMC conodensin I complex subunit G (NCAPG) and ligand dependent nuclear receptor corepressor-like protein (LCORL) are positional candidate genes within this region. Previously identified genetic markers in both genes were associated with average daily gain (ADG) and average daily feed intake (ADFI) in a crossbred population of beef steers. These markers were also associated with hot carcass weight, ribeye area and adjusted fat thickness suggesting that they may have a role in lean muscle growth and/or fat deposition. The purpose of this study was to determine whether the transcript abundance of either of these genes in cattle adipose and muscle tissue was associated with variation in feed intake and average daily gain phenotypes. Transcript abundance for NCAPG and LCORL in adipose and muscle tissue was measured in heifers (adipose only), cows and steers using real-time polymerase chain reaction. In the adipose tissue from cows and heifers, a negative correlation between LCORL transcript abundance and ADFI were detected (P = 0.05). In the muscle tissue from cows, transcript abundance of NCAPG was associated with ADG (r = 0.26; P = 0.009). A positive correlation between LCORL transcript abundance from muscle tissue of steers and ADFI was detected (P = 0.04). LCORL protein levels in the muscle of steers were investigated and were associated with ADFI (P = 0.01). These data support our earlier genetic associations with ADFI and ADG within this region and represent the potential for biological activity of these genes in the muscle and adipose tissues of beef cattle; however, they also suggest that sex, age and/or nutrition-specific interactions may affect the expression of NCAPG and LCORL in these tissues.	[Lindholm-Perry, Amanda K.; Kuehn, Larry A.; Oliver, William T.; Sexten, Andrea K.; Miles, Jeremy R.; Rempel, Lea A.; Cushman, Robert A.; Freetly, Harvey C.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE USA	United States Department of Agriculture (USDA)	Lindholm-Perry, AK (corresponding author), ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE USA.	Amanda.Lindholm@ars.usda.gov	Miles, Jeremy R/A-7572-2009; Miles, Jeremy/AAV-1029-2021; Lindholm-Perry, Amanda/AAF-2023-2020; Rempel, Lea/AAD-5841-2019	Miles, Jeremy R/0000-0003-4765-8400; Miles, Jeremy/0000-0003-4765-8400; Rempel, Lea/0000-0002-8344-5085; Kuehn, Larry/0000-0002-7573-5365; Lindholm-Perry, Amanda/0000-0002-5555-118X	ARS [ARS-0422392] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		BOLDMAN KG, 1995, MANUAL USE IN PRESS; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Casas E, 2000, J ANIM SCI, V78, P560; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; FASS, 1999, GUID CAR US AGR AN A; Gutierrez-Gil B, 2009, J ANIM SCI, V87, P24, DOI 10.2527/jas.2008-0922; Kneeland J, 2004, J ANIM SCI, V82, P3405; Kuehn L.A., 2008, BEEF IMPROVEMENT FED, P49; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makvandi-Nejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039929; Maltecca C, 2009, ANIM GENET, V40, P27, DOI 10.1111/j.1365-2052.2008.01793.x; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Merz K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062693; Metzger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056497; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Snelling WM, 2011, J ANIM SCI, V89, P1731, DOI 10.2527/jas.2010-3526; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Sovio U, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000409; Tetens J, 2013, ANIM GENET IN PRESS, V18; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	28	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80882	10.1371/journal.pone.0080882	http://dx.doi.org/10.1371/journal.pone.0080882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278337	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100122
J	Pellatt, AJ; Wolff, RK; John, EM; Torres-Mejia, G; Hines, LM; Baumgartner, KB; Giuliano, AR; Lundgreen, A; Slattery, ML				Pellatt, Andrew J.; Wolff, Roger K.; John, Esther M.; Torres-Mejia, Gabriela; Hines, Lisa M.; Baumgartner, Kathy B.; Giuliano, Anna R.; Lundgreen, Abbie; Slattery, Martha L.			SEPP1 Influences Breast Cancer Risk among Women with Greater Native American Ancestry: The Breast Cancer Health Disparities Study	PLOS ONE			English	Article							GPX1 PRO198LEU POLYMORPHISM; MULTILOCUS GENOTYPE DATA; GENETIC-VARIATION; SELENOPROTEIN GENES; SELENOENZYME GENES; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; COLORECTAL-CANCER; SELENIUM; POPULATION	Selenoproteins are a class of proteins containing a selenocysteine residue, many of which have been shown to have redox functions, acting as antioxidants to decrease oxidative stress. Selenoproteins have previously been associated with risk of various cancers and redox-related diseases. In this study we evaluated possible associations between breast cancer risk and survival and single nucleotide polymorphisms (SNPs) in the selenoprotein genes GPX1, GPX2, GPX3, GPX4, SELS, SEP15, SEPN1, SEPP1, SEPW1, TXNRD1, and TXNRD2 among Hispanic/Native American (2111 cases, 2597 controls) and non-Hispanic white (NHW) (1481 cases, 1586 controls) women in the Breast Cancer Health Disparities Study. Adaptive Rank Truncated Product (ARTP) analysis was used to determine both gene and pathway significance with these genes. The overall selenoprotein pathway P-ARTP was not significantly associated with breast cancer risk (P-ARTP = 0.69), and only one gene, GPX3, was of borderline significance for the overall population (P-ARTP =0.09) and marginally significant among women with 0-28% Native American (NA) ancestry (P-ARTP=0.06). The SEPP1 gene was statistically significantly associated with breast cancer risk among women with higher NA ancestry (P-ARTP=0.002) and contributed to a significant pathway among those women (P-ARTP=0.04). GPX1, GPX3, and SELS were associated with Estrogen Receptor-/Progesterone Receptor+ status (P-ARTP = 0.002, 0.05, and 0.01, respectively). Four SNPs (GPX3 rs2070593, rsGPX4 rs2074451, SELS rs9874, and TXNRD1 rs17202060) significantly interacted with dietary oxidative balance score after adjustment for multiple comparisons to alter breast cancer risk. GPX4 was significantly associated with breast cancer survival among those with the highest NA ancestry (P-ARTP = 0.05) only. Our data suggest that SEPP1 alters breast cancer risk among women with higher levels of NA ancestry.	[Pellatt, Andrew J.; Wolff, Roger K.; Lundgreen, Abbie; Slattery, Martha L.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Torres-Mejia, Gabriela] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Hines, Lisa M.] Univ Colorado, Dept Biol, Colorado Springs, CO 80907 USA; [Baumgartner, Kathy B.] Univ Louisville, James Graham Brown Canc Ctr, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	Utah System of Higher Education; University of Utah; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Instituto Nacional de Salud Publica; University of Colorado System; University of Colorado at Colorado Springs; University of Louisville; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Slattery, ML (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	Marty.Slattery@hsc.utah.edu		Pellatt, Andrew/0000-0002-0127-9790	National Cancer Institute [CA14002, CA63446, CA77305, CA078682, CA078762, CA078552, CA078802, N01-PC-67000]; U.S. Department of Defense [DAMD17-96-1-6071]; California Breast Cancer Research Program [7PB-0068]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000036C]; Centers for Disease Control and Prevention's National Program of Cancer Registries [1U58 DP000807-01]; Utah Cancer Registry; State of Utah Department of Health; New Mexico Tumor Registry; Arizona and Colorado cancer registries; Centers for Disease Control and Prevention National Program of Cancer Registries; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [SALUD-2002-C01-7462]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense); California Breast Cancer Research Program; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Utah Cancer Registry; State of Utah Department of Health; New Mexico Tumor Registry; Arizona and Colorado cancer registries; Centers for Disease Control and Prevention National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Breast Cancer Health Disparities Study was funded by grant CA14002 from the National Cancer Institute to Dr. Slattery. The San Francisco Bay Area Breast Cancer Study was supported by grants CA63446 and CA77305 from the National Cancer Institute, grant DAMD17-96-1-6071 from the U.S. Department of Defense and grant 7PB-0068 from the California Breast Cancer Research Program. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000036C awarded to the Cancer Prevention Institute of California; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement #1U58 DP000807-01 awarded to the Public Health Institute. The 4-Corners Breast Cancer Study was funded by grants CA078682, CA078762, CA078552, and CA078802 from the National Cancer Institute. The research also was supported by the Utah Cancer Registry, which is funded by contract N01-PC-67000 from the National Cancer Institute, with additional support from the State of Utah Department of Health, the New Mexico Tumor Registry, and the Arizona and Colorado cancer registries, funded by the Centers for Disease Control and Prevention National Program of Cancer Registries and additional state support. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official view of the National Cancer Institute or endorsement by the State of California Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors. The Mexico Breast Cancer Study was funded by Consejo Nacional de Ciencia y Tecnologia (CONACyT) (SALUD-2002-C01-7462). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Chen YC, 2013, NUTRIENTS, V5, P1149, DOI 10.3390/nu5041149; Cheng Q, 2009, J BIOL CHEM, V284, P3998, DOI 10.1074/jbc.M807068200; Chua PJ, 2009, EXP BIOL MED, V234, P1086, DOI 10.3181/0903-RM-98; Cox DG, 2004, CANCER EPIDEM BIOMAR, V13, P1821; Damdimopoulos AE, 2004, J BIOL CHEM, V279, P38721, DOI 10.1074/jbc.M402753200; Edvardsen H, 2013, INT J RADIAT ONCOL, V86, P791, DOI 10.1016/j.ijrobp.2013.02.025; Falush D, 2003, GENETICS, V164, P1567; Ferguson Lynnette R., 2011, Frontiers in Genetics, V2, P15, DOI 10.3389/fgene.2011.00015; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; Gautrey H, 2011, BBA-GEN SUBJECTS, V1810, P284, DOI 10.1016/j.bbagen.2011.03.016; Gentschew L, 2012, NUTRIENTS, V4, P1247, DOI 10.3390/nu4091247; Geybels MS, 2013, PROSTATE, V73, P734, DOI 10.1002/pros.22617; Gresner P, 2009, LUNG CANCER, V65, P34, DOI 10.1016/j.lungcan.2008.10.023; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hu J, 2010, BREAST CANCER RES TR, V124, P425, DOI 10.1007/s10549-010-0841-z; Hu YJ, 2003, CANCER RES, V63, P3347; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jardim BV, 2013, ONCOL REP, V30, P1119, DOI 10.3892/or.2013.2540; John EM, 2005, CANCER EPIDEM BIOMAR, V14, P2905, DOI 10.1158/1055-9965.EPI-05-0483; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; Kai Yu OL, 2011, ARTP GENE PATHWAY P; Karunasinghe N, 2012, GENES NUTR, V7, P179, DOI 10.1007/s12263-011-0259-1; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Meplan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073316; Meplan C, 2012, MUTAGENESIS, V27, P177, DOI 10.1093/mutage/ger058; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Penney KL, 2013, PROSTATE, V73, P700, DOI 10.1002/pros.22611; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Pritchard JK, 2000, GENETICS, V155, P945; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Slattery ML, 2007, BREAST CANCER RES TR, V102, P85, DOI 10.1007/s10549-006-9292-y; Slattery ML, 2012, CARCINOGENESIS, V33, P1512, DOI 10.1093/carcin/bgs163; Slattery ML, 2013, INT J CANC; Steinbrecher A, 2010, CANCER EPIDEM BIOMAR, V19, P2958, DOI 10.1158/1055-9965.EPI-10-0364; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; Takata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038612; Takata Y, 2012, J NUTR, V142, P419, DOI 10.3945/jn.111.151845; Udler M, 2007, J CLIN ONCOL, V25, P3015, DOI 10.1200/JCO.2006.10.0099; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhou XD, 2012, J NUTR BIOCHEM, V23, P532, DOI 10.1016/j.jnutbio.2011.02.008; Zhu XJ, 2011, ORAL ONCOL, V47, P609, DOI 10.1016/j.oraloncology.2011.05.006; Zhuo P, 2009, BBA-GEN SUBJECTS, V1790, P1546, DOI 10.1016/j.bbagen.2009.03.004; Zhuo P, 2009, CANCER RES, V69, P8183, DOI 10.1158/0008-5472.CAN-09-1791	50	30	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80554	10.1371/journal.pone.0080554	http://dx.doi.org/10.1371/journal.pone.0080554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278290	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100092
J	Klarkowski, D; Glass, K; O'Brien, D; Lokuge, K; Piriou, E; Shanks, L				Klarkowski, Derryck; Glass, Kathryn; O'Brien, Daniel; Lokuge, Kamalini; Piriou, Erwan; Shanks, Leslie			Variation in Specificity of HIV Rapid Diagnostic Tests over Place and Time: An Analysis of Discordancy Data Using a Bayesian Approach	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICA	Background: Recent trends to earlier access to anti-retroviral treatment underline the importance of accurate HIV diagnosis. The WHO HIV testing strategy recommends the use of two or three rapid diagnostic tests (RDTs) combined in an algorithm and assume a population is serologically stable over time. Yet RDTs are prone to cross reactivity which can lead to false positive or discordant results. This paper uses discordancy data from Medecins Sans Frontieres (MSF) programmes to test the hypothesis that the specificity of RDTs change over place and time. Methods: Data was drawn from all MSF test centres in 2007-8 using a parallel testing algorithm. A Bayesian approach was used to derive estimates of disease prevalence, and of test sensitivity and specificity using the software WinBUGS. A comparison of models with different levels of complexity was performed to assess the evidence for changes in test characteristics by location and over time. Results: 106, 035 individuals were included from 51 centres in 10 countries using 7 different RDTs. Discordancy patterns were found to vary by location and time. Model fit statistics confirmed this, with improved fit to the data when test specificity and sensitivity were allowed to vary by centre and over time. Two examples show evidence of variation in specificity between different testing locations within a single country. Finally, within a single test centre, variation in specificity was seen over time with one test becoming more specific and the other less specific. Conclusion: This analysis demonstrates the variable specificity of multiple HIV RDTs over geographic location and time. This variability suggests that cross reactivity is occurring and indicates a higher than previously appreciated risk of false positive HIV results using the current WHO testing guidelines. Given the significant consequences of false HIV diagnosis, we suggest that current testing and evaluation strategies be reviewed.	[Klarkowski, Derryck; O'Brien, Daniel; Lokuge, Kamalini; Piriou, Erwan; Shanks, Leslie] Operat Ctr Amsterdam, Med Sans Frontieres, Amsterdam, Netherlands; [Glass, Kathryn; Lokuge, Kamalini] Australian Natl Univ, Canberra, ACT, Australia; [O'Brien, Daniel] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia	Doctors Without Borders; Australian National University; Royal Melbourne Hospital; University of Melbourne	Shanks, L (corresponding author), Operat Ctr Amsterdam, Med Sans Frontieres, Amsterdam, Netherlands.	Leslie.Shanks@amsterdam.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; Lokuge, Kamalini/0000-0002-6287-1296; Glass, Kathryn/0000-0001-5905-1310	M�decins Sans Fronti�res [OCA009-04] Funding Source: researchfish	M�decins Sans Fronti�res		BARTHEL HR, 1993, SEMIN ARTHRITIS RHEU, V23, P1, DOI 10.1016/S0049-0172(05)80021-6; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; *CDC WHO APHL, 2001, GUID APPR EV HIV TES; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Clerici M, 2001, CLIN DIAGN LAB IMMUN, V8, P864, DOI 10.1128/CDLI.8.5.864-866.2001; CRASKE J, 1990, VOX SANG, V59, P160, DOI 10.1111/j.1423-0410.1990.tb00851.x; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Department of Health and Human Services, 2011, GUIDELINES USE ANTIR; Everett DB, 2010, J CLIN MICROBIOL, V48, P1570, DOI 10.1128/JCM.02264-09; Fonseca MO, 2000, T ROY SOC TROP MED H, V94, P171, DOI 10.1016/S0035-9203(00)90263-3; Gasasira AF, 2006, J CLIN MICROBIOL, V44, P3021, DOI 10.1128/JCM.02207-05; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Kroidl I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039529; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Messele T, 1999, CLIN EXP IMMUNOL, V115, P443; NG VL, 1991, CLIN CHEM, V37, P1667; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; World Health Organisation, 2012, ANT TREATM PREV TASP; World Health Organization, 2012, SERV DEL APPR HIV TE	23	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81656	10.1371/journal.pone.0081656	http://dx.doi.org/10.1371/journal.pone.0081656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282615	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500118
J	Shi, T; Wang, GL; Wang, ZW; Fu, J; Chen, T; Zhao, XM				Shi, Ting; Wang, Guanglu; Wang, Zhiwen; Fu, Jing; Chen, Tao; Zhao, Xueming			Establishment of a Markerless Mutation Delivery System in Bacillus subtilis Stimulated by a Double-Strand Break in the Chromosome	PLOS ONE			English	Article							REPLACEMENT SYSTEM; SELECTABLE MARKER; GENE REPLACEMENT; DNA UPTAKE; GENOME; COMPETENCE; DELETIONS; REGIONS; COMK; TRANSFORMATION	Bacillus subtilis has been a model for gram-positive bacteria and it has long been exploited for industrial and biotechnological applications. However, the availability of facile genetic tools for physiological analysis has generally lagged substantially behind traditional genetic models such as Escherichia coli and Saccharomyces cerevisiae. In this work, we have developed an efficient, precise and scarless method for rapid multiple genetic modifications without altering the chromosome of B. subtilis. This method employs upp gene as a counter-selectable marker, double-strand break (DSB) repair caused by exogenous endonuclease I-SceI and comK overexpression for fast preparation of competent cell. Foreign dsDNA can be simply and efficiently integrated into the chromosome by double-crossover homologous recombination. The DSB repair is a potent inducement for stimulating the second intramolecular homologous recombination, which not only enhances the frequency of resolution by one to two orders of magnitude, but also selects for the resolved product. This method has been successfully and reiteratively used in B. subtilis to deliver point mutations, to generate in-frame deletions, and to construct large-scale deletions. Experimental results proved that it allowed repeated use of the selectable marker gene for multiple modifications and could be a useful technique for B. subtilis.	[Shi, Ting; Wang, Guanglu; Wang, Zhiwen; Fu, Jing; Chen, Tao; Zhao, Xueming] Tianjin Univ, Dept Biochem Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Shi, Ting; Wang, Guanglu; Wang, Zhiwen; Fu, Jing; Chen, Tao; Zhao, Xueming] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Shi, Ting; Wang, Guanglu; Wang, Zhiwen; Fu, Jing; Chen, Tao; Zhao, Xueming] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China; [Shi, Ting; Wang, Guanglu; Wang, Zhiwen; Fu, Jing; Chen, Tao; Zhao, Xueming] Tianjin Univ, Edinburgh Tianjin Joint Res Ctr Syst Biol & Synth, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University; Tianjin University	Wang, ZW (corresponding author), Tianjin Univ, Dept Biochem Engn, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	zww@tju.edu.cn	Zhao, Xueming/W-4891-2019; CHEN, Tao/N-1817-2015	CHEN, Tao/0000-0001-9588-1821; Jing, Fu/0000-0001-8651-0658	National Program on Key Basic Research Project [2011CBA00804, 2012CB725203]; National Natural Science Foundation of China [NSFC-21206112, NSFC-21176182]; National High-tech R&D Program of China [2012AA022103, 2012AA02A702]; Innovation Foundation of Tianjin University [1308]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Innovation Foundation of Tianjin University	This work was supported by National Program on Key Basic Research Project (2011CBA00804, 2012CB725203), National Natural Science Foundation of China (NSFC-21206112, NSFC-21176182), National High-tech R&D Program of China (2012AA022103, 2012AA02A702) and the Innovation Foundation of Tianjin University (1308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Billerbeck S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-110; Brans A, 2004, APPL ENVIRON MICROB, V70, P7241, DOI 10.1128/AEM.70.12.7241-7250.2004; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Defoor E, 2007, MICROBIOL-SGM, V153, P3645, DOI 10.1099/mic.0.2007/005959-0; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; Horzempa J, 2010, J MICROBIOL METH, V80, P106, DOI 10.1016/j.mimet.2009.10.013; Itaya M, 2012, BIOSCI BIOTECH BIOCH, V76, P180, DOI 10.1271/bbb.110528; Keller KL, 2009, APPL ENVIRON MICROB, V75, P7682, DOI 10.1128/AEM.01839-09; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kristich CJ, 2005, APPL ENVIRON MICROB, V71, P5837, DOI 10.1128/AEM.71.10.5837-5849.2005; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Morimoto T, 2008, DNA RES, V15, P73, DOI 10.1093/dnares/dsn002; Morimoto T, 2009, GENES GENET SYST, V84, P315, DOI 10.1266/ggs.84.315; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Peters B, 2013, APPL MICROBIOL BIOT, V97, P2521, DOI 10.1007/s00253-012-4354-z; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Tannler S, 2008, METAB ENG, V10, P216, DOI 10.1016/j.ymben.2008.06.002; Tanaka K, 2013, NUCLEIC ACIDS RES, V41, P687, DOI 10.1093/nar/gks963; van Dijl JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-3; VILLAFANE R, 1987, J BACTERIOL, V169, P4822, DOI 10.1128/jb.169.10.4822-4829.1987; Wang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks248; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Yan X, 2008, APPL ENVIRON MICROB, V74, P5556, DOI 10.1128/AEM.01156-08; Yu HJ, 2010, J MICROBIOL BIOTECHN, V20, P45, DOI 10.4014/jmb.0904.04051; Zhang C, 2011, CAN J MICROBIOL, V57, P427, DOI 10.1139/W11-035; Zhang XZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl358; Zhang XZ, 2011, MICROB BIOTECHNOL, V4, P98, DOI 10.1111/j.1751-7915.2010.00230.x	43	25	28	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81370	10.1371/journal.pone.0081370	http://dx.doi.org/10.1371/journal.pone.0081370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282588	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500090
J	Tague, CL; McDowell, NG; Allen, CD				Tague, Christina L.; McDowell, Nathan G.; Allen, Craig D.			An Integrated Model of Environmental Effects on Growth, Carbohydrate Balance, and Mortality of Pinus ponderosa Forests in the Southern Rocky Mountains	PLOS ONE			English	Article							INDUCED TREE MORTALITY; CLIMATE-CHANGE; DIE-OFF; CARBON; DROUGHT; MECHANISMS; VEGETATION; WATER; RESPONSES; HYDROCLIMATE	Climate-induced tree mortality is an increasing concern for forest managers around the world. We used a coupled hydrologic and ecosystem carbon cycling model to assess temperature and precipitation impacts on productivity and survival of ponderosa pine (Pinus ponderosa). Model predictions were evaluated using observations of productivity and survival for three ponderosa pine stands located across an 800 m elevation gradient in the southern Rocky Mountains, USA, during a 10-year period that ended in a severe drought and extensive tree mortality at the lowest elevation site. We demonstrate the utility of a relatively simple representation of declines in non-structural carbohydrate (NSC) as an approach for estimating patterns of ponderosa pine vulnerability to drought and the likelihood of survival along an elevation gradient. We assess the sensitivity of simulated net primary production, NSC storage dynamics, and mortality to site climate and soil characteristics as well as uncertainty in the allocation of carbon to the NSC pool. For a fairly wide set of assumptions, the model estimates captured elevational gradients and temporal patterns in growth and biomass. Model results that best predict mortality risk also yield productivity, leaf area, and biomass estimates that are qualitatively consistent with observations across the sites. Using this constrained set of parameters, we found that productivity and likelihood of survival were equally dependent on elevation-driven variation in temperature and precipitation. Our results demonstrate the potential for a coupled hydrology-ecosystem carbon cycling model that includes a simple model of NSC dynamics to predict drought-related mortality. Given that increases in temperature and in the frequency and severity of drought are predicted for a broad range of ponderosa pine and other western North America conifer forest habitats, the model potentially has broad utility for assessing ecosystem vulnerabilities.	[Tague, Christina L.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [McDowell, Nathan G.] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Allen, Craig D.] US Geol Survey, Ft Collins Sci Ctr, Jemez Mt Field Stn, Los Alamos, NM USA	University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of the Interior; United States Geological Survey	Tague, CL (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	ctague@bren.ucsb.edu	Allen, Craig D./K-1121-2019	Allen, Craig D./0000-0002-8777-5989; Tague, Christina (Naomi)/0000-0003-1463-308X	United States Geological Survey	United States Geological Survey(United States Geological Survey)	This study was funded by Ecosystems and the Climate and Land Use programs of the United States Geological Survey (http://www.usgs.gov/contracts/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 1989, THESIS U CALIF; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Anderson-Teixeira KJ, 2011, GLOBAL CHANGE BIOL, V17, P410, DOI 10.1111/j.1365-2486.2010.02269.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Barbaroux C, 2003, NEW PHYTOL, V157, P605, DOI 10.1046/j.1469-8137.2003.00681.x; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Breshears DD, 2009, FRONT ECOL ENVIRON, V7, P185, DOI 10.1890/080016; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; CALLAWAY RM, 1994, ECOLOGY, V75, P1474, DOI 10.2307/1937470; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; Dickinson RE, 1998, J CLIMATE, V11, P2823, DOI 10.1175/1520-0442(1998)011<2823:ICFACM>2.0.CO;2; Farquhar G. D., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P549; Fisher JB, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003621; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Franklin O, 2012, TREE PHYSIOL, V32, P648, DOI 10.1093/treephys/tpr138; Friend AD, 2007, GLOBAL CHANGE BIOL, V13, P610, DOI 10.1111/j.1365-2486.2006.01223.x; Galiano L, 2011, NEW PHYTOL, V190, P750, DOI 10.1111/j.1469-8137.2010.03628.x; Genet H, 2010, TREE PHYSIOL, V30, P177, DOI 10.1093/treephys/tpp105; Gruber A, 2012, PLANT BIOLOGY, V14, P142, DOI 10.1111/j.1438-8677.2011.00467.x; Guerard N, 2007, ANN FOREST SCI, V64, P601, DOI 10.1051/forest:2007038; Guneralp B, 2007, TREE PHYSIOL, V27, P269, DOI 10.1093/treephys/27.2.269; Hartman MD, 1999, WATER RESOUR RES, V35, P1587, DOI 10.1029/1998WR900096; Hoch G, 2005, FUNCT ECOL, V19, P941, DOI 10.1111/j.1365-2435.2005.01040.x; Holtta T, 2009, J THEOR BIOL, V259, P325, DOI 10.1016/j.jtbi.2009.03.039; HUNGERFORD RD, 1989, USDA FOR SERV INT R, P1; Hwang T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR007775; IPCC, 2007, CONTRIBUTION WORKING; IPCC, 2007, 4 IPCC WORK GROUPS 1; Jarvis PG, 1981, SOC EXPT BIOL SEMINA; Joyce LA, PRELIMINARY REV ADAP; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007561; Mackay DS, 2003, J HYDROL, V277, P230, DOI 10.1016/S0022-1694(03)00130-6; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McDowell NG, 2010, NEW PHYTOL, V186, P264, DOI 10.1111/j.1469-8137.2010.03232.x; McDowell NG, 2010, GLOBAL CHANGE BIOL, V16, P399, DOI 10.1111/j.1365-2486.2009.01994.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Monserud R.A., 2003, BIOMODELL INFO SCI, V1, P35; Monteith JL, 1965, S SOC EXP BIOL STAT, P205; Nightingale JM, 2004, PROG PHYS GEOG, V28, P241, DOI 10.1191/0309133304pp411ra; Parton WJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P401, DOI 10.1029/96GB01455; Peterson DL, 2011, ECOLOGICAL CONSEQUEN, P163; Piper FI, 2011, ANN FOREST SCI, V68, P415, DOI 10.1007/s13595-011-0030-1; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Rummukainen M, 2010, WIRES CLIM CHANGE, V1, P82, DOI 10.1002/wcc.8; RYAN MG, 1991, TREE PHYSIOL, V9, P255, DOI 10.1093/treephys/9.1-2.255; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Schoeneberger P.J., 2002, FIELD BOOK DESCRIBIN; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Suarez ML, 2004, J ECOL, V92, P954, DOI 10.1111/j.1365-2745.2004.00941.x; Tague C, 2009, ECOHYDROLOGY, V2, P541, DOI 10.1002/eco.88; Tague CL, 2004, EARTH INTERACT, V8; Tague C, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007179; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Williams M, 2001, TREE PHYSIOL, V21, P287, DOI 10.1093/treephys/21.5.287; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; Zierl B, 2007, HYDROL PROCESS, V21, P3328, DOI 10.1002/hyp.6540	71	30	31	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80286	10.1371/journal.pone.0080286	http://dx.doi.org/10.1371/journal.pone.0080286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282532	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500033
J	Wu, XY; Luo, J; Huang, S; Chen, ZM; Xiao, H; Zhang, YP				Wu, Xiaoyun; Luo, Jing; Huang, Song; Chen, Ziming; Xiao, Heng; Zhang, Yaping			Molecular Phylogeography and Evolutionary History of Poropuntius huangchuchieni (Cyprinidae) in Southwest China	PLOS ONE			English	Article							GENUS SCHIZOTHORAX TELEOSTEI; TIBETAN PLATEAU; POPULATION-GROWTH; PHYLOGENY; MITOCHONDRIAL; BIOGEOGRAPHY; QUATERNARY; UPLIFT; TESTS; DIVERGENCE	Background: The evolution of the Yunnan Plateau's drainages network during the Pleistocene was dominated by the intense uplifts of the Qinghai-Tibetan Plateau. In the present study, we investigated the association between the evolutionary histories of three main drainage systems and the geographic patterns of genetic differentiation of Poropuntius huangchuchieni. Methodology/Principal Findings: We sequenced the complete sequences of mitochondrial control region for 304 specimens and the sequences of Cytochrome b gene for 15 specimens of the species P. huangchuchieni and 5 specimens of Poropuntius opisthoptera. Phylogenetic analysis identified five major lineages, of which lineages MK-A and MK-B constrained to the Mekong River System, lineages RL and LX to the Red River System, and lineage SW to the Salween River System. The genetic distance and network analysis detected significant divergences among these lineages. Mismatch distribution analysis implied that the population of P. huangchuchieni underwent demographic stability and the lineage MK-B, sublineages MK-A1 and LX-1 underwent a recent population expansion. The divergence of the 5 major lineages was dated back to 0.73-1.57 MYA. Conclusions/Significance: Our results suggest that P. opisthoptera was a paraphyletic group of P. huangchuchieni. The phylogenetic pattern of P. huangchuchieni was mostly associated with the drainage's structures and the geomorphological history of the Southwest Yunnan Plateau. Also the differentiation of the major lineages among the three drainages systems coincides with the Kunlun-Yellow River Movement (1.10-0.60 MYA). The genetic differentiation within river basins and recent demographical expansions that occurred in some lineages and sublineages are consistent with the palaeoclimatic oscillations during the Pleistocene. Additionally, our results also suggest that the populations of P. huangchuchieni had keep long term large effective population sizes and demographic stability in the recent evolutionary history, which may be responsible for the high genetic diversity and incomplete lineages sorting of Poropuntius huangchuchieni.	[Wu, Xiaoyun; Luo, Jing; Chen, Ziming; Xiao, Heng; Zhang, Yaping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Yaping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Wu, Xiaoyun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Huang, Song] Kunming Zoo, Kunming, Yunnan, Peoples R China	Yunnan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Xiao, H (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresource, Key Lab Anim Genet Divers & Evolut High Educ Yunn, Sch Life Sci, Kunming, Yunnan, Peoples R China.	xiaoheng@ynu.edu.cn; zhangyp@mail.kiz.ac.cn			National Basic Research Program of China; National Natural Science Foundation of China; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This work was supported by National Basic Research Program of China, National Natural Science Foundation of China, Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BERMINGHAM E, 1986, GENETICS, V113, P939; Bermingham E, 1997, FISH BIOGEOGRAPHY MO, P113; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; CHENG J, 2001, GEOSCIENCE, V15, P290; CHENG J, 1994, GEOSCIENCE, V8, P11; Chu X., 1989, P354; Chu X, 1989, FISHES YUNNAN 1, P201; Chu X.-L., 1986, P471; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1993, GENETICS, V134, P959; Cui ZJ, 1998, CHINESE SCI BULL, V43, P833, DOI 10.1007/BF03182748; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubut V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034423; Durand JD, 1999, MOL ECOL, V8, P989, DOI 10.1046/j.1365-294x.1999.00654.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu YX, 1997, GENETICS, V147, P915; Gilles A, 2001, MOL PHYLOGENET EVOL, V19, P22, DOI 10.1006/mpev.2000.0916; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Li F, 2006, J GUANGXI NORMAL U N, V24, P77; Li J. J., 1999, MAR GEOL Q GEOL, V19, P1; LI JJ, 1981, GEOLOGICAL ECOLOGICA, P111; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Ming Q.Z., 2006, YUNNAN GEOG ENV RES, V18, P1, DOI [10.3969/j.issn.1001-7852.2006.04.001, DOI 10.3969/J.ISSN.1001-7852.2006.04.001]; Nei M., 1987, MOL EVOLUTIONARY GEN; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER1 5; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf FJ, 2018, TPSDIG; Shan X.H., 2000, FAUNA SINICA OSTEICH, P3; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1993, GENETICS, V134, P659; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Waters JM, 2007, SYST BIOL, V56, P271, DOI 10.1080/10635150701313855; Xiao H, 2005, MOL PHYLOGENET EVOL, V36, P67, DOI 10.1016/j.ympev.2004.12.007; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; Yang J, 2012, J ZOOL SYST EVOL RES, V50, P184, DOI 10.1111/j.1439-0469.2012.00661.x; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zink RM, 2002, INTEGR COMP BIOL, V42, P953, DOI 10.1093/icb/42.5.953	61	86	88	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79975	10.1371/journal.pone.0079975	http://dx.doi.org/10.1371/journal.pone.0079975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282516	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500017
J	Ziv, E; Tymofiyeva, O; Ferriero, DM; Barkovich, AJ; Hess, CP; Xu, D				Ziv, Etay; Tymofiyeva, Olga; Ferriero, Donna M.; Barkovich, A. James; Hess, Chris P.; Xu, Duan			A Machine Learning Approach to Automated Structural Network Analysis: Application to Neonatal Encephalopathy	PLOS ONE			English	Article							BRAIN ANATOMICAL NETWORKS; DIFFUSION-WEIGHTED MRI; WHOLE-BODY HYPOTHERMIA; CONNECTIVITY; PREDICTION; PATTERNS; FEATURES; MOTIFS	Neonatal encephalopathy represents a heterogeneous group of conditions associated with life-long developmental disabilities and neurological deficits. Clinical measures and current anatomic brain imaging remain inadequate predictors of outcome in children with neonatal encephalopathy. Some studies have suggested that brain development and, therefore, brain connectivity may be altered in the subgroup of patients who subsequently go on to develop clinically significant neurological abnormalities. Large-scale structural brain connectivity networks constructed using diffusion tractography have been posited to reflect organizational differences in white matter architecture at the mesoscale, and thus offer a unique tool for characterizing brain development in patients with neonatal encephalopathy. In this manuscript we use diffusion tractography to construct structural networks for a cohort of patients with neonatal encephalopathy. We systematically map these networks to a high-dimensional space and then apply standard machine learning algorithms to predict neurological outcome in the cohort. Using nested cross-validation we demonstrate high prediction accuracy that is both statistically significant and robust over a broad range of thresholds. Our algorithm offers a novel tool to evaluate neonates at risk for developing neurological deficit. The described approach can be applied to any brain pathology that affects structural connectivity.	[Ziv, Etay; Tymofiyeva, Olga; Barkovich, A. James; Hess, Chris P.; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ziv, E (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	etay.ziv@ucsf.edu	Xu, Duan/GMW-4195-2022; Xu, Duan/B-3197-2013	Xu, Duan/0000-0003-0550-4235; 	NIH [R01HD072074, P50NS035902, R01EB009756]; T32 training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, P01NS082330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially funded by NIH R01HD072074, P50NS035902 and R01EB009756, and EZ was funded by the T32 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angluin D., 1988, Machine Learning, V2, P343, DOI 10.1007/BF00116829; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Barnett A, 2002, NEUROPEDIATRICS, V33, P242, DOI 10.1055/s-2002-36737; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chung F., 2006, CBMS REGIONAL C SERI; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Dammann O, 2011, PEDIATR RES, V70, P1, DOI 10.1203/01.pdr.0000403893.61640.b6; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gaonkar B, 2012, LECT NOTES COMPUT SC, V7510, P723, DOI 10.1007/978-3-642-33415-3_89; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Golland P, 2005, LECT NOTES COMPUT SC, V3559, P501, DOI 10.1007/11503415_34; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hajnal BL, 1999, PEDIATR NEUROL, V21, P788, DOI 10.1016/S0887-8994(99)00101-0; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Janecek A.G., 2008, JMLR P WORKSH C ANTW, V4, P90; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kashima H., 2003, P 20 INT C MACHINE L, P321; Khundrakpam BS, 2012, DEV CHANGES ORG STRU; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; Leung YY, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P5596; Lu Y, 2007, IMAGE; Lyons-weiler J, 2005, CANC INFORM; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; Middendorf M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-181; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pfister RH, 2010, J PERINATOL, V30, pS82, DOI 10.1038/jp.2010.91; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Scholkopf B., 2002, LEARNING KERNELS; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Tymofiyeva O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063310; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Vishwanathan SVN, 2010, J MACH LEARN RES, V11, P1201; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055347; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016110	56	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e78824	10.1371/journal.pone.0078824	http://dx.doi.org/10.1371/journal.pone.0078824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282501	gold, Green Published			2022-12-27	WOS:000327543500007
J	Bai, YL; Cheng, H; Bordeaux, J; Neumeister, V; Kumar, S; Rimm, DL; Stern, DF				Bai, Yalai; Cheng, Huan; Bordeaux, Jennifer; Neumeister, Veronique; Kumar, Sudha; Rimm, David L.; Stern, David F.			Comparison of HER2 and Phospho-HER2 Expression between Biopsy and Resected Breast Cancer Specimens Using a Quantitative Assessment Method	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COLD ISCHEMIC TIME; INTRATUMORAL HETEROGENEITY; PROTEIN EXPRESSION; ESTROGEN-RECEPTOR; TRASTUZUMAB; ACTIVATION; HYPOXIA; IMPACT; IMMUNOHISTOCHEMISTRY	Background: HER2/Neu (ErbB-2) overexpression, which occurs in 15-20% of breast cancer cases, is associated with better response to treatment with the drug trastuzumab. PhosphoHER2 (pHER2) has been evaluated for prediction of response to trastuzumab. Both markers are heterogeneously detected and are potentially subject to loss as a consequence of delayed time to fixation. Here, we quantitatively assess both markers in core needle biopsies (CNBs) and matched tumor resections to assess concordance between the core and the resection and between HER2 and pHER2. Methods: A selected retrospective collection of archival breast cancer cases yielded 67 cases with both core and resection specimens. Both HER2 and pTyr(1248)HER2 were analyzed by the AQUA (R) method of quantitative immunofluorescence on each specimen pair. Results: Both HER2 immunoreactivity (P<0.0001) and pTyr(1248)HER2 immunoreactivity (P<0.0001) were lower in resections relative to CNB specimens. However, clinical implications of this change may not be evident since no case changed from 3+ (CNB) to negative (resection). Assessment of pTyr(1248)HER2 showed no direct correlation with HER2 in either CNB or resection specimens. Conclusions: The data suggest that measurement of both HER2 and phospho- Tyr(1248)HER2, in formalin-fixed tissue by immunological methods is significantly affected by pre-analytic variables. The current study warrants the adequate handling of resected specimens for the reproducible evaluation of HER2 and pHER2. The level of pTyr(1248)HER2, was not correlated to total HER2 protein. Further studies are required to determine the significance of these observations with respect to response to HER2 directed therapies.	[Bai, Yalai; Cheng, Huan; Bordeaux, Jennifer; Neumeister, Veronique; Kumar, Sudha; Rimm, David L.; Stern, David F.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Stern, DF (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	DF.Stern@yale.edu		Rimm, David/0000-0001-5820-4397	US Public Health Service [R01CA45708]; NATIONAL CANCER INSTITUTE [R01CA045708] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from the US Public Health Service Grant R01CA45708. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN J, 1992, RENAL FAILURE, V14, P453, DOI 10.3109/08860229209047652; Bai YL, 2011, LAB INVEST, V91, P1253, DOI 10.1038/labinvest.2011.75; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Brunelli M, 2009, AM J CLIN PATHOL, V131, P678, DOI 10.1309/AJCP09VUTZWZXBMJ; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Connor CS, 2002, AM J SURG, V184, P322, DOI 10.1016/S0002-9610(02)00953-4; CROSS SS, 1990, J CLIN PATHOL, V43, P597, DOI 10.1136/jcp.43.7.597; DiGiovanna MP, 1998, ONCOGENE, V17, P1877, DOI 10.1038/sj.onc.1202091; DIGIOVANNA MP, 1995, CANCER RES, V55, P1946; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Ginestier C, 2007, ONCOGENE, V26, P7163, DOI 10.1038/sj.onc.1210528; Glockner S, 2002, LAB INVEST, V82, P1419, DOI 10.1097/01.LAB.0000032371.16521.40; Hanna W, 2007, BREAST J, V13, P122, DOI 10.1111/j.1524-4741.2007.00396.x; Hudelist G, 2003, BRIT J CANCER, V89, P983, DOI 10.1038/sj.bjc.6601160; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Lebeau A, 2010, J CLIN ONCOL, V28, P3264, DOI 10.1200/JCO.2009.25.9366; Li XX, 2013, MODERN PATHOL, V26, P71, DOI 10.1038/modpathol.2012.135; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Modi S, 2005, CANCER INVEST, V23, P483, DOI 10.1080/07357900500201301; Moeder CB, 2007, J CLIN ONCOL, V25, P5418, DOI 10.1200/JCO.2007.12.8033; Moeder Christopher B., 2009, V520, P163, DOI 10.1007/978-1-60327-811-9_12; Nakamura R, 2012, BREAST CANC; Neumeister VM, 2012, JNCI-J NATL CANCER I, V104, P1815, DOI 10.1093/jnci/djs438; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Perez EA, 2006, J CLIN ONCOL, V24, P3032, DOI 10.1200/JCO.2005.03.4744; Pertschuk Louis P., 1999, Breast J, V5, P369, DOI 10.1046/j.1524-4741.1999.97088.x; Pirrelli M, 2013, DIGEST DIS SCI, V58, P397, DOI 10.1007/s10620-012-2357-3; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Shin SJ, 2006, INT J SURG PATHOL, V14, P279, DOI 10.1177/1066896906293055; Sliwkowski MX, 2003, NAT STRUCT BIOL, V10, P158, DOI 10.1038/nsb0303-158; Taniyama K, 2008, BREAST CANCER-TOKYO, V15, P231, DOI 10.1007/s12282-007-0026-8; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; Tsuda H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-534; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Welsh AW, 2011, J CLIN ONCOL, V29, P2978, DOI 10.1200/JCO.2010.32.9706; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yildiz-Aktas IZ, 2012, MODERN PATHOL, V25, P1098, DOI 10.1038/modpathol.2012.59	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79901	10.1371/journal.pone.0079901	http://dx.doi.org/10.1371/journal.pone.0079901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278211	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800031
J	Kim, S; Jin, D; Lee, H				Kim, Shinhyuk; Jin, Daeyong; Lee, Hyunju			Predicting Drug-Target Interactions Using Drug-Drug Interactions	PLOS ONE			English	Article							PROTEIN; DATABASE; IDENTIFICATION; NETWORKS; MODELS	Computational methods for predicting drug-target interactions have become important in drug research because they can help to reduce the time, cost, and failure rates for developing new drugs. Recently, with the accumulation of drug-related data sets related to drug side effects and pharmacological data, it has became possible to predict potential drug-target interactions. In this study, we focus on drug-drug interactions (DDI), their adverse effects (DDIAE) and pharmacological information (DDIPharm), and investigate the relationship among chemical structures, side effects, and DDIs from several data sources. In this study, DDIPharm data from the STITCH database, DDIAE from drugs.com, and drug-target pairs from ChEMBL and SIDER were first collected. Then, by applying two machine learning approaches, a support vector machine (SVM) and a kernel-based L1-norm regularized logistic regression (KL1LR), we showed that DDI is a promising feature in predicting drug-target interactions. Next, the accuracies of predicting drug-target interactions using DDI were compared to those obtained using the chemical structure and side effects based on the SVM and KL1LR approaches, showing that DDI was the data source contributing the most for predicting drug-target interactions.	[Kim, Shinhyuk; Jin, Daeyong; Lee, Hyunju] Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Lee, H (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Kwangju, South Korea.	hyunjulee@gist.ac.kr		Lee, Hyunju/0000-0003-2389-7183	MKE (The Ministry of Knowledge Economy), Korea; Microsoft Research; NIPA (National IT Industry Promotion Agency) [NIPA-2012-H0503-12-101]; MEST [2011-0029447]	MKE (The Ministry of Knowledge Economy), Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Microsoft Research(Microsoft); NIPA (National IT Industry Promotion Agency); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the MKE (The Ministry of Knowledge Economy), Korea and Microsoft Research, under IT/SW Creative research program supervised by the NIPA (National IT Industry Promotion Agency) (NIPA-2012-H0503-12-101), and Mid-career Researcher Program through NRF grant funded by the MEST (No. 2011-0029447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach F. R., 2004, P 21 INT C MACH LEAR; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P443, DOI 10.1177/0091270003252519; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Faulon JL, 2012, SIGNATURE MOL DESCRI; Ferrara P, 2007, J MOL MODEL, V13, P897, DOI 10.1007/s00894-007-0207-6; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Johnson MA, 1990, CONCEPTS APPL MOL SI, P99; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Ko S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-455; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lee H, 2006, OMICS, V10, P40, DOI 10.1089/omi.2006.10.40; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Matter H, 1997, J MED CHEM, V40, P1219, DOI 10.1021/jm960352+; Mattingly CJ, 2003, ENVIRON HEALTH PERSP, V111, P793, DOI 10.1289/ehp.6028; Obozinski G, 2012, SEQUENTIAL MINIMAL O; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik V., 1998, STAT LEARNING THEORY; Wang YC, 2011, COMPUT BIOL CHEM, V35, P353, DOI 10.1016/j.compbiolchem.2011.10.003; Whittle M, 2004, J CHEM INF COMP SCI, V44, P1840, DOI 10.1021/ci049867x; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	36	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80129	10.1371/journal.pone.0080129	http://dx.doi.org/10.1371/journal.pone.0080129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278248	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800055
J	Martin, LJ; Katzenelson, A; Koehler, RC; Chang, Q				Martin, Lee J.; Katzenelson, Alyssa; Koehler, Raymond C.; Chang, Qing			The Olfactory Bulb in Newborn Piglet Is a Reservoir of Neural Stem and Progenitor Cells	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; HYPOXIA-ISCHEMIA; SELF-RENEWAL; BRAIN-INJURY; FOREBRAIN; TRANSPLANTATION; NEUROGENESIS; EXPRESSION; MIGRATION; PRECURSOR	The olfactory bulb (OB) periventricular zone is an extension of the forebrain subventricular zone (SVZ) and thus is a source of neuroprogenitor cells and neural stem cells. While considerable information is available on the SVZ-OB neural stem cell (NSC)/neuroprogenitor cell (NPC) niche in rodents, less work has been done on this system in large animals. The newborn piglet is used as a preclinical translational model of neonatal hypoxic-ischemic brain damage, but information about the endogenous sources of NSCs/NPCs in piglet is needed to implement endogenous or autologous cell-based therapies in this model. We characterized NSC/NPC niches in piglet forebrain and OB-SVZ using western blotting, histological, and cell culture methods. Immunoblotting revealed nestin, a NSC/NPC marker, in forebrain-SVZ and OB-SVZ in newborn piglet. Several progenitor or newborn neuron markers, including Dlx2, musashi, doublecortin, and polysialated neural cell adhesion molecule were also detected in OB-SVZ by immunoblotting. Immunohistochemistry confirmed the presence of nestin, musashi, and doublecortin in forebrain-SVZ and OB-SVZ. Bromodeoxyuridine (BrdU) labeling showed that the forebrain-SVZ and OB-SVZ accumulate newly replicated cells. BrdU-positive cells were immunolabeled for astroglial, oligodendroglial, and neuronal markers. A lateral migratory pathway for newly born neuron migration to primary olfactory cortex was revealed by BrdU labeling and co-labeling for doublecortin and class III beta tubulin. Isolated and cultured forebrain-SVZ and OB-SVZ cells from newborn piglet had the capacity to generate numerous neurospheres. Single cell clonal analysis of neurospheres revealed the capacity for self-renewal and multipotency. Neurosphere-derived cells differentiated into neurons, astrocytes, and oligodendrocytes and were amenable to permanent genetic tagging with lentivirus encoding green fluorescent protein. We conclude that the piglet OB-SVZ is a reservoir of NSCs and NPCs suitable to use in autologous cell therapy in preclinical models of neonatal/pediatric brain injury.	[Martin, Lee J.; Chang, Qing] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Martin, Lee J.] Johns Hopkins Univ, Sch Med, Pathobiol Grad Program, Baltimore, MD USA; [Martin, Lee J.; Katzenelson, Alyssa] Johns Hopkins Univ, Sch Med, Grad Program, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Koehler, Raymond C.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.	martinl@jhmi.edu			NINDS [NS060703]; ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060703] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant NS060703 and the ALS Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNEW DM, 2003, PEDIATR RES, V54, P1, DOI DOI 10.1203/01.PDR.0000066622.02736.A8.PUBMED:12646714; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Berendse HW, 2006, J NEURAL TRANSM-SUPP, P321; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; De Marchis S, 2004, J COMP NEUROL, V476, P290, DOI 10.1002/cne.20217; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; Doetsch F., 1999, BRAIN CELL, V97, P1, DOI DOI 10.1016/S0092-8674(00)80707-2.PUBMED:10199395; DUBOIS C, 1994, NEUROMUSCULAR DISORD, V4, P171, DOI 10.1016/0960-8966(94)90018-3; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Ikeda T, 2005, AM J OBSTET GYNECOL, V193, P849, DOI 10.1016/j.ajog.2005.01.029; Jensen PS, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/761843; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Liu Z, 2004, J NEUROTRAUM, V21, P1479, DOI 10.1089/neu.2004.21.1479; Liu ZP, 2006, J COMP NEUROL, V497, P468, DOI 10.1002/cne.21012; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MacNicol AM, 2008, BIOCHEM SOC T, V36, P528, DOI 10.1042/BST0360528; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Martin LJ, 2000, NEUROBIOL DIS, V7, P169, DOI 10.1006/nbdi.2000.0282; McEvoy AW, 2002, STEREOT FUNCT NEUROS, V79, P88, DOI 10.1159/000070104; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104; Mueller D, 2005, J NEUROSCI RES, V82, P592, DOI 10.1002/jnr.20673; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rath T, 2013, EXPERT OPIN PHARMACO, V14, P115, DOI 10.1517/14656566.2013.751374; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santner-Nanan B, 2005, AUST NZ J OBSTET GYN, V45, P102, DOI 10.1111/j.1479-828X.2005.00362.x; Schoeberlein A, 2005, AM J OBSTET GYNECOL, V192, P1044, DOI 10.1016/j.ajog.2005.01.031; Schwartz PH, 2005, STEM CELLS, V23, P1286, DOI 10.1634/stemcells.2004-0306; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; Spektor S, 2005, NEUROSURGERY, V57, P268, DOI 10.1227/01.NEU.0000176409.70668.EB; Teng YC, 2009, BIOCHEM BIOPH RES CO, V390, P463, DOI 10.1016/j.bbrc.2009.09.094; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Yin F, 2011, CYTOTECHNOLOGY, V63, P363, DOI 10.1007/s10616-011-9353-x; Zheng T, 2006, BRAIN RES, V1112, P99, DOI 10.1016/j.brainres.2006.07.014	66	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81105	10.1371/journal.pone.0081105	http://dx.doi.org/10.1371/journal.pone.0081105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278384	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800102
J	Mettler, R; Schaefer, HM; Chernetsov, N; Fiedler, W; Hobson, KA; Ilieva, M; Imhof, E; Johnsen, A; Renner, SC; Rolshausen, G; Serrano, D; Wesolowski, T; Segelbacher, G				Mettler, Raeann; Schaefer, H. Martin; Chernetsov, Nikita; Fiedler, Wolfgang; Hobson, Keith A.; Ilieva, Mihaela; Imhof, Elisabeth; Johnsen, Arild; Renner, Swen C.; Rolshausen, Gregor; Serrano, David; Wesolowski, Tomasz; Segelbacher, Gernot			Contrasting Patterns of Genetic Differentiation among Blackcaps (Sylvia atricapilla) with Divergent Migratory Orientations in Europe	PLOS ONE			English	Article							POPULATION DIFFERENTIATION; HYBRID ZONE; EVOLUTION; BIRD; INHERITANCE; PANMIXIA; CONSEQUENCES; DIRECTIONS; DISTANCE; HYDROGEN	Migratory divides are thought to facilitate behavioral, ecological, and genetic divergence among populations with different migratory routes. However, it is currently contentious how much genetic divergence is needed to maintain distinct migratory behavior across migratory divides. Here we investigate patterns of neutral genetic differentiation among Blackcap (Sylvia atricapilla) populations with different migratory strategies across Europe. We compare the level of genetic divergence of populations migrating to southwestern (SW) or southeastern (SE) wintering areas with birds wintering in the British Isles following a recently established northwesterly (NW) migration route. The migratory divide between SW and SE wintering areas can be interpreted as a result of a re-colonization process after the last glaciation. Thus we predicted greater levels of genetic differentiation among the SW/SE populations. However, a lack of genetic differentiation was found between SW and SE populations, suggesting that interbreeding likely occurs among Blackcaps with different migratory orientations across a large area; therefore the SW/SE migratory divide can be seen as diffuse, broad band and is, at best, a weak isolating barrier. Conversely, weak, albeit significant genetic differentiation was evident between NW and SW migrants breeding sympatrically in southern Germany, suggesting a stronger isolating mechanism may be acting in this population. Populations located within/near the SW/SE contact zone were the least genetically divergent from NW migrants, confirming NW migrants likely originated from within the contact zone. Significant isolation-by-distance was found among eastern Blackcap populations (i.e. SE migrants), but not among western populations (i.e. NW and SW migrants), revealing different patterns of genetic divergence among Blackcap populations in Europe. We discuss possible explanations for the genetic structure of European Blackcaps and how gene flow influences the persistence of divergent migratory behaviors.	[Mettler, Raeann; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, D-79106 Freiburg, Germany; [Chernetsov, Nikita] Inst Zool, Biol Stn Rybachy, Rybachy, Kaliningrad Reg, Russia; [Fiedler, Wolfgang] Max Planck Inst Ornithol, Vogelwarte, Radolfzell, Germany; [Fiedler, Wolfgang] Univ Konstanz, Dept Biol, Constance, Germany; [Hobson, Keith A.] Environm Canada, Sci & Technol Branch, Saskatoon, SK, Canada; [Ilieva, Mihaela] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Sofia, Bulgaria; [Imhof, Elisabeth; Segelbacher, Gernot] Univ Freiburg, D-79106 Freiburg, Germany; [Johnsen, Arild] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Renner, Swen C.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Rolshausen, Gregor] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Rolshausen, Gregor] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Serrano, David] CSIC, EBD, Dept Conservat Biol, E-41080 Seville, Spain; [Wesolowski, Tomasz] Univ Wroclaw, Lab Forest Biol, PL-50138 Wroclaw, Poland	University of Freiburg; Max Planck Society; University of Konstanz; Environment & Climate Change Canada; Bulgarian Academy of Sciences; University of Freiburg; University of Oslo; Ulm University; McGill University; McGill University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Wroclaw	Mettler, R (corresponding author), Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, Hugstetter Str 55, D-79106 Freiburg, Germany.	raeann.mettler@gmail.com	Chernetsov, Nikita/K-7957-2012; Hobson, Keith/Q-9306-2019; Fiedler, Wolfgang/AAG-4510-2021; Serrano, David/B-5352-2013; Segelbacher, Gernot/F-3633-2011	Chernetsov, Nikita/0000-0001-7299-6829; Fiedler, Wolfgang/0000-0003-1082-4161; Serrano, David/0000-0001-6205-386X; Segelbacher, Gernot/0000-0002-8024-7008; Ilieva, Mihaela/0000-0003-1020-3162; /0000-0002-6893-4219; Johnsen, Arild/0000-0003-4864-6284	Deutsche Forschungsgemeinschaft [Scha 1008/6-1]; Environment Canada; Wroclaw University [1067/S/PBLas/2012]; Bulgarian Science Fund [DO02-277]; Deutsche Ornithologen-Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Environment Canada(CGIAR); Wroclaw University; Bulgarian Science Fund(National Science Fund of Bulgaria); Deutsche Ornithologen-Gesellschaft	This research was supported by a grant from the Deutsche Forschungsgemeinschaft to H. M. Schaefer (grant Scha 1008/6-1), an operating grant from Environment Canada to K. A. Hobson, an internal grant from Wroclaw University to T. Wesolowski (grant 1067/S/PBLas/2012), a project grant from the Bulgarian Science Fund (grant DO02-277), and by the Deutsche Ornithologen-Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2013, MOL ECOL RESOUR, V13, P341, DOI 10.1111/1755-0998.12061; [Anonymous], J EVOLUTIONARY BIOL; [Anonymous], MOL ECOL, DOI [10.1111/j. 1365-294X.2011.05381.x, DOI 10.1111/J.1365-294X.2011.05381.X.PUBMED:22574833]; [Anonymous], 1985, ZUG EUROPAISCHER SIN; [Anonymous], 1992, HDB BIRDS EUROPE MID; [Anonymous], 2006, MOL ECOL NOTES, DOI [DOI 10.1111/J.1471-8286.2005.01155.X, DOI doi:10.1111/j.1471-8286.2005.01155.x]; [Anonymous], CZECH SLOVAK BIRD MI; [Anonymous], MAGYAR MADARVONULASI; [Anonymous], 2008, SVENSK RINGMARKNINGS; [Anonymous], 2006, ENTOMOL REV, DOI DOI 10.1134/S0013873806100058; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Coyne J.A., 2004, SPECIATION; Dallimer M, 2003, MOL ECOL, V12, P345, DOI 10.1046/j.1365-294X.2003.01733.x; Davis LA, 2006, MOL ECOL, V15, P2141, DOI 10.1111/j.1365-294X.2006.02914.x; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Helbig AJ, 1996, J EXP BIOL, V199, P49; HELBIG AJ, 1994, NATURWISSENSCHAFTEN, V81, P184, DOI 10.1007/BF01134540; HELBIG AJ, 1992, OECOLOGIA, V90, P483, DOI 10.1007/BF01875441; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kopiec K, 2012, ORNIS FENNICA, V89, P254; Kovach RP, 2012, P ROY SOC B-BIOL SCI, V279, P3870, DOI 10.1098/rspb.2012.1158; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McKay BD, 2009, J AVIAN BIOL, V40, P181, DOI 10.1111/j.1600-048X.2009.04503.x; Moller AP, 2011, J EVOLUTION BIOL, V24, P1744, DOI 10.1111/j.1420-9101.2011.02302.x; Neethling M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-325; Neto JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038497; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Oomen RA, 2011, J HERED, V102, P584, DOI 10.1093/jhered/esr055; Payevsky Vladimir A., 1999, Avian Ecology and Behaviour, V2, P19; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Piersma T, 2005, ANN NY ACAD SCI, V1046, P282, DOI 10.1196/annals.1343.026; Pritchard JK, 2000, GENETICS, V155, P945; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reudink MW, 2011, BIOL J LINN SOC, V102, P583, DOI 10.1111/j.1095-8312.2010.01608.x; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Rohwer S, 2011, AUK, V128, P419, DOI 10.1525/auk.2011.10176; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruegg K, 2012, J EVOLUTION BIOL, V25, P1741, DOI 10.1111/j.1420-9101.2012.02554.x; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Ruegg K, 2008, EVOLUTION, V62, P452, DOI 10.1111/j.1558-5646.2007.00263.x; Segelbacher G, 2008, MOL ECOL RESOUR, V8, P1108, DOI 10.1111/j.1755-0998.2008.02171.x; SLATKIN M, 1995, GENETICS, V139, P457; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; TERRILL SB, 1990, OECOLOGIA, V85, P266, DOI 10.1007/BF00319412; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wesolowski T, 2011, J ORNITHOL, V152, P319, DOI 10.1007/s10336-010-0585-x	71	27	27	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81365	10.1371/journal.pone.0081365	http://dx.doi.org/10.1371/journal.pone.0081365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278428	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800126
J	Paganelli, MA; Kussius, CL; Popescu, GK				Paganelli, Meaghan A.; Kussius, Cassandra L.; Popescu, Gabriela K.			Role of Cross-Cleft Contacts in NMDA Receptor Gating	PLOS ONE			English	Article							PARTIAL AGONIST ACTION; LIGAND-BINDING DOMAIN; D-ASPARTATE RECEPTOR; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; TETRAMERIC STRUCTURE; ACTIVATION; CHANNEL; MECHANISM; EFFICACY	In response to brief glutamate exposure, NMDA receptors produce excitatory currents that have sub-maximal amplitudes and characteristically slow kinetics. The activation sequence starts when glutamate binds to residues located on the upper lobe of extracellularly located ligand-binding domains (LBDs) and then contacts lower lobe residues to bridge the cleft between the two hinged lobes. This event stabilizes a narrow-cleft LBD conformation and may facilitate subsequent inter-lobe contacts that further stabilize the closed cleft. Agonist efficacy has been traced to the degree of agonist-induced cleft-closure and may also depend on the stability of the closed-cleft conformation. To investigate how cross-cleft contacts contribute to the amplitude and kinetics of NMDA receptor response, we examined the activation reaction of GluN1/GluN2A receptors that had single-residue substitutions at the interface between LBD lobes. We found that side-chain truncations at residues of putative contact between lobes increased glutamate efficacy through independent additive mechanisms in GluN1 and GluN2A subunits. In contrast, removing side-chain charge with isosteric substitutions at the same sites decreased glutamate efficacy. These results support the view that in GluN1/GluN2A receptors' natural interactions between residues on opposing sides of the ligand-binding cleft encode the stability of the glutamate-bound closed-cleft conformations and limit the degree of cleft closure, thus contributing to the sub-maximal response and emblematically slow NMDA receptor deactivation after brief stimulation.	[Paganelli, Meaghan A.; Popescu, Gabriela K.] SUNY Buffalo, Neurosci Program, Buffalo, NY 14260 USA; [Kussius, Cassandra L.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Neurosci Program, Buffalo, NY 14260 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	National Institutes of Health National Institute of Neurological Disorders and Stroke [RO1NS052669]; National Institutes of Health National Institute on Drug Abuse [RO3DA24795]; National Institute of Health National Institute of Neurological Disorders and Stroke [F31NS076235]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052669, F31NS076235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024795] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health National Institute of Neurological Disorders and Stroke RO1NS052669 and National Institutes of Health National Institute on Drug Abuse RO3DA24795 to Gabriela K. Popescu and National Institute of Health National Institute of Neurological Disorders and Stroke F31NS076235 to Meaghan A. Paganelli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Kalbaugh TL, 2004, MOL PHARMACOL, V66, P209, DOI 10.1124/mol.66.2.209; Kussius CL, 2010, CHANNELS, V4, P79; Kussius CL, 2010, J NEUROSCI, V30, P12474, DOI 10.1523/JNEUROSCI.3337-10.2010; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Laube B, 1998, J NEUROSCI, V18, P2954; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Maier W, 2007, J BIOL CHEM, V282, P1863, DOI 10.1074/jbc.M608156200; Maki BA, 2012, J BIOL CHEM, V287, P36071, DOI 10.1074/jbc.M112.390013; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Popescu GK, 2012, J PHYSIOL-LONDON, V590, P73, DOI 10.1113/jphysiol.2011.223750; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Speranskiy K, 2005, BIOCHEMISTRY-US, V44, P11508, DOI 10.1021/bi050547w; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80953	10.1371/journal.pone.0080953	http://dx.doi.org/10.1371/journal.pone.0080953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278352	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800093
J	Shen, Q; Du, F; Huang, SL; Rodriguez, P; Watts, LT; Duong, TQ				Shen, Qiang; Du, Fang; Huang, Shiliang; Rodriguez, Pavel; Watts, Lora Talley; Duong, Timothy Q.			Neuroprotective Efficacy of Methylene Blue in Ischemic Stroke: An MRI Study	PLOS ONE			English	Article							DIFFUSION; PERFUSION	Methylene blue (MB) has unique energy-enhancing and antioxidant properties and is FDA-approved drug to treat methemoglobinemia and cyanide poisoning. This study evaluated the efficacy of MB to treat ischemic stroke in rats using longitudinal MRI and behavioral measures. Rats were subjected to 60-minute middle-cerebral-artery occlusion. In a randomized double-blinded design, vehicle or MB was administered after reperfusion. The initial lesion volumes at 30 minutes post-ischemia were not significantly different between the two groups (P = 0.92). The final infarct volumes two days after stroke increased in the vehicle group but decreased in the MB group, yielding a 30% difference in infarct volume (P = 0.03). Tracking tissue fate on a pixel-by-pixel basis showed that MB salvaged more initial core pixels compared to controls (22 +/- 3% versus 11 +/- 3%, P = 0.03), and more mismatch pixels compared to controls (83 +/- 3% versus 61 +/- 8%, P = 0.02). This study demonstrates MB treatment minimizes ischemic brain injury and improves functional outcomes.	[Shen, Qiang; Du, Fang; Huang, Shiliang; Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Shen, Qiang; Rodriguez, Pavel; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Shen, Qiang/B-8784-2008; Duong, Tim/AAL-8357-2021	Shen, Qiang/0000-0002-4287-3403; Duong, Tim/0000-0001-6403-2827	NIH [R01NS45879, UL1TR000149]; American Heart Association [EIA0940104N, BGIA9300047]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by NIH (R01NS45879, UL1TR000149) and American Heart Association (EIA0940104N, BGIA9300047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shen Q, 2011, J CEREBR BLOOD F MET, V31, P2076, DOI 10.1038/jcbfm.2011.64; van der Plaat L W, 2012, Eur Spine J, V21 Suppl 4, pS445, DOI 10.1007/s00586-011-2053-6; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Yoo AJ, 2012, J STROKE CEREBROVASC	16	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79833	10.1371/journal.pone.0079833	http://dx.doi.org/10.1371/journal.pone.0079833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278191	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800026
J	Chou, J; Fitzgibbon, MP; Mortales, CLL; Towlerton, AMH; Upton, MP; Yeung, RS; McIntosh, MW; Warren, EH				Chou, Jeffrey; Fitzgibbon, Matthew P.; Mortales, Christie-Lynn L.; Towlerton, Andrea M. H.; Upton, Melissa P.; Yeung, Raymond S.; McIntosh, Martin W.; Warren, Edus H.			Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; HUMAN COLORECTAL-CANCER; STEM-LIKE CELLS; TUMOR-GROWTH; TYROSINE KINASE; RNA-SEQ; EXPRESSION; IMMUNOTHERAPY; HETEROGENEITY; DIFFERENTIATION	Xenografts of human colorectal cancer (CRC) in immune-deficient mice have great potential for accelerating the study of tumor biology and therapy. We evaluated xenografts established in NOD/scid/IL2R gamma-null mice from the primary or metastatic tumors of 27 patients with CRC to estimate their capacity for expanding tumor cells for in vitro studies and to assess how faithfully they recapitulated the transcriptional profile of their parental tumors. RNA-seq analysis of parental human CRC tumors and their derivative xenografts demonstrated that reproducible transcriptional changes characterize the human tumor to murine xenograft transition. In most but not all cases, the human stroma, vasculature, and hematopoietic elements were systematically replaced by murine analogues while the carcinoma component persisted. Once established as xenografts, human CRC cells that could be propagated by serial transplantation remained transcriptionally stable. Three histologically atypical xenografts, established from patients with peritoneal metastases, contained abundant human stromal elements and blood vessels in addition to human tumor cells. The transcriptomes of these mixed tumor/stromal xenografts did not closely resemble those of their parental tumors, and attempts to propagate such xenografts by serial transplantation were unsuccessful. Stable expression of numerous genes previously identified as high priority targets for immunotherapy was observed in most xenograft lineages. Aberrant expression in CRC cells of human genes that are normally only expressed in hematopoietic cells was also observed. Our results suggest that human CRC cells expanded in murine xenografts have great utility for studies of tumor immunobiology and targeted therapies such as immunotherapy but also identify potential limitations.	[Chou, Jeffrey; Mortales, Christie-Lynn L.; Towlerton, Andrea M. H.; Warren, Edus H.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, Seattle, WA 98104 USA; [Chou, Jeffrey; Warren, Edus H.] Univ Washington, Med Ctr, Dept Med, Div Med Oncol, Seattle, WA 98195 USA; [Fitzgibbon, Matthew P.; McIntosh, Martin W.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, Seattle, WA 98104 USA; [Upton, Melissa P.] Univ Washington, Dept Pathol, Gastrointestinal & Liver Pathol Serv, Seattle, WA 98195 USA; [Yeung, Raymond S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chou, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.	jchou2@uw.edu; ehwarren@u.washington.edu		Warren, Edus/0000-0002-9570-2755	Irvington Institute of the Cancer Research Institute; Burroughs Wellcome Fund [1007475]; Department of Defense [W81XWH-12-0349]; NCI/NIH: SAIC contract [HHSN261200800001E, U01 CA176270, P30 DK56465]; NATIONAL CANCER INSTITUTE [U01CA176270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	Irvington Institute of the Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Defense(United States Department of Defense); NCI/NIH: SAIC contract; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a postdoctoral fellowship in cancer immunology from the Irvington Institute of the Cancer Research Institute (J.C.) (www.cancerresearch.org), the J. Orin Edson Fund for Immunotherapy, a Clinical Scientist Award in Translational Research (#1007475) from the Burroughs Wellcome Fund (E.H.W.) (www.bwfund.org), a grant from the Department of Defense (W81XWH-12-0349) (M. P. F. and M. W. M.) (cdmrp.army.mil), and grants from the NCI/NIH: SAIC contract #HHSN261200800001E (M.P.F. and M.W.M.), U01 CA176270 (M. W. M. and E. H. W.), and P30 DK56465 (to B. Torok-Storb) (www.nih.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Q, 2012, STEM CELLS DEV, V21, P2355, DOI 10.1089/scd.2012.0060; Benitez AC, 2011, P NATL ACAD SCI USA, V108, P4081, DOI 10.1073/pnas.1018603108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Blankenstein T, 2005, CURR OPIN IMMUNOL, V17, P180, DOI 10.1016/j.coi.2005.01.008; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chou J, 2012, J IMMUNOTHER, V35, P131, DOI 10.1097/CJI.0b013e31824300c7; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fichtner I, 2004, EUR J CANCER, V40, P298, DOI 10.1016/j.ejca.2003.10.011; Francipane MG, 2008, CANCER RES, V68, P4022, DOI 10.1158/0008-5472.CAN-07-6874; Guenot D, 2006, J PATHOL, V208, P643, DOI 10.1002/path.1936; Harashima N, 2001, EUR J IMMUNOL, V31, P323, DOI 10.1002/1521-4141(200102)31:2<323::AID-IMMU323>3.0.CO;2-0; Jin KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028384; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kammertoens T, 2005, TRENDS MOL MED, V11, P225, DOI 10.1016/j.molmed.2005.03.002; Kopetz S, 2012, CLIN CANCER RES, V18, P5160, DOI 10.1158/1078-0432.CCR-12-2408; Kreso A, 2008, CURR PROTOC STEM CEL, P1; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; McCracken S, 1997, ONCOGENE, V15, P2929, DOI 10.1038/sj.onc.1201474; Monsma DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-125; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wen YA, 2010, CANCER SCI, V101, P2325, DOI 10.1111/j.1349-7006.2010.01695.x; Wu YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041001; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	50	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79874	10.1371/journal.pone.0079874	http://dx.doi.org/10.1371/journal.pone.0079874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278200	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100062
J	Huelsken, T; Keyse, J; Liggins, L; Penny, S; Treml, EA; Riginos, C				Huelsken, Thomas; Keyse, Jude; Liggins, Libby; Penny, Shane; Treml, Eric A.; Riginos, Cynthia			A Novel Widespread Cryptic Species and Phylogeographic Patterns within Several Giant Clam Species (Cardiidae: Tridacna) from the Indo-Pacific Ocean	PLOS ONE			English	Article							GENETIC-STRUCTURE; MAXIMA POPULATIONS; CORAL TRIANGLE; GIGAS POPULATIONS; CROCEA; REEFS; SEA; DNA; DIFFERENTIATION; CONNECTIVITY	Giant clams (genus Tridacna) are iconic coral reef animals of the Indian and Pacific Oceans, easily recognizable by their massive shells and vibrantly colored mantle tissue. Most Tridacna species are listed by CITES and the IUCN Redlist, as their populations have been extensively harvested and depleted in many regions. Here, we survey Tridacna crocea and Tridacna maxima from the eastern Indian and western Pacific Oceans for mitochondrial (COI and 16S) and nuclear (ITS) sequence variation and consolidate these data with previous published results using phylogenetic analyses. We find deep intraspecific differentiation within both T. crocea and T. maxima. In T. crocea we describe a previously undocumented phylogeographic division to the east of Cenderawasih Bay (northwest New Guinea), whereas for T. maxima the previously described, distinctive lineage of Cenderawasih Bay can be seen to also typify western Pacific populations. Furthermore, we find an undescribed, monophyletic group that is evolutionarily distinct from named Tridacna species at both mitochondrial and nuclear loci. This cryptic taxon is geographically widespread with a range extent that minimally includes much of the central Indo-Pacific region. Our results reinforce the emerging paradigm that cryptic species are common among marine invertebrates, even for conspicuous and culturally significant taxa. Additionally, our results add to identified locations of genetic differentiation across the central Indo-Pacific and highlight how phylogeographic patterns may differ even between closely related and co-distributed species.	[Huelsken, Thomas; Keyse, Jude; Liggins, Libby; Treml, Eric A.; Riginos, Cynthia] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Penny, Shane] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, Australia; [Treml, Eric A.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Queensland; Charles Darwin University; University of Melbourne	Riginos, C (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	c.riginos@uq.edu.au	Riginos, Cynthia/G-3320-2010; Treml, Eric A/C-7580-2013; Liggins, Libby/K-2410-2013	Riginos, Cynthia/0000-0002-5485-4197; Treml, Eric A/0000-0003-4844-4420; Liggins, Libby/0000-0003-1143-2346	Australian Research Council [DP0878306]; German Research Foundation (DFG) [Hu 1806/1-1, Hu 1806/2-1]; World Wildlife Fund; Malacological Society of Australasia; Joyce Vickery Fund	Australian Research Council(Australian Research Council); German Research Foundation (DFG)(German Research Foundation (DFG)); World Wildlife Fund; Malacological Society of Australasia; Joyce Vickery Fund	Funding for this work was provided by the Australian Research Council (www.arc.gov.au, DP0878306 to CR), the German Research Foundation (www.dfg.de/en, DFG, Hu 1806/1-1, Hu 1806/2-1 to TH), the World Wildlife Fund (worldwildlife.org/initiatives/fuller-science-for-nature-fund, Kathryn Fuller Post-doctoral Research Fellowship to EAT), the Malacological Society of Australasia (www.malsocaus.org, to TH), and the Joyce Vickery Fund (linneansocietynsw.org.au/grants.html, to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1953, ZOOGEOGRAPHY SEA; Barber PH, 2006, EVOLUTION, V60, P1825; BENZIE JAH, 1992, MAR BIOL, V113, P373, DOI 10.1007/BF00349161; Benzie JAH, 1998, MAR BIOL, V132, P123, DOI 10.1007/s002270050378; BENZIE JAH, 1992, CORAL REEFS, V11, P135, DOI 10.1007/BF00255467; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; BENZIE JAH, 1995, MAR BIOL, V123, P781, DOI 10.1007/BF00349121; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; bin Othman AS, 2010, RAFFLES B ZOOL, V58, P103; Black R, 2011, MAR FRESHWATER RES, V62, P1318, DOI 10.1071/MF11093; Carpenter KE, 2010, J MAR BIOL, V2011, P1; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; DeBoer TS, 2014, B MAR SCI IN PRESS; Duda TF, 2009, BIOL BULL-US, V217, P292, DOI 10.1086/BBLv217n3p292; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gardner JPA, 2012, MAR ECOL PROG SER, V453, P297, DOI 10.3354/meps09625; Harzhauser M, 2008, PALAEONTOLOGY, V51, P199, DOI 10.1111/j.1475-4983.2007.00742.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Heslinga G, 1996, CTR TROPICAL SUBTROP, V125, P47; Hoeksema Bert W., 2007, V29, P117; HUELSKEN T, 2011, MITTEILUNGEN DTSCH M, V85, P17; IUCN, 2013, IUCN RED LIST THREAT; Juinio-Menez MA, 2003, MAR BIOL, V142, P717, DOI 10.1007/s00227-002-0998-z; Kinch J, 2009, P REG WORKSH MAN SUS; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Laurent V, 2002, BIOL J LINN SOC, V77, P221, DOI 10.1046/j.1095-8312.2002.00106.x; LUCAS JS, 1991, NAUTILUS, V105, P92; LUCAS JS, 1988, GIANT CLAMS ASIA PAC, P21; MACARANAS JM, 1992, MAR BIOL, V113, P231; Maruyama T, 1998, BIOL BULL, V195, P70, DOI 10.2307/1542777; McMillan WO, 1999, EVOLUTION, V53, P247, DOI 10.1111/j.1558-5646.1999.tb05350.x; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Neo ML, 2012, AQUAT BIOL, V14, P265, DOI 10.3354/ab00400; Nuryanto A, 2009, CORAL REEFS, V28, P607, DOI 10.1007/s00338-009-0483-y; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Plazzi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027147; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; Richter C, 2008, CURR BIOL, V18, P1349, DOI 10.1016/j.cub.2008.07.060; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosewater J, 1965, MOLLUSCAN RES, V1, P347; Schneider JA, 1999, MOL PHYLOGENET EVOL, V13, P59, DOI 10.1006/mpev.1999.0636; Sims CA, 2014, CORAL REEFS IN PRESS; Sirenko B.I., 1991, Conchiglia, V22, P4; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tang YC, 2005, THESIS NATL TAIWAN O; Tisdell C, 1992, GIANT CLAMS SUSTAINA, P3; UNEP-WCMC, 2013, CONV INT TRAD END SP; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Wells S., 1997, GIANT CLAMS STATUS T; Yu ET, 2000, MAR BIOTECHNOL, V2, P511, DOI 10.1007/s101260000033	58	42	49	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80858	10.1371/journal.pone.0080858	http://dx.doi.org/10.1371/journal.pone.0080858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278333	gold, Green Published			2022-12-27	WOS:000327313100119
J	Li, J; Shi, ZR; Wang, Z; Liu, ZB; Wu, XH; Shen, ZT; Li, B; Song, Y; Zhu, XX				Li, Jing; Shi, ZhaoRong; Wang, Zhen; Liu, Zhibing; Wu, Xinhu; Shen, Zetian; Li, Bing; Song, Yong; Zhu, Xixu			Treating Adrenal Tumors in 26 Patients with CyberKnife: A Mono-Institutional Experience	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; LOCALIZED PROSTATE-CANCER; CELL LUNG-CANCER; TRACKING	Background: CyberKnife (CK) is a novel stereotactic radiosurgery system for treating tumors in any part of the body. It is a non-invasive or minimally invasive tumor treatment modality that can deliver high doses of spatially precise radiation and minimize exposure to neighboring healthy tissues or vital organs. The purpose of this study was to investigate the safety and efficacy of CK in the treatment of adrenal tumors. Methods and Results: We performed a retrospective analysis of 26 patients with adrenal tumors who had been treated with CK in the radiotherapy center of our hospital between March 2009 and March 2012. Eight patients had primary adrenal tumors and 18 patients had metastatic adrenal tumors. In addition to CK, 4 patients received chemotherapy and 2 patients received immunotherapy. The average tumor volume was 72.1 cm(3) and the prescribed radiation dosage ranged from 30 to 50 Gy and was fractionated 3 to 5 times with a 58% to 80% isodose line. Abdominal CT was performed between 1 to 3 months after the CK treatment to evaluate the short-term efficacy with follow-up examinations once every 3 months. Three patients had complete remission, 12 patients had partial remission, 5 patients had stable disease, and 6 patients had progressive illness. The effective rate of pain relief was 93.8% and the disease control rate was 77% with a median overall survival of 17 months and a median progression-free survival of 14 months. Treatment Related toxicity was well-tolerated, but preventative measure need to be taken for radiation enteritis. Conclusions: CK is safe and effective for treating adrenal tumors with few adverse reactions. Nonetheless, its long-term effects requires further follow-up.	[Liu, Zhibing] Nanjing Univ, Sch Med, Jingling Hosp, Dept Radiotherapy Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Li, Jing; Wang, Zhen; Wu, Xinhu; Shen, Zetian; Li, Bing; Zhu, Xixu] Jingling Hosp, Dept Radiotherapy Ctr, Nanjing, Jiangsu, Peoples R China; [Shi, ZhaoRong; Song, Yong] Jingling Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhu, XX (corresponding author), Jingling Hosp, Dept Radiotherapy Ctr, Nanjing, Jiangsu, Peoples R China.	13913026297@163.com						Aluwini S, 2010, J ENDOUROL, V24, P865, DOI 10.1089/end.2009.0438; Choi C, 2007, INT J RADIAT ONCOL, V69, pS375, DOI 10.1016/j.ijrobp.2007.07.1481; Collins BT, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-39; Dunlap NE, 2010, J THORAC CARDIOV SUR, V140, P583, DOI 10.1016/j.jtcvs.2010.01.046; Friedland JL, 2009, TECHNOL CANCER RES T, V8, P387, DOI 10.1177/153303460900800509; Iwata H, 2012, RADIOTHER ONCOL, V104, P355, DOI 10.1016/j.radonc.2012.01.017; Iwata H, 2012, J NEURO-ONCOL, V106, P571, DOI 10.1007/s11060-011-0693-3; Jang J, 2007, IFMBE PROC, V14, P2024; King CR, 2009, INT J RADIAT ONCOL, V73, P1043, DOI 10.1016/j.ijrobp.2008.05.059; Lartigau E, 2009, ONKOLOGIE, V32, P209, DOI 10.1159/000200929; McBride SM, 2012, CANCER-AM CANCER SOC, V118, P3681, DOI 10.1002/cncr.26699; Ng AWY, 2008, RADIOTHER ONCOL, V87, P24, DOI 10.1016/j.radonc.2008.02.015; Nuyttens JJ, 2006, ACTA ONCOL, V45, P961, DOI 10.1080/02841860600902205; Oshiro Y, 2011, AM J CLIN ONCOL-CANC, V34, P249, DOI 10.1097/COC.0b013e3181dbb727; Prevost JB, 2008, TECHNOL CANCER RES T, V7, P27, DOI 10.1177/153303460800700103; Sotiropoulou E, 2010, CARDIOVASC INTER RAD, V33, P586, DOI 10.1007/s00270-009-9748-7; van Zyp NCV, 2009, RADIOTHER ONCOL, V91, P296, DOI 10.1016/j.radonc.2009.02.011; Wang CC, 2012, J NEURO-ONCOL, V106, P601, DOI 10.1007/s11060-011-0697-z	18	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80654	10.1371/journal.pone.0080654	http://dx.doi.org/10.1371/journal.pone.0080654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278303	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100099
J	Mathai, S; Derraik, JGB; Cutfield, WS; Dalziel, SR; Harding, JE; Biggs, J; Jefferies, C; Hofman, PL				Mathai, Sarah; Derraik, Jose G. B.; Cutfield, Wayne S.; Dalziel, Stuart R.; Harding, Jane E.; Biggs, Janene; Jefferies, Craig; Hofman, Paul L.			Increased Adiposity in Adults Born Preterm and Their Children	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CARDIOVASCULAR RISK-FACTORS; LOW-PROTEIN DIET; BLOOD-PRESSURE; CONTROLLED-TRIAL; FOLLOW-UP; PREMATURE-INFANTS; PUBERTAL CHANGES; YOUNG ADULTHOOD; GROWTH	Background: Preterm birth is associated with abnormalities in growth, body composition, and metabolism during childhood, but adult data are scarce and none exist for their offspring. We therefore aimed to examine body composition and cardiovascular risk factors in adults born preterm and their children. Methods: A cohort of 52 adults (aged 35.7 years, 54% female, 31 born preterm) and their term-born children (n=61, aged 8.0 years, 54% female, 60% from a preterm parent) were studied. Auxology and body composition (whole-body dual-energy X-ray absorptiometry) were measured, and fasting blood samples taken for metabolic and hormonal assessments. Results: Adults born preterm had greater abdominal adiposity, displaying more truncal fat (p=0.006) and higher android to gynoid fat ratio (p=0.004). Although women born preterm and at term were of similar weight and BMI, men born preterm (n=8) were on average 20 kg heavier (p=0.010) and of greater BMI (34.2 vs 28.4 kg/m(2); p=0.021) than men born at term (n=16). Adults born preterm also displayed a less favourable lipid profile, including lower HDL-C concentrations (p=0.007) and greater total cholesterol to HDL-C ratio (p=0.047). Children of parents born preterm tended to have more body fat than the children of parents born at term (21.3 vs 17.6%; p=0.055). Even after adjustment for mean parental BMI, children of parents born preterm had altered fat distribution, with more truncal fat (p=0.048) and greater android to gynoid fat ratio (p=0.009). Conclusions: Adults born preterm, particularly men, have markedly increased fat mass and altered fat distribution. A similar increase in abdominal adiposity was observed in the term born offspring of parents born preterm, indicating that adverse outcomes associated with preterm birth may extend to the next generation.	[Mathai, Sarah; Derraik, Jose G. B.; Cutfield, Wayne S.; Harding, Jane E.; Biggs, Janene; Jefferies, Craig; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Mathai, Sarah; Cutfield, Wayne S.; Hofman, Paul L.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand; [Dalziel, Stuart R.] Auckland Dist Hlth Board, Starship Childrens Hosp, Childrens Emergency Dept, Auckland, New Zealand	University of Auckland; Auckland District Health Board; Starship Children's Hospital	Hofman, PL (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	p.hofman@auckland.ac.nz	Jefferies, craig/ABA-1921-2021; Derraik, José Guilherme Behrensdorf/A-1925-2008; Harding, Jane E/J-5853-2015	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Harding, Jane E/0000-0003-2697-1422; Jefferies, Craig/0000-0002-0541-6094	Gravida: National Centre for Growth and Development; Australasian Paediatric Endocrine Group (APEG)	Gravida: National Centre for Growth and Development; Australasian Paediatric Endocrine Group (APEG)	This research was supported by grants from Gravida: National Centre for Growth and Development and the Australasian Paediatric Endocrine Group (APEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adair LS, 2001, CIRCULATION, V104, P1034, DOI 10.1161/hc3401.095037; Aerts L, 2006, INT J BIOCHEM CELL B, V38, P894, DOI 10.1016/j.biocel.2005.07.006; Atkinson SA, 2000, ANN NY ACAD SCI, V904, P393; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80; Cutfield WS, 2002, J CLIN ENDOCR METAB, V87, P235, DOI 10.1210/jc.87.1.235; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Dalziel SR, 2007, INT J EPIDEMIOL, V36, P907, DOI 10.1093/ije/dym067; Dalziel SR, 2006, J BONE MINER RES, V21, P1175, DOI 10.1359/JBMR.060516; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Harding JE, 2010, EXPERT REV ENDOCRINO, V5, P297, DOI [10.1586/eem.09.62, 10.1586/EEM.09.62]; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906; Kajantie E, 2010, DIABETES CARE, V33, P2623, DOI 10.2337/dc10-0912; Keijzer-Veen MG, 2010, PEDIATR NEPHROL, V25, P509, DOI 10.1007/s00467-009-1373-9; Knops Noel B B, 2005, BMC Pediatr, V5, P26, DOI 10.1186/1471-2431-5-26; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lumey LH, 1997, AM J EPIDEMIOL, V146, P810, DOI 10.1093/oxfordjournals.aje.a009198; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Rowe DL, 2011, CLIN ENDOCRINOL, V75, P661, DOI 10.1111/j.1365-2265.2011.04116.x; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zambrano E, 2005, J PHYSIOL-LONDON, V563, P275, DOI 10.1113/jphysiol.2004.078543	39	57	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81840	10.1371/journal.pone.0081840	http://dx.doi.org/10.1371/journal.pone.0081840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278462	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100162
J	Mishra, J; Gazzaley, A				Mishra, Jyoti; Gazzaley, Adam			Preserved Discrimination Performance and Neural Processing during Crossmodal Attention in Aging	PLOS ONE			English	Article							TOP-DOWN SUPPRESSION; MULTISENSORY INTEGRATION; SELECTIVE ATTENTION; BIASED COMPETITION; HUMAN BRAIN; VISUAL-ATTENTION; WORKING-MEMORY; AGE; DEFICIT; SPREAD	In a recent study in younger adults (19-29 year olds) we showed evidence that distributed audiovisual attention resulted in improved discrimination performance for audiovisual stimuli compared to focused visual attention. Here, we extend our findings to healthy older adults (60-90 year olds), showing that performance benefits of distributed audiovisual attention in this population match those of younger adults. Specifically, improved performance was revealed in faster response times for semantically congruent audiovisual stimuli during distributed relative to focused visual attention, without any differences in accuracy. For semantically incongruent stimuli, discrimination accuracy was significantly improved during distributed relative to focused attention. Furthermore, event-related neural processing showed intact crossmodal integration in higher performing older adults similar to younger adults. Thus, there was insufficient evidence to support an age-related deficit in crossmodal attention.	[Mishra, Jyoti; Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mishra, J (corresponding author), Univ Calif San Francisco, Dept Neurol Physiol & Psychiat, San Francisco, CA 94143 USA.	jyoti@gazzaleylab.ucsf.edu; adam.gazzaley@ucsf.edu	Mishra, Jyoti/AAM-3589-2021	Mishra, Jyoti/0000-0001-6612-4557	National Institute of Health [5R01AG030395, 5R24TW007988-05, VUMC38412]; Sandler Program for Breakthrough Biomedical Research grant; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030395] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Breakthrough Biomedical Research grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of Health grants 5R01AG030395 (AG), 5R24TW007988-05 subaward VUMC38412 (JM) and the Sandler Program for Breakthrough Biomedical Research grant (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLES A, 1987, COMMUNICATION COGNIT; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bennett IJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.017; Bollinger J, 2011, NEUROPSYCHOLOGIA, V49, P1466, DOI 10.1016/j.neuropsychologia.2010.12.021; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Calvert G., 2004, HDB MULTISENSORY PRO; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cienkowski KM, 2002, EAR HEARING, V23, P439, DOI 10.1097/00003446-200210000-00006; Clapp WC, 2011, P NATL ACAD SCI USA, V108, P7212, DOI 10.1073/pnas.1015297108; Clapp WC, 2012, NEUROBIOL AGING, V33, P134, DOI 10.1016/j.neurobiolaging.2010.01.012; Craik FIM, 2000, HDB AGING COGNITION; Degerman A, 2007, NEUROIMAGE, V34, P1683, DOI 10.1016/j.neuroimage.2006.11.019; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Diaconescu AO, 2013, NEUROIMAGE, V65, P152, DOI 10.1016/j.neuroimage.2012.09.057; Diederich A, 2008, NEUROPSYCHOLOGIA, V46, P2556, DOI 10.1016/j.neuropsychologia.2008.03.026; Duzel E, 2011, HIPPOCAMPUS, V21, P803, DOI 10.1002/hipo.20834; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Fiebelkorn IC, 2010, CEREB CORTEX, V20, P109, DOI 10.1093/cercor/bhp083; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A., 2013, PRINCIPLES FRONTAL L, P593; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; Gorus E, 2006, AGING CLIN EXP RES, V18, P407, DOI 10.1007/BF03324837; Guerreiro MJS, 2013, ACTA PSYCHOL, V142, P184, DOI 10.1016/j.actpsy.2012.11.007; Guerreiro MJS, 2011, PSYCHOL AGING, V26, P415, DOI 10.1037/a0021507; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hasher L, 1999, ATTENTION PERFORM, V17, P653; He J, 2012, NEUROBIOL AGING, V33, P2612, DOI 10.1016/j.neurobiolaging.2011.12.029; Hugenschmidt CE, 2009, EXP BRAIN RES, V198, P273, DOI 10.1007/s00221-009-1816-3; Hugenschmidt CE, 2009, NEUROREPORT, V20, P349, DOI 10.1097/WNR.0b013e328323ab07; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kalkstein J, 2011, J NEUROSCI, V31, P15768, DOI 10.1523/JNEUROSCI.3209-11.2011; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Laurienti PJ, 2006, NEUROBIOL AGING, V27, P1155, DOI 10.1016/j.neurobiolaging.2005.05.024; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Macmillan N. A., 1991, DETECTION THEORY USE; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mishra J, 2012, J NEUROSCI, V32, P12294, DOI 10.1523/JNEUROSCI.0867-12.2012; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; Nusbaum NJ, 1999, SOUTHERN MED J, V92, P267, DOI 10.1097/00007611-199903000-00002; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Setti A, 2011, NEUROREPORT, V22, P554, DOI 10.1097/WNR.0b013e328348c731; Spence C, 2012, NEURAL BASES MULTISE; Stephen JM, 2010, NEUROSCI LETT, V484, P76, DOI 10.1016/j.neulet.2010.08.023; STINE EAL, 1990, J GERONTOL B-PSYCHOL, V45, P1, DOI DOI 10.1093/GER0NJ/45.1.P1; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Weschler D., 2008, WECHSLER ADULT INTEL; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Zanto TP, 2011, J NEUROSCI, V31, P12461, DOI 10.1523/JNEUROSCI.1149-11.2011; Zanto TP, 2010, CORTEX, V46, P564, DOI 10.1016/j.cortex.2009.08.003; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003; Zimmer U, 2010, EUR J NEUROSCI, V31, P1744, DOI 10.1111/j.1460-9568.2010.07229.x; Zimmer U, 2010, NEUROIMAGE, V52, P606, DOI 10.1016/j.neuroimage.2010.04.245; Zimmerman ME, 2006, AM J GERIAT PSYCHIAT, V14, P823, DOI 10.1097/01.JGP.0000238502.40963.ac	70	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81894	10.1371/journal.pone.0081894	http://dx.doi.org/10.1371/journal.pone.0081894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278464	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100163
J	Orrock, JL				Orrock, John L.			Exposure of Unwounded Plants to Chemical Cues Associated with Herbivores Leads to Exposure-Dependent Changes in Subsequent Herbivore Attack	PLOS ONE			English	Article							SNAIL HELIX-ASPERSA; SEEDLING HERBIVORY; PREDATION RISK; INFORMATION; FIELD; COMMUNICATION; RESISTANCE; EVOLUTION; SURVIVAL; ANIMALS	Although chemical predator cues often lead to changes in the anti-predator behavior of animal prey, it is not clear whether non-volatile herbivore kairomones (i.e. incidental chemical cues produced by herbivore movement or metabolism but not produced by an attack) trigger the induction of defense in plants prior to attack. I found that unwounded plants (Brassica nigra) that were regularly exposed to kairomones from snails (mucus and feces produced during movement of Helix aspersa) subsequently experienced reduced rates of attack by snails, unlike unwounded plants that received only one initial early exposure to snail kairomones. A follow-up experiment found that mucus alone did not affect snail feeding on previously harvested B. oleracea leaves, suggesting that changes in herbivory on B. nigra were due to changes in plant quality. The finding that chemicals associated with herbivores leads to changes in palatability of unwounded plants suggests that plants eavesdrop on components of non-volatile kairomones of their snail herbivores. Moreover, this work shows that the nature of plant exposure matters, supporting the conclusion that plants that have not been attacked or wounded nonetheless tailor their use of defenses based on incidental chemical information associated with herbivores and the timing with which cues of potential attack are encountered.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Orrock, JL (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	jorrock@wisc.edu						[Anonymous], 2001, BIOL TERRESTRIAL MOL; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Bednekoff PA, 2011, AM NAT, V177, P147, DOI 10.1086/657440; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cleland EE, 2006, ECOLOGY, V87, P686, DOI 10.1890/05-0529; Coleman RA, 2007, FUNCT ECOL, V21, P101, DOI 10.1111/j.1365-2435.2006.01210.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Falk K, MOL ECOLOGY IN PRESS; Felton Gary W., 2008, P369, DOI 10.1007/978-1-4020-8182-8_18; Fenner M, 1999, FUNCT ECOL, V13, P546, DOI 10.1046/j.1365-2435.1999.00346.x; FENNER M, 1987, NEW PHYTOL, V106, P35, DOI 10.1111/j.1469-8137.1987.tb04681.x; Hanley ME, 2004, PLANT ECOL, V170, P35, DOI 10.1023/B:VEGE.0000019022.48043.56; HANLEY ME, 1995, J ECOL, V83, P621, DOI 10.2307/2261630; HANLEY ME, 1995, FUNCT ECOL, V9, P754, DOI 10.2307/2390248; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Helms AM, 2013, P NATL ACAD SCI USA, V110, P199, DOI 10.1073/pnas.1218606110; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Iglesias J, 1999, J MOLLUS STUD, V65, P411, DOI 10.1093/mollus/65.4.411; Jensen EL, 2011, AM NAT, V177, P377, DOI 10.1086/658343; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Motheral SM, 2010, AM MIDL NAT, V163, P106, DOI 10.1674/0003-0031-163.1.106; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; POTTS DC, 1975, OECOLOGIA, V21, P313, DOI 10.1007/BF00345824; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Schaller A., 2008, INDUCED PLANT RESIST; SIH A, 1992, AM NAT, V139, P1052, DOI 10.1086/285372; Strauss SY, 2009, ECOLOGY, V90, P419, DOI 10.1890/07-1533.1; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	34	15	15	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79900	10.1371/journal.pone.0079900	http://dx.doi.org/10.1371/journal.pone.0079900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278210	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100068
J	Zhang, SW; Zhao, YL; Xu, M; Yu, L; Zhao, YJ; Chen, JH; Yuan, YQ; Zheng, QS; Niu, XL				Zhang, Shenwei; Zhao, Yilin; Xu, Ming; Yu, Li; Zhao, Yujie; Chen, Jianghong; Yuan, Yiqiang; Zheng, Qiangsun; Niu, Xiaolin			FoxO3a Modulates Hypoxia Stress Induced Oxidative Stress and Apoptosis in Cardiac Microvascular Endothelial Cells	PLOS ONE			English	Article							INDUCED ROS PRODUCTION; MEDIATED APOPTOSIS; CANCER-CELLS; OXYGEN; SENSITIVITY; METABOLISM; INDUCTION; PROTEINS; BIM	Cardiac microvascular endothelial cells (CMECs) dysfunction induced by hypoxia is an important pathophysiological event in myocardium ischemic injury, whereas, the underlying mechanism is not fully clarified. FoxO transcription factors regulate target genes involved in apoptosis and cellular reactive oxygen species (ROS) production. Therefore, the present study was designed to elucidate the potential role of FoxOs on the hypoxia-induced ROS formation and apoptosis in CMECs. Exposure to low oxygen tension stimulated ROS accumulation and increased apoptosis in CMECs within 6-24 h. Hypoxia also significantly increased the expressions of HIF-1 alpha and FoxO3a. However, hypoxia decreased the phosphorylation of Akt and FoxO3a, correlated with increased nuclear accumulation. Conversely, the expression of FoxO1 was not significantly altered by hypoxia. After inhibition of HIF-1 alpha by siRNA, we observed that hypoxia-induced ROS accumulation and apoptosis of CMECs were decreased. Meanwhile, knockdown of HIF-1 alpha also inhibited hypoxia induced FoxO3a expression in CMECs, but did not affect FoxO1 expression. Furthermore, hypoxia-induced ROS formation and apoptosis in CMECs were correlated with the disturbance of Bcl-2 family proteins, which were abolished by FoxO3a silencing with siRNA. In conclusion, our data provide evidence that FoxO3a leads to ROS accumulation in CMECs, and in parallel, induces the disturbance of Bcl-2 family proteins which results in apoptosis.	[Zhang, Shenwei; Yu, Li; Zhao, Yujie; Yuan, Yiqiang] Seventh Peoples Hosp Zhengzhou, Dept Cardiol, Zhengzhou, Peoples R China; [Zhao, Yilin] Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xian 710032, Peoples R China; [Xu, Ming] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Chen, Jianghong; Zheng, Qiangsun; Niu, Xiaolin] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Niu, XL (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China.	faithword@163.com		niu, xiaolin/0000-0002-8320-5516; xu, ming/0000-0001-5234-2203	National Nature Science Foundation of China [81200099]; Tangdu Hospital, the Fourth Military Medical University [TDCX2011009]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tangdu Hospital, the Fourth Military Medical University	This work was supported by National Nature Science Foundation of China (No. 81200099) and Technological Innovation Grant from Tangdu Hospital, the Fourth Military Medical University (TDCX2011009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Braunwald E, 2000, CIRCULATION, V102, P14; Du SC, 2012, CELL MOL BIOL NOIS S, V58; Dvoriantchikova G, 2012, INVEST OPHTH VIS SCI, V53, P2823, DOI 10.1167/iovs.12-9526; Ferber EC, 2012, CELL DEATH DIFFER, V19, P968, DOI 10.1038/cdd.2011.179; Gonzalez C, 2002, RESP PHYSIOL NEUROBI, V132, P17, DOI 10.1016/S1569-9048(02)00047-2; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Harford TJ, 2010, APOPTOSIS, V15, P71, DOI 10.1007/s10495-009-0428-5; Jiang LL, 2011, BIOCHEM BIOPH RES CO, V405, P314, DOI 10.1016/j.bbrc.2011.01.036; Kim BM, 2007, BIOCHEM BIOPH RES CO, V363, P745, DOI 10.1016/j.bbrc.2007.09.024; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kou BJ, 2009, MICROVASC RES, V77, P125, DOI 10.1016/j.mvr.2008.08.001; Lee BC, 2011, J CELL BIOCHEM, V112, P118, DOI 10.1002/jcb.22896; Li JM, 2001, J MOL CELL CARDIOL, V33, P1119, DOI 10.1006/jmcc.2001.1372; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015; Morey M, 2003, J CELL SCI, V116, P4597, DOI 10.1242/jcs.00783; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nakamura T, 2008, MOL CELL ENDOCRINOL, V281, P47, DOI 10.1016/j.mce.2007.10.007; Nguyen LK, 2013, J CELL SCI, V126, P1454, DOI 10.1242/jcs.119974; Oh J, 2009, ONCOGENE, V28, P3145, DOI 10.1038/onc.2009.169; Prabhakar NR, 2007, ANTIOXID REDOX SIGN, V9, P1397, DOI 10.1089/ars.2007.1732; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Sanada M, 2011, BIOSCI BIOTECH BIOCH, V75, P1546, DOI 10.1271/bbb.110226; Scarabelli T, 2001, CIRCULATION, V104, P253, DOI 10.1161/01.CIR.104.3.253; Singal PK, 2001, ADV EXP MED BIOL, V498, P213; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	38	27	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80342	10.1371/journal.pone.0080342	http://dx.doi.org/10.1371/journal.pone.0080342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278276	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100085
J	Zeng, DW; Liu, YR; Zhang, JM; Zhu, YY; Lin, S; You, J; Li, YB; Chen, J; Zheng, Q; Jiang, JJ; Dong, J				Zeng, Da-Wu; Liu, Yu-Rui; Zhang, Jie-Min; Zhu, Yue-Yong; Lin, Su; You, Jia; Li, You-Bing; Chen, Jing; Zheng, Qi; Jiang, Jia-Ji; Dong, Jing			Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease	PLOS ONE			English	Article							C VIRUS-INFECTION; VALIDATED PREDICTOR; BIOCHEMICAL MARKERS; WILSON-DISEASE; CIRRHOSIS; UPDATE; BIOPSY; COHORT; COPPER; INDEX	Aims: This study aimed to investigate associations between ceruloplasmin (CP) levels, inflammation grade and fibrosis stages in patients with chronic hepatitis B (CHB) and to establish a noninvasive model to predict cirrhosis. Methods: Liver biopsy samples and sera were collected from 198 CHB patients randomized into a training group (n=109) and a validation group (n=89). CP levels were determined using nephelometric immunoassays. Relationships between CP and liver inflammation and fibrosis were analyzed by Spearman rank correlation. Receiver operator characteristic (ROC) curves were used to evaluate the diagnostic value of CP for determining liver fibrosis in CHB. The liver pathology-predictive model was built using multivariate logistic regression analysis to identify relevant indicators. Results: CP levels were lower in males than in females, lower in patients with inflammation stage G4 compared to other stages and lower in cirrhotic compared to non-cirrhotic patients. Using area under the curve (AUC) values, CP levels distinguished different stages of inflammation and fibrosis. Multivariate analysis showed that CP levels were all significantly associated with cirrhosis in males. A model was developed combining routine laboratory markers APPCI (alpha-fetoprotein [AFP], prothrombin time, and platelets [PLT] with CP) to predict fibrosis in CHB patients. The APPCI had a significantly greater AUC than FIB-4 (aspartate aminotransferase [AST]/ alanine aminotransferase [ALT]/PLT/age), APRI (AST/PLT ratio index), GPI (globin/PLT), and APGA (AST/PLT/gammaglutamyl transpeptidase [GGT]) models (all P-values<0.001). Conclusions: CP levels correlate negatively and indirectly with inflammation and fibrosis stages in male CHB patients. The APPCI model uses routine laboratory variables with CP to accurately predict liver fibrosis in CHB.	[Zeng, Da-Wu; Liu, Yu-Rui; Zhu, Yue-Yong; Lin, Su; You, Jia; Li, You-Bing; Chen, Jing; Zheng, Qi; Jiang, Jia-Ji; Dong, Jing] Fujian Med Univ, Ctr Liver, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China; [Zhang, Jie-Min] Fujian Med Univ, Dept Pharm, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University	Dong, J (corresponding author), Fujian Med Univ, Ctr Liver, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China.	doctordong@126.com						Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruce MG, 2008, J VIRAL HEPATITIS, V15, P179, DOI 10.1111/j.1365-2893.2007.00928.x; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chan HLY, 2009, ANTIVIR THER, V14, P489; Chinese Society of Infectious Disease and Parasitology and Chinese Society of Hepatology of Chinese Medical Association, 2000, CHIN J HEPATOL, V8, P324; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; CZAJA MJ, 1987, J CLIN INVEST, V80, P1200, DOI 10.1172/JCI113180; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Giannini E, 2003, AM J GASTROENTEROL, V98, P2516, DOI 10.1111/j.1572-0241.2003.08665.x; HOLMBERG CG, 1947, ACTA CHEM SCAND, V1, P944, DOI 10.3891/acta.chem.scand.01-0944; Hsu YS, 2002, HEPATOLOGY, V35, P1522, DOI 10.1053/jhep.2002.33638; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Kim Sun Min, 2009, Korean J Hepatol, V15, P454, DOI 10.3350/kjhep.2009.15.4.454; Lee IC, 2011, J CLIN GASTROENTEROL, V45, P278, DOI 10.1097/MCG.0b013e3181dd5357; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liu XD, 2012, WORLD J GASTROENTERO, V18, P2784, DOI 10.3748/wjg.v18.i22.2784; Livingston SE, 2010, CAN J GASTROENTEROL, V24, P445, DOI 10.1155/2010/692036; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; Montazeri G, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-32; Myers RP, 2003, J HEPATOL, V39, P222, DOI 10.1016/S0168-8278(03)00171-5; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park SH, 2011, DIGEST DIS SCI, V56, P1828, DOI 10.1007/s10620-010-1477-x; PERMAN JA, 1979, J PEDIATR-US, V94, P564, DOI 10.1016/S0022-3476(79)80011-6; Poynard T, 2005, GASTROENTEROLOGY, V128, P1146, DOI 10.1053/j.gastro.2005.02.056; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; SCHAFF Z, 1991, EXP PATHOL-JENA, V43, P111, DOI 10.1016/S0232-1513(11)80156-8; Scheuer Peter J, 2002, Clin Liver Dis, V6, P335, DOI 10.1016/S1089-3261(02)00009-0; Scheuer PJ, 2002, CLIN LIVER DIS, V6, pv, DOI DOI 10.1016/S1089-3261(02)00009-0; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; STERNLIEB I, 1961, ANN NY ACAD SCI, V94, P71, DOI 10.1111/j.1749-6632.1961.tb35533.x; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Tong MJ, 2010, HEPATOL INT, V4, P516, DOI 10.1007/s12072-010-9179-1; Uhlikova E, 2008, BRATISL MED J, V109, P431; Vallet-Pichard A, 2006, HEPATOLOGY, V44, P769, DOI 10.1002/hep.21334; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Walshe JM, 2005, MOVEMENT DISORD, V20, P1658, DOI 10.1002/mds.20628; WALSHE JM, 1962, LANCET, V2, P263; Yang Xu, 2005, Zhonghua Nei Ke Za Zhi, V44, P13; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960	54	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77942	10.1371/journal.pone.0077942	http://dx.doi.org/10.1371/journal.pone.0077942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24282481	Green Published, Green Submitted, gold			2022-12-27	WOS:000326155400063
J	Ben-Gida, H; Kirchhefer, A; Taylor, ZJ; Bezner-Kerr, W; Guglielmo, CG; Kopp, GA; Gurka, R				Ben-Gida, Hadar; Kirchhefer, Adam; Taylor, Zachary J.; Bezner-Kerr, Wayne; Guglielmo, Christopher G.; Kopp, Gregory A.; Gurka, Roi			Estimation of Unsteady Aerodynamics in the Wake of a Freely Flying European Starling (Sturnus vulgaris)	PLOS ONE			English	Article							TIME-RESOLVED PIV; VORTEX WAKE; FLAPPING FLIGHT; ANIMAL FLIGHT; WINGBEAT KINEMATICS; BAT; IDENTIFICATION; PERFORMANCE; VORTICES; ROBINS	Wing flapping is one of the most widespread propulsion methods found in nature; however, the current understanding of the aerodynamics in bird wakes is incomplete. The role of the unsteady motion in the flow and its contribution to the aerodynamics is still an open question. In the current study, the wake of a freely flying European starling has been investigated using long-duration high-speed Particle Image Velocimetry (PIV) in the near wake. Kinematic analysis of the wings and body of the bird has been performed using additional high-speed cameras that recorded the bird movement simultaneously with the PIV measurements. The wake evolution of four complete wingbeats has been characterized through reconstruction of the time-resolved data, and the aerodynamics in the wake have been analyzed in terms of the streamwise forces acting on the bird. The profile drag from classical aerodynamics was found to be positive during most of the wingbeat cycle, yet kinematic images show that the bird does not decelerate. It is shown that unsteady aerodynamics are necessary to satisfy the drag/thrust balance by approximating the unsteady drag term. These findings may shed light on the flight efficiency of birds by providing a partial answer to how they minimize drag during flapping flight.	[Ben-Gida, Hadar; Taylor, Zachary J.] Tel Aviv Univ, Sch Mech Engn, IL-69978 Tel Aviv, Israel; [Kirchhefer, Adam; Kopp, Gregory A.] Univ Western Ontario, Fac Engn, Boundary Layer Wind Tunnel Lab, London, ON, Canada; [Bezner-Kerr, Wayne; Guglielmo, Christopher G.] Univ Western Ontario, Adv Facil Avian Res, Dept Biol, London, ON, Canada; [Gurka, Roi] Ben Gurion Univ Negev, Dept Mech Engn, IL-84105 Beer Sheva, Israel	Tel Aviv University; Western University (University of Western Ontario); Western University (University of Western Ontario); Ben Gurion University	Gurka, R (corresponding author), Ben Gurion Univ Negev, Dept Mech Engn, IL-84105 Beer Sheva, Israel.	gurka@bgu.ac.il	Morbey, Yolanda/F-9035-2013; GURKA, ROI/F-1493-2012; Ben-Gida, Hadar/GLU-4962-2022	Ben-Gida, Hadar/0000-0003-2488-3234; Gurka, Roi/0000-0002-8907-6663; Kopp, Gregory/0000-0002-0784-3014	Tel Aviv University; NSERC; Canada Foundation for Innovation; AFAR at the University of Western Ontario	Tel Aviv University; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); AFAR at the University of Western Ontario	Z.J. Taylor gratefully acknowledges the support of the Tel Aviv University Post-doctoral Fellow Scholarship. R. Gurka and C. G. Guglielmo gratefully acknowledge funding from the NSERC Discovery Grants Program, and the Canada Foundation for Innovation and Ontario Research Fund for construction of the AFAR at the University of Western Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jr J D, 2001, FUNDAMENTALS AERODYN; [Anonymous], 1949, GEN THEORY AERODYNAM; [Anonymous], STUDIES PORTABLE AIR; BROWN RHJ, 1963, BIOL REV, V38, P460, DOI 10.1111/j.1469-185X.1963.tb00790.x; Brunton S, 2010, 48 AIAA AER SCI M EX; Chakraborty P, 2005, J FLUID MECH, V535, P189, DOI 10.1017/S0022112005004726; Dong H, 2006, J FLUID MECH, V566, P309, DOI 10.1017/S002211200600190X; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; Hall KC, 2002, PROGR ASTRONAUT AERO, V195, P249; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; Hedenstrom A, 2008, J R SOC INTERFACE, V5, P595, DOI 10.1098/rsif.2008.0027; Hedenstrom A, 2009, EXP FLUIDS, V46, P923, DOI 10.1007/s00348-009-0634-5; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Henningsson P, 2008, J EXP BIOL, V211, P717, DOI 10.1242/jeb.012146; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Hubel TY, 2010, J EXP BIOL, V213, P1930, DOI 10.1242/jeb.040857; Hubel TY, 2009, EXP FLUIDS, V46, P933, DOI 10.1007/s00348-009-0624-7; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Johansson LC, 2009, J EXP BIOL, V212, P3365, DOI 10.1242/jeb.034454; Johansson LC, 2008, J EXP BIOL, V211, P2909, DOI 10.1242/jeb.018192; Kirchhefer AJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4807064; Linton J. O., 2007, Physics Education, V42, P358, DOI 10.1088/0031-9120/42/4/004; Muijres FT, 2008, SCIENCE, V319, P1250, DOI 10.1126/science.1153019; Muijres FT, 2011, J R SOC INTERFACE, V8, P1418, DOI 10.1098/rsif.2011.0015; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; NACHTIGA.W, 1966, Z VERGL PHYSIOL, V52, P333, DOI 10.1007/BF00302288; Raffel M., 1998, EXP FLUID MECH; RAYNER JMV, 1979, J EXP BIOL, V80, P17; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; RAYNER JMV, 1979, J FLUID MECH, V91, P731, DOI 10.1017/S0022112079000422; Rayner JMV, 2001, MATH METHOD APPL SCI, V24, P1485, DOI 10.1002/mma.196; Rayner JMV, 2001, AM ZOOL, V41, P188, DOI 10.1668/0003-1569(2001)041[0188:AAEOIF]2.0.CO;2; Rosen M, 2007, J R SOC INTERFACE, V4, P659, DOI 10.1098/rsif.2007.0215; Rosen M, 2004, J EXP BIOL, V207, P4255, DOI 10.1242/jeb.01283; Shyy W, 2008, CAMB AERO SER, P1; Soloff SM, 1997, MEAS SCI TECHNOL, V8, P1441, DOI 10.1088/0957-0233/8/12/008; Spedding GR, 2009, EXP FLUIDS, V46, P749, DOI 10.1007/s00348-008-0597-y; SPEDDING GR, 1987, J EXP BIOL, V127, P59; SPEDDING GR, 1986, J EXP BIOL, V125, P287; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Taylor ZJ, 2010, IEEE T INSTRUM MEAS, V59, P3262, DOI 10.1109/TIM.2010.2047149; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; van Doorne CWH, 2007, EXP FLUIDS, V42, P259, DOI 10.1007/s00348-006-0235-5; Vernet A, 1999, J FLUID MECH, V394, P303, DOI 10.1017/S0022112099005807; VIDELER J, 1985, J EXP BIOL, V119, P265; Wagner H, 1925, Z ANGEW MATH MECH, V5, P17, DOI 10.1002/zamm.19250050103; Waldman RM, 2012, EXP FLUIDS, V53, P1487, DOI 10.1007/s00348-012-1368-3; Zheng L, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/3/036001	50	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80086	10.1371/journal.pone.0080086	http://dx.doi.org/10.1371/journal.pone.0080086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278243	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700024
J	Chen, CH; Tang, SC; Tsai, LK; Yeh, SJ; Chen, KH; Li, CH; Hsiao, YJ; Chen, YW; Yip, BS; Jeng, JS				Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Yeh, Shin-Joe; Chen, Kai-Hsiang; Li, Chen-Hua; Hsiao, Yu-Jen; Chen, Yu-Wei; Yip, Bak-Sau; Jeng, Jiann-Shing			Proteinuria Independently Predicts Unfavorable Outcome of Ischemic Stroke Patients Receiving Intravenous Thrombolysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL DYSFUNCTION; HEMORRHAGIC TRANSFORMATION; CARDIOVASCULAR-DISEASE; SAFE IMPLEMENTATION; RISK-FACTOR; SITS-MOST; FOLLOW-UP; MICROALBUMINURIA; THERAPY	Background and Purpose: Patients with low estimated glomerular filtration rate (eGFR) and proteinuria may be at increased risk for stroke. This study investigated whether low eGFR and proteinuria are outcome predictors in stroke patients treated with intravenous thrombolysis. Methods: We studied 432 consecutive stroke patients who received thrombolysis from January 2006 to December 2012, in Taiwan. Unfavorable outcome was defined as modified Rankin scale >= 2 at 3 months after stroke. Proteinuria was classified as negative or trace, mild, and moderate to severe. Using logistic regression analysis, we identified independent factors for unfavorable outcome after thrombolysis. Results: Of all patients, 32.7% had proteinuria. Patients with proteinuria were older, had higher frequencies of diabetes mellitus, hyperlipidemia, atrial fibrillation, lower eGFR, and greater severity of stroke upon admission than those without proteinuria. Proteinuria, not low eGFR, was an independent predictor for unfavorable outcome for stroke (OR = 2.00 for mild proteinuria, p = 0.035; OR = 2.54 for moderate to severe proteinuria, p = 0.035). However, no clear relationship was found between proteinuria and symptomatic hemorrhage after thrombolysis. Conclusions: Proteinuria is an independent predictor of unfavorable outcome for acute ischemic stroke in patients treated with intravenous thrombolysis, indicating the crucial role of chronic kidney disease on the effectiveness of thrombolysis.	[Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Yeh, Shin-Joe; Chen, Yu-Wei; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Yeh, Shin-Joe; Chen, Yu-Wei; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Chih-Hao] Far Eastern Mem Hosp, Dept Internal Med, Div Neurol, New Taipei City, Taiwan; [Tsai, Li-Kai; Hsiao, Yu-Jen] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Neurol, Yunlin, Taiwan; [Chen, Kai-Hsiang; Yip, Bak-Sau] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Neurol, Hsinchu, Taiwan; [Li, Chen-Hua; Chen, Yu-Wei] Landseed Hosp, Dept Neurol, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jeng, JS (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	jsjeng@ntu.edu.tw	Chen, Chih-Hao/AAA-7297-2022; yeh, shin-joe/HGV-0244-2022	Chen, Chih-Hao/0000-0002-1258-8775; Tsai, Li-Kai/0000-0001-8420-6951; JENG, JIANN-SHING/0000-0002-1456-3686; CHEN, KAI-HSIANG/0000-0002-9527-4084; Yeh, Shin-Joe/0000-0003-1511-6295; Yip, Bak-Sau/0000-0001-7942-8293; Tang, Sung-Chun/0000-0003-3731-5973	National Taiwan University Hospital [NTUH.102-S2186]; Academia Sinica, Taiwan [BM102021169]	National Taiwan University Hospital(National Taiwan University); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This study was supported in part by grants from the National Taiwan University Hospital (NTUH.102-S2186) and Academia Sinica, Taiwan (BM102021169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agrawal V, 2010, NEPHROL DIAL TRANSPL, V25, P1150, DOI 10.1093/ndt/gfp619; Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Cho BH, 2013, EUR J NEUROL, V20, P1145, DOI 10.1111/ene.12127; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fox KAA, 2007, J AM COLL CARDIOL, V49, P2249, DOI 10.1016/j.jacc.2006.12.049; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KNOBL P, 1993, DIABETOLOGIA, V36, P1045, DOI 10.1007/BF02374497; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Lee M, 2010, STROKE, V41, P2625, DOI 10.1161/STROKEAHA.110.581215; Lyrer PA, 2008, NEUROLOGY, V71, P1548, DOI 10.1212/01.wnl.0000338459.82173.78; MacWalter RS, 2002, STROKE, V33, P1630, DOI 10.1161/01.STR.0000016344.49819.F7; Madison JR, 2006, ARCH INTERN MED, V166, P884, DOI 10.1001/archinte.166.8.884; Naganuma M, 2011, CEREBROVASC DIS, V31, P123, DOI 10.1159/000321516; Ninomiya T, 2009, AM J KIDNEY DIS, V53, P417, DOI 10.1053/j.ajkd.2008.08.032; Norris JW, 1998, CAN J NEUROL SCI, V25, P257, DOI 10.1017/S0317167100034120; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; Ovbiagele B, 2008, J NEUROL SCI, V271, P21, DOI 10.1016/j.jns.2008.04.007; Rodriguez-Yanez M, 2006, NEUROLOGY, V67, P1172, DOI 10.1212/01.wnl.0000238353.89194.08; Saposnik G, 2012, STROKE, V43, P1315, DOI 10.1161/STROKEAHA.111.646265; Sharma VK, 2010, J STROKE CEREBROVASC, V19, P424, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.015; Slowik A, 2002, CEREBROVASC DIS, V14, P15, DOI 10.1159/000063718; Stroke Study Group National Institute of Neurological Disorders, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Toyoda K, 2009, STROKE, V40, P3591, DOI 10.1161/STROKEAHA.109.562991; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wahlgren N, 2008, STROKE, V39, P3316, DOI 10.1161/STROKEAHA.107.510768; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882; Yuyun MF, 2004, J INTERN MED, V255, P247, DOI 10.1046/j.1365-2796.2003.01264.x	35	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80527	10.1371/journal.pone.0080527	http://dx.doi.org/10.1371/journal.pone.0080527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278288	Green Submitted, gold, Green Published			2022-12-27	WOS:000327541700029
J	Choi, BY; Kim, JH; Kim, HJ; Yoo, JH; Song, HK; Sohn, M; Won, SJ; Suh, SW				Choi, Bo Young; Kim, Jin Hee; Kim, Hyun Jung; Yoo, Jin Hyuk; Song, Hong Ki; Sohn, Min; Won, Seok Joon; Suh, Sang Won			Pyruvate Administration Reduces Recurrent/Moderate Hypoglycemia-Induced Cortical Neuron Death in Diabetic Rats	PLOS ONE			English	Article							INSULIN-INDUCED HYPOGLYCEMIA; MITOCHONDRIAL PERMEABILITY TRANSITION; BLOOD-BRAIN-BARRIER; AMINO-ACIDS; CELL-DEATH; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; CYCLOSPORINE-A; DNA-DAMAGE; ACTIVATION	Recurrent/moderate (R/M) hypoglycemia is common in type 1 diabetes patients. Moderate hypoglycemia is not life-threatening, but if experienced recurrently it may present several clinical complications. Activated PARP-1 consumes cytosolic NAD, and because NAD is required for glycolysis, hypoglycemia-induced PARP-1 activation may render cells unable to use glucose even when glucose availability is restored. Pyruvate, however, can be metabolized in the absence of cytosolic NAD. We therefore hypothesized that pyruvate may be able to improve the outcome in diabetic rats subjected to insulin-induced R/M hypoglycemia by terminating hypoglycemia with glucose plus pyruvate, as compared with delivering just glucose alone. In an effort to mimic juvenile type 1 diabetes the experiments were conducted in one-month-old young rats that were rendered diabetic by streptozotocin (STZ, 50mg/kg, i.p.) injection. One week after STZ injection, rats were subjected to moderate hypoglycemia by insulin injection (10U/kg, i.p.) without anesthesia for five consecutive days. Pyruvate (500mg/kg) was given by intraperitoneal injection after each R/M hypoglycemia. Three hours after last R/M hypoglycemia, zinc accumulation was evaluated. Three days after R/M hypoglycemia, neuronal death, oxidative stress, microglial activation and GSH concentrations in the cerebral cortex were analyzed. Sparse neuronal death was observed in the cortex. Zinc accumulation, oxidative injury, microglial activation and GSH loss in the cortex after R/M hypoglycemia were all reduced by pyruvate injection. These findings suggest that when delivered alongside glucose, pyruvate may significantly improve the outcome after R/M hypoglycemia by circumventing a sustained impairment in neuronal glucose utilization resulting from PARP-1 activation.	[Choi, Bo Young; Kim, Jin Hee; Kim, Hyun Jung; Yoo, Jin Hyuk; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Song, Hong Ki] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea; [Won, Seok Joon] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	Hallym University; Hallym University; Inha University; University of California System; University of California San Francisco	Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea.	swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120202]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; CONN AR, 1982, AM J PHYSIOL, V243, pE272, DOI 10.1152/ajpendo.1982.243.4.E272; Cryer PE, 2001, AM J PHYSIOL-ENDOC M, V281, pE1115, DOI 10.1152/ajpendo.2001.281.6.E1115; Davis EA, 1998, J PEDIATR ENDOCR MET, V11, P177; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Dienel GA, 2004, NEUROCHEM INT, V45, P321, DOI 10.1016/j.neuint.2003.10.011; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; ENGELSEN B, 1986, J NEUROCHEM, V47, P1634, DOI 10.1111/j.1471-4159.1986.tb00806.x; Ferrand-Drake M, 1999, NEUROSCIENCE, V90, P1325, DOI 10.1016/S0306-4522(98)00559-4; Ferrand-Drake M, 2003, J NEUROCHEM, V85, P1431, DOI 10.1046/j.1471-4159.2003.01794.x; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GERICH JE, 1991, ENDOCR REV, V12, P356, DOI 10.1210/edrv-12-4-356; Graesser D, 2000, J NEUROIMMUNOL, V109, P121, DOI 10.1016/S0165-5728(00)00275-7; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; JUHLER M, 1984, BRAIN RES, V302, P347, DOI 10.1016/0006-8993(84)90249-X; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Lee JY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0002.2001; LEWIS LD, 1974, J NEUROCHEM, V23, P673, DOI 10.1111/j.1471-4159.1974.tb04390.x; Liblau RS, 1996, P NATL ACAD SCI USA, V93, P3031, DOI 10.1073/pnas.93.7.3031; MCCRIMMON RJ, 1994, DIABETES METAB, V20, P503; NELLGARD B, 1992, EXP BRAIN RES, V92, P259; OLDENDORF WH, 1973, AM J PHYSIOL, V224, P1450, DOI 10.1152/ajplegacy.1973.224.6.1450; PAPAGAPIOU MP, 1990, J CEREBR BLOOD F MET, V10, P270, DOI 10.1038/jcbfm.1990.44; Patockova J, 2003, PHYSIOL RES, V52, P131; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Puente EC, 2010, DIABETES, V59, P1055, DOI 10.2337/db09-1495; SANDBERG M, 1986, J NEUROCHEM, V47, P178; SELTZER HS, 1989, ENDOCRIN METAB CLIN, V18, P163, DOI 10.1016/S0889-8529(18)30395-5; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Singh P, 2004, MOL CELL BIOCHEM, V260, P153, DOI 10.1023/B:MCBI.0000026067.08356.13; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2005, DIABETES, V54, P1452, DOI 10.2337/diabetes.54.5.1452; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; TALLROTH G, 1990, DIABETOLOGIA, V33, P319, DOI 10.1007/BF00403327; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Won SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-182; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Yamada KA, 2004, PEDIATR RES, V55, P372, DOI 10.1203/01.PDR.0000110523.07240.C1; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Zammitt NN, 2008, DIABETES, V57, P732, DOI 10.2337/db07-0695; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81523	10.1371/journal.pone.0081523	http://dx.doi.org/10.1371/journal.pone.0081523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278448	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700067
J	Hu, YH; Sheng, DY; Xiang, YZ; Yang, ZJ; Xu, DP; Zhang, NN; Shi, LL				Hu, Yue-Hua; Sheng, Da-Yong; Xiang, Yang-Zhou; Yang, Zeng-Jiang; Xu, Da-Ping; Zhang, Ning-Nan; Shi, Lei-Lei			The Environment, Not Space, Dominantly Structures the Landscape Patterns of the Richness and Composition of the Tropical Understory Vegetation	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; BETA-DIVERSITY; DISPERSAL LIMITATION; SPATIAL AUTOCORRELATION; COMMUNITY COMPOSITION; FLORISTIC VARIATION; SCALE-DEPENDENCE; FOREST; DISTRIBUTIONS; TEMPERATE	The mechanisms driving the spatial patterns of species richness and composition are essential to the understanding of biodiversity. Numerous studies separately identify the contributions of the environment (niche process) and space (neutral process) to the species richness or composition at different scales, but few studies have investigated the contributions of both types of processes in the two types of data at the landscape scale. In this study, we partitioned the spatial variations in all, exotic and native understory plant species richness and composition constrained by environmental variables and space in 134 plots that were spread across 10 counties in Hainan Island in southern China. The 134 plots included 70 rubber (Hevea brasiliensis) plantation plots, 50 eucalyptus (Eucalyptus urophylla) plantation plots, and 14 secondary forest plots. RDA based variation partitioning was run to assess the contribution of environment and space to species richness and composition. The results showed that the environmental variables alone explained a large proportion of the variations in both the species richness and composition of all, native, and exotic species. The RDA results indicated that overstory composition (forest type here) plays a leading role in determining species richness and composition patterns. The alpha and beta diversities of the secondary forest plots were markedly higher than that of the two plantations. In conclusion, niche differentiation processes are the principal mechanisms that shape the alpha and beta diversities of understory plant species in Hainan Island.	[Hu, Yue-Hua] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Hu, Yue-Hua; Xiang, Yang-Zhou; Yang, Zeng-Jiang; Xu, Da-Ping; Zhang, Ning-Nan; Shi, Lei-Lei] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Sheng, Da-Yong] South China Agr Univ, Coll Forestry, Guangzhou, Guangdong, Peoples R China; [Sheng, Da-Yong] Huizhou Inst Forestry Sci, Huizhou, Guangdong, Peoples R China; [Xiang, Yang-Zhou] Guizhou Inst Forest Inventory & Planning, Guiyang, Guizhou, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; South China Agricultural University	Xiang, YZ (corresponding author), Guizhou Inst Forest Inventory & Planning, Guiyang, Guizhou, Peoples R China.	yzhxiang18@126.com; gzfsrd@163.com			National Science and Technology Pillar Program for the Research and Demonstration of Sustainable Management Technology of Fast Growing Eucalyptus and Acacia Pulp Plantations [2006BAD32B02]; Monitoring Program of Ecological and Environmental Impact of Eucalyptus Plantation of the Hainan Jinhua Forestry Limited Company; West Light Foundation of the Chinese Academy of Sciences	National Science and Technology Pillar Program for the Research and Demonstration of Sustainable Management Technology of Fast Growing Eucalyptus and Acacia Pulp Plantations; Monitoring Program of Ecological and Environmental Impact of Eucalyptus Plantation of the Hainan Jinhua Forestry Limited Company; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Science and Technology Pillar Program for the Research and Demonstration of Sustainable Management Technology of Fast Growing Eucalyptus and Acacia Pulp Plantations (2006BAD32B02), by the Monitoring Program of Ecological and Environmental Impact of Eucalyptus Plantation of the Hainan Jinhua Forestry Limited Company, and by the West Light Foundation of the Chinese Academy of Sciences to Yue-Hua Hu. This does not alter the authors' adherence to all of the PLOS ONE policies on the sharing of data and materials. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Bartels SF, 2010, ECOLOGY, V91, P1931, DOI 10.1890/09-1376.1; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown RL, 2003, ECOLOGY, V84, P32, DOI 10.1890/0012-9658(2003)084[0032:DAIOSA]2.0.CO;2; Chen HYH, 2004, CAN J BOT, V82, P1314, DOI [10.1139/b04-086, 10.1139/B04-086]; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Davies KF, 2005, ECOLOGY, V86, P1602, DOI 10.1890/04-1196; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; DRAY S, 2006, ECOL MODEL, V196, P483, DOI DOI 10.1016/J.EC0LM0DEL.2006.02.015; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilbert B, 2005, ECOLOGY, V86, P1848, DOI 10.1890/04-09997; GILLIAM FS, 1993, B TORREY BOT CLUB, V120, P445, DOI 10.2307/2996749; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; HALPERN CB, 1995, ECOL APPL, V5, P913, DOI 10.2307/2269343; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell Stephen P., 2001, V32, pi; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Legare S, 2002, SILVA FENN, V36, P353, DOI 10.14214/sf.567; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Pare D, 1996, CAN J FOREST RES, V26, P1022, DOI 10.1139/x26-113; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2021, R LANGUAGE ENV STAT; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Tuomisto H, 2002, BIOTROPICA, V34, P516, DOI 10.1111/j.1744-7429.2002.tb00571.x; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	55	7	13	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81308	10.1371/journal.pone.0081308	http://dx.doi.org/10.1371/journal.pone.0081308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278417	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700058
J	Mielcarek, M; Seredenina, T; Stokes, MP; Osborne, GF; Landles, C; Inuabasi, L; Franklin, SA; Silva, JC; Luthi-Carter, R; Beaumont, V; Bates, GP				Mielcarek, Michal; Seredenina, Tamara; Stokes, Matthew P.; Osborne, Georgina F.; Landles, Christian; Inuabasi, Linda; Franklin, Sophie A.; Silva, Jeffrey C.; Luthi-Carter, Ruth; Beaumont, Vahri; Bates, Gillian P.			HDAC4 Does Not Act as a Protein Deacetylase in the Postnatal Murine Brain In Vivo	PLOS ONE			English	Article							HISTONE DEACETYLASES; INTRACELLULAR TRAFFICKING; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; CELL-DEATH; ACETYLATION; MEMORY; NEURODEGENERATION; PHOSPHORYLATION; LOCALIZATION	Reversible protein acetylation provides a central mechanism for controlling gene expression and cellular signaling events. It is governed by the antagonistic commitment of two enzymes families: the histone acetyltransferases (HATs) and the histone deacetylases (HDACs). HDAC4, like its class IIa counterparts, is a potent transcriptional repressor through interactions with tissue specific transcription factors via its N-terminal domain. Whilst the lysine deacetylase activity of the class IIa HDACs is much less potent than that of the class I enzymes, HDAC4 has been reported to influence protein deacetylation through its interaction with HDAC3. To investigate the influence of HDAC4 on protein acetylation we employed the immunoaffinity-based AcetylScan proteomic method. We identified many proteins known to be modified by acetylation, but found that the absence of HDAC4 had no effect on the acetylation profile of the murine neonate brain. This is consistent with the biochemical data suggesting that HDAC4 may not function as a lysine deacetylase, but these in vivo data do not support the previous report showing that the enzymatic activity of HDAC3 might be modified by its interaction with HDAC4. To complement this work, we used Affymetrix arrays to investigate the effect of HDAC4 knock-out on the transcriptional profile of the postnatal murine brain. There was no effect on global transcription, consistent with the absence of a differential histone acetylation profile. Validation of the array data by Taq-man qPCR indicated that only protamine 1 and Igfbp6 mRNA levels were increased by more than one-fold and only Calml4 was decreased. The lack of a major effect on the transcriptional profile is consistent with the cytoplasmic location of HDAC4 in the P3 murine brain.	[Mielcarek, Michal; Osborne, Georgina F.; Landles, Christian; Inuabasi, Linda; Franklin, Sophie A.; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London, England; [Seredenina, Tamara; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Stokes, Matthew P.; Silva, Jeffrey C.] Cell Signaling Technol, Danvers, MA USA; [Beaumont, Vahri] CHDI Fdn Inc, CHDI Management Inc, Los Angeles, CA USA	University of London; King's College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bates, GP (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	gillian.bates@kcl.ac.uk	Mielcarek, Michal/M-6302-2018; Bates, Gillian/E-1146-2012	Mielcarek, Michal/0000-0002-9874-6753; Bates, Gillian/0000-0002-4041-6305; Beaumont, Vahri/0000-0002-6488-2175; Osborne, Georgina/0000-0001-8308-3179; Landles, Christian/0000-0001-9715-6447	CHDI Foundation	CHDI Foundation	This work was supported by the CHDI Foundation, a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research at Cell Signaling Technologies was conducted under a fee-for-service agreement for King's College London. Research conducted at King's College was performed in collaboration with and funded by the CHDI Foundation. In these cases, the funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Davies SW, 1999, METHOD ENZYMOL, V309, P687; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Majdzadeh N, 2008, DEV NEUROBIOL, V68, P1076, DOI 10.1002/dneu.20637; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mielcarek M, 2013, PLOS BIOL IN PRESS; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Price V, 2013, J NEUROSCI RES, V91, P407, DOI 10.1002/jnr.23170; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Yang WW, 2011, FEBS LETT, V585, P761, DOI 10.1016/j.febslet.2011.01.040; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	38	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80849	10.1371/journal.pone.0080849	http://dx.doi.org/10.1371/journal.pone.0080849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278330	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700035
J	Prieto-Marquez, A; Wagner, JR				Prieto-Marquez, Albert; Wagner, Jonathan R.			The 'Unicorn' Dinosaur That Wasn't: A New Reconstruction of the Crest of Tsintaosaurus and the Early Evolution of the Lambeosaurine Crest and Rostrum	PLOS ONE			English	Article							ARAL SEA REGION; HADROSAURID DINOSAURIA; NASAL CAVITY; ORNITHISCHIA; ANATOMY; ORNITHOPODA; HOMOLOGIES; PHYLOGENY	The lambeosaurine Tsintaosaurus spinorhinus has traditionally been reconstructed with an elevated, hollow, spike-like crest composed entirely of the nasal bones, although this has been disputed. Here, we provide a new reconstruction of the skull of this species based on reexamination and reinterpretation of the morphology and articular relationships of the type and Paratype skulls and a fragmentary crest. We confirm the presence of a supracranial crest composed of the elevated nasal bones, but also including the premaxillae. We hypothesize that the crest is a tall, lobate, hollow structure that projects dorsally and slightly caudally a distance greater than the height of the skull along the quadrate. In our reconstruction, the nasal passage passes through the crest, but enters the skull rostral to the tubular process of the nasals, not through it. Tsintaosaurus spinorhinus is rediagnosed on the basis of a suite of cranial autapomorphies including a circumnarial fossa subdivided into three accessory fossae, prefrontal with ascending rostral process and lateral flange, nasals fused sagittally to form elongate tubular process that rises dorsally from skull roof, each nasal being expanded rostrocaudally into a rhomboid distal process, and medial processes of premaxillae at the summit of the cranial crest inserted between rhomboid processes of nasals. Tsintaosaurus spinorhinus lacks characters that are present in more derived lambeosaurines (parasaurolophins and lambeosaurins), such as rotation of the caudal margin of the crest to an acute angle with the skull roof, lateral processes of the nasals that enclose part of the intracranial cavity and participate in the formation of the walls of the common median chamber, and a smooth narial fossa lacking ridges and accessory fossae. We hypothesize that ancestrally the rostrum of lambeosaurines may have been more similar to that in Saurolophinae, and became subsequently reduced in complexity during evolution of the group.	[Prieto-Marquez, Albert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Wagner, Jonathan R.] Texas State Univ San Marcos, Dept Geog, San Marcos, TX USA	Texas State University System; Texas State University San Marcos	Prieto-Marquez, A (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	redshore@gmail.com	Prieto-Marquez, Albert/AAA-1470-2019	Prieto-Marquez, Albert/0000-0002-4836-4052	Charlotte and Walter Kohler Charitable Trust; Kalbfleisch Research Fellowship from the American Museum of Natural History; Alexander von Humboldt Foundation; Ministry of Education and Science of Spain [CGL2011-30069-C02-01]	Charlotte and Walter Kohler Charitable Trust; Kalbfleisch Research Fellowship from the American Museum of Natural History; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Ministry of Education and Science of Spain	Traveling and research funds provided by a Charlotte and Walter Kohler Charitable Trust Grant, a Kalbfleisch Research Fellowship from the American Museum of Natural History, and the Alexander von Humboldt Foundation. Additional research and publication fees were funded by a grant (CGL2011-30069-C02-01) from the Ministry of Education and Science of Spain presented to A. Galobart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov AO, 2007, CRETACEOUS RES, V28, P532, DOI 10.1016/j.cretres.2006.08.008; Bell PR, 2013, CRETACEOUS RES, V45, P265, DOI 10.1016/j.cretres.2013.05.003; Benton M, 2004, GREAT BOOK DINOSAURS; Brink KS, 2011, HIST BIOL, V23, P63, DOI 10.1080/08912963.2010.499169; Brown B, 1914, B AM MUS NAT HIST, V33, P559; Brown B, 1916, B AM MUS NAT HIST, V35, P701; BUFFETAUT E, 1993, CR ACAD SCI II, V317, P1255; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Casanovas ML, 1999, GEOL MAG, V136, P205, DOI 10.1017/S0016756899002319; Casanovas-Cladellas M.L., 1995, Paleontologia i Evolucio, V26-27, P121; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Dixon D, 2008, TSINTAOSAURUS OTHER; Dixon D, 1988, MACMILLAN ENCY DINOS; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2006, PALEOBIOLOGY, V32, P109, DOI 10.1666/0094-8373(2006)032[0109:NCHACC]2.0.CO;2; Evans DC., 2007, THESIS U TORONTO; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gilmore CW, 1924, CANADA GEOLOGICAL SU, V38, P29; GILMORE CW, 1924, B CANADA DEP MINES G, V38, P49; Godefroit P., 2004, B I ROYAL SCI NATURE, V74, P139; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Godefroit P, 2012, ACTA PALAEONTOL POL, V57, P527, DOI 10.4202/app.2011.0051; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Hong JP, 1999, ISL ARC, V8, P80, DOI 10.1046/j.1440-1738.1999.00226.x; HOPSON J A, 1975, Paleobiology, V1, P21; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Hu C, 2001, SHANTUNGOSAURUS GIGA, P135; Kordikova EG, 2001, J PALEONTOL, V75, P390, DOI 10.1666/0022-3360(2001)075<0390:SVFTLC>2.0.CO;2; Lambe L., 1914, Ottawa Naturalist, V27; Lambe L. M., 1917, Ottawa Naturalist, V31; LAMBE LM, 1920, GEOLOGICAL SURVEY ME, V120, P1; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Lund Eric K., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P263; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Nessov Lev, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V2, P65; Novas F. E., 2009, AGE DINOSAURS S AM; Ostrom J. H., 1962, Postilla, VNo. 62, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Parks W. A, 1922, GEOLOGICAL SERIES, V13, P1; Parks WA, 1923, GEOLOGICAL SERIES, V15, P5; Powell J.E., 1987, 10 C GEOL ARG ACT, P149; Prieto-Marquez A, 2005, J VERTEBR PALEONTOL, V25, P144, DOI 10.1671/0272-4634(2005)025[0144:NIOTCO]2.0.CO;2; Prieto-Marquez A, HADROSAURS IN PRESS; Prieto-Marquez A, 2006, J VERTEBR PALEONTOL, V26, P929, DOI 10.1671/0272-4634(2006)26[929:HDFTLC]2.0.CO;2; Prieto-Marquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069835; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; RIABININ AN, 1939, CENTRALNYJ NAUCNOISS, V118, P1; Rozhdestvensky AK, 1968, UPPER PALEOZOIC MESO, P97; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sternberg C. M., 1953, Bulletin National Museum of Canada, VNo. 128, P275; Sullivan R.M., 1999, NEW MEXICO MUSEUM NA, V15, P1; Taquet P, 1991, CONTRIBUTIONS PALEON, P63; Wagner J, 2004, J VERTEBR PALEONTOL, V24, p125A; Weishampel D.B., 1990, P534; WEISHAMPEL DB, 1981, J PALEONTOL, V55, P1046; Young CC., 1958, PALAEONTOLOGICA SI C, V16, P53	64	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82268	10.1371/journal.pone.0082268	http://dx.doi.org/10.1371/journal.pone.0082268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278478	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700077
J	Blanc, L; Castanier, R; Mishra, AK; Ray, A; Besra, GS; Sutcliffe, I; Vercellone, A; Nigou, J				Blanc, Landry; Castanier, Romain; Mishra, Arun K.; Ray, Aurelie; Besra, Gurdyal S.; Sutcliffe, Iain; Vercellone, Alain; Nigou, Jerome			Gram-Positive Bacterial Lipoglycans Based on a Glycosylated Diacylglycerol Lipid Anchor Are Microbe-Associated Molecular Patterns Recognized by TLR2	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; MEMBRANE-ASSOCIATED LIPOMANNAN; LIPOTEICHOIC ACID; MYCOBACTERIAL LIPOARABINOMANNAN; MICROCOCCUS-LUTEUS; BINDING; STREPTOCOCCUS; LIPOPROTEINS; LIPOPEPTIDES	Innate immune recognition is the first line of host defense against invading microorganisms. It is a based on the detection, by pattern recognition receptors (PRRs), of invariant molecular signatures that are unique to microorganisms. TLR2 is a PRR that plays a major role in the detection of Gram-positive bacteria by recognizing cell envelope lipid-linked polymers, also called macroamphiphiles, such as lipoproteins, lipoteichoic acids and mycobacterial lipoglycans. These microbe-associated molecular patterns (MAMPs) display a structure based on a lipid anchor, being either an acylated cysteine, a glycosylated diacylglycerol or a mannosyl-phosphatidylinositol respectively, and having in common a diacylglyceryl moiety. A fourth class of macroamphiphile, namely lipoglycans, whose lipid anchor is made, as for lipoteichoic acids, of a glycosylated diacylglycerol unit rather than a mannosyl-phosphatidylinositol, is found in Gram-positive bacteria and produced by certain Actinobacteria, including Micrococcus luteus, Stomatococcus mucilaginosus and Corynebacterium glutamicum. We report here that these alternative lipoglycans are also recognized by TLR2 and that they stimulate TLR2-dependant cytokine production, including IL-8, TNF-alpha and IL-6, and cell surface co-stimulatory molecule CD40 expression by a human macrophage cell line. However, they differ by their co-receptor requirement and the magnitude of the innate immune response they elicit. M. luteus and S. mucilaginosus lipoglycans require TLR1 for recognition by TLR2 and induce stronger responses than C. glutamicum lipoglycan, sensing of which by TLR2 is dependent on TLR6. These results expand the repertoire of MAMPs recognized by TLR2 to lipoglycans based on a glycosylated diacylglycerol lipid anchor and reinforce the paradigm that macroamphiphiles based on such an anchor, including lipoteichoic acids and alternative lipoglycans, induce TLR2-dependant innate immune responses.	[Blanc, Landry; Castanier, Romain; Ray, Aurelie; Vercellone, Alain; Nigou, Jerome] CNRS, IPBS, F-31077 Toulouse, France; [Blanc, Landry; Castanier, Romain; Ray, Aurelie; Vercellone, Alain; Nigou, Jerome] Univ Toulouse, UPS, IPBS, F-31077 Toulouse, France; [Mishra, Arun K.] Natl Inst Med Res, London NW7 1AA, England; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sutcliffe, Iain] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; MRC National Institute for Medical Research; University of Birmingham; Northumbria University	Nigou, J (corresponding author), CNRS, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	jerome.nigou@ipbs.fr	Sutcliffe, Iain C./A-5354-2009; BLANC, Landry/AAQ-2749-2021; Nigou, Jérôme/D-6802-2019	Sutcliffe, Iain C./0000-0002-9036-2683; BLANC, Landry/0000-0001-5622-356X; Nigou, Jérôme/0000-0002-6233-2487; Besra, Gurdyal/0000-0002-5605-0395	CNRS; Universite de Toulouse; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM); Cayla-Invivogen (Toulouse); Region Midi-Pyrenees; Prof Douglas Young; MRC [MRC U117581288]; Wellcome Trust [081569/Z/06/Z]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Toulouse; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Cayla-Invivogen (Toulouse); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Prof Douglas Young; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	This work was supported by CNRS and Universite de Toulouse. RC and AR are recipients of PhD fellowships from the French Ministere de l'Enseignement Superieur et de la Recherche. AR was awarded a "Fin de These'' fellowship from Fondation pour la Recherche Medicale (FRM). LB PhD fellowship was sponsored by Cayla-Invivogen (Toulouse) and the Region Midi-Pyrenees. AKM acknowledges the support and sponsorship from Prof Douglas Young and MRC Grant MRC U117581288. GSB acknowledges support in the form of a Personal Research Chair from Mr James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, the Medical Research Council and the Wellcome Trust (081569/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Cot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026316; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Fischer W, 1994, BACTERIAL CELL WALL, P199; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Krishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028476; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pakkiri LS, 2005, GLYCOBIOLOGY, V15, P291, DOI 10.1093/glycob/cwi003; Pakkiri LS, 2004, GLYCOBIOLOGY, V14, P73, DOI 10.1093/glycob/cwh012; Rahman O, 2009, TRENDS MICROBIOL, V17, P219, DOI 10.1016/j.tim.2009.03.003; Ray A, 2013, BIOCHIMIE, V95, P33, DOI 10.1016/j.biochi.2012.06.007; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Sutcliffe Iain C., 1994, Systematic and Applied Microbiology, V17, P467; SUTCLIFFE IC, 1991, J BACTERIOL, V173, P7065, DOI 10.1128/jb.173.22.7065-7069.1991; SUTCLIFFE IC, 1995, ARCH MICROBIOL, V163, P70; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	40	14	14	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81593	10.1371/journal.pone.0081593	http://dx.doi.org/10.1371/journal.pone.0081593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278450	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327539800136
J	Chen, AY; Zeremski, M; Chauhan, R; Jacobson, IM; Talal, AH; Michalak, TI				Chen, Annie Y.; Zeremski, Marija; Chauhan, Ranjit; Jacobson, Ira M.; Talal, Andrew H.; Michalak, Tomasz I.			Persistence of Hepatitis C Virus during and after Otherwise Clinically Successful Treatment of Chronic Hepatitis C with Standard Pegylated Interferon alpha-2b and Ribavirin Therapy	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HUMAN T-LYMPHOCYTES; HEPATOCELLULAR-CARCINOMA; B-VIRUS; LIVER; HCV; INFECTION; EXPRESSION; CELLS; RNA	Resolution of chronic hepatitis C is considered when serum HCV RNA becomes repeatedly undetectable and liver enzymes normalize. However, long-term persistence of HCV following therapy with pegylated interferon-alpha/ribavirin (PegIFN/R) was reported when more sensitive assays and testing of serial plasma, lymphoid cells (PBMC) and/or liver biopsies was applied. Our aim was to reassess plasma and PBMCs collected during and after standard PegIFN/R therapy from individuals who became HCV RNA nonreactive by clinical testing. Of particular interest was to determine if HCV genome and its replication remain detectable during ongoing treatment with PegIFN/R when evaluated by more sensitive detection approaches. Plasma acquired before (n = 11), during (n = 25) and up to 12-88 weeks post-treatment (n = 20) from 9 patients and PBMC (n = 23) from 3 of them were reanalyzed for HCV RNA with sensitivity <2 IU/mL. Clone sequencing of the HCV 59'-untranslated region from plasma and PBMCs was done in 2 patients. HCV RNA was detected in 17/25 (68%) plasma and 8/10 (80%) PBMC samples collected from 8 of 9 patients during therapy, although only 5.4% plasma samples were positive by clinical assays. Among post-treatment HCV RNA-negative plasma samples, 9 of 20 (45.3%) were HCV reactive for up to 59 weeks post-treatment. Molecularly evident replication was found in 6/12 (50%) among PBMC reactive for virus RNA positive strand collected during or after treatment. Pre-treatment point mutations persisted in plasma and/or PBMC throughout therapy and follow-up. Therefore, HCV is not completely cleared during ongoing administration of PegIFN/R otherwise capable of ceasing progression of CHC and virus commonly persists at levels not detectable by the current clinical testing. The findings suggest the need for continued evaluation even after patients achieve undetectable HCV RNA post-treatment.	[Chen, Annie Y.; Chauhan, Ranjit; Michalak, Tomasz I.] Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, Mol Virol & Hepatol Res Grp, St John, NF, Canada; [Zeremski, Marija; Jacobson, Ira M.; Talal, Andrew H.] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY USA; [Zeremski, Marija; Jacobson, Ira M.; Talal, Andrew H.] Weill Cornell Med Coll, Div Gastroenterol & Hepatol, New York, NY USA; [Talal, Andrew H.] SUNY Buffalo, Dept Med, Div Gastroenterol Hepatol & Nutr, Buffalo, NY 14260 USA	Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Michalak, TI (corresponding author), Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, Mol Virol & Hepatol Res Grp, St John, NF, Canada.	timich@mun.ca	Chauhan, Ranjit/L-7777-2014	Chauhan, Ranjit/0000-0003-1682-0460	Canadian Institutes of Health Research (CIHR) [MOP-126056]; Canada Research Chair allowance provided by Memorial University; CIHR; Canada Foundation for Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair allowance provided by Memorial University; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was supported by an operating grant MOP-126056 from the Canadian Institutes of Health Research (CIHR) awarded to TIM. AYC is supported by the Canada Research Chair allowance provided by Memorial University. TIM holds the Senior Canada Research Chair in Viral Hepatitis/Immunology sponsored by the Canada Research Chair Program and funds from the CIHR and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Camma C, 1999, AM J GASTROENTEROL, V94, P581, DOI 10.1111/j.1572-0241.1999.00919.x; Castillo I, 2006, CLIN INFECT DIS, V43, P1277, DOI 10.1086/508198; Di Liberto G, 2006, GASTROENTEROLOGY, V131, P76, DOI 10.1053/j.gastro.2006.04.016; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hoare M, 2008, HEPATOLOGY, V48, P1737, DOI 10.1002/hep.22484; Katayama K, 2004, INTERVIROLOGY, V47, P57, DOI 10.1159/000076643; Kobayashi S, 2007, LIVER INT, V27, P186, DOI 10.1111/j.1478-3231.2006.01406.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lee WM, 2005, J INFECT DIS, V192, P1088, DOI 10.1086/432917; Lin A, 2008, J MED VIROL, V80, P1720, DOI 10.1002/jmv.21257; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; MacParland SA, 2006, J GEN VIROL, V87, P3577, DOI 10.1099/vir.0.81868-0; MacParland SA, 2009, HEPATOLOGY, V49, P1431, DOI 10.1002/hep.22802; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Manns MP, 2013, J VIRAL HEPATITIS, V20, P524, DOI 10.1111/jvh.12074; Michalak TI, 1999, HEPATOLOGY, V29, P928, DOI 10.1002/hep.510290329; MICHALAK TI, 1994, J CLIN INVEST, V93, P230, DOI 10.1172/JCI116950; Michalak TI, 2007, FUTURE VIROL, V2, P451, DOI 10.2217/17460794.2.5.451; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Navas S, 1998, J VIROL, V72, P1640, DOI 10.1128/JVI.72.2.1640-1646.1998; Nudo CG, 2008, TRANSPL P, V40, P1449, DOI 10.1016/j.transproceed.2008.03.158; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Pham TNQ, 2007, J VIRAL HEPATITIS, V14, P537, DOI 10.1111/j.1365-2893.2006.00834.x; Pham TNQ, 2012, J VIRAL HEPATITIS, V19, P103, DOI 10.1111/j.1365-2893.2011.01442.x; Pham TNQ, 2009, J VIRAL HEPATITIS, V16, P547, DOI 10.1111/j.1365-2893.2009.01092.x; Pham TNQ, 2004, J VIROL, V78, P5867, DOI 10.1128/JVI.78.11.5867-5874.2004; Pham TNQ, 2005, J GEN VIROL, V86, P657, DOI 10.1099/vir.0.80624-0; Pham TNQ, 2008, GASTROENTEROLOGY, V134, P812, DOI 10.1053/j.gastro.2007.12.011; Pham TNQ, 2010, LIVER INT, V30, P502, DOI 10.1111/j.1478-3231.2009.02193.x; Quiroga JA, 2006, J MED VIROL, V78, P1190, DOI 10.1002/jmv.20680; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Sarhan MA, 2012, J VIROL, V86, P3723, DOI 10.1128/JVI.06956-11; Scherzer TM, 2008, J VIRAL HEPATITIS, V15, P659, DOI 10.1111/j.1365-2893.2008.01006.x; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sewell JL, 2009, EUR J GASTROEN HEPAT, V21, P225, DOI 10.1097/MEG.0b013e32831101b7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torres HA, 2012, NAT REV CLIN ONCOL, V9, P156, DOI 10.1038/nrclinonc.2012.1; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878	44	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80078	10.1371/journal.pone.0080078	http://dx.doi.org/10.1371/journal.pone.0080078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278242	gold, Green Published, Green Accepted			2022-12-27	WOS:000327539800052
J	Goldstein, MC; Titmus, AJ; Ford, M				Goldstein, Miriam C.; Titmus, Andrew J.; Ford, Michael			Scales of Spatial Heterogeneity of Plastic Marine Debris in the Northeast Pacific Ocean	PLOS ONE			English	Article							SUBTROPICAL GYRE; COASTAL WATERS; SARGASSO SEA; ZOOPLANKTON; ENVIRONMENT; ABUNDANCE; SURFACE; ATLANTIC; MICROPLASTICS; ACCUMULATION	Plastic debris has been documented in many marine ecosystems, including remote coastlines, the water column, the deep sea, and subtropical gyres. The North Pacific Subtropical Gyre (NPSG), colloquially called the "Great Pacific Garbage Patch," has been an area of particular scientific and public concern. However, quantitative assessments of the extent and variability of plastic in the NPSG have been limited. Here, we quantify the distribution, abundance, and size of plastic in a subset of the eastern Pacific (approximately 20-40 degrees N, 120-155 degrees W) over multiple spatial scales. Samples were collected in Summer 2009 using surface and subsurface plankton net tows and quantitative visual observations, and Fall 2010 using surface net tows only. We documented widespread, though spatially variable, plastic pollution in this portion of the NPSG and adjacent waters. The overall median microplastic numerical concentration in Summer 2009 was 0.448 particles m(-2) and in Fall 2010 was 0.021 particles m(-2), but plastic concentrations were highly variable over the submesoscale (10 s of km). Size-frequency spectra were skewed towards small particles, with the most abundant particles having a cross-sectional area of approximately 0.01 cm(2). Most microplastic was found on the sea surface, with the highest densities detected in low-wind conditions. The numerical majority of objects were small particles collected with nets, but the majority of debris surface area was found in large objects assessed visually. Our ability to detect high-plastic areas varied with methodology, as stations with substantial microplastic did not necessarily also contain large visually observable objects. A power analysis of our data suggests that high variability of surface microplastic will make future changes in abundance difficult to detect without substantial sampling effort. Our findings suggest that assessment and monitoring of oceanic plastic debris must account for high spatial variability, particularly in regards to the evaluation of initiatives designed to reduce marine debris.	[Goldstein, Miriam C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Titmus, Andrew J.] Hawaii Pacific Univ, Marine Sci Program, Kaneohe, HI USA; [Ford, Michael] NOAA, Natl Marine Fisheries Serv, Silver Spring, MD USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	Goldstein, MC (corresponding author), Calif Sea Grant, John A Knauss Marine Policy Fellowship, La Jolla, CA USA.	miriam.goldstein@gmail.com		Goldstein, Miriam/0000-0002-3225-1694	University of California Ship Funds; Project Kaisei/Ocean Voyages Institute; AWIS-San Diego; NSF IGERT [0333444]; NSF; California Department of Boating and Waterways [05-106-115]; NSF GK-12 Grant [0841407]; National Fish and Wildlife Foundation Marine Debris Programs [2007-0088-007]; Division Of Ocean Sciences [1026607] Funding Source: National Science Foundation	University of California Ship Funds(University of California System); Project Kaisei/Ocean Voyages Institute; AWIS-San Diego; NSF IGERT(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); California Department of Boating and Waterways; NSF GK-12 Grant; National Fish and Wildlife Foundation Marine Debris Programs; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for the SEAPLEX cruise was provided by University of California Ship Funds, Project Kaisei/Ocean Voyages Institute (http://www.projectkaisei.org), AWIS-San Diego (http://sdawis.org/), and NSF IGERT Grant No. 0333444. EX1006 samples courtesy of the NOAA Okeanos Explorer Program (http://oceanexplorer.noaa.gov/), 2010 Always Exploring expedition. EX1006 supplies and M.C.G.'s travel were provided by NOAA National Marine Fisheries Service. Laboratory supplies, support, and some analytical equipment were provided by the SIO Pelagic Invertebrate Collection (http://collections.ucsd.edu/pi/) and the California Current Ecosystem LTER site supported by NSF (http://cce.lternet.edu/). M. C. G. was supported by California Department of Boating and Waterways (Contract 05-106-115), NSF GK-12 Grant No. 0841407 and donations from Jim & Kris McMillan, Jeffrey & Marcy Krinsk, Lyn & Norman Lear, Ellis Wyer, and an anonymous donor. A.J.T. was supported by the National Fish and Wildlife Foundation Marine Debris Programs (Grant 2007-0088-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp M., 2006, PLASTIC DEBRIS WORLD; Bagulayan A, 2012, OCEANOGRAPHY, V25, P200, DOI 10.5670/oceanog.2012.55; Ballance LT, 1998, MAR MAMMAL SCI, V14, P429, DOI 10.1111/j.1748-7692.1998.tb00736.x; Barnes DKA, 2005, THESCIENTIFICWORLDJO, V5, P915, DOI 10.1100/tsw.2005.120; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; BEERS JR, 1966, LIMNOL OCEANOGR, V11, P520; BROWN DM, 1981, MAR ECOL PROG SER, V5, P225, DOI 10.3354/meps005225; Browne MA, 2010, ENVIRON SCI TECHNOL, V44, P3404, DOI 10.1021/es903784e; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; COLTON JB, 1974, SCIENCE, V185, P491, DOI 10.1126/science.185.4150.491; Convention on Biological Diversity STAP-GEF, 2012, IMP MAR DEBR BIOD CU; CRESSIE N, 1980, J INT ASS MATH GEOL, V12, P115, DOI 10.1007/BF01035243; Davison P, 2011, MAR ECOL PROG SER, V432, P173, DOI 10.3354/meps09142; DAY RH, 1987, MAR POLLUT BULL, V18, P311, DOI 10.1016/S0025-326X(87)80017-6; Day RH, 1990, P 2 INT C MAR DEBR A, V1, P247; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Doney SC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000843; Doyle MJ, 2011, MAR ENVIRON RES, V71, P41, DOI 10.1016/j.marenvres.2010.10.001; Fisch G, 2010, J AEROSP TECHNOL MAN, V2, P105, DOI 10.5028/jatm.2010.0201105110; Gilfillan LR, 2009, CAL COOP OCEAN FISH, V50, P123; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Haifley D, 2010, OUR OCEAN BACKYARD P; HEINEMANN D, 1981, J WILDLIFE MANAGE, V45, P489, DOI 10.2307/3807930; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Howell EA, 2012, MAR POLLUT BULL, V65, P16, DOI 10.1016/j.marpolbul.2011.04.034; Kahru M, 2011, SATELLITE PROJECTS; KALUZNY SP, 1998, S SPATIAL STATS; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Knowles D, 2013, NY DAILY NEWS; Kramer D, 1972, US DEP COMMERCE NOAA, V370, P1; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; Laist David W., 1997, P99; Lattin GL, 2004, MAR POLLUT BULL, V49, P291, DOI 10.1016/j.marpolbul.2004.01.020; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Martinez E, 2009, MAR POLLUT BULL, V58, P1347, DOI 10.1016/j.marpolbul.2009.04.022; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Moore CJ, 2002, MAR POLLUT BULL, V44, P1035, DOI 10.1016/S0025-326X(02)00150-9; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; MOSER ML, 1992, COLON WATERBIRD, V15, P83, DOI 10.2307/1521357; Mumby PJ, 2002, MAR POLLUT BULL, V44, P85, DOI 10.1016/S0025-326X(01)00097-2; National Research Council, 2009, TACKL MAR DEBR 21 CE TACKL MAR DEBR 21 CE; OMORI M, 1978, INT REV GES HYDROBIO, V63, P261, DOI 10.1002/iroh.19780630211; Omori M., 1984, METHODS MARINE ZOOPL; Pichel WG, 2007, MAR POLLUT BULL, V54, P1207, DOI 10.1016/j.marpolbul.2007.04.010; R Development Core Team, 2012, R LANG ENV STAT COMP; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Robards Martin D., 1997, P71; Ryan PG, 2013, MAR POLLUT BULL, V69, P128, DOI 10.1016/j.marpolbul.2013.01.016; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Slambrouck PV, 2010, CHRISTIAN SCI MONITO; Smith SR, 1999, J ATMOS OCEAN TECH, V16, P939, DOI 10.1175/1520-0426(1999)016<0939:EMTITW>2.0.CO;2; STAP-GEF, 2011, MAR DEBR GLOB ENV PR; Stevenson C., 2011, PLASTIC DEBRIS CALIF; Thiel M, 2013, MAR POLLUT BULL, V71, P307, DOI 10.1016/j.marpolbul.2013.01.005; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Titmus AJ, 2011, MAR POLLUT BULL, V62, P2496, DOI 10.1016/j.marpolbul.2011.08.007; VENRICK EL, 1973, NATURE, V241, P271, DOI 10.1038/241271a0; Winston Judith E., 1997, P81; WONG CS, 1974, NATURE, V247, P30, DOI 10.1038/247030a0; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Wurpel G, 2011, PLASTICS DO NOT BELO; YODER JA, 1987, LIMNOL OCEANOGR, V32, P929, DOI 10.4319/lo.1987.32.4.0929; Zettler ER, 2013, ENVIRON SCI TECHNOL, DOI DOI 10.1021/ES401288X.ACCESSED	68	121	130	7	410	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80020	10.1371/journal.pone.0080020	http://dx.doi.org/10.1371/journal.pone.0080020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278233	Green Published, gold			2022-12-27	WOS:000327313100072
J	Helmer, RA; Martinez-Zaguilan, R; Dertien, JS; Fulford, C; Foreman, O; Peiris, V; Chilton, BS				Helmer, Rebecca A.; Martinez-Zaguilan, Raul; Dertien, Janet S.; Fulford, Candra; Foreman, Oded; Peiris, Vasum; Chilton, Beverly S.			Helicase-Like Transcription Factor (Hltf) Regulates G2/M Transition, Wt1/Gata4/Hif-1a Cardiac Transcription Networks, and Collagen Biogenesis	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; ACTIVATOR INHIBITOR-1 GENE; CELL NUCLEAR ANTIGEN; FLUORESCENCE MICROSCOPY; JAK2 PHOSPHORYLATION; EXTRACELLULAR-MATRIX; SIGNALING PATHWAYS; REPLICATION FORK; STEM-CELLS; EXPRESSION	HLTF/Hltf regulates transcription, remodels chromatin, and coordinates DNA damage repair. Hltf is expressed in mouse brain and heart during embryonic and postnatal development. Silencing Hltf is semilethal. Seventy-four percent of congenic C57BL/6J Hltf knockout mice died, 75% within 12-24 hours of birth. Previous studies in neonatal (6-8 hour postpartum) brain revealed silencing Hltf disrupted cell cycle progression, and attenuated DNA damage repair. An RNA-Seq snapshot of neonatal heart transcriptome showed 1,536 of 20,000 total transcripts were altered (p < 0.05) - 10 up- and 1,526 downregulated. Pathway enrichment analysis with MetaCore (TM) showed Hltf's regulation of the G2/M transition (p=9.726E(-15)) of the cell cycle in heart is nearly identical to its role in brain. In addition, Brca1 and 12 members of the Brca1 associated genome surveillance complex are also downregulated. Activation of caspase 3 coincides with transcriptional repression of Bcl-2. Hltf loss caused downregulation of Wt1/Gata4/Hif-1a signaling cascades as well as Myh7b/miR499 transcription. Hltf-specific binding to promoters and/or regulatory regions of these genes was authenticated by ChIP-PCR. Hif-1a targets for prolyl (P4ha1, P4ha2) and lysyl (Plod2) collagen hydroxylation, PPIase enzymes (Ppid, Ppif, Ppil3) for collagen trimerization, and lysyl oxidase (Loxl2) for collagen-elastin crosslinking were downregulated. However, transcription of genes for collagens, fibronectin, Mmps and their inhibitors (Timps) was unaffected. The collective downregulation of genes whose protein products control collagen biogenesis caused disorganization of the interstitial and perivascular myocardial collagen fibrillar network as viewed with picrosirius red-staining, and authenticated with spectral imaging. Wavy collagen bundles in control hearts contrasted with collagen fibers that were thin, short and disorganized in Hltf null hearts. Collagen bundles in Hltf null hearts were tangled and fragmented. Thus, silencing Hltf during heart organogenesis compromised DNA double-strand break repair, and caused aberrant collagen biogenesis altering the structural network that transmits cardiomyocyte force into muscle contraction.	[Helmer, Rebecca A.; Fulford, Candra; Chilton, Beverly S.] Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA; [Martinez-Zaguilan, Raul] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Dertien, Janet S.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Foreman, Oded] Jackson Lab, Sacramento, CA USA; [Peiris, Vasum] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Jackson Laboratory; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Chilton, BS (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biochem & Cell Biol, Lubbock, TX 79430 USA.	beverly.chilton@ttuhsc.edu		Chilton, Beverly/0000-0002-8066-8697	TTUHSC (Texas Tech University Health Sciences Center) Cardiology Seed Grant Program	TTUHSC (Texas Tech University Health Sciences Center) Cardiology Seed Grant Program	This work was supported by TTUHSC (Texas Tech University Health Sciences Center) Cardiology Seed Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Bhattacharya S, 2006, CLIN SCI, V111, P35, DOI 10.1042/cs20060003; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Borges LF, 2005, CELL TISSUE RES, V320, P551, DOI 10.1007/s00441-005-1108-6; Caestecker KW, 2012, PRESENT EXP CELL RES, V319, P575; Capouillez A, 2009, HISTOPATHOLOGY, V55, P77, DOI 10.1111/j.1365-2559.2009.03330.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chilton BS, 2008, BIOCHEM SOC T, V36, P632, DOI 10.1042/BST0360632; Debauve G, 2008, CELL MOL LIFE SCI, V65, P591, DOI 10.1007/s00018-007-7392-4; Dimitrova J, 2010, ATLAS GENET CYTOGENE, V14, P970; Ding H, 1996, DNA CELL BIOL, V15, P429, DOI 10.1089/dna.1996.15.429; Ding H, 1999, J BIOL CHEM, V274, P19573, DOI 10.1074/jbc.274.28.19573; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gong XH, 1997, DEV BIOL, V183, P166, DOI 10.1006/dbio.1996.8486; Guillaumond F, 2011, FASEB J, V25, P2740, DOI 10.1096/fj.10-178616; HaywardLester A, 1996, MOL ENDOCRINOL, V10, P1335, DOI 10.1210/me.10.11.1335; Helmer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066799; Helmer RA, 2011, MOL CELL ENDOCRINOL, V338, P79, DOI 10.1016/j.mce.2011.03.009; Helmer RA, 2010, MOL CELL ENDOCRINOL, V325, P143, DOI 10.1016/j.mce.2010.05.010; Hewetson A, 2004, BIOL REPROD, V71, P1907, DOI 10.1095/biolreprod.104.031435; Hewetson A, 2003, J BIOL CHEM, V278, P40177, DOI 10.1074/jbc.M303921200; Hewetson A, 2002, MOL ENDOCRINOL, V16, P2101, DOI 10.1210/me.2002-0064; Hewetson A, 2008, MOL ENDOCRINOL, V22, P813, DOI 10.1210/me.2007-0432; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Le Gloan L, 2011, CIRC J, V75, P2287, DOI 10.1253/circj.CJ-11-0601; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Longerich S, 2011, P NATL ACAD SCI USA, V108, P13881, DOI 10.1073/pnas.1110698108; Mahajan MC, 2002, BLOOD, V99, P348, DOI 10.1182/blood.V99.1.348; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Patterson AJ, 2010, CURR MOL MED, V10, P653; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Sandhu S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-18; Schlueter J, 2011, ASWAN HEART CTR SCI, P11, DOI DOI 10.5339/AHCSPS.2011.11; SHERIDAN PL, 1995, J BIOL CHEM, V270, P4575, DOI 10.1074/jbc.270.9.4575; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Stecklein SR, 2012, TRANSL RES, V160, P178, DOI 10.1016/j.trsl.2012.01.022; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Suzuki YJ, 2011, CELL SIGNAL, V23, P1094, DOI 10.1016/j.cellsig.2011.02.007; Svensson EC, 2010, CIRC RES, V106, P1789, DOI 10.1161/CIRCRESAHA.110.222216; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Van Vliet P, 2012, CARDIOVASC RES, V96, P352, DOI 10.1093/cvr/cvs270; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Warkman AS, 2012, CYTOSKELETON, V69, P324, DOI 10.1002/cm.21029; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Zhang LL, 2012, BIOCHEM BIOPH RES CO, V420, P875, DOI 10.1016/j.bbrc.2012.03.092; Zhang Q, 1997, GENE, V202, P31, DOI 10.1016/S0378-1119(97)00446-0	62	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80461	10.1371/journal.pone.0080461	http://dx.doi.org/10.1371/journal.pone.0080461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278285	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100090
J	Long, PM; Tighe, SW; Driscoll, HE; Moffett, JR; Namboodiri, AMA; Viapiano, MS; Lawler, SE; Jaworski, DM				Long, Patrick M.; Tighe, Scott W.; Driscoll, Heather E.; Moffett, John R.; Namboodiri, Aryan M. A.; Viapiano, Mariano S.; Lawler, Sean E.; Jaworski, Diane M.			Acetate Supplementation Induces Growth Arrest of NG2/PDGFR alpha-Positive Oligodendroglioma-Derived Tumor-Initiating Cells	PLOS ONE			English	Article							N-ACETYLASPARTATE CONCENTRATION; INTEGRATED GENOMIC ANALYSIS; NEURAL STEM-CELLS; MESENCHYMAL DIFFERENTIATION; TISSUE INHIBITOR; PROGENITOR CELLS; MOUSE MODEL; CELLULAR ADAPTATION; GLYCERYL TRIACETATE; PREDICT PROGNOSIS	Cancer is associated with globally hypoacetylated chromatin and considerable attention has recently been focused on epigenetic therapies. N-acetyl-L-aspartate (NAA), the primary storage form of acetate in the brain, and aspartoacylase (ASPA), the enzyme responsible for NAA catalysis to generate acetate and ultimately acetyl-Coenzyme A for histone acetylation, are reduced in oligodendroglioma. The short chain triglyceride glyceryl triacetate (GTA), which increases histone acetylation and inhibits histone deacetylase expression, has been safely used for acetate supplementation in Canavan disease, a leukodystrophy due to ASPA mutation. We demonstrate that GTA induces cytostatic G(0) growth arrest of oligodendroglioma-derived cells in vitro, without affecting normal cells. Sodium acetate, at doses comparable to that generated by complete GTA catalysis, but not glycerol also promoted growth arrest, whereas long chain triglycerides promoted cell growth. To begin to elucidate its mechanism of action, the effects of GTA on ASPA and acetyl-CoA synthetase protein levels and differentiation of established human oligodendroglioma cells (HOG and Hs683) and primary tumor-derived oligodendroglioma cells that exhibit some features of cancer stem cells (grade II OG33 and grade III OG35) relative to an oligodendrocyte progenitor line (Oli-Neu) were examined. The nuclear localization of ASPA and acetyl-CoA synthetase-1 in untreated cells was regulated during the cell cycle. GTA-mediated growth arrest was not associated with apoptosis or differentiation, but increased expression of acetylated proteins. Thus, GTA-mediated acetate supplementation may provide a safe, novel epigenetic therapy to reduce the growth of oligodendroglioma cells without affecting normal neural stem or oligodendrocyte progenitor cell proliferation or differentiation.	[Long, Patrick M.; Jaworski, Diane M.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Tighe, Scott W.] Vermont Canc Ctr, Burlington, VT USA; [Driscoll, Heather E.] Norwich Univ, Vermont Genet Network, Northfield, VT USA; [Moffett, John R.; Namboodiri, Aryan M. A.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Viapiano, Mariano S.; Lawler, Sean E.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA	University of Vermont; Uniformed Services University of the Health Sciences - USA; Harvard University; Brigham & Women's Hospital	Jaworski, DM (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	diane.jaworski@uvm.edu	Viapiano, Mariano/AAE-5787-2019	Viapiano, Mariano/0000-0002-8756-388X; Driscoll, Heather/0000-0002-3772-9933	NINDS; NCRR; Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium; Neuroscience COBRE [NIH NCRR P20 RR016435]; UVM College of Medicine;  [R01NS045225]; NATIONAL CANCER INSTITUTE [P30CA022435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045225] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium; Neuroscience COBRE; UVM College of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01NS045225 co-funded by NINDS (http://www.ninds.nih.gov) and NCRR (http://www.nih.gov/about/almanac/organization/NCRR.htm), and Pilot Project grants from the Vermont Cancer Center/Lake Champlain Cancer Research Organization consortium (http://www.uvm.edu/medicine/vtcancercenter/), Neuroscience COBRE (NIH NCRR P20 RR016435), and UVM College of Medicine (DMJ). Facilities and equipment supported by the Neuroscience COBRE Molecular Core Facility (NIH NCRR P20 RR016435), Vermont Cancer Center DNA Analysis facility (NIH P30 CA22435) (http://www.cancer.gov/), and Vermont Genetics Network Microarray Facility (National Institutes of Health P20 GM103449) (http://www.nigms.nih.gov/) were instrumental to the completion of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Ariyannur PS, 2010, J COMP NEUROL, V518, P2952, DOI 10.1002/cne.22373; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Bailey P, 1926, CLASSIFICATION TUMOR; Bakondi B, 2010, BIOCHEM BIOPH RES CO, V400, P212, DOI 10.1016/j.bbrc.2010.08.040; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; Bhakoo KK, 2001, J NEUROCHEM, V79, P211, DOI 10.1046/j.1471-4159.2001.00561.x; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Bhatt DP, 2013, NEUROCHEM INT, V62, P296, DOI 10.1016/j.neuint.2013.01.004; Briancon-Marjollet A, 2010, CARCINOGENESIS, V31, P1718, DOI 10.1093/carcin/bgq154; Brissette CA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-249; Calatozzolo C, 2005, J NEURO-ONCOL, V74, P113, DOI 10.1007/s11060-004-6152-7; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Fiume MZ, 2003, INT J TOXICOL, V22, P1, DOI 10.1080/10915810390204845; Francis JS, 2006, J NEUROSCI RES, V84, P151, DOI 10.1002/jnr.20866; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Goldberg R P, 1980, Adv Exp Med Biol, V132, P413; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hershfield JR, 2006, FASEB J, V20, P2139, DOI 10.1096/fj.05-5358fje; Hu J, 2013, P NATL ACAD SCI USA, V110, P14520, DOI 10.1073/pnas.1308610110; Inglese M, 2008, NEUROIMAGE, V41, P270, DOI 10.1016/j.neuroimage.2008.02.034; Jaworski DM, 2006, J NEUROCHEM, V98, P234, DOI 10.1111/j.1471-4159.2006.03855.x; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kaul R, 1996, AM J HUM GENET, V59, P95; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; Kumar S, 2006, ADV EXP MED BIOL, V576, P175; Kumar S, 2009, J NEUROSCI RES, V87, P3415, DOI 10.1002/jnr.22233; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lamoral-Theys D, 2010, NEOPLASIA, V12, P69, DOI 10.1593/neo.91360; Lluri G, 2008, EXP CELL RES, V314, P11, DOI 10.1016/j.yexcr.2007.06.007; Long PM, 2013, J BIOL CHEM, V288, P26188, DOI 10.1074/jbc.M113.487553; Madhavarao CN, 2009, J INHERIT METAB DIS, V32, P640, DOI 10.1007/s10545-009-1155-3; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Mathew R, 2005, J PHARMACOL EXP THER, V315, P297, DOI 10.1124/jpet.105.087536; Mattan NS, 2010, NEUROBIOL DIS, V40, P432, DOI 10.1016/j.nbd.2010.07.003; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moffett JR, 2011, GLIA, V59, P1414, DOI 10.1002/glia.21186; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Parkinson JF, 2011, J CLIN NEUROSCI, V18, P329, DOI 10.1016/j.jocn.2010.07.101; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Rae C, 2012, NEUROCHEM RES, V37, P2541, DOI 10.1007/s11064-012-0847-5; Reisenauer CJ, 2011, J NEUROCHEM, V117, P264, DOI 10.1111/j.1471-4159.2011.07198.x; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Rieske P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-54; Rigotti DJ, 2011, AM J NEURORADIOL, V32, P1011, DOI 10.3174/ajnr.A2452; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Segel R, 2011, MOL GENET METAB, V103, P203, DOI 10.1016/j.ymgme.2011.03.012; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soliman ML, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-51; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Surendran S, 2004, DEV BRAIN RES, V153, P19, DOI 10.1016/j.devbrainres.2004.07.003; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; TSEN AR, 2013, INT J CANCER, DOI DOI 10.1002/IJC.28465:*; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weiss WA, 2003, CANCER RES, V63, P1589; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Williams AC, 1999, ONCOGENE, V18, P3199, DOI 10.1038/sj.onc.1202660; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Xie J, 2011, INT J ONCOL, V38, P409, DOI 10.3892/ijo.2010.851; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	87	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80714	10.1371/journal.pone.0080714	http://dx.doi.org/10.1371/journal.pone.0080714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278309	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100102
J	Mezzapesa, DM; D'Errico, E; Tortelli, R; Distaso, E; Cortese, R; Tursi, M; Federico, F; Zoccolella, S; Logroscino, G; Dicuonzo, F; Simone, IL				Mezzapesa, Domenico Maria; D'Errico, Eustachio; Tortelli, Rosanna; Distaso, Eugenio; Cortese, Rosa; Tursi, Marianna; Federico, Francesco; Zoccolella, Stefano; Logroscino, Giancarlo; Dicuonzo, Franca; Simone, Isabella Laura			Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; WHOLE-BRAIN; ALSFRS-R; DIAGNOSIS; SYMPTOMS; MRI; THICKNESS; SURVIVAL; CORTEX	Amyotrophic lateral sclerosis (ALS) has heterogeneous clinical features that could be translated into specific patterns of brain atrophy. In the current study we have evaluated the relationship between different clinical expressions of classical ALS and measurements of brain cortical thickness. Cortical thickness analysis was conducted from 3D-MRI using FreeSurfer software in 29 ALS patients and 20 healthy controls. We explored three clinical traits of the disease, subdividing the patients into two groups for each of them: the bulbar or spinal onset, the higher or lower upper motor neuron burden, the faster or slower disease progression. We used both a whole brain vertex-wise analysis and a ROI analysis on primary motor areas. ALS patients showed cortical thinning in bilateral precentral gyrus, bilateral middle frontal gyrus, right superior temporal gyrus and right occipital cortex. ALS patients with higher upper motor neuron burden showed a significant cortical thinning in the right precentral gyrus and in other frontal extra-motor areas, compared to healthy controls. ALS patients with spinal onset showed a significant cortical thinning in the right precentral gyrus and paracentral lobule, compared to healthy controls. ALS patients with faster progressive disease showed a significant cortical thinning in widespread bilateral frontal and temporal areas, including the bilateral precentral gyrus, compared to healthy controls. Focusing on the primary motor areas, the ROI analysis revealed that the mean cortical thickness values were significantly reduced in ALS patients with higher upper motor neuron burden, spinal onset and faster disease progression related to healthy controls. In conclusion, the thickness of primary motor cortex could be a useful surrogate marker of upper motor neuron involvement in ALS; also our results suggest that cortical thinning in motor and non motor areas seem to reflect the clinical heterogeneity of the disease.	[Mezzapesa, Domenico Maria; D'Errico, Eustachio; Tortelli, Rosanna; Distaso, Eugenio; Cortese, Rosa; Tursi, Marianna; Federico, Francesco; Logroscino, Giancarlo; Simone, Isabella Laura] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Neurol Unit, Bari, Italy; [Zoccolella, Stefano] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Neurophysiopathol Unit, Bari, Italy; [Dicuonzo, Franca] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Neuroradiol Unit, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Simone, IL (corresponding author), Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Neurol Unit, Bari, Italy.	isabellalaura.simone@uniba.it	LOGROSCINO, GIANCARLO/K-5148-2016; Simone, sabella laura/K-9755-2018; zoccolella, stefano/AAA-2515-2020	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Simone, Isabella Laura/0000-0002-7429-3091; Cortese, Rosa/0000-0002-9803-7914; Dicuonzo, Franca/0000-0003-3999-6346	National Institutes of Health; Amyotrophic Lateral Sclerosis Association (ALSA); Italian Ministry of Health; Italian Ministry of School and University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotrophic Lateral Sclerosis Association (ALSA); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of School and University	Dr Simone received honoraria from Genzyme Sanofi-Aventis, TEVA, Bayer and Biogen for educational lectures. Dr Logroscino has received investigator-initiated research funding from the National Institutes of Health, The Amyotrophic Lateral Sclerosis Association (ALSA), Italian Ministry of Health, Italian Ministry of School and University, and received honoraria from Pfeizer and Lilly Pharmaceutical, Novartis, and Lundbeck for educational lectures. All other authors have nothing to declare. All authors have no actual or potential conflicts of interest. The appropriate approval and procedures were used concerning human subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2010, AM J NEURORADIOL, V31, P1769, DOI 10.3174/ajnr.A2043; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; Bede P, 2013, NEUROLOGY, V81, P361, DOI 10.1212/WNL.0b013e31829c5eee; Bede P, 2013, J NEUROL NEUROSUR PS, V84, P766, DOI 10.1136/jnnp-2012-302674; Benton AL, 1976, MULTILINGUAL APHASIA; Bocci T, 2012, J NEUROL SCI, V316, P67, DOI 10.1016/j.jns.2012.01.028; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen ZY, 2010, AMYOTROPH LATERAL SC, V11, P549, DOI 10.3109/17482968.2010.516265; Chio A, 2011, J NEUROL NEUROSUR PS, V82, P740, DOI 10.1136/jnnp.2010.235952; Cosottini M, 2012, EXP NEUROL, V234, P169, DOI 10.1016/j.expneurol.2011.12.024; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Habert MO, 2007, AMYOTROPH LATERAL SC, V8, P9, DOI 10.1080/14660820601048815; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kanouchi T, 2012, J NEUROL NEUROSUR PS, V83, P739, DOI 10.1136/jnnp-2011-301826; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Korner S, 2011, MUSCLE NERVE, V43, P636, DOI 10.1002/mus.21936; Mezzapesa DM, 2007, AM J NEURORADIOL, V28, P255; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; Roccatagliata L, 2009, AMYOTROPH LATERAL SC, V10, P47, DOI 10.1080/17482960802267530; Smith A., 1982, SYMBOL DIGIT MODALIT; SPINNLER H, 1987, ITAL J NEUROL SCI S8, V6, P47; Strong MJ, 2001, CAN J NEUROL SCI, V28, P283, DOI 10.1017/S0317167100001505; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Turner Martin R, 2010, Expert Opin Med Diagn, V4, P483, DOI 10.1517/17530059.2010.536836; van den Berg LH, 2011, J NEUROL NEUROSUR PS, V82, P711, DOI 10.1136/jnnp.2011.241513; Venturini R., 1983, COLOR WORD TEST TEST; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Zoccolella S, 2006, EUR J NEUROL, V13, P789, DOI 10.1111/j.1468-1331.2006.01384.x; Zoccolella S, 2008, J NEUROL SCI, V268, P28, DOI 10.1016/j.jns.2007.10.023	40	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80748	10.1371/journal.pone.0080748	http://dx.doi.org/10.1371/journal.pone.0080748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278317	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100109
J	Natunen, T; Martiskainen, H; Sarajarvi, T; Helisalmi, S; Pursiheimo, JP; Viswanathan, J; Laitinen, M; Makinen, P; Kauppinen, T; Rauramaa, T; Leinonen, V; Alafuzoff, I; Haapasalo, A; Soininen, H; Hiltunen, M				Natunen, Teemu; Martiskainen, Henna; Sarajarvi, Timo; Helisalmi, Seppo; Pursiheimo, Juha-Pekka; Viswanathan, Jayashree; Laitinen, Marjo; Makinen, Petra; Kauppinen, Tarja; Rauramaa, Tuomas; Leinonen, Ville; Alafuzoff, Irina; Haapasalo, Annakaisa; Soininen, Hilkka; Hiltunen, Mikko			Effects of NR1H3 Genetic Variation on the Expression of Liver X Receptor alpha and the Progression of Alzheimer's Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; AD MOUSE MODELS; GENOME-WIDE ASSOCIATION; E MESSENGER-RNA; REVERSE DEFICITS; BETA-SECRETASE; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; NUCLEAR RECEPTORS; THERAPEUTICS	Alzheimer's disease (AD) has been postulated to involve defects in the clearance of amyloid-beta (A beta). Activation of liver X receptor alpha (LXR alpha) increases the expression of apolipoprotein E (ApoE) as well as cholesterol transporters ABCA1 and ABCG1, leading to augmented clearance of A beta. We have previously shown that the C allele of rs7120118 in the NR1H3 gene encoding LXR alpha reduces the risk of AD. Here, we wanted to assess whether the rs7120118 variation affects the progression of AD and modulates the expression of NR1H3 and its downstream targets APOE, ABCA1 and ABCG1. We utilized tissue samples from the inferior temporal cortex of 87 subjects, which were subdivided according to Braak staging into mild, moderate and severe AD groups on the basis of AD-related neurofibrillary pathology. APOE epsilon 4 allele increased soluble A beta 42 levels in the tissue samples in a dose-dependent manner, but did not affect the expression status of APOE. In contrast, the CC genotype of rs7120118 was underrepresented in the severe group, although this result did not reach statistical significance. Also, patients with the CC genotype of rs7120118 showed significantly decreased soluble A beta 42 levels as compared to the patients with TT genotype. Although the severity of AD did not affect NR1H3 expression, the mRNA levels of NR1H3 among the patients with CT genotype of rs7120118 were significantly increased as compared to the patients with TT genotype. These results suggest that genetic variation in NR1H3 modulates the expression of LXR alpha and the levels of soluble A beta 42.	[Natunen, Teemu; Martiskainen, Henna; Sarajarvi, Timo; Helisalmi, Seppo; Viswanathan, Jayashree; Laitinen, Marjo; Makinen, Petra; Kauppinen, Tarja; Haapasalo, Annakaisa; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Natunen, Teemu; Martiskainen, Henna; Sarajarvi, Timo; Helisalmi, Seppo; Viswanathan, Jayashree; Laitinen, Marjo; Makinen, Petra; Kauppinen, Tarja; Haapasalo, Annakaisa; Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Pursiheimo, Juha-Pekka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Rauramaa, Tuomas] Kuopio Univ Hosp, Dept Pathol, SF-70210 Kuopio, Finland; [Rauramaa, Tuomas] Univ Eastern Finland, Inst Clin Med, Unit Pathol, Kuopio, Finland; [Leinonen, Ville] Univ Eastern Finland, Inst Clin Med Neurosurg, Kuopio, Finland; [Leinonen, Ville] Kuopio Univ Hosp, Neurosurg NeuroCtr, SF-70210 Kuopio, Finland; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Turku; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University	Hiltunen, M (corresponding author), Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland.	mikko.hiltunen@uef.fi	Sarajärvi, Timo/AAN-3855-2021	Sarajärvi, Timo/0000-0001-8710-1282; Chadchankar, Jayashree/0000-0002-0189-569X; Haapasalo, Annakaisa/0000-0003-0959-2957	Academy of Finland; EVO of Kuopio University Hospital [5772708]; Sigrid Juselius Foundation; University of Eastern Finland (UEF-Brain); BIOMARKAPD project in the JPND programme	Academy of Finland(Academy of Finland); EVO of Kuopio University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Eastern Finland (UEF-Brain); BIOMARKAPD project in the JPND programme	This study was funded by the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, Sigrid Juselius Foundation, the Strategic Funding of the University of Eastern Finland (UEF-Brain), and BIOMARKAPD project in the JPND programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; Bekris LM, 2010, AM J MED GENET B, V153B, P409, DOI 10.1002/ajmg.b.30993; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cao GQ, 2007, CURR ALZHEIMER RES, V4, P179, DOI 10.2174/156720507780362173; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; De Strooper B, 2000, J CELL SCI, V113, P1857; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Glockner F, 2002, NEUROSCIENCE, V114, P1103; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Herukka SK, 2007, NEUROBIOL AGING, V28, P507, DOI 10.1016/j.neurobiolaging.2006.02.001; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Natunen T, 2012, J ALZHEIMERS DIS, V28, P553, DOI 10.3233/JAD-2011-111109; Ou ZM, 2011, MOL ENDOCRINOL, V25, P584, DOI 10.1210/me.2010-0360; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Prince JA, 2004, NEUROLOGY, V62, P2116, DOI 10.1212/01.WNL.0000128088.08695.05; Ramassamy C, 2000, NEUROBIOL DIS, V7, P23, DOI 10.1006/nbdi.1999.0273; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; YAMADA T, 1995, J NEUROL SCI, V129, P56, DOI 10.1016/0022-510X(94)00249-N; Yamagata K, 2001, DEMENT GERIATR COGN, V12, P57, DOI 10.1159/000051236; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	50	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80700	10.1371/journal.pone.0080700	http://dx.doi.org/10.1371/journal.pone.0080700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278306	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100100
J	Pezzulo, G; Donnarumma, F; Dindo, H				Pezzulo, Giovanni; Donnarumma, Francesco; Dindo, Haris			Human Sensorimotor Communication: A Theory of Signaling in Online Social Interactions	PLOS ONE			English	Article							JOINT ACTION; BEHAVIOR; ARCHITECTURE; PRINCIPLES; PREDICTION; INTENTIONS; MOTIONESE	Although the importance of communication is recognized in several disciplines, it is rarely studied in the context of online social interactions and joint actions. During online joint actions, language and gesture are often insufficient and humans typically use non-verbal, sensorimotor forms of communication to send coordination signals. For example, when playing volleyball, an athlete can exaggerate her movements to signal her intentions to her teammates (say, a pass to the right) or to feint an adversary. Similarly, a person who is transporting a table together with a co-actor can push the table in a certain direction to signal where and when he intends to place it. Other examples of "signaling" are over-articulating in noisy environments and over-emphasizing vowels in child-directed speech. In all these examples, humans intentionally modify their action kinematics to make their goals easier to disambiguate. At the moment no formal theory exists of these forms of sensorimotor communication and signaling. We present one such theory that describes signaling as a combination of a pragmatic and a communicative action, and explains how it simplifies coordination in online social interactions. We cast signaling within a "joint action optimization" framework in which co-actors optimize the success of their interaction and joint goals rather than only their part of the joint action. The decision of whether and how much to signal requires solving a trade-off between the costs of modifying one's behavior and the benefits in terms of interaction success. Signaling is thus an intentional strategy that supports social interactions; it acts in concert with automatic mechanisms of resonance, prediction, and imitation, especially when the context makes actions and intentions ambiguous and difficult to read. Our theory suggests that communication dynamics should be studied within theories of coordination and interaction rather than only in terms of the maximization of information transmission.	[Pezzulo, Giovanni; Donnarumma, Francesco] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Dindo, Haris] Univ Palermo, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Palermo	Pezzulo, G (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	giovanni.pezzulo@istc.cnr.it	Pezzulo, Giovanni/AAY-3586-2020; Donnarumma, Francesco/F-6894-2014	Pezzulo, Giovanni/0000-0001-6813-8282; Donnarumma, Francesco/0000-0003-4248-5360	European's Community [FP7-270108]	European's Community	he research leading to these results has received funding from the European's Community (http://ec.europa.eu) Seventh Framework Programme (http://cordis.europa.eu/fp7/) under grant agreement no. FP7-270108 (Goal-Leaders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin John, 1960, DO THINGS WORDS; Bacharach Michael, 2006, INDIVIDUAL CHOICE TE, DOI 10.1515/9780691186313; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00117; Bishop Christopher M., 2006, PATTERN RECOGNITION; Blokpoel M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00253; Brand RJ, 2008, DEVELOPMENTAL SCI, V11, P853, DOI 10.1111/j.1467-7687.2008.00734.x; Brand RJ, 2002, DEVELOPMENTAL SCI, V5, P72, DOI 10.1111/1467-7687.00211; Braun D, 2011, EXP BRAIN RES, V211, P631, DOI 10.1007/s00221-011-2642-y; Castelfranchi C, 2010, INT J AMBIENT COMPUT, V2, P1, DOI 10.4018/jaci.2010010101; Castelfranchi C, 2006, HUM FAC ER, P157; Chater N, 2006, TRENDS COGN SCI, V10, P335, DOI 10.1016/j.tics.2006.05.006; Chatzis SP, 2011, IEEE T NEURAL NETWOR, V22, P1435, DOI 10.1109/TNN.2011.2162109; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CLARK H. H., 1996, USING LANGUAGE, DOI DOI 10.1017/CBO9780511620539; CLARK HH, 1991, PERSPECTIVES ON SOCIALLY SHARED COGNITION, P127, DOI 10.1037/10096-006; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; D'Ausilio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035757; Demiris Y, 2006, ROBOT AUTON SYST, V54, P361, DOI 10.1016/j.robot.2006.02.003; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Dindo H., 2011, P 22 INT JOINT C ART, V2011, P2113; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Galantucci B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00011; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Gonzalez DA, 2011, ACTA PSYCHOL, V136, P347, DOI 10.1016/j.actpsy.2010.12.009; Grau-Moya J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0554; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Jerde TE, 2003, J NEUROSCI, V23, P2383; Kelso JAS, 2013, NEURAL NETWORKS, V37, P120, DOI 10.1016/j.neunet.2012.09.003; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Knoblich G, 2008, PHILOS T R SOC B, V363, P2021, DOI 10.1098/rstb.2008.0006; Kroger BJ, 2010, COGN PROCESS, V11, P187, DOI 10.1007/s10339-009-0351-2; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moore RK, 2007, IEEE T COMPUT, V56, P1176, DOI 10.1109/TC.2007.1080; Neal A, 2010, EUR J NEUROSCI, V32, P1765, DOI 10.1111/j.1460-9568.2010.07435.x; Newman-Norlund SE, 2009, COGNITION, V111, P46, DOI 10.1016/j.cognition.2008.12.004; Noordzij ML, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00188; Pezzulo G, 2013, NEW IDEAS PSYCHOL; Pezzulo G, 2011, REV PHILOS PSYCHOL, V2, P303, DOI 10.1007/s13164-011-0060-5; Pezzulo G, 2013, BEHAV BRAIN SCI, V36, P371, DOI 10.1017/S0140525X12002816; Pezzulo G, 2011, EXP BRAIN RES, V211, P613, DOI 10.1007/s00221-011-2712-1; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Rigoux L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002716; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sacheli LM, 2013, EXP BRAIN RES; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Searle John, 1975, LANGUAGE MIND KNOWLE, V7, P344; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smeeton NJ, 2012, BRIT J PSYCHOL, V103, P539, DOI 10.1111/j.2044-8295.2011.02092.x; Sperber Dan, 1986, RELEVANCE COMMUNICAT, V142; Sugden R., 2003, PHILOS EXPLOR, V16, P165, DOI [10.1080/10002003098538748, DOI 10.1080/10002003098538748]; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2009, P NATL ACAD SCI USA, V106, P11478, DOI 10.1073/pnas.0710743106; Tollefsen D, 2012, PHILOS PSYCHOL, V25, P385, DOI 10.1080/09515089.2011.579418; Tomeo E, 2012, CEREB CORTEX; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; van der Wel R., 2010, J EXPT PSYCHOL HUMAN; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; Vesper C, 2011, EXP BRAIN RES, V211, P517, DOI 10.1007/s00221-011-2706-z; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Wang Z, 2013, INT J ROBOTICS RES; Wilson E.O., 1975, P1; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 2012, CURR OPIN NEUROBIOL, V22, P996, DOI 10.1016/j.conb.2012.05.003; Yoshida W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000254	72	86	86	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79876	10.1371/journal.pone.0079876	http://dx.doi.org/10.1371/journal.pone.0079876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278201	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100063
J	Torres, MP; Rachagani, S; Souchek, JJ; Mallya, K; Johansson, SL; Batra, SK				Torres, Maria P.; Rachagani, Satyanarayana; Souchek, Joshua J.; Mallya, Kavita; Johansson, Sonny L.; Batra, Surinder K.			Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy	PLOS ONE			English	Article							EXPRESSION; GEMCITABINE; PROGRESSION; MUC4; GROWTH; GENES; MICE	Pancreatic cancer (PC) remains one of the most lethal human malignancies with poor prognosis. Despite all advances in preclinical research, there have not been significant translation of novel therapies into the clinics. The development of genetically engineered mouse (GEM) models that produce spontaneous pancreatic adenocarcinoma (PDAC) have increased our understanding of the pathogenesis of the disease. Although these PDAC mouse models are ideal for studying potential therapies and specific genetic mutations, there is a need for developing syngeneic cell lines from these models. In this study, we describe the successful establishment and characterization of three cell lines derived from two (PDAC) mouse models. The cell line UN-KC-6141 was derived from a pancreatic tumor of a Kras(G12D);Pdx1-Cre (KC) mouse at 50 weeks of age, whereas UN-KPC-960 and UN-KPC-961 cell lines were derived from pancreatic tumors of Kras(G12D);Trp53(R172H);Pdx1-Cre (KPC) mice at 17 weeks of age. The cancer mutations of these parent mice carried over to the daughter cell lines (i.e. Kras(G12D) mutation was observed in all three cell lines while Trp53 mutation was observed only in KPC cell lines). The cell lines showed typical cobblestone epithelial morphology in culture, and unlike the previously established mouse PDAC cell line Panc02, expressed the ductal marker CK19. Furthermore, these cell lines expressed the epithelial-mesenchymal markers E-cadherin and N-cadherin, and also, Muc1 and Muc4 mucins. In addition, these cell lines were resistant to the chemotherapeutic drug Gemcitabine. Their implantation in vivo produced subcutaneous as well as tumors in the pancreas (orthotopic). The genetic mutations in these cell lines mimic the genetic compendium of human PDAC, which make them valuable models with a high potential of translational relevance for examining diagnostic markers and therapeutic drugs.	[Torres, Maria P.; Rachagani, Satyanarayana; Mallya, Kavita; Batra, Surinder K.] Univ Nebraska Med Ctr, Omaha, NE USA; [Souchek, Joshua J.; Batra, Surinder K.] Univ Nebraska Med Ctr, Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Johansson, Sonny L.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Omaha, NE USA.	sbatra@unmc.edu	Torres, Maria/GVU-3391-2022	Souchek, Joshua/0000-0002-7607-2823	NIH [TMEN U54 CA163120, EDRN UO1, CA111294, SPORE P50 CA127297, RO1 CA133774, RO1 CA78590, RO3 CA167342]; NATIONAL CANCER INSTITUTE [R01CA133774, R03CA167342, R01CA078590, P50CA127297, U54CA163120, U01CA111294] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was, in part, supported by grants from the NIH (TMEN U54 CA163120, EDRN UO1, CA111294, SPORE P50 CA127297, RO1 CA133774, RO1 CA78590, and RO3 CA167342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bhadury J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.8; BOUWENS L, 1995, J HISTOCHEM CYTOCHEM, V43, P245, DOI 10.1177/43.3.7532655; Campen CJ, 2011, AM J HEALTH-SYST PH, V68, P573, DOI 10.2146/ajhp100254; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; CORBETT TH, 1984, CANCER RES, V44, P717; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Kurata N, 2011, INT J ONCOL, V39, P473, DOI 10.3892/ijo.2011.1058; Long J, 2011, EXPERT OPIN THER TAR, V15, P817, DOI 10.1517/14728222.2011.566216; Moniaux N, 2007, BRIT J CANCER, V97, P345, DOI 10.1038/sj.bjc.6603868; Rachagani S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-68; Regiba S, 2009, NEOPLASIA, V11, P637, DOI 10.1593/neo.81686; Rozenblum E, 1997, CANCER RES, V57, P1731; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh M, 2006, CLIN CANCER RES, V12, P5312, DOI 10.1158/1078-0432.CCR-06-0437; TAYLORPAPADIMITRIOU J, 1980, J CELL PHYSIOL, V102, P317, DOI 10.1002/jcp.1041020306; Torres MP, 2010, MOL CANCER THER, V9, P1419, DOI 10.1158/1535-7163.MCT-10-0075; Wang Y, 2012, CURR MOL MED, V12, P331, DOI 10.2174/156652412799218868; Wood LD, 2012, CANCER J, V18, P492, DOI 10.1097/PPO.0b013e31827459b6	31	86	86	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80580	10.1371/journal.pone.0080580	http://dx.doi.org/10.1371/journal.pone.0080580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278292	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100093
J	Azimi, M; Mofrad, MRK				Azimi, Mohammad; Mofrad, Mohammad R. K.			Higher Nucleoporin-Importin beta Affinity at the Nuclear Basket Increases Nucleocytoplasmic Import	PLOS ONE			English	Article							PORE COMPLEX; NONSPECIFIC COMPETITION; PERMEABILITY BARRIER; TRANSPORT; TRANSLOCATION; HYDROGEL; PROTEINS; GRADIENT; FEATURES; REPEATS	Several in vitro studies have shown the presence of an affinity gradient in nuclear pore complex proteins for the import receptor Importin beta, at least partially contributing to nucleocytoplasmic transport, while others have historically argued against the presence of such a gradient. Nonetheless, the existence of an affinity gradient has remained an uncharacterized contributing factor. To shed light on the affinity gradient theory and better characterize how the existence of such an affinity gradient between the nuclear pore and the import receptor may influence the nucleocytoplasmic traffic, we have developed a general-purpose agent based modeling (ABM) framework that features a new method for relating rate constants to molecular binding and unbinding probabilities, and used our ABM approach to quantify the effects of a wide range of forward and reverse nucleoporin-Importin beta affinity gradients. Our results indicate that transport through the nuclear pore complex is maximized with an effective macroscopic affinity gradient of 2000 mu M, 200 mM and 10 mu M in the cytoplasmic, central channel and nuclear basket respectively. The transport rate at this gradient is approximately 10% higher than the transport rate for a comparable pore lacking any affinity gradient, which has a peak transport rate when all nucleoporins have an affinity of 200 mu M for Importin beta. Furthermore, this optimal ratio of affinity gradients is representative of the ratio of affinities reported for the yeast nuclear pore complex - suggesting that the affinity gradient seen in vitro is highly optimized.	[Azimi, Mohammad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn & Mech Engn, Mol Cell Biomechan Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mofrad, MRK (corresponding author), Univ Calif Berkeley, Dept Bioengn & Mech Engn, Mol Cell Biomechan Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	/R-6010-2019	/0000-0001-7004-4859				Adam SA, 2001, GENOME BIOL, V2; Antonin W, 2013, EMBO J, V32, P173, DOI 10.1038/emboj.2012.338; Azimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025306; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Berry BJL, 2002, P NATL ACAD SCI USA, V99, P7187, DOI 10.1073/pnas.092078899; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bonchev D, 2010, SAR QSAR ENVIRON RES, V21, P77, DOI 10.1080/10629360903568580; Cangiani A, 2010, J THEOR BIOL, V267, P614, DOI 10.1016/j.jtbi.2010.08.017; Cardarelli F, 2012, J BIOL CHEM, V287, P5554, DOI 10.1074/jbc.M111.304899; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Devillers J, 2010, SAR QSAR ENVIRON RES, V21, P337, DOI 10.1080/10629361003773963; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Jamali Y, J COMPUTATIONAL PHYS; Kolodkin AN, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.102; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Petri M, 2012, BIOMACROMOLECULES, V13, P1882, DOI 10.1021/bm300412q; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Schoch RL, 2012, P NATL ACAD SCI US; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tetenbaum-Novatt J, 2012, MOL CELL PROTEOMICS, V11, P31, DOI 10.1074/mcp.M111.013656; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	52	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81741	10.1371/journal.pone.0081741	http://dx.doi.org/10.1371/journal.pone.0081741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282617	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500121
J	Bohmer, M; Sharbati, J; zur Bruegge, J; Einspanier, R; Sharbati, S				Bohmer, Marc; Sharbati, Jutta; zur Bruegge, Jennifer; Einspanier, Ralf; Sharbati, Soroush			Structural Analysis of microRNA-Target Interaction by Sequential Seed Mutagenesis and Stem-Loop 3' RACE	PLOS ONE			English	Article							HOMEOBOX GENE; NKX3.1; TRANSLATION	Background: As a consequence of recent RNAseq efforts, miRNAomes of diverse tissues and species are available. However, most interactions between microRNAs and regulated mRNAs are still to be deciphered. While in silico analysis of microRNAs results in prediction of hundreds of potential targets, bona-fide interactions have to be verified e. g. by luciferase reporter assays using fused target sites as well as controls incorporating mutated seed sequences. The aim of this study was the development of a straightforward approach for sequential mutation of multiple target sites within a given 3' UTR. Methodology/Principal Findings: The established protocol is based on Seed Mutagenesis Assembly PCR (SMAP) allowing for rapid identification of microRNA target sites. Based on the presented approach, we were able to determine the transcription factor NKX3.1 as a genuine target of miR-155. The sequential mutagenesis of multiple microRNA target sites was examined by miR-29a mediated CASP7 regulation, which revealed one of two predicted target sites as the predominant site of interaction. Since 3' UTR sequences of non-model organisms are either lacking in databases or computationally predicted, we developed a Stem-Loop 3' UTR RACE PCR (SLURP) for efficient generation of required 3' UTR sequence data. The stem-loop primer allows for first strand cDNA synthesis by nested PCR amplification of the 3' UTR. Besides other applications, the SLURP method was used to gain data on porcine CASP7 3' UTR evaluating evolutionary conservation of the studied interaction. Conclusions/Significance: Sequential seed mutation of microRNA targets based on the SMAP approach allows for rapid structural analysis of several target sites within a given 3' UTR. The combination of both methods (SMAP and SLURP) enables targeted analysis of microRNA binding sites in hitherto unknown mRNA 3' UTRs within a few days.	[Bohmer, Marc; Sharbati, Jutta; zur Bruegge, Jennifer; Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany	Free University of Berlin	Sharbati, S (corresponding author), Free Univ Berlin, Inst Vet Biochem, Berlin, Germany.	soroush.sharbati@fu-berlin.de	Sharbati, Soroush/D-2548-2014	Sharbati, Soroush/0000-0003-3338-7654	Berlin Funding for Graduates (Elsa-Neumann-Stipendium des Landes Berlin); Deutsche Forschungsgemeinschaft [SFB 852, SH 465/1-1]	Berlin Funding for Graduates (Elsa-Neumann-Stipendium des Landes Berlin); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Berlin Funding for Graduates (Elsa-Neumann-Stipendium des Landes Berlin) and Deutsche Forschungsgemeinschaft (SFB 852 project B4 and SH 465/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoeke L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067300; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Orom UA, 2010, GENE, V451, P1, DOI 10.1016/j.gene.2009.11.008; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Wang BB, 2007, METHODS, V43, P91, DOI 10.1016/j.ymeth.2007.04.003	30	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81427	10.1371/journal.pone.0081427	http://dx.doi.org/10.1371/journal.pone.0081427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282594	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500096
J	Brueggemann, AB; Muroki, BM; Kulohoma, BW; Karani, A; Wanjiru, E; Morpeth, S; Kamau, T; Sharif, S; Scott, JAG				Brueggemann, Angela B.; Muroki, Beth Mbesu; Kulohoma, Benard W.; Karani, Angela; Wanjiru, Eva; Morpeth, Susan; Kamau, Tatu; Sharif, Shahnaaz; Scott, J. Anthony G.			Population Genetic Structure of Streptococcus pneumoniae in Kilifi, Kenya, Prior to the Introduction of Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							UNITED-STATES; SEROTYPE 19A; CAPSULAR SEROTYPES; CHILDREN; DISEASE; CARRIAGE; EPIDEMIOLOGY; MENINGITIS; CLONES; IMPACT	Background: The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Introduction of any PCV will perturb the existing pneumococcal population structure, thus the aim was to genotype pneumococci collected in Kilifi before PCV10. Methods and Findings: Using multilocus sequence typing (MLST), we genotyped >1100 invasive and carriage pneumococci from children, the largest collection genotyped from a single resource-poor country and reported to date. Serotype 1 was the most common serotype causing invasive disease and was rarely detected in carriage; all serotype 1 isolates were members of clonal complex (CC) 217. There were temporal fluctuations in the major circulating sequence types (STs); and although 1-3 major serotype 1, 14 or 23F STs co-circulated annually, the two major serotype 5 STs mainly circulated independently. Major STs/CCs also included isolates of serotypes 3, 12F, 18C and 19A and each shared <= 2 MLST alleles with STs that circulate widely elsewhere. Major CCs associated with non-PCV10 serotypes were predominantly represented by carriage isolates, although serotype 19A and 12F CCs were largely invasive and a serotype 10A CC was equally represented by invasive and carriage isolates. Conclusions: Understanding the pre-PCV10 population genetic structure in Kilifi will allow for the detection of changes in prevalence of the circulating genotypes and evidence for capsular switching post-vaccine implementation.	[Brueggemann, Angela B.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Brueggemann, Angela B.; Morpeth, Susan; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Muroki, Beth Mbesu; Kulohoma, Benard W.; Karani, Angela; Wanjiru, Eva; Morpeth, Susan; Scott, J. Anthony G.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Kamau, Tatu; Sharif, Shahnaaz] Minist Publ Hlth & Sanitat, Nairobi, Kenya	University of Oxford; University of Oxford	Brueggemann, AB (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	angela.brueggemann@ndm.ox.ac.uk		Brueggemann, Angela/0000-0002-2329-1934; Kulohoma, Benard/0000-0001-6825-1832	Wellcome Trust [081835, 083511/Z/07/Z, 098532, 092654/Z/10/A]; Robert Austrian Research Award in Pneumococcal Vaccinology	Wellcome Trust(Wellcome TrustEuropean Commission); Robert Austrian Research Award in Pneumococcal Vaccinology	This project was funded by the Wellcome Trust (ref: 081835, awarded to JAGS) and the Robert Austrian Research Award in Pneumococcal Vaccinology (awarded to ABB). ABB and JAGS are funded by research fellowships from the Wellcome Trust (ref: 083511/Z/07/Z and 098532, respectively). The KEMRI-Wellcome Trust Research Programme is supported by core funding from the Wellcome Trust (ref: 092654/Z/10/A). Surveillance for pneumococcal disease in Kilifi is supported by the GAVI Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; FINLAND M, 1977, J CLIN MICROBIOL, V5, P154; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; HODGES RG, 1946, AM J HYG, V44, P183, DOI 10.1093/oxfordjournals.aje.a119088; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Hyams C, 2013, INFECT IMMUN, V81, P354, DOI 10.1128/IAI.00862-12; Jefferies JM, 2010, J CLIN MICROBIOL, V48, P87, DOI 10.1128/JCM.01485-09; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; LODA FA, 1975, J PEDIATR-US, V87, P1087, DOI 10.1016/S0022-3476(75)80120-X; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moisi JC, 2012, 8 INT S PNEUM PNEUM; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Robinson DA, 1999, J INFECT DIS, V179, P414, DOI 10.1086/314589; Rodenburg GD, 2010, EMERG INFECT DIS, V16, P816, DOI 10.3201/eid1605.091223; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Wang SA, 2013, MMWR-MORBID MORTAL W, V62, P308; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81539	10.1371/journal.pone.0081539	http://dx.doi.org/10.1371/journal.pone.0081539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282605	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000327543500108
J	Hu, YJ; Ru, N; Xiao, HS; Chaturbedi, A; Hoa, NT; Tian, XJ; Zhang, H; Ke, C; Yan, FR; Nelson, J; Li, ZZ; Gramer, R; Yu, LP; Siegel, E; Zhang, XN; Jia, ZY; Jadus, MR; Limoli, CL; Linskey, ME; Xing, JH; Zhou, YH				Hu, Yuanjie; Ru, Ning; Xiao, Huasheng; Chaturbedi, Abhishek; Hoa, Neil T.; Tian, Xiao-Jun; Zhang, Hang; Ke, Chao; Yan, Fengrong; Nelson, Jodi; Li, Zhenzhi; Gramer, Robert; Yu, Liping; Siegel, Eric; Zhang, Xiaona; Jia, Zhenyu; Jadus, Martin R.; Limoli, Charles L.; Linskey, Mark E.; Xing, Jianhua; Zhou, Yi-Hong			Tumor-Specific Chromosome Mis-Segregation Controls Cancer Plasticity by Maintaining Tumor Heterogeneity	PLOS ONE			English	Article							GROWTH-FACTOR; STEM-CELLS; GLIOBLASTOMA-MULTIFORME; GLIOMA-CELLS; MALIGNANT GLIOMA; INITIATING CELLS; CLONAL EVOLUTION; MITOTIC ERRORS; ANEUPLOIDY; EXPRESSION	Aneuploidy with chromosome instability is a cancer hallmark. We studied chromosome 7 (Chr7) copy number variation (CNV) in gliomas and in primary cultures derived from them. We found tumor heterogeneity with cells having Chr7-CNV commonly occurs in gliomas, with a higher percentage of cells in high-grade gliomas carrying more than 2 copies of Chr7, as compared to low-grade gliomas. Interestingly, all Chr7-aneuploid cell types in the parental culture of established glioma cell lines reappeared in single-cell-derived subcultures. We then characterized the biology of three syngeneic glioma cultures dominated by different Chr7-aneuploid cell types. We found phenotypic divergence for cells following Chr7 mis-segregation, which benefited overall tumor growth in vitro and in vivo. Mathematical modeling suggested the involvement of chromosome instability and interactions among cell subpopulations in restoring the optimal equilibrium of tumor cell types. Both our experimental data and mathematical modeling demonstrated that the complexity of tumor heterogeneity could be enhanced by the existence of chromosomes with structural abnormality, in addition to their mis-segregations. Overall, our findings show, for the first time, the involvement of chromosome instability in maintaining tumor heterogeneity, which underlies the enhanced growth, persistence and treatment resistance of cancers.	[Hu, Yuanjie; Zhou, Yi-Hong] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Ru, Ning; Chaturbedi, Abhishek; Ke, Chao; Yan, Fengrong; Nelson, Jodi; Li, Zhenzhi; Gramer, Robert; Linskey, Mark E.; Zhou, Yi-Hong] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92717 USA; [Xiao, Huasheng; Zhang, Xiaona] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Hoa, Neil T.; Jadus, Martin R.] Vet Affairs Med Ctr, Diagnost & Mol Hlth Care Grp, Long Beach, CA USA; [Tian, Xiao-Jun; Zhang, Hang; Xing, Jianhua] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ke, Chao] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Ke, Chao] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Liping] Ziren Res LLC, Irvine, CA USA; [Siegel, Eric] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Jia, Zhenyu] Guizhou Normal Coll, Guizhou Prov Key Lab Computat Nanomat Sci, Guiyang, Peoples R China; [Jia, Zhenyu] Univ Akron, Dept Stat, Akron, OH 44325 USA; [Jia, Zhenyu] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH USA; [Jia, Zhenyu; Jadus, Martin R.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Limoli, Charles L.] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Virginia Polytechnic Institute & State University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; University of Arkansas System; University of Arkansas Medical Sciences; Guizhou Education University; University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED); University of California System; University of California Irvine; University of California System; University of California Irvine	Zhou, YH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	jxing@vt.edu; yihongz@uci.edu	tian, xiaojun/AAW-4984-2020; Tian, Xiaojun/M-9242-2014; Limoli, Charles/AAW-1748-2020; Hu, Yuanjie/C-1731-2014; Xing, Jianhua/A-8101-2012	tian, xiaojun/0000-0002-5601-2057; Tian, Xiaojun/0000-0002-5601-2057; Limoli, Charles/0000-0002-1321-4142; Hu, Yuanjie/0000-0003-0306-0298; Xing, Jianhua/0000-0002-3700-8765; Siegel, Eric/0000-0001-9824-6612; Gramer, Robert/0000-0001-7550-6397; Chaturbedi, Abhishek/0000-0001-9299-4388	UC Cancer Research Coordinating Committee, UC Irvine Committee on Research, Cancer Center Seed Grant from the National Cancer Institute [P30CA062203]; Direct For Mathematical & Physical Scien [0969417] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	UC Cancer Research Coordinating Committee, UC Irvine Committee on Research, Cancer Center Seed Grant from the National Cancer Institute; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by UC Irvine set-up funds and a generous Stern Family gift (YHZ and ML), grants provided by UC Cancer Research Coordinating Committee, UC Irvine Committee on Research, Cancer Center Seed Grant (Award Number P30CA062203 from the National Cancer Institute), Musella Foundation for Brain Tumor Research & Information, and Voice Against Brain Cancer (YHZ), National Science Foundation DMS-0969417 (JX), VA Merit Review Grant (MRJ). Zhenyu Jia is partially supported by Guizhou Normal College, Guiyang, Guizhou, China, QKHJ[2013]2238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Chaturbedi A, 2012, BIOMARK INSIGHTS, V7, P9, DOI 10.4137/BMI.S9003; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; COONS SW, 1995, CANCER RES, V55, P1569; Dahlback HSS, 2009, GENE CHROMOSOME CANC, V48, P908, DOI 10.1002/gcc.20690; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Driessens G, 2012, NATURE; Duesberg P, 2011, CELL CYCLE, V10, P2100, DOI 10.4161/cc.10.13.16352; Ehtesham M, 2007, ONCOGENE, V26, P5752, DOI 10.1038/sj.onc.1210359; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; HAMLY DH, 1947, SCIENCE, V106, P169, DOI 10.1126/science.106.2747.169; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hoa N, 2010, J IMMUNOL, V185, P4793, DOI 10.4049/jimmunol.1001526; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hu YJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-123; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li L, 2009, CANCER GENET CYTOGEN, V188, P1, DOI 10.1016/j.cancergencyto.2008.08.016; Liu XM, 2011, J NEURO-ONCOL, V105, P173, DOI 10.1007/s11060-011-0578-5; Loeper S, 2001, CYTOGENET CELL GENET, V94, P1, DOI 10.1159/000048773; Lopez-Gines C, 2005, CLIN NEUROPATHOL, V24, P209; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nicholson JM, 2011, ADV CANCER RES, V112, P43, DOI 10.1016/B978-0-12-387688-1.00003-X; Nobusawa S, 2010, BRAIN PATHOL, V20, P936, DOI 10.1111/j.1750-3639.2010.00395.x; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; PERSHOUSE MA, 1993, CANCER RES, V53, P5043; Press W.H., 1997, NUMER RECIPES C; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Ricci-Vitiani L, 2010, NATURE; Ried T, 2012, BBA-GENE REGUL MECH, V1819, P784, DOI 10.1016/j.bbagrm.2012.02.020; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang H, 2003, CANCER RES, V63, P4315; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wemmert S, 2006, INT J ONCOL, V28, P353; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; Zhou YH, 2010, BIOMARK INSIGHTS, V5, P79, DOI 10.4137/BMI.S5596; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	58	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80898	10.1371/journal.pone.0080898	http://dx.doi.org/10.1371/journal.pone.0080898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282558	gold, Green Published			2022-12-27	WOS:000327543500060
J	Van Lippevelde, W; Velde, SJT; Verloigne, M; Van Stralen, MM; De Bourdeaudhuij, I; Manios, Y; Bere, E; Vik, FN; Jan, N; Alvira, JMF; Chinapaw, MJM; Bringolf-Isler, B; Kovacs, E; Brug, J; Maes, L				Van Lippevelde, Wendy; Velde, Saskia J. Te; Verloigne, Maite; Van Stralen, Maartje M.; De Bourdeaudhuij, Ilse; Manios, Yannis; Bere, Elling; Vik, Froydis N.; Jan, Natasa; Fernandez Alvira, Juan M.; Chinapaw, Mai J. M.; Bringolf-Isler, Bettina; Kovacs, Eva; Brug, Johannes; Maes, Lea			Associations between Family-Related Factors, Breakfast Consumption and BMI among 10-to 12-Year-Old European Children: The Cross-Sectional ENERGY-Study	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; TEST-RETEST RELIABILITY; EXCESSIVE WEIGHT-GAIN; PARENTING STYLES; CONSTRUCT-VALIDITY; FOOD-CONSUMPTION; ADOLESCENTS; OBESITY; QUESTIONNAIRE; DETERMINANTS	Objective: To investigate associations of family-related factors with children's breakfast consumption and BMI-z-score and to examine whether children's breakfast consumption mediates associations between family-related factors and children's BMI-z-score. Subjects: Ten-to twelve-year-old children (n = 6374; mean age = 11.6 +/- 0.7 years, 53.2% girls, mean BMI-z-score = 0.4 +/- 1.2) and one of their parents (n = 6374; mean age = 41.4 +/- 5.3 years, 82.7% female, mean BMI = 24.5 +/- 4.2 kg/m(2)) were recruited from schools in eight European countries (Belgium, Greece, Hungary, the Netherlands, Norway, Slovenia, Spain, and Switzerland). The children self-reported their breakfast frequency per week. The body weight and height of the children were objectively measured. The parents responded to items on family factors related to breakfast (automaticity, availability, encouragement, paying attention, permissiveness, negotiating, communicating health beliefs, parental self-efficacy to address children's nagging, praising, and family breakfast frequency). Mediation analyses were performed using multi-level regression analyses (child-school-country). Results: Three of the eleven family-related variables were significantly associated with children's BMI-z-score. The family breakfast frequency was negatively associated with the BMI-z-score; permissiveness concerning skipping breakfast and negotiating about breakfast were positively associated with the BMI-z-score. Children's breakfast consumption was found to be a mediator of the two associations. All family-related variables except for negotiating, praising and communicating health beliefs, were significantly associated with children's breakfast consumption. Conclusions: Future breakfast promotion and obesity prevention interventions should focus on family-related factors including the physical home environment and parenting practices. Nevertheless, more longitudinal research and intervention studies to support these findings between family-related factors and both children's breakfast consumption and BMI-z-score are needed.	[Van Lippevelde, Wendy; Maes, Lea] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Velde, Saskia J. Te; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Verloigne, Maite; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Stralen, Maartje M.; Chinapaw, Mai J. M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Bere, Elling; Vik, Froydis N.] Univ Agder, Fac Hlth & Sport, Kristiansand, Norway; [Jan, Natasa] Slovenian Heart Fdn, Ljubljana, Slovenia; [Fernandez Alvira, Juan M.] Univ Zaragoza, Inst Aragones Ciencias Salud, Zaragoza, Spain; [Bringolf-Isler, Bettina] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Bringolf-Isler, Bettina] Univ Basel, Basel, Switzerland; [Kovacs, Eva] Univ Pecs, Dept Paediat, Pecs, Hungary	Ghent University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ghent University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harokopio University Athens; University of Agder; University of Zaragoza; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Pecs	Van Lippevelde, W (corresponding author), Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.	wendy.vanlippevelde@ugent.be	Brug, Johannes/A-8242-2018; Paw, Mai Chin A/N-1665-2019; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Van Lippevelde, Wendy/AAM-6490-2021; Manios, Yannis/AAM-8953-2021; Maes, Lea/D-6014-2013; Fernández-Alvira, Juan Miguel/O-9665-2019	Brug, Johannes/0000-0002-1904-7349; Paw, Mai Chin A/0000-0001-6259-2441; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Manios, Yannis/0000-0001-6486-114X; Van Lippevelde, Wendy/0000-0002-8535-0215; te Velde, Saskia/0000-0002-4674-8052; van Stralen, Maartje/0000-0001-5534-4271; Fernandez-Alvira, Juan Miguel/0000-0002-4145-5103	European Commission [223254]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was conducted as a part of the "EuropeaN Energy balance Research to prevent excessive weight Gain among Youth" (ENERGY)-project. The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2007-B), Grant agreement no. 223254. The content of this article reflects only the authors' views and the European Community and is not liable for any use that maybe made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenito SG, 2007, J AM DIET ASSOC, V107, P565, DOI 10.1016/j.jada.2007.01.011; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; COSTANZO PR, 1985, J SOC CLIN PSYCHOL, V3, P425, DOI 10.1521/jscp.1985.3.4.425; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; de Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P189, DOI 10.1079/PHN2004673; DeJong CS, 2009, PREV MED, V48, P372, DOI 10.1016/j.ypmed.2009.02.009; Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023; Haug E, 2009, INT J PUBLIC HEALTH, V54, P167, DOI 10.1007/s00038-009-5408-6; Hill JO, 2000, MED CLIN N AM, V84, P333, DOI 10.1016/S0025-7125(05)70224-8; Hughes SO, 2005, APPETITE, V44, P83, DOI 10.1016/j.appet.2004.08.007; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Klepp KI, 2005, ANN NUTR METAB, V49, P212, DOI 10.1159/000087245; Leidy HJ, 2013, AM J CLIN NUTR, V97, P677, DOI 10.3945/ajcn.112.053116; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MacKinnon D.P., 2012, INTRO STAT MEDIATION; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Martens MK, 2005, PUBLIC HEALTH NUTR, V8, P1258, DOI 10.1079/PHN2005828; Moore Julie, 2007, Health Promot J Austr, V18, P143; NICKLAS TA, 1993, J AM DIET ASSOC, V93, P886, DOI 10.1016/0002-8223(93)91527-W; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Pearson N, 2009, APPETITE, V52, P1, DOI 10.1016/j.appet.2008.08.006; Raaijmakers LGM, 2010, EUR J PUBLIC HEALTH, V20, P318, DOI 10.1093/eurpub/ckp191; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Shaw ME, 1998, ADOLESCENCE, V33, P851; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Singh Amika S, 2012, BMC Res Notes, V5, P434, DOI 10.1186/1756-0500-5-434; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Story M, 2006, FUTURE CHILD, V16, P109, DOI 10.1353/foc.2006.0007; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; Van Assema P, 2007, J NUTR EDUC BEHAV, V39, P84, DOI 10.1016/j.jneb.2006.08.031; van der Horst K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-142; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Vereecken C, 2009, AM J HEALTH PROMOT, V23, P233, DOI 10.4278/ajhp.07061355; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195; WHO, 2009, ANTHROPLUS PERS COMP; Young EM, 2001, J SCHOOL HEALTH, V71, P483, DOI 10.1111/j.1746-1561.2001.tb07285.x	43	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79550	10.1371/journal.pone.0079550	http://dx.doi.org/10.1371/journal.pone.0079550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282508	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000327543500011
J	Fan, XZ; Li, DG; Zhang, YF; Green, TA				Fan, Xiuzhen; Li, Dingge; Zhang, Yafang; Green, Thomas A.			Differential Phosphoproteome Regulation of Nucleus Accumbens in Environmentally Enriched and Isolated Rats in Response to Acute Stress	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION; PSYCHOLOGICAL STRESS; UBIQUITIN; DOPAMINE; CORTICOSTERONE; DEGRADATION; STIMULI; NEURONS; PATHWAY; COCAINE	Increasing evidence shows that stress contributes to the pathogenesis of major depressive disorder which is a severe neuropsychiatric disorder and influences over 10% of the world's population. Our previous studies revealed that rats reared in an enriched environment display less depression-related behavior compared to rats raised in an isolated environment, which implies that environmental enrichment produces an antidepressant-like behavioral phenotype. However, the molecular mechanisms are not fully understood. Protein phosphorylation rapidly changes signaling pathway function and alters the function of proteins associated with the stress-induced depressive disorder. Thus, in this study, a phosphoproteomic approach was used to uncover differential phosphoprotein regulation in rat nucleus accumbens between isolated (IC) and enriched environmental conditions (EC) under basal conditions, and in response to acute stress. We found 23 phosphoproteins were regulated in EC vs. IC rats under basal conditions; 10 phosphoproteins regulated by stress in IC rats; and 15 regulated by stress in EC rats. Among all significantly regulated phosphoproteins, 11 of them were represented in at least two conditions. The regulated phosphoproteins represent signaling pathway proteins (including ERK2), enzymes, transcriptional regulators, protein translation regulators, transporters, chaperones and cytoskeletal proteins. These findings provide a global view for further understanding the contribution of protein phosphorylation in depression pathogenesis and antidepressant action.	[Fan, Xiuzhen; Li, Dingge; Zhang, Yafang; Green, Thomas A.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Green, TA (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Galveston, TX 77555 USA.	tom.green@utmb.edu			National Institute on Drug Abuse, part of National Institutes of Health in the USA [R01 DA029091]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029091] Funding Source: NIH RePORTER	National Institute on Drug Abuse, part of National Institutes of Health in the USA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by R01 DA029091 (TAG), from the National Institute on Drug Abuse, part of National Institutes of Health in the USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badrinarayan A, 2012, J NEUROSCI, V32, P15779, DOI 10.1523/JNEUROSCI.3557-12.2012; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bevins RA, 2002, BEHAV BRAIN RES, V129, P41, DOI 10.1016/S0166-4328(01)00326-6; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Blackburn AC, 1999, FREE RADICAL BIO MED, V27, P262, DOI 10.1016/S0891-5849(99)00065-9; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; CALCAGNETTI DJ, 1992, PHYSIOL BEHAV, V51, P667, DOI 10.1016/0031-9384(92)90101-7; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; CROWDER WF, 1992, PHARMACOL BIOCHEM BE, V41, P817, DOI 10.1016/0091-3057(92)90233-6; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Einat H, 2003, J NEUROSCI, V23, P7311; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Forsberg L, 2006, J BIOTECHNOL, V126, P582, DOI 10.1016/j.jbiotec.2006.05.020; Green TA, 2003, PSYCHOPHARMACOLOGY, V170, P235, DOI 10.1007/s00213-003-1538-3; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Green TA, 2006, CPDD M 72, P285; Green TA, 2008, J NEUROSCI, V28, P2025, DOI 10.1523/JNEUROSCI.5273-07.2008; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Hikida T, 2013, P NATL ACAD SCI USA, V110, P342, DOI 10.1073/pnas.1220358110; Hutchinson EK, 2012, J AM ASSOC LAB ANIM, V51, P18; Hutchinson KM, 2012, NEUROBIOL LEARN MEM, V97, P250, DOI 10.1016/j.nlm.2012.01.003; Iio W, 2011, NEUROSCI LETT, V504, P281, DOI 10.1016/j.neulet.2011.09.047; Jha S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.33; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kearns RR, 2013, PHYSL BEHAV IN PRESS; Li D, 2013, PLOS ONE, V8; Lin J, 2010, BRIEF FUNCT GENOMICS, V9, P32, DOI 10.1093/bfgp/elp045; Lin YS, 2013, BBA-MOL BASIS DIS, V1832, P742, DOI 10.1016/j.bbadis.2013.02.006; LOUILOT A, 1986, BRAIN RES, V397, P395, DOI 10.1016/0006-8993(86)90646-3; Martins-de-Souza D, 2012, EUR ARCH PSY CLIN N, V262, P657, DOI 10.1007/s00406-012-0301-3; Martins-De-Souza D, 2010, EUR ARCH PSY CLIN N, V260, P499, DOI 10.1007/s00406-009-0093-2; Meller E, 2003, BRAIN RES, V979, P57, DOI 10.1016/S0006-8993(03)02866-X; Morrison RS, 2002, MOL CELL PROTEOMICS, V1, P553, DOI 10.1074/mcp.R200004-MCP200; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Palmer AK, 2008, FASEB J, V22; Pavlovsky AA, 2013, NEUROSCIENCE, V246, P160, DOI 10.1016/j.neuroscience.2013.04.057; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; QUEST AFG, 1990, FEBS LETT, V269, P457, DOI 10.1016/0014-5793(90)81215-A; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shirayama Y, 2006, CURR NEUROPHARMACOL, V4, P277, DOI 10.2174/157015906778520773; Silva E, 2010, J PROTEOME RES, V9, P1522, DOI 10.1021/pr9010298; Stairs DJ, 2011, PSYCHOPHARMACOLOGY, V218, P293, DOI 10.1007/s00213-011-2448-4; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zhu J, 2007, J NEUROCHEM, V103, P2575, DOI 10.1111/j.1471-4159.2007.04951.x	54	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79893	10.1371/journal.pone.0079893	http://dx.doi.org/10.1371/journal.pone.0079893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278208	Green Submitted, gold, Green Published			2022-12-27	WOS:000327541700018
J	Chu, YH; Lin, FH; Chou, YJ; Tsai, KWK; Kuo, WJ; Jaaskelainen, IP				Chu, Ying-Hua; Lin, Fa-Hsuan; Chou, Yu-Jen; Tsai, Kevin W. -K.; Kuo, Wen-Jui; Jaaskelainen, Iiro P.			Effective Cerebral Connectivity during Silent Speech Reading Revealed by Functional Magnetic Resonance Imaginge	PLOS ONE			English	Article							CROSS-MODAL INTEGRATION; AUDIOVISUAL SPEECH; VISUAL SPEECH; MULTISENSORY INTEGRATION; HEARING LIPS; PERCEPTION; CORTEX; PATHWAYS; FMRI; ORGANIZATION	Seeing the articulatory gestures of the speaker ("speech reading'') enhances speech perception especially in noisy conditions. Recent neuroimaging studies tentatively suggest that speech reading activates speech motor system, which then influences superior-posterior temporal lobe auditory areas via an efference copy. Here, nineteen healthy volunteers were presented with silent videoclips of a person articulating Finnish vowels /a/, /i/(non-targets), and /o/(targets) during event-related functional magnetic resonance imaging (fMRI). Speech reading significantly activated visual cortex, posterior fusiform gyrus (pFG), posterior superior temporal gyrus and sulcus (pSTG/S), and the speech motor areas, including premotor cortex, parts of the inferior (IFG) and middle (MFG) frontal gyri extending into frontal polar (FP) structures, somatosensory areas, and supramarginal gyrus (SMG). Structural equation modelling (SEM) of these data suggested that information flows first from extrastriate visual cortex to pFS, and from there, in parallel, to pSTG/S and MFG/FP. From pSTG/S information flow continues to IFG or SMG and eventually somatosensory areas. Feedback connectivity was estimated to run from MFG/FP to IFG, and pSTG/S. The direct functional connection from pFG to MFG/FP and feedback connection from MFG/FP to pSTG/S and IFG support the hypothesis of prefrontal speech motor areas influencing auditory speech processing in pSTG/S via an efference copy.	[Chu, Ying-Hua; Lin, Fa-Hsuan; Chou, Yu-Jen; Tsai, Kevin W. -K.] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, Fa-Hsuan; Jaaskelainen, Iiro P.] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	National Taiwan University; Aalto University; National Yang Ming Chiao Tung University	Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	fhlin@ntu.edu.tw	Jaaskelainen, Iiro P/C-7392-2012; Tsai, Kevin/GQR-1990-2022; Lin, Fa-Hsuan/G-6988-2012	Jaaskelainen, Iiro P/0000-0001-6001-6950; Lin, Fa-Hsuan/0000-0002-9539-1731	National Science Council, Taiwan [NSC 101-2628-B-002-005-MY3, NSC 102-2325-B-002-042]; National Health Research Institute, Taiwan [NHRI-EX102-10247EI]; Ministry of Economic Affairs, Taiwan [100-EC-17-A-19-S1-175]; Academy of Finland [127624, 138145]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); Academy of Finland(Academy of Finland)	This work was supported by National Science Council, Taiwan (NSC 101-2628-B-002-005-MY3, NSC 102-2325-B-002-042), National Health Research Institute, Taiwan (NHRI-EX102-10247EI), Ministry of Economic Affairs, Taiwan (100-EC-17-A-19-S1-175), and Academy of Finland (127624, 138145, and the FiDiPro program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho J, 2012, NEUROIMAGE, V60, P1937, DOI 10.1016/j.neuroimage.2012.02.011; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Benoit MM, 2010, HUM BRAIN MAPP, V31, P526, DOI 10.1002/hbm.20884; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brazdil M, 2007, NEUROIMAGE, V35, P827, DOI 10.1016/j.neuroimage.2006.12.020; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bullmore ET, 2000, NEUROIMAGE, V11, P289, DOI 10.1006/nimg.2000.0544; Callan DE, 2004, J COGNITIVE NEUROSCI, V16, P805, DOI 10.1162/089892904970771; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P10, DOI 10.1016/B978-012372560-8/50002-4; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hocking J, 2009, BRAIN LANG, V108, P89, DOI 10.1016/j.bandl.2008.10.005; Jaaskelainen Iiro P, 2008, Open Neuroimag J, V2, P14, DOI 10.2174/1874440000802010014; Jaaskelainen Iiro P, 2010, Open Neuroimag J, V4, P30, DOI 10.2174/1874440001004020030; Jaaskelainen IP, 2004, NEUROREPORT, V15, P2741; Liberman A.M, 2000, TRENDS COGN SCI, V3, P254; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MCINTOSH AR, 1991, BRAIN RES, V547, P295, DOI 10.1016/0006-8993(91)90974-Z; McIntosh AR, 1996, CEREB CORTEX, V6, P571, DOI 10.1093/cercor/6.4.571; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Murase M, 2008, NEUROSCI LETT, V434, P71, DOI 10.1016/j.neulet.2008.01.044; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Olson IR, 2002, COGNITIVE BRAIN RES, V14, P129, DOI 10.1016/S0926-6410(02)00067-8; Pekkola J, 2006, NEUROIMAGE, V29, P797, DOI 10.1016/j.neuroimage.2005.09.069; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tzourio-Mazoyer N, 2004, NEUROIMAGE, V21, P422, DOI 10.1016/j.neuroimage.2003.08.032; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	61	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80265	10.1371/journal.pone.0080265	http://dx.doi.org/10.1371/journal.pone.0080265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278266	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800068
J	Gewies, A; Castineiras-Vilarino, M; Ferch, U; Jahrling, N; Heinrich, K; Hoeckendorf, U; Przemeck, GKH; Munding, M; Gross, O; Schroeder, T; Horsch, M; Karran, EL; Majid, A; Antonowicz, S; Beckers, J; de Angelis, MH; Dodt, HU; Peschel, C; Forster, I; Dyer, MJS; Ruland, J				Gewies, Andreas; Castineiras-Vilarino, Mercedes; Ferch, Uta; Jaehrling, Nina; Heinrich, Katja; Hoeckendorf, Ulrike; Przemeck, Gerhard K. H.; Munding, Matthias; Gross, Olaf; Schroeder, Timm; Horsch, Marion; Karran, E. Loraine; Majid, Aneela; Antonowicz, Stefan; Beckers, Johannes; de Angelis, Martin Hrabe; Dodt, Hans-Ulrich; Peschel, Christian; Foerster, Irmgard; Dyer, Martin J. S.; Ruland, Juergen			Prdm6 Is Essential for Cardiovascular Development In Vivo	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; T-CELL HOMEOSTASIS; VASCULAR DEVELOPMENT; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; BREAST-CANCER; MICE LACKING; YOLK-SAC; ANGIOGENESIS; GENE	Members of the PRDM protein family have been shown to play important roles during embryonic development. Previous in vitro and in situ analyses indicated a function of Prdm6 in cells of the vascular system. To reveal physiological functions of Prdm6, we generated conditional Prdm6-deficient mice. Complete deletion of Prdm6 results in embryonic lethality due to cardiovascular defects associated with aberrations in vascular patterning. However, smooth muscle cells could be regularly differentiated from Prdm6-deficient embryonic stem cells and vascular smooth muscle cells were present and proliferated normally in Prdm6-deficient embryos. Conditional deletion of Prdm6 in the smooth muscle cell lineage using a SM22-Cre driver line resulted in perinatal lethality due to hemorrhage in the lungs. We thus identified Prdm6 as a factor that is essential for the physiological control of cardiovascular development.	[Gewies, Andreas; Castineiras-Vilarino, Mercedes; Ferch, Uta; Heinrich, Katja; Hoeckendorf, Ulrike; Gross, Olaf; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany; [Gewies, Andreas; Ruland, Juergen] German Canc Consortium DKTK, Heidelberg, Germany; [Gewies, Andreas; Ruland, Juergen] German Canc Res Ctr, Heidelberg, Germany; [Gewies, Andreas; Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, Neuherberg, Germany; [Jaehrling, Nina; Dodt, Hans-Ulrich] Vienna Univ Technol, Inst Solid State Elect, Dept Bioelect, A-1040 Vienna, Austria; [Jaehrling, Nina; Dodt, Hans-Ulrich] Med Univ Vienna, Sect Bioelect, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Przemeck, Gerhard K. H.; Horsch, Marion; Beckers, Johannes; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Inst Expt Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Munding, Matthias; Schroeder, Timm] German Res Ctr Environm Hlth, Res Unit Stem Cell Dynam, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Karran, E. Loraine; Majid, Aneela; Antonowicz, Stefan; Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Karran, E. Loraine; Majid, Aneela; Antonowicz, Stefan; Dyer, Martin J. S.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany; [Peschel, Christian] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 3, D-80290 Munich, Germany; [Foerster, Irmgard] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Foerster, Irmgard] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Ruland, Juergen] German Ctr Infect Res DZIF, Munich, Germany	Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Leicester; University of Leicester; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; University of Bonn; German Center for Infection Research	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-80290 Munich, Germany.	jruland@lrz.tum.de	Przemeck, Gerhard K. H./A-5991-2012; Ruland, Jürgen/Q-6680-2018; Beckers, Johannes/K-7237-2012; Förster, Irmgard/P-8545-2016; Schroeder, Timm/F-8448-2010; de Angelis, Martin Hrabe/F-5531-2012; Gross, Olaf/E-4570-2010; Dyer, Martin/F-2691-2014	Przemeck, Gerhard K. H./0000-0003-3730-3454; Ruland, Jürgen/0000-0002-8381-3597; Beckers, Johannes/0000-0001-7874-3822; Förster, Irmgard/0000-0002-7644-5642; Schroeder, Timm/0000-0001-9320-0252; de Angelis, Martin Hrabe/0000-0002-7898-2353; Gross, Olaf/0000-0001-8660-3619; Gewies, Andreas/0000-0002-7606-6482; Dyer, Martin/0000-0002-5033-2236; Hockendorf, Ulrike/0000-0002-8218-3343	Deutsche Forschungsgemeinschaft [TRR54]; Medical Research Council; German National Genome Research Network [NGFN 01GS0850]; Bavarian Ministry of Sciences, Research and the Arts	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German National Genome Research Network; Bavarian Ministry of Sciences, Research and the Arts	Jurgen Ruland: Deutsche Forschungsgemeinschaft TRR54, "Growth and survival, plasticity and cellular interactivity of lymphatic neoplasies", (http://www.trr54.de/), Martin Dyer: Medical Research Council "Consequences of genomic instability in B cells", (http://www.mrc.ac.uk/index.htm), Johannes Beckers: German National Genome Research Network, NGFN 01GS0850, (http://www.ngfn.de/en/start.html), Olaf Gross: fund by the "Bavarian Ministry of Sciences, Research and the Arts" in the Framework of the Bavarian Molecular Biosystems Research Network, (http://biosysnet.jimdo.com/projekte/regul%C3%A4re-juniorgruppen/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Byrd N, 2002, DEVELOPMENT, V129, P361; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Davis CA, 2006, MOL CELL BIOL, V26, P2626, DOI 10.1128/MCB.26.7.2626-2636.2006; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezan J, 2004, CARDIOVASC RES, V63, P731, DOI 10.1016/j.cardiores.2004.05.006; Ferch U, 2007, NAT IMMUNOL, V8, P984, DOI 10.1038/ni1493; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; French WJ, 2008, MOL CELL BIOL, V28, P5646, DOI 10.1128/MCB.00441-08; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Goodwin AM, 2006, DEV DYNAM, V235, P3110, DOI 10.1002/dvdy.20939; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; He LS, 1998, CANCER RES, V58, P4238; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Huang Shi, 1999, Frontiers in Bioscience, V4, pd528, DOI 10.2741/Huang; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Jiang GL, 2000, HISTOL HISTOPATHOL, V15, P109, DOI 10.14670/HH-15.109; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Krebs LT, 2000, GENE DEV, V14, P1343; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mock BA, 1996, GENOMICS, V37, P24, DOI 10.1006/geno.1996.0516; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Noveroske JK, 2002, GENESIS, V32, P218, DOI 10.1002/gene.10060; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; SCHNAPER HW, 1993, J CELL PHYSIOL, V156, P235, DOI 10.1002/jcp.1041560204; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Shu WG, 2002, DEVELOPMENT, V129, P4831; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Terai Y, 2001, J CELL PHYSIOL, V188, P394, DOI 10.1002/jcp.1122; van de Schans VAM, 2008, EUR J PHARMACOL, V585, P338, DOI 10.1016/j.ejphar.2008.02.093; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu YX, 2008, J MOL CELL CARDIOL, V44, P47, DOI 10.1016/j.yjmcc.2007.06.008; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yang X, 1999, DEVELOPMENT, V126, P1571	67	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81833	10.1371/journal.pone.0081833	http://dx.doi.org/10.1371/journal.pone.0081833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278461	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800143
J	Jin, Z; Zhang, WH; Yang, HL; Wang, XF; Zheng, YQ; Zhang, QY; Zhi, JM				Jin, Zhu; Zhang, Wenhui; Yang, Hailiang; Wang, Xiaofang; Zheng, Yanqian; Zhang, Qiaoyan; Zhi, Jianming			Maternal Treatment with Agonistic Autoantibodies against Type-1 Angiotensin II Receptor in Late Pregnancy Increases Apoptosis of Myocardial Cells and Myocardial Susceptibility to Ischemia-Reperfusion Injury in Offspring Rats	PLOS ONE			English	Article							NUTRIENT RESTRICTION; HYPOXIA; PREECLAMPSIA; DYSFUNCTION; HEART	Epidemiological studies have demonstrated that offspring born to mothers preeclampsia (PE) are at increased risk for developing cardiovascular diseases after birth, but the underlying mechanism is unknown. Angiotensin II receptor type 1 autoantibody (AT1-AA), an agonist acting via activation of the AT1 receptor, is believed to be involved in the pathogenesis of both PE and fetal growth restriction. The aim of the present study was to confirm the hypothesis that prenatal AT1-AA exposure increases the heart susceptibility to ischemia/reperfusion injury (IRI) in the offspring in an AT1-AA-induced animal model of PE, and determine whether or not the increase of maternal AT1-AA level is a factor contributing to sustained abnormalities of the heart structure during infancy. The hearts of 45-day-old offspring rats were studied using Langendorff preparation to determine the susceptibility of the heart to IRI. The results showed that the body weight of the maternal rats was not significantly different between the study and control groups, but the body weight of their offspring in AT1-AA group was decreased slightly at day 21 of gestational age, and at day 3 after birth. Although the heart weight index was not significantly affected at all ages examined, AT1-AA significantly increased the size of myocardial cells of the left ventricle (LV) at the age of 45 days. AT1-AA gained access to fetal circulation via the placenta and induced apoptosis of fetal myocardial cells. AT1-AA also significantly delayed recovery from IRI and affected the LV function of 45-day-old offspring. This was associated with a significant increase in IRI-induced LV myocardial infarct size. These results suggest that AT1-AA induced abnormal apoptosis of fetal myocardial cells during the fetal period and increased the cardiac susceptibility to IRI in adult offspring.	[Jin, Zhu; Zhang, Wenhui; Wang, Xiaofang; Zheng, Yanqian; Zhi, Jianming] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China; [Yang, Hailiang] Yuncheng City Ctr Dis Control & Prevent, Dept Lab, Yuncheng, Shanxi, Peoples R China; [Zhang, Qiaoyan] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Zhang, QY (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	zyq1695@163.com; jyzhijm@shsmu.edu.cn			National Natural Science Foundation of China [31101070]; Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine [12XJ10041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine	This work was supported by grants from the National Natural Science Foundation of China (No. 31101070). This work was also supported by a grant from Natural Science Foundation of Shanghai Jiao Tong University, School of Medicine (No. 12XJ10041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Chai WR, 2012, ACTA BIOCH BIOPH SIN, V44, P984, DOI 10.1093/abbs/gms087; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Deng AH, 1996, KIDNEY INT, V50, P1132, DOI 10.1038/ki.1996.420; Faas MM, 2000, AM J OBSTET GYNECOL, V182, P351, DOI 10.1016/S0002-9378(00)70223-7; Gluckman PD, 2007, LANCET, V369, P1081, DOI 10.1016/S0140-6736(07)60524-8; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; JAMES TN, 1994, CIRCULATION, V90, P556, DOI 10.1161/01.CIR.90.1.556; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; JIN Z, 2011, ACTA BIOCHIM BIOPHYS, V87; Ronco AM, 2011, TOXICOL APPL PHARM, V251, P137, DOI 10.1016/j.taap.2011.01.001; Meyer KD, 2009, AM J PHYSIOL-HEART C, V296, pH1566, DOI 10.1152/ajpheart.00898.2008; Rueda-Clausen CF, 2009, CARDIOVASC RES, V81, P713, DOI 10.1093/cvr/cvn341; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Wambolt RB, 2001, CAN J CARDIOL, V17, P889; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Xia Y, 2007, J IMMUNOL, V179, P3391, DOI 10.4049/jimmunol.179.6.3391; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004; Zhi JM, 2004, ACTA BIOCH BIOPH SIN, V36, P793, DOI 10.1093/abbs/36.12.793; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	25	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80709	10.1371/journal.pone.0080709	http://dx.doi.org/10.1371/journal.pone.0080709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278308	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800081
J	Tu, YL; Chang, SW; Tsai, HJ; Chen, LC; Lee, WI; Hua, MC; Cheng, JH; Ou, LS; Yeh, KW; Huang, JL; Yao, TC				Tu, Yu-Ling; Chang, Su-Wei; Tsai, Hui-Ju; Chen, Li-Chen; Lee, Wen-I; Hua, Man-Chin; Cheng, Ju-Hui; Ou, Liang-Shiou; Yeh, Kuo-Wei; Huang, Jing-Long; Yao, Tsung-Chieh		PATCH Study Grp	Total Serum IgE in a Population-Based Study of Asian Children in Taiwan: Reference Value and Significance in the Diagnosis of Allergy	PLOS ONE			English	Article							IMMUNOGLOBULIN-E LEVELS; HEALTHY-SUBJECTS; AGE; ASSOCIATIONS; DISEASES; SAMPLE	Background: Total serum immunoglobulin (IgE) test is usually performed to aid in the diagnosis of allergic diseases, but its reference values may vary among people of different ethnic backgrounds. Objectives: To establish reference values of total IgE in Asian children and to assess their significance in the diagnosis of atopy and allergic diseases. Study design: 1321 Asian children aged 5-18 years in the Prediction of Allergies in Taiwanese CHildren (PATCH) study, a population-based cohort, were evaluated for total and specific IgE by ImmunoCAP and Phadiatop Infant, respectively. Results: Male, atopy, allergic diseases, recent symptoms of upper respiratory infection, and lower FEV1/FVC, were associated with higher total IgE levels in univariate analyses. Multivariate analysis revealed that atopy was the single most important determinant explaining 66.1% of the variability of total IgE levels in this population. The area under the receiver-operator characteristic (ROC) curve of total IgE for diagnosing atopy, asthma, rhinitis, and eczema were 0.92, 0.72, 0.70, and 0.70, respectively. The sensitivity, specificity, and positive and negative predictive values of total IgE at the optimal cutoff of 77.7 kU/L on the ROC curve for diagnosing atopy were 82.3%, 87.1%, 89.5%, and 78.6%, respectively. The corresponding values using the upper 95% CI of total IgE (164.3 kU/L) in non-atopic children were 61.2%, 95.0%, 94.3%, and 64.6%, respectively; whereas a customary cutoff (100 kU/L) provided accuracy between that of the aforementioned two cutoffs. Total IgE at the cutoff of 77.7 kU/L provided modest sensitivity and specificity (49.0%-78.3%) for diagnosing allergic diseases, but had high negative predictive values (84.2%-97.9%). Conclusions: Total serum IgE discriminates Asian children with and without atopy independent of allergic symptoms, with an optimal cutoff of 77.7 kU/L. The study confirms the insufficient diagnostic accuracy of total IgE alone to detect allergic diseases, but low total IgE levels may help exclude allergic diseases.	[Tu, Yu-Ling; Chen, Li-Chen; Lee, Wen-I; Cheng, Ju-Hui; Ou, Liang-Shiou; Yeh, Kuo-Wei; Huang, Jing-Long; Yao, Tsung-Chieh] Chang Gung Mem Hosp, Div Allergy Asthma & Rheumatol, Dept Pediat, Tao Yuan, Taiwan; [Tu, Yu-Ling; Chen, Li-Chen; Lee, Wen-I; Cheng, Ju-Hui; Ou, Liang-Shiou; Yeh, Kuo-Wei; Huang, Jing-Long; Yao, Tsung-Chieh] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tu, Yu-Ling; Chen, Li-Chen; Lee, Wen-I; Ou, Liang-Shiou; Yeh, Kuo-Wei; Huang, Jing-Long; Yao, Tsung-Chieh] Chang Gung Mem Hosp Keelung, Community Med Res Ctr, Keelung, Taiwan; [Tu, Yu-Ling] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Coll Med, Tao Yuan, Taiwan; [Tsai, Hui-Ju] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli, Taiwan; [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Hua, Man-Chin] Chang Gung Mem Hosp Keelung, Dept Pediat, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Health Research Institutes - Taiwan; Northwestern University; Feinberg School of Medicine; Chang Gung Memorial Hospital	Huang, JL (corresponding author), Chang Gung Mem Hosp, Div Allergy Asthma & Rheumatol, Dept Pediat, Tao Yuan, Taiwan.	long@adm.cgmh.org.tw; yao@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Tsai, Hui-Ju/E-3937-2010	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	National Science Council of Taiwan [NSC 101-2314-B-182A-044, NSC 102-2314-B-182A-048]; Chang Gung Memorial Hospital [CMRPG260291similar to260293, CMRPG2B0071similar to2B0073, CMRPG4B0031similar to4B0033]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by the National Science Council of Taiwan (grants NSC 101-2314-B-182A-044 and NSC 102-2314-B-182A-048) and by Chang Gung Memorial Hospital (grants CMRPG260291 similar to 260293, CMRPG2B0071 similar to 2B0073, and CMRPG4B0031 similar to 4B0033). The funders only provided financial support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Biggar RJ, 2009, INT J CANCER, V124, P2616, DOI 10.1002/ijc.24245; Campos A, 2005, Allergol Immunopathol (Madr), V33, P303, DOI 10.1016/S0301-0546(05)73247-X; Carosso A, 2007, INT ARCH ALLERGY IMM, V142, P230, DOI 10.1159/000097025; CLINE MG, 1989, THORAX, V44, P425, DOI 10.1136/thx.44.5.425; Ezeamuzie CI, 1999, CLIN EXP ALLERGY, V29, P375; Gergen PJ, 2009, J ALLERGY CLIN IMMUN, V124, P447, DOI 10.1016/j.jaci.2009.06.011; GRUNDBACHER FJ, 1985, J ALLERGY CLIN IMMUN, V75, P651, DOI 10.1016/0091-6749(85)90089-2; KOJIMA S, 1972, AM J TROP MED HYG, V21, P913, DOI 10.4269/ajtmh.1972.21.913; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Parks CG, 2010, LUPUS, V19, P1614, DOI 10.1177/0961203310379870; Salo PM, 2011, J ALLERGY CLIN IMMUN, V127, P1226, DOI 10.1016/j.jaci.2010.12.1106; Sharma S, 2006, CLIN EXP ALLERGY, V36, P1019, DOI 10.1111/j.1365-2222.2006.02525.x; Simoni M, 2001, EUR J EPIDEMIOL, V17, P231, DOI 10.1023/A:1017929831911; Soldin OP, 2008, CLIN BIOCHEM, V41, P937, DOI 10.1016/j.clinbiochem.2008.04.025; WALDMANN TA, 1972, J IMMUNOL, V109, P304; WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911; Yao TC, 2011, CLIN EXP ALLERGY, V41, P556, DOI 10.1111/j.1365-2222.2010.03687.x; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743; ZETTERSTROM O, 1981, ALLERGY, V36, P537, DOI 10.1111/j.1398-9995.1981.tb01871.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	26	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80996	10.1371/journal.pone.0080996	http://dx.doi.org/10.1371/journal.pone.0080996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278361	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100132
J	Valle, MS; Cioni, M; Pisasale, M; Panto, MR; Casabona, A				Valle, Maria Stella; Cioni, Matteo; Pisasale, Mariangela; Panto, Maria Rosita; Casabona, Antonino			Timing of Muscle Response to a Sudden Leg Perturbation: Comparison between Adolescents and Adults with Down Syndrome	PLOS ONE			English	Article							PENDULUM TEST; LIFE-SPAN; TYPICAL DEVELOPMENT; SYNDROME CHILDREN; POSTURAL CONTROL; FEEDBACK-CONTROL; CEREBRAL-PALSY; MOTOR CORTEX; INDIVIDUALS; GAIT	Movement disturbances associated with Down syndrome reduce mechanical stability, worsening the execution of important tasks such as walking and upright standing. To compensate these deficits, persons with Down syndrome increase joint stability modulating the level of activation of single muscles or producing an agonist-antagonist co-activation. Such activations are also observed when a relaxed, extended leg is suddenly released and left to oscillate passively under the influence of gravity (Wartenberg test). In this case, the Rectus femoris of adults with Down syndrome displayed peaks of activation after the onset of the first leg flexion. With the aim to verify if these muscular reactions were acquired during the development time and to find evidences useful to give them a functional explanation, we used the Wartenberg test to compare the knee joint kinematics and the surface electromyography of the Rectus femoris and Biceps femoris caput longus between adolescents and adults with Down syndrome. During the first leg flexion, adolescents and adults showed single Rectus femoris activations while, a restricted number of participants exhibited agonist-antagonist co-activations. However, regardless the pattern of activation, adults initiated the muscle activity significantly later than adolescents. Although most of the mechanical parameters and the total movement variability were similar in the two groups, the onset of the Rectus femoris activation was well correlated with the time of the minimum acceleration variability. Thus, in adolescents the maximum mechanical stability occurred short after the onset of the leg fall, while adults reached their best joint stability late during the first flexion. These results suggest that between the adolescence and adulthood, persons with Down syndrome explore a temporal window to select an appropriate timing of muscle activation to overcome their inherent mechanical instability.	[Valle, Maria Stella; Panto, Maria Rosita; Casabona, Antonino] Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy; [Cioni, Matteo; Pisasale, Mariangela; Casabona, Antonino] Univ Catania, Gait Anal Lab, Phys Med & Rehabil Residency Program, Catania, Italy; [Cioni, Matteo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Panto, Maria Rosita] Italian People Assoc, Sect Catania, Catania, Italy	University of Catania; University of Catania; University of Catania	Casabona, A (corresponding author), Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy.	casabona@unict.it		Casabona, Antonino/0000-0003-0180-4695; CIONI, Matteo/0000-0002-7594-6939; VALLE, Maria Stella/0000-0001-9728-3542	University of Catania	University of Catania	University of Catania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiovlasitis S, 2009, GAIT POSTURE, V30, P345, DOI 10.1016/j.gaitpost.2009.06.003; ALMEIDA GL, 1994, PHYS THER, V74, P1000, DOI 10.1093/ptj/74.11.1000; Aylward EH, 1997, PSYCHIAT RES-NEUROIM, V74, P73, DOI 10.1016/S0925-4927(97)00011-5; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Black DP, 2007, EXP BRAIN RES, V183, P511, DOI 10.1007/s00221-007-1066-1; Carmeli E, 2012, RES DEV DISABIL, V33, P165, DOI 10.1016/j.ridd.2011.09.008; Carvalho RL, 2009, J INTELL DISABIL RES, V53, P389, DOI 10.1111/j.1365-2788.2008.01147.x; Casabona A, 2012, J APPL PHYSIOL, V113, P1747, DOI 10.1152/japplphysiol.00960.2012; Casabona A, 2010, CEREBELLUM, V9, P103, DOI 10.1007/s12311-009-0149-x; CASELLI MA, 1991, J AM PODIAT MED ASSN, V81, P119, DOI 10.7547/87507315-81-3-119; Chang CL, 2009, HUM MOVEMENT SCI, V28, P283, DOI 10.1016/j.humov.2008.12.002; CIONI M, 1994, AM J MENT RETARD, V99, P166; Cioni M, 2001, AM J MENT RETARD, V106, P470, DOI 10.1352/0895-8017(2001)106<0470:AOAKDW>2.0.CO;2; Cioni M, 2002, PHYS MED REHABILITAT, P303; CONNOLLY BH, 1993, PHYS THER, V73, P170, DOI 10.1093/ptj/73.3.170; CRONK CE, 1985, AM J MENT DEF, V89, P433; DIAMOND LS, 1981, ORTHOP CLIN N AM, V12, P57; Dressler A, 2010, WIEN KLIN WOCHENSCHR, V122, P673, DOI 10.1007/s00508-010-1504-0; EDWARDS JM, 1989, J CLIN EXP NEUROPSYC, V11, P959, DOI 10.1080/01688638908400948; Esbensen AJ, 2008, AM J MENT RETARD, V113, P263, DOI 10.1352/0895-8017(2008)113[263:SACIHF]2.0.CO;2; Fowler EG, 2000, DEV MED CHILD NEUROL, V42, P182; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Galli M, 2008, GAIT POSTURE, V28, P502, DOI 10.1016/j.gaitpost.2008.03.001; Glaser EM, 1976, PRINCIPLES NEUROBIOL, P233; Gontijo APB, 2008, HUM MOVEMENT SCI, V27, P610, DOI 10.1016/j.humov.2008.01.003; Hyde LA, 2001, DEV PSYCHOBIOL, V38, P33, DOI 10.1002/1098-2302(2001)38:1<33::AID-DEV3>3.0.CO;2-0; Jobling A, 2000, PERCEPTUAL-MOTOR BEHAVIOR IN DOWN SYNDROME, P225; Klass M, 2011, EUR J APPL PHYSIOL, V111, P1909, DOI 10.1007/s00421-010-1815-x; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; Lam MY, 2009, AJIDD-AM J INTELLECT, V114, P411, DOI 10.1352/1944-7558-114.6.411; LATASH ML, 1991, AM J MENT RETARD, V96, P189; LATASH ML, 1993, ARCH PHYS MED REHAB, V74, P391; Lewis GN, 2006, EXP BRAIN RES, V174, P413, DOI 10.1007/s00221-006-0475-x; Li XY, 2007, ANN BIOMED ENG, V35, P1532, DOI 10.1007/s10439-007-9320-z; Looper J, 2006, J MOTOR BEHAV, V38, P367, DOI 10.3200/JMBR.38.5.367-372; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Manni E, 2004, NAT REV NEUROSCI, V5, P241, DOI 10.1038/nrn1347; Marsden C D, 1983, Adv Neurol, V39, P509; MATTHEWS PBC, 1991, TRENDS NEUROSCI, V14, P87, DOI 10.1016/0166-2236(91)90064-2; MORRIS AF, 1982, J MENT DEFIC RES, V26, P41; Obata H, 2010, J ELECTROMYOGR KINES, V20, P55, DOI 10.1016/j.jelekin.2009.01.009; Palisano RJ, 2001, ARCH PHYS MED REHAB, V82, P494, DOI 10.1053/apmr.2001.21956; PARKER AW, 1985, J MENT DEFIC RES, V29, P207; Pereira K, 2013, RES DEV DISABIL, V34, P894, DOI 10.1016/j.ridd.2012.11.021; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; Pinter JD, 2001, AM J PSYCHIAT, V158, P1659, DOI 10.1176/appi.ajp.158.10.1659; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; Rigoldi C, 2011, RES DEV DISABIL, V32, P158, DOI 10.1016/j.ridd.2010.09.009; Rigoldi C, 2011, RES DEV DISABIL, V32, P170, DOI 10.1016/j.ridd.2010.09.007; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SHUMWAYCOOK A, 1985, PHYS THER, V65, P1315, DOI 10.1093/ptj/65.9.1315; Smith BA, 2007, PHYS THER, V87, P766, DOI 10.2522/ptj.20060289; Smith BA, 2011, J NEUROL PHYS THER, V35, P170, DOI 10.1097/NPT.0b013e3182386de1; Solnik S, 2010, EUR J APPL PHYSIOL, V110, P489, DOI 10.1007/s00421-010-1521-8; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Ulrich BD, 2004, HUM MOVEMENT SCI, V23, P133, DOI 10.1016/j.humov.2004.06.002; Valle MS, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-89; van Gameren-Oosterom HBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021879; Wartenberg R., 1951, NEUROLOGY, V1, P8; White H, 2007, GAIT POSTURE, V26, P97, DOI 10.1016/j.gaitpost.2006.07.012; Winter D., 2009, BIOMECHANICS MOTOR C, V4th ed, P82	64	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81053	10.1371/journal.pone.0081053	http://dx.doi.org/10.1371/journal.pone.0081053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278374	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100139
J	Beck, Z; Jagodzinski, LL; Eller, MA; Thelian, D; Matyas, GR; Kunz, AN; Alving, CR				Beck, Zoltan; Jagodzinski, Linda L.; Eller, Michael A.; Thelian, Doris; Matyas, Gary R.; Kunz, Anjali N.; Alving, Carl R.			Platelets and Erythrocyte-Bound Platelets Bind Infectious HIV-1 in Plasma of Chronically Infected Patients	PLOS ONE			English	Article							DUFFY ANTIGEN RECEPTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CELL SPREAD; DC-SIGN; TRANS-INFECTION; PROGRESSION; RESERVOIRS; INTERNALIZATION; IDENTIFICATION; ACQUISITION	Chronic HIV-1 infection is associated with persistent viremia in most patients, but it remains unclear how free virus may survive the potential hostile effects of plasma. We investigated whether sites might exist on the surfaces of circulating blood cells for protection of infectious HIV-1 particles. Red blood cells (RBC) either from blood of uninfected normal individuals, or from blood obtained without EDTA from chronically infected HIV-1 patients, invariably contained a small number of RBC having attached platelets as determined by flow cytometry, light microscopy, and immunofluorescence microscopy. After mixing normal RBC with platelet-rich plasma, discrete populations of RBC, platelets, and complexes of platelets attached to RBC were purified by fluorescence-activated cell sorting. Upon incubation of purified cells or platelets with HIV-1 followed by washing and co-incubation with CD4-positive peripheral blood mononuclear cells (PBMC), platelets, and platelet-RBC complexes, but not platelet-free RBC, caused infection of PBMC. Infection was prevented by pre-treating the platelet-RBC complexes with EDTA. Plasma and RBC (comprising a RBC/platelet-RBC mixture) from chronically infected patients with low viral loads were also co-incubated with PBMC ex vivo to determine the presence of infectious HIV-1. All freshly isolated plasmas from the HIV-1-infected donors, obtained in the absence of anticoagulant, were noninfectious. Interestingly, the RBC from most of the patients caused cell-cell infection of PBMC that was prevented by stripping the RBC with EDTA. A monoclonal antibody to DC-SIGN partially inhibited cell-cell HIV-1 infection of PBMC by normal RBC pre-incubated with platelets and HIV-1. We conclude: (a) platelet-free EDTA-free plasma from chronically infected HIV-1 patients, although containing viral RNA, is an environment that lacks detectable infectious HIV-1; (b) platelets and platelet-RBC complexes, but not purified RBC, bind infectious HIV-1; (c) DC-SIGN, and possibly other C-type lectins, may represent binding sites for infectious HIV-1 on platelets and platelet-RBC complexes.	[Beck, Zoltan; Jagodzinski, Linda L.; Eller, Michael A.; Thelian, Doris; Matyas, Gary R.; Kunz, Anjali N.; Alving, Carl R.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Beck, Zoltan; Eller, Michael A.; Thelian, Doris] Henry M Jackson Fdn Adv Mil Med, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Alving, CR (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.	calving@hivresearch.org	Matyas, Gary/AAK-6785-2021; Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877; Matyas, Gary/0000-0002-2074-2373	Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. [W81XWH-07-2-0067]; U.S. Medical Research and Material Command [W81XWH-07-2-0067]	Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.; U.S. Medical Research and Material Command	This work was supported by cooperative agreement W81XWH-07-2-0067, between the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. and the U.S. Medical Research and Material Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt PA, 2010, TRANSFUS MED REV, V24, P172, DOI 10.1016/j.tmrv.2010.03.001; Auerbach DJ, 2012, P NATL ACAD SCI USA, V109, P9569, DOI 10.1073/pnas.1207314109; Beck Z, 2011, VIROLOGY, V412, P441, DOI 10.1016/j.virol.2011.01.037; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Boukour S, 2006, J THROMB HAEMOST, V4, P426, DOI 10.1111/j.1538-7836.2006.01749.x; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BRUISTEN S, 1993, AIDS RES HUM RETROV, V9, P259, DOI 10.1089/aid.1993.9.259; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chaipan C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-47; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Dale BM, 2013, IMMUNOL REV, V251, P113, DOI 10.1111/imr.12022; Fierer DS, 2007, J INFECT DIS, V196, P587, DOI 10.1086/519741; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Julg B, 2009, CELL HOST MICROBE, V5, P413, DOI 10.1016/j.chom.2009.04.009; Kulkarni H, 2009, BLOOD, V114, P2783, DOI 10.1182/blood-2009-04-215186; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; LEE TH, 1993, SCIENCE, V262, P1585, DOI 10.1126/science.8248811; Lee TH, 1998, TRANSFUSION, V38, P580, DOI 10.1046/j.1537-2995.1998.38698326338.x; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Garcia MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045808; Garcia MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014544; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; Palmer S, 2011, J INTERN MED, V270, P550, DOI 10.1111/j.1365-2796.2011.02457.x; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; PHILLIPS DM, 1994, AIDS, V8, P719, DOI 10.1097/00002030-199406000-00001; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Smith BA, 2001, J IMMUNOL, V166, P690, DOI 10.4049/jimmunol.166.1.690; Smith MZ, 2012, CURR HIV-AIDS REP, V9, P5, DOI 10.1007/s11904-011-0108-2; Sutherland DR, 2012, CYTOM PART B-CLIN CY, V82B, P195, DOI 10.1002/cyto.b.21023; Tsegaye TS, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-48; van Montfort T, 2007, J IMMUNOL, V178, P3177, DOI 10.4049/jimmunol.178.5.3177; Walley NM, 2009, CELL HOST MICROBE, V5, P408, DOI 10.1016/j.chom.2009.04.011; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; ZUCKERFRANKLIN D, 1990, BLOOD, V75, P1920	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81002	10.1371/journal.pone.0081002	http://dx.doi.org/10.1371/journal.pone.0081002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282562	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500064
J	Brennan, SC; Finney, BA; Lazarou, M; Rosser, AE; Scherf, C; Adriaensen, D; Kemp, PJ; Riccardi, D				Brennan, Sarah C.; Finney, Brenda A.; Lazarou, Maria; Rosser, Anne E.; Scherf, Caroline; Adriaensen, Dirk; Kemp, Paul J.; Riccardi, Daniela			Fetal Calcium Regulates Branching Morphogenesis in the Developing Human and Mouse Lung: Involvement of Voltage-Gated Calcium Channels	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; SENSING RECEPTOR; EMBRYONIC LUNG; RAT LUNG; PERISTALSIS; CLONING; GROWTH; IDENTIFICATION; METABOLISM; EXPRESSION	Airway branching morphogenesis in utero is essential for optimal postnatal lung function. In the fetus, branching morphogenesis occurs during the pseudoglandular stage (weeks 9-17 of human gestation, embryonic days (E)11.5-16.5 in mouse) in a hypercalcaemic environment (similar to 1.7 in the fetus vs. similar to 1.1-1.3 mM for an adult). Previously we have shown that fetal hypercalcemia exerts an inhibitory brake on branching morphogenesis via the calcium-sensing receptor. In addition, earlier studies have shown that nifedipine, a selective blocker of L-type voltage-gated Ca2+ channels (VGCC), inhibits fetal lung growth, suggesting a role for VGCC in lung development. The aim of this work was to investigate the expression of VGCC in the pseudoglandular human and mouse lung, and their role in branching morphogenesis. Expression of L-type (Ca(V)1.2 and Ca(V)1.3), P/Q type (Ca(V)2.1), N-type (Ca(V)2.2), R-type (Ca(V)2.3), and T-type (Ca(V)3.2 and Ca(V)3.3) VGCC was investigated in paraffin sections from week 9 human fetal lungs and E12.5 mouse embryos. Here we show, for the first time, that Ca(v)1.2 and Ca(v)1.3 are expressed in both the smooth muscle and epithelium of the developing human and mouse lung. Additionally, Ca(v)2.3 was expressed in the lung epithelium of both species. Incubating E12.5 mouse lung rudiments in the presence of nifedipine doubled the amount of branching, an effect which was partly mimicked by the Ca(v)2.3 inhibitor, SNX-482. Direct measurements of changes in epithelial cell membrane potential, using the voltage-sensitive fluorescent dye DiSBAC(2)(3), demonstrated that cyclic depolarisations occur within the developing epithelium and coincide with rhythmic occlusions of the lumen, driven by the naturally occurring airway peristalsis. We conclude that VGCC are expressed and functional in the fetal human and mouse lung, where they play a role in branching morphogenesis. Furthermore, rhythmic epithelial depolarisations evoked by airway peristalsis would allow for branching to match growth and distension within the developing lung.	[Brennan, Sarah C.; Finney, Brenda A.; Lazarou, Maria; Rosser, Anne E.; Kemp, Paul J.; Riccardi, Daniela] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Finney, Brenda A.] Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Edgbaston, England; [Scherf, Caroline] Cardiff & Vale Univ Hlth Board, Llandough Hosp, Cardiff, S Glam, Wales; [Adriaensen, Dirk] Univ Antwerp, Dept Vet Sci, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium	Cardiff University; University of Birmingham; University of Antwerp	Brennan, SC (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	BrennanSC@cardiff.ac.uk	Brennan, Sarah C/L-3011-2013; Kemp, Paul/A-4634-2010; Finney, Brenda/ABF-3763-2020; Riccardi, Daniela/A-4674-2010	Brennan, Sarah C/0000-0002-8719-4367; Kemp, Paul/0000-0003-2773-973X; Riccardi, Daniela/0000-0002-7322-3163; Finney, Brenda/0000-0003-4770-5270; Rosser, Anne/0000-0002-4716-4753	Biotechnology and Biological Sciences Research Council [BB/D01591X]; Marie Curie Initial Training Network "Multifaceted CaSR" [FA648A0405]; Fund for Scientific Research-Flanders (FWO) [G.0589.11]; Hercules Foundation [AUAH- 09-001]; University of Antwerp (GOA BOF)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Initial Training Network "Multifaceted CaSR"; Fund for Scientific Research-Flanders (FWO)(FWO); Hercules Foundation; University of Antwerp (GOA BOF)	This study was funded by the Biotechnology and Biological Sciences Research Council (grant BB/D01591X to DR and PJK), by a Marie Curie Initial Training Network "Multifaceted CaSR" (grant FA648A0405 to DR and PJK), and by grants of the Fund for Scientific Research-Flanders (FWO; G.0589.11 to DA), the Hercules Foundation (AUAH- 09-001 to DA) and the University of Antwerp (GOA BOF 2007 to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN D, 1977, J ANAT, V123, P649; AUWERX J, 1985, EUR J CLIN INVEST, V15, P6, DOI 10.1111/j.1365-2362.1985.tb00136.x; Brandt A, 2003, J NEUROSCI, V23, P10832; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; De Proost I, 2007, HISTOCHEM CELL BIOL, V128, P301, DOI 10.1007/s00418-007-0318-2; del Moral PM, 2010, METHODS MOL BIOL, V633, P71, DOI 10.1007/978-1-59745-019-5_5; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; *DEP HLTH, 1995, GUID SUPPL FET TISS; Featherstone NC, 2005, AM J RESP CELL MOL, V33, P153, DOI 10.1165/rcmb.2005-0137OC; FEWELL JE, 1983, J PHYSIOL-LONDON, V339, P495, DOI 10.1113/jphysiol.1983.sp014729; Finney B, 2011, EXP LUNG RES, V37, P269, DOI 10.3109/01902148.2010.545471; Finney BA, 2008, J PHYSIOL-LONDON, V586, P6007, DOI 10.1113/jphysiol.2008.161687; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; Jesudason EC, 2006, AM J PHYSIOL-LUNG C, V291, pL559, DOI 10.1152/ajplung.00498.2005; Jesudason EC, 2009, THORAX, V64, P541, DOI 10.1136/thx.2008.107094; Jesudason EC, 2005, AM J RESP CELL MOL, V32, P118, DOI 10.1165/rcmb.2004-0304OC; Kovacs CS, 1998, J CLIN INVEST, V101, P2812, DOI 10.1172/JCI2940; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mitchell JW, 2002, BBA-GENE STRUCT EXPR, V1577, P17, DOI 10.1016/S0167-4781(02)00371-8; Polkinghorne J, 1989, REV GUIDANCE RES USE; Post M, 2002, ACTA PHARMACOL SIN, V23, P4; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Riccardi D, 2012, ANNU REV PHYSIOL, V74, P271, DOI 10.1146/annurev-physiol-020911-153318; ROMAN J, 1995, EXP LUNG RES, V21, P489, DOI 10.3109/01902149509031754; Schittny JC, 2000, AM J RESP CELL MOL, V23, P11, DOI 10.1165/ajrcmb.23.1.3926; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stewart BA, 2013, J AUTISM DEV DISORD, V43, P911, DOI 10.1007/s10803-012-1635-4; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80294	10.1371/journal.pone.0080294	http://dx.doi.org/10.1371/journal.pone.0080294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282533	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500034
J	Chen, JW; Wang, M; Guo, MZ; Xie, YT; Cong, YS				Chen, Jingwen; Wang, Miao; Guo, Mingzhou; Xie, Yuntao; Cong, Yu-Sheng			miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6	PLOS ONE			English	Article							DNA-DAMAGE; BREAST-CANCER; IN-VIVO; EXPRESSION; MIR-433; P53; MICRORNA-127; PROTEIN	Cellular senescence occurs as a response to extracellular and intracellular stresses and contributes to aging and age-related pathologies. Emerging evidence suggests that cellular senescence also acts as a potent tumor suppression mechanism that prevents the oncogenic transformation of primary human cells. Recent reports have indicated that miRNAsact as key modulators of cellular senescence by targeting critical regulators of the senescence pathways. We previously reported that miR-127 is up-regulated in senescent fibroblasts. In this report, we identified miR-127 as a novel regulator of cellular senescence that directly targets BCL6. We further showed that miR-127 is down-regulated in breast cancer tissuesand that this down-regulation is associated with up-regulation of BCL6. Over-expression of miR-127 or depletion of BCL6 inhibits breast cancer cell proliferation. Our data suggest that miR-127 may function as a tumor suppressor that modulates the oncogene BCL6.	[Chen, Jingwen] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Minist Educ,Key Lab Cell Proliferat & Regulat Bio, Beijing 100875, Peoples R China; [Chen, Jingwen; Wang, Miao; Cong, Yu-Sheng] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China; [Xie, Yuntao] Peking Univ, Canc Hosp, Beijing Canc Hosp & Inst, Breast Ctr, Beijing 100871, Peoples R China	Beijing Normal University; Hangzhou Normal University; Chinese People's Liberation Army General Hospital; Peking University	Cong, YS (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China.	yscong@hznu.edu.cn			National Basic Research Program of China [2012CB911203, 2010CB912802]; National Natural Science Foundation of China [31201038, 31071200, 31171320]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Basic Research Program of China [2012CB911203, 2010CB912802] and the National Natural Science Foundation of China [31201038, 31071200, 31171320]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Liu FJ, 2012, AGEING RES REV, V11, P41, DOI 10.1016/j.arr.2011.06.001; Logarajah S, 2003, ONCOGENE, V22, P5572, DOI 10.1038/sj.onc.1206689; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Pan CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039151; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; te Poele RH, 2002, CANCER RES, V62, P1876; Wang M, 2011, MOL CELL BIOCHEM, V352, P271, DOI 10.1007/s11010-011-0763-z; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100	31	49	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80266	10.1371/journal.pone.0080266	http://dx.doi.org/10.1371/journal.pone.0080266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282530	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500031
J	Crous-Bou, M; Rennert, G; Cuadras, D; Salazar, R; Cordero, D; Rennert, HS; Lejbkowicz, F; Kopelovich, L; Lipkin, SM; Gruber, SB; Moreno, V				Crous-Bou, Marta; Rennert, Gad; Cuadras, Daniel; Salazar, Ramon; Cordero, David; Rennert, Hedy Saltz; Lejbkowicz, Flavio; Kopelovich, Levy; Lipkin, Steven Monroe; Gruber, Stephen Bernard; Moreno, Victor			Polymorphisms in Alcohol Metabolism Genes ADH1B and ALDH2, Alcohol Consumption and Colorectal Cancer	PLOS ONE			English	Article							DEHYDROGENASE POLYMORPHISMS; LIVER-DISEASE; RISK; ACETALDEHYDE; METAANALYSIS; SMOKING; ASSOCIATION; POPULATION; NUTRITION; STATINS	Background: Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Epidemiological risk factors for CRC included alcohol intake, which is mainly metabolized to acetaldehyde by alcohol dehydrogenase and further oxidized to acetate by aldehyde dehydrogenase; consequently, the role of genes in the alcohol metabolism pathways is of particular interest. The aim of this study is to analyze the association between SNPs in ADH1B and ALDH2 genes and CRC risk, and also the main effect of alcohol consumption on CRC risk in the study population. Methodology/Principal Findings: SNPs from ADH1B and ALDH2 genes, included in alcohol metabolism pathway, were genotyped in 1694 CRC cases and 1851 matched controls from the Molecular Epidemiology of Colorectal Cancer study. Information on clinicopathological characteristics, lifestyle and dietary habits were also obtained. Logistic regression and association analysis were conducted. A positive association between alcohol consumption and CRC risk was observed in male participants from the Molecular Epidemiology of Colorectal Cancer study (MECC) study (OR = 1.47; 95% CI = 1.18-1.81). Moreover, the SNPs rs1229984 in ADH1B gene was found to be associated with CRC risk: under the recessive model, the OR was 1.75 for A/A genotype (95%CI = 1.21-2.52; p-value = 0.0025). A path analysis based on structural equation modeling showed a direct effect of ADH1B gene polymorphisms on colorectal carcinogenesis and also an indirect effect mediated through alcohol consumption. Conclusions/Significance: Genetic polymorphisms in the alcohol metabolism pathways have a potential role in colorectal carcinogenesis, probably due to the differences in the ethanol metabolism and acetaldehyde oxidation of these enzyme variants.	[Crous-Bou, Marta; Cordero, David; Moreno, Victor] Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain; [Crous-Bou, Marta; Cuadras, Daniel; Salazar, Ramon; Cordero, David; Moreno, Victor] Bellvitge Biomed Res Inst, Colorectal Canc Grp, Barcelona, Spain; [Crous-Bou, Marta; Cuadras, Daniel; Salazar, Ramon; Cordero, David; Moreno, Victor] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Barcelona, Spain; [Rennert, Gad; Rennert, Hedy Saltz; Lejbkowicz, Flavio] Technion Israel Inst Technol, Dept Community Med & Epidemiol, Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel; [Rennert, Gad; Rennert, Hedy Saltz; Lejbkowicz, Flavio] Technion Israel Inst Technol, Med Carmel Med Ctr, B Rappaport Fac, Haifa, Israel; [Salazar, Ramon] Catalan Inst Oncol, Med Oncol Serv, Barcelona, Spain; [Kopelovich, Levy] NCI, Canc Prevent Div, Rockville, MD USA; [Lipkin, Steven Monroe] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Gruber, Stephen Bernard] Univ Michigan Med Sch, Dept Internal Med Epidemiol & Human Genet, Ann Arbor, MI USA; [Gruber, Stephen Bernard] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona 7, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Clalit Health Services; Technion Israel Institute of Technology; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Catalan Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; University of Michigan System; University of Michigan; University of Southern California; University of Barcelona	Gruber, SB (corresponding author), Univ Michigan Med Sch, Dept Internal Med Epidemiol & Human Genet, Ann Arbor, MI USA.	sgruber@usc.edu; v.moreno@iconcologia.net	Cordero, David/D-1650-2019; Moreno, Victor/A-1697-2010; Crous-Bou, Marta/A-9499-2019	Cordero, David/0000-0003-1470-2356; Moreno, Victor/0000-0002-2818-5487; Crous-Bou, Marta/0000-0003-1493-4288; Cuadras, Daniel/0000-0001-8780-1764	National Cancer Institute [N01-CN43308, NCI R01-CA81488]; University of Michigan's Cancer Center Support Grant [5 P30 CA46592]; Catalan Institute of Oncology; Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL); Instituto de Salud Carlos III [PI08-1635, PI08-1359, PS09-1037]; CIBERESP [CB06/02/2005]; Accion Transversal del Cancer; Catalan Government DURSI [2009SGR1489]; AECC (Spanish Association Against Cancer) Scientific Foundation; USC Norris Cancer Center Support Grant [NCI P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA046592, P30CA014089, R01CA081488] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Michigan's Cancer Center Support Grant; Catalan Institute of Oncology; Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERESP; Accion Transversal del Cancer(Instituto de Salud Carlos III); Catalan Government DURSI; AECC (Spanish Association Against Cancer) Scientific Foundation; USC Norris Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute [N01-CN43308 (SML), NCI R01-CA81488 (SBG)], University of Michigan's Cancer Center Support Grant [5 P30 CA46592]. Also the Catalan Institute of Oncology and the Private Foundation of the Biomedical Research Institute of Bellvitge (IDIBELL), the Instituto de Salud Carlos III [grants PI08-1635, PI08-1359, PS09-1037], CIBERESP CB06/02/2005 and the "Accion Transversal del Cancer", the Catalan Government DURSI [grant 2009SGR1489], and the AECC (Spanish Association Against Cancer) Scientific Foundation. USC Norris Cancer Center Support Grant [NCI P30 CA014089 (SBG). No authors have financial conflict of interest with this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Bongaerts BWC, 2008, INT J CANCER, V123, P2411, DOI 10.1002/ijc.23774; Bongaerts BWC, 2006, ALCOHOL, V38, P147, DOI 10.1016/j.alcohol.2006.06.003; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferrari P, 2012, EUR J CLIN NUTR, V66, P1303, DOI 10.1038/ejcn.2012.173; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Gerber M, 2009, ANN NUTR METAB, V55, P140, DOI 10.1159/000229000; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Hasin D, 2002, AM J PSYCHIAT, V159, P1432, DOI 10.1176/appi.ajp.159.8.1432; Jokelainen K, 1996, ALCOHOL CLIN EXP RES, V20, P967, DOI 10.1111/j.1530-0277.1996.tb01932.x; Joreskog KG, 1996, EUR CHILD ADOLES PSY, V5, P8; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Lipkin SM, 2010, CANCER PREV RES, V3, P597, DOI 10.1158/1940-6207.CAPR-10-0007; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; Matsuo K, 2006, CARCINOGENESIS, V27, P1018, DOI 10.1093/carcin/bgi282; Moghe A, 2011, WORLD J GASTROENTERO, V17, P2465, DOI 10.3748/wjg.v17.i20.2465; Moskal A, 2007, INT J CANCER, V120, P664, DOI 10.1002/ijc.22299; Neumark YD, 2004, ALCOHOL CLIN EXP RES, V28, P10, DOI 10.1097/01.ALC.0000108667.79219.4D; Park JY, 2010, BRIT J CANCER, V103, P747, DOI 10.1038/sj.bjc.6605802; Park JY, 2009, CANCER EPIDEMIOL, V33, P347, DOI 10.1016/j.canep.2009.10.015; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Potter JD, 2008, TXB CANC EPIDEMIOLOG; Poynter JN, 2009, CANCER EPIDEM BIOMAR, V18, P2745, DOI 10.1158/1055-9965.EPI-09-0517; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Salaspuro MP, 2003, BEST PRACT RES CL GA, V17, P679, DOI 10.1016/S1521-6918(03)00035-0; Seitz HK, 2007, TRANSL RES, V149, P293, DOI 10.1016/j.trsl.2006.12.002; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; Seitz Helmut K, 2007, Novartis Found Symp, V285, P110; SEITZ HK, 1990, GASTROENTEROLOGY, V98, P406, DOI 10.1016/0016-5085(90)90832-L; Seitz HK, 2001, ALCOHOL CLIN EXP RES, V25, p137S, DOI 10.1097/00000374-200105051-00024; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simanowski UA, 2001, GUT, V49, P418, DOI 10.1136/gut.49.3.418; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; van Duijnhoven FJB, 2009, AM J CLIN NUTR, V89, P1441, DOI 10.3945/ajcn.2008.27120; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; World Health Organization IAfRoCI, 2006, MON EV CARC RISKS HU; Yang H, 2009, CANCER EPIDEM BIOMAR, V18, P2522, DOI 10.1158/1055-9965.EPI-09-0398; Yin G, 2007, CANCER SCI, V98, P1248, DOI 10.1111/j.1349-7006.2007.00519.x	45	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80158	10.1371/journal.pone.0080158	http://dx.doi.org/10.1371/journal.pone.0080158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282520	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500021
J	Dumard, CH; Barroso, SPC; de Oliveira, GAP; Carvalho, CAM; Gomes, AMO; Couceiro, JNSS; Ferreira, DF; Nico, D; Oliveira, AC; Silva, JL; Santos, PS				Dumard, Carlos H.; Barroso, Shana P. C.; de Oliveira, Guilherme A. P.; Carvalho, Carlos A. M.; Gomes, Andre M. O.; Couceiro, Jose Nelson S. S.; Ferreira, Davis F.; Nico, Dirlei; Oliveira, Andrea C.; Silva, Jerson L.; Santos, Patricia S.			Full Inactivation of Human Influenza Virus by High Hydrostatic Pressure Preserves Virus Structure and Membrane Fusion While Conferring Protection to Mice against Infection	PLOS ONE			English	Article							A VIRUS; HETEROSUBTYPIC IMMUNITY; VACCINE; PROTEIN; HEMAGGLUTININ; STABILITY; RESPONSES; IMMUNOGENICITY; ANTIBODIES; INDUCTION	Whole inactivated vaccines (WIVs) possess greater immunogenicity than split or subunit vaccines, and recent studies have demonstrated that WIVs with preserved fusogenic activity are more protective than non-fusogenic WIVs. In this work, we describe the inactivation of human influenza virus X-31 by high hydrostatic pressure (HHP) and analyze the effects on the structure by spectroscopic measurements, light scattering, and electron microscopy. We also investigated the effects of HHP on the glycoprotein activity and fusogenic activity of the viral particles. The electron microscopy data showed pore formation on the viral envelope, but the general morphology was preserved, and small variations were seen in the particle structure. The activity of hemagglutinin (HA) during the process of binding and fusion was affected in a time-dependent manner, but neuraminidase (NA) activity was not affected. Infectious activity ceased after 3 hours of pressurization, and mice were protected from infection after being vaccinated. Our results revealed full viral inactivation with overall preservation of viral structure and maintenance of fusogenic activity, thereby conferring protection against infection. A strong response consisting of serum immunoglobulin IgG1, IgG2a, and serum and mucosal IgA was also detected after vaccination. Thus, our data strongly suggest that applying hydrostatic pressure may be an effective method for developing new vaccines against influenza A as well as other viruses.	[Dumard, Carlos H.; Barroso, Shana P. C.; de Oliveira, Guilherme A. P.; Carvalho, Carlos A. M.; Gomes, Andre M. O.; Oliveira, Andrea C.; Silva, Jerson L.; Santos, Patricia S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil; [Dumard, Carlos H.; Barroso, Shana P. C.; de Oliveira, Guilherme A. P.; Carvalho, Carlos A. M.; Gomes, Andre M. O.; Oliveira, Andrea C.; Silva, Jerson L.; Santos, Patricia S.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrut & Bioimage, Rio De Janeiro, RJ, Brazil; [Couceiro, Jose Nelson S. S.; Ferreira, Davis F.; Nico, Dirlei] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, RJ, Brazil.	jerson@bioqmed.ufrj.br; pssantos@bioqmed.ufrj.br	Oliveira, Andrea C/O-6695-2018; Nico, Dirlei/GZA-3726-2022; Couceiro, José Nelson SS/J-3933-2016; Ferreira, Davis/D-9356-2014; Gomes, Andre M.O./C-4009-2014; Silva, Jerson/J-8984-2014; de Oliveira, Guilherme A. P./O-1192-2013; Barroso, Shana/ABH-9716-2020; SILVA, JERSON Lima/GRF-1442-2022	Couceiro, José Nelson SS/0000-0001-8712-4847; Gomes, Andre M.O./0000-0003-1052-8004; Silva, Jerson/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; SILVA, JERSON Lima/0000-0001-9523-9441; Dumard, Carlos/0000-0002-9276-6518; Barroso, Shana/0000-0001-7890-9255; Carvalho, Carlos/0000-0001-6615-1387	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharifi M, 2009, PLOS ONE, V4, pe5536, DOI [10.1371/journal.pone.0005536, DOI 10.1371/J0URNAL.P0NE.0005536.PUBMED:19436754]; Barroso SPC, 2012, PROCEDIA VACCINOL, V6, P98, DOI 10.1016/j.provac.2012.04.014; Bodewes R, 2010, J GEN VIROL, V91, P1743, DOI 10.1099/vir.0.020784-0; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Calci KR, 2005, APPL ENVIRON MICROB, V71, P339, DOI 10.1128/AEM.71.1.339-343.2005; Chawla R, 2011, J FOOD SCI TECH MYS, V48, P260, DOI 10.1007/s13197-010-0180-4; Daum LT, 2002, J CLIN VIROL, V25, P345, DOI 10.1016/S1386-6532(02)00043-4; Demazeau G, 2011, APPL MICROBIOL BIOT, V89, P1305, DOI 10.1007/s00253-010-3070-9; Freitas MS, 2006, CELL BIOCHEM BIOPHYS, V44, P325, DOI 10.1385/CBB:44:3:325; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gaspar LP, 2002, J BIOL CHEM, V277, P8433, DOI 10.1074/jbc.M106096200; Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gomes AMO, 2003, BIOCHEMISTRY-US, V42, P5540, DOI 10.1021/bi027207k; Goncalves LDR, 2008, J PERIODONTAL RES, V43, P570, DOI 10.1111/j.1600-0765.2008.01101.x; Goncalves RB, 2007, J MOL BIOL, V366, P295, DOI 10.1016/j.jmb.2006.11.033; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Hierholzer JC, 1996, VIROLOGY METHODS MAN, P41; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Huckriede A, 2005, VACCINE, V23, pS26, DOI 10.1016/j.vaccine.2005.04.026; Isbarn S, 2007, J FOOD PROTECT, V70, P667, DOI 10.4315/0362-028X-70.3.667; Ishimaru D, 2004, VACCINE, V22, P2334, DOI 10.1016/j.vaccine.2003.10.034; Janulikova J, 2012, ACTA VIROL, V56, P169, DOI 10.4149/av_2012_03_169; JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935; Kovac K, 2012, INT J FOOD MICROBIOL, V152, P35, DOI 10.1016/j.ijfoodmicro.2011.10.005; Leimkuhler M, 2000, J MOL BIOL, V296, P1295, DOI 10.1006/jmbi.2000.3538; Neuzil KM, 2008, NEW ENGL J MED, V342, P225; Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5; PALADINI AA, 1981, REV SCI INSTRUM, V52, P419, DOI 10.1063/1.1136596; PALATNIKDESOUSA CB, 1995, T ROY SOC TROP MED H, V89, P390, DOI 10.1016/0035-9203(95)90022-5; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Pontes L, 2001, J MOL BIOL, V307, P1171, DOI 10.1006/jmbi.2001.4512; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; REED L. J., 1938, AMER JOUR HYG, V27, P493; RENEGAR KB, 1991, J IMMUNOL, V146, P1972; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Schwarcz WD, 2004, CELL MOL BIOL, V50, P419; SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tian SM, 2000, EUR J BIOCHEM, V267, P4486, DOI 10.1046/j.1432-1327.2000.01496.x; URQUHART GE, 1974, J CLIN PATHOL, V27, P198, DOI 10.1136/jcp.27.3.198; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Winter R, 2009, SOFT MATTER, V5, P3157, DOI 10.1039/b901690b	55	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80785	10.1371/journal.pone.0080785	http://dx.doi.org/10.1371/journal.pone.0080785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282553	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500055
J	Gang, CC; Zhou, W; Li, JL; Chen, YZ; Mu, SJ; Ren, JZ; Chen, JM; Groisman, PY				Gang, Chengcheng; Zhou, Wei; Li, Jianlong; Chen, Yizhao; Mu, Shaojie; Ren, Jizhou; Chen, Jingming; Groisman, Pavel Ya.			Assessing the Spatiotemporal Variation in Distribution, Extent and NPP of Terrestrial Ecosystems in Response to Climate Change from 1911 to 2000	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; PRIMARY PRODUCTIVITY; GLOBAL RESPONSE; CARBON-DIOXIDE; CHINA; MODEL; VARIABILITY; SATELLITE; DYNAMICS; BIOMASS	To assess the variation in distribution, extent, and NPP of global natural vegetation in response to climate change in the period 1911-2000 and to provide a feasible method for climate change research in regions where historical data is difficult to obtain. In this research, variations in spatiotemporal distributions of global potential natural vegetation (PNV) from 1911 to 2000 were analyzed with the comprehensive sequential classification system (CSCS) and net primary production (NPP) of different ecosystems was evaluated with the synthetic model to determine the effect of climate change on the terrestrial ecosystems. The results showed that consistently rising global temperature and altered precipitation patterns had exerted strong influence on spatiotemporal distribution and productivities of terrestrial ecosystems, especially in the mid/high latitudes. Ecosystems in temperate zones expanded and desert area decreased as a consequence of climate variations. The vegetation that decreased the most was cold desert (18.79%), while the maximum increase (10.31%) was recorded in savanna. Additionally, the area of tundra and alpine steppe reduced significantly (5.43%) and were forced northward due to significant ascending temperature in the northern hemisphere. The global terrestrial ecosystems productivities increased by 2.09%, most of which was attributed to savanna (6.04%), tropical forest (0.99%), and temperate forest (5.49%). Most NPP losses were found in cold desert (27.33%). NPP increases displayed a latitudinal distribution. The NPP of tropical zones amounted to more than a half of total NPP, with an estimated increase of 1.32%. The increase in northern temperate zone was the second highest with 3.55%. Global NPP showed a significant positive correlation with mean annual precipitation in comparison with mean annual temperature and biological temperature. In general, effects of climate change on terrestrial ecosystems were deep and profound in 1911-2000, especially in the latter half of the period.	[Gang, Chengcheng; Zhou, Wei; Li, Jianlong; Chen, Yizhao; Mu, Shaojie] Nanjing Univ, Sch Life Sci, Global Change Res Inst, Nanjing, Jiangsu, Peoples R China; [Ren, Jizhou] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China; [Chen, Jingming] Univ Toronto, Dept Geog, Toronto, ON M5S 1A1, Canada; [Groisman, Pavel Ya.] NOAA, Natl Climat Data Ctr, Asheville, NC USA	Nanjing University; Lanzhou University; University of Toronto; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Li, JL (corresponding author), Nanjing Univ, Sch Life Sci, Global Change Res Inst, Nanjing, Jiangsu, Peoples R China.	jlli2008@nju.edu.cn	Gang, Chengcheng/Z-4286-2019; Chen, Jing/AAD-4768-2020; Groisman, Pavel Y/C-8145-2016	Gang, Chengcheng/0000-0002-2804-5636; Chen, Jing/0000-0002-8682-1293; Groisman, Pavel/0000-0001-6255-324X	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program) [2010CB950702]; APN (Asia Pacific Network) Global Change Fund Project [APCR2013-16NMY-Li]; National High Technology Project [2007AA10Z231]; National Natural Science Foundation of China [40871012, J1103512, J1210026]; Public Sector Linkages Program; Australian Agency for International Development [64828]; ICER [1348085] Funding Source: National Science Foundation	Key Project of Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China); APN (Asia Pacific Network) Global Change Fund Project; National High Technology Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Sector Linkages Program; Australian Agency for International Development; ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the "The Key Project of Chinese National Programs for Fundamental Research and Development (973 Program, 2010CB950702)", "APN (Asia Pacific Network) Global Change Fund Project (APCR2013-16NMY-Li)", "The National High Technology Project (2007AA10Z231)", the National Natural Science Foundation of China (40871012, J1103512, J1210026), and the Public Sector Linkages Program supported by Australian Agency for International Development (64828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY RG, 1989, ENVIRON CONSERV, V16, P307, DOI 10.1017/S0376892900009711; Berthelot M, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001827; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bonsal BR, 2003, CLIMATIC CHANGE, V57, P341, DOI 10.1023/A:1022810531237; Bunn A.G., 2007, EOS T AM GEOPHYS UN, V88, P333, DOI [10.1029/2007EO340001, DOI 10.1029/2007EO340001]; Canadell J., 2006, TERRESTRIAL ECOSYSTE; Cao MK, 1998, GLOBAL CHANGE BIOL, V4, P185, DOI 10.1046/j.1365-2486.1998.00125.x; Cao MK, 2005, SCI CHINA SER D, V48, P17, DOI 10.1360/05zd0002; Chinese Academy of Sciences, 1994, GLOB CHANG EC SYST, P62; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Cramer W, 1999, GLOBAL CHANGE BIOL, V5, P1, DOI 10.1046/j.1365-2486.1999.00009.x; Cruz RV, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P469; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Field CB, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P617; Foley JA, 2000, ECOL APPL, V10, P1620, DOI 10.1890/1051-0761(2000)010[1620:IDVCWG]2.0.CO;2; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; GIFFORD RM, 2001, ENVIRON SCI POLICY, V4, P59, DOI DOI 10.1016/S1462-9011(00)00109-X; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Gruber N, 2004, SCOPE SER, V62, P45; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Horion S, 2013, INT J APPL EARTH OBS, V20, P20, DOI 10.1016/j.jag.2011.12.010; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Hu Z.Z., 1995, ACTA PRATACULTURAE S, V3, P1; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; IPCC, 2007, CLIM CHANG 2007 SCI; IPCC, 1996, FULL TEXT CLIM CHANG; IPCC, 2001, ADV CLIM CHANG RES; Ito A, 2011, GLOBAL CHANGE BIOL, V17, P3161, DOI 10.1111/j.1365-2486.2011.02450.x; Jager HI, 2000, ECOSYSTEMS, V3, P396, DOI 10.1007/s100210000035; Li ZhenQing, 2003, Acta Prataculturae Sinica, V12, P4; Lin HL, 2013, INT J SUST DEV WORLD, V20, P83, DOI 10.1080/13504509.2012.749815; Lobo A, 2010, PHYS CHEM EARTH, V35, P52, DOI 10.1016/j.pce.2010.03.010; Magrin G., 2007, LATIN AM CLIMATE CHA, P581; McGuire AD, 1995, J BIOGEOGR, V22, P785, DOI 10.2307/2845980; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Muriuki GW, 2005, AGR ECOSYST ENVIRON, V106, P99, DOI 10.1016/j.agee.2004.04.005; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Oak Ridge National Laboradtory DAAC, 2009, NET PRIM PROD NPP; Odum E.P., 1976, FUNDAMENTALS ECOLOGY; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PRINCE SD, 1991, INT J REMOTE SENS, V12, P1313, DOI 10.1080/01431169108929728; Reich PF, 2004, AGROSCIENCE, V2; Ren JZ, 2008, RANGELAND J, V30, P199, DOI 10.1071/RJ08002; Rohde R, 2013, COMP BERK EARTH NASA; Roy J., 2001, TERRESTRIAL GLOBAL P, DOI 10.1016/b978-012505290-0/50024-7; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Schlesinger W.H., 2013, BIOGEOCHEMISTRY; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shiyatov SG, 2005, RUSS J ECOL+, V36, P69, DOI 10.1007/s11184-005-0051-9; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; SUNDQUIST ET, 1993, SCIENCE, V259, P934, DOI 10.1126/science.259.5097.934; Sykes MT, 1999, CLIMATIC CHANGE, V41, P37, DOI 10.1023/A:1005435831549; Wang W, 2010, AUTOMOBILE TECHNOLOG, P3; Whittaker R.H, 1977, PRIMARY PRODUCTIVITY, V14, P237; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; WOODWELL GM, 1968, AM ZOOL, V8, P19; Yue TX, 2005, GLOBAL PLANET CHANGE, V48, P287, DOI 10.1016/j.gloplacha.2005.03.001; Zhang GG, 2011, GLOBAL CHANGE BIOL, V17, P377, DOI 10.1111/j.1365-2486.2010.02237.x; Zhang X. S., 1993, QUATERNARY SCI, V2, P157; Zhang YJ, 2011, ENVIRON EARTH SCI, V62, P1481, DOI 10.1007/s12665-010-0632-1; Zhou G., 1995, CHIN J PLANT ECOL, P193, DOI DOI 10.1007/S11769-006-0334-5; Zhou G.S., 1996, ACTA PHYTOECOLOGICA, V20, P11, DOI DOI 10.1016/J.CHNAES.2014.11.001; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5; Zhou GuangSheng, 1998, Scientia Silvae Sinicae, V34, P2; [朱文泉 Zhu Wenquan], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P296	73	35	42	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80394	10.1371/journal.pone.0080394	http://dx.doi.org/10.1371/journal.pone.0080394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282539	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500040
J	Kouyoumdjian, FG; Findlay, N; Schwandt, M; Calzavara, LM				Kouyoumdjian, Fiona G.; Findlay, Nicole; Schwandt, Michael; Calzavara, Liviana M.			A Systematic Review of the Relationships between Intimate Partner Violence and HIV/AIDS	PLOS ONE			English	Review							GENDER-BASED VIOLENCE; HIV-INFECTED WOMEN; DOMESTIC VIOLENCE; SEXUAL-ABUSE; RELATIONSHIP POWER; CONDOM USE; RISK; PREVENTION; HEALTH; PREVALENCE	Background: Intimate partner violence (IPV) is a significant health problem that has been associated with HIV infection in numerous studies. We aimed to systematically review the literature on relationships between IPV and HIV in order to describe the prevalence of IPV in people with HIV, the prevalence of HIV in people experiencing IPV, the association between IPV and HIV, and evidence regarding mechanisms of risk and interventions. Methods: Data sources were 10 electronic databases and reference lists. Studies were included if they reported data on the relationship between IPV and HIV. All records were independently reviewed by two authors at the stages of title and abstract review and full text review. Any abstract considered eligible by either reviewer was reviewed in full, and any disagreement regarding eligibility of full texts or data extracted was resolved by discussion. Results: 101 articles were included. Experiencing IPV and HIV infection were associated in unadjusted analyses in most studies, as well as in adjusted analyses in many studies. The findings of qualitative and quantitative studies assessing potential mechanisms linking IPV and HIV were variable. Few interventions have been assessed, but two identified in this review were promising in terms of preventing IPV, though not HIV infection. Conclusions: Experiencing IPV and HIV infection tend to be associated in unadjusted analyses, suggesting that IPV screening and linkage with relevant programs and services may be valuable. It is unclear whether there is a causal association between experiencing IPV and HIV infection. Research should focus on defining parameters of IPV which are relevant to HIV infection, including type of IPV and period of exposure and risk, on assessing potential mechanisms, and on developing and assessing interventions which build on the strengths of existing studies.	[Kouyoumdjian, Fiona G.; Findlay, Nicole; Schwandt, Michael; Calzavara, Liviana M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto	Kouyoumdjian, FG (corresponding author), St Michaels Hosp, Ctr Res Inner City Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	fiona.kouyoumdjian@mail.utoronto.ca		Schwandt, Michael/0000-0002-3164-8972	CIHR Social Research Centre in HIV Prevention; Public Health Agency of Canada; Canadian Institutes for Health Research	CIHR Social Research Centre in HIV Prevention(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this review was provided through a Student Award from the CIHR Social Research Centre in HIV Prevention to FGK. FGK was supported by a Fellowship from the Public Health Agency of Canada and by a Fellowship from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S., 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Amuyunzu-Nyamongo M, 2007, AIDS CARE, V19, pS25, DOI 10.1080/09540120601114618; Andersson N, 2008, AIDS, V22, pS73, DOI 10.1097/01.aids.0000341778.73038.86; Apondi R, 2007, JAIDS-J ACQ IMM DEF, V44, P71, DOI 10.1097/01.qai.0000243113.29412.dd; Barros C, 2011, REV SAUDE PUBL, V45, P1, DOI DOI 10.1590/S0034-89102011000100001.PUBMED:21181047; Bartholomew K, 2008, VIOLENCE VICTIMS, V23, P344, DOI 10.1891/0886-6708.23.3.344; Bogart LM, 2005, AIDS BEHAV, V9, P325, DOI 10.1007/s10461-005-9006-1; Brady S, 2002, AIDS PATIENT CARE ST, V16, P121, DOI 10.1089/108729102317330463; Burke JG, 2005, VIOLENCE AGAINST WOM, V11, P1140, DOI 10.1177/1077801205276943; CAMPBELL ANC, 2009, SOCIAL WORK; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Chandrasekaran Varalakshmi, 2007, Indian J Med Sci, V61, P253; Craft SM, 2005, J INTERPERS VIOLENCE, V20, P777, DOI 10.1177/0886260505277101; Davila YR, 2008, J ASSOC NURSE AIDS C, V19, P219, DOI 10.1016/j.jana.2007.10.005; DAYAPRASAD GK, 2010, EUROPEAN J CONTRACEP; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; DiStefano AS, 2011, QUAL HEALTH RES, V21, P884, DOI 10.1177/1049732311403501; Dude AM, 2011, AIDS BEHAV, V15, P142, DOI 10.1007/s10461-009-9526-1; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Eloff I, 2011, S AFR J PSYCHOL, V41, P38, DOI 10.1177/008124631104100105; Emusu D, 2009, AIDS CARE, V21, P1363, DOI 10.1080/09540120902883077; Ezeanochie MC, 2011, ACTA OBSTET GYN SCAN, V90, P535, DOI 10.1111/j.1600-0412.2011.01083.x; Ezechi OC, 2009, ARCH GYNECOL OBSTET, V280, P745, DOI 10.1007/s00404-009-0956-9; Fonck K, 2005, AIDS BEHAV, V9, P335, DOI 10.1007/s10461-005-9007-0; Fox AM, 2007, VIOLENCE AGAINST WOM, V13, P583, DOI 10.1177/1077801207299209; FRANCISCO LV, 2010, SYNERGY INTIMATE PAR, P117; Frye V, 2007, JAIDS-J ACQ IMM DEF, V46, pS101, DOI 10.1097/QAI.0b013e31815767e6; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Galvan FH, 2004, AIDS BEHAV, V8, P441, DOI 10.1007/s10461-004-7328-z; Garcia-Moreno C, 2000, AIDS, V14, pS253; GARD TL, 2002, ANN M SOC AD MED; Ghosh P, 2011, INT J STD AIDS, V22, P140, DOI 10.1258/ijsa.2010.010127; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; Gielen A.C., 2002, AIDS BEHAV, V6, P107, DOI DOI 10.1023/A:1015494513192; Gielen AC, 1997, WOMEN HEALTH, V25, P19, DOI 10.1300/J013v25n03_02; Gielen AC, 2007, TRAUMA VIOLENCE ABUS, V8, P178, DOI 10.1177/1524838007301476; Go VF, 2003, AIDS BEHAV, V7, P263, DOI 10.1023/A:1025443719490; Gonzalez-Guarda RM, 2010, WESTERN J NURS RES, V32, P128, DOI 10.1177/0193945909343594; Greenwood GL, 2002, AM J PUBLIC HEALTH, V92, P1964, DOI 10.2105/AJPH.92.12.1964; Gupta RN, 2008, CULT DIVERS ETHN MIN, V14, P256, DOI 10.1037/1099-9809.14.3.256; Hamburger ME, 2004, AIDS BEHAV, V8, P333, DOI 10.1023/B:AIBE.0000044080.04397.97; Harling G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014257; Heller RF, 2008, PUBLIC HEALTH, V122, P92, DOI 10.1016/j.puhe.2007.04.012; Henny KD, 2007, AIDS BEHAV, V11, P842, DOI 10.1007/s10461-007-9251-6; Herman L, 2005, J HIV-AIDS SOC SERV, V3, P97, DOI 10.1300/J187v03n03_08; ILLANGASEKARE S, 2010, J GEN INTERNAL MED; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2008, BMJ-BRIT MED J, V337, P506, DOI DOI 10.1136/BMJ.A506.PUBMED:18687720; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024256; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jones DJ, 2003, J FAM VIOLENCE, V18, P257; Kalokhe AS, 2011, J INVEST MED, V59, P522; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kaye Dan K, 2004, Afr Health Sci, V4, P67; Ketchen B, 2009, WOMEN HEALTH, V49, P197, DOI 10.1080/03630240902963648; Kiarie JN, 2006, AIDS, V20, P1763, DOI 10.1097/01.aids.0000242823.51754.0c; Koenig LJ, 2002, AM J PUBLIC HEALTH, V92, P367, DOI 10.2105/AJPH.92.3.367; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; KRUG EG, 2013, WORLD REPORT VIOLENC; KULKARNI D, 2009, 5 IAS C HIV PATH TRE; Lang DL, 2007, JAIDS-J ACQ IMM DEF, V46, P216, DOI 10.1097/QAI.0b013e31814d4dad; Laughon K, 2007, RES NURS HEALTH, V30, P413, DOI 10.1002/nur.20226; Lewis I, 2008, J FAM STUD, V14, P183, DOI 10.5172/jfs.327.14.2-3.183; Lichtenstein B, 2005, SOC SCI MED, V60, P701, DOI 10.1016/j.socscimed.2004.06.021; MAKAYOTO LA, 2012, MATERNAL CHILD HLTH; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; MAMAN S, 2000, ASS HIV 1 VIOLENCE W; Manfrin-Ledet Linda, 2003, J Assoc Nurses AIDS Care, V14, P56, DOI 10.1177/1055329003252056; Mattson CL, 2009, AM J EPIDEMIOL, V169, pS28; MAYANJA SP, 2009, 5 EUR DEV COUNTR CLI, pS1; McDonnell KA, 2003, J URBAN HEALTH, V80, P494, DOI 10.1093/jurban/jtg047; Moreno CL, 2007, QUAL HEALTH RES, V17, P340, DOI 10.1177/1049732306297387; MUKANYONGA H, 2011, WOM HLTH 2011 19 ANN, P473; MULDOON KA, 2011, CAHR 2011 HON HIST E, pR1000; Murray LK, 2006, J NERV MENT DIS, V194, P610, DOI 10.1097/01.nmd.0000230662.01953.bc; NAVA MDL, 2010, HIV INFECT WOMEN WHO; Neundorfer MM, 2005, GERONTOLOGIST, V45, P617, DOI 10.1093/geront/45.5.617; Newcomb MD, 2004, AIDS BEHAV, V8, P417, DOI 10.1007/s10461-004-7326-1; Ntaganira J, 2009, RURAL REMOTE HEALTH, V9; Ntaganira Joseph, 2008, BMC Womens Health, V8, P17, DOI 10.1186/1472-6874-8-17; O'Campo P, 2002, PATIENT EDUC COUNS, V46, P205, DOI 10.1016/S0738-3991(01)00214-2; PANTALONE DW, 2007, MIXED METHODS APPROA, P174; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Phorano Odireleng, 2005, SAHARA J, V2, P188; PORTO JR, 2003, ONLINE BRAZILIAN J N, V2; Prabhu M, 2011, INT J GYNECOL OBSTET, V113, P63, DOI 10.1016/j.ijgo.2010.10.019; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Ramachandran S, 2010, AIDS CARE, V22, P1536, DOI 10.1080/09540121.2010.482199; READING CL, 2009, OUR SEARCH SAFE SPAC; Sa ZH, 2008, J BIOSOC SCI, V40, P505, DOI 10.1017/S002193200700257X; Sareen J, 2009, GEN HOSP PSYCHIAT, V31, P274, DOI 10.1016/j.genhosppsych.2009.02.004; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; SHAMU S, 2011, IASSCS C MADR SPAIN, pS1; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Shelton AJ, 2005, AIDS CARE, V17, P814, DOI 10.1080/09540120500100536; Sherbourne C, 2003, WOMEN HEALTH ISS, V13, P104, DOI 10.1016/S1049-3867(03)00023-9; Shi CF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-512; Siemieniuk RAC, 2010, AIDS PATIENT CARE ST, V24, P763, DOI 10.1089/apc.2010.0235; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Sormanti M, 2008, HEALTH SOC WORK, V33, P33, DOI 10.1093/hsw/33.1.33; Stevens P E, 1998, Health Care Women Int, V19, P9, DOI 10.1080/073993398246548; Strebel A, 2006, SAHARA J, V3, P516; Ulibarri MD, 2010, PSYCHOL TRAUMA-US, V2, P318, DOI 10.1037/a0017500; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; Were E, 2011, AIDS, V25, P2009, DOI 10.1097/QAD.0b013e32834b005d; Williams John K, 2008, J Aggress Maltreat Trauma, V16, P296, DOI 10.1080/10926770801925726; WNCHESTER MS, 2011, LIVING GLOBALIZATION; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V; WRIGHT TN, 2004, EXPT BIOL 2004 ANN M, pS316; ZABLER B, 2009, VIOLENCE ABUSE LIVES, P390; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	113	83	85	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81044	10.1371/journal.pone.0081044	http://dx.doi.org/10.1371/journal.pone.0081044			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282566	gold, Green Published			2022-12-27	WOS:000327543500068
J	Luo, YL; Cheng, YL; Gao, XH; Tan, SQ; Li, JM; Wang, W; Chen, Q				Luo, Ya Li; Cheng, Yu Li; Gao, Xiao Hui; Tan, Shu Qin; Li, Jian Mei; Wang, Wei; Chen, Qing			Maternal Age, Parity and Isolated Birth Defects: A Population-Based Case-Control Study in Shenzhen, China	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; ORAL CLEFTS; OROFACIAL CLEFTS; ORGANIC-SOLVENTS; PARENTAL AGE; RISK-FACTORS; PREGNANCY; EXPOSURE; ORDER; MALFORMATIONS	Background: The etiology of birth defects has been widely studied but is not yet fully clarified, previously published data had suggested that maternal age or parity maybe involved, but without consistent conclusions. Methods: A population-based, case-control study was nested in a cohort of perinatal infants born from 2010 to 2012 in Baoan District, Shenzhen. Four categories of isolated birth defects were defined as cases: congenital heart defects (CHD, n=693), polydactyly (n=352), cleft lip with or without palate (CL/P, n=159) and equinovarus (n=119). Controls were non-malformed infants (n=11,307) randomly selected from the same area and period. Odds ratios (ORs) and the 95% confidence intervals (CIs) were computed by multivariable unconditional logistic regression analysis. Results: Young maternal age (<25 years old) was associated with a reduced risk of CHD (adjusted OR=0.73, 95% CI 0.59-0.90), while with an elevated risk of polydactyly (adjusted OR=1.42, 95% CI 1.09-1.84). Increased risk of CL/P-affected pregnancy was observed in mothers older than 35 years old (adjusted OR=2.12, 95% CI 1.26-3.57). Compared to primipara, those having their second, and third or more delivery were less likely to have infants with equinovarus, with significant adjusted ORs of 0.59 (0.40-0.89) and 0.42 (0.19-0.93), respectively. Conclusion: Maternal age was significantly associated with CHD, polydactyly and CL/P relevant pregnancy. Mothers with higher parity might have lower risk of equinovarus occurrence in offsprings.	[Luo, Ya Li; Tan, Shu Qin; Chen, Qing] Southern Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Luo, Ya Li; Cheng, Yu Li; Wang, Wei] Baoan Maternal & Child Hlth Hosp, Dept Hlth Care, Shenzhen, Peoples R China; [Gao, Xiao Hui] Shenzhen Maternal & Child Hlth Hosp, Dept Hlth Care, Shenzhen, Peoples R China; [Li, Jian Mei] Baoan Maternal & Child Hlth Hosp, Fac Womens Hlth, Shenzhen, Peoples R China	Southern Medical University - China	Chen, Q (corresponding author), Southern Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	QingChen_smu@163.com						Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Baird Jr JT, 1972, VITAL HLTH STAT, V11, P1; Carey M, 2005, PAEDIATR PERINAT EP, V19, P238, DOI 10.1111/j.1365-3016.2005.00648.x; Carmichael SL, 2007, PAEDIATR PERINAT EP, V21, P210, DOI 10.1111/j.1365-3016.2007.00809.x; Herkrath APCD, 2012, J DENT, V40, P3, DOI 10.1016/j.jdent.2011.10.002; Desrosiers TA, 2012, OCCUP ENVIRON MED, V69, P493, DOI 10.1136/oemed-2011-100245; Duong HT, 2012, BIRTH DEFECTS RES A, V94, P230, DOI 10.1002/bdra.22889; Hollier LM, 2000, OBSTET GYNECOL, V96, P701, DOI 10.1016/S0029-7844(00)01019-X; Honein MA, 2007, EPIDEMIOLOGY, V18, P226, DOI 10.1097/01.ede.0000254430.61294.c0; Lorente C, 2000, AM J PUBLIC HEALTH, V90, P415, DOI 10.2105/AJPH.90.3.415; Luo LX, 2010, BASIC DEMOGRAPHIC CH, P37; Messer LC, 2010, ANN EPIDEMIOL, V20, P32, DOI 10.1016/j.annepidem.2009.09.006; Miller A, 2011, AM J MED GENET A, V155A, P2137, DOI 10.1002/ajmg.a.34130; Norwitz Errol R, 2007, OXFORD AM HDB OBSTET; Oddsberg J, 2008, J PEDIATR SURG, V43, P1660, DOI 10.1016/j.jpedsurg.2007.11.021; Parker SE, 2009, BIRTH DEFECTS RES A, V85, P897, DOI 10.1002/bdra.20625; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; SHAW GM, 1991, TERATOLOGY, V43, P225, DOI 10.1002/tera.1420430306; TAY JSH, 1982, J MED GENET, V19, P441, DOI 10.1136/jmg.19.6.441; Vaktskjold A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-83; Vieira AR, 2002, ORAL SURG ORAL MED O, V94, P530, DOI 10.1067/moe.2002.128875; Vieira AR, 2002, TERATOLOGY, V66, P209, DOI 10.1002/tera.10088; ZHAN SY, 1991, J EPIDEMIOL COMMUN H, V45, P299, DOI 10.1136/jech.45.4.299	24	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81369	10.1371/journal.pone.0081369	http://dx.doi.org/10.1371/journal.pone.0081369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282587	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500089
J	van Asselen, S; Verburg, PH; Vermaat, JE; Janse, JH				van Asselen, Sanneke; Verburg, Peter H.; Vermaat, Jan E.; Janse, Jan H.			Drivers of Wetland Conversion: a Global Meta-Analysis	PLOS ONE			English	Article							LAND-USE; CONSERVATION; AGRICULTURE; STRATEGIES; SYSTEMS	Meta-analysis of case studies has become an important tool for synthesizing case study findings in land change. Meta-analyses of deforestation, urbanization, desertification and change in shifting cultivation systems have been published. This present study adds to this literature, with an analysis of the proximate causes and underlying forces of wetland conversion at a global scale using two complementary approaches of systematic review. Firstly, a meta-analysis of 105 case-study papers describing wetland conversion was performed, showing that different combinations of multiple-factor proximate causes, and underlying forces, drive wetland conversion. Agricultural development has been the main proximate cause of wetland conversion, and economic growth and population density are the most frequently identified underlying forces. Secondly, to add a more quantitative component to the study, a logistic meta-regression analysis was performed to estimate the likelihood of wetland conversion worldwide, using globally-consistent biophysical and socioeconomic location factor maps. Significant factors explaining wetland conversion, in order of importance, are market influence, total wetland area (lower conversion probability), mean annual temperature and cropland or built-up area. The regression analyses results support the outcomes of the meta-analysis of the processes of conversion mentioned in the individual case studies. In other meta-analyses of land change, similar factors (e. g., agricultural development, population growth, market/economic factors) are also identified as important causes of various types of land change (e. g., deforestation, desertification). Meta-analysis helps to identify commonalities across the various local case studies and identify which variables may lead to individual cases to behave differently. The meta-regression provides maps indicating the likelihood of wetland conversion worldwide based on the location factors that have determined historic conversions.	[van Asselen, Sanneke; Verburg, Peter H.; Vermaat, Jan E.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands; [Vermaat, Jan E.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Janse, Jan H.] PBL Netherlands Environm Assessment Agcy, Bilthoven, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Asselen, S (corresponding author), Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands.	svasselen@gmail.com	Verburg, Peter H/Z-1582-2019; Verburg, Peter h./A-8469-2010	Verburg, Peter h./0000-0002-6977-7104	Netherlands Organization for Scientific Research (NWO) [IGLO-830.10.003]; European Research Council under the European Union's Seventh Framework Programme ERC (GLOLAND) [311819]; Netherlands Environmental Assessment Agency; NWO	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council under the European Union's Seventh Framework Programme ERC (GLOLAND); Netherlands Environmental Assessment Agency; NWO(Netherlands Organization for Scientific Research (NWO))	This research is funded by the Netherlands Organization for Scientific Research (NWO; project IGLO-830.10.003), the European Research Council under the European Union's Seventh Framework Programme ERC Grant Agreement nr. 311819 (GLOLAND), and the Netherlands Environmental Assessment Agency. The position of the corresponding author (SVA) at the Institute for Environmental Studies was funded by NWO. She had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade R., 2011, LAND USE CLIMATE CHA, P150; Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; [Anonymous], 1984, WETLANDS US CURRENT; [Anonymous], P 21 INT C MACH LEAR; Bouwman AF., 2006, INTEGRATED MODELLING, P1; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Chebo AK, 2009, PROCED EARTH PLAN SC, V1, P1010, DOI 10.1016/j.proeps.2009.09.156; CRUICKSHANK MM, 1995, APPL GEOGR, V15, P365, DOI 10.1016/0143-6228(95)00017-X; Dahl T.E., 1990, WETLANDS LOSSES US 1, P1780; Ferraz SFD, 2009, FOREST ECOL MANAG, V257, P1586, DOI 10.1016/j.foreco.2009.01.013; Dearing JA, 2012, ENVIRON MANAGE, V49, P767, DOI 10.1007/s00267-012-9833-6; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO/IIASA/ISRIC/ISSCAS/JRC, 2012, HARM WORLD SOIL DAT; Fischer G, 2002, GLOBAL AGROECOLOGICA; Frazier, 1998, GLOBAL OVERVIEW WETL; Geist HJ, 2004, BIOSCIENCE, V54, P817, DOI 10.1641/0006-3568(2004)054[0817:DCPOD]2.0.CO;2; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hansen MC, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034001; Hertel T.W., 1997, GLOBAL TRADE ANAL MO, DOI DOI 10.1017/CBO9781139174688; IIASA and FAO, 2012, GLOB AGR ZON GAEZ V3, P196; Keddy PA, 2009, BIOSCIENCE, V59, P39, DOI 10.1525/bio.2009.59.1.8; Keys E, 2005, GLOBAL ENVIRON CHANG, V15, P320, DOI 10.1016/j.gloenvcha.2005.04.004; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; McFadden L, 2007, HYDROBIOLOGIA, V577, P5, DOI 10.1007/s10750-006-0413-8; MEA, 2005, EC HUM WELL BEING WE; MEYER WB, 1992, ANNU REV ECOL SYST, V23, P39, DOI 10.1146/annurev.es.23.110192.000351; Miettinen J, 2010, AMBIO, V39, P394, DOI 10.1007/s13280-010-0051-2; Minayeva T, 2009, QUICK SCAN PEATLANDS; NAWCC (North American Wetland Conservation Council (Canada)), 2003, 032 NAWCC CDA; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Peltomaa R, 2007, IRRIG DRAIN, V56, pS151, DOI 10.1002/ird.334; Peltonen-Sainio P, 2009, AGR FOOD SCI, V18, P171, DOI 10.2137/145960609790059479; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prigent C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051276; Ragin C.C., 1987, COMPUT METHOD BIOMEC; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; RAO BLSP, 1999, MG STAT PRO, V83, P1; Rebelo LM, 2009, J ENVIRON MANAGE, V90, P2144, DOI 10.1016/j.jenvman.2007.06.027; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rudel TK, 2008, GLOBAL ENVIRON CHANG, V18, P18, DOI 10.1016/j.gloenvcha.2007.06.001; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Stanley TD, 2001, J ECON PERSPECT, V15, P131, DOI 10.1257/jep.15.3.131; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Turunen J, 2008, BOREAL ENVIRON RES, V13, P319; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Verburg PH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034019; White WA, 2002, GEOMORPHOLOGY, V44, P47, DOI 10.1016/S0169-555X(01)00140-4; World Bank, 2010, WORLDW GOV IND WGI P; Young OR, 2006, ECOL SOC, V11; Zhang SQ, 2009, WETLANDS, V29, P302, DOI 10.1672/08-04.1; Zhang WW, 2011, PROCEDIA ENVIRON SCI, V10, P583, DOI 10.1016/j.proenv.2011.09.094; Zhao H, 2010, PROCEDIA ENVIRON SCI, V2, P1265, DOI 10.1016/j.proenv.2010.10.137	57	167	173	13	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81292	10.1371/journal.pone.0081292	http://dx.doi.org/10.1371/journal.pone.0081292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282580	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500082
J	Norton, N; Sun, ZF; Asmann, YW; Serie, DJ; Necela, BM; Bhagwate, A; Jen, J; Eckloff, BW; Kalari, KR; Thompson, KJ; Carr, JM; Kachergus, JM; Geiger, XJ; Perez, EA; Thompson, EA				Norton, Nadine; Sun, Zhifu; Asmann, Yan W.; Serie, Daniel J.; Necela, Brian M.; Bhagwate, Aditya; Jen, Jin; Eckloff, Bruce W.; Kalari, Krishna R.; Thompson, Kevin J.; Carr, Jennifer M.; Kachergus, Jennifer M.; Geiger, Xochiquetzal J.; Perez, Edith A.; Thompson, E. Aubrey			Gene Expression, Single Nucleotide Variant and Fusion Transcript Discovery in Archival Material from Breast Tumors	PLOS ONE			English	Article							DUPLEX-SPECIFIC NUCLEASE; CDNA NORMALIZATION; RNA; QUALITY; SAMPLES	Advantages of RNA-Seq over array based platforms are quantitative gene expression and discovery of expressed single nucleotide variants (eSNVs) and fusion transcripts from a single platform, but the sensitivity for each of these characteristics is unknown. We measured gene expression in a set of manually degraded RNAs, nine pairs of matched fresh-frozen, and FFPE RNA isolated from breast tumor with the hybridization based, NanoString nCounter (226 gene panel) and with whole transcriptome RNA-Seq using RiboZeroGold ScriptSeq V2 library preparation kits. We performed correlation analyses of gene expression between samples and across platforms. We then specifically assessed whole transcriptome expression of lincRNA and discovery of eSNVs and fusion transcripts in the FFPE RNA-Seq data. For gene expression in the manually degraded samples, we observed Pearson correlations of >0.94 and >0.80 with NanoString and ScriptSeq protocols, respectively. Gene expression data for matched fresh-frozen and FFPE samples yielded mean Pearson correlations of 0.874 and 0.783 for NanoString (226 genes) and ScriptSeq whole transcriptome protocols respectively, p<2x10(-16). Specifically for lincRNAs, we observed superb Pearson correlation (0.988) between matched fresh-frozen and FFPE pairs. FFPE samples across NanoString and RNA-Seq platforms gave a mean Pearson correlation of 0.838. In FFPE libraries, we detected 53.4% of high confidence SNVs and 24% of high confidence fusion transcripts. Sensitivity of fusion transcript detection was not overcome by an increase in depth of sequencing up to 3-fold (increase from similar to 56 to similar to 159 million reads). Both NanoString and ScriptSeq RNA-Seq technologies yield reliable gene expression data for degraded and FFPE material. The high degree of correlation between NanoString and RNA-Seq platforms suggests discovery based whole transcriptome studies from FFPE material will produce reliable expression data. The RiboZeroGold ScriptSeq protocol performed particularly well for lincRNA expression from FFPE libraries, but detection of eSNV and fusion transcripts was less sensitive.	[Norton, Nadine; Necela, Brian M.; Carr, Jennifer M.; Kachergus, Jennifer M.; Thompson, E. Aubrey] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Sun, Zhifu; Bhagwate, Aditya; Kalari, Krishna R.; Thompson, Kevin J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Asmann, Yan W.; Serie, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Jen, Jin; Eckloff, Bruce W.] Mayo Clin, Med Genome Facil, Rochester, MN USA; [Geiger, Xochiquetzal J.] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA; [Perez, Edith A.] Mayo Clin, Dept Med, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Norton, N (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	Norton.nadine@mayo.edu		Sun, Zhifu/0000-0001-8461-7523; Kalari, Krishna/0000-0001-8944-8378; Thompson, Kevin/0000-0002-9348-4686	Technology Development Team, Center for Individualized Medicine, Mayo Clinic; Breast Cancer Research Foundation; 26.2 with Donna Foundation	Technology Development Team, Center for Individualized Medicine, Mayo Clinic; Breast Cancer Research Foundation; 26.2 with Donna Foundation	This work was supported by the Technology Development Team, Center for Individualized Medicine, Mayo Clinic, the Breast Cancer Research Foundation, and by the 26.2 with Donna Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova Veronika E., 2008, BMC Biochemistry, V9, P14, DOI 10.1186/1471-2091-9-14; Asmann YW, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr362; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; VanderNoot VA, 2012, BIOTECHNIQUES, V53, P373, DOI 10.2144/000113937; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waldron L, 2012, CLIN CANCER RES, V18, P6136, DOI 10.1158/1078-0432.CCR-12-1915; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	15	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81925	10.1371/journal.pone.0081925	http://dx.doi.org/10.1371/journal.pone.0081925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278466	gold, Green Submitted, Green Published			2022-12-27	WOS:000327541700072
J	Shoae-Hassani, A; Keyhanvar, P; Seifalian, AM; Mortazavi-Tabatabaei, SA; Ghaderi, N; Issazadeh, K; Amirmozafari, N; Verdi, J				Shoae-Hassani, Alireza; Keyhanvar, Peyman; Seifalian, Alexander Marcus; Mortazavi-Tabatabaei, Seyed Abdolreza; Ghaderi, Narmin; Issazadeh, Khosro; Amirmozafari, Nour; Verdi, Javad			lambda Phage Nanobioparticle Expressing Apoptin Efficiently Suppress Human Breast Carcinoma Tumor Growth In Vivo	PLOS ONE			English	Article							GENE DELIVERY; SOLID TUMOR; CELL-DEATH; PROTEIN; MECHANISM; BACTERIOPHAGES; INHIBITION; REGRESSION; INDUCTION; APOPTOSIS	Using phages is a novel field of cancer therapy and phage nanobioparticles (NBPs) such as lambda phage could be modified to deliver and express genetic cassettes into eukaryotic cells safely in contrast with animal viruses. Apoptin, a protein from chicken anemia virus (CAV) has the ability to specifically induce apoptosis only in carcinoma cells. We presented a safe method of breast tumor therapy via the apoptin expressing lambda NBPs. Here, we constructed a lambda ZAP-CMV-apoptin recombinant NBP and investigated the effectiveness of its apoptotic activity on BT-474, MDA-MB-361, SKBR-3, UACC-812 and ZR-75 cell lines that over-expressing her-2 marker. Apoptosis was evaluated via annexin-V fluorescent iso-thiocyanate/ propidium iodide staining, flow-cytometric method and TUNEL assay. Transfection with NBPs carrying lambda ZAP-CMV-apoptin significantly inhibited growth of all the breast carcinoma cell lines in vitro. Also nude mice model implanted BT-474 human breast tumor was successfully responded to the systemic and local injection of untargeted recombinant lambda NBPs. The results presented here reveal important features of recombinant lambda nanobioparticles to serve as safe delivery and expression platform for human cancer therapy.	[Shoae-Hassani, Alireza; Verdi, Javad] Univ Tehran Med Sci, Sch Adv Technol Med, Appl Cell Sci Dept, Tehran, Iran; [Shoae-Hassani, Alireza; Mortazavi-Tabatabaei, Seyed Abdolreza; Ghaderi, Narmin; Issazadeh, Khosro; Verdi, Javad] Univ Tehran Med Sci, Res Ctr Sci & Technol Med RCSTiM, Tehran, Iran; [Keyhanvar, Peyman] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran; [Seifalian, Alexander Marcus] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England; [Amirmozafari, Nour] Iran Univ Med Sci, Sch Med, Dept Med Microbiol, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; University of London; University College London; Iran University of Medical Sciences	Verdi, J (corresponding author), Univ Tehran Med Sci, Sch Adv Technol Med, Appl Cell Sci Dept, Tehran, Iran.	nanobiotechnology@ymail.com	Seifalian, Alexander M/I-6028-2013; Hassani, Alireza Shoae/AAH-2575-2021	Seifalian, Alexander M/0000-0002-1180-3322; Shoae-Hassani, Alireza/0000-0002-5502-6457; Amirmozafari, Nour/0000-0001-5186-8406; seifalian, Alexander/0000-0002-8334-9376; Shoae-Hassani, Alireza/0000-0002-0655-1343				Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Backendorf C, 2008, ANNU REV PHARMACOL, V48, P143, DOI 10.1146/annurev.pharmtox.48.121806.154910; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; BLOCH HUBERT, 1940, ARCH GES VIRUSFORSCH, V1, P481, DOI 10.1007/BF01240654; Burek M, 2006, ONCOGENE, V25, P2213, DOI 10.1038/sj.onc.1209258; Clark JR, 2011, FEMS IMMUNOL MED MIC, V61, P197, DOI 10.1111/j.1574-695X.2010.00763.x; Dabrowska K, 2004, ACTA VIROL, V48, P241; Danen-van Oorschot AAAM, 2000, J VIROL, V74, P7072, DOI 10.1128/JVI.74.15.7072-7078.2000; Danen-van Oorschot AAAM, 2003, J BIOL CHEM, V278, P27729, DOI 10.1074/jbc.M303114200; DanenVanOorschot AAAM, 1997, APOPTOSIS, V2, P395, DOI 10.1023/A:1026409808732; Eriksson F, 2007, CANCER IMMUNOL IMMUN, V56, P677, DOI 10.1007/s00262-006-0227-6; Fuchs E J, 1996, Semin Immunol, V8, P271, DOI 10.1006/smim.1996.0035; Gdynia G, 2008, APOPTOSIS, V13, P437, DOI 10.1007/s10495-007-0176-3; Gomez-Roman VR, 2002, JAIDS, V31, P147, DOI 10.1097/00126334-200210010-00004; Gorski Andrzej, 2003, Med Immunol, V2, P2, DOI 10.1186/1476-9433-2-2; Hassani AS, 2009, CURR MICROBIOL, V59, P446, DOI 10.1007/s00284-009-9458-z; Iyer AK, 2006, DRUG DISCOV TODAY, V11, P812, DOI 10.1016/j.drudis.2006.07.005; KANTOCH M, 1958, Postepy Hig Med Dosw, V12, P191; Lankes HA, 2007, J APPL MICROBIOL, V102, P1337, DOI 10.1111/j.1365-2672.2006.03182.x; Larocca D, 2001, MOL THER, V3, P476, DOI 10.1006/mthe.2001.0284; Leliveld SR, 2003, J BIOL CHEM, V278, P9042, DOI 10.1074/jbc.M210803200; Maddika S, 2008, ONCOGENE, V27, P3060, DOI 10.1038/sj.onc.1210958; Maddika S, 2006, CANCER BIOL THER, V5, P10, DOI 10.4161/cbt.5.1.2400; Maddika S, 2005, J CELL SCI, V118, P4485, DOI 10.1242/jcs.02580; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; March JB, 2004, VACCINE, V22, P1666, DOI 10.1016/j.vaccine.2003.10.047; MATSUMURA Y, 1986, CANCER RES, V46, P6387; MEEHAN BM, 1992, ARCH VIROL, V124, P301, DOI 10.1007/BF01309811; MURIALDO H, 1975, NATURE, V257, P815, DOI 10.1038/257815a0; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NOTEBORN MHM, 1995, AVIAN PATHOL, V24, P11, DOI 10.1080/03079459508419046; NOTEBORN MHM, 1991, J VIROL, V65, P3131, DOI 10.1128/JVI.65.6.3131-3139.1991; Olijslagers S, 2001, CANCER GENE THER, V8, P958, DOI 10.1038/sj.cgt.7700392; Oro C, 2004, CURR DRUG TARGETS, V5, P179, DOI 10.2174/1389450043490631; Pederson L C, 1998, J Gastrointest Surg, V2, P283, DOI 10.1016/S1091-255X(98)80024-3; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Pietersen AM, 2004, J MOL MED, V82, P56, DOI 10.1007/s00109-003-0486-z; Rohn JL, 2002, J BIOL CHEM, V277, P50820, DOI 10.1074/jbc.M208557200; Sambrook J., 2001, MOL CLONING LAB MANU; Shoae-Hassani A, 2013, ARCH IMMUNOL THER EX, V61, P75, DOI 10.1007/s00005-012-0206-x; Tavassoli M, 2005, APOPTOSIS, V10, P717, DOI 10.1007/s10495-005-0930-3; Unezaki S, 1996, INT J PHARM, V144, P11, DOI 10.1016/S0378-5173(96)04674-1; van der Eb MM, 2002, CANCER GENE THER, V9, P53, DOI 10.1038/sj.cgt.7700397; WENGER SL, 1978, IN VITRO CELL DEV B, V14, P543; Zhuang SM, 1995, CARCINOGENESIS, V16, P2939, DOI 10.1093/carcin/16.12.2939	46	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79907	10.1371/journal.pone.0079907	http://dx.doi.org/10.1371/journal.pone.0079907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278212	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700019
J	Vallejo-Diez, S; Bernardo, D; Moreno, MD; Munoz-Suano, A; Fernandez-Salazar, L; Calvo, C; Sousa, C; Garrote, JA; Cebolla, A; Arranz, E				Vallejo-Diez, Sara; Bernardo, David; de Lourdes Moreno, Mara; Munoz-Suano, Alba; Fernandez-Salazar, Luis; Calvo, Carmen; Sousa, Carolina; Garrote, Jose A.; Cebolla, Angel; Arranz, Eduardo			Detection of Specific IgA Antibodies against a Novel Deamidated 8-Mer Gliadin Peptide in Blood Plasma Samples from Celiac Patients	PLOS ONE			English	Article							GLUTEN-FREE DIET; TRANSGLUTAMINASE ANTIBODIES; CELL EPITOPES; DISEASE; DIAGNOSIS; CHILDREN; DATABASE; ENZYMES; AGE	We studied whether celiac disease (CD) patients produce antibodies against a novel gliadin peptide specifically generated in the duodenum of CD patients by a previously described pattern of CD-specific duodenal proteases. Fingerprinting and ion-trap mass spectrometry of CD-specific duodenal gliadin-degrading protease pattern revealed a new 8-mer gliadin-derived peptide. An ELISA against synthetic deamidated 8-mer peptides (DGP 8-mer) was used to study the presence of IgA anti-DGP 8-mer antibodies in plasma samples from 81 children (31 active CD patients (aCD), 17 CD patients on a gluten-free diet (GFD), 10 healthy controls (C) and 23 patients with other gastrointestinal pathology (GP)) and 101 adults (16 aCD, 12 GFD, 27 C and 46 GP-patients). Deamidation of the 8-mer peptide significantly increased the reactivity of the IgA antibodies from CD patients against the peptide. Significant IgA anti-DGP 8-mer antibodies levels were detected in 93.5% of aCD-, 11.8% of GFD- and 4.3% of GP-patients in children. In adults, antibodies were detected in 81.3% of aCD-patients and 8.3% of GFD-patients while were absent in 100% of C- and GP-patients. Duodenal CD-specific gliadin degrading proteases release an 8-mer gliadin peptide that once deamidated is an antigen for specific IgA antibodies in CD patients which may provide a new accurate diagnostic tool in CD.	[Vallejo-Diez, Sara; Bernardo, David; Garrote, Jose A.; Arranz, Eduardo] Univ Valladolid, CSIC, IBGM, Mucosal Immunol Lab, Valladolid, Spain; [de Lourdes Moreno, Mara; Sousa, Carolina] Univ Seville, Dept Microbiol & Parasitol, Seville, Spain; [Munoz-Suano, Alba; Cebolla, Angel] Biomedal SL, Seville, Spain; [Fernandez-Salazar, Luis] Hosp Clin Univ, Gastroenterol Serv, Valladolid, Spain; [Calvo, Carmen] Hosp Clin Univ, Serv Pediat, Valladolid, Spain; [Garrote, Jose A.] Hosp Univ Rio Hortega, Clin Lab, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; University of Sevilla; Universidad de la Laguna; Universidad de la Laguna; Hospital del Rio Hortega	Arranz, E (corresponding author), Univ Valladolid, CSIC, IBGM, Mucosal Immunol Lab, Valladolid, Spain.	earranz@med.uva.es	Garrote, Jose A/B-1257-2013; Fernández Salazar, Luis/GLN-5812-2022; Bernardo, David/GXH-8727-2022; Arranz, Eduardo/I-4958-2015; de Lourdes Moreno Amador, María/H-5836-2012	Garrote, Jose A/0000-0003-1797-6520; Fernández Salazar, Luis/0000-0002-9951-7979; Arranz, Eduardo/0000-0003-1957-3186; de Lourdes Moreno Amador, María/0000-0002-7490-2037; Sousa Martin, Carolina/0000-0002-9235-9496; Bernardo, David/0000-0002-2843-6696	Instituto de Salud Carlos III - FEDER [PI070244, PI10/01647]; Junta de Castilla y Leon [SAN126/VA31/09]; AECID [A/019196/08]; ThermoFisher Scientific	Instituto de Salud Carlos III - FEDER(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); AECID; ThermoFisher Scientific	This work has been supported by grants (to EA) from the Instituto de Salud Carlos III - FEDER (PI070244, PI10/01647), Junta de Castilla y Leon (SAN126/VA31/09), AECID (A/019196/08), and Phadia Spain S.L (now ThermoFisher Scientific). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleanzi M, 2001, CLIN CHEM, V47, P2023; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Bernardo D, 2009, GUT, V58, P886, DOI 10.1136/gut.2008.167296; Bizzaro N, 2003, DIGEST DIS SCI, V48, P2360, DOI 10.1023/B:DDAS.0000007875.72256.e8; Ciacci C, 2002, GASTROENTEROLOGY, V122, P588, DOI 10.1053/gast.2002.31598; Comino I, 2012, AM J CLIN NUTR, V95, P670, DOI 10.3945/ajcn.111.026708; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; Dorum S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014056; Feighery L, 2003, BRIT J BIOMED SCI, V60, P14, DOI 10.1080/09674845.2003.11783671; Garrote JA, 2002, IMMUNOGENETICS, V54, P551, DOI 10.1007/s00251-002-0498-9; Gourbeyre P, 2012, MOL NUTR FOOD RES, V56, P336, DOI 10.1002/mnfr.201100353; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kaukinen K, 2002, EUR J GASTROEN HEPAT, V14, P311, DOI 10.1097/00042737-200203000-00017; KLAPP G, 2012, POPULATION J PEDIAT; Lock RJ, 2004, EUR J GASTROEN HEPAT, V16, P467, DOI 10.1097/00042737-200405000-00005; Marai I, 2004, LUPUS, V13, P241, DOI 10.1191/0961203304lu1004oa; Mesin L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00313; MORELL A, 1973, CLIN EXP IMMUNOL, V13, P521; Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830; Osman AA, 2000, CLIN EXP IMMUNOL, V121, P248, DOI 10.1046/j.1365-2249.2000.01312.x; Parizade M, 2010, CLIN VACCINE IMMUNOL, V17, P884, DOI 10.1128/CVI.00425-09; Rashtak S, 2008, CLIN GASTROENTEROL H, V6, P426, DOI 10.1016/j.cgh.2007.12.030; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, J IMMUNOL, V161, P1585; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; Villalta D, 2005, CLIN CHIM ACTA, V356, P102, DOI 10.1016/j.cccn.2005.01.015; Vivas S, 2008, AM J GASTROENTEROL, V103, P2360, DOI 10.1111/j.1572-0241.2008.01977.x	36	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80982	10.1371/journal.pone.0080982	http://dx.doi.org/10.1371/journal.pone.0080982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278359	Green Published, gold			2022-12-27	WOS:000327541700042
J	Boisvert, RA; Rego, MA; Azzinaro, PA; Mauro, M; Howlett, NG				Boisvert, Rebecca A.; Rego, Meghan A.; Azzinaro, Paul A.; Mauro, Maurizio; Howlett, Niall G.			Coordinate Nuclear Targeting of the FANCD2 and FANCI Proteins via a FANCD2 Nuclear Localization Signal	PLOS ONE			English	Article							CROSS-LINK REPAIR; ANEMIA PATHWAY; DNA-DAMAGE; TY1 INTEGRASE; IDENTIFICATION; DOMAIN; SLX4; REPLICATION; MUTATIONS; COMPLEX	Fanconi anemia (FA) is a rare recessive disease, characterized by congenital defects, bone marrow failure, and increased cancer susceptibility. FA is caused by biallelic mutation of any one of sixteen genes. The protein products of these genes function cooperatively in the FA-BRCA pathway to repair DNA interstrand crosslinks (ICLs). A central step in the activation of this pathway is the monoubiquitination of the FANCD2 and FANCI proteins. Monoubiquitinated FANCD2 and FANCI localize to discrete chromatin regions where they function in ICL repair. Despite their critical role in ICL repair, very little is known about the structure, function, and regulation of the FANCD2 and FANCI proteins, or how they are targeted to the nucleus and chromatin. In this study, we describe the functional characterization of an amino-terminal FANCD2 nuclear localization signal (NLS). We demonstrate that the amino terminal 58 amino acids of FANCD2 can promote the nuclear expression of GFP and is necessary for the nuclear localization of FANCD2. Importantly, mutation of this FANCD2 NLS reveals that intact FANCD2 is required for the nuclear localization of a subset of FANCI. In addition, the NLS is necessary for the efficient monoubiquitination of FANCD2 and FANCI and, consequently, for their localization to chromatin. As a result, FANCD2 NLS mutants fail to rescue the ICL sensitivity of FA-D2 patient cells. Our studies yield important insight into the domain structure of the poorly characterized FANCD2 protein, and reveal a previously unknown mechanism for the coordinate nuclear import of a subset of FANCD2 and FANCI, a key early step in the cellular ICL response.	[Boisvert, Rebecca A.; Azzinaro, Paul A.; Howlett, Niall G.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Rego, Meghan A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Mauro, Maurizio] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA	University of Rhode Island; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Howlett, NG (corresponding author), Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA.	nhowlett@mail.uri.edu		Mauro, Maurizio/0000-0002-5452-0795; Boisvert, Rebecca/0000-0003-2720-2676	National Institutes of Health/National Heart, Lung and Blood Institute [R01HL101977]; Department of Defense Bone Marrow Failure Research Program New Investigator Award [BM W81XWH-11-1-0318]; National Center for Research Resources [P20RR016457-09]; National Science Foundation EPSCoR [1004057]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101977] Funding Source: NIH RePORTER; Office Of The Director [1004057] Funding Source: National Science Foundation	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Defense Bone Marrow Failure Research Program New Investigator Award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation EPSCoR(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Institutes of Health/National Heart, Lung and Blood Institute grant R01HL101977 (NGH); Department of Defense Bone Marrow Failure Research Program New Investigator Award BM W81XWH-11-1-0318 (NGH); Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) grant P20RR016457-09 from the National Center for Research Resources (Zahir A. Shaikh, PI/NGH, faculty development); and National Science Foundation EPSCoR grant #1004057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Colnaghi L, 2011, BLOOD, V117, P2247, DOI 10.1182/blood-2010-07-295758; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; *FARF I, 2003, FANCONI ANEMIA STAND, P172; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hejna J, 2010, CELL BIOL INT, V34, P893, DOI 10.1042/CBI20090251; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Rego MA, 2012, ONCOGENE, V31, P366, DOI 10.1038/onc.2011.237; Rego MA, 2012, BLOOD, V120, P2109, DOI 10.1182/blood-2012-02-410472; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Sareen A, 2012, NUCLEIC ACIDS RES, V40, P8425, DOI 10.1093/nar/gks638; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang J, 2010, P NATL ACAD SCI USA, V107, P16131, DOI 10.1073/pnas.1002603107; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Zhi G, 2010, BRIT J HAEMATOL, V150, P88, DOI 10.1111/j.1365-2141.2010.08217.x	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81387	10.1371/journal.pone.0081387	http://dx.doi.org/10.1371/journal.pone.0081387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278431	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800127
J	Liu, HT; Von Ohlen, T; Cheng, CM; Faburay, B; Ganta, RR				Liu, Huitao; Von Ohlen, Tonia; Cheng, Chuanmin; Faburay, Bonto; Ganta, Roman R.			Transcription of Ehrlichia chaffeensis Genes Is Accomplished by RNA Polymerase Holoenzyme Containing either Sigma 32 or Sigma 70	PLOS ONE			English	Article							ESCHERICHIA-COLI; INFECTION; EXPRESSION; MEMBRANE; PROMOTER; SEQUENCE; RPOH; IDENTIFICATION; MACROPHAGE; BACTERIAL	Bacterial gene transcription is initiated by RNA polymerase containing a sigma factor. To understand gene regulation in Ehrlichia chaffeensis, an important tick-transmitted rickettsiae responsible for human monocytic ehrlichiosis, we initiated studies evaluating the transcriptional machinery of several genes of this organism. We mapped the transcription start sites of 10 genes and evaluated promoters of five genes (groE, dnaK, hup, p28-Omp14 and p28-Omp19 genes). We report here that the RNA polymerase binding elements of E. chaffeensis gene promoters are highly homologous for its only two transcription regulators, sigma 32 and sigma 70, and that gene expression is accomplished by either of the transcription regulators. RNA analysis revealed that although transcripts for both sigma 32 and sigma 70 are upregulated during the early replicative stage, their expression patterns remained similar for the entire replication cycle. We further present evidence demonstrating that the organism's -35 motifs are essential to transcription initiations. The data suggest that E. chaffeensis gene regulation has evolved to support the organism's growth, possibly to facilitate its intraphagosomal growth. Considering the limited availability of genetic tools, this study offers a novel alternative in defining gene regulation in E. chaffeensis and other related intracellular pathogens.	[Liu, Huitao; Von Ohlen, Tonia; Cheng, Chuanmin; Faburay, Bonto; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Ganta, RR (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health, USA [AI070908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA grant # AI070908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet AF, 2005, GENE, V353, P89, DOI 10.1016/j.gene.2005.03.036; Boor KJ, 2006, PLOS BIOL, V4, P18, DOI 10.1371/journal.pbio.0040023; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; CHAMBERLIN M, 1983, METHOD ENZYMOL, V101, P540; CHENG C, 2005, CURRENT PROTOCOLS MI; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cheng ZH, 2011, MOL MICROBIOL, V82, P1217, DOI 10.1111/j.1365-2958.2011.07885.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson WR, 2001, J WILDLIFE DIS, V37, P538, DOI 10.7589/0090-3558-37.3.538; DAWSON JE, 1991, J CLIN MICROBIOL, V29, P2741, DOI 10.1128/JCM.29.12.2741-2745.1991; Dawson JE, 1996, AM J VET RES, V57, P1175; Dedonder SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036749; Dugan VG, 2000, J CLIN MICROBIOL, V38, P448; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; ERICKSON JW, 1987, GENE DEV, V1, P419, DOI 10.1101/gad.1.5.419; Faburay B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-83; FISHBEIN DB, 1987, JAMA-J AM MED ASSOC, V257, P3100, DOI 10.1001/jama.257.22.3100; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Grall N, 2009, MICROBIOL-SGM, V155, P2560, DOI 10.1099/mic.0.029058-0; Green HA, 2006, J BACTERIOL, V188, P5712, DOI 10.1128/JB.00405-06; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Gunesekere IC, 2006, J BACTERIOL, V188, P4769, DOI 10.1128/JB.01807-05; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; HINKLE DC, 1972, J MOL BIOL, V70, P157, DOI 10.1016/0022-2836(72)90531-1; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Kim ES, 2008, J BACTERIOL, V190, P7559, DOI 10.1128/JB.00470-08; Kocan A, 2000, EMERG INFECT DIS, V6, P477, DOI 10.3201/eid0605.000505; Koo BM, 2009, MOL MICROBIOL, V72, P815, DOI 10.1111/j.1365-2958.2009.06690.x; Kourennaia OV, 2005, J BACTERIOL, V187, P6762, DOI 10.1128/JB.187.19.6762-6769.2005; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long SW, 2002, INFECT IMMUN, V70, P1824, DOI 10.1128/IAI.70.4.1824-1831.2002; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Okamoto-Kainuma A, 2011, J BIOSCI BIOENG, V111, P429, DOI 10.1016/j.jbiosc.2010.12.016; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Peddireddi L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-99; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Ramirez-Romero MA, 2006, NUCLEIC ACIDS RES, V34, P1470, DOI 10.1093/nar/gkl023; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; Singh SS, 2011, NUCLEIC ACIDS RES, V39, P5109, DOI 10.1093/nar/gkr080; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Sirigireddy KR, 2005, J MOL DIAGN, V7, P308, DOI 10.1016/S1525-1578(10)60559-4; Slamti L, 2007, J BACTERIOL, V189, P351, DOI 10.1128/JB.01297-06; Tan M, 1996, J BACTERIOL, V178, P6975, DOI 10.1128/jb.178.23.6975-6982.1996; Tare P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043900; Ueki T, 2007, MICROBIOL-SGM, V153, P838, DOI 10.1099/mic.0.2006/000638-0; Unver A, 2002, INFECT IMMUN, V70, P4701, DOI 10.1128/IAI.70.8.4701-4704.2002; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Wang Y, 2003, J BACTERIOL, V185, P5800, DOI 10.1128/JB.185.19.5800-5806.2003; Yu HHY, 2003, MOL MICROBIOL, V50, P577, DOI 10.1046/j.1365-2958.2003.03708.x; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Yura T, 2007, P NATL ACAD SCI USA, V104, P17638, DOI 10.1073/pnas.0708819104; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062454; Zhang XF, 2003, J MED MICROBIOL, V52, P1021, DOI 10.1099/jmm.0.05234-0; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81780	10.1371/journal.pone.0081780	http://dx.doi.org/10.1371/journal.pone.0081780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278458	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800140
J	Moyano, AJ; Feliziani, S; Di Rienzo, JA; Smania, AM				Moyano, Alejandro J.; Feliziani, Sofia; Di Rienzo, Julio A.; Smania, Andrea M.			Simple Sequence Repeats Together with Mismatch Repair Deficiency Can Bias Mutagenic Pathways in Pseudomonas aeruginosa during Chronic Lung Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; DNA-POLYMERASE-IV; GENETIC ADAPTATION; PROKARYOTIC GENOMES; MUCOID CONVERSION; MUCA; AIRWAYS; MUTS	Pseudomonas aeruginosa is an opportunistic pathogen that chronically infects the airways of cystic fibrosis (CF) patients and undergoes a process of genetic adaptation based on mutagenesis. We evaluated the role of mononucleotide G:C and A:T simple sequence repeats (SSRs) in this adaptive process. An in silico survey of the genome sequences of 7 P. aeruginosa strains showed that mononucleotide G:C SSRs but not A:T SSRs were greatly under-represented in coding regions, suggesting a strong counterselection process for G:C SSRs with lengths >5 bp but not for A:T SSRs. A meta-analysis of published whole genome sequence data for a P. aeruginosa strain from a CF patient with chronic airway infection showed that G:C SSRs but not A:T SSRs were frequently mutated during the infection process through the insertion or deletion of one or more SSR subunits. The mutation tendency of G:C SSRs was length-dependent and increased exponentially as a function of SSR length. When this strain naturally became a stable Mismatch Repair System (MRS)-deficient mutator, the degree of increase of G:C SSRs mutations (5-fold) was much higher than that of other types of mutation (2.2-fold or less). Sequence analysis of several mutated genes reported for two different collections, both containing mutator and nonmutator strains of P. aeruginosa from CF chronic infections, showed that the proportion of G:C SSR mutations was significantly higher in mutators than in non-mutators, whereas no such difference was observed for A:T SSR mutations. Our findings, taken together, provide genome-scale evidences that under a MRS-deficient background, long G:C SSRs are able to stochastically bias mutagenic pathways by making the genes in which they are harbored more prone to mutation. The combination of MRS deficiency and virulence-related genes that contain long G:C SSRs is therefore a matter of concern in P. aeruginosa CF chronic infection.	[Moyano, Alejandro J.; Feliziani, Sofia; Smania, Andrea M.] Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC,Dept Quim B, RA-5000 Cordoba, Argentina; [Di Rienzo, Julio A.] Univ Nacl Cordoba, Fac Ciencias Agr, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Smania, AM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CONICET, Ctr Invest Quim Biol Cordoba CIQUIBIC,Dept Quim B, RA-5000 Cordoba, Argentina.	asmania@fcq.unc.edu.ar	Smania, Andrea/AFK-2800-2022; Smania, Andrea/AAG-1105-2022; Moyano, Alejandro/AAB-9092-2019	Moyano, Alejandro/0000-0002-4976-7611; Smania, Andrea/0000-0002-6527-7719	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT-2012-2088]; Secretaria de Ciencia y Tecnica (SECYT-UNC) [05/C532]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Secretaria de Ciencia y Tecnica (SECYT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT))	This study was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) Grant PICT-2012-2088 (http://www.agencia.gov.ar), and Secretaria de Ciencia y Tecnica (SECYT-UNC) Grant 05/C532 (http://www.secyt.unc.edu.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, PLOS GENET, V2, P224, DOI 10.1371/journal.pgen.0020022; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Feliziani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012669; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Levy DD, 2001, MUTAT RES-FUND MOL M, V474, P1, DOI 10.1016/S0027-5107(00)00169-X; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Moyano AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008203; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; R Core Team, 2013, R LANG ENV STAT COMP; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Wanner RM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-249; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80514	10.1371/journal.pone.0080514	http://dx.doi.org/10.1371/journal.pone.0080514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278287	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800074
J	Saxena, T; Tandon, B; Sharma, S; Chameettachal, S; Ray, P; Ray, AR; Kulshreshtha, R				Saxena, Tanvi; Tandon, Bhavna; Sharma, Shivani; Chameettachal, Shibu; Ray, Pratima; Ray, Alok R.; Kulshreshtha, Ritu			Combined miRNA and mRNA Signature Identifies Key Molecular Players and Pathways Involved in Chikungunya Virus Infection in Human Cells	PLOS ONE			English	Article							UP-REGULATION; MICRORNA; FEATURES; BETA; PATHOGENESIS; OUTBREAK; GENES	Since its discovery, Chikungunya fever caused by a virus (CHIKV) has ravaged most of Africa and Southeast Asia. Despite there being more than a million reported cases in India alone and the seriousness of the disease in the chronic phase, a clear understanding of the disease pathogenesis and host response remains elusive. Here, we use microarray technology and quantitative PCR method to establish the complete miRNA, snoRNA and mRNA signature of host response upon CHIKV infection in human cell line infection model, HEK293T. The results were further validated in human primary cells (dermal fibroblasts). miRNA expression profiling revealed regulation of 152 miRNAs post CHIKV infection. An interesting overlap in miRNA signature was seen majorly with HCV, HPV and HIV1 virus. The microarray data further validated by qRT-PCR revealed induction of miR-744, miR-638, miR-503 and others among the top upregulated miRNAs. Notably, we found induction of snoRNAs belonging to C/D cluster including close paralogs of U3, U44, U76 and U78 snoRNAs. Genes were found to be differentially expressed along 3 major pathways; TGF-beta, endocytosis and the cell cycle pathways. qRT-PCR data confirmed strong induction of TGF-beta (SMAD6, JUN, SKIL) and endocytosis pathway (CXCR4, HSPA8, ADRB1) genes while downregulation of cell cycle genes (CDC27 and CDC23). Interestingly, use of TGF-beta inhibitor, SB-431542, increased CHIKV mediated cell death. Overall, this study aims at providing the first complete transcriptome signature of host response upon CHIKV infection to aid identification of possible biomarkers and therapeutic targets.	[Saxena, Tanvi; Tandon, Bhavna; Sharma, Shivani; Kulshreshtha, Ritu] Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India; [Chameettachal, Shibu] Indian Inst Technol, Dept Text Technol, Delhi, India; [Ray, Pratima] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Ray, Alok R.] Indian Inst Technol, Ctr Biomed Engn, Delhi, India; [Ray, Alok R.] All India Inst Med Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Kulshreshtha, R (corresponding author), Indian Inst Technol, Dept Biochem Engn & Biotechnol, Delhi, India.	ritu@dbeb.iitd.ac.in	ray, alok/N-9901-2019	Ray, Pratima/0000-0002-2182-2279	Department of Biotechnology, GOI (DBT) [BT/PR9367/MED/32/09/2007]	Department of Biotechnology, GOI (DBT)	PR and ARR acknowledge support from Department of Biotechnology, GOI for financial support (DBT Grant NO. BT/PR9367/MED/32/09/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Hutzinger R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000547; Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672	39	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79886	10.1371/journal.pone.0079886	http://dx.doi.org/10.1371/journal.pone.0079886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278205	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800029
J	Yoshimura, Y; Kasuya, E				Yoshimura, Yuri; Kasuya, Eiiti			Odorous and Non-Fatal Skin Secretion of Adult Wrinkled Frog (Rana rugosa) Is Effective in Avoiding Predation by Snakes	PLOS ONE			English	Article							AMPHIBIAN VENOMS; AVIAN PREDATORS; APOSEMATIC PREY; XENOPUS SKIN; DEFENSE; TASTE; PEPTIDES; ROLES; COLOR	The roles played by nonfatal secretions of adult anurans in the avoidance of predation remain unknown. The adult Wrinkled frog (Rana rugosa) has warty skin with the odorous mucus secretion that is not fatal to the snake Elaphe quadrivirgata. We fed R. rugosa or Fejervarya limnocharis, which resembles R. rugosa in appearance and has mucus secretion, to snakes and compared the snakes' responses to the frogs. Compared to F. limnocharis, R. rugosa was less frequently bitten or swallowed by snakes. The snakes that bit R. rugosa spat out the frogs and showed mouth opening (gaping) behavior, while the snakes that bit F. limnocharis did not show gaping behavior. We also compared the responses of the snakes to R. rugosa and F. limnocharis secretions. We coated palatable R. japonica with secretions from R. rugosa or F. limnocharis. The frogs coated by R. rugosa secretion were less frequently bitten or swallowed than those coated by F. limnocharis secretion. We concluded that compared to different frog species of similar sizes, the adult R. rugosa was less frequently preyed upon by, and that its skin secretion was effective in avoiding predation by snakes.	[Yoshimura, Yuri] Kyushu Univ, Grad Sch Syst Life Sci, Dept Biol, Fukuoka 812, Japan; [Kasuya, Eiiti] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Kyushu University; Kyushu University	Yoshimura, Y (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Dept Biol, Fukuoka 812, Japan.	yuriyoshimura530@gmail.com	Kasuya, Eiiti/B-6447-2013		Global COE Program (Ministry of Education, Culture, Sports, Science and Technology, Japan; Center of excellence for Asian conservation ecology as a basis of human-nature mutualism); Japan Society for the Promotion of Science [22370010]; Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	Global COE Program (Ministry of Education, Culture, Sports, Science and Technology, Japan; Center of excellence for Asian conservation ecology as a basis of human-nature mutualism); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	This study was in part supported by Global COE Program (Ministry of Education, Culture, Sports, Science and Technology, Japan; Center of excellence for Asian conservation ecology as a basis of human-nature mutualism), Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to E. K. (No. 22370010) and the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Barthalmus George T., 1994, P382; BARTHALMUS GT, 1988, PHARMACOL BIOCHEM BE, V30, P957, DOI 10.1016/0091-3057(88)90126-8; Bowie JH, 1999, PROTEIN PEPTIDE LETT, V6, P259; BRODIE ED, 1991, BIOTROPICA, V23, P58, DOI 10.2307/2388688; CAMAZINE S, 1985, J CHEM ECOL, V11, P1289, DOI 10.1007/BF01024116; Cott H.B., 1940, ADAPTIVE COLORATION; Gamberale-Stille G, 2004, P ROY SOC B-BIOL SCI, V271, P2621, DOI 10.1098/rspb.2004.2893; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; HALPERN M, 1979, PHYSIOL BEHAV, V22, P1183, DOI 10.1016/0031-9384(79)90274-9; Halpin CG, 2008, ANIM BEHAV, V75, P771, DOI 10.1016/j.anbehav.2007.06.009; Maeda N, 2003, FROGS TOADS JAPAN; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; MARPLES NM, 1994, ANIM BEHAV, V48, P967, DOI 10.1006/anbe.1994.1322; MATSUI M, 1992, J HERPETOL, V26, P9, DOI 10.2307/1565015; MORI A, 1988, Snake, V20, P98; Mori A., 1989, P459; Poulton EB, 1890, COLOURS ANIMALS THEI; PREUSSER HJ, 1975, TOXICON, V13, P285, DOI 10.1016/0041-0101(75)90135-X; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Roper TJ, 1997, ANIM BEHAV, V53, P1241, DOI 10.1006/anbe.1996.0384; ROTHSCHILD M, 1984, BIOL J LINN SOC, V23, P375, DOI 10.1111/j.1095-8312.1984.tb00153.x; Rothschild M., 1961, Transactions of the Royal Entomological Society of London, V113, P101; Rowe C, 1999, ANIM BEHAV, V57, P341, DOI 10.1006/anbe.1998.0974; Ruxton G. D., 2004, AVOIDING ATTACK; Skelhorn J, 2005, P ROY SOC B-BIOL SCI, V272, P339, DOI 10.1098/rspb.2004.2953; Skelhorn J, 2007, ANIM BEHAV, V74, P1563, DOI 10.1016/j.anbehav.2007.03.021; Skelhorn J, 2006, BIOL LETT-UK, V2, P348, DOI 10.1098/rsbl.2006.0483; Skelhorn J, 2009, ANIM BEHAV, V78, P761, DOI 10.1016/j.anbehav.2009.07.006; TERRICK TD, 1995, ANIM BEHAV, V49, P857, DOI 10.1006/anbe.1995.0118; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; ZIELINSKI WJ, 1989, ANIM BEHAV, V38, P1083, DOI 10.1016/S0003-3472(89)80149-6	35	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81280	10.1371/journal.pone.0081280	http://dx.doi.org/10.1371/journal.pone.0081280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278410	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800117
J	Bruske, I; Thiering, E; Heinrich, J; Huster, K; Nowak, D				Brueske, Irene; Thiering, Elisabeth; Heinrich, Joachim; Huster, Katharina; Nowak, Dennis			Biopersistent Granular Dust and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							AIR-FLOW LIMITATION; LUNG-FUNCTION; RESPIRATORY SYMPTOMS; OCCUPATIONAL-EXPOSURE; VENTILATORY FUNCTION; GENERAL-POPULATION; CARBON-BLACK; RESPONSE RELATIONSHIPS; CHRONIC-BRONCHITIS; NATIONAL-HEALTH	Objective: Applying a systematic review to identify studies eligible for meta-analysis of the association between occupational exposure to inorganic dust and the development of chronic obstructive pulmonary disease (COPD), and conducting a meta-analysis. Data Sources: Searches of PubMed and Embase for the time period 1970-2010 yielded 257 cross-sectional and longitudinal studies on people exposed to inorganic dust at the workplace with data on lung function. These studies were independently abstracted and evaluated by two authors; any disagreement was resolved by a third reviewer. Of 55 publications accepted for meta-analysis, 27 investigated the effects of occupational exposure to biopersistent granular dust (bg-dust). Methods: A random effects meta-analysis allowed us to provide an estimate of the average exposure effect on spirometric parameters presented in forest plots. Between-study heterogeneity was assessed by using I-2 statistics, with I-2>25% indicating significant heterogeneity. Publication bias was investigated by visual inspection of funnel plots. The influence of individual studies was assessed by dropping the respective study before pooling study-specific estimates. Results: The mean FEV1 of workers exposed to bg-dust was 160 ml lower or 5.7% less than predicted compared to workers with no/low exposure. The risk of an obstructive airway disease-defined as FEV1/FVC < 70%-increased by 7% per 1 mg . m(-3) respirable bg-dust. Conclusion: Occupational inhalative exposure to bg-dust was associated with a statistically significant decreased FEV1 and FEV1/FVC revealing airway obstruction consistent with COPD.	[Brueske, Irene; Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Inst Epidemiol 1, Helmholtz Zentrum Munchen, Munich, Germany; [Huster, Katharina; Nowak, Dennis] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Ctr Clin, Munich, Germany; [Heinrich, Joachim; Nowak, Dennis] CPC M, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Bruske, I (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol 1, Helmholtz Zentrum Munchen, Munich, Germany.	brueske@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Brüske, Irene/N-3125-2013	Heinrich, Joachim/0000-0002-9620-1629; Thiering, Elisabeth/0000-0002-5429-9584	GermanFederal Ministry of Labor and Social Affairs	GermanFederal Ministry of Labor and Social Affairs	The systematic review and meta-analysis was funded by the GermanFederal Ministry of Labor and Social Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRONS HL, 1988, BRIT J IND MED, V45, P368; AbuDhaise B A, 1997, Int J Occup Med Environ Health, V10, P417; BAKKE PS, 1991, THORAX, V46, P863, DOI 10.1136/thx.46.12.863; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Balmes JR, 2005, J OCCUP ENVIRON MED, V47, P154, DOI 10.1097/01.jom.0000152923.07801.e1; Beach JR, 2001, INT ARCH OCC ENV HEA, V74, P489, DOI 10.1007/s004200100245; Beeckman LAF, 2001, AM J RESP CRIT CARE, V163, P633, DOI 10.1164/ajrccm.163.3.2008084; Blanc RD, 2007, INT J TUBERC LUNG D, V11, P251; Blanc PD, 2009, THORAX, V64, P6, DOI 10.1136/thx.2008.099390; Boggia B, 2008, J OCCUP ENVIRON MED, V50, P366, DOI 10.1097/JOM.0b013e318162f601; Boojar MMA, 2002, J OCCUP ENVIRON MED, V44, P282; BURGE PS, 1994, EUR RESPIR J, V7, P1032; CHANYEUNG M, 1989, ARCH ENVIRON HEALTH, V44, P134, DOI 10.1080/00039896.1989.9935876; Chen PC, 2006, IND HEALTH, V44, P190, DOI 10.2486/indhealth.44.190; Commission E, 2013, REP CURR SIT REL OCC; COWIE RL, 1991, AM REV RESPIR DIS, V143, P80, DOI 10.1164/ajrccm/143.1.80; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Elliehausen HJ, 2007, ARBEITSMED SOZIALMED, V42, P564; Fell AKM, 2003, J OCCUP ENVIRON MED, V45, P1008, DOI 10.1097/01.jom.0000083036.56116.9d; FINE LJ, 1976, ARCH ENVIRON HEALTH, V31, P136, DOI 10.1080/00039896.1976.10667207; FINE LJ, 1976, ARCH ENVIRON HEALTH, V31, P195, DOI 10.1080/00039896.1976.10667219; Fishwick D, 1997, AM J RESP CRIT CARE, V156, P1440, DOI 10.1164/ajrccm.156.5.97-03007; Fishwick David, 2010, Chron Respir Dis, V7, P113, DOI 10.1177/1479972309354690; Gardiner K, 2001, OCCUP ENVIRON MED, V58, P496, DOI 10.1136/oem.58.8.496; GARDINER K, 1993, BRIT J IND MED, V50, P1082; Harber P, 2003, J OCCUP ENVIRON MED, V45, P144, DOI 10.1097/01.jom.0000052955.59271.66; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hnizdo E, 2000, INT ARCH OCC ENV HEA, V73, P235, DOI 10.1007/s004200050423; Hnizdo E, 2003, OCCUP ENVIRON MED, V60, P237, DOI 10.1136/oem.60.4.237; Hnizdo E, 2002, AM J EPIDEMIOL, V156, P738, DOI 10.1093/aje/kwf105; Huvinen M, 1996, OCCUP ENVIRON MED, V53, P741, DOI 10.1136/oem.53.11.741; Jaen Angeles, 2006, Environ Health, V5, P2, DOI 10.1186/1476-069X-5-2; Johnsen HL, 2008, AM J IND MED, V51, P296, DOI 10.1002/ajim.20557; Johnsen HL, 2010, AM J RESP CRIT CARE, V181, P1234, DOI 10.1164/rccm.200809-1381OC; KONGERUD J, 1990, SCAND J WORK ENV HEA, V16, P270, DOI 10.5271/sjweh.1785; Krajewski-Siuda Krzysztof, 2004, Int J Occup Med Environ Health, V17, P487; KRZYZANOWSKI M, 1988, INT J EPIDEMIOL, V17, P397, DOI 10.1093/ije/17.2.397; Kuo HW, 1999, OCCUP MED-OXFORD, V49, P499, DOI 10.1093/occmed/49.8.499; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lotz G, 2008, INT ARCH OCC ENV HEA, V81, P1003, DOI 10.1007/s00420-007-0294-9; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mannino DM, 2006, AM J RESP CRIT CARE, V173, P985, DOI 10.1164/rccm.200508-1344OC; Meijer E, 1998, AM J IND MED, V33, P16; Meijers JMM, 1997, OCCUP ENVIRON MED, V54, P708, DOI 10.1136/oem.54.10.708; Mohner M, 2012, J OCCUP ENVIRON MED, V70, P9; Mwaiselage J, 2004, J OCCUP ENVIRON MED, V46, P658, DOI 10.1097/01.jom.0000131787.02250.79; Neghab M, 2007, INT ARCH OCC ENV HEA, V80, P539, DOI 10.1007/s00420-006-0161-0; Neghab M, 2007, J OCCUP HEALTH, V49, P273, DOI 10.1539/joh.49.273; Nordby KC, 2011, EUR RESPIR J, V38, P1278, DOI 10.1183/09031936.00007711; Organization IL, 2010, ID REC OCC DIS CRIT; Quanjer PH, 2012, EUROPEAN RESP J; Rushton Lesley, 2007, Reviews on Environmental Health, V22, P195; Schouten JP, 1996, AM J RESP CRIT CARE, V154, pS278, DOI 10.1164/ajrccm/154.6_Pt_2.S278; Selden AI, 2001, OCCUP ENVIRON MED, V58, P670, DOI 10.1136/oem.58.10.670; Soyseth V, 2011, OCCUP ENVIRON MED, V68, P24, DOI 10.1136/oem.2009.049452; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sunyer J, 1998, AM J RESP CRIT CARE, V157, P512, DOI 10.1164/ajrccm.157.2.9705029; TOWNSEND MC, 1985, AM REV RESPIR DIS, V132, P1174; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; VIEGI G, 1991, AM REV RESPIR DIS, V143, P510, DOI 10.1164/ajrccm/143.3.510; Viegi G, 2002, CURR OPIN ALLERGY CL, V2, P115, DOI 10.1097/00130832-200204000-00006; Wang ML, 2004, J OCCUP ENVIRON MED, V46, P591, DOI 10.1097/01.jom.0000128159.09520.2a; Wang ML, 1996, AM J RESP CRIT CARE, V153, P1907, DOI 10.1164/ajrccm.153.6.8665054; Weinmann S, 2008, J OCCUP ENVIRON MED, V50, P561, DOI 10.1097/JOM.0b013e3181651556; WILD P, 1995, OCCUP ENVIRON MED, V52, P470, DOI 10.1136/oem.52.7.470; XU XP, 1992, AM REV RESPIR DIS, V146, P413, DOI 10.1164/ajrccm/146.2.413	66	11	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80977	10.1371/journal.pone.0080977	http://dx.doi.org/10.1371/journal.pone.0080977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278358	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100131
J	Fardo, F; Spironelli, C; Angrilli, A				Fardo, Francesca; Spironelli, Chiara; Angrilli, Alessandro			Horizontal Body Position Reduces Cortical Pain-Related Processing: Evidence from Late ERPs	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVOKED-POTENTIALS; SIMULATED MICROGRAVITY; EMOTIONAL RESPONSES; GENDER-DIFFERENCES; BRAIN RESPONSES; STIMULATION; SEX	The present study investigated the influence of short-term horizontal body position on pain-related somatosensory processing, by measuring subjective and cortical responses to electrical pain stimulation. Twenty-eight healthy women were randomly assigned to either the experimental horizontal group (Bed Rest, BR) or to the sitting control group (Sitting Control, SC). After 90 minutes in either horizontal or sitting position, the individual pain thresholds were assessed and EEG/self-evaluations recorded during the administration of 180 stimuli delivered to the left forearm. Electrical pain stimuli, calibrated to subjects' individual pain thresholds, consisted of two different intensity levels: no pain (40% below pain threshold) and pain (40% above pain threshold). Compared with control, BR condition significantly inhibited subjective sensitivity to painless stimuli, whereas electrophysiological results pointed to a reduced slow cortical wave (interval: 300-600 ms) at all stimulus intensities, and smaller amplitude in BR's right vs. left prefrontal sites. sLORETA analysis revealed that cortical responses were associated with a decreased activation of superior frontal gyrus and anterior cingulate cortex (BA 6/24). Interestingly, BR group only showed significant negative correlations between self-evaluation of painful intensities and frontal cortical negativity, revealing increasingly differentiated responses in bed rest: indeed those BR participants who reported lower pain ratings, displayed reduced negativity within anterior regions. Taken together, results indicate that short-term horizontal position is able to inhibit a fronto-parietal pain network, particularly at the level of central prefrontal regions typically involved in cognitive, affective and motor aspects of pain processing.	[Fardo, Francesca; Spironelli, Chiara; Angrilli, Alessandro] Univ Padua, Dept Gen Psychol, Padua, Italy; [Angrilli, Alessandro] CNR, Inst Neurosci, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Angrilli, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	alessandro.angrilli@unipd.it	Fardo, Francesca/J-7578-2019; Spironelli, Chiara/AAC-1701-2021; Spironelli, Chiara/D-1548-2014	Fardo, Francesca/0000-0002-9974-6261; Spironelli, Chiara/0000-0002-8547-2431; Spironelli, Chiara/0000-0002-8547-2431; Angrilli, Alessandro/0000-0002-5571-7637				Angrilli A, 1997, PHYSIOL BEHAV, V62, P391, DOI 10.1016/S0031-9384(97)00039-5; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Becker DE, 2000, PAIN, V84, P37, DOI 10.1016/S0304-3959(99)00182-7; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; BERG P, 1991, ELECTROEN CLIN NEURO, V79, P36, DOI 10.1016/0013-4694(91)90154-V; Bianchin M, 2012, PHYSIOL BEHAV, V105, P925, DOI 10.1016/j.physbeh.2011.10.031; Bromm B, 1998, ELECTROEN CLIN NEURO, V107, P227, DOI 10.1016/S0013-4694(98)00075-3; BROMM B, 1985, ADV PAIN RES THER, V9, P305; Bromm B, 1984, PAIN MEASUREMENT MAN, P257; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dowman R, 2007, NEUROIMAGE, V34, P743, DOI 10.1016/j.neuroimage.2006.09.021; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Guell A., 1993, SPECIAL PUBLICATION, VSP-1160; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lopez-Sola M, 2010, NEUROIMAGE, V50, P1177, DOI 10.1016/j.neuroimage.2010.01.031; MacNamara A, 2009, NEUROPSYCHOLOGIA, V47, P2975, DOI 10.1016/j.neuropsychologia.2009.06.026; Messerotti Benvenuti S, 2013, BRAIN COGNITION, V82, P313, DOI 10.1016/j.bandc.2013.05.006; Messerotti Benvenuti S, 2011, PHYSIOL BEHAV, V104, P503, DOI 10.1016/j.physbeh.2011.05.019; MINI A, 1995, INT J PSYCHOPHYSIOL, V19, P67, DOI 10.1016/0167-8760(94)00084-R; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; RAU H, 1993, PSYCHOPHYSIOLOGY, V30, P322, DOI 10.1111/j.1469-8986.1993.tb03359.x; Spironelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024932; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Talairach J., 1988, COPLANAR STEREOTAXIC; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; Vaitl D, 1996, BIOL PSYCHOL, V42, P87, DOI 10.1016/0301-0511(95)05148-1; VAITL D, 1992, J PSYCHOPHYSIOL, V6, P111; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 2006, EUR J NEUROSCI, V8, P1461; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006	41	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81964	10.1371/journal.pone.0081964	http://dx.doi.org/10.1371/journal.pone.0081964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278467	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100164
J	Patil, R; Ghosh, K; Satoskar, P; Shetty, S				Patil, Rucha; Ghosh, Kanjaksha; Satoskar, Purnima; Shetty, Shrimati			Elevated Procoagulant Endothelial and Tissue Factor Expressing Microparticles in Women with Recurrent Pregnancy Loss	PLOS ONE			English	Article							ANNEXIN-V; THROMBOPHILIA; MISCARRIAGE; EPIDEMIOLOGY; PREECLAMPSIA; HEMOSTASIS; THROMBOSIS	Background: 15% of reproducing couples suffer from pregnancy loss(PL) and recurs in 2-3%. One of the most frequently hypothesized causes of unexplained PL refers to a defective maternal haemostatic response leading to uteroplacental thrombosis. Hereditary thrombophilia and antiphospholipid antibodies have been extensively described as risk factors for PL in women with unknown aetiology. Recently, a new marker has emerged: the cell-derived procoagulant circulating microparticles(MPs) which have been reported to have a major role in many thrombosis complicated diseases. This study aims to analyze the significance of procoagulant MPs in women suffering from unexplained recurrent pregnancy loss(RPL), and characterize their cellular origin. Method and Findings: 115 women with RPL were analyzed for common thrombophilia markers and different cell derived MPs-total annexinV, platelet(CD41a), endothelial(CD146, CD62e), leukocyte(CD45), erythrocyte(CD235a) and tissue factor(CD142)(TF) expressing MPs and were compared with 20 healthy non-pregnant women. Methodology for MP analysis was standardized by participating in the "Vascular Biology Scientific and Standardization Committee workshop". Results: Total annexinV, TF and endothelial MPs were found significantly increased(p<0.05, 95% confidence interval) in women with RPL. The procoagulant activity of MPs measured by STA-PPL clotting time assay was found in correspondence with annexinV MP levels, wherein the clot time was shortened in samples with increased MP levels. Differences in platelet, leukocyte and erythrocyte derived MPs were not significant. Thirty seven of 115 women were found to carry any of the acquired or hereditary thrombophilia markers. No significant differences were seen in the MP profile of women with and without thrombophilia marker. Conclusion: The presence of elevated endothelial, TF and phosphatidylserine expressing MPs at a distance (at least 3 months) from the PL suggests a continued chronic endothelial damage/activation which may get exaggerated at the onset of pregnancy. The data suggests that MPs may contribute to uteroplacental thrombosis and are associated with the pathogenesis of RPL.	[Patil, Rucha; Ghosh, Kanjaksha; Shetty, Shrimati] King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India; [Satoskar, Purnima] Nowrosjee Wadia Matern Hosp, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Shetty, S (corresponding author), King Edward Mem Hosp, Natl Inst Immunohaematol ICMR, Dept Haemostasis & Thrombosis, Bombay, Maharashtra, India.	shrimatishetty@yahoo.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Council of Scientific and Industrial Research, India CSIR [09/859 (0001)/2011-EMR-I]	Council of Scientific and Industrial Research, India CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The source of funding: Council of Scientific and Industrial Research, India CSIR Sanction No.: File No.: 09/859 (0001)/2011-EMR-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alijotas-Reig J, 2005, MED CLIN-BARCELONA, V125, P626, DOI 10.1157/13080830; Alijotas-Reig J, 2011, AM J REPROD IMMUNOL, V66, P199, DOI 10.1111/j.1600-0897.2010.00972.x; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; Carp H, 2004, HUM REPROD, V19, P191, DOI 10.1093/humrep/deg512; COULAM CB, 1991, AM J REPROD IMMUNOL, V26, P23, DOI 10.1111/j.1600-0897.1991.tb00697.x; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Ghosh K, 2008, CLIN APPL THROMB-HEM, V14, P174, DOI 10.1177/1076029607306400; Gonzalez-Quintero VH, 2004, AM J OBSTET GYNECOL, V191, P1418, DOI 10.1016/j.ajog.2004.06.044; Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Jimenez JJ, 2001, BRIT J HAEMATOL, V112, P81, DOI 10.1046/j.1365-2141.2001.02516.x; Jy W, 2010, SEMIN THROMB HEMOST, V36, P876, DOI 10.1055/s-0030-1267041; Kaptan K, 2008, INT J GYNECOL OBSTET, V102, P271, DOI 10.1016/j.ijgo.2008.04.007; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Laude I, 2001, THROMB HAEMOSTASIS, V85, P18, DOI 10.1055/s-0037-1612657; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Rai R, 2003, CURR OPIN OBSTET GYN, V15, P265, DOI 10.1097/00001703-200306000-00010; RAND JH, 1994, AM J OBSTET GYNECOL, V171, P1566, DOI 10.1016/0002-9378(94)90403-0; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Sugimura M, 1999, PLACENTA, V20, P555, DOI 10.1053/plac.1999.0420; Vora S, 2008, NATL MED J INDIA, V21, P116; Wang XQ, 1999, AM J OBSTET GYNECOL, V180, P1008, DOI 10.1016/S0002-9378(99)70674-5; Zahra S, 2011, BRIT J HAEMATOL, V152, P688, DOI 10.1111/j.1365-2141.2010.08452.x	26	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81407	10.1371/journal.pone.0081407	http://dx.doi.org/10.1371/journal.pone.0081407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278436	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100156
J	Sepulveda, CS; Garcia, CC; Macleod, JML; Lopez, N; Damonte, EB				Sepulveda, Claudia S.; Garcia, Cybele C.; Levingston Macleod, Jesica M.; Lopez, Nora; Damonte, Elsa B.			Targeting of Arenavirus RNA Synthesis by a Carboxamide-Derivatized Aromatic Disulfide with Virucidal Activity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN ZINC FINGERS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; JUNIN VIRUS; ENVELOPE GLYCOPROTEIN; SIGNAL PEPTIDE; RETROVIRAL INFECTIVITY; RING DOMAINS; LASSA FEVER; ANTI-HIV	Several arenaviruses can cause severe hemorrhagic fever (HF) in humans, representing a public health threat in endemic areas of Africa and South America. The present study characterizes the potent virucidal activity of the carboxamide-derivatized aromatic disulfide NSC4492, an antiretroviral zinc finger-reactive compound, against Junin virus (JUNV), the causative agent of Argentine HF. The compound was able to inactivate JUNV in a time and temperature-dependent manner, producing more than 99 % reduction in virus titer upon incubation with virions at 37 degrees C for 90 min. The ability of NSC4492-treated JUNV to go through different steps of the multiplication cycle was then evaluated. Inactivated virions were able to bind and enter into the host cell with similar efficiency as control infectious particles. In contrast, treatment with NSC4492 impaired the capacity of JUNV to drive viral RNA synthesis, as measured by quantitative RT-PCR, and blocked viral protein expression, as determined by indirect immunofluorescence. These results suggest that the disulfide NSC4492 targets on the arenavirus replication complex leading to impairment in viral RNA synthesis. Additionally, analysis of VLP produced in NSC4492-treated cells expressing JUNV matrix Z protein revealed that the compound may interact with Z resulting in an altered aggregation behavior of this protein, but without affecting its intrinsic self-budding properties. The potential perspectives of NSC4492 as an inactivating vaccinal compound for pathogenic arenaviruses are discussed.	[Sepulveda, Claudia S.; Garcia, Cybele C.; Damonte, Elsa B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Virol,Dept Quim Biol, IQUIBICEN Consejo Nacl Invest Cient & Tecn CONICE, Buenos Aires, DF, Argentina; [Levingston Macleod, Jesica M.; Lopez, Nora] Consejo Nacl Invest Cient & Tecn, Centro Virol Anim CEVAN, Inst Ciencia & Tecnol Dr Cesar Milstein, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Damonte, EB (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Virol,Dept Quim Biol, IQUIBICEN Consejo Nacl Invest Cient & Tecn CONICE, Buenos Aires, DF, Argentina.	edamonte@qb.fcen.uba.ar		Lopez, Nora/0000-0003-1932-1843; Levingston Mac Leod, Jesica/0000-0001-8172-4876; garcia, cybele/0000-0002-6431-7176	Agencia Nacional para la Promocion Cientifica y Tecnologica [PICT 0506/2011, 1931/2008]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET-PIP 0467, CONICET-PIP 0275]; Universidad de Buenos Aires [UBACyT 00145]	Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires)	This research was supported by Agencia Nacional para la Promocion Cientifica y Tecnologica (PICT 0506/2011 and 1931/2008), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-PIP 0467 and 0275) and Universidad de Buenos Aires (UBACyT 00145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311; Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; Buchmeier MJ, 2002, CURR TOP MICROBIOL, V262, P159; CASTILLA V, 1994, ARCH VIROL, V136, P363, DOI 10.1007/BF01321064; Charrel RN, 2010, VET MICROBIOL, V140, P213, DOI 10.1016/j.vetmic.2009.08.027; CONTIGIANI MS, 1977, MEDICINA-BUENOS AIRE, V37, P244; Casabona JC, 2009, J VIROL, V83, P7029, DOI 10.1128/JVI.00329-09; Eichler R, 2004, VIRUS RES, V100, P249, DOI 10.1016/j.virusres.2003.11.017; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Ellenberg P, 2007, J GEN VIROL, V88, P2730, DOI 10.1099/vir.0.83041-0; Enria DA, 2002, CURR TOP MICROBIOL, V263, P239; ENRIA DA, 1994, ANTIVIR RES, V23, P23, DOI 10.1016/0166-3542(94)90030-2; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Loureiro ME, 2011, J VIROL, V85, P12304, DOI 10.1128/JVI.05691-11; FISHERHOCH SP, 1992, ANTIVIR RES, V19, P139, DOI 10.1016/0166-3542(92)90073-E; Garcia CC, 2006, J GEN VIROL, V87, P1217, DOI 10.1099/vir.0.81667-0; Garcia CC, 2002, ANTIVIR RES, V55, P437, DOI 10.1016/S0166-3542(02)00076-1; Garcia CC, 2000, ANTIVIR CHEM CHEMOTH, V11, P231, DOI 10.1177/095632020001100306; Garcia CC, 2009, VIRUS RES, V143, P106, DOI 10.1016/j.virusres.2009.03.010; GUINEA R, 1994, BIOCHEM BIOPH RES CO, V201, P1270, DOI 10.1006/bbrc.1994.1842; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Huang MJ, 1998, J MED CHEM, V41, P1371, DOI 10.1021/jm9708543; Irurzun A, 1997, VIROLOGY, V227, P488, DOI 10.1006/viro.1996.8340; Jacamo R, 2003, J VIROL, V77, P10383, DOI 10.1128/JVI.77.19.10383-10393.2003; Jenkins LMM, 2006, J AM CHEM SOC, V128, P11964, DOI 10.1021/ja063329e; Kentsis A, 2001, J MOL BIOL, V312, P609, DOI 10.1006/jmbi.2001.5003; Kerber R, 2011, J VIROL, V85, P12518, DOI 10.1128/JVI.05091-11; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Macleod JML, 2011, J VIROL, V85, P2012, DOI 10.1128/JVI.01875-10; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Lukashevich IS, 2012, VIRUSES-BASEL, V4, P2514, DOI 10.3390/v4112514; Maiztegui JI, 1998, J INFECT DIS, V177, P277, DOI 10.1086/514211; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MERSICH SE, 1981, INTERVIROLOGY, V16, P123, DOI 10.1159/000149257; Morcock DR, 2005, J VIROL, V79, P1533, DOI 10.1128/JVI.79.3.1533-1542.2005; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Parisi G, 1996, VIRUS GENES, V13, P247, DOI 10.1007/BF00366985; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Rein A, 1996, J VIROL, V70, P4966, DOI 10.1128/JVI.70.8.4966-4972.1996; Rice WG, 1996, J MED CHEM, V39, P3606, DOI 10.1021/jm960375o; RICE WG, 1995, SCIENCE, V270, P1194, DOI 10.1126/science.270.5239.1194; Rice WG, 1997, NAT MED, V3, P341, DOI 10.1038/nm0397-341; Richmond JK, 2003, BRIT MED J, V327, P1271, DOI 10.1136/bmj.327.7426.1271; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Salvato M.S., 2012, VIRUS TAXONOMY, P715; SALVATO MS, 1992, VIRUS RES, V22, P185, DOI 10.1016/0168-1702(92)90050-J; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Schlie K, 2010, J VIROL, V84, P3178, DOI 10.1128/JVI.02240-09; Sepulveda CS, 2012, ANTIVIR RES, V93, P16, DOI 10.1016/j.antiviral.2011.10.007; Sepulveda CS, 2010, ANTIVIR RES, V87, P329, DOI 10.1016/j.antiviral.2010.06.005; Shtanko O, 2010, J VIROL, V84, P5415, DOI 10.1128/JVI.02417-09; Strandin T, 2011, J GEN VIROL, V92, P1189, DOI 10.1099/vir.0.027896-0; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; Topcu Z, 1999, ONCOGENE, V18, P7091, DOI 10.1038/sj.onc.1203201; Tummino PJ, 1997, ANTIMICROB AGENTS CH, V41, P394, DOI 10.1128/AAC.41.2.394; Turpin JA, 1997, ANTIVIR CHEM CHEMOTH, V8, P60, DOI 10.1177/095632029700800107; Urata S, 2009, J VIROL, V83, P12651, DOI 10.1128/JVI.01012-09; Volpon L, 2010, P NATL ACAD SCI USA, V107, P5441, DOI 10.1073/pnas.0909877107; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2007, J VIROL, V81, P13385, DOI 10.1128/JVI.01785-07; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	69	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81251	10.1371/journal.pone.0081251	http://dx.doi.org/10.1371/journal.pone.0081251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278404	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100149
J	Chu, CW; Gerstenzang, E; Ossipova, O; Sokol, SY				Chu, Chih-Wen; Gerstenzang, Emma; Ossipova, Olga; Sokol, Sergei Y.			Lulu Regulates Shroom-Induced Apical Constriction during Neural Tube Closure	PLOS ONE			English	Article							EPITHELIAL-CELL SHAPE; MORPHOGENETIC MOVEMENTS; MESENCHYMAL TRANSITION; JUNCTION FORMATION; CRUMBS COMPLEX; MOSAIC EYES; RHO-KINASES; XENOPUS; PROTEIN; MECHANISMS	Apical constriction is an essential cell behavior during neural tube closure, but its underlying mechanisms are not fully understood. Lulu, or EPB4.1l5, is a FERM domain protein that has been implicated in apical constriction and actomyosin contractility in mouse embryos and cultured cells. Interference with the function of Lulu in Xenopus embryos by a specific antisense morpholino oligonucleotide or a carboxy-terminal fragment of Lulu impaired apical constriction during neural plate hinge formation. This effect was likely due to lack of actomyosin contractility in superficial neuroectodermal cells. By contrast, overexpression of Lulu RNA in embryonic ectoderm cells triggered ectopic apico-basal elongation and apical constriction, accompanied by the apical recruitment of F-actin. Depletion of endogenous Lulu disrupted the localization and activity of Shroom3, a PDZ-containing actin-binding protein that has also been implicated in apical constriction. Furthermore, Lulu and Shroom3 RNAs cooperated in triggering ectopic apical constriction in embryonic ectoderm. Our findings reveal that Lulu is essential for Shroom3-dependent apical constriction during vertebrate neural tube closure.	[Chu, Chih-Wen; Gerstenzang, Emma; Ossipova, Olga; Sokol, Sergei Y.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Sokol, SY (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY USA.	sergei.sokol@mssm.edu		Chu, Chih-Wen/0000-0002-0918-2301; Sokol, Sergei/0000-0002-3963-9202	National Institutes of Health [RO1-NS40972]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health grant RO1-NS40972. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSH KT, 1990, ANAT EMBRYOL, V181, P49; Christensen AK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-3; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Hirano M, 2008, J CELL BIOL, V182, P1217, DOI 10.1083/jcb.200712086; Hsu YC, 2006, DEVELOPMENT, V133, P4849, DOI 10.1242/dev.02685; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; Kim K, 2012, DEV DYNAM, V241, P1385, DOI 10.1002/dvdy.23826; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee C, 2007, DEVELOPMENT, V134, P1431, DOI 10.1242/dev.02828; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Lee JY, 2007, DEV BIOL, V311, P40, DOI 10.1016/j.ydbio.2007.08.010; NAGELE RG, 1987, J EXP ZOOL, V241, P197, DOI 10.1002/jez.1402410206; Nakajima H, 2011, J CELL BIOL, V195, P245, DOI 10.1083/jcb.201104118; Nakajima H, 2010, J CELL SCI, V123, P555, DOI 10.1242/jcs.057752; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Ossipova O, 2007, DEVELOPMENT, V134, P4297, DOI 10.1242/dev.009282; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; Suzuki M, 2012, DEV GROWTH DIFFER, V54, P266, DOI 10.1111/j.1440-169X.2012.01346.x; Suzuki M, 2010, DEVELOPMENT, V137, P2329, DOI 10.1242/dev.048769; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wei L, 2001, DEVELOPMENT, V128, P2953	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81854	10.1371/journal.pone.0081854	http://dx.doi.org/10.1371/journal.pone.0081854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282618	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500122
J	Kanber, D; Buiting, K; Roos, C; Gromoll, J; Kaya, S; Horsthemke, B; Lohmann, D				Kanber, Deniz; Buiting, Karin; Roos, Christian; Gromoll, Joerg; Kaya, Sabine; Horsthemke, Bernhard; Lohmann, Dietmar			The Origin of the RB1 Imprint	PLOS ONE			English	Article							MONOALLELIC EXPRESSION; GENE; METHYLATION; PROTEIN; MOUSE; TRANSCRIPTION; MECHANISMS	The human RB1 gene is imprinted due to a differentially methylated CpG island in intron 2. This CpG island is part of PPP1R26P1, a truncated retrocopy of PPP1R26, and serves as a promoter for an alternative RB1 transcript. We show here by in silico analyses that the parental PPP1R26 gene is present in the analysed members of Haplorrhini, which comprise Catarrhini (Old World Monkeys, Small apes, Great Apes and Human), Platyrrhini (New World Monkeys) and tarsier, and Strepsirrhini (galago). Interestingly, we detected the retrocopy, PPP1R26P1, in all Anthropoidea (Catarrhini and Platyrrhini) that we studied but not in tarsier or galago. Additional retrocopies are present in human and chimpanzee on chromosome 22, but their distinct composition indicates that they are the result of independent retrotransposition events. Chimpanzee and marmoset have further retrocopies on chromosome 8 and chromosome 4, respectively. To examine the origin of the RB1 imprint, we compared the methylation patterns of the parental PPP1R26 gene and its retrocopies in different primates (human, chimpanzee, orangutan, rhesus macaque, marmoset and galago). Methylation analysis by deep bisulfite sequencing showed that PPP1R26 is methylated whereas the retrocopy in RB1 intron 2 is differentially methylated in all primates studied. All other retrocopies are fully methylated, except for the additional retrocopy on marmoset chromosome 4, which is also differentially methylated. Using an informative SNP for the methylation analysis in marmoset, we could show that the differential methylation pattern of the retrocopy on chromosome 4 is allele-specific. We conclude that the epigenetic fate of a PPP1R26 retrocopy after integration depends on the DNA sequence and selective forces at the integration site.	[Kanber, Deniz; Buiting, Karin; Kaya, Sabine; Horsthemke, Bernhard; Lohmann, Dietmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Roos, Christian] Leibniz Inst Primatenforschung, Deutsch Primatenzentrum, Gene Bank Primates, Gottingen, Germany; [Roos, Christian] Leibniz Inst Primatenforschung, Deutsch Primatenzentrum, Abt Primatengenet, Gottingen, Germany; [Gromoll, Joerg] Univ Klinikum Munster, Ctr Reprod Med & Androl, Munster, Germany	University of Duisburg Essen; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); University of Munster	Kanber, D (corresponding author), Univ Klinikum Essen, Inst Humangenet, Essen, Germany.	deniz.kanber@uni-due.de	Lohmann, Dietmar R./X-4895-2019; Lohmann, Dietmar R/B-4041-2013; Gromoll, Joerg/AAB-2146-2019	Lohmann, Dietmar R./0000-0002-2624-9889; Lohmann, Dietmar R/0000-0002-2624-9889; Gromoll, Joerg/0000-0002-7788-8138	Deutsche Forschungsgemeinschaft (DFG) [LO 530/7-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG, LO 530/7-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Betran E, 2002, MOL BIOL EVOL, V19, P654, DOI 10.1093/oxfordjournals.molbev.a004124; Beygo J, 2013, HUM MOL GENET, V22, P544, DOI 10.1093/hmg/dds465; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cowley M, 2012, NUCLEIC ACIDS RES, V40, P8917, DOI 10.1093/nar/gks654; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; HELLMANNBLUMBERG U, 1993, MOL CELL BIOL, V13, P4523, DOI 10.1128/MCB.13.8.4523; Ichiyanagi K, 2013, GENES GENET SYST, V88, P19, DOI 10.1266/ggs.88.19; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Korneev SA, 1999, J NEUROSCI, V19, P7711; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wood AJ, 2008, GENE DEV, V22, P1141, DOI 10.1101/gad.473408; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81502	10.1371/journal.pone.0081502	http://dx.doi.org/10.1371/journal.pone.0081502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282601	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500104
J	Marino, IP; Ullner, E; Zaikin, A				Marino, Ines P.; Ullner, Ekkehard; Zaikin, Alexey			Parameter Estimation Methods for Chaotic Intercellular Networks	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; ESTIMATING MODEL PARAMETERS; SEQUENTIAL MONTE-CARLO; DIFFERENTIAL-EQUATIONS; SYNCHRONIZATION; SYSTEMS	We have investigated simulation-based techniques for parameter estimation in chaotic intercellular networks. The proposed methodology combines a synchronization-based framework for parameter estimation in coupled chaotic systems with some state-of-the-art computational inference methods borrowed from the field of computational statistics. The first method is a stochastic optimization algorithm, known as accelerated random search method, and the other two techniques are based on approximate Bayesian computation. The latter is a general methodology for non-parametric inference that can be applied to practically any system of interest. The first method based on approximate Bayesian computation is a Markov Chain Monte Carlo scheme that generates a series of random parameter realizations for which a low synchronization error is guaranteed. We show that accurate parameter estimates can be obtained by averaging over these realizations. The second ABC-based technique is a Sequential Monte Carlo scheme. The algorithm generates a sequence of "populations", i.e., sets of randomly generated parameter values, where the members of a certain population attain a synchronization error that is lesser than the error attained by members of the previous population. Again, we show that accurate estimates can be obtained by averaging over the parameter values in the last population of the sequence. We have analysed how effective these methods are from a computational perspective. For the numerical simulations we have considered a network that consists of two modified repressilators with identical parameters, coupled by the fast diffusion of the autoinducer across the cell membranes.	[Marino, Ines P.] Univ Rey Juan Carlos, Dept Fis, Madrid, Spain; [Ullner, Ekkehard] Univ Aberdeen, Dept Phys, Inst Complex Syst & Math Biol, Aberdeen, Scotland; [Ullner, Ekkehard] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Zaikin, Alexey] UCL, Inst Women Hlth, London, England; [Zaikin, Alexey] UCL, Dept Math, London, England; [Zaikin, Alexey] King Abdulaziz Univ, Dept Math, Jeddah 21413, Saudi Arabia	Universidad Rey Juan Carlos; University of Aberdeen; University of Aberdeen; University of London; University College London; University of London; University College London; King Abdulaziz University	Marino, IP (corresponding author), Univ Rey Juan Carlos, Dept Fis, Madrid, Spain.	ines.perez@urjc.es	Zaikin, Alexey/T-7171-2019; Zaikin, Alexey/K-6581-2017; Mariño, Ines P./L-2318-2017	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Mariño, Ines P./0000-0003-0152-0174	Spanish Ministry of Economy and Competitiveness [FIS2009-09898]; Universidad Rey Juan Carlos ("Ayudas a la Movilidad", PPFDI); Scottish Universities Life Sciences Alliance (SULSA); CR-UK; Eve Appeal funded project [PROMISE-2016]; King Abdulaziz University, Jeddah [20/34/Gr]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Universidad Rey Juan Carlos ("Ayudas a la Movilidad", PPFDI); Scottish Universities Life Sciences Alliance (SULSA); CR-UK(Cancer Research UK); Eve Appeal funded project; King Abdulaziz University, Jeddah	The work of IPM has been partially supported by the Spanish Ministry of Economy and Competitiveness (Project No. FIS2009-09898) and Universidad Rey Juan Carlos ("Ayudas a la Movilidad", PPFDI). EU's work is supported by the Scottish Universities Life Sciences Alliance (SULSA). AZ acknowledges support from the CR-UK and Eve Appeal funded project PROMISE-2016 and from the Deanship of Scientific Research, King Abdulaziz University, Jeddah, grant No. (20/34/Gr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2009, SIAM J APPL DYN SYST, V8, P1341, DOI 10.1137/090749761; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Appel MJ, 2004, SIAM J OPTIMIZ, V14, P708, DOI 10.1137/S105262340240063X; BAAKE E, 1992, PHYS REV A, V45, P5524, DOI 10.1103/PhysRevA.45.5524; Balazsi G, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041912; Beaumont MA, 2002, GENETICS, V162, P2025; Brunel N, 2000, J PHYSIOLOGY-PARIS, V94, P445, DOI 10.1016/S0928-4257(00)01084-6; d'Anjou A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046213; Del Moral P, 2006, J R STAT SOC B, V68, P411, DOI 10.1111/j.1467-9868.2006.00553.x; Del Moral P, 2012, STAT COMPUT, V22, P1009, DOI 10.1007/s11222-011-9271-y; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Freitas US, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.047203; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Ghosh A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056222; Ghosh D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.056211; Glass L., 1988, CLOCKS CHAOS RHYTHMS; HAN SK, 1995, PHYS REV LETT, V75, P3190, DOI 10.1103/PhysRevLett.75.3190; Hatz K, 2012, SIAM J SCI COMPUT, V34, pA1707, DOI 10.1137/110823390; Huang DB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.067201; Konnur R, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.027204; Koseska A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031916; Koseska A, 2010, J THEOR BIOL, V263, P189, DOI 10.1016/j.jtbi.2009.11.007; Laje R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288102; Marino IP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.057203; Marino IP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056218; Marino IP, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.057202; Marino IP, 2006, PHYS LETT A, V351, P262, DOI 10.1016/j.physleta.2005.11.005; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Maybhate A, 1999, PHYS REV E, V59, P284, DOI 10.1103/PhysRevE.59.284; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Meinhardt H., 1982, MODELS BIOL PATTERN; Parlitz U, 1996, PHYS REV LETT, V76, P1232, DOI 10.1103/PhysRevLett.76.1232; Parlitz U, 1996, PHYS REV E, V54, P6253, DOI 10.1103/PhysRevE.54.6253; Petridis V, 1998, IEEE T NEURAL NETWOR, V9, P862, DOI 10.1109/72.712158; Pisarenko VF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036122; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Sakaguchi H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.027201; Schumann-Bischoff J, 2013, COMMUN NONLINEAR SCI, V18, P2733, DOI 10.1016/j.cnsns.2013.02.017; Singer H, 2002, J COMPUT GRAPH STAT, V11, P972, DOI 10.1198/106186002808; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sitz A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016210; SOMPOLINSKY H, 1988, PHYS REV LETT, V61, P259, DOI 10.1103/PhysRevLett.61.259; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tao C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016209; Timmer J, 2000, CHAOS SOLITON FRACT, V11, P2571, DOI 10.1016/S0960-0779(00)00015-1; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Ullner E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148103; Ullner E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031904; van Leeuwen PJ, 2010, Q J ROY METEOR SOC, V136, P1991, DOI 10.1002/qj.699; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; VOLKOV EI, 1991, PHYS LETT A, V159, P61, DOI 10.1016/0375-9601(91)90162-2; Yang XL, 2007, PHYS LETT A, V364, P378, DOI 10.1016/j.physleta.2006.08.093; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Yu DC, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066221; Zhou CS, 1999, PHYS REV E, V59, P6629, DOI 10.1103/PhysRevE.59.6629	55	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79892	10.1371/journal.pone.0079892	http://dx.doi.org/10.1371/journal.pone.0079892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282513	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500014
J	Mathe, C; Devineau, S; Aude, JC; Lagniel, G; Chedin, S; Legros, V; Mathon, MH; Renault, JP; Pin, S; Boulard, Y; Labarre, J				Mathe, Christelle; Devineau, Stephanie; Aude, Jean-Christophe; Lagniel, Gilles; Chedin, Stephane; Legros, Veronique; Mathon, Marie-Helene; Renault, Jean-Philippe; Pin, Serge; Boulard, Yves; Labarre, Jean			Structural Determinants for Protein adsorption/non-adsorption to Silica Surface	PLOS ONE			English	Article							AROMATIC-AROMATIC INTERACTION; MOLECULAR-DYNAMICS; AMINO-ACIDS; THERMAL-STABILITY; HYDROPHOBIC CORE; YEAST PROTEINS; IDENTIFICATION; NANOPARTICLES; MECHANISM; DISCOVERY	The understanding of the mechanisms involved in the interaction of proteins with inorganic surfaces is of major interest in both fundamental research and applications such as nanotechnology. However, despite intense research, the mechanisms and the structural determinants of protein/surface interactions are still unclear. We developed a strategy consisting in identifying, in a mixture of hundreds of soluble proteins, those proteins that are adsorbed on the surface and those that are not. If the two protein subsets are large enough, their statistical comparative analysis must reveal the physicochemical determinants relevant for adsorption versus non-adsorption. This methodology was tested with silica nanoparticles. We found that the adsorbed proteins contain a higher number of charged amino acids, particularly arginine, which is consistent with involvement of this basic amino acid in electrostatic interactions with silica. The analysis also identified a marked bias toward low aromatic amino acid content (phenylalanine, tryptophan, tyrosine and histidine) in adsorbed proteins. Structural analyses and molecular dynamics simulations of proteins from the two groups indicate that non-adsorbed proteins have twice as many pi-pi interactions and higher structural rigidity. The data are consistent with the notion that adsorption is correlated with the flexibility of the protein and with its ability to spread on the surface. Our findings led us to propose a refined model of protein adsorption.	[Mathe, Christelle; Devineau, Stephanie; Renault, Jean-Philippe; Pin, Serge] IRAMIS, SIS2M, Lab Radiolyse, Saclay, France; [Mathe, Christelle; Devineau, Stephanie; Renault, Jean-Philippe; Pin, Serge] CNRS, CEA, UMR3299, Saclay, France; [Mathe, Christelle; Aude, Jean-Christophe; Lagniel, Gilles; Chedin, Stephane; Boulard, Yves; Labarre, Jean] Univ Paris 11, Serv Biol Integrat & Genet Mol, CNRS, IBiTec S,CEA,FRE3377, Saclay, France; [Mathe, Christelle; Legros, Veronique] Univ Evry Val dEssonne, CNRS, UMR 8587, Lab Analyse & Modelisat Biol & Environm, Evry, France; [Mathon, Marie-Helene] IRAMIS, Lab Leon Brillouin, Saclay, France; [Mathon, Marie-Helene] CNRS, CEA, UMR12, Saclay, France; [Boulard, Yves] IRAMIS, SIS2M, Lab Struct & Dynam Resonance Magnet, Saclay, France; [Boulard, Yves] CNRS, CEA, UMR3299, Saclay, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS)	Labarre, J (corresponding author), Univ Paris 11, Serv Biol Integrat & Genet Mol, CNRS, IBiTec S,CEA,FRE3377, Saclay, France.	jean.labarre@cea.fr	Devineau, Stéphanie/I-7842-2016	Devineau, Stéphanie/0000-0002-1133-5223; Renault, Jean-Philippe/0000-0003-2555-5857; AUDE, Jean-Christophe/0000-0002-1755-7417	"programme de Toxicologie" of the CEA; "programme NanoSciences Ile-de-France"	"programme de Toxicologie" of the CEA; "programme NanoSciences Ile-de-France"	The authors acknowledge support from the "programme de Toxicologie" of the CEA and from the "programme NanoSciences Ile-de-France". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; ANDERSON DE, 1993, PROTEIN SCI, V2, P1285, DOI 10.1002/pro.5560020811; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andrade J. D., 1986, PROTEIN ADSORPTION M; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Baudouin-Cornu P, 2009, PROTEOMICS, V9, P4606, DOI 10.1002/pmic.200800975; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BORDERS CL, 1994, PROTEIN SCI, V3, P541; Boucherie H, 1996, ELECTROPHORESIS, V17, P1683, DOI 10.1002/elps.1150171106; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brocchieri L, 1995, P NATL ACAD SCI USA, V92, P12136, DOI 10.1073/pnas.92.26.12136; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001; Foote M, 2007, BIOTECHNOL ANN REV, V13, P345, DOI 10.1016/S1387-2656(07)13012-X; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gao Q, 2008, J PHYS CHEM B, V112, P2261, DOI 10.1021/jp0763580; Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033; Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292; HECHT MH, 1984, P NATL ACAD SCI-BIOL, V81, P5685, DOI 10.1073/pnas.81.18.5685; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020925; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Ikeda T, 2011, COLLOID SURFACE B, V86, P359, DOI 10.1016/j.colsurfb.2011.04.020; Janson JC, 1989, PROTEIN PURIFICATION, P35; Jarque CM, 1980, ECON LETT, V5, P177; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KARLIN S, 1994, J MOL BIOL, V239, P227, DOI 10.1006/jmbi.1994.1365; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Kubiak K, 2009, J PHYS CHEM B, V113, P12189, DOI 10.1021/jp901521x; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lanzarotti E, 2011, J CHEM INF MODEL, V51, P1623, DOI 10.1021/ci200062e; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263; Mathon MH, 1999, J PHYS 4, V09; McNaught A. D., 1997, COMPENDIUM CHEM TERM, P1; MORTIMER RK, 1986, GENETICS, V113, P35; Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Noguchi K., 2009, LAWSTAT R PACKAGE BI; NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W; NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I; Norde W, 2008, COLLOID SURFACE B, V61, P1, DOI 10.1016/j.colsurfb.2007.09.029; Orts-Gil G, 2011, J NANOPART RES, V13, P1593, DOI 10.1007/s11051-010-9910-9; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Palaniyar N, 1999, AM J PHYSIOL-LUNG C, V276, pL631, DOI 10.1152/ajplung.1999.276.4.L631; Patwardhan SV, 2012, J AM CHEM SOC, V134, P6244, DOI 10.1021/ja211307u; Peng Q, 2013, BIOMATERIALS, V34, P8521, DOI 10.1016/j.biomaterials.2013.07.102; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862; Shemetov AA, 2012, ACS NANO, V6, P4585, DOI 10.1021/nn300415x; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Vlasova NN, 2004, COLLOID J+, V66, P657, DOI 10.1007/s10595-005-0042-3; Vondrasek J, 2005, J AM CHEM SOC, V127, P2615, DOI 10.1021/ja044607h; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012; Willett RL, 2005, P NATL ACAD SCI USA, V102, P7817, DOI 10.1073/pnas.0408565102	70	81	87	5	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81346	10.1371/journal.pone.0081346	http://dx.doi.org/10.1371/journal.pone.0081346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282583	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500085
J	Abe, K; Zhao, LL; Periasamy, A; Intes, X; Barroso, M				Abe, Ken; Zhao, Lingling; Periasamy, Ammasi; Intes, Xavier; Barroso, Margarida			Non-Invasive In Vivo Imaging of Near Infrared-labeled Transferrin in Breast Cancer Cells and Tumors Using Fluorescence Lifetime FRET	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-PROTEIN INTERACTIONS; DRUG-DELIVERY; TISSUE DISTRIBUTION; RECEPTOR COMPLEXES; ONE-PHOTON; MICROSCOPY; PERMEABILITY; BRAIN; PET	The conjugation of anti-cancer drugs to endogenous ligands has proven to be an effective strategy to enhance their pharmacological selectivity and delivery towards neoplasic tissues. Since cell proliferation has a strong requirement for iron, cancer cells express high levels of transferrin receptors (TfnR), making its ligand, transferrin (Tfn), of great interest as a delivery agent for therapeutics. However, a critical gap exists in the ability to non-invasively determine whether drugs conjugated to Tfn are internalized into target cells in vivo. Due to the enhanced permeability and retention (EPR) effect, it remains unknown whether these Tfn-conjugated drugs are specifically internalized into cancer cells or are localized nonspecifically as a result of a generalized accumulation of macromolecules near tumors. By exploiting the dimeric nature of the TfnR that binds two molecules of Tfn in close proximity, we utilized a Forster Resonance Energy Transfer (FRET) based technique that can discriminate bound and internalized Tfn from free, soluble Tfn. In order to non-invasively visualize intracellular amounts of Tfn in tumors through live animal tissues, we developed a novel near infrared (NIR) fluorescence lifetime FRET imaging technique that uses an active wide-field time gated illumination platform. In summary, we report that the NIR fluorescence lifetime FRET technique is capable of non-invasively detecting bound and internalized forms of Tfn in cancer cells and tumors within a live small animal model, and that our results are quantitatively consistent when compared to well-established intensity-based FRET microscopy methods used in in vitro experiments.	[Abe, Ken; Barroso, Margarida] Albany Med Coll, Ctr Cardiovasc sci, Albany, NY 12208 USA; [Zhao, Lingling; Intes, Xavier] Jonsson Engn Ctr Troy, Rensselaer Polytech Inst, Dept Biomed Engn, New York, NY USA; [Periasamy, Ammasi] Univ Virginia, WM Keck Ctr Cellular Imaging, Charlottesville, VA USA	Albany Medical College; Rensselaer Polytechnic Institute; University of Virginia	Barroso, M (corresponding author), Albany Med Coll, Ctr Cardiovasc sci, Albany, NY 12208 USA.	barrosm@mail.amc.edu		Barroso, Margarida/0000-0002-0407-3181	National Institutes of Health [R21 CA161782-01, R21 EB013421]; National Science Foundation CAREER AWARD [CBET-1149407]; NATIONAL CANCER INSTITUTE [R21CA161782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB013421] Funding Source: NIH RePORTER; Directorate For Engineering [1149407] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER AWARD(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Institutes of Health Grant, R21 CA161782-01, R21 EB013421 and National Science Foundation CAREER AWARD CBET-1149407. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloj L, 1999, J NUCL MED, V40, P1547; Barbet Jacques, 2012, Methods Mol Biol, V907, P681, DOI 10.1007/978-1-61779-974-7_38; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Dijkers ECF, 2008, CURR PHARM DESIGN, V14, P3348, DOI 10.2174/138161208786549425; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Evans MJ, 2013, J NUCL MED, V54, P90, DOI 10.2967/jnumed.112.109777; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Holland JP, 2012, NAT MED, V18, P1586, DOI 10.1038/nm.2935; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee HJ, 2000, J DRUG TARGET, V8, P413, DOI 10.3109/10611860008997917; Luck AN, 2013, ADV DRUG DELIVER REV, V65, P1012, DOI 10.1016/j.addr.2012.11.001; Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1907, DOI 10.1364/BOE.2.001907; McGrath N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939417; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; PROST AC, 1990, NUCL MED BIOL, V17, P209; Renz M, 2012, P NATL ACAD SCI USA, V109, pE2989, DOI 10.1073/pnas.1211753109; SKARLATOS S, 1995, BRAIN RES, V683, P164, DOI 10.1016/0006-8993(95)00363-U; Smith TAD, 2004, NUCL MED COMMUN, V25, P387, DOI 10.1097/00006231-200404000-00012; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Sun YS, 2011, CHEMPHYSCHEM, V12, P462, DOI 10.1002/cphc.201000664; Talati R, 2014, METHODS, V66, P139, DOI 10.1016/j.ymeth.2013.08.017; Talekar M, 2011, ANTI-CANCER DRUG, V22, P949, DOI 10.1097/CAD.0b013e32834a4554; van Dongen GAMS, 2012, TUMOR BIOL, V33, P607, DOI 10.1007/s13277-012-0316-4; Vavere AL, 2005, J NUCL MED, V46, P683; Venugopal V, 2012, BIOMED OPT EXPRESS, V3; Venugopal V, 2010, BIOMED OPT EXPRESS, V1, P143, DOI 10.1364/BOE.1.000143; Venugopal V, 2010, OPT LETT, V35, P3189, DOI 10.1364/OL.35.003189; Wallrabe H, 2007, MOL BIOL CELL, V18, P2226, DOI 10.1091/mbc.E06-08-0700; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281; Wallrabe H, 2003, J BIOMED OPT, V8, P339, DOI 10.1117/1.1584444; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Wang LS, 2012, INT J NANOMED, V7, P4679, DOI 10.2147/IJN.S33065; Williams SP, 2012, AAPS J, V14, P389, DOI 10.1208/s12248-012-9348-3; Xiong LQ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2197; Yoon DJ, 2011, ANN BIOMED ENG, V39, P1235, DOI 10.1007/s10439-011-0280-y; Zacharias David A, 2002, Sci STKE, V2002, ppe23, DOI 10.1126/stke.2002.131.pe23; Zhang Y, 2011, CURR RADIOPHARM, V4, P131, DOI 10.2174/1874471011104020131; ZIMET DB, 1995, BIOPHYS J, V68, P1592, DOI 10.1016/S0006-3495(95)80332-2	48	62	62	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80269	10.1371/journal.pone.0080269	http://dx.doi.org/10.1371/journal.pone.0080269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278268	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800069
J	Azuma, K; Uchiyama, I; Takano, H; Tanigawa, M; Azuma, M; Bamba, I; Yoshikawa, T				Azuma, Kenichi; Uchiyama, Iwao; Takano, Hirohisa; Tanigawa, Mari; Azuma, Michiyo; Bamba, Ikuko; Yoshikawa, Toshikazu			Changes in Cerebral Blood Flow during Olfactory Stimulation in Patients with Multiple Chemical Sensitivity: A Multi-Channel Near-Infrared Spectroscopic Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; NEURAL SENSITIZATION; IDENTIFICATION TEST; BRAIN ACTIVATION; CASE DEFINITION; AGE DEPENDENCY; SCALE; MCS; INTOLERANCES; HEMOGLOBIN	Multiple chemical sensitivity (MCS) is characterized by somatic distress upon exposure to odors. Patients with MCS process odors differently from controls. This odor-processing may be associated with activation in the prefrontal area connecting to the anterior cingulate cortex, which has been suggested as an area of odorant-related activation in MCS patients. In this study, activation was defined as a significant increase in regional cerebral blood flow (rCBF) because of odorant stimulation. Using the well-designed card-type olfactory test kit, changes in rCBF in the prefrontal cortex (PFC) were investigated after olfactory stimulation with several different odorants. Near-infrared spectroscopic (NIRS) imaging was performed in 12 MCS patients and 11 controls. The olfactory stimulation test was continuously repeated 10 times. The study also included subjective assessment of physical and psychological status and the perception of irritating and hedonic odors. Significant changes in rCBF were observed in the PFC of MCS patients on both the right and left sides, as distinct from the center of the PFC, compared with controls. MCS patients adequately distinguished the non-odorant in 10 odor repetitions during the early stage of the olfactory stimulation test, but not in the late stage. In comparison to controls, autonomic perception and negative affectivity were poorer in MCS patients. These results suggest that prefrontal information processing associated with odor-processing neuronal circuits and memory and cognition processes from past experience of chemical exposure play significant roles in the pathology of this disorder.	[Azuma, Kenichi; Bamba, Ikuko] Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Basic Res Div, Sick House Med Sci Lab, Kyoto, Japan; [Uchiyama, Iwao] Outpatient Dept Sick House Syndrome, Hyakumanben Clin, Kyoto, Japan; [Takano, Hirohisa] Kyoto Univ, Grad Sch Engn, Dept Environm Engn, Div Environm Hlth, Kyoto, Japan; [Tanigawa, Mari] Louis Pasteur Ctr Med Res, Basic Res Div, Clin Immune Funct Lab, Kyoto, Japan; [Tanigawa, Mari] Div Internal Med, Hyakumanben Clin, Kyoto, Japan; [Azuma, Michiyo] Kio Univ, Fac Hlth Sci, Dept Human Environm Design, Nara, Japan; [Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Kyoto, Japan	Kindai University (Kinki University); Kyoto University; Kyoto Prefectural University of Medicine	Azuma, K (corresponding author), Kinki Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan.	kenazuma@med.kindai.ac.jp		Azuma, Kenichi/0000-0002-6382-9807	Japan Ministry of Education, Culture, Sports, Science and Technology [ID: 22590568]	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by a Grant-in-Aid for Scientific Research (ID: 22590568) provided by the Japan Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.jsps.go.jp/english/e-grants/index.html	[Anonymous], 1999, ARCH ENV HLTH, V54, P147; BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007; BELL IR, 1992, BIOL PSYCHIAT, V32, P218, DOI 10.1016/0006-3223(92)90105-9; Bell IR, 1997, ENVIRON HEALTH PERSP, V105, P457, DOI 10.2307/3433353; BENDIG AW, 1956, J CONSULT PSYCHOL, V20, P384, DOI 10.1037/h0045580; Berg ND, 2009, INT ARCH OCC ENV HEA, V82, P509, DOI 10.1007/s00420-008-0352-y; Bornschein S, 2002, PSYCHOL MED, V32, P1387, DOI 10.1017/S0033291702006554; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cardinal RN, 2003, INT CONGR SER, V1250, P347, DOI 10.1016/S0531-5131(03)01013-6; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; CULLEN MR, 1987, OCCUP MED, V2, P655; DOTY RL, 1988, ARCH OTOLARYNGOL, V114, P1422; Eis D, 2008, INT J HYG ENVIR HEAL, V211, P658, DOI 10.1016/j.ijheh.2008.03.002; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Graveling RA, 1999, OCCUP ENVIRON MED, V56, P73, DOI 10.1136/oem.56.2.73; Hausteiner C, 2007, TOXICOL LETT, V171, P1, DOI 10.1016/j.toxlet.2007.04.010; Hillert L, 2007, HUM BRAIN MAPP, V28, P172, DOI 10.1002/hbm.20266; Hillert L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054781; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; Hojo S, 2008, INT J HYG ENVIR HEAL, V211, P682, DOI 10.1016/j.ijheh.2007.09.007; Hojo Sachiko, 2009, Environmental Health and Preventive Medicine, V14, P267, DOI 10.1007/s12199-009-0095-8; Horaguchi T, 2008, NEUROSCI RES, V61, P294, DOI 10.1016/j.neures.2008.03.011; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kan, 2010, KITASATO MED J, V40, P27; Kobayakawa T, 2008, CHEM SENSES, V33, pS108; Lacour M, 2005, INT J HYG ENVIR HEAL, V208, P141, DOI 10.1016/j.ijheh.2005.01.017; Lavergne MR, 2010, CAN FAM PHYSICIAN, V56, pE57; Lewls MD, 2005, BEHAV BRAIN SCI, V28, P169; Lu J., 2009, INT J PSYCHOL STUDIE, V1, P35; MANDLER G, 1958, J ABNORM SOC PSYCH, V56, P367, DOI 10.1037/h0048083; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; McKeown-Eyssen GE, 2001, ARCH ENVIRON HEALTH, V56, P406, DOI 10.1080/00039890109604475; MEGGS WJ, 1995, ENVIRON HEALTH PERSP, V103, P54, DOI 10.2307/3432256; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Miller CS, 1997, ENVIRON HEALTH PERSP, V105, P445, DOI 10.2307/3433351; Miwa T, 2008, CHEM SENSES, V33, pS108; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; NETHERCOTT JR, 1993, ARCH ENVIRON HEALTH, V48, P19, DOI 10.1080/00039896.1993.9938389; Nordin S, 2004, INT ARCH OCC ENV HEA, V77, P249, DOI 10.1007/s00420-004-0504-7; Okamoto M, 2006, NEUROIMAGE, V31, P796, DOI 10.1016/j.neuroimage.2005.12.021; Orriols R, 2009, J NEUROL SCI, V287, P72, DOI 10.1016/j.jns.2009.09.003; Park Jungwee, 2007, Health Rep, V18, P43; RANDOLPH TG, 1965, ANN ALLERGY, V23, P7; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Siddiqui Shazia Veqar, 2008, Indian J Psychiatry, V50, P202, DOI 10.4103/0019-5545.43634; Sorg BA, 1999, CRIT REV NEUROBIOL, V13, P283, DOI 10.1615/CritRevNeurobiol.v13.i3.30; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tanida M, 2004, NEUROSCI LETT, V369, P69, DOI 10.1016/j.neulet.2004.07.076; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Winder C, 2002, TOXICOL LETT, V128, P85, DOI 10.1016/S0378-4274(01)00536-7	54	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80567	10.1371/journal.pone.0080567	http://dx.doi.org/10.1371/journal.pone.0080567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278291	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800075
J	Clark-Knowles, KV; Dewar-Darch, D; Jardine, KE; McBurney, MW				Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.			SIRT1 Catalytic Activity Has Little Effect on Tumor Formation and Metastases in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							CALORIC RESTRICTION; NEGATIVE REGULATION; CELL-SURVIVAL; MAMMARY-GLAND; DEACETYLASE; SUPPRESSES; EXPRESSION; TUMORIGENESIS; GROWTH; PROGRESSION	The protein deacetylase SIRT1 has been implicated in the regulation of a large number of cellular processes that are thought to be required for cancer initiation and progression. There are conflicting data that make it unclear whether Sirt1 functions as an oncogene or tumor suppressor. To assess the effect of SIRT1 on the emergence and progression of mammary tumors, we crossed mice that harbor a point mutation that abolishes SIRT1 catalytic activity with mice carrying the polyoma middle T transgene driven by the murine mammary tumor virus promoter (MMTV-PyMT). The absence of SIRT1 catalytic activity neither accelerated nor blocked the formation of tumors and metastases in this model. There was a lag in tumor latency that modestly extended survival in Sirt1 mutant mice that we attribute to a delay in mammary gland development and not to a direct effect of SIRT1 on carcinogenesis. These results are consistent with previous evidence suggesting that Sirt1 is not a tumor promoter or a tumor suppressor.	[Clark-Knowles, Katherine V.; Dewar-Darch, Danielle; Jardine, Karen E.; McBurney, Michael W.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [McBurney, Michael W.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Clark-Knowles, KV (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	kaclark@ohri.ca			Canadian Institute of Health Research [74511]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the Canadian Institute of Health Research (www.cihr.ca grant # 74511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2012, AM J HUM BIOL, V24, P101, DOI 10.1002/ajhb.22243; Beane J, 2012, CANCER RES, V72, P5702, DOI 10.1158/0008-5472.CAN-12-1043; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dabrosin C, 2003, BREAST CANCER RES TR, V78, P1, DOI 10.1023/A:1022133219353; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HERRANZ D, 2013, ONCOGENE, P86535; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jang SH, 2012, J CLIN PATHOL, V65, P735, DOI 10.1136/jclinpath-2012-200685; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lee JS, 2010, EXP DERMATOL, V19, P1060, DOI 10.1111/j.1600-0625.2010.01129.x; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2009, EXP GERONTOL, V44, P70, DOI 10.1016/j.exger.2008.06.005; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MCBURNEY MW, 2013, GENES CANC, P20004; MOORE R, 2012, J ENDOCRINOL; MORRIS BJ, 2013, FREE RADIC BIOL MED, P4101; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sharma A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00040; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Tang BL, 2010, CELL ADHES MIGR, V4, P163, DOI 10.4161/cam.4.2.10972; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e82106	10.1371/journal.pone.0082106	http://dx.doi.org/10.1371/journal.pone.0082106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278473	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800146
J	Hecksteden, A; Grutters, T; Meyer, T				Hecksteden, Anne; Gruetters, Teresa; Meyer, Tim			Associations between Acute and Chronic Effects of Exercise on Indicators of Metabolic Health: A Pilot Training Trial	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MUSCLE GLUCOSE-TRANSPORT; BLOOD-PRESSURE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; POSTEXERCISE HYPOTENSION; SENSITIVITY; MECHANISMS; HYPERTENSION; ADAPTATIONS	Background: The interindividual variability in the health-related efficacy of regular endurance training is high. This impedes on the individual optimization of preventive training prescriptions when optimal efficacy is intended. As a consequence, health-gains remain below what could be achieved. Practicable predictors of an individual's responsiveness to physical exercise would offer a solution to this problem. Therefore, the present study aims to test the association of acute changes in indicators of metabolic health after an exhaustive exercise test and the respective chronic changes in response to an endurance training program. Methods: Fasting blood samples of healthy, untrained, non-smoking subjects (n=12, age 49 +/- 7 years; body mass index 29 +/- 4; maximum oxygen uptake 34 +/- 7 ml.min(-1).kg(-1)) were collected before and 1 hour after an exhaustive exercise test as well as after a 4 week supervised training period (walking / running 4 times per week at 60 % heart rate reserve). Results: A close linear relationship between acute and chronic changes could be demonstrated for insulin concentration (p=0.001; r=0.83), the fasting indicator of insulin sensitivity HOMA-IR (p<0.001; r=0.78) and non-esterified fatty acid concentration (p=0.001; r=0.88). No association became apparent for standard blood lipid parameters. Conclusion: It is concluded that the magnitude of acute exercise-induced changes in indicators of insulin sensitivity and non-esterified fatty acid concentration is a promising candidate for the prediction of chronic training induced changes in the respective parameter. However, further studies are needed to assess predictive accuracy.	[Hecksteden, Anne; Gruetters, Teresa; Meyer, Tim] Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany	Saarland University	Hecksteden, A (corresponding author), Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany.	a.hecksteden@mx.uni-saarland.de			HOMFOR (Homburger Forschungsforderungsprogramm) program (Saarland University, Faculty of Medicine)	HOMFOR (Homburger Forschungsforderungsprogramm) program (Saarland University, Faculty of Medicine)	The study has been supported by the HOMFOR (Homburger Forschungsforderungsprogramm) program (Saarland University, Faculty of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Cornelissen VA, 2011, HYPERTENSION, V58, P950, DOI 10.1161/HYPERTENSIONAHA.111.177071; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010; Hecksteden A, 2013, CLIN J SPORT MED, V23, P58, DOI 10.1097/JSM.0b013e31825b6974; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; JENNINGS G, 1986, CIRCULATION, V73, P30, DOI 10.1161/01.CIR.73.1.30; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Liu S, 2012, MED SCI SPORT EXER, V44, P1644, DOI 10.1249/MSS.0b013e31825408fb; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meyer T, 2006, EUR J CARDIOV PREV R, V13, P578, DOI 10.1097/01.hjr.0000198921.34814.4d; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Pescatello LS, 2001, MED SCI SPORT EXER, V33, P1855, DOI 10.1097/00005768-200111000-00009; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; Scharhag-Rosenberger F, 2009, MED SCI SPORT EXER, V41, P1130, DOI 10.1249/MSS.0b013e3181935a11; Taylor CE, 2010, J HUM HYPERTENS, V24, P585, DOI 10.1038/jhh.2009.112; Timmons JA, 2011, J APPL PHYSIOL, V110, P846, DOI 10.1152/japplphysiol.00934.2010; TONINO RP, 1989, AM J PHYSIOL, V256, pE352, DOI 10.1152/ajpendo.1989.256.3.E352; Tsai JC, 2002, CLIN EXP HYPERTENS, V24, P315, DOI 10.1081/CEH-120004234; Wojtaszewski JFP, 2006, ESSAYS BIOCHEM, V42, P31, DOI 10.1042/bse0420031	26	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81181	10.1371/journal.pone.0081181	http://dx.doi.org/10.1371/journal.pone.0081181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278393	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800109
J	Jiang, W; Yu, HT; Zhao, K; Zhang, Y; Du, H; Wang, PZ; Bai, XF				Jiang, Wei; Yu, Hai-tao; Zhao, Ke; Zhang, Ye; Du, Hong; Wang, Ping-zhong; Bai, Xue-fan			Quantification of Hantaan Virus with a SYBR Green I-Based One-Step qRT-PCR Assay	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE CHAIN-REACTION; HEMORRHAGIC-FEVER; RENAL SYNDROME; PUUMALA-HANTAVIRUS; CHINA; RNA; EXPRESSION; DISEASE; RODENTS	Hantaan virus (HTNV) is a major zoonotic pathogen that causes hemorrhagic fever with renal syndrome (HFRS) in Asia, especially in China. Shaanxi province, which is located in northwest of China, is one of the areas in China most severely afflicted with HFRS epidemics annually. This study aims to establish a quantitative RT-PCR (qRT-PCR) assay to detect HTNV both in cell culture and clinical serum samples. We established a SYBR Green.-based one-step qRT-PCR assay that targets the S segment of the HTNV genome for rapid detection and quantification. The HTNV cRNA standards were constructed by in vitro transcription, and the copy numbers of the HTNV cRNA were quantified. Standard curve was generated by determining the mean cycle threshold (Ct) values versus 10-fold serial dilutions of the HTNV cRNA over a range of 1x10(8) to 1x10(3) copies/mu l. The standard curve had a reaction efficiency of 102.1%, a correlation coefficient (R-2) of 0.998, and a slope of -3.273. The coefficient of variation (CV) of the intra- and inter-assays ranged from 0.68% to 3.00% and from 0.86% to 3.21%, respectively. The cycle intervals of the qRT-PCR assay between each dilution ranged from 2.9 to 3.8 cycles, and the lowest detection limit of the qRT-PCR assay was 10 copies/mu l. The assay exhibited high specificity that was confirmed by melting curve analysis, and no cross reaction with the Seoul virus (SEOV) and other viruses (HBV, HCV and HIV) was observed. HTNV RNA was also detected in the 27 serum samples of clinical HFRS patients using the assay, and the HTNV RNA viral load ranged from 2.06x10(1) to 1.95x10(5) copies/mu l. The SYBR Green.-based one-step qRT-PCR assay is a sensitive, specific, reproducible, and simple method for detecting and quantifying HTNV in cell culture and clinical samples.	[Jiang, Wei; Yu, Hai-tao; Zhao, Ke; Zhang, Ye; Du, Hong; Wang, Ping-zhong; Bai, Xue-fan] Fourth Mil Med Univ, Tangdu Hosp, Ctr Infect Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Wang, PZ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Ctr Infect Dis, Xian 710032, Shaanxi, Peoples R China.	wangpz63@126.com; xfbai2011@163.com	Gaobo, Huang/AAP-9975-2020		National Natural Science Foundation of China [30872215, 81373118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant number: 30872215 and 81373118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitichou M, 2005, J VIROL METHODS, V124, P21, DOI 10.1016/j.jviromet.2004.10.004; Amer HM, 2011, MOL CELL PROBE, V25, P101, DOI 10.1016/j.mcp.2011.03.001; CHEN HX, 1993, CHINESE MED J-PEKING, V106, P857; Dash PK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-27; Evander M, 2007, J CLIN MICROBIOL, V45, P2491, DOI 10.1128/JCM.01902-06; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Garin D, 2001, MICROBES INFECT, V3, P739, DOI 10.1016/S1286-4579(01)01424-1; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Perez LJ, 2011, J VIROL METHODS, V174, P53, DOI 10.1016/j.jviromet.2011.03.022; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Ma CF, 2012, J GEN VIROL, V93, P2227, DOI 10.1099/vir.0.043364-0; Plyusnin A, 2002, ARCH VIROL, V147, P665, DOI 10.1007/s007050200017; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; Totzke G, 1996, MOL CELL PROBE, V10, P427, DOI 10.1006/mcpr.1996.0059; Wang H, 2000, VIROLOGY, V278, P332, DOI 10.1006/viro.2000.0630; Yi J, 2013, J INFECT DIS, V207, P1457, DOI 10.1093/infdis/jis475; Zhang FL, 2007, BIOCHEM BIOPH RES CO, V354, P858, DOI 10.1016/j.bbrc.2007.01.020; Zhang N, 2011, DISCRETE DYN NAT SOC, V2011, DOI 10.1155/2011/473949; Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470; Zhang YZ, 2009, EMERG INFECT DIS, V15, P885, DOI 10.3201/eid1506.081126; Zou Y, 2008, J MED VIROL, V80, P1033, DOI 10.1002/jmv.21149	22	7	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81525	10.1371/journal.pone.0081525	http://dx.doi.org/10.1371/journal.pone.0081525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278449	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800134
J	van Peet, PG; Drewes, YM; de Craen, AJM; Gussekloo, J; de Ruijter, W				van Peet, Petra G.; Drewes, Yvonne M.; de Craen, Anton J. M.; Gussekloo, Jacobijn; de Ruijter, Wouter			NT-proBNP Best Predictor of Cardiovascular Events and Cardiovascular Mortality in Secondary Prevention in Very Old Age: The Leiden 85-Plus Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BRAIN NATRIURETIC PEPTIDE; CORONARY-HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; MULTIPLE BIOMARKERS; VASCULAR EVENTS; ISCHEMIC-STROKE; OUTCOMES; COHORT	Background: In the aging population cardiovascular disease (CVD) is highly prevalent. Identification of very old persons at high risk of recurrent CVD is difficult, since traditional risk markers loose predictive value with age. Methods: In a population-based sample of 282 85-year old participants with established CVD from the Leiden 85-plus Study, we studied predictive values of traditional cardiovascular risk markers, a history of major CVD (myocardial infarction, stroke or arterial surgery), and new cardiovascular biomarkers (estimated glomerular filtration rate (MDRD), C-reactive protein (CRP), homocysteine and N-terminal pro B-type natriuretic peptide (NT-proBNP)) regarding 5-year risk of recurrent cardiovascular events and mortality (composite endpoint). Results: During complete 5-year follow-up 157 (56%) participants died. 109 (39%) had a cardiovascular event or died from cardiovascular causes. Individually related to the composite endpoint were: a history of major CVD (HR 1.5 (95% CI 1.03-2.3)), CRP (HR 1.3 (95% CI 1.03-1.5)), homocysteine (HR 1.4 (95% CI 1.2-2.6)) and NT-proBNP (HR 1.7 (95% CI 1.4-2.1)). A prediction model including all traditional risk markers yielded a C-statistic of 0.59 (95% CI 0.52-0.66). Of all five new markers only addition of NT-proBNP improved the C-statistic (0.67 (95% CI 0.61-0.74, p=0.023)). The categoryless net reclassification improvement for NT-proBNP was 39% (p=0.001), for a history of major CVD 27.2% (p=0.03) and for homocysteine 24.7% (p=0.04). Conclusions: Among very old subjects with established CVD, NT-proBNP was the strongest risk marker for cardiovascular events and cardiovascular mortality. When estimating risk in secondary prevention in very old age, use of NT-proBNP should be considered.	[van Peet, Petra G.; Drewes, Yvonne M.; Gussekloo, Jacobijn; de Ruijter, Wouter] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [de Craen, Anton J. M.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Peet, PG (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	P.G.van_Peet@lumc.nl	de Ruijter, Wouter/GRF-3867-2022; Gussekloo, Jacobijn/ABE-3879-2021	Gussekloo, Jacobijn/0000-0001-7186-8278; van Peet, Petra/0000-0002-7963-6575	Dutch Ministry of Health, Welfare and Sports	Dutch Ministry of Health, Welfare and Sports	The Leiden 85-plus Study was partly funded by an unrestricted grant from the Dutch Ministry of Health, Welfare and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alhusban A, 2011, AM J GERIATR PHARMAC, V9, P143, DOI 10.1016/j.amjopharm.2011.04.002; Anderson JL, 2000, CIRCULATION, V102, P1227, DOI 10.1161/01.CIR.102.11.1227; Arima H, 2006, STROKE, V37, P1497, DOI 10.1161/01.STR.0000221212.36860.c9; Asberg S, 2010, STROKE, V41, P1338, DOI 10.1161/STROKEAHA.110.580209; Battistoni A, 2012, INT J CARDIOL, V157, P160, DOI 10.1016/j.ijcard.2011.06.066; Bhatt DL, 2009, EUR HEART J, V30, P1195, DOI 10.1093/eurheartj/ehp099; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Bootsma-van der Wiel A, 2002, J CLIN EPIDEMIOL, V55, P1119, DOI 10.1016/S0895-4356(02)00505-X; de Ruijter W, 2010, BRIT J GEN PRACT, V60, P47, DOI 10.3399/bjgp10X482103; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Deedwania P, 2007, CIRCULATION, V115, P700, DOI 10.1161/CIRCULATIONAHA.106.654756; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Dorresteijn JAN, 2013, HEART, V99, P866, DOI 10.1136/heartjnl-2013-303640; Ford I, 2009, PLOS MED, V6, P76, DOI 10.1371/journal.pmed.1000016; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kerr AJ, 2009, HEART, V95, P125, DOI 10.1136/hrt.2007.140905; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Macchia A, 2012, EUR HEART J, V33, P515, DOI 10.1093/eurheartj/ehr410; Macfarlane PW, 1996, J ELECTROCARDIOL, V29, P29, DOI 10.1016/S0022-0736(96)80016-1; Manzano-Fernandez S, 2009, AM J CARDIOL, V103, P1753, DOI 10.1016/j.amjcard.2009.02.029; McDermott MM, 2007, JAMA-J AM MED ASSOC, V297, P1253, DOI 10.1001/jama.297.11.1253; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Naderi SH, 2012, AM J MED, V125, P882, DOI 10.1016/j.amjmed.2011.12.013; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pikula A, 2012, CIRCULATION, V125, P2100, DOI 10.1161/CIRCULATIONAHA.110.989145; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shlipak MG, 2008, AM J MED, V121, P50, DOI 10.1016/j.amjmed.2007.06.030; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Subherwal S, 2012, CIRCULATION, V126, P1345, DOI 10.1161/CIRCULATIONAHA.112.108787; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; Uthoff H, 2010, VASA, V39, P325, DOI 10.1024/0301-1526/a000057; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x; van Peet PG, 2013, AGE, V35, P1433, DOI 10.1007/s11357-012-9443-5; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zhang M, 2012, INT HEART J, V53, P85, DOI 10.1536/ihj.53.85; Zuckerman IH, 2012, J AM GERIATR SOC, V60, P1854, DOI 10.1111/j.1532-5415.2012.04165.x	49	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81400	10.1371/journal.pone.0081400	http://dx.doi.org/10.1371/journal.pone.0081400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278434	gold, Green Published			2022-12-27	WOS:000327539800129
J	Zhao, JZ; Miao, K; Wang, HR; Ding, H; Wang, DW				Zhao, Jinzhao; Miao, Kun; Wang, Haoran; Ding, Hu; Wang, Dao Wen			Association between Telomere Length and Type 2 Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; RISK	Background: Several epidemiological studies have examined the association between shortened telomere length and type 2 diabetes mellitus (T2DM), while the results remained conflicting. We conducted a meta-analysis to derive a more precise estimation of the relationship between them. Methods: We systematically reviewed the databases of PubMed, EMBASE, and Web of Science for all studies on the association between telomere length and T2DM. We conducted this study assessed by STATA 11.0. Data were summarized using random-effects or fixed-effects meta-analysis. The heterogeneity and publication bias among studies were examined by using chi(2)-based Q statistic test and Egger's test, respectively. Results: Nine cohorts consisting of 5759 cases and 6518 controls were selected into the meta-analysis. The results indicated that shortened telomere length was significantly associated with T2DM risk (OR: 1.291; 95% CI: 1.112, 1.498; P<0.001) with heterogeneity (I-2 = 71.6%). When three cohorts responsible for the heterogeneity were excluded, the pooled OR for the remaining cohorts indicated a significant association between shortened telomere length and T2DM (OR: 1.117; 95% CI: 1.002, 1.246; P = 0.045) without heterogeneity. Conclusion: We found a statistically significant association between shortened telomere length and T2DM.	[Zhao, Jinzhao; Miao, Kun; Wang, Haoran; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Hypertens, Wuhan 430074, Peoples R China; [Zhao, Jinzhao; Miao, Kun; Wang, Haoran; Ding, Hu; Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan 430074, Peoples R China; [Wang, Dao Wen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Genet Diag Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ding, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Hypertens, Wuhan 430074, Peoples R China.	dingo8369@163.com; dwwang@tjh.tjmu.edu.cn	Wang, Haoran/ABC-6993-2021	Wang, Haoran/0000-0002-5534-6610; Zhao, Jinzhao/0000-0003-0698-2220; ding, hu/0000-0002-1814-1552; Wang, Dao Wen/0000-0002-9774-3980	National "973" projects [2012CB518004]; "863" project [2012AA02A510]; Ministry of Education of China for Outstanding Young Teachers in University [20110142120012]; Key Project of Health Ministration	National "973" projects(National Basic Research Program of China); "863" project; Ministry of Education of China for Outstanding Young Teachers in University; Key Project of Health Ministration	This work was supported by grants from National "973" projects (Nos. 2012CB518004), "863" project (No. 2012AA02A510), Ministry of Education of China for Outstanding Young Teachers in University (20110142120012), and Key Project of Health Ministration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V282, P356, DOI 10.1006/bbrc.2001.4533; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding H, 2012, STROKE, V43, P658, DOI 10.1161/STROKEAHA.111.637207; Eckers A, 2012, Z GERONTOL GERIATR, V45, P90, DOI 10.1007/s00391-011-0277-z; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P228, DOI 10.1002/ajhb.21126; Hamel FG, 2010, TRANSL RES, V155, P164, DOI 10.1016/j.trsl.2009.12.004; Harte AL, 2012, EXP DIABETES RES, DOI 10.1155/2012/895185; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochstrasser T, 2012, EXP GERONTOL, V47, P160, DOI 10.1016/j.exger.2011.11.012; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Kanvah S, 2005, NUCLEIC ACIDS RES, V33, P5133, DOI 10.1093/nar/gki801; Maiese K, 2007, CURR NEUROVASC RES, V4, P63, DOI 10.2174/156720207779940653; Maubaret CG, 2010, J MOL MED, V88, P785, DOI 10.1007/s00109-010-0624-3; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Shen Q, 2012, J CLIN ENDOCR METAB, V97, P1371, DOI 10.1210/jc.2011-1562; Testa R, 2011, DIABETIC MED, V28, P1388, DOI 10.1111/j.1464-5491.2011.03370.x; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCH SCI; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; WOLFF SP, 1991, FREE RADICAL BIO MED, V10, P339, DOI 10.1016/0891-5849(91)90040-A; Xiao F, 2011, DIABETES CARE, V34, P2273, DOI 10.2337/dc10-2431; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250; You NC, 2012, DIABETES; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012; Zhang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047029	32	138	143	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79993	10.1371/journal.pone.0079993	http://dx.doi.org/10.1371/journal.pone.0079993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278229	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800043
J	Bautista-Castano, I; Henriquez-Sanchez, P; Aleman-Perez, N; Garcia-Salvador, JJ; Gonzalez-Quesada, A; Garcia-Hernandez, JA; Serra-Majem, L				Bautista-Castano, Inmaculada; Henriquez-Sanchez, Patricia; Aleman-Perez, Nestor; Garcia-Salvador, Jose J.; Gonzalez-Quesada, Alicia; Garcia-Hernandez, Jose A.; Serra-Majem, Luis			Maternal Obesity in Early Pregnancy and Risk of Adverse Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; CARBOHYDRATE-METABOLISM; WEIGHT-GAIN; WOMEN; COMPLICATIONS; GROWTH	Objectives: To assess the role of the health consequences of maternal overweight and obesity at the start of pregnancy on gestational pathologies, delivery and newborn characteristics. Methods: A cohort of pregnant women (n = 6.558) having delivered at the Maternal & Child University Hospital of Gran Canaria (HUMIGC) in 2008 has been studied. Outcomes were compared using multivariate analyses controlling for confounding variables. Results: Compared to normoweight, overweight and obese women have greater risks of gestational diabetes mellitus (RR = 2.13 (95% CI: 1.52-2.98) and (RR = 2.85 (95% CI: 2.01-4.04), gestational hypertension (RR = 2.01 (95% CI: 1.27-3.19) and (RR = 4.79 (95% CI: 3.13-7.32) and preeclampsia (RR = 3.16 (95% CI: 1.12-8.91) and (RR = 8.80 (95% CI: 3.46-22.40). Obese women have also more frequently oligodramnios (RR = 2.02 (95% CI: 1.25-3.27), polyhydramnios. (RR = 1.76 (95% CI: 1.03-2.99), tearing (RR = 1.24 (95% CI: 1.05-1.46) and a lower risk of induced deliveries (RR = 0.83 (95% CI: 0.72-0.95). Both groups have more frequently caesarean section (RR = 1.36 (95% CI: 1.14-1.63) and (RR = 1.84 (95% CI: 1.53-2.22) and manual placenta extraction (RR = 1.65 (95% CI: 1.28-2.11) and (RR = 1.77 (95% CI: 1.35-2.33). Newborns from overweight and obese women have higher weight (p<0.001) and a greater risk of being macrosomic (RR = 2.00 (95% CI: 1.56-2.56) and (RR = 2.74 (95% CI: 2.12-3.54). Finally, neonates from obese mother have a higher risk of being admitted to special care units (RR = 1.34 (95% CI: 1.01-1.77). Apgar 1 min was significantly higher in newborns from normoweight mothers: 8.65 (95% CI: 8.62-8.69) than from overweight: 8.56 (95% CI: 8.50-8.61) or obese mothers: 8.48 (95% CI: 8.41-8.54). Conclusion: Obesity and overweight status at the beginning of pregnancy increase the adverse outcomes of the pregnancy. It is important to promote the normalization of bodyweight in those women who intend to get pregnant and to provide appropriate advice to the obese women of the risks of obesity at the start of the pregnancy.	[Bautista-Castano, Inmaculada; Henriquez-Sanchez, Patricia; Aleman-Perez, Nestor; Garcia-Salvador, Jose J.; Gonzalez-Quesada, Alicia; Serra-Majem, Luis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Garcia-Hernandez, Jose A.] Maternal & Child Univ Hosp Gran Canaria, Dept Gynecol & Obstet, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Serra-Majem, L (corresponding author), Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain.	lserra@dcc.ulpgc.es	Serra-Majem, Lluis/I-6708-2019; Bautista-Castaño, Inmaculada/AFT-1699-2022	Serra-Majem, Lluis/0000-0002-9658-9061; Bautista-Castano, Inmaculada/0000-0001-9257-8739				Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Bautista-Castano I, 2011, MED CLIN-BARCELONA, V136, P478, DOI 10.1016/j.medcli.2010.07.021; Boots C, 2011, SEMIN REPROD MED, V29, P507, DOI 10.1055/s-0031-1293204; Catalano PM, 2003, J CLIN ENDOCR METAB, V88, P3505, DOI 10.1210/jc.2003-031046; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x; Dixit A, 2008, J OBSTET GYNAECOL, V28, P14, DOI 10.1080/01443610701814203; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Kabali C, 2007, INT J GYNECOL OBSTET, V97, P100, DOI 10.1016/j.ijgo.2007.02.001; Khandaker GM, 2012, OBES REV, V13, P518, DOI 10.1111/j.1467-789X.2011.00971.x; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; MARRIOT H, 2004, NUTR B, V29, P249; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Ogunyemi D, 1998, J Matern Fetal Med, V7, P190; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P958, DOI 10.1016/S0002-9378(12)80019-6; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Prentice AM, 2000, AM J CLIN NUTR, V71, p1226S, DOI 10.1093/ajcn/71.5.1226s; Ramachenderan J, 2008, AUST NZ J OBSTET GYN, V48, P228, DOI 10.1111/j.1479-828X.2008.00860.x; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rode L, 2005, OBSTET GYNECOL, V105, P537, DOI 10.1097/01.AOG.0000152304.39492.1c; Rode L, 2012, MATERN CHILD HLTH J, V16, P406, DOI 10.1007/s10995-011-0775-z; Sama J C, 1998, Med Law, V17, P61; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sivan E, 1997, DIABETES CARE, V20, P1470, DOI 10.2337/diacare.20.9.1470; Smith SA, 2008, JOGNN-J OBST GYN NEO, V37, P176, DOI 10.1111/j.1552-6909.2008.00222.x; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x	36	53	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80410	10.1371/journal.pone.0080410	http://dx.doi.org/10.1371/journal.pone.0080410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278281	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100088
J	Breniere, SF; Salas, R; Buitrago, R; Bremond, P; Sosa, V; Bosseno, MF; Waleckx, E; Depickere, S; Barnabe, C				Breniere, Simone Frederique; Salas, Renata; Buitrago, Rosio; Bremond, Philippe; Sosa, Victor; Bosseno, Marie-France; Waleckx, Etienne; Depickere, Stephanie; Barnabe, Christian			Wild Populations of Triatoma infestans Are Highly Connected to Intra-Peridomestic Conspecific Populations in the Bolivian Andes	PLOS ONE			English	Article							CHAGAS-DISEASE VECTOR; GENETIC-STRUCTURE; SYLVATIC FOCI; COMMUNITY PARTICIPATION; HEMIPTERA REDUVIIDAE; MECCUS-LONGIPENNIS; MAIN VECTOR; 1ST REPORT; CHACO; REINFESTATION	Triatoma infestans, the major vector of Chagas disease south of the Amazon in South America, has a large distribution of wild populations, contrary to what has previously been stated. These populations have been suspected of being the source of reinfestation of human habitats and could impede the full success of vector control campaigns. This study examined gene flow between intra-peridomestic populations and wild populations collected in the surround areas in three Andean localities in Bolivia. The populations were defined according to temporal, ecological, and spatial criteria. After DNA extraction from the legs of each insect, the samples were analyzed using seven microsatellite markers. First, the analysis of molecular variance (AMOVA) detected an absence of differentiation between wild and intra-peridomestic populations, although strong structuring was observed between the populations within each environment. Then for some populations, the Bayesian method of assignment to inferred populations showed very similar assignment patterns of the members of wild or intra-peridomestic populations in each locality. Finally, the detection of the first-generation migrants within the different populations provided evidence of insect displacement from the wild to the intra-peridomestic environment. This result indicates that, after control campaigns in the Andes, controlling this new paradigm of vector transmission risk stemming from the invasion of human habitats by wild populations of T. infestans requires long-term maintenance of public monitoring to keep the risk at a minimal level. Since wild populations of T. infestans have also been detected elsewhere in Argentina, Paraguay, and Chile, there is an urgent need to take these populations into account in future monitoring of Chagas disease transmission.	[Breniere, Simone Frederique; Salas, Renata; Buitrago, Rosio; Bremond, Philippe; Sosa, Victor; Bosseno, Marie-France; Waleckx, Etienne; Depickere, Stephanie; Barnabe, Christian] Univ Montpellier 1 & 2, CNRS 5290, IRD 224, Hlth Dept,IRD, Montpellier, France; [Breniere, Simone Frederique; Salas, Renata; Buitrago, Rosio; Bosseno, Marie-France; Depickere, Stephanie; Barnabe, Christian] Inst Nacl Labs Salud INLASA, Lab Entomol Med, La Paz, Bolivia; [Sosa, Victor] Univ Mayor San Simon, Fac Med, Inst Invest Biomed & Interacc Social IIBISMED, Cochabamba, Bolivia; [Waleckx, Etienne] Ctr Invest Reg Dr Hideyo Noguchi, Parasitol Lab, Merida, Yucatan, Mexico	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Breniere, SF (corresponding author), Univ Montpellier 1 & 2, CNRS 5290, IRD 224, Hlth Dept,IRD, Montpellier, France.	Frederique.Breniere@ird.fr	Waleckx, Etienne/G-2439-2017; Barnabé, Christian/R-2904-2016; Waleckx, Etienne/GOG-9370-2022; Depickere, Stephanie/I-3746-2019; Breniere, Simone Frederique/J-9214-2016	Waleckx, Etienne/0000-0002-3270-6476; Barnabé, Christian/0000-0003-1857-0741; Depickere, Stephanie/0000-0002-6734-1155; Breniere, Simone Frederique/0000-0003-4385-3989	National Agency for Research (ANR, France) [3624]; IRD Institute; European Union [223034]	National Agency for Research (ANR, France)(French National Research Agency (ANR)); IRD Institute; European Union(European Commission)	This work was funded by the National Agency for Research (ANR No 3624, France), the IRD Institute, and the European Union Seventh Program Grant 223034 (ChagasEpiNet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2013, MEM I OSWALDO CRUZ, V108, P251, DOI 10.1590/0074-0276108022013022; Abad-Franch F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001207; Bacigalupo A, 2010, MEM I OSWALDO CRUZ, V105, P633, DOI 10.1590/S0074-02762010000500006; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Belkhir K., 2001, GENETIX 4 02 LOGICIE; Breniere SF, 1998, J MED ENTOMOL, V35, P911, DOI 10.1093/jmedent/35.6.911; Breniere SF, 2012, INFECT GENET EVOL, V12, P254, DOI 10.1016/j.meegid.2011.11.003; Buitrago R, 2010, AM J TROP MED HYG, V82, P574, DOI 10.4269/ajtmh.2010.09-0325; Canals M, 2001, J MED ENTOMOL, V38, P303, DOI 10.1603/0022-2585-38.2.303; Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Ceballos LA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001365; Cecere M C, 1997, Rev Panam Salud Publica, V1, P273, DOI 10.1590/S1020-49891997000400003; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Cecere MC, 2002, ACTA TROP, V84, P101, DOI 10.1016/S0001-706X(02)00183-3; Cortez MR, 2010, INFECT GENET EVOL, V10, P350, DOI 10.1016/j.meegid.2009.12.006; Depickere S, 2012, MEM I OSWALDO CRUZ, V107, P1042, DOI 10.1590/S0074-02762012000800013; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Dorn PL, 2007, INFECT GENET EVOL, V7, P343, DOI 10.1016/j.meegid.2006.10.001; Dujardin JP, 1998, MED VET ENTOMOL, V12, P20, DOI 10.1046/j.1365-2915.1998.00076.x; Dujardin JP, 1997, ACTA TROP, V66, P145, DOI 10.1016/S0001-706X(97)00038-7; Dujardin JP, 1997, J MED ENTOMOL, V34, P544, DOI 10.1093/jmedent/34.5.544; DUJARDIN JP, 1987, J MED ENTOMOL, V24, P40, DOI 10.1093/jmedent/24.1.40; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards JK, 1998, MINIPREP PROCEDURES; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Breniere SF, 2010, AM J TROP MED HYG, V83, P382, DOI 10.4269/ajtmh.2010.10-0080; Garcia BA, 2004, MOL ECOL NOTES, V4, P568, DOI 10.1111/j.1471-8286.2004.00735.x; Gaspe MS, 2013, INFECT GENET EVOL, V17, P93, DOI 10.1016/j.meegid.2013.03.044; Gorla D, 2010, ELSEV INSIGHT, P209, DOI 10.1016/B978-0-12-384876-5.00009-5; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Gurevitz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001349; Gurtler RE, 1999, MEDICINA-BUENOS AIRE, V59, P47; Gurtler RE, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000168; Ibisch P.L., 2008, BIODIVERSIDAD RIQUEZ, P47; Lardeux F, 2010, TROP MED INT HEALTH, V15, P1037, DOI 10.1111/j.1365-3156.2010.02573.x; Marcet PL, 2008, INFECT GENET EVOL, V8, P835, DOI 10.1016/j.meegid.2008.08.002; Nei M., 1987, MOL EVOLUTIONARY GEN; Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009; Noireau F, 2005, TRENDS PARASITOL, V21, P7, DOI 10.1016/j.pt.2004.10.007; Noireau F, 2000, MEM I OSWALDO CRUZ, V95, P119, DOI 10.1590/S0074-02762000000700020; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; De Rosas ARP, 2007, MOL ECOL, V16, P1401, DOI 10.1111/j.1365-294X.2007.03251.x; Piccinali RV, 2011, INFECT GENET EVOL, V11, P895, DOI 10.1016/j.meegid.2011.02.013; Picollo MI, 2005, J MED ENTOMOL, V42, P637, DOI 10.1603/0022-2585(2005)042[0637:HRTPIA]2.0.CO;2; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pizarro JC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000202; Pritchard JK, 2000, GENETICS, V155, P945; Quisberth S, 2011, INFECT GENET EVOL, V11, P1006, DOI 10.1016/j.meegid.2011.03.014; de Rosas ARP, 2008, GENETICA, V133, P247, DOI 10.1007/s10709-007-9208-8; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Richer W, 2007, TROP MED INT HEALTH, V12, P759, DOI 10.1111/j.1365-3156.2007.01846.x; Rolon M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001026; Buitrago NLR, 2013, INFECT GENET EVOL, V19, P141, DOI 10.1016/j.meegid.2013.07.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schofield C. J., 1988, BIOSYSTEMATICS HAEMA, P284; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; USINGER RL, 1966, ANNU REV ENTOMOL, V11, P309, DOI 10.1146/annurev.en.11.010166.001521; Waleckx E, 2012, AM J TROP MED HYG, V86, P455, DOI 10.4269/ajtmh.2012.11-0205; Waleckx E, 2011, INFECT GENET EVOL, V11, P1045, DOI 10.1016/j.meegid.2011.03.020; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	64	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80786	10.1371/journal.pone.0080786	http://dx.doi.org/10.1371/journal.pone.0080786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278320	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100112
J	Oyama, T; Schmitz, GE; Dodd, D; Han, YJ; Burnett, A; Nagasawa, N; Mackie, RI; Nakamura, H; Morikawa, K; Cann, I				Oyama, Takuji; Schmitz, George E.; Dodd, Dylan; Han, Yejun; Burnett, Alanna; Nagasawa, Naoko; Mackie, Roderick I.; Nakamura, Haruki; Morikawa, Kosuke; Cann, Isaac			Mutational and Structural Analyses of Caldanaerobius polysaccharolyticus Man5B Reveal Novel Active Site Residues for Family 5 Glycoside Hydrolases	PLOS ONE			English	Article							ANION-EXCHANGE CHROMATOGRAPHY; BACTERIUM THERMOTOGA-MARITIMA; THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; MECHANISM; BINDING; CRYSTALLOGRAPHY; RECOGNITION; MUTAGENESIS	CpMan5B is a glycoside hydrolase (GH) family 5 enzyme exhibiting both beta-1,4-mannosidic and beta-1,4-glucosidic cleavage activities. To provide insight into the amino acid residues that contribute to catalysis and substrate specificity, we solved the structure of CpMan5B at 1.6 angstrom resolution. The structure revealed several active site residues (Y12, N92 and R196) in CpMan5B that are not present in the active sites of other structurally resolved GH5 enzymes. Residue R196 in GH5 enzymes is thought to be strictly conserved as a histidine that participates in an electron relay network with the catalytic glutamates, but we show that an arginine fulfills a functionally equivalent role and is found at this position in every enzyme in subfamily GH5_36, which includes CpMan5B. Residue N92 is required for full enzymatic activity and forms a novel bridge over the active site that is absent in other family 5 structures. Our data also reveal a role of Y12 in establishing the substrate preference for CpMan5B. Using these molecular determinants as a probe allowed us to identify Man5D from Caldicellulosiruptor bescii as a mannanase with minor endo-glucanase activity.	[Oyama, Takuji; Nagasawa, Naoko; Nakamura, Haruki; Morikawa, Kosuke; Cann, Isaac] Osaka Univ, Inst Prot Res, Osaka, Japan; [Schmitz, George E.; Dodd, Dylan; Han, Yejun; Burnett, Alanna; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Schmitz, George E.; Dodd, Dylan; Han, Yejun; Burnett, Alanna; Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Burnett, Alanna; Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	Osaka University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cann, I (corresponding author), Osaka Univ, Inst Prot Res, Osaka, Japan.	icann@illinois.edu	Han, Yejun/AAC-7411-2019	Oyama, Takuji/0000-0002-3411-7608; Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute (EBI); International Collaborative Research Program of the Institute for Protein Research, Osaka University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute (EBI); International Collaborative Research Program of the Institute for Protein Research, Osaka University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by the Energy Biosciences Institute (EBI) and the International Collaborative Research Program of the Institute for Protein Research, Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BAIRD SD, 1990, BIOCHEM BIOPH RES CO, V169, P1035, DOI 10.1016/0006-291X(90)91998-8; BORTOLIGERMAN I, 1995, J MOL BIOL, V246, P82, DOI 10.1006/jmbi.1994.0068; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Cann IKO, 2001, INT J SYST EVOL MICR, V51, P293, DOI 10.1099/00207713-51-2-293; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Chhabra SR, 2002, APPL ENVIRON MICROB, V68, P545, DOI 10.1128/AEM.68.2.545-554.2002; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DOMINGUEZ R, 1995, NAT STRUCT BIOL, V2, P569, DOI 10.1038/nsb0795-569; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lee YC, 1996, J CHROMATOGR A, V720, P137, DOI 10.1016/0021-9673(95)00222-7; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; NAVAS J, 1992, BIOCHEM BIOPH RES CO, V189, P807, DOI 10.1016/0006-291X(92)92274-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rosengren A, 2012, BIOCATAL BIOTRANSFOR, V30, P338, DOI 10.3109/10242422.2012.674726; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Weitzhandler M, 1996, ANAL BIOCHEM, V241, P135, DOI 10.1006/abio.1996.0387; Williams SJ, 2000, J AM CHEM SOC, V122, P4229, DOI 10.1021/ja0002870; Wu TH, 2011, BBA-PROTEINS PROTEOM, V1814, P1832, DOI 10.1016/j.bbapap.2011.07.020; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zheng BS, 2012, J BIOL CHEM, V287, P8336, DOI 10.1074/jbc.M111.266346	31	8	8	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80448	10.1371/journal.pone.0080448	http://dx.doi.org/10.1371/journal.pone.0080448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278284	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100089
J	Tsantoulas, C; Farmer, C; Machado, P; Baba, K; McMahon, SB; Raouf, R				Tsantoulas, Christoforos; Farmer, Clare; Machado, Patricia; Baba, Katsuhiro; McMahon, Stephen B.; Raouf, Ramin			Probing Functional Properties of Nociceptive Axons Using a Microfluidic Culture System	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; DORSAL-ROOT-GANGLIA; SODIUM-CHANNELS; SENSORY NEURONS; IN-VITRO; NERVE NEUROMA; PAIN; MECHANISMS; NGF; TRPV1	Pathological changes in axonal function are integral features of many neurological disorders, yet our knowledge of the molecular basis of axonal dysfunction remains limited. Microfluidic chambers (MFCs) can provide unique insight into the axonal compartment independent of the soma. Here we demonstrate how an MFC based cell culture system can be readily adapted for the study of axonal function in vitro. We illustrate the ease and versatility to assay electrogenesis and conduction of action potentials (APs) in naive, damaged or sensitized DRG axons using calcium imaging at the soma for pharmacological screening or patch-clamp electrophysiology for detailed biophysical characterisation. To demonstrate the adaptability of the system, we report by way of example functional changes in nociceptor axons following sensitization by neurotrophins and axotomy in vitro. We show that NGF can locally sensitize axonal responses to capsaicin, independent of the soma. Axotomizing neurons in MFC results in a significant increase in the proportion of neurons that respond to axonal stimulation, and interestingly leads to accumulation of Nav1.8 channels in regenerating axons. Axotomy also augmented AP amplitude following axotomy and altered activation thresholds in a subpopulation of regenerating axons. We further show how the system can readily be used to study modulation of axonal function by non-neuronal cells such as keratinocytes. Hence we describe a novel in vitro platform for the study of axonal function and a surrogate model for nerve injury and sensitization.	[Tsantoulas, Christoforos; Farmer, Clare; Machado, Patricia; Raouf, Ramin] Kings Coll London, Wolfson Ctr Age Related Dis, Pfizer KCL Pain Labs, London WC2R 2LS, England; [Tsantoulas, Christoforos; Farmer, Clare; Machado, Patricia; Baba, Katsuhiro; Raouf, Ramin] Pfizer Global R&D, Sandwich, Kent, England; [McMahon, Stephen B.; Raouf, Ramin] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	Pfizer; University of London; King's College London; Pfizer; University of London; King's College London	Raouf, R (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Pfizer KCL Pain Labs, London WC2R 2LS, England.	ramin.raouf@kcl.ac.uk	Tsantoulas, Christoforos/H-3060-2019	Tsantoulas, Christoforos/0000-0003-3831-1878; McMahon, Stephen/0000-0003-4656-5536; Raouf, Ramin/0000-0002-5890-2221	Pfizer Neusentis, UK	Pfizer Neusentis, UK	The authors would like to declare that this work has been partly funded by a grant from Pfizer Neusentis, UK to King's College London as part of the Pfizer KCL Pain Lab collaboration based in the Wolfson Centre for Age-Related Diseases, King's College London. Ramin Raouf, Clare Farmer, Christoforos Tsantoulas, Katsuhiro Baba, and Patricia Machado were employed by Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla FA, 2002, J NEUROPHYSIOL, V88, P2518, DOI 10.1152/jn.00913.2001; Anand U, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-82; Bennett DLH, 1998, EUR J NEUROSCI, V10, P1282, DOI 10.1046/j.1460-9568.1998.00139.x; Benoliel R, 2002, PAIN, V97, P203, DOI 10.1016/S0304-3959(01)00428-6; Calvo M, 2012, EXP NEUROL, V234, P271, DOI 10.1016/j.expneurol.2011.08.018; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Chevrier P, 2004, BRIT J PHARMACOL, V142, P576, DOI 10.1038/sj.bjp.0705796; Coward K, 2000, PAIN, V85, P41, DOI 10.1016/S0304-3959(99)00251-1; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dussor G, 2009, BRAIN RES REV, V60, P24, DOI 10.1016/j.brainresrev.2008.12.013; Fabbretti E, 2006, J NEUROSCI, V26, P6163, DOI 10.1523/JNEUROSCI.0647-06.2006; Ferrari LF, 2013, J PAIN, V14, P731, DOI 10.1016/j.jpain.2013.01.779; Gemes G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-46; Gemes G, 2011, J NEUROSCI, V31, P3536, DOI 10.1523/JNEUROSCI.5053-10.2011; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gross PG, 2007, J NEUROL SCI, V252, P135, DOI 10.1016/j.jns.2006.11.009; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hendrich J, 2013, PAIN, V154, P2207, DOI 10.1016/j.pain.2013.07.004; Huang HL, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-33; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Joseph EK, 2010, NEUROSCIENCE, V169, P431, DOI 10.1016/j.neuroscience.2010.04.082; Josephson A, 2001, J COMP NEUROL, V440, P204, DOI 10.1002/cne.1380; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kawano T, 2009, P NATL ACAD SCI USA, V106, P8725, DOI 10.1073/pnas.0901815106; Kim HJ, 2012, ANN BIOMED ENG, V40, P1268, DOI 10.1007/s10439-012-0515-6; Koltzenburg M, 1999, EUR J NEUROSCI, V11, P1698, DOI 10.1046/j.1460-9568.1999.00590.x; LEIGH IM, 1993, BRIT J DERMATOL, V129, P110, DOI 10.1111/j.1365-2133.1993.tb03511.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Lu X, 2012, J NEUROSCI METH, V209, P35, DOI 10.1016/j.jneumeth.2012.05.021; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; McLean WG, 1997, NEUROCHEM RES, V22, P951, DOI 10.1023/A:1022466624223; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Park J, 2009, BIOMED MICRODEVICES, V11, P1145, DOI 10.1007/s10544-009-9331-7; Park SB, 2008, CURR MED CHEM, V15, P3081, DOI 10.2174/092986708786848569; Radtke C, 2010, PAIN, V148, P94, DOI 10.1016/j.pain.2009.10.014; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Rivera L, 2000, J PHYSIOL-LONDON, V527, P305, DOI 10.1111/j.1469-7793.2000.t01-1-00305.x; Roggenkamp D, 2012, J INVEST DERMATOL, V132, P1892, DOI 10.1038/jid.2012.44; Roza C, 2003, J PHYSIOL-LONDON, V550, P921, DOI 10.1113/jphysiol.2003.046110; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Sun W, 2012, BRAIN, V135, P359, DOI 10.1093/brain/awr345; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor Anne M., 2011, Critical Reviews in Biomedical Engineering, V39, P185, DOI 10.1615/CritRevBiomedEng.v39.i3.20; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Tsantoulas C, 2012, J NEUROSCI, V32, P17502, DOI 10.1523/JNEUROSCI.3561-12.2012; Tsutsumi M, 2011, EXP DERMATOL, V20, P464, DOI 10.1111/j.1600-0625.2011.01276.x; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Vogelaar CF, 2009, MOL CELL NEUROSCI, V42, P102, DOI 10.1016/j.mcn.2009.06.002; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; WELK E, 1990, J NEUROPHYSIOL, V63, P759, DOI 10.1152/jn.1990.63.4.759; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	65	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80722	10.1371/journal.pone.0080722	http://dx.doi.org/10.1371/journal.pone.0080722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278311	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100103
J	Wiesinger, A; Peters, W; Chappell, D; Kentrup, D; Reuter, S; Pavenstadt, H; Oberleithner, H; Kumpers, P				Wiesinger, Anne; Peters, Wladimir; Chappell, Daniel; Kentrup, Dominik; Reuter, Stefan; Pavenstaedt, Hermann; Oberleithner, Hans; Kuempers, Philipp			Nanomechanics of the Endothelial Glycocalyx in Experimental Sepsis	PLOS ONE			English	Article							IN-VITRO; CELL; BARRIER; VIVO; PERMEABILITY; CYTOSKELETON; DYSFUNCTION; THICKNESS; ADHESION; SURGERY	The endothelial glycocalyx (eGC), a carbohydrate-rich layer lining the luminal side of the endothelium, regulates vascular adhesiveness and permeability. Although central to the pathophysiology of vascular barrier dysfunction in sepsis, glycocalyx damage has been generally understudied, in part because of the aberrancy of in vitro preparations and its degradation during tissue handling. The aim of this study was to analyze inflammation-induced damage of the eGC on living endothelial cells by atomic-force microscopy (AFM) nanoindentation technique. AFM revealed the existence of a mature eGC on the luminal endothelial surface of freshly isolated rodent aorta preparations ex vivo, as well as on cultured human pulmonary microvascular endothelial cells (HPMEC) in vitro. AFM detected a marked reduction in glycocalyx thickness (266 +/- 12 vs. 137 +/- 17 nm, P<0.0001) and stiffness (0.34 +/- 0.03 vs. 0.21 +/- 0.01 pN/mn, P<0.0001) in septic mice (1 mg E. coli lipopolysaccharides (LPS)/kg BW i.p.) compared to controls. Corresponding in vitro experiments revealed that sepsis-associated mediators, such as thrombin, LPS or Tumor Necrosis Factor-a alone were sufficient to rapidly decrease eGC thickness (-50%, all P<0.0001) and stiffness (-20% P<0.0001) on HPMEC. In summary, AFM nanoindentation is a promising novel approach to uncover mechanisms involved in deterioration and refurbishment of the eGC in sepsis.	[Wiesinger, Anne; Kentrup, Dominik; Reuter, Stefan; Pavenstaedt, Hermann; Kuempers, Philipp] Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Peters, Wladimir; Oberleithner, Hans] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Chappell, Daniel] Univ Munich, Anesthesiol Clin, Munich, Germany	University of Munster; University of Munster; University of Munich	Kumpers, P (corresponding author), Univ Hosp, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	Philipp.kuempers@ukmuenster.de		Kentrup, Dominik/0000-0003-3887-4304	University of Muenster Medical School [KU111015]; Deutsche Forschungsgemeinschaft; University of Munster	University of Muenster Medical School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	This work was supported by the fund "Innovative Medical Research" of the University of Muenster Medical School (KU111015). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Munster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1990, J PHYSIOL-LONDON, V428, P1; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Bai K, 2012, J R SOC INTERFACE, V9, P2290, DOI 10.1098/rsif.2011.0901; Barakat AI, 2008, CIRC RES, V102, P747, DOI 10.1161/CIRCRESAHA.108.174839; Bruegger D, 2008, CRIT CARE, V12, DOI 10.1186/cc6913; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; Carl P, 2008, PFLUG ARCH EUR J PHY, V457, P551, DOI 10.1007/s00424-008-0524-3; Chappell D, 2009, CURR OPIN ANESTHESIO, V22, P155, DOI 10.1097/ACO.0b013e328328d1b6; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Chappell D, 2009, BASIC RES CARDIOL, V104, P78, DOI 10.1007/s00395-008-0749-5; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Constantinescu AA, 2011, THROMB HAEMOSTASIS, V105, P790, DOI 10.1160/TH10-08-0560; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; Dokukin ME, 2013, BIOPHYS J, V104, P2123, DOI [10.1016/j.bpj.2013.04.019, 10.1016/j.bpj.2013.03.019]; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Gao LJ, 2010, MICROVASC RES, V80, P394, DOI 10.1016/j.mvr.2010.06.005; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hofmann-Kiefer KF, 2009, EUR J MED RES, V14, P526; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Korte S, 2012, PFLUG ARCH EUR J PHY, V463, P269, DOI 10.1007/s00424-011-1038-y; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; Marechal X, 2008, SHOCK, V29, P572, DOI 10.1097/SHK.0b013e318157e926; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Peters W, 2012, PLOS ONE, V7, P264, DOI 10.1371/journal.pone.0029972; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Pries A. R., 2006, V176, P1; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Pries AR, 2005, AM J PHYSIOL-HEART C, V289, pH2657, DOI 10.1152/ajpheart.00297.2005; Rehm M, 2001, ANESTHESIOLOGY, V95, P849, DOI 10.1097/00000542-200110000-00011; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Reitsma S, 2011, THROMB HAEMOSTASIS, V106, P939, DOI 10.1160/TH11-02-0133; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; van den Berg BM, 2006, AM J PHYSIOL-HEART C, V290, pH915, DOI 10.1152/ajpheart.00051.2005; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Wang X., 2010, APPL PHYS LETT, V97; Yen WY, 2012, MICROVASC RES, V83, P337, DOI 10.1016/j.mvr.2012.02.005	56	99	103	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80905	10.1371/journal.pone.0080905	http://dx.doi.org/10.1371/journal.pone.0080905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278345	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100127
J	Jiang, JX; Aitken, KJ; Sotiropolous, C; Kirwan, T; Panchal, T; Zhang, N; Pu, SY; Wodak, S; Tolg, C; Bagli, DJ				Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Panchal, Trupti; Zhang, Nicole; Pu, Shuye; Wodak, Shoshana; Tolg, Cornelia; Baegli, Darius J.			Phenotypic Switching Induced by Damaged Matrix Is Associated with DNA Methyltransferase 3A (DNMT3A) Activity and Nuclear Localization in Smooth Muscle Cells (SMC)	PLOS ONE			English	Article							BLADDER OUTLET OBSTRUCTION; NERVE GROWTH-FACTOR; CONTRACTILE PROTEIN-CHANGES; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; TENASCIN-C; IN-VITRO; METHYLATION; ACETYLATION; INTEGRIN	Extracellular matrix changes are often crucial inciting events for fibroproliferative disease. Epigenetic changes, specifically DNA methylation, are critical factors underlying differentiated phenotypes. We examined the dependency of matrix-induced fibroproliferation and SMC phenotype on DNA methyltransferases. The cooperativity of matrix with growth factors, cell density and hypoxia was also examined. Primary rat visceral SMC of early passage (0-2) were plated on native collagen or damaged/heat-denatured collagen. Hypoxia was induced with 3% O-2 (balanced 5% CO2 and 95% N-2) over 48 hours. Inhibitors were applied 2-3 hours after cells were plated on matrix, or immediately before hypoxia. Cells were fixed and stained for DNMT3A and smooth muscle actin (SMA) or smooth muscle myosin heavy chain. Illumina 450 K array of CpG sites was performed on bisulfite-converted DNA from smooth muscle cells on damaged matrix vs native collagen. Matrix exquisitely regulates DNMT3A localization and expression, and influences differentiation in SMCs exposed to denatured matrix +/- hypoxia. Analysis of DNA methylation signatures showed that Matrix caused significant DNA methylation alterations in a discrete number of CpG sites proximal to genes related to SMC differentiation. Matrix has a profound effect on the regulation of SMC phenotype, which is associated with altered expression, localization of DNMTs and discrete changes DNA methylation.	[Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Tolg, Cornelia; Baegli, Darius J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Jiang, Jia-Xin; Aitken, Karen J.; Sotiropolous, Chris; Kirwan, Tyler; Tolg, Cornelia; Baegli, Darius J.] Hosp Sick Children, Div Urol, Toronto, ON M5G 1X8, Canada; [Jiang, Jia-Xin; Sotiropolous, Chris; Zhang, Nicole; Baegli, Darius J.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Panchal, Trupti; Baegli, Darius J.] Univ Toronto, Toronto, ON, Canada; [Pu, Shuye; Wodak, Shoshana] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada; [Baegli, Darius J.] Univ Toronto, Dept Surg, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Aitken, KJ (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	kjglennie@rogers.com	Aitken, KJ/AAC-5383-2019	wodak, shoshana/0000-0002-0701-6545	CIHR	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken K, 2009, NATURE REV UROLOGY; Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969; Aitken KJ, 2010, AM J PATHOL, V176, P304, DOI 10.2353/ajpath.2010.080834; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Aprelikova O, 2012, ONCOGENE; Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674; Barendrecht MM, 2009, NEUROUROL URODYNAM, V28, P349, DOI 10.1002/nau.20642; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bissell M J, 1987, Prog Clin Biol Res, V249, P251; BISSELL MJ, 1987, J CELL SCI, P327; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Burkhard FC, 2001, J UROLOGY, V165, P963, DOI 10.1016/S0022-5347(05)66585-8; Chacko S, 1999, ADV EXP MED BIOL, V462, P137; CHACKO S, 1994, WORLD J UROL, V12, P292; Chacko S, 1997, SCAND J UROL NEPHROL, V31, P67; Chaqour B, 2002, AM J PHYSIOL-ENDOC M, V283, pE765, DOI 10.1152/ajpendo.00131.2002; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cowan DB, 2003, ARTERIOSCL THROM VAS, V23, P1754, DOI 10.1161/01.ATV.0000093546.10162.B2; Dakhlallah D, 2013, AM J RESP CRITICAL C; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; DiSanto ME, 2003, AM J PHYSIOL-CELL PH, V285, pC1397, DOI 10.1152/ajpcell.00513.2002; Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Ghafar MA, 2002, J UROLOGY, V167, P1508, DOI 10.1016/S0022-5347(05)65354-2; Ghafar MA, 2002, LAB INVEST, V82, P903, DOI 10.1097/01.LAB.0000021135.87203.92; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Glass TF, 2002, NEUROSCI LETT, V328, P133, DOI 10.1016/S0304-3940(02)00510-4; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Halachmi S, 2006, CELL TISSUE RES, V326, P149, DOI 10.1007/s00441-006-0204-6; Herz DB, 2003, J UROLOGY, V170, P2072, DOI 10.1097/01.ju.0000091810.33953.13; Ho B, 2009, CELL ADHES MIGR, V3, P174, DOI 10.4161/cam.3.2.7374; Hodges SJ, 2010, UROLOGY, V75, P868, DOI 10.1016/j.urology.2009.11.022; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Huang SK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.146; Imamura M, 2009, AM J PHYSIOL-RENAL, V297, pF46, DOI 10.1152/ajprenal.90207.2008; Jiang GF, 2008, TOXICOLOGY, V244, P49, DOI 10.1016/j.tox.2007.10.028; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; Jones PL, 1999, J CELL SCI, V112, P435; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kim JC, 2004, BJU INT, V94, P915, DOI 10.1111/j.1464-4096.2003.05059.x; Kim JY, 2010, CELL CYCLE, V9, P3680, DOI 10.4161/cc.9.18.12716; Koontongkaew S, 2011, MED ONCOL; Kotini AG, 2011, MOL CELL BIOL, V31, P1577, DOI 10.1128/MCB.01093-10; Kuo Hann-Chorng, 2010, Rev Urol, V12, pe69; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b; Lu P, 2011, COLD SPRING HARB PER, V3; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malloy BJ, 1998, J UROLOGY, V160, P937, DOI 10.1016/S0022-5347(01)62836-2; MALMQVIST U, 1991, AM J PHYSIOL, V260, pC1085, DOI 10.1152/ajpcell.1991.260.5.C1085; MALMQVIST U, 1991, SCAND J UROL NEPHROL, V25, P261, DOI 10.3109/00365599109024556; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mann J, 2013, CURR OPIN RHEUMATOL, V25, P101, DOI 10.1097/BOR.0b013e32835b13e1; Matsumoto S, 2003, INT J UROL, V10, P339, DOI 10.1046/j.1442-2042.2003.00637.x; Metcalfe PD, 2010, BJU INT; Michelotti Gregory A, 2004, Curr Urol Rep, V5, P258, DOI 10.1007/s11934-004-0048-0; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; Ning YY, 2013, ARCH TOXICOL, V87, P871, DOI 10.1007/s00204-012-1008-y; Oh BK, 2007, INT J MOL MED, V20, P65; Orlandi A, 2005, EXP CELL RES, V311, P317, DOI 10.1016/j.yexcr.2005.10.008; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114; PERSSON K, 1995, AM J PHYSIOL-CELL PH, V269, pC1018, DOI 10.1152/ajpcell.1995.269.4.C1018; Pickard A, 2010, J CELL SCI, V123, P3718, DOI 10.1242/jcs.068924; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Robert L, 2000, BIOGERONTOLOGY, V1, P123, DOI 10.1023/A:1010048014925; Robinson CM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-74; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Sabha N, 2006, IN VITRO CELL DEV-AN, V42, P124; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Schumacher A, 2006, CURR TOP MICROBIOL, V310, P81; Singh N, 2011, CIRC RES, V109, P1240, DOI 10.1161/CIRCRESAHA.111.255067; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Spin JM, 2012, CARDIOVASC RES; Spin JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014301; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Stein R, 2001, J UROLOGY, V166, P651, DOI 10.1016/S0022-5347(05)66037-5; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Sun X, 2013, CELLULAR SIGNALLING; Thieszen SL, 1996, EXP CELL RES, V227, P135, DOI 10.1006/excr.1996.0258; Tolg C, 2011, LAB INVEST; Wang L, 2009, CIRC RES; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053; Yang L, 2008, ACTA PHARMACOL SIN, V29, P600, DOI 10.1111/j.1745-7254.2008.00784.x; Zeisberg EM, 2012, J PATHOLOGY; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang N, 2012, J UNDERGRADUATE LIFE, V6, P70; Zhang Xu, 2012, Frontiers in Genetics, V3, P73, DOI 10.3389/fgene.2012.00073; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng QH, 2006, J CELL BIOCHEM, V98, P1230, DOI 10.1002/jcb.20838; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	107	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2013	8	8							e69089	10.1371/journal.pone.0069089	http://dx.doi.org/10.1371/journal.pone.0069089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZE	24282625	Green Published, gold, Green Submitted			2022-12-27	WOS:000323109700013
J	Campos, PE; Buffardi, AL; Carcamo, CP; Garcia, PJ; Buendia, C; Chiappe, M; Garnett, GP; Xet-Mull, AM; Holmes, KK				Campos, Pablo E.; Buffardi, Anne L.; Carcamo, Cesar P.; Garcia, Patricia J.; Buendia, Clara; Chiappe, Marina; Garnett, Geoff P.; Xet-Mull, Ana Maria; Holmes, King K.			Reaching the Unreachable: Providing STI Control Services to Female Sex Workers via Mobile Team Outreach	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV-1 INFECTION; INTERVENTIONS; PREVALENCE; PREVENTION; RISK; BEHAVIOR; DISEASES; DECLINE; IMPACT	Background: As part of a community-randomized trial of a multicomponent intervention to prevent sexually transmitted infections, we created Mobile Teams (MTs) in ten intervention cities across Peru to improve outreach to female sex workers (FSW) for strengthened STI prevention services. Methods: Throughout 20 two-month cycles, MTs provided counseling; condoms; screening and specific treatment for Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and vaginal Trichomonas vaginalis (TV) infections; and periodic presumptive metronidazole treatment for vaginal infections. Results: MTs had 48,207 separate encounters with 24,814 FSW; numbers of sex work venues and of FSW reached increased steadily over several cycles. Approximately 50% of FSW reached per cycle were new. Reported condom use with last client increased from 73% to 93%. Presumptive metronidazole treatment was accepted 83% of times offered. Over 38 months, CT prevalence declined from 15.4% to 8.2%, and TV prevalence from 7.3% to 2.6%. Among participants in >= 9 cycles, CT prevalence decreased from 12.9% to 6.0% (p <0.001); TV from 4.6% to 1.5% (p <0.001); and NG from 0.8% to 0.4% (p =0.07). Conclusions: Mobile outreach to FSW reached many FSW not utilizing government clinics. Self-reported condom use substantially increased; CT and TV prevalences declined significantly. The community-randomized trial, reported separately, demonstrated significantly greater reductions in composite prevalence of CT, NG, TV, or high-titer syphilis serology in FSW in these ten intervention cities than in ten matched control cities.	[Campos, Pablo E.; Carcamo, Cesar P.; Garcia, Patricia J.; Buendia, Clara; Chiappe, Marina] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD AIDS Unit, Lima, Peru; [Buffardi, Anne L.; Xet-Mull, Ana Maria; Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Dept Med, Seattle, WA USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, STD AIDS Unit, Lima, Peru.	patricia.garcia@upch.pe	, Holmes/K-6215-2019; Garnett, Geoffrey P/A-9312-2008		Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health NIAID STD Cooperative Research Center [U19AI31448]; Center for AIDS Research [P30-AI027757]; CIPRA [U19AI053218]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U19AI031448, U19AI053218] Funding Source: NIH RePORTER	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative(Burroughs Wellcome FundWellcome Trust); National Institutes of Health NIAID STD Cooperative Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research; CIPRA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative 059131/Z/99/Z, 078835/Z/05/Z, and 078835/Z/05/B; and by the National Institutes of Health NIAID STD Cooperative Research Center U19AI31448, Center for AIDS Research P30-AI027757, and CIPRA U19AI053218 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Campos PE, 2006, SEX TRANSM INFECT, V82, pV22, DOI 10.1136/sti.2006.023325; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Cwikel JG, 2008, SEX HEALTH, V5, P9, DOI 10.1071/SH07024; Farrell DJ, 1999, J CLIN MICROBIOL, V37, P386, DOI 10.1128/JCM.37.2.386-390.1999; Ford K, 2002, SEX TRANSM DIS, V29, P50, DOI 10.1097/00007435-200201000-00009; Garcia PJ, 2012, LANCET, V379, P1120, DOI 10.1016/S0140-6736(11)61846-1; Garnett GP, 2000, SEX TRANSM DIS, V27, P588, DOI 10.1097/00007435-200011000-00007; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; Levine WC, 1998, AIDS, V12, P1899, DOI 10.1097/00002030-199814000-00022; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; Palmer HM, 2003, J CLIN MICROBIOL, V41, P835, DOI 10.1128/JCM.41.2.835-837.2003; *PAN AM HLTH ORG, 2005, REG HIV STI PLAN HLT; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Sanchez J, 1998, SEX TRANSM DIS, V25, P82, DOI 10.1097/00007435-199802000-00005; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Steen R, 2012, CURR OPIN INFECT DIS, V25, P100, DOI 10.1097/QCO.0b013e32834e9ad1; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; WHO, 2008, PER PRES TREATM SEX; Williams BG, 2003, AIDS, V17, P2099, DOI 10.1097/00002030-200309260-00011; WILLIAMS BG, 2002, SEX TRANSM INFECT, V78, P110, DOI DOI 10.1136/STI.78.2.110.PUBMED:12081170	30	14	14	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81041	10.1371/journal.pone.0081041	http://dx.doi.org/10.1371/journal.pone.0081041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282565	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500067
J	Denadai, M; Pombo, M; Santos, FB; Bessa, E; Ferreira, A; Turra, A				Denadai, Marcia; Pombo, Maira; Santos, Flavia Borges; Bessa, Eduardo; Ferreira, Adriana; Turra, Alexander			Population Dynamics and Diet of the Madamango Sea Catfish Cathorops spixii ( Agassiz, 1829) ( Siluriformes: Ariidae) in a Tropical Bight in Southeastern Brazil	PLOS ONE			English	Article							DEMERSAL FISH ASSEMBLAGES; COASTAL AREA; BAY	The madamango sea catfish, Cathorops spixii (Siluriformes: Ariidae), is often among the most abundant fishes on the South American Atlantic coast. In the present study, conducted in shallow, non-estuarine coastal areas of Caraguatatuba Bight in southeastern Brazil, collections of this species, the most abundant member of the ichthyofauna, included primarily mediumsized individuals, indicating that the area may play a specific role in their development. Although studies of the local ichthyofauna have been much neglected, the area is economically important and its ecological significance is undervalued. This study primarily treats habitat use by C. spixii, assessing certain population parameters and the dietary composition. Monthly samples were taken from August 2003 through October 2004, with three trawls in two areas, corresponding to depths of about 1 to 4 m. The catfish showed two main peaks of abundance in the area, in April/May and July 2004. A mode around 9 cm SL persisted through time, and the entrance of younger recruits peaked from January to April. The low estimate for body-growth parameters (K = 0.16) corroborates some K-strategist characteristics of the species. The asymptotic length was 27.3 cm SL and total mortality (Z) was 1.01 yr(-1). Cathorops spixii showed an omnivorous feeding habit, preying mainly upon polychaetes, copepods and bivalves, with considerable seasonality in its diet.	[Denadai, Marcia] Ctr Univ Modulo Caraguatatuba, Sao Paulo, Brazil; [Pombo, Maira; Turra, Alexander] Univ Sao Paulo, Inst Oceanog, Dept Oceanog Biol, Sao Paulo, Brazil; [Santos, Flavia Borges] Univ Estadual Sudoeste Bahia, Dept Ciencias Nat, Vitoria Da Conquista, Bahia, Brazil; [Bessa, Eduardo] Univ Estado Mato Grosso, Lab Ecol Comportamental Reprod, Tangara Da Serra, Mato Grosso, Brazil; [Ferreira, Adriana] Ctr Univ, Fundacao Ensino Octavio Bastos, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual do Sudoeste da Bahia; Universidade do Estado de Mato Grosso	Pombo, M (corresponding author), Univ Sao Paulo, Inst Oceanog, Dept Oceanog Biol, Sao Paulo, Brazil.	mairapombo@gmail.com	Pombo, Maíra/J-7791-2015; Turra, Alexander/G-1352-2012; Bessa, Eduardo/C-8360-2019; Denadai, Marcia R/P-9927-2015	Turra, Alexander/0000-0003-2225-8371; Bessa, Eduardo/0000-0003-0606-5860; Denadai, Marcia R/0000-0002-7236-9478	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) within Biota/FAPESP -The Biodiversity Virtual Institute Program; FAPESP [05/60041-6, 06/57575-1]; Project Aware Foundation; Padi Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) within Biota/FAPESP -The Biodiversity Virtual Institute Program(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Project Aware Foundation; Padi Foundation	This work was partially financed by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) within Biota/FAPESP - The Biodiversity Virtual Institute Program (www.biota.org.br). The authors also thank FAPESP for the "Programa Jovem Pesquisador em Centro Emergente'' grant awarded to M. R. D. (Proc. No. 05/60041-6 and 06/57575-1). The Project Aware Foundation and the Padi Foundation also financed part of this research. Essential logistical support was provided by the Instituto Costa Brasilis - Desenvolvimento Socio-Ambiental and by the Centro Universitario da Fundacao de Ensino Octavio Bastos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO F G, 1988, Revista Brasileira de Zoologia, V5, P509; Araujo FG, 2002, ESTUARIES, V25, P441, DOI 10.1007/BF02695986; Azevedo JS, 2009, ECOTOXICOLOGY, V18, P577, DOI 10.1007/s10646-009-0315-4; Azevedo JD, 2012, BRAZ J OCEANOGR, V60, P323, DOI 10.1590/S1679-87592012000300005; Azevedo M. C. C., 1999, Revista Brasileira de Biologia, V59, P443; Barletta M, 2008, J FISH BIOL, V73, P1314, DOI 10.1111/j.1095-8649.2008.02005.x; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; Branco JO, 2006, REV BRAS ZOOL, V23, P381, DOI 10.1590/S0101-81752006000200011; Camargo Mauricio, 1998, Acta Scientiarum, V20, P171; CHALOM A., 2008, OCEANOGRAFIA MUDANCA, P257; Chaves Paula De Tarso Da C., 1994, Revista Brasileira de Zoologia, V11, P641; Dantas DV, 2012, ESTUAR COAST, DOI DOI 10.1007/S12237-012-9563-2.ACCESSED; Denadai MR, 2005, J NAT HIST, V39, P3275, DOI 10.1080/00222930500126156; Diaz A, 1984, B I OCEANOGRAFICO VE, V39, P3275; Diogo R, 2004, ANIM BIOL, V54, P331, DOI 10.1163/1570756042729546; ESPIRITO SANTO RV, 1999, B MUS PARA E GOELD Z, V15, P95; Favaro LF, 2005, REV BRAS ZOOL, V22, P1022, DOI 10.1590/S0101-81752005000400030; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Garcia CB, 2006, J APPL ICHTHYOL, V22, P193, DOI 10.1111/j.1439-0426.2006.00720.x; Gomes ID, 2004, ENVIRON BIOL FISH, V71, P341, DOI 10.1007/s10641-004-1265-6; Gomes Iracema David, 1999, Revista Brasileira de Zoologia, V16, P171; GOMEZCANCHONG P, 2004, ATLAS PESQUERO AREA; Gurgel Helio de Castro Bezerra, 2000, Acta Scientiarum, V22, P503; Kawakami E., 1980, Boletim do Instituto Oceanografico, V29, P205; Melo Simone C., 1992, Revista Brasileira de Biologia, V52, P169; Menezes NA, 1980, MANUAL PEIXES MARINH, VIV; Mishima M., 1984, Boletim do Instituto de Pesca (Sao Paulo), V10, P129; Pauly D., 1994, NAGA ICLARM Q, V17, P46; Pauly D., 1983, FISHBYTE WORLD FISH, V1, p9?13; Pombo M, 2012, BRAZ J OCEANOGR, V60, P271, DOI 10.1590/S1679-87592012000300001; Possatto FE, 2011, MAR POLLUT BULL, V62, P1098, DOI 10.1016/j.marpolbul.2011.01.036; Rueda M, 2003, J EXP MAR BIOL ECOL, V296, P93, DOI 10.1016/S0022-0981(03)00319-8; Schmidt Thassya Christina dos Santos, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000400006; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schwarz R. Jr, 2006, Brazilian Journal of Aquatic Science and Technology, V10, P27; Silva J, 1999, BRAZ J OCEANOGR, V46, P171; SZELISTOWSKI WA, 1989, COPEIA, P517, DOI 10.2307/1445459; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366; Taylor W. R., 1978, FAO SPECIES IDENTIFI; Tijaro Rocio, 1998, Boletin de Investigaciones Marinas y Costeras, V27, P87	41	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81257	10.1371/journal.pone.0081257	http://dx.doi.org/10.1371/journal.pone.0081257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282575	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500077
J	Perez-Cobas, AE; Artacho, A; Knecht, H; Ferrus, ML; Friedrichs, A; Ott, SJ; Moya, A; Latorre, A; Gosalbes, MJ				Elena Perez-Cobas, Ana; Artacho, Alejandro; Knecht, Henrik; Ferrus, Maria Loreto; Friedrichs, Anette; Ott, Stephan J.; Moya, Andres; Latorre, Amparo; Jose Gosalbes, Maria			Differential Effects of Antibiotic Therapy on the Structure and Function of Human Gut Microbiota	PLOS ONE			English	Article							HUMAN INTESTINAL MICROBIOTA; LONG-TERM IMPACTS; ANTIMICROBIAL RESISTANCE; CARBOHYDRATE-METABOLISM; ESCHERICHIA-COLI; DIVERSITY; GENES; SUSCEPTIBILITY; EXPRESSION	The human intestinal microbiota performs many essential functions for the host. Antimicrobial agents, such as antibiotics (AB), are also known to disturb microbial community equilibrium, thereby having an impact on human physiology. While an increasing number of studies investigate the effects of AB usage on changes in human gut microbiota biodiversity, its functional effects are still poorly understood. We performed a follow-up study to explore the effect of ABs with different modes of action on human gut microbiota composition and function. Four individuals were treated with different antibiotics and samples were taken before, during and after the AB course for all of them. Changes in the total and in the active (growing) microbiota as well as the functional changes were addressed by 16S rRNA gene and metagenomic 454-based pyrosequencing approaches. We have found that the class of antibiotic, particularly its antimicrobial effect and mode of action, played an important role in modulating the gut microbiota composition and function. Furthermore, analysis of the resistome suggested that oscillatory dynamics are not only due to antibiotic-target resistance, but also to fluctuations in the surviving bacterial community. Our results indicated that the effect of AB on the human gut microbiota relates to the interaction of several factors, principally the properties of the antimicrobial agent, and the structure, functions and resistance genes of the microbial community.	[Elena Perez-Cobas, Ana; Artacho, Alejandro; Ferrus, Maria Loreto; Moya, Andres; Latorre, Amparo; Jose Gosalbes, Maria] Univ Valencia, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ, Valencia, Spain; [Elena Perez-Cobas, Ana; Artacho, Alejandro; Ferrus, Maria Loreto; Moya, Andres; Latorre, Amparo; Jose Gosalbes, Maria] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Elena Perez-Cobas, Ana; Moya, Andres; Latorre, Amparo; Jose Gosalbes, Maria] CIBER Epidemiol & Salud Publ, Madrid, Spain; [Knecht, Henrik; Friedrichs, Anette; Ott, Stephan J.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Friedrichs, Anette; Ott, Stephan J.] Univ Hosp Schleswig Holstein, Dept Internal Med, Kiel, Germany	University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Latorre, A (corresponding author), Univ Valencia, Unidad Mixta Invest Genom & Salud, Ctr Super Invest Salud Publ, Valencia, Spain.	amparo.latorre@uv.es; maria.jose.gosalbes@uv.es	Moya, Andrés/A-8190-2008; Pérez-Cobas, Ana Elena/A-9471-2019; Latorre, Amparo/E-4997-2015; Gosalbes, Maria Jose/C-7194-2011; Ott, Stephan J/G-1965-2010; Artacho, Alejandro/Z-4613-2019; Pérez-Cobas, Ana Elena/K-7881-2019; Pérez Cobas, Ana Elena/GRY-4537-2022	Moya, Andrés/0000-0002-2867-1119; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; Latorre, Amparo/0000-0002-9146-7284; Gosalbes, Maria Jose/0000-0003-0460-1105; Pérez-Cobas, Ana Elena/0000-0002-3995-5571; 	Spanish Ministry of Economy and Competitiveness [BFU2008-04501-E/BMC, SAF2009-13032-C02-01, SAF2012-31187]; ERA NET PathoGenoMics2 programme [0315441A]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ERA NET PathoGenoMics2 programme	This work was supported by the Spanish Ministry of Economy and Competitiveness (BFU2008-04501-E/BMC, SAF2009-13032-C02-01 and SAF2012-31187) and by the ERA NET PathoGenoMics2 programme (0315441A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Booijink CCGM, 2010, APPL ENVIRON MICROB, V76, P5533, DOI 10.1128/AEM.00502-10; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2000, STAT SINICA, V10, P227; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; DEREUSE H, 1991, J BACTERIOL, V173, P727, DOI 10.1128/jb.173.2.727-733.1991; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Durban A, 2012, FEMS MICROBIOL ECOL, V81, P427, DOI 10.1111/j.1574-6941.2012.01368.x; Durbin R., 1998, BIOL SEQUENCE ANAL P; Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hedberg M, 2003, CLIN MICROBIOL INFEC, V9, P475, DOI 10.1046/j.1469-0691.2003.00674.x; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lee EW, 2003, BIOL PHARM BULL, V26, P266, DOI 10.1248/bpb.26.266; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Nakano V, 2011, CLINICS, V66, P543, DOI 10.1590/S1807-59322011000400004; Nyberg SD, 2007, SCAND J INFECT DIS, V39, P514, DOI 10.1080/00365540701199790; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; WILSON KH, 1993, CLIN INFECT DIS, V16, pS214, DOI 10.1093/clinids/16.Supplement_4.S214; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	54	119	122	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80201	10.1371/journal.pone.0080201	http://dx.doi.org/10.1371/journal.pone.0080201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282523	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500024
J	Chang, KV; Hung, CY; Chen, WS; Lai, MS; Chien, KL; Han, DS				Chang, Ke-Vin; Hung, Chen-Yu; Chen, Wen-Shiang; Lai, Mei-Shu; Chien, Kuo-Liong; Han, Der-Sheng			Effectiveness of Bisphosphonate Analogues and Functional Electrical Stimulation on Attenuating Post-Injury Osteoporosis in Spinal Cord Injury Patients- a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BONE-MINERAL DENSITY; PARAPLEGIC PATIENTS; BODY-COMPOSITION; ALENDRONATE; EXERCISE; ACID; INDIVIDUALS; PREVENTION; EFFICACY; THERAPY	Background: Various pharmacologic and non-pharmacologic approaches have been applied to reduce sublesional bone loss after spinal cord injury (SCI), and the results are inconsistent across the studies. The objective of this meta-analysis was to investigate whether the two most-studied interventions, bisphosphonate analogues and functional electrical stimulation (FES), could effectively decrease bone mineral density (BMD) attenuation and/or restore lost BMD in the SCI population. Methods: Randomized controlled trials, quasi-experimental studies, and prospective follow-up studies employing bisphosphonates or FES to treat post-SCI osteoporosis were identified in PubMed and Scopus. The primary outcome was the percentage of BMD change from baseline measured by dual-energy X-ray absorptiometry (DEXA) or computed tomography (CT). Data were extracted from four points: the 3rd, 6th, 12th, and 18th month after intervention. Results: A total of 19 studies were included in the analysis and involved 364 patients and 14 healthy individuals. Acute SCI participants treated with bisphosphonate therapy demonstrated a trend toward less bone loss than participants who received placebos or usual care. A significant difference in BMD decline was noted between both groups at the 3rd and 12th month post-medication. The subgroup analysis failed to show the superiority of intravenous bisphosphonate over oral administration. Regarding FES training, chronic SCI patients had 5.96% (95% CI, 2.08% to 9.84%), 7.21% (95% CI, 1.79% to 12.62%), and 9.56% (95% CI, 2.86% to 16.26%) increases in BMD at the 3rd, 6th, and 12th months post-treatment, respectively. The studies employing FES >= 5 days per week were likely to have better effectiveness than studies using FES <= 3 days per week. Conclusions: Our meta-analysis indicated bisphosphonate administration early following SCI effectively attenuated sublesional bone loss. FES intervention for chronic SCI patients could significantly increase sublesional BMD near the site of maximal mechanical loading.	[Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, BeiHu Branch, Taipei, Taiwan; [Chang, Ke-Vin; Hung, Chen-Yu; Chen, Wen-Shiang; Chien, Kuo-Liong; Han, Der-Sheng] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Ke-Vin; Lai, Mei-Shu; Chien, Kuo-Liong] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Hung, Chen-Yu; Chen, Wen-Shiang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw; dshan1121@yahoo.com.tw	Wen-shiang, Chen/B-4794-2009	Wen-shiang, Chen/0000-0003-1488-5164; Lai, Mei-shu/0000-0001-6130-3468; CHIEN, KUO-LIONG/0000-0003-4979-8351; HAN, DER-SHENG/0000-0001-7642-8060	National Science Council [102-2314-B-002-013, 100-2314-B-002-012-MY3, NSC 99-2320-B-002-005-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Science Council (102-2314-B-002-013, 100-2314-B-002-012-MY3 and NSC 99-2320-B-002-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman WA, 2005, J REHABIL RES DEV, V42, P625, DOI 10.1682/JRRD.2004.11.0145; Bauman WA, 2005, J REHABIL RES DEV, V42, P305, DOI 10.1682/JRRD.2004.05.0062; BeDell KK, 1996, AM J PHYS MED REHAB, V75, P29, DOI 10.1097/00002060-199601000-00008; Belanger M, 2000, ARCH PHYS MED REHAB, V81, P1090, DOI 10.1053/apmr.2000.7170; Biering-Sorensen F, 2009, SPINAL CORD, V47, P508, DOI 10.1038/sc.2008.177; Bloomfield SA, 1996, BONE, V19, P61, DOI 10.1016/8756-3282(96)00109-3; Bryson JE, 2009, J SPINAL CORD MED, V32, P215, DOI 10.1080/10790268.2009.11760776; Bubbear JS, 2011, OSTEOPOROSIS INT, V22, P271, DOI 10.1007/s00198-010-1221-6; Chang KV, 2013, ARCH PHYS MED REHAB, V94, P951, DOI 10.1016/j.apmr.2012.10.030; Chang KV, 2012, ARCH PHYS MED REHAB, V93, P1259, DOI 10.1016/j.apmr.2012.02.023; CHAPPARD D, 1995, J BONE MINER RES, V10, P112; Charmetant C., 2010, Annals of Physical and Rehabilitation Medicine, V53, P655, DOI 10.1016/j.rehab.2010.10.001; Chen SC, 2005, DISABIL REHABIL, V27, P1337, DOI 10.1080/09638280500164032; Clark JM, 2007, SPINAL CORD, V45, P78, DOI 10.1038/sj.sc.3101929; de Brito CMM, 2005, SPINAL CORD, V43, P341, DOI 10.1038/sj.sc.3101725; Dionyssiotis Y, 2011, J MUSCULOSKEL NEURON, V11, P257; Dolbow DR, 2011, NEUROREHABILITATION, V29, P261, DOI 10.3233/NRE-2011-0702; Eser P, 2003, EUR J CLIN INVEST, V33, P412, DOI 10.1046/j.1365-2362.2003.01156.x; Frotzler A, 2008, BONE, V43, P169, DOI 10.1016/j.bone.2008.03.004; Galea MP, 2012, SPINAL CORD, V50, P344, DOI 10.1038/sc.2011.149; Gater DR, 2011, NEUROREHABILITATION, V28, P231, DOI 10.3233/NRE-2011-0652; Giangregorio L, 2012, J SPINAL CORD MED, V35, P351, DOI 10.1179/2045772312Y.0000000041; Gilchrist NL, 2007, J CLIN ENDOCR METAB, V92, P1385, DOI 10.1210/jc.2006-2013; Griffin L, 2009, J ELECTROMYOGR KINES, V19, P614, DOI 10.1016/j.jelekin.2008.03.002; HANGARTNER TN, 1994, J REHABIL RES DEV, V31, P50; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jansen JP, 2011, SEMIN ARTHRITIS RHEU, V40, P275, DOI 10.1016/j.semarthrit.2010.06.001; Jiang SD, 2006, OSTEOPOROSIS INT, V17, P180, DOI 10.1007/s00198-005-2028-8; Lai CH, 2010, J REHABIL MED, V42, P150, DOI 10.2340/16501977-0499; Lauer RT, 2011, SPINAL CORD, V49, P917, DOI 10.1038/sc.2011.19; LEEDS EM, 1990, ARCH PHYS MED REHAB, V71, P207; Maimoun L, 2006, SPINAL CORD, V44, P203, DOI 10.1038/sj.sc.3101832; MINAIRE P, 1987, BONE, V8, pS63; MINAIRE P, 1981, J CLIN INVEST, V68, P1086, DOI 10.1172/JCI110331; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; Nance PW, 1999, ARCH PHYS MED REHAB, V80, P243, DOI 10.1016/S0003-9993(99)90133-8; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; PACY PJ, 1988, CLIN SCI, V75, P481, DOI 10.1042/cs0750481; Pearson EG, 1997, ARCH PHYS MED REHAB, V78, P269, DOI 10.1016/S0003-9993(97)90032-0; Shapiro J, 2007, CALCIFIED TISSUE INT, V80, P316, DOI 10.1007/s00223-007-9012-6; Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154; SLOAN KE, 1994, PARAPLEGIA, V32, P407, DOI 10.1038/sc.1994.67; Zehnder Y, 2004, J BONE MINER RES, V19, P1067, DOI 10.1359/JBMR.040313	43	41	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81124	10.1371/journal.pone.0081124	http://dx.doi.org/10.1371/journal.pone.0081124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278386	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700049
J	Engin, HB; Guney, E; Keskin, O; Oliva, B; Gursoy, A				Engin, H. Billur; Guney, Emre; Keskin, Ozlem; Oliva, Baldo; Gursoy, Attila			Integrating Structure to Protein-Protein Interaction Networks That Drive Metastasis to Brain and Lung in Breast Cancer	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; ENTAMOEBA-HISTOLYTICA; HOT-SPOTS; PATHWAY; MECHANISMS; RECEPTOR; DISEASE; GENES; IDENTIFICATION; ANNOTATION	Blocking specific protein interactions can lead to human diseases. Accordingly, protein interactions and the structural knowledge on interacting surfaces of proteins (interfaces) have an important role in predicting the genotype-phenotype relationship. We have built the phenotype specific sub-networks of protein-protein interactions (PPIs) involving the relevant genes responsible for lung and brain metastasis from primary tumor in breast cancer. First, we selected the PPIs most relevant to metastasis causing genes (seed genes), by using the "guilt-by-association" principle. Then, we modeled structures of the interactions whose complex forms are not available in Protein Databank (PDB). Finally, we mapped mutations to interface structures (real and modeled), in order to spot the interactions that might be manipulated by these mutations. Functional analyses performed on these sub-networks revealed the potential relationship between immune system-infectious diseases and lung metastasis progression, but this connection was not observed significantly in the brain metastasis. Besides, structural analyses showed that some PPI interfaces in both metastasis sub-networks are originating from microbial proteins, which in turn were mostly related with cell adhesion. Cell adhesion is a key mechanism in metastasis, therefore these PPIs may be involved in similar molecular pathways that are shared by infectious disease and metastasis. Finally, by mapping the mutations and amino acid variations on the interface regions of the proteins in the metastasis sub-networks we found evidence for some mutations to be involved in the mechanisms differentiating the type of the metastasis.	[Engin, H. Billur; Keskin, Ozlem; Gursoy, Attila] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey; [Engin, H. Billur; Keskin, Ozlem; Gursoy, Attila] Koc Univ, Coll Engn, Istanbul, Turkey	Koc University; Koc University	Gursoy, A (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	agursoy@ku.edu.tr	Oliva, Baldomero/A-2690-2009; Gasull, Martina/J-4076-2019; Gursoy, Attila/Z-4394-2019; Guney, Emre/B-2568-2017; Gursoy, Attila/E-9565-2015	Oliva, Baldomero/0000-0003-0702-0250; Gursoy, Attila/0000-0002-2297-2113; Guney, Emre/0000-0002-3466-6535; Gursoy, Attila/0000-0002-2297-2113	Spanish Government (MINECO) [FEDER BIO2011-22568, EUI2009-04018]; Scientific and Technological Research Council of Turkey (TUBITAK) [113E164]	Spanish Government (MINECO); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work is supported by Spanish Government (MINECO) grant FEDER BIO2011-22568 and EUI2009-04018 (ERASysBio + SHIPREC) and The Scientific and Technological Research Council of Turkey (TUBITAK) grant 113E164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Engin HB, 2012, J CHEM INF MODEL, V52, P2273, DOI 10.1021/ci300072q; ENGIN HB, 2013, CURR PHARM DES MEDLI, P13773; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garcia-Garcia J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-56; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Haile S, 2008, MED HYPOTHESES, V70, P375, DOI 10.1016/j.mehy.2007.04.042; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; LEROY A, 1994, INVAS METAST, V14, P177; Liang ZX, 2005, CANCER RES, V65, P967; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu K.-J., 2007, J CANC MOL, V3, P45; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Mehrotra J, 2004, CLIN CANCER RES, V10, P3104, DOI 10.1158/1078-0432.CCR-03-0118; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; OROZCO E, 1994, MUTAT RES, V305, P229, DOI 10.1016/0027-5107(94)90243-7; Ozbabacan SEA, 2012, J STRUCT BIOL, V179, P338, DOI 10.1016/j.jsb.2012.02.002; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RCore Team, 2020, R LANG ENV STAT COMP; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sato K, 2003, FEBS LETT, V553, P232, DOI 10.1016/S0014-5793(03)01005-6; Shin SY, 2003, J PEPT SCI, V9, P244, DOI 10.1002/psc.450; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SORDAT B, 1990, INVAS METAST, V10, P178; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tuncbag N, 2012, PROTEINS, V80, P1239, DOI 10.1002/prot.24022; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; WALTER FPB, 2003, MED PHYSL CELLULAR M, P15253; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	73	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81035	10.1371/journal.pone.0081035	http://dx.doi.org/10.1371/journal.pone.0081035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278371	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700045
J	Yuan, CQ; Zhang, HL; He, SS				Yuan, Chaoqun; Zhang, Hailong; He, Shisheng			Efficacy and Safety of Using Antifibrinolytic Agents in Spine Surgery: a Meta-Analysis	PLOS ONE			English	Article							EPSILON-AMINOCAPROIC ACID; PERIOPERATIVE BLOOD-LOSS; TRANEXAMIC ACID; DOUBLE-BLIND; TRANSFUSION; APROTININ; FUSION; SCOLIOSIS; AMICAR	Purpose: Spine surgery, particularly reconstructive surgery, can be associated with significant blood loss, and blood transfusion. Antifibrinolytic agents are used routinely to reduce bleeding in cardiac, orthopaedic, and hepatic surgery. The purpose of this study was to assess the efficacy and safety of using antifibrinolytic agents in reducing blood loss and blood transfusions in spine surgery. Methods: A systematic search of all related studies written in English published by October 2012 was conducted using the MEDLINE, EMBASE and the Cochrane Library databases. Randomized controlled trials that reported the drug dosage, total blood loss, blood transfusion and incidence of deep vein thrombosis as the primary outcome were included. Results: Nine studies involving 482 patients were identified. Patients receiving antifibrinolytic agents had reduced blood loss (WMD =-288.8, 95 % CI - 46.49, - 110.19; P = 0.002), reduced blood transfusion (WMD =-242.7, 95 % CI - 422.57, - 62.95; P = 0.008), reduced blood transfusion rate (RR 0.73, 95% CI 0.58, 0.93; p = 0.010) and no increase (RR 0.25, 95 % CI 0.03, 2.22; P = 0.21) in the risk of deep vein thrombosis. Conclusions: We conclude that antifibrinolytic agents significantly decrease blood loss, blood transfusion, and there is no increase in the risk of deep vein thrombosisfor transfusion requirements in spine surgery.	[Yuan, Chaoqun; Zhang, Hailong; He, Shisheng] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthopaed, Shanghai 200092, Peoples R China	Tongji University	He, SS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthopaed, Shanghai 200092, Peoples R China.	ycq890722@163.com		Yuan, Chaoqun/0000-0003-4354-422X				Baldus CR, 2010, SPINE, V35, P235, DOI 10.1097/BRS.0b013e3181c86cb9; Berenholtz SM, 2009, SPINE, V34, P2096, DOI 10.1097/BRS.0b013e3181b1fab2; Carless PA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub2; Cole JW, 2003, SPINE, V28, P2482, DOI 10.1097/01.BRS.0000090835.45437.7F; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Elwatidy S, 2008, SPINE, V33, P2577, DOI 10.1097/BRS.0b013e318188b9c5; Eubanks JD, 2010, J AM ACAD ORTHOP SUR, V18, P132, DOI 10.5435/00124635-201003000-00002; Farrokhi MR, 2011, J NEUROSURG ANESTH, V23, P290, DOI 10.1097/ANA.0b013e31822914a1; Florentino-Pineda I, 2004, SPINE, V29, P233, DOI 10.1097/01.BRS.0000109883.18015.B9; Gill JB, 2008, J BONE JOINT SURG AM, V90A, P2399, DOI 10.2106/JBJS.G.01179; Hassan N, 2011, TRANSFUSION, V51, P2133, DOI 10.1111/j.1537-2995.2011.03175.x; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Henry DA, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003602; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Ipema HJ, 2012, ANN PHARMACOTHER, V46, P97, DOI 10.1345/aph.1Q383; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Karski JM, 1998, J CARDIOTHOR VASC AN, V12, P642, DOI 10.1016/S1053-0770(98)90235-X; Khoshhal K, 2003, J PEDIATR ORTHOPED, V23, P661, DOI 10.1097/01241398-200309000-00017; Laupacis A, 1998, TRANSFUSION MED, V8, P309; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Neilipovitz DT, 2001, ANESTH ANALG, V93, P82; Niskanen RO, 2005, ACTA ORTHOP, V76, P829, DOI 10.1080/17453670510045444; Sethna NF, 2005, ANESTHESIOLOGY, V102, P727, DOI 10.1097/00000542-200504000-00006; Shah SA, 2012, SPINE, V37, P549; Slaughter TF, 1997, AM J HEMATOL, V56, P32, DOI 10.1002/(SICI)1096-8652(199709)56:1<32::AID-AJH7>3.0.CO;2-3; Thompson GH, 2008, SPINE, V33, P2237, DOI 10.1097/BRS.0b013e31817bd889; Tsutsumimoto T, 2011, SPINE, V36, P1913, DOI 10.1097/BRS.0b013e3181fb3a42; Urban MK, 2001, SPINE, V26, P1152, DOI 10.1097/00007632-200105150-00012; Verma K, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-13; Wong J, 2008, ANESTH ANALG, V107, P1479, DOI 10.1213/ane.0b013e3181831e44; Yagi M, 2012, SPINE, V37, pE1336, DOI 10.1097/BRS.0b013e318266b6e5; Zufferey P, 2006, ANESTHESIOLOGY, V105, P1034, DOI 10.1097/00000542-200611000-00026	32	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82063	10.1371/journal.pone.0082063	http://dx.doi.org/10.1371/journal.pone.0082063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278471	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700073
J	Fournier, D; Palidwor, GA; Shcherbinin, S; Szengel, A; Schaefer, MH; Perez-Iratxeta, C; Andrade-Navarro, MA				Fournier, David; Palidwor, Gareth A.; Shcherbinin, Sergey; Szengel, Angelika; Schaefer, Martin H.; Perez-Iratxeta, Carol; Andrade-Navarro, Miguel A.			Functional and Genomic Analyses of Alpha-Solenoid Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HEAT REPEATS; DOMAIN; MECHANISM; COMPLEX; FAMILY; PREDICTION; REVEALS; BINDING	Alpha-solenoids are flexible protein structural domains formed by ensembles of alpha-helical repeats (Armadillo and HEAT repeats among others). While homology can be used to detect many of these repeats, some alpha-solenoids have very little sequence homology to proteins of known structure and we expect that many remain undetected. We previously developed a method for detection of alpha-helical repeats based on a neural network trained on a dataset of protein structures. Here we improved the detection algorithm and updated the training dataset using recently solved structures of alpha-solenoids. Unexpectedly, we identified occurrences of alpha-solenoids in solved protein structures that escaped attention, for example within the core of the catalytic subunit of PI3KC. Our results expand the current set of known alpha-solenoids. Application of our tool to the protein universe allowed us to detect their significant enrichment in proteins interacting with many proteins, confirming that alpha-solenoids are generally involved in protein-protein interactions. We then studied the taxonomic distribution of alpha-solenoids to discuss an evolutionary scenario for the emergence of this type of domain, speculating that alpha-solenoids have emerged in multiple taxa in independent events by convergent evolution. We observe a higher rate of alpha-solenoids in eukaryotic genomes and in some prokaryotic families, such as Cyanobacteria and Planctomycetes, which could be associated to increased cellular complexity. The method is available at http://cbdm.mdc-berlin.de/(-)ard2/.	[Fournier, David; Szengel, Angelika; Schaefer, Martin H.; Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Palidwor, Gareth A.; Perez-Iratxeta, Carol] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Shcherbinin, Sergey] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia	Andrade-Navarro, MA (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	miguel.andrade@mdc-berlin.de	Andrade, Miguel/B-6565-2008	Andrade, Miguel/0000-0001-6650-1711; Palidwor, Gareth/0000-0001-5317-319X; Schaefer, Martin/0000-0001-7503-6364	Collaborative Research Center for Theoretical Biology: Robustness, Modularity and Evolutionary Design of Living Systems, Humboldt-University of Berlin, Germany [Sonderforschungsbereich 618 (SFB 618)]	Collaborative Research Center for Theoretical Biology: Robustness, Modularity and Evolutionary Design of Living Systems, Humboldt-University of Berlin, Germany	This work is funded by the Collaborative Research Center for Theoretical Biology: Robustness, Modularity and Evolutionary Design of Living Systems [Sonderforschungsbereich 618 (SFB 618)], Humboldt-University of Berlin, Germany. Website: http://www.biologie.hu-berlin.de/forschung/SFB_618. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; CHITNIS PR, 1991, J BIOL CHEM, V266, P58; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Fournier D, 2011, BIOINFORMATICS, V27, P2605, DOI 10.1093/bioinformatics/btr419; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Hast MA, 2008, J BIOL CHEM, V283, P31933, DOI 10.1074/jbc.M805330200; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; He FH, 2012, FEBS LETT, V586, P3858, DOI 10.1016/j.febslet.2012.09.009; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huska MR, 2007, BIOINFORMATICS, V23, P3093, DOI 10.1093/bioinformatics/btm489; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liberman N, 2008, J MOL BIOL, V383, P539, DOI 10.1016/j.jmb.2008.08.013; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Manca A, 2012, P NATL ACAD SCI USA, V109, P2009, DOI 10.1073/pnas.1121138109; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Melkani GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022579; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Mills RD, 2012, BIOCHEM SOC T, V40, P1086, DOI 10.1042/BST20120088; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Perez-Iratxeta C, 2007, EMBO REP, V8, P1135, DOI 10.1038/sj.embor.7401117; Peters JW, 1996, NAT STRUCT BIOL, V3, P991, DOI 10.1038/nsb1296-991; Punta Marco, 2008, V458, P203; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schaefer MH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002860; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Schlesner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-56; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stevens NR, 2009, J CELL BIOL, V187, P355, DOI 10.1083/jcb.200905031; Studholme DJ, 2004, FEMS MICROBIOL LETT, V236, P333, DOI 10.1016/j.femsle.2004.06.007; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	84	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79894	10.1371/journal.pone.0079894	http://dx.doi.org/10.1371/journal.pone.0079894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278209	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000327539800030
J	Ge, JP; Ju, YQ; Xue, ZG; Feng, Y; Huang, XF; Liu, HW; Zhao, SL				Ge, Jianping; Ju, Yanqin; Xue, Zhigang; Feng, Yun; Huang, Xiaofeng; Liu, Hongwei; Zhao, Shouliang			Distal C Terminus of Ca(V)1.2 Channels Plays a Crucial Role in the Neural Differentiation of Dental Pulp Stem Cells	PLOS ONE			English	Article							CALCIUM-CHANNELS; PATHWAYS; SUBUNIT; DOMAIN; AGE	L-type voltage-dependent Ca(V)1.2 channels play an important role in the maintenance of intracellular calcium homeostasis, and influence multiple cellular processes. C-terminal cleavage of Ca(V)1.2 channels was reported in several types of excitable cells, but its expression and possible roles in non-excitable cells is still not clear. The aim of this study was to determine whether distal C-terminal fragment of Ca(V)1.2 channels is present in rat dental pulp stem cells and its possible role in the neural differentiation of rat dental pulp stem cells. We generated stable Ca(V)1.2 knockdown cells via short hairpin RNA (shRNA). Rat dental pulp stem cells with deleted distal C-terminal of Ca(V)1.2 channels lost the potential of differentiation to neural cells. Re-expression of distal C-terminal of Ca(V)1.2 rescued the effect of knocking down the endogenous Ca(V)1.2 on the neural differentiation of rat dental pulp stem cells, indicating that the distal C-terminal of Ca(V)1.2 is required for neural differentiation of rat dental pulp stem cells. These results provide new insights into the role of voltage-gated Ca2+ channels in stem cells during differentiation.	[Ge, Jianping; Ju, Yanqin; Huang, Xiaofeng; Liu, Hongwei; Zhao, Shouliang] Tongji Univ, Sch Stomatol, Lab Oral Biomed Sci & Translat Med, Dept Conservat Dent, Shanghai 200092, Peoples R China; [Xue, Zhigang; Feng, Yun] Tongji Univ, Sch Med, Tongji Hosp, Dept Regenerat Med,Stem Cell Res Ctr,Translat Ctr, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Liu, HW (corresponding author), Tongji Univ, Sch Stomatol, Lab Oral Biomed Sci & Translat Med, Dept Conservat Dent, Shanghai 200092, Peoples R China.	hwliu@tongji.edu.cn; slzhao@tongji.edu.cn			National Natural Science Foundation of China [81070825, 81170951]; Shanghai Science and Technology Committee [10411964600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grant 81070825 and 81170951 from National Natural Science Foundation of China, also by grant 10411964600 from Shanghai Science and Technology Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki M, 2012, J BIOL CHEM, V287, P10590, DOI 10.1074/jbc.M111.285874; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Dodson SA, 1996, J PERIODONTOL, V67, P184, DOI 10.1902/jop.1996.67.3.184; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Feliciano DM, 2009, J BIOL CHEM, V284, P26466, DOI 10.1074/jbc.M109.027680; Ferreira-Martins J, 2009, CIRC RES, V105, P764, DOI 10.1161/CIRCRESAHA.109.206698; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Gomez-Ospina N, 2013, PLOS ONE, DOI [10.1371/journal.pone.0060526, DOI 10.1371/J0URNAL.P0NE.0060526.PUBMED:23613729]; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grimm I, 2009, J CELL SCI, V122, P2524, DOI 10.1242/jcs.044891; Guo ZX, 2010, NEUROSCI LETT, V478, P156, DOI 10.1016/j.neulet.2010.05.007; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Karaoz E, 2011, HISTOCHEM CELL BIOL, V136, P455, DOI 10.1007/s00418-011-0858-3; Karnabi E, 2009, BIOCHEM BIOPH RES CO, V384, P409, DOI 10.1016/j.bbrc.2009.04.150; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kim BC, 2012, TISSUE ENG PART B-RE, V18, P235, DOI [10.1089/ten.TEB.2011.0642, 10.1089/ten.teb.2011.0642]; Lepski G, 2010, EXP CELL RES, V316, P216, DOI 10.1016/j.yexcr.2009.08.006; Lu CB, 2009, NEUROSCIENCE, V161, P403, DOI 10.1016/j.neuroscience.2009.03.063; Malmersjo S, 2010, STEM CELLS DEV, V19, P1355, DOI 10.1089/scd.2009.0436; Soria JM, 2011, J BIOMED MATER RES A, V97A, P85, DOI 10.1002/jbm.a.33032; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Sedgley Christine M, 2012, Dent Clin North Am, V56, P549, DOI 10.1016/j.cden.2012.05.004; TSUJI T, 1990, MECH AGEING DEV, V51, P121, DOI 10.1016/0047-6374(90)90094-V; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; Zahanich I, 2005, J BONE MINER RES, V20, P1637, DOI 10.1359/JBMR.050521	31	12	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81332	10.1371/journal.pone.0081332	http://dx.doi.org/10.1371/journal.pone.0081332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278424	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800123
J	Zachar, N; Neiman, M				Zachar, Nicholas; Neiman, Maurine			Profound Effects of Population Density on Fitness-Related Traits in an Invasive Freshwater Snail	PLOS ONE			English	Article							GASTROPOD POTAMOPYRGUS-ANTIPODARUM; NEW-ZEALAND SNAIL; INTERSPECIFIC COMPETITION; EMBRYO PRODUCTION; LIFE-HISTORY; DYNAMICS; SEX; REPRODUCTION; SENSITIVITY; LINEAGES	Population density can profoundly influence fitness-related traits and population dynamics, and density dependence plays a key role in many prominent ecological and evolutionary hypotheses. Here, we evaluated how individual-level changes in population density affect growth rate and embryo production early in reproductive maturity in two different asexual lineages of Potamopyrgus antipodarum, a New Zealand freshwater snail that is an important model system for ecotoxicology and the evolution of sexual reproduction as well as a potentially destructive worldwide invader. We showed that population density had a major influence on individual growth rate and early-maturity embryo production, effects that were often apparent even when comparing treatments that differed in population density by only one individual. While individual growth rate generally decreased as population density increased, we detected a hump-shaped relationship between embryo production and density, with females from intermediate-density treatments producing the most embryos and females from low-and high-density treatments producing the fewest embryos. The two lineages responded similarly to the treatments, indicating that these effects of population density might apply more broadly across P. antipodarum. These results indicate that there are profound and complex relationships between population density, growth rate, and early-maturity embryo production in at least two lineages of this important model system, with potential implications for the study of invasive populations, research on the maintenance of sex, and approaches used in ecotoxicology.	[Zachar, Nicholas; Neiman, Maurine] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Neiman, M (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	maurine-neiman@uiowa.edu			University of Iowa; Research Council of Norway [196468/V40]	University of Iowa; Research Council of Norway(Research Council of Norway)	This research was funded by the University of Iowa and by the Research Council of Norway (grant number # 196468/V40; http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2012, AQUAT SCI, V74, P375, DOI 10.1007/s00027-012-0254-7; BAUR B, 1990, J ANIM ECOL, V59, P301, DOI 10.2307/5174; Benton TG, 2012, PHILOS T R SOC B, V367, P200, DOI 10.1098/rstb.2011.0168; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Cope NJ, 2004, AQUAT ECOL, V38, P83; Cross WF, 2002, OIKOS, V96, P251, DOI 10.1034/j.1600-0706.2002.960207.x; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; DORGELO J, 1987, Hydrobiological Bulletin, V21, P95, DOI 10.1007/BF02255459; Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4; Duft M, 2007, ECOTOXICOLOGY, V16, P169, DOI 10.1007/s10646-006-0106-0; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Gust M, 2011, AQUAT TOXICOL, V101, P396, DOI 10.1016/j.aquatox.2010.11.013; Haase M, 2003, J ROY SOC NEW ZEAL, V33, P549, DOI 10.1080/03014223.2003.9517743; Jokela J, 2003, BIOL J LINN SOC, V79, P165, DOI 10.1046/j.1095-8312.2003.00181.x; Jokela J, 1997, ECOLOGY, V78, P452; Kerans BL, 2005, J N AM BENTHOL SOC, V24, P123, DOI 10.1899/0887-3593(2005)024<0123:PADDAE>2.0.CO;2; King KC, 2011, EVOLUTION, V65, P1474, DOI 10.1111/j.1558-5646.2010.01215.x; LIVELY CM, 1987, NATURE, V328, P519, DOI 10.1038/328519a0; Macken A, 2012, ENVIRON TOXICOL CHEM, V31, P1989, DOI 10.1002/etc.1875; Mangal TD, 2010, J PARASITOL RES, V2010; McKenzie VJ, 2013, CAN J ZOOL, V91, P30, DOI 10.1139/cjz-2012-0183; Neiman M, 2006, INVERTEBR BIOL, V125, P45, DOI 10.1111/j.1744-7410.2006.00038.x; Neiman M, 2013, EVOL ECOL, V27, P1117, DOI 10.1007/s10682-013-9632-4; Neiman M, 2013, EVOLUTION, V67, P1511, DOI 10.1111/evo.12026; Neiman M, 2010, MOL BIOL EVOL, V27, P954, DOI 10.1093/molbev/msp300; Oehlmann J, 2007, ECOTOXICOLOGY, V16, P29, DOI 10.1007/s10646-006-0109-x; Schreiber ESG, 1998, MAR FRESHWATER RES, V49, P73, DOI 10.1071/MF97113; Sieratowicz A, 2013, J ENVIRON SCI HEAL A, V48, P481, DOI 10.1080/10934529.2013.730390; Stange D, 2012, J MOLLUS STUD, V78, P337, DOI 10.1093/mollus/eys019; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; THOMAS JD, 1974, J ANIM ECOL, V43, P31, DOI 10.2307/3156; Tibbets TM, 2010, OECOLOGIA, V163, P549, DOI 10.1007/s00442-009-1522-7; Wagner M, 2009, ENVIRON SCI POLLUT R, V16, P278, DOI 10.1007/s11356-009-0107-7; WINTERBOURN M J, 1970, Proceedings of the Malacological Society of London, V39, P139	35	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80067	10.1371/journal.pone.0080067	http://dx.doi.org/10.1371/journal.pone.0080067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278240	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800050
J	Zhang, L; Meng, XX; Ju, XB; Cai, HZ; Li, P; Cao, Q; Shao, PF; Qin, C; Yin, CJ				Zhang, Lei; Meng, Xiaoxin; Ju, Xiaobing; Cai, Hongzhou; Li, Pu; Cao, Qiang; Shao, Pengfei; Qin, Chao; Yin, Changjun			One-Carbon Metabolism Pathway Gene Variants and Risk of Clear Cell Renal Cell Carcinoma in a Chinese Population	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; LUNG-CANCER; THYMIDYLATE-SYNTHASE; METHIONINE SYNTHASE; DNA HYPOMETHYLATION; KIDNEY CANCER; COLON-CANCER; POLYMORPHISMS; ASSOCIATION; REDUCTASE	Background: One-carbon metabolism is the basement of nucleotide synthesis and the methylation of DNA linked to cancer risk. Variations in one-carbon metabolism genes are reported to affect the risk of many cancers, including renal cancer, but little knowledge about this mechanism is known in Chinese population. Methods: Each subject donated 5 mL venous blood after signing the agreement. The study was approved by the Institutional Review Board of the Nanjing Medical University, Nanjing, China. 18 SNPs in six one-carbon metabolism-related genes (CBS, MTHFR, MTR, MTRR, SHMT1, and TYMS) were genotyped in 859 clear cell renal cell carcinoma (ccRCC) patients and 1005 cancer-free controls by the Snapshot. Results: Strong associations with ccRCC risk were observed for rs706209 (P = 0.006) in CBS and rs9332 (P = 0.027) in MTRR. Compared with those carrying none variant allele, individuals carrying one or more variant alleles in these two genes had a statistically significantly decreased risk of ccRCC [P = 0.001, adjusted odds ratio (OR) = 0.73, 95% confidence interval (CI) = 0.06-0.90]. In addition, patients carrying one or more variant alleles were more likely to develop localized stage disease (P = 0.002, adjusted OR = 1.37, 95% CI = 1.11-1.69) and well-differentiated ccRCC (P, 0.001, adjusted OR = 1.42, 95% CI = 0.87-1.68). In the subgroup analysis, individuals carrying none variant allele in older group (P = 0.007, adjusted OR = 0.67, 95% CI = 0.49-0.91), male group (P = 0.007, adjusted OR = 0.71, 95% CI = 0.55-0.92), never smoking group (P = 0.002, adjusted OR = 0.68, 95% CI = 0.53-0.88) and never drinking group (P, 0.001, adjusted OR = 0.68, 95% CI = 0.53-0.88) had an increased ccRCC risk. Conclusions: Our results suggest that the polymorphisms of the one-carbon metabolism-related genes are associated with ccRCC risk in Chinese population. Future population-based prospective studies are required to confirm the results.	[Zhang, Lei; Meng, Xiaoxin; Ju, Xiaobing; Cai, Hongzhou; Li, Pu; Cao, Qiang; Shao, Pengfei; Qin, Chao; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Qin, C (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	qinchao@njmu.edu.cn; drcjyin@gmail.com	Cao, Qiang/K-2349-2019	Cai, Hongzhou/0000-0001-6915-564X	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81171963, 81102089, 81201998]	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, the National Natural Science Foundation of China [grant number 81171963, 81102089, and 81201998]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccia S, 2009, CANCER LETT, V273, P55, DOI 10.1016/j.canlet.2008.07.026; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cui LH, 2011, PHARMACOGENOMICS, V12, P797, DOI [10.2217/pgs.11.27, 10.2217/PGS.11.27]; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Flores KG, 2012, CARCINOGENESIS, V33, P1542, DOI 10.1093/carcin/bgs194; Galbiatti ALS, 2010, ARCH MED SCI, V6, P772, DOI 10.5114/aoms.2010.17094; Gibson TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026165; Hirata H, 2009, J UROLOGY, V182, P721, DOI 10.1016/j.juro.2009.03.081; Kawai Y, 2007, EUR UROL, V52, P1147, DOI 10.1016/j.eururo.2007.01.073; Kawakami T, 2003, UROLOGY, V61, P226, DOI 10.1016/S0090-4295(02)02110-6; Kleinrath T, 2007, J CLIN ONCOL, V25, P845, DOI 10.1200/JCO.2006.07.8154; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Llorca Javier, 2005, Gac Sanit, V19, P321, DOI 10.1157/13078032; Mandola MV, 2004, PHARMACOGENETICS, V14, P319, DOI 10.1097/00008571-200405000-00007; Mao RF, 2008, J HUM GENET, V53, P340, DOI 10.1007/s10038-008-0262-6; Marchand LL, 2002, CANCER CAUSE CONTROL, V13, P239, DOI 10.1023/A:1015057614870; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Moore LE, 2008, INT J CANCER, V122, P1710, DOI 10.1002/ijc.23318; Morrissey C, 2001, CANCER RES, V61, P7277; Qin C, 2012, ANN ONCOL, V23, P981, DOI 10.1093/annonc/mdr325; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Shi QL, 2005, CANCER EPIDEM BIOMAR, V14, P1477, DOI 10.1158/1055-9965.EPI-04-0905; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skibola CF, 2004, BLOOD, V104, P2155, DOI 10.1182/blood-2004-02-0557; Teodoridis JM, 2004, BIOCHEM SOC T, V32, P916, DOI 10.1042/BST0320916; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81129	10.1371/journal.pone.0081129	http://dx.doi.org/10.1371/journal.pone.0081129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278388	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800104
J	Babazadeh, R; Adiels, CB; Smedh, M; Petelenz-Kurdziel, E; Goksor, M; Hohmann, S				Babazadeh, Roja; Adiels, Caroline Beck; Smedh, Maria; Petelenz-Kurdziel, Elzbieta; Goksor, Mattias; Hohmann, Stefan			Osmostress-Induced Cell Volume Loss Delays Yeast Hog1 Signaling by Limiting Diffusion Processes and by Hog1-Specific Effects	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE REQUIRES; OSMOTIC-STRESS RESPONSE; TRANSCRIPTIONAL RESPONSE; MAP KINASE; TYROSINE PHOSPHATASES; GENOME EXPRESSION; GENE-EXPRESSION; 2 ISOENZYMES; GLYCEROL	Signal transmission progresses via a series of transient protein-protein interactions and protein movements, which require diffusion within a cell packed with different molecules. Yeast Hog1, the effector protein kinase of the High Osmolarity Glycerol pathway, translocates transiently from the cytosol to the nucleus during adaptation to high external osmolarity. We followed the dynamics of osmostress-induced cell volume loss and Hog1 nuclear accumulation upon exposure of cells to different NaCl concentrations. While Hog1 nuclear accumulation peaked within five minutes following mild osmotic shock it was delayed up to six-fold under severe stress. The timing of Hog1 nuclear accumulation correlated with the degree of cell volume loss and the cells capacity to recover. Also the nuclear translocation of Msn2, the transcription factor of the general stress response pathway, is delayed upon severe osmotic stress suggesting a general phenomenon. We show by direct measurements that the general diffusion rate of Hog1 in the cytoplasm as well as its rate of nuclear transport are dramatically reduced following severe volume reduction. However, neither Hog1 phosphorylation nor Msn2 nuclear translocation were as much delayed as Hog1 nuclear translocation. Our data provide direct evidence that signaling slows down during cell volume compression, probably as a consequence of molecular crowding. Hence one purpose of osmotic adaptation is to restore optimal diffusion rates for biochemical and cell biological processes. In addition, there may be mechanisms slowing down especially Hog1 nuclear translocation under severe stress in order to prioritize Hog1 cytosolic targets.	[Babazadeh, Roja; Petelenz-Kurdziel, Elzbieta; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Adiels, Caroline Beck; Smedh, Maria; Goksor, Mattias] Univ Gothenburg, Dept Phys, Gothenburg, Sweden; [Smedh, Maria] Univ Gothenburg, Ctr Cellular Imaging, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Hohmann, S (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden.	stefan.hohmann@gu.se	Hohmann, Stefan/K-9895-2013	Hohmann, Stefan/0000-0002-0809-1985; Beck Adiels, Caroline/0000-0002-2403-2213	Swedish Research Council; EC [201142, 289995]	Swedish Research Council(Swedish Research CouncilEuropean Commission); EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Swedish Research Council (to MG and SH, respectively) as well as the EC-funded FP7 projects UNICELLSYS (collaborative project contract 201142 to MG and SH) and ISOLATE (Initial Training Network contract 289995 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Baltanas R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003312; Beese SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000738; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen HM, 2008, METHOD CELL BIOL, V89, P3, DOI 10.1016/S0091-679X(08)00601-8; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; DAY CA, 2012, CURR PROTOC CYTOM, V19, P42527; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Eriksson E, 2010, LAB CHIP, V10, P617, DOI 10.1039/b913587a; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Frey S, 2011, MOL BIOSYST, V7, P215, DOI 10.1039/c005305h; Furukawa K, 2009, MOL MICROBIOL, V74, P1272, DOI 10.1111/j.1365-2958.2009.06933.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geijer C, 2013, FEBS J, V280, P3854, DOI 10.1111/febs.12382; Hanninen AL, 1999, MOL BIOL CELL, V10, P3623, DOI 10.1091/mbc.10.11.3623; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; JACOBSON K, 1984, P NATL ACAD SCI-BIOL, V81, P6747, DOI 10.1073/pnas.81.21.6747; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Jung G, 2000, GENETICS, V156, P559; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; Lee YJ, 2012, MOL CELL BIOL, V32, P4705, DOI 10.1128/MCB.00897-12; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; MartinezPastor MT, 1996, FEBS LETT, V390, P319, DOI 10.1016/0014-5793(96)00683-7; Mattison CP, 2000, GENE DEV, V14, P1229; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Norbeck J, 1996, FEMS MICROBIOL LETT, V137, P1; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; Oliveira AP, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.55; Patterson JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001275; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; PETELENZKURDZIE.E, 2013, STRESS PLOS COMPUT B, V9, P3084; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Reiser V, 1999, GENE EXPRESSION, V7, P247; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Siderius M, 2000, MOL MICROBIOL, V36, P1381, DOI 10.1046/j.1365-2958.2000.01955.x; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; van den Bogaart G, 2007, MOL MICROBIOL, V64, P858, DOI 10.1111/j.1365-2958.2007.05705.x; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522	68	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80901	10.1371/journal.pone.0080901	http://dx.doi.org/10.1371/journal.pone.0080901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278344	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100126
J	Nielsen, I; Bentsen, IB; Andersen, AH; Gasser, SM; Bjergbaek, L				Nielsen, Ida; Bentsen, Iben Bach; Andersen, Anni H.; Gasser, Susan M.; Bjergbaek, Lotte			A Rad53 Independent Function of Rad9 Becomes Crucial for Genome Maintenance in the Absence of the RecQ Helicase Sgs1	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; TOPOISOMERASE-III-ALPHA; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; S-PHASE; BUDDING YEAST; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPLICATION FORKS; PYRIMIDINE DIMERS	The conserved family of RecQ DNA helicases consists of caretaker tumour suppressors, that defend genome integrity by acting on several pathways of DNA repair that maintain genome stability. In budding yeast, Sgs1 is the sole RecQ helicase and it has been implicated in checkpoint responses, replisome stability and dissolution of double Holliday junctions during homologous recombination. In this study we investigate a possible genetic interaction between SGS1 and RAD9 in the cellular response to methyl methane sulphonate (MMS) induced damage and compare this with the genetic interaction between SGS1 and RAD24. The Rad9 protein, an adaptor for effector kinase activation, plays well-characterized roles in the DNA damage checkpoint response, whereas Rad24 is characterized as a sensor protein also in the DNA damage checkpoint response. Here we unveil novel insights into the cellular response to MMS-induced damage. Specifically, we show a strong synergistic functionality between SGS1 and RAD9 for recovery from MMS induced damage and for suppression of gross chromosomal rearrangements, which is not the case for SGS1 and RAD24. Intriguingly, it is a Rad53 independent function of Rad9, which becomes crucial for genome maintenance in the absence of Sgs1. Despite this, our dissection of the MMS checkpoint response reveals parallel, but unequal pathways for Rad53 activation and highlights significant differences between MMS- and hydroxyurea (HU)-induced checkpoint responses with relation to the requirement of the Sgs1 interacting partner Topoisomerase III (Top3). Thus, whereas earlier studies have documented a Top3-independent role of Sgs1 for an HU-induced checkpoint response, we show here that upon MMS treatment, Sgs1 and Top3 together define a minor but parallel pathway to that of Rad9.	[Nielsen, Ida; Bentsen, Iben Bach; Andersen, Anni H.; Bjergbaek, Lotte] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Aarhus University; Friedrich Miescher Institute for Biomedical Research	Bjergbaek, L (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	lbj@mb.au.dk	Bjergbæk, Lotte/AAW-6302-2021; Andersen, Anni/O-1162-2017	Andersen, Anni/0000-0001-7194-3258; Bjergbaek, Lotte/0000-0002-8233-3356; Gasser, Susan/0000-0003-3610-9123; Jensen, Ida Skodt/0000-0003-1204-1283	Danish Research Council [FNU 272-07-0366]; Aase og Einar Danielsens Foundation; Danish Cancer Society; Lundbeckfoundation [53/06]; Swiss Cancer League grant	Danish Research Council(Det Frie Forskningsrad (DFF)); Aase og Einar Danielsens Foundation; Danish Cancer Society(Danish Cancer Society); Lundbeckfoundation(Lundbeckfonden); Swiss Cancer League grant	This work was supported by grants from the Danish Research Council (FNU 272-07-0366), and Aase og Einar Danielsens Foundation to L.B., and the Danish Cancer Society to A.H.A. and L.B. I.B.B. is supported by the Lundbeckfoundation (53/06). S.M.G. was supported by a Swiss Cancer League grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Al-Moghrabi NM, 2001, NUCLEIC ACIDS RES, V29, P2020, DOI 10.1093/nar/29.10.2020; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chakraverty RK, 2001, MOL CELL BIOL, V21, P7150, DOI 10.1128/MCB.21.21.7150-7162.2001; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; Foss EJ, 2001, GENETICS, V157, P567; Frei C, 2000, GENE DEV, V14, P81; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Goodwin A, 1999, NUCLEIC ACIDS RES, V27, P4050, DOI 10.1093/nar/27.20.4050; Hegnauer AM, 2012, EMBO J, V31, P3768, DOI 10.1038/emboj.2012.195; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Klein HL, 2001, GENETICS, V159, P1501; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Lea DEaC C.A., 1948, J GENET, V49, P264; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Longhese MP, 1996, MOL CELL BIOL, V16, P3235; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lottersberger F, 2013, P NATL ACAD SCI USA, V110, P2146, DOI 10.1073/pnas.1222617110; Lowndes NF, 2010, DNA REPAIR, V9, P1112, DOI 10.1016/j.dnarep.2010.07.012; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Mohaghegh P, 2002, INT J BIOCHEM CELL B, V34, P1496, DOI 10.1016/S1357-2725(02)00039-0; Mullen JR, 2001, GENETICS, V157, P103; Murakami-Sekimata A, 2010, DNA REPAIR, V9, P824, DOI 10.1016/j.dnarep.2010.04.007; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Paulovich AG, 1997, GENETICS, V145, P45; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schwartz MF, 2002, MOL CELL, V9, P1055, DOI 10.1016/S1097-2765(02)00532-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang Y, 2000, GENE DEV, V14, P927; Watt PM, 1996, GENETICS, V144, P935; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yu SR, 2001, MUTAT RES-DNA REPAIR, V485, P229, DOI 10.1016/S0921-8777(01)00061-1; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	68	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81015	10.1371/journal.pone.0081015	http://dx.doi.org/10.1371/journal.pone.0081015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278365	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100135
J	Wang, L; Lu, KY; Hao, HH; Li, XY; Wang, J; Wang, K; Wang, J; Yan, Z; Zhang, SL; Du, YH; Liu, HR				Wang, Li; Lu, Keyi; Hao, Haihu; Li, Xiaoyu; Wang, Jie; Wang, Ke; Wang, Jin; Yan, Zi; Zhang, Suli; Du, Yunhui; Liu, Huirong			Decreased Autophagy in Rat Heart Induced by Anti-beta 1-Adrenergic Receptor Autoantibodies Contributes to the Decline in Mitochondrial Membrane Potential	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; CARDIAC CELLULAR AUTOPHAGY; BETA-ADRENERGIC-RECEPTORS; 2ND EXTRACELLULAR LOOP; ACETYLCHOLINE-RECEPTORS; SERUM AUTOANTIBODIES; OXIDATIVE STRESS; QUALITY-CONTROL; FAILURE; DISEASE	It has been recognized that changes in mitochondrial structure plays a key role in development of cardiac dysfunction, and autophagy has been shown to exert maintenance of mitochondrial homeostasis effects. Our previous study found that anti-beta(1)-adrenergic receptor autoantibodies (beta(1)-AABs) could lead to cardiac dysfunction along with abnormalities in mitochondrial structure. The present study tested the hypothesis that beta(1)-AABs may induce the decline in mitochondrial membrane potential (Delta psi m) by suppression of cardiac autophagy, which contributed to cardiac dysfunction. Male adult rats were randomized to receive a vehicle or peptide corresponding to the second extracellular loop of the beta(1) adrenergic receptor (beta(1)-AAB group, 0.4 mu g/g every two weeks for 12 weeks) and treated with rapamycin (RAPA, an autophagy agonist) at 5 mg/kg/day for two days before detection. At the 4th week, 8th week and 12th week of active immunization, the rats were sacrificed and cardiac function and the levels of cardiac LC3 and Beclin-1 were detected. Delta psi m in cardiac myocytes was determined by myocardial radionuclide imaging technology and JC-1 staining. In the present study, beta(1)-AABs caused cardiac dysfunction, reduced Delta psi m and decreased cardiac autophagy. Treatment with RAPA markedly attenuated beta(1)-AABs-induced cardiac injury evidenced by recovered Delta psi m. Taken together, these results suggested that beta(1)-AABs exerted significant decreased Delta psi m, which may contribute to cardiac dysfunction, most likely by decreasing cardiac autophagy in vivo. Moreover, myocardial radionuclide imaging technology may be needed to assess the risk in developing cardiac dysfunction for the people who have beta(1)-AABs in their blood.	[Wang, Li; Li, Xiaoyu; Wang, Jie; Wang, Jin; Yan, Zi; Liu, Huirong] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Lu, Keyi] Shanxi Med Univ, Dept Nucl Med, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Hao, Haihu] Shanxi Dayi Hosp, Dept Orthopaed, Shanxi Acad Med Sci, Taiyuan, Shanxi, Peoples R China; [Wang, Ke; Zhang, Suli; Du, Yunhui; Liu, Huirong] Capital Med Univ, Dept Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Capital Medical University	Liu, HR (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China.	liuhr2000@126.com			Natural Sciences Foundation of China [81070263]; Science Foundation for Youths of Shanxi Medical University [02201004]; Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi, STIP [2010010]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for Youths of Shanxi Medical University; Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi, STIP	This study was supported by Natural Sciences Foundation of China (grant number 81070263) and Science Foundation for Youths of Shanxi Medical University (grant number 02201004). In addition, the work during the revision process was supported by Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi, STIP. number 2010010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHRO M, 1987, J MOL CELL CARDIOL, V19, P1169, DOI 10.1016/S0022-2828(87)80527-8; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bowser DN, 1998, BIOPHYS J, V75, P2004, DOI 10.1016/S0006-3495(98)77642-8; CARVALHO PA, 1992, J NUCL MED, V33, P1516; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jiang H, 2009, HEART, V95, P1727, DOI 10.1136/hrt.2008.150177; Kaasik A, 2004, FASEB J, V18, P1219, DOI 10.1096/fj.04-1508com; Kaul P, 2011, HEART, V97, P1048, DOI 10.1136/hrt.2010.217869; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Krause E G, 1996, Blood Press Suppl, V3, P37; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kumagai T, 2007, LEUKEMIA RES, V31, P523, DOI 10.1016/j.leukres.2006.08.019; Labovsky V, 2007, CLIN EXP IMMUNOL, V148, P440, DOI 10.1111/j.1365-2249.2007.03381.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Mai S, 2012, AUTOPHAGY, V8, P47, DOI 10.4161/auto.8.1.18174; Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mijares A, 1996, MOL CELL BIOCHEM, V164, P107, DOI 10.1007/BF00408646; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; PIWNICAWORMS D, 1990, CIRCULATION, V82, P1826, DOI 10.1161/01.CIR.82.5.1826; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; ROSENBAUM MB, 1994, J CARDIOVASC ELECTR, V5, P367, DOI 10.1111/j.1540-8167.1994.tb01174.x; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Srinivasan S, 2000, DIABETES, V49, P1932, DOI 10.2337/diabetes.49.11.1932; Sterin-Borda L, 1999, CARDIOVASC RES, V41, P116, DOI 10.1016/S0008-6363(98)00225-9; Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wrighton KH, 2011, NAT REV MOL CELL BIO, V12, P344, DOI 10.1038/nrm3116; Yamada T, 2003, J AM COLL CARDIOL, V41, P231, DOI 10.1016/S0735-1097(02)02700-6; Zhang L, 2001, Zhonghua Nei Ke Za Zhi, V40, P445; Zhu JX, 2006, CYTOKINE, V34, P96, DOI 10.1016/j.cyto.2006.04.010; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	51	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81296	10.1371/journal.pone.0081296	http://dx.doi.org/10.1371/journal.pone.0081296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278413	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100150
J	Liu, SY; Liu, CF; Min, XY; Ji, YY; Wang, N; Liu, D; Cai, JY; Li, K				Liu, Shuyan; Liu, Chengfei; Min, Xiaoyun; Ji, Yuanyuan; Wang, Na; Liu, Dan; Cai, Jiangyi; Li, Ke			Prognostic Value of Cancer Stem Cell Marker Aldehyde Dehydrogenase in Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							INITIATING CELLS; IDENTIFICATION; ALDH1; POPULATION; METASTASIS; EXPRESSION; DISEASE; BIOLOGY; CD44	Objective: Aldehyde dehydrogenase (ALDH) has recently been reported as a marker of cancer stem-like cells in ovarian cancer. However, the prognostic role of ALDH in ovarian cancer still remains controversial. In this study, we aimed to evaluate the association between the expression of ALDH and the outcome of ovarian cancer patients by performing a meta-analysis. Methods: We systematically searched for studies investigating the relationships between ALDH expression and outcome of ovarian cancer patients. Only articles in which ALDH expression was detected by immunohistochemical staining were included. A meta-analysis was performed to generate combined hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS) and disease-free survival (DFS). Results: A total of 1,258 patients from 7 studies (6 articles) were included in the analysis. Our results showed that high ALDH expression in patients with ovarian cancer was associated with poor prognosis in terms of Os (HR, 1.25; 95% CI, 1.07-1.47; P = 0.005) and DFS (HR, 1.58; 95% CI, 1.00-2.49; P = 0.052), though the difference for DFS was not statistically significant. In addition, there was no evidence of publication bias as suggested by Begg's and Egger's tests (Begg's test, P = 0.707; Egger's test, P = 0.355). Conclusion: The present meta-analysis indicated that elevated ALDH expression was associated with poor prognosis in patients with ovarian cancer.	[Liu, Shuyan; Liu, Chengfei; Min, Xiaoyun; Ji, Yuanyuan; Wang, Na; Liu, Dan; Li, Ke] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Core Res Lab, Xian 710049, Peoples R China; [Liu, Shuyan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China; [Cai, Jiangyi] Aerosp Gen Hosipital, Dept Pathol, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Li, K (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Core Res Lab, Xian 710049, Peoples R China.	ke.li@mail.xjtu.edu.cn	Li, Ke/O-6291-2014		National Natural Science Foundation of China [81000922]; Fundamental Research Funds for the Central Universities [2010jdgz09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grant from the National Natural Science Foundation of China (No. 81000922) and the Fundamental Research Funds for the Central Universities (No. 2010jdgz09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kuroda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065158; Landen CN, 2010, MOL CANCER THER, V9, P3186, DOI 10.1158/1535-7163.MCT-10-0563; Liebscher CA, 2013, HUM PATHOL, V44, P1465, DOI 10.1016/j.humpath.2012.12.016; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Neumeister V, 2010, AM J PATHOL, V176, P2131, DOI 10.2353/ajpath.2010.090712; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rahadiani N, 2011, CANCER SCI, V102, P903, DOI 10.1111/j.1349-7006.2011.01864.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci F, 2013, AM J CANCER RES, V3, P221; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Zhou L, 2013, HUM PATHOL, V44, P2180, DOI 10.1016/j.humpath.2013.03.021	36	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81050	10.1371/journal.pone.0081050	http://dx.doi.org/10.1371/journal.pone.0081050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282568	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500070
J	Walker, BK; Gilliam, DS				Walker, Brian K.; Gilliam, David S.			Determining the Extent and Characterizing Coral Reef Habitats of the Northern Latitudes of the Florida Reef Tract (Martin County)	PLOS ONE			English	Article							THEMATIC MAP ACCURACY; REMOTELY SENSED DATA; ATLANTIC WARM POOL; EAST-COAST; SHELF; GEOMORPHOLOGY; AUSTRALIA; EXPANSION; BOUNDARY	Climate change has recently been implicated in poleward shifts of many tropical species including corals; thus attention focused on higher-latitude coral communities is warranted to investigate possible range expansions and ecosystem shifts due to global warming. As the northern extension of the Florida Reef Tract (FRT), the third-largest barrier reef ecosystem in the world, southeast Florida (25-27 degrees N latitude) is a prime region to study such effects. Most of the shallow-water FRT benthic habitats have been mapped, however minimal data and limited knowledge exist about the coral reef communities of its northernmost reaches off Martin County. First benthic habitat mapping was conducted using newly acquired high resolution LIDAR bathymetry and aerial photography where possible to map the spatial extent of coral reef habitats. Quantitative data were collected to characterize benthic cover and stony coral demographics and a comprehensive accuracy assessment was performed. The data were then analyzed in a habitat biogeography context to determine if a new coral reef ecosystem region designation was warranted. Of the 374 km(2) seafloor mapped, 95.2% was Sand, 4.1% was Coral Reef and Colonized Pavement, and 0.7% was Other Delineations. Map accuracy assessment yielded an overall accuracy of 94.9% once adjusted for known map marginal proportions. Cluster analysis of cross-shelf habitat type and widths indicated that the benthic habitats were different than those further south and warranted designation of a new coral reef ecosystem region. Unlike the FRT further south, coral communities were dominated by cold-water tolerant species and LIDAR morphology indicated no evidence of historic reef growth during warmer climates. Present-day hydrographic conditions may be inhibiting poleward expansion of coral communities along Florida. This study provides new information on the benthic community composition of the northern FRT, serving as a baseline for future community shift and range expansion investigations.	[Walker, Brian K.; Gilliam, David S.] Nova SE Univ, Oceanog Ctr, Dania, FL USA	Nova Southeastern University	Walker, BK (corresponding author), Nova SE Univ, Oceanog Ctr, Dania, FL USA.	walkerb@nova.edu			Florida Fish and Wildlife Conservation Commission's program (FWC); Florida's Wildlife Legacy Initiative; U.S. Fish and Wildlife Service's State Wildlife Grants program [08014]; National Oceanic and Atmospheric Administration Coastal Ocean Program [NA09NOS4260253]; Broward County Environmental Protection and Growth Management Department Natural Resources Planning and Management Division	Florida Fish and Wildlife Conservation Commission's program (FWC); Florida's Wildlife Legacy Initiative; U.S. Fish and Wildlife Service's State Wildlife Grants program(US Fish & Wildlife Service); National Oceanic and Atmospheric Administration Coastal Ocean Program(National Oceanic Atmospheric Admin (NOAA) - USA); Broward County Environmental Protection and Growth Management Department Natural Resources Planning and Management Division	This work was partially funded by the Florida Fish and Wildlife Conservation Commission's program (FWC), Florida's Wildlife Legacy Initiative, and the U.S. Fish and Wildlife Service's State Wildlife Grants program (grant number 08014). Funding for quantitative ground validation to enhance the present Martin County benthic habitat mapping with quantitative assessment and characterization of the mapped hardbottoms was provided by the National Oceanic and Atmospheric Administration Coastal Ocean Program under award NA09NOS4260253 to the National Coral Reef Institute at Nova Southeastern University. Thanks to Steve Higgins and the Broward County Environmental Protection and Growth Management Department Natural Resources Planning and Management Division for providing the matching funds for the State Wildlife Grant. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. FWC provided a vessel and captain for the habitat map groundtruthing and accuracy assessment.	Almada-Villela PC, 2003, MANUAL METHODS MBRS; AVENT RM, 1977, INT REV GES HYDROBIO, V62, P185, DOI 10.1002/iroh.1977.3510620201; Axelsson A, 2010, RAPID TOPOGRAPHIC BA; Baird AH, 2012, CORAL REEFS, V31, P1063, DOI 10.1007/s00338-012-0928-6; Banks KW, 2007, CORAL REEFS, V26, P617, DOI 10.1007/s00338-007-0231-0; CARD DH, 1982, PHOTOGRAMM ENG REM S, V48, P431; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; CONGALTON RG, 1988, PHOTOGRAMM ENG REM S, V54, P593; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; DAVIS GE, 1982, B MAR SCI, V32, P608; Donders TH, 2011, CLIM DYNAM, V36, P109, DOI 10.1007/s00382-009-0702-9; Engle VD, 1999, J BIOGEOGR, V26, P1007, DOI 10.1046/j.1365-2699.1999.00341.x; Finkl CW, 2008, J COASTAL RES, V24, P823, DOI 10.2112/08A-0001.1; Finkl CW, 2005, J COASTAL RES, V21, P501, DOI 10.2112/05-756A.1; FMRI, 2000, BENTH HAB FLOR KEYS; Gilliam D, 2009, PLOUGHSHARES, V35, P42; Gilliam DS, 2010, YEAR 9 ANN REPORT; GILMORE MD, 1976, J SEDIMENT PETROL, V46, P519; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Harris PT, 2012, ELSEV INSIGHT, P93, DOI 10.1016/B978-0-12-385140-6.00005-0; HAY AM, 1979, PHOTOGRAMM ENG REM S, V45, P529; Hayden BP, 1976, J BIOGEOGR, V3, P71, DOI DOI 10.2307/3038100; HUDSON JH, 1976, GEOLOGY, V4, P361, DOI 10.1130/0091-7613(1976)4<361:SATFIP>2.0.CO;2; HUDSON WD, 1987, PHOTOGRAMM ENG REM S, V53, P421; Jaap W.C., 1990, P574; Kendall M.S., 2002, METHODS USED MAP BEN; Kendall MS, 2003, ENVIRON BIOL FISH, V66, P19, DOI 10.1023/A:1023255022513; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; KLITGORD KD, 1984, J GEOPHYS RES, V89, P7753, DOI 10.1029/JB089iB09p07753; Lang J.C., 2010, ATLANTIC GULF RAPID; Lapointe B. E., 2007, COMP ECOLOGY HARMFUL; LEE TN, 1981, DEEP-SEA RES, V28, P347, DOI 10.1016/0198-0149(81)90004-2; Lighty R.G., 1977, RELICT SHELF EDGE HO, P215; LIGHTY RG, 1978, NATURE, V276, P59, DOI 10.1038/276059a0; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; MA ZK, 1995, PHOTOGRAMM ENG REM S, V61, P435; Monaco ME, 2012, NATL SUMMARY NOAAS S; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Pitts P.A., 1993, P AM AC UND SCI 13 A, P99; Pitts PA, 1999, J EXP MAR BIOL ECOL, V235, P135, DOI 10.1016/S0022-0981(98)00179-8; Pitts PA, 1997, J COASTAL RES, V13, P105; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Riegl B, 2005, DEV GIS MAPS SE FLOR; Ruzicka R, 2010, CREMP 2009 FINAL REP; SHINN E. A., 1966, J PALEONTOL, V40, P233; Smale DA, 2010, ESTUAR COAST SHELF S, V86, P83, DOI 10.1016/j.ecss.2009.10.016; SMITH NP, 1983, J PHYS OCEANOGR, V13, P1709, DOI 10.1175/1520-0485(1983)013<1709:TASCOS>2.0.CO;2; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; VANGENDEREN JL, 1978, REMOTE SENS ENVIRON, V7, P3, DOI 10.1016/0034-4257(78)90003-2; VANGENDEREN JL, 1977, PHOTOGRAMM ENG REM S, V43, P1135; Veron J.E.N, 1995, CORAL SPACE TIME BIO; VUKOVICH FM, 1979, J PHYS OCEANOGR, V9, P1214, DOI 10.1175/1520-0485(1979)009<1214:GSBEOT>2.0.CO;2; Walker B.K, 2012, CHARACTERIZING DETER; Walker BK, 2010, ACCURACY ASSESSMENT; Walker BK, 2009, ACCURACY ASSESSMENT; Walker BK, 2009, RM069 DEP; Walker BK, 2008, J COASTAL RES, V24, P1138, DOI 10.2112/06-0809.1; Walker BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030466; Walker N.D., 1982, Coral Reefs, V1, P83, DOI 10.1007/BF00301689; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Ziegler M, 2008, NAT GEOSCI, V1, P601, DOI 10.1038/ngeo277	62	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80439	10.1371/journal.pone.0080439	http://dx.doi.org/10.1371/journal.pone.0080439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282542	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500043
J	Zhang, JB; Yan, JJ; Zhang, YW; Ma, X; Bai, SQ; Wu, YQ; Dao, ZX; Li, DX; Zhang, CB; Zhang, Y; You, MH; Yang, FY; Zhang, J				Zhang, Jianbo; Yan, Jiajun; Zhang, Yunwei; Ma, Xiao; Bai, Shiqie; Wu, Yanqi; Dao, Zhixue; Li, Daxu; Zhang, Changbing; Zhang, Yu; You, Minghong; Yang, Fuyu; Zhang, Jin			Molecular Insights of Genetic Variation in Erianthus arundinaceus Populations Native to China	PLOS ONE			English	Article							WILD SUGARCANE; DIVERSITY; SRAP	Background: E. arundinaceus (Retz.) Jeswiet is a warm-season, tall-growing perennial species native to much southern portion in China. The grass has been extensively used in sugarcane breeding and is recently targeted as a bioenergy feedstock crop. However, information on the genetic structure of the Chinese wild germplasm is limited. Knowledge of genetic variation within and among populations is essential for breeding new cultivars in the species. The major objective of this study was to quantify the magnitude of genetic variation among and within natural populations in China. Methodology/Principal Findings: In this experiment, we analyzed genetic variation of 164 individuals of 18 populations collected from natural habitats in six Chinese provinces using 20 sequence-related amplified polymorphism (SRAP) primer pairs generating 277 polymorphic bands. Among and within the populations, the percentage of polymorphic bands (PPB) was 80.00% and 27.07%, genetic diversity (H-E) was 0.245 and 0.099, effective number of alleles (N-E) was 1.350 and 1.170, and Shannon's information index (I) was 0.340 and 0.147, respectively. The populations were clustered into six groups exhibiting a high level of genetic differentiation, which was highly associated with geographic origins of respective germplasm populations, but was not significantly associated with geographic distances between the populations. Conclusions/Significance: This is the first report indicating that large genetic variation exists in the Chinese E. arundinaceus germplasm based on the SRAP molecular marker analysis of native populations. The genetic structure of populations in the species has been substantially affected by geographic landforms and environments. The diverse collection will be highly valuable in genetic improvement in the species per se and likely in sugarcane.	[Zhang, Jianbo; Ma, Xiao; Bai, Shiqie] Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China; [Zhang, Jianbo; Yan, Jiajun; Bai, Shiqie; Dao, Zhixue; Li, Daxu; Zhang, Changbing; Zhang, Yu; You, Minghong; Zhang, Jin] Sichuan Acad Grassland Sci, Chengdu, Sichuan, Peoples R China; [Zhang, Jianbo] Guizhou Grassland Sci Inst, Guiyang, Guizhou, Peoples R China; [Zhang, Yunwei; Yang, Fuyu] China Agr Univ, Grassland Inst, Beijing 100094, Peoples R China; [Wu, Yanqi] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA	Sichuan Agricultural University; China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater	Bai, SQ (corresponding author), Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Yaan, Sichuan, Peoples R China.	baishiqie@126.com	Wu, Yanqi/N-8180-2016	Wu, Yanqi/0000-0003-0802-6881	National High-Tech R&D Program of China (863 Program) [2012AA101801-01]; Innovation Fund of Guizhou Academy of Agricultural Sciences [2011014]; earmarked fund for China Agriculture Research System [CARS35-35]	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Innovation Fund of Guizhou Academy of Agricultural Sciences; earmarked fund for China Agriculture Research System	This work was supported by the National High-Tech R&D Program of China (863 Program, #2012AA101801-01) the Innovation Fund of Guizhou Academy of Agricultural Sciences (#2011014), and the earmarked fund for China Agriculture Research System(#CARS35-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, TFPGA TOOLS POPULATI; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Besse P, 1996, THEOR APPL GENET, V92, P733, DOI 10.1007/BF00226096; Besse P, 1997, EUPHYTICA, V93, P283, DOI 10.1023/A:1002940701171; Breinholt JW, 2009, AM J BOT, V96, P661, DOI 10.3732/ajb.0800035; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cai Q, 2012, GENET RESOUR CROP EV, V59, P1483, DOI 10.1007/s10722-011-9776-4; Cai Qing, 2002, Southwest China Journal of Agricultural Sciences, V15, P16; Chang D, 2012, GENET MOL RES, V11, P1245, DOI 10.4238/2012.May.9.3; Clayton W. D., 2006, GRASSBASE ONLINE WOR; Deng HH., 2002, SUGARCANE CANESUGAR, V1, P1; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; EXCOFFIER L, 1992, GENETICS, V131, P479; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Hamrick JL, 1989, POPULATION GENETICS, P44; He, 1997, J YUNNAN AGR U, V12, P253; He SC, 1987, J YUNNAN AGR U, V2, P105; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; [金燕 Jin Yan], 2003, [生物多样性, Chinese Biodiversity], V11, P155; Koike, 1980, HAWAII PLANT REC, V59, P176; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li Jing, 2011, Journal of Tropical and Subtropical Botany, V19, P506; Li SP, 2010, GENETICS; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MANTEL N, 1967, CANCER RES, V27, P209; Ming R, 2006, PL BRED RE, V27, P15; Mukherjee S. K, 1957, BOT GAZ, V119, P55, DOI DOI 10.1086/335962; Nair NV, 2006, CURR SCI INDIA, V90, P1118; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nevo E, 1998, GENET RESOUR CROP EV, V45, P355, DOI 10.1023/A:1008689304103; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Santiago AD, 2011, RSC ENERGY ENVIRON S, P77; Shouliang C., 2006, FLORA CHINA, V22, P576; Tew Thomas L., 2008, P249, DOI 10.1007/978-0-387-70805-8_9; Tsuruta S, 2012, GRASSL SCI, V58, P174, DOI 10.1111/j.1744-697X.2012.00258.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu ZY, 1994, FLORA CHINA, V22, p[576, 589]; [张富民 Zhang Fumin], 2002, [生物多样性, Chinese Biodiversity], V10, P438; Zhang HY, 2008, AFR J BIOTECHNOL, V7, P3414; Zhang Mu-qing, 2004, Journal of Plant Resources and Environment, V13, P1	41	17	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80388	10.1371/journal.pone.0080388	http://dx.doi.org/10.1371/journal.pone.0080388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282538	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500039
J	Liu, JW; Numata, S; Ikeda, M; Watanabe, Y; Zheng, XB; Luo, XJ; Kinoshita, M; Nunokawa, A; Someya, T; Ohmori, T; Bei, JX; Chong, SA; Lee, J; Li, ZQ; Liu, JJ; Iwata, N; Shi, YY; Li, M; Su, B				Liu, Jiewei; Numata, Shusuke; Ikeda, Masashi; Watanabe, Yuichiro; Zheng, Xue-bin; Luo, Xiongjian; Kinoshita, Makoto; Nunokawa, Ayako; Someya, Toshiyuki; Ohmori, Tetsuro; Bei, Jin-xin; Chong, Siow-Ann; Lee, Jimmy; Li, Zhiqiang; Liu, Jianjun; Iwata, Nakao; Shi, Yongyong; Li, Ming; Su, Bing			An Evaluation of Association between a Novel Hippocampal Biology Related SNP (rs7294919) and Schizophrenia	PLOS ONE			English	Article							COMMON VARIANTS; NO ASSOCIATION; BRAIN VOLUMES; GENE; METAANALYSIS; RISK; IDENTIFICATION; ZNF804A; CHINESE; CMYA5	Recent genetic analyses have implicated several candidate susceptibility variants for schizophrenia. The single nucleotide polymorphism (SNP) rs7294919 is likely a schizophrenia-susceptibility variant according to its significant association with hippocampal volume, hippocampus function, and cognitive performance as well as the nominal association with schizophrenia. However, all previous analyses were conducted only in Europeans, and whether rs7294919 is associated with schizophrenia in other populations are yet to be tested. Here, we conducted a case-control analysis of rs7294919 with schizophrenia in six independent Chinese (N = 3) and Japanese (N = 3) samples, including a total of 7,352 cases and 10,824 controls. The results of our association analysis were not able to confirm the association of rs7294919 with schizophrenia (p = 0.51 in total samples, odds ratio = 1.02 for allele[C]). The absence of rs7294919's association in Chinese and Japanese suggest a potential genetic heterogeneity in the susceptibility of schizophrenia on this locus and also demonstrate the difficulties in replicating associations of schizophrenia across different ethnic populations.	[Liu, Jiewei; Li, Ming; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Numata, Shusuke; Kinoshita, Makoto; Ohmori, Tetsuro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Course Integrated Brain Sci,Dept Psychiat, Tokushima 770, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Watanabe, Yuichiro; Nunokawa, Ayako; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Zheng, Xue-bin; Bei, Jin-xin; Liu, Jianjun] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Luo, Xiongjian] Univ Rochester, Flaum Eye Inst, Rochester, NY USA; [Luo, Xiongjian] Univ Rochester, Dept Ophthalmol, Rochester, NY USA; [Chong, Siow-Ann; Lee, Jimmy] Inst Mental Hlth, Singapore, Singapore; [Li, Zhiqiang; Shi, Yongyong] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Liu, Jiewei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Tokushima University; Fujita Health University; Niigata University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Rochester; University of Rochester; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, M (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	limingkiz@gmail.com; sub@mail.kiz.ac.cn	Shi, Yongyong/GSO-1627-2022; Lee, Jimmy/ABB-2919-2020; Someya, Toshiyuki/ABD-1878-2021; Bei, Jin-Xin/AAO-1259-2020; Watanabe, Yuichiro/ABB-7176-2021; Liu, Jianjun/AAK-4989-2020	Shi, Yongyong/0000-0003-1710-1505; Lee, Jimmy/0000-0002-7724-7445; Watanabe, Yuichiro/0000-0002-5496-5997; Liu, Jianjun/0000-0002-3255-3019; IWATA, Nakao/0000-0003-3189-6076	National 973 project of China [2011CBA00401]; National Natural Science Foundation of China [U1202225, 31130051, 31071101]; National Research Foundation Singapore under the National Medical Research Council Translational and Clinical Research Flagship Program [NMRC/TCR/003/2008]; Grants-in-Aid for Scientific Research [24791203] Funding Source: KAKEN	National 973 project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation Singapore under the National Medical Research Council Translational and Clinical Research Flagship Program(National Research Foundation, Singapore); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National 973 project of China (grant number, 2011CBA00401), the National Natural Science Foundation of China (grant number, U1202225, 31130051 and 31071101), and the National Research Foundation Singapore under the National Medical Research Council Translational and Clinical Research Flagship Program (grant number, NMRC/TCR/003/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Erk S, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.57; Furukawa M, 2013, PSYCHIAT GENET, V23, P179, DOI 10.1097/YPG.0b013e328360c8be; Gruber O, 2008, J PSYCHIATR RES, V43, P1, DOI 10.1016/j.jpsychires.2008.01.009; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Hashimoto R, 2011, SCHIZOPHR RES, V129, P80, DOI 10.1016/j.schres.2011.03.024; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Ikeda M, 2013, MOL PSYCHIATR, V18, P636, DOI 10.1038/mp.2012.74; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Kinoshita M, 2012, SCHIZOPHR RES, V141, P271, DOI 10.1016/j.schres.2012.07.020; Li M, 2012, SCHIZOPHR RES, V142, P200, DOI 10.1016/j.schres.2012.10.008; Li M, 2013, WORLD J BIOL PSYCHIA, V14, P91, DOI 10.3109/15622975.2011.587891; Li M, 2012, AM J MED GENET B, V159B, P794, DOI 10.1002/ajmg.b.32084; Li M, 2011, SCHIZOPHR RES, V133, P165, DOI 10.1016/j.schres.2011.09.013; Li M, 2011, SCHIZOPHR RES, V129, P217, DOI 10.1016/j.schres.2010.12.016; Luo XJ, 2014, MOL PSYCHIATR, V19, P774, DOI 10.1038/mp.2013.103; Luo XJ, 2008, J MED GENET, V45, P818, DOI 10.1136/jmg.2008.060657; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tamminga CA, 2010, AM J PSYCHIAT, V167, P1178, DOI 10.1176/appi.ajp.2010.09081187; Trost S, 2013, EUR ARCH PSY CLIN N, V263, P53, DOI 10.1007/s00406-012-0320-0; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Watanabe Y, 2012, SCHIZOPHR RES, V137, P264, DOI 10.1016/j.schres.2012.01.034	38	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80696	10.1371/journal.pone.0080696	http://dx.doi.org/10.1371/journal.pone.0080696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278305	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700032
J	Okuda, H; Ohdan, H; Nakayama, M; Koseki, H; Nakagawa, T; Ito, T				Okuda, Hiroshi; Ohdan, Hideki; Nakayama, Manabu; Koseki, Haruhiko; Nakagawa, Takeya; Ito, Takashi			The USP21 Short Variant (USP21SV) Lacking NES, Located Mostly in the Nucleus In Vivo, Activates Transcription by Deubiquitylating ubH2A In Vitro	PLOS ONE			English	Article							LIVER-REGENERATION; CROSS-TALK; HISTONE; CHROMATIN; ORGANIZATION; NUCLEOSOMES; ISWI; ACF; DNA	USP21 is a deubiquitylase that catalyzes isopeptide bond hydrolysis between ubiquitin and histone H2A. Since ubiqutylated H2A (ubH2A) represses transcription, USP21 plays a role in transcriptional activation. On the other hand, the localization of USP21 suggests it has an additional function in the cytoplasm. Here, we identified a USP21 short variant (USP21SV) lacking a nuclear export signal (NES). Differential localization of USP21SV, more in the nucleus than the USP21 long variant (USP21LV), suggests they have redundant roles in the cell. Ectopic expression of both USP21 variants decreased ubH2A in the nucleus. Furthermore, both recombinant USP21 variants activate transcription by deubiquitylating ubH2A in vitro. These data suggest multiple roles for USP21 in the ubiquitylation-deubiquitylation network in the cell.	[Okuda, Hiroshi; Nakagawa, Takeya; Ito, Takashi] Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 852, Japan; [Okuda, Hiroshi; Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Surg, Hiroshima, Japan; [Nakayama, Manabu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan; [Koseki, Haruhiko] RIKEN, Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Koseki, Haruhiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Yokohama, Kanagawa, Japan	Nagasaki University; Hiroshima University; Kazusa DNA Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Nakagawa, T (corresponding author), Nagasaki Univ, Sch Med, Dept Biochem, Nagasaki 852, Japan.	tnakagawa@nagasaki-u.ac.jp; tito@nagasaki-u.ac.jp	Ohdan, Hideki/G-4719-2019; Koseki, Haruhiko/I-3825-2014	Ohdan, Hideki/0000-0002-9066-1288; Koseki, Haruhiko/0000-0001-8424-5854	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24118003]; Japan Society for the Promotion of Science (JSPS) [21390085]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (grant number 24118003) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and Grant-in-Aid for Scientific Research (B) (grant number 21390085) from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLAL NR, 1975, J BIOL CHEM, V250, P5921; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GERMOND JE, 1976, NUCLEIC ACIDS RES, V3, P3173, DOI 10.1093/nar/3.11.3173; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malyavantham KS, 2008, CHROMOSOMA, V117, P553, DOI 10.1007/s00412-008-0172-6; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	24	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79813	10.1371/journal.pone.0079813	http://dx.doi.org/10.1371/journal.pone.0079813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278184	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700016
J	Rushton, DJ; Mattis, VB; Svendsen, CN; Allen, ND; Kemp, PJ				Rushton, David J.; Mattis, Virginia B.; Svendsen, Clive N.; Allen, Nicholas D.; Kemp, Paul J.			Stimulation of GABA-Induced Ca2+ Influx Enhances Maturation of Human Induced Pluripotent Stem Cell-Derived Neurons	PLOS ONE			English	Article							CALCIUM-CHANNELS; IN-VITRO; N-TYPE; DIFFERENTIATION; EXCITATION; INHIBITION; ASTROCYTES; PROMOTES; ACID	Optimal use of patient-derived, induced pluripotent stem cells for modeling neuronal diseases is crucially dependent upon the proper physiological maturation of derived neurons. As a strategy to develop defined differentiation protocols that optimize electrophysiological function, we investigated the role of Ca2+ channel regulation by astrocyte conditioned medium in neuronal maturation, using whole-cell patch clamp and Ca2+ imaging. Standard control medium supported basic differentiation of induced pluripotent stem cell-derived neurons, as assayed by the ability to fire simple, single, induced action potentials. In contrast, treatment with astrocyte conditioned medium elicited complex and spontaneous neuronal activity, often with rhythmic and biphasic characteristics. Such augmented spontaneous activity correlated with astrocyte conditioned medium-evoked hyperpolarization and was dependent upon regulated function of L-, N- and R-type Ca2+ channels. The requirement for astrocyte conditioned medium could be substituted by simply supplementing control differentiation medium with high Ca2+ or.-amino butyric acid (GABA). Importantly, even in the absence of GABA signalling, opening Ca2+ channels directly using Bay K8644 was able to hyperpolarise neurons and enhance excitability, producing fully functional neurons. These data provide mechanistic insight into how secreted astrocyte factors control differentiation and, importantly, suggest that pharmacological modulation of Ca2+ channel function leads to the development of a defined protocol for improved maturation of induced pluripotent stem cell-derived neurons.	[Rushton, David J.; Allen, Nicholas D.; Kemp, Paul J.] Cardiff Univ, Sch Biosci, Div Pathophysiol & Repair & Neurosci, Cardiff, Wales; [Mattis, Virginia B.; Svendsen, Clive N.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA	Cardiff University; Cedars Sinai Medical Center	Allen, ND (corresponding author), Cardiff Univ, Sch Biosci, Div Pathophysiol & Repair & Neurosci, Cardiff, Wales.	AllenND@cf.ac.uk; Kemp@cf.ac.uk	Kemp, Paul/A-4634-2010	Kemp, Paul/0000-0003-2773-973X; Allen, Nicholas/0000-0003-4009-186X	Medical Research Council [G0900180]; CHDI [A-3337, A-4528]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CHDI	This work was supported by: Medical Research Council (G0900180), http://www.mrc.ac.uk; and CHDI (A-3337 & A-4528), http://chdifoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold S, 2000, INT J DEV NEUROSCI, V18, P201, DOI 10.1016/S0736-5748(99)00089-1; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chang MY, 2003, MOL CELL NEUROSCI, V23, P414, DOI 10.1016/S1044-7431(03)00068-X; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jelitai M, 2004, J NEUROSCI RES, V76, P801, DOI 10.1002/jnr.20106; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Mazzanti M, 2003, GLIA, V41, P128, DOI 10.1002/glia.10135; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Toyoda H, 2005, MOL BRAIN RES, V133, P12, DOI 10.1016/j.molbrainres.2004.09.015; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; VIGERS AJ, 1991, DEV BRAIN RES, V60, P197, DOI 10.1016/0165-3806(91)90048-N; YAMASHITA M, 1993, J NEUROBIOL, V24, P1600, DOI 10.1002/neu.480241205; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	36	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81031	10.1371/journal.pone.0081031	http://dx.doi.org/10.1371/journal.pone.0081031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278369	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000327541700044
J	Zeitoun, JD; Lefevre, JH; de Parades, V; Sejourne, C; Sobhani, I; Coffin, B; Hamonet, C				Zeitoun, Jean-David; Lefevre, Jeremie H.; de Parades, Vincent; Sejourne, Cesar; Sobhani, Iradj; Coffin, Benoit; Hamonet, Claude			Functional Digestive Symptoms and Quality of Life in Patients with Ehlers-Danlos Syndromes: Results of a National Cohort Study on 134 Patients	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; VALIDATION; INDEX	Background and Objectives: Ehlers-Danlos syndromes (EDS) are a heterogeneous group of heritable connective tissue disorders. Gastrointestinal manifestations in EDS have been described but their frequency, nature and impact are poorly known. We aimed to assess digestive features in a national cohort of EDS patients. Methods: A questionnaire has been sent to 212 EDS patients through the French patient support group, all of which had been formally diagnosed according to the Villefranche criteria. The questionnaire included questions about digestive functional symptoms, the GIQLI (Gastrointestinal Quality of Life Index), KESS scoring system and the Rome III criteria. Results: Overall, 135 patients (64% response rate) completed the questionnaire and 134 were analyzable (123 women; 91%). Mean age and Body Mass Index were respectively 35 +/- 14.7 years and 24.3 +/- 6.1 kg/m(2). The most common EDS subtype was hypermobility form (n=108; 80.6%). GIQLI and KESS median values were respectively 63.5 (27-117) and 19 [13.5-22]. Eighty four percent of patients had functional bowel disorders (FBD) according to the Rome III criteria. An irritable bowel syndrome according to the same criteria was observed in 64 patients (48%) and 48 patients (36%) reported functional constipation. A gastro-esophageal reflux disease (GERD) was reported in 90 patients (68.7%), significantly associated with a poorer GIQLI (60.5 +/- 16.8 versus 75.9 +/- 20.3; p<0.0001). GIQLI was also negatively impacted by the presence of an irritable bowel syndrome or functional constipation (p=0.007). There was a significant correlation between FBD and GERD. Conclusions: Natural frequency of gastrointestinal manifestations in EDS seems higher than previously assessed. FBD and GERD are very common in our study population, the largest ever published until now. Their impact is herein shown to be important. A systematic clinical assessment of digestive features should be recommended in EDS.	[Zeitoun, Jean-David] St Antoine Hosp, APHP, Dept Gastroenterol & Nutr, Paris, France; [Zeitoun, Jean-David] Deaconesses Hosp, Dept Proctol, Paris, France; [Lefevre, Jeremie H.] St Antoine Hosp, APHP, Dept Digest & Gen Surg, Paris, France; [Lefevre, Jeremie H.] Univ Paris 06, Paris, France; [de Parades, Vincent] St Joseph Hosp, Dept Proctol, Paris, France; [Sejourne, Cesar] Private Off, Marolles En Hurepoix, France; [Sobhani, Iradj] Henri Mondor Hosp, APHP, Dept Gastroenterol, Creteil, France; [Coffin, Benoit] Louis Mourier Hosp, APHP, Dept Gastroenterol, Colombes, France; [Coffin, Benoit] Univ Paris 07, Paris, France; [Hamonet, Claude] Hop Hotel Dieu, APHP, Dept Phys & Rehabil Med, Paris, France; [Hamonet, Claude] Univ Paris East Creteil, Dept Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Sanofi-Aventis; Sanofi France; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Zeitoun, JD (corresponding author), St Antoine Hosp, APHP, Dept Gastroenterol & Nutr, Paris, France.	jdzeitoun@yahoo.fr	Lefevre, Jeremie/I-6952-2019	Lefevre, Jeremie/0000-0001-7601-7464				BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON PH, 1969, GUT, V10, P1004, DOI 10.1136/gut.10.12.1004; Bretagne JF, 2006, PRESSE MED, V35, P23, DOI 10.1016/S0755-4982(06)74515-8; Callewaert B, 2008, BEST PRACT RES CL RH, V22, P165, DOI 10.1016/j.berh.2007.12.005; Castori M, 2012, AM J MED GENET A, V158A, P2055, DOI 10.1002/ajmg.a.35483; Castori M, 2010, AM J MED GENET A, V152A, P556, DOI 10.1002/ajmg.a.33231; Danlos H, 1908, B SOC FRANC DEMATAL, V19, P70; Dapoigny M, 2004, EUR J GASTROEN HEPAT, V16, P995, DOI 10.1097/00042737-200410000-00008; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; Ehlers E., 1901, DERMATOLOGISCHE Z, V8, P173; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Slim K, 1999, GASTROEN CLIN BIOL, V23, P25	16	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80321	10.1371/journal.pone.0080321	http://dx.doi.org/10.1371/journal.pone.0080321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278273	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700027
J	Bai, Y; Malania, L; Castillo, DA; Moran, D; Boonmar, S; Chanlun, A; Suksawat, F; Maruyama, S; Knobel, D; Kosoy, M				Bai, Ying; Malania, Lile; Alvarez Castillo, Danilo; Moran, David; Boonmar, Sumalee; Chanlun, Aran; Suksawat, Fanan; Maruyama, Soichi; Knobel, Darryn; Kosoy, Michael			Global Distribution of Bartonella Infections in Domestic Bovine and Characterization of Bartonella bovis Strains Using Multi-Locus Sequence Typing	PLOS ONE			English	Article							SP-NOV; HENSELAE; CATTLE; VINSONII; BLOOD; ENDOCARDITIS; SUGGESTS; REVEALS; DISEASE; PATIENT	Bartonella bovis is commonly detected in cattle. One B. bovis strain was recently isolated from a cow with endocarditis in the USA, suggesting its role as an animal pathogen. In the present study, we investigated bartonella infections in 893 cattle from five countries (Kenya, Thailand, Japan, Georgia, and Guatemala) and 103 water buffaloes from Thailand to compare the prevalence of the infection among different regions and different bovid hosts. We developed a multi-locus sequence typing (MLST) scheme based on nine loci (16S rRNA, gltA, ftsZ, groEL, nuoG, ribC, rpoB, ssrA, and ITS) to compare genetic divergence of B. bovis strains, including 26 representatives from the present study and two previously described reference strains (one from French cows and another from a cow with endocarditis in the USA). Bartonella bacteria were cultured in 6.8% (7/103) of water buffaloes from Thailand; all were B. bovis. The prevalence of bartonella infections in cattle varied tremendously across the investigated regions. In Japan, Kenya, and the Mestia district of Georgia, cattle were free from the infection; in Thailand, Guatemala, and the Dusheti and Marneuli districts of Georgia, cattle were infected with prevalences of 10-90%. The Bartonella isolates from cattle belonged to three species: B. bovis (n=165), B. chomelii (n=9), and B. schoenbuchensis (n=1), with the latter two species found in Georgia only. MLST analysis suggested genetic variations among the 28 analyzed B. bovis strains, which fall into 3 lineages (I, II, and III). Lineages I and II were found in cattle while lineage III was restricted to water buffaloes. The majority of strains (17/28), together with the strain causing endocarditis in a cow in the USA, belonged to lineage I. Further investigations are needed to determine whether B. bovis causes disease in bovids.	[Bai, Ying; Kosoy, Michael] Ctr Dis Control & Prevent, Bacterial Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA; [Malania, Lile] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Alvarez Castillo, Danilo; Moran, David] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Boonmar, Sumalee] Thailand MOPH US CDC Collaborat, Int Emerging Infect Program, Nonthaburi, Thailand; [Chanlun, Aran; Suksawat, Fanan] Khon Kaen Univ, Khon Kaen, Thailand; [Maruyama, Soichi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Kanagawa, Japan; [Knobel, Darryn] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Knobel, Darryn] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Publ Hlth Collaborat, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; National Center for Disease Control & Public Health - Georgia; Universidad del Valle de Guatemala; Khon Kaen University; Nihon University; University of Pretoria; Kenya Medical Research Institute	Bai, Y (corresponding author), Ctr Dis Control & Prevent, Bacterial Dis Branch, Div Vector Borne Dis, Ft Collins, CO USA.	bby5@cdc.gov	Knobel, Darryn/O-7057-2014	Knobel, Darryn/0000-0002-0425-3799	Wellcome Trust, UK [081828/B/06/Z]	Wellcome Trust, UK(Wellcome Trust)	Specimens from cattle in Kenya were collected under a project supported by the Wellcome Trust, UK (grant number 081828/B/06/Z). The funders had no role to publish, or preparation of the manuscript.	Arvand M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009765; Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002; Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383; Billeter SA, 2012, SE ASIAN J TROP MED, V43, P1186; Breitschwerdt EB, 2001, J CLIN MICROBIOL, V39, P879, DOI 10.1128/JCM.39.3.879-882.2001; Chaloner GL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001248; Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313; Cherry NA, 2009, VET MICROBIOL, V135, P308, DOI 10.1016/j.vetmic.2008.09.063; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Erol E, 2013, J VET DIAGN INVEST, V25, P288, DOI 10.1177/1040638713477408; GARCIACACERES U, 1991, AM J CLIN PATHOL, V95, pS58; Hassanin A, 2013, MOL PHYLOGENET EVOL, V66, P766, DOI 10.1016/j.ympev.2012.11.003; Higgins JA, 1996, J MED ENTOMOL, V33, P490, DOI 10.1093/jmedent/33.3.490; Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999; Kosoy M, 2003, J CLIN MICROBIOL, V41, P645, DOI 10.1128/JCM.41.2.645-650.2003; Kosoy M, 2008, J CLIN MICROBIOL, V46, P772, DOI 10.1128/JCM.02120-07; Maillard R, 2007, EMERG INFECT DIS, V13, P1383, DOI 10.3201/eid1309.070236; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martini M, 2008, VET REC, V162, P58, DOI 10.1136/vr.162.2.58; Mietze A, 2011, VET MICROBIOL, V148, P238, DOI 10.1016/j.vetmic.2010.08.012; Pappalardo BL, 1997, AM J VET RES, V58, P467; Raoult D, 2005, VET MICROBIOL, V105, P155, DOI [10.1016/j.cetmic.2004.10.013, 10.1016/j.vetmic.2004.10.013]; Rolain JM, 2003, ANN NY ACAD SCI, V990, P236, DOI 10.1111/j.1749-6632.2003.tb07370.x; Roux V, 2000, J CLIN MICROBIOL, V38, P1698, DOI 10.1128/JCM.38.4.1698-1700.2000; Roux V, 1999, J CLIN MICROBIOL, V37, P596, DOI 10.1128/JCM.37.3.596-599.1999; Saisongkorh W, 2009, CLIN MICROBIOL INFEC, V15, P124, DOI 10.1111/j.1469-0691.2008.02198.x; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P179, DOI 10.1016/j.cimid.2010.11.003; Welc-Faleciak R, 2013, VET MICROBIOL, V162, P954, DOI 10.1016/j.vetmic.2012.09.019; Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999; WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992	33	44	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80894	10.1371/journal.pone.0080894	http://dx.doi.org/10.1371/journal.pone.0080894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278342	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800089
J	Dou, W; Shen, GM; Niu, JZ; Ding, TB; Wei, DD; Wang, JJ				Dou, Wei; Shen, Guang-Mao; Niu, Jin-Zhi; Ding, Tian-Bo; Wei, Dan-Dan; Wang, Jin-Jun			Mining Genes Involved in Insecticide Resistance of Liposcelis bostrychophila Badonnel by Transcriptome and Expression Profile Analysis	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR SUBUNITS; GLUTATHIONE TRANSFERASES; DETOXIFICATION ENZYMES; PSOCID PESTS; PSOCOPTERA; EVOLUTION; FAMILY; ENTOMOPHILA; SPINOSAD; BEETLE	Background: Recent studies indicate that infestations of psocids pose a new risk for global food security. Among the psocids species, Liposcelis bostrychophila Badonnel has gained recognition in importance because of its parthenogenic reproduction, rapid adaptation, and increased worldwide distribution. To date, the molecular data available for L. bostrychophila is largely limited to genes identified through homology. Also, no transcriptome data relevant to psocids infection is available. Methodology and Principal Findings: In this study, we generated de novo assembly of L. bostrychophila transcriptome performed through the short read sequencing technology (Illumina). In a single run, we obtained more than 51 million sequencing reads that were assembled into 60,012 unigenes (mean size = 711 bp) by Trinity. The transcriptome sequences from different developmental stages of L. bostrychophila including egg, nymph and adult were annotated with non-redundant (Nr) protein database, gene ontology (GO), cluster of orthologous groups of proteins (COG), and KEGG orthology (KO). The analysis revealed three major enzyme families involved in insecticide metabolism as differentially expressed in the L. bostrychophila transcriptome. A total of 49 P450-, 31 GST- and 21 CES-specific genes representing the three enzyme families were identified. Besides, 16 transcripts were identified to contain target site sequences of resistance genes. Furthermore, we profiled gene expression patterns upon insecticide (malathion and deltamethrin) exposure using the tag-based digital gene expression (DGE) method. Conclusion: The L. bostrychophila transcriptome and DGE data provide gene expression data that would further our understanding of molecular mechanisms in psocids. In particular, the findings of this investigation will facilitate identification of genes involved in insecticide resistance and designing of new compounds for control of psocids.	[Dou, Wei; Shen, Guang-Mao; Niu, Jin-Zhi; Ding, Tian-Bo; Wei, Dan-Dan; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			National Natural Sciences Foundation [30871631, 31000860]; Program for Innovative Research Team in University [IRT0976]; Specialized Research Fund for the Doctoral Program of Higher Education [20100182120022]; Fundamental Research Funds for the Central Universities, China [XDJK2013A005, XDJK2011C009]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This study was funded in part by the National Natural Sciences Foundation (30871631, 31000860), the Program for Innovative Research Team in University (IRT0976), the Specialized Research Fund for the Doctoral Program of Higher Education (20100182120022), and the Fundamental Research Funds for the Central Universities, China (XDJK2013A005, XDJK2011C009). The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Athanassiou CG, 2009, PEST MANAG SCI, V65, P1140, DOI 10.1002/ps.1804; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balamurugan K, 2009, BIOL CHEM, V390, P109, DOI 10.1515/BC.2009.020; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dou W, 2006, J APPL ENTOMOL, V130, P251, DOI 10.1111/j.1439-0418.2006.01059.x; Dou W, 2009, PESTIC BIOCHEM PHYS, V94, P10, DOI 10.1016/j.pestbp.2009.02.005; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HO SH, 1995, J STORED PROD RES, V31, P191, DOI 10.1016/0022-474X(95)00005-R; HOSIE AM, 1995, BRIT J PHARMACOL, V115, P909, DOI 10.1111/j.1476-5381.1995.tb15896.x; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; Jiang HB, 2012, J ECON ENTOMOL, V105, P560, DOI 10.1603/EC11324; Jones AK, 2005, GENOMICS, V85, P176, DOI 10.1016/j.ygeno.2004.09.001; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Li SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029793; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu ZL, 2012, MOLECULES, V17, P12049, DOI 10.3390/molecules171012049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikac KM, 2006, B ENTOMOL RES, V96, P523, DOI 10.1079/BER2006453; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nayak MK, 2008, PEST MANAG SCI, V64, P971, DOI 10.1002/ps.1586; Nayak MK, 2007, PEST MANAG SCI, V63, P104, DOI 10.1002/ps.1313; Nayak MK, 2005, J STORED PROD RES, V41, P455, DOI 10.1016/j.jspr.2004.07.002; Nayak MK, 2003, J STORED PROD RES, V39, P343, DOI 10.1016/S0022-474X(02)00029-2; Niu JZ, 2012, INSECT MOL BIOL, V21, P422, DOI 10.1111/j.1365-2583.2012.01148.x; Opit GP, 2008, J ECON ENTOMOL, V101, P616, DOI 10.1603/0022-0493(2008)101[616:EODOPG]2.0.CO;2; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; Pascual-Villalobos MJ, 2005, J STORED PROD RES, V41, P231, DOI 10.1016/j.jspr.2004.03.003; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rinkevich FD, 2009, INSECT MOL BIOL, V18, P233, DOI 10.1111/j.1365-2583.2009.00873.x; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Tang PA, 2009, ARCH INSECT BIOCHEM, V72, P34, DOI 10.1002/arch.20321; Turner B., 1998, Pesticide Outlook, V9, P27; TURNER BD, 1994, INT J PEST MANAGE, V40, P179, DOI 10.1080/09670879409371879; Vache C, 2006, ENVIRON TOXICOL CHEM, V25, P572, DOI 10.1897/04-425.1; Wang JJ, 2000, ANN ENTOMOL SOC AM, V93, P261, DOI 10.1603/0013-8746(2000)093[0261:DAROTP]2.0.CO;2; Wang JJ, 2003, J APPL ENTOMOL, V127, P107, DOI 10.1046/j.1439-0418.2003.00718.x; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	56	13	14	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79878	10.1371/journal.pone.0079878	http://dx.doi.org/10.1371/journal.pone.0079878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278202	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100064
J	Liu, HC; Han, D; Wong, SW; Nan, X; Zhao, HS; Feng, HL				Liu, Haochen; Han, Dong; Wong, Singwai; Nan, Xu; Zhao, Hongshan; Feng, Hailan			rs929387 of GLI3 Is Involved in Tooth Agenesis in Chinese Han Population	PLOS ONE			English	Article							NON-SYNDROMIC HYPODONTIA; GENETIC-BASIS; DENTAL AGENESIS; MUTATIONS; WNT10A; MSX1	Tooth agenesis is one of the most common anomalies of human dentition. Recent studies suggest that a number of genes are related to both syndromic and non-syndromic forms of hypodontia. In a previous study, we observed that polymorphism in rs929387 of GLI3 might be associated with hypodontia in the Chinese Han population based on a limited population. To further confirm this observation, in this study, we employed 89 individuals diagnosed with sporadic non-syndromic oligodontia (40 males and 49 females) to investigate the relationship between polymorphism in rs929387 of GLI3 and tooth agenesis. These individuals were analyzed with 273 subjects (125 males and 148 females) diagnosed with non-syndromic hypodontia and 200 healthy control subjects (100 males and 100 females). DNA was obtained from whole blood or saliva samples and genotyping was performed by a Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) method. Significant differences were observed in the allele and genotype frequencies of rs929387 of GLI3. Distributions of genotypes TT, TC and CC of rs929387 polymorphism were significantly different between the case group and the control group (P = 0.013) and C allelic frequency was higher in case group [P = 0.002, OR = 1.690, 95% CI (1.200-2.379)]. Additionally, our analysis shows that this difference is more pronounced when compared between the male case group and the male control group. The function study suggests that variation in GLI3 caused by rs929387 leads to a decrease in its transcriptional activity. These data demonstrated an association between rs929387 of GLI3 and non-syndromic tooth agenesis in Chinese Han individuals. This information may provide further understanding of the molecular mechanisms of tooth agenesis. Furthermore, GLI3 can be regarded as a marker gene for the risk of tooth agenesis.	[Liu, Haochen; Han, Dong; Wong, Singwai; Feng, Hailan] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Nan, Xu; Zhao, Hongshan] Peking Univ, Hlth Sci Ctr, Dept Med Genet, Beijing 100871, Peoples R China; [Nan, Xu; Zhao, Hongshan] Peking Univ, Hlth Sci Ctr, Ctr Human Dis Genom, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhao, HS (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Med Genet, Beijing 100871, Peoples R China.	hongshan@bjmu.edu.cn; kqfenghl@bjmu.edu.cn	Wong, Sing-Wai/AAX-6018-2020; Han, Dong/V-2128-2018	Wong, Sing-Wai/0000-0002-6905-3050; Han, Dong/0000-0001-9625-3384	Beijing Natural Science Foundation [7092113]; National Natural Science Foundation [81070814, 81100725]; Capital Medical Developing Foundation [2007-1005]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Capital Medical Developing Foundation	This work was supported by grants from the Beijing Natural Science Foundation (No. 7092113), the National Natural Science Foundation (No. 81070814 and No. 81100725), and the Capital Medical Developing Foundation (No. 2007-1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Galluccio G, 2012, ARCH ORAL BIOL, V57, P918, DOI 10.1016/j.archoralbio.2012.01.005; Gerits A, 2006, Orthod Craniofac Res, V9, P129, DOI 10.1111/j.1601-6343.2006.00367.x; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Hu JCC, 2007, ORTHOD CRANIOFAC RES, V10, P45, DOI 10.1111/j.1601-6343.2007.00384.x; Hu XF, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-11; Kantaputra P, 2011, AM J MED GENET A, V155A, P1119, DOI 10.1002/ajmg.a.33840; Lamana A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043661, DOI 10.1371/J0URNAL.P0NE.0043661.PUBMED:22937072]; Li SF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002396; Liu HC, 2012, EUR J ORAL SCI, V120, P378, DOI 10.1111/j.1600-0722.2012.00986.x; Mitsiadis TA, 2011, CLIN GENET, V80, P319, DOI 10.1111/j.1399-0004.2011.01762.x; Naruse I, 2010, CONGENIT ANOM, V50, P1, DOI 10.1111/j.1741-4520.2009.00266.x; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Opitz JM, 2000, AM J MED GENET, V90, P336, DOI 10.1002/(SICI)1096-8628(20000214)90:4<336::AID-AJMG14>3.0.CO;2-H; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Thesleff I, 2000, ACTA ODONTOL SCAND, V58, P191, DOI 10.1080/000163500750051728; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Tseng WEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067506; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vastardis H, 2000, AM J ORTHOD DENTOFAC, V117, P650, DOI 10.1016/S0889-5406(00)70173-9; Vieira AR, 2013, EUR ARCH PAEDIAT DEN; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; VORTKAMP A, 1995, DNA CELL BIOL, V14, P629, DOI 10.1089/dna.1995.14.629	28	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							0080860	10.1371/journal.pone.0080860	http://dx.doi.org/10.1371/journal.pone.0080860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278334	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100120
J	Stahl, M; Schupp, J; Jager, B; Schmid, M; Zissel, G; Muller-Quernheim, J; Prasse, A				Stahl, Mirjam; Schupp, Jonas; Jaeger, Benedikt; Schmid, Michael; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje			Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation	PLOS ONE			English	Article							MEDIATED CELL-ADHESION; KAPPA-B ACTIVATION; RECEPTOR CLASS-A; SERUM AMYLOID P; SCAVENGER RECEPTOR; ALVEOLAR MACROPHAGES; SYSTEMIC-SCLEROSIS; METALLOPROTEINASES; EXPRESSION; MONOCYTES	Idiopathic pulmonary fibrosis is characterized by abundant collagen production and accumulation of alternatively activated macrophages (M2) in the lower respiratory tract. Mechanisms as to how alveolar macrophages are activated by collagen breakdown products are unknown. Alveolar macrophages were obtained by bronchoalveolar lavage from 30 patients with idiopathic pulmonary fibrosis (IPF) and 37 healthy donors (HD). Alveolar macrophages were cultured in the presence of collagen type I, III, IV and V monomers w/wo a neutralizing antibody against scavenger receptor I class A (CD204). Culture supernatants were assayed for the M2 markers CCL18, CCL2, and interleukin-1 receptor antagonist (IL-1ra) by ELISA. Furthermore, expression of phospho-Akt was measured using ELISA and expression of CD204 by RT-PCR and flow cytometry. Stimulation with collagen type I and III monomers significantly up-regulated CCL18, IL-1ra production of alveolar macrophages. Furthermore, expression of CCL2 and CD204 were up-regulated by collagen type I exposure. In addition, collagen type I stimulation increased pospho-Akt expression. Collagen type I effects were abrogated by neutralizing antiCD204 and a non-selective Phosphatidylinositide 3-kinase inhibitor (LY294002). Spontaneous CD204 expression of alveolar macrophages was significantly increased in patients with IPF. In conclusion, our findings demonstrate that monomeric collagen type I via CD204 induces phospho-Akt expression shifting alveolar macrophages to the profibrotic M2 type. Innate immune responses induced by collagen monomers might perpetuate pulmonary fibrosis.	[Stahl, Mirjam; Schupp, Jonas; Jaeger, Benedikt; Schmid, Michael; Zissel, Gernot; Mueller-Quernheim, Joachim; Prasse, Antje] Univ Med Ctr, Dept Pneumol, Freiburg, Germany	University of Freiburg	Prasse, A (corresponding author), Univ Med Ctr, Dept Pneumol, Freiburg, Germany.	antje.prasse@uniklinik-freiburg.de	Prasse, Antje/AAY-6279-2020; Prasse, Antje/AAM-7521-2021; Stahl, Mirjam/S-9442-2019; Zissel, Gernot/B-1208-2010	Prasse, Antje/0000-0002-7336-7458; Schupp, Jonas/0000-0002-7714-8076; Zissel, Gernot/0000-0001-8021-9798				Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Cholewa J, 2010, J LEUKOCYTE BIOL, V87, P443, DOI 10.1189/jlb.0509318; Dancer RCA, 2011, EUR RESPIR J, V38, P1461, DOI 10.1183/09031936.00024711; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; GARDI C, 1990, RES COMMUN CHEM PATH, V68, P235; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9; Gowen BB, 2001, J LEUKOCYTE BIOL, V69, P575; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hayashi T, 1996, AM J PATHOL, V149, P1241; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; LAURENT GJ, 1986, THORAX, V41, P418, DOI 10.1136/thx.41.6.418; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Nikolic DM, 2007, AM J PHYSIOL-CELL PH, V292, pC1450, DOI 10.1152/ajpcell.00401.2006; Pardo A, 2001, J LEUKOCYTE BIOL, V70, P610; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, ARTHRITIS RHEUM-US, V56, P1685, DOI 10.1002/art.22559; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Shiraishi D, 2012, BIOCHEM BIOPH RES CO, V425, P304, DOI 10.1016/j.bbrc.2012.07.086; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Yano S, 1996, J IMMUNOL, V157, P2660; Yu HH, 2012, BBA-MOL CELL RES, V1823, P1192, DOI 10.1016/j.bbamcr.2012.05.004; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	34	71	73	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81382	10.1371/journal.pone.0081382	http://dx.doi.org/10.1371/journal.pone.0081382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278429	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100154
J	Asgari, Y; Salehzadeh-Yazdi, A; Schreiber, F; Masoudi-Nejad, A				Asgari, Yazdan; Salehzadeh-Yazdi, Ali; Schreiber, Falk; Masoudi-Nejad, Ali			Controllability in Cancer Metabolic Networks According to Drug Targets as Driver Nodes	PLOS ONE			English	Article							MOLECULAR NETWORKS; PROTEIN; PHARMACOLOGY; DISCOVERY; PARADIGM; DYNAMICS	Networks are employed to represent many nonlinear complex systems in the real world. The topological aspects and relationships between the structure and function of biological networks have been widely studied in the past few decades. However dynamic and control features of complex networks have not been widely researched, in comparison to topological network features. In this study, we explore the relationship between network controllability, topological parameters, and network medicine (metabolic drug targets). Considering the assumption that targets of approved anticancer metabolic drugs are driver nodes (which control cancer metabolic networks), we have applied topological analysis to genome-scale metabolic models of 15 normal and corresponding cancer cell types. The results show that besides primary network parameters, more complex network metrics such as motifs and clusters may also be appropriate for controlling the systems providing the controllability relationship between topological parameters and drug targets. Consequently, this study reveals the possibilities of following a set of driver nodes in network clusters instead of considering them individually according to their centralities. This outcome suggests considering distributed control systems instead of nodal control for cancer metabolic networks, leading to a new strategy in the field of network medicine.	[Asgari, Yazdan; Salehzadeh-Yazdi, Ali; Masoudi-Nejad, Ali] Univ Tehran, Inst Biochem & Biophys, Lab Syst Biol & Bioinformat LBB, Tehran, Iran; [Schreiber, Falk] Leibniz Inst Plant Genet & Crop Plant Res Gatersl, Gatersleben, Germany; [Schreiber, Falk] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Schreiber, Falk] Monash Univ, Clayton Sch Informat Technol, Clayton, Vic, Australia	University of Tehran; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Martin Luther University Halle Wittenberg; Monash University	Schreiber, F (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res Gatersl, Gatersleben, Germany.	schreibe@ipk-gatersleben.de; amasoudin@ibb.ut.ac.ir	Salehzadeh-Yazdi, Ali/J-9510-2019; Masoudi-Nejad, Ali/ABH-2078-2021; asgari, yazdan/AAL-9037-2020	Salehzadeh-Yazdi, Ali/0000-0002-1678-0051; asgari, yazdan/0000-0001-6993-6956				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; BANERJEE SJ, 2012, KEY NETWORK CONTROLL; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bordbar A, 2010, MOL SYSTEMS BIOL, P6; Bordbar A, 2011, BMC SYSTEMS BIOL, P5; Caldarelli G., 2007, SCALE FREE NETWORKS; Chang RL, 2010, PLOS COMPUTATIONAL B, V6; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dong-Hee K, 2009, NEW J PHYS, V11; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Ferrarini A, 2011, NETW BIOL, V1, P3; Folger O, 2011, MOL SYST BIOL, P7; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Gille C, 2010, MOL SYST BIOL, V6; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034101; Gonzalez-Diaz H, 2011, J PROTEOME RES, V10, P1698, DOI 10.1021/pr101009e; Gupta Eric K, 2002, Heart Dis, V4, P124; Hao T, 2010, BMC BIOINFORMATICS, V11; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Junker B. H., 2008, WILEY SERIES BIOINFO; Kashani ZRM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-318; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khakabimamaghani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068073; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; Miller F. P., 2010, FRESNEL EQUATIONS; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Nacher JC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073005; Nelson HS, 2001, J ALLERGY CLIN IMMUN, V107, P397, DOI 10.1067/mai.2001.112939; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Olivares-Hernandez R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-33; Osterlund T, 2012, BIOTECHNOL ADV, V30, P979, DOI 10.1016/j.biotechadv.2011.07.021; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Resendis-Antonio O, 2010, PLOS ONE, P5; Romero P, 2005, GENOME BIOL, V6; Russell J, 2012, DISTRIBUTED CONTROL; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Wang W, 2005, BIOL CYBERN, V92, P38, DOI 10.1007/s00422-004-0527-x; Warburg OH, 1953, BIOCHEM Z, V152, P309; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; [No title captured]	67	44	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79397	10.1371/journal.pone.0079397	http://dx.doi.org/10.1371/journal.pone.0079397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282504	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500009
J	Wang, W; Zeng, WJ; Chen, WL; Yang, YH; Zeng, H				Wang, Wei; Zeng, Wenjing; Chen, Weile; Yang, Yuanhe; Zeng, Hui			Effects of Forest Age on Soil Autotrophic and Heterotrophic Respiration Differ between Evergreen and Deciduous Forests	PLOS ONE			English	Article							OLD-GROWTH FORESTS; CO2 EFFLUX; TEMPERATURE SENSITIVITY; ECOSYSTEM RESPIRATION; CARBON ALLOCATION; FAGUS-SYLVATICA; CLIMATE; CHRONOSEQUENCE; FLUXES; PHOTOSYNTHESIS	We examined the effects of forest stand age on soil respiration (SR) including the heterotrophic respiration (HR) and autotrophic respiration (AR) of two forest types. We measured soil respiration and partitioned the HR and AR components across three age classes similar to 15, similar to 25, and similar to 35-year-old Pinus sylvestris var. mongolica (Mongolia pine) and Larix principis-rupprechtii (larch) in a forest-steppe ecotone, northern China (June 2006 to October 2009). We analyzed the relationship between seasonal dynamics of SR, HR, AR and soil temperature (ST), soil water content (SWC) and normalized difference vegetation index (NDVI, a plant greenness and net primary productivity indicator). Our results showed that ST and SWC were driving factors for the seasonal dynamics of SR rather than plant greenness, irrespective of stand age and forest type. For similar to 15-year-old stands, the seasonal dynamics of both AR and HR were dependent on ST. Higher Q(10) of HR compared with AR occurred in larch. However, in Mongolia pine a similar Q(10) occurred between HR and AR. With stand age, Q(10) of both HR and AR increased in larch. For Mongolia pine, Q(10) of HR increased with stand age, but AR showed no significant relationship with ST. As stand age increased, HR was correlated with SWC in Mongolia pine, but for larch AR correlated with SWC. The dependence of AR on NDVI occurred in similar to 35-year-old Mongolia pine. Our study demonstrated the importance of separating autotrophic and heterotrophic respiration components of SR when stimulating the response of soil carbon efflux to environmental changes. When estimating the response of autotrophic and heterotrophic respiration to environmental changes, the effect of forest type on age-related trends is required.	[Wang, Wei; Zeng, Wenjing; Chen, Weile] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Wang, Wei; Zeng, Wenjing; Chen, Weile] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China; [Zeng, Hui] Peking Univ, Key Lab Urban Habitat Environm Sci & Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Yang, Yuanhe] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen; Chinese Academy of Sciences; Institute of Botany, CAS	Wang, W (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	Zeng, Wen/GPS-8058-2022; Yang, Yuanhe/D-1448-2011		National Basic Research Program of China [2010CB950600, 2013CB956303]; Projects of National Natural Science Foundation of China [31222011, 31270363, 31070428]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31021001]	National Basic Research Program of China(National Basic Research Program of China); Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2010CB950600 and 2013CB956303), the Projects of National Natural Science Foundation of China (No. 31222011, 31270363 and 31070428) and supported by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 31021001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrends HE, 2009, CLIM RES, V39, P261, DOI 10.3354/cr00811; Azzali S, 2000, INT J REMOTE SENS, V21, P973, DOI 10.1080/014311600210380; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050441; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Campbell JL, 2005, BIOGEOCHEMISTRY, V73, P109, DOI 10.1007/s10533-004-5165-9; Carbone MS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000611; Chen GS, 2011, PLANT ECOL, V212, P195, DOI 10.1007/s11258-010-9814-x; Cisneros-Dozal LM, 2006, GLOBAL CHANGE BIOL, V12, P194, DOI 10.1111/j.1365-2486.2005.001061.x; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Drake P, 2012, PLANT SOIL, V350, P221, DOI 10.1007/s11104-011-0897-5; Ekblad A, 2001, OECOLOGIA, V127, P305, DOI 10.1007/s004420100667; Elberling B, 2007, SOIL BIOL BIOCHEM, V39, P646, DOI 10.1016/j.soilbio.2006.09.017; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P203, DOI 10.1016/j.agrformet.2006.08.002; Genet H, 2010, TREE PHYSIOL, V30, P177, DOI 10.1093/treephys/tpp105; Gong JR, 2012, PLANT SOIL, V360, P109, DOI 10.1007/s11104-011-1121-3; Grogan P, 2006, GLOBAL CHANGE BIOL, V12, P1479, DOI 10.1111/j.1365-2486.2006.01184.x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hasselquist NJ, 2010, OECOLOGIA, V164, P881, DOI 10.1007/s00442-010-1725-y; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Ide R, 2010, ECOL INFORM, V5, P339, DOI 10.1016/j.ecoinf.2010.07.002; Jakubauskas ME, 2001, PHOTOGRAMM ENG REM S, V67, P461; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jassal RS, 2012, AGR FOREST METEOROL, V153, P134, DOI 10.1016/j.agrformet.2011.05.002; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kuptz D, 2011, PLANT CELL ENVIRON, V34, P363, DOI 10.1111/j.1365-3040.2010.02246.x; Kurganova I, 2003, TELLUS B, V55, P338, DOI 10.1034/j.1600-0889.2003.00047.x; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Lee NY, 2010, ECOL RES, V25, P609, DOI 10.1007/s11284-010-0691-5; Liang N, 2010, BIOGEOSCIENCES, V7, P3447, DOI 10.5194/bg-7-3447-2010; Liu Q, 2006, GLOBAL CHANGE BIOL, V12, P2136, DOI 10.1111/j.1365-2486.2006.01245.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Lyr H., 1967, Int. Rev. For Res., N. Y., V2, P181; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Martin JG, 2005, BIOGEOCHEMISTRY, V73, P149, DOI 10.1007/s10533-004-5166-8; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Muhr J, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000998; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Oishi AC, 2013, AGR FOREST METEOROL, V171, P256, DOI 10.1016/j.agrformet.2012.12.007; Pang XY, 2013, AGR FOREST METEOROL, V171, P57, DOI 10.1016/j.agrformet.2012.12.001; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Pypker TG, 2003, FOREST ECOL MANAG, V172, P249, DOI 10.1016/S0378-1127(01)00799-X; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Shi WY, 2012, SOIL BIOL BIOCHEM, V52, P99, DOI 10.1016/j.soilbio.2012.04.020; Smith DR, 2010, BIOGEOSCIENCES, V7, P1375, DOI 10.5194/bg-7-1375-2010; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Tagesson T, 2009, INT J REMOTE SENS, V30, P5619, DOI 10.1080/01431160802695709; Tang JW, 2009, GLOBAL CHANGE BIOL, V15, P145, DOI 10.1111/j.1365-2486.2008.01741.x; Verhoef W, 1996, INT J REMOTE SENS, V17, P231, DOI 10.1080/01431169608949001; Vogel JG, 2005, CAN J FOREST RES, V35, P2112, DOI 10.1139/X05-117; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Wang CK, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000861; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P1236, DOI 10.1016/j.soilbio.2010.04.013; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; Yermakov Z, 2006, OECOLOGIA, V149, P690, DOI 10.1007/s00442-006-0474-4; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zhou YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015134	71	9	11	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80937	10.1371/journal.pone.0080937	http://dx.doi.org/10.1371/journal.pone.0080937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282560	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500062
J	Ziakas, PD; Prodromou, ML; El Khoury, J; Zintzaras, E; Mylonakis, E				Ziakas, Panayiotis D.; Prodromou, Michael L.; El Khoury, Joseph; Zintzaras, Elias; Mylonakis, Eleftherios			The Role of TLR4 896 A > G and 1196 C > T in Susceptibility to Infections: A Review and Meta-Analysis of Genetic Association Studies	PLOS ONE			English	Review							TOLL-LIKE-RECEPTOR; SINGLE NUCLEOTIDE POLYMORPHISMS; PATTERN-RECOGNITION RECEPTORS; THR399ILE POLYMORPHISMS; TOLL-LIKE-RECEPTOR-4 POLYMORPHISMS; ASP299GLY POLYMORPHISM; PULMONARY TUBERCULOSIS; MENINGOCOCCAL DISEASE; CHRONIC PERIODONTITIS; IMMUNE-RESPONSE	Background: Toll-like receptor 4 plays a role in pathogen recognition, and common polymorphisms may alter host susceptibility to infectious diseases. Purpose: To review the association of two common polymorphisms (TLR4 896A>G and TLR4 1196C>T) with infectious diseases. Data Sources: We searched PubMed and EMBASE up to March 2013 for pertinent literature in English, and complemented search with references lists of eligible studies. Study Selection: We included all studies that: reported an infectious outcome; had a case-control design and reported the TLR4 896A>G and/or TLR4 1196C>T genotype frequencies; 59 studies fulfilled these criteria and were analyzed. Data Extraction: Two authors independently extracted study data. Data Synthesis: The generalized odds ratio metric (ORG) was used to quantify the impact of TLR4 variants on disease susceptibility. A meta-analysis was undertaken for outcomes reported in >1 study. Eleven of 37 distinct outcomes were significant. TLR4 896 A>G increased risk for all parasitic infections (ORG 1.59; 95% CI 1.05-2.42), malaria (1.31; 95% CI 1.04-1.66), brucellosis (2.66; 95% CI 1.66-4.27), cutaneous leishmaniasis (7.22; 95% CI 1.91-27.29), neurocysticercosis (4.39; 95% CI 2.53-7.61), Streptococcus pyogenes tonsillar disease (2.93; 95% CI 1.24-6.93), typhoid fever (2.51; 95% CI 1.18-5.34) and adult urinary tract infections (1.98; 95% CI 1.04-3.98), but was protective for leprosy (0.36; 95% CI 0.22-0.60). TLR4 1196 C>T effects were similar to TLR4 896 A>G for brucellosis, cutaneous leishmaniasis, leprosy, typhoid fever and S. pyogenes tonsillar disease, and was protective for bacterial vaginosis in pregnancy (0.55; 95% CI 0.31-0.98) and Haemophilus influenzae tonsillar disease (0.42; 95% CI 0.17-1.00). The majority of significant associations were among predominantly Asian populations and significant associations were rare among European populations. Conclusions: Depending on the type of infection and population, TLR4 polymorphisms are associated with increased, decreased or no difference in infectious disease. This may be due to differential functional expression of TLR4, the co-segregation of TLR4 variants or a favorable inflammatory response.	[Ziakas, Panayiotis D.; Prodromou, Michael L.; Mylonakis, Eleftherios] Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA; [Ziakas, Panayiotis D.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Prodromou, Michael L.] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [El Khoury, Joseph] Harvard Univ, Sch Med, Charlestown, MA USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Zintzaras, Elias] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Boston, MA USA; [Zintzaras, Elias] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Tufts Medical Center; University of Thessaly	Mylonakis, E (corresponding author), Rhode Isl Hosp, Div Infect Dis, Providence, RI 02903 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635	Warren Alpert School of Brown University; Department of Medicine; Division of Infectious Diseases	Warren Alpert School of Brown University; Department of Medicine; Division of Infectious Diseases	The Brown University Infectious Diseases Program in Outcomes Research is supported through funding from the Warren Alpert School of Brown University, the Department of Medicine and the Division of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Ahmad-Nejad P, 2011, GENET TEST MOL BIOMA, V15, P645, DOI 10.1089/gtmb.2010.0258; Ajdary S, 2011, MICROBES INFECT, V13, P226, DOI 10.1016/j.micinf.2010.10.018; Akil I, 2012, INT J IMMUNOGENET, V39, P303, DOI 10.1111/j.1744-313X.2012.01090.x; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Allen A, 2003, PEDIATR INFECT DIS J, V22, P1018, DOI 10.1097/01.inf.0000095431.15606.68; Berdeli A, 2007, J CLIN PERIODONTOL, V34, P551, DOI 10.1111/j.1600-051X.2007.01092.x; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bhuvanendran S, 2011, MICROBES INFECT, V13, P844, DOI 10.1016/j.micinf.2011.04.007; Biebl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007374; Bochud PY, 2009, EUR J CLIN MICROBIOL, V28, P1055, DOI 10.1007/s10096-009-0746-0; Brett PM, 2005, J DENT RES, V84, P1149, DOI 10.1177/154405910508401211; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Carregaro F, 2010, MEM I OSWALDO CRUZ, V105, P649, DOI 10.1590/S0074-02762010000500008; Carvalho A, 2008, J INFECT DIS, V197, P618, DOI 10.1086/526500; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; Emingil G, 2007, J PERIODONTOL, V78, P1968, DOI 10.1902/jop.2007.060360; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Ertan P, 2011, INDIAN J PEDIATR, V78, P1229, DOI 10.1007/s12098-011-0399-8; Esposito S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-196; Faber J, 2006, PEDIATR INFECT DIS J, V25, P80, DOI 10.1097/01.inf.0000195595.22547.fe; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Feterowski C, 2003, IMMUNOLOGY, V109, P426, DOI 10.1046/j.1365-2567.2003.01674.x; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; Folwaczny M, 2004, CLIN EXP IMMUNOL, V135, P330, DOI 10.1111/j.1365-2249.2004.02383.x; Garlet GP, 2012, J CLIN PERIODONTOL, V39, P323, DOI 10.1111/j.1600-051X.2012.01859.x; Goepfert AR, 2005, AM J OBSTET GYNECOL, V193, P1478, DOI 10.1016/j.ajog.2005.03.053; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Holla LI, 2007, J PERIODONTAL RES, V42, P340, DOI [10.1111/j.1600-0765.2006.00954.x, 10.1111/j.1600-0765.2006.00954x]; Hoshino K, 1999, J IMMUNOL, V162, P3749; James JA, 2007, J CLIN PERIODONTOL, V34, P111, DOI 10.1111/j.1600-051X.2006.01030.x; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; Kinane DF, 2006, PERIODONTOL 2000, V40, P107, DOI 10.1111/j.1600-0757.2005.00136.x; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Laine ML, 2005, J DENT RES, V84, P1042, DOI 10.1177/154405910508401114; Laisk T, 2010, J REPROD IMMUNOL, V87, P74, DOI 10.1016/j.jri.2010.06.001; Lee SO, 2011, TRANSPLANTATION, V92, P690, DOI 10.1097/TP.0b013e31822b589f; Liadaki K, 2011, CLIN VACCINE IMMUNOL, V18, P217, DOI 10.1128/CVI.00460-10; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Miggin SM, 2006, J LEUKOCYTE BIOL, V80, P220, DOI 10.1189/jlb.1105672; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Moens L, 2007, MICROBES INFECT, V9, P15, DOI 10.1016/j.micinf.2006.10.002; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montes AH, 2006, CLIN EXP IMMUNOL, V143, P404, DOI 10.1111/j.1365-2249.2005.03002.x; Moreno-Eutimio MA, 2013, IMMUNOLOGY, V139, P459, DOI 10.1111/imm.12093; Mori Y, 2003, ORAL MICROBIOL IMMUN, V18, P54, DOI 10.1034/j.1399-302X.2003.180109.x; Moura SB, 2008, MICROBES INFECT, V10, P1477, DOI 10.1016/j.micinf.2008.08.009; Mrazek F, 2013, INFLAMM RES, V62, P483, DOI 10.1007/s00011-013-0601-8; Murray HW, 2013, INFECT IMMUN, V81, P2318, DOI 10.1128/IAI.01468-12; Najmi N, 2010, TISSUE ANTIGENS, V76, P102, DOI 10.1111/j.1399-0039.2010.01481.x; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Noack B, 2008, J CLIN PERIODONTOL, V35, P1020, DOI 10.1111/j.1600-051X.2008.01334.x; Noack B, 2009, IMMUNOL INVEST, V38, P297, DOI 10.1080/08820130902846290; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Nuolivirta K, 2009, PEDIATR INFECT DIS J, V28, P1121, DOI 10.1097/INF.0b013e3181af37ee; Ohto U, 2012, J BIOL CHEM, V287, P40611, DOI 10.1074/jbc.M112.404608; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Plantinga TS, 2010, JAIDS-J ACQ IMM DEF, V55, P87, DOI 10.1097/QAI.0b013e3181e53c64; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Rasouli M, 2012, MOL BIOL REP, V39, P10795, DOI 10.1007/s11033-012-1973-5; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Reddy Bavigadda Harish, 2011, J Indian Soc Periodontol, V15, P366, DOI 10.4103/0972-124X.92571; Ren L, 2005, J PERIODONTOL, V76, P1950, DOI 10.1902/jop.2005.76.11.1950; Rezazadeh M, 2006, J INFECTION, V53, P206, DOI 10.1016/j.jinf.2005.10.018; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Sahingur SE, 2011, J PERIODONTAL RES, V46, P184, DOI 10.1111/j.1600-0765.2010.01327.x; Sanchez D, 2012, INT J IMMUNOGENET, V39, P216, DOI 10.1111/j.1744-313X.2011.01077.x; Sanchez D, 2010, CELL IMMUNOL, V260, P128, DOI 10.1016/j.cellimm.2009.10.007; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schulz S, 2008, INT J IMMUNOGENET, V35, P457, DOI 10.1111/j.1744-313X.2008.00811.x; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Smirnova I, 2000, GENOME BIOL, V1; Szebeni B, 2006, J PEDIATR GASTR NUTR, V42, P27, DOI 10.1097/01.mpg.0000192246.47959.b2; Tian T, 2013, INFECT GENET EVOL, V14, P156, DOI 10.1016/j.meegid.2012.11.009; van Well GTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035837; Verma A, 2011, MED MICROBIOL IMMUN, V200, P255, DOI 10.1007/s00430-011-0198-x; Verma A, 2010, J INFECT DIS, V202, P1219, DOI 10.1086/656395; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Weitzel T, 2012, AM J TROP MED HYG, V86, P229, DOI 10.4269/ajtmh.2012.11-0539; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; Yin XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014223; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155; Zafra G, 2008, MEM I OSWALDO CRUZ, V103, P27, DOI 10.1590/S0074-02762008000100004; Zakeri S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-77; Zhu LF, 2012, GENE, V501, P213, DOI 10.1016/j.gene.2012.04.027; ZIAKAS PD, 2013, BIOMARKERS; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011; Zintzaras E, 2012, J APPL STAT, V39, P2569, DOI 10.1080/02664763.2012.722611; Zintzaras E, 2012, PSYCHIAT GENET, V22, P189, DOI 10.1097/YPG.0b013e328353ae53; Zintzaras E, 2012, CANCER EPIDEMIOL, V36, P169, DOI 10.1016/j.canep.2011.10.002; Zintzaras E, 2010, EUR J EPIDEMIOL, V25, P553, DOI 10.1007/s10654-010-9467-z; Zintzaras E, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1542	103	32	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81047	10.1371/journal.pone.0081047	http://dx.doi.org/10.1371/journal.pone.0081047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282567	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500069
J	Roberts, DA; de Nys, R; Paul, NA				Roberts, David A.; de Nys, Rocky; Paul, Nicholas A.			The Effect of CO2 on Algal Growth in Industrial Waste Water for Bioenergy and Bioremediation Applications	PLOS ONE			English	Article							HEAVY-METALS; FLUE-GAS; BIOSORPTION; RATIONALE; TOXICITY	The energy, mining and mineral processing industries are point sources of metal-contaminated waste water and carbon dioxide (CO2). Freshwater macroalgae from the genus Oedogonium can be grown in metal-contaminated waste water to generate biomass for bioenergy applications and concomitantly bioremediate metals. However, interactions between CO2 addition and algal growth, which can affect bioremediation, remain untested. The addition of CO2 to algal cultures in the Ash Dam Water (ADW) from a coal-fired power station increased the biomass productivity of Oedogonium sp. from 6.8 g dry weight (DW) m(-2) d(-1) to a maximum of 22.5 g DW m(-2) d(-1). The greater productivity increased the rate of bioremediation of most elements. However, over time carbon-amended cultures experienced a decline in productivity. Possible explanations include metal toxicity at low pH or essential trace element limitation as a result of competition between toxic and essential trace elements for uptake into algae. Higher productivity increased bioremediation rate and yielded more biomass for bioenergy applications, making maintenance of maximum productivity the central aim of the integrated culture model. To do so it will be necessary to resolve the mechanisms responsible for declining yields over time in carbon-amended cultures. Regardless, our data demonstrate that freshwater macroalgae are ideal candidates for bioremediation of metal-contaminated waste streams. Algal culture delivered significant improvement in ADW quality, reducing 5 elements that were initially in excess of water quality criteria (Al, As, Cd, Ni and Zn) to meet guidelines within two to four weeks.	[Roberts, David A.; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Roberts, DA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	david.roberts1@jcu.edu.au	Roberts, David A/D-9322-2012; Paul, Nicholas/B-6496-2009; de Nys, Rocky/D-6741-2012	Roberts, David A/0000-0003-0261-691X; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme; Australian Renewable Energy Agency (ARENA)	Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Renewable Energy Agency (ARENA)(Australian Renewable Energy Agency (ARENA))	This project is supported by the Advanced Manufacturing Cooperative Research Centre (AMCRC), through the Australian Government's Cooperative Research Centre Scheme, and the Australian Renewable Energy Agency (ARENA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; BAKER MD, 1983, CHEMOSPHERE, V12, P35, DOI 10.1016/0045-6535(83)90177-7; Chojnacka K, 2010, ENVIRON INT, V36, P299, DOI 10.1016/j.envint.2009.12.001; Cole A, 2013, GLOB CHANGE IN PRESS; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Gensemer RW, 1999, CRIT REV ENV SCI TEC, V29, P315, DOI 10.1080/10643389991259245; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; He L, 2012, BIOMASS BIOENERG, V41, P131, DOI 10.1016/j.biombioe.2012.02.025; INAP (International Network for Acid Prevention), 2002, DIFF GRAD THIN FILMS; Israel A, 2005, AQUACULTURE, V249, P311, DOI 10.1016/j.aquaculture.2005.04.058; Kraan S, 2013, MITIG ADAPT STRAT GL, V18, P27, DOI 10.1007/s11027-010-9275-5; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064168; Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001; MCCRACKEN MD, 1974, AM MIDL NAT, V92, P247, DOI 10.2307/2424223; Mulbry WW, 2001, J APPL PHYCOL, V13, P301, DOI 10.1023/A:1017545116317; National Research Council of the National Academics (NRC), 2012, SUST DEV ALG BIOF US; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Nishikawa K, 2003, FEMS MICROBIOL ECOL, V44, P253, DOI 10.1016/S0168-6496(03)00049-7; Olguin EJ, 2012, NEW BIOTECHNOL, V30, P3, DOI 10.1016/j.nbt.2012.05.020; Palumbo AJ, 2012, J IND MICROBIOL BIOT, V39, P1345, DOI 10.1007/s10295-012-1129-6; Park JBK, 2011, BIORESOURCE TECHNOL, V102, P35, DOI 10.1016/j.biortech.2010.06.158; Paul NA, 2008, AQUACULTURE, V281, P49, DOI 10.1016/j.aquaculture.2008.05.024; Pawlik-Skowronska B, 2001, AQUAT TOXICOL, V52, P241, DOI 10.1016/S0166-445X(00)00144-2; Quinn GP, 2003, EXPT DESIGN DATA ANA; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rickman M, 2013, ALGAL RES, V2, P59, DOI 10.1016/j.algal.2012.11.003; Rothman NJ, 2013, ECOL ENG, V52, P290, DOI 10.1016/j.ecoleng.2012.11.002; Rowbotham JS, 2012, BIOFUELS-UK, V3, P441, DOI [10.4155/BFS.12.29, 10.4155/bfs.12.29]; Saunders RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036470; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Simmons DBD, 2009, ANAL BIOANAL CHEM, V395, P809, DOI 10.1007/s00216-009-3016-1; Slade R, 2013, BIOMASS BIO IN PRESS; Van den Hende S, 2012, BIOTECHNOL ADV, V30, P1405, DOI 10.1016/j.biotechadv.2012.02.015; Ward C, 2007, LAB ASSESSMENT FLY A; Zhang H., 2003, DGT MEASUREMENTS WAT	38	46	46	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81631	10.1371/journal.pone.0081631	http://dx.doi.org/10.1371/journal.pone.0081631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278451	Green Published, gold, Green Accepted			2022-12-27	WOS:000327541700068
J	Scott, RA; Paderi, JE; Sturek, M; Panitch, A				Scott, Rebecca A.; Paderi, John E.; Sturek, Michael; Panitch, Alyssa			Decorin Mimic Inhibits Vascular Smooth Muscle Proliferation and Migration	PLOS ONE			English	Article							CELL-PROLIFERATION; NEOINTIMAL HYPERPLASIA; CORONARY ANGIOPLASTY; EXTRACELLULAR-MATRIX; HUMAN THROMBOMODULIN; ELUTING STENTS; ACTIVATION; RESTENOSIS; EXPRESSION; MECHANISM	Over the past 10 years, the number of percutaneous coronary intervention procedures performed in the United States increased by 33%; however, restenosis, which inhibits complete functional recovery of the vessel wall, complicates this procedure. A wide range of anti-restenotic therapeutics have been developed, although many elicit non-specific effects that compromise vessel healing. Drawing inspiration from biologically-relevant molecules, our lab developed a mimic of the natural proteoglycan decorin, termed DS-SILY, which can mask exposed collagen and thereby effectively decrease platelet activation, thus contributing to suppression of vascular intimal hyperplasia. Here, we characterize the effects of DS-SILY on both proliferative and quiescent human SMCs to evaluate the potential impact of DS-SILY-SMC interaction on restenosis, and further characterize in vivo platelet interactions. DS-SILY decreased proliferative SMC proliferation and pro-inflammatory cytokine secretion in vitro in a concentration dependent manner as compared to untreated controls. The addition of DS-SILY to in vitro SMC cultures decreased SMC migration and protein synthesis by 95% and 37%, respectively. Furthermore, DS-SILY decreased platelet activation, as well as reduced neointimal hyperplasia by 60%, in vivo using Ossabaw swine. These results indicate that DS-SILY demonstrates multiple biological activities that may all synergistically contribute to an improved treatment paradigm for balloon angioplasty.	[Scott, Rebecca A.; Paderi, John E.; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sturek, Michael] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46204 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis	Panitch, A (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	apanitch@purdue.edu	Sturek, Michael/CAH-2948-2022	Scott, Rebecca/0000-0002-2409-0712	NSF [DGE-1333468]; NIH [R01HL106792]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106792] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	RS is supported by a NSF Graduate Research Fellowship (DGE-1333468). Funding for this research was through NIH R01HL106792. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Association AH, 2010, HEART DIS STROK STAT; AZRIN MA, 1994, CIRCULATION, V90, P433, DOI 10.1161/01.CIR.90.1.433; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; Belmiro CLR, 2011, BRAZ J MED BIOL RES, V44, P624, DOI [10.1590/S0100-879X2011007500077, 10.1590/S0100-879X2011000700003]; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Buie VC, 2010, NATL HOSP DISCHARGE; Chaterji S, 2010, TISSUE ENG PT A, V16, P1901, DOI [10.1089/ten.tea.2009.0271, 10.1089/ten.TEA.2009.0271]; D'Antoni ML, 2008, AM J PHYSIOL-LUNG C, V294, pL764, DOI 10.1152/ajplung.00436.2007; Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Farndale RW, 2006, BLOOD CELL MOL DIS, V36, P162, DOI 10.1016/j.bcmd.2005.12.016; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Garcia-Touchard A, 2006, EUR HEART J, V27, P988, DOI 10.1093/eurheartj/ehi752; HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651; Huang CC, 2008, CIRCULATION, V118, pS1101; IP JH, 1991, J AM COLL CARDIOL, V17, pB77; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; KARAS SP, 1992, J AM COLL CARDIOL, V20, P467, DOI 10.1016/0735-1097(92)90119-8; Li JM, 2004, J VASC SURG, V39, P1074, DOI 10.1016/j.jvs.2003.12.030; Lo IC, 2009, CARDIOVASC RES, V81, P771, DOI 10.1093/cvr/cvn351; Long X, 2010, J APPL PHYSIOL, V108, P1766, DOI 10.1152/japplphysiol.01014.2009; Loppnow H, 1998, BLOOD, V91, P134, DOI 10.1182/blood.V91.1.134.134_134_141; MACLEOD DC, 1994, J AM COLL CARDIOL, V23, P59, DOI 10.1016/0735-1097(94)90502-9; MAJACK RA, 1984, J CELL PHYSIOL, V118, P253, DOI 10.1002/jcp.1041180306; Matter CM, 2006, J CARDIOVASC PHARM, V48, P286, DOI 10.1097/01.fjc.0000248233.22570.8b; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Nili N, 2003, AM J PATHOL, V163, P869, DOI 10.1016/S0002-9440(10)63447-5; NOBUYOSHI M, 1991, J AM COLL CARDIOL, V17, P433, DOI 10.1016/S0735-1097(10)80111-1; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Paderi JE, 2008, BIOMACROMOLECULES, V9, P2562, DOI 10.1021/bm8006852; Paderi JE, 2011, BIOMATERIALS, V32, P2516, DOI 10.1016/j.biomaterials.2010.12.025; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Regar E, 2001, BRIT MED BULL, V59, P227, DOI 10.1093/bmb/59.1.227; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; RIESSEN R, 1994, AM J PATHOL, V144, P962; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; SALISBURY BGJ, 1981, J BIOL CHEM, V256, P8050; Sanchez-Guerrero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039811; Sturek M, 2007, SWINE LAB SURG ANEST, P397; Sukkar MB, 2004, IMMUNOL CELL BIOL, V82, P471, DOI 10.1111/j.0818-9641.2004.01275.x; van der Hoeven BL, 2005, INT J CARDIOL, V99, P9, DOI 10.1016/j.ijcard.2004.01.021; Waugh JM, 2000, CIRCULATION, V102, P332; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165	48	29	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82456	10.1371/journal.pone.0082456	http://dx.doi.org/10.1371/journal.pone.0082456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278482	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700079
J	Yang, P; Glukhova, A; Tesmer, JJG; Chen, Z				Yang, Pei; Glukhova, Alisa; Tesmer, John J. G.; Chen, Zhan			Membrane Orientation and Binding Determinants of G Protein-Coupled Receptor Kinase 5 as Assessed by Combined Vibrational Spectroscopic Studies	PLOS ONE			English	Article							SUM-FREQUENCY GENERATION; INTERFACIAL WATER-STRUCTURE; MOLECULAR-INTERACTIONS; SECONDARY STRUCTURES; PHASE-TRANSITION; SURFACE; LOCALIZATION; ADSORPTION; ACTIVATION; IDENTIFICATION	G-protein coupled receptors (GPCRs) are integral membrane proteins involved in a wide variety of biological processes in eukaryotic cells, and are targeted by a large fraction of marketed drugs. GPCR kinases (GRKs) play important roles in feedback regulation of GPCRs, such as of beta-adrenergic receptors in the heart, where GRK2 and GRK5 are the major isoforms expressed. Membrane targeting is essential for GRK function in cells. Whereas GRK2 is recruited to the membrane by heterotrimeric G beta gamma subunits, the mechanism of membrane binding by GRK5 is not fully understood. It has been proposed that GRK5 is constitutively associated with membranes through elements located at its N-terminus, its C-terminus, or both. The membrane orientation of GRK5 is also a matter of speculation. In this work, we combined sum frequency generation (SFG) vibrational spectroscopy and attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) to help determine the membrane orientation of GRK5 and a C-terminally truncated mutant (GRK5(1-531)) on membrane lipid bilayers. It was found that GRK5 and GRK5(1-531) adopt a similar orientation on model cell membranes in the presence of PIP2 that is similar to that predicted for GRK2 in prior studies. Mutation of the N-terminal membrane binding site of GRK5 did not eliminate membrane binding, but prevented observation of this discrete orientation. The C-terminus of GRK5 does not have substantial impact on either membrane binding or orientation in this model system. Thus, the C-terminus of GRK5 may drive membrane binding in cells via interactions with other proteins at the plasma membrane or bind in an unstructured manner to negatively charged membranes.	[Yang, Pei; Chen, Zhan] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Glukhova, Alisa; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Glukhova, Alisa; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Glukhova, Alisa] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA.	tesmerjj@umich.edu; zhanc@umich.edu	Yang, Pei/C-4043-2012; Chen, Zhan/G-8312-2016	Chen, Zhan/0000-0001-8687-8348; Tesmer, John/0000-0003-1125-3727; Glukhova, Alisa/0000-0003-4146-965X	NIH [GM081655, HL071818, HL086865]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081655] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM081655 to Z.C. and J.T., and by NIH grants HL071818 and HL086865 (to J.T.). NIH (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN CD, 1995, J CHEM SOC FARADAY T, V91, P1281, DOI 10.1039/ft9959101281; Barth C, 2012, LANGMUIR, V28, P8456, DOI 10.1021/la301241s; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Boughton AP, 2011, P NATL ACAD SCI USA, V108, pE667, DOI 10.1073/pnas.1108236108; Campen RK, 2010, J AM CHEM SOC, V132, P8037, DOI 10.1021/ja100838q; Chen XY, 2007, J AM CHEM SOC, V129, P12658, DOI 10.1021/ja075542w; Chen X, 2007, J AM CHEM SOC, V129, P12272, DOI 10.1021/ja073869r; Chen X, 2010, LANGMUIR, V26, P16447, DOI 10.1021/la1015862; Ding B, 2012, J PHYS CHEM B, V116, P2545, DOI 10.1021/jp209604m; Eisenthal KB, 1996, CHEM REV, V96, P1343, DOI 10.1021/cr9502211; Engelhardt K, 2012, LANGMUIR, V28, P7780, DOI 10.1021/la301368v; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9; Fu L, 2011, J AM CHEM SOC, V133, P8094, DOI 10.1021/ja201575e; Fu L, 2010, J AM CHEM SOC, V132, P5405, DOI 10.1021/ja909546b; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Han XF, 2011, LANGMUIR, V27, P7042, DOI 10.1021/la200388y; Haupert LM, 2009, ANNU REV PHYS CHEM, V60, P345, DOI 10.1146/annurev.physchem.59.032607.093712; Homan KT, 2013, CURR MED CHEM, V20, P39; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; Jen SH, 2006, J PHYS CHEM B, V110, P23000, DOI 10.1021/jp0644762; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n; Kim J, 2001, CHEMPHYSCHEM, V2, P543, DOI 10.1002/1439-7641(20010917)2:8/9<543::AID-CPHC543>3.0.CO;2-5; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; Leung BO, 2012, LANGMUIR, V28, P5724, DOI 10.1021/la204805x; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; Li QF, 2009, PHYS CHEM CHEM PHYS, V11, P3436, DOI 10.1039/b821045d; Liljebad JFD, 2011, J PHYS CHEM C, V115, P10617, DOI 10.1021/jp111587e; Liu J, 2004, J AM CHEM SOC, V126, P8894, DOI 10.1021/ja031570c; Liu YW, 2013, J AM CHEM SOC, V135, P12660, DOI 10.1021/ja403672s; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Ma G, 2004, LANGMUIR, V20, P11620, DOI 10.1021/la0487343; Marsh D, 1997, BIOPHYS J, V72, P2710, DOI 10.1016/S0006-3495(97)78914-8; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Nguyen KT, 2010, J PHYS CHEM B, V114, P8291, DOI 10.1021/jp102343h; Nguyen KT, 2009, J PHYS CHEM B, V113, P12358, DOI 10.1021/jp904154w; Nguyen KT, 2009, J PHYS CHEM B, V113, P12169, DOI 10.1021/jp904153z; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Ramakrishnan M, 2005, BIOCHEMISTRY-US, V44, P3515, DOI 10.1021/bi047603y; Richmond GL, 2002, CHEM REV, V102, P2693, DOI 10.1021/cr0006876; RODIONOVA NA, 1995, BIOCHEMISTRY-US, V34, P1921, DOI 10.1021/bi00006a013; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thennarasu S, 2010, BIOCHEMISTRY-US, V49, P10595, DOI 10.1021/bi101394r; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tong YJ, 2010, ANGEW CHEM INT EDIT, V49, P2319, DOI 10.1002/anie.200904950; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Wang HF, 2005, INT REV PHYS CHEM, V24, P191, DOI 10.1080/01442350500225894; Wang HF, 2007, J PHYS CHEM C, V111, P8708, DOI 10.1021/jp066873i; Wang T, 2011, J PHYS CHEM C, V115, P7613, DOI 10.1021/jp200546h; Weidner T, 2012, J AM CHEM SOC, V134, P8750, DOI 10.1021/ja301711w; Weidner T, 2010, P NATL ACAD SCI USA, V107, P13288, DOI 10.1073/pnas.1003832107; Wood JF, 2012, J BIOL CHEM, V287, P12634, DOI 10.1074/jbc.M111.336818; Yang P, 2013, J PHYS CHEM C, V117, P17039, DOI 10.1021/jp4047215; Yang P, 2013, J AM CHEM SOC, V135, P5044, DOI 10.1021/ja3116026; Yang P, 2013, J PHYS CHEM C, V117, P3358, DOI 10.1021/jp3099522; Yang P, 2011, LANGMUIR, V27, P7760, DOI 10.1021/la201048t; Ye HK, 2006, LANGMUIR, V22, P1863, DOI 10.1021/la052030r; Ye H, 2007, J PHYS CHEM C, V111, P13250, DOI 10.1021/jp072767k; Ye SJ, 2012, J AM CHEM SOC, V134, P6237, DOI 10.1021/ja2110784; Ye SJ, 2012, LANGMUIR, V28, P1374, DOI 10.1021/la203690p	77	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e82072	10.1371/journal.pone.0082072	http://dx.doi.org/10.1371/journal.pone.0082072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278472	Green Published, gold			2022-12-27	WOS:000327541700074
J	Banet, AI; Trexler, JC				Banet, Amanda I.; Trexler, Joel C.			Space-for-Time Substitution Works in Everglades Ecological Forecasting Models	PLOS ONE			English	Article							CLIMATE ENVELOPE; MANAGEMENT; DYNAMICS; PATTERNS; DESIGNS; FISHES	Space-for-time substitution is often used in predictive models because long-term time-series data are not available. Critics of this method suggest factors other than the target driver may affect ecosystem response and could vary spatially, producing misleading results. Monitoring data from the Florida Everglades were used to test whether spatial data can be substituted for temporal data in forecasting models. Spatial models that predicted bluefin killifish (Lucania goodei) population response to a drying event performed comparably and sometimes better than temporal models. Models worked best when results were not extrapolated beyond the range of variation encompassed by the original dataset. These results were compared to other studies to determine whether ecosystem features influence whether space-for-time substitution is feasible. Taken in the context of other studies, these results suggest space-for-time substitution may work best in ecosystems with low beta-diversity, high connectivity between sites, and small lag in organismal response to the driver variable.	[Banet, Amanda I.; Trexler, Joel C.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Banet, AI (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	mandybanet@gmail.com	Trexler, Joel C/I-5265-2012		FIU [W912HZ-10-2-0033, CA-H5000060104, J5297070024, 4600001083]; US Army Corps of Engineers [W912HZ-10-2-0033]; Everglades National Park [CA-H5000060104, J5297070024]; South Florida Water Management District [4600001083]; National Science Foundation [DEB-9910514]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	FIU; US Army Corps of Engineers(United States Department of DefenseUnited States Army); Everglades National Park; South Florida Water Management District; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by Cooperative Agreement W912HZ-10-2-0033 between FIU and the US Army Corps of Engineers. The data used were produced by Cooperative Agreements CA-H5000060104, Task No. J5297070024 between FIU and the Everglades National Park and contract 4600001083 between FIU and the South Florida Water Management District. This material is based upon work supported by the National Science Foundation through the Florida Coastal Everglades Long-Term Ecological Research program under Cooperative Agreement DEB-9910514 and is publication number 645 from the Southeastern Environmental Research Center at FIU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; *CEC, 1995, WIS US CONS WETL; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Dixon P, 1993, BOOTSTRAP JACKKNIFE, P290; Doren R, 2008, TECHNICAL REPORT; Frederick Peter C., 1994, P659; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Isaac NJB, 2011, J INSECT CONSERV, V15, P233, DOI 10.1007/s10841-010-9340-0; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Jordan F, 1997, T AM FISH SOC, V126, P1012, DOI 10.1577/1548-8659(1997)126<1012:SFIVHE>2.3.CO;2; Kappes H, 2010, ECOL INDIC, V10, P1202, DOI 10.1016/j.ecolind.2010.03.012; Knapp AK., 1998, GRASSLAND DYNAMICS L, P193; Kratz TK, 2003, BIOSCIENCE, V53, P57, DOI 10.1641/0006-3568(2003)053[0057:EVISAT]2.0.CO;2; Larsen DP, 2001, BIOSCIENCE, V51, P1069, DOI 10.1641/0006-3568(2001)051[1069:DFELAR]2.0.CO;2; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lindegren M, 2009, PREVENTING COLLAPSE; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Mcelroy TC, 2003, MOL ECOL, V12, P355, DOI 10.1046/j.1365-294X.2003.01738.x; McElroy TC, 2011, J HERED, V102, P678, DOI 10.1093/jhered/esr088; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2009, P NATL ACAD SCI USA, V106, pE47, DOI 10.1073/pnas.0809722106; PICKETT S T A, 1989, P110; Ruetz CR, 2005, J ANIM ECOL, V74, P322, DOI 10.1111/j.1365-2656.2005.00926.x; Sarmento H, 2010, PHILOS T R SOC B, V365, P2137, DOI 10.1098/rstb.2010.0045; Schippers P, 1996, ECOGRAPHY, V19, P97, DOI 10.1111/j.1600-0587.1996.tb00160.x; Soininen J, 2010, BIOSCIENCE, V60, P433, DOI 10.1525/bio.2010.60.6.7; Sparling G, 2003, SOIL BIOL BIOCHEM, V35, P1575, DOI 10.1016/j.soilbio.2003.08.002; Ter Braak CJF, 1998, INCIDENCE FUNCTION A; Trexler JC, 2003, MONITORING ECOSYSTEM; Trexler JC, 2009, ECOL INDIC, V9, pS108, DOI 10.1016/j.ecolind.2008.11.001; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; WALTERS C, 1992, ECOL APPL, V2, P189, DOI 10.2307/1941775	36	22	22	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81025	10.1371/journal.pone.0081025	http://dx.doi.org/10.1371/journal.pone.0081025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278368	Green Published, gold			2022-12-27	WOS:000327539800096
J	Bolitho, SJ; Naismith, SL; Salahuddin, P; Terpening, Z; Grunstein, RR; Lewis, SJG				Bolitho, Samuel J.; Naismith, Sharon L.; Salahuddin, Pierre; Terpening, Zoe; Grunstein, Ron R.; Lewis, Simon J. G.			Objective Measurement of Daytime Napping, Cognitive Dysfunction and Subjective Sleepiness in Parkinson's Disease	PLOS ONE			English	Article							SELF-REPORTED SLEEP; OLDER WOMEN; ALZHEIMERS-DISEASE; OSTEOPOROTIC FRACTURES; WAKE DISTURBANCES; NAP DURATION; DOUBLE-BLIND; SOMNOLENCE; BEHAVIOR; SCALE	Introduction: Sleep-wake disturbances and concomitant cognitive dysfunction in Parkinson's disease (PD) contribute significantly to morbidity in patients and their carers. Subjectively reported daytime sleep disturbance is observed in over half of all patients with PD and has been linked to executive cognitive dysfunction. The current study used daytime actigraphy, a novel objective measure of napping and related this to neuropsychological performance in a sample of PD patients and healthy, age and gender-matched controls. Furthermore this study aimed to identify patients with PD who may benefit from pharmacologic and behavioural intervention to improve these symptoms. Methods: Eighty-five PD patients and 21 healthy, age-matched controls completed 14 days of wrist actigraphy within two weeks of neuropsychological testing. Objective napping measures were derived from actigraphy using a standardised protocol and subjective daytime sleepiness was recorded by the previously validated Epworth Sleepiness Scale. Results: Patients with PD had a 225% increase in the mean nap time per day (minutes) as recorded by actigraphy compared to age matched controls (39.2 +/- 35.2 vs. 11.5 +/- 11.0 minutes respectively, p < 0.001). Significantly, differences in napping duration between patients, as recorded by actigraphy were not distinguished by their ratings on the subjective measurement of excessive daytime sleepiness. Finally, those patients with excessive daytime napping showed greater cognitive deficits in the domains of attention, semantic verbal fluency and processing speed. Conclusion: This study confirms increased levels of napping in PD, a finding that is concordant with subjective reports. However, subjective self-report measures of excessive daytime sleepiness do not robustly identify excessive napping in PD. Fronto-subcortical cognitive dysfunction was observed in those patients who napped excessively. Furthermore, this study suggests that daytime actigraphy, a non-invasive and inexpensive objective measure of daytime sleep, can identify patients with PD who may benefit from pharmacologic and behavioural interventions to improve these symptoms.	[Bolitho, Samuel J.; Salahuddin, Pierre; Lewis, Simon J. G.] Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia; [Naismith, Sharon L.; Terpening, Zoe] Univ Sydney, Brain & Mind Res Inst, Ageing Brain Ctr, Hlth Brain Ageing Clin, Sydney, NSW 2006, Australia; [Grunstein, Ron R.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Clin, Sydney, NSW 2006, Australia.	simonl@med.usyd.edu.au	Lewis, Simon/R-9469-2016	Lewis, Simon/0000-0002-4093-7071; Naismith, Sharon/0000-0001-9076-2778	NHMRC PhD Scholarship; CIRUS; NHMRC Career Development Award; NHMRC Practitioner Fellowship	NHMRC PhD Scholarship(National Health and Medical Research Council (NHMRC) of Australia); CIRUS; NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding of the study was supported by NHMRC PhD Scholarship and CIRUS (Dr SJB); NHMRC Career Development Award (Associate Professor SLN); NHMRC Practitioner Fellowship (Professor RRG); NHMRC Practitioner Fellowship (Associated Professor SJGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2000, J AM GERIATR SOC, V48, P938, DOI 10.1111/j.1532-5415.2000.tb06891.x; Abbott RD, 2005, NEUROLOGY, V65, P1442, DOI 10.1212/01.wnl.0000183056.89590.0d; Adler CH, 2005, NEUROLOGY, V64, pS12, DOI 10.1212/WNL.64.12_suppl_3.S12; Asada T, 2000, SLEEP, V23, P629; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blackwell T, 2006, J GERONTOL A-BIOL, V61, P405, DOI 10.1093/gerona/61.4.405; Blackwell T, 2008, SLEEP, V31, P283, DOI 10.1093/sleep/31.2.283; Boddy F, 2007, INT J GERIATR PSYCH, V22, P529, DOI 10.1002/gps.1709; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; Datta S, 2007, NEUROSCI BIOBEHAV R, V31, P775, DOI 10.1016/j.neubiorev.2007.02.004; Datta S, 2010, SLEEP MED, V11, P431, DOI 10.1016/j.sleep.2010.02.002; Dautovich ND, 2008, J AM GERIATR SOC, V56, P1681, DOI 10.1111/j.1532-5415.2008.01822.x; Dautovich ND, 2012, HEALTH PSYCHOL, V31, P671, DOI 10.1037/a0027374; De Cock VC, 2008, NAT CLIN PRACT NEURO, V4, P254, DOI 10.1038/ncpneuro0775; Douglas NJ, 2001, AM J RESP CRIT CARE, V163, P1310, DOI 10.1164/ajrccm.163.6.2007021; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao JJ, 2011, AM J EPIDEMIOL, V173, P1032, DOI 10.1093/aje/kwq478; Gjerstad MD, 2006, NEUROLOGY, V67, P853, DOI 10.1212/01.wnl.0000233980.25978.9d; Gjerstad MD, 2002, NEUROLOGY, V58, P1544, DOI 10.1212/WNL.58.10.1544; Gunn DG, 2010, J GERIATR PSYCH NEUR, V23, P131, DOI 10.1177/0891988709358591; HARDINGE FM, 1995, RESP MED, V89, P617, DOI 10.1016/0954-6111(95)90230-9; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hogl B, 2002, SLEEP, V25, P905; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kanady JC, 2011, J SLEEP RES, V20, P214, DOI 10.1111/j.1365-2869.2010.00858.x; Keage HAD, 2012, SLEEP MED, V13, P886, DOI 10.1016/j.sleep.2012.02.003; Knie B, 2011, CNS DRUGS, V25, P203, DOI 10.2165/11539720-000000000-00000; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Martinez J, 2003, J BIOL CHEM, V278, P17379, DOI 10.1074/jbc.M209020200; McDevitt EA, 2012, PHYSIOL BEHAV, V107, P40, DOI 10.1016/j.physbeh.2012.05.021; Moriguchi S, 2012, J NEUROCHEM, V120, P541, DOI 10.1111/j.1471-4159.2011.07608.x; Naismith SL, 2011, MOVEMENT DISORD, V26, P1537, DOI 10.1002/mds.23640; Naismith SL, 2011, J CLIN NEUROSCI, V18, P352, DOI 10.1016/j.jocn.2010.07.106; Naismith SL, 2010, CLIN NEUROL NEUROSUR, V112, P420, DOI 10.1016/j.clineuro.2010.02.011; Naismith SL, 2010, J GERIATR PSYCH NEUR, V23, P123, DOI 10.1177/0891988710363710; Ondo WG, 2005, J NEUROL NEUROSUR PS, V76, P1636, DOI 10.1136/jnnp.2005.065870; Ondo WG, 2008, ARCH NEUROL-CHICAGO, V65, P1337, DOI 10.1001/archneur.65.10.1337; Peeraully T, 2012, MOVEMENT DISORD, V27, P1729, DOI 10.1002/mds.25197; Perez-Lloret S, 2009, J NEUROL, V256, P1480, DOI 10.1007/s00415-009-5141-3; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Reitan RM., 1979, TRAIL MAKING TEST MA; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Ross GW, 2012, PARKINSONISM RELA S1, V18, pS199, DOI DOI 10.1016/S1353-8020(11)70062-1; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stone KL, 2006, J AM GERIATR SOC, V54, P1177, DOI 10.1111/j.1532-5415.2006.00818.x; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Takahashi M, 2003, SLEEP MED REV, V7, P227, DOI 10.1053/smrv.2002.0241; Takahashi M, 2000, SLEEP, V23, P813; Tietzel AJ, 2001, SLEEP, V24, P293, DOI 10.1093/sleep/24.3.293; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vecchierini MF, 2010, PSYCHOL NEUROPSYCHIA, V8, P15, DOI 10.1684/pnv.2010.0203; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Zhong G, 2011, J NEUROL SCI, V307, P9, DOI 10.1016/j.jns.2011.04.020	65	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81233	10.1371/journal.pone.0081233	http://dx.doi.org/10.1371/journal.pone.0081233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278399	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800111
J	Carruthers, CW; Gerdts, C; Johnson, MD; Webb, P				Carruthers, Carl W., Jr.; Gerdts, Cory; Johnson, Michael D.; Webb, Paul			A Microfluidic, High Throughput Protein Crystal Growth Method for Microgravity	PLOS ONE			English	Article							STRUCTURAL BIOLOGY; MACROMOLECULAR CRYSTALLIZATION; PPAR-GAMMA; SPACE; CRYSTALLOGRAPHY; LYSOZYME; FACILITY; INSULIN; LIGAND; SYNTHETASE	The attenuation of sedimentation and convection in microgravity can sometimes decrease irregularities formed during macromolecular crystal growth. Current terrestrial protein crystal growth (PCG) capabilities are very different than those used during the Shuttle era and that are currently on the International Space Station (ISS). The focus of this experiment was to demonstrate the use of a commercial off-the-shelf, high throughput, PCG method in microgravity. Using Protein BioSolutions' microfluidic Plug Maker (TM)/CrystalCard (TM) system, we tested the ability to grow crystals of the regulator of glucose metabolism and adipogenesis: peroxisome proliferator-activated receptor gamma (apo-hPPAR-gamma LBD), as well as several PCG standards. Overall, we sent 25 CrystalCards (TM) to the ISS, containing similar to 10,000 individual microgravity PCG experiments in a 3U NanoRacks NanoLab (1U = 10(3) cm.). After 70 days on the ISS, our samples were returned with 16 of 25 (64%) microgravity cards having crystals, compared to 12 of 25 (48%) of the ground controls. Encouragingly, there were more apo-hPPAR-gamma LBD crystals in the microgravity PCG cards than the 1g controls. These positive results hope to introduce the use of the PCG standard of low sample volume and large experimental density to the microgravity environment and provide new opportunities for macromolecular samples that may crystallize poorly in standard laboratories.	[Carruthers, Carl W., Jr.; Webb, Paul] Houston Methodist Res Inst, Dept Genom Med, Houston, TX USA; [Gerdts, Cory] Prot BioSolut Inc, Gaithersburg, MD USA; [Johnson, Michael D.] NanoRacks LLC, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston	Carruthers, CW (corresponding author), Houston Methodist Res Inst, Dept Genom Med, Houston, TX USA.	CWCarruthers@tmhs.org						Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106; BETZEL C, 1994, MICROGRAVITY SCI TEC, V7, P242; Boggon TJ, 1998, PHILOS T R SOC A, V356, P1045, DOI 10.1098/rsta.1998.0208; Borgstahl GEO, 2001, ACTA CRYSTALLOGR D, V57, P1204, DOI 10.1107/S0907444901007892; BOSCH R, 1992, J CRYST GROWTH, V122, P310, DOI 10.1016/0022-0248(92)90262-H; Broutin I, 1997, J CRYST GROWTH, V181, P97, DOI 10.1016/S0022-0248(97)00281-9; Carter DC, 1999, J CRYST GROWTH, V196, P602, DOI 10.1016/S0022-0248(98)00857-4; Carter DC, 2005, J APPL CRYSTALLOGR, V38, P87, DOI 10.1107/S0021889804028055; Carter DC, 1999, J CRYST GROWTH, V196, P610, DOI 10.1016/S0022-0248(98)00858-6; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; Dauter Z, 2006, ACTA CRYSTALLOGR D, V62, P1, DOI 10.1107/S0907444905034050; Dauter Z, 2010, J SYNCHROTRON RADIAT, V17, P433, DOI 10.1107/S0909049510011611; DeLucas L J, 1999, Gravit Space Biol Bull, V12, P39; Dong J, 1999, ACTA CRYSTALLOGR D, V55, P745, DOI 10.1107/S0907444998016047; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; ERDMANN VA, 1989, FEBS LETT, V259, P194, DOI 10.1016/0014-5793(89)81526-1; Gerdts CJ, 2008, ACTA CRYSTALLOGR D, V64, P1116, DOI 10.1107/S0907444908028060; Gerdts CJ, 2010, J APPL CRYSTALLOGR, V43, P1078, DOI 10.1107/S0021889810027378; Gileadi Opher, 2007, Journal of Structural and Functional Genomics, V8, P107, DOI 10.1007/s10969-007-9027-2; Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010; Helliwell JR, 2007, NATURE, V448, P658, DOI 10.1038/448658a; HELLIWELL JR, 2006, INT TABLES CRYSTALLO, Vf, P155; HILGENFELD R, 1992, J CRYST GROWTH, V122, P330, DOI 10.1016/0022-0248(92)90265-K; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Kundrot CE, 2001, CRYST GROWTH DES, V1, P87, DOI 10.1021/cg005511b; Long MM, 1996, J CRYST GROWTH, V168, P233, DOI 10.1016/0022-0248(96)00325-9; Lorber B, 2002, ACTA CRYSTALLOGR D, V58, P1674, DOI 10.1107/S0907444902014245; Maes D, 2007, MICROGRAVITY SCI TEC, V19, P90; Matsumura H, 2011, J SYNCHROTRON RADIAT, V18, P16, DOI 10.1107/S090904951003445X; McPherson A, 1999, J CRYST GROWTH, V196, P572, DOI 10.1016/S0022-0248(98)00853-7; MCPHERSON A, 1996, CRYSTALLOGRAPHY REV, V6; Ng JD, 2002, ACTA CRYSTALLOGR D, V58, P645, DOI 10.1107/S0907444902003177; Otalora F, 1999, ACTA CRYSTALLOGR D, V55, P644, DOI 10.1107/S0907444998014462; Pletser V, 1999, J CRYST GROWTH, V196, P638, DOI 10.1016/S0022-0248(98)00865-3; RAJAGOPALAN S, 2012, ENDOCR REV, V33, pOR10; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SAUSER B, 2010, MIT TECHNOLOGY REV; SNELL EH, 1995, ACTA CRYSTALLOGR D, V51, P1099, DOI 10.1107/S0907444995012170; Snell EH, 2005, REP PROG PHYS, V68, P799, DOI 10.1088/0034-4885/68/4/R02; SNYDER RS, 1991, J CRYST GROWTH, V110, P333, DOI 10.1016/0022-0248(91)90903-I; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stevens RC, 2000, CURR OPIN STRUC BIOL, V10, P558, DOI 10.1016/S0959-440X(00)00131-7; Symersky J, 2002, ACTA CRYSTALLOGR D, V58, P1138, DOI 10.1107/S0907444902006698; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Uppenberg J, 1998, J BIOL CHEM, V273, P31108, DOI 10.1074/jbc.273.47.31108; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; Vekilov PG, 1999, ADV SPACE RES, V24, P1231, DOI 10.1016/S0273-1177(99)00725-5; Vergara A, 2003, ACTA CRYSTALLOGR D, V59, P2, DOI 10.1107/S0907444902021443; Xu HE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.148pe52; Yoon TS, 2001, J CRYST GROWTH, V232, P520, DOI 10.1016/S0022-0248(01)01165-4	53	10	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e82298	10.1371/journal.pone.0082298	http://dx.doi.org/10.1371/journal.pone.0082298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278480	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800147
J	Okamoto, M; Hayase, S; Miyakoshi, M; Murata, T; Kimura, S				Okamoto, Minoru; Hayase, Suguru; Miyakoshi, Masaaki; Murata, Tsubasa; Kimura, Shioko			Stem Cell Antigen 1-Positive Mesenchymal Cells Are the Origin of Follicular Cells during Thyroid Regeneration	PLOS ONE			English	Article							SIDE POPULATION CELLS; THYROTROPIN RECEPTOR GENE; ULTIMOBRANCHIAL BODY CYST; TRANSCRIPTION FACTOR-I; LABEL-RETAINING CELLS; TEMPLATE DNA STRANDS; PROGENITOR CELLS; C-CELLS; EXPRESSION; MOUSE	Many tissues are thought to contain adult stem/progenitor cells that are responsible for repair of the tissue where they reside upon damage and/or carcinogenesis, conditions when cellular homeostasis becomes uncontrolled. While the presence of stem/progenitor cells of the thyroid has been suggested, how these cells contribute to thyroid regeneration remains unclear. Here we show the origin of thyroid follicular cells and the process of their maturation to become follicular cells during regeneration. By using beta-galactosidase (beta-gal) reporter mice in conjunction with partial thyroidectomy as a model for thyroid regeneration, and bromodeoxyuridine (BrdU) long label-retaining cell analysis, we demonstrated that stem cell antigen 1 (Sca1) and BrdU-positive, but beta-gal and NKX2-1 negative cells were found in the non-follicular mesenchymal area 7 days after partial thyroidectomy. They temporarily co-expressed cytokeratin 14, and were observed in part of follicles by day 35 post-partial thyroidectomy. Sca1, BrdU, beta-gal, and NKX2-1-positive cells were found 120 days post-partial thyroidectomy. These results suggested that Sca1 and BrdU positive cells may participate in the formation of new thyroid follicles after partial thyroidectomy. The process of thyroid follicular cell regeneration was recapitulated in ex vivo thyroid slice collagen gel culture studies. These studies will facilitate research on thyroid stem/progenitor cells and their roles in thyroid diseases, particularly thyroid carcinomas.	[Okamoto, Minoru; Hayase, Suguru; Miyakoshi, Masaaki; Murata, Tsubasa; Kimura, Shioko] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kimura, S (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	kimuras@mail.nih.gov			National Cancer Institute, Center for Cancer Research, Intramural Research Program; Japanese Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [ZIABC005522] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, Intramural Research Program; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, Center for Cancer Research, Intramural Research Program. TM was supported by a fellowship from the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Asano-Miyoshi M, 2008, J MOL HISTOL, V39, P193, DOI 10.1007/s10735-007-9151-0; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Burstein DE, 2004, HUM PATHOL, V35, P465, DOI 10.1016/j.humpath.2003.10.027; CAMESELLETEIJEIRO J, 1994, HUM PATHOL, V25, P684, DOI 10.1016/0046-8177(94)90302-6; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; CIVITAREALE D, 1993, MOL ENDOCRINOL, V7, P1589, DOI 10.1210/me.7.12.1589; De Felice Mario, 2007, V10, P1, DOI 10.1159/000106814; Di Lauro R, 2001, THYROID GLAND ANATOM; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; Fierabracci A, 2008, J ENDOCRINOL, V198, P471, DOI 10.1677/JOE-07-0552; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HARACH HR, 1985, ACTA ANAT, V122, P249; Haruna Y, 1996, HEPATOLOGY, V23, P476; Hoshi N, 2007, ENDOCRINOLOGY, V148, P4251, DOI 10.1210/en.2006-0490; Hussain SZ, 2005, DIGEST DIS SCI, V50, P1755, DOI 10.1007/s10620-005-2933-x; Iwatani H, 2004, KIDNEY INT, V65, P1604, DOI 10.1111/j.1523-1755.2004.00561.x; KAMEDA Y, 1980, CELL TISSUE RES, V208, P405; Kameda Y, 2007, J HISTOCHEM CYTOCHEM, V55, P1075, DOI 10.1369/jhc.7A7179.2007; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; KIKKAWA F, 1990, MOL CELL BIOL, V10, P6216, DOI 10.1128/MCB.10.12.6216; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Kusakabe T, 2004, GENESIS, V39, P212, DOI 10.1002/gene.20043; Kusakabe T, 2006, DEV DYNAM, V235, P1300, DOI 10.1002/dvdy.20655; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; Merok JR, 2002, CANCER RES, V62, P6791; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ozaki T, 2012, ENDOCRINOLOGY, V153, P2514, DOI 10.1210/en.2011-1365; Ozaki T, 2011, LAB INVEST, V91, P138, DOI 10.1038/labinvest.2010.137; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Potten CS, 2002, J CELL SCI, V115, P2381; Preto A, 2004, MODERN PATHOL, V17, P819, DOI 10.1038/modpathol.3800124; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Reis JS, 2003, MODERN PATHOL, V16, P43, DOI 10.1097/01.MP.0000047306.72278.39; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; SHIMURA H, 1994, MOL ENDOCRINOL, V8, P1049, DOI 10.1210/me.8.8.1049; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Summer R, 2004, AM J PHYSIOL-LUNG C, V287, pL477, DOI 10.1152/ajplung.00020.2004; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Taurog A, 1996, WERNERS THYROID, P53; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Toda S, 2003, CELL TISSUE RES, V312, P281, DOI 10.1007/s00441-003-0718-0; Tokar EJ, 2005, DIFFERENTIATION, V73, P463, DOI 10.1111/j.1432-0436.2005.00047.x; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; WILLIAMS ED, 1989, J PATHOL, V159, P135, DOI 10.1002/path.1711590208; Wollman S H, 1971, Recent Prog Horm Res, V27, P213; WOLLMAN SH, 1978, ANAT REC, V191, P111, DOI 10.1002/ar.1091910110; Wulf GG, 2003, HAEMATOLOGICA, V88, P368; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yamamoto Y, 1996, BLOOD, V88, P445, DOI 10.1182/blood.V88.2.445.bloodjournal882445	58	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80801	10.1371/journal.pone.0080801	http://dx.doi.org/10.1371/journal.pone.0080801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278321	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800083
J	Verbeek, EC; Bevova, MR; Bochdanovits, Z; Rizzu, P; Bakker, IMC; Uithuisje, T; De Geus, EJ; Smit, JH; Penninx, BW; Boomsma, DI; Hoogendijk, WJG; Heutink, P				Verbeek, Eva C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Bakker, Ingrid M. C.; Uithuisje, Tiny; De Geus, Eco J.; Smit, Johannes H.; Penninx, Brenda W.; Boomsma, Dorret I.; Hoogendijk, Witte J. G.; Heutink, Peter			Resequencing Three Candidate Genes for Major Depressive Disorder in a Dutch Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STRESSFUL LIFE EVENTS; RISK-FACTOR; PCLO GENE; PICCOLO; NESDA; IMPUTATION; NTR	Major depressive disorder (MDD) is a psychiatric disorder, characterized by periods of low mood of more than two weeks, loss of interest in normally enjoyable activities and behavioral changes. MDD is a complex disorder and does not have a single genetic cause. In 2009 a genome wide association study (GWAS) was performed on the Dutch GAIN-MDD cohort. Many of the top signals of this GWAS mapped to a region spanning the gene PCLO, and the non-synonymous coding single nucleotide polymorphism (SNP) rs2522833 in the PCLO gene became genome wide significant after post-hoc analysis. We performed resequencing of PCLO, GRM7, and SLC6A4 in 50 control samples from the GAIN-MDD cohort, to detect new genomic variants. Subsequently, we genotyped these variants in the entire GAIN-MDD cohort and performed association analysis to investigate if rs2522833 is the causal variant or simply in linkage disequilibrium with a more associated variant. GRM7 and SLC6A4 are both candidate genes for MDD from literature. We aimed to gather more evidence that rs2522833 is indeed the causal variant in the GAIN-MDD cohort or to find a previously undetected common variant in either PCLO, GRM7, or SLC6A4 with a higher association in this cohort. After next generation sequencing and association analysis we excluded the possibility of an undetected common variant to be more associated. For neither PCLO nor GRM7 we found a more associated variant. For SLC6A4, we found a new SNP that showed a lower P-value (P = 0.07) than in the GAIN-MDD GWAS (P = 0.09). However, no evidence for genome-wide significance was found. Although we did not take into account rare variants, we conclude that our results provide further support for the hypothesis that the non-synonymous coding SNP rs2522833 in the PCLO gene is indeed likely to be the causal variant in the GAIN-MDD cohort.	[Verbeek, Eva C.; Bevova, Marianna R.; Bochdanovits, Zoltan; Rizzu, Patrizia; Bakker, Ingrid M. C.; Uithuisje, Tiny; Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Smit, Johannes H.; Penninx, Brenda W.; Hoogendijk, Witte J. G.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [De Geus, Eco J.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Med Ctr, Dept Biol Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Verbeek, EC (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	eef.verbeek@gmail.com	de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Penninx, Brenda WJH/S-7627-2017	de Geus, Eco J.C./0000-0001-6022-2666; Penninx, Brenda WJH/0000-0001-7779-9672; Heutink, Peter/0000-0001-5218-1737	Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20]; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ institute; ZonMW [10-000-1002]; National Institute of Mental Health (NIMH) [RO1 MH059160]; NESDA (Netherlands Study of Depression and Anxiety); NTR; Genetic Association Information Network (GAIN) of the Foundation; GAIN; NIMH [MH081802]; Center for Medical Systems Biology (CMSB); TIPharma project [T5-203]	Netherlands Scientific Organization; Centre for Medical Systems Biology (NWO Genomics); Neuroscience Campus Amsterdam (NCA); EMGO+ institute; ZonMW(Netherlands Organization for Health Research and Development); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NESDA (Netherlands Study of Depression and Anxiety); NTR; Genetic Association Information Network (GAIN) of the Foundation; GAIN; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Medical Systems Biology (CMSB); TIPharma project	Funding support for NESDA and NTR was provided by the Netherlands Scientific Organization (904-61-090, 904-61-193, 480-04-004, 400-05-717, 912-100-20) Centre for Medical Systems Biology (NWO Genomics), the Neuroscience Campus Amsterdam (NCA) and the EMGO+ institute; ZonMW (Geestkracht program, 10-000-1002), National Institute of Mental Health (NIMH, RO1 MH059160) and matching funds from participating institutes in NESDA (Netherlands Study of Depression and Anxiety) and NTR. Genotyping was funded by the Genetic Association Information Network (GAIN) of the Foundation for the U.S. National Institutes of Health, and analysis was supported by grants from GAIN and the NIMH (MH081802). Genotype data were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/dbgap, accession number phs000020.v1.p1). The additional genotyping project was performed within the framework of the Center for Medical Systems Biology (CMSB) and TIPharma project T5-203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Furukawa-Hibi Y, 2010, NEUROREPORT, V21, P1177, DOI 10.1097/WNR.0b013e3283411685; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529; Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028; Mitsukawa K, 2006, NEUROPSYCHOPHARMACOL, V31, P1112, DOI 10.1038/sj.npp.1300926; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SCHILDKRAUT J J, 1975, Psychopharmacology Bulletin, V11, P35; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wall L., 2000, PROGRAMMING PERL; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	44	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79921	10.1371/journal.pone.0079921	http://dx.doi.org/10.1371/journal.pone.0079921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278217	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800034
J	Dan, M; Cochran, DB; Yokel, RA; Dziubla, TD				Dan, Mo; Cochran, David B.; Yokel, Robert A.; Dziubla, Thomas D.			Binding, Transcytosis and Biodistribution of Anti-PECAM-1 Iron Oxide Nanoparticles for Brain-Targeted Delivery	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; MAGNETIC NANOPARTICLES; DRUG-DELIVERY; POLYMER NANOCARRIERS; BARRIER TRANSPORT; ENDOCYTOSIS; TECHNOLOGY; EXPRESSION; PACLITAXEL; DEPLETION	Objective: Characterize the flux of platelet-endothelial cell adhesion molecule (PECAM-1) antibody-coated superparamagnetic iron oxide nanoparticles (IONPs) across the blood-brain barrier (BBB) and its biodistribution in vitro and in vivo. Methods: Anti-PECAM-1 IONPs and IgG IONPs were prepared and characterized in house. The binding affinity of these nanoparticles was investigated using human cortical microvascular endothelial cells (hCMEC/D3). Flux assays were performed using a hCMEC/D3 BBB model. To test their immunospecificity index and biodistribution, nanoparticles were given to Sprague Dawley rats by intra-carotid infusion. The capillary depletion method was used to elucidate their distribution between the BBB and brain parenchyma. Results: Anti-PECAM-1 IONPs were similar to 130 nm. The extent of nanoparticle antibody surface coverage was 63.6+/-8.4%. Only 6.39+/-1.22% of labeled antibody dissociated from IONPs in heparin-treated whole blood over 4 h. The binding affinity of PECAM-1 antibody (K-D) was 32 nM with a maximal binding (B-max) of 17610 5 antibody molecules/cell. Anti-PECAM-1 IONP flux across a hCMEC/D3 monolayer was significantly higher than IgG IONP's with 31% of anti-PECAM-1 IONPs in the receiving chamber after 6 h. Anti-PECAM-1 IONPs showed higher concentrations in lung and brain, but not liver or spleen, than IgG IONPs after infusion. The capillary depletion method showed that 17+/-12% of the anti-PECAM-1 IONPs crossed the BBB into the brain ten minutes after infusion. Conclusions: PECAM-1 antibody coating significantly increased IONP flux across the hCMEC/D3 monolayer. In vivo results showed that the PECAM-1 antibody enhanced BBB association and brain parenchymal accumulation of IONPs compared to IgG. This research demonstrates the benefit of anti-PECAM-1 IONPs for association and flux across the BBB into the brain in relation to its biodistribution in peripheral organs. The results provide insight into potential application and toxicity concerns of anti-PECAM-1 IONPs in the central nervous system.	[Dan, Mo; Yokel, Robert A.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Dan, Mo; Yokel, Robert A.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Cochran, David B.; Dziubla, Thomas D.] Univ Kentucky, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Yokel, RA (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA.	ryokel@email.uky.edu	Yokel, Robert/P-6310-2019	Yokel, Robert/0000-0001-5188-3972	NCI-CNTC (National Cancer Institute Cancer Nanotechnology Training Center) [NCI 5R25CA153954]; NATIONAL CANCER INSTITUTE [R25CA153954] Funding Source: NIH RePORTER	NCI-CNTC (National Cancer Institute Cancer Nanotechnology Training Center); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support from a NCI-CNTC (National Cancer Institute Cancer Nanotechnology Training Center) predoctoral traineeship (NCI 5R25CA153954)(http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernacki J, 2008, PHARMACOL REP, V60, P600; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Carl SM, 2010, MOL PHARMACEUT, V7, P1057, DOI 10.1021/mp900178j; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Chang J, 2009, INT J PHARMACEUT, V379, P285, DOI 10.1016/j.ijpharm.2009.04.035; Cole AJ, 2011, BIOMATERIALS, V32, P6291, DOI 10.1016/j.biomaterials.2011.05.024; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; CROWE A, 1992, BRAIN RES, V592, P8, DOI 10.1016/0006-8993(92)91652-U; Dan M, 2013, PHARM RES-DORDR, V30, P552, DOI 10.1007/s11095-012-0900-8; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; Dilnawaz F, 2012, BIOMATERIALS, V33, P2936, DOI 10.1016/j.biomaterials.2011.12.046; Ding BS, 2006, MOL INTERV, V6, P98, DOI 10.1124/mi.6.2.7; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dziubla TD, 2008, BIOMATERIALS, V29, P215, DOI 10.1016/j.biomaterials.2007.09.023; Frimpong RA, 2010, NANOMEDICINE-UK, V5, P1401, DOI [10.2217/nnm.10.114, 10.2217/NNM.10.114]; Frimpong RA, 2010, J MAGN MAGN MATER, V322, P326, DOI 10.1016/j.jmmm.2009.09.050; Garnacho C, 2008, BLOOD, V111, P3024, DOI 10.1182/blood-2007-06-098657; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hu JM, 2012, LANGMUIR, V28, P2073, DOI 10.1021/la203992q; Jiang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037376; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kalinowska A, 2006, EUR J NEUROL, V13, P1284, DOI 10.1111/j.1468-1331.2006.01640.x; Kawabe T, 2012, PROG NEUROL SURG, V25, P148, DOI 10.1159/000331188; Kuang BH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0536-5; Meenach SA, 2010, ACTA BIOMATER, V6, P1039, DOI 10.1016/j.actbio.2009.10.017; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Morgan EH, 2002, DEV NEUROSCI-BASEL, V24, P106, DOI 10.1159/000065699; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muro S, 2006, J PHARMACOL EXP THER, V317, P1161, DOI 10.1124/jpet.105.098970; Nozinic D, 2010, CROAT CHEM ACTA, V83, P323; Papademetriou J, 2013, J INHERIT METAB DIS, V36, P467, DOI 10.1007/s10545-012-9534-6; Peng XH, 2008, INT J NANOMED, V3, P311; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; SHIN SU, 1995, P NATL ACAD SCI USA, V92, P2820, DOI 10.1073/pnas.92.7.2820; Shuvaev VV, 2007, J PHARMACOL EXP THER, V323, P450, DOI 10.1124/jpet.107.127126; Silva AC, 2011, INT J NANOMED, V6, P591, DOI 10.2147/IJN.S14737; Smith Q R, 1996, Pharm Biotechnol, V8, P285; TRIGUERO D, 1990, J NEUROCHEM, V54, P1882, DOI 10.1111/j.1471-4159.1990.tb04886.x; Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157; Wankhede M, 2012, EXPERT REV CLIN PHAR, V5, P173, DOI [10.1586/ECP.12.1, 10.1586/ecp.12.1]; Weinstein JS, 2010, J CEREBR BLOOD F MET, V30, P15, DOI 10.1038/jcbfm.2009.192; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wong D, 1996, BRAIN RES, V731, P217, DOI 10.1016/0006-8993(96)00673-7; Wu DF, 1997, DRUG METAB DISPOS, V25, P768; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang PC, 2012, J CONTROL RELEASE, V159, P429, DOI 10.1016/j.jconrel.2012.01.031	51	32	34	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81051	10.1371/journal.pone.0081051	http://dx.doi.org/10.1371/journal.pone.0081051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278373	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100138
J	Kondo, Y; Jadlowiec, CC; Muto, A; Yi, T; Protack, C; Collins, MJ; Tellides, G; Sessa, WC; Dardik, A				Kondo, Yuka; Jadlowiec, Caroline C.; Muto, Akihito; Yi, Tai; Protack, Clinton; Collins, Michael J.; Tellides, George; Sessa, William C.; Dardik, Alan			The Nogo-B-PirB Axis Controls Macrophage-Mediated Vascular Remodeling	PLOS ONE			English	Article							GRAFT INTIMAL HYPERPLASIA; MONOCYTE CHEMOTACTIC PROTEIN-1; RECEPTOR	Objective: Nogo-B mediates vascular protection and facilitates monocyte-and macrophage-dependent vascular remodeling. PirB is an alternate receptor for Nogo-B, but a role for the Nogo-PirB axis within the vascular system has not been previously reported. We examined whether Nogo-B or PirB play a role in regulating macrophage-mediated vascular remodeling and hypothesized that endothelial Nogo-B regulates vein graft macrophage infiltration via its alternate receptor PirB. Methods: Vein grafts were performed using Nogo and PirB wild type and knockout mice. Human vein grafts were similarly analyzed. The hindlimb ischemia model was performed in PirB wild type and knockout mice. Accompanying in vitro work included isolation of macrophages from PirB wild type and knockout mice. Results: Increased Nogo-B and PirB mRNA transcripts and protein expression were observed within mouse and human vein grafts. Both Nogo knockout and PirB knockout vein grafts showed increased wall thickness and increased numbers of F4/80-positive macrophages. Macrophages derived from PirB knockout mice had increased adhesion to fibronectin, increased EC-specific binding, and increased numbers of mRNA transcripts of M2 markers as well as MMP3 and MMP9. PirB knockout vein grafts had increased active MMP9 compared to wild type vein grafts. PirB knockout mice had increased recovery from hindlimb ischemia and increased macrophage infiltration compared to wild type mice. Conclusions: Vein graft adaptation shows increased expression of both Nogo-B and PirB. Loss of PirB, or its endothelial ligand Nogo-B, results in increased inflammatory cell infiltration and vein graft wall thickening. These findings suggest that PirB regulates macrophage activity in vein grafts and that Nogo-B in the vein graft limits macrophage infiltration and vein graft thickening. PirB may play a more general role in regulating macrophage responses to vascular injury. Macrophage inhibition via Nogo-PirB interactions may be an important mechanism regulating vein graft adaptation to the arterial circulation.	[Kondo, Yuka; Jadlowiec, Caroline C.; Muto, Akihito; Yi, Tai; Protack, Clinton; Collins, Michael J.; Tellides, George; Sessa, William C.; Dardik, Alan] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Kondo, Yuka; Jadlowiec, Caroline C.; Muto, Akihito; Yi, Tai; Protack, Clinton; Collins, Michael J.; Tellides, George; Sessa, William C.; Dardik, Alan] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Kondo, Yuka; Muto, Akihito] Mie Univ, Grad Sch Med, Dept Thorac & Cardiovasc Surg, Tsu, Mie 514, Japan; [Jadlowiec, Caroline C.] Univ Connecticut, Dept Surg, Farmington, CT USA; [Dardik, Alan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; Yale University; Mie University; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Dardik, A (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.	alan.dardik@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938; Dardik, Alan/0000-0001-5022-7367	National Institute of Health [R01-HL095498, RO1-HL-081190]; American Vascular Association William J. von Liebig Award; Hartford Hospital Ludwig J. Pyrtek Fund; Japan Society for the Promotion of Science (JSPS) KAKENHI [24390299, 24791372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095498, R01HL081190] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Vascular Association William J. von Liebig Award; Hartford Hospital Ludwig J. Pyrtek Fund; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health (R01-HL095498 to A. D and RO1-HL-081190 to WCS.); the American Vascular Association William J. von Liebig Award (to A.D.); the Hartford Hospital Ludwig J. Pyrtek Fund (to C.C.J.); the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 24390299 (to A.M.) and 24791372 (to Y.K.); as well as with the resources and the use of facilities at the VA Connecticut Healthcare System, West Haven, CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Hoch JR, 1999, SURGERY, V126, P428, DOI 10.1016/S0039-6060(99)70188-1; Kritz AB, 2008, MOL THER, V16, P1798, DOI 10.1038/mt.2008.188; Kudo FA, 2007, ARTERIOSCL THROM VAS, V27, P1562, DOI 10.1161/ATVBAHA.107.143032; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; Munitz A, 2010, GASTROENTEROLOGY, V139, P530, DOI 10.1053/j.gastro.2010.04.006; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Paszkowiak JJ, 2007, VASC PHARMACOL, V46, P293, DOI 10.1016/j.vph.2006.11.003; Pereira S, 2004, J IMMUNOL, V173, P5757, DOI 10.4049/jimmunol.173.9.5757; Schanda Kathrin, 2011, BMC Res Notes, V4, P6, DOI 10.1186/1756-0500-4-6; Stark VK, 1997, ARTERIOSCL THROM VAS, V17, P1614, DOI 10.1161/01.ATV.17.8.1614; Takai T, 2005, ADV IMMUNOL, V88, P161, DOI 10.1016/S0065-2776(05)88005-8; Wolff RA, 2004, J VASC SURG, V39, P878, DOI 10.1016/j.jvs.2003.11.039; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106	19	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81019	10.1371/journal.pone.0081019	http://dx.doi.org/10.1371/journal.pone.0081019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278366	Green Submitted, gold, Green Published			2022-12-27	WOS:000327313100136
J	Urashima, M; Hama, T; Suda, T; Suzuki, Y; Ikegami, M; Sakanashi, C; Akutsu, T; Amagaya, S; Horiuchi, K; Imai, Y; Mezawa, H; Noya, M; Nakashima, A; Mafune, A; Kato, T; Kojima, H				Urashima, Mitsuyoshi; Hama, Takanori; Suda, Toshihito; Suzuki, Yutaka; Ikegami, Masahiro; Sakanashi, Chikako; Akutsu, Taisuke; Amagaya, Suguru; Horiuchi, Kazuhumi; Imai, Yu; Mezawa, Hidetoshi; Noya, Miki; Nakashima, Akio; Mafune, Aki; Kato, Takakuni; Kojima, Hiromi			Distinct Effects of Alcohol Consumption and Smoking on Genetic Alterations in Head and Neck Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER EPIDEMIOLOGY CONSORTIUM; HUMAN-PAPILLOMAVIRUS; INTERNATIONAL HEAD; CIGARETTE-SMOKING; POOLED ANALYSIS; TOBACCO; RISK; MUTATIONS; LANDSCAPE	Background: Tobacco and alcohol consumption are risk factors for head and neck squamous cell carcinoma (HNSCC). Recently, whole-exome sequencing clarified that smoking increased TP53 and other mutations in HNSCC; however, the effects of alcohol consumption on these genetic alterations remain unknown. We explored the association between alcohol consumption and somatic copy-number alterations (SCNAs) across the whole genome in human papillomavirus (HPV)-negative HNSCCs, and compared with the effects of smoking on genetic alterations. Methods: SCNA and TP53 mutations in tumor samples were examined by high-resolution comparative genomic hybridization microarray 180K and by direct sequencing, respectively, and statistically analyzed for associations with alcohol consumption and smoking during the 20 years preceding diagnosis of HNSCC. Probes with a corrected p-value (=q-value) less than 0.05 and fold change greater than 1.2 or less than -1.2 were considered statistically significant. Results: A total of 248 patients with HNSCC were enrolled. In the HPV-negative patients (n=221), heavy alcohol consumption was significantly associated with SCNAs of oncogenes/oncosuppressors that were previously reported to occur frequently in HNSCCs: CDKN2A (q=0.005), FHIT (q=0.005), 11q13 region including CCND1, FADD and CTTN (q=0.005), ERBB2 (HER2) (q=0.009), 3q25-qter including CCNL1, TP63, DCUN1D1 and PIK3CA (q=0.014), and CSMD1 (q=0.019). But, TP53 mutations were not affected. In contrast, smoking was associated with increased risk of TP53 mutations, but did not induce any significant SCNAs of oncogenes/oncosuppressors. Conclusion: These results suggest that both alcohol consumption and smoking had distinct effects on genetic alterations in HNSCCs. Heavy alcohol consumption may trigger previously known and unknown SCNAs, but may not induce TP53 mutation. In contrast, smoking may induce TP53 mutation, but may not trigger any SCNAs.	[Urashima, Mitsuyoshi; Hama, Takanori; Sakanashi, Chikako; Akutsu, Taisuke; Amagaya, Suguru; Horiuchi, Kazuhumi; Imai, Yu; Mezawa, Hidetoshi; Noya, Miki; Nakashima, Akio; Mafune, Aki] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Hama, Takanori; Suda, Toshihito; Kato, Takakuni; Kojima, Hiromi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Ikegami, Masahiro] Jikei Univ, Dept Pathol, Sch Med, Tokyo 105, Japan; [Suzuki, Yutaka] Int Univ Hlth & Welf, Dept Surg, Tokyo, Japan	Jikei University; Jikei University; Jikei University; International University of Health & Welfare	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp	Mezawa, Hidetoshi/K-9108-2019; Mafune, Aki/AAL-2293-2021	Mezawa, Hidetoshi/0000-0002-5151-164X; Mafune, Aki/0000-0002-6160-2879; Nakashima, Akio/0000-0002-3730-0301; Akutsu, Taisuke/0000-0003-3649-4519	Ministry of Education, Culture, Sports, Science and Technology in the Japan; Jikei University School of Medicine	Ministry of Education, Culture, Sports, Science and Technology in the Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University School of Medicine(Jikei University)	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities and the Jikei University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Braakhuis BJM, 2004, JNCI-J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Jacinto-Aleman LF, 2013, MED ORAL PATOL ORAL, V18, pE325, DOI 10.4317/medoral.18068; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kraunz KS, 2006, CANCER RES, V66, P4512, DOI 10.1158/0008-5472.CAN-05-3748; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Smeets SJ, 2009, CELL ONCOL, V31, P291, DOI 10.3233/CLO-2009-0471; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130	18	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80828	10.1371/journal.pone.0080828	http://dx.doi.org/10.1371/journal.pone.0080828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278325	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100115
J	Wagner, BD; Takatsuki, S; Accurso, FJ; Ivy, DD				Wagner, Brandie D.; Takatsuki, Shinichi; Accurso, Frank J.; Ivy, David Dunbar			Evaluation of Circulating Proteins and Hemodynamics Towards Predicting Mortality in Children with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; GROWTH-FACTOR EXPRESSION; TIMP-1 GENE-TRANSFER; MATRIX METALLOPROTEINASES; PEDIATRIC-PATIENTS; VASCULAR-RESISTANCE; PROGNOSTIC VALUE; SURVIVAL; CAPACITANCE; OUTCOMES	Background: Although many predictors have been evaluated, a set of strong independent prognostic mortality indicators has not been established in children with pediatric pulmonary arterial hypertension (PAH). The aim of this study was to identify a combination of clinical and molecular predictors of survival in PAH. Methods: This single-center, retrospective cohort study was performed from children with PAH between 2001 and 2008 at Children's Hospital Colorado. Blood samples from 83 patients (median age of 8.3 years-old) were obtained. We retrospectively analyzed 46 variables, which included 27 circulating proteins, 7 demographic variables and 12 hemodynamic and echocardiographic variables for establishing the best predictors of mortality. A data mining approach was utilized to evaluate predictor variables and to uncover complex data structures while performing variable selection in high dimensional problems. Results: Thirteen children (16%) died during follow-up (median; 3.1 years) and survival rates from time of sample collection at 1 year, 3 years and 5 years were 95%, 85% and 79%, respectively. A subset of potentially informative predictors were identified, the top four are listed here in order of importance: Tissue inhibitors of metalloproteinases-1 (TIMP-1), apolipoprotein-AI, RV/LV diastolic dimension ratio and age at diagnosis. In univariate analysis, TIMP-1 and apolipoprotein-AI had significant association with survival time (hazard ratio [95% confidence interval]: 1.25 [1.03, 1.51] and 0.70 [0.54-0.90], respectively). Patients grouped by TIMP-1 and apolipoprotein-AI values had significantly different survival risks (p<0.01). Conclusion: Important predictors of mortality were identified from a large number of circulating proteins and clinical markers in this cohort. If confirmed in other populations, measurement of a subset of these predictors could aid in management of pediatric PAH by identifying patients at risk for death. These findings also further support a role for the clinical utility of measuring circulating proteins.	[Wagner, Brandie D.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Takatsuki, Shinichi; Accurso, Frank J.; Ivy, David Dunbar] Univ Colorado, Sch Med, Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Wagner, BD (corresponding author), Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA.	Brandie.Wagner@ucdenver.edu		Wagner, brandie/0000-0002-2745-0103	Jayden DeLuca Foundation; Leah Bult Foundation; Frederick and Margaret L Weyerhaeuser Foundation; Colorado Clinical Translational Science Institute, National Center for Research Resources, and National Institutes of Health (NIH) [RR025780, UL1 TR000154];  [HL-084923];  [HL114753];  [U01 HL081335-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114753, U01HL081335, P50HL084923] Funding Source: NIH RePORTER	Jayden DeLuca Foundation; Leah Bult Foundation; Frederick and Margaret L Weyerhaeuser Foundation; Colorado Clinical Translational Science Institute, National Center for Research Resources, and National Institutes of Health (NIH); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Jayden DeLuca Foundation; the Leah Bult Foundation; the Frederick and Margaret L Weyerhaeuser Foundation; RR025780 and UL1 TR000154: Colorado Clinical Translational Science Institute, National Center for Research Resources, and National Institutes of Health (NIH); HL-084923, HL114753, and U01 HL081335-01. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barst RJ, 2011, EUR RESPIR J, V37, P665, DOI 10.1183/09031936.00056110; Barst RJ, 1999, CIRCULATION, V99, P1197, DOI 10.1161/01.CIR.99.9.1197; Barst RJ, 2012, CIRCULATION, V125, P113, DOI 10.1161/CIRCULATIONAHA.111.026591; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Benza RL, 2012, CHEST; Berger RMF, 2012, LANCET, V379, P537, DOI 10.1016/S0140-6736(11)61621-8; Bernus A, 2009, CHEST, V135, P745, DOI 10.1378/chest.08-0187; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; Clabby ML, 1997, J AM COLL CARDIOL, V30, P554, DOI 10.1016/S0735-1097(97)00155-1; Corbel M, 2002, CELL BIOL TOXICOL, V18, P51, DOI 10.1023/A:1014471213371; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Fraisse A, 2010, ARCH CARDIOVASC DIS, V103, P66, DOI 10.1016/j.acvd.2009.12.001; Hastie T., 2009, UNSUPERVISED LEARNIN; Haworth SG, 2009, HEART, V95, P312, DOI 10.1136/hrt.2008.150086; Humbert M, 1998, EUR RESPIR J, V11, P554; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; Hunter KS, 2008, AM HEART J, V155, P166, DOI 10.1016/j.ahj.2007.08.014; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Ivy DD, 2010, AM J CARDIOL, V106, P1332, DOI 10.1016/j.amjcard.2010.06.064; Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041; LAFARGE CG, 1970, CARDIOVASC RES, V4, P23, DOI 10.1093/cvr/4.1.23; Lammers AE, 2009, INT J CARDIOL, V135, P21, DOI 10.1016/j.ijcard.2008.03.009; Lepetit H, 2005, EUR RESPIR J, V25, P834, DOI 10.1183/09031936.05.00072504; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Moledina S, 2010, HEART, V96, P1401, DOI 10.1136/hrt.2009.182378; Nagaya N, 2000, CIRCULATION, V102, P865; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Roberts Justin D, 2011, Pulm Circ, V1, P160, DOI 10.4103/2045-8932.83446; Sajan I, 2011, AM HEART J, V162, P562, DOI 10.1016/j.ahj.2011.06.014; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; SANDOVAL J, 1995, J AM COLL CARDIOL, V25, P466, DOI 10.1016/0735-1097(94)00391-3; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Van Albada ME, 2008, PEDIATR RES, V63, P321, DOI 10.1203/PDR.0b013e318163a2e7; van Loon RLE, 2010, AM J CARDIOL, V106, P117, DOI 10.1016/j.amjcard.2010.02.023; Vieillard-Baron A, 2000, CIRC RES, V87, P418; Vieillard-Baron A, 2003, HUM GENE THER, V14, P861, DOI 10.1089/104303403765701150; Yeager ME, 2012, EUR RESPIR J, V39, P104, DOI 10.1183/09031936.00072311; Yeager ME, 2012, CHEST, V141, P944, DOI 10.1378/chest.11-0205; Yung D, 2004, CIRCULATION, V110, P660, DOI 10.1161/01.CIR.0000138104.83366.E9	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80235	10.1371/journal.pone.0080235	http://dx.doi.org/10.1371/journal.pone.0080235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278261	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100079
J	Yoshimura, Y; Kikuchi, M; Ueno, S; Okumura, E; Hiraishi, H; Hasegawa, C; Remijn, GB; Shitamichi, K; Munesue, T; Tsubokawa, T; Higashida, H; Minabe, Y				Yoshimura, Yuko; Kikuchi, Mitsuru; Ueno, Sanae; Okumura, Eiichi; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Remijn, Gerard B.; Shitamichi, Kiyomi; Munesue, Toshio; Tsubokawa, Tsunehisa; Higashida, Haruhiro; Minabe, Yoshio			The Brain's Response to the Human Voice Depends on the Incidence of Autistic Traits in the General Population	PLOS ONE			English	Article							LINGUISTIC PITCH PATTERNS; EVENT-RELATED POTENTIALS; ASPERGER-SYNDROME; MISMATCH NEGATIVITY; SPECTRUM DISORDERS; AUDITORY-CORTEX; STEM RESPONSE; SPEECH; ATTENTION; CHILDREN	Optimal brain sensitivity to the fundamental frequency (F0) contour changes in the human voice is important for understanding a speaker's intonation, and consequently, the speaker's attitude. However, whether sensitivity in the brain's response to a human voice F0 contour change varies with an interaction between an individual's traits (i.e., autistic traits) and a human voice element (i.e., presence or absence of communicative action such as calling) has not been investigated. In the present study, we investigated the neural processes involved in the perception of F0 contour changes in the Japanese monosyllables "ne" and "nu." "Ne" is an interjection that means "hi" or "hey" in English; pronunciation of "ne" with a high falling F0 contour is used when the speaker wants to attract a listener's attention (i.e., social intonation). Meanwhile, the Japanese concrete noun "nu" has no communicative meaning. We applied an adaptive spatial filtering method to the neuromagnetic time course recorded by whole-head magnetoencephalography (MEG) and estimated the spatiotemporal frequency dynamics of event-related cerebral oscillatory changes in beta band during the oddball paradigm. During the perception of the F0 contour change when "ne" was presented, there was event-related de-synchronization (ERD) in the right temporal lobe. In contrast, during the perception of the F0 contour change when "nu" was presented, ERD occurred in the left temporal lobe and in the bilateral occipital lobes. ERD that occurred during the social stimulus "ne" in the right hemisphere was significantly correlated with a greater number of autistic traits measured according to the Autism Spectrum Quotient (AQ), suggesting that the differences in human voice processing are associated with higher autistic traits, even in non-clinical subjects.	[Yoshimura, Yuko; Kikuchi, Mitsuru; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Munesue, Toshio; Higashida, Haruhiro] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Ueno, Sanae; Shitamichi, Kiyomi; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Okumura, Eiichi] Yokogawa Elect Corp, Dept MEG, Tokyo, Japan; [Remijn, Gerard B.] Kyushu Univ, Int Educ Ctr, Fukuoka 812, Japan; [Tsubokawa, Tsunehisa] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Yokogawa Electric Corporation; Kyushu University; Kanazawa University	Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.	mitsuru@zc4.so-net.ne.jp	Hasegawa, Chiaki/HHS-2658-2022; Remijn, Gerard/CAF-9960-2022; Romanova, Raisa/O-5724-2018; higashida, haruhiro/L-3773-2015	Remijn, Gerard/0000-0002-8681-9951; higashida, haruhiro/0000-0002-1779-0606; Hasegawa, Chiaki/0000-0001-8730-8769	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); MEXT, Japan;  [24000012]	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by Grant-in-Aid for Specially Promoted (Research Number 24000012), the Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation), and the Strategic Research Program for Brain Sciences from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V., 2007, JPN KOREAN LINGUIST, V15, P43; [Anonymous], [No title captured]; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bonnel A, 2010, NEUROPSYCHOLOGIA, V48, P2465, DOI 10.1016/j.neuropsychologia.2010.04.020; BRANCH C, 1964, J NEUROSURG, V21, P399, DOI 10.3171/jns.1964.21.5.0399; CARLSON BD, 1988, IEEE T AERO ELEC SYS, V24, P397, DOI 10.1109/7.7181; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN., 2002, SOCIAL RESPONSIVENES; Constantino JN, 2011, PEDIATR RES, V69, p55R, DOI 10.1203/PDR.0b013e318212ec6e; Cook H. M., 1990, SENTENCE FINAL PARTI; COX H, 1987, IEEE T ACOUST SPEECH, V35, P1365, DOI 10.1109/TASSP.1987.1165054; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; De Giacomo A, 1998, EUR CHILD ADOLES PSY, V7, P131, DOI 10.1007/s007870050058; Dietl T, 1999, CLIN NEUROPHYSIOL, V110, P1204, DOI 10.1016/S1388-2457(99)00057-7; Dohn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037961; First M.B., 2014, STRUCTURED CLIN INTE; Fujikawa-Brooks S, 2010, INT J AUDIOL, V49, P129, DOI 10.3109/14992020903289790; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Heaton P, 2008, AUTISM, V12, P203, DOI 10.1177/1362361307085270; Hirata M, 2007, NEUROIMAGE, V35, P420, DOI 10.1016/j.neuroimage.2006.11.025; Jones CRG, 2009, NEUROPSYCHOLOGIA, V47, P2850, DOI 10.1016/j.neuropsychologia.2009.06.015; Kajikawa S, 2004, J CHILD LANG, V31, P215, DOI 10.1017/S0305000903005968; Kallstrand J, 2010, NEUROPSYCH DIS TREAT, V6, P289; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kim JS, 2008, NEUROIMAGE, V42, P1499, DOI 10.1016/j.neuroimage.2008.06.001; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2007, BIOL PSYCHOL, V75, P109, DOI 10.1016/j.biopsycho.2006.12.007; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2009, BIOL PSYCHOL, V82, P301, DOI 10.1016/j.biopsycho.2009.09.004; Lepisto T, 2007, NEUROSCI LETT, V414, P136, DOI 10.1016/j.neulet.2006.12.009; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Mottron L, 2011, NATURE, V479, P33, DOI 10.1038/479033a; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; O'Riordan M, 2006, J AUTISM DEV DISORD, V36, P665, DOI 10.1007/s10803-006-0106-1; Perreault A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019519; Rama P, 2012, BRAIN LANG, V122, P114, DOI 10.1016/j.bandl.2012.04.018; Ren GQ, 2009, NEUROSCIENCE, V162, P87, DOI 10.1016/j.neuroscience.2009.04.021; Robinson SE., 1998, BIOMAG; Samson F, 2011, HUM BRAIN MAPP; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Sekihara K, 2008, SER BIOMED ENG, P1; Squires T., 2009, PRAGMATICS, V4, P1; Stevenson CM, 2011, HUM BRAIN MAPP, V32, P182, DOI 10.1002/hbm.21016; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Ueno S, 2012, NEUROSCI LETT, V515, P141, DOI 10.1016/j.neulet.2012.03.031; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wei JH, 1998, ELECTROEN CLIN NEURO, V106, P416, DOI 10.1016/S0013-4694(97)00161-2; Wetherby AM, 2004, J AUTISM DEV DISORD, V34, P473, DOI 10.1007/s10803-004-2544-y; Whitehouse AJO, 2008, DEVELOPMENTAL SCI, V11, P516, DOI 10.1111/j.1467-7687.2008.00697.x; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Yamamoto M, 2006, NEUROPSYCHOBIOLOGY, V53, P215, DOI 10.1159/000094835; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	63	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80126	10.1371/journal.pone.0080126	http://dx.doi.org/10.1371/journal.pone.0080126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278247	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100075
J	Holler, Y; Bergmann, J; Thomschewski, A; Kronbichler, M; Holler, P; Crone, JS; Schmid, EV; Butz, K; Nardone, R; Trinka, E				Hoeller, Yvonne; Bergmann, Juergen; Thomschewski, Aljoscha; Kronbichler, Martin; Hoeller, Peter; Crone, Julia S.; Schmid, Elisabeth V.; Butz, Kevin; Nardone, Raffaele; Trinka, Eugen			Comparison of EEG-Features and Classification Methods for Motor Imagery in Patients with Disorders of Consciousness	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MULTIVARIATE AUTOREGRESSIVE MODELS/; INDEPENDENT COMPONENT ANALYSIS; VEGETATIVE STATE; BEDSIDE DETECTION; FEATURE-SELECTION; AWARENESS; BCI; RECOGNITION; EIGENMODES	Current research aims at identifying voluntary brain activation in patients who are behaviorally diagnosed as being unconscious, but are able to perform commands by modulating their brain activity patterns. This involves machine learning techniques and feature extraction methods such as applied in brain computer interfaces. In this study, we try to answer the question if features/classification methods which show advantages in healthy participants are also accurate when applied to data of patients with disorders of consciousness. A sample of healthy participants (N = 22), patients in a minimally conscious state (MCS; N = 5), and with unresponsive wakefulness syndrome (UWS; N = 9) was examined with a motor imagery task which involved imagery of moving both hands and an instruction to hold both hands firm. We extracted a set of 20 features from the electroencephalogram and used linear discriminant analysis, k-nearest neighbor classification, and support vector machines (SVM) as classification methods. In healthy participants, the best classification accuracies were seen with coherences (mean = .79; range = .53-.94) and power spectra (mean = .69; range =.40-.85). The coherence patterns in healthy participants did not match the expectation of central modulated m-rhythm. Instead, coherence involved mainly frontal regions. In healthy participants, the best classification tool was SVM. Five patients had at least one feature-classifier outcome with p<0.05 (none of which were coherence or power spectra), though none remained significant after false-discovery rate correction for multiple comparisons. The present work suggests the use of coherences in patients with disorders of consciousness because they show high reliability among healthy subjects and patient groups. However, feature extraction and classification is a challenging task in unresponsive patients because there is no ground truth to validate the results.	[Hoeller, Yvonne; Thomschewski, Aljoscha; Hoeller, Peter; Crone, Julia S.; Schmid, Elisabeth V.; Butz, Kevin; Nardone, Raffaele; Trinka, Eugen] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth V.] Paracelsus Med Univ, Christian Doppler Klin, Inst Neurosci, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth V.] Paracelsus Med Univ, Christian Doppler Klin, Ctr Neurocognit Res, Salzburg, Austria; [Hoeller, Yvonne; Thomschewski, Aljoscha; Hoeller, Peter; Nardone, Raffaele; Trinka, Eugen] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr, Salzburg, Austria; [Bergmann, Juergen; Thomschewski, Aljoscha; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Bergmann, Juergen; Thomschewski, Aljoscha; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Salzburg University; Salzburg University	Holler, Y (corresponding author), Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria.	y.hoeller@salk.at	Höller, Yvonne/I-8928-2017; Kronbichler, Martin/A-5599-2008; Kronbichler, Martin/AAY-1519-2021	Höller, Yvonne/0000-0002-1727-8557; Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Butz, Kevin/0000-0003-4502-2492; Butz, Kevin/0000-0001-8070-4128; Crone, Julia Sophia/0000-0002-0787-7003; Trinka, Eugen/0000-0002-5950-2692; Nardone, Raffaele/0000-0001-5243-6760; Thomschewski, Aljoscha/0000-0002-1811-5469	Jubil aumsfonds of the National Bank of Austria [14201]	Jubil aumsfonds of the National Bank of Austria	This research project is being supported by the Jubil aumsfonds of the National Bank of Austria (project no. 14201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi Farnaz, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1146; Aloise F, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045012; [Anonymous], 2006, HDB TIME SERIES ANAL; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bassani T, 2010, ADV EXP MED BIOL, V657, P147, DOI 10.1007/978-0-387-79100-5_8; Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blokland Y, 2012, IEEE ENG MED BIO, P3967, DOI 10.1109/EMBC.2012.6346835; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boostani R, 2007, MED BIOL ENG COMPUT, V45, P403, DOI 10.1007/s11517-007-0169-y; Cabrera AF, 2010, MED BIOL ENG COMPUT, V48, P123, DOI 10.1007/s11517-009-0569-2; Cohen J., 1983, APPL MULTIPLE REGRES; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Damborska A, 2012, PHYSIOL RES, V61, P307, DOI 10.33549/physiolres.932237; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Dias NS, 2007, P ANN INT IEEE EMBS, P2540, DOI 10.1109/IEMBS.2007.4352846; Diez PF, 2009, IEEE ENG MED BIO, P2579, DOI 10.1109/IEMBS.2009.5335278; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Garrett D, 2003, IEEE T NEUR SYS REH, V11, P141, DOI 10.1109/TNSRE.2003.814441; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; Hjorth B., 1975, CEAN COMPUTERIZED EE, P3; Holler Y, 2013, INT J PSYCHOPHYSIOL, V87, P35, DOI 10.1016/j.ijpsycho.2012.10.015; Holler Y, 2012, INT J PSYCHOPHYSIOL, V86, P206, DOI 10.1016/j.ijpsycho.2012.09.005; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P1744, DOI 10.1016/j.clinph.2011.02.009; Holler Y, 2011, INT J PSYCHOPHYSIOL, V80, P227, DOI 10.1016/j.ijpsycho.2011.03.012; Hung CI, 2005, ANN BIOMED ENG, V33, P1053, DOI 10.1007/s10439-005-5772-1; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; John ER, 2011, BRAIN INJURY, V25, P426, DOI 10.3109/02699052.2011.558045; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 1998, ADV NEUR IN, V10, P894; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Kotchoubey B, 2004, BRAINWAVES MIND RECE, P75; Krusienski DJ, 2012, BRAIN RES BULL, V87, P130, DOI 10.1016/j.brainresbull.2011.09.019; Lechinger J, 2013, CLIN NEUROPHYSIOL, V124, P27, DOI 10.1016/j.clinph.2012.05.016; Liang XW, 2014, J NEUROIMAGING, V24, P31, DOI 10.1111/j.1552-6569.2012.00744.x; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MAKEIG S, 1996, ADV NEUR IN, V88, P145; Manyakov NV, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/519868; Marcoulides G, 1974, STAT METHODS 1 COURS; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Mohamed AK, 2011, IEEE ENG MED BIO, P6289, DOI 10.1109/IEMBS.2011.6091552; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nam CS, 2012, ERGONOMICS, V55, P581, DOI 10.1080/00140139.2011.647095; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; Omidvarnia A., 2011, 2011 7th International Workshop on Systems, Signal Processing and their Applications (WOSSPA 2011), P179, DOI 10.1109/WOSSPA.2011.5931445; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pop-Jordanova N, 2005, CONTRIBUTIONS SEC BI, V2, P35; Sacchet MD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00189; Schlogl A, 2008, COMPUTER, V41, P44, DOI 10.1109/MC.2008.407; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Schneider T, 2001, ACM T MATH SOFTWARE, V27, P58, DOI 10.1145/382043.382316; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shoker L, 2005, P ANN INT IEEE EMBS, P5420, DOI 10.1109/IEMBS.2005.1615708; Szabo Z, 2007, J MACH LEARN RES, V8, P1063; Szabo Z, 2012, PATTERN RECOGN, V45, P1782, DOI 10.1016/j.patcog.2011.09.007; Vidaurre C, 2008, IEEE ENG MED BIO, P173, DOI 10.1109/IEMBS.2008.4649118; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; WANG S, 2007, COMPUT INTELL NEUROS; YANG B, 1995, IEEE T SIGNAL PROCES, V43, P95, DOI 10.1109/78.365290; Zhang HJ, 2012, IEEE ENG MED BIO, P6740, DOI 10.1109/EMBC.2012.6347541	72	29	29	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80479	10.1371/journal.pone.0080479	http://dx.doi.org/10.1371/journal.pone.0080479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282545	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500046
J	Mastrobuoni, G; Qiao, HL; Iovinella, I; Sagona, S; Niccolini, A; Boscaro, F; Caputo, B; Orejuela, MR; della Torre, A; Kempa, S; Felicioli, A; Pelosi, P; Moneti, G; Dani, FR				Mastrobuoni, Guido; Qiao, Huili; Iovinella, Immacolata; Sagona, Simona; Niccolini, Alberto; Boscaro, Francesca; Caputo, Beniamino; Orejuela, Marta R.; della Torre, Alessandra; Kempa, Stefan; Felicioli, Antonio; Pelosi, Paolo; Moneti, Gloriano; Dani, Francesca Romana			A Proteomic Investigation of Soluble Olfactory Proteins in Anopheles gambiae	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; MALARIA-TRANSMITTING MOSQUITO; CHEMOSENSORY PROTEINS; CRYSTAL-STRUCTURE; LIGAND-BINDING; REGENERATING LEGS; PURIFICATION; EXPRESSION; MECHANISM; ANTENNAE	Odorant-binding proteins (OBPs) and chemosensory proteins (CSPs) are small soluble polypeptides that bind semiochemicals in the lymph of insect chemosensilla. In the genome of Anopheles gambiae, 66 genes encode OBPs and 8 encode CSPs. Here we monitored their expression through classical proteomics (2D gel-MS analysis) and a shotgun approach. The latter method proved much more sensitive and therefore more suitable for tiny biological samples as mosquitoes antennae and eggs. Females express a larger number and higher quantities of OBPs in their antennae than males (24 vs 19). OBP9 is the most abundant in the antennae of both sexes, as well as in larvae, pupae and eggs. Of the 8 CSPs, 4 were detected in antennae, while SAP3 was the only one expressed in larvae. Our proteomic results are in fairly good agreement with data of RNA expression reported in the literature, except for OBP4 and OBP5, that we could not identify in our analysis, nor could we detect in Western Blot experiments. The relatively limited number of soluble olfactory proteins expressed at relatively high levels in mosquitoes makes further studies on the coding of chemical messages at the OBP level more accessible, providing for few specific targets. Identification of such proteins in Anopheles gambiae might facilitate future studies on host finding behavior in this important disease vector.	[Mastrobuoni, Guido; Orejuela, Marta R.; Kempa, Stefan] Max Delbruck Ctr Mol Med, Berlin, Germany; [Qiao, Huili] Nanyang Normal Univ, China UK NYNU RRes Joint Libratory Insect Biol, Nanyang, Peoples R China; [Iovinella, Immacolata; Pelosi, Paolo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Sagona, Simona; Niccolini, Alberto; Felicioli, Antonio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Boscaro, Francesca; Moneti, Gloriano; Dani, Francesca Romana] Univ Florence, Mass Spectrometry Ctr, CISM, Florence, Italy; [Caputo, Beniamino; della Torre, Alessandra] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Dani, Francesca Romana] Univ Florence, Dept Biol, Florence, Italy	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Nanyang Normal College; University of Pisa; University of Pisa; University of Florence; Sapienza University Rome; University of Florence	Dani, FR (corresponding author), Univ Florence, Mass Spectrometry Ctr, CISM, Florence, Italy.	francescaromana.dani@unifi.it	Caputo, Beniamino/I-2880-2015; Rocco, Patricia/I-7460-2012; kempa, stefan/C-5213-2008; Sagona, Simona/AAT-8969-2021; sagona, simona/GXH-0254-2022; Felicioli, Antonio/AAT-2167-2021; Dani, Francesca Romana/O-9120-2018	Caputo, Beniamino/0000-0002-5650-8773; Rocco, Patricia/0000-0003-1412-7136; kempa, stefan/0000-0002-0696-9299; Dani, Francesca Romana/0000-0002-2939-2103; Mastrobuoni, Guido/0000-0003-4509-1295; Iovinella, Immacolata/0000-0002-5001-7842; Boscaro, Francesca/0000-0003-2845-9182	European Union [FP7-22292 7]; MIUR-FIRB "Futuro in Ricerca" [RBFR106NTE]	European Union(European Commission); MIUR-FIRB "Futuro in Ricerca"(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by a European Union grant (FP7/2007-2013, Grant Agreement No. FP7-22292 7) to FRD and PP. BC is supported by a MIUR-FIRB "Futuro in Ricerca 2010" grant (number: RBFR106NTE). MRO acknowledges Prof. Dr. Nikolaus Rajewsky for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Anholt RRH, 2010, CHEM SENSES, V35, P21, DOI 10.1093/chemse/bjp073; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Dani FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002822; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; DYANOV HM, 1995, BIOTECHNIQUES, V18, P822; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Iovinella I, 2013, CHEM SENSES, V38, P409, DOI 10.1093/chemse/bjt012; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon Jean-Francois, 2003, P539, DOI 10.1016/B978-012107151-6/50020-7; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ren H, 2009, CRYSTAL STRUCTURE AN; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179	58	24	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e75162	10.1371/journal.pone.0075162	http://dx.doi.org/10.1371/journal.pone.0075162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282496	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000327543500002
J	Valladares, D; Almarza, G; Contreras, A; Pavez, M; Buvinic, S; Jaimovich, E; Casas, M				Valladares, Denisse; Almarza, Gonzalo; Contreras, Ariel; Pavez, Mario; Buvinic, Sonja; Jaimovich, Enrique; Casas, Mariana			Electrical Stimuli Are Anti-Apoptotic in Skeletal Muscle via Extracellular ATP. Alteration of This Signal in Mdx Mice Is a Likely Cause of Dystrophy	PLOS ONE			English	Article							PANNEXIN-1 HEMICHANNELS; MUSCULAR-DYSTROPHY; TRANSVERSE TUBULES; CALCIUM-RELEASE; MOUSE; ACTIVATION; EXPRESSION; DENERVATION; CHANNELS; RECEPTORS	ATP signaling has been shown to regulate gene expression in skeletal muscle and to be altered in models of muscular dystrophy. We have previously shown that in normal muscle fibers, ATP released through Pannexin1 (Panx1) channels after electrical stimulation plays a role in activating some signaling pathways related to gene expression. We searched for a possible role of ATP signaling in the dystrophy phenotype. We used muscle fibers from flexor digitorum brevis isolated from normal and mdx mice. We demonstrated that low frequency electrical stimulation has an anti-apoptotic effect in normal muscle fibers repressing the expression of Bax, Bim and PUMA. Addition of exogenous ATP to the medium has a similar effect. In dystrophic fibers, the basal levels of extracellular ATP were higher compared to normal fibers, but unlike control fibers, they do not present any ATP release after low frequency electrical stimulation, suggesting an uncoupling between electrical stimulation and ATP release in this condition. Elevated levels of Panx1 and decreased levels of Cav1.1 (dihydropyridine receptors) were found in triads fractions prepared from mdx muscles. Moreover, decreased immunoprecipitation of Cav1.1 and Panx1, suggest uncoupling of the signaling machinery. Importantly, in dystrophic fibers, exogenous ATP was pro-apoptotic, inducing the transcription of Bax, Bim and PUMA and increasing the levels of activated Bax and cytosolic cytochrome c. These evidence points to an involvement of the ATP pathway in the activation of mechanisms related with cell death in muscular dystrophy, opening new perspectives towards possible targets for pharmacological therapies.	[Valladares, Denisse; Almarza, Gonzalo; Contreras, Ariel; Pavez, Mario; Buvinic, Sonja; Jaimovich, Enrique; Casas, Mariana] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile; [Casas, Mariana] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile; [Buvinic, Sonja] Univ Chile, Fac Odontol, Dept Ciencias Basicas & Comunitarias, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Casas, M (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile.	mcasas@med.uchile.cl	Jaimovich, Enrique/A-2782-2008; Pavez-Giani, Mario/AAV-3110-2021; Valladares-Ide, Denisse/AAE-6675-2019; Jaimovich, Enrique/AAY-7632-2020; Buvinic, Sonja/I-2658-2013	Jaimovich, Enrique/0000-0002-4938-7176; Pavez-Giani, Mario/0000-0002-3330-9384; Valladares-Ide, Denisse/0000-0001-7625-7978	FONDECYT, University of Chile [N 1110467, 11100454, AT-24110211, U-INICIA 02/12M]	FONDECYT, University of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was financed by FONDECYT N 1110467 (EJ, SB, MC), 11100454 (SB), AT-24110211(DV), and U-INICIA VID 2011, U-INICIA 02/12M; University of Chile (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Altamirano F, 2013, PLOS ONE IN PRESS; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Arakawa Takuya, 2010, NeuroRehabilitation, V27, P147, DOI 10.3233/NRE-2010-0591; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Casas M, 2010, J GEN PHYSIOL, V136, P455, DOI 10.1085/jgp.200910397; Cea LA, 2012, J MEMBRANE BIOL, V245, P423, DOI 10.1007/s00232-012-9485-8; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; De Paepe B, 2012, MUSCLE NERVE, V46, P917, DOI 10.1002/mus.23481; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Erb L, 2006, PFLUG ARCH EUR J PHY, V452, P552, DOI 10.1007/s00424-006-0069-2; Favier FB, 2008, PFLUG ARCH EUR J PHY, V456, P587, DOI 10.1007/s00424-007-0423-z; Fernandez-Verdejo R, 2013, INT J SPORT IN PRESS; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; HIDALGO C, 1986, BIOCHIM BIOPHYS ACTA, V854, P279, DOI 10.1016/0005-2736(86)90121-5; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hirose T, 2013, J CRITICAL CARE; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iwata Y, 2007, AM J PATHOL, V171, P1576, DOI 10.2353/ajpath.2007.070452; JAIMOVICH E, 1986, BIOCHIM BIOPHYS ACTA, V855, P89, DOI 10.1016/0005-2736(86)90192-6; Jia M, 2007, DEV NEUROBIOL, V67, P924, DOI 10.1002/dneu.20402; Jorquera G, 2013, J CELL SCI; Kern H, 2004, J NEUROPATH EXP NEUR, V63, P919, DOI 10.1093/jnen/63.9.919; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim JH, 2012, J MUSCLE RES CELL MO; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lim JY, 2010, MUSCLE NERVE, V42, P422, DOI 10.1002/mus.21719; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010; Pietri-Rouxel F, 2010, EMBO J, V29, P643, DOI 10.1038/emboj.2009.366; Quadrilatero J, 2011, SKELETAL MUSCLE APOP; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Ryten M, 2004, FASEB J, V18, P1404, DOI 10.1096/fj.03-1175fje; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Sabourin J, 2012, CELL CALCIUM, V52, P445, DOI 10.1016/j.ceca.2012.08.003; Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005; SANDRI M, 1995, FEBS LETT, V373, P291, DOI 10.1016/0014-5793(95)00908-R; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Siu PM, 2009, MED SCI SPORT EXER, V41, P1876, DOI 10.1249/MSS.0b013e3181a6470b; Terrill JR, 2012, NEUROMUSCULAR DISORD, V22, P427, DOI 10.1016/j.nmd.2011.11.007; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; TIDBALL JG, 1995, J CELL SCI, V108, P2197; Vasquez I, 2012, J PHYSIOL-LONDON, V590, P6167, DOI 10.1113/jphysiol.2012.240044; Veal EA, 1996, BIOCHEM SOC T, V24, pS486, DOI 10.1042/bst024486s; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Young CNJ, 2012, J CELL MOL MED, V16, P1026, DOI 10.1111/j.1582-4934.2011.01397.x; Zhu SM, 2013, MUSCLE NERVE, V47, P711, DOI 10.1002/mus.23642	75	24	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e75340	10.1371/journal.pone.0075340	http://dx.doi.org/10.1371/journal.pone.0075340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282497	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500003
J	Vos, SB; Viergever, MA; Leemans, A				Vos, Sjoerd B.; Viergever, Max A.; Leemans, Alexander			Multi-Fiber Tractography Visualizations for Diffusion MRI Data	PLOS ONE			English	Article							GEOMETRIC STRUCTURE; FIBER ORIENTATION; TENSOR; TRACTS; IMAGES	In recent years, several new diffusion MRI approaches have been proposed to explore microstructural properties of the white matter, such as Q-ball imaging and spherical deconvolution-based techniques to estimate the orientation distribution function. These methods can describe the estimated diffusion profile with a higher accuracy than the more conventional second-rank diffusion tensor imaging technique. Despite many important advances, there are still inconsistent findings between different models that investigate the "crossing fibers" issue. Due to the high information content and the complex nature of the data, it becomes virtually impossible to interpret and compare results in a consistent manner. In this work, we present novel fiber tractography visualization approaches that provide a more complete picture of the microstructural architecture of fiber pathways: multi-fiber hyperstreamlines and streamribbons. By visualizing, for instance, the estimated fiber orientation distribution along the reconstructed tract in a continuous way, information of the local fiber architecture is combined with the global anatomical information derived from tractography. Facilitating the interpretation of diffusion MRI data, this approach can be useful for comparing different diffusion reconstruction techniques and may improve our understanding of the intricate white matter network.	[Vos, Sjoerd B.; Viergever, Max A.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Vos, SB (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	sjoerd@isi.uu.nl	Leemans, Alexander/A-1784-2011; Viergever, Max A/J-1215-2014	Leemans, Alexander/0000-0002-9306-6126; 	Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research program Information Technology for European Advancement	Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research program Information Technology for European Advancement	This work was financially supported by the project Care4Me (Cooperative Advanced REsearch for Medical Efficiency) in the framework of the EU research program Information Technology for European Advancement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2013, NEUROIMAGE, V74, P117, DOI 10.1016/j.neuroimage.2013.01.061; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assemlal HE, 2011, MED IMAGE ANAL, V15, P369, DOI 10.1016/j.media.2011.02.002; ATKINSON D, 2007, P 15 ANN M INT SOC M, P79; Bagadia A, 2011, J CLIN NEUROSCI, V18, P633, DOI 10.1016/j.jocn.2010.08.026; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Brunenberg EJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039061; Castellano A, 2012, NEURO-ONCOLOGY, V14, P192, DOI 10.1093/neuonc/nor188; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, NEUROIMAGE, V41, P1184, DOI 10.1016/j.neuroimage.2008.03.041; Catani M, 2012, SCIENCE, V337, DOI 10.1126/science.1223425; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Coenen VA, 2001, NEUROSURGERY, V49, P86, DOI 10.1097/00006123-200107000-00013; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jeurissen B, 2012, HUM BRAIN M IN PRESS; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2005, MAGNET RESON MED, V53, P1462, DOI 10.1002/mrm.20484; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kezele I, 2008, LECT NOTES COMPUT SC, V5241, P1034, DOI 10.1007/978-3-540-85988-8_123; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kuhnt D, 2013, NEUROSURGERY, V72, pA165, DOI 10.1227/NEU.0b013e318270d9fb; Leemans A, 2005, MAGN RESON MED, V53, P944, DOI 10.1002/mrm.20418; Leemans A, 2009, P 17 ANN M INT SOC M, V17, P3537; Leemans A., 2010, DIFFUSION MRI, P354; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Metzler-Baddeley C, 2012, NEUROLOGY, V79, P2233, DOI 10.1212/WNL.0b013e31827689e8; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Peeters THJM, 2009, IEEE PAC VIS SYMP, P153, DOI 10.1109/PACIFICVIS.2009.4906851; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Prckovska V, 2011, IEEE T VIS COMPUT GR, V17, P1407, DOI 10.1109/TVCG.2010.244; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Reijmer YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044074; Shattuck DW, 2008, LECT NOTES COMPUT SC, V5242, P298, DOI 10.1007/978-3-540-85990-1_36; Sijbers J, 2004, MAGNET RESON MED, V51, P586, DOI 10.1002/mrm.10728; Thudium MO, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7424b; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V337, DOI 10.1126/science.1223493; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Ye WX, 2012, IEEE T MED IMAGING, V31, P1043, DOI 10.1109/TMI.2012.2184551; Zhang S, 2003, IEEE T VIS COMPUT GR, V9, P454, DOI 10.1109/TVCG.2003.1260740	60	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81453	10.1371/journal.pone.0081453	http://dx.doi.org/10.1371/journal.pone.0081453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282597	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500099
J	Wang, HZ; Han, JL; Kanagarajan, S; Lundgren, A; Brodelius, PE				Wang, Hongzhen; Han, Junli; Kanagarajan, Selvaraju; Lundgren, Anneli; Brodelius, Peter E.			Studies on the Expression of Sesquiterpene Synthases Using Promoter-beta-Glucuronidase Fusions in Transgenic Artemisia annua L	PLOS ONE			English	Article							IN-VIVO TRANSFORMATIONS; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; AMORPHA-4,11-DIENE SYNTHASE; GENE-EXPRESSION; ESSENTIAL OIL; (E)-BETA-FARNESENE SYNTHASE; CARYOPHYLLENE SYNTHASE; ANTIMALARIAL COMPOUND; VOLATILE CONSTITUENTS	In order to better understand the influence of sesquiterpene synthases on artemisinin yield in Artemisia annua, the expression of some sesquiterpene synthases has been studied using transgenic plants expressing promoter-GUS fusions. The cloned promoter sequences were 923, 1182 and 1510 bp for beta-caryophyllene (CPS), epi-cedrol (ECS) and beta-farnesene (FS) synthase, respectively. Prediction of cis-acting regulatory elements showed that the promoters are involved in complex regulation of expression. Transgenic A. annua plants carrying promoter-GUS fusions were studied to elucidate the expression pattern of the three sesquiterpene synthases and compared to the previously studied promoter of amorpha-4,11-diene synthase (ADS), a key enzyme of artemisinin biosynthesis. The CPS and ECS promoters were active in T-shaped trichomes of leaves and stems, basal bracts of flower buds and also in some florets cells but not in glandular secretory trichome while FS promoter activity was only observed in leaf cells and trichomes of transgenic shoots. ADS, CPS, ECS and FS transcripts were induced by wounding in a time depended manner. The four sesquiterpene synthases may be involved in responsiveness of A. annua to herbivory. Methyl jasmonate treatment triggered activation of the promoters of all four sesquiterpene synthases in a time depended manner. Southern blot result showed that the GUS gene was inserted into genomic DNA of transgenic lines as a single copy or two copies. The relative amounts of CPS and ECS as well as germacrene A synthase (GAS) transcripts are much lower than that of ADS transcript. Consequently, down-regulation of the expression of the CPS, ECS or GAS gene may not improve artemsinin yield. However, blocking the expression of FS may have effects on artemisinin production.	[Wang, Hongzhen; Han, Junli; Kanagarajan, Selvaraju; Lundgren, Anneli; Brodelius, Peter E.] Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden	Linnaeus University	Brodelius, PE (corresponding author), Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden.	peter.brodelius@lnu.se	Kanagarajan, Selvaraju/F-9992-2010; Kanagarajan, Selvaraju/AAV-4239-2021	Kanagarajan, Selvaraju/0000-0003-4341-9322	Faculty of Natural Science and Engineering, Linnaeus University, Kalmar	Faculty of Natural Science and Engineering, Linnaeus University, Kalmar	This work was supported by grants from the Faculty of Natural Science and Engineering, Linnaeus University, Kalmar, awarded to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab T, 2010, J PLANT INTERACT, V5, P1; Banyai W, 2011, PLANT GROWTH REGUL, V63, P45, DOI 10.1007/s10725-010-9510-9; Baumann K, 1999, PLANT CELL, V11, P323, DOI 10.1105/tpc.11.3.323; Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bilia AR, 2008, NAT PROD COMMUN, V3, P2075; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Bouwmeester HJ, 1999, PHYTOCHEMISTRY, V52, P843, DOI 10.1016/S0031-9422(99)00206-X; Brown GD, 2004, TETRAHEDRON, V60, P1139, DOI 10.1016/j.tet.2003.11.070; Brown GD, 2007, TETRAHEDRON, V63, P9548, DOI 10.1016/j.tet.2007.06.062; Cai Y, 2002, PHYTOCHEMISTRY, V61, P523, DOI 10.1016/S0031-9422(02)00265-0; Caretto S, 2011, PLANT BIOLOGY, V13, P51, DOI 10.1111/j.1438-8677.2009.00306.x; Chen JL, 2011, PLANTA MED, V77, P1759, DOI 10.1055/s-0030-1271038; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; Cockram J, 2012, PLANT GENET RESOUR-C, V10, P152, DOI 10.1017/S1479262112000159; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feng LL, 2009, PLANT SCI, V177, P57, DOI 10.1016/j.plantsci.2009.03.014; Fisher AA, 2002, J BIOL CHEM, V277, P22980, DOI 10.1074/jbc.M203347200; Futterer J., 1995, P215; Goel D, 2007, J NAT MED-TOKYO, V61, P458, DOI 10.1007/s11418-007-0175-2; GOLDSBROUGH AP, 1993, PLANT J, V3, P563, DOI 10.1046/j.1365-313X.1993.03040563.x; GUBLER F, 1992, PLANT CELL, V4, P1435; Han JL, 2006, J INTEGR PLANT BIOL, V48, P482, DOI 10.1111/j.1744-7909.2006.00208.x; Hobo T, 1999, PLANT J, V19, P679, DOI 10.1046/j.1365-313x.1999.00565.x; Holm Y, 1997, FLAVOUR FRAG J, V12, P335, DOI [10.1002/(SICI)1099-1026(199711/12)12:6&lt;397::AID-FFJ670&gt;3.0.CO;2-Z, 10.1002/(SICI)1099-1026(199711/12)12:6<397::AID-FFJ670>3.3.CO;2-Q, 10.1002/(SICI)1099-1026(199709/10)12:5<335::AID-FFJ664>3.3.CO;2-9]; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jia JW, 1999, ARCH BIOCHEM BIOPHYS, V372, P143, DOI 10.1006/abbi.1999.1466; Jing FY, 2009, BIOLOGIA, V64, P319, DOI 10.2478/s11756-009-0040-8; Kim J, 2006, BBA-GENE STRUCT EXPR, V1759, P191, DOI 10.1016/j.bbaexp.2006.03.002; Klotz KL, 1996, PLANT MOL BIOL, V31, P565, DOI 10.1007/BF00042229; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Lei CY, 2011, IND CROP PROD, V33, P176, DOI 10.1016/j.indcrop.2010.10.001; Liu Y, 2003, ACTA BOT SIN, V45, P608; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lommen WJM, 2007, PLANTA MED, V73, P1133, DOI 10.1055/s-2007-981567; Lommen WJM, 2006, PLANTA MED, V72, P336, DOI 10.1055/s-2005-916202; Ma DM, 2009, PLANT CELL PHYSIOL, V50, P2146, DOI 10.1093/pcp/pcp149; Maes L, 2011, NEW PHYTOL, V189, P176, DOI 10.1111/j.1469-8137.2010.03466.x; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Maruyama T, 2001, BIOL PHARM BULL, V24, P1171, DOI 10.1248/bpb.24.1171; Mercke P, 1999, ARCH BIOCHEM BIOPHYS, V369, P213, DOI 10.1006/abbi.1999.1358; Mercke P, 2000, ARCH BIOCHEM BIOPHYS, V381, P173, DOI 10.1006/abbi.2000.1962; Miller J.N., 2010, STAT CHEMOMETRICS AN, Vsixth; Miyamoto K, 2012, J PLANT PHYSIOL, V169, P621, DOI 10.1016/j.jplph.2011.12.008; Mohammadreza V. R., 2008, African Journal of Plant Science, V2, P16; Nafis T, 2011, PLANT BIOTECHNOL REP, V5, P53, DOI 10.1007/s11816-010-0156-x; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Olofsson L, 2012, PLANT SCI, V183, P9, DOI 10.1016/j.plantsci.2011.10.019; Olofsson L, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-45; Padalia RC, 2011, NAT PROD COMMUN, V6, P239; Pastuglia M, 1997, PLANT CELL, V9, P49, DOI 10.1105/tpc.9.1.49; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Polichuk D, 2010, Patent, Patent No. [WO 2010/012074, 2010012074]; Pu GB, 2009, PLANT CELL REP, V28, P1127, DOI 10.1007/s00299-009-0713-3; Rathore D, 2005, EXPERT OPIN INV DRUG, V14, P871, DOI 10.1517/13543784.14.7.871; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schnee C, 2002, PLANT PHYSIOL, V130, P2049, DOI 10.1104/pp.008326; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; SHEN QX, 1995, PLANT CELL, V7, P295, DOI 10.1105/tpc.7.3.295; SOLANO R, 1995, EMBO J, V14, P1773, DOI 10.1002/j.1460-2075.1995.tb07166.x; Soylu EM, 2005, Z PFLANZENK PFLANZEN, V112, P229; Sugimoto K, 2003, PLANT J, V36, P550, DOI 10.1046/j.1365-313X.2003.01899.x; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Wang HZ, 2013, PLANT MOL BIOL, V81, P119, DOI 10.1007/s11103-012-9986-y; Wang HongZhen, 2011, American Journal of Plant Sciences, V2, P619, DOI 10.4236/ajps.2011.24073; WOOLF TM, 1992, P NATL ACAD SCI USA, V89, P7305, DOI 10.1073/pnas.89.16.7305; Wu W, 2011, PLANTA MED, V77, P1048, DOI 10.1055/s-0030-1250744; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yang RY, 2010, PLANTA MED, V76, P734, DOI 10.1055/s-0029-1240620; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yin Lulu, 2008, Chinese Journal of Applied and Environmental Biology, V14, P1; Yu ZW, 2011, IRAN J PHARM RES, V10, P265; Yu ZX, 2012, MOL PLANT, V5, P353, DOI 10.1093/mp/ssr087; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200; Zhang YS, 2005, RUSS J PLANT PHYSL+, V52, P58, DOI 10.1007/s11183-005-0009-6	83	13	14	6	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80643	10.1371/journal.pone.0080643	http://dx.doi.org/10.1371/journal.pone.0080643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278301	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700031
J	Castaneda, B; Simon, Y; Ferbus, D; Robert, B; Chesneau, J; Mueller, C; Berdal, A; Lezot, F				Castaneda, Beatriz; Simon, Yohann; Ferbus, Didier; Robert, Benoit; Chesneau, Julie; Mueller, Christopher; Berdal, Ariane; Lezot, Frederic			Role of RANKL (TNFSF11)-Dependent Osteopetrosis in the Dental Phenotype of Msx2 Null Mutant Mice	PLOS ONE			English	Article							KAPPA-B RANK; RECEPTOR ACTIVATOR; GENE-EXPRESSION; BONE MASS; CXCL10; CELLS; INVOLVEMENT; MONOCYTES	The MSX2 homeoprotein is implicated in all aspects of craniofacial skeletal development. During postnatal growth, MSX2 is expressed in all cells involved in mineralized tissue formation and plays a role in their differentiation and function. Msx2 null (Msx2(-/-)) mice display complex craniofacial skeleton abnormalities with bone and tooth defects. A moderate form osteopetrotic phenotype is observed, along with decreased expression of RANKL (TNFSF11), the main osteoclast-differentiating factor. In order to elucidate the role of such an osteopetrosis in the Msx2(-/-) mouse dental phenotype, a bone resorption rescue was performed by mating Msx2(-/-) mice with a transgenic mouse line overexpressing Rank (Tnfrsf11a). Msx2(-/-) Rank(Tg) mice had significant improvement in the molar phenotype, while incisor epithelium defects were exacerbated in the enamel area, with formation of massive osteolytic tumors. Although compensation for RANKL loss of function could have potential as a therapy for osteopetrosis, but in Msx2(-/-) mice, this approach via RANK overexpression in monocyte-derived lineages, amplified latent epithelial tumor development in the peculiar continuously growing incisor.	[Castaneda, Beatriz; Simon, Yohann; Ferbus, Didier; Berdal, Ariane; Lezot, Frederic] Ctr Rech Cordeliers, INSERM, UMR 872, Lab Physiopathol Orale Mol,Equipe 5, F-75006 Paris, France; [Castaneda, Beatriz; Simon, Yohann; Ferbus, Didier; Berdal, Ariane; Lezot, Frederic] Univ Paris 05, F-75006 Paris, France; [Castaneda, Beatriz; Simon, Yohann; Ferbus, Didier; Berdal, Ariane; Lezot, Frederic] Univ Paris 06, F-75006 Paris, France; [Castaneda, Beatriz; Simon, Yohann; Ferbus, Didier; Berdal, Ariane; Lezot, Frederic] Univ Paris 07, F-75006 Paris, France; [Castaneda, Beatriz] Univ Antioquia, Fac Odontol, Dept Basic Studies, Medellin, Colombia; [Robert, Benoit] Inst Pasteur, CNRS, URA 2578, Unite Genet Mol Morphogenese, F-75015 Paris, France; [Chesneau, Julie; Lezot, Frederic] INSERM, UMR 957, Equipe Ligue Canc, F-44035 Nantes, France; [Chesneau, Julie; Lezot, Frederic] Univ Nantes, EA3822, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, F-44035 Nantes, France; [Mueller, Christopher] Univ Strasbourg, CNRS,UPR 9021, Inst Biol Mol & Cellulaire, Lab Immunol & Chim Therapeut, F-67084 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Universidad de Antioquia; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lezot, F (corresponding author), Ctr Rech Cordeliers, INSERM, UMR 872, Lab Physiopathol Orale Mol,Equipe 5, F-75006 Paris, France.	Frederic.lezot@univ-nantes.fr	Lézot, Frédéric/K-8075-2015; Berdal, Ariane/AAC-8745-2022	Lézot, Frédéric/0000-0001-6274-6981; Berdal, Ariane/0000-0001-5833-5813; Mueller, Christopher/0000-0002-4119-2729	Institute Francais de la Recherche Odontologique; INSERM [UMR872]; French Hospital Research Program (PHRC funding Teios); French National Cancer Institute [INCA-6001]	Institute Francais de la Recherche Odontologique; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Hospital Research Program (PHRC funding Teios); French National Cancer Institute(Institut National du Cancer (INCA) France)	B. Castaneda was a grantee of the Institute Francais de la Recherche Odontologique. This work was supported by funding from INSERM UMR872 team5, French Hospital Research Program (PHRC funding Teios) and French National Cancer Institute (Funding INCA-6001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Amling M, 2000, BONE, V27, P603, DOI 10.1016/S8756-3282(00)00373-2; Berdal A, 2011, CELLS TISSUES ORGANS, V194, P238, DOI 10.1159/000324787; Castaneda B, 2011, J CELL PHYSIOL, V226, P74, DOI 10.1002/jcp.22305; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Davideau JL, 1999, PEDIATR RES, V46, P650, DOI 10.1203/00006450-199912000-00003; Depondt J, 2008, HUM PATHOL, V39, P350, DOI 10.1016/j.humpath.2007.06.017; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Grassi F, 2003, HISTOCHEM CELL BIOL, V120, P391, DOI 10.1007/s00418-003-0587-3; Gremel G, 2011, BRIT J CANCER, V105, P565, DOI 10.1038/bjc.2011.249; Heise CE, 2005, J PHARMACOL EXP THER, V313, P1263, DOI 10.1124/jpet.105.083683; Kwak HB, 2008, ARTHRITIS RHEUM-US, V58, P1332, DOI 10.1002/art.23372; Lee Y, 2012, BLOOD, V119, P227, DOI 10.1182/blood-2011-06-357442; Lei SF, 2009, BONE, V44, P1010, DOI 10.1016/j.bone.2008.05.016; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Lu XC, 2009, EUR J ORAL SCI, V117, P625, DOI 10.1111/j.1600-0722.2009.00690.x; Molla M, 2010, AM J PATHOL, V177, P2516, DOI 10.2353/ajpath.2010.091224; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Qian Y, 2010, J ORAL PATHOL MED, V39, P592, DOI 10.1111/j.1600-0714.2009.00882.x; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Ruhin-Poncet B, 2009, J HISTOCHEM CYTOCHEM, V57, P69, DOI 10.1369/jhc.2008.951707; Soderquest K, 2011, BLOOD, V117, P4511, DOI 10.1182/blood-2010-10-312264; Stelnicki EJ, 1997, DIFFERENTIATION, V62, P33, DOI 10.1046/j.1432-0436.1997.6210033.x; Suda N, 2006, Orthod Craniofac Res, V9, P52, DOI 10.1111/j.1601-6343.2006.00337.x; Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070	27	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80054	10.1371/journal.pone.0080054	http://dx.doi.org/10.1371/journal.pone.0080054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278237	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800047
J	Dorn, M; Jurk, M; Wartenberg, A; Hahn, A; Schmieder, P				Dorn, Matthias; Jurk, Marcel; Wartenberg, Anne; Hahn, Aaron; Schmieder, Peter			LOV Takes a Pick: Thermodynamic and Structural Aspects of the Flavin-LOV-Interaction of the Blue-Light Sensitive Photoreceptor YtvA from Bacillus subtilis	PLOS ONE			English	Article							SIGMA(B)-DEPENDENT STRESS-RESPONSE; SIZE-DISTRIBUTION ANALYSIS; ADENINE-DINUCLEOTIDE; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; RECEPTOR YTVA; HUMAN PLASMA; DOMAIN; FLAVOPROTEIN	LOV domains act as versatile photochromic switches servicing multiple effector domains in a variety of blue light sensing photoreceptors abundant in a multitude of organisms from all kingdoms of life. The perception of light is realized by a flavin chromophore that upon illumination reversibly switches from the non-covalently bound dark-state to a covalently linked flavin-LOV adduct. It is usually assumed that most LOV domains preferably bind FMN, but heterologous expression frequently results in the incorporation of all natural occurring flavins, i.e. riboflavin, FMN and FAD. Over recent years, the structures, photochemical properties, activation mechanisms and physiological functions of a multitude of LOV proteins have been studied intensively, but little is known about its affinities to physiologically relevant flavins or the thermodynamics of the flavin-LOV interaction. We have investigated the interaction of the LOV domain of the well characterized bacterial photoreceptor YtvA with riboflavin, FMN and FAD by ITC experiments providing binding constants and thermodynamic profiles of these interactions. For this purpose, we have developed a protocol for the production of the apo forms of YtvA and its isolated LOV domain and we demonstrate that the latter can be used as a molecular probe for free flavins in cell lysates. Furthermore, we show here using NMR spectroscopic techniques and Analytical Ultracentrifugation that the flavin moiety stabilizes the conformation of the LOV domain and that dimerization of YtvA is caused not only by intermolecular LOV-LOV but also by STAS-STAS contacts.	[Dorn, Matthias; Jurk, Marcel; Wartenberg, Anne; Schmieder, Peter] Leibniz Inst Mol Pharmacol, Dept Biol Struct, Berlin, Germany; [Dorn, Matthias; Wartenberg, Anne; Hahn, Aaron] Free Univ Berlin, Dept Chem & Biochem, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin	Schmieder, P (corresponding author), Leibniz Inst Mol Pharmacol, Dept Biol Struct, Berlin, Germany.	schmieder@fmp-berlin.de		Schmieder, Peter/0000-0001-9968-9327	Deutsche Forschungsgemeinschaft (DFG) [SCHM880/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funded by the Deutsche Forschungsgemeinschaft (DFG), Grant SCHM880/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 2001, J BACTERIOL, V183, P1329, DOI 10.1128/JB.183.4.1329-1338.2001; Anderson S, 2005, BIOCHEMISTRY-US, V44, P7998, DOI 10.1021/bi0502691; [Anonymous], PYMOL MOL GRAPH SYST; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Briggs WR, 2007, J INTEGR PLANT BIOL, V49, P4, DOI 10.1111/j.1744-7909.2006.00406.x; Broecker J, 2011, ANAL BIOCHEM, V418, P307, DOI 10.1016/j.ab.2011.07.027; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Dorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029201; Durr H, 2005, BIOCHEMISTRY-US, V44, P3050, DOI 10.1021/bi0478897; Eisenreich W, 2007, FEBS J, V274, P5876, DOI 10.1111/j.1742-4658.2007.06111.x; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hayes D, 1995, PROGRAM SEDNTERP SED; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Husain M, 1978, Methods Enzymol, V53, P429; Hustad S, 2002, CLIN CHEM, V48, P1571; Hustad S, 1999, CLIN CHEM, V45, P862; Islam SDM, 2003, CHEM PHYS, V295, P137, DOI 10.1016/j.chemphys.2003.08.013; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Jurk M, 2013, BIOCHEM BIOPH RES CO, V432, P499, DOI 10.1016/j.bbrc.2013.02.025; Jurk M, 2011, BIOCHEMISTRY-US, V50, P8163, DOI 10.1021/bi200782j; Jurk M, 2010, J MOL BIOL, V403, P78, DOI 10.1016/j.jmb.2010.08.036; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kennis JTM, 2006, FLAVINS PHOTOCHEMIST; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Laan W, 2004, PHOTOCH PHOTOBIO SCI, V3, P1011, DOI 10.1039/b410923f; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; Mansurova M, 2011, CHEMBIOCHEM, V12, P641, DOI 10.1002/cbic.201000515; Marles-Wright J, 2008, SCIENCE, V322, P92, DOI 10.1126/science.1159572; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2013, PLANT CELL PHYSIOL, V54, P171, DOI 10.1093/pcp/pcs173; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P5706, DOI 10.1021/bi00476a010; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Rinaldi J, 2012, J MOL BIOL, V420, P112, DOI 10.1016/j.jmb.2012.04.006; Schroeder C, 2008, CHEMBIOCHEM, V9, P2463, DOI 10.1002/cbic.200800280; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Suzuki N, 2007, J GEN APPL MICROBIOL, V53, P81, DOI 10.2323/jgam.53.81; VANBERKEL WJH, 1988, EUR J BIOCHEM, V178, P197; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zhu G, 2008, PROG NUCL MAG RES SP, V52, P49, DOI 10.1016/j.pnmrs.2007.10.001; Zirak P, 2007, J PHOTOCH PHOTOBIO B, V86, P22, DOI 10.1016/j.jphotobiol.2006.08.007; Zirak P, 2006, J PHOTOCH PHOTOBIO B, V83, P180, DOI 10.1016/j.jphotobiol.2005.12.015; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	66	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81268	10.1371/journal.pone.0081268	http://dx.doi.org/10.1371/journal.pone.0081268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278408	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800116
J	Li, JJ; Tay, HL; Plank, M; Essilfie, AT; Hansbro, PM; Foster, PS; Yang, M				Li, Jing Jing; Tay, Hock L.; Plank, Maximilian; Essilfie, Ama-Tawiah; Hansbro, Philip M.; Foster, Paul S.; Yang, Ming			Activation of Olfactory Receptors on Mouse Pulmonary Macrophages Promotes Monocyte Chemotactic Protein-1 Production	PLOS ONE			English	Article							RESISTANT AIRWAY HYPERRESPONSIVENESS; AMINO-ACID ANALYSIS; TASTE RECEPTORS; GENE FAMILY; POLARIZATION; SYSTEM; EXPRESSION; PLASTICITY; IMMUNITY; BITTER	Background: Emerging evidence suggests that non-olfactory tissues and cells can express olfactory receptors (ORs), however, the exact function of ectopic OR expression remains unknown. We have previously shown in mouse models that a unique cooperation between interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS) drives the activation of pulmonary macrophages and leads to the induction of pathogenic responses in the respiratory tract. Further, through gene array studies, we have shown that activation of macrophages by these molecules results in the selective expression of a number of ORs. In this study, we validated the expression of these ORs in mouse airway and pulmonary macrophages in response to IFN-gamma and LPS (gamma/LPS) stimulation, and further explored the effect of odorant stimulation on macrophage function. Methodology/Principal Findings: OR expression in airway and pulmonary macrophages in response to IFN-gamma, LPS or gamma/LPS treatments was assessed by microarray and validated by q-PCR. OR expression (e.g. OR622) on macrophages was confirmed by visualization in immunofluoresence assays. Functional responses to odorants were assessed by quantifying inflammatory cytokine and chemokine expression using q-PCR and cell migration was assessed by a modified Boyden chamber migration assay. Our results demonstrate that eight ORs are expressed at basal levels in both airway and pulmonary macrophages, and that gamma/LPS stimulation cooperatively increased this expression. Pulmonary macrophages exposed to the combined treatment of gamma/LPS+ octanal (an odorant) exhibited a 3-fold increase in MCP-1 protein production, compared to cells treated with gamma/LPS alone. Supernatants from gamma/LPS+ octanal exposed macrophages also increased macrophage migration in vitro. Conclusions/Significance: Eight different ORs are expressed at basal levels in pulmonary macrophages and expression is upregulated by the synergistic action of gamma/LPS. Octanal stimulation further increased MCP-1 production and the motility of macrophages. Our results suggest that ORs may mediate macrophage function by regulating MCP-1 production and cell migration.	[Foster, Paul S.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia; Hunter Med Res Inst, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Foster, PS (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Ctr Asthma & Resp Dis, Callaghan, NSW 2308, Australia.	Paul.Foster@newcastle.edu.au; Ming.Yang@newcastle.edu.au	Foster, Paul/G-5057-2013; Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Essilfie, Ama-Tawiah/0000-0003-0443-9005; , Paul/0000-0002-0827-8299	National Health and Medical Research Council Project [510717, 1008323]; CRC Asthma and Airway Research	National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia); CRC Asthma and Airway Research	This study has been supported by National Health and Medical Research Council Project Grant (PSF and MY, #510717 and #1008323, www.nhmrc.gov.au) and CRC Asthma and Airway Research Grant (PSF and MY, http://asthmacrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cui LY, 1997, ELECTROEN CLIN NEURO, V102, P303, DOI 10.1016/S0013-4694(96)96109-X; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; HASKILL S, 1992, ANN NY ACAD SCI, V664, P93; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; LEONARD EJ, 1993, ADV EXP MED BIOL, V351, P55; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Moshkin MP, 2013, BRAIN BEHAV IMMUN, V30, P150, DOI 10.1016/j.bbi.2012.12.006; Moshkin MP, BRAIN BEHAV IMMUN; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESTREPO D, 1993, BIOPHYS J, V64, P1961, DOI 10.1016/S0006-3495(93)81565-0; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Triballeau N, 2008, NEURON, V60, P767, DOI 10.1016/j.neuron.2008.11.014; Weber M, 2002, J NEUROSCI RES, V68, P176, DOI 10.1002/jnr.10164; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yang M, 2012, J LEUKOCYTE BIOL, V91, P557, DOI 10.1189/jlb.0711357; Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956; YOSHIMURA T, 1991, ADV EXP MED BIOL, V305, P47; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10	54	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80148	10.1371/journal.pone.0080148	http://dx.doi.org/10.1371/journal.pone.0080148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278251	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800057
J	Scholten, ET; de Hoop, B; Jacobs, C; van Amelsvoort-van de Vorst, S; van Klaveren, RJ; Oudkerk, M; Vliegenthart, R; de Koning, HJ; van der Aalst, CM; Mali, WTM; Gietema, HA; Prokop, M; van Ginneken, B; de Jong, PA				Scholten, Ernst Th.; de Hoop, Bartjan; Jacobs, Colin; van Amelsvoort-van de Vorst, Saskia; van Klaveren, Rob J.; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; de Koning, Harry J.; van der Aalst, Carlijn M.; Mali, Willem Th M.; Gietema, Hester A.; Prokop, Mathias; van Ginneken, Bram; de Jong, Pim A.			Semi-Automatic Quantification of Subsolid Pulmonary Nodules: Comparison with Manual Measurements	PLOS ONE			English	Article							GROUND-GLASS NODULES; FLEISCHNER-SOCIETY; CT; VOLUMETRY; MANAGEMENT; SEGMENTATION; OPACITY; GROWTH; MASS	Rationale: Accurate measurement of subsolid pulmonary nodules (SSN) is becoming increasingly important in the management of these nodules. SSNs were previously quantified with time-consuming manual measurements. The aim of the present study is to test the feasibility of semi-automatic SSNs measurements and to compare the results to the manual measurements. Methods: In 33 lung cancer screening participants with 33 SSNs, the nodules were previously quantified by two observers manually. In the present study two observers quantified these nodules by using semi-automated nodule volumetry software. Nodules were quantified for effective diameter, volume and mass. The manual and semi-automatic measurements were compared using Bland-Altman plots and paired T tests. Observer agreement was calculated as an intraclass correlation coefficient. Data are presented as mean (SD). Results: Semi-automated measurements were feasible in all 33 nodules. Nodule diameter, volume and mass were 11.2 (3.3) mm, 935 (691) ml and 379 (311) milligrams for observer 1 and 11.1 (3.7) mm, 986 (797) ml and 399 (344) milligrams for observer 2, respectively. Agreement between observers and within observer 1 for the semi-automatic measurements was good with an intraclass correlation coefficient >0.89. For observer 1 and observer 2, measured diameter was 8.8% and 10.3% larger (p<0.001), measured volume was 24.3% and 26.5% larger (p<0.001) and measured mass was 10.6% and 12.0% larger (p<0.001) with the semi-automatic program compared to the manual measurements. Conclusion: Semi-automated measurement of the diameter, volume and mass of SSNs is feasible with good observer agreement. Semi-automated measurement makes quantification of mass and volume feasible in daily practice.	[Scholten, Ernst Th.; de Hoop, Bartjan; van Amelsvoort-van de Vorst, Saskia; Mali, Willem Th M.; Gietema, Hester A.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Scholten, Ernst Th.] Kennemer Gasthuis, Dept Radiol, Haarlem, Netherlands; [Jacobs, Colin; van Ginneken, Bram] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Image Anal Grp, Nijmegen, Netherlands; [Jacobs, Colin; van Ginneken, Bram] Fraunhofer MEVIS, Bremen, Germany; [van Klaveren, Rob J.] Lievensberg Hosp, Dept Pulmonol, Bergen Op Zoom, Netherlands; [Oudkerk, Matthijs; Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [de Koning, Harry J.; van der Aalst, Carlijn M.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen Med Ctr, Dept Radiol, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Spaarne Hospital; Radboud University Nijmegen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	pimdejong@gmail.com	Jacobs, Colin/P-6938-2015; van der Aalst, Carlijn/AAG-7522-2019; de+Koning, Harry/AAF-9062-2019; de Jong, Pim A/G-7220-2014; Prokop, W.M./H-8081-2014; Mali, Willem PThM/I-1123-2014; van Ginneken, Bram/A-3728-2012	Jacobs, Colin/0000-0003-1180-3805; de+Koning, Harry/0000-0003-4682-3646; de Jong, Pim A/0000-0003-4840-6854; Mali, Willem PThM/0000-0003-4391-0904; van Ginneken, Bram/0000-0003-2028-8972; Oudkerk, Matthijs/0000-0003-2800-4110; Prokop, Mathias/0000-0001-8157-8055	"Zorg Onderzoek Nederland-Medische Wetenschappen'' (ZonMw); "KWF Kankerbestrijding''; "Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen'' (RvvZ); "G. Ph. Verhagen Foundation''; "Rotterdam Oncologic Thoracic Study Group"; "Erasmus Trust Fund''; "Stichting tegen Kanker''; "Vlaamse Liga tegen Kanker''; "LOGO Leuven and Hageland''	"Zorg Onderzoek Nederland-Medische Wetenschappen'' (ZonMw)(Netherlands Organization for Health Research and Development); "KWF Kankerbestrijding''; "Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen'' (RvvZ); "G. Ph. Verhagen Foundation''; "Rotterdam Oncologic Thoracic Study Group"; "Erasmus Trust Fund''; "Stichting tegen Kanker''; "Vlaamse Liga tegen Kanker''; "LOGO Leuven and Hageland''	The NELSON trial is supported by: "Zorg Onderzoek Nederland-Medische Wetenschappen'' (ZonMw), "KWF Kankerbestrijding'', "Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen'' (RvvZ), "G. Ph. Verhagen Foundation'', "Rotterdam Oncologic Thoracic Study Group'' and "Erasmus Trust Fund'', "Stichting tegen Kanker'', "Vlaamse Liga tegen Kanker'' and "LOGO Leuven and Hageland''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Hoop B, 2010, RADIOLOGY, V255, P199, DOI 10.1148/radiol.09090571; Godoy MCB, 2012, J THORAC IMAG, V27, P240, DOI 10.1097/RTI.0b013e31825d515b; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; Kim HY, 2007, RADIOLOGY, V245, P267, DOI 10.1148/radiol.2451061682; Ko JP, 2012, RADIOLOGY, V262, P662, DOI 10.1148/radiol.11100878; Kuhnigk JM, 2006, IEEE T MED IMAGING, V25, P417, DOI 10.1109/TMI.2006.871547; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oda S, 2010, AM J ROENTGENOL, V194, P398, DOI 10.2214/AJR.09.2583; Scholten ET, 2013, AM J ROENTGENOL, V201, P295, DOI 10.2214/AJR.12.9640; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085	13	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80249	10.1371/journal.pone.0080249	http://dx.doi.org/10.1371/journal.pone.0080249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278264	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800066
J	Ahmed, Z; McLeod, MC; Barber, N; Jacklin, A; Franklin, BD				Ahmed, Zamzam; McLeod, Monsey Chan; Barber, Nick; Jacklin, Ann; Franklin, Bryony Dean			The Use and Functionality of Electronic Prescribing Systems in English Acute NHS Trusts: A Cross-Sectional Survey	PLOS ONE			English	Article							ASHP NATIONAL-SURVEY	Objectives: To describe current use of electronic prescribing (EP) in English acute NHS hospital trusts, and the use of multiple EP systems within the same hospital. Design: Descriptive cross-sectional postal survey. Setting: Acute NHS hospital trusts in England. Participants: The survey was sent to chief pharmacists in all acute English NHS hospital trusts in 2011. Where trusts comprised multiple hospitals, respondents were asked to complete the questionnaire for their main acute hospital. Main Outcome Measures: Prevalence of EP use in acute NHS hospitals; number of different EP systems in each hospital; stages of the patient pathway in which EP used; extent of deployment across the hospital; comprehensiveness regarding the drugs prescribed; decision support functionalities used. Results: We received responses from 101 trusts (61%). Seventy (69%) respondent hospitals had at least one form of EP in use. More than half (39; 56%) of hospitals with EP had more than one system in use, representing 60 different systems. The most common were systems used only for discharge prescribing, used in 48 (48% of respondent hospitals). Specialist chemotherapy EP systems were second most common (34; 34%). Sixteen specialist inpatient systems were used across 15 hospitals, most commonly in adult critical care. Only 13 (13%) respondents used inpatient electronic prescribing across all adult medical and surgical wards. Overall, 24 (40%) systems were developed 'in-house'. Decision support functionality varied widely. Conclusions: It is UK government policy to encourage the adoption of EP in hospitals. Our work shows that EP is prevalent in English hospitals, although often in limited clinical areas and for limited types of prescribing. The diversity of systems in use, often within the same hospital, may create challenges for staff training and patient safety.	[Ahmed, Zamzam; McLeod, Monsey Chan; Barber, Nick; Jacklin, Ann; Franklin, Bryony Dean] UCL Sch Pharm, Ctr Medicat Safety & Serv Qual, London, England; [Ahmed, Zamzam; McLeod, Monsey Chan; Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, Dept Pharm, London, England	University of London; University College London; Imperial College London	Franklin, BD (corresponding author), UCL Sch Pharm, Ctr Medicat Safety & Serv Qual, London, England.	Bryony.deanfranklin@imperial.nhs.uk	McLeod, Monsey/AAR-7989-2021	McLeod, Monsey/0000-0001-5571-2417; Franklin, Bryony/0000-0002-2892-1245	UCL School of Pharmacy Oversees Research Award (SOPORA), UCL School of Pharmacy; NIHR	UCL School of Pharmacy Oversees Research Award (SOPORA), UCL School of Pharmacy; NIHR(National Institute for Health Research (NIHR))	ZA is funded by the UCL School of Pharmacy Oversees Research Award (SOPORA), UCL School of Pharmacy. The Centre for Medication Safety and Service Quality is affiliated with the National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre which is funded by the NIHR. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The researchers are independent from the funders. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Barber N, 2013, J ROY SOC MED, V106, P6, DOI 10.1258/jrsm.2012.120172; CAR J, 2008, IMPACT EHEALTH QUALI; Cornford T, 2009, CONNECTING HLTH EPRE; Cresswell K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053369; Crowe Sarah, 2010, JRSM Short Rep, V1, P33, DOI 10.1258/shorts.2010.010040; Department of Health, 2000, ORG MEM; Dornan T, 2009, EQUIP STUDY; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; *NAT AUD OFF, 2008, NAT PROGR IT NHS PRO; Pedersen CA, 2012, AM J HEALTH-SYST PH, V69, P768, DOI 10.2146/ajhp110735; Pedersen CA, 2011, AM J HEALTH-SYST PH, V68, P669, DOI [10.2146/ajhp100711, 10.2146/ajhp090596]; Price WaterhouseCooper, 2013, REV POT BEN BETT US; Seden K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002036; Sitzia J, 1998, INT J QUAL HEALTH C, V10, P311, DOI 10.1093/intqhc/10.4.311; Summers V, 2000, SURVEY UK TRUST CHIE; The National Audit Office, 2011, HC888SESSION20102010	20	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80378	10.1371/journal.pone.0080378	http://dx.doi.org/10.1371/journal.pone.0080378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278279	Green Published, gold			2022-12-27	WOS:000327313100087
J	Yokosawa, K; Pamilo, S; Hirvenkari, L; Hari, R; Pihko, E				Yokosawa, Koichi; Pamilo, Siina; Hirvenkari, Lotta; Hari, Riitta; Pihko, Elina			Activation of Auditory Cortex by Anticipating and Hearing Emotional Sounds: An MEG Study	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; REACTION-TIME; PROSODY; BRAIN; COMPONENTS; RESPONSES; RECOGNITION; PERCEPTION; INTENSITY; STIMULI	To study how auditory cortical processing is affected by anticipating and hearing of long emotional sounds, we recorded auditory evoked magnetic fields with a whole-scalp MEG device from 15 healthy adults who were listening to emotional or neutral sounds. Pleasant, unpleasant, or neutral sounds, each lasting for 6 s, were played in a random order, preceded by 100-ms cue tones (0.5, 1, or 2 kHz) 2 s before the onset of the sound. The cue tones, indicating the valence of the upcoming emotional sounds, evoked typical transient N100m responses in the auditory cortex. During the rest of the anticipation period (until the beginning of the emotional sound), auditory cortices of both hemispheres generated slow shifts of the same polarity as N100m. During anticipation, the relative strengths of the auditory-cortex signals depended on the upcoming sound: towards the end of the anticipation period the activity became stronger when the subject was anticipating emotional rather than neutral sounds. During the actual emotional and neutral sounds, sustained fields were predominant in the left hemisphere for all sounds. The measured DC MEG signals during both anticipation and hearing of emotional sounds implied that following the cue that indicates the valence of the upcoming sound, the auditory-cortex activity is modulated by the upcoming sound category during the anticipation period.	[Yokosawa, Koichi; Pamilo, Siina; Hirvenkari, Lotta; Hari, Riitta; Pihko, Elina] Aalto Univ, Sch Sci, Aalto NeuroImaging, Brain Res Unit,OV Lounasmaa Lab, Espoo, Finland; [Yokosawa, Koichi; Pamilo, Siina; Hirvenkari, Lotta; Hari, Riitta; Pihko, Elina] Aalto Univ, Sch Sci, Aalto NeuroImaging, MEG Core, Espoo, Finland; [Yokosawa, Koichi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Aalto University; Aalto University; Hokkaido University	Yokosawa, K (corresponding author), Aalto Univ, Sch Sci, Aalto NeuroImaging, Brain Res Unit,OV Lounasmaa Lab, Espoo, Finland.	yokosawa@med.hokudai.ac.jp	Hari, Riitta K/J-1880-2012	Hari, Riitta K/0000-0002-3142-2703	JSPS (Japan Society for the Promotion of Science); Academy of Finland (National Centers of Excellence Program); aivoAALTO research program of the Aalto University	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Academy of Finland (National Centers of Excellence Program); aivoAALTO research program of the Aalto University	This work was supported by JSPS (Japan Society for the Promotion of Science, http://www.jsps.go.jp/english/index.html) researcher exchange program 2009, by the Academy of Finland (http://www.aka.fi/eng; National Centers of Excellence Program 2006-2011), and aivoAALTO research program of the Aalto University (http://www.aalto.fi/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Chiu P, 2004, J COGNITIVE NEUROSCI, V16, P1830, DOI 10.1162/0898929042947946; CHWILLA DJ, 1991, BIOL PSYCHOL, V32, P125, DOI 10.1016/0301-0511(91)90005-2; Czigler I, 2007, NEUROSCI LETT, V420, P251, DOI 10.1016/j.neulet.2007.05.007; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Ethofer T, 2006, NEUROREPORT, V17, P249, DOI 10.1097/01.wnr.0000199466.32036.5d; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Gomez CM, 2004, COGNITIVE BRAIN RES, V21, P59, DOI 10.1016/j.cogbrainres.2004.05.005; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; HARI R, 1987, AUDIOLOGY, V26, P31; Hari R., 1990, ADV AUDIOL, V6, P222; Korrchoubey B, 2009, COGN AFFECT BEHAV NE, V9, P153, DOI 10.3758/CABN.9.2.153; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Leynes PA, 1998, INT J PSYCHOPHYSIOL, V31, P33, DOI 10.1016/S0167-8760(98)00032-4; LOVELESS NE, 1973, ELECTROEN CLIN NEURO, V35, P369, DOI 10.1016/0013-4694(73)90193-4; LOVELESS NE, 1975, BIOL PSYCHOL, V2, P217, DOI 10.1016/0301-0511(75)90021-6; Makela J P, 1990, Adv Neurol, V54, P177; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; PANTEV C, 1988, ELECTROEN CLIN NEURO, V69, P160, DOI 10.1016/0013-4694(88)90211-8; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Plichta MM, 2011, NEUROIMAGE, V55, P1200, DOI 10.1016/j.neuroimage.2011.01.011; REGAN M, 1995, PSYCHOPHYSIOLOGY, V32, P208, DOI 10.1111/j.1469-8986.1995.tb02950.x; Rohrbaugh J, 1983, TUTORIALS ERP RES EN, V10, P269; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; Viinikainen M, 2012, HUM BRAIN MAPP, V33, P2295, DOI 10.1002/hbm.21362; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; YEE CM, 1988, J ABNORM PSYCHOL, V97, P54, DOI 10.1037/0021-843X.97.1.54	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80284	10.1371/journal.pone.0080284	http://dx.doi.org/10.1371/journal.pone.0080284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278270	Green Published, gold, Green Accepted			2022-12-27	WOS:000327313100080
J	Zhou, KN; Zhuang, GH; Zhang, HM; Liang, PF; Yin, J; Kou, LL; Hao, MM; You, LJ				Zhou, Kaina; Zhuang, Guihua; Zhang, Hongmei; Liang, Peifeng; Yin, Juan; Kou, Lingling; Hao, Mengmeng; You, Lijuan			Psychometrics of the Short Form 36 Health Survey Version 2 (SF-36v2) and the Quality of Life Scale for Drug Addicts (QOL-DAv2.0) in Chinese Mainland Patients with Methadone Maintenance Treatment	PLOS ONE			English	Article							VALIDATION; USERS	Objective: To test psychometrics of the Short Form 36 Health Survey version 2 (SF-36v2) and the Quality of Life Scale for Drug Addicts (QOL-DAv2.0) in Chinese mainland patients with methadone maintenance treatment (MMT). Methods: A total of 1,212 patients were recruited from two MMT clinics in Xi'an, China. Reliability was estimated with Cronbach's a and intra-class correlation (ICC). Convergent and discriminant validity was assessed using multitrait-multimethod correlation matrix. Sensitivity was measured with ANOVA and relative efficiency. Responsiveness was evaluated by pre-post paired-samples t-test and standardized response mean based on the patients' health status changes following 6-month period. Results: Cronbach's alpha of the SF-36v2 physical and mental summary components were 0.80 and 0.86 (eight scales range 0.73-0.92) and the QOL-DAv2.0 was 0.96 (four scales range: 0.80-0.93). ICC of the SF-36v2 two components were 0.86 and 0.85 (eight scales range: 0.72-0.87) and the QOL-DAv2.0 was 0.94 (four scales range: 0.88-0.92). Convergent validity was lower between the two instruments (gamma<0.70) while discriminant validity was acceptable within each instrument. Sensitivity was satisfied in self-evaluated health status (both instruments) and average daily methadone dose (SF-36v2 physical functioning and vitality scales; QOL-DAv2.0 except psychology scale). Responsiveness was acceptable in the improved health status change (SF-36v2 except vitality scale; QOL-DAv2.0 except psychology and symptoms scales) and deteriorated health status change (SF-36v2 except vitality, social functioning and mental health scales; QOL-DAv2.0 except society scale). Conclusions: The SF-36v2 and the QOL-DAv2.0 are valid tools and can be used independently or complementary according to different emphases of health-related quality of life evaluation in patients with MMT.	[Zhou, Kaina; Zhuang, Guihua; Zhang, Hongmei; Liang, Peifeng; Yin, Juan; Kou, Lingling; Hao, Mengmeng; You, Lijuan] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Zhuang, GH (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian 710049, Shaanxi, Peoples R China.	zhuanggh@mail.xjtu.edu.cn	Zhou, Kaina/J-6601-2018	Zhou, Kaina/0000-0002-1898-6379; Liang, Peifeng/0000-0002-8473-9843	National T&S Major Project of China [2012ZX10002001]	National T&S Major Project of China	This study was supported by the grants (no. 2012ZX10002001) from National T&S Major Project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Amiri P, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-3; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Baharom N, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-32; Bao Yanping, 2009, HIV Therapy, V3, P237, DOI [10.2217/hiv.09.4, 10.2217/HIV.09.4]; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Batki SL, 2009, DRUG ALCOHOL DEPEN, V101, P176, DOI 10.1016/j.drugalcdep.2008.12.012; Cao Xiao-bin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P879; Carpentier PJ, 2009, AM J ADDICTION, V18, P470, DOI 10.3109/10550490903205652; De Maeyer J, 2013, INT J DRUG POLICY, V24, P342, DOI 10.1016/j.drugpo.2012.09.005; Deering DE, 2004, DRUG ALCOHOL REV, V23, P273, DOI 10.1080/09595230412331289428; Dewey C., 2010, MULTIVARIATE DATA AN; Faggiano F, 2008, METHADONE MAINTENANC; Fayers PM, 2007, QUALITY LIFE ASSESSM; Hillier W, 2011, METHADONE MAINTENANC; Hubley AM, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-46; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Jin Y, 2005, PSYCHOL MEASUREMENT, P147; Katschnig H, 1997, QUALITY OF LIFE IN MENTAL DISORDERS, P3; Lam ETP, 2009, WORLD J GASTROENTERO, V15, P3288, DOI 10.3748/wjg.15.3288; Li XM, 2002, ADDICTION, V97, P575, DOI 10.1046/j.1360-0443.2002.00119.x; Luo L, 2012, CHIN J AIDS STD, V18, P30; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pedro Ruiz ECS, 2011, SUBSTANCE ABUSE COMP; Reist D., 2010, METHADONE MAINTENANC; Ryan CF, 1996, ADDICTION, V91, P39, DOI 10.1111/j.1360-0443.1996.tb03160.x; Schipper H., 1996, QUALITY LIFE PHARMAC, V2, P11; Shang X, 2013, MINISTRY PUBLIC SECU; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wan C. H., 1997, CHINESE J BEHAV MED, V6; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; Winklbaur B, 2008, EUR ADDICT RES, V14, P99, DOI 10.1159/000113724; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; XIE Xiao-hu., 2011, CHIN J INTEGR MED, V17, P314, DOI [10.15900/j.cnki.zylf1995.2011.06.016, DOI 10.15900/J.CNKI.ZYLF1995.2011.06.016]; Xie Y, 2009, MODERN PREV MED, V36, P2128; Zhang JB, 2008, CHIN J DRUG ABUSE PR, V14, P320; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130; Zubaran C, 2012, EUR ADDICT RES, V18, P220, DOI 10.1159/000337213; Zubaran C, 2009, CURR OPIN PSYCHIATR, V22, P281, DOI 10.1097/YCO.0b013e328328d154	41	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79828	10.1371/journal.pone.0079828	http://dx.doi.org/10.1371/journal.pone.0079828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278188	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100053
J	Zhou, LY; Zang, GY; Zhang, GF; Wang, HS; Zhang, XS; Johnston, N; Min, WP; Luke, P; Jevnikar, A; Haig, A; Zheng, XF				Zhou, Liangyi; Zang, Guoyao; Zhang, Guangfeng; Wang, Hansong; Zhang, Xusheng; Johnston, Nathan; Min, Weiping; Luke, Patrick; Jevnikar, Anthony; Haig, Aaron; Zheng, Xiufen			MicroRNA and mRNA Signatures in Ischemia Reperfusion Injury in Heart Transplantation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DOWN-REGULATION; UP-REGULATION; EXPRESSION; PROTECTS; TARGET; CARDIOPROTECTION; PRESERVATION; APOPTOSIS; SURVIVAL	Ischemia reperfusion (I/R) injury is an unavoidable event occurring during heart transplantation, leading to graft failures and lower long-term survival rate of the recipient. Several studies have demonstrated that microRNAs (miRNAs) are vital regulators of signalling pathways involved in I/R injury. The present study aims to quantify the altered expression levels of miRNA and mRNA upon I/R injury in a mouse heart transplantation model, and to investigate whether these miRNA can regulate genes involved in I/R injury. We performed heterotopic heart transplantation on mouse models to generate heart tissue samples with I/R and non-I/R (control). The expression levels of miRNAs as well as genes were measured in heart grafts by microarray and real time RT-PCR. miRNA alteration in cardiomyocytes exposed to hypoxia was also detected by qRT-PCR. We observed significant alterations in miRNA and gene expression profile after I/R injury. There were 39 miRNAs significantly downregulated and 20 upregulated up to 1.5 fold in heart grafts with I/R injury compared with the grafts without I/R. 48 genes were observed with 3 fold change and p<0.05 and 18 signalling pathways were enriched using Keggs pathway library. Additionally, hypoxia/reperfusion induced primary cardiomyocyte apoptosis and altered miRNA expression profiles. In conclusion, this is the first report on miRNA expression profile for heart transplantation associated with I/R injury. These findings provide us with an insight into the role of miRNA in I/R injury in heart transplantation.	[Zhou, Liangyi; Zhang, Guangfeng; Wang, Hansong; Zhang, Xusheng; Johnston, Nathan; Min, Weiping; Luke, Patrick; Jevnikar, Anthony; Haig, Aaron; Zheng, Xiufen] Univ Western Ontario, Dept Pathol Surg Med & Microbiol & Immunol, London, ON, Canada; [Zang, Guoyao] Zhejiang Univ, Sch Med, Sir Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Min, Weiping; Jevnikar, Anthony; Zheng, Xiufen] Lawson Hlth Res Inst, London, ON, Canada; [Min, Weiping; Luke, Patrick; Jevnikar, Anthony] Multiple Organ Transplant Program, London, ON, Canada	Western University (University of Western Ontario); Zhejiang University; Western University (University of Western Ontario)	Zheng, XF (corresponding author), Univ Western Ontario, Dept Pathol Surg Med & Microbiol & Immunol, London, ON, Canada.	xzheng26@uwo.ca	Jevnikar, Anthony M./G-3309-2011		Heart and Stroke Foundation of Canada; Lawson Health Research Institute; Multiple Organ Transplant Program	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Lawson Health Research Institute; Multiple Organ Transplant Program	This study was supported by the Heart and Stroke Foundation of Canada; Lawson Health Research Institute; and Multiple Organ Transplant Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2008, AM J PHYSIOL-HEART C, V295, pH509, DOI 10.1152/ajpheart.00368.2008; Bao YY, 2013, APOPTOSIS, V18, P260, DOI 10.1007/s10495-013-0802-1; Barker WH, 2006, CIRCULATION, V113, P799, DOI 10.1161/CIRCULATIONAHA.104.492033; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Brody MJ, J MOL CELL CARDIOL; Brody MJ, 2012, J MOL CELL CARDIOL; Chatzikyriakidou A, 2012, AUTOIMMUN REV, V11, P636, DOI 10.1016/j.autrev.2011.11.004; Chen Q, 2013, TRANSPL P, V45, P492, DOI 10.1016/j.transproceed.2012.10.045; Doeppner TR, 2013, ACTA NEUROPATHOL; Fasanaro P., 2013, CURR VASC PHARM; Gui T, 2012, LAB INVEST, V92, P1250, DOI 10.1038/labinvest.2012.85; Hazarika S, 2013, CIRCULATION, V127, P1818, DOI 10.1161/CIRCULATIONAHA.112.000860; Heger J, 2013, J CELL PHYSL, V224, P120; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Jia P, 2013, ANESTHESIOLOGY; Kirklin JK, 1999, ANN THORAC SURG, V68, P1978, DOI 10.1016/S0003-4975(99)01016-4; Klotz S, 2011, CURR OPIN ANESTHESIO, V24, P86, DOI 10.1097/ACO.0b013e328340ff64; Knight RJ, 1997, TRANSPLANTATION, V64, P1102, DOI 10.1097/00007890-199710270-00003; Lee SW, 2011, MOL MED, V17, P1095, DOI 10.2119/molmed.2011.00106; Lepic E, 2006, AM J PHYSIOL-CELL PH, V291, pC1240, DOI 10.1152/ajpcell.00092.2006; Li ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010755; Li ZY, 2011, MOL BIOSYST, V7, P871, DOI 10.1039/c0mb00230e; Liu LF, 2012, J GERIATR CARDIOL, V9, P28, DOI 10.3724/SP.J.1263.2012.00028; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Martin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025044; McDaneld TG, 2008, J ANIM SCI, V86, P2897, DOI 10.2527/jas.2008-1076; Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Qin H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-154; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Ralfkiaer U, 2011, BLOOD, V118, P5891, DOI 10.1182/blood-2011-06-358382; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; SLATER JP, 1995, CIRCULATION, V92, P223, DOI 10.1161/01.CIR.92.9.223; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Song Yan-Rui, 2011, Yichuan, V33, P549, DOI 10.3724/SP.J.1005.2011.00549; Subramaniam K, 2012, INT ANESTHESIOL CLIN, V50, P202, DOI 10.1097/AIA.0b013e3182603ead; Tanaka M, 2005, J HEART LUNG TRANSPL, V24, P1906, DOI 10.1016/j.healun.2004.06.007; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Vislovukh A, 2013, BRIT J CANCER, V108, P2304, DOI 10.1038/bjc.2013.243; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang X, CIRCULATION, V122, P1308; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Xu CF, 2009, OMICS, V13, P513, DOI 10.1089/omi.2009.0035; Yang YF, 2009, CIRCULATION, V120, pS758; Ye Y, PHYSL GENOMICS, V43, P534; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Yin C, 2009, CIRC RES, V104, P572, DOI 10.1161/CIRCRESAHA.108.193250; Zhao HP, 2013, STROKE, V44, P1706, DOI 10.1161/STROKEAHA.111.000504; Zhao N, 2013, SCI CHINA LIFE SCI, V56, P431, DOI 10.1007/s11427-013-4477-1; Zhou M, 2013, MED HYPOTHESES, V81, P108, DOI 10.1016/j.mehy.2013.03.043	63	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79805	10.1371/journal.pone.0079805	http://dx.doi.org/10.1371/journal.pone.0079805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278182	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100049
J	Hopkins, JB; Cutting, KA; Warren, JM				Hopkins, John B., III; Cutting, Kyle A.; Warren, Jeffrey M.			Use of Stable Isotopes to Investigate Keratin Deposition in the Claw Tips of Ducks	PLOS ONE			English	Article							LESSER SCAUP; MIGRATORY SONGBIRD; NORTH-AMERICA; DELTA-D; FEATHERS; HYDROGEN; BLOOD; TURNOVER; ORIGINS; CARBON	Stable isotopes derived from the claws of birds could be used to determine the migratory origins of birds if the time periods represented in excised sections of claws were known. We investigated new keratin growth in the claws of adult female Lesser Scaup (Aythya affinis) by estimating the equilibration rates of stable isotopes (delta C-13, delta N-15, and delta H-2) from the breeding grounds into 1 mm claw tips. We sampled birds on their breeding ground through time and found that it took approximately 3-3.5 months for isotope values in most claw tips to equilibrate to isotope values that reflected those present in the environment on their breeding grounds. Results from this study suggest that isotopes equilibrate slowly into claw tips of Lesser Scaup, suggesting isotopes could potentially be used to determine the wintering grounds of birds. We suggest using controlled feeding experiments or longitudinal field investigations to understand claw growth and isotopic equilibration in claw tips. Such information would be valuable in ascertaining whether claw tips can be used in future studies to identify the migratory origins of birds.	[Hopkins, John B., III] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Cutting, Kyle A.; Warren, Jeffrey M.] US Fish & Wildlife Serv, Red Rock Lakes Natl Wildlife Refuge, Lima, MT USA	University of California System; University of California Santa Cruz; United States Department of the Interior; US Fish & Wildlife Service	Hopkins, JB (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jbhopkins3@gmail.com			Delta Waterfowl, Inc.; U.S. Fish and Wildlife Service	Delta Waterfowl, Inc.; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	The authors are grateful to Delta Waterfowl, Inc., the U.S. Fish and Wildlife Service for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisauskas RT, 1992, COST EGG LAYING ITS, P30; Bearhop S, 2003, FUNCT ECOL, V17, P270, DOI 10.1046/j.1365-2435.2003.00725.x; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; COWAN IM, 1952, J WILDLIFE MANAGE, V16, P438, DOI 10.2307/3797492; Cutting KA, 2011, J AVIAN BIOL, V42, P505, DOI 10.1111/j.1600-048X.2011.05406.x; Devries JH, 2008, AUK, V125, P618, DOI 10.1525/auk.2008.07055; Dietz MW, 2010, CONDOR, V112, P48, DOI 10.1525/cond.2010.090139; Ethier DM, 2010, CAN J ZOOL, V88, P1043, DOI 10.1139/Z10-073; Fraser KC, 2008, AVIAN CONSERV ECOL, V3; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 2006, WATERBIRDS, V29, P137, DOI 10.1675/1524-4695(2006)29[137:USHIAO]2.0.CO;2; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, CONDOR, V111, P188, DOI 10.1525/cond.2009.080001; IAEA (International Atomic Energy Association), 2009, REF SHEET VSMOW2 SLA; LOKEMOEN JT, 1985, WILDLIFE SOC B, V13, P53; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mazerolle DF, 2005, OECOLOGIA, V144, P541, DOI 10.1007/s00442-005-0031-6; Mazerolle DF, 2005, CONDOR, V107, P280, DOI 10.1650/7681; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Oppel S, 2008, MAR ECOL PROG SER, V373, P149, DOI 10.3354/meps07744; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Prochazka P, 2008, J ORNITHOL, V149, P141, DOI 10.1007/s10336-007-0250-1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reudink MW, 2009, J AVIAN BIOL, V40, P34, DOI 10.1111/j.1600-048X.2008.04377.x; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; TRAUGER DL, 1974, AUK, V91, P242; U.S. Fish and Wildlife Service, 2008, WAT POP STAT 2008; Warren JM, 2011, ECOTOXICOLOGY, V20, P110, DOI 10.1007/s10646-010-0561-5; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Yerkes T, 2008, J WILDLIFE MANAGE, V72, P715, DOI 10.2193/2007-115; Yohannes E, 2010, J AVIAN BIOL, V41, P580, DOI 10.1111/j.1600-048X.2010.04965.x	41	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81026	10.1371/journal.pone.0081026	http://dx.doi.org/10.1371/journal.pone.0081026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282563	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500065
J	Agunbiade, TA; Sun, WL; Coates, BS; Djouaka, R; Tamo, M; Ba, MN; Binso-Dabire, C; Baoua, I; Olds, BP; Pittendrigh, BR				Agunbiade, Tolulope A.; Sun, Weilin; Coates, Brad S.; Djouaka, Rousseau; Tamo, Manuele; Ba, Malick N.; Binso-Dabire, Clementine; Baoua, Ibrahim; Olds, Brett P.; Pittendrigh, Barry R.			Development of Reference Transcriptomes for the Major Field Insect Pests of Cowpea: A Toolbox for Insect Pest Management Approaches in West Africa	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DE-NOVO TRANSCRIPTOME; LEGUME POD-BORER; BUCHNERA-APHIDICOLA; SYMBIOTIC BACTERIA; MOLECULAR MARKERS; BLACKEYE COWPEA; CODING REGIONS; SNP DISCOVERY; MOSAIC-VIRUS	Cowpea is a widely cultivated and major nutritional source of protein for many people that live in West Africa. Annual yields and longevity of grain storage is greatly reduced by feeding damage caused by a complex of insect pests that include the pod sucking bugs, Anoplocnemis curvipes Fabricius (Hemiptera: Coreidae) and Clavigralla tomentosicollis Stal (Hemiptera: Coreidae); as well as phloem-feeding cowpea aphids, Aphis craccivora Koch (Hemiptera: Aphididae) and flower thrips, Megalurothrips sjostedti Trybom (Thysanoptera: Thripidae). Efforts to control these pests remain a challenge and there is a need to understand the structure and movement of these pest populations in order to facilitate the development of integrated pest management strategies (IPM). Molecular tools have the potential to help facilitate a better understanding of pest populations. Towards this goal, we used 454 pyrosequencing technology to generate 319,126, 176,262, 320,722 and 227,882 raw reads from A. curvipes, A. craccivora, C. tomentosicollis and M. sjostedti, respectively. The reads were de novo assembled into 11,687, 7,647, 10,652 and 7,348 transcripts for A. curvipes, A. craccivora, C. tomentosicollis and M. sjostedti, respectively. Functional annotation of the resulting transcripts identified genes putatively involved in insecticide resistance, pathogen defense and immunity. Additionally, sequences that matched the primary aphid endosymbiont, Buchnera aphidicola, were identified among A. craccivora transcripts. Furthermore, 742, 97, 607 and 180 single nucleotide polymorphisms (SNPs) were respectively predicted among A. curvipes, A. craccivora, C. tomentosicollis and M. sjostedti transcripts, and will likely be valuable tools for future molecular genetic marker development. These results demonstrate that Roche 454-based transcriptome sequencing could be useful for the development of genomic resources for cowpea pest insects in West Africa.	[Agunbiade, Tolulope A.; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Coates, Brad S.] ARS, Corn Insects & Crop Genet Res Unit, USDA, Ames, IA USA; [Djouaka, Rousseau; Tamo, Manuele] Int Inst Trop Agr, Cotonou, Benin; [Ba, Malick N.; Binso-Dabire, Clementine] Inst Environm & Rech Agr, Ouagadougou, Burkina Faso; [Baoua, Ibrahim] Inst Natl Rech Agron Niger, Maradi, Niger; [Olds, Brett P.] Univ Illinois, Dept Anim Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Agunbiade, TA (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	agunbia1@illinois.edu	Ba, Malick Niango/I-8557-2012	Ba, Malick Niango/0000-0001-7323-8739; Coates, Brad/0000-0001-8908-1529	Bureau for Economic Growth, Agriculture, and Trade, United States Agency for International Development [EDH-A-00-07-00005]; United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project) [3625-22000-017-00]; Howard Hughes Medical Institute International Student Research Fellowship	Bureau for Economic Growth, Agriculture, and Trade, United States Agency for International Development(United States Agency for International Development (USAID)); United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute)	This project has been made possible through support provided to the Dry Grains Pulses Collaborative Research Support Program (CRSP) by the Bureau for Economic Growth, Agriculture, and Trade, United States Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. A portion of research data analysis was supported by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS: CRIS Project 3625-22000-017-00). The opinions expressed are those of the authors and do not necessarily reflect the views of the United States Agency for International Development or the United States Government. TAA was supported by the Howard Hughes Medical Institute International Student Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2007, MYCOLOGIA, V99, P714, DOI 10.3852/mycologia.99.5.714; Adati T., 2007, International Journal of Tropical Insect Science, V27, P123, DOI 10.1017/S1742758407883172; Agunbiade T., 2012, IMPROVING LIVELIHOOD, P231; Agunbiade TA, 2012, B ENTOMOL RES, V102, P589, DOI 10.1017/S0007485312000156; Akey JM, 2003, MOL BIOL EVOL, V20, P232, DOI 10.1093/molbev/msg032; Altincicek B, 2007, INSECT BIOCHEM MOLEC, V37, P726, DOI 10.1016/j.ibmb.2007.03.012; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amevoin K, 2007, J STORED PROD RES, V43, P240, DOI 10.1016/j.jspr.2006.06.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATIRI GI, 1986, CROP PROT, V5, P406, DOI 10.1016/0261-2194(86)90073-6; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Banerjee S, 2004, J BIOL CHEM, V279, P23782, DOI 10.1074/jbc.M401405200; Bartels DW, 1997, J ECON ENTOMOL, V90, P449, DOI 10.1093/jee/90.2.449; Bashir M, 1996, PLANT PATHOL, V45, P54, DOI 10.1046/j.1365-3059.1996.d01-97.x; Bean Cowpea CRSP, 2001, DAK S WORKSH GEN IMP, P8; Bennett C W, 1969, Adv Virus Res, V14, P221, DOI 10.1016/S0065-3527(08)60561-8; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BOCK KR, 1974, COWPEA APHID BORNE M; BRADSHAW JWS, 1983, CROP PROT, V2, P63, DOI 10.1016/0261-2194(83)90026-1; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Brunt A, 1990, VIRUSES TROPICAL PLA, P97; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Champ BR, 1976, 5 FAOUN FAO PLANT PR; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Cheng TC, 2004, INSECT BIOCHEM MOLEC, V34, P523, DOI 10.1016/j.ibmb.2004.02.004; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; Coates Brad Steven, 2011, Frontiers in Genetics, V2, P38, DOI 10.3389/fgene.2011.00038; Cork A, 2009, REV PRE POSTHARVEST; DIJKSTRA J, 1987, NETH J PLANT PATHOL, V93, P115, DOI 10.1007/BF02000562; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Downham MCA, 2004, ENTOMOL EXP APPL, V110, P151, DOI 10.1111/j.0013-8703.2004.00128.x; Dugje I.Y., 2009, FARMERS GUIDE COWPEA; Ekesi S, 1999, INT J PEST MANAGE, V45, P57, DOI 10.1080/096708799228058; Friesen LR, 2012, J PARASITOL, V98, P509, DOI 10.1645/GE-2973.1; Georghiou G, 1991, OCCURRENCE RESISTANC; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; GILLASPIE AG, 1993, PLANT DIS, V77, P875, DOI 10.1094/PD-77-0875; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hayes B, 2007, AQUACULTURE, V265, P82, DOI 10.1016/j.aquaculture.2007.01.037; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huse SM, 2007, J MED ENTOMOL, V42, P36; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; JACKAI LEN, 1986, ANNU REV ENTOMOL, V31, P95, DOI 10.1146/annurev.en.31.010186.000523; Jalving R, 2004, POULTRY SCI, V83, P1925, DOI 10.1093/ps/83.12.1925; Kamara A. Y., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P179; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; LAI CY, 1994, P NATL ACAD SCI USA, V91, P3819, DOI 10.1073/pnas.91.9.3819; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; LEWIS T, 1976, ECOL ENTOMOL, V1, P175, DOI 10.1111/j.1365-2311.1976.tb01221.x; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mokbel ES, 2009, EGYPTIAN J BIOL SCI, V1, P65; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566, DOI 10.1099/00207713-41-4-566; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oparaeke, 2006, Journal of Plant Sciences, V1, P132; Oparaeke Alphonsus Mbonu, 2007, Plant Protection Science, V43, P103; Orsini L, 2008, MOL ECOL, V17, P2629, DOI 10.1111/j.1365-294X.2008.03782.x; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sandstrom J, 1999, ENTOMOL EXP APPL, V91, P203, DOI 10.1023/A:1003605508487; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Sharma Anupam, 2012, Journal of Entomology, V9, P319, DOI 10.3923/je.2012.319.331; Shaw DR, 1999, AM J HUM GENET, V65, pA419; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Singh S. R., 1980, Advances in legume science, P419; SINGH SR, 1979, ANNU REV ENTOMOL, V24, P255, DOI 10.1146/annurev.en.24.010179.001351; Sloan DB, 2012, MOL ECOL RESOUR, V12, P333, DOI 10.1111/j.1755-0998.2011.03079.x; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tamo M., 2012, IMPROVING LIVELIHOOD, P249; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Thottappilly G, 1985, VIRUS DIS IMPORTANT, P35; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; WILKINSON TL, 1995, J INSECT PHYSIOL, V41, P921, DOI 10.1016/0022-1910(95)00063-Z; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamamoto K, 2006, J APPL ENTOMOL, V130, P515, DOI 10.1111/j.1439-0418.2006.01092.x; Yu ZD, 2009, J FOOD AGRIC ENVIRON, V7, P791; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	101	14	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e79929	10.1371/journal.pone.0079929	http://dx.doi.org/10.1371/journal.pone.0079929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278221	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700023
J	Khalife, N; Glover, V; Taanila, A; Ebeling, H; Jarvelin, MR; Rodriguez, A				Khalife, Natasha; Glover, Vivette; Taanila, Anja; Ebeling, Hanna; Jarvelin, Marjo-Riitta; Rodriguez, Alina			Prenatal Glucocorticoid Treatment and Later Mental Health in Children and Adolescents	PLOS ONE			English	Article							HYPERACTIVITY SYMPTOMS; ALCOHOL EXPOSURE; ADHD SYMPTOMS; BIRTH-WEIGHT; HPA AXIS; STRESS; PREGNANCY; DEXAMETHASONE; INATTENTION; BEHAVIOR	Background: Animal studies demonstrate a clear link between prenatal exposure to glucocorticoids (GC) and altered offspring brain development. We aim to examine whether prenatal GC exposure programs long-term mental health in humans. Methods: Using propensity-score-matching, children prenatally exposed to synthetic glucocorticoids (sGC), n=37, and controls, n=185, were balanced on important confounders related to sGC treatment - gestational age and pre-pregnancy BMI. We also used mixed-effects modeling to analyse the entire cohort - matching each sGC case, n=37, to all possible controls, n=6079, on gestational age and sex. We obtained data from the Northern Finland Birth Cohort 1986 at four waves - pregnancy, birth, 8 and 16 years. Data on pregnancy and birth outcomes came from medical records. Mental health was assessed at 8 years by teachers with the Rutter B2 scale, and at 16 years by parents with the Strengths and Weaknesses of ADHD symptoms and Normal behavior (SWAN) scale and adolescents by the Youth Self-Report (YSR) scale. Results: Prenatal sGC treatment was consistently associated with adverse mental health in childhood and adolescence, as shown by both the propensity-score method and mixed-effects model. Using the propensity-score-matched subsample, linear multiple regression showed prenatal sGC was significantly linked with general psychiatric disturbance (B=8.34 [95% CI: .23-16.45]) and inattention (B=.97 [95% CI:. 16-1.80]) at 8 years after control for relevant confounders. Similar findings were obtained at 16 years, but did not reach statistical significance. Mediation by birthweight/placental weight was not detected. Conclusions: This study is the first to prospectively investigate the long-term associations between prenatal exposure to sGC treatment and mental health in children and adolescents. We report an association between prenatal exposure to sGC and child mental health, supportive of the idea that sGC has a programming effect on the fetal brain.	[Khalife, Natasha; Jarvelin, Marjo-Riitta; Rodriguez, Alina] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Glover, Vivette] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Taanila, Anja; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Taanila, Anja] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland; [Ebeling, Hanna] Univ Oulu, Clin Child Psychiat, Inst Clin Med, Oulu, Finland; [Ebeling, Hanna] Oulu Univ Hosp, Clin Child Psychiat, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC, Hlth Protect Agcy, Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Rodriguez, Alina] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Imperial College London; Imperial College London; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Health Protection Agency; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; Mid-Sweden University	Rodriguez, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	a.rodriguez@imperial.ac.uk	Glover, Vivette/M-2711-2016; Rodriguez, Alina/B-3541-2015	Glover, Vivette/0000-0001-6543-1651; Rodriguez, Alina/0000-0003-1209-8802; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland [103451]; Sigrid Juselius Foundation, Finland; Thule Institute, University of Oulu, Finland; National Institute of Mental Health [MH63706]; EURO-BLCS; Swedish Council for Working Life and Social Research (FAS)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Thule Institute, University of Oulu, Finland; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EURO-BLCS; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Funding was received from the following: Academy of Finland (103451); Sigrid Juselius Foundation, Finland; Thule Institute, University of Oulu, Finland; the National Institute of Mental Health (MH63706); and EURO-BLCS. Prof Rodriguez received funding partly from the Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Alexander N, 2012, J CLIN ENDOCR METAB, V97, P3538, DOI 10.1210/jc.2012-1970; Andrews M. H., 2003, FETAL MATERN MED REV, V14, P329, DOI DOI 10.1017/S0965539503001141; [Anonymous], 2011, Obstet Gynecol, V117, P422, DOI 10.1097/AOG.0b013e31820eee00; Antonow-Schlorke I, 2003, J PHYSIOL-LONDON, V547, P117, DOI 10.1113/jphysiol.2002.025700; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; BLANFORD AT, 1977, AM J OBSTET GYNECOL, V127, P264, DOI 10.1016/0002-9378(77)90466-5; Bollen K.A., 1990, SOCIOL METHODOL, V20, P115, DOI [DOI 10.2307/271084, 10.2307/271084]; Crowther CA, 2007, NEW ENGL J MED, V357, P1179, DOI 10.1056/NEJMoa071152; Dalziel SR, 2005, BMJ-BRIT MED J, V331, P665, DOI 10.1136/bmj.38576.494363.E0; Davis EP, 2013, BRAIN DEV BIOL PSYCH, DOI [10.1016/j.biopsych.2013.03.009, DOI 10.1016/J.BIOPSYCH.2013.03.009]; Diaz R, 1998, J NEUROSCI, V18, P2570; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Godfrey K M, 2001, Public Health Nutr, V4, P611; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hirvikoski T, 2008, EUR J ENDOCRINOL, V159, P309, DOI 10.1530/EJE-08-0280; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; International Agency for Research of Cancer, 1999, CANC EPIDEMIOLOGY PR; Kapoor A, 2008, BRAIN RES REV, V57, P586, DOI 10.1016/j.brainresrev.2007.06.013; Khalife N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040534; Khan AA, 2011, PAEDIATR PERINAT EP, V25, P20, DOI 10.1111/j.1365-3016.2010.01147.x; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Lombardo MV, 2012, BIOL PSYCHIAT, V72, P839, DOI 10.1016/j.biopsych.2012.05.027; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MELBY JC, 1977, ANNU REV PHARMACOL, V17, P511, DOI 10.1146/annurev.pa.17.040177.002455; MEYER JS, 1983, EXP NEUROL, V82, P432, DOI 10.1016/0014-4886(83)90415-6; Ming KW, 2000, BIOMETRICS, V56, P118, DOI 10.1111/j.0006-341X.2000.00118.x; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Noorlandler CW, 2008, DEV NEUROBIOL, V68, P237, DOI 10.1002/dneu.20583; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Obel C, 2009, INT J EPIDEMIOL, V38, P698, DOI 10.1093/ije/dym290; Owen D, 2007, J PHYSIOL-LONDON, V578, P249, DOI 10.1113/jphysiol.2006.122887; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Potijk MR, 2012, ARCH DIS CHILD, V97, P112, DOI 10.1136/adc.2011.300131; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Riordan DV, 2012, SOC PSYCH PSYCH EPID, V47, P975, DOI 10.1007/s00127-011-0405-5; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rodriguez A, 2009, J CHILD PSYCHOL PSYC, V50, P1073, DOI 10.1111/j.1469-7610.2009.02071.x; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Rodriguez A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-327; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Sawady J, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.041; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Swanson J, 2005, CATEGORICAL DIMENSIO; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tegethoff M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014478; Thorp JA, 2003, OBSTET GYNECOL, V101, P363, DOI 10.1016/S0029-7844(02)02509-7; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; TRAUTMAN PD, 1995, PSYCHONEUROENDOCRINO, V20, P439, DOI 10.1016/0306-4530(94)00070-0; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	67	49	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81394	10.1371/journal.pone.0081394	http://dx.doi.org/10.1371/journal.pone.0081394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278432	gold, Green Accepted, Green Published			2022-12-27	WOS:000327541700063
J	Lin, YJ; Chang, JS; Liu, X; Hung, CH; Lin, TH; Huang, SM; Jeang, KT; Chen, CY; Liao, CC; Lin, CW; Lai, CH; Tien, N; Lan, YC; Ho, MW; Chien, WK; Chen, JH; Huang, YC; Tsang, H; Wu, JY; Chen, CH; Chang, LC; Tsai, FJ				Lin, Ying-Ju; Chang, Jeng-Sheng; Liu, Xiang; Hung, Chien-Hui; Lin, Ting-Hsu; Huang, Shao-Mei; Jeang, Kuan-Teh; Chen, Chia-Yen; Liao, Chiu-Chu; Lin, Cheng-Wen; Lai, Chih-Ho; Tien, Ni; Lan, Yu-Ching; Ho, Mao-Wang; Chien, Wen-Kuei; Chen, Jin-Hua; Huang, Yu-Chuen; Tsang, Hsinyi; Wu, Jer-Yuarn; Chen, Chien-Hsiun; Chang, Li-Ching; Tsai, Fuu-Jen			Association between GRIN3A Gene Polymorphism in Kawasaki Disease and Coronary Artery Aneurysms in Taiwanese Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; SUSCEPTIBILITY; ACTIVATION; RECEPTOR; RISK; RNA; ABNORMALITIES; INTERLEUKIN-1	Kawasaki disease (KD) is pediatric systemic vasculitis with the classic complication of coronary artery aneurysm (CAA). It is the leading cause of acquired cardiovascular diseases in children. Some severe cases present with multi-organ involvement or neurological dysfunction. To identify the role of the glutamate receptor, ionotropic, N-methyl-D-aspartate 3A (GRIN3A) in KD, we investigated genetic variations in GRIN3A in a Taiwanese cohort of 262 KD patients (76 with and 186 without CAA complications). We used univariate and multivariate regression analyses to identify the associations between clinical characteristics and GRIN3A genetic variations in KD. According to univariate regression analysis, CAA formation in KD was significantly associated with fever duration (p < 0.0001), first Intravenous immunoglobulin (IVIG) used (days after day one of fever) (p < 0.0001), and the GRIN3A (rs7849782) genetic variant (p < 0.001). KD patients with GG+GC genotype showed a lower rate of developing CAA (GG+GC genotype: odds ratio = 0.26; 95% CI = 0.14-0.46). Significant associations were identified between KD with CAA complication and the GRIN3A (rs7849782) genetic variant by using multivariate regression analysis. Specifically, significant correlations were observed between KD with CAA complications and the presence of GG+GC genotypes for the GRIN3A rs7849782 single-nucleotide polymorphism (full model: odds ratio = 0.25; 95% CI = 0.14-0.46). Our results suggest that a polymorphism of the GRIN3A gene may play a role in KD pathogenesis.	[Lin, Ying-Ju; Lin, Ting-Hsu; Huang, Shao-Mei; Liao, Chiu-Chu; Huang, Yu-Chuen; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Ying-Ju; Huang, Yu-Chuen; Wu, Jer-Yuarn; Chen, Chien-Hsiun; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Chang, Jeng-Sheng] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Liu, Xiang; Jeang, Kuan-Teh] NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Hung, Chien-Hui] Chang Gung Univ, Grad Inst Clin Med Sci, Chiayi, Taiwan; [Chen, Chia-Yen] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Lin, Cheng-Wen; Tien, Ni] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Lai, Chih-Ho] China Med Univ, Sch Med, Dept Microbiol, Taichung, Taiwan; [Lan, Yu-Ching] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Ho, Mao-Wang] China Med Univ Hosp, Infect Dis Sect, Dept Internal Med, Taichung, Taiwan; [Chien, Wen-Kuei; Chen, Jin-Hua] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Chien, Wen-Kuei; Chen, Jin-Hua] Taipei Med Univ, Ctr Biostat, Taichung, Taiwan; [Tsang, Hsinyi] NIAID, Immunogenet Mol Lab, NIH, Bethesda, MD 20892 USA; [Wu, Jer-Yuarn; Chen, Chien-Hsiun; Chang, Li-Ching] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Tsai, Fuu-Jen] Asia Univ, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Academia Sinica - Taiwan; Asia University Taiwan	Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	d0704@mail.cmuh.org.tw	Tsai, Fuu-Jen/J-4140-2015; Liu, Xiang/F-5731-2014; Lan, Yu-Ching/F-2449-2017; Chen, Chien Hsiun/Q-3826-2018; Lai, Chih-Ho/M-2433-2013; Wu, Jer-Yuarn/S-7010-2018	Lan, Yu-Ching/0000-0003-4781-6405; Lai, Chih-Ho/0000-0001-9229-818X; 	CMU [CMU100-S-01]; CMUH [DMR-102-034]; Republic of China National Science Council [NSC100-2320-B-039-012-MY3, NSC101-2314-B-039-008-MY3]	CMU; CMUH; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	Support for this research was provided by CMU (CMU100-S-01), CMUH (DMR-102-034), and the Republic of China National Science Council (NSC100-2320-B-039-012-MY3; NSC101-2314-B-039-008-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 2002, PEDIATR INFECT DIS J, V21, P993, DOI 10.1097/00006454-200211000-00002; Callinan LS, 2012, PEDIATR INFECT DIS J, V31, P894, DOI 10.1097/INF.0b013e31825c4d7c; Chang LY, 2004, PEDIATRICS, V114, pE678, DOI 10.1542/peds.2004-0726; Cheung YF, 2004, HEART, V90, P1281, DOI 10.1136/hrt.2003.018507; Falcini F, 2006, CURR OPIN RHEUMATOL, V18, P33, DOI 10.1097/01.bor.0000197998.50450.f6; Fernandez-Pisonero I, 2012, J IMMUNOL, V189, P5402, DOI 10.4049/jimmunol.1201309; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gitiaux C, 2012, DEV MED CHILD NEUROL, V54, P1160, DOI 10.1111/dmcn.12002; Hsieh YY, 2011, GENET TEST MOL BIOMA, V15, P755, DOI 10.1089/gtmb.2011.0001; Hsieh YY, 2010, J CLIN LAB ANAL, V24, P262, DOI 10.1002/jcla.20409; Huang YC, 2010, INT J IMMUNOGENET, V37, P439, DOI 10.1111/j.1744-313X.2010.00943.x; Iannetti L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/698327; Jin HS, 2007, PEDIATR RES, V61, P584, DOI 10.1203/pdr.0b013e3180459fb5; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kawasaki Tomisaku, 2001, Acta Paediatrica Taiwanica, V42, P8; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kim JJ, 2008, HUM IMMUNOL, V69, P867, DOI 10.1016/j.humimm.2008.10.002; Kim S, 2005, CURR OPIN PEDIATR, V17, P695, DOI 10.1097/01.mop.0000187190.97166.83; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Krizbai IA, 1998, J NEUROSCI RES, V54, P814; Kuo HC, 2012, SCI WORLD J, DOI 10.1100/2012/520865; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; LAPOINTE JS, 1984, PEDIATR RADIOL, V14, P1, DOI 10.1007/BF02386720; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; LEUNG DYM, 1989, LANCET, V2, P1298; LEUNG DYM, 1986, J EXP MED, V164, P1958, DOI 10.1084/jem.164.6.1958; LIN CY, 1992, J PEDIATR-US, V121, P924, DOI 10.1016/S0022-3476(05)80343-9; Lin WY, 2013, BIOMEDICINE-TAIWAN, V3, P73, DOI 10.1016/j.biomed.2013.03.001; Lin YJ, 2009, ARTHRITIS RHEUM-US, V60, P604, DOI 10.1002/art.24261; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Mitani Y, 2005, CIRCULATION, V111, P38, DOI 10.1161/01.CIR.0000151311.38708.29; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Sharp CD, 2005, AM J PHYSIOL-HEART C, V288, pH1893, DOI 10.1152/ajpheart.01110.2003; Sharp CD, 2003, AM J PHYSIOL-HEART C, V285, pH2592, DOI 10.1152/ajpheart.00520.2003; Sherry ST, 2000, HUM MUTAT, V15, P68, DOI 10.1002/(SICI)1098-1004(200001)15:1<68::AID-HUMU14>3.0.CO;2-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Takanashi J, 2012, J NEUROL SCI, V315, P167, DOI 10.1016/j.jns.2011.11.022; Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597; Tindall Elizabeth A, 2010, BMC Res Notes, V3, P39, DOI 10.1186/1756-0500-3-39; Tsai FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016853; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; von Ahsen N, 2004, BLOOD, V103, P586, DOI 10.1182/blood-2003-02-0419; Wu SF, 2005, J CLIN LAB ANAL, V19, P99, DOI 10.1002/jcla.20059; Wu SF, 2004, PEDIATR CARDIOL, V25, P529, DOI 10.1007/s00246-003-0662-5; Yoshio T, 2013, ARTHRITIS RHEUM-US, V65, P457, DOI 10.1002/art.37745	56	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81384	10.1371/journal.pone.0081384	http://dx.doi.org/10.1371/journal.pone.0081384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278430	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700061
J	Wei, L; Xue, T; Yang, H; Zhao, GY; Zhang, G; Lu, ZH; Huang, YH; Ma, XD; Liu, HX; Liang, SR; Yang, F; Chen, BL				Wei, Li; Xue, Tao; Yang, Hong; Zhao, Guang-Yue; Zhang, Geng; Lu, Zhi-Hong; Huang, Yan-Hong; Ma, Xiang-Dong; Liu, Hai-Xia; Liang, Sheng-Ru; Yang, Fang; Chen, Bi-Liang			Modified Uterine Allotransplantation and Immunosuppression Procedure in the Sheep Model	PLOS ONE			English	Article							END-TO-SIDE; EARLY REPERFUSION EVENTS; UTERUS TRANSPLANTATION; DIFFERENT COMBINATIONS; MYCOPHENOLATE-MOFETIL; SURGICAL TECHNIQUE; RAT MODEL; PREGNANCY; AUTOTRANSPLANTATION; ANASTOMOSIS	Objective: To develop an orthotopic, allogeneic, uterine transplantation technique and an effective immunosuppressive protocol in the sheep model. Methods: In this pilot study, 10 sexually mature ewes were subjected to laparotomy and total abdominal hysterectomy with oophorectomy to procure uterus allografts. The cold ischemic time was 60 min. End-to-end vascular anastomosis was performed using continuous, non-interlocking sutures. Complete tissue reperfusion was achieved in all animals within 30 s after the vascular re-anastomosis, without any evidence of arterial or venous thrombosis. The immunosuppressive protocol consisted of tacrolimus, mycophenolate mofetil and methylprednisolone tablets. Graft viability was assessed by transrectal ultrasonography and second-look laparotomy at 2 and 4 weeks, respectively. Results: Viable uterine tissue and vascular patency were observed on transrectal ultrasonography and second-look laparotomy. Histological analysis of the graft tissue (performed in one ewe) revealed normal tissue architecture with a very subtle inflammatory reaction but no edema or stasis. Conclusion: We have developed a modified procedure that allowed us to successfully perform orthotopic, allogeneic, uterine transplantation in sheep, whose uterine and vascular anatomy (apart from the bicornuate uterus) is similar to the human anatomy, making the ovine model excellent for human uterine transplant research.	[Wei, Li; Yang, Hong; Huang, Yan-Hong; Ma, Xiang-Dong; Liu, Hai-Xia; Liang, Sheng-Ru; Yang, Fang; Chen, Bi-Liang] Fourth Mil Med Univ, Dept Obstet & Gynecol, Xijing Hosp, Xian 710032, Peoples R China; [Xue, Tao] Fourth Mil Med Univ, Xijing Hosp, Dept Otorhinolaryngol, Xian 710032, Peoples R China; [Zhao, Guang-Yue] Fourth Mil Med Univ, Xijing Hosp, Dept Osteol, Xian 710032, Peoples R China; [Zhang, Geng] Fourth Mil Med Univ, Xijing Hosp, Dept Urinary Surg, Xian 710032, Peoples R China; [Lu, Zhi-Hong] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wei, L (corresponding author), Fourth Mil Med Univ, Dept Obstet & Gynecol, Xijing Hosp, Xian 710032, Peoples R China.	wei_li@fmmu.edu.cn; cblxjh@fmmu.edu.cn	huang, yan/GWM-4747-2022		National Natural Science Foundation of China [81001161, 81271070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81001161 and 81271070). The funder of Nos. 81001161 had role in study design, data collection, decision to publish, and preparation of the manuscript. The funder of Nos. 81271070 had role in data analysis, decision to publish, and preparation of the manuscript.	Adams WP, 2000, PLAST RECONSTR SURG, V105, P156, DOI 10.1097/00006534-200001000-00026; Avison DL, 2009, TRANSPLANTATION, V88, P465, DOI 10.1097/TP.0b013e3181b07666; Bigolin S, 2009, J OBSTET GYNAECOL RE, V35, P1012, DOI 10.1111/j.1447-0756.2009.01075.x; Brannstrom M, 2003, EUR J OBSTET GYN R B, V109, P121, DOI 10.1016/S0301-2115(03)00050-2; Brannstrom M, 2008, ACTA OBSTET GYN SCAN, V87, P1097, DOI 10.1080/00016340802495509; Brannstrom M, 2012, FERTIL STERIL, V97, P1269, DOI 10.1016/j.fertnstert.2012.04.001; Buiret G, 2007, TRANSPLANTATION, V84, P1584, DOI 10.1097/01.tp.0000295716.21536.76; Ciancio G, 2005, TRANSPLANTATION, V80, pS191, DOI 10.1097/01.tp.0000187035.22298.ba; COHEN B M, 1980, Clinical Obstetrics and Gynecology, V23, P1275, DOI 10.1097/00003081-198012000-00033; Dahm-Kahler P, 2008, J OBSTET GYNAECOL RE, V34, P784, DOI 10.1111/j.1447-0756.2008.00854.x; Del Priore G, 2011, SEMIN REPROD MED, V29, P55, DOI 10.1055/s-0030-1268704; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Diaz-Garcia C, 2010, ACTA OBSTET GYN SCAN, V89, P1491, DOI 10.3109/00016349.2010.520688; Dubernard J M, 2000, Transpl Int, V13 Suppl 1, pS521, DOI 10.1007/s001470000288; El-Akouri RR, 2003, HUM REPROD, V18, P2018, DOI 10.1093/humrep/deg396; El-Akouri RR, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740157; Enskog A, 2010, HUM REPROD, V25, P1980, DOI 10.1093/humrep/deq109; Fageeh W, 2002, INT J GYNECOL OBSTET, V76, P245, DOI 10.1016/S0020-7292(01)00597-5; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; Gauthier T, 2011, HUM REPROD, V26, P3028, DOI 10.1093/humrep/der288; Grazyna P, 2002, BIOL REPROD, V67, P1719, DOI [10.1095/biolreprod.102.006171, DOI 10.1095/BI0LREPR0D.102.006171.PUBMED:12444045]; Grynberg M, 2011, ANN NY ACAD SCI, V1221, P47, DOI 10.1111/j.1749-6632.2011.05952.x; Guntinas-Lichius O, 2008, NEW ENGL J MED, V358, P2179, DOI 10.1056/NEJMc080003; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Kallen B, 2005, BJOG-INT J OBSTET GY, V112, P904, DOI 10.1111/j.1471-0528.2005.00607.x; Kisu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035124; Kuo PC, 1996, CLIN TRANSPLANT, V10, P282; Lehr EJ, 2006, J THORAC CARDIOV SUR, V132, P1156, DOI 10.1016/j.jtcvs.2006.06.026; McKay DB, 2006, NEW ENGL J MED, V354, P1281, DOI 10.1056/NEJMra050431; Mihara M, 2011, HUM REPROD, V26, P3019, DOI 10.1093/humrep/der276; Miyamoto S, 2008, PLAST RECONSTR SURG, V122, P449, DOI 10.1097/PRS.0b013e31817d62c5; Miyamoto S, 2009, J TRAUMA, V66, P831, DOI 10.1097/TA.0b013e318160e201; Monaco AP, 2001, NEW ENGL J MED, V344, P1712, DOI 10.1056/NEJM200105313442211; OLEARY JA, 1969, FERTIL STERIL, V20, P757; Ozkan F, 2010, BOSNIAN J BASIC MED, V10, P297, DOI 10.17305/bjbms.2010.2675; Ramirez ER, 2008, J MINIM INVAS GYN, V15, P311, DOI 10.1016/j.jmig.2008.01.014; Ramirez ER, 2011, J MINIM INVAS GYN, V18, P238, DOI 10.1016/j.jmig.2010.11.006; Schneeberger S, 2007, AM J TRANSPLANT, V7, P1753, DOI 10.1111/j.1600-6143.2007.01837.x; SCOTT JR, 1970, GYNECOL OBSTET INVES, V1, P140, DOI 10.1159/000301940; SCOTT JR, 1971, SURG GYNECOL OBSTETR, V133, P414; Sieunarine K, 2005, INT SURG, V90, P249; Sieunarine K, 2005, INT J GYNECOL CANCER, V15, P967, DOI 10.1111/j.1525-1438.2005.00161.x; STEPTOE PC, 1978, LANCET, V2, P366; Vento M, 2008, PEDIATRICS, V122, P184, DOI 10.1542/peds.2008-0348; Wranning CA, 2008, FERTIL STERIL, V90, P817, DOI 10.1016/j.fertnstert.2007.07.1340; Wranning CA, 2011, HUM REPROD, V26, P553, DOI 10.1093/humrep/deq358; Wranning CA, 2006, J OBSTET GYNAECOL RE, V32, P358, DOI 10.1111/j.1447-0756.2006.00426.x; Yabuki Y, 2000, GYNECOL ONCOL, V77, P155, DOI 10.1006/gyno.1999.5723; ZHORDANIA I F, 1964, Acta Chir Plast, V6, P23	49	25	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81300	10.1371/journal.pone.0081300	http://dx.doi.org/10.1371/journal.pone.0081300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278415	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700057
J	Akweongo, P; Dalaba, MA; Hayden, MH; Awine, T; Nyaaba, GN; Anaseba, D; Hodgson, A; Forgor, AA; Pandya, R				Akweongo, Patricia; Dalaba, Maxwell A.; Hayden, Mary H.; Awine, Timothy; Nyaaba, Gertrude N.; Anaseba, Dominic; Hodgson, Abraham; Forgor, Abdulai A.; Pandya, Rajul			The Economic Burden of Meningitis to Households in Kassena-Nankana District of Northern Ghana	PLOS ONE			English	Article							HEALTH; COSTS; EPIDEMIC; MALARIA	Objective: To estimate the direct and indirect costs of meningitis to households in the Kassena-Nankana District of Ghana. Methods: A Cost of illness (COI) survey was conducted between 2010 and 2011. The COI was computed from a retrospective review of 80 meningitis cases answers to questions about direct medical costs, direct non-medical costs incurred and productivity losses due to recent meningitis incident. Results: The average direct and indirect costs of treating meningitis in the district was GH phi 152.55 (US$101.7) per household. This is equivalent to about two months minimum wage earned by Ghanaians in unskilled paid jobs in 2009. Households lost 29 days of work per meningitis case and thus those in minimum wage paid jobs lost a monthly minimum wage of GH phi 76.85 (US$51.23) due to the illness. Patients who were insured spent an average of GH phi 38.5 (US$25.67) in direct medical costs whiles the uninsured patients spent as much as GH phi 177.9 (US$118.6) per case. Patients with sequelae incurred additional costs of GH phi 22.63 (US$15.08) per case. The least poor were more exposed to meningitis than the poorest. Conclusion: Meningitis is a debilitating but preventable disease that affects people living in the Sahel and in poorer conditions. The cost of meningitis treatment may further lead to impoverishment for these households. Widespread mass vaccination will save households' an equivalent of GH phi 175.18 (US$117) and impairment due to meningitis.	[Akweongo, Patricia] Univ Ghana, Sch Publ Hlth, Accra, Ghana; [Dalaba, Maxwell A.; Awine, Timothy; Nyaaba, Gertrude N.; Anaseba, Dominic] Navrongo Hlth Res Ctr, Ghana Hlth Serv, Navrongo, Ghana; [Hayden, Mary H.; Pandya, Rajul] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Hodgson, Abraham] Div Res & Dev, Ghana Hlth Serv, Accra, Ghana; [Forgor, Abdulai A.] War Mem Hosp, Ghana Hlth Serv, Navrongo, Ghana	University of Ghana; Ghana Health Service; Navrongo Health Research Center; National Center Atmospheric Research (NCAR) - USA; Ghana Health Service; Ghana Health Service	Akweongo, P (corresponding author), Univ Ghana, Sch Publ Hlth, Accra, Ghana.	akweongo@gmail.com	Nyaaba, Gertrude Nsorma/M-2003-2019; Nyaaba, Gertrude Nsorma/HCH-1283-2022	Nyaaba, Gertrude Nsorma/0000-0002-1113-3832; Awine, Timothy/0000-0002-7340-6111; AKWEONGO, PATRICIA/0000-0001-6728-3365; Dalaba, Maxwell/0000-0002-7101-769X	Google.org	Google.org	The study was funded by Google.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazili J, 2008, AFRICAN J HLTH SCI, V14; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-149; Colombini A, 2009, CLIN INFECT DIS, V49, P1520, DOI 10.1086/644623; CRUICKSHANK S, 2012, STRATEGIES ERADICATI; Dang DA, 2010, J HEALTH POPUL NUTR, V28, P436; Deressa W, 2007, TROP MED INT HEALTH, V12, P1148, DOI 10.1111/j.1365-3156.2007.01901.x; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Filipovic I, 2011, RHEUMATOLOGY; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Flessa S., 2009, COSTING HLTH CARE SE; GHS, 2011, GHAN HLTH SERV 2011; GHS, 2009, HLTH SECT GHAN FACTS; GHS, 2010, ANN HLTH SECT PERF R; Hayden MH, 2013, AM J TROP MED HYG; Hodgson A, 2001, INT J EPIDEMIOL, V30, P1440, DOI 10.1093/ije/30.6.1440; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Hyder AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-309; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Joubert G, 2007, EPIDEMIOLOGY RES MAN; KNDMHIS, 2012, KASSENA NANKANA DIST; KNE-DHMT, 2012, DIS SURV CONTR; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; NDPC, 2012, ACH MDGS EQ GHAN UNM; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Su T, 2006, CATASTROPHIC HOUSEHO, V2006, P618; Sulzbach S., 2005, EVALUATING EFFECTS N; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P1754, DOI 10.1136/ard.2004.033977; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Whitfield L, 2009, NEW POVERTY AGENDA G; WHO, 2012, WHO MEN DIS SIT AFR; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79880	10.1371/journal.pone.0079880	http://dx.doi.org/10.1371/journal.pone.0079880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278203	Green Published, gold, Green Accepted			2022-12-27	WOS:000327539800028
J	Feller, T; Thom, P; Koch, N; Spiegel, H; Addai-Mensah, O; Fischer, R; Reimann, A; Pradel, G; Fendel, R; Schillberg, S; Scheuermayer, M; Schinkel, H				Feller, Tatjana; Thom, Pascal; Koch, Natalie; Spiegel, Holger; Addai-Mensah, Otchere; Fischer, Rainer; Reimann, Andreas; Pradel, Gabriele; Fendel, Rolf; Schillberg, Stefan; Scheuermayer, Matthias; Schinkel, Helga			Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate	PLOS ONE			English	Article							MALARIA VACCINE; BALANCING SELECTION; N-GLYCANS; FALCIPARUM; EXPRESSION; ANTIBODIES; IDENTIFICATION; TRANSMISSION; TOBACCO; ANTIGEN	Pf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responses to Pf38 in this African subset were comparable to reactivities to AMA-1 and MSP119. Pf38 and RFP-Pf38 were successfully used to immunise mice, although titres from these mice were low (on average 1:11.000 and 1:39.000, respectively). In immune fluorescence assays, the purified IgG fraction from the sera of immunised mice recognised Pf38 on the surface of schizonts, gametocytes, macrogametes and zygotes, but not sporozoites. Growth inhibition assays using aPf38 antibodies demonstrated strong inhibition (>= 60%) of the growth of blood-stage P. falciparum. The development of zygotes was also effectively inhibited by aPf38 antibodies, as determined by the zygote development assay. Collectively, these results suggest that Pf38 is an interesting candidate for the development of a malaria vaccine.	[Feller, Tatjana; Thom, Pascal; Koch, Natalie; Spiegel, Holger; Fischer, Rainer; Reimann, Andreas; Fendel, Rolf; Schillberg, Stefan; Schinkel, Helga] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany; [Addai-Mensah, Otchere; Fischer, Rainer; Pradel, Gabriele; Fendel, Rolf] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Scheuermayer, Matthias] Univ Wurzburg, Res Ctr Infect Dis, Wurzburg, Germany	Fraunhofer Gesellschaft; RWTH Aachen University; University of Wurzburg	Schinkel, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	helga.schinkel@ime.fraunhofer.de	Schillberg, Stefan/K-4211-2019; Schillberg, Stefan/I-5449-2013; Fendel, Rolf/K-3985-2013; Addai-Mensah, Otchere/AAI-6182-2021	Schillberg, Stefan/0000-0002-1896-4575; Fendel, Rolf/0000-0003-4716-0311; 	Fraunhofer Future Foundation ("Innovative technologies to manufacture ground-breaking biopharmaceutical products in microbes and plants"); Emmy Noether programme of the Deutsche Forschungsgemeinschaft; MALSIG consortium of the EU 7th framework programme	Fraunhofer Future Foundation ("Innovative technologies to manufacture ground-breaking biopharmaceutical products in microbes and plants"); Emmy Noether programme of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MALSIG consortium of the EU 7th framework programme	This study was supported by the Fraunhofer Future Foundation ("Innovative technologies to manufacture ground-breaking biopharmaceutical products in microbes and plants"). Part of the study was funded by a grant of the Emmy Noether programme of the Deutsche Forschungsgemeinschaft and by the MALSIG consortium of the EU 7th framework programme (to GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2011, IEDB ANAL RESOURCE; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Belard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022525; BISHOP A, 1946, PARASITOLOGY, V37, P85, DOI 10.1017/S0031182000013202; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Chilengi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S1; Clemente M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/206918; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Genton B, 2008, EXPERT REV VACCINES, V7, P597, DOI 10.1586/14760584.7.5.597; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Greenwood B, 2009, PARASITE IMMUNOL, V31, P582, DOI 10.1111/j.1365-3024.2009.01140.x; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Joosse S. A., 2011, FISHERS EXACT TEST; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Kirchhoff J, 2012, PLANT BIOTECHNOL J, V10, P936, DOI 10.1111/j.1467-7652.2012.00722.x; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mordmuller B, 2010, VACCINE, V28, P6698, DOI 10.1016/j.vaccine.2010.07.085; MULLIGAN H. W., 1941, JOUR MALARIA INST INDIA, V4, P25; Persson KEM, 2010, ACTA TROP, V114, P138, DOI 10.1016/j.actatropica.2009.05.017; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; R Core Team, 2012, R LANG ENV STAT COMP; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reeder JC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-126; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Schiermeyer A, 2005, BIOTECHNOL BIOENG, V89, P848, DOI 10.1002/bit.20410; Schillberg S, 2005, VACCINE, V23, P1764, DOI 10.1016/j.vaccine.2004.11.002; Simon N, 2013, CELL HOST MICROBE, V13, P29, DOI 10.1016/j.chom.2012.11.013; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1	48	33	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79920	10.1371/journal.pone.0079920	http://dx.doi.org/10.1371/journal.pone.0079920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278216	Green Published, gold			2022-12-27	WOS:000327539800033
J	Li, J; Tang, HF; Zhang, Y; Tang, C; Li, B; Wang, YG; Gao, ZH; Luo, P; Yin, AA; Wang, XY; Cheng, G; Fei, Z				Li, Juan; Tang, Haifeng; Zhang, Yun; Tang, Chi; Li, Bo; Wang, Yuangang; Gao, Zhenhui; Luo, Peng; Yin, Anan; Wang, Xiaoyang; Cheng, Guang; Fei, Zhou			Saponin 1 Induces Apoptosis and Suppresses NF-kappa B-Mediated Survival Signaling in Glioblastoma Multiforme (GBM)	PLOS ONE			English	Article							EXPRESSION; PATHWAY; CANCER; CELLS; PROLIFERATION; COMBINATION; ACTIVATION; CARCINOMA; RECEPTOR; TARGET	Saponin 1 is a triterpeniod saponin extracted from Anemone taipaiensis, a traditional Chinese medicine against rheumatism and phlebitis. It has also been shown to exhibit significant anti-tumor activity against human leukemia (HL-60 cells) and human hepatocellular carcinoma (Hep-G2 cells). Herein we investigated the effect of saponin 1 in human glioblastoma multiforme (GBM) U251MG and U87MG cells. Saponin 1 induced significant growth inhibition in both glioblastoma cell lines, with a 50% inhibitory concentration at 24 h of 7.4 mu g/ml in U251MG cells and 8.6 mu g/ml in U87MG cells, respectively. Nuclear fluorescent staining and electron microscopy showed that saponin 1 caused characteristic apoptotic morphological changes in the GBM cell lines. Saponin 1-induced apoptosis was also verified by DNA ladder electrophoresis and flow cytometry. Additionally, immunocytochemistry and western blotting analyses revealed a time-dependent decrease in the expression and nuclear location of NF-kappa B following saponin 1 treatment. Western blotting data indicated a significant decreased expression of inhibitors of apoptosis (IAP) family members, (e. g., survivin and XIAP) by saponin 1. Moreover, saponin 1 caused a decrease in the Bcl-2/Bax ratio and initiated apoptosis by activating caspase-9 and caspase-3 in the GBM cell lines. These findings indicate that saponin 1 inhibits cell growth of GBM cells at least partially by inducing apoptosis and inhibiting survival signaling mediated by NF-kappa B. In addition, in vivo study also demonstrated an obvious inhibition of saponin 1 treatment on the tumor growth of U251MG and U87MG cells-produced xenograft tumors in nude mice. Given the minimal toxicities of saponin 1 in non-neoplastic astrocytes, our results suggest that saponin 1 exhibits significant in vitro and in vivo anti-tumor efficacy and merits further investigation as a potential therapeutic agent for GBM.	[Li, Juan; Li, Bo; Wang, Yuangang; Gao, Zhenhui; Luo, Peng; Yin, Anan; Cheng, Guang; Fei, Zhou] Fourth Mil Med Univ, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Peoples R China; [Tang, Haifeng; Wang, Xiaoyang] Fourth Mil Med Univ, Xijing Hosp, Dept Pharma, Xian 710032, Peoples R China; [Zhang, Yun] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Peoples R China; [Li, Juan; Tang, Chi] Fourth Mil Med Univ, Fac Biomed Engn, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Cheng, G (corresponding author), Fourth Mil Med Univ, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Peoples R China.	chg16801@163.com; feizhou@fmmu.edu.cn	Lv, Yuanjie/AER-0767-2022		National Natural Science Foundation of China [30873402]; Natural Science Foundation of Shaanxi Province [2012JM4010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	The work was supported by National Natural Science Foundation of China (No. 30873402) and Natural Science Foundation of Shaanxi Province (No. 2012JM4010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Chen XQ, 2012, MOL MED REP, V5, P917, DOI 10.3892/mmr.2012.755; Chung CH, 2010, ANN ONCOL, V21, P864, DOI 10.1093/annonc/mdp390; Curcic MG, 2012, INT J MOL SCI, V13, P2521, DOI 10.3390/ijms13022521; Darefsky AS, 2012, CANCER-AM CANCER SOC, V118, P2163, DOI 10.1002/cncr.26494; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Diwu Yong-chang, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P209, DOI 10.3736/jcim20110215; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; George J, 2010, NEURO-ONCOLOGY, V12, P1088, DOI 10.1093/neuonc/noq079; Guo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-100; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Kiskova T, 2012, EUR J CANCER PREV, V21, P163, DOI 10.1097/CEJ.0b013e32834c9c0f; Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012; Lee MH, 2009, CANCER RES, V69, P7449, DOI 10.1158/0008-5472.CAN-09-1266; Lin H, 2008, APOPTOSIS, V13, P247, DOI 10.1007/s10495-007-0170-9; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Nogueira L, 2011, ONCOTARGET, V2, P646, DOI 10.18632/oncotarget.322; Pavlyukov MS, 2011, J BIOL CHEM, V286, P23296, DOI 10.1074/jbc.M111.237586; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Smith D, 2008, MOL CELL BIOCHEM, V307, P141, DOI 10.1007/s11010-007-9593-4; Stupp R, 2010, CURR OPIN NEUROL, V23, P553, DOI 10.1097/WCO.0b013e3283407eed; Wang XY, 2011, PLANTA MED, V77, P1550, DOI 10.1055/s-0030-1270821; Williams DB, 2009, SPRINGER, P407, DOI DOI 10.1295/KOBUNSHI.43.94; Xiong J, 2009, ENVIRON TOXICOL PHAR, V27, P264, DOI 10.1016/j.etap.2008.11.008; Zanotto A, 2011, BIOCHEM PHARMACOL, V81, P412, DOI 10.1016/j.bcp.2010.10.014; Zhao XY, 2011, J NEURO-ONCOL, V102, P367, DOI 10.1007/s11060-010-0346-y; Zhen HN, 2005, CANCER-AM CANCER SOC, V104, P2775, DOI 10.1002/cncr.21490	29	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81258	10.1371/journal.pone.0081258	http://dx.doi.org/10.1371/journal.pone.0081258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278406	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800114
J	Liu, RN; Dong, YP; Fan, GQ; Zhao, ZL; Deng, MJ; Cao, XB; Niu, SY				Liu, Rongning; Dong, Yanpeng; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Cao, Xibing; Niu, Suyan			Discovery of Genes Related to Witches Broom Disease in Paulownia tomentosa x Paulownia fortunei by a De Novo Assembled Transcriptome	PLOS ONE			English	Article							PHYTOPLASMAL INFECTION; EXPRESSION PROFILES; OXIDATIVE BURST; DATABASE; GENERATION; REVEALS; DROUGHT; MILDEW; COLD; TOOL	In spite of its economic importance, very little molecular genetics and genomic research has been targeted at the family Paulownia spp. The little genetic information on this plant is a big obstacle to studying the mechanisms of its ability to resist Paulownia Witches' Broom (PaWB) disease. Analysis of the Paulownia transcriptome and its expression profile data are essential to extending the genetic resources on this species, thus will greatly improves our studies on Paulownia. In the current study, we performed the de novo assembly of a transcriptome on P. tomentosa x P. fortunei using the short-read sequencing technology (Illumina). 203,664 unigenes with a mean length of 1,328 bp was obtained. Of these unigenes, 32,976 (30% of all unigenes) containing complete structures were chosen. Eukaryotic clusters of orthologous groups, gene orthology, and the Kyoto Encyclopedia of Genes and Genomes annotations were performed of these unigenes. Genes related to PaWB disease resistance were analyzed in detail. To our knowledge, this is the first study to elucidate the genetic makeup of Paulownia. This transcriptome provides a quick way to understanding Paulownia, increases the number of gene sequences available for further functional genomics studies and provides clues to the identification of potential PaWB disease resistance genes. This study has provided a comprehensive insight into gene expression profiles at different states, which facilitates the study of each gene's roles in the developmental process and in PaWB disease resistance.	[Liu, Rongning; Dong, Yanpeng; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Niu, Suyan] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Liu, Rongning; Dong, Yanpeng; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Cao, Xibing] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			Zhongyuan Scholarship Foundation of Henan Provinance [122101110700]	Zhongyuan Scholarship Foundation of Henan Provinance	This research was supported with Zhongyuan Scholarship Foundation of Henan Provinance (122101110700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ates S, 2008, AFR J BIOTECHNOL, V7, P4153; Attardo GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-160; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BASSETT S, 1998, PAULOWNIA COMMERCIAL; Bayliss KL, 2005, AUSTRALAS PLANT PATH, V34, P123, DOI 10.1071/AP04089; Bergmann BA, 1999, PLANT CELL TISS ORG, V55, P45, DOI 10.1023/A:1026481926560; Bertamini M, 2002, PHYSIOL MOL PLANT P, V61, P357, DOI 10.1006/pmpp.2003.0449; Bertamini M, 2002, PHYSIOL MOL PLANT P, V61, P349, DOI 10.1006/pmpp.2003.0450; Bray EA, 2002, PLANT CELL ENVIRON, V25, P153, DOI 10.1046/j.1365-3040.2002.00746.x; Broberg P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-199; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Choi YH, 2004, PLANT PHYSIOL, V135, P2398, DOI 10.1104/pp.104.041012; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Guthrie JN, 2001, PHYSIOL MOL PLANT P, V58, P23, DOI 10.1006/pmpp.2000.0311; Hancock-Hanser BL, 2013, MOL ECOL RESOUR, V13, P254, DOI 10.1111/1755-0998.12059; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hiruki C, 1999, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.1999.496.6; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Ipekci Z, 2003, PLANT CELL REP, V22, P16, DOI 10.1007/s00299-003-0650-5; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jarausch ML W, 2003, PLANT PATHOL, V45, P778; Jiang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-1; Judith S, 2005, PLANT CELL ENVIRON, V28; Junqueira A, 2004, PHYSIOL MOL PLANT P, V65, P181, DOI 10.1016/j.pmpp.2005.01.005; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Krikorian AD, 1986, PAULOWNIA CHINA CULT; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lepka P, 1999, PHYSIOL MOL PLANT P, V55, P59, DOI 10.1006/pmpp.1999.0202; Li JW, 2011, PLANT CELL REP, V30, P345, DOI 10.1007/s00299-010-0959-9; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; LYONS A, 1993, AGROFORESTRY TREES P, P149; Marsh E, 2010, PROTEOMICS, V10, P2057, DOI 10.1002/pmic.200900712; Maust BE, 2003, PHYTOPATHOLOGY, V93, P976, DOI 10.1094/PHYTO.2003.93.8.976; Mayda E, 2000, MOL PLANT MICROBE IN, V13, P23, DOI 10.1094/MPMI.2000.13.1.23; MELHUISH J H JR, 1990, Journal of Environmental Horticulture, V8, P205; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakamura H, 1996, PLANT DIS, V80, P302, DOI 10.1094/PD-80-0302; Newman SM, 1997, AGROFOREST SYST, V39, P23, DOI 10.1023/A:1005938310106; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; WANG QB, 1992, AGR ECOSYST ENVIRON, V39, P145, DOI 10.1016/0167-8809(92)90050-L; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang L, 2003, GENE, V314, P141, DOI 10.1016/S0378-1119(03)00713-3; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhai XiaoQiao, 2010, Scientia Silvae Sinicae, V46, P176; Zhang H, 2000, PAULOWNIA BREEDING C	65	37	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80238	10.1371/journal.pone.0080238	http://dx.doi.org/10.1371/journal.pone.0080238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278262	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800064
J	Brodribb, TJ; McAdam, SAM				Brodribb, Timothy J.; McAdam, Scott A. M.			Unique Responsiveness of Angiosperm Stomata to Elevated CO2 Explained by Calcium Signalling	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; WATER-USE EFFICIENCY; ANION CHANNEL SLAC1; ABSCISIC-ACID; CARBON-DIOXIDE; LEAF CONDUCTANCE; GUARD-CELLS; MESOPHYLL; EVOLUTION; RESPONSES	Angiosperm and conifer tree species respond differently when exposed to elevated CO2, with angiosperms found to dynamically reduce water loss while conifers appear insensitive. Such distinct responses are likely to affect competition between these tree groups as atmospheric CO2 concentration rises. Seeking the mechanism behind this globally important phenomenon we targeted the Ca2+-dependent signalling pathway, a mediator of stomatal closure in response to elevated CO2, as a possible explanation for the differentiation of stomatal behaviours. Sampling across the diversity of vascular plants including lycophytes, ferns, gymnosperms and angiosperms we show that only angiosperms possess the stomatal behaviour and prerequisite genetic coding, linked to Ca2+-dependent stomatal signalling. We conclude that the evolution of Ca2+-dependent stomatal signalling gives angiosperms adaptive benefits in terms of highly efficient water use, but that stomatal sensitivity to high CO2 may penalise angiosperm productivity relative to other plant groups in the current era of soaring atmospheric CO2.	[Brodribb, Timothy J.; McAdam, Scott A. M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Tasmania	Brodribb, TJ (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	timothyb@utas.edu.au	Brodribb, Timothy John/C-6797-2013; McAdam, Scott/J-7197-2014	Brodribb, Timothy John/0000-0002-4964-6107; McAdam, Scott/0000-0002-9625-6750	Australian Research Council [DP0878177, FT100100237]	Australian Research Council(Australian Research Council)	This study was funded by Australian Research Council (http://www.arc.gov.au/) grants DP0878177 and FT100100237 (to TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Assmann SM, 1999, PLANT CELL ENVIRON, V22, P629, DOI 10.1046/j.1365-3040.1999.00408.x; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BEADLE CL, 1979, PHYSIOL PLANTARUM, V45, P158, DOI 10.1111/j.1399-3054.1979.tb01680.x; Betts RA, 2007, NATURE, V448, P1037, DOI 10.1038/nature06045; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Brodribb TJ, 2011, SCIENCE, V331, P582, DOI 10.1126/science.1197985; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Brodribb TJ, 2013, PLANT PHYSIOL, V162, P1370, DOI 10.1104/pp.113.217877; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Cousson A, 2007, BIOL PLANTARUM, V51, P285, DOI 10.1007/s10535-007-0057-1; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; de Boer HJ, 2011, P NATL ACAD SCI USA, V108, P4041, DOI 10.1073/pnas.1100555108; Demir F, 2013, P NATL ACAD SCI USA, V110, P8296, DOI 10.1073/pnas.1211667110; Doi M, 2008, PLANT PHYSIOL, V147, P922, DOI 10.1104/pp.108.118950; Dreyer I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00263; DUBBE DR, 1978, PLANT PHYSIOL, V62, P413, DOI 10.1104/pp.62.3.413; Feild TS, 1998, P NATL ACAD SCI USA, V95, P14256, DOI 10.1073/pnas.95.24.14256; Fletcher BJ, 2008, NAT GEOSCI, V1, P43, DOI 10.1038/ngeo.2007.29; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Fujita T, 2013, NEW PHYTOL, V199, P395, DOI 10.1111/nph.12261; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hedrich R, 2001, PLANTA, V213, P594, DOI 10.1007/s004250100524; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hubbard KE, 2012, ANN BOT-LONDON, V109, P5, DOI 10.1093/aob/mcr252; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Katul G, 2010, ANN BOT-LONDON, V105, P431, DOI 10.1093/aob/mcp292; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; LEE J, 1992, J EXP BOT, V43, P951, DOI 10.1093/jxb/43.7.951; LEE JS, 1995, AUST J PLANT PHYSIOL, V22, P357, DOI 10.1071/PP9950357; LINSBAUER K, 1917, FLORA, V109, P100; Marten H, 2008, PLANT J, V55, P698, DOI 10.1111/j.1365-313X.2008.03542.x; McAdam SAM, 2012, PLANT CELL, V24, P1510, DOI 10.1105/tpc.112.096404; McAdam SAM, 2011, J EXP BOT, V62, P195, DOI 10.1093/jxb/erq260; MCAINSH MR, 1991, P ROY SOC B-BIOL SCI, V243, P195, DOI 10.1098/rspb.1991.0031; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Messinger SM, 2006, PLANT PHYSIOL, V140, P771, DOI 10.1104/pp.105.073676; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; MORISON JIL, 1983, PLANT CELL ENVIRON, V6, P95, DOI 10.1111/j.1365-3040.1983.tb01881.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Roelfsema MRG, 2002, PLANT J, V32, P65, DOI 10.1046/j.1365-313X.2002.01403.x; Ruszala EM, 2011, CURR BIOL, V21, P1030, DOI 10.1016/j.cub.2011.04.044; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Sibbernsen E, 2010, PLANT PHYSIOL, V153, P1435, DOI 10.1104/pp.110.157685; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Ward EJ, 2013, TREE PHYSIOL, V33, P135, DOI 10.1093/treephys/tps118; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	61	39	40	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e82057	10.1371/journal.pone.0082057	http://dx.doi.org/10.1371/journal.pone.0082057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278470	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100166
J	Caboux, E; Paciencia, M; Durand, G; Robinot, N; Wozniak, MB; Galateau-Salle, F; Byrnes, G; Hainaut, P; Le Calvez-Kelm, F				Caboux, Elodie; Paciencia, Maria; Durand, Geoffroy; Robinot, Nivonirina; Wozniak, Magdalena B.; Galateau-Salle, Francoise; Byrnes, Graham; Hainaut, Pierre; Le Calvez-Kelm, Florence			Impact of Delay to Cryopreservation on RNA Integrity and Genome-Wide Expression Profiles in Resected Tumor Samples	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; NEOADJUVANT CHEMOTHERAPY; PREDICTING RESPONSE; ISCHEMIA TIME; WARM ISCHEMIA; TISSUE; IDENTIFICATION; MICROARRAY; QUALITY	The quality of tissue samples and extracted mRNA is a major source of variability in tumor transcriptome analysis using genome-wide expression microarrays. During and immediately after surgical tumor resection, tissues are exposed to metabolic, biochemical and physical stresses characterized as "warm ischemia". Current practice advocates cryopreservation of biosamples within 30 minutes of resection, but this recommendation has not been systematically validated by measurements of mRNA decay over time. Using Illumina HumanHT-12 v3 Expression BeadChips, providing a genome-wide coverage of over 24,000 genes, we have analyzed gene expression variation in samples of 3 hepatocellular carcinomas (HCC) and 3 lung carcinomas (LC) cryopreserved at times up to 2 hours after resection. RNA Integrity Numbers (RIN) revealed no significant deterioration of mRNA up to 2 hours after resection. Genome-wide transcriptome analysis detected nonsignificant gene expression variations of -3.5%/hr (95% CI: -7.0%/hr to 0.1%/hr; p = 0.054). In LC, no consistent gene expression pattern was detected in relation with warm ischemia. In HCC, a signature of 6 up-regulated genes (CYP2E1, IGLL1, CABYR, CLDN2, NQO1, SCL13A5) and 6 down-regulated genes (MT1G, MT1H, MT1E, MT1F, HABP2, SPINK1) was identified (FDR<0.05). Overall, our observations support current recommendation of time to cryopreservation of up to 30 minutes and emphasize the need for identifying tissue-specific genes deregulated following resection to avoid misinterpreting expression changes induced by warm ischemia as pathologically significant changes.	[Caboux, Elodie] Int Agcy Res Canc, Lab Serv & Biobank, F-69372 Lyon, France; [Paciencia, Maria; Galateau-Salle, Francoise] CHU Caen, Dept Pathol, F-14000 Caen, France; [Durand, Geoffroy; Robinot, Nivonirina; Le Calvez-Kelm, Florence] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Wozniak, Magdalena B.] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Byrnes, Graham] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Hainaut, Pierre] Int Agcy Res Canc, F-69372 Lyon, France; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC); CHU de Caen NORMANDIE; Universite de Caen Normandie; World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC)	Le Calvez-Kelm, F (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	lecalvezf@iarc.fr	Salle, Francoise BJ Galateau/J-1530-2015; Caboux, Elodie/AAJ-3233-2020; Caboux, Elodie/AGW-7436-2022; Hainaut, Pierre/B-6018-2012	Salle, Francoise BJ Galateau/0000-0003-3642-0165; Hainaut, Pierre/0000-0002-1303-1610; Caboux, Elodie/0000-0001-8393-6979; Ranoroarivony Robiniot, Nivonirina/0000-0002-2532-1455; galateau salle, francoise/0000-0002-2814-1644; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Byrnes, Graham/0000-0003-3893-7539				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blackhall FH, 2004, NEOPLASIA, V6, P761, DOI 10.1593/neo.04301; Borgan E, 2011, MOL ONCOL, V5, P564, DOI 10.1016/j.molonc.2011.08.004; Chan KYY, 2006, MODERN PATHOL, V19, P1546, DOI 10.1038/modpathol.3800674; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Chung EJ, 2002, MOL CELLS, V14, P382; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Dash A, 2002, AM J PATHOL, V161, P1743, DOI 10.1016/S0002-9440(10)64451-3; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Delpuech O, 2002, ONCOGENE, V21, P2926, DOI 10.1038/sj.onc.1205392; Dong H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-5; Dumur CI, 2008, DIAGN MOL PATHOL, V17, P200, DOI 10.1097/PDM.0b013e318169bfaf; Freidin MB, 2012, J MOL DIAGN, V14, P140, DOI 10.1016/j.jmoldx.2011.11.002; Goldenberg D, 2002, MOL CARCINOGEN, V33, P113, DOI 10.1002/mc.10027.abs; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Hou J, 2010, PLOS ONE, V5; Huang GW, 2002, WORLD J GASTROENTERO, V8, P650, DOI 10.3748/wjg.v8.i4.650; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Iizuka N, 2006, J CANCER RES CLIN, V132, P473, DOI 10.1007/s00432-006-0094-8; Jewell SD, 2002, AM J CLIN PATHOL, V118, P733; Kato K, 2005, NUCLEIC ACIDS RES, V33, pD533; Kim BY, 2004, BBA-MOL BASIS DIS, V1739, P50, DOI 10.1016/j.bbadis.2004.07.004; Kurokawa Y, 2003, J HEPATOL, V39, P1004, DOI 10.1016/S0168-8278(03)00473-2; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lee L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S3; Lee MJ, 2008, CLIN CANCER RES, V14, P1080, DOI 10.1158/1078-0432.CCR-07-1615; Li Y, 2002, J CANCER RES CLIN, V128, P369, DOI 10.1007/s00432-002-0347-0; Lu Dong-Dong, 2003, Yale Journal of Biology and Medicine, V76, P55; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; NCI-NIH OoBaBR, 2011, NCI BEST PRACT BIOSP; Neyman J, 1937, SKAND AKTUARIETIDSKR, V20, P149; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Okabe H, 2001, CANCER RES, V61, P2129; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Simon R, 2007, CANCER INFORM, V3, P11; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spruessel A, 2004, BIOTECHNIQUES, V36, P1030, DOI 10.2144/04366RR04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Tackels-Horne D, 2001, CANCER-AM CANCER SOC, V92, P395, DOI 10.1002/1097-0142(20010715)92:2<395::AID-CNCR1335>3.0.CO;2-U; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Tao X, 2007, HEPATOL RES, V37, P820, DOI 10.1111/j.1872-034X.2007.00113.x; Tavtigian Sean V, 2006, Breast Cancer Res, V8, P303, DOI 10.1186/bcr1609; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; van Maldegem F, 2008, DIAGN MOL PATHOL, V17, P51, DOI 10.1097/PDM.0b013e31814b8866; Vermeulen J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr065; Xu L, 2001, CANCER RES, V61, P3176; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398; Yamashita T, 2001, BIOCHEM BIOPH RES CO, V282, P647, DOI 10.1006/bbrc.2001.4610; Zekri Abdel-Rahman N, 2008, BMC Res Notes, V1, P106, DOI 10.1186/1756-0500-1-106; Zembutsu H, 2009, INT J ONCOL, V34, P361, DOI 10.3892/ijo_00000159	60	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79826	10.1371/journal.pone.0079826	http://dx.doi.org/10.1371/journal.pone.0079826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278187	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100052
J	Chang, WC; Yang, KD; Wu, MTM; Wen, YF; Hsi, E; Chang, JC; Lin, YM; Kuo, HC; Chang, WP				Chang, Wei-Chiao; Yang, Kuender D.; Wu, Man-Tzu Marcie; Wen, Ya-Feng; Hsi, Edward; Chang, Jen-Chieh; Lin, You-Meei; Kuo, Ho-Chang; Chang, Wei-Pin			Close Correlation between Season of Birth and the Prevalence of Bronchial Asthma in a Taiwanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; AIR-POLLUTION; ALLERGY; INFANCY; ATOPY; LIFE; POLYMORPHISM; COHORT; GENE	Background: Bronchial asthma (BA), atopic dermatitis (AD), and allergic rhinitis (AR) are common allergic diseases. Environmental factors were indicated to influence the development of allergic diseases. Objective: To evaluate the correlation between the month of birth and the prevalence of allergic diseases in Taiwan. Methods: Data from 104,455 children were collected from the National Insurance Research Database of Taiwan. Subjects were identified by at least two service claims for ambulatory care or one claim for inpatient care. All of the enrolled patients were aged 7 similar to 15 years in 2010. In a bio-clinical data analysis, total immunoglobulin E (IgE) and ImmunoCAP (TM) allergen data (CAP) from mothers and infants were collected in a medical center in Taiwan. Correlations between children's allergic factors and the season of birth were assessed. Results: A significant difference in the prevalence of BA according to the month of birth (X-2 = 18.2, p<0.001) was found in the Taiwanese population. The fewest schoolchildren with were born in May (7.21%), and the most were born in October (10.59%). However, no tendency for the prevalence of AD (X-2 = 4.6, P = 0.204) or AR (X-2 = 4.3 P = 0.229) was found. In addition, we found that children born in autumn (August to October) had a higher prevalence of BA compared to those born in spring (February to April) (odds ratio: 1.13; 95% confidence interval: 1.05-1.21). In a bio-clinical data study, markers of maternal and childhood allergies including IgE and CAP were detected in a risk analysis section. Children who were born in autumn had higher levels of CAP and total IgE. Conclusions: The findings of this study showed that the month of birth was closely correlated with the prevalence of BA and higher levels of CAP and IgE.	[Chang, Wei-Chiao; Wu, Man-Tzu Marcie; Wen, Ya-Feng; Lin, You-Meei] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Chiao; Wu, Man-Tzu Marcie] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Yang, Kuender D.] Show Chwan Mem Hosp Chang Bing, Dept Med Res & Dev, Changhua, Taiwan; [Yang, Kuender D.] Natl Yang Ming Univ, Inst Clin Med Sci, Taipei 112, Taiwan; [Hsi, Edward] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chang, Jen-Chieh] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan; [Chang, Jen-Chieh; Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan	Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	erickuo48@yahoo.com.tw; wpchang@mail.ypu.edu.tw	Hsi, Edward/A-1356-2013; Kuo, Ho-Chang/AAQ-6644-2020	Hsi, Edward/0000-0002-8272-6707; Kuo, Ho-Chang/0000-0002-3295-2984; Chang, Wei-Chiao/0000-0002-8573-5924; Wen, Ya-Feng/0000-0001-5090-4153	National Science Council of Taiwan [NSC101-2628-B038-001-MY2, NSC101-2320-B038-029-MY3]; Taipei Medical University [TMU 101-AE1-B14]; Chang Gung University, Taiwan [CMRPG8B0151]; Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C. [DOH102-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University; Chang Gung University, Taiwan; Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C.	This study was supported by grants (NSC101-2628-B038-001-MY2; NSC101-2320-B038-029-MY3) from the National Science Council of Taiwan, TMU 101-AE1-B14 from Taipei Medical University, CMRPG8B0151 from Chang Gung University, Taiwan and DOH102-TD-C-111-002 from an Excellence for Cancer Research Center grant, Department of Health, Executive Yuan, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; [Anonymous], 2006, PUBLIC HLTH REPORT; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Carlsten C, 2012, CURR OPIN ALLERGY CL, V12, P455, DOI 10.1097/ACI.0b013e328357cc55; Chen Y-W, 2012, J MICROBIOLOGY IMMUN; Clark NM, 2007, CHEST, V132, P88, DOI 10.1378/chest.06-2539; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Guo YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042232; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Huang YC, 2001, EUR J PEDIATR, V160, P581, DOI 10.1007/s004310100803; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kotaniemi-Syrjanen A, 2003, J ALLERGY CLIN IMMUN, V111, P66, DOI 10.1067/mai.2003.33; Kuo HC, 2010, ALLERGY, V65, P1625, DOI 10.1111/j.1398-9995.2010.02427.x; Kusunoki T, 1999, J ALLERGY CLIN IMMUN, V103, P1148, DOI 10.1016/S0091-6749(99)70191-0; Liu CA, 2003, J ALLERGY CLIN IMMUN, V112, P899, DOI 10.1016/j.jaci.2003.08.030; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Sly PD, 2010, J ALLERGY CLIN IMMUN, V125, P1202, DOI 10.1016/j.jaci.2010.01.024; Society AT, 2000, AM J RESP CRIT CARE, V161, P665; Tamari Mayumi, 2011, Allergology International, V60, P247, DOI 10.2332/allergolint.11-RAI-0320; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Yang KD, 2007, CLIN EXP ALLERGY, V37, P680, DOI 10.1111/j.1365-2222.2007.02698.x; Yang KD, 2010, ALLERGY, V65, P731, DOI 10.1111/j.1398-9995.2009.02260.x; Yang KD, 2007, J ALLERGY CLIN IMMUN, V120, P842, DOI 10.1016/j.jaci.2007.07.009; Zhang YM, 2012, CURR OPIN PULM MED, V18, P6, DOI 10.1097/MCP.0b013e32834dc532	28	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80285	10.1371/journal.pone.0080285	http://dx.doi.org/10.1371/journal.pone.0080285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278271	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100081
J	Cote, JP; Charbonneau, ME; Mourez, M				Cote, Jean-Philippe; Charbonneau, Marie-Eve; Mourez, Michael			Glycosylation of the Escherichia coli TibA Self-Associating Autotransporter Influences the Conformation and the Functionality of the Protein	PLOS ONE			English	Article							AIDA-I; DOMAIN; STABILITY; BACTERIA; SITE	The self-associating autotransporters (SAATs) are multifunctional secreted proteins of Escherichia coli, comprising the AIDA-I, TibA and Ag43 proteins. One of their characteristics is that they can be glycosylated. Glycosylation of AIDA-I and Ag43 have been investigated, but not that of TibA. It is still not clear whether glycosylation of the SAATs affect their structure or their functionality. Therefore, we have looked at the effects of glycosylation on the TibA adhesin/invasin. TibA is glycosylated by TibC, a specific glycosyltransferase, and the two genes are encoded in an operon. In this study, we have found that the glycosylation of TibA is not limited to the extracellular functional domain, as previously observed with AIDA-I and Ag43. We have determined that unglycosylated TibA is not able to promote the adhesion of bacteria on cultured epithelial cell, even though it is still able to promote invasion, biofilm formation and autoaggregation of bacteria. We have purified the glycosylated and unglycosylated forms of TibA, and determined that TibA is less stable when not glycosylated. We finally observed that glycosylation affects the oligomerisation of TibA and that unglycosylated TibA is locked in a conformation that is not suited for adhesion. Our results suggest that the effect of glycosylation on the functionality of TibA is indirect.	[Cote, Jean-Philippe; Charbonneau, Marie-Eve; Mourez, Michael] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Cote, JP (corresponding author), Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada.	jpcote@mcmaster.ca			Canadian Institutes for Health Research [84578]; Natural Sciences and Engineering Research Council; Groupe de Recherche sur les Maladies Infectieuses du Porc; Canada Research Chair program	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Groupe de Recherche sur les Maladies Infectieuses du Porc; Canada Research Chair program(Canada Research Chairs)	This work was supported by the Canadian Institutes for Health Research (grant 84578) and the Natural Sciences and Engineering Research Council, as well as by funds from the Groupe de Recherche sur les Maladies Infectieuses du Porc and the Canada Research Chair program. JPC was supported by a graduate fellowship from Natural Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Berthiaume F, 2010, FEMS MICROBIOL LETT, V311, P176, DOI 10.1111/j.1574-6968.2010.02088.x; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Charbonneau ME, 2007, J BACTERIOL, V189, P8880, DOI 10.1128/JB.00969-07; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Cote JP, 2011, INFECT IMMUN, V79, P1826, DOI 10.1128/IAI.01129-10; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Girard V, 2010, J BIOL CHEM, V285, P10616, DOI 10.1074/jbc.M109.069070; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Knudsen SK, 2008, BIOCHEM J, V412, P563, DOI 10.1042/BJ20071497; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lindenthal C, 2001, INFECT IMMUN, V69, P52, DOI 10.1128/IAI.69.1.52-57.2001; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Mogensen JE, 2005, BIOCHEMISTRY-US, V44, P4533, DOI 10.1021/bi0475121; Moormann C, 2002, INFECT IMMUN, V70, P2264, DOI 10.1128/IAI.70.5.2264-2270.2002; Mourez M, 1997, MOL MICROBIOL, V26, P821, DOI 10.1046/j.1365-2958.1997.6271992.x; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Reidl S, 2009, INT J MED MICROBIOL, V299, P389, DOI 10.1016/j.ijmm.2009.01.001; Rutherford N, 2006, J BACTERIOL, V188, P4111, DOI 10.1128/JB.01949-05; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tang GY, 2012, INFECT IMMUN, V80, P2868, DOI 10.1128/IAI.00372-12; Wyss DF, 1996, CURR OPIN BIOTECH, V7, P409, DOI 10.1016/S0958-1669(96)80116-9	38	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80739	10.1371/journal.pone.0080739	http://dx.doi.org/10.1371/journal.pone.0080739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278316	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100108
J	Feld, JJ; Grebely, J; Matthews, GV; Applegate, T; Hellard, M; Sherker, A; Cherepanov, V; Petoumenos, K; Yeung, B; Kaldor, JM; Lloyd, AR; Dore, GJ				Feld, Jordan J.; Grebely, Jason; Matthews, Gail V.; Applegate, Tanya; Hellard, Margaret; Sherker, Alana; Cherepanov, Vera; Petoumenos, Kathy; Yeung, Barbara; Kaldor, John M.; Lloyd, Andrew R.; Dore, Gregory J.			Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENE-EXPRESSION; VIRAL RESPONSE; RIBAVIRIN THERAPY; IMMUNE-RESPONSES; STIMULATED GENES; IP-10 PREDICTS; IL28B; CLEARANCE; PEGINTERFERON	Background: High plasma levels of interferon-gamma inducible protein-10 (IP-10) have been shown to be associated with impaired treatment response in chronic hepatitis C virus (HCV) infection. Whether IP-10 levels predict treatment in acute HCV infection is unknown. Methods: Patients with acute or early chronic HCV infection from the Australian Trial in Acute Hepatitis C (ATAHC) cohort were evaluated. Baseline and on-treatment plasma IP-10 levels were measured by ELISA. IL28B genotype was determined by sequencing. Results: Overall, 74 HCV mono-infected and 35 HIV/HCV co-infected patients were treated in ATAHC, of whom 89 were adherent to therapy and were included for analysis. IP-10 levels correlated with HCV RNA levels at baseline (r = 0.48, P<0.001) and during treatment. Baseline IP-10 levels were higher in patients who failed to achieve rapid virological response (RVR). Only one patient with a plasma IP-10 level >600 pg/mL achieved RVR. There was no association with IP-10 levels and early virological response (EVR) or sustained virological response (SVR). Conclusions: Baseline IP-10 levels are associated with early viral kinetics but not ultimate treatment outcome in acute HCV infection. Given previous data showing that patients with high baseline IP-10 are unlikely to spontaneously clear acute HCV infection, they should be prioritized for early antiviral therapy.	[Feld, Jordan J.; Sherker, Alana; Cherepanov, Vera] Univ Toronto, Toronto Ctr Liver Dis, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada; [Grebely, Jason; Matthews, Gail V.; Applegate, Tanya; Petoumenos, Kathy; Yeung, Barbara; Kaldor, John M.; Dore, Gregory J.] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Matthews, Gail V.; Dore, Gregory J.] St Vincents Hosp, HIV Immunol Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; [Hellard, Margaret] Burnet Inst, Melbourne, Vic, Australia; [Hellard, Margaret] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Lloyd, Andrew R.] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of Toronto; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Burnet Institute; Florey Institute of Neuroscience & Mental Health; University of New South Wales Sydney	Feld, JJ (corresponding author), Univ Toronto, Toronto Ctr Liver Dis, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada.	Jordan.Feld@uhn.ca	Lloyd, Andrew/E-7334-2017; matthews, gail/AFL-8501-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/AFJ-8960-2022; Dore, Gregory John/ABD-5665-2021; matthews, gail/AAG-8626-2022; Feld, Jordan/AAH-5628-2020	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Dore, Gregory John/0000-0002-4741-2622; Feld, Jordan/0000-0003-2640-2211; Sherker, Alana/0000-0001-5827-4678; Matthews, Gail/0000-0002-1048-6396; Applegate, Tanya/0000-0002-8657-4261	National Institutes of Health [RO1 DA 15999-01]; Australian Government Department of Health and Ageing; National Health and Medical Research Council; Victorian Operational Infrastructure Support Program, Department of Health, Victoria, Australia; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure Support Program, Department of Health, Victoria, Australia; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health grant RO1 DA 15999-01. The Kirby Institute for Infection and Immunity in Society is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. Roche Pharmaceuticals supplied financial support for pegylated IFN-alfa-2a/ribavirin. JG is supported by a National Health and Medical Research Council Career Development Fellowship. GD and AL were supported by National Health and Medical Research Council Practitioner Research Fellowships. MH and JK were supported by National Health and Medical Research Council Research Fellowship. The Burnet Institute receives funding support from the Victorian Operational Infrastructure Support Program, Department of Health, Victoria, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044; Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Falconer K, 2010, SCAND J INFECT DIS, V42, P896, DOI 10.3109/00365548.2010.498019; Feld JJ, 2007, HEPATOLOGY; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Feld JJ, 2012, BEST PRACT RES CL GA, V26, P429, DOI 10.1016/j.bpg.2012.09.013; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grebely J, 2013, HEPATOLOGY IN PRESS; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Grebely J, 2011, NAT REV GASTRO HEPAT, V8, P265, DOI 10.1038/nrgastro.2011.32; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Pawlotsky JM, 2004, GASTROENTEROLOGY, V126, P703, DOI 10.1053/j.gastro.2003.12.002; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Selvarajah S, 2012, J GEN VIROL, V93, P1673, DOI 10.1099/vir.0.041277-0; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Wiegand J, 2008, J ANTIMICROB CHEMOTH, V62, P860, DOI 10.1093/jac/dkn346; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80003	10.1371/journal.pone.0080003	http://dx.doi.org/10.1371/journal.pone.0080003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278230	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100070
J	Mescher, AL; Neff, AW; King, MW				Mescher, Anthony L.; Neff, Anton W.; King, Michael W.			Changes in the Inflammatory Response to Injury and Its Resolution during the Loss of Regenerative Capacity in Developing Xenopus Limbs	PLOS ONE			English	Article							CHRONIC BERYLLIUM DISEASE; IMMUNE-SYSTEM; TISSUE REGENERATION; MODEL INTERACTION; GENE-EXPRESSION; INNATE; MECHANISMS; CELLS; FORELIMB; BALANCE	Tissue and organ regeneration, unlike development, involves an injury that in postembryonic animals triggers inflammation followed by resolution. How inflammation affects epimorphic regeneration is largely uninvestigated. Here we examine inflammation and its resolution in Xenopus laevis hindlimb regeneration, which declines during larval development. During the first 5 days postamputation, both regeneration-competent stage 53 and regeneration-deficient stage 57 hindlimbs showed very rapid accumulation of leukocytes and cells expressing interleukin-1 beta and matrix metalloproteinase 9. Expression of genes for factors mediating inflammatory resolution appeared more persistent at stages 55 and 57 than at stage 53, suggesting changes in this process during development. FoxP3, a marker for regulatory T cells, was upregulated by amputation in limbs at all three stages but only persisted at stage 57, when it was also detected before amputation. Expression of genes for cellular reprogramming, such as SALL4, was upregulated in limbs at all 3 stages, but markers of limb patterning, such as Shh, were expressed later and less actively after amputation in regeneration-deficient limbs. Topical application of specific proinflammatory agents to freshly amputated limbs increased interleukin-1 beta expression locally. With aqueous solutions of the proinflammatory metal beryllium sulfate, this effect persisted through 7 days postamputation and was accompanied by inhibition of regeneration. In BeSO4-treated limbs expression of markers for both inflammation and resolution, including FoxP3, was prolonged, while genes for cellular reprogramming were relatively unaffected and those for limb patterning failed to be expressed normally. These data imply that in Xenopus hindlimbs postamputation inflammation and its resolution change during development, with little effect on cellular dedifferentiation or reprogramming, but potentially interfering with the expression of genes required for blastema patterning. The results suggest that developmental changes in the larval anuran immune system may be involved in the ontogenetic loss of epimorphic regeneration in this system.	[Mescher, Anthony L.; Neff, Anton W.] Indiana Univ, Indiana Univ Sch Med, Ctr Regenerat Biol & Med, Bloomington, IN 47405 USA; [King, Michael W.] Indiana Univ Sch Med, Terre Haute, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System	Mescher, AL (corresponding author), Indiana Univ, Indiana Univ Sch Med, Ctr Regenerat Biol & Med, Bloomington, IN 47405 USA.	mescher@indiana.edu			U.S. National Science Foundation [IOS-0814399]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the U.S. National Science Foundation to A. L. M. (Grant IOS-0814399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; ASHBY J, 1990, MUTAT RES, V240, P217, DOI 10.1016/0165-1218(90)90061-6; Barrero MJ, 2011, EMBO REP, V12, P208, DOI 10.1038/embor.2011.10; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Brockes JP, 2001, J ANAT, V199, P3; CARRILLOFARGA J, 1990, J ANAT, V172, P39; Castell-Rodriguez AE, 1999, DEV COMP IMMUNOL, V23, P473, DOI 10.1016/S0145-305X(99)00031-2; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chen GC, 2011, VIRUSES-BASEL, V3, P2065, DOI 10.3390/v3112065; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; COHEN N, 1971, AM ZOOL, V11, P193; Cummings KJ, 2009, ENVIRON HEALTH PERSP, V117, P1250, DOI 10.1289/ehp.0800455; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Du Pasquier L, 1990, DEV IMMUNOL, V1; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Fontenot AP, 2003, TISSUE ANTIGENS, V62, P449, DOI 10.1046/j.1399-0039.2003.00160.x; Franchini A, 2011, CELL TISSUE RES, V344, P261, DOI 10.1007/s00441-011-1136-3; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Grow M, 2006, DEV DYNAM, V235, P2667, DOI 10.1002/dvdy.20897; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kinefuchi K, 2011, ZOOL SCI, V28, P509, DOI 10.2108/zsj.28.509; King MW, 2012, ANAT REC, V295, P1552, DOI 10.1002/ar.22443; King MW, 2009, INT J DEV BIOL, V53, P955, DOI 10.1387/ijdb.082719mk; King MW, 1998, DEV DYNAM, V212, P563, DOI 10.1002/(SICI)1097-0177(199808)212:4<563::AID-AJA9>3.0.CO;2-F; King MW, 2003, DEV DYNAM, V226, P398, DOI 10.1002/dvdy.10250; KOMALA ZOFIA, 1957, FOLIA BIOL, V5, P1; KORNELUK RG, 1984, CAN J ZOOL, V62, P2383, DOI 10.1139/z84-351; Kunzmann S, 2013, AM J OBSTET GYNECOL, V208, P429, DOI 10.1016/j.ajog.2013.01.008; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Levesque M, 2010, J EXP ZOOL PART B, V314B, P684, DOI 10.1002/jez.b.21371; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Lindblad, 1992, WOUND HEALING BIOCH, P248; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Love NR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-70; Mastellos DC, 2013, SEMIN IMMUNOL, V25, P29, DOI 10.1016/j.smim.2013.04.002; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MESCHER AL, 1981, J EXP ZOOL, V216, P235, DOI 10.1002/jez.1402160204; Mescher AL, 2007, DEV COMP IMMUNOL, V31, P383, DOI 10.1016/j.dci.2006.07.001; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Needham AE, 1941, P ZOOL SOC LOND A-GE, V111, P59; Neff AW, 2005, DEV DYNAM, V233, P356, DOI 10.1002/dvdy.20363; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Sawyer RT, 2011, BIOMETALS, V24, P1, DOI 10.1007/s10534-010-9376-3; Sawyer RT, 2002, INT IMMUNOPHARMACOL, V2, P249, DOI 10.1016/S1567-5769(01)00177-1; SCHEUING MR, 1957, J EXP ZOOL, V136, P301, DOI 10.1002/jez.1401360207; Schmidt AJ, 1968, CELLULAR BIOL VERTEB; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; SESSIONS SK, 1988, J EXP ZOOL, V247, P39, DOI 10.1002/jez.1402470106; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; SICARD RE, 1985, REGULATION VERTEBRAT, P128; Silva S, 2009, J OCCUP ENVIRON HYG, V6, P775, DOI 10.1080/15459620903267986; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Strupp C, 2011, ANN OCCUP HYG, V55, P43, DOI 10.1093/annhyg/meq073; THORNTON CS, 1951, J EXP ZOOL, V118, P467, DOI 10.1002/jez.1401180307; THORNTON CS, 1950, J EXP ZOOL, V114, P305, DOI 10.1002/jez.1401140206; THORNTON CS, 1949, J MORPHOL, V84, P459, DOI 10.1002/jmor.1050840305; Tournefier A, 1998, IMMUNOL REV, V166, P259, DOI 10.1111/j.1600-065X.1998.tb01268.x; TSONIS PA, 1991, J EXP ZOOL, V259, P252, DOI 10.1002/jez.1402590215; USSING AP, 1995, GEN COMP ENDOCR, V97, P308, DOI 10.1006/gcen.1995.1031; Wallace, 1981, VERTEBRATE LIMB REGE; Widgerow AD, 2012, WOUND REPAIR REGEN, V20, P2, DOI 10.1111/j.1524-475X.2011.00754.x; Wilgus TA, 2003, WOUND REPAIR REGEN, V11, P25, DOI 10.1046/j.1524-475X.2003.11106.x; Wolfe AD, 2000, DEV DYNAM, V218, P681, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1018>3.0.CO;2-6; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Wormald S, 2007, CURR OPIN HEMATOL, V14, P9, DOI 10.1097/00062752-200701000-00004; Yokoyama H, 2008, DEV GROWTH DIFFER, V50, P13, DOI 10.1111/j.1440-169x.2007.00973.x	79	60	60	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80477	10.1371/journal.pone.0080477	http://dx.doi.org/10.1371/journal.pone.0080477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278286	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100091
J	Ono, D; Honma, S; Honma, K				Ono, Daisuke; Honma, Sato; Honma, Ken-ichi			Postnatal Constant Light Compensates Cryptochrome1 and 2 Double Deficiency for Disruption of Circadian Behavioral Rhythms in Mice under Constant Dark	PLOS ONE			English	Article							MOUSE SUPRACHIASMATIC NUCLEUS; CLOCK; RESTORATION	Clock genes Cryptochrome (Cry1) and Cry2 are essential for expression of circadian rhythms in mice under constant darkness (DD). However, circadian rhythms in clock gene Per1 expression or clock protein PER2 are detected in the cultured suprachiasmatic nucleus (SCN) of neonatal Cry1 and Cry2 double deficient (Cry1(-/-)/Cry2(-/-)) mice. A lack of circadian rhythms in adult Cry1(-/-)/Cry2(-/-) mice is most likely due to developmentally disorganized cellular coupling of oscillating neurons in the SCN. On the other hand, neonatal rats exposed to constant light (LL) developed a tenable circadian system under prolonged LL which was known to fragment circadian behavioral rhythms. In the present study, Cry1(-/-)/Cry2(-/-) mice were raised under LL from postnatal day 1 for 7 weeks and subsequently exposed to DD for 3 weeks. Spontaneous movement was monitored continuously after weaning and PER2::LUC was measured in the cultured SCN obtained from mice under prolonged DD. Surprisingly, Chi square periodogram analysis revealed significant circadian rhythms of spontaneous movement in the LL-raised Cry1(-/-)/Cry2(-/-) mice, but failed to detect the rhythms in Cry1(-/-)/Cry2(-/-) mice raised under light-dark cycles (LD). By contrast, prolonged LL in adulthood did not rescue the circadian behavioral rhythms in the LD raised Cry1(-/-)/Cry2(-/-) mice. Visual inspection disclosed two distinct activity components with different periods in behavioral rhythms of the LL-raised Cry1(-/-)/Cry2(-/-) mice under DD: one was shorter and the other was longer than 24 hours. The two components repeatedly merged and separated. The patterns resembled the split behavioral rhythms of wild type mice under prolonged LL. In addition, circadian rhythms in PER2:: LUC were detected in some of the LL-raised Cry1(-/-)/Cry2(-/-) mice under DD. These results indicate that neonatal exposure to LL compensates the CRY double deficiency for the disruption of circadian behavioral rhythms under DD in adulthood.	[Ono, Daisuke] Hokkaido Univ, Grad Sch Med, Res Ctr Cooperat Projects, Photon Bioimaging Sect, Sapporo, Hokkaido, Japan; [Honma, Sato; Honma, Ken-ichi] Hokkaido Univ, Grad Sch Med, Dept Chronomed, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Honma, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Chronomed, Sapporo, Hokkaido, Japan.	sathonma@med.hokudai.ac.jp; kenhonma@med.hokudai.ac.jp			JSPS KAKENHI [20249010, 24390055, 24890001]; Project for Developing Innovation Systems of the MEXT; Strategic Research Program for Brain Sciences (SRPBS); Grants-in-Aid for Scientific Research [23560446] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project for Developing Innovation Systems of the MEXT; Strategic Research Program for Brain Sciences (SRPBS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI, Nos. 20249010, 24390055, 24890001, Project for Developing Innovation Systems of the MEXT, and by Strategic Research Program for Brain Sciences (SRPBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraham D, 2006, J BIOL RHYTHM, V21, P169, DOI 10.1177/0748730406288040; Canal-Corretger MM, 2001, AM J PHYSIOL-REG I, V280, pR1023, DOI 10.1152/ajpregu.2001.280.4.R1023; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Hong J, 2013, EXP EYE RES, V111, P17, DOI 10.1016/j.exer.2013.03.011; HONMA KI, 1978, AM J PHYSIOL, V235, pR250, DOI 10.1152/ajpregu.1978.235.5.R250; Honma S, 2008, J BIOL RHYTHM, V23, P91, DOI 10.1177/0748730407311124; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Ono D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2670; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Smith L, 2009, J NEUROENDOCRINOL, V21, P946, DOI 10.1111/j.1365-2826.2009.01914.x; Spoelstra K, 2002, J BIOL RHYTHM, V17, P520, DOI 10.1177/0748730402238234; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Worden, 1974, NEUROSCIENCES 3RD ST, P437; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	17	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80615	10.1371/journal.pone.0080615	http://dx.doi.org/10.1371/journal.pone.0080615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278295	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100095
J	Cappa, EP; El-Kassaby, YA; Garcia, MN; Acuna, C; Borralho, NMG; Grattapaglia, D; Poltri, SNM				Cappa, Eduardo P.; El-Kassaby, Yousry A.; Garcia, Martin N.; Acuna, Cintia; Borralho, Nuno M. G.; Grattapaglia, Dario; Marcucci Poltri, Susana N.			Impacts of Population Structure and Analytical Models in Genome-Wide Association Studies of Complex Traits in Forest Trees: A Case Study in Eucalyptus globulus	PLOS ONE			English	Article							GENETIC DISSECTION; LINKAGE DISEQUILIBRIUM; PAIRWISE RELATEDNESS; NATURAL-POPULATION; DIVERSITY ARRAYS; WOOD PROPERTIES; MARKERS; QUALITY; LOCI; PREDICTION	The promise of association genetics to identify genes or genomic regions controlling complex traits has generated a flurry of interest. Such phenotype-genotype associations could be useful to accelerate tree breeding cycles, increase precision and selection intensity for late expressing, low heritability traits. However, the prospects of association genetics in highly heterozygous undomesticated forest trees can be severely impacted by the presence of cryptic population and pedigree structure. To investigate how to better account for this, we compared the GLM and five combinations of the Unified Mixed Model (UMM) on data of a low-density genome-wide association study for growth and wood property traits carried out in a Eucalyptus globulus population (n = 303) with 7,680 Diversity Array Technology (DArT) markers. Model comparisons were based on the degree of deviation from the uniform distribution and estimates of the mean square differences between the observed and expected p-values of all significant marker-trait associations detected. Our analysis revealed the presence of population and family structure. There was not a single best model for all traits. Striking differences in detection power and accuracy were observed among the different models especially when population structure was not accounted for. The UMM method was the best and produced superior results when compared to GLM for all traits. Following stringent correction for false discoveries, 18 marker-trait associations were detected, 16 for tree diameter growth and two for lignin monomer composition (S: G ratio), a key wood property trait. The two DArT markers associated with S: G ratio on chromosome 10, physically map within 1 Mbp of the ferulate 5-hydroxylase (F5H) gene, providing a putative independent validation of this marker-trait association. This study details the merit of collectively integrate population structure and relatedness in association analyses in undomesticated, highly heterozygous forest trees, and provides additional insights into the nature of complex quantitative traits in Eucalyptus.	[Cappa, Eduardo P.] INTA, Ctr Invest Recursos Nat, Inst Recursos Biol, Buenos Aires, DF, Argentina; [Cappa, Eduardo P.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC V6T 1W5, Canada; [Garcia, Martin N.; Acuna, Cintia; Marcucci Poltri, Susana N.] INTA, Ctr Invest Ciencias Vet & Agron, Inst Biotecnol, Buenos Aires, DF, Argentina; [Borralho, Nuno M. G.] Univ Tecn Lisboa, Inst Super Agron, Ctr Estudos Florestais, P-1100 Lisbon, Portugal; [Grattapaglia, Dario] Univ Catolica Brasilia, EMBRAPA Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia, Genom Sci Program, Brasilia, DF, Brazil	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of British Columbia; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidade de Lisboa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Universidade Catolica de Brasilia	Cappa, EP (corresponding author), INTA, Ctr Invest Recursos Nat, Inst Recursos Biol, Buenos Aires, DF, Argentina.	ecappa@cnia.inta.gov.ar	El-Kassaby, Yousry A/K-9856-2016; Grattapaglia, Dario/B-5864-2014; Grattapaglia, Dario/AAB-6805-2020	El-Kassaby, Yousry A/0000-0002-4887-8977; Grattapaglia, Dario/0000-0002-0050-970X; Grattapaglia, Dario/0000-0002-0050-970X; Garcia, Martin Nahuel/0000-0001-5760-986X; Borralho, Nuno/0000-0001-5606-7878; Marcucci Poltri, Susana Noemi/0000-0002-1676-1635; Acuna, Cintia/0000-0001-6658-4780	BiotecSur UE [127118]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [PICT 00118, PICT 00321]; CNPq CBAB (Brazil-Argentina Biotechnology Center) [577047/2008-6]; Programa de Modernizacion Tecnologica III, Contrato de Prestamo BID [1728/OC-AR]	BiotecSur UE; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT); CNPq CBAB (Brazil-Argentina Biotechnology Center); Programa de Modernizacion Tecnologica III, Contrato de Prestamo BID	This research was supported by grant from BiotecSur UE 127118 project to SNMP and DG, Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 00118 and PICT 00321) of Argentina to SNMP and EPC, and CNPq CBAB (Brazil-Argentina Biotechnology Center) grant 577047/2008-6 to DG that supported the DArT marker array development. PICT 00321 is below the Programa de Modernizacion Tecnologica III, Contrato de Prestamo BID 1728/OC-AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves A, 2012, WOOD SCI TECHNOL, V46, P157, DOI 10.1007/s00226-010-0383-x; Arumugasundaram S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028252; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Bundock PC, 2008, TREE GENET GENOMES, V4, P85, DOI 10.1007/s11295-007-0090-4; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Denis M, 2013, TREE GENET GENOMES, V9, P927, DOI [10.1007/s11295-013-0606-z, 10.1007/s11295-012-0528-1]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; ELKASSABY YA, 1982, GENETICS, V101, P103; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Freeman JS, 2013, NEW PHYTOL; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Freeman JS, 2009, TREE GENET GENOMES, V5, P713, DOI 10.1007/s11295-009-0222-0; Gion JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-301; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gonzalez-Martinez SC, 2008, HEREDITY, V101, P19, DOI 10.1038/hdy.2008.21; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Gutierrez L, 2011, PLANT GENOME-US, V4, P256, DOI 10.3835/plantgenome2011.07.0020; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Hudson CJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-240; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jones RC, 2002, CAN J FOREST RES, V32, P59, DOI 10.1139/x01-172; Kemper KE, 2012, GENET RES, V94, P191, DOI 10.1017/S0016672312000365; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kullan ARK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-60; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lepoittevin C, 2012, TREE GENET GENOMES, V8, P113, DOI 10.1007/s11295-011-0426-y; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lopez GA, 2001, SILVAE GENET, V50, P244; Lynch M, 1999, GENETICS, V152, P1753; Mandrou E, 2012, TREE GENET GENOMES, V8, P353, DOI 10.1007/s11295-011-0446-7; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marcucci Poltri S, 2011, BMC P, V5, pP33; Meuwissen THE, 2001, GENETICS, V157, P1819; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Quesada T, 2010, GENETICS, V186, P677, DOI 10.1534/genetics.110.117549; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; SAS Institute, 2003, SAS US GUID STAT VER; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thamarus K, 2004, THEOR APPL GENET, V109, P856, DOI 10.1007/s00122-004-1699-4; Thumma BR, 2010, TREE GENET GENOMES, V6, P877, DOI 10.1007/s11295-010-0298-6; Thumma BR, 2010, TREE GENET GENOMES, V6, P305, DOI 10.1007/s11295-009-0250-9; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Wegrzyn JL, 2010, NEW PHYTOL, V188, P515, DOI 10.1111/j.1469-8137.2010.03415.x; Weir B. S., 1996, GENETIC DATA ANAL; WILLIAMS P, 1992, ELLIS HOR S, P441; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	88	52	62	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81267	10.1371/journal.pone.0081267	http://dx.doi.org/10.1371/journal.pone.0081267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282578	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500080
J	Du, TY; Luo, HM; Qin, HC; Wang, F; Wang, Q; Xiang, Y; Zhang, Y				Du, Ting-yi; Luo, Hui-ming; Qin, Hai-chun; Wang, Fang; Wang, Qing; Xiang, Yang; Zhang, Yun			Circulating Serum Trefoil Factor 3 (TFF3) Is Dramatically Increased in Chronic Kidney Disease	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELLS; EXPRESSION; MARKER; IDENTIFICATION; BIOMARKERS; PROGNOSIS; DISCOVERY; PEPTIDES	Objectives: Trefoil factor 3 (TFF3) is a small peptide that plays an important role in mucosal protection, cell proliferation, and cell migration. The aberrant expression of TFF3 is correlated with gastrointestinal inflammation, solid tumors, and other clinical diseases. The objective of this study was to identify the distribution characteristics of serum TFF3 in common clinical diseases. Materials and Methods: A large prospective randomized study of 1,072 Chinese patients was performed using an enzyme-linked immunosorbent assay (ELISA) to examine the serum TFF3 concentrations in patients with different diseases. A matched case-control study was conducted on patients with chronic kidney disease (CKD) stages 1-5. Immunohistochemistry (IHC) was performed using renal tissues to determine the relationship between the severity of CKD and the serum and urine concentrations of TFF3 peptides. Results: The mean serum concentrations of TFF3 in patients with CKD, metastatic and secondary carcinoma (MC) and acute gastroenteritis (AG) (200.9 ng/ml, 95.7 ng/ml and 71.7 ng/ml, respectively) were significantly higher than those in patients with other common clinical diseases. A positive correlation tendency was observed between the serum TFF3 concentrations and the severity of CKD. The mean serum TFF3 values for CKD stages 1-5 were 23.6 ng/ml, 29.9 ng/ml, 54.9 ng/ml, 85.0 ng/ml and 176.6 ng/ml, respectively. The same trend was observed in the urine TFF3 concentrations and the CKD stages. The creatinine(Cr)-corrected concentrations of TFF3 in urine were 367.1 ng/mg.Cr, 910.6 ng/mg.Cr, 1,149.0 ng/mg.Cr, 1,610.0 ng/mg.Cr and 3,475.0 ng/mg.Cr for CKD stages 1-5, respectively. IHC revealed that TFF3 expression was concentrated in tubular epithelial cells. Conclusions: The influence of kidney injuries must be fully considered when performing clinical TFF3 research. Further studies on TFF3 in CKD will contribute to our understanding of its pathological roles and mechanisms in other diseases.	[Du, Ting-yi; Xiang, Yang; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China; [Du, Ting-yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Du, Ting-yi; Wang, Fang] First Peoples Hosp Yunnan Prov, Dept Clin Lab Med, Kunming, Yunnan Province, Peoples R China; [Luo, Hui-ming] First Peoples Hosp Yunnan Prov, Dept Nephrol, Kunming, Yunnan Province, Peoples R China; [Qin, Hai-chun] First Peoples Hosp Yunnan Prov, Dept Gastroenterol, Kunming, Yunnan Province, Peoples R China; [Wang, Qing] First Peoples Hosp Yunnan Prov, Dept Gynecol, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China.	zhangy@mail.kiz.ac.cn			National Natural Science Foundation of China (NSFC-Yunnan) [U1132601, 31270835]; 1/4OEthe National Basic Research Program of China (973 Program) [1/4OEthe National Basic Research Program of China (973 Program, 2010CB529800]; Chinese Academy of Sciences [KJZD-EW-L03]	National Natural Science Foundation of China (NSFC-Yunnan)(National Natural Science Foundation of China (NSFC)); 1/4OEthe National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (NSFC-Yunnan joint funding U1132601, 31270835) 1/4OEthe National Basic Research Program of China (973 Program, 2010CB529800), and the key research program of the Chinese Academy of Sciences (KJZD-EW-L03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2011, AM J NEPHROL, V34, P291, DOI 10.1159/000330699; Bignotti E, 2008, BRIT J CANCER, V99, P768, DOI 10.1038/sj.bjc.6604546; Bosma AJ, 2002, CLIN CANCER RES, V8, P1871; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; Ciacci C, 2002, CLIN EXP IMMUNOL, V130, P526, DOI 10.1046/j.1365-2249.2002.02011.x; Dhar DK, 2005, CLIN CANCER RES, V11, P6472, DOI 10.1158/1078-0432.CCR-05-0671; Hammond MEH, 2002, SEMIN ONCOL, V29, P213, DOI 10.1053/sonc.2002.32896; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hartwell L, 2006, NAT BIOTECHNOL, V24, P905, DOI 10.1038/nbt0806-905; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; JORGENSEN KH, 1982, REGUL PEPTIDES, V3, P207, DOI 10.1016/0167-0115(82)90126-4; Kalinina J, 2011, NEURO-ONCOLOGY, V13, P926, DOI 10.1093/neuonc/nor078; Khoury Thaer, 2005, Int J Gastrointest Cancer, V35, P171, DOI 10.1385/IJGC:35:3:171; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Korbet SM, 2002, SEMIN NEPHROL, V22, P254, DOI 10.1053/snep.2002.31713; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Meng JR, 2013, CLIN EXP MED, V13, P297, DOI 10.1007/s10238-012-0210-9; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Rinnert M, 2010, CELL TISSUE RES, V339, P639, DOI 10.1007/s00441-009-0913-8; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Samson MH, 2008, SCAND J CLIN LAB INV, V68, P369, DOI 10.1080/00365510701767862; Samson MH, 2011, CLIN CHEM LAB MED, V49, P2057, DOI 10.1515/CCLM.2011.712; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Takano T, 2009, ENDOCR J, V56, P9, DOI 10.1507/endocrj.K08E-105; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Vestergaard EM, 2006, CLIN CANCER RES, V12, P807, DOI 10.1158/1078-0432.CCR-05-1545; Vestergaard EM, 2002, CLIN CHEM, V48, P1689; Weigelt B, 2004, BRIT J CANCER, V90, P1531, DOI 10.1038/sj.bjc.6601659; Weigelt B, 2003, BRIT J CANCER, V88, P1091, DOI 10.1038/sj.bjc.6600868; Whittier WL, 2004, CURR OPIN NEPHROL HY, V13, P661, DOI 10.1097/00041552-200411000-00013; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Xue H, 2010, J PROTEOME RES, V9, P545, DOI 10.1021/pr9008817; Yamachika T, 2002, CLIN CANCER RES, V8, P1092; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu Y, 2010, NAT BIOTECHNOL, V28, P470, DOI 10.1038/nbt.1624; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; Zhang Y, 2011, INT J BIOCHEM CELL B, V43, P1277, DOI 10.1016/j.biocel.2011.05.008	47	33	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80271	10.1371/journal.pone.0080271	http://dx.doi.org/10.1371/journal.pone.0080271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282531	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500032
J	Haley, NJ; Van de Motter, A; Carver, S; Henderson, D; Davenport, K; Seelig, DM; Mathiason, C; Hoover, E				Haley, Nicholas J.; Van de Motter, Alexandra; Carver, Scott; Henderson, Davin; Davenport, Kristen; Seelig, Davis M.; Mathiason, Candace; Hoover, Edward			Prion-Seeding Activity in Cerebrospinal Fluid of Deer with Chronic Wasting Disease	PLOS ONE			English	Article							CERVUS-ELAPHUS-NELSONI; ROCKY-MOUNTAIN ELK; CREUTZFELDT-JAKOB-DISEASE; QUAKING-INDUCED CONVERSION; RANGING MULE DEER; SPONGIFORM ENCEPHALOPATHY; LYMPHOID-TISSUES; ODOCOILEUS-VIRGINIANUS; CYCLIC AMPLIFICATION; INFECTIOUS PRIONS	Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a uniformly fatal family of neurodegenerative diseases in mammals that includes chronic wasting disease (CWD) of cervids. The early and ante-mortem identification of TSE-infected individuals using conventional western blotting or immunohistochemistry (IHC) has proven difficult, as the levels of infectious prions in readily obtainable samples, including blood and bodily fluids, are typically beyond the limits of detection. The development of amplification-based seeding assays has been instrumental in the detection of low levels of infectious prions in clinical samples. In the present study, we evaluated the cerebrospinal fluid (CSF) of CWD-exposed (n=44) and naive (n=4) deer (n=48 total) for CWD prions (PrPd) using two amplification assays: serial protein misfolding cyclic amplification with polytetrafluoroethylene beads (sPMCAb) and real-time quaking induced conversion (RT-QuIC) employing a truncated Syrian hamster recombinant protein substrate. Samples were evaluated blindly in parallel with appropriate positive and negative controls. Results from amplification assays were compared to one another and to obex immunohistochemistry, and were correlated to available clinical histories including CWD inoculum source (e. g. saliva, blood), genotype, survival period, and duration of clinical signs. We found that both sPMCAb and RT-QuIC were capable of amplifying CWD prions from cervid CSF, and results correlated well with one another. Prion seeding activity in either assay was observed in approximately 50% of deer with PrPd detected by IHC in the obex region of the brain. Important predictors of amplification included duration of clinical signs and time of first tonsil biopsy positive results, and ultimately the levels of PrPd identified in the obex by IHC. Based on our findings, we expect that both sPMCAb and RT-QuIC may prove to be useful detection assays for the detection of prions in CSF.	[Haley, Nicholas J.; Van de Motter, Alexandra; Henderson, Davin; Davenport, Kristen; Mathiason, Candace; Hoover, Edward] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Carver, Scott] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Seelig, Davis M.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA	Colorado State University; University of Tasmania; University of Minnesota System; University of Minnesota Twin Cities	Haley, NJ (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	njhaley@lamar.colostate.edu	Davenport, Kristen A/O-3327-2017; Mathiason, Candace K/E-7843-2017; Carver, Scott/J-7654-2014; Mathiason, Candace/H-9769-2017	Mathiason, Candace K/0000-0002-5920-4556; Carver, Scott/0000-0002-3579-7588; Mathiason, Candace/0000-0002-5920-4556; Davenport, Kristen/0000-0003-3496-2454	National Center for Research Resources, National Institutes of Health [K01OD010994]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010994] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Center for Research Resources, National Institutes of Health under award number K01OD010994. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Fournier JG, 2008, ACTA NEUROPATHOL, V115, P643, DOI 10.1007/s00401-008-0365-3; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Haley NJ, 2011, J VIROL; Haley NJ, 2012, J GEN VIROL; Henderson DM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074377, DOI 10.1371/J0URNAL.P0NE.0074377.PUBMED:24040235]; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Keane DP, 2008, J VET DIAGN INVEST, V20, P58, DOI 10.1177/104063870802000110; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Monello RJ, 2013, J WILDLIFE DIS, V49, P270, DOI 10.7589/2011-12-362; Nichols TA, 2012, J VET DIAGN INVEST, V24, P746, DOI 10.1177/1040638712448060; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Spraker TR, 2004, VET REC, V155, P295, DOI 10.1136/vr.155.10.295; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; WELLS GAH, 1989, VET REC, V125, P521, DOI 10.1136/vr.125.21.521; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	39	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81488	10.1371/journal.pone.0081488	http://dx.doi.org/10.1371/journal.pone.0081488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282599	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500101
J	Moran, MT; Tare, M; Kango-Singh, M; Singh, A				Moran, Michael T.; Tare, Meghana; Kango-Singh, Madhuri; Singh, Amit			Homeotic Gene teashirt (tsh) Has a Neuroprotective Function in Amyloid-Beta 42 Mediated Neurodegeneration	PLOS ONE			English	Article							PHOTORECEPTOR AXON GUIDANCE; DROSOPHILA EYE DEVELOPMENT; ALZHEIMERS-DISEASE; CELL-SURVIVAL; MORPHOGENETIC FURROW; NUCLEAR-LOCALIZATION; TARGETED EXPRESSION; ECTOPIC EYES; WINGLESS; HOMOTHORAX	Background: Alzheimer's disease (AD) is a debilitating age related progressive neurodegenerative disorder characterized by the loss of cognition, and eventual death of the affected individual. One of the major causes of AD is the accumulation of Amyloid-beta 42 (A beta 42) polypeptides formed by the improper cleavage of amyloid precursor protein (APP) in the brain. These plaques disrupt normal cellular processes through oxidative stress and aberrant signaling resulting in the loss of synaptic activity and death of the neurons. However, the detailed genetic mechanism(s) responsible for this neurodegeneration still remain elusive. Methodology/ Principle Findings: We have generated a transgenic Drosophila eye model where high levels of human A beta 42 is misexpressed in the differentiating photoreceptor neurons of the developing eye, which phenocopy Alzheimer's like neuropathology in the neural retina. We have utilized this model for a gain of function screen using members of various signaling pathways involved in the development of the fly eye to identify downstream targets or modifiers of A beta 42 mediated neurodegeneration. We have identified the homeotic gene teashirt (tsh) as a suppressor of the A beta 42 mediated neurodegenerative phenotype. Targeted misexpression of tsh with A beta 42 in the differentiating retina can significantly rescue neurodegeneration by blocking cell death. We found that Tsh protein is absent/downregulated in the neural retina at this stage. The structure function analysis revealed that the PLDLS domain of Tsh acts as an inhibitor of the neuroprotective function of tsh in the Drosophila eye model. Lastly, we found that the tsh paralog, tiptop (tio) can also rescue A beta 42 mediated neurodegeneration. Conclusions/Significance: We have identified tsh and tio as new genetic modifiers of A beta 42 mediated neurodegeneration. Our studies demonstrate a novel neuroprotective function of tsh and its paralog tio in A beta 42 mediated neurodegeneration. The neuroprotective function of tsh is independent of its role in retinal determination.	[Moran, Michael T.; Tare, Meghana; Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Kango-Singh, Madhuri; Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton	Kango-Singh, M (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	asingh1@udayton.edu; mkangosingh1@udayton.edu	Singh, Amit/T-5619-2019	Singh, Amit/0000-0002-2962-2255	National Institute of Health (NIH)	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Atkins M, 2009, DEV DYNAM, V238, P2139, DOI 10.1002/dvdy.22034; Azpiazu N, 1998, GENE DEV, V12, P261, DOI 10.1101/gad.12.2.261; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Bessa J, 2009, DEV DYNAM, V238, P19, DOI 10.1002/dvdy.21808; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Brachmann CB, 2003, TRENDS GENET, V19, P91, DOI 10.1016/S0168-9525(02)00041-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Cowan CM, 2010, BIOCHEM SOC T, V38, P988, DOI 10.1042/BST0380988; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Datta RR, 2011, DEV BIOL, V360, P391, DOI 10.1016/j.ydbio.2011.09.030; Datta RR, 2009, DEV DYNAM, V238, P2202, DOI 10.1002/dvdy.21927; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; Gallet A, 1998, CURR BIOL, V8, P893, DOI 10.1016/S0960-9822(07)00369-7; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Go MJ, 1998, DEVELOPMENT, V125, P2031; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Inbal A, 2001, DEVELOPMENT, V128, P3405; Jaw TJ, 2000, MECH DEVELOP, V91, P279, DOI 10.1016/S0925-4773(99)00316-0; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; LAAH TEM, 1993, DEV DROSOPHILA MELAN, P1363; Laugier E, 2005, DEV BIOL, V283, P446, DOI 10.1016/j.ydbio.2005.05.005; Legent Kevin, 2008, V469, P141, DOI 10.1007/978-1-60327-469-2_12; MA CY, 1995, DEVELOPMENT, V121, P2279; McCall K, 2004, METH MOL B, V247, P431; Mehlen P, 2005, J NEUROBIOL, V64, P357, DOI 10.1002/neu.20167; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Newsome TP, 2000, DEVELOPMENT, V127, P851; OBRIEN RJ, 2010, ANN REV NEUROSCIENCE; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; RINCONLIMAS DE, 2012, CURR PHARM DES; Royet J, 1997, DEVELOPMENT, V124, P4793; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shen WP, 1997, DEVELOPMENT, V124, P45; Singh A, 2005, GENETICS, V171, P169, DOI 10.1534/genetics.105.044180; Singh A, 2004, MECH DEVELOP, V121, P365, DOI 10.1016/j.mod.2004.02.005; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh A, 2005, AD DEV BIOL, V14, P59, DOI 10.1016/S1574-3349(04)14004-0; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Singh A, 2012, DEV DYNAM, V241, P1, DOI 10.1002/dvdy.23712; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219; SUN YH, 1995, GENETICS, V141, P1075; SWARUP S, 2012, COLD SPRING HARB PER, V4, P35229; Tare M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024361; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Tsachaki M, 2012, DEV DYNAM, V241, P40, DOI 10.1002/dvdy.22738; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wolfe MS, 2013, NAT MED, V19, P22, DOI 10.1038/nm.3053; Wolff Tanya, 1993, P1277; Yeh PA, 2012, INT J BIOL SCI, V8, P606, DOI 10.7150/ijbs.3782; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	82	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80829	10.1371/journal.pone.0080829	http://dx.doi.org/10.1371/journal.pone.0080829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282556	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500058
J	Warren, S; Wan, XF; Conant, G; Korkin, D				Warren, Samantha; Wan, Xiu-Feng; Conant, Gavin; Korkin, Dmitry			Extreme Evolutionary Conservation of Functionally Important Regions in H1N1 Influenza Proteome	PLOS ONE			English	Article							A VIRUS; STRUCTURAL BASIS; BINDING-SITE; RNA-BINDING; PREEXISTING IMMUNITY; NEUTRALIZING EPITOPE; ANTIGENIC STRUCTURE; NUCLEOPROTEIN GENE; HEMAGGLUTININ GENE; CRYSTAL-STRUCTURE	The H1N1 subtype of influenza A virus has caused two of the four documented pandemics and is responsible for seasonal epidemic outbreaks, presenting a continuous threat to public health. Co-circulating antigenically divergent influenza strains significantly complicates vaccine development and use. Here, by combining evolutionary, structural, functional, and population information about the H1N1 proteome, we seek to answer two questions: (1) do residues on the protein surfaces evolve faster than the protein core residues consistently across all proteins that constitute the influenza proteome? and (2) in spite of the rapid evolution of surface residues in influenza proteins, are there any protein regions on the protein surface that do not evolve? To answer these questions, we first built phylogenetically-aware models of the patterns of surface and interior substitutions. Employing these models, we found a single coherent pattern of faster evolution on the protein surfaces that characterizes all influenza proteins. The pattern is consistent with the events of inter-species reassortment, the worldwide introduction of the flu vaccine in the early 80's, as well as the differences caused by the geographic origins of the virus. Next, we developed an automated computational pipeline to comprehensively detect regions of the protein surface residues that were 100% conserved over multiple years and in multiple host species. We identified conserved regions on the surface of 10 influenza proteins spread across all avian, swine, and human strains; with the exception of a small group of isolated strains that affected the conservation of three proteins. Surprisingly, these regions were also unaffected by genetic variation in the pandemic 2009 H1N1 viral population data obtained from deep sequencing experiments. Finally, the conserved regions were intrinsically related to the intra-viral macromolecular interaction interfaces. Our study may provide further insights towards the identification of novel protein targets for influenza antivirals.	[Warren, Samantha; Korkin, Dmitry] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Wan, Xiu-Feng] Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA; [Conant, Gavin] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Conant, Gavin; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO USA; [Korkin, Dmitry] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Mississippi State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Korkin, D (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	korkin@korkinlab.org	Conant, Gavin/R-7022-2019	Conant, Gavin/0000-0002-8677-4933	National Science Foundation [DBI-0845196]; Department of Education GAANN Fellowship [P200A100053]; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103646] Funding Source: NIH RePORTER; Direct For Biological Sciences [0845196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Education GAANN Fellowship(US Department of Education); Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge funding from National Science Foundation (DBI-0845196 to DK) and the Department of Education GAANN Fellowship (P200A100053 to SW). G.C.C. is supported by the Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdussamad J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-6; Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Bachmann PA, 1989, SWINE INFLUENZA VIRU, P193; Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Blok V, 1996, J GEN VIROL, V77, P1025, DOI 10.1099/0022-1317-77-5-1025; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Brown IH, 1998, J GEN VIROL, V79, P2947, DOI 10.1099/0022-1317-79-12-2947; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; Conant GC, 2009, TRENDS GENET, V25, P377, DOI 10.1016/j.tig.2009.07.004; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Darapaneni V, 2009, J GEN VIROL, V90, P2124, DOI 10.1099/vir.0.011270-0; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Elton D, 1999, VIROLOGY, V260, P190, DOI 10.1006/viro.1999.9818; FEDSON DS, 1983, AM J PUBLIC HEALTH, V73, P442, DOI 10.2105/AJPH.73.4.442; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GAYDOS JC, 1977, J INFECT DIS, V136, pS356, DOI 10.1093/infdis/136.Supplement_3.S356; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; KOBAYASHI M, 1994, J VIROL, V68, P8433, DOI 10.1128/JVI.68.12.8433-8436.1994; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; Kuang XY, 2012, NUCLEIC ACIDS RES, V40, pD501, DOI 10.1093/nar/gkr1128; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Matsuzaki Y, 2003, J VIROL, V77, P871, DOI 10.1128/JVI.77.2.871-881.2003; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; NOBLE S, 1993, J GEN VIROL, V74, P1197, DOI 10.1099/0022-1317-74-6-1197; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; ORLICH M, 1994, VIROLOGY, V204, P462, DOI 10.1006/viro.1994.1555; Panjkovich A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-9; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Phongphanphanee S, 2010, J AM CHEM SOC, V132, P9782, DOI 10.1021/ja1027293; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULTZ U, 1991, VIROLOGY, V183, P61, DOI 10.1016/0042-6822(91)90118-U; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Swapna LS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00334; Tharakaraman K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01822; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Wang J, 2011, CURR OPIN STRUC BIOL, V21, P68, DOI 10.1016/j.sbi.2010.12.002; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3410889; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Zinder D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003104; Zurcher T, 1996, J GEN VIROL, V77, P1745, DOI 10.1099/0022-1317-77-8-1745	95	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81027	10.1371/journal.pone.0081027	http://dx.doi.org/10.1371/journal.pone.0081027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282564	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500066
J	Aoyama, D; Hashimoto, N; Sakamoto, K; Kohnoh, T; Kusunose, M; Kimura, M; Ogata, R; Imaizumi, K; Kawabe, T; Hasegawa, Y				Aoyama, Daisuke; Hashimoto, Naozumi; Sakamoto, Koji; Kohnoh, Takashi; Kusunose, Masaaki; Kimura, Motohiro; Ogata, Ryo; Imaizumi, Kazuyoshi; Kawabe, Tsutomu; Hasegawa, Yoshinori			Involvement of TGF beta-Induced Phosphorylation of the PTEN C-Terminus on TGF beta-Induced Acquisition of Malignant Phenotypes in Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN-KINASE CK2; E-CADHERIN; CATENIN; PHOSPHATASE; EXPRESSION; ADHESION; OVEREXPRESSION; ACTIVATION; REQUIRES	Transforming growth factor beta (TGF beta) derived from the tumor microenvironment induces malignant phenotypes such as epithelial-mesenchymal transition (EMT) and aberrant cell motility in lung cancers. TGF beta-induced translocation of beta-catenin from E-cadherin complexes into the cytoplasm is involved in the transcription of EMT target genes. PTEN (phosphatase and tensin homologue deleted from chromosome 10) is known to exert phosphatase activity by binding to E-cadherin complexes via beta-catenin, and recent studies suggest that phosphorylation of the PTEN C-terminus tail might cause loss of this PTEN phosphatase activity. However, whether TGF beta can modulate both beta-catenin translocation and PTEN phosphatase activity via phosphorylation of the PTEN C-terminus remains elusive. Furthermore, the role of phosphorylation of the PTEN C-terminus in TGF beta-induced malignant phenotypes has not been evaluated. To investigate whether modulation of phosphorylation of the PTEN C-terminus can regulate malignant phenotypes, here we established lung cancer cells expressing PTEN protein with mutation of phosphorylation sites in the PTEN C-terminus (PTEN4A). We found that TGF beta stimulation yielded a two-fold increase in the phosphorylated -PTEN/PTEN ratio. Expression of PTEN4A repressed TGF beta-induced EMT and cell motility even after snail expression. Our data showed that PTEN4A might repress EMT through complete blockade of beta-catenin translocation into the cytoplasm, besides the inhibitory effect of PTEN4A on TGF beta-induced activation of smad-independent signaling pathways. In a xenograft model, the tumor growth ratio was repressed in cells expressing PTEN4A. Taken together, these data suggest that phosphorylation sites in the PTEN C-terminus might be a therapeutic target for TGF beta-induced malignant phenotypes in lung cancer cells.	[Aoyama, Daisuke; Hashimoto, Naozumi; Sakamoto, Koji; Kohnoh, Takashi; Kusunose, Masaaki; Kimura, Motohiro; Ogata, Ryo; Hasegawa, Yoshinori] Nagoya Univ, Dept Resp Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Imaizumi, Kazuyoshi] Fujita Hlth Univ, Dept Resp Med & Allergy, Toyoake, Aichi, Japan; [Kawabe, Tsutomu] Nagoya Univ, Grad Sch Hlth Sci, Dept Med Technol, Nagoya, Aichi 4648601, Japan	Nagoya University; Fujita Health University; Nagoya University	Hashimoto, N (corresponding author), Nagoya Univ, Dept Resp Med, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	hashinao@med.nagoya-u.ac.jp	Hasegawa, Yoshinori/I-1277-2012; SAKAMOTO, Koji/E-2138-2017; HASHIMOTO, NAOZUMI/I-1979-2012; Kawabe, Tsutomu/I-6277-2014; Kimura, Motohiro/Q-3375-2016	SAKAMOTO, Koji/0000-0002-1794-576X; Kawabe, Tsutomu/0000-0002-9319-9930; Kimura, Motohiro/0000-0001-5251-0684	Kowa Life Science Foundation; Ministry of Health, Labour and Welfare, Japan;  [21590987];  [24591162]	Kowa Life Science Foundation; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); ; 	This work was supported by Kowa Life Science Foundation and Grant-in-Aid for Scientific Research (C) (21590987 and 24591162). This study was partly supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Chuang CY, 2009, TOXICOL LETT, V191, P132, DOI 10.1016/j.toxlet.2009.08.015; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Deng BQ, 2010, MOL CELL BIOCHEM, V340, P21, DOI 10.1007/s11010-010-0396-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Ikenoue T, 2008, CANCER RES, V68, P6908, DOI 10.1158/0008-5472.CAN-08-1107; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaur P, 2008, CARCINOGENESIS, V29, P2210, DOI 10.1093/carcin/bgn201; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee HY, 2003, J BIOL CHEM, V278, P23630, DOI 10.1074/jbc.M300997200; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Lima-Fernandes E, 2011, EMBO J, V30, P2557, DOI 10.1038/emboj.2011.178; Liu TJ, 2002, AM J RESP CELL MOL, V26, P534, DOI 10.1165/ajrcmb.26.5.4668; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Nakashima H, 2012, MOL CARCINOGEN, V51, P400, DOI 10.1002/mc.20802; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Sakamoto K, 2012, AM J PHYSIOL-LUNG C, V303, pL43, DOI 10.1152/ajplung.00061.2012; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shehata M, 2010, BLOOD, V116, P2513, DOI 10.1182/blood-2009-10-248054; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Takagi Y, 2009, AM J PHYSIOL-LUNG C, V297, pL420, DOI 10.1152/ajplung.90477.2008; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81133	10.1371/journal.pone.0081133	http://dx.doi.org/10.1371/journal.pone.0081133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278390	Green Submitted, Green Published, gold			2022-12-27	WOS:000327541700050
J	Gillingham, MAF; Cezilly, F; Wattier, R; Bechet, A				Gillingham, Mark A. F.; Cezilly, Frank; Wattier, Remi; Bechet, Arnaud			Evidence for an Association between Post-Fledging Dispersal and Microsatellite Multilocus Heterozygosity in a Large Population of Greater Flamingos	PLOS ONE			English	Article							PHOENICOPTERUS-RUBER-ROSEUS; SPATIALLY STRUCTURED POPULATIONS; CAPTURE-RECAPTURE; FITNESS CORRELATIONS; BODY CONDITION; INBREEDING AVOIDANCE; MODEL SELECTION; NATAL DISPERSAL; COMPETITION; PHILOPATRY	Dispersal can be divided into three stages: departure, transience and settlement. Despite the fact that theoretical studies have emphasized the importance of heterozygosity on dispersal strategies, empirical evidence of its effect on different stages of dispersal is lacking. Here, using multi-event capture-mark-recapture models, we show a negative association between microsatellite multilocus heterozygosity (MLH; 10 loci; n = 1023) and post-fledging dispersal propensity for greater flamingos, Phoenicopterus roseus, born in southern France. We propose that the negative effects of inbreeding depression affects competitive ability and therefore more homozygous individuals are more likely to disperse because they are less able to compete within the highly saturated natal site. Finally, a model with the effect of MLH on propensity of post-fledgling dispersers to disperse to the long-distance sites of Africa was equivalent to the null model, suggesting that MLH had low to no effect on dispersal distance. Variations in individual genetic quality thus result in context-dependent heterogeneity in dispersal strategies at each stage of dispersal. Our results have important implications on fitness since sites visited early in life are known to influence site selection later on in life and future survival.	[Gillingham, Mark A. F.; Cezilly, Frank; Wattier, Remi] Univ Bourgogne, Equipe Ecol Evolut, CNRS, UMR Biogeosci 6282, Dijon, France; [Gillingham, Mark A. F.; Bechet, Arnaud] Ctr Rech Tour Valat, Arles, France; [Gillingham, Mark A. F.] Leibniz Inst Zoo & Wildlife Res, Dpt Evolutionary Genet, Berlin, Germany; [Cezilly, Frank] Insitut Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Leibniz Institut fur Zoo und Wildtierforschung	Gillingham, MAF (corresponding author), Univ Bourgogne, Equipe Ecol Evolut, CNRS, UMR Biogeosci 6282, Dijon, France.	Mark.Gillingham@u-bourgogne.fr	Béchet, Arnaud/AAA-4398-2021; Gillingham, Mark AF/B-2152-2012; Wattier, Remi/ABC-3410-2021	Béchet, Arnaud/0000-0002-0330-6342; 	TOTAL foundation; Conseil Regional de Bourgogne; MAVA foundation; Centre National de la Recherche Scientifique (CNRS)	TOTAL foundation(Total SA); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); MAVA foundation; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This study was funded by the TOTAL foundation, the Conseil Regional de Bourgogne, the MAVA foundation, and the Centre National de la Recherche Scientifique (CNRS). Mark Gillingham was supported by a post-doctoral grant from the Conseil Regional de Bourgogne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2005, BIOL CONSERV, V125, P183, DOI 10.1016/j.biocon.2005.02.018; Anderson P.K, 1989, DISPERSAL RODENTS RE; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Barbraud C, 2003, J ANIM ECOL, V72, P246, DOI 10.1046/j.1365-2656.2003.00695.x; Bechet A, 2008, IBIS, V150, P69, DOI 10.1111/j.1474-919X.2007.00740.x; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; BULMER MG, 1973, HEREDITY, V30, P313, DOI 10.1038/hdy.1973.41; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CEZILLY F, 1995, IBIS, V137, P543, DOI 10.1111/j.1474-919X.1995.tb03264.x; Cezilly F, 1996, ECOLOGY, V77, P1143, DOI 10.2307/2265583; CEZILLY F, 1995, ECOLOGY, V76, P20, DOI 10.2307/1940628; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Choquet R., 2011, E SURGE 1 8 USERS MA; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Geraci J, 2012, J AVIAN BIOL, V43, P341, DOI 10.1111/j.1600-048X.2012.05549.x; Gillingham MAF, 2012, MOL ECOL, V21, P4024, DOI 10.1111/j.1365-294X.2012.05669.x; GREEN RE, 1989, J ANIM ECOL, V58, P543, DOI 10.2307/4847; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hadany L, 2004, J EVOLUTION BIOL, V17, P1328, DOI 10.1111/j.1420-9101.2004.00768.x; JOHNSON A, 1993, ARDEA, V81, P25; Johnson A, 2007, GREATER FLAMINGO; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; MITTON JB, 1997, SELECTION NATURAL PO; MORTON ML, 1991, ORNIS SCAND, V22, P98, DOI 10.2307/3676540; MOTRO U, 1991, AM NAT, V137, P108, DOI 10.1086/285148; Nager RG, 1996, OECOLOGIA, V107, P204, DOI 10.1007/BF00327904; Nichols J., 2001, DISPERSAL; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; Olano-Marin J, 2011, MOL ECOL, V20, P4028, DOI 10.1111/j.1365-294X.2011.05177.x; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Perrin Nicolas, 2001, P123; Pradel R, 2003, BIOMETRICS, V59, P43, DOI 10.1111/1541-0420.00006; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, ECOLOGY, V78, P1431; Rendon MA, 2001, BEHAV ECOL SOCIOBIOL, V50, P55, DOI 10.1007/s002650100326; Roze D, 2009, J EVOLUTION BIOL, V22, P1221, DOI 10.1111/j.1420-9101.2009.01735.x; Sanz-Aguilar A, 2012, J ANIM ECOL, V81, P1171, DOI 10.1111/j.1365-2656.2012.01997.x; Schiegg K, 2006, BIOL CONSERV, V131, P544, DOI 10.1016/j.biocon.2006.03.001; Selonen V, 2010, J ANIM ECOL, V79, P1093, DOI 10.1111/j.1365-2656.2010.01714.x; Shafer ABA, 2011, BIOL LETTERS, V7, P433, DOI 10.1098/rsbl.2010.1119; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Szulkin M, 2008, P R SOC B, V275, P703, DOI 10.1098/rspb.2007.0989; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x	54	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81118	10.1371/journal.pone.0081118	http://dx.doi.org/10.1371/journal.pone.0081118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278385	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700048
J	Libro, S; Kaluziak, ST; Vollmer, SV				Libro, Silvia; Kaluziak, Stefan T.; Vollmer, Steven V.			RNA-seq Profiles of Immune Related Genes in the Staghorn Coral Acropora cervicornis Infected with White Band Disease	PLOS ONE			English	Article							C-TYPE-LECTIN; REEF-BUILDING CORALS; TOLL-LIKE RECEPTOR-2; CELL-DEATH; ARACHIDONIC-ACID; CARIBBEAN CORAL; ANTHOPLEURA-ELEGANTISSIMA; CA2+-DEPENDENT APOPTOSIS; PROSTAGLANDIN SYNTHESIS; BACTERIAL PATHOGENS	Coral diseases are among the most serious threats to coral reefs worldwide, yet most coral diseases remain poorly understood. How the coral host responds to pathogen infection is an area where very little is known. Here we used next-generation RNA-sequencing (RNA-seq) to produce a transcriptome-wide profile of the immune response of the Staghorn coral Acropora cervicornis to White Band Disease (WBD) by comparing infected versus healthy (asymptomatic) coral tissues. The transcriptome of A. cervicornis was assembled de novo from A-tail selected Illumina mRNA-seq data from whole coral tissues, and parsed bioinformatically into coral and non-coral transcripts using existing Acropora genomes in order to identify putative coral transcripts. Differentially expressed transcripts were identified in the coral and non-coral datasets to identify genes that were up-and down-regulated due to disease infection. RNA-seq analyses indicate that infected corals exhibited significant changes in gene expression across 4% (1,805 out of 47,748 transcripts) of the coral transcriptome. The primary response to infection included transcripts involved in macrophage-mediated pathogen recognition and ROS production, two hallmarks of phagocytosis, as well as key mediators of apoptosis and calcium homeostasis. The strong up-regulation of the enzyme allene oxide synthase-lipoxygenase suggests a key role of the allene oxide pathway in coral immunity. Interestingly, none of the three primary innate immune pathways - Toll-like receptors (TLR), Complement, and prophenoloxydase pathways, were strongly associated with the response of A. cervicornis to infection. Five-hundred and fifty differentially expressed non-coral transcripts were classified as metazoan (n = 84), algal or plant (n = 52), fungi (n = 24) and protozoans (n = 13). None of the 52 putative Symbiodinium or algal transcript had any clear immune functions indicating that the immune response is driven by the coral host, and not its algal symbionts.	[Libro, Silvia; Kaluziak, Stefan T.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Libro, S (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	libro.s@husky.neu.edu	libro, silvia/AAM-7256-2021; Kaluziak, Stefan T/AAW-5009-2020	Kaluziak, Stefan T/0000-0002-7531-2602; libro, silvia/0000-0003-0230-3876	NSF [NSF-OCE 0751666]; Division Of Ocean Sciences [0848345] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Grant funding was provided by the NSF to Steve Vollmer (NSF-OCE 0751666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Alikhani M, 2004, J DENT RES, V83, P671, DOI 10.1177/154405910408300903; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; Ayala P, 2002, INFECT IMMUN, V70, P5965, DOI 10.1128/IAI.70.11.5965-5971.2002; BRASH AR, 1987, J BIOL CHEM, V262, P15829; Brown BE, 1985, ADV MARINE BIOL; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Chapman D.D., 1974, COELENTERATE BIOL RE, P2; Consortium U, 2012, REORGANIZING PROTEIN; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1988, TETRAHEDRON LETT, V29, P2555, DOI 10.1016/S0040-4039(00)86110-9; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Dunn SR, 2009, ISJ-INVERT SURVIV J, V6, P7; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; DYKENS JA, 1992, J EXP BIOL, V168, P219; Ellner SP, 2007, AM NAT, V170, pE143, DOI 10.1086/522841; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Gao LY, 1999, INFECT IMMUN, V67, P4886, DOI 10.1128/IAI.67.9.4886-4894.1999; Gignoux-Wolfsohn SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00804; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hogarth WT, 2005, FED REGISTER, V70, P24359; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hutton MC, 1996, BIOL BULL, V191, P441, DOI [10.2307/1543017, DOI 10.2307/1543017]; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Langmead B., 2009, ULTRAFAST MEMORY EFF; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, ACROPORA MILLE UNPUB; Mittler R, 1997, J CELL SCI, V110, P1333; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Olano CT, 2000, J INVERTEBR PATHOL, V76, P176, DOI 10.1006/jipa.2000.4974; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; PATTERSON MJ, 1979, J INVERTEBR PATHOL, V33, P189, DOI 10.1016/0022-2011(79)90152-6; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; PETERS EC, 1983, J INVERTEBR PATHOL, V41, P394, DOI 10.1016/0022-2011(83)90260-4; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Rojas M, 1999, J IMMUNOL, V162, P6122; Samuelsson B, 1991, Z RHEUMATOLOGIE S1, V50, P3; Schwarz RS, 2008, DEV COMP IMMUNOL, V32, P1192, DOI 10.1016/j.dci.2008.03.007; Seipp S, 2001, DEVELOPMENT, V128, P4891; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Suzuki E, 2007, EXP CELL RES, V313, P2451, DOI 10.1016/j.yexcr.2007.03.041; Suzuki N, 1996, J IMMUNOL, V156, P128; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Varvas K, 1999, J BIOL CHEM, V274, P9923, DOI 10.1074/jbc.274.15.9923; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; WAITE M, 1979, BIOCHEM BIOPH RES CO, V90, P984, DOI 10.1016/0006-291X(79)91924-7; Wang ZJ, 2009, PLANT SIGNAL BEHAV, V4, P165, DOI 10.4161/psb.4.3.7722; Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; Weiss Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-400; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; YOUNG JAC, 1974, J MAR BIOL ASSOC UK, V54, P599, DOI 10.1017/S0025315400022773; Yu W, 2002, LAB INVEST, V82, P1229; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Ziegler J, 2001, PHYTOCHEMISTRY, V58, P729, DOI 10.1016/S0031-9422(01)00284-9; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	98	80	80	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81821	10.1371/journal.pone.0081821	http://dx.doi.org/10.1371/journal.pone.0081821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278460	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800142
J	Wang, P; Du, B; Yin, WZ; Wang, XR; Zhu, W				Wang, Ping; Du, Bo; Yin, Wanzhong; Wang, Xinrui; Zhu, Wei			Resveratrol Attenuates CoCl2-Induced Cochlear Hair Cell Damage through Upregulation of Sirtuin1 and NF-kappa B Deacetylation	PLOS ONE			English	Article							CHLORIDE-INDUCED APOPTOSIS; OXIDATIVE STRESS; HYPOXIA-ISCHEMIA; HEARING-LOSS; EXPRESSION; TRANSCRIPTION; OTOTOXICITY; INHIBITION; SURVIVAL; ASPHYXIA	The goals of this study were to investigate the effects of hypoxia on cochlear hair cell damage, and to explore the role of sirtuin1 in hypoxia-induced hair cell damage. Cochlear organotypic cultures from postnatal day 4 rats were used in this study. Hypoxia was induced by treating cochlear explants with CoCl2. Cochlear cultures were treated with CoCl2 alone or in combination with the sirtuin1 activator resveratrol and the sirtuin1 inhibitor sirtinol. Hair cell damage was identified by phalloidin staining and imaged using scanning electron microscopy. RT-PCR and Western blot analyses were used to detect the expression of sirtuin1 and acetylated nuclear factor-kappa B (NF-kappa B). Low concentrations of CoCl2 (100-200 mu M) did not cause an obvious change in the number and morphology of hair cells, whereas higher concentrations of CoCl2 (300-400 mu M) induced swelling of hair cells, accompanied by cell loss. Increased sirtuin1 expression was induced by CoCl2 at 100 to 200 mu M, but not at 400 mu M. NF-kappa B acetylation was significantly increased in explants treated with 400 mu M CoCl2. Pretreatment with resveratrol prevented CoCl2-induced hair cell loss and acetylation of NF-kappa B. The protective effect of resveratrol was significantly reduced by sirtinol. CoCl2 induces hair cell damage in organotypic cochleae cultures. Resveratrol attenuates CoCl2-induced cochlear hair cell damage possibly via activation of sirtuin1, which deacetylates NF-kappa B.	[Wang, Ping; Du, Bo; Yin, Wanzhong; Zhu, Wei] Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Peoples R China; [Wang, Xinrui] Jilin Univ, Inst Zoonoses, Minist Educ, Key Lab Zoonoses, Changchun 130023, Peoples R China	Jilin University; Jilin University	Zhu, W (corresponding author), Jilin Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Changchun 130023, Peoples R China.	zhuwei30000@163.com			National Science Foundation of China [81260422]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (Grant No. 81260422). The above funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medjaden Bioscience Limited assisted in the preparation of this manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Amarjargal N, 2008, PHYSIOL RES, V57, P631, DOI 10.33549/physiolres.931259; Amarjargal N, 2009, PHYSIOL RES, V58, P895, DOI 10.33549/physiolres.931466; Borg E, 1997, SCAND AUDIOL, V26, P77, DOI 10.3109/01050399709074979; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen JX, 2009, NEUROSCI BULL, V25, P67, DOI 10.1007/s12264-009-1215-6; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chen SL, 2010, CLIN EXP PHARMACOL P, V37, P316, DOI 10.1111/j.1440-1681.2009.05289.x; Dai P, 2004, ACTA OTO-LARYNGOL, V124, P130, DOI 10.1080/00016480410016586; Ding D L, 1993, Zhonghua Er Bi Yan Hou Ke Za Zhi, V28, P265; Erdem T, 2012, EUR ARCH OTO-RHINO-L, V269, P2185, DOI 10.1007/s00405-011-1883-5; Fang D, 2008, BBA-MOL BASIS DIS, V1782, P658, DOI 10.1016/j.bbadis.2008.09.007; Gerhardt KJ, 1998, OTOLARYNG HEAD NECK, V118, P338, DOI 10.1016/S0194-5998(98)70312-2; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ji QL, 2012, TOXICOL IN VITRO, V26, P455, DOI 10.1016/j.tiv.2012.01.016; Jiang ZD, 2005, EUR J PEDIATR, V164, P84, DOI 10.1007/s00431-004-1569-8; Jiang ZD, 2004, ACTA PAEDIATR, V93, P82, DOI 10.1080/08035250310007952; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Khan M, 2010, NEUROSCI LETT, V479, P249, DOI 10.1016/j.neulet.2010.05.072; Kim YJ, 2007, ACTA OTO-LARYNGOL, V127, P73, DOI 10.1080/03655230701624905; Lee JH, 2013, MOL CELL BIOCH; Lee M, 2013, BRAIN RES BULL, V96, P19, DOI 10.1016/j.brainresbull.2013.04.007; Lin CD, 2011, LAB INVEST, V91, P1092, DOI 10.1038/labinvest.2011.69; Lorito G, 2008, MED SCI MONITOR, V14, pBR159; Mazurek B, 2003, HEARING RES, V182, P2, DOI 10.1016/S0378-5955(03)00134-5; Mazurek B, 2011, HEARING RES, V277, P54, DOI 10.1016/j.heares.2011.03.011; Murphy-Lavoie H, 2012, UNDERSEA HYPERBAR M, V39, P777; Naves T, 2013, BIOCHEM PHARMACOL, V85, P1153, DOI 10.1016/j.bcp.2013.01.022; Olgun Y, 2013, INT J PEDIATR OTORHI, V77, P739, DOI 10.1016/j.ijporl.2013.01.029; Pan WW, 2010, J BIOL CHEM, V285, P34348, DOI 10.1074/jbc.M110.109165; Segawa A, 1998, CELL TISSUE RES, V291, P325, DOI 10.1007/s004410051002; Tan XL, 2008, NEUROSCI LETT, V441, P272, DOI 10.1016/j.neulet.2008.06.050; van der Kooij MA, 2010, NEUROBIOL DIS, V38, P266, DOI 10.1016/j.nbd.2010.01.016; Wang Liping, 2008, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V22, P1040; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yumusakhuylu AC, 2012, INT J PEDIATR OTORHI, V76, P404, DOI 10.1016/j.ijporl.2011.12.021; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou WG, 2002, J NEUROSCI RES, V67, P837, DOI 10.1002/jnr.10168	40	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80854	10.1371/journal.pone.0080854	http://dx.doi.org/10.1371/journal.pone.0080854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278331	Green Submitted, gold, Green Published			2022-12-27	WOS:000327539800085
J	De Lellis, L; Aceto, GM; Curia, MC; Catalano, T; Mammarella, S; Veschi, S; Fantini, F; Battista, P; Stigliano, V; Messerini, L; Mareni, C; Sala, P; Bertario, L; Radice, P; Cama, A				De Lellis, Laura; Aceto, Gitana Maria; Curia, Maria Cristina; Catalano, Teresa; Mammarella, Sandra; Veschi, Serena; Fantini, Fabiana; Battista, Pasquale; Stigliano, Vittoria; Messerini, Luca; Mareni, Cristina; Sala, Paola; Bertario, Lucio; Radice, Paolo; Cama, Alessandro			Integrative Analysis of Hereditary Nonpolyposis Colorectal Cancer: the Contribution of Allele-Specific Expression and Other Assays to Diagnostic Algorithms	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; LYNCH-SYNDROME; COLON-CANCER; MSH2 MISSENSE; MICROSATELLITE INSTABILITY; GENOMIC REARRANGEMENTS; ADENOMATOUS POLYPOSIS; TUMOR CHARACTERISTICS; GERMLINE EPIMUTATION; FUNCTIONAL-ANALYSIS	The identification of germline variants predisposing to hereditary nonpolyposis colorectal cancer (HNPCC) is crucial for clinical management of carriers, but several probands remain negative for such variants or bear variants of uncertain significance (VUS). Here we describe the results of integrative molecular analyses in 132 HNPCC patients providing evidences for improved genetic testing of HNPCC with traditional or next generation methods. Patients were screened for: germline allele-specific expression (ASE), nucleotide variants, rearrangements and promoter methylation of mismatch repair (MMR) genes; germline EPCAM rearrangements; tumor microsatellite instability (MSI) and immunohistochemical (IHC) MMR protein expression. Probands negative for pathogenic variants of MMR genes were screened for germline APC and MUTYH sequence variants. Most germline defects identified were sequence variants and rearrangements of MMR genes. Remarkably, altered germline ASE of MMR genes was detected in 8/22 (36.5%) probands analyzed, including 3 cases negative at other screenings. Moreover, ASE provided evidence for the pathogenic role and guided the characterization of a VUS shared by 2 additional probands. No germline MMR gene promoter methylation was observed and only one EPCAM rearrangement was detected. In several cases, tumor IHC and MSI diverged from germline screening results. Notably, APC or biallelic MUTYH germline defects were identified in 2/19 probands negative for pathogenic variants of MMR genes. Our results show that ASE complements gDNA-based analyses in the identification of MMR defects and in the characterization of VUS affecting gene expression, increasing the number of germline alterations detected. An appreciable fraction of probands negative for MMR gene variants harbors APC or MUTYH variants. These results indicate that germline ASE analysis and screening for APC and MUTYH defects should be included in HNPCC diagnostic algorithms.	[De Lellis, Laura; Mammarella, Sandra; Cama, Alessandro] Univ G DAnnunzio, Dept Pharm, Chieti, Italy; [Aceto, Gitana Maria; Fantini, Fabiana; Battista, Pasquale] Univ G DAnnunzio, Dept Expt & Clin Sci, Chieti, Italy; [Curia, Maria Cristina] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Aceto, Gitana Maria; Curia, Maria Cristina; Veschi, Serena] Univ G dAnnunzio, Unit Mol Pathol & Genom, Aging Res Ctr, Chieti, Italy; [Catalano, Teresa] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Stigliano, Vittoria] Regina Elena IRE, Dept Gastroenterol, Unit Hereditary Colorectal Canc, Natl Canc Inst, Rome, Italy; [Messerini, Luca] Univ Florence, Sect Pathol Anat, Dept Med & Surg Crit Care, Florence, Italy; [Mareni, Cristina] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Sala, Paola; Bertario, Lucio] Fdn IRCCS, Ist Nazl Tumori, Unit Hereditary Digest Tract Tumors, Dept Prevent & Predict Med, Milan, Italy; [Radice, Paolo] Fdn IRCCS, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Ist Nazl Tumori, Milan, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Messina; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Florence; University of Genoa; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Cama, A (corresponding author), Univ G DAnnunzio, Dept Pharm, Chieti, Italy.	cama@unich.it	Catalano, Teresa/AAL-5483-2020; Aceto, Gitana Maria/AAY-5801-2020; CAMA, Alessandro/J-3964-2018; Radice, Paolo/O-3119-2013; de lellis, laura/AAQ-8789-2020; Messerini, Luca/AAB-3356-2019; Veschi, Serena/J-2627-2018	CAMA, Alessandro/0000-0003-3647-1368; Radice, Paolo/0000-0001-6298-4111; Veschi, Serena/0000-0003-0450-9210; Bertario, Lucio/0000-0001-5653-1431; DE LELLIS, Laura/0000-0002-6460-2508	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	The study was supported by funds from the Italian Ministry of Education, University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto GM, 2009, CLIN CHEM, V55, P1711, DOI 10.1373/clinchem.2009.126300; Ali H, 2012, HUM MUTAT, V33, P642, DOI 10.1002/humu.22038; Arnold S, 2009, HUM MUTAT, V30, P757, DOI 10.1002/humu.20936; Auclair J, 2006, HUM MUTAT, V27, P145, DOI 10.1002/humu.20280; Boland CR, 1998, CANCER RES, V58, P5248; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Chao EC, 2008, HUM MUTAT, V29, P852, DOI 10.1002/humu.20735; Crepin M, 2012, HUM MUTAT, V33, P180, DOI 10.1002/humu.21617; Curia MC, 2012, GASTROENTEROLOGY, V142, P71, DOI 10.1053/j.gastro.2011.09.048; Curia MC, 1999, CANCER RES, V59, P3570; Curia MC, 1998, HUM MUTAT, V11, P197, DOI 10.1002/(SICI)1098-1004(1998)11:3<197::AID-HUMU3>3.0.CO;2-F; De Lellis L, 2006, HUM MUTAT, V27, P1047, DOI 10.1002/humu.20386; De Lellis L, 2012, TUMORI J, V98, P126, DOI 10.1700/1053.11511; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; Gammie AE, 2007, GENETICS, V177, P707, DOI 10.1534/genetics.107.071084; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Kievit W, 2005, GUT, V54, P97, DOI 10.1136/gut.2004.039123; Kloor M, 2011, J CLIN ONCOL, V29, P223, DOI 10.1200/JCO.2010.32.0820; Kovacs ME, 2009, HUM MUTAT, V30, P197, DOI 10.1002/humu.20942; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lutzen A, 2008, MUTAT RES-FUND MOL M, V645, P44, DOI 10.1016/j.mrfmmm.2008.08.015; Morak M, 2011, EUR J CANCER, V47, P1046, DOI 10.1016/j.ejca.2010.11.016; Mueller J, 2009, CANCER RES, V69, P7053, DOI 10.1158/0008-5472.CAN-09-0358; Nakagawa H, 2002, CANCER RES, V62, P4579; Nieminen TT, 2011, GASTROENTEROLOGY, V141, pE23, DOI 10.1053/j.gastro.2011.03.063; Niessen RC, 2009, GENE CHROMOSOME CANC, V48, P737, DOI 10.1002/gcc.20678; Ollila S, 2008, HUM MUTAT, V29, P1355, DOI 10.1002/humu.20893; Pastrello C, 2011, GENET MED, V13, P115, DOI 10.1097/GIM.0b013e3182011489; Pensotti V, 1997, GENE CHROMOSOME CANC, V19, P135; Peterlongo P, 2006, CARCINOGENESIS, V27, P2243, DOI 10.1093/carcin/bgl093; Pineda M, 2010, MUTAT RES-FUND MOL M, V693, P19, DOI 10.1016/j.mrfmmm.2009.11.002; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pritchard CC, 2012, J MOL DIAGN, V14, P357, DOI 10.1016/j.jmoldx.2012.03.002; Renkonen E, 2003, J CLIN ONCOL, V21, P3629, DOI 10.1200/JCO.2003.03.181; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; Rumilla K, 2011, J MOL DIAGN, V13, P93, DOI 10.1016/j.jmoldx.2010.11.011; Soravia C, 2006, INT J COLORECTAL DIS, V21, P79, DOI 10.1007/s00384-005-0772-z; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Tanko Q, 2002, MUTAT RES-FUND MOL M, V503, P37, DOI 10.1016/S0027-5107(02)00031-3; Terui H, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-25; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Thompson BA, 2013, HUM MUTAT, V34, P200, DOI 10.1002/humu.22213; van Lier MGF, 2012, J PATHOL, V226, P764, DOI 10.1002/path.3963; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wijnen J, 1996, AM J HUM GENET, V58, P300; Woods MO, 2010, GUT, V59, P1369, DOI 10.1136/gut.2010.208462	55	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81194	10.1371/journal.pone.0081194	http://dx.doi.org/10.1371/journal.pone.0081194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278394	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100143
J	Fuka, MM; Wallisch, S; Engel, M; Welzl, G; Havranek, J; Schloter, M				Fuka, Mirna Mrkonjic; Wallisch, Stefanie; Engel, Marion; Welzl, Gerhard; Havranek, Jasmina; Schloter, Michael			Dynamics of Bacterial Communities during the Ripening Process of Different Croatian Cheese Types Derived from Raw Ewe's Milk Cheeses	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; PHYSICOCHEMICAL PROPERTIES; MICROBIAL COMMUNITIES; INDEPENDENT METHODS; MONTASIO CHEESE; IDENTIFICATION; BIODIVERSITY; STAPHYLOCOCCUS; CULTURES; QUALITY	Microbial communities play an important role in cheese ripening and determine the flavor and taste of different cheese types to a large extent. However, under adverse conditions human pathogens may colonize cheese samples during ripening and may thus cause severe outbreaks of diarrhoea and other diseases. Therefore in the present study we investigated the bacterial community structure of three raw ewe's milk cheese types, which are produced without the application of starter cultures during ripening from two production sites based on fingerprinting in combination with next generation sequencing of 16S rRNA gene amplicons. Overall a surprisingly high diversity was found in the analyzed samples and overall up to 213 OTU97 could be assigned. 20 of the major OTUs were present in all samples and include mostly lactic acid bacteria (LAB), mainly Lactococcus, and Enterococcus species. Abundance and diversity of these genera differed to a large extent between the 3 investigated cheese types and in response to the ripening process. Also a large number of non LAB genera could be identified based on phylogenetic alignments including mainly Enterobacteriaceae and Staphylococcacae. Some species belonging to these two families could be clearly assigned to species which are known as potential human pathogens like Staphylococcus saprophyticus or Salmonella spp. However, during cheese ripening their abundance was reduced. The bacterial genera, namely Lactobacillus, Streptococcus, Leuconostoc, Bifidobacterium, Brevibacterium, Corynebacterium, Clostridium, Staphylococcus, Thermoanerobacterium, E. coli, Hafnia, Pseudomonas, Janthinobacterium, Petrotoga, Kosmotoga, Megasphaera, Macrococcus, Mannheimia, Aerococcus, Vagococcus, Weissella and Pediococcus were identified at a relative low level and only in selected samples. Overall the microbial composition of the used milk and the management of the production units determined the bacterial community composition for all cheese types to a large extend, also at the late time points of cheese ripening.	[Fuka, Mirna Mrkonjic] Univ Zagreb, Fac Agr, Dept Microbiol, Zagreb 41000, Croatia; [Fuka, Mirna Mrkonjic; Wallisch, Stefanie; Engel, Marion; Welzl, Gerhard; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Havranek, Jasmina] Univ Zagreb, Fac Agr, Dept Dairy Sci, Zagreb 41000, Croatia	University of Zagreb; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Zagreb	Schloter, M (corresponding author), Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany.	schloter@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013		German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was funded by German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenzio M, 2001, INT J FOOD MICROBIOL, V67, P35, DOI 10.1016/S0168-1605(00)00533-X; Alegria A, 2012, APPL ENVIRON MICROB, V78, P1890, DOI 10.1128/AEM.06081-11; Ampe F, 1999, APPL ENVIRON MICROB, V65, P5464; Antonsson M, 2003, INT J FOOD MICROBIOL, V85, P159, DOI 10.1016/S0168-1605(02)00536-6; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; BLACKALL LL, 1995, SYST APPL MICROBIOL, V17, P513, DOI 10.1016/S0723-2020(11)80070-6; Callon C, 2007, SYST APPL MICROBIOL, V30, P547, DOI 10.1016/j.syapm.2007.05.004; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Caridi A, 2003, INT DAIRY J, V13, P191, DOI 10.1016/S0958-6946(02)00157-7; Carraro L, 2011, RES MICROBIOL, V162, P231, DOI 10.1016/j.resmic.2011.01.002; Collins RE, 2007, NUCLEIC ACIDS RES, V35, pW58, DOI 10.1093/nar/gkm384; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; DelvesBroughton J, 1996, ANTON LEEUW INT J G, V69, P193, DOI 10.1007/BF00399424; Di Cagno R, 2008, INT J FOOD MICROBIOL, V127, P220, DOI 10.1016/j.ijfoodmicro.2008.07.010; Donnelly C. W., 2004, CHEESE CHEM PHYS MIC, V1, p541e559; El-Baradei G, 2008, INT J FOOD MICROBIOL, V121, P295, DOI 10.1016/j.ijfoodmicro.2007.11.014; El-Baradei G, 2007, APPL ENVIRON MICROB, V73, P1248, DOI 10.1128/AEM.01667-06; Ercolini D, 2008, INT J FOOD MICROBIOL, V124, P164, DOI 10.1016/j.ijfoodmicro.2008.03.007; Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0; Fuka MM, 2010, INT J FOOD MICROBIOL, V142, P19, DOI 10.1016/j.ijfoodmicro.2010.05.008; Fuka MM, 2012, AFR J BIOTECHNOL, V101, P16650; Giannino ML, 2009, INT J FOOD MICROBIOL, V130, P188, DOI 10.1016/j.ijfoodmicro.2009.01.022; Glass K, 2005, FRI BRIEFINGS SAFETY; Gori K, 2013, MICROB ECOL, V65, P602, DOI 10.1007/s00248-012-0138-3; Grappin R, 1997, INT DAIRY J, V7, P751, DOI 10.1016/S0958-6946(98)00006-5; HOVELIUS B, 1984, REV INFECT DIS, V6, P328; Irlinger F, 2012, INT J FOOD MICROBIOL, V153, P332, DOI 10.1016/j.ijfoodmicro.2011.11.022; Ishikawa M, 2007, LETT APPL MICROBIOL, V44, P308, DOI 10.1111/j.1472-765X.2006.02073.x; Ishikawa M, 2013, INT J SYST EVOL MICR, V63, P1471, DOI 10.1099/ijs.0.042556-0; JOHNSON EA, 1990, J FOOD PROTECT, V53, P519, DOI 10.4315/0362-028X-53.6.519; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Juste A, 2008, FOOD MICROBIOL, V25, P745, DOI 10.1016/j.fm.2008.04.009; Kitonic T, 1998, MILCHWISSENSCHAFT, V53, P20; Kloos WE, 1998, INT J SYST BACTERIOL, V48, P859, DOI 10.1099/00207713-48-3-859; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Magdic V, 2013, MLJEKARSTVO, V63, P55; Marino M, 2003, FEMS MICROBIOL LETT, V229, P133, DOI 10.1016/S0378-1097(03)00816-4; Masoud W, 2012, INT J FOOD MICROBIOL, V153, P192, DOI 10.1016/j.ijfoodmicro.2011.11.014; McSweeney PLH, 2004, INT J DAIRY TECHNOL, V57, P127, DOI 10.1111/j.1471-0307.2004.00147.x; Mikulec N, 2008, INT J DAIRY TECHNOL, V61, P126, DOI 10.1111/j.1471-0307.2008.00400.x; Moroni P, 2005, J DAIRY SCI, V88, P1694, DOI 10.3168/jds.S0022-0302(05)72841-1; Ndoye B, 2011, DAIRY SCI TECHNOL, V91, P495, DOI 10.1007/s13594-011-0031-8; Nero LA, 2008, ZOONOSES PUBLIC HLTH, V55, P299, DOI 10.1111/j.1863-2378.2008.01130.x; O'Sullivan DJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00001; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pelaez C, 2005, INT DAIRY J, V15, P831, DOI 10.1016/j.idairyj.2004.12.001; Pitkala A, 2008, J DAIRY SCI, V91, P4075, DOI 10.3168/jds.2008-1040; Pogacic T, 2010, FOOD TECHNOL BIOTECH, V48, P3; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Randazzo CL, 2006, INT J FOOD MICROBIOL, V109, P1, DOI 10.1016/j.ijfoodmicro.2005.11.002; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Skelin A, 2012, FOOD TECHNOL BIOTECH, V50, P362; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Yumoto I, 2011, EXTREMOPHILES HDB, P65; Zago M, 2007, ANN MICROBIOL, V57, P49, DOI 10.1007/BF03175049; Zengler K, 2009, MICROBIOL MOL BIOL R, V73, P712, DOI 10.1128/MMBR.00027-09	61	66	67	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80734	10.1371/journal.pone.0080734	http://dx.doi.org/10.1371/journal.pone.0080734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278315	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100107
J	Weinberg, SH				Weinberg, Seth H.			High-Frequency Stimulation of Excitable Cells and Networks	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; OF-THE-ART; NERVE-CONDUCTION; BLOCK; SIMULATION; DYNAMICS; THRESHOLD; CURRENTS; NEURONS; MODELS	High-frequency (HF) stimulation has been shown to block conduction in excitable cells including neurons and cardiac myocytes. However, the precise mechanisms underlying conduction block are unclear. Using a multi-scale method, the influence of HF stimulation is investigated in the simplified FitzhHugh-Nagumo and biophysically-detailed Hodgkin-Huxley models. In both models, HF stimulation alters the amplitude and frequency of repetitive firing in response to a constant applied current and increases the threshold to evoke a single action potential in response to a brief applied current pulse. Further, the excitable cells cannot evoke a single action potential or fire repetitively above critical values for the HF stimulation amplitude. Analytical expressions for the critical values and thresholds are determined in the FitzHugh-Nagumo model. In the Hodgkin-Huxley model, it is shown that HF stimulation alters the dynamics of ionic current gating, shifting the steady-state activation, inactivation, and time constant curves, suggesting several possible mechanisms for conduction block. Finally, we demonstrate that HF stimulation of a network of neurons reduces the electrical activity firing rate, increases network synchronization, and for a sufficiently large HF stimulation, leads to complete electrical quiescence. In this study, we demonstrate a novel approach to investigate HF stimulation in biophysically-detailed ionic models of excitable cells, demonstrate possible mechanisms for HF stimulation conduction block in neurons, and provide insight into the influence of HF stimulation on neural networks.	Coll William & Mary, Dept Appl Sci, Williamsburg, VA USA	William & Mary	Weinberg, SH (corresponding author), Coll William & Mary, Dept Appl Sci, Williamsburg, VA USA.	shweinberg@wm.edu		Weinberg, Seth/0000-0003-1170-0419	Biomathematics Initiative; College of Arts and Sciences at The College of William and Mary	Biomathematics Initiative; College of Arts and Sciences at The College of William and Mary	The work was supported by the Biomathematics Initiative and the Dean of the College of Arts and Sciences at The College of William and Mary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann DM, 2010, MUSCLE NERVE, V41, P117, DOI 10.1002/mus.21496; Agarwal R, 2012, PLOS COMPUTATIONAL B; Anderson WS, 2009, EPILEPSY RES, V84, P42, DOI 10.1016/j.eplepsyres.2008.12.005; Benabid AL., 2001, J NEUROL S3, V248, P37, DOI DOI 10.1007/PL00007825; Bhadra N, 2004, P ANN INT IEEE EMBS, V26, P4729; Bhadra N, 2007, J COMPUT NEUROSCI, V22, P313, DOI [10.1007/s10827-006-0015-5, 10.1007/S10827-006-0015-5]; Boger A, 2008, NEUROUROL URODYNAM, V27, P435, DOI 10.1002/nau.20538; Boger AS, 2012, NEUROUROL URODYNAM, V31, P677, DOI 10.1002/nau.21075; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Cubero D, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061102; Desroches M, 2013, J MATH BIOL, V67, P989, DOI 10.1007/s00285-012-0576-z; Fall CP., 2002, COMPUTATIONAL CELL B; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Gao Z., 2001, PHYS REV E, V65, DOI DOI 10.1103/PHYSREVE.65.016209; GOLOMB D, 1993, PHYS REV E, V48, P4810, DOI 10.1103/PhysRevE.48.4810; Guckenheimer J, 2013, APPL MATH SCI, V42; Hodgkin A. L., 1952, J PHYSL; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Keener JP, 2009, MATH PHYSL; Kilgore KL, 2004, MED BIOL ENG COMPUT, V42, P394, DOI 10.1007/BF02344716; KNISLEY SB, 1994, BIOPHYS J, V66, P719, DOI 10.1016/S0006-3495(94)80846-X; Koch C., 2004, BIOPHYSICS COMPUTATI; Liu HL, 2009, IEEE T BIO-MED ENG, V56, P137, DOI 10.1109/TBME.2008.2006013; Loddenkemper T, 2001, J CLIN NEUROPHYSIOL, V18, P514, DOI 10.1097/00004691-200111000-00002; Longtin A, 1997, PHYS REV E, V55, P868, DOI 10.1103/PhysRevE.55.868; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Mitry J, 2013, J MATH NEUROSCI, V3, DOI 10.1186/2190-8567-3-12; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Plonsey R., 2007, BIOELECTRICITY QUANT; Ratas I, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046211; Ratas I, 2012, NONLINEAR DYNAM, V67, P2899, DOI 10.1007/s11071-011-0197-x; RINZEL J, 1985, FED PROC, V44, P2944; Rubin JE, 2004, J COMPUT NEUROSCI, V16, P211, DOI 10.1023/B:JCNS.0000025686.47117.67; Sanders J.A., 2007, AVERAGING METHODS NO, V59; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Strogatz S. H., 2008, NONLINEAR DYNAMICS C; Tai CF, 2005, IEEE T NEUR SYS REH, V13, P415, DOI 10.1109/TNSRE.2005.847356; Tai CF, 2005, IEEE T BIO-MED ENG, V52, P1323, DOI 10.1109/TBME.2005.847561; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; TANNER JA, 1962, NATURE, V195, P712, DOI 10.1038/195712b0; Tokano T, 1998, J CARDIOVASC ELECTR, V9, P791, DOI 10.1111/j.1540-8167.1998.tb00118.x; Vasalou C, 2009, J BIOL RHYTHM, V24, P243, DOI 10.1177/0748730409333220; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Weinberg SH, 2013, HEART RHYTHM, V10, P740, DOI 10.1016/j.hrthm.2013.01.016; Zhang X, IEEE T BIOMEDICAL EN, V53, P2445; ZIPES DP, 1975, AM J CARDIOL, V36, P37, DOI 10.1016/0002-9149(75)90865-6	50	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81402	10.1371/journal.pone.0081402	http://dx.doi.org/10.1371/journal.pone.0081402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278435	Green Published, gold			2022-12-27	WOS:000327313100155
J	Armstrong, MT; Rickles, FR; Armstrong, PB				Armstrong, Margaret T.; Rickles, Frederick R.; Armstrong, Peter B.			Capture of Lipopolysaccharide (Endotoxin) by the Blood Clot: A Comparative Study	PLOS ONE			English	Article							LIMULUS-POLYPHEMUS; FACTOR-C; THROMBUS FORMATION; INNATE IMMUNITY; HORSESHOE-CRAB; HOST RESPONSE; FIBRIN; RECOGNITION; COAGULATION; PLATELETS	In vertebrates and arthropods, blood clotting involves the establishment of a plug of aggregated thrombocytes (the cellular clot) and an extracellular fibrillar clot formed by the polymerization of the structural protein of the clot, which is fibrin in mammals, plasma lipoprotein in crustaceans, and coagulin in the horseshoe crab, Limulus polyphemus. Both elements of the clot function to staunch bleeding. Additionally, the extracellular clot functions as an agent of the innate immune system by providing a passive anti-microbial barrier and microbial entrapment device, which functions directly at the site of wounds to the integument. Here we show that, in addition to these passive functions in immunity, the plasma lipoprotein clot of lobster, the coagulin clot of Limulus, and both the platelet thrombus and the fibrin clot of mammals (human, mouse) operate to capture lipopolysaccharide (LPS, endotoxin). The lipid A core of LPS is the principal agent of gram-negative septicemia, which is responsible for more than 100,000 human deaths annually in the United States and is similarly toxic to arthropods. Quantification using the Limulus Amebocyte Lysate (LAL) test shows that clots capture significant quantities of LPS and fluorescent-labeled LPS can be seen by microscopy to decorate the clot fibrils. Thrombi generated in the living mouse accumulate LPS in vivo. It is suggested that capture of LPS released from gram-negative bacteria entrapped by the blood clot operates to protect against the disease that might be caused by its systemic dispersal.	[Armstrong, Margaret T.; Rickles, Frederick R.; Armstrong, Peter B.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Armstrong, Margaret T.; Armstrong, Peter B.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Rickles, Frederick R.] George Washington Univ, Sch Med, Dept Med, Washington, DC USA	Marine Biological Laboratory - Woods Hole; University of California System; University of California Davis; George Washington University	Armstrong, PB (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	pbarmstrong@ucdavis.edu		Armstrong, Peter/0000-0001-5197-1999	National Science Foundation [0344360]	National Science Foundation(National Science Foundation (NSF))	Grant # 0344360 from the National Science Foundation (PBA). The research reported in this manuscript was not influenced in any manner by any of the funders of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Andra J, 2009, ADV EXP MED BIOL, V667, P39, DOI 10.1007/978-1-4419-1603-7_4; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Armstrong MT, 2006, FASEB J, V20, P2145, DOI 10.1096/fj.05-5484fje; Armstrong P, 2008, JVISEXP, V20; Armstrong PB, 2010, ISJ-INVERT SURVIV J, V7, P165; ARMSTRONG PB, 1984, THROMB HAEMOSTASIS, V52, P117; ARMSTRONG PB, 1982, EXP CELL RES, V140, P15, DOI 10.1016/0014-4827(82)90150-1; Armstrong PB, 2003, BIOL BULL-US, V205, P201, DOI 10.2307/1543252; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; BANG FB, 1956, B JOHNS HOPKINS HOSP, V98, P325; BANG FB, 1979, BIOMEDICAL APPLICATI, P109; Bosniak Peter A., 2004, Biological Bulletin (Woods Hole), V207, P172; Cho J, 2005, J BIOL CHEM, V280, P35490, DOI 10.1074/jbc.M506289200; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; DUBOIS C, 2006, PLATELETS, P611; Falati S, 2002, NAT MED, V8, P1175, DOI 10.1038/nm782; Ferguson AD, 2000, STRUCTURE, V8, P585; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Furie B, 2007, J THROMB HAEMOST, V5, P12, DOI 10.1111/j.1538-7836.2007.02482.x; Furie B., 2000, HEMATOLOGY BASIC PRI, P1783; GOTO T, 1994, CLIN DIAGN LAB IMMUN, V1, P684, DOI 10.1128/CDLI.1.6.684-688.1994; Iwanaga Sadaaki, 1998, Frontiers in Bioscience, V3, pD973; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LEVIN J, 1964, B JOHNS HOPKINS HOSP, V115, P265; LEVIN J, 1970, J LAB CLIN MED, V75, P903; Levin J., 1979, Progress in Clinical and Biological Research, V29, P235; Levin J., 1988, Progress in Clinical and Biological Research, V272, P3; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MORRISON DC, 1978, AM J PATHOL, V93, P526; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; Ng PML, 2004, J ENDOTOXIN RES, V10, P163, DOI 10.1179/096805104225004833; NIKAIDO H, 1987, ESCHERICHIA COLI SAL, P7; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARK NG, 1992, BIOCHEMISTRY-US, V31, P12241, DOI 10.1021/bi00163a038; PEARSON FC, 1985, J CLIN MICROBIOL, V21, P865, DOI 10.1128/JCM.21.6.865-868.1985; Persson K, 2003, J BIOL CHEM, V278, P31884, DOI 10.1074/jbc.M302522200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; Richter W, 2011, INNATE IMMUN-LONDON, V17, P427, DOI 10.1177/1753425910372434; Roth RI, 1998, J INFECT DIS, V177, P388, DOI 10.1086/514204; ROTSTEIN OD, 1992, EUR J CLIN MICROBIOL, V11, P1064, DOI 10.1007/BF01967800; Sands Kenneth E., 1997, JAMA (Journal of the American Medical Association), V278, P234, DOI 10.1001/jama.278.3.234; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; TABLIN F, 1988, BIOL BULL, V175, P417, DOI 10.2307/1541734; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301	57	18	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80192	10.1371/journal.pone.0080192	http://dx.doi.org/10.1371/journal.pone.0080192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282521	Green Published, gold			2022-12-27	WOS:000327543500022
J	Dai, HJ; Wu, JCY; Tsai, RTH				Dai, Hong-Jie; Wu, Johnny Chi-Yang; Tsai, Richard Tzong-Han			Collective Instance-Level Gene Normalization on the IGN Corpus	PLOS ONE			English	Article							TEXT; CHALLENGES; RESOLUTION; TASK	A high proportion of life science researches are gene-oriented, in which scientists aim to investigate the roles that genes play in biological processes, and their involvement in biological mechanisms. As a result, gene names and their related information turn out to be one of the main objects of interest in biomedical literatures. While the capability of recognizing gene mentions has made significant progress, the results of recognition are still insufficient for direct use due to the ambiguity of gene names. Gene normalization (GN) goes beyond the recognition task by linking a gene mention to a database ID. Unlike most previous works, we approach GN on the instance-level and evaluate its overall performance on the recognition and normalization steps in abstracts and full texts. We release the first instance-level gene normalization (IGN) corpus in the BioC format, which includes annotations for the boundaries of all gene mentions and the corresponding IDs for human gene mentions. Species information, along with existing co-reference chains and full name/abbreviation pairs are also provided for each gene mention. Using the released corpus, we have designed a collective instance-level GN approach using not only the contextual information of each individual instance, but also the relations among instances and the inherent characteristics of full-text sections. Our experimental results show that our collective approach can achieve an Fscore of 0.743. The proposed approach that exploits section characteristics in full-text articles can improve the F-scores of information lacking sections by up to 1.8%. In addition, using the proposed refinement process improved the F-score of gene mention recognition by 0.125 and that of GN by 0.03. Whereas current experimental results are limited to the human species, we seek to continue updating the annotations of the IGN corpus and observe how the proposed approach can be extended to other species.	[Dai, Hong-Jie] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst BioMed Informat, Taipei, Taiwan; [Wu, Johnny Chi-Yang] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Tsai, Richard Tzong-Han] Natl Cent Univ, Dept Comp Sci & Informat Engn, Tao Yuan, Taiwan	Taipei Medical University; Academia Sinica - Taiwan; National Central University	Dai, HJ (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst BioMed Informat, Taipei, Taiwan.	hjdai@tmu.edu.tw		Tsai, Richard Tzong-Han/0000-0003-0513-107X	Taipei Medical University [TMU101-AE1-B55]	Taipei Medical University	This work was funded by Grant: TMU101-AE1-B55 of Taipei Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Baran J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024716; Ceol A, 2008, FEBS LETT, V582, P1171, DOI 10.1016/j.febslet.2008.02.071; Comeau DC, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat064; Cucerzan S., 2007, P 2007 JOINT C EMP M, P708, DOI DOI 10.1145/2187836.2187900; Dai H., 2007, P 2 BIOCREATIVE CHAL, P69; Dai H.J., 2011, P 22 INT JOINT C ART, P248; Dai HJ, 2011, BIOINFORMATICS, V27, P2586, DOI 10.1093/bioinformatics/btr358; Dai HJ, 2010, J COMPUT SCI TECH-CH, V25, P169, DOI 10.1007/s11390-010-9313-5; Dogan RI, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap018; Gerner M, 2012, BIOINFORMATICS, V28, P2154, DOI 10.1093/bioinformatics/bts332; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Huang ML, 2011, J AM MED INFORM ASSN, V18, P660, DOI 10.1136/amiajnl-2010-000055; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Kafkas S, 2012, P 8 INT C LANG RES E; Khalid MA, 2008, LECT NOTES COMPUT SC, V4956, P705; Kulkarni S, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P457; Leitner F, 2010, IEEE ACM T COMPUT BI, V7, P385, DOI 10.1109/TCBB.2010.61; Lu ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S2; McNamee P., 2011, P 5 INT JOINT C NAT, P255; Mihalcea R., 2001, Studies in Informatics and Control, V10, P21; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Oda K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S5; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Sen P, 2008, AI MAG, V29, P93, DOI 10.1609/aimag.v29i3.2157; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Soon WM, 2001, COMPUT LINGUIST, V27, P521, DOI 10.1162/089120101753342653; Tsai RTH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S11; Tsai RTH, 2009, BIOINFORMATICS, V25, P3031, DOI 10.1093/bioinformatics/btp475; Van Landeghem S, 2011, P BIONLP 2011 WORKSH, P28; Van Landeghem S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055814; Wei CH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S5	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e79517	10.1371/journal.pone.0079517	http://dx.doi.org/10.1371/journal.pone.0079517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282506	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500010
J	Laukka, EJ; Lovden, M; Kalpouzos, G; Li, TQ; Jonsson, T; Wahlund, LO; Fratiglioni, L; Backman, L				Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Li, Tie-Qiang; Jonsson, Tomas; Wahlund, Lars-Olof; Fratiglioni, Laura; Backman, Lars			Associations between White Matter Microstructure and Cognitive Performance in Old and Very Old Age	PLOS ONE			English	Article							DIFFUSION ANISOTROPY; ALZHEIMERS-DISEASE; PROCESSING-SPEED; INTEGRITY; BRAIN; TRACTS; ATLAS	Increasing age is associated with deficits in a wide range of cognitive domains as well as with structural brain changes. Recent studies using diffusion tensor imaging (DTI) have shown that microstructural integrity of white matter is associated with cognitive performance in elderly persons, especially on tests that rely on perceptual speed. We used structural equation modeling to investigate associations between white matter microstructure and cognitive functions in a population-based sample of elderly persons (age >= 60 years), free of dementia, stroke, and neurological disorders (n = 253). Participants underwent a magnetic resonance imaging scan, from which mean fractional anisotropy (FA) and mean diffusivity (MD) of seven white matter tracts were quantified. Cognitive functioning was analyzed according to performance in five task domains (perceptual speed, episodic memory, semantic memory, letter fluency, and category fluency). After controlling for age, FA and MD were exclusively related to perceptual speed. When further stratifying the sample into two age groups, the associations were reliable in the old-old (>= 78 years) only. This relationship between white matter microstructure and perceptual speed remained significant after excluding persons in a preclinical dementia phase. The observed pattern of results suggests that microstructural white matter integrity may be especially important to perceptual speed among very old adults.	[Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Fratiglioni, Laura; Backman, Lars] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Fratiglioni, Laura; Backman, Lars] Stockholm Univ, S-10691 Stockholm, Sweden; [Li, Tie-Qiang; Jonsson, Tomas] Karolinska Inst, Dept Med Phys, Stockholm, Sweden; [Wahlund, Lars-Olof] Karolinska Inst, Dept Clin Geriatr, Stockholm, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Laukka, EJ (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	Erika.Jonsson.Laukka@ki.se		Li, Tie-Qiang/0000-0002-4866-5904; wahlund, lars-olof/0000-0002-9905-8426	Swedish Ministry of Health and Social Affairs; participating County Councils and Municipalities; Swedish Research Council; Swedish Council for Working Life and Social Research; Swedish Brain Power; Gun and Bertil Stohne's foundation; Osterman's foundation; foundation for age-related diseases at Karolinska Institutet; Alexander von Humboldt Research Award; af Jochnick Foundation	Swedish Ministry of Health and Social Affairs; participating County Councils and Municipalities; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Brain Power; Gun and Bertil Stohne's foundation; Osterman's foundation; foundation for age-related diseases at Karolinska Institutet; Alexander von Humboldt Research Award(Alexander von Humboldt Foundation); af Jochnick Foundation	SNAC-K is financially supported by the Swedish Ministry of Health and Social Affairs, the participating County Councils and Municipalities, and the Swedish Research Council. This work was further funded by grants from the Swedish Council for Working Life and Social Research (E. L., L. F., L. B.), Swedish Brain Power (L. F., L. B.), Gun and Bertil Stohne's foundation (G. K.), Osterman's foundation (G. K.), the foundation for age-related diseases at Karolinska Institutet (E. L.), an Alexander von Humboldt Research Award (L. B.), and a donation from the af Jochnick Foundation (L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Burzynska AZ, 2012, HUM BRAIN MAPP, V33, P1607, DOI 10.1002/hbm.21311; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dahl M, 2009, PSYCHOL AGING, V24, P234, DOI 10.1037/a0014048; Dureman I., 1960, SRB 1; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Gold BT, 2007, NEUROPSYCHOLOGIA, V45, P2439, DOI 10.1016/j.neuropsychologia.2007.04.011; HERTZOG C, 1985, RES AGING, V7, P7, DOI 10.1177/0164027585007001002; Hofer SM, 2001, GERONTOLOGY, V47, P341, DOI 10.1159/000052825; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Laukka EJ, 2013, PSYCHOL AGING, V28, P262, DOI 10.1037/a0030829; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lezak M, 2004, NEUROPSYCHOLOGICAL T; Lovden M, 2013, HUM BRAIN MAPP, V34, P1386, DOI 10.1002/hbm.21518; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; Salami A, 2012, BBA-MOL BASIS DIS, V1822, P408, DOI 10.1016/j.bbadis.2011.09.001; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Schaie K.W, 2005, DEV INFLUENCES ADULT; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Zazzo R., 1974, ACTUALITES PEDAGOGIQ, V7	42	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81419	10.1371/journal.pone.0081419	http://dx.doi.org/10.1371/journal.pone.0081419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282593	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500095
J	Ruck, T; Bittner, S; Gross, CC; Breuer, J; Albrecht, S; Korr, S; Gobel, K; Pankratz, S; Henschel, CM; Schwab, N; Staszewski, O; Prinz, M; Kuhlmann, T; Meuth, SG; Wiendl, H				Ruck, Tobias; Bittner, Stefan; Gross, Catharina C.; Breuer, Johanna; Albrecht, Stefanie; Korr, Sabrina; Goebel, Kerstin; Pankratz, Susann; Henschel, Christian M.; Schwab, Nicholas; Staszewski, Ori; Prinz, Marco; Kuhlmann, Tanja; Meuth, Sven G.; Wiendl, Heinz			CD4(+) NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; RECEPTOR NKG2D; BLOCKADE; ACTIVATION; EXPRESSION; RESPONSES; DISEASE; BLOOD; IMMUNORECEPTOR; PATHOGENESIS	Migration of encephalitogenic CD4(+) T lymphocytes across the blood-brain barrier is an essential step in the pathogenesis of multiple sclerosis ( MS). We here demonstrate that expression of the co-stimulatory receptor NKG2D defines a subpopulation of CD4(+) T cells with elevated levels of markers for migration, activation, and cytolytic capacity especially when derived from MS patients. Furthermore, CD4(+)NKG2D(+) cells produce high levels of proinflammatory IFN-gamma and IL-17 upon stimulation. NKG2D promotes the capacity of CD4(+)NKG2D(+) cells to migrate across endothelial cells in an in vitro model of the blood-brain barrier. CD4(+)NKG2D(+) T cells are enriched in the cerebrospinal fluid of MS patients, and a significant number of CD4(+) T cells in MS lesions coexpress NKG2D. We further elucidated the role of CD4(+)NKG2D(+) T cells in the mouse system. NKG2D blockade restricted central nervous system migration of T lymphocytes in vivo, leading to a significant decrease in the clinical and pathologic severity of experimental autoimmune encephalomyelitis, an animal model of MS. Blockade of NKG2D reduced killing of cultivated mouse oligodendrocytes by activated CD4(+) T cells. Taken together, we identify CD4(+)NKG2D(+) cells as a subpopulation of T helper cells with enhanced migratory, encephalitogenic and cytotoxic properties involved in inflammatory CNS lesion development.	[Ruck, Tobias; Bittner, Stefan; Gross, Catharina C.; Breuer, Johanna; Goebel, Kerstin; Pankratz, Susann; Henschel, Christian M.; Schwab, Nicholas; Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Bittner, Stefan] Interdisciplinary Ctr Clin Res IZKF, Munster, Germany; [Albrecht, Stefanie; Korr, Sabrina; Kuhlmann, Tanja] Univ Munster, Inst Neuropathol, D-48149 Munster, Germany; [Staszewski, Ori; Prinz, Marco] Univ Freiburg, Inst Neuropathol & BIOSS Ctr Biol Signaling Studi, D-79106 Freiburg, Germany; [Meuth, Sven G.] Univ Munster, Inst Physiol Neuropathophysiol 1, D-48149 Munster, Germany	University of Munster; University of Munster; University of Freiburg; University of Munster	Wiendl, H (corresponding author), Univ Munster, Dept Neurol, D-48149 Munster, Germany.	heinz.wiendl@ukmuenster.de	Ruck, Tobias/AAH-4627-2021; Schwab, Nicholas/H-4516-2019; Wiendl, Heinz/AAX-6041-2021; Ruck, Tobias/AAQ-3703-2020; Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Bittner, Stefan/0000-0003-2179-3655; Eichler (born Pankratz), Susann/0000-0003-3321-3232; Wiendl, Heinz/0000-0003-4310-3432; Ruck, Tobias/0000-0001-6332-8650; Schwab, Nicholas/0000-0001-5494-9885; Gross, Catharina/0000-0002-4872-9189; Staszewski, Ori/0000-0002-0579-6701	Transregio centre grant SFB "Multiple Sclerosis" [B1, B5]; German Ministry for Research and Education (BMBF, UNDERSTANDMS, belonging to the "German Competence Network); Interdisciplinary Center for Clinical Research (IZKF) Munster [SEED 03/12, KuT3/006/11, Meu3/010/12]; Novo Nordisk, Copenhagen, Denmark	Transregio centre grant SFB "Multiple Sclerosis"(German Research Foundation (DFG)); German Ministry for Research and Education (BMBF, UNDERSTANDMS, belonging to the "German Competence Network)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (IZKF) Munster; Novo Nordisk, Copenhagen, Denmark(Novo Nordisk)	This work was supported by the Transregio centre grant SFB "Multiple Sclerosis" (B1 to NS and HW; B5 to SGM), by the German Ministry for Research and Education (BMBF, UNDERSTANDMS, belonging to the "German Competence Network of MS", to HW and MP), by Interdisciplinary Center for Clinical Research (IZKF) Munster (SEED 03/12, to SB, KuT3/006/11 to TK and Meu3/010/12 to SGM) and by materials and a project grant by Novo Nordisk, Copenhagen, Denmark (to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Andersson AK, 2011, ARTHRITIS RHEUM-US, V63, P2617, DOI 10.1002/art.30460; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; de Rosbo NK, 1998, J AUTOIMMUN, V11, P287, DOI 10.1006/jaut.1998.0202; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Feger U, 2007, BLOOD, V110, P568, DOI 10.1182/blood-2006-11-057125; Gobel K, 2011, J AUTOIMMUN, V36, P106, DOI 10.1016/j.jaut.2010.11.004; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Ito Y, 2008, AM J PHYSIOL-GASTR L, V294, pG199, DOI 10.1152/ajpgi.00286.2007; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; Kjellev S, 2007, EUR J IMMUNOL, V37, P1397, DOI 10.1002/eji.200636473; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; Lanz TV, 2013, P NATL ACAD SCI USA, V110, P14735, DOI 10.1073/pnas.1302569110; Maccalli C, 2009, CANCER IMMUNOL IMMUN, V58, P801, DOI 10.1007/s00262-008-0635-x; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ortler S, 2008, EUR J IMMUNOL, V38, P1734, DOI 10.1002/eji.200738071; Pariente B, 2011, GASTROENTEROLOGY, V141, P217, DOI 10.1053/j.gastro.2011.03.061; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rentzos M, 2006, J NEUROL SCI, V241, P25, DOI 10.1016/j.jns.2005.10.003; Saikali P, 2007, J NEUROSCI, V27, P1220, DOI 10.1523/JNEUROSCI.4402-06.2007; Saikali P, 2010, J IMMUNOL, V185, P5693, DOI 10.4049/jimmunol.1002188; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tejada-Simon MV, 2001, EUR J IMMUNOL, V31, P907, DOI 10.1002/1521-4141(200103)31:3<907::AID-IMMU907>3.0.CO;2-1; Van Belle TL, 2013, J AUTOIMMUN, V40, P66, DOI 10.1016/j.jaut.2012.08.001; Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008	38	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81455	10.1371/journal.pone.0081455	http://dx.doi.org/10.1371/journal.pone.0081455			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282598	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500100
J	Clavel, J; Poulet, N; Porcher, E; Blanchet, S; Grenouillet, G; Pavoine, S; Biton, A; Seon-Massin, N; Argillier, C; Daufresne, M; Teillac-Deschamps, P; Julliard, R				Clavel, Joanne; Poulet, Nicolas; Porcher, Emmanuelle; Blanchet, Simon; Grenouillet, Gael; Pavoine, Sandrine; Biton, Anne; Seon-Massin, Nirmala; Argillier, Christine; Daufresne, Martin; Teillac-Deschamps, Pauline; Julliard, Romain			A New Freshwater Biodiversity Indicator Based on Fish Community Assemblages	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; CLIMATE-CHANGE; EFFECTS MODELS; STREAM; INDEX; ORIGINALITY; SIMILARITY; PATTERNS; IMPACTS; TRAITS	Biodiversity has reached a critical state. In this context, stakeholders need indicators that both provide a synthetic view of the state of biodiversity and can be used as communication tools. Using river fishes as model, we developed community indicators that aim at integrating various components of biodiversity including interactions between species and ultimately the processes influencing ecosystem functions. We developed indices at the species level based on (i) the concept of specialization directly linked to the niche theory and (ii) the concept of originality measuring the overall degree of differences between a species and all other species in the same clade. Five major types of originality indices, based on phylogeny, habitat-linked and diet-linked morphology, life history traits, and ecological niche were analyzed. In a second step, we tested the relationship between all biodiversity indices and land use as a proxy of human pressures. Fish communities showed no significant temporal trend for most of these indices, but both originality indices based on diet-and habitat-linked morphology showed a significant increase through time. From a spatial point of view, all indices clearly singled out Corsica Island as having higher average originality and specialization. Finally, we observed that the originality index based on niche traits might be used as an informative biodiversity indicator because we showed it is sensitive to different land use classes along a landscape artificialization gradient. Moreover, its response remained unchanged over two other land use classifications at the global scale and also at the regional scale.	[Clavel, Joanne] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Clavel, Joanne; Porcher, Emmanuelle; Pavoine, Sandrine; Teillac-Deschamps, Pauline; Julliard, Romain] Univ Paris 06, Dept Ecol & Gest Biodivers, Unite Mixte Rech 7204, Paris, France; [Clavel, Joanne; Porcher, Emmanuelle; Pavoine, Sandrine; Teillac-Deschamps, Pauline; Julliard, Romain] Museum Natl Hist Nat, CNRS, Paris, France; [Poulet, Nicolas] Off Natl Eau & Milieux Aquat, Dept Ecohydraul, Toulouse, France; [Poulet, Nicolas] Inst Mecan Fluides Toulouse, Toulouse, France; [Poulet, Nicolas] Inst Natl Rech Sci & Technol Environm & Agr, Toulouse, France; [Blanchet, Simon] CNRS, Unite Rech 2936, Stn Ecol Expt, Moulis, France; [Blanchet, Simon; Grenouillet, Gael] Univ Toulouse 3, Unite Mixte Rech 5174, Dept Evolut & Divers Biol, F-31062 Toulouse, France; [Blanchet, Simon; Grenouillet, Gael] Ecole Natl Format Agron, CNRS, Toulouse, France; [Pavoine, Sandrine] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Biton, Anne] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Seon-Massin, Nirmala] Off Natl Eau & Milieux Aquat, Dept Act Sci & Tech, Vincennes, France; [Argillier, Christine; Daufresne, Martin] Off Natl Eau & Milieux Aquat, Unite Rech HYAX, Dept Eaux Hydroecol, Aix En Provence, France; [Argillier, Christine; Daufresne, Martin] Inst Natl Rech Sci & Technol Environm & Agr, Aix En Provence, France	University of California System; University of California Berkeley; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); University of Oxford; University of California System; University of California Berkeley; INRAE	Clavel, J (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	joanne.clavel@gmail.com	Biton, Anne/AAO-8729-2020; Blanchet, Simon/AAA-5871-2019; Grenouillet, Gael/E-6518-2019; Blanchet, Simon/D-4850-2013; Christine, Argillier/Z-1282-2019	Biton, Anne/0000-0002-3814-4195; Blanchet, Simon/0000-0002-3843-589X; Blanchet, Simon/0000-0002-3843-589X; Poulet, Nicolas/0000-0002-5611-0749; Porcher, Emmanuelle/0000-0002-9264-8239	"Departement Evolution et Diversite Biologique" (EDB) is part of the "Laboratoire d'Excellence" (LABEX) [ANR-10-LABX-41]; ONEMA - Officie National des Eaux et des Milieux Aquatiques	"Departement Evolution et Diversite Biologique" (EDB) is part of the "Laboratoire d'Excellence" (LABEX); ONEMA - Officie National des Eaux et des Milieux Aquatiques	"Departement Evolution et Diversite Biologique" (EDB) is part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41), ONEMA - Officie National des Eaux et des Milieux Aquatiques." Both funders (EDB and ONEMA) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ME, 2013, FRESHW SCI, V32, P489, DOI 10.1899/12-142.1; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; BERG LS, 1965, FISHES USSR ADJACENT, V1; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Blum MGB, 2006, PLOS GENET, V2, P1138, DOI 10.1371/journal.pgen.0020122; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; BOSSARD M, 2000, CORINE LAND COVER TE; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; *CEN, 2003, 140112003 CEN EN EUR; Chessel D., 2004, R NEWS, V4, P5; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; DUBOIS A, 2009, COMMISSARIAT GEN DEV, V18, P1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FROESE R, 2000, FISHBASE 2000 CONCEP; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; KOTTELAT M, 2007, HDB EUROPEAN FRESH W; Labropoulou M, 1998, ENVIRON BIOL FISH, V51, P309, DOI 10.1023/A:1007445112309; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LENAT D R, 1988, Journal of the North American Benthological Society, V7, P222, DOI 10.2307/1467422; Leps J, 2006, PRESLIA, V78, P481; LEVREL H, 2007, SELECTING INDICATORS, P1; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Mace GM, 2005, NATURE, V434, P32, DOI 10.1038/434032a; Marzin A, 2013, HYDROBIOLOGIA, V704, P375, DOI 10.1007/s10750-012-1254-2; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; *MILL, 2005, EC ASS SYNTH BIOD; Mouillot D, 2008, BIOL CONSERV, V141, P1569, DOI 10.1016/j.biocon.2008.04.002; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Oberdorff T, 2001, FRESHWATER BIOL, V46, P399, DOI 10.1046/j.1365-2427.2001.00669.x; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; PINHEIRO J, 2012, R LANG ENV STAT COMP; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; RAHEL FJ, 1991, T AM FISH SOC, V120, P319, DOI 10.1577/1548-8659(1991)120<0319:FAAHGI>2.3.CO;2; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schleuter D, 2012, GLOBAL ECOL BIOGEOGR, V21, P1083, DOI 10.1111/j.1466-8238.2012.00763.x; Sibbing FA, 2001, REV FISH BIOL FISHER, V10, P393; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; TACHET H, 1984, INTRO ETUDE MACROINV; Wang LZ, 2003, CAN J FISH AQUAT SCI, V60, P491, DOI 10.1139/F03-043; Zalewski M., 1990, P89	69	8	10	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80968	10.1371/journal.pone.0080968	http://dx.doi.org/10.1371/journal.pone.0080968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278356	Green Published, Green Submitted, gold			2022-12-27	WOS:000327541700040
J	Zhao, P; Wang, CY; Liu, WW; Chen, G; Liu, XY; Wang, X; Wang, B; Yu, LM; Sun, YR; Liang, XM; Yang, HZ; Zhang, F				Zhao, Pan; Wang, Chunya; Liu, Weiwei; Chen, Gang; Liu, Xinying; Wang, Xi; Wang, Bao; Yu, Liming; Sun, Yanrong; Liang, Xiaoming; Yang, Haozhen; Zhang, Fei			Causes and Outcomes of Acute Liver Failure in China	PLOS ONE			English	Article							ETIOLOGY	Objectives: No extensive investigation has been performed and thus no representative data are available regarding acute liver failure (ALF) in China. This study aims to investigate the causes and outcomes of ALF in China and establish a prognostic model. Methods: Patients diagnosed as ALF in seven hospitals in different areas of China from January 2007 to December 2012 were retrospectively selected. Results: Of the 177 patients included in this study, 112 (63.28%) eventually died. The common causes of ALF were drug toxicity (43.50%), indeterminate etiology (29.38%) and acute viral hepatitis (11.30%). Additionally, traditional Chinese herbs predominated in the causes of drug-induced ALF (30/77). No patients in this study received liver transplantation. In the established model for predicting death in ALF, four variables were finally selected out, including age (P=0.01), the entry hepatic encephalopathy grade (P=0.04), international normalized ratio (P<0.01) and arterial blood ammonia (P=0.02). Using a threshold value of 0.5683, this model had a sensitivity of 95.24% and a specificity of 91.30%. Conclusions: Traditional Chinese medicine was a major cause of ALF in China. The spontaneous mortality of ALF was high, whereas the rate of liver transplantation was significantly low. The established prognostic model of ALF had superior sensitivity and specificity.	[Zhao, Pan; Yang, Haozhen] Beijing 302 Hosp, PLA Hosp 302, Liver Failure Therapy & Res Ctr, Beijing, Peoples R China; [Wang, Chunya] Capital Med Univ, Beijing Anzhen Hosp, Emergency Dept, Beijing, Peoples R China; [Liu, Weiwei] Acad Mil Med Sci, Postgrad Div, Beijing, Peoples R China; [Chen, Gang] Second Artillery Force PLA, Dis Prevent & Control Off, Beijing, Peoples R China; [Liu, Xinying] Beijing 302 Hosp, PLA Hosp 302, Western & Tradit Chinese Med Ctr, Beijing, Peoples R China; [Wang, Xi] Second Mil Med Univ, Changhai Hosp, Med Adm Dept, Shanghai, Peoples R China; [Wang, Bao] PLA 477 Hosp, Med Adm Dept, Wuhan, Hubei Province, Peoples R China; [Yu, Liming] Gen Hosp Jinan Mil Reg, Med Adm Dept, Jinan, Shandong, Peoples R China; [Sun, Yanrong] Gen Hosp Lanzhou Mil Reg, Med Adm Dept, Lanzhou, Gansu, Peoples R China; [Liang, Xiaoming] PLA 161 Hosp, Dept Gastroenterol, Wuhan, Hunan, Peoples R China; [Zhang, Fei] Gen Hosp PLA, Intens Care Unit, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Capital Medical University; Academy of Military Medical Sciences - China; Fifth Medical Center of Chinese PLA General Hospital; Naval Medical University; Chinese People's Liberation Army General Hospital	Zhao, P (corresponding author), Beijing 302 Hosp, PLA Hosp 302, Liver Failure Therapy & Res Ctr, Beijing, Peoples R China.	doczhaopan@126.com						Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Bretherick A, 2011, QJM-INT J MED, V104, P945, DOI 10.1093/qjmed/hcr098; Canbay A, 2011, DTSCH ARZTEBL INT, V108, P714, DOI 10.3238/arztebl.2011.0714; Claridge LC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6764; Hadem J, 2012, CLIN GASTROENTEROL H, V10, P664, DOI 10.1016/j.cgh.2012.02.016; Harbrecht BG, 2012, CRIT CARE MED, V40, P1666, DOI 10.1097/CCM.0b013e3182451f9f; Ichai P, 2011, CLIN RES HEPATOL GAS, V35, P610, DOI 10.1016/j.clinre.2011.03.010; Kantola T, 2011, SCAND J SURG, V100, P8, DOI 10.1177/145749691110000103; Lee WM, 2012, BEST PRACT RES CL GA, V26, P3, DOI 10.1016/j.bpg.2012.01.014; Liu Q, 2007, J GASTROEN HEPATOL, V22, P2101, DOI 10.1111/j.1440-1746.2006.04362.x; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Rutherford A, 2012, GASTROENTEROLOGY, V143, P1237, DOI 10.1053/j.gastro.2012.07.113; Singhal A, 2012, TRANSPL INT, V25, P658, DOI 10.1111/j.1432-2277.2012.01470.x; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Wlodzimirow KA, 2012, ALIMENT PHARM THER, V35, P1245, DOI 10.1111/j.1365-2036.2012.05097.x; Wlodzimirow KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050952; Zhang H, 2011, CHINESE MED J-PEKING, V124, P2661, DOI 10.3760/cma.j.issn.0366-6999.2011.17.017	19	51	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80991	10.1371/journal.pone.0080991	http://dx.doi.org/10.1371/journal.pone.0080991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278360	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700043
J	Costa, P; Ferreira, AS; Amaro, A; Albuquerque, T; Botelho, A; Couto, I; Cunha, MV; Viveiros, M; Inacio, J				Costa, Pedro; Ferreira, Ana S.; Amaro, Ana; Albuquerque, Teresa; Botelho, Ana; Couto, Isabel; Cunha, Monica V.; Viveiros, Miguel; Inacio, Joao			Enhanced Detection of Tuberculous Mycobacteria in Animal Tissues Using a Semi-Nested Probe-Based Real-Time PCR	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; BOVIS; COMPLEX; IS6110; DIFFERENTIATION; SEQUENCE; CAPRAE; DNA; IDENTIFICATION; SPECIMENS	Bovine tuberculosis has been tackled for decades by costly eradication programs in most developed countries, involving the laboratory testing of tissue samples from allegedly infected animals for detection of Mycobacterium tuberculosis complex (MTC) members, namely Mycobacterium bovis. Definitive diagnosis is usually achieved by bacteriological culture, which may take up to 6-12 weeks, during which the suspect animal carcass and herd are under sanitary arrest. In this work, a user-friendly DNA extraction protocol adapted for tissues was coupled with an IS6110-targeted semi-nested duplex real-time PCR assay to enhance the direct detection of MTC bacteria in animal specimens, reducing the time to achieve a diagnosis and, thus, potentially limiting the herd restriction period. The duplex use of a novel beta-actin gene targeted probe, with complementary targets in most mammals, allowed the assessment of amplification inhibitors in the tissue samples. The assay was evaluated with a group of 128 fresh tissue specimens collected from bovines, wild boars, deer and foxes. Mycobacterium bovis was cultured from 57 of these samples. Overall, the full test performance corresponds to a diagnostic sensitivity and specificity of 98.2% (CIP95% 89.4-99.9%) and 88.7% (CIP95% 78.5-94.7%), respectively. An observed kappa coefficient was estimated in 0.859 (CIP95% 0.771-0.948) for the overall agreement between the semi-nested PCR assay and the bacteriological culture. Considering only bovine samples (n = 69), the diagnostic sensitivity and specificity were estimated in 100% (CIP95% 84.0-100%) and 97.7% (CIP95% 86.2-99.9%), respectively. Eight negative culture samples exhibiting TB-like lesions were detected by the semi-nested real-time PCR, thus emphasizing the increased potential of this molecular approach to detect MTC-infected animal tissues. This novel IS6110-targeted assay allows the fast detection of tuberculous mycobacteria in animal specimens with very high sensitivity and specificity, being amenable and cost effective for use in the routine veterinary diagnostic laboratory with further automation possibilities.	[Costa, Pedro; Ferreira, Ana S.; Amaro, Ana; Albuquerque, Teresa; Botelho, Ana; Cunha, Monica V.; Inacio, Joao] INIAV, IP, Unidade Estrateg Invest & Serv Prod & Saude Anim, Lisbon, Portugal; [Costa, Pedro; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Grp Micobacterias, Unidade Ensino & Invest Microbiol Med, P-1200 Lisbon, Portugal; [Ferreira, Ana S.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Couto, Isabel] Univ Nova Lisboa, Ctr Recursos Microbiol CREM, P-1200 Lisbon, Portugal; [Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal	Instituto Nacional de Investigacao Agraria e Veterinaria, IP (INIAV); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade do Porto; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Inacio, J (corresponding author), INIAV, IP, Unidade Estrateg Invest & Serv Prod & Saude Anim, Lisbon, Portugal.	joao.inacio@iniav.pt	Cunha, Mónica V./AAH-6246-2019; Couto, Isabel/I-2640-2012; Ferreira, AnaS/O-6745-2019; Inacio, Joao/D-5762-2011; Viveiros, Miguel/A-7326-2008; Cunha, Monica V./D-5544-2011; Ferreira, Ana/O-3755-2014	Cunha, Mónica V./0000-0003-0401-0276; Couto, Isabel/0000-0003-3536-2733; Ferreira, AnaS/0000-0001-7222-9101; Inacio, Joao/0000-0001-7367-5007; Viveiros, Miguel/0000-0001-9676-6251; Cunha, Monica V./0000-0003-0401-0276; Ferreira, Ana/0000-0001-7222-9101; Botelho, Ana/0000-0002-1843-9455; Amaro, Ana/0000-0002-5139-3268	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/CVT/117794/2010]; FCT, Portugal [PTDC/CVT/111634/2009]; FCT [SFRH/BD/64136/2009, SFRH/BD/62317/2009]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	MVC acknowledges funding from Fundacao para a Ciencia e Tecnologia (FCT), Portugal ("Ciencia 2008" research contract and PTDC/CVT/117794/2010 research project); JI acknowledges funding from FCT, Portugal ("Ciencia 2007" research contract and PTDC/CVT/111634/2009 research project); PC and ASF are a recipients of PhD grants from FCT (SFRH/BD/64136/2009 and SFRH/BD/62317/2009, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; Coetsier C, 2000, J CLIN MICROBIOL, V38, P3048, DOI 10.1128/JCM.38.8.3048-3054.2000; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Costa P, 2010, CLIN MICROBIOL INFEC, V16, P1464, DOI [10.1111/j.1469-0691.2010.03120.x, 10.1111/j.1469-0691.2009.03120.x]; Cunha Monica V, 2011, Vet Med Int, V2011, P795165, DOI 10.4061/2011/795165; Cunha MV, 2012, RES VET SCI, V92, P225, DOI 10.1016/j.rvsc.2011.03.009; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027; Kubica T, 2003, J CLIN MICROBIOL, V41, P3070, DOI 10.1128/JCM.41.7.3070-3077.2003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIEBANA E, 1995, J CLIN MICROBIOL, V33, P33; Miller J, 1997, J VET DIAGN INVEST, V9, P244, DOI 10.1177/104063879700900304; Niemann S, 2000, J CLIN MICROBIOL, V38, P3231, DOI 10.1128/JCM.38.9.3231-3234.2000; OIE, 2013, MAN DIAGN TESTS VACC; Parra A, 2008, VET MICROBIOL, V127, P315, DOI 10.1016/j.vetmic.2007.09.001; Pounder JI, 2010, DIAGN MICR INFEC DIS, V67, P101, DOI 10.1016/j.diagmicrobio.2009.12.014; Reddington K, 2012, J CLIN MICROBIOL, V50, P2203, DOI 10.1128/JCM.00718-12; Restrepo BI, 2006, J MICROBIOL METH, V67, P220, DOI 10.1016/j.mimet.2006.03.016; Rodriguez E, 2009, INT J TUBERC LUNG D, V13, P1536; Roring S, 2000, VET MICROBIOL, V74, P227, DOI 10.1016/S0378-1135(00)00189-9; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Savelkoul PHM, 2006, J MICROBIOL METH, V66, P177, DOI 10.1016/j.mimet.2005.12.003; Stewart LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058374; Stewart LD, 2012, J CLIN MICROBIOL, V50, P1598, DOI 10.1128/JCM.05747-11; Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08; Taylor G Michael, 2007, BMC Vet Res, V3, P12, DOI 10.1186/1746-6148-3-12; Taylor MJ, 2001, J CLIN MICROBIOL, V39, P1272, DOI 10.1128/JCM.39.4.1272-1278.2001; Thacker TC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-50; Torres-Gonzalez P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002177; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; WARDS BJ, 1995, VET MICROBIOL, V43, P227, DOI 10.1016/0378-1135(94)00096-F; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527	35	23	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81337	10.1371/journal.pone.0081337	http://dx.doi.org/10.1371/journal.pone.0081337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278425	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800124
J	Fang, L; Coutts, RHA				Fang, Liang; Coutts, Robert H. A.			Investigations on the Tobacco Necrosis Virus D p60 Replicase Protein	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; COMPLETE NUCLEOTIDE-SEQUENCE; TURNIP-CRINKLE-VIRUS; STRAIN-D; TOMBUSVIRUS REPLICATION; BINDING DOMAINS; SATELLITE; EXPRESSION; PLANTS	Tobacco Necrosis Virus D (TNV-D), in the genus Betanecrovirus (family Tombusviridae), possesses a single-stranded, positive-sense RNA genome containing six open reading frames (ORFs). Two 5'-proximal ORFs (1 and 2) encode overlapping polypeptides of 22 and 82 kDa (p22 and p82, respectively) which are both required for replication. The p22 auxiliary protein contains no replication motifs but the C-terminal region, downstream of a leaky stop codon, encodes a 60 kDa polypeptide (p60) which contains conserved RNA-dependent RNA polymerase (RdRP) motifs. Here we have expressed and purified recombinant p60 and show that in vitro it binds and efficiently synthesises both TNV-D RNA and Satellite tobacco necrosis virus C RNA. Alanine scanning mutagenesis of conserved amino acids in characteristic motifs in p60 revealed that some mutations significantly reduced RNA synthesis but mutating the second asparagine residue in the conserved GDD box was lethal. The effects of mutating identical amino acids in p60 on virus replication in vivo were examined in Nicotiana benthamiana plants following infection with RNA transcribed from wild type (wt) and mutant constructs. In inoculated leaves the behaviour of the mutants paralleled the in vitro data but systemic infection was precluded in all but one mutant which had reverted to wt. This study is the first to demonstrate the nucleic acid-binding and synthetic capabilities of a betanecrovirus polymerase.	[Fang, Liang; Coutts, Robert H. A.] Univ Hertfordshire, Dept Human & Environm Sci, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Coutts, RHA (corresponding author), Univ Hertfordshire, Dept Human & Environm Sci, Hatfield AL10 9AB, Herts, England.	r.coutts@imperial.ac.uk						ANDRIESSEN M, 1995, VIROLOGY, V212, P222, DOI 10.1006/viro.1995.1472; Batten JS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-12; Boonrod K, 2005, J GEN VIROL, V86, P823, DOI 10.1099/vir.0.80625-0; Bringloe DH, 1998, J GEN VIROL, V79, P1539, DOI 10.1099/0022-1317-79-6-1539; Buck KW, 1996, ADV VIRUS RES, V47, P525; COUTTS RHA, 1991, J GEN VIROL, V72, P1521, DOI 10.1099/0022-1317-72-7-1521; Coutts RHA, 2001, J PHYTOPATHOL, V149, P167, DOI 10.1046/j.1439-0434.2001.00603.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Molnar A, 1997, J GEN VIROL, V78, P1235, DOI 10.1099/0022-1317-78-6-1235; Nagy PD, 1998, VIROLOGY, V249, P379, DOI 10.1006/viro.1998.9341; Nagy Peter D., 2008, V451, P55, DOI 10.1007/978-1-59745-102-4_4; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Offei SK, 1996, J PHYTOPATHOL, V144, P13, DOI 10.1111/j.1439-0434.1996.tb01481.x; Panaviene Z, 2003, VIROLOGY, V308, P191, DOI 10.1016/S0042-6822(02)00132-0; Pathak KB, 2013, VIROLOGY, V437, P48, DOI 10.1016/j.virol.2012.12.009; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; Rajendran KS, 2002, J VIROL, V76, P1707, DOI 10.1128/JVI.76.4.1707-1717.2002; Rochon D., 2012, 9 REPORT INT COMMITT, P1111, DOI DOI 10.1007/S00705-003-0258-7; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zhang YJ, 2011, VIRUS RES, V155, P307, DOI 10.1016/j.virusres.2010.10.029	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80912	10.1371/journal.pone.0080912	http://dx.doi.org/10.1371/journal.pone.0080912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278346	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800090
J	Majek, P; Riedelova-Reicheltova, Z; Pecankova, K; Dyr, JE				Majek, Pavel; Riedelova-Reicheltova, Zuzana; Pecankova, Klara; Dyr, Jan E.			Improved Coomassie Blue Dye-Based Fast Staining Protocol for Proteins Separated by SDS-PAGE	PLOS ONE			English	Article							GELS	The time required to visualize proteins using Coomassie Blue dye has been significantly reduced with the introduction of fast staining protocols based on staining with a Coomassie Blue dye solution at boiling temperatures. However, fast stainings suffer from high gel backgrounds, reducing the signal-to-noise ratio and limiting the number of detectable spots in the case of 2D SDS-PAGE. The aim of this work was to eliminate the high gel background, and thus improve fast staining protocols based on Coomassie Blue dye. We show that merely replacing water with a 4 mM EDTA washing solution at boiling temperatures, results in a transparent gel background within 50 to 60 minutes of destaining. Moreover, when a combination of imidazole-zinc reverse staining and Coomassie Blue-based fast staining is used the sensitivity is improved significantly; nanogram amounts of proteins can be detected using 1D SDS-PAGE, and about 30% to 60% more spots can be detected with 2D SDS-PAGE in plasma, platelet, and rat brain tissue samples. This work represents an optimized fast staining protocol with improved sensitivity, requiring between 60 to 75 minutes to complete protein visualization.	[Majek, Pavel; Riedelova-Reicheltova, Zuzana; Pecankova, Klara; Dyr, Jan E.] Inst Hematol & Blood Transfus, Dept Biochem, CR-12820 Prague, Czech Republic	Institute of Hematology Prague	Majek, P (corresponding author), Inst Hematol & Blood Transfus, Dept Biochem, CR-12820 Prague, Czech Republic.	pavel.majek@uhkt.cz	Dyr, Jan/G-5580-2017	Dyr, Jan/0000-0002-7970-5868; Riedelova-Reicheltova, Zuzana/0000-0001-5614-1871; Majek, Pavel/0000-0002-9946-3819	Czech Science Foundation [P205/12/G118]; Ministry of Health, Czech Republic; Institute of Hematology and Blood Transfusion	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government); Institute of Hematology and Blood Transfusion	This study was supported by the Czech Science Foundation P205/12/G118 and by the project (Ministry of Health, Czech Republic) for conceptual development of research organization (Institute of Hematology and Blood Transfusion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022394; Fernandez-Patron C, 1998, ELECTROPHORESIS, V19, P2398, DOI 10.1002/elps.1150191407; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Majek P, 2013, ELECTROPHORESIS, V34, P1972, DOI 10.1002/elps.201300087; Majek P, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-84; Majek P, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-56; Reicheltova Z, 2012, PROTEOM CLIN APPL, V6, P374, DOI 10.1002/prca.201100101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smejkal GB, 2004, EXPERT REV PROTEOMIC, V1, P381, DOI 10.1586/14789450.1.4.381; Westermeier R, 2006, PROTEOMICS, P61, DOI 10.1002/pmic.200690121	10	7	8	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81696	10.1371/journal.pone.0081696	http://dx.doi.org/10.1371/journal.pone.0081696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278455	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800139
J	Nilsson, OR; Lannergard, J; Morgan, BP; Lindahl, G; Gustafsson, MCU				Nilsson, O. Rickard; Lannergard, Jonas; Morgan, B. Paul; Lindahl, Gunnar; Gustafsson, Mattias C. U.			Affinity Purification of Human Factor H on Polypeptides Derived from Streptococcal M Protein: Enrichment of the Y402 Variant	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; MACULAR DEGENERATION; ANTIGENIC VARIATION; SURFACE PROTEIN; PEPTIDE; SYSTEM; IMMUNE	Recent studies indicate that defective activity of complement factor H (FH) is associated with several human diseases, suggesting that pure FH may be used for therapy. Here, we describe a simple method to isolate human FH, based on the specific interaction between FH and the hypervariable region (HVR) of certain Streptococcus pyogenes M proteins. Special interest was focused on the FH polymorphism Y402H, which is associated with the common eye disease age-related macular degeneration (AMD) and has also been implicated in the binding to M protein. Using a fusion protein containing two copies of the M5-HVR, we found that the Y402 and H402 variants of FH could be efficiently purified by single-step affinity chromatography from human serum containing the corresponding protein. Different M proteins vary in their binding properties, and the M6 and M5 proteins, but not the M18 protein, showed selective binding of the FH Y402 variant. Accordingly, chromatography on a fusion protein derived from the M6-HVR allowed enrichment of the Y402 protein from serum containing both variants. Thus, the exquisite binding specificity of a bacterial protein can be exploited to develop a simple and robust procedure to purify FH and to enrich for the FH variant that protects against AMD.	[Nilsson, O. Rickard; Lannergard, Jonas; Lindahl, Gunnar; Gustafsson, Mattias C. U.] Lund Univ, Dept Lab Med, Lund, Sweden; [Nilsson, O. Rickard; Lindahl, Gunnar; Gustafsson, Mattias C. U.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Morgan, B. Paul] Cardiff Univ, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Lund University; University of Copenhagen; Cardiff University	Lindahl, G (corresponding author), Lund Univ, Dept Lab Med, Lund, Sweden.	gunnar.lindahl@med.lu.se	Gustafsson, Mattias C. U./A-7451-2010; Lannergård, Jonas/L-6513-2013	Gustafsson, Mattias C. U./0000-0003-3260-0724; Lannergard, Jonas/0000-0001-9072-6486; Morgan, Paul/0000-0003-4075-7676	Swedish Research Council [K2011-56X-09490-21-6]; Danish Strategic Research Council (Center for Nano-Vaccines); Foundation Olle Engkvist Byggmastare; trust of Osterlund; Swedish Government Support for Clinical Research (ALF); Royal Physiographic Society in Lund; trust of Golje	Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Strategic Research Council (Center for Nano-Vaccines); Foundation Olle Engkvist Byggmastare; trust of Osterlund; Swedish Government Support for Clinical Research (ALF); Royal Physiographic Society in Lund; trust of Golje	This work was supported by the Swedish Research Council (Project K2011-56X-09490-21-6), the Danish Strategic Research Council (Center for Nano-Vaccines), and the Foundation Olle Engkvist Byggmastare, the trust of Osterlund (all to GL), the Swedish Government Support for Clinical Research (ALF) (to GL, MCUG and JL), and by the Royal Physiographic Society in Lund and the trust of Golje (to MCUG and JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Brandstatter H, 2012, VOX SANG, V103, P201, DOI 10.1111/j.1423-0410.2012.01610.x; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; Farkas H, 2012, BIOL THER, V2, P1, DOI [10.1007/s13554-012-0001-6, DOI 10.1007/S13554-012-0001-6]; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gustafsson MCU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003323; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Hakobyan S, 2010, KIDNEY INT, V78, P782, DOI 10.1038/ki.2010.275; Harris CL, 2000, COMPLEMENT METHODS P, P83; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kim SJ, 2013, BRIT J OPHTHALMOL, V97, P367, DOI 10.1136/bjophthalmol-2012-302307; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Morfeldt E, 2001, J IMMUNOL, V167, P3870, DOI 10.4049/jimmunol.167.7.3870; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; SIM RB, 1993, METHOD ENZYMOL, V223, P13; Sofat R, 2013, J IMMUNOL METHODS, V390, P63, DOI 10.1016/j.jim.2013.01.009; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Troutbeck R, 2012, CLIN EXP OPHTHALMOL, V40, P18, DOI 10.1111/j.1442-9071.2011.02581.x; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81303	10.1371/journal.pone.0081303	http://dx.doi.org/10.1371/journal.pone.0081303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278416	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800119
J	Togashi, K; Wakatsuki, S; Furuno, A; Tokunaga, S; Nagai, Y; Araki, T				Togashi, Kazuya; Wakatsuki, Shuji; Furuno, Akiko; Tokunaga, Shinji; Nagai, Yoshitaka; Araki, Toshiyuki			Na+/H+ Exchangers Induce Autophagy in Neurons and Inhibit Polyglutamine-Induced Aggregate Formation	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; INTRACELLULAR PH; MICE; MECHANISMS; BRAIN; CELLS; DEGRADATION; ACTIVATION; DIVERSITY; HEALTH	In polyglutamine diseases, an abnormally elongated polyglutamine results in protein misfolding and accumulation of intracellular aggregates. Autophagy is a major cellular degradative pathway responsible for eliminating unnecessary proteins, including polyglutamine aggregates. Basal autophagy constitutively occurs at low levels in cells for the performance of homeostatic function, but the regulatory mechanism for basal autophagy remains elusive. Here we show that the Na+/H+ exchanger (NHE) family of ion transporters affect autophagy in a neuron-like cell line (Neuro-2a cells). We showed that expression of NHE1 and NHE5 is correlated to polyglutamine accumulation levels in a cellular model of Huntington's disease, a fatal neurodegenerative disorder characterized by accumulation of polyglutamine-containing aggregate formation in the brain. Furthermore, we showed that loss of NHE5 results in increased polyglutamine accumulation in an animal model of Huntington's disease. Our data suggest that cellular pH regulation by NHE1 and NHE5 plays a role in regulating basal autophagy and thereby promotes autophagy-mediated degradation of proteins including polyglutamine aggregates.	[Togashi, Kazuya; Wakatsuki, Shuji; Furuno, Akiko; Tokunaga, Shinji; Araki, Toshiyuki] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Peripheral Nervous Syst Res, Kodaira, Tokyo 187, Japan; [Nagai, Yoshitaka] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 187, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Araki, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Peripheral Nervous Syst Res, Kodaira, Tokyo 187, Japan.	taraki@ncnp.go.jp	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Tokunaga, Shinji/0000-0001-8398-3054	Ministry of Health, Labour, and Welfare; Kakenhi [19800066, 22700407]; Grants-in-Aid for Scientific Research [23390237, 25110741] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by grants from the Ministry of Health, Labour, and Welfare (T.A.), and Kakenhi (19800066 and 22700407, for K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Diering GH, 2011, MOL BIOL CELL, V22, P2246, DOI 10.1091/mbc.E11-01-0066; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Wulff Heike, 2008, ACS Chem Biol, V3, P399, DOI 10.1021/cb800140m; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	27	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81313	10.1371/journal.pone.0081313	http://dx.doi.org/10.1371/journal.pone.0081313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278418	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800120
J	van der Meijden, E; Bialasiewicz, S; Rockett, RJ; Tozer, SJ; Sloots, TP; Feltkamp, MCW				van der Meijden, Els; Bialasiewicz, Seweryn; Rockett, Rebecca J.; Tozer, Sarah J.; Sloots, Theo P.; Feltkamp, Mariet C. W.			Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; GLUTATHIONE-S-TRANSFERASE; TRICHODYSPLASIA SPINULOSA; CROSS-REACTIVITY; HUMAN INFECTION; SEROPREVALENCE; IDENTIFICATION; ANTIBODIES; CARCINOMA; TISSUES	The polyomavirus family is rapidly expanding with twelve new human viruses identified since 2007. A significant number of the new human polyomaviruses (HPyV) has been found on the skin. Whether these viruses share biological properties and should be grouped together is unknown. Here we investigated the serological behavior of cutaneous HPyVs in a general population. 799 sera from immunocompetent Australian individuals aged between 0-87 were analyzed with a Luminex xMAP technology-based immunoassay for the presence of VP1-directed IgG antibodies against MCPyV, HPyV6, HPyV7, TSPyV, HPyV9, and BKPyV as a control. Except for HPyV9, overall seropositivity was high for the cutanous polyomaviruses (66-81% in adults), and gradually increased with age. Children below 6 months displayed seropositivity rates comparable to the adults, indicative of maternal antibodies. TSPyV seroreactivity levels strongly increased after age 2 and waned later in life comparable to BKPyV, whereas MCPyV, HPyV6 and HPyV7 seroreactivity remained rather stable throughout. Based on the identified serologic profiles, MCPyV seems to cluster with HPyV6 and HPyV7, and TSPyV and HPyV9 by themselves. These profiles indicate heterogeneity among cutaneous polyomaviruses and probably reflect differences in exposure and pathogenic behavior of these viruses.	[van der Meijden, Els; Feltkamp, Mariet C. W.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Bialasiewicz, Seweryn; Rockett, Rebecca J.; Tozer, Sarah J.; Sloots, Theo P.] Univ Queensland, Queensland Paediat Infect Dis Lab, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Bialasiewicz, Seweryn; Rockett, Rebecca J.; Tozer, Sarah J.; Sloots, Theo P.] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Brisbane, Qld, Australia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Queensland; Royal Children's Hospital Brisbane	van der Meijden, E (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	p.z.van_der_meijden@lumc.nl	Feltkamp, Mariet/A-3788-2010; Bialasiewicz, Seweryn/F-1414-2010	Feltkamp, Mariet/0000-0001-5993-9846; Bialasiewicz, Seweryn/0000-0001-9474-6943; Tozer, Sarah/0000-0002-3001-7642	QCMRI Early Career Fellowship from the Children's Hospital Foundation [50056]	QCMRI Early Career Fellowship from the Children's Hospital Foundation	SB is supported by a QCMRI Early Career Fellowship (# 50056) from the Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Antonsson A, 2013, J MED VIROL, V85, P327, DOI 10.1002/jmv.23472; Boldorini R, 2011, J GEN VIROL, V92, P1044, DOI 10.1099/vir.0.028571-0; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Feltkamp MCW, 2013, J GEN VIROL, V94, P482, DOI 10.1099/vir.0.048462-0; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fischer MK, 2012, ARCH DERMATOL, V148, P726, DOI 10.1001/archdermatol.2011.3298; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Foulongne V, 2010, EMERG INFECT DIS, V16, P685, DOI 10.3201/eid1604.091278; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Moens U, 2013, REV MED VIROL, V23, P250, DOI 10.1002/rmv.1747; Nguyen NL, 2009, EMERG INFECT DIS, V15, P1199, DOI 10.3201/eid1508.090270; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Nicol JTJ, 2012, EMERG INFECT DIS, V18, P1329, DOI 10.3201/eid1808.111625; Paulson KG, 2010, CANCER RES, V70, P8388, DOI 10.1158/0008-5472.CAN-10-2128; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Sauvage V, 2011, EMERG INFECT DIS, V17, P1364, DOI 10.3201/eid1708.110278; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Tozer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1287, DOI 10.1007/s10096-011-1225-y; Trusch F, 2012, J GEN VIROL, V93, P698, DOI 10.1099/vir.0.039156-0; van der Meijden E, 2011, EMERG INFECT DIS, V17, P1355, DOI 10.3201/eid1708.110114; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	41	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81078	10.1371/journal.pone.0081078	http://dx.doi.org/10.1371/journal.pone.0081078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278381	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800099
J	Guo, QX; Li, HM; Cole, AL; Hur, JY; Li, YM; Zheng, H				Guo, Qinxi; Li, Hongmei; Cole, Allysa L.; Hur, Ji-Yeun; Li, Yueming; Zheng, Hui			Modeling Alzheimer's Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of A beta and Tau	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; GENE-TARGETED MICE; PRESENILIN-1; INFLAMMATION; DEPOSITION; NEUROINFLAMMATION; PATHOLOGY; MUTATION; HYPOTHESIS	Background: Alzheimer's disease (AD), the most common cause of dementia in the elderly, has two pathological hallmarks: A beta plaques and aggregation of hyperphosphorylated tau (p-tau). A beta is a cleavage product of Amyloid Precursor Protein (APP). Presenilin 1 (PS1) and presenilin 2 (PS2) are the catalytic subunit of.-secretase, which cleaves APP and mediates A beta production. Genetic mutations in APP, PSEN1 or PSEN2 can lead to early onset of familial AD (FAD). Although mutations in the tau encoding gene MAPT leads to a subtype of frontotemporal dementia and these mutations have been used to model AD tauopathy, no MAPT mutations have been found to be associated with AD. Results: To model AD pathophysiology in mice without the gross overexpression of mutant transgenes, we created a humanized AD mouse model by crossing the APP and PSEN1 FAD knock-in mice with the htau mice which express wildtype human MAPT genomic DNA on mouse MAPT null background (APP/PS1/htau). The APP/PS1/htau mice displayed mild, age-dependent, A beta plaques and tau hyperphosphorylation, thus successfully recapitulating the late-onset AD pathological hallmarks. Selected biochemical analyses, including p-tau western blot, gamma-secretase activity assay, and A beta ELISA, were performed to study the interaction between A beta and p-tau. Subsequent behavioral studies revealed that the APP/PS1/htau mice showed reduced mobility in old ages and exaggerated fear response. Genetic analysis suggested that the fear phenotype is due to a synergic interaction between A beta and p-tau, and it can be completely abolished by tau deletion. Conclusion: The APP/PS1/htau model represents a valuable and disease-relevant late-onset pre-clinical AD animal model because it incorporates human AD genetics without mutant protein overexpression. Analysis of the mice revealed both cooperative and independent effects of A beta and p-tau.	[Guo, Qinxi; Li, Hongmei; Cole, Allysa L.; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Hur, Ji-Yeun; Li, Yueming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA	Baylor College of Medicine; Memorial Sloan Kettering Cancer Center	Zheng, H (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	huiz@bcm.edu	LI, Yue/GRS-8071-2022	Hur, Ji Yeun/0000-0002-9895-3090	NIH [AG020670, AG032051, NS076117]; Belfer Neurodegeneration Consortium; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020670, R01AG032051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belfer Neurodegeneration Consortium; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from NIH (AG020670, AG032051 and NS076117 to HZ) and the Belfer Neurodegeneration Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Broussard G. Joseph, 2012, Inflammopharmacology, V20, P109, DOI 10.1007/s10787-012-0130-z; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Guo QX, 2012, NEUROBIOL AGING, V33, P2678, DOI 10.1016/j.neurobiolaging.2012.01.002; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kohler C, 2005, NEUROBIOL DIS, V20, P528, DOI 10.1016/j.nbd.2005.04.009; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li HM, 2010, J BIOL CHEM, V285, P30598, DOI 10.1074/jbc.M110.137729; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; McAlpine FE, 2008, J INFLAMM RES, V1, P29; MICHAUD M, 2013, J AM MED DIR ASS; Morris HR, 1999, MOVEMENT DISORD, V14, P731, DOI 10.1002/1531-8257(199909)14:5<731::AID-MDS1004>3.0.CO;2-J; Qiao XX, 2001, EUR J NEUROSCI, V14, P474, DOI 10.1046/j.0953-816x.2001.01666.x; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schott JM, 2013, BRAIN, V136, P2654, DOI 10.1093/brain/awt231; Sheng JG, 2003, NEUROBIOL DIS, V14, P133, DOI 10.1016/S0969-9961(03)00069-X; Siman R, 2000, J NEUROSCI, V20, P8717; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	37	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80706	10.1371/journal.pone.0080706	http://dx.doi.org/10.1371/journal.pone.0080706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278307	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100101
J	Mugambi, ML; Deo, S; Kekitiinwa, A; Kiyaga, C; Singer, ME				Mugambi, Melissa Latigo; Deo, Sarang; Kekitiinwa, Adeodata; Kiyaga, Charles; Singer, Mendel E.			Do Diagnosis Delays Impact Receipt of Test Results? Evidence from the HIV Early Infant Diagnosis Program in Uganda	PLOS ONE			English	Article							EXPOSED INFANTS; CARE-SEEKING; OUTCOMES; MORTALITY; INFECTION; SERVICES; CHILDREN	Background: There is scant evidence on the association between diagnosis delays and the receipt of test results in HIV Early Infant Diagnosis (EID) programs. We determine the association between diagnosis delays and other health care system and patient factors on result receipt. Methods: We reviewed 703 infant HIV test records for tests performed between January 2008 and February 2009 at a regional referral hospital and level four health center in Uganda. The main outcome was caregiver receipt of the test result. The primary study variable was turnaround time (time between sample collection and result availability at the health facility). Additional variables included clinic entry point, infant age at sample collection, reported HIV status and receipt of antiretroviral prophylaxis for prevention of mother-to-child transmission. We conducted a pooled analysis in addition to separate analyses for each facility. We estimated the relative risk of result receipt using modified Poisson regression with robust standard errors. Results: Overall, the median result turnaround time, was 38 days. 59% of caregivers received infant test results. Caregivers were less likely to receive results at turnaround times greater than 49 days compared to 28 days or fewer (ARR = 0.83; 95% CI = 0.70-0.98). Caregivers were more likely to receive results at the PMTCT clinic (ARR = 1.81; 95% CI = 1.40-2.33) and less likely at the pediatric ward (ARR = 0.54; 95% CI = 0.37-0.81) compared to the immunization clinic. At the level four health center, result receipt was half as likely among infants older than 9 months compared to 3 months and younger (ARR = 0.47; 95% CI = 0.25-0.93). Conclusion: In this study setting, we find evidence that longer turnaround times, clinic entry point and age at sample collection may be associated with receipt of infant HIV test results.	[Mugambi, Melissa Latigo; Singer, Mendel E.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Deo, Sarang] Indian Sch Business, Hyderabad, Andhra Pradesh, India; [Kekitiinwa, Adeodata] Mulago Hosp, Baylor Coll Med, Bristol Myers Squibb Childrens Clin Ctr, Kampala, Uganda; [Kiyaga, Charles] Minist Hlth, AIDS Control Program, Kampala, Uganda	Case Western Reserve University; Indian School of Business (ISB); Baylor College of Medicine; Bristol-Myers Squibb; Mulago National Referral Hospital	Mugambi, ML (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	melissa.latigo@case.edu	Singer, Mendel/S-8775-2019; Deo, Sarang/B-5895-2015	Deo, Sarang/0000-0002-3233-6014; Singer, Mendel/0000-0002-3331-3340	Northwestern University, Center for Innovation in Global Health Technologies (NU CIGHT) through a research grant from the Bill and Melinda Gates Foundation (Grand Challenges in Global Health) [37774]	Northwestern University, Center for Innovation in Global Health Technologies (NU CIGHT) through a research grant from the Bill and Melinda Gates Foundation (Grand Challenges in Global Health)	MLM conducted this study as part of self-funded doctoral research. The study was also funded in part by the Northwestern University, Center for Innovation in Global Health Technologies (NU CIGHT) through a research grant from the Bill and Melinda Gates Foundation (Grand Challenges in Global Health, Grant No. 37774). The NU CIGHT and The Bill and Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; JOINT UN, 2010, REP UNAIDS REP GLOB; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; McCollum ED, 2012, JAIDS-J ACQ IMM DEF, V60, pE107, DOI 10.1097/QAI.0b013e31825aa721; Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b; MOODLEY D, 1995, PEDIATR INFECT DIS J, V14, P850, DOI 10.1097/00006454-199510000-00006; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Ong'ech JO, 2012, JAIDS-J ACQ IMM DEF, V61, P83, DOI 10.1097/QAI.0b013e31825bd842; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Sherman GG, 2005, JAIDS-J ACQ IMM DEF, V38, P615, DOI 10.1097/01.qai.0000143604.71857.5d; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; *UG SPA, 2008, UG SERV PROV ASS SUR; *UNAIDS, 2012, UG AIDS COMM GLOB AI; *UNICEF, 2011, PREV MOTH TO CHILD T; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2010, WHO REC DIAGN HIV IN; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	26	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e78891	10.1371/journal.pone.0078891	http://dx.doi.org/10.1371/journal.pone.0078891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	24282502	gold, Green Published			2022-12-27	WOS:000326499300041
J	Williams, LM; Timme-Laragy, AR; Goldstone, JV; McArthur, AG; Stegeman, JJ; Smolowitz, RM; Hahn, ME				Williams, Larissa M.; Timme-Laragy, Alicia R.; Goldstone, Jared V.; McArthur, Andrew G.; Stegeman, John J.; Smolowitz, Roxanna M.; Hahn, Mark E.			Developmental Expression of the Nfe2-Related Factor (Nrf) Transcription Factor Family in the Zebrafish, Danio rerio	PLOS ONE			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; GLOBIN GENE-EXPRESSION; IN-SITU HYBRIDIZATION; LIFE-STAGE TOXICITY; FACTOR NF-E2; OXIDATIVE-STRESS; FUNCTIONAL-CHARACTERIZATION; SWIMBLADDER DEVELOPMENT; OXIDIZED PHOSPHOLIPIDS; EMBRYONIC LETHALITY	Transcription factors in the CNC-bZIP family (NFE2, NRF1, NRF2 and NRF3) regulate genes with a wide range of functions in response to both physiological and exogenous signals, including those indicating changes in cellular redox status. Given their role in helping to maintain cellular homeostasis, it is imperative to understand the expression, regulation, and function of CNC-bZIP genes during embryonic development. We explored the expression and function of six nrf genes (nfe2, nrf1a, nrf1b, nrf2a, nrf2b, and nrf3) using zebrafish embryos as a model system. Analysis by microarray and quantitative RT-PCR showed that genes in the nrf family were expressed throughout development from oocytes to larvae. The spatial expression of nrf3 suggested a role in regulating the development of the brain, brachia and pectoral fins. Knock-down by morpholino anti-sense oligonucleotides suggested that none of the genes were necessary for embryonic viability, but nfe2 was required for proper cellular organization in the pneumatic duct and subsequent swim bladder function, as well as for proper formation of the otic vesicles. nrf genes were induced by the oxidant tert-butylhydroperoxide, and some of this response was regulated through family members Nrf2a and Nrf2b. Our results provide a foundation for understanding the role of nrf genes in normal development and in regulating the response to oxidative stress in vertebrate embryos.	[Williams, Larissa M.; Timme-Laragy, Alicia R.; Goldstone, Jared V.; Stegeman, John J.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Williams, Larissa M.] Bates Coll, Dept Biol, Lewiston, ME 04240 USA; [McArthur, Andrew G.] Andrew McArthur Consulting, Hamilton, ON, Canada; [Smolowitz, Roxanna M.] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA	Woods Hole Oceanographic Institution	Hahn, ME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	mhahn@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; Williams, Larissa/0000-0001-8972-9735; McArthur, Andrew/0000-0002-1142-3063; Timme-Laragy, Alicia/0000-0002-8835-5038; Goldstone, Jared/0000-0002-9618-4961; Stegeman, John/0000-0001-8204-5357	National Institutes of Health [F32ES019832, F32ES017585, R01ES015912, R01ES016366]; J. Seward Johnson Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016366, F32ES017585, P42ES007381, R01ES015912, F32ES019832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. Seward Johnson Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health grants F32ES019832 (to L. M. W.), F32ES017585 (to A. R. T.-L.), R01ES015912 (to J.J.S.), and R01ES016366 (to M. E. H.). This work was also supported by Walter A. and Hope Noyes Smith and the J. Seward Johnson Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Balasubramanian S, 2012, J BIOL CHEM; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 2001, BLOOD, V97, P2151, DOI 10.1182/blood.V97.7.2151; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chen LY, 2003, MOL CELL BIOL, V23, P4673, DOI 10.1128/MCB.23.13.4673-4686.2003; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; Chevillard G, 2011, BLOOD, V117, P2005, DOI 10.1182/blood-2010-02-271460; Chevillard G, 2010, FEBS LETT, V584, P923, DOI 10.1016/j.febslet.2010.01.028; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Evans BR, 2005, ARCH BIOCHEM BIOPHYS, V441, P151, DOI 10.1016/j.abb.2005.07.008; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Han WN, 2012, J BIOL CHEM, V287, P18788, DOI 10.1074/jbc.M112.363614; Heideman W, 2005, CARDIOVASC TOXICOL, V5, P203, DOI 10.1385/CT:5:2:203; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jenny MJ, 2009, TOXICOL SCI, V110, P426, DOI 10.1093/toxsci/kfp116; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Jonsson ME, 2012, TOXICOL APPL PHARM, V265, P166, DOI 10.1016/j.taap.2012.09.023; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Korzh S, 2011, DEV BIOL, V359, P262, DOI 10.1016/j.ydbio.2011.08.024; Kubota A, 2011, TOXICOL APPL PHARM, V253, P244, DOI 10.1016/j.taap.2011.03.025; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Lassiter CS, 2007, ZEBRAFISH, V4, P49, DOI 10.1089/zeb.2006.9995; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Liao W, 1997, ZEBRAFISH GENE CLOCH, P381; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2010, BLOOD, V115, P677, DOI 10.1182/blood-2009-05-223107; Nakajima H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026884; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Pettazzoni P, 2011, FREE RADICAL BIO MED, V51, P1610, DOI 10.1016/j.freeradbiomed.2011.07.009; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pratt SJ, 2002, PHYSIOL GENOMICS, V11, P91, DOI 10.1152/physiolgenomics.00112.2001; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Sapede D, 2010, J NEUROSCI, V30, P3612, DOI 10.1523/JNEUROSCI.5109-09.2010; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Shen-Orr SS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r58; Shin JT, 2002, ANNU REV GENOM HUM G, V3, P311, DOI 10.1146/annurev.genom.3.031402.131506; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; Sisman T, 2007, TOXICOL IND HEALTH, V23, P529, DOI 10.1177/0748233708089042; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Timme-Laragy AR, 2009, TOXICOL SCI, V109, P217, DOI 10.1093/toxsci/kfp038; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Van de Peer Y, 2002, NUCLEIC ACIDS RES, V30, P109, DOI 10.1093/nar/30.1.109; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ward AC, 2002, FRONT BIOSCI, V7, pD827, DOI 10.2741/ward; Winata CL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-3; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; ZeRuth G, 2007, CHEM-BIOL INTERACT, V170, P100, DOI 10.1016/j.cbi.2007.07.003	87	19	20	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e79574	10.1371/journal.pone.0079574	http://dx.doi.org/10.1371/journal.pone.0079574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24298298	gold, Green Submitted, Green Published			2022-12-27	WOS:000326152300096
J	Abubakar, YF; Meng, ZF; Zhang, XY; Xu, JQ				Abubakar, Yassir F.; Meng, Zhefeng; Zhang, Xiaoyan; Xu, Jianqing			Multiple Independent Introductions of HIV-1 CRF01_AE Identified in China: What Are the Implications for Prevention?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL TRANSMISSION; GENETIC-CHARACTERIZATION; EXPANDING EPIDEMIC; SUBTYPE CRF01-AE; DRUG-USERS; GUANGXI; SEX; MEN; SEQUENCES	Background: HIV-1 CRF01_AE accounts for an important fraction of HIV infections in Asia including China, but little is known about the phylogenetic and evolutionary history of this CRF (circulating recombinant form). In the current study, we collected a large number of 1,957 CRF01_AE gag p17 sequences with known sampling year (1990-2010) from 5 global regions representing 15 countries to better understand the phylogenetic relationships and epidemic history of CRF01_AE strains in China. Methodology/Principal Findings: CRF01_AE gag p17 sequences were retrieved from public databases to explore phylogenetic relationships and phylogeographic dynamics of CRF01_AE in Asia by using maximum-likelihood phylogenetics and Bayesian coalescent-based analyses. We found close phylogenetic relationships between sequences from Thailand, Vietnam and China. Moreover, at least 5 independent introductions and 5 independent autochthonous clades of CRF01_AE, which descended from Thailand or Vietnam were identified in China from 1991 through 2003. Conclusion/Significance: The current study not only defines the migration of CRF01_AE clades to/in Asia, but also demonstrates the criticalness of identifying the circulating strains in the population for the development of vaccine and microbicides.	[Abubakar, Yassir F.; Meng, Zhefeng; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Abubakar, Yassir F.; Meng, Zhefeng; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Minist Educ Hlth, Inst Biomed Sci,Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] State Key Lab Infect Dis Control & Prevent CDC, Beijing, Peoples R China	Fudan University; Fudan University	Xu, JQ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com		meng, zhefeng/0000-0001-9396-0673	National Grand Program on Key Infectious Disease Control [2012ZX10001-006, 2013ZX10001-002]; China Ministry of Health; 973 National Key Basic Research Project, Ministry of Science and Technology of P.R. China [2012CB519005]	National Grand Program on Key Infectious Disease Control; China Ministry of Health; 973 National Key Basic Research Project, Ministry of Science and Technology of P.R. China	This work was supported by the National Grand Program on Key Infectious Disease Control (2012ZX10001-006, 2013ZX10001-002), the China Ministry of Health, and the 973 National Key Basic Research Project (2012CB519005), Ministry of Science and Technology of P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MH, 2012, J VIROL, V86, P12402, DOI 10.1128/JVI.00262-12; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Gesprasert G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011179; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo DM, 2009, AIDS RES HUM RETROV, V25, P619, DOI 10.1089/aid.2009.0002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Han ZG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-148; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Huang HL, 2006, CHINESE MED J-PEKING, V119, P1622, DOI 10.1097/00029330-200610010-00006; Jinnopat P, 2009, JAIDS-J ACQ IMM DEF, V52, P320, DOI 10.1097/QAI.0b013e3181b4b18c; Kato K, 1999, AIDS RES HUM RETROV, V15, P1157, DOI 10.1089/088922299310250; Li L, 2013, J MED VIROL, V85, P388, DOI 10.1002/jmv.23360; Li L, 2012, AIDS RES HUM RETROV, V28, P947, DOI [10.1089/aid.2011.0379, 10.1089/AID.2011.0379]; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li L, 2010, AIDS RES HUM RETROV, V26, P699, DOI 10.1089/aid.2010.0026; Lu Lin, 2004, Zhonghua Yufang Yixue Zazhi, V38, P309; Meng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052373; Afonso JM, 2012, INFECT GENET EVOL, V12, P1458, DOI 10.1016/j.meegid.2012.05.005; Pagan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069218; Pang W, 2012, AIDS; Rambaut A, 2009, FIGTREE V1 3 1 TREE; RAMBAUT A, 2009, PATH O GEN TEMPORAL; Sanchez-Merino V, 2003, AIDS RES HUM RETROV, V19, P49, DOI 10.1089/08892220360473961; Shao YM, 2001, AIDS PATIENT CARE ST, V15, P431, DOI 10.1089/108729101316914449; Tran TTH, 2004, AIDS RES HUM RETROV, V20, P341; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Ye JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054238; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Zeng H, 2011, AIDS RES HUMAN RETRO, P10; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80487	10.1371/journal.pone.0080487	http://dx.doi.org/10.1371/journal.pone.0080487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282546	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500047
J	Adamson, SW; Browning, RE; Budachetri, K; Ribeiro, JMC; Karim, S				Adamson, Steven W.; Browning, Rebecca E.; Budachetri, Khemraj; Ribeiro, Jose M. C.; Karim, Shahid			Knockdown of Selenocysteine-Specific Elongation Factor in Amblyomma maculatum Alters the Pathogen Burden of Rickettsia parkeri with Epigenetic Control by the Sin3 Histone Deacetylase Corepressor Complex	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GULF-COAST TICKS; BORRELIA-BURGDORFERI; ANTIOXIDANT SYSTEM; IXODES-SCAPULARIS; OXIDATIVE STRESS; SELENOPROTEIN; DROSOPHILA; HOST; REDUCTASE	Selenocysteine is the 21st naturally-occurring amino acid. Selenoproteins have diverse functions and many remain uncharacterized, but they are typically associated with antioxidant activity. The incorporation of selenocysteine into the nascent polypeptide chain recodes the TGA stop codon and this process depends upon a number of essential factors including the selenocysteine elongation factor (SEF). The transcriptional expression of SEF did not change significantly in tick midguts throughout the blood meal, but decreased in salivary glands to 20% at the end of the fast feeding phase. Since selenoprotein translation requires this specialized elongation factor, we targeted this gene for knockdown by RNAi to gain a global view of the role selenoproteins play in tick physiology. We found no significant differences in tick engorgement and embryogenesis but detected no antioxidant capacity in tick saliva. The transcriptional profile of selenoproteins in R. parkeri-infected Amblyomma maculatum revealed declined activity of selenoprotein M and catalase and increased activity of selenoprotein O, selenoprotein S, and selenoprotein T. Furthermore, the pathogen burden was significantly altered in SEF-knockdowns. We then determined the global impact of SEF-knockdown by RNA-seq, and mapped huge shifts in secretory gene expression that could be the result of downregulation of the Sin3 histone deacetylase corepressor complex.	[Adamson, Steven W.; Browning, Rebecca E.; Budachetri, Khemraj; Karim, Shahid] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Ribeiro, Jose M. C.] NIAID, NIH, Vector Biol Sect, Lab Malaria & Vector Res, Bethesda, MD 20892 USA	University of Southern Mississippi; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Karim, S (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	shahid.karim@usm.edu	Ribeiro, Jose/J-7011-2015; Budachetri, Khemraj/B-8959-2017	Budachetri, Khemraj/0000-0003-1254-792X; Karim, Shahid/0000-0001-5596-3304; Ribeiro, Jose/0000-0002-9107-0818	National Institute of Allergy and Infectious Diseases [AI099919]; United States Department of State [PGAP21049]; Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institutes of Health National Institute of General Medical Sciences [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, R15AI099910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of State; Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institute of Allergy and Infectious Diseases award #AI099919, United States Department of State award #PGAP21049 (Pakistan-United States Science and Technology Cooperation Program) to SK. The Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, to JMCR and the National Institutes of Health National Institute of General Medical Sciences award #P20RR016476 to the MS-INBRE core facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bando Y, 2012, ANAT SCI INT, V87, P14, DOI 10.1007/s12565-011-0127-5; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Bowman LAH, 2011, ADV MICROB PHYSIOL, V59, P135, DOI 10.1016/B978-0-12-387661-4.00006-9; BROWNING R, 2012, J MED ENTOM IN PRESS; Chapple CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002968; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Das TK, 2013, ONCOGENE, V32, P3184, DOI 10.1038/onc.2012.326; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Ferrari FAG, 2013, TICKS TICK-BORNE DIS, V4, P439, DOI 10.1016/j.ttbdis.2013.04.010; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; Grasperge BJ, 2012, INFECT IMMUN, V80, P1846, DOI 10.1128/IAI.00109-12; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Gursinsky T, 2008, APPL ENVIRON MICROB, V74, P1385, DOI 10.1128/AEM.02238-07; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Karim S, 2012, ADV INSECT PHYSIOL, V42, P119, DOI 10.1016/B978-0-12-387680-5.00004-5; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kocan KM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-42; Kromayer M, 1996, J MOL BIOL, V262, P413, DOI 10.1006/jmbi.1996.0525; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JI, 2009, CANCER PREV RES, V2, P683, DOI 10.1158/1940-6207.CAPR-09-0047; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Lescure A, 2002, CURR PROTEIN PEPT SC, V3, P143, DOI 10.2174/1389203023380783; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Maya-Monteiro CM, 2004, INSECT BIOCHEM MOLEC, V34, P81, DOI 10.1016/j.ibmb.2003.09.005; Mccoy KD, 2008, PARASITE, V15, P444, DOI 10.1051/parasite/2008153444; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; MORGAN JF, 1950, P SOC EXP BIOL MED, V73, P1, DOI 10.3181/00379727-73-17557; MORGAN JF, 1955, J NATL CANCER I, V16, P557; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; NEEDHAM GR, 1979, J PARASITOL, V65, P531, DOI 10.2307/3280316; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Pinto JT, 2011, AMINO ACIDS, V41, P29, DOI 10.1007/s00726-010-0578-3; Qiu WG, 2002, GENETICS, V160, P833; Reeves MA, 2009, CELL MOL LIFE SCI, V66, P2457, DOI 10.1007/s00018-009-0032-4; RIBEIRO JMC, 1992, EXP PARASITOL, V74, P112, DOI 10.1016/0014-4894(92)90145-Z; Shchedrina VA, 2011, J BIOL CHEM, V286, P29449, DOI 10.1074/jbc.M111.257600; Stolf BS, 2011, THESCIENTIFICWORLDJO, V11, P1749, DOI 10.1100/2011/289182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thepparit C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-149; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; Walczak CP, 2012, ANTIOXID REDOX SIGN, V16, P809, DOI 10.1089/ars.2011.4425; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wright CL, 2011, EMERG INFECT DIS, V17, P896, DOI 10.3201/eid1705.101836; Wu J, 2010, J BIOL CHEM, V285, P16606, DOI 10.1074/jbc.M109.094615; Xiang N, 2008, CARCINOGENESIS, V29, P2175, DOI 10.1093/carcin/bgn179; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Yuan JY, 2006, MOL CELL, V23, P1, DOI 10.1016/j.molcel.2006.06.008	74	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82012	10.1371/journal.pone.0082012	http://dx.doi.org/10.1371/journal.pone.0082012			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282621	Green Published, gold, Green Submitted			2022-12-27	WOS:000327543500125
J	Chen, YB; Chen, Q; Wang, Z; Zhou, J				Chen, Yan-bo; Chen, Qi; Wang, Zhong; Zhou, Juan			Insulin Therapy and Risk of Prostate Cancer: a Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							ANALOG GLARGINE; RECEPTOR; GLUCOSE; PROLIFERATION; MALIGNANCIES; PREVALENCE; CELLS; BIAS	Background: Previous observational studies have shown that insulin therapy may modify the risk of prostate cancer (PCa). However, these studies yielded controversial results. Thus, we performed this meta-analysis to determine whether insulin use was associated with PCa risk in patients with diabetes mellitus (DM). Method: A literature search was carried out in PubMed, EMBASE, and Cochrane Library Central database between January 1966 and January 2013. Fixed-effect and random-effect models were used to estimate pooled relative risks (RR) and corresponding 95% confidence intervals (CIs). Subgroup analyses and sensitivity analyses were also performed. Result: A total of 11 (10 cohorts, and one case-control) studies published between 2007 and 2013 were included in the meta-analysis, representing data for 205,523 male subjects and 7,053 PCa cases. There were five studies investigating the influence of insulin and other glucose-lowering agents on the risk of PCa, and six studies investigating the influence of glargine and non-glargine insulin. Insulin use was not associated with PCa risk when compared with other glucose-lowering agents (RR=0.89, 95% CI, 0.72-1.09). Use of insulin glargine did not contribute to susceptibility to PCa as compared with use of non-glargine insulin (RR=1.26, 95% CI, 0.86-1.84). Sensitivity analysis confirmed the stability of present results, since no individual study affected the pooled result significantly. Conclusions: Our results suggest that, there may be no significant association between insulin use and risk of PCa as compared with other glucose-lowering agents in patients with DM, and there was no substantial evidence for increase risk of PCa among insulin glargine users as compared to non-glargine insulin users. Further studies are warranted to validate these conclusions.	[Chen, Yan-bo; Chen, Qi; Wang, Zhong; Zhou, Juan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol & Androl, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Urol & Androl, Shanghai 200030, Peoples R China.	wz_wzz@126.com	Chen, Yanbo/K-8163-2019					BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Blin P, 2012, DIABETOLOGIA, V55, P644, DOI 10.1007/s00125-011-2429-5; Carstensen B, 2012, DIABETOLOGIA, V55, P948, DOI 10.1007/s00125-011-2381-4; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Colmers IN, 2012, DIABETES METAB, V38, P485, DOI 10.1016/j.diabet.2012.08.011; Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Gu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053411; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Janghorbani M, 2012, HORM CANCER-US, V3, P137, DOI 10.1007/s12672-012-0112-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koro C, 2007, PHARMACOEPIDEM DR S, V16, P485, DOI 10.1002/pds.1352; Li QA, 2010, CANCER CAUSE CONTROL, V21, P1025, DOI 10.1007/s10552-010-9530-9; Ljung R, 2011, ACTA ONCOL, V50, P685, DOI 10.3109/0284186X.2011.558913; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Staiger K, 2005, DIABETOLOGIA, V48, P1898, DOI 10.1007/s00125-005-1874-4; Tseng CH, 2011, ANN MED, V43, P142, DOI 10.3109/07853890.2010.530683; Tseng CH, 2011, DIABETES CARE, V34, P616, DOI 10.2337/dc10-1640; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Wada T, 2008, DIABETES RES CLIN PR, V81, P269, DOI 10.1016/j.diabres.2008.05.007; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; Xu H, 2013, DIABETES RES CLIN PR	43	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81594	10.1371/journal.pone.0081594	http://dx.doi.org/10.1371/journal.pone.0081594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282613	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500116
J	Lee, YK; Low, WY; Ng, CJ				Lee, Yew Kong; Low, Wah Yun; Ng, Chirk Jenn			Exploring Patient Values in Medical Decision Making: A Qualitative Study	PLOS ONE			English	Article							PSYCHOLOGICAL INSULIN-RESISTANCE; PRIMARY-CARE; HEALTH-CARE; BARRIERS; INITIATION; THERAPY; PREFERENCES; PREVALENCE; MODEL; AID	Background: Patient decisions are influenced by their personal values. However, there is a lack of clarity and attention on the concept of patient values in the clinical context despite clear emphasis on patient values in evidence-based medicine and shared decision making. The aim of the study was to explore the concept of patient values in the context of making decisions about insulin initiation among people with type 2 diabetes. Methods and Findings: We conducted individual in-depth interviews with people with type 2 diabetes who were making decisions about insulin treatment. Participants were selected purposively to achieve maximum variation. A semi-structured topic guide was used to guide the interviews which were audio-recorded and analysed using a thematic approach. We interviewed 21 participants between January 2011 and March 2012. The age range of participants was 28-67 years old. Our sample comprised 9 women and 12 men. Three main themes, 'treatment-specific values', 'life goals and philosophies', and 'personal and social background', emerged from the analysis. The patients reported a variety of insulin-specific values, which were negative and/or positive beliefs about insulin. They framed insulin according to their priorities and philosophies in life. Patients' decisions were influenced by sociocultural (e. g. religious background) and personal backgrounds (e. g. family situations). Conclusions: This study highlighted the need for expanding the current concept of patient values in medical decision making. Clinicians should address more than just values related to treatment options. Patient values should include patients' priorities, life philosophy and their background. Current decision support tools, such as patient decision aids, should consider these new dimensions when clarifying patient values.	[Lee, Yew Kong; Ng, Chirk Jenn] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Low, Wah Yun] Univ Malaya, Fac Med, Deans Off, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Lee, YK (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.	leeyk@um.edu.my	Lee, Yew Kong/K-4339-2013; NG, CHIRK JENN/C-1344-2010; Low, Wah-Yun/B-1775-2009	Lee, Yew Kong/0000-0002-3034-8601; Low, Wah-Yun/0000-0003-4409-1509; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya [UMRG 236/10HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya Research Grant, Reference Number: UMRG 236/10HTM (http://ippp.um.edu.my/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed US, 2010, DIABETIC MED, V27, P169, DOI 10.1111/j.1464-5491.2009.02904.x; Ban N., 2003, ASIA PAC FAM MED, V2, P74; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Barratt A, 2008, PATIENT EDUC COUNS, V73, P407, DOI 10.1016/j.pec.2008.07.054; Brod M, 2009, QUAL LIFE RES, V18, P23, DOI 10.1007/s11136-008-9419-1; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000140; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charon R, 2008, LANCET, V371, P296, DOI 10.1016/S0140-6736(08)60156-7; Couet N, 2013, HLTH EXPECT; Davis SN, 2006, DIABETES EDUCATOR, V32, p146S, DOI 10.1177/0145721706289226; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Fu AZ, 2009, CURR MED RES OPIN, V25, P1413, DOI 10.1185/03007990902905724; Goderis G, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-41; Goodall G, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-19; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Hayes RP, 2008, INT J CLIN PRACT, V62, P860, DOI 10.1111/j.1742-1241.2008.01742.x; Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292; International Diabetes Federation, 2009, IDF DIAB ATL GLOB BU; International Patient Decision Aids Collaboration, 2006, IPDAS 2005 CRIT JUDG; Karel MJ, 2000, J AGING STUD, V14, P403, DOI 10.1016/S0890-4065(00)80005-5; Karter AJ, 2010, DIABETES CARE, V33, P733, DOI 10.2337/dc09-1184; Khan H, 2008, DIABETIC MED, V25, P1108, DOI 10.1111/j.1464-5491.2008.02538.x; Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869; Lee YK, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-28; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; Lockwood S, 2004, BRIT MED J, V329, P1033, DOI 10.1136/bmj.329.7473.1033; Mafauzy M, 2005, Med J Malaysia, V60, P212; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Mastura I, 2011, INT J COLLAB RES INT, V3, P98; Matthias MS, 2013, PATIENT EDUC COUNS, V91, P176, DOI 10.1016/j.pec.2013.01.006; Meisel ZF, 2011, JAMA-J AM MED ASSOC, V306, P2022, DOI 10.1001/jama.2011.1648; Ministry of Health Clinical Practice Guidelines, 2009, CLIN PRACT GUID MAN; Mulley AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6572; Nunn R, 2011, J EVAL CLIN PRACT, V17, P920, DOI 10.1111/j.1365-2753.2011.01727.x; Nur Azmiah Z, 2011, INT MED J MALAYSIA, V10; O'Connor A., 2001, EVID BASED MED, V6, P100, DOI DOI 10.1136/EBM.6.4.100; O'Connor A M, 1999, Eff Clin Pract, V2, P163; OConnor AM, 2006, OTTAWA DECISION SUPP; Petrova M, 2006, BRIT J GEN PRACT, V56, P703; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Reyna VF, 2008, MED DECIS MAKING, V28, P829, DOI 10.1177/0272989X08327069; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schwartz A, 2008, MED DECIS MAKING, V28, P209, DOI 10.1177/0272989X07311749; Schwartz S. H., 2006, BASIC HUMAN VALUES O; SCHWARTZ SH, 1988, J PERS SOC PSYCHOL, V54, P396, DOI 10.1037/0022-3514.54.3.396; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Strauss A., 1990, BASICS QUALITATIVE R; The PME, 2009, PLOS MED, V6; The World Bank, 2012, COUNTR CLASS COUNTR; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	51	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80051	10.1371/journal.pone.0080051	http://dx.doi.org/10.1371/journal.pone.0080051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259RH	24282518	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500019
J	Lee, YJ; Ha, YJ; Kang, YN; Kang, KJ; Hwang, JS; Chung, WJ; Cho, KB; Park, KS; Kim, ES; Seo, HY; Kim, MK; Park, KG; Jang, BK				Lee, Yoo Jin; Ha, Yu Jin; Kang, Yu Na; Kang, Koo Jeong; Hwang, Jae Seok; Chung, Woo Jin; Cho, Kwang Bum; Park, Kyung Sik; Kim, Eun Soo; Seo, Hye-Young; Kim, Mi-Kyung; Park, Keun-Gyu; Jang, Byoung Kuk			The Autophagy-Related Marker LC3 Can Predict Prognosis in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BECLIN 1 EXPRESSION; LIGHT-CHAIN 3; DECREASED EXPRESSION; ER STRESS; CANCER; LIVER; METASTASIS; GRP78; OVEREXPRESSION	Background: Defects of autophagy and endoplasmic reticulum (ER) stress are related to many diseases and tumors. However, only a few studies have examined hepatocellular carcinoma (HCC) as related to these processes. Therefore, in this study, we investigated the expression and extent of autophagy and ER stress-related markers in HCC and their influence on clinical characteristics and prognosis for each protein. Methodology: The expression of autophagy-related markers (LC3 and Beclin-1) and ER stress-related markers (GRP78 and CHOP) was analyzed by immunohistochemistry on tissues from completely resected specimens of 190 HCC patients. Their influence on clinicopathologic features and prognosis were evaluated using the chi-square test and Kaplan-Meier analysis. Correlations of each protein were determined by Spearman's correlation analysis. Principal Findings: LC3 expression was not correlated with TNM, BCLC stage, or Edmonson-Steiner grading, whereas it was correlated with longer overall survival (OS) (p = 0.039) and tended to be related with longer time to recurrence (TTR) (p=0.068) although it did not show statistical significance. Multivariate analysis indicated that LC3 expression was a significantly independent prognostic factor of OS (HR, 0.42; 95% CI, 0.22-0.80; p-value=0.009) and TTR (HR, 0.54; 95% CI, 0.33-0.90; p=0.017). Expression of LC3 in advanced stages of TNM (III) (p=0.045) and Edmonson-Steiner Grades (III and IV) (p=0.043) was correlated with longer survival, but not in the early stages. A positive correlation was not observed between the expression of autophagy-related markers and ER stress-related markers. Conclusion: Our results suggest that the expression and extent of LC3 might be a strong prognostic factor of HCC, especially in patients with surgical resection.	[Lee, Yoo Jin; Ha, Yu Jin; Hwang, Jae Seok; Chung, Woo Jin; Cho, Kwang Bum; Park, Kyung Sik; Kim, Eun Soo; Seo, Hye-Young; Kim, Mi-Kyung; Jang, Byoung Kuk] Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea; [Kang, Yu Na] Keimyung Univ, Sch Med, Dept Pathol, Taegu, South Korea; [Kang, Koo Jeong] Keimyung Univ, Sch Med, Dept Surg, Taegu, South Korea; [Park, Keun-Gyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea	Keimyung University; Keimyung University; Keimyung University; Kyungpook National University	Jang, BK (corresponding author), Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea.	jangha106@dsmc.or.kr	Kang, Koo Jeong/Z-4448-2019; Lee, Yoojin/AAB-9799-2022	Lee, Yoojin/0000-0003-1799-0146; Jang, Byoung Kuk/0000-0002-8950-0866	Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea [A111345]	Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health technology Research & Development Project, Ministry of Health & Welfare, Republic of Korea. (Grant Number: A111345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal M, 1999, INT J MOL MED, V4, P545; Berardi DE, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/595092; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Choi GH, 2009, AM J SURG, V198, P693, DOI 10.1016/j.amjsurg.2008.09.019; Cui JZ, 2013, BBA-REV CANCER, V1836, P15, DOI 10.1016/j.bbcan.2013.02.003; Czaja MJ, 2011, GASTROENTEROLOGY, V140, P1895, DOI 10.1053/j.gastro.2011.04.038; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Han CR, 2011, TOHOKU J EXP MED, V223, P243, DOI 10.1620/tjem.223.243; He JH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0468-0; Huang JW, 2012, J SURG RES, V178, P743, DOI 10.1016/j.jss.2012.04.058; Jiang LC, 2012, PATHOL RES PRACT, V208, P635, DOI 10.1016/j.prp.2012.07.008; Jiang ZF, 2012, MOL BIOL REP, V39, P259, DOI 10.1007/s11033-011-0734-1; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Karpathiou G, 2011, CHEST, V140, P127, DOI 10.1378/chest.10-1831; Kim KM, 2012, INT J CANCER, V131, pE362, DOI 10.1002/ijc.26463; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Ko YH, 2013, PANCREAS, V42, P829, DOI 10.1097/MPA.0b013e318279d0dc; Korabiowska M, 2002, HISTOL HISTOPATHOL, V17, P805, DOI 10.14670/HH-17.805; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li BX, 2009, AUTOPHAGY, V5, P303, DOI 10.4161/auto.5.3.7491; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Miracco C, 2007, INT J ONCOL, V30, P429; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Peng ZW, 2013, CANCER; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Sun Q, 2012, MOL BIOL REP, V39, P6753, DOI 10.1007/s11033-012-1500-8; Takahashi H, 2011, HISTOL HISTOPATHOL, V26, P663, DOI 10.14670/HH-26.663; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wang GH, 2010, AM J TRANSL RES, V2, P65; Xi SY, 2013, BIOCHEM BIOPH RES CO, V431, P760, DOI 10.1016/j.bbrc.2012.12.151; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu M, 2013, TUMOR BIOL, V34, P1071, DOI 10.1007/s13277-013-0648-8; Zhu WP, 2012, TUMOR BIOL, V33, P1653, DOI 10.1007/s13277-012-0421-4; Zou MJ, 2012, CELL SIGNAL, V24, P1722, DOI 10.1016/j.cellsig.2012.04.009	43	64	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81540	10.1371/journal.pone.0081540	http://dx.doi.org/10.1371/journal.pone.0081540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282606	Green Submitted, Green Published, gold			2022-12-27	WOS:000327543500109
J	Meng, FG; Zhao, RC; Liu, P; Liu, LX; Liu, SJ				Meng, Fangang; Zhao, Rencheng; Liu, Peng; Liu, Lixiang; Liu, Shoujun			Assessment of Iodine Status in Children, Adults, Pregnant Women and Lactating Women in Iodine-Replete Areas of China	PLOS ONE			English	Article							SERUM THYROGLOBULIN; THYROID-FUNCTION; DEFICIENCY; INDICATOR	Background: Iodine deficiency disorders (IDD) are widespread in China. Presently, IDD have been put under control by Universal Salt Iodisation (USI) in China; however, there is a lack of evidence on whether the iodine status in adults, pregnant women and lactating women is optimal. This study was therefore conducted to assess the iodine nutrition and thyroid function of children, adults, pregnant women and lactating women residing in areas where the USI program is fully established. Design: Six areas were selected according to the geographical regions in China. In each of these areas, we selected 4 distinct groups of subjects (children, adults, pregnant women and lactating women) in regions where the coverage rate of iodised salt was more than 95% and the levels of iodine and fluoride in drinking water were less than or equal to 10 mu g/L and 1 mg/ L, respectively. We tested the iodine content of salt, urinary iodine (UI), free thyroxin (FT4), thyrotropin (TSH), thyroglobulin (Tg), thyroglobulin antibody (Tg-Ab) and antimicrosomal antibody (TM-Ab) in the 4 groups, and examined the thyroid volume in children. Results: The median urinary iodine (MUI) concentrations were 271.4 mu g/L, 260.2 mu g/L, 205.9 mu g/L and 193.9 mu g/L in children, adults, pregnant women and lactating women, respectively; MUI in children and adults were more than adequate. The goitre prevalence (GP) in children was 6.70%. The odds ratios (OR) of subclinical hypothyroidism in the Tg-Ab- or TM-Ab-positive groups were 3.80, 7.65, 2.01 and 7.47 for children, adults, pregnant women and lactating women, respectively, compared with the negative groups. Conclusions: The iodine status in children and adults is above the requirement, we should reduce their iodine intake. Subclinical hypothyroidism easily occurs in the Tg-Ab or TM-Ab positive groups.	[Meng, Fangang; Zhao, Rencheng; Liu, Peng; Liu, Lixiang; Liu, Shoujun] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Inst Iodine Deficiency Disorders, Harbin, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Liu, SJ (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Ctr Endem Dis Control, Inst Iodine Deficiency Disorders, Harbin, Peoples R China.	liusjhmu@163.com			National Support Projects for Science and Technology in China [2006BAI06B05]	National Support Projects for Science and Technology in China	This work was supported, in part, by the National Support Projects for Science and Technology in China (project 2006BAI06B05). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 1992, IND ASS IOD DEF DIS; BENMILOUD M, 1994, J CLIN ENDOCR METAB, V79, P20, DOI 10.1210/jc.79.1.20; de Vijlder JJM, 1999, EUR J ENDOCRINOL, V140, P7, DOI 10.1530/eje.0.1400007; Endemic Disease Control Department, 1989, CHIN J ENDEMIOL, V8, P252; FENZI GF, 1985, CLIN ENDOCRINOL, V23, P115, DOI 10.1111/j.1365-2265.1985.tb00205.x; General test method in salt industry-Determination of iodine ion, 1999, 1302571999 GBT; HETZEL BS, 1983, LANCET, V2, P1126; Kapelari Klaus, 2008, BMC Endocr Disord, V8, P15, DOI 10.1186/1472-6823-8-15; Knudsen N, 2001, J CLIN ENDOCR METAB, V86, P3599, DOI 10.1210/jc.86.8.3599; Method for determination of Iodine in urine by As3+Ce4+catalytic spectrophotometry, 2006, 1072006 WST MIN HLTH; Ministry of Health of the People's Republic of China, 2011, 268782011 GB MIN HLT; MISSLER U, 1994, EUR J CLIN CHEM CLIN, V32, P137; Panesar NS, 2001, ANN CLIN BIOCHEM, V38, P329, DOI 10.1258/0004563011900830; Pennington J. A. T., 1989, IODINE TOXICITY; Raverot V, 2012, THYROID, V22, P522, DOI 10.1089/thy.2011.0184; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Torrens JI, 2001, ENDOCRIN METAB CLIN, V30, P429, DOI 10.1016/S0889-8529(05)70194-8; van den Briel T, 2001, J NUTR, V131, P2701, DOI 10.1093/jn/131.10.2701; Wang YL, 2009, ASIA PAC J CLIN NUTR, V18, P34; WHO/UNICEF, 2007, ICCIDD ASS IOD DEF D; Xiao DL, 2007, CHINA NATL IDD SURVE, P3; [阎玉芹 YAN Yuqin], 2008, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V24, P609; Zimmermann MB, 2006, J CLIN ENDOCR METAB, V91, P4881, DOI 10.1210/jc.2006-1370	24	29	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81294	10.1371/journal.pone.0081294	http://dx.doi.org/10.1371/journal.pone.0081294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282581	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500083
J	Wicky, BIM; Stenta, M; Dal Peraro, M				Wicky, Basile I. M.; Stenta, Marco; Dal Peraro, Matteo			TAL Effectors Specificity Stems from Negative Discrimination	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY DECOMPOSITION; DNA-BINDING SPECIFICITY; CRYSTAL-STRUCTURE; METHYLATED DNA; RECOGNITION; NUCLEASE; DOMAIN; ACIDS	Transcription Activator-Like (TAL) effectors are DNA-binding proteins secreted by phytopathogenic bacteria that interfere with native cellular functions by binding to plant DNA promoters. The key element of their architecture is a domain of tandem-repeats with almost identical sequences. Most of the polymorphism is located at two consecutive amino acids termed Repeat Variable Diresidue (RVD). The discovery of a direct link between the RVD composition and the targeted nucleotide allowed the design of TAL-derived DNA-binding tools with programmable specificities that revolutionized the field of genome engineering. Despite structural data, the molecular origins of this specificity as well as the recognition mechanism have remained unclear. Molecular simulations of the recent crystal structures suggest that most of the protein-DNA binding energy originates from non-specific interactions between the DNA backbone and non-variable residues, while RVDs contributions are negligible. Based on dynamical and energetic considerations we postulate that, while the first RVD residue promotes helix breaks - allowing folding of TAL as a DNA-wrapping super-helix - the second provides specificity through a negative discrimination of matches. Furthermore, we propose a simple pharmacophore-like model for the rationalization of RVD-DNA interactions and the interpretation of experimental findings concerning shared affinities and binding efficiencies. The explanatory paradigm presented herein provides a better comprehension of this elegant architecture and we hope will allow for improved designs of TAL-derived biotechnological tools.	[Wicky, Basile I. M.; Stenta, Marco; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Biomol Modeling, CH-1015 Lausanne, Switzerland; [Dal Peraro, Matteo] SIB, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Dal Peraro, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Biomol Modeling, CH-1015 Lausanne, Switzerland.	matteo.dalperaro@epfl.ch		Wicky, Basile I. M./0000-0002-2501-7875	EPFL	EPFL	This project was supported by EPFL intramural fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu G, 2004, J MOL BIOL, V342, P1053, DOI 10.1016/j.jmb.2004.07.047; Best RB, 2012, BIOPHYS J, V102, P1462, DOI 10.1016/j.bpj.2012.02.024; Blasco B, 2011, MOL MICROBIOL, V82, P251, DOI 10.1111/j.1365-2958.2011.07813.x; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bochtler M, 2012, BIOL CHEM, V393, P1055, DOI 10.1515/hsz-2012-0164; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Brice AR, 2011, J COMPUT CHEM, V32, P1431, DOI 10.1002/jcc.21727; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen L, 2012, J BIOMOL STRUCT DYN, V30, P716, DOI 10.1080/07391102.2012.689702; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Frisch G. W., 2013, GAUSSIAN 09; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Levitt M, 2001, NAT STRUCT BIOL, V8, P392, DOI 10.1038/87545; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moroni E, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-61; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Murakami MT, 2010, PROTEINS, V78, P3386, DOI 10.1002/prot.22846; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Noskov SY, 2001, BIOPHYS J, V81, P737, DOI 10.1016/S0006-3495(01)75738-4; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rucker R, 2010, PROTEINS, V78, P671, DOI 10.1002/prot.22596; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Wagner S, 2010, P NATL ACAD SCI USA, V107, P13860, DOI 10.1073/pnas.1006985107; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zou XQ, 2012, NUCLEIC ACIDS RES, V40, P2747, DOI 10.1093/nar/gkr1057	50	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80261	10.1371/journal.pone.0080261	http://dx.doi.org/10.1371/journal.pone.0080261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282528	Green Submitted, gold, Green Published			2022-12-27	WOS:000327543500029
J	Chavez-Galan, L; Ramon-Luing, LA; Torre-Bouscoulet, L; Perez-Padilla, R; Sada-Ovalle, I				Chavez-Galan, Leslie; Ramon-Luing, Lucero A.; Torre-Bouscoulet, Luis; Perez-Padilla, Rogelio; Sada-Ovalle, Isabel			Pre-Exposure of Mycobacterium tuberculosis-Infected Macrophages to Crystalline Silica Impairs Control of Bacterial Growth by Deregulating the Balance between Apoptosis and Necrosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; ALVEOLAR MACROPHAGES; JNK1-MEDIATED PHOSPHORYLATION; SIGNALING PATHWAYS; CELL-DEATH; TNF-ALPHA; ACTIVATION; PROTEIN; INDUCTION; MONOCYTES	Inhalation of crystalline silica (CS) particles increases the risk of pulmonary tuberculosis; however, the precise mechanism through which CS exposure facilitates Mycobacterium tuberculosis (Mtb) infection is unclear. We speculate that macrophage exposure to CS deregulates the cell death pathways that could explain, at least in part, the association observed between exposure to CS and pulmonary tuberculosis. We therefore established an in vitro model in which macrophages were exposed to CS and then infected with Mtb. Expression of surface markers was analyzed by flow cytometry, JNK1/2, ASK1, caspase 9, P-p38, Bcl-2 and Mcl-1 were analyzed by Western blot, and cytokines by ELISA. Our results show that exposure to CS limits macrophage ability to control Mtb growth. Moreover, this exposure reduced the expression of TLR2, Bcl-2 and Mcl-1, but increased that of JNK1 and ASK1 molecules in the macrophages. Finally, when the pre-exposed macrophages were infected with Mtb, the concentrations of TNF alpha, IL-1 beta and caspase-9 expression increased. This pro-inflammatory profile of the macrophage unbalanced the apoptosis/necrosis pathway. Taken together, these data suggest that macrophages exposed to CS are sensitized to cell death by MAPK kinase-dependent signaling pathway. Secretion of TNF-alpha and IL-1 beta by Mtb-infected macrophages promotes necrosis, and this deregulation of cell death pathways may favor the release of viable bacilli, thus leading to the progression of tuberculosis.	[Chavez-Galan, Leslie; Ramon-Luing, Lucero A.; Sada-Ovalle, Isabel] Natl Inst Resp Dis Ismael Cosio Villegas, Lab Integrat Immunol, Mexico City, DF, Mexico; [Torre-Bouscoulet, Luis; Perez-Padilla, Rogelio] Natl Inst Resp Dis Ismael Cosio Villegas, Dept Resp Physiol, Mexico City, DF, Mexico		Sada-Ovalle, I (corresponding author), Natl Inst Resp Dis Ismael Cosio Villegas, Lab Integrat Immunol, Mexico City, DF, Mexico.	isadamx@gmail.com	Chavez Galan, Leslie Chavez/AAX-3817-2021; Chavez-Galan, Leslie/ABB-8270-2021; Sada, Isabel/AAM-9090-2021; Ramon Luing, Lucero/AEX-0055-2022; Sada-Ovalle, Isabel/GPG-7076-2022	Chavez Galan, Leslie Chavez/0000-0002-2334-0361; Ramon Luing, Lucero/0000-0003-2004-7570; Sada-Ovalle, Isabel/0000-0001-7769-7625; Torre-Bouscoulet, Luis/0000-0003-2183-7662	National Council for Science and Technology (CONACYT) [166555, 104003]	National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by a research grant from the National Council for Science and Technology (CONACYT, www.conacyt.gob.mx) to LTB (166555) and the grant to ISO (104003). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141; [Anonymous], 2000, MMWR RECOMM REP, V49, P1; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Beamer CA, 2008, FASEB J, V22, P2053, DOI 10.1096/fj.07-095299; Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Calvert GM, 2003, OCCUP ENVIRON MED, V60, P122, DOI 10.1136/oem.60.2.122; Castranova V, 2004, FREE RADICAL BIO MED, V37, P916, DOI 10.1016/j.freeradbiomed.2004.05.032; Chao SL, 2001, TOXICOL APPL PHARM, V174, P10, DOI 10.1006/taap.2001.9190; Chavez-Galan L, 2012, IMMUNOLOGY, V135, P299, DOI 10.1111/j.1365-2567.2011.03543.x; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Heldwein KA, 2002, MICROBES INFECT, V4, P937, DOI 10.1016/S1286-4579(02)01611-8; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Hu SY, 2006, J TOXICOL ENV HEAL A, V69, P1261, DOI 10.1080/15287390500361875; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kulkarni NS, 2005, SCI TOTAL ENVIRON, V345, P23, DOI 10.1016/j.scitotenv.2004.10.016; Kuo PL, 2007, CANCER RES, V67, P7406, DOI 10.1158/0008-5472.CAN-07-1089; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lazarevic V, 2008, CELL HOST MICROBE, V3, P199, DOI 10.1016/j.chom.2008.03.006; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Muller B, 1998, EUR J CLIN INVEST, V28, P762; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Neumann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042526; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; Rees D, 2007, INT J TUBERC LUNG D, V11, P474; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Samb B, 1999, INT J TUBERC LUNG D, V3, P330; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu HC, 2011, TOXICOLOGY, V289, P103, DOI 10.1016/j.tox.2011.07.013; Yang Eun-Jeoung, 2013, Immune Netw, V13, P94, DOI 10.4110/in.2013.13.3.94; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Yuk JM, 2009, IMMUNOL CELL BIOL, V87, P100, DOI 10.1038/icb.2008.74; 1997, HLTH AM J RESP CRIT, V155, P761, DOI DOI 10.1164/AJRCCM.155.2.9032226	55	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80971	10.1371/journal.pone.0080971	http://dx.doi.org/10.1371/journal.pone.0080971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278357	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700041
J	Fontenete, S; Guimaraes, N; Leite, M; Figueiredo, C; Wengel, J; Azevedo, NF				Fontenete, Silvia; Guimaraes, Nuno; Leite, Marina; Figueiredo, Ceu; Wengel, Jesper; Azevedo, Nuno Filipe			Hybridization-Based Detection of Helicobacter pylori at Human Body Temperature Using Advanced Locked Nucleic Acid (LNA) Probes	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CONFOCAL LASER ENDOMICROSCOPY; FLOW-FISH; UPPER-GI; RNA; PHOSPHOROTHIOATE; OLIGONUCLEOTIDES; IDENTIFICATION; STABILITY; CELLS	The understanding of the human microbiome and its influence upon human life has long been a subject of study. Hence, methods that allow the direct detection and visualization of microorganisms and microbial consortia (e. g. biofilms) within the human body would be invaluable. In here, we assessed the possibility of developing a variant of fluorescence in situ hybridization (FISH), named fluorescence in vivo hybridization (FIVH), for the detection of Helicobacter pylori. Using oligonucleotide variations comprising locked nucleic acids (LNA) and 2'-O-methyl RNAs (2'OMe) with two types of backbone linkages (phosphate or phosphorothioate), we were able to successfully identify two probes that hybridize at 37 degrees C with high specificity and sensitivity for H. pylori, both in pure cultures and in gastric biopsies. Furthermore, the use of this type of probes implied that toxic compounds typically used in FISH were either found to be unnecessary or could be replaced by a non-toxic substitute. We show here for the first time that the use of advanced LNA probes in FIVH conditions provides an accurate, simple and fast method for H. pylori detection and location, which could be used in the future for potential in vivo applications either for this microorganism or for others.	[Fontenete, Silvia; Guimaraes, Nuno; Azevedo, Nuno Filipe] Univ Porto, Fac Engn, Dept Chem Engn, Lab Proc Engn Environm Biotechnol & Energy,LEPABE, P-4100 Oporto, Portugal; [Fontenete, Silvia; Guimaraes, Nuno; Leite, Marina; Figueiredo, Ceu] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Fontenete, Silvia; Guimaraes, Nuno; Wengel, Jesper] Univ Southern Denmark, Nucle Acid Ctr, Dept Phys Chem & Pharm, Odense M, Denmark; [Fontenete, Silvia] Univ Porto, ICBAS, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal; [Figueiredo, Ceu] Univ Porto, FMUP, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Southern Denmark; Universidade do Porto; Universidade do Porto	Azevedo, NF (corresponding author), Univ Porto, Fac Engn, Dept Chem Engn, Lab Proc Engn Environm Biotechnol & Energy,LEPABE, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	nazevedo@fe.up.pt	Leite, Carla Marina Gonçalves/J-5976-2013; Fontenete, Sílvia/Q-1936-2018; Guimaraes, Nuno/H-3270-2019; Figueiredo, Ceu/B-8776-2008	Leite, Carla Marina Gonçalves/0000-0003-4286-0247; Fontenete, Sílvia/0000-0003-1972-6349; Guimaraes, Nuno/0000-0002-7623-3877; Figueiredo, Ceu/0000-0001-5247-840X; Azevedo, Nuno/0000-0001-5864-3250; Wengel, Jesper/0000-0001-9835-1009	Fundacao de Ciencia e Tecnologia (DNA mimics Research Project) [PIC/IC/82815/2007]; MCTES;  [SFRH/BD/72999/2010];  [SFRH/BPD/33420/2008];  [SFRH/BPD/78846/2011]	Fundacao de Ciencia e Tecnologia (DNA mimics Research Project); MCTES; ; ; 	This research was supported by the Fundacao de Ciencia e Tecnologia (DNA mimics Research Project (Ref. PIC/IC/82815/2007), MCTES and PhD grant SFRH/BD/72999/2010, and Pos-doc grants SFRH/BPD/33420/2008 and SFRH/BPD/78846/2011 and performed under the framework of the COST-Action TD1004: Theragnostics for imaging and therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida C, 2010, APPL ENVIRON MICROB, V76, P4476, DOI 10.1128/AEM.01678-09; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; Borisova EVB, 2008, ADV OPTICAL TECHNOLO; Cerqueira L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-101; Dewald GW, 2009, MAYO CLIN PROC, V84, P801, DOI 10.1016/S0025-6196(11)60490-4; Dias N, 2002, MOL CANCER THER, V1, P347; Englert Ha, 2001, MOL BIOL PROBLEMS SO; Erdem I, 2009, CLIN MICROBIOL INFEC, V15, P943, DOI 10.1111/j.1469-0691.2009.02863.x; FLEXNER C, 1991, ANTIMICROB AGENTS CH, V35, P2544, DOI 10.1128/AAC.35.12.2544; Garcia-Hernandez J, 2012, LETT APPL MICROBIOL; Guga P, 2011, CHEM BIODIVERS, V8, P1642, DOI 10.1002/cbdv.201100130; Guimaraes N, 2007, J CLIN MICROBIOL, V45, P3089, DOI 10.1128/JCM.00858-07; HOKE GD, 1991, NUCLEIC ACIDS RES, V19, P5743, DOI 10.1093/nar/19.20.5743; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; Ji R, 2010, J GASTROEN HEPATOL, V25, P700, DOI 10.1111/j.1440-1746.2009.06197.x; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kiesslich R, 2005, GASTROENTEROLOGY, V128, P2119, DOI 10.1053/j.gastro.2004.12.035; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Krauss E, 2012, INT J CLIN EXP PATHO, V5, P956; Kubota K, 2006, APPL ENVIRON MICROB, V72, P5311, DOI 10.1128/AEM.03039-05; Kumar R, 1998, BIOORG MED CHEM LETT, V8, P2219, DOI 10.1016/S0960-894X(98)00366-7; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Maruo R, 2011, MOL BIOTECHNOL, V49, P42, DOI 10.1007/s12033-011-9375-9; Matsukura M, 1995, TOXICOL LETT, V82-3, P435, DOI 10.1016/0378-4274(95)03574-5; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; McNulty CAM, 2011, HELICOBACTER, V16, P10, DOI 10.1111/j.1523-5378.2011.00875.x; Miller SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017384; Molenaar C, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e89; Neumann H, 2011, WORLD J GASTROENTERO, V17, P63, DOI 10.3748/wjg.v17.i1.63; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Ngo JT, 2013, INFECTION, V41, P41, DOI 10.1007/s15010-012-0389-4; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; Rickard A., 2003, BIOFILM COMMUNITIES, P105; Robertson KL, 2012, JOVE-J VIS EXP, DOI 10.3791/3655; Robertson KL, 2009, ANAL BIOCHEM, V390, P109, DOI 10.1016/j.ab.2009.04.026; Shukla R, 2011, WORLD J GASTRO ENDOS, V3, P183, DOI 10.4253/wjge.v3.i10.183; Silahtaroglu A, 2004, CYTOGENET GENOME RES, V107, P32, DOI 10.1159/000079569; Silahtaroglu AN, 2003, MOL CELL PROBE, V17, P165, DOI 10.1016/S0890-8508(03)00048-3; Simard C, 2001, ELECTROPHORESIS, V22, P2679, DOI 10.1002/1522-2683(200108)22:13<2679::AID-ELPS2679>3.0.CO;2-L; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Soe MJ, 2011, J HISTOCHEM CYTOCHEM, V59, P661, DOI 10.1369/0022155411409411; STEIN CA, 1988, GENE, V72, P333, DOI 10.1016/0378-1119(88)90160-6; SZOLLOSI J, 1995, CYTOMETRY, V20, P356, DOI 10.1002/cyto.990200412; Theves C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021733; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Wiegant J, 2010, METHODS MOL BIOL, V659, P239, DOI 10.1007/978-1-60761-789-1_17; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOOLF TM, 1990, NUCLEIC ACIDS RES, V18, P1763, DOI 10.1093/nar/18.7.1763; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175	56	37	38	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81230	10.1371/journal.pone.0081230	http://dx.doi.org/10.1371/journal.pone.0081230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278398	Green Published, gold, Green Submitted			2022-12-27	WOS:000327541700053
J	Bando, SY; Silva, FN; Costa, LDF; Silva, AV; Pimentel-Silva, LR; Castro, LHM; Wen, HT; Amaro, E; Moreira-Filho, CA				Bando, Silvia Yumi; Silva, Filipi Nascimento; Costa, Luciano Da Fontoura; Silva, Alexandre V.; Pimentel-Silva, Luciana R.; Castro, Luiz H. M.; Wen, Hung-Tzu; Amaro, Edson, Jr.; Moreira-Filho, Carlos Alberto			Complex Network Analysis of CA3 Transcriptome Reveals Pathogenic and Compensatory Pathways in Refractory Temporal Lobe Epilepsy	PLOS ONE			English	Article							G-PROTEIN GAMMA(3); SYNAPTIC-TRANSMISSION; HISTONE DEACETYLASE; STRIATAL PLASTICITY; FEBRILE SEIZURES; CELL DISPERSION; GENE; EXPRESSION; BASSOON; NEURONS	We previously described - studying transcriptional signatures of hippocampal CA3 explants - that febrile (FS) and afebrile (NFS) forms of refractory mesial temporal lobe epilepsy constitute two distinct genomic phenotypes. That network analysis was based on a limited number (hundreds) of differentially expressed genes (DE networks) among a large set of valid transcripts (close to two tens of thousands). Here we developed a methodology for complex network visualization (3D) and analysis that allows the categorization of network nodes according to distinct hierarchical levels of gene-gene connections (node degree) and of interconnection between node neighbors (concentric node degree). Hubs are highly connected nodes, VIPs have low node degree but connect only with hubs, and high-hubs have VIP status and high overall number of connections. Studying the whole set of CA3 valid transcripts we: i) obtained complete transcriptional networks (CO) for FS and NFS phenotypic groups; ii) examined how CO and DE networks are related; iii) characterized genomic and molecular mechanisms underlying FS and NFS phenotypes, identifying potential novel targets for therapeutic interventions. We found that: i) DE hubs and VIPs are evenly distributed inside the CO networks; ii) most DE hubs and VIPs are related to synaptic transmission and neuronal excitability whereas most CO hubs, VIPs and high hubs are related to neuronal differentiation, homeostasis and neuroprotection, indicating compensatory mechanisms. Complex network visualization and analysis is a useful tool for systems biology approaches to multifactorial diseases. Network centrality observed for hubs, VIPs and high hubs of CO networks, is consistent with the network disease model, where a group of nodes whose perturbation leads to a disease phenotype occupies a central position in the network. Conceivably, the chance for exerting therapeutic effects through the modulation of particular genes will be higher if these genes are highly interconnected in transcriptional networks.	[Bando, Silvia Yumi; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Silva, Filipi Nascimento; Costa, Luciano Da Fontoura] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Silva, Alexandre V.; Pimentel-Silva, Luciana R.] Univ Fed Sao Paulo, Dept Biosci, Santos, SP, Brazil; [Castro, Luiz H. M.] FMUSP, Hosp Clin, Clin Neurol Div, Sao Paulo, Brazil; [Wen, Hung-Tzu] FMUSP, Hosp Clin, Epilepsy Surg Grp, Sao Paulo, Brazil; [Amaro, Edson, Jr.] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Moreira-Filho, CA (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	carlos.moreira@hc.fm.usp.br	Silva, Filipi Nascimento/C-7620-2012; da F. Costa, Luciano/H-5475-2011; amaro, edson/GLR-7735-2022; Castro, Luiz H M/H-9427-2012; moreira-filho, carlos alberto/J-2551-2014; Amaro, Edson/B-6653-2009; Pimentel-Silva, Luciana Ramalho/AAB-4792-2021	Silva, Filipi Nascimento/0000-0002-9151-6517; da F. Costa, Luciano/0000-0001-5203-4366; amaro, edson/0000-0002-5889-1382; Castro, Luiz H M/0000-0003-1878-8548; moreira-filho, carlos alberto/0000-0003-3433-4714; Amaro, Edson/0000-0002-5889-1382; Pimentel-Silva, Luciana Ramalho/0000-0001-5045-9512; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/53443-1, 2005/56446-0, 2005/00587-5, 2011/50761-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305635/2009-3, 301303/06-1, 573583/2008-0]; FAPESP-MCT/CNPq/PRONEX [2011/50761-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP-MCT/CNPq/PRONEX	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) research grants 2009/53443-1 and 2005/56446-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 305635/2009-3 to CAM-F. L da FC was funded by FAPESP grants 2005/00587-5 and 2011/50761-2 and CNPq grants 301303/06-1 and 573583/2008-0). CAM-F and L da FC are funded by FAPESP-MCT/CNPq/PRONEX grant 2011/50761-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alegro MD, 2012, MAGN RESON MED, V68, P1647, DOI 10.1002/mrm.24174; Babbio F, 2004, CELL CYCLE, V3, P486; Bae EK, 2010, J CLIN NEUROL, V6, P73, DOI 10.3988/jcn.2010.6.2.73; Bai J, 2011, NEUROTOX RES, V19, P412, DOI 10.1007/s12640-010-9183-1; Bando SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026268; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5; Bradley J, 1997, J NEUROSCI, V17, P1993; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brooks-Kayal AR, 2012, JASPERS BASIC MECH E; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Carpio A, 2009, CURR NEUROL NEUROSCI, V9, P319, DOI 10.1007/s11910-009-0048-z; Casillas-Espinosa PM, 2012, EPILEPSIA, V53, P41, DOI 10.1111/epi.12034; Castro PA, 2002, NEUROSCIENCE, V114, P961, DOI 10.1016/S0306-4522(02)00296-8; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/00019052-200404000-00013; Chen J, 2013, BBA-MOL CELL BIOL L, V1831, P263, DOI 10.1016/j.bbalip.2012.09.007; Chungath M, 2008, NAT CLIN PRACT NEURO, V4, P610, DOI 10.1038/ncpneuro0922; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costa LD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098702; Costa LD, 2008, PHYSICA A, V387, P6201, DOI 10.1016/j.physa.2008.06.034; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Engel J, 2011, ARCH NEUROL-CHICAGO, V68, P707, DOI 10.1001/archneurol.2011.113; Fang R, 2013, MOL CELL, V49, P558, DOI 10.1016/j.molcel.2012.11.019; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Ferraro TN, 2012, PHARMACOGENOMICS, V13, P731, DOI [10.2217/pgs.12.31, 10.2217/PGS.12.31]; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Gaiteri C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00095; Gao H, 2003, MOL BIOL CELL, V14, P4826, DOI 10.1091/mbc.E03-05-0276; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Ghiglieri V, 2010, NEUROPSYCHOPHARMACOL, V35, P1531, DOI 10.1038/npp.2010.23; Ghiglieri V, 2009, EUR J NEUROSCI, V29, P1979, DOI 10.1111/j.1460-9568.2009.06733.x; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134; GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9; Griebel M, 2007, NUMERICAL SIMULATION, P476; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Helgager J, 2013, J COMP NEUROL, V521, P499, DOI 10.1002/cne.23225; Hemming K, 2013, COCHRANE DB SYST REV, V1; Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24; Heverin M, 2012, BRAIN RES, V1480, P81, DOI 10.1016/j.brainres.2012.08.018; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kennard JTT, 2011, NEUROBIOL DIS, V42, P48, DOI 10.1016/j.nbd.2011.01.003; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; Kwon KH, 2013, J PROTEOME RES, V12, P97, DOI 10.1021/pr3008368; Lacey CJ, 2012, J NEUROSCI, V32, P11067, DOI 10.1523/JNEUROSCI.5604-11.2012; Lambert JD, 1992, NUMERICAL METHODS OR, P304; Lawton M, 2010, OXID MED CELL LONGEV, V3, P347, DOI 10.4161/oxim.3.5.13296; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Liu Y, 2009, ADV ENZYME REGUL, V49, P75, DOI 10.1016/j.advenzreg.2009.01.006; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Loeb JA, 2011, NEUROSCI LETT, V497, P205, DOI 10.1016/j.neulet.2011.02.041; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006; Masuda N, 2006, SOC NETWORKS, V28, P297, DOI 10.1016/j.socnet.2005.07.005; McAuley JJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773951; McBain CJ, 2012, SCIENCE, V338, P482, DOI 10.1126/science.1230338; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; McNamara JO, 2012, JASPERS BASIC MECH E; Moriguchi S, 2006, P NATL ACAD SCI USA, V103, P10811, DOI 10.1073/pnas.0509863103; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Muley PD, 2008, DEV NEUROBIOL, V68, P1441, DOI 10.1002/dneu.20670; Musto AE, 2011, EPILEPSIA, V52, P551, DOI 10.1111/j.1528-1167.2010.02920.x; Nguyen MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041899; Nishi M, 2002, BIOCHEM BIOPH RES CO, V292, P318, DOI 10.1006/bbrc.2002.6649; Nomura DK, 2008, TOXICOL APPL PHARM, V228, P42, DOI 10.1016/j.taap.2007.11.021; Owuor K, 2009, MOL CELL NEUROSCI, V42, P448, DOI 10.1016/j.mcn.2009.09.008; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Parent J. M., 2012, JASPERS BASIC MECH E; Park KA, 2011, J NEURAL TRANSM, V118, P433, DOI 10.1007/s00702-010-0490-8; Pavlakis E, 2011, INT J BIOCHEM CELL B, V43, P487, DOI 10.1016/j.biocel.2010.12.016; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Potier S, 2005, EUR J NEUROSCI, V21, P1828, DOI 10.1111/j.1460-9568.2005.04026.x; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Ryan SD, 2012, MOL BIOL CELL, V23, P553, DOI 10.1091/mbc.E11-06-0573; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Schneider JW, 2012, ACS CHEM NEUROSCI, V3, P557, DOI 10.1021/cn300025a; Schneider-Mizell CM, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046008; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395; Shibayama H, 2004, J EXP MED, V199, P581, DOI 10.1084/jem.20031858; da Silva AV, 2007, EPILEPTIC DISORD, V9, P438; Silva FN, 2013, J INFORMETR, V7, P469, DOI 10.1016/j.joi.2013.01.007; Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tastet J, 2012, BIOCHEM BIOPH RES CO, V420, P247, DOI 10.1016/j.bbrc.2012.02.134; Tellez-Zenteno Jose F, 2012, Epilepsy Res Treat, V2012, P630853, DOI 10.1155/2012/630853; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Uittenbogaard M, 2010, J NEUROSCI RES, V88, P33, DOI 10.1002/jnr.22182; Vellano CP, 2011, TRENDS PHARMACOL SCI, V32, P666, DOI 10.1016/j.tips.2011.07.005; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Walczak A, 2013, J NEUROSCI, V33, P2507, DOI 10.1523/JNEUROSCI.1085-12.2013; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Wu YM, 2009, ACTA MED OKAYAMA, V63, P305; Yamada M, 2001, MOL CELL BIOL, V21, P3807, DOI 10.1128/MCB.21.11.3807-3819.2001; Yang Y, 2007, PLOS GENET, V3, P1275, DOI 10.1371/journal.pgen.0030124; Young TR, 2009, INT J BIOCHEM CELL B, V41, P990, DOI 10.1016/j.biocel.2008.06.014; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhang XF, 2010, NAT NEUROSCI, V13, P1056, DOI 10.1038/nn.2610; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	132	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79913	10.1371/journal.pone.0079913	http://dx.doi.org/10.1371/journal.pone.0079913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278214	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800032
J	Butala, NM; Chang, H; Horwitz, LI; Bartlett, M; Ellis, P				Butala, Neel M.; Chang, Harry; Horwitz, Leora I.; Bartlett, Mary; Ellis, Peter			Improving Quality of Preventive Care at a Student-Run Free Clinic	PLOS ONE			English	Article							IMPROVEMENT; SERVICES; ADULTS	Student-run clinics increasingly serve as primary care providers for patients of lower socioeconomic status, but studies show that quality of care at student-run clinics has room for improvement. Purpose: To examine change in provision of preventive services in a student-run free clinic after implementation of a student-led QI intervention involving prompting. Method: Review of patient charts pre- and post-intervention, examining adherence to screening guidelines for diabetes, dyslipidemia, HIV, and cervical cancer. Results: Adherence to guidelines among eligible patients increased after intervention in 3 of 4 services examined. Receipt of HIV testing increased from 33% (80/240) to 48% (74/154; p = 0.004), fasting lipid panel increased from 53% (46/86) to 72% (38/53; p = 0.033), and fasting blood glucose increased from 59% (27/46) to 82% (18/22; p = 0.059). Conclusions: This student-run free clinic implemented a student-led QI intervention that increased provision of prevention. Such a model for QI could extend to other student-run clinics nationally.	[Butala, Neel M.; Chang, Harry] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Horwitz, Leora I.; Ellis, Peter] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Bartlett, Mary] Fair Haven Community Hlth Ctr, New Haven, CT USA	Yale University; Yale University	Butala, NM (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.	neel.butala@yale.edu	Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Horwitz, Leora/0000-0003-1800-6040	Gilead Foundation; National Institute on Aging; American Federation for Aging Research [K08 AG038336]; NATIONAL INSTITUTE ON AGING [K08AG038336] Funding Source: NIH RePORTER	Gilead Foundation(Gilead Sciences); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Gilead Foundation and John A. Jones provided necessary financial support to HAVEN and to the student Executive Director, Neel Butala. Dr. Horwitz is supported by the National Institute on Aging and the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program (K08 AG038336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMC, 2001, CONT ISS MED QUAL CA; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Butala NM, 2012, J HEALTH CARE POOR U, V23, P414, DOI 10.1353/hpu.2012.0034; Byrd TL, 2007, ETHNIC DIS, V17, P129; Dexheimer JW, 2008, J AM MED INFORM ASSN, V15, P311, DOI 10.1197/jamia.M2555; *HHS, 2000, HLTH PEOPL 2010; Liberman KM, 2011, J COMMUN HEALTH, V36, P733, DOI 10.1007/s10900-011-9367-5; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; ORNSTEIN SM, 1991, J FAM PRACTICE, V32, P82; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Ryskina KL, 2009, J HEALTH CARE POOR U, V20, P969, DOI 10.1353/hpu.0.0231; Simpson SA, 2007, J GEN INTERN MED, V22, P352, DOI 10.1007/s11606-006-0073-4; United States Preventive Services Task Force (USPSTF), 2012, GUID CLIN PREV SERV; Watts L, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.014; Wong BM, 2012, MED EDUC, V46, P107, DOI 10.1111/j.1365-2923.2011.04154.x; Wong BM, 2010, ACAD MED, V85, P1425, DOI 10.1097/ACM.0b013e3181e2d0c6; Yabroff KR, 2003, J AM BOARD FAM PRACT, V16, P188, DOI 10.3122/jabfm.16.3.188; Yarnall KS, 2003, J INFORM, V93; Zucker J, 2013, J HEALTH CARE POOR U, V24, P344, DOI 10.1353/hpu.2013.0009; Zucker J, 2011, ACAD MED, V86, P239, DOI 10.1097/ACM.0b013e31820465e0	22	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81441	10.1371/journal.pone.0081441	http://dx.doi.org/10.1371/journal.pone.0081441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278438	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800131
J	Everitt, AR; Clare, S; McDonald, JU; Kane, L; Harcourt, K; Ahras, M; Lall, A; Hale, C; Rodgers, A; Young, DB; Haque, A; Billker, O; Tregoning, JS; Dougan, G; Kellam, P				Everitt, Aaron R.; Clare, Simon; McDonald, Jacqueline U.; Kane, Leanne; Harcourt, Katherine; Ahras, Malika; Lall, Amar; Hale, Christine; Rodgers, Angela; Young, Douglas B.; Haque, Ashraful; Billker, Oliver; Tregoning, John S.; Dougan, Gordon; Kellam, Paul			Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MEDIATES MEMBRANE DISRUPTION; WEST NILE VIRUS; IMMUNE-RESPONSE; DENGUE VIRUS; GENETIC SUSCEPTIBILITY; CITROBACTER-RODENTIUM; EPITHELIAL-CELLS; CEREBRAL MALARIA; INFECTION	The interferon-inducible transmembrane (IFITM) family of proteins has been shown to restrict a broad range of viruses in vitro and in vivo by halting progress through the late endosomal pathway. Further, single nucleotide polymorphisms (SNPs) in its sequence have been linked with risk of developing severe influenza virus infections in humans. The number of viruses restricted by this host protein has continued to grow since it was first demonstrated as playing an antiviral role; all of which enter cells via the endosomal pathway. We therefore sought to test the limits of antimicrobial restriction by Ifitm3 using a knockout mouse model. We showed that Ifitm3 does not impact on the restriction or pathogenesis of bacterial (Salmonella typhimurium, Citrobacter rodentium, Mycobacterium tuberculosis) or protozoan (Plasmodium berghei) pathogens, despite in vitro evidence. However, Ifitm3 is capable of restricting respiratory syncytial virus (RSV) in vivo either through directly restricting RSV cell infection, or by exerting a previously uncharacterised function controlling disease pathogenesis. This represents the first demonstration of a virus that enters directly through the plasma membrane, without the need for the endosomal pathway, being restricted by the IFITM family; therefore further defining the role of these antiviral proteins.	[Everitt, Aaron R.; Clare, Simon; Kane, Leanne; Harcourt, Katherine; Ahras, Malika; Hale, Christine; Billker, Oliver; Dougan, Gordon; Kellam, Paul] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [McDonald, Jacqueline U.; Tregoning, John S.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Infect Dis Sect, Mucosal Infect & Immun Grp, London, England; [Lall, Amar] Univ Oxford, Jenner Inst, Oxford, England; [Rodgers, Angela; Young, Douglas B.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Haque, Ashraful] Queensland Inst Med Res, Malaria Immunol Lab, Brisbane, Qld 4006, Australia; [Haque, Ashraful] Australian Ctr Vaccine Dev, Brisbane, Qld, Australia; [Kellam, Paul] UCL, Dept Infect, London, England	Wellcome Trust Sanger Institute; Imperial College London; University of Oxford; Jenner Institute; MRC National Institute for Medical Research; QIMR Berghofer Medical Research Institute; University of London; University College London	Everitt, AR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	ae3@sanger.ac.uk	Haque, Ashraful/H-8697-2014	Haque, Ashraful/0000-0003-2260-0026; McDonald, Jacqueline/0000-0003-4156-2176; Tregoning, John/0000-0001-8093-8741; Billker, Oliver/0000-0003-1716-168X; Kellam, Paul/0000-0003-3166-4734	Wellcome Trust; Innovative Medicines Initiative Joint Undertaking [115308]; European Union; EFPIA; MRC [U117581288]; MRC [G0501670, MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288, G0501670] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no [115308] Biovacsafe, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA members' in kind contribution. MRC grant U117581288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Ball EA, 2013, J IMMUNOL, V190, P5118, DOI 10.4049/jimmunol.1300114; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Bucasas KL, 2013, PEDIATR INFECT DIS J, V32, pE68, DOI 10.1097/INF.0b013e318278b4b3; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; Clare S, 2013, INFECT IMMUN, V81, P723, DOI 10.1128/IAI.00969-12; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; de Oca Marcela Montes, 2013, Methods Mol Biol, V1031, P203, DOI 10.1007/978-1-62703-481-4_23; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Lay MK, 2013, MICROBES INFECT, V15, P230, DOI 10.1016/j.micinf.2012.11.012; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Mudhasani R, 2013, J VIROL; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021461; Ravi LI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-190; San-Juan-Vergara H, 2012, J VIROL, V86, P1832, DOI 10.1128/JVI.06274-11; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067816; Stark JM, 2002, J MED VIROL, V67, P92, DOI 10.1002/jmv.2196; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tregoning JS, 2010, J IMMUNOL, V185, P5384, DOI 10.4049/jimmunol.1001594; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Yamaguchi Y, 2012, J VIROL, V86, P10456, DOI 10.1128/JVI.01082-12; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433	51	50	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80723	10.1371/journal.pone.0080723	http://dx.doi.org/10.1371/journal.pone.0080723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278312	Green Published, gold			2022-12-27	WOS:000327539800082
J	Lee, JK; Chung, J; Kannarkat, GT; Tansey, MG				Lee, Jae-Kyung; Chung, Jaegwon; Kannarkat, George T.; Tansey, Malu G.			Critical Role of Regulator G-Protein Signaling 10 (RGS10) in Modulating Macrophage M1/M2 Activation	PLOS ONE			English	Article							EXPRESSION; MICROGLIA; NUCLEAR; INFLAMMATION; ASSOCIATION; METABOLISM; MECHANISMS; MONOCYTE	Regulator of G protein signaling 10 (RGS10), a GTPase accelerating protein (GAP) for G alpha subunits, is a negative regulator of NF-kappa B in microglia. Here, we investigated the role of RGS10 in macrophages, a closely related myeloid-derived cell type. Features of classical versus alternative activation were assessed in Rgs10-/- peritoneal and bone marrow-derived macrophages upon LPS or IL-4 treatments, respectively. Our results showed that Rgs10-/- macrophages produced higher levels of pro-inflammatory cytokines including TNF, IL-1 beta and IL-12p70 in response to LPS treatment and exerted higher cytotoxicity on dopaminergic MN9D neuroblastoma cells. We also found that Rgs10-/- macrophages displayed a blunted M2 phenotype upon IL-4 priming. Specifically, Rgs10-/- macrophages displayed lower YM1 and Fizz1 mRNA levels as measured by QPCR compared to wild type macrophages upon IL-4 treatment and this response was not attributable to differences in IL-4 receptor expression. Importantly, phagocytic activities of Rgs10-/- macrophages were blunted in response to IL-4 priming and/or LPS treatments. However, there was no difference in chemotaxis between Rgs10-/- and WT macrophages. Our data indicate that Rgs10-/- macrophages displayed dysregulated M1 responses along with blunted M2 alternative activation responses, suggesting that RGS10 plays an important role in determining macrophage activation responses.	[Lee, Jae-Kyung; Chung, Jaegwon; Kannarkat, George T.; Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Lee, JK (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	jaekyung.lee@emory.edu; malu.tansey@emory.edu	Kannarkat, George/ABB-6064-2021	LEE, JAE-KYUNG/0000-0003-0104-8623	Emory Parkinson's Disease Collaborative Environmental Research Center [5P01ES016731-04]; NIH/NINDS [5R01NS072467]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081830, R01NS072467] Funding Source: NIH RePORTER	Emory Parkinson's Disease Collaborative Environmental Research Center; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a pilot grant to JKL from the Emory Parkinson's Disease Collaborative Environmental Research Center (5P01ES016731-04) and NIH/NINDS 5R01NS072467 grant to MGT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hishimoto A, 2004, PSYCHIAT CLIN NEUROS, V58, P579, DOI 10.1111/j.1440-1819.2004.01303.x; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lee JK, 2011, J NEUROSCI, V31, P11879, DOI 10.1523/JNEUROSCI.1002-11.2011; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Munder M, 1999, J IMMUNOL, V163, P3771; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Vats D, 2006, CELL METAB, V4, P255, DOI 10.1016/j.cmet.2006.08.006; Weischenfeldt J, 2008, CSH PROTOC, V2008	32	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81785	10.1371/journal.pone.0081785	http://dx.doi.org/10.1371/journal.pone.0081785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278459	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800141
J	Shimizu, K; Chiba, S; Hori, Y				Shimizu, Kazuya; Chiba, Sachie; Hori, Yuichi			Identification of a Novel Subpopulation of Tumor-Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma Patients	PLOS ONE			English	Article							CANCER STEM-CELLS; CD133 EXPRESSION; IN-VITRO; GROWTH; DIFFERENTIATION; METASTASIS; POPULATIONS; PHENOTYPE; CARCINOMA; THERAPY	Pancreatic ductal adenocarcinoma is highly resistant to systemic chemotherapy. Although there are many reports using pancreatic cancer cells derived from patients who did not receive chemotherapy, characteristics of pancreatic cancer cells from chemotherapy-resistant patients remain unclear. In this study, we set out to establish a cancer cell line in disseminated cancer cells derived from gemcitabine-resistant pancreatic ductal adenocarcinoma patients. By use of in vitro co-culture system with stromal cells, we established a novel pancreatic tumor-initiating cell line. The cell line required its direct interaction with stromal cells for its in vitro clonogenic growth and passaging. Their direct interaction induced basal lamina-like extracellular matrix formation that maintained colony formation. The cell line expressed CD133 protein, which expression level changed autonomously and by culture conditions. These results demonstrated that there were novel pancreatic tumor-initiating cells that required direct interactions with stromal cells for their in vitro cultivation in gemcitabine-resistant pancreatic ductal adenocarcinoma. This cell line would help to develop novel therapies that enhance effects of gemcitabine or novel anti-cancer drugs.	[Shimizu, Kazuya] Kobe Med Ctr, Dept Internal Med, Kobe, Hyogo, Japan; [Shimizu, Kazuya; Chiba, Sachie; Hori, Yuichi] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Div Med Chem, Kobe, Hyogo 657, Japan	Kobe City Medical Center General Hospital; Kobe University	Hori, Y (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Div Med Chem, Kobe, Hyogo 657, Japan.	horiy@people.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592007, 21591773]; Grants-in-Aid for Scientific Research [23592007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan to K. S. (23592007) and Y.H. (21591773). This work was performed in part under the Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chao CL, 2012, LAB INVEST, V92, P420, DOI 10.1038/labinvest.2011.185; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HEYDERMAN E, 1990, J CLIN PATHOL, V43, P448, DOI 10.1136/jcp.43.6.448; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hori Y, 2008, STEM CELLS, V26, P2912, DOI 10.1634/stemcells.2008-0192; Hosokawa T, 2007, CONNECT TISSUE RES, V48, P9, DOI 10.1080/03008200601017488; Immervoll H, 2011, J HISTOCHEM CYTOCHEM, V59, P441, DOI 10.1369/0022155411398275; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Maeda S, 2008, BRIT J CANCER, V98, P1389, DOI 10.1038/sj.bjc.6604307; MATSUO M, 1982, J GERONTOL, V37, P33, DOI 10.1093/geronj/37.1.33; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Romanus D, 2012, J PAIN SYMPTOM MANAG, V43, P205, DOI 10.1016/j.jpainsymman.2011.09.001; Ruckert F, 2012, J SURG RES, V172, P29, DOI 10.1016/j.jss.2011.04.021; Shimizu K, 2009, PANCREAS, V38, pE207, DOI 10.1097/MPA.0b013e3181bb5037; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Wang DQ, 2013, ACTA HISTOCHEM, V115, P349, DOI 10.1016/j.acthis.2012.09.007; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Welsch T, 2009, CLIN EXP METASTAS, V26, P701, DOI 10.1007/s10585-009-9269-4; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	38	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81283	10.1371/journal.pone.0081283	http://dx.doi.org/10.1371/journal.pone.0081283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278411	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800118
J	Simo, R; Plana-Ripoll, O; Puente, D; Morros, R; Mundet, X; Vilca, LM; Hernandez, C; Fuentes, I; Procupet, A; Tabernero, JM; Violan, C				Simo, Rafael; Plana-Ripoll, Oleguer; Puente, Diana; Morros, Rosa; Mundet, Xavier; Vilca, Luz M.; Hernandez, Cristina; Fuentes, Inmaculada; Procupet, Adriana; Tabernero, Josep M.; Violan, Concepcion			Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study	PLOS ONE			English	Article							INSULIN GLARGINE; INCIDENT CANCER; REDUCED RISK; PRIMARY-CARE; METFORMIN; COHORT; METAANALYSIS; MORTALITY; THERAPY; THIAZOLIDINEDIONES	Background: The aim of the present study is to evaluate the impact of glucose-lowering agents in the risk of cancer in a large type 2 diabetic population. Methods: A nested case-control study was conducted within a defined cohort (275,164 type 2 diabetic patients attending 16 Primary Health Care Centers of Barcelona). Cases (n = 1,040) comprised those subjects with any cancer diagnosed between 2008 and 2010, registered at the Cancer Registry of Hospital Vall d'Hebron (Barcelona). Three control subjects for each case (n = 3,120) were matched by age, sex, diabetes duration, and geographical area. The treatments analyzed (within 3 years prior to cancer diagnosis) were: insulin glargine, insulin detemir, human insulin, fast-acting insulin and analogues, metformin, sulfonylureas, repaglinide, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, and alpha glucosidase inhibitors. Conditional logistic regressions were used to calculate the risk of cancer associated with the use of each drug adjusted by age, BMI, dose and duration of treatment, alcohol use, smoking habit, and diabetes duration. Results: No differences were observed between case and control subjects for the proportion, dose or duration of exposure to each treatment. None of the types of insulin and oral agents analyzed showed a significant increase in the risk of cancer. Moreover, no cancer risk was observed when glargine was used alone or in combination with metformin. Conclusions: Our results suggest that diabetes treatment does not influence the risk of cancer associated with type 2 diabetes. Therefore, an eventual increase of cancer should not be a reason for biasing the selection of any glucose-lowering treatment in type 2 diabetic population.	[Simo, Rafael; Hernandez, Cristina] Inst Recerca Hosp Vall Hebron, Grp Recerca Diabet & Metab, Barcelona, Spain; [Simo, Rafael; Hernandez, Cristina] Inst Recerca Hosp Vall Hebron, CIBER Diabet & Malalties Metab Assoc CIBERDEM, Barcelona, Spain; [Simo, Rafael; Plana-Ripoll, Oleguer; Puente, Diana; Morros, Rosa; Mundet, Xavier; Vilca, Luz M.; Tabernero, Josep M.; Violan, Concepcion] Univ Autonoma Barcelona, Bellaterra, Spain; [Plana-Ripoll, Oleguer; Puente, Diana; Morros, Rosa; Mundet, Xavier; Violan, Concepcion] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Plana-Ripoll, Oleguer] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Morros, Rosa; Procupet, Adriana] Inst Catala Salut, Barcelona, Spain; [Vilca, Luz M.] Hosp Univ Vall Hebron, Serv Farmacol Clin, Barcelona, Spain; [Fuentes, Inmaculada] Hosp Univ Vall Hebron, Serv Med Prevent & Epidemiol, Barcelona, Spain; [Tabernero, Josep M.] Hosp Univ Vall Hebron, Serv Oncol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Autonomous University of Barcelona; Aarhus University; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Simo, R (corresponding author), Inst Recerca Hosp Vall Hebron, Grp Recerca Diabet & Metab, Barcelona, Spain.	rafael.simo@vhir.org	Violan, Concepcion/I-4493-2019; Violán, Concepcion/HHC-2893-2022; Puente, Diana/N-9108-2018; Yengle, Luz Maria Vilca/AAM-1688-2020; Plana-Ripoll, Oleguer/E-1448-2015; Tabernero, Josep/AAG-5026-2019	Violan, Concepcion/0000-0003-3309-5360; Violán, Concepcion/0000-0003-3309-5360; Puente, Diana/0000-0003-4725-537X; Yengle, Luz Maria Vilca/0000-0002-9217-2912; Plana-Ripoll, Oleguer/0000-0002-6470-7465; Tabernero, Josep/0000-0002-2495-8139; Hernandez, Cristina/0000-0002-3109-1721; Simo Canonge, Rafael/0000-0003-0475-3096; Morros, Rosa/0000-0001-6752-8748	Ministry of Health and Social Policy [EC10-338]	Ministry of Health and Social Policy	This work has received financial support by a grant for the development of independent clinical research from Ministry of Health and Social Policy EC10-338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Ciaraldi TP, 2011, HORM METAB RES, V43, P1, DOI 10.1055/s-0030-1267203; Col NF, 2012, BREAST CANCER RES TR, V135, P639, DOI 10.1007/s10549-012-2170-x; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fagot JP, 2013, DIABETES CARE, V36, P294, DOI 10.2337/dc12-0506; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hsu IR, 2007, AM J CLIN NUTR, V86, p867S, DOI 10.1093/ajcn/86.3.867S; Johnson JA, 2011, DIABETOLOGIA, V54, P25, DOI 10.1007/s00125-010-1933-3; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Koro C, 2007, PHARMACOEPIDEM DR S, V16, P485, DOI 10.1002/pds.1352; Lewis JD, 2008, GASTROENTEROLOGY, V135, P1914, DOI 10.1053/j.gastro.2008.09.004; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lind M, 2012, PRIM CARE DIABETES, V6, P53, DOI 10.1016/j.pcd.2011.10.004; Mamtani R, 2012, JNCI-J NATL CANCER I, V104, P1411, DOI 10.1093/jnci/djs328; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Monami M, 2008, EXP CLIN ENDOCR DIAB, V116, P184, DOI 10.1055/s-2007-992157; Monami M, 2007, DIABETES-METAB RES, V23, P479, DOI 10.1002/dmrr.736; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pierre-Eugene C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041992; Ramos R, 2012, REV ESP CARDIOL, V65, P29, DOI [10.1016/j.rec.2011.07.016, 10.1016/j.recesp.2011.07.017]; Rattan R, 2012, J ONCOL, V2012, DOI 10.1155/2012/928127; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Singh S, 2013, WORLD J CLIN ONCOL, V4, P43, DOI 10.5306/wjco.v4.i2.43; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Vinagre I, 2012, DIABETES CARE, V35, P774, DOI 10.2337/dc11-1679; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; World Health Organization, ICD 10 INT STAT CLAS, V2nd; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	48	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79968	10.1371/journal.pone.0079968	http://dx.doi.org/10.1371/journal.pone.0079968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278227	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800041
J	Dobarro, I; Carmona, CP; Peco, B				Dobarro, Iker; Perez Carmona, Carlos; Peco, Begona			Dissecting the Effects of Simulated Cattle Activity on Floristic Composition and Functional Traits in Mediterranean Grasslands	PLOS ONE			English	Article							PLANT DIVERSITY; SPECIES RICHNESS; PRODUCTIVITY GRADIENT; GRAZING ABANDONMENT; MOUNTAIN PASTURES; SEED SIZE; LAND-USE; SOIL; VEGETATION; COMMUNITY	Livestock exerts direct and indirect effects on plant communities, changing colonization and extinction rates of species and the surrounding environmental conditions. There is scarce knowledge on how and to what extent these effects control the floristic and functional composition of plant communities in grasslands. We performed an experiment that included several treatments simulating trampling, defoliation, faeces addition and their combinations in a Mediterranean scrub community grazing-abandoned for at least 50 years. We monitored the plots for four years, and collected data on species composition, photosynthetically active radiation (PAR) and red: far-red ratio (R:FR), soil moisture and compaction. We estimated community weighted means (CWM) for height, habit, life cycle, seed mass and SLA. Neither compaction nor soil moisture were modified by the treatments, while PAR and R: FR increased in all treatments in comparison to the Control and Faeces treatments. The floristic composition of all treatments, except for Faeces, converged over time, but deviated from that of the Control. The functional traits displayed the trends expected in the presence of grazing: loss of erect species and increased cover of short species with light seeds, with rosettes and prostrate habit. However, contrary to the results in literature, SLA was lower in all the treatments than Control plots. Like the results for floristic composition, all treatments except for Faeces converged towards a similar functional composition at the end of the four year period. The results of this study show the initial evolution of a Mediterranean plant community in the presence of grazing, driven primarily by the destructive action of livestock. These actions seem to directly affect the rates of extinction/colonization, and indirectly affect the light environment but not the soil conditions. However, their effects on floristic and trait composition do not seem to differ, at least at the small spatio-temporal scale.	[Dobarro, Iker; Perez Carmona, Carlos; Peco, Begona] Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain	Autonomous University of Madrid	Dobarro, I (corresponding author), Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain.	iker.dobarro@gmail.com	Peco, Begoña/C-1197-2012; del Moral, Iker Dobarro/H-9292-2019; Carmona, Carlos P./J-1536-2012	Peco, Begoña/0000-0003-2149-1438; Carmona, Carlos P./0000-0001-6935-4913; Dobarro del Moral, Iker/0000-0003-2093-257X	Spanish Ministry of Education and Science [CGL2007-63382, CGL2011-24871]; Spanish Ministry of Education and Science (FPI scholarship) [BES-2004-4396, BES-2008-009821]; Programa de Actividades de I+D de la Comunidad de Madrid (Consejeria de Educacion, Comunidad Autonoma de Madrid, Spain) REMEDINAL-CM [S-0505/AMB/000335, S-2009/AMB/1783]; REMEDINAL2 Programme [S-2009/AMB/1783]; Comunidad de Madrid; European Social Fund	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Education and Science (FPI scholarship)(German Research Foundation (DFG)); Programa de Actividades de I+D de la Comunidad de Madrid (Consejeria de Educacion, Comunidad Autonoma de Madrid, Spain) REMEDINAL-CM; REMEDINAL2 Programme; Comunidad de Madrid(Comunidad de Madrid); European Social Fund(European Social Fund (ESF))	Financial support was provided by the Spanish Ministry of Education and Science (CGL2007-63382, CGL2011-24871, FPI scholarship BES-2004-4396 for Iker Dobarro and FPI scholarship BES-2008-009821 for C. P. Carmona), the Programa de Actividades de I+D de la Comunidad de Madrid (Consejeria de Educacion, Comunidad Autonoma de Madrid, Spain) REMEDINAL-CM (S-0505/AMB/000335, S-2009/AMB/1783) and the REMEDINAL2 Programme (S-2009/AMB/1783), supported by the Comunidad de Madrid and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamad MN, 2008, BASIC APPL ECOL, V9, P224, DOI 10.1016/j.baae.2007.03.008; Allington GRH, 2011, RANGELAND ECOL MANAG, V64, P424, DOI 10.2111/REM-D-10-00098.1; Allred BW, 2012, BASIC APPL ECOL, V13, P149, DOI 10.1016/j.baae.2012.02.007; ANDERSON VJ, 1995, ECOL APPL, V5, P1014, DOI 10.2307/2269351; Anten NPR, 2001, FUNCT ECOL, V15, P804, DOI 10.1046/j.0269-8463.2001.00582.x; Azcarate FM, 2002, J VEG SCI, V13, P159, DOI 10.1111/j.1654-1103.2002.tb02035.x; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bakker ES, 2003, J VEG SCI, V14, P465, DOI 10.1111/j.1654-1103.2003.tb02173.x; Bonanomi G, 2006, ACTA OECOL, V30, P419, DOI 10.1016/j.actao.2006.06.007; Carmona CP, 2013, ACTA OECOL, V47, P1, DOI 10.1016/j.actao.2012.11.001; Carmona CP, 2012, J APPL ECOL, V49, P1084, DOI 10.1111/j.1365-2664.2012.02193.x; CASADO MA, 1985, VEGETATIO, V64, P75; Castro H, 2010, AGR ECOSYST ENVIRON, V137, P183, DOI 10.1016/j.agee.2010.02.002; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Crawley M.J., 2007, R BOOK; Dai XB, 2000, J VEG SCI, V11, P715, DOI 10.2307/3236578; De Bello F, 2005, J APPL ECOL, V42, P824, DOI 10.1111/j.1365-2664.2005.01079.x; de Bello F, 2006, ECOGRAPHY, V29, P801, DOI 10.1111/j.2006.0906-7590.04683.x; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; Del-Val EK, 2005, J ECOL, V93, P1005, DOI 10.1111/j.1365-2745.2005.01011.x; Di HJ, 2001, NEW ZEAL J AGR RES, V44, P111, DOI 10.1080/00288233.2001.9513465; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Dijkstra P., 1989, CAUSES CONSEQUENCES, P125; Dobarro I, 2010, ACTA OECOL, V36, P74, DOI 10.1016/j.actao.2009.10.005; Dunne T, 2011, J ARID ENVIRON, V75, P58, DOI 10.1016/j.jaridenv.2010.09.001; Gillet F, 2010, AGR ECOSYST ENVIRON, V135, P34, DOI 10.1016/j.agee.2009.08.006; Golodets C, 2010, PLANT SOIL, V329, P365, DOI 10.1007/s11104-009-0164-1; Greenwood KL, 2001, AUST J EXP AGR, V41, P1231, DOI 10.1071/EA00102; Grime J. P., 2001, PLANT STRATEGIES VEG; Gustavsson E, 2007, BIOL CONSERV, V138, P47, DOI 10.1016/j.biocon.2007.04.004; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Kohler F, 2006, FOLIA GEOBOT, V41, P289, DOI 10.1007/BF02904943; Lavoral S, 1999, J VEG SCI, V10, P661, DOI 10.2307/3237081; MALO JE, 1995, J VEG SCI, V6, P169, DOI 10.2307/3236211; Malo JE, 2000, J RANGE MANAGE, V53, P322, DOI 10.2307/4003440; MALO JE, 1995, OECOLOGIA, V104, P246, DOI 10.1007/BF00328589; Manzano P, 2005, SEED SCI RES, V15, P21, DOI 10.1079/SSR2004192; MAPA (Ministerio de Agricultura Pesca y Alimentacion), 1981, MET OF AN; McDowell RW, 2005, J ENVIRON QUAL, V34, P598, DOI 10.2134/jeq2005.0598; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Mullholland B, 1991, SOIL USE MANAGE, V7, P189; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pakeman RJ, 2009, BASIC APPL ECOL, V10, P656, DOI 10.1016/j.baae.2009.03.007; Peco B, 2006, AGR ECOSYST ENVIRON, V113, P284, DOI 10.1016/j.agee.2005.09.017; Peco B, 2005, BASIC APPL ECOL, V6, P175, DOI 10.1016/j.baae.2005.01.002; Peco B, 2012, AGR ECOSYST ENVIRON, V152, P27, DOI 10.1016/j.agee.2012.02.009; Peco B, 2003, SEED SCI RES, V13, P87, DOI 10.1079/SSR2002127; Pinheiro J, 2013, NLME LINEAR NONLINEA; R Core Team, 2012, R LANG ENV STAT COMP; Reitalu T, 2010, J APPL ECOL, V47, P1216, DOI 10.1111/j.1365-2664.2010.01875.x; Rusch GM, 2009, BASIC APPL ECOL, V10, P466, DOI 10.1016/j.baae.2009.01.004; Sanchez AM, 2002, SEED SCI RES, V12, P101, DOI 10.1079/SSR2002102; Schultz NL, 2011, J VEG SCI, V22, P130, DOI 10.1111/j.1654-1103.2010.01235.x; SOANE BD, 1981, SOIL TILL RES, V1, P207, DOI 10.1016/0167-1987(80)90026-4; Spasojevic MJ, 2010, ECOLOGY, V91, P1651, DOI 10.1890/09-0431.1; Staalduinen MA, 2010, PLANT ECOL, V208, P55; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Striker GG, 2011, APPL VEG SCI, V14, P95, DOI 10.1111/j.1654-109X.2010.01093.x; Sun D, 1993, ENVIRON MANAGE, V17, P551; Thornes JB, 2007, GEOGR RES, V45, P13, DOI 10.1111/j.1745-5871.2007.00426.x; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; Traba J, 2006, J VEG SCI, V17, P5, DOI 10.1111/j.1654-1103.2006.tb02417.x; Traba J, 2003, RESTOR ECOL, V11, P378, DOI 10.1046/j.1526-100X.2003.00227.x; Tutin T.G., 1968, FLORA EUROPAEA, V2, P368; Valdes B., 1987, FLORA VASCULAR ANDAL; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]	74	8	9	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79822	10.1371/journal.pone.0079822	http://dx.doi.org/10.1371/journal.pone.0079822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278185	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100050
J	Hao, MZ; He, X; Xiao, Q; Alstermark, B; Lan, N				Hao, Manzhao; He, Xin; Xiao, Qin; Alstermark, Bror; Lan, Ning			Corticomuscular Transmission of Tremor Signals by Propriospinal Neurons in Parkinson's Disease	PLOS ONE			English	Article							DISYNAPTIC PYRAMIDAL EXCITATION; CEREBRAL OSCILLATORY NETWORK; LATERAL RETICULAR NUCLEUS; BASAL GANGLIA; SUBTHALAMIC NUCLEUS; MOTOR CONTROL; FORELIMB MOTONEURONS; MULTIPLE OSCILLATORS; INHIBITORY PATHWAYS; MATHEMATICAL-MODELS	Cortical oscillatory signals of single and double tremor frequencies act together to cause tremor in the peripheral limbs of patients with Parkinson's disease (PD). But the corticospinal pathway that transmits the tremor signals has not been clarified, and how alternating bursts of antagonistic muscle activations are generated from the cortical oscillatory signals is not well understood. This paper investigates the plausible role of propriospinal neurons (PN) in C3-C4 in transmitting the cortical oscillatory signals to peripheral muscles. Kinematics data and surface electromyogram (EMG) of tremor in forearm were collected from PD patients. A PN network model was constructed based on known neurophysiological connections of PN. The cortical efferent signal of double tremor frequencies were integrated at the PN network, whose outputs drove the muscles of a virtual arm (VA) model to simulate tremor behaviors. The cortical efferent signal of single tremor frequency actuated muscle spindles. By comparing tremor data of PD patients and the results of model simulation, we examined two hypotheses regarding the corticospinal transmission of oscillatory signals in Parkinsonian tremor. Hypothesis I stated that the oscillatory cortical signals were transmitted via the mono-synaptic corticospinal pathways bypassing the PN network. The alternative hypothesis II stated that they were transmitted by way of PN multi-synaptic corticospinal pathway. Simulations indicated that without the PN network, the alternating burst patterns of antagonistic muscle EMGs could not be reliably generated, rejecting the first hypothesis. However, with the PN network, the alternating burst patterns of antagonist EMGs were naturally reproduced under all conditions of cortical oscillations. The results suggest that cortical commands of single and double tremor frequencies are further processed at PN to compute the alternating burst patterns in flexor and extensor muscles, and the neuromuscular dynamics demonstrated a frequency dependent damping on tremor, which may prevent tremor above 8 Hz to occur.	[Hao, Manzhao; He, Xin; Lan, Ning] Shanghai Jiao Tong Univ, Sch Biomed Engn, Med X Res Inst, Inst Rehabil Engn, Shanghai 200030, Peoples R China; [Xiao, Qin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Xiao, Qin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China; [Alstermark, Bror] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Lan, Ning] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Umea University; University of Southern California	Lan, N (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Med X Res Inst, Inst Rehabil Engn, Shanghai 200030, Peoples R China.	ninglan@sjtu.edu.cn	Hao, Manzhao/AAP-3085-2021	Hao, Manzhao/0000-0001-8744-7128	Shanghai Jiao Tong University; University of Michigan; Natural Science Foundation of China [31070749, 81271684]; Ministry of Science and Technology of China [2011CB013304]	Shanghai Jiao Tong University; University of Michigan(University of Michigan System); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported in part by a joint project between Shanghai Jiao Tong University and University of Michigan, grants from the Natural Science Foundation of China (No. 31070749 and No. 81271684) and a basic research program of project 973 from the Ministry of Science and Technology of China (No. 2011CB013304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALSTERMARK B, 1981, EXP BRAIN RES, V42, P282, DOI 10.1007/BF00237495; Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P308, DOI 10.1007/BF00236286; ALSTERMARK B, 1985, EXP BRAIN RES, V59, P353; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P279, DOI 10.1007/BF00236284; ALSTERMARK B, 1984, EXP BRAIN RES, V56, P293, DOI 10.1007/BF00236285; Alstermark B, 2012, ANNU REV NEUROSCI, V35, P559, DOI 10.1146/annurev-neuro-062111-150527; Amtage F, 2008, NEUROSCI LETT, V442, P195, DOI 10.1016/j.neulet.2008.06.087; ANDREWS CJ, 1973, J NEUROL NEUROSUR PS, V36, P329, DOI 10.1136/jnnp.36.3.329; Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Ben-Pazi H, 2001, J NEURAL TRANSM, V108, P287, DOI 10.1007/s007020170074; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Breit S, 2008, J NEUROL, V255, P103, DOI 10.1007/s00415-008-0712-2; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Cheng EJ, 2000, J NEUROSCI METH, V101, P117, DOI 10.1016/S0165-0270(00)00258-2; Deuschl G, 2000, J NEUROL, V247, P33, DOI 10.1007/PL00007781; Dovzhenok A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041598; Du YF, 2010, IEEE ENG MED BIO, P4866, DOI 10.1109/IEMBS.2010.5627281; Fetz EE, 2002, BRAIN RES REV, V40, P53, DOI 10.1016/S0165-0173(02)00188-1; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Ghez C, 2007, J NEUROPHYSIOL, V98, P3614, DOI 10.1152/jn.00652.2007; GORDON CR, 1995, EXP BRAIN RES, V102, P540; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Hao M, 2012, IEEE ENG MED BIO, P3874, DOI 10.1109/EMBC.2012.6346813; He X, 2013, C P IEEE ENG MED BIO; He X, 2013, IEEE T NEURAL SYST R; Hurtado JM, 2000, MOVEMENT DISORD, V15, P683, DOI 10.1002/1531-8257(200007)15:4<683::AID-MDS1013>3.0.CO;2-#; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; ILLERT M, 1977, EXP BRAIN RES, V29, P323; ILLERT M, 1978, NEUROSCI LETT, V7, P167, DOI 10.1016/0304-3940(78)90162-3; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Isa T, 2007, PHYSIOLOGY, V22, P145, DOI 10.1152/physiol.00045.2006; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lafreniere-Roula M, 2005, J NEUROPHYSIOL, V94, P1120, DOI 10.1152/jn.00216.2005; Lan N, 2005, IEEE T NEUR SYS REH, V13, P60, DOI 10.1109/TNSRE.2004.841882; Lan N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00066; Lee R G, 1975, Can J Neurol Sci, V2, P285; LELLI S, 1991, NEUROLOGY, V41, P553, DOI 10.1212/WNL.41.4.553; Lemon RN, 2004, PROG BRAIN RES, V143, P263, DOI 10.1016/S0079-6123(03)43026-4; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Levy R, 2000, J NEUROSCI, V20, P7766; Litvak V, 2011, BRAIN, V134, P359, DOI 10.1093/brain/awq332; Milanov I, 2001, CLIN NEUROPHYSIOL, V112, P1626, DOI 10.1016/S1388-2457(01)00629-0; Mileusnic MP, 2006, J NEUROPHYSIOL, V96, P1772, DOI 10.1152/jn.00868.2005; Mileusnic MP, 2006, J NEUROPHYSIOL, V96, P1789, DOI 10.1152/jn.00869.2005; Modolo J, 2010, MATH MODEL NAT PHENO, V5, P185, DOI 10.1051/mmnp/20105207; Muthuraman M, 2008, IEEE ENG MED BIO, P4716, DOI 10.1109/IEMBS.2008.4650266; Nakashima K, 1994, Electromyogr Clin Neurophysiol, V34, P67; Nistico R, 2011, PARKINSONISM RELAT D, V17, P30, DOI 10.1016/j.parkreldis.2010.10.006; O'Haver T C, 1995, VERSION 5 1; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Pollok B, 2004, J PHYSIOL-LONDON, V554, P871, DOI 10.1113/jphysiol.2003.051235; Potter M, 2004, NEUROLOGY, V63, P1234, DOI 10.1212/01.WNL.0000140287.42535.37; Raethjen J, 2000, MOVEMENT DISORD, V15, P84, DOI 10.1002/1531-8257(200001)15:1<84::AID-MDS1014>3.0.CO;2-K; Raethjen J, 2009, CLIN NEUROPHYSIOL, V120, P1866, DOI 10.1016/j.clinph.2009.06.028; Raethjen J, 2009, CURR OPIN NEUROL, V22, P400, DOI 10.1097/WCO.0b013e32832dc056; Reck C, 2009, EUR J NEUROSCI, V29, P599, DOI 10.1111/j.1460-9568.2008.06597.x; ROTHWELL JC, 1983, J NEUROL NEUROSUR PS, V46, P35, DOI 10.1136/jnnp.46.1.35; Sapir N, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031903; Song D, 2008, J NEURAL ENG, V5, P175, DOI 10.1088/1741-2560/5/2/008; Song D, 2008, ANN BIOMED ENG, V36, P1033, DOI 10.1007/s10439-008-9461-8; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Taylor A, 2004, CAN J PHYSIOL PHARM, V82, P793, DOI 10.1139/Y04-053; Taylor A, 2006, J PHYSIOL-LONDON, V571, P711, DOI 10.1113/jphysiol.2005.101634; Taylor A, 2000, J PHYSIOL-LONDON, V529, P825, DOI 10.1111/j.1469-7793.2000.00825.x; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Timmermann L, 2007, EXPERT REV MED DEVIC, V4, P651, DOI 10.1586/17434440.4.5.651; Timmermann L, 2011, BRAIN, V134, P332, DOI 10.1093/brain/awq381; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Xin He, 2012, 2012 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI), P1020, DOI 10.1109/BHI.2012.6211763; Zehr EP, 2004, CAN J PHYSIOL PHARM, V82, P556, DOI 10.1139/Y04-056; Zehr EP, 2005, J NEUROPHYSIOL, V93, P633, DOI 10.1152/jn.00525.2004	76	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79829	10.1371/journal.pone.0079829	http://dx.doi.org/10.1371/journal.pone.0079829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278189	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100054
J	Ishimura, S; Furuhashi, M; Watanabe, Y; Hoshina, K; Fuseya, T; Mita, T; Okazaki, Y; Koyama, M; Tanaka, M; Akasaka, H; Ohnishi, H; Yoshida, H; Saitoh, S; Miura, T				Ishimura, Shutaro; Furuhashi, Masato; Watanabe, Yuki; Hoshina, Kyoko; Fuseya, Takahiro; Mita, Tomohiro; Okazaki, Yusuke; Koyama, Masayuki; Tanaka, Marenao; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Miura, Tetsuji			Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIAC DAMAGE; SERUM RATIO; PLASMA; OBESITY; MYOGLOBIN; BIOMARKER; MARKER; MICE; ACCUMULATION	Objective: Fatty acid-binding proteins (FABPs) are a family of 14-15-kDa proteins, and some FABPs have been to be used as biomarkers of tissue injury by leak from cells. However, recent studies have shown that FABPs can be secreted from cells into circulation. Here we examined determinants and roles of circulating FABPs in a general population. Methods: From the database of the Tanno-Sobetsu Study, a study with a population-based cohort design, data in 2011 for 296 subjects on no medication were retrieved, and FABP1 similar to 5 in their serum samples were assayed. Results: Level of FABP4, but not the other isoforms, showed a gender difference, being higher in females than in males. Levels of all FABPs were negatively correlated with estimated glomerular filtration rate (eGFR), but a distinct pattern of correlation with other clinical parameters was observed for each FABP isoform; significant correlates were alanine aminotransferase (ALT), blood pressure (BP), and brain natriuretic peptide (BNP) for FABP1, none besides eGFR for FABP2, age, BP, and BNP for FABP3, age, waist circumference (WC), BP, BNP, lipid variables, high-sensitivity C-reactive protein (hsCRP), and HOMA-R for FABP4, and age, WC, BP, ALT, BNP, and HOMA-R for FABP5. FABP4 is the most strongly related to metabolic markers among FABPs. In a multivariate regression analysis, FABP4 level was an independent predictor of HOMAR after adjustment of age, gender, WC, BP, HDL cholesterol, and hsCRP. Conclusions: Each FABP isoform level showed a distinct pattern of correlation with clinical parameters, although levels of all FABPs were negatively determined by renal function. Circulating FABP4 appears to be a useful biomarker for detecting preclinical stage of metabolic syndrome, especially insulin resistance, in the general population.	[Ishimura, Shutaro; Furuhashi, Masato; Watanabe, Yuki; Hoshina, Kyoko; Fuseya, Takahiro; Mita, Tomohiro; Okazaki, Yusuke; Koyama, Masayuki; Tanaka, Marenao; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Miura, Tetsuji] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University	Furuhashi, M (corresponding author), Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sch Med, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Furuhashi, Masato/AAT-5518-2021; Koyama, Masayuki/GQP-8789-2022; Marenao, Tanaka/ABA-4054-2020	Furuhashi, Masato/0000-0002-0145-3541; Ohnishi, Hirofumi/0000-0002-5873-6438; Tanaka, Marenao/0000-0002-6575-9996; Koyama, Masayuki/0000-0002-8165-5855	Ministry of Education, Culture, Sports, Science and Technology; Uehara Memorial Foundation; Mitsubishi Pharma Research Foundation; Naito Foundation Natural Science Scholarship; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Cardiovascular Research Foundation; Suzuken Memorial Foundation; Sumitomo Foundation; Tokyo Biochemical Research Foundation; Japan Diabetes Foundation; Ono Medical Research Foundation; Novartis Foundation (Japan) for the Promotion of Science; Akiyama Life Science Foundation; Terumo Life Science Foundation; Daiwa Securities Health Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Foundation for Applied Enzymology; Ichiro Kanehara Foundation; Grants-in-Aid for Scientific Research [23591106] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Pharma Research Foundation; Naito Foundation Natural Science Scholarship; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Cardiovascular Research Foundation; Suzuken Memorial Foundation; Sumitomo Foundation; Tokyo Biochemical Research Foundation; Japan Diabetes Foundation; Ono Medical Research Foundation; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Akiyama Life Science Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation); Daiwa Securities Health Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Foundation for Applied Enzymology; Ichiro Kanehara Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.F. has been supported by grants from Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Uehara Memorial Foundation, Mitsubishi Pharma Research Foundation, Naito Foundation Natural Science Scholarship, Takeda Science Foundation, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Kanae Foundation for the Promotion of Medical Science, Cardiovascular Research Foundation, Suzuken Memorial Foundation, Sumitomo Foundation, Tokyo Biochemical Research Foundation, Japan Diabetes Foundation, Ono Medical Research Foundation, Novartis Foundation (Japan) for the Promotion of Science, Akiyama Life Science Foundation, Terumo Life Science Foundation, Daiwa Securities Health Foundation, Suhara Memorial Foundation, Takeda Medical Research Foundation, Japan Foundation for Applied Enzymology, and Ichiro Kanehara Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri R, 2010, AM J CARDIOL, V106, P1118, DOI 10.1016/j.amjcard.2010.06.028; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; Furuhashi M, 2004, CIRC J, V68, P656, DOI 10.1253/circj.68.656; Furuhashi M, 2003, NEPHRON CLIN PRACT, V93, pC69, DOI 10.1159/000068520; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Guthmann F, 2002, MOL CELL BIOCHEM, V239, P227, DOI 10.1023/A:1020508420058; Hoekstra M, 2006, J LIPID RES, V47, P2198, DOI 10.1194/jlr.M600095-JLR200; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ito K, 1999, DIABETIC MED, V16, P119, DOI 10.1046/j.1464-5491.1999.00034.x; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morariu AM, 2005, CHEST, V128, P2677, DOI 10.1378/chest.128.4.2677; Narumi T, 2012, EXP DIABETES RES, DOI 10.1155/2012/815098; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Niizeki T, 2007, CIRC J, V71, P1452, DOI 10.1253/circj.71.1452; OHKARU Y, 1995, J IMMUNOL METHODS, V178, P99, DOI 10.1016/0022-1759(94)00248-U; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Owada Y, 2002, MOL CELL BIOCHEM, V239, P83, DOI 10.1023/A:1020524621933; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Pelsers MMAL, 2002, CLIN CHEM, V48, P2055; Pelsers MMAL, 1999, CLIN CHEM, V45, P441; Setsuta K, 2002, AM J MED, V113, P717, DOI 10.1016/S0002-9343(02)01394-3; Stan S, 2005, J LIPID RES, V46, P320, DOI 10.1194/jlr.M400346-JLR200; TANAKA T, 1991, CLIN BIOCHEM, V24, P195, DOI 10.1016/0009-9120(91)90571-U; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yeung DCY, 2008, EUR HEART J, V29, P2156, DOI 10.1093/eurheartj/ehn295	41	104	109	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e81318	10.1371/journal.pone.0081318	http://dx.doi.org/10.1371/journal.pone.0081318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278421	gold, Green Submitted, Green Published			2022-12-27	WOS:000327313100152
J	Mathieu, Y; Prosper, P; Favier, F; Harvengt, L; Didierjean, C; Jacquot, JP; Morel-Rouhier, M; Gelhaye, E				Mathieu, Yann; Prosper, Pascalita; Favier, Frederique; Harvengt, Luc; Didierjean, Claude; Jacquot, Jean-Pierre; Morel-Rouhier, Melanie; Gelhaye, Eric			Diversification of Fungal Specific Class A Glutathione Transferases in Saprotrophic Fungi	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; S-TRANSFERASES; BINDING-SITE; TARGET	Glutathione transferases (GSTs) form a superfamily of multifunctional proteins with essential roles in cellular detoxification processes and endogenous metabolism. The distribution of fungal-specific class A GSTs was investigated in saprotrophic fungi revealing a recent diversification within this class. Biochemical characterization of eight GSTFuA isoforms from Phanerochaete chrysosporium and Coprinus cinereus demonstrated functional diversity in saprotrophic fungi. The three-dimensional structures of three P. chrysosporium isoforms feature structural differences explaining the functional diversity of these enzymes. Competition experiments between fluorescent probes, and various molecules, showed that these GSTs function as ligandins with various small aromatic compounds, derived from lignin degradation or not, at a L-site overlapping the glutathione binding pocket. By combining genomic data with structural and biochemical determinations, we propose that this class of GST has evolved in response to environmental constraints induced by wood chemistry.	[Mathieu, Yann; Jacquot, Jean-Pierre; Morel-Rouhier, Melanie; Gelhaye, Eric] Univ Lorraine, IAM, UMR 1136, IFR EFABA 110, Vandoeuvre Les Nancy, France; [Mathieu, Yann; Jacquot, Jean-Pierre; Morel-Rouhier, Melanie; Gelhaye, Eric] INRA, IAM, UMR 1136, Champenoux, France; [Prosper, Pascalita; Favier, Frederique; Didierjean, Claude] Univ Lorraine, CRM2, UMR 7036, Vandoeuvre Les Nancy, France; [Prosper, Pascalita; Favier, Frederique; Didierjean, Claude] CNRS, CRM2, UMR 7036, Vandoeuvre Les Nancy, France; [Mathieu, Yann; Harvengt, Luc] FCBA, Lab Biotechnol, Pole Biotechnol & Sylviculture Avancee, Cestas, France	Universite de Lorraine; INRAE; Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine	Gelhaye, E (corresponding author), Univ Lorraine, IAM, UMR 1136, IFR EFABA 110, Vandoeuvre Les Nancy, France.	Eric.Gelhaye@univ-lorraine.fr	DIDIERJEAN, Claude/L-1493-2013; Favier, Frederique/B-3090-2013; Harvengt, Luc/G-4569-2011; Jacquot, Jean-Pierre/A-1571-2012	DIDIERJEAN, Claude/0000-0002-3176-8974; Favier, Frederique/0000-0003-3249-997X; Harvengt, Luc/0000-0003-1524-5273; Jacquot, Jean-Pierre/0000-0003-4975-8587; Morel-Rouhier, Melanie/0000-0001-5149-0474; MATHIEU, Yann/0000-0001-6698-1911	Convention industrielle de formation par la recherche (CIFRE); French National Research Agency [ANR-09-BLAN-0012]; Laboratory of Excellence ARBRE [ANR-12-LABXARBRE-01]; Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie; Institut National de la Recherche Agronomique (INRA); Centre National de la Recherche Scientifique (CNRS)	Convention industrielle de formation par la recherche (CIFRE); French National Research Agency(French National Research Agency (ANR)); Laboratory of Excellence ARBRE; Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie; Institut National de la Recherche Agronomique (INRA); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Convention industrielle de formation par la recherche (CIFRE) and the French National Research Agency through the (ANR-09-BLAN-0012) grant and the Laboratory of Excellence ARBRE (ANR-12-LABXARBRE-01) grant, the Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie, the Institut National de la Recherche Agronomique (INRA), and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060324; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conn S, 2008, J EXP BOT, V59, P3621, DOI 10.1093/jxb/ern217; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guiraud P, 1999, CHEMOSPHERE, V38, P2775, DOI 10.1016/S0045-6535(98)00479-2; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Ji XH, 1996, P NATL ACAD SCI USA, V93, P8208, DOI 10.1073/pnas.93.16.8208; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; Mathieu Y, 2012, J BIOL CHEM; Matsuzaki F, 2008, J PROTEOME RES, V7, P2342, DOI 10.1021/pr700617s; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morel M, 2013, MICROB BIOTECHNOL, V6, P248, DOI 10.1111/1751-7915.12015; Nakamura T, 2012, BIODEGRADATION, V23, P343, DOI 10.1007/s10532-011-9521-x; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Reinemer P, 1996, J MOL BIOL, V255, P289, DOI 10.1006/jmbi.1996.0024; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Shimizu M, 2005, PROTEOMICS, V5, P3919, DOI 10.1002/pmic.200401251; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thuillier A., 2011, INT J EVOL BIOL, V2011; Thuillier A, 2013, FEBS LETT; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2011, J AM CHEM SOC, V133, P14109, DOI 10.1021/ja205500y; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047	35	35	35	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80298	10.1371/journal.pone.0080298	http://dx.doi.org/10.1371/journal.pone.0080298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278272	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100082
J	Alant, JDD; Senjaya, F; Ivanovic, A; Forden, J; Shakhbazau, A; Midha, R				Alant, Jacob Daniel de Villiers; Senjaya, Ferry; Ivanovic, Aleksandra; Forden, Joanne; Shakhbazau, Antos; Midha, Rajiv			The Impact of Motor Axon Misdirection and Attrition on Behavioral Deficit Following Experimental Nerve Injuries	PLOS ONE			English	Article							RAT SCIATIC-NERVE; POOR FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; PREFERENTIAL REINNERVATION; CONTRIBUTING FACTORS; FEMORAL NERVE; REPAIR; REGENERATION; SPECIFICITY; COORDINATION	Peripheral nerve transection and neuroma-in-continuity injuries are associated with permanent functional deficits, often despite successful end-organ reinnervation. Axonal misdirection with non-specific reinnervation, frustrated regeneration and axonal attrition are believed to be among the anatomical substrates that underlie the poor functional recovery associated with these devastating injuries. Yet, functional deficits associated with axonal misdirection in experimental neuroma-in-continuity injuries have not yet been studied. We hypothesized that experimental neuroma-in-continuity injuries would result in motor axon misdirection and attrition with proportional persistent functional deficits. The femoral nerve misdirection model was exploited to assess major motor pathway misdirection and axonal attrition over a spectrum of experimental nerve injuries, with neuroma-in-continuity injuries simulated by the combination of compression and traction forces in 42 male rats. Sciatic nerve injuries were employed in an additional 42 rats, to evaluate the contribution of axonal misdirection to locomotor deficits by a ladder rung task up to 12 weeks. Retrograde motor neuron labeling techniques were utilized to determine the degree of axonal misdirection and attrition. Characteristic histological neuroma-in-continuity features were demonstrated in the neuroma-in-continuity groups and poor functional recovery was seen despite successful nerve regeneration and muscle reinnervation. Good positive and negative correlations were observed respectively between axonal misdirection (p<.0001, r(2)=.67), motor neuron counts (attrition) (p<.0001, r(2)=.69) and final functional deficits. We demonstrate prominent motor axon misdirection and attrition in neuroma-in-continuity and transection injuries of mixed motor nerves that contribute to the long-term functional deficits. Although widely accepted in theory, to our knowledge, this is the first experimental evidence to convincingly demonstrate these correlations with data inclusive of the neuroma-in-continuity spectrum. This work emphasizes the need to focus on strategies that promote both robust and accurate nerve regeneration to optimize functional recovery. It also demonstrates that clinically relevant neuroma-in-continuity injuries can now also be subjected to experimental investigation.	[Alant, Jacob Daniel de Villiers; Senjaya, Ferry; Midha, Rajiv] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Ivanovic, Aleksandra; Forden, Joanne; Shakhbazau, Antos] Univ Calgary, Hotchkiss Brain Inst, Dept Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Alant, JDD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.	japiealant@hotmail.com			AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award; Plastic Surgery Foundation; American Association for Peripheral Nerve	AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award; Plastic Surgery Foundation; American Association for Peripheral Nerve	The authors thank the AANS/CNS Joint Section for Spine and Peripheral Nerve for the Kline Award (http://www.spinesection.org/fellowships_awards.php?id=3) and the Plastic Surgery Foundation/(http://www.thepsf.org/x365.xml?keyword=&investigator=alant&year=&institution=&location=&fundingmechanism=&focusarea=) American Association for Peripheral Nerve (http://www.peripheralnerve.org/fellowships/fellowships.html) for funding provided in partial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alant JD, 2002, J NEUROTRAUM, V29, P1691; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; BRUSHART TM, 1983, J HAND SURG-AM, V8, P248, DOI 10.1016/S0363-5023(83)80152-X; Brushart TM, 2011, NERVE REPAIR, P135; Brushart TM., 2011, NERVE REPAIR, P353; Brushart TM, 2011, NERVE REPAIR, P159; BRUSHART TME, 1988, J NEUROSCI, V8, P1026; de Ruiter GCW, 2008, EXP NEUROL, V211, P339, DOI 10.1016/j.expneurol.2007.12.023; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Hamilton SK, 2011, J COMP NEUROL, V519, P21, DOI 10.1002/cne.22446; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; Kemp SWP, 2010, EUR J NEUROSCI, V31, P1074, DOI 10.1111/j.1460-9568.2010.07130.x; MACKINNON SE, 1989, ANN PLAS SURG, V22, P257, DOI 10.1097/00000637-198903000-00013; Madison RD, 2007, ACTA PHYSIOL, V189, P201, DOI 10.1111/j.1748-1716.2006.01657.x; Madison RD, 1996, J NEUROSCI, V16, P5698; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Sabatier MJ, 2011, CELLS TISSUES ORGANS, V193, P298, DOI 10.1159/000323677; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Spencer P S, 1974, Bull Hosp Joint Dis, V35, P85; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; SWETT JE, 1986, EXP NEUROL, V93, P227, DOI 10.1016/0014-4886(86)90161-5; TADA K, 1979, EXP NEUROL, V65, P301, DOI 10.1016/0014-4886(79)90100-6; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Valero-Cabre A, 2002, J NEUROTRAUM, V19, P1475, DOI 10.1089/089771502320914705; Valls-Sole J, 2011, CLIN NEUROPHYSIOL, V122, P219, DOI 10.1016/j.clinph.2010.06.024; WASSERSCHAFF M, 1990, BRAIN RES, V515, P241, DOI 10.1016/0006-8993(90)90602-8; WIKHOLM RP, 1988, OTOLARYNG HEAD NECK, V99, P353, DOI 10.1177/019459988809900401; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	32	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82546	10.1371/journal.pone.0082546	http://dx.doi.org/10.1371/journal.pone.0082546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282624	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500128
J	Cristescu, RH; Banks, PB; Carrick, FN; Frere, C				Cristescu, Romane H.; Banks, Peter B.; Carrick, Frank N.; Frere, Celine			Potential 'Ecological Traps' of Restored Landscapes: Koalas Phascolarctos cinereus Re-Occupy a Rehabilitated Mine Site	PLOS ONE			English	Article							NORTH-STRADBROKE-ISLAND; RESTORATION ECOLOGY; TREE USE; HABITAT QUALITY; CONSERVATION; DENSITY; SUCCESS; WATER; MANAGEMENT; DYNAMICS	With progressively increasing anthropogenic habitat disturbances, restoration of impacted landscapes is becoming a critical element of biodiversity conservation. Evaluation of success in restoration ecology rarely includes faunal components, usually only encompassing abiotic and floral components of the ecosystems. Even when fauna is explicitly included, it is usually only species presence/absence criteria that are considered. If restoration is to have a positive outcome, however, populations in restored habitats should exhibit comparable survival and reproductive rates to populations found in undisturbed surroundings. If a species recolonises restored areas but later experiences decreased fitness, restored areas could become ecological sinks or traps. We investigated this possibility in a case study of koalas Phascolarctos cinereus occupying rehabilitated mining areas on North Stradbroke Island, Australia. Our holistic approach compared rehabilitated and undisturbed areas on the basis of their vegetation characteristics, of koalas' body condition, roosting trees, diet, as well as predator index. Koalas using rehabilitated areas appeared to be able to access an adequate supply of roosting and fodder trees, were in good condition and had high reproductive output. We did not find any significant differences in predator density between rehabilitated areas and undisturbed surroundings. The results presented in this study showed there was no evidence that the post-mining rehabilitated areas constitute ecological sinks or traps. However, to reach a definitive conclusion as to whether areas rehabilitated post-mining provide at least equivalent habitat to undisturbed locations, additional research could be undertaken to assess foliar nutrient/water/toxin differences and predation risk in rehabilitated areas compared with undisturbed areas. More generally, the evaluation of whether restoration successfully produces a functional ecological community should include criteria on the fitness of faunal populations reoccupying such sites, so as to ensure functioning ecosystems, rather than ecological sinks or traps, are the outcome.	[Cristescu, Romane H.; Banks, Peter B.] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Cristescu, Romane H.; Carrick, Frank N.] Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, St Lucia, Qld, Australia; [Banks, Peter B.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Frere, Celine] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of New South Wales Sydney; University of Queensland; University of Sydney; University of Exeter	Cristescu, RH (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, POB 1, Kensington, NSW 2033, Australia.	romromfr@yahoo.fr	Frere, Celine Henria/GYJ-3882-2022; Frere, Celine Henria/B-4905-2013	Frere, Celine Henria/0000-0002-9671-2138; Banks, Peter/0000-0002-4340-6495	Endeavour Europe Award; Endeavour International Postgraduate Research Scholarship	Endeavour Europe Award; Endeavour International Postgraduate Research Scholarship(Australian Government)	The first author is supported by an Endeavour Europe Award and an Endeavour International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 1996, WILDLIFE RES, V23, P197, DOI 10.1071/WR9960197; Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bennett AF, 2000, OCCASIONAL PUBLICATI, V2, P101; BESHKAREV AB, 1994, OIKOS, V71, P375, DOI 10.2307/3545825; BRADSHAW AD, 1983, J APPL ECOL, V20, P1, DOI 10.2307/2403372; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CANFIELD PM, 1989, AUST VET J, V66, P324, DOI 10.1111/j.1751-0813.1989.tb09717.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clifton Irene Delma, 2007, Australian Mammalogy, V29, P85; COALDRAKE JE, 1979, LANDSCAPE PLAN, V6, P359, DOI 10.1016/0304-3924(79)90038-8; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cork S.J., 1990, P129; Cork SJ, 2000, CONSERV BIOL, V14, P660, DOI 10.1046/j.1523-1739.2000.99389.x; Cristescu R., 2011, P ROYAL SOC QUEENSLA, V117, P309; Cristescu R, 2011, FAUNA RECOLONISATION; Cristescu Romane H., 2012, International Journal of Zoology, P1; DEGABRIELE R, 1981, AUST J ECOL, V6, P139, DOI 10.1111/j.1442-9993.1981.tb01284.x; Delibes M, 2009, ANIM CONSERV, V12, P400, DOI 10.1111/j.1469-1795.2009.00263.x; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; ELLIS W, 1992, AUST VET J, V69, P229, DOI 10.1111/j.1751-0813.1992.tb09933.x; Ellis W, 2003, ENV PLANNING LAW J, V20, P66; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; Ellis W, 2013, AUST MAMMAL, V35, P160, DOI 10.1071/AM12023; Ellis William, 1999, Australian Zoologist, V31, P127; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; GATES JE, 1978, ECOLOGY, V59, P871, DOI 10.2307/1938540; GOERTZ JW, 1964, ECOL MONOGR, V34, P359, DOI 10.2307/2937068; GORDON G, 1991, Australian Mammalogy, V14, P5; Gordon G., 1990, P85; Gorley C.K., 2006, GETTING STARTED PRIM; Grant Carl, 2007, Ecological Management & Restoration, V8, P92, DOI 10.1111/j.1442-8903.2007.00346.x; Hasegawa M, 1995, HABITAT UTILISATION; Hawlena D, 2006, J APPL ECOL, V43, P701, DOI 10.1111/j.1365-2664.2006.01177.x; Hawlena D, 2010, CONSERV BIOL, V24, P803, DOI 10.1111/j.1523-1739.2010.01477.x; Herbarium Queensland, 2009, REGIONAL ECOSYSTEM D; Hobbs RJ, 2004, FRONT ECOL ENVIRON, V2, P43, DOI 10.2307/3868294; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; Horvath G, 1998, NATURWISSENSCHAFTEN, V85, P292, DOI 10.1007/s001140050503; Horvath G, 1996, NATURE, V379, P303, DOI 10.1038/379303a0; Hume I., 1990, BIOL BASIS VULNERABI, P32; HURLBERT SH, 1994, TRENDS ECOL EVOL, V9, P495; IBM, 2009, PASW 18 0; Jones ZF, 2005, CONDOR, V107, P731, DOI 10.1650/7741.1; Jurskis V, 1997, KOALA SURVEYS ECOLOG; Kavanagh RP, 2007, WILDLIFE RES, V34, P94, DOI 10.1071/WR06126; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kolbe JJ, 2002, ECOLOGY, V83, P269, DOI 10.1890/0012-9658(2002)083[0269:IONSSO]2.0.CO;2; Kriska G, 1998, J EXP BIOL, V201, P2273; Kristan WB, 2003, OIKOS, V103, P457; Laycock J., 1978, U QLD PAP DEP GEOL, V8, P89; Lloyd JD, 2005, CONDOR, V107, P363, DOI 10.1650/7701; MacMahon JA, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P245; Martin R, 1999, AUSTR NATURAL HIST S; Matthews A, 2007, WILDLIFE RES, V34, P84, DOI 10.1071/WR06075; May SA, 1996, WILDLIFE RES, V23, P387, DOI 10.1071/WR9960387; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Melzer A, 2011, FOX PREDATION KOALAS; Melzer Alistair, 2003, Queensland Naturalist, V41, P38; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; NPWS, 2003, REC PLAN KOAL PHASC; OSAWA R, 1989, AUST WILDLIFE RES, V16, P95, DOI 10.1071/WR9890095; PACKARD JM, 1989, J WILDLIFE MANAGE, V53, P692, DOI 10.2307/3809199; PAUSAS JG, 1995, FOREST ECOL MANAG, V78, P39, DOI 10.1016/0378-1127(95)03598-5; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Primer-E Ltd, 2009, PRIM 6 1 12 PERM 1 0; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Queensland Government, 2006, NAT CONS KOAL CONS P, P1; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Ries L, 2001, CONSERV BIOL, V15, P401, DOI 10.1046/j.1523-1739.2001.015002401.x; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; RODGERS AR, 2007, HRT HOME RANGE TOOLS; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; SER, 2022, US; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shochat E, 2005, OIKOS, V111, P159, DOI 10.1111/j.0030-1299.2005.13907.x; Smyth CR, 1998, J ENVIRON MANAGE, V53, P209, DOI 10.1006/jema.1998.0209; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Specht RL, 2009, AUSTRAL ECOL, V34, P761, DOI 10.1111/j.1442-9993.2009.01982.x; Sutherland WJ, 2011, ORYX, V45, P56, DOI 10.1017/S0030605310000852; Thomas CD, 1996, AM NAT, V148, P957, DOI 10.1086/285966; Tun NU, 1993, REESTABLISHMENT REHA; TyndaleBiscoe H, 2005, LIFE OF MARSUPIALS, P1; ULLREY DE, 1981, AUST J ZOOL, V29, P839, DOI 10.1071/ZO9810839; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; White NA, 1999, WILDLIFE RES, V26, P731, DOI 10.1071/WR98002; Wiggins NL, 2006, J CHEM ECOL, V32, P1133, DOI 10.1007/s10886-006-9076-1; Wiggins NL, 2003, J CHEM ECOL, V29, P1447, DOI 10.1023/A:1024221705354; Woodward W, 2008, WILDLIFE RES, V35, P606, DOI 10.1071/WR07172; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Worton BJ, 1995, BIOMETRICS, V51, P1206, DOI 10.2307/2533254; Young TP, 2000, BIOL CONSERV, V92, P73, DOI 10.1016/S0006-3207(99)00057-9; ZOIDIS AM, 1992, ZOO BIOL, V11, P417, DOI 10.1002/zoo.1430110608	102	13	13	9	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e80469	10.1371/journal.pone.0080469	http://dx.doi.org/10.1371/journal.pone.0080469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282544	gold, Green Published, Green Submitted			2022-12-27	WOS:000327543500045
J	Mo, FT; Zheng, JX; Wang, P; Lian, L; Yi, GQ; Xu, GY; Yang, N				Mo, Fengtao; Zheng, Jiangxia; Wang, Peng; Lian, Ling; Yi, Guoqiang; Xu, Guiyun; Yang, Ning			Quail FMO3 Gene Cloning, Tissue Expression Profiling, Polymorphism Detection and Association Analysis with Fishy Taint in Eggs	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; ODOR SYNDROME; CHEMICAL METABOLISM; OFF-FLAVOR; TRIMETHYLAMINURIA; DRUG; MUTATIONS; DISEASE; ENZYMES; HUMANS	Quail eggs comprise a significant and favourable part of table eggs in certain countries. Some quail eggs, however, present fishy off-flavor which directly influences their quality. It is reported that flavin-containing monooxygenase 3 (FMO3) is associated with fish-odour trait in human and animal products. FMO3 is responsible for the degradation of trimethylamine (TMA) in vivo. Loss-of-function mutations in FMO3 gene can result in defective TMA N-oxygenation, giving rise to disorder known as "fish-odour syndrome" in human, as well as the fishy off-flavor in cow milk and chicken eggs. In order to reveal the genetic factor of fishy taint in quail eggs, we cloned the cDNA sequence of quail FMO3 gene, investigated FMO3 mRNA expression level in various tissues, detected SNPs in the coding region of the gene and conducted association analysis between a mutation and the TMA content in quail egg yolks. The 1888 bp cDNA sequence of quail FMO3 gene encoding 532 amino acids was obtained and characterized. The phylogenetic analysis revealed quail FMO3 had a closer relationship with chicken FMO3. The FMO3 mRNA was highly expressed in liver and kidney of quail. Nine SNPs were detected in the coding sequence of quail FMO3 gene, including a nonsense mutation (Q319X) which was significantly associated with the elevated TMA content in quail egg yolks. Genotype TT at Q319X mutation loci was sensitive to choline. With addition of choline in the feed, the quails with homozygote TT at the Q319X mutation loci laid fish-odour eggs, indicating an interaction between genotype and diet. The results indicated that Q319X mutation was associated with the fishy off-flavor in quail eggs. Identification of the unfavorable allele T of quail FMO3 gene can be applied in future quail breeding to eliminate fishy off-flavor trait in quail eggs.	[Mo, Fengtao; Zheng, Jiangxia; Wang, Peng; Lian, Ling; Yi, Guoqiang; Xu, Guiyun; Yang, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University	Yang, N (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320; wang, peng/0000-0003-1845-7589	Programs for Changjiang Scholars; Innovative Research in University [IRT0945, IRT1191]	Programs for Changjiang Scholars; Innovative Research in University	This study was supported in part by funds from Programs for Changjiang Scholars and Innovative Research in University (IRT0945 and IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akerman BR, 1999, HUM MUTAT, V13, P376, DOI 10.1002/(SICI)1098-1004(1999)13:5<376::AID-HUMU5>3.0.CO;2-A; ALWAIZ M, 1987, CLIN PHARMACOL THER, V42, P588, DOI 10.1038/clpt.1987.201; AYESH R, 1993, BRIT MED J, V307, P655, DOI 10.1136/bmj.307.6905.655; BAIN MD, 1988, LANCET, V1, P1078; BURNETT VL, 1994, J BIOL CHEM, V269, P14314; CASHMAN JR, 1995, CHEM-BIOL INTERACT, V96, P33, DOI 10.1016/0009-2797(94)03581-R; Dolphin CT, 1996, EUR J BIOCHEM, V235, P683, DOI 10.1111/j.1432-1033.1996.00683.x; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Hernandez D, 2003, HUM MUTAT, V22, P209, DOI 10.1002/humu.10252; HOBSONFROHOCK A, 1973, NATURE, V243, P304, DOI 10.1038/243304a0; Hodgson E, 1995, TOXICOL LETT, V82-3, P73, DOI 10.1016/0378-4274(95)03469-2; Honkatukia M, 2005, GENOMICS, V86, P225, DOI 10.1016/j.ygeno.2005.04.005; Koukouritaki SB, 2005, PHARMACOGENOMICS, V6, P807, DOI 10.2217/14622416.6.8.807; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Lattard V, 2001, ARCH BIOCHEM BIOPHYS, V391, P30, DOI 10.1006/abbi.2001.2317; Lunden A, 2002, GENOME RES, V12, P1885, DOI 10.1101/gr.240202; Lunden A, 2002, J DAIRY RES, V69, P383, DOI 10.1017/S002202990200568X; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Wang P, 2013, MOL CELL BIOCHEM, V379, P141, DOI 10.1007/s11010-013-1636-4; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; Zhang AQ, 1995, J INHERIT METAB DIS, V18, P669, DOI 10.1007/BF02436755; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171; ZIEGLER DM, 1993, ANNU REV PHARMACOL, V33, P179, DOI 10.1146/annurev.pharmtox.33.1.179; Ziegler DM., 1980, ENZYMATIC BASIS DETO, VI, P201	29	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e81416	10.1371/journal.pone.0081416	http://dx.doi.org/10.1371/journal.pone.0081416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282592	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500094
J	Duran, C; Nato, F; Dartevelle, S; Phuong, LNT; Taneja, N; Ungeheuer, MN; Soza, G; Anderson, L; Benadof, D; Zamorano, A; Diep, TT; Nguyen, TQ; Nguyen, VH; Ottone, C; Begaud, E; Pahil, S; Prado, V; Sansonetti, P; Germani, Y				Duran, Claudia; Nato, Faridabano; Dartevelle, Sylvie; Lan Nguyen Thi Phuong; Taneja, Neelam; Ungeheuer, Marie Noelle; Soza, Guillermo; Anderson, Leslie; Benadof, Dona; Zamorano, Agustin; Tai The Diep; Truong Quang Nguyen; Vu Hoang Nguyen; Ottone, Catherine; Begaud, Evelyne; Pahil, Sapna; Prado, Valeria; Sansonetti, Philippe; Germani, Yves			Rapid Diagnosis of Diarrhea Caused by Shigella sonnei Using Dipsticks; Comparison of Rectal Swabs, Direct Stool and Stool Culture	PLOS ONE			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; POLYMERASE-CHAIN-REACTION; B-CELL EPITOPES; DYSENTERY PATIENTS; PCR; INVASION; FLEXNERI; PLASMID; IDENTIFICATION; EPIDEMIOLOGY	Background: We evaluated a dipstick test for rapid detection of Shigella sonnei on bacterial colonies, directly on stools and from rectal swabs because in actual field situations, most pathologic specimens for diagnosis correspond to stool samples or rectal swabs. Methodology/Principal Findings: The test is based on the detection of S. sonnei lipopolysaccharide (LPS) O-side chains using phase I-specific monoclonal antibodies coupled to gold particles, and displayed on a one-step immunochromatographic dipstick. A concentration as low as 5 ng/ml of LPS was detected in distilled water and in reconstituted stools in 6 minutes. This is the optimal time for lecture to avoid errors of interpretation. In distilled water and in reconstituted stools, an unequivocal positive reaction was obtained with 4 x 106 CFU/ml of S. sonnei. The specificity was 100% when tested with a battery of Shigella and different unrelated strains. When tested on 342 rectal swabs in Chile, specificity (281/295) was 95.3% (95% CI: 92.9% - 97.7%) and sensitivity (47/47) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 95.5 % of cases (328/342) in comparative studies. Positive and negative predictive values were 77% (95% CI: 65% - 86.5%) and 100% respectively. When tested on 219 stools in Chile, Vietnam, India and France, specificity (190/198) was 96% (95% CI 92%-98%) and sensitivity (21/21) was 100%. Stool cultures and the immunochromatographic test showed concordant results in 96.3 % of cases (211/219) in comparative studies. Positive and negative predictive values were 72.4% (95% CI 56.1%-88.6%) and 100 %, respectively. Conclusion: This one-step dipstick test performed well for diagnosis of S. sonnei both on stools and on rectal swabs. These data confirm a preliminary study done in Chile.	[Duran, Claudia; Prado, Valeria] Univ Chile, Fac Med, Santiago, Chile; [Nato, Faridabano; Dartevelle, Sylvie; Ungeheuer, Marie Noelle] Inst Pasteur, F-75724 Paris, France; [Lan Nguyen Thi Phuong; Tai The Diep] Pasteur Inst Ho Chi Minh City, Dept Immunol & Microbiol, Ho Chi Minh City, Vietnam; [Taneja, Neelam; Pahil, Sapna] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India; [Soza, Guillermo; Anderson, Leslie] Hosp Dr Hernan Henriquez, Temuco, Chile; [Benadof, Dona; Zamorano, Agustin] Hosp Roberto del Rio Santiago, Region Metropolitana, Chile; [Truong Quang Nguyen; Vu Hoang Nguyen] Paediat Hosp I, Ho Chi Minh City, Vietnam; [Begaud, Evelyne] Inst Pasteur, Ctr Ressources Biol, F-75724 Paris, France; [Sansonetti, Philippe; Germani, Yves] Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U786, F-75724 Paris, France	Universidad de Chile; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Germani, Y (corresponding author), Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U786, F-75724 Paris, France.	yves.germani@pasteur.fr	Diep, Tai/ABG-9477-2021	Diep, Tai/0000-0001-7166-6369; TANEJA, NEELAM/0000-0003-1198-6138; Pahil, Sapna/0000-0002-7395-3991	Institut Pasteur [PTR 179]; TOTAL SA; Banque Nationale de Paris (BNP) Paribas at Santiago (Chile)	Institut Pasteur(European Commission); TOTAL SA(Total SA); Banque Nationale de Paris (BNP) Paribas at Santiago (Chile)	This work was supported by the Institut Pasteur (grant PTR 179). Part of the work was supported by a grant from TOTAL SA (http://www.total.com/en/home-page-940596.html) and Banque Nationale de Paris (BNP) Paribas at Santiago (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; BARZU S, 1993, INFECT IMMUN, V61, P3825, DOI 10.1128/IAI.61.9.3825-3831.1993; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; BRENNER DJ, 1984, INT J SYST BACTERIOL, V34, P87, DOI 10.1099/00207713-34-1-87; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dykman LA, 2000, FEMS IMMUNOL MED MIC, V27, P135, DOI 10.1111/j.1574-695X.2000.tb01423.x; ECHEVERRIA P, 1991, REV INFECT DIS, V13, pS220; FRANKEL G, 1990, J INFECT DIS, V161, P1252, DOI 10.1093/infdis/161.6.1252; Gaudio PA, 1997, J INFECT DIS, V176, P1013, DOI 10.1086/516531; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gupta A, 2004, CLIN INFECT DIS, V38, P1372, DOI 10.1086/386326; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Houng HSH, 1997, DIAGN MICR INFEC DIS, V28, P19, DOI 10.1016/S0732-8893(97)89154-7; Hsu WB, 2007, FEMS MICROBIOL LETT, V270, P291, DOI 10.1111/j.1574-6968.2007.00686.x; ISLAM D, 1992, J CLIN MICROBIOL, V30, P2801, DOI 10.1128/JCM.30.11.2801-2806.1992; Islam MS, 1998, J DIARRHOEAL DIS RES, V16, P248; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; KENNE L, 1980, CARBOHYD RES, V78, P119, DOI 10.1016/S0008-6215(00)83665-4; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOPECKO DJ, 1980, INFECT IMMUN, V29, P207, DOI 10.1128/IAI.29.1.207-214.1980; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; LAMPEL KA, 1990, APPL ENVIRON MICROB, V56, P1536, DOI 10.1128/AEM.56.6.1536-1540.1990; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Liang SY, 2007, J CLIN MICROBIOL, V45, P3574, DOI 10.1128/JCM.00675-07; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; McDonnell J, 2013, CODESIGN, V9, P1, DOI 10.1080/15710882.2013.782994; Nato F, 2003, CLIN DIAGN LAB IMMUN, V10, P476, DOI 10.1128/CDLI.10.3.476-478.2003; Nato F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000361; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oyofo BA, 1996, J DIARRHOEAL DIS RES, V14, P207; Paek SH, 2000, METHODS, V22, P53, DOI 10.1006/meth.2000.1036; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Prado V, 1999, PEDIATR INFECT DIS J, V18, P500, DOI 10.1097/00006454-199906000-00005; Qu F, 2012, DIAGN MICR INFEC DIS, V74, P166, DOI 10.1016/j.diagmicrobio.2012.06.026; Ricci Karen A, 2006, Nature, V444 Suppl 1, P29; SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75, DOI 10.1128/IAI.34.1.75-83.1981; Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150; SETHABUTR O, 1994, J DIARRHOEAL DIS RES, V12, P265; SETHABUTR O, 1993, J INFECT DIS, V167, P458, DOI 10.1093/infdis/167.2.458; Shears P, 1996, ANN TROP MED PARASIT, V90, P105, DOI 10.1080/00034983.1996.11813034; Szakal D, 2003, DIAGN MICR INFEC DIS, V45, P165, DOI 10.1016/S0732-8893(02)00512-6; Taneja N, 2007, J CLIN MICROBIOL, V45, P678, DOI 10.1128/JCM.02247-06; Taneja N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024830; TAYLOR WI, 1975, J CLIN MICROBIOL, V2, P281; Theron J, 2001, WATER RES, V35, P869, DOI 10.1016/S0043-1354(00)00348-1; THIEM DV, 2004, VIETNAM J CLIN MICRO, V42, P2031, DOI DOI 10.1128/JCM.42.5.2031-2035.2004; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Villalobo E, 1998, APPL ENVIRON MICROB, V64, P1242; Warren BR, 2005, J FOOD PROTECT, V68, P621, DOI 10.4315/0362-028X-68.3.621; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; *WHO, 2005, WEEKLY EPIDEMIOLOGIC, V80, P93; YE LY, 1993, J DIARRHOEAL DIS RES, V11, P38	54	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e80267	10.1371/journal.pone.0080267	http://dx.doi.org/10.1371/journal.pone.0080267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278267	gold, Green Published, Green Submitted			2022-12-27	WOS:000327541700026
J	Derrett, S; Wilson, S; Samaranayaka, A; Langley, J; Wyeth, E; Ameratunga, S; Lilley, R; Davie, G; Mauiliu, M				Derrett, Sarah; Wilson, Suzanne; Samaranayaka, Ari; Langley, John; Wyeth, Emma; Ameratunga, Shanthi; Lilley, Rebbecca; Davie, Gabrielle; Mauiliu, Melbourne			Prevalence and Predictors of Disability 24-Months after Injury for Hospitalised and Non-Hospitalised Participants: Results from a Longitudinal Cohort Study in New Zealand	PLOS ONE			English	Article							OF-LIFE OUTCOMES; FUNCTIONAL CONSEQUENCES; MAJOR TRAUMA; HEALTH; QUALITY; DISPARITIES; BURDEN; WOMEN; CARE	Introduction: Most studies investigating disability outcomes following injury have examined hospitalised patients. It is not known whether variables associated with disability outcomes are similar for injured people who are not hospitalised. Aims: This paper compares the prevalence of disability 24 months after injury for participants in the Prospective Outcomes of Injury Study who were hospitalised and those non-hospitalised, and also seeks to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised participants. Methods: Participants, aged 18-64 years, were recruited from an injury claims register managed by New Zealand's no-fault injury compensation insurer after referral by health care professionals. A wide range of pre-injury socio-demographic, health and psychosocial characteristics were collected, as well as injury-related characteristics; outcome is assessed using the WHODAS. Multivariable models estimating relative risks of disability for hospitalised and non-hospitalised participants were developed using Poisson regression methods. Results: Of 2856 participants, analyses were restricted to 2184 (76%) participants for whom both pre-injury and 24 month WHODAS data were available. Of these, 25% were hospitalised. In both hospitalised and non-hospitalised groups, 13% experience disability (WHODAS >= 10) 24 months after injury; higher than pre-injury (5%). Of 28 predictor variables, seven independently placed injured participants in the hospitalised group at increased risk of disability 24 months after injury; eight in the non-hospitalised. Only four predictors (pre-injury disability, two or more pre-injury chronic conditions, pre-injury BMI>30 and trouble accessing healthcare services) were common to both the hospitalised and non-hospitalised groups. There is some evidence to suggest that among the hospitalised group, Maori ori have higher risk of disability relative to nonMaori. Conclusions: At 24 months considerable disability is borne, equally, by hospitalised and non-hospitalised groups. However, predictors of disability are not necessarily consistent between the hospitalised and non-hospitalised groups, suggesting caution in generalising results from one group to the other.	[Derrett, Sarah; Wilson, Suzanne; Samaranayaka, Ari; Langley, John; Lilley, Rebbecca; Davie, Gabrielle; Mauiliu, Melbourne] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Wyeth, Emma] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Ngai Tahu Maori Hlth Res Unit, Dunedin, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand; [Derrett, Sarah] Massey Univ, Coll Hlth, Sch Hlth & Social Serv, Palmerston North, New Zealand	University of Otago; University of Otago; University of Auckland; Massey University	Derrett, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.	s.l.derrett@massey.ac.nz	Wyeth, Emma/GLU-8874-2022	Davie, Gabrielle/0000-0001-5466-5364; Wyeth, Emma/0000-0002-6869-5190; Derrett, Sarah/0000-0003-2867-0498; Ameratunga, Shanthi/0000-0001-8042-2251	Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand	This study is funded by the Health Research Council of New Zealand (2007-2013), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010). The views and conclusions expressed herein are the authors and may not reflect those of the funders. The Accident Compensation Corporation sent out invitations to eligible potential participants on the research team's behalf, and also provided, following participants' consent, information from the electronic record about participants' injuries. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Accident Compensation Corporation, 2010, ANNUAL REPORT 2010; American Psychiatric Association Committee of Nomenclature and Statistics, 1980, DIAGNOSTIC AND STATI; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Delaibatiki Cammock R, 2012, AUSTRALAS EPIDEMIOL, V19, P17; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kendrick D, 2013, INJURY PREV, V19, P370, DOI 10.1136/injuryprev-2012-040658; Langley JD, 2013, INJURY PREV, V19, P428, DOI 10.1136/injuryprev-2012-040685; Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93; Mauri Ora Associates, 2010, ORI EXPERIENCE OF AC; Ministry of Health, 2012, TUPU OLA MOUI PACIFI; Ministry of Health, 2010, TATAU KAHUKURA MA OR; Ministry of Health, 2008, PORTRAIT HLTH KEY RE; Ministry of Social Development, 2000, DIRECT MEASUREMENT O; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Portney KE, 1997, AM BEHAV SCI, V40, P632, DOI 10.1177/0002764297040005009; Ratima K, 2007, HAUORA MA ORI STANDA; Robroek SJW, 2013, SCANDANAVIAN JOURNAL, DOI [10.5271/ sjweh. 3354., DOI 10.5271/SJWEH.3354.]; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rumball-Smith JML, 2009, NEW ZEAL MED J, V122, P68; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Smith DL, 2008, DISABIL HEALTH J, V1, P79, DOI 10.1016/j.dhjo.2008.01.001; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Sport and Recreation New Zealand, 2004, THE NEW ZEALAND PHYS; StataCorp, 2011, STATA RELEASE 12 STA; Statistics New Zealand, 2007, QUICKSTATS ABOUT MA; Statistics New Zealand, 2006, 2006 CENSUS OF POPUL; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; T Ustun, 2010, MEASURING HEALTH AND; Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Ware J, 2000, SF 36H HEALTH SURVEY; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; World Health Organization (WHO), 2011, BMI CLASSIFICATION; Wyeth EH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-120; Wyeth EH, 2010, ETHNIC HEALTH, V15, P303, DOI 10.1080/13557851003721194; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	52	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80194	10.1371/journal.pone.0080194	http://dx.doi.org/10.1371/journal.pone.0080194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278258	Green Published, gold			2022-12-27	WOS:000327539800063
J	Groenke, S; Larson, ED; Alber, S; Zhang, R; Lamp, ST; Ren, XY; Nakano, H; Jordan, MC; Karagueuzian, HS; Roos, KP; Nakano, A; Proenza, C; Philipson, KD; Goldhaber, JI				Groenke, Sabine; Larson, Eric D.; Alber, Sarah; Zhang, Rui; Lamp, Scott T.; Ren, Xiaoyan; Nakano, Haruko; Jordan, Maria C.; Karagueuzian, Hrayr S.; Roos, Kenneth P.; Nakano, Atsushi; Proenza, Catherine; Philipson, Kenneth D.; Goldhaber, Joshua I.			Complete Atrial-Specific Knockout of Sodium-Calcium Exchange Eliminates Sinoatrial Node Pacemaker Activity	PLOS ONE			English	Article							PROTEIN-KINASE-A; NA+-CA2+ EXCHANGER; FUNCTIONAL ROLES; I-F; MICE; MECHANISM; CHANNELS; CELLS; BLOCK; PHOSPHORYLATION	The origin of sinoatrial node (SAN) pacemaker activity in the heart is controversial. The leading candidates are diastolic depolarization by "funny'' current (If) through HCN4 channels (the "Membrane Clock" hypothesis), depolarization by cardiac Na-Ca exchange (NCX1) in response to intracellular Ca cycling (the "Calcium Clock" hypothesis), and a combination of the two ("Coupled Clock''). To address this controversy, we used Cre/loxP technology to generate atrial-specific NCX1 KO mice. NCX1 protein was undetectable in KO atrial tissue, including the SAN. Surface ECG and intracardiac electrograms showed no atrial depolarization and a slow junctional escape rhythm in KO that responded appropriately to beta-adrenergic and muscarinic stimulation. Although KO atria were quiescent they could be stimulated by external pacing suggesting that electrical coupling between cells remained intact. Despite normal electrophysiological properties of I-f in isolated patch clamped KO SAN cells, pacemaker activity was absent. Recurring Ca sparks were present in all KO SAN cells, suggesting that Ca cycling persists but is uncoupled from the sarcolemma. We conclude that NCX1 is required for normal pacemaker activity in murine SAN.	[Groenke, Sabine; Ren, Xiaoyan; Jordan, Maria C.; Karagueuzian, Hrayr S.; Roos, Kenneth P.; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; [Larson, Eric D.; Alber, Sarah; Proenza, Catherine] Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO USA; [Zhang, Rui; Lamp, Scott T.; Goldhaber, Joshua I.] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Nakano, Haruko; Nakano, Atsushi] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Goldhaber, JI (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	Joshua.Goldhaber@cshs.org	Jordan, Maria/HHN-5358-2022	Proenza, Catherine/0000-0003-4324-6206; Goldhaber, Joshua/0000-0001-8413-5719; Larson, Eric/0000-0002-2881-4861	NIH [HL048509, HL088427]; AHA [12IRG9140020]; Dorothy and E. Phillip Lyon Endowment for Laser Research; NIH/NINDS [T32NS007083]; NIH/NCRR Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088427, R37HL048509, R01HL048509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Dorothy and E. Phillip Lyon Endowment for Laser Research; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge the following funding: NIH HL048509 (to JIG and KDP), AHA 12IRG9140020 and the Dorothy and E. Phillip Lyon Endowment for Laser Research (to JIG), NIH/NINDS T32NS007083 (to EDL) and NIH HL088427 (to CP). Immunofluorescence microscopy was performed at the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core, supported in part by NIH/NCRR Colorado CTSI Grant UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Eisner D, 2013, J MOL CELL CARDIOL, V58, P110, DOI 10.1016/j.yjmcc.2012.11.017; Gao Z, 2013, CIRC RES, V112, P309, DOI 10.1161/CIRCRESAHA.111.300193; Gizurarson S, 2007, EUROPACE, V9, P411, DOI 10.1093/europace/eum065; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOLDHABER JI, 1991, J PHYSIOL-LONDON, V443, P371, DOI 10.1113/jphysiol.1991.sp018838; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH823, DOI 10.1152/ajpheart.1996.271.3.H823; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Henderson SA, 2004, CIRC RES, V95, P604, DOI 10.1161/01.RES.0000142316.08250.68; Herrmann S, 2013, CARDIOVASC RES, V99, P780, DOI 10.1093/cvr/cvt154; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Jordan MC, 2010, J CARD FAIL, V16, P786, DOI 10.1016/j.cardfail.2010.03.012; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larbig R, 2010, J PHYSIOL-LONDON, V588, P3266, DOI 10.1113/jphysiol.2010.187708; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Lipsius SL, 2001, NEWS PHYSIOL SCI, V16, P101; Maltsev AV, 2011, BIOPHYS J, V100, P271, DOI 10.1016/j.bpj.2010.11.081; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Marger L, 2011, CHANNELS, V5, P251, DOI 10.4161/chan.5.3.15266; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Nakano H, 2011, J MOL CELL CARDIOL, V50, P337, DOI 10.1016/j.yjmcc.2010.10.009; PORZIG H, 1993, AM J PHYSIOL, V265, pC748, DOI 10.1152/ajpcell.1993.265.3.C748; Pott C, 2005, CIRC RES, V97, P1288, DOI 10.1161/01.RES.0000196563.84231.21; Pott C, 2007, BIOPHYS J, V92, P1431, DOI 10.1529/biophysj.106.091538; Pott C, 2007, AM J PHYSIOL-CELL PH, V292, pC968, DOI 10.1152/ajpcell.00177.2006; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Reuter H, 2003, CELL CALCIUM, V34, P19, DOI 10.1016/S0143-4160(03)00018-6; Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; ROZANSKI GJ, 1985, AM J PHYSIOL, V249, pH594, DOI 10.1152/ajpheart.1985.249.3.H594; Sanders L, 2006, J PHYSIOL-LONDON, V571, P639, DOI 10.1113/jphysiol.2005.100305; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Verduyn SC, 2001, AM J PHYSIOL-HEART C, V280, pH2882, DOI 10.1152/ajpheart.2001.280.6.H2882; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Volders PGA, 1998, CIRCULATION, V98, P1136, DOI 10.1161/01.CIR.98.11.1136; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582; Yaniv Y, 2011, J MOL CELL CARDIOL, V51, P740, DOI 10.1016/j.yjmcc.2011.07.018; Younes A, 2008, J BIOL CHEM, V283, P14461, DOI 10.1074/jbc.M707540200; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2; ZIPES DP, 1974, CIRC RES, V34, P184, DOI 10.1161/01.RES.34.2.184	50	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81633	10.1371/journal.pone.0081633	http://dx.doi.org/10.1371/journal.pone.0081633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278453	Green Submitted, Green Published, gold			2022-12-27	WOS:000327539800137
J	Gustafsson, PE; San Sebastian, M; Janlert, U; Theorell, T; Westerlund, H; Hammarstrom, A				Gustafsson, Per E.; San Sebastian, Miguel; Janlert, Urban; Theorell, Tores; Westerlund, Hugo; Hammarstrom, Anne			Residential Selection across the Life Course: Adolescent Contextual and Individual Determinants of Neighborhood Disadvantage in Mid-Adulthood	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC DISADVANTAGE; MULTILEVEL ANALYSIS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; ALLOSTATIC LOAD; CAUSAL INFERENCE; CHRONIC STRESS; AGED WOMEN; MORTALITY	Background: Numerous cross-sectional studies have examined neighborhood effects on health. Residential selection in adulthood has been stressed as an important cause of selection bias but has received little empirical attention, particularly its determinants from the earlier life course. The present study aims to examine whether neighborhood, family, school, health behaviors and health in adolescence are related to socioeconomic disadvantage of one's neighborhood of residence in adulthood. Methods: Based on the prospective Northern Swedish Cohort (analytical N = 971, 90.6% retention rate), information was collected at age 16 years concerning family circumstances, school adjustment, health behaviors and mental and physical health. Neighborhood register data was linked to the cohort and used to operationalize aggregated measures of neighborhood disadvantage (ND) at age 16 and 42. Data was analyzed with linear mixed models, with ND in adulthood regressed on adolescent predictors and neighborhood of residence in adolescence as the level-2 unit. Results: Neighborhood disadvantage in adulthood was clustered by neighborhood of residence in adolescence (ICC = 8.6%). The clustering was completely explained by ND in adolescence. Of the adolescent predictors, ND (b =.14 (95% credible interval =.07-.22)), final school marks (b =-.18 (-.26--.10)), socioeconomic disadvantage (b =.07 (.01-.14)), and, with borderline significance, school peer problems (b =-.07 (-.00-.13)), were independently related to adulthood ND in the final adjusted model. In sex-stratified analyses, the most important predictors were school marks (b =-.21 (-.32--.09)) in women, and neighborhood of residence (ICC = 15.5%) and ND (b =.20 (.09-.31)) in men. Conclusions: These findings show that factors from adolescence - which also may impact on adult health - could influence the neighborhood context in which one will live in adulthood. This indicates that residential selection bias in neighborhood effects on health research may have its sources in early life.	[Gustafsson, Per E.; San Sebastian, Miguel; Janlert, Urban; Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Theorell, Tores; Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Umea University; Stockholm University	Gustafsson, PE (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	Per.E.Gustafsson@umu.se	Gustafsson, Per/AAY-5068-2021; Westerlund, Hugo/A-3049-2012	Westerlund, Hugo/0000-0002-8806-5698; Theorell, Tores/0000-0003-1956-7931; San Sebastian, Miguel/0000-0001-7234-3510; Hammarstrom, Anne/0000-0002-4095-7961	Swedish Research Council Formas [259-2012-37]; Umea University Young Researcher Award [223-514-09]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Umea University Young Researcher Award	The study was supported by The Swedish Research Council Formas (www.formas.se, grant# 259-2012-37) and by Umea University (www.umu.se, Young Researcher Award, grant# 223-514-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist Y, 2009, J EPIDEMIOL COMMUN H, V63, P1028, DOI 10.1136/jech.2009.088377; Bell BA, 2008, CLUSTER SIZE MULTILE; Boone-Heinonen J, 2011, PSYCHOL SPORT EXERC, V12, P54, DOI 10.1016/j.psychsport.2009.09.003; Boone-Heinonen J, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-70; Browne WJ, 2004, MCMC ESTIMATION MLWI; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009; Clarke P, 2008, J EPIDEMIOL COMMUN H, V62, P752, DOI 10.1136/jech.2007.060798; Curtis S, 2004, SOC SCI MED, V58, P57, DOI 10.1016/S0277-9536(03)00149-7; Diez Roux Ana V, 2004, Soc Sci Med, V58, P1953, DOI 10.1016/S0277-9536(03)00414-3; Gustafsson PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039385; Gustafsson PE, 2012, EUR J PUBLIC HEALTH, V22, P322, DOI 10.1093/eurpub/ckr061; Gustafsson PE, 2012, SOC SCI MED, V74, P1630, DOI 10.1016/j.socscimed.2012.01.044; Gustafsson PE, 2012, ANN BEHAV MED, V43, P117, DOI 10.1007/s12160-011-9309-6; Gustafsson PE, 2011, J EPIDEMIOL COMMUN H, V65, P986, DOI 10.1136/jech.2010.108332; Gustafsson PE, 2011, ANN EPIDEMIOL, V21, P103, DOI 10.1016/j.annepidem.2010.08.012; Gustafsson PE, 2010, PSYCHONEUROENDOCRINO, V35, P613, DOI 10.1016/j.psyneuen.2009.09.019; Hammarstrom A, 1986, THESIS KAROLINSKA I; Hammarstrom A, 2012, INT J EPIDEMIOL, V41, P1545, DOI 10.1093/ije/dyr118; Johnson RC, 2012, SOC SCI MED, V74, P625, DOI 10.1016/j.socscimed.2011.10.021; Kuh D, 2002, BRIT MED J, V325, P1076, DOI 10.1136/bmj.325.7372.1076; Leckie G, 2013, J STAT SOFTW, V52, P1; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Matheson FI, 2010, J EPIDEMIOL COMMUN H, V64, P705, DOI 10.1136/jech.2008.083303; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2010, PSYCHOSOC INTERV, V20, P109; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Murray Emily T, 2010, Am J Epidemiol, V171, P1099, DOI 10.1093/aje/kwq044; Naess O, 2010, SCAND J PUBLIC HEALT, V38, P119, DOI 10.1177/1403494810384646; National Board of Health and Welfare, 2010, SOC REP 2010 NAT REP; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Ohlsson H, 2011, SOC SCI MED, V73, P1145, DOI 10.1016/j.socscimed.2011.08.005; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sampson RJ, 2008, DEMOGRAPHY, V45, P1, DOI 10.1353/dem.2008.0012; Scaramella LV, 1998, DEV PSYCHOL, V34, P1233, DOI 10.1037/0012-1649.34.6.1233; Serbin LA, 2004, ANNU REV PSYCHOL, V55, P333, DOI 10.1146/annurev.psych.54.101601.145228; Smith GD, 2002, AM J PUBLIC HEALTH, V92, P1295, DOI 10.2105/AJPH.92.8.1295; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Theall KP, 2011, J EPIDEMIOL COMMUN H, V65, P688, DOI 10.1136/jech.2009.097956; van Lenthe FJ, 2007, HEALTH PLACE, V13, P123, DOI 10.1016/j.healthplace.2005.09.013; Wennberg P, 2013, DIABETES CARE, V36, P2090, DOI 10.2337/dc12-1948; Westerlund H, 2013, J EPIDEMIOL COMMUN H, V67, P508, DOI 10.1136/jech-2012-202052	50	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80241	10.1371/journal.pone.0080241	http://dx.doi.org/10.1371/journal.pone.0080241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	259PW	24278263	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800065
J	Martins, P; Cleary, DFR; Pires, ACC; Rodrigues, AM; Quintino, V; Calado, R; Gomes, NCM				Martins, Patricia; Cleary, Daniel F. R.; Pires, Ana C. C.; Rodrigues, Ana Maria; Quintino, Victor; Calado, Ricardo; Gomes, Newton C. M.			Molecular Analysis of Bacterial Communities and Detection of Potential Pathogens in a Recirculating Aquaculture System for Scophthalmus maximus and Solea senegalensis	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; SP NOV.; VIBRIO-PARAHAEMOLYTICUS; PHYLOGENETIC ANALYSIS; ORGANIC-CARBON; GYRB GENE; DIVERSITY; IDENTIFICATION; NITRATE; GROWTH	The present study combined a DGGE and barcoded 16S rRNA pyrosequencing approach to assess bacterial composition in the water of a recirculating aquaculture system (RAS) with a shallow raceway system (SRS) for turbot (Scophthalmus maximus) and sole (Solea senegalensis). Barcoded pyrosequencing results were also used to determine the potential pathogen load in the RAS studied. Samples were collected from the water supply pipeline (Sup), fish production tanks (Pro), sedimentation filter (Sed), biofilter tank (Bio), and protein skimmer (Ozo; also used as an ozone reaction chamber) of twin RAS operating in parallel (one for each fish species). Our results revealed pronounced differences in bacterial community composition between turbot and sole RAS, suggesting that in the systems studied there is a strong species-specific effect on water bacterial communities. Proteobacteria was the most abundant phylum in the water supply and all RAS compartments. Other important taxonomic groups included the phylum Bacteriodetes. The saltwater supplied displayed a markedly lower richness and appeared to have very little influence on bacterial composition. The following potentially pathogenic species were detected: Photobacterium damselae in turbot (all compartments), Tenacibaculum discolor in turbot and sole (all compartments), Tenacibaculum soleae in turbot (all compartments) and sole (Pro, Sed and Bio), and Serratia marcescens in turbot (Sup, Sed, Bio and Ozo) and sole (only Sed) RAS. Despite the presence of these pathogens, no symptomatic fish were observed. Although we were able to identify potential pathogens, this approach should be employed with caution when monitoring aquaculture systems, as the required phylogenetic resolution for reliable identification of pathogens may not always be possible to achieve when employing 16S rRNA gene fragments.	[Gomes, Newton C. M.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Gomes, NCM (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	gomesncm@ua.pt	Rodrigues, Ana/GYQ-6273-2022; Cleary, Daniel/ABA-9393-2021; Martins, Patricia/W-8942-2019; Gomes, Newton CM/F-7430-2012; Calado, Ricardo Jorge Guerra/C-7035-2008; Martins, Paulo N./AAO-5680-2021; Pires, Ana/L-1817-2014; Cleary, Daniel/D-2582-2012; Quintino, Victor/E-7436-2010; Rodrigues, Ana Maria/F-6968-2019; Gomes, Newton Carlos Marcial/K-3211-2015; Gomes, Newton Carlos Marcial/AAV-4603-2021	Cleary, Daniel/0000-0002-6143-3390; Martins, Patricia/0000-0002-3815-7922; Gomes, Newton CM/0000-0003-1934-0091; Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Martins, Paulo N./0000-0001-9333-0233; Pires, Ana/0000-0002-0219-6321; Cleary, Daniel/0000-0002-6143-3390; Quintino, Victor/0000-0001-6298-4285; Rodrigues, Ana Maria/0000-0003-4506-5783; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton Carlos Marcial/0000-0003-1934-0091	Portuguese FCT (Fundacao para a Ciencia e Tecnologia) [SFRH/BD/73889/2010]; AQUASAFE [PROMAR 31-03-05-FEP-0016]	Portuguese FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); AQUASAFE	Patricia Martins benefited from a PhD grant (SFRH/BD/73889/2010) provided by the Portuguese FCT (Fundacao para a Ciencia e Tecnologia). This study has been carried out with the financial support of project AQUASAFE - Development of new technologies to anticipate and diagnose disease outbreaks in aquaculture (PROMAR 31-03-05-FEP-0016) (PROMAR, a Portuguese instrument for the sectors of fisheries and aquaculture funded by the European Fisheries Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 1997, FEMS MICROBIOL ECOL, V24, P27, DOI 10.1111/j.1574-6941.1997.tb00420.x; Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Altinok I, 2006, AQUACULTURE, V261, P850, DOI 10.1016/j.aquaculture.2006.09.009; Aranda CP, 2012, WORLD J MICROB BIOT, V28, P2365, DOI 10.1007/s11274-012-1044-z; BAYA AM, 1992, J FISH DIS, V15, P15, DOI 10.1111/j.1365-2761.1992.tb00632.x; BEAZHIDALGO R, 2012, AQUATIC, V37, P113; Blancheton JP, 2000, AQUACULT ENG, V22, P17, DOI 10.1016/S0144-8609(00)00030-3; Borges MT, 2008, MICROB ECOL, V55, P107, DOI 10.1007/s00248-007-9256-8; Byun SO, 2009, ANAL BIOCHEM, V385, P174, DOI 10.1016/j.ab.2008.10.024; Chang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044034; Chinabut S, 1999, FISH DISEASES AND DISORDERS, VOL 3, P319; Cleary DFR, 2013, FEMS MICROBIOL ECOL, V85, P465, DOI 10.1111/1574-6941.12135; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; D'Alvise PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043996; Dauga C, 2002, INT J SYST EVOL MICR, V52, P531, DOI 10.1099/00207713-52-2-531; De Schryver P, 2008, AQUACULTURE, V277, P125, DOI 10.1016/j.aquaculture.2008.02.019; Defoirdt T, 2004, AQUACULTURE, V240, P69, DOI 10.1016/j.aquaculture.2004.06.031; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Du C, 2008, J ENVIRON SCI-CHINA, V20, P1210, DOI 10.1016/S1001-0742(08)62211-1; FOUZ B, 1992, DIS AQUAT ORGAN, V12, P155, DOI 10.3354/dao012155; Garcia-Gonzalez P, 2011, AQUACULTURE, V319, P1, DOI 10.1016/j.aquaculture.2011.06.013; Gauger E, 2006, AQUACULTURE, V260, P10, DOI 10.1016/j.aquaculture.2006.06.012; Gomes NCM, 2010, ECOTOX ENVIRON SAFE, V73, P1255, DOI 10.1016/j.ecoenv.2010.07.027; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gutierrez-Salazar GJ, 2011, AQUACULTURE, V321, P34, DOI 10.1016/j.aquaculture.2011.08.032; Hess-Erga OK, 2008, AQUAT BIOL, V4, P147, DOI 10.3354/ab00105; HOLM JC, 1990, AQUACULTURE, V89, P225, DOI 10.1016/0044-8486(90)90128-A; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; Itoi S, 2006, AQUACULTURE, V256, P287, DOI 10.1016/j.aquaculture.2006.02.037; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Jung SY, 2006, INT J SYST EVOL MICR, V56, P33, DOI 10.1099/ijs.0.63920-0; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lahav O, 2009, AQUACULTURE, V288, P76, DOI 10.1016/j.aquaculture.2008.11.020; LEKANG OI, 2013, AQUACULTURE ENG, P50; LIESSENS J, 1993, J AM WATER WORKS ASS, V85, P155; Liltved H, 1999, AQUAC RES, V30, P445, DOI 10.1046/j.1365-2109.1999.00349.x; Michaud L, 2006, AQUACULT ENG, V34, P224, DOI 10.1016/j.aquaeng.2005.07.005; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nichols CM, 2005, INT J SYST EVOL MICR, V55, P1557, DOI 10.1099/ijs.0.63642-0; Nubel U, 1996, J BACTERIOL, V178, P5636; Oiestad V, 1999, AQUAC RES, V30, P831, DOI 10.1046/j.1365-2109.1999.00408.x; Osaka T, 2006, MICROB ECOL, V52, P253, DOI 10.1007/s00248-006-9071-7; Osorio CR, 2000, J BACTERIOL, V182, P526, DOI 10.1128/JB.182.2.526-528.2000; Park S, 2011, INT J SYST EVOL MICR, V61, P2573, DOI 10.1099/ijs.0.027821-0; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P881, DOI 10.1099/ijs.0.65539-0; Pineiro-Vidal M, 2008, INT J SYST EVOL MICR, V58, P21, DOI 10.1099/ijs.0.65397-0; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Porsby CH, 2008, APPL ENVIRON MICROB, V74, P7356, DOI 10.1128/AEM.01738-08; Prado S, 2009, INT MICROBIOL, V12, P107, DOI 10.2436/20.1501.01.87; Prol MJ, 2009, J APPL MICROBIOL, V106, P1292, DOI 10.1111/j.1365-2672.2008.04096.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Romalde Jesus L., 2002, International Microbiology, V5, P3, DOI 10.1007/s10123-002-0051-6; RUIMY R, 1994, INT J SYST BACTERIOL, V44, P416, DOI 10.1099/00207713-44-3-416; Salati F, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P375, DOI 10.1079/9781845935542.0375; Saulnier D, 2009, J MICROBIOL METH, V77, P191, DOI 10.1016/j.mimet.2009.01.021; Schreier HJ, 2010, CURR OPIN BIOTECH, V21, P318, DOI 10.1016/j.copbio.2010.03.011; Schwieger F, 1998, APPL ENVIRON MICROB, V64, P4870; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Sugita H, 2005, AQUACULTURE, V243, P403, DOI 10.1016/j.aquaculture.2004.09.028; Suzuki M, 2001, INT J SYST EVOL MICR, V51, P1639, DOI 10.1099/00207713-51-5-1639; Thompson CC, 2004, INT J SYST EVOL MICR, V54, P919, DOI 10.1099/ijs.0.02963-0; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; TORANZO AE, 1993, AQUACULTURE, V114, P189, DOI 10.1016/0044-8486(93)90295-A; Torres M, 2013, MICROBIOL RES, V168, P547, DOI 10.1016/j.micres.2013.04.011; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; VIGNEULLE M, 1995, AQUACULTURE, V132, P121, DOI 10.1016/0044-8486(94)00375-X; Wada M, 2008, MAR POLLUT BULL, V57, P86, DOI 10.1016/j.marpolbul.2007.10.004; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wawrik B, 2012, FEMS MICROBIOL ECOL, V79, P400, DOI 10.1111/j.1574-6941.2011.01226.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WELCH EB, 1992, APPL LIMNOL POLL EFF, P7591; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhu SM, 2001, AQUACULT ENG, V25, P1, DOI 10.1016/S0144-8609(01)00071-1; Zorrilla I, 2003, J FISH DIS, V26, P103, DOI 10.1046/j.1365-2761.2003.00437.x; Zorrilla I, 1999, J FISH DIS, V22, P167, DOI 10.1046/j.1365-2761.1999.00157.x	85	71	81	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80847	10.1371/journal.pone.0080847	http://dx.doi.org/10.1371/journal.pone.0080847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278329	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800084
J	Mern, DS; Fontana, J; Beierfuss, A; Thome, C; Hegewald, AA				Mern, Demissew S.; Fontana, Johann; Beierfuss, Anja; Thome, Claudius; Hegewald, Aldemar A.			A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches	PLOS ONE			English	Article							AGE-RELATED-CHANGES; EXTRACELLULAR-MATRIX; IN-VIVO; AGGRECAN DEGRADATION; GROWTH-FACTORS; END-PLATE; EXPRESSION; DIFFUSION; TRANSPLANTATION; BIOSYNTHESIS	Painful degenerative disc diseases have been targeted by different biological treatment approaches. Nucleus pulposus (NP) cells play a central role in intervertebral disc (IVD) maintenance by orchestrating catabolic, anabolic and inflammatory factors that affect the extracellular matrix. IVD degeneration is associated with imbalances of these factors, resulting in a catabolic inflammatory metabolism. Therefore, accurate knowledge about their quantity and quality with regard to matrix synthesis is vital for a rational gene therapeutic approach. NP cells were isolated from 63 patients operated due to lumbar disc herniation (mean age 56 / range 29 - 84 years). Then, three-dimensional culture with low-glucose was completed in a collagen type I scaffold for four weeks. Subsequently cell proliferation evaluation was performed using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide and intracellular concentration of 28 endogenously expressed anabolic, catabolic, inflammatory factors and relevant matrix proteins was determined by enzyme-linked immunosorbent assay. Specimen-related grades of degeneration were confirmed by preoperative magnetic resonance imaging. Independent from gender, age and grade of degeneration proliferation rates remained similar in all groups of NP cells. Progressive grades of degeneration, however, showed a significant influence on accumulation of selective groups of factors such as disintegrin and metalloproteinase with thrombospondin motifs 4 and 5, matrix metalloproteinase 3, metalloproteinase inhibitor 1 and 2, interleukin-1 beta and interleukin-1 receptor. Along with these changes, the key NP matrix proteins aggrecan and collagen II decreased significantly. The concentration of anabolic factors bone morphogenetic proteins 2, 4, 6 and 7, insulin-like growth factor 1, transforming growth factor beta 1 and 3, however, remained below the minimal detectable quantities. These findings indicate that progressive degenerative changes in NP may be problematic with regard to biologic treatment strategies. Hence, gene therapeutic interventions regulating relevant bioactive factors identified in this work might contribute to the development of regenerative treatment approaches for degenerative disc diseases.	[Mern, Demissew S.; Thome, Claudius; Hegewald, Aldemar A.] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria; [Mern, Demissew S.; Fontana, Johann; Beierfuss, Anja; Hegewald, Aldemar A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany	Medical University of Innsbruck; Ruprecht Karls University Heidelberg	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.	demissew.shenegelegn-mern@uki.at	, Hegewald/H-2847-2019	, Hegewald/0000-0002-2022-2060; Shenegelegn Mern, Demissew/0000-0001-5893-981X	University Medical Center Mannheim, Heidelberg University	University Medical Center Mannheim, Heidelberg University	The study is financed by University Medical Center Mannheim, Heidelberg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou J, 1996, SPINE, V21, P1153, DOI 10.1097/00007632-199605150-00006; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x; Gruber HE, 2003, SPINE, V28, P186, DOI 10.1097/00007632-200301150-00017; Gruber HE, 2002, SPINE, V27, P798, DOI 10.1097/00007632-200204150-00004; Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kanemoto M, 1996, SPINE, V21, P1, DOI 10.1097/00007632-199601010-00001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; MAROUDAS A, 1975, J ANAT, V120, P113; Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Mern DS, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term 1583, DOI 10.1002/TERM]; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x; Nishida K, 1999, SPINE, V24, P2419, DOI 10.1097/00007632-199912010-00002; Nishida K, 2006, SPINE, V31, P1415, DOI 10.1097/01.brs.0000219945.70675.dd; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Seki S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2851; Selard E, 2003, SPINE, V28, P1945, DOI 10.1097/01.BRS.0000087210.93541.23; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003; Tolonen J, 2006, EUR SPINE J, V15, P588, DOI 10.1007/s00586-005-0930-6; Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang ZH, 2008, ACTA PHARMACOL SIN, V29, P1215, DOI 10.1111/j.1745-7254.2008.00856.x; Wang ZH, 2010, BIOTECHNOL BIOENG, V107, P730, DOI 10.1002/bit.22862; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285	47	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81467	10.1371/journal.pone.0081467	http://dx.doi.org/10.1371/journal.pone.0081467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278441	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800132
J	Riley, MC; Aubrey, W; Young, M; Clare, A				Riley, Michael C.; Aubrey, Wayne; Young, Michael; Clare, Amanda			PD5: A General Purpose Library for Primer Design Software	PLOS ONE			English	Article							DNA DUPLEX STABILITY; PCR; SEQUENCE; TOOL; PARAMETERS; PROGRAM; GALAXY	Background: Complex PCR applications for large genome-scale projects require fast, reliable and often highly sophisticated primer design software applications. Presently, such applications use pipelining methods to utilise many third party applications and this involves file parsing, interfacing and data conversion, which is slow and prone to error. A fully integrated suite of software tools for primer design would considerably improve the development time, the processing speed, and the reliability of bespoke primer design software applications. Results: The PD5 software library is an open-source collection of classes and utilities, providing a complete collection of software building blocks for primer design and analysis. It is written in object-oriented C++ with an emphasis on classes suitable for efficient and rapid development of bespoke primer design programs. The modular design of the software library simplifies the development of specific applications and also integration with existing third party software where necessary. We demonstrate several applications created using this software library that have already proved to be effective, but we view the project as a dynamic environment for building primer design software and it is open for future development by the bioinformatics community. Therefore, the PD5 software library is published under the terms of the GNU General Public License, which guarantee access to source-code and allow redistribution and modification. Conclusions: The PD5 software library is downloadable from Google Code and the accompanying Wiki includes instructions and examples: http://code. google.com/p/primer-design	[Riley, Michael C.; Aubrey, Wayne; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales; [Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Aberystwyth University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Riley, MC (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales.	mhr@aber.ac.uk	Aubrey, Wayne/AAE-7321-2021	Clare, Amanda/0000-0001-8315-3659	Biotechnology and Biological Sciences Research Council [BB/G024782/1]; Royal Academy of Engineering/Engineering and Physical Sciences Research Council Research Fellowship [A.C.]; Aberystwyth University; BBSRC [BB/G024782/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Academy of Engineering/Engineering and Physical Sciences Research Council Research Fellowship [A.C.]; Aberystwyth University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/G024782/1); a Royal Academy of Engineering/Engineering and Physical Sciences Research Council Research Fellowship [A.C.], and Aberystwyth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boutros R, 2009, NUCLEIC ACIDS RES, V37, pW209, DOI 10.1093/nar/gkp269; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Fredslund J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-369; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gordon PMK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh127; Li K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-191; Pearson W R, 2000, Methods Mol Biol, V132, P185; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Piriyapongsa J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S4; Rozen S, 2000, Methods Mol Biol, V132, P365; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Shen ZY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-143; Tannenbaum T., 2001, BEOWULF CLUSTER COMP; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tsai MF, 2007, NUCLEIC ACIDS RES, V35, pW63, DOI 10.1093/nar/gkm383; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; WALLACE RB, 1979, NUCLEIC ACIDS RES, V6, P3543, DOI 10.1093/nar/6.11.3543; You FM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-331; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	25	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80156	10.1371/journal.pone.0080156	http://dx.doi.org/10.1371/journal.pone.0080156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278254	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800060
J	Tien, MZ; Meyer, AG; Sydykova, DK; Spielman, SJ; Wilke, CO				Tien, Matthew Z.; Meyer, Austin G.; Sydykova, Dariya K.; Spielman, Stephanie J.; Wilke, Claus O.			Maximum Allowed Solvent Accessibilites of Residues in Proteins	PLOS ONE			English	Article							ACID SIDE-CHAINS; SECONDARY STRUCTURE; STRUCTURAL DETERMINANTS; GLOBULAR-PROTEINS; NEURAL-NETWORKS; LIPID-BILAYERS; INDEX DATABASE; PREDICTION; SEQUENCE; EVOLUTION	The relative solvent accessibility (RSA) of a residue in a protein measures the extent of burial or exposure of that residue in the 3D structure. RSA is frequently used to describe a protein's biophysical or evolutionary properties. To calculate RSA, a residue's solvent accessibility (ASA) needs to be normalized by a suitable reference value for the given amino acid; several normalization scales have previously been proposed. However, these scales do not provide tight upper bounds on ASA values frequently observed in empirical crystal structures. Instead, they underestimate the largest allowed ASA values, by up to 20%. As a result, many empirical crystal structures contain residues that seem to have RSA values in excess of one. Here, we derive a new normalization scale that does provide a tight upper bound on observed ASA values. We pursue two complementary strategies, one based on extensive analysis of empirical structures and one based on systematic enumeration of biophysically allowed tripeptides. Both approaches yield congruent results that consistently exceed published values. We conclude that previously published ASA normalization values were too small, primarily because the conformations that maximize ASA had not been correctly identified. As an application of our results, we show that empirically derived hydrophobicity scales are sensitive to accurate RSA calculation, and we derive new hydrophobicity scales that show increased correlation with experimentally measured scales.	[Tien, Matthew Z.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Meyer, Austin G.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX 79430 USA; [Meyer, Austin G.; Sydykova, Dariya K.; Spielman, Stephanie J.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sydykova, Dariya K.; Spielman, Stephanie J.; Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Sydykova, Dariya K.; Spielman, Stephanie J.; Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Chicago; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Wilke, CO (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	wilke@austin.utexas.edu	Wilke, Claus O./B-4643-2008	Sydykova, Dariya/0000-0002-9016-5081; Wilke, Claus/0000-0002-7470-9261; Tien, Matthew/0000-0002-0006-9644; Meyer, Austin/0000-0002-0581-800X; Spielman, Stephanie/0000-0002-9090-4788	National Institutes of Health [R01 GM088344]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://nih.gov/) grant R01 GM088344 to COW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Chothia C, 1976, J MOL BIOL, P1; Contant GC, 2009, MOL BIOL EVOL, V26, P1155; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Franzosa EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046602; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Goldman N, 1998, GENETICS, V149, P445; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim H, 2004, PROTEINS, V54, P557, DOI 10.1002/prot.10602; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; Meyer AG, 2012, MOL BIOL EVOL; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moelbert S, 2004, PROTEIN SCI, V13, P752, DOI 10.1110/ps.03431704; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nguyen MN, 2005, PROTEINS, V59, P30, DOI 10.1002/prot.20404; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Scherrer MP, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-179; Shaytan AK, 2009, BIOMACROMOLECULES, V10, P1224, DOI 10.1021/bm8015169; Singh H, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-25; Tien MZ, 2013, PEERJ, V1, DOI 10.7717/peerj.80; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	40	189	191	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80635	10.1371/journal.pone.0080635	http://dx.doi.org/10.1371/journal.pone.0080635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278298	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800077
J	Rueda, ZV; Lopez, L; Velez, LA; Marin, D; Giraldo, MR; Pulido, H; Orozco, LC; Montes, F; Arbelaez, MP				Vanessa Rueda, Zulma; Lopez, Lucelly; Velez, Lazaro A.; Marin, Diana; Rosa Giraldo, Margarita; Pulido, Henry; Carlos Orozco, Luis; Montes, Fernando; Patricia Arbelaez, Maria			High Incidence of Tuberculosis, Low Sensitivity of Current Diagnostic Scheme and Prolonged Culture Positivity in Four Colombian Prisons. A Cohort Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; TRANSMISSION; SMEAR; PREVALENCE	Objective: To determine the incidence of pulmonary tuberculosis (TB) in inmates, factors associated with TB, and the time to sputum smear and culture conversion during TB treatment. Methods: Prospective cohort study. All prisoners with respiratory symptoms (RS) of any duration were evaluated. After participants signed consent forms, we collected three spontaneous sputum samples on consecutive days. We performed auramine-rhodamine staining, culturing with the thin-layer agar method, Lowestein-Jensen medium and MGIT, susceptibility testing for first-line drugs; and HIV testing. TB cases were followed, and the times to smear and culture conversion to negative were evaluated. Results: Of 9,507 prisoners held in four prisons between April/30/2010 and April/30/2012, among them 4,463 were screened, 1,305 were evaluated for TB because of the lower RS of any duration, and 72 were diagnosed with TB. The annual incidence was 505 cases/100,000 prisoners. Among TB cases, the median age was 30 years, 25% had <15 days of cough, 12.5% had a history of prior TB, and 40.3% had prior contact with a TB case. TB-HIV coinfection was diagnosed in three cases. History of prior TB, contact with a TB case, and being underweight were risk factors associated with TB. Overweight was a protective factor. Almost a quarter of TB cases were detected only by culture; three cases were isoniazid resistant, and two resistant to streptomycin. The median times to culture conversion was 59 days, and smear conversion was 33. Conclusions: The TB incidence in prisons is 20 times higher than in the general Colombian population. TB should be considered in inmates with lower RS of any duration. Our data demonstrate that patients receiving adequate anti-TB treatment remain infectious for prolonged periods. These findings suggest that current recommendations regarding isolation of prisoners with TB should be reconsidered, and suggest the need for mycobacterial cultures during follow-up.	[Vanessa Rueda, Zulma; Velez, Lazaro A.] Univ Antioquia, Fac Med, Grp Invest Problemas Enfermedades Infecc, Medellin, Colombia; [Vanessa Rueda, Zulma; Patricia Arbelaez, Maria] Univ Antioquia, Fac Nacl Salud Publ, Grup Epidemiol, Medellin, Colombia; [Lopez, Lucelly] Univ Antioquia, Escuela Microbiol, Medellin, Colombia; [Velez, Lazaro A.] Univ Antioquia, Fac Med, Dept Internal Med, Secc Enfermedades Infecc, Medellin, Colombia; [Marin, Diana] Univ Antioquia, Fac Nacl Salud Publ, Medellin, Colombia; [Rosa Giraldo, Margarita] Secretaria Secc Salud & Protecc Social Antioquia, Gobernacion Antioquia, Medellin, Colombia; [Pulido, Henry] Secretaria Salud Bello, Bello, Colombia; [Carlos Orozco, Luis] Univ Ind Santander, Fac Enfermeria, Santander, Spain; [Montes, Fernando] Secretaria Salud Medellin, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Rueda, ZV (corresponding author), Univ Antioquia, Fac Med, Grp Invest Problemas Enfermedades Infecc, Medellin, Colombia.	zulmaruedav@gmail.com	Rueda, Zulma Vanessa/AAH-4650-2019	Rueda, Zulma Vanessa/0000-0001-6342-1812; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; Marin Pineda, Diana/0000-0002-4715-8388; Lopez Lopez, Lucelly/0000-0002-1534-520X	Colciencias (Administrative Department of Science, Technology and Innovation); Government of Colombia; Universidad de Antioquia [111549326144]; Universidad de Antioquia	Colciencias (Administrative Department of Science, Technology and Innovation); Government of Colombia; Universidad de Antioquia; Universidad de Antioquia	This research was fully funded by Colciencias (Administrative Department of Science, Technology and Innovation), a public agency from the Government of Colombia, http://www.colciencias.gov.co/; and Universidad de Antioquia (Grant No. 111549326144), www.udea.edu.co. Thanks to "Estrategia de sostenibilidad CODI 2013-2014", from Universidad de Antioquia, who paid the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Beggs CB, 2003, INT J TUBERC LUNG D, V7, P1015; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Bouti K, 2013, ISRN PULMONOL, V2013, DOI [10.1155/2013/486507, DOI 10.1155/2013/486507]; Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001; Dara M, 2009, GUIDELINES CONTROL T; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Dhingra VK, 2003, INDIAN J ALLERGY AST, V17, P67; Federal Bureau of Prisons, 2010, MAN TUB CLIN PRACT G; Fitzwater SP, 2010, CLIN INFECT DIS, V51, P371, DOI 10.1086/655127; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; MacIntyre CR, 1997, CLIN INFECT DIS, V24, P1060, DOI 10.1086/513632; Matthys F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007954; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Noeske J, 2011, INT J TUBERC LUNG D, V15, P223; O'Grady J, 2011, EUR RESPIR J, V38, P752, DOI 10.1183/09031936.00041211; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Paranjothy S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1184; Parikh Raunak, 2012, J Assoc Physicians India, V60, P22; Robledo J, 2008, INT J TUBERC LUNG D, V12, P1482; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	28	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e80592	10.1371/journal.pone.0080592	http://dx.doi.org/10.1371/journal.pone.0080592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278293	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800076
J	Zhang, YF; Guan, MP; Zheng, ZJ; Zhang, Q; Gao, F; Xue, YM				Zhang, Yanfei; Guan, Meiping; Zheng, Zongji; Zhang, Qian; Gao, Fang; Xue, Yaoming			Effects of Metformin on CD133+Colorectal Cancer Cells in Diabetic Patients	PLOS ONE			English	Article							EUROPEAN ASSOCIATION; CONSENSUS STATEMENT; MEDICAL-MANAGEMENT; COLORECTAL-CANCER; MELLITUS; SUPPRESSES; THERAPY; RISK; HYPERGLYCEMIA; METASTASIS	In diabetic patients complicated with colorectal cancer (CRC), metformin treatment was reported to have diverse correlation with CRC-specific mortality. In laboratory studies, metformin was reported to affect the survival of cancer stem cells (CSCs) in breast and pancreatic cancers and glioblastoma. Although cscs play a critical role in the resistance to 5-fluorouracil (5-FU) chemotherapy in CRC patients, the effect of metformin on cscs in CRC patients and the synergistic effect of metformin in combination with 5-FU on cscs are not reported. In the present study pathological examinations were performed in 86 CRC patients complicated with type 2 DM who had been divided into a metformin group and a non-metformin group. Comparisons regarding pathological type, incidence of metastasis, expression of CD133 and beta-catenin were conducted between the two groups. We explored the synergistic effects of metformin in combination with 5-FU on the proliferation, cell cycle, apoptosis and the proportion of CD133+ cscs of SW620 human colorectal cancer cell lines. The results show that metformin treatment had reverse correlations with the proportion of patients with poorly differentiated adenocarcinoma, the proportion of CD133+ cscs in CRC patients with type 2 DM. Metformin enhanced the antiproliferative effects of 5-FU on CD133+ cscs in SW620 cells. These findings provide an important complement to previous study. Inhibition of the proliferation of CD133+ cscs may be a potential mechanism responsible for the association of metformin use with improved CRC outcomes in CRC patients with type 2 diabetes.	[Zhang, Yanfei; Guan, Meiping; Zheng, Zongji; Zhang, Qian; Gao, Fang; Xue, Yaoming] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Xue, YM (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China.	xymbright@163.com		zheng, zongji/0000-0003-0434-0152	Province Industrial Technology Research and Development Projects [(2010) 207]; Research Fund of Guangdong Pharmaceutical Association for Medication of Type 2 Diabetes, Guangdong, China [2012C07]	Province Industrial Technology Research and Development Projects; Research Fund of Guangdong Pharmaceutical Association for Medication of Type 2 Diabetes, Guangdong, China	This research was supported by a grant from the Province Industrial Technology Research and Development Projects, NO. (2010) 207 and the Research Fund of Guangdong Pharmaceutical Association for Medication of Type 2 Diabetes, NO. 2012C07, Guangdong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aomatsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045865; Bao Bin, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1425s61; BELLA F, 2013, J CANCER RES CLIN, P33003; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Chiu CC, 2013, INTERNAL MED, V52, P939, DOI 10.2169/internalmedicine.52.8276; Chung HH, 2013, DIABETES METAB J, V37, P125, DOI 10.4093/dmj.2013.37.2.125; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Cufi S, 2012, ONCOTARGET, V3, P395, DOI 10.18632/oncotarget.488; Deng Yan-Hong, 2010, Chin J Cancer, V29, P810; Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969; Horst D, 2009, EUR J CANCER, V45, P2034, DOI 10.1016/j.ejca.2009.04.004; Hosono K, 2010, CANCER PREV RES, V3, P1077, DOI 10.1158/1940-6207.CAPR-10-0186; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Kim SL, 2013, CANCER LETT, V335, P479, DOI 10.1016/j.canlet.2013.03.007; Kwan HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053597; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Lee JH, 2012, INT J CANCER, V131, P752, DOI 10.1002/ijc.26421; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; MORGILLO F, 2013, CLIN CANCER RES, P95170; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pierotti MA, 2013, ONCOGENE, V32, P1475, DOI 10.1038/onc.2012.181; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Rizos CV, 2013, EUR J PHARMACOL, V705, P96, DOI 10.1016/j.ejphar.2013.02.038; Tan BK, 2011, J CLIN ENDOCR METAB, V96, P808, DOI 10.1210/jc.2010-1803; Vazquez-Martin A, 2011, ONCOL REP, V25, P135, DOI 10.3892/or_00001052; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512; Zhou Xiao-zhi, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1935; [周小智 Zhou Xiaozhi], 2012, [中国糖尿病杂志, Chinese Journal of Diabetes], V20, P546; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	33	47	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81264	10.1371/journal.pone.0081264	http://dx.doi.org/10.1371/journal.pone.0081264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278407	gold, Green Published, Green Submitted			2022-12-27	WOS:000327539800115
J	Hoppe, CJM; Hassler, CS; Payne, CD; Tortell, PD; Rost, B; Trimborn, S				Hoppe, Clara J. M.; Hassler, Christel S.; Payne, Christopher D.; Tortell, Philippe D.; Rost, Bjoern; Trimborn, Scarlett			Iron Limitation Modulates Ocean Acidification Effects on Southern Ocean Phytoplankton Communities	PLOS ONE			English	Article							DIATOM PSEUDO-NITZSCHIA; SEA-ICE; WEDDELL SEA; DISSOLVED IRON; CARBONIC-ACID; GROWTH; PHOTOSYNTHESIS; AVAILABILITY; CO2; BACILLARIOPHYCEAE	The potential interactive effects of iron (Fe) limitation and Ocean Acidification in the Southern Ocean (SO) are largely unknown. Here we present results of a long-term incubation experiment investigating the combined effects of CO2 and Fe availability on natural phytoplankton assemblages from the Weddell Sea, Antarctica. Active Chl a fluorescence measurements revealed that we successfully cultured phytoplankton under both Fe-depleted and Fe-enriched conditions. Fe treatments had significant effects on photosynthetic efficiency (F-v/F-m; 0.3 for Fe-depleted and 0.5 for Fe-enriched conditions), non-photochemical quenching (NPQ), and relative electron transport rates (rETR). pCO(2) treatments significantly affected NPQ and rETR, but had no effect on F-v/F-m. Under Fe limitation, increased pCO(2) had no influence on C fixation whereas under Fe enrichment, primary production increased with increasing pCO(2) levels. These CO2-dependent changes in productivity under Fe-enriched conditions were accompanied by a pronounced taxonomic shift from weakly to heavily silicified diatoms (i.e. from Pseudo-nitzschia sp. to Fragilariopsis sp.). Under Fe-depleted conditions, this functional shift was absent and thinly silicified species dominated all pCO(2) treatments (Pseudo-nitzschia sp. and Synedropsis sp. for low and high pCO(2), respectively). Our results suggest that Ocean Acidification could increase primary productivity and the abundance of heavily silicified, fast sinking diatoms in Fe-enriched areas, both potentially leading to a stimulation of the biological pump. Over much of the SO, however, Fe limitation could restrict this possible CO2 fertilization effect.	[Hoppe, Clara J. M.; Rost, Bjoern; Trimborn, Scarlett] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Hassler, Christel S.] Univ Technol Sydney, Plant Funct Biol & Climate Chance Cluster, Sydney, NSW 2007, Australia; [Payne, Christopher D.; Tortell, Philippe D.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Technology Sydney; University of British Columbia	Hoppe, CJM (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany.	Clara.Hoppe@awi.de	Trimborn, Scarlett/AAM-1061-2021; Rost, Bjoern/B-4447-2015; Hoppe, Clara Jule Marie/AFT-1558-2022	Trimborn, Scarlett/0000-0003-1434-9927; Rost, Bjoern/0000-0001-5452-5505; Hoppe, Clara Jule Marie/0000-0002-2509-0546; Tortell, Philippe/0000-0003-0212-2151	German Science Foundation (DFG) [TR 899/2]; European Research Council (ERC); European Community [205150]; Australian Research Council [DP1092892]; UTS Chancellor Fellowship; Alexander von Humboldt research fellowship; Natural Sciences and Engineering Research Council of Canada	German Science Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); European Community(European Commission); Australian Research Council(Australian Research Council); UTS Chancellor Fellowship; Alexander von Humboldt research fellowship(Alexander von Humboldt Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	S.T. was funded by the German Science Foundation (DFG; www.dfg.de), project TR 899/2. B. R. and C.J.M.H. were funded by the European Research Council (ERC; erc.europa.eu) under the European Community's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement no. 205150. C. H. was funded by the Australian Research Council (www.arc.gov.au; DP1092892) and a UTS Chancellor Fellowship (www.uts.edu.au). P.D.T. was funded by an Alexander von Humboldt research fellowship (http://www.humboldt-foundation.de) and grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Almandoz GO, 2008, POLAR BIOL, V31, P429, DOI 10.1007/s00300-007-0369-9; Armand LK, 2005, PALAEOGEOGR PALAEOCL, V223, P93, DOI 10.1016/j.palaeo.2005.02.015; Assmy P, 2007, DEEP-SEA RES PT I, V54, P340, DOI 10.1016/j.dsr.2006.12.005; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; BILGER W, 1991, PLANTA, V184, P226, DOI [10.1007/BF01102422, 10.1007/BF00197951]; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Brewer PG, 1986, CHANGING CARBON CYCL, P358; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Crosta X, 2005, PALAEOGEOGR PALAEOCL, V223, P66, DOI 10.1016/j.palaeo.2005.03.028; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; de Jong JTM, 1998, ANAL CHIM ACTA, V377, P113, DOI 10.1016/S0003-2670(98)00427-9; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; FISCHER G, 1988, NATURE, V335, P426, DOI 10.1038/335426a0; Garibotti IA, 2005, J PLANKTON RES, V27, P825, DOI 10.1093/plankt/fbi056; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gledhill M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00069; Gorbunov M., 2004, FLUORESCENCE INDUCTI; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd, P600, DOI DOI 10.1002/9783527613984; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; HASLE GR, 1994, PHYCOLOGIA, V33, P248, DOI 10.2216/i0031-8884-33-4-248.1; Hassler CS, 2012, OCEANOGR MAR BIOL, V50, P1; Hassler CS, 2011, MAR CHEM, V123, P88, DOI 10.1016/j.marchem.2010.10.003; Hassler CS, 2009, BIOGEOSCIENCES, V6, P2281, DOI 10.5194/bg-6-2281-2009; Hassler CS, 2011, P NATL ACAD SCI USA, V108, P1076, DOI 10.1073/pnas.1010963108; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoppe CJM, 2012, BIOGEOSCIENCES, V9, P2401, DOI 10.5194/bg-9-2401-2012; Ihnken S, 2011, PHYCOLOGIA, V50, P182, DOI 10.2216/10-11.1; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; KANG SH, 1993, MAR BIOL, V116, P335, DOI 10.1007/BF00350024; Knap A., 1996, 19 JGOFS UNESCO; KOLBER ZS, 1994, NATURE, V371, P145, DOI 10.1038/371145a0; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Le Quere C, 2010, GLOBAL BIOGEOCHEM CY, P24; Leblanc K, 2012, EARTH SYST SCI DATA, V4, P149, DOI 10.5194/essd-4-149-2012; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Maldonado M. T., 2005, GLOBAL BIOGEOCHEM CY, V19; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Marchetti A, 2006, LIMNOL OCEANOGR, V51, P2092, DOI 10.4319/lo.2006.51.5.2092; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Martin JH, 1990, GLOBAL BIOGEOCHEM CY, V4, P5, DOI 10.1029/GB004i001p00005; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Moore JK, 2000, GLOBAL BIOGEOCHEM CY, V14, P455, DOI 10.1029/1999GB900051; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Parsons ML, 2002, LIMNOL OCEANOGR, V47, P551, DOI 10.4319/lo.2002.47.2.0551; Pierrot D. E, 2006, MS EXEL PROGRAM DEV; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; SAKSHAUG E, 1991, MAR CHEM, V35, P259, DOI 10.1016/S0304-4203(09)90021-4; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Shaked Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00123; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Smetacek V, 2012, NATURE, V487, P313, DOI 10.1038/nature11229; Stickley CE, 2009, NATURE, V460, P376, DOI 10.1038/nature08163; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Sugie K, 2013, BIOGEOSCIENCES, V10, P6309, DOI 10.5194/bg-10-6309-2013; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; Tomas CR, 1997, IDENTIFYING MARINE P; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Tortell PD, 2008, LIMNOL OCEANOGR, V53, P1266, DOI 10.4319/lo.2008.53.4.1266; Trimborn S, 2013, LIMNOL OCEANOGR, V58, P997, DOI 10.4319/lo.2013.58.3.0997; Van Oijen T, 2004, EUR J PHYCOL, V39, P161, DOI 10.1080/0967026042000202127; Velasquez I, 2011, MAR CHEM, V126, P97, DOI 10.1016/j.marchem.2011.04.003	73	90	90	4	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79890	10.1371/journal.pone.0079890	http://dx.doi.org/10.1371/journal.pone.0079890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278207	Green Published, gold			2022-12-27	WOS:000327313100067
J	Kellogg, CA; Piceno, YM; Tom, LM; DeSantis, TZ; Gray, MA; Zawada, DG; Andersen, GL				Kellogg, Christina A.; Piceno, Yvette M.; Tom, Lauren M.; DeSantis, Todd Z.; Gray, Michael A.; Zawada, David G.; Andersen, Gary L.			Comparing Bacterial Community Composition between Healthy and White Plague-Like Disease States in Orbicella annularis Using PhyloChip (TM) G3 Microarrays	PLOS ONE			English	Article							BLACK BAND DISEASE; CORAL DISEASE; CAUSATIVE AGENT; ELKHORN CORAL; DIVERSITY; CULTURE; FLORIDA; SHIFTS; GULF; SPP.	Coral disease is a global problem. Diseases are typically named or described based on macroscopic changes, but broad signs of coral distress such as tissue loss or discoloration are unlikely to be specific to a particular pathogen. For example there appear to be multiple diseases that manifest the rapid tissue loss that characterizes 'white plague'. PhyloChip (TM) G3 microarrays were used to compare the bacterial community composition of both healthy and white plague-like diseased corals. Samples of lobed star coral (Orbicella annularis, formerly of the genus Montastraea [1]) were collected from two geographically distinct areas, Dry Tortugas National Park and Virgin Islands National Park, to determine if there were biogeographic differences between the diseases. In fact, all diseased samples clustered together, however there was no consistent link to Aurantimonas coralicida, which has been disease as the causative agent of white plague type II. The microarrays revealed a large amount of bacterial heterogeneity within the healthy corals and less diversity in the diseased corals Gram-positive bacterial groups (Actinobacteria, Firmicutes) comprised a greater proportion of the operational taxonomic units (OTUs) unique to healthy samples. Diseased samples were enriched in OTUs from the families Corynebacteriacea, Lachnospiracea, Rhodobacteraceae, and Streptococcaceae. Much previous coral disease work has used clone libraries, which seem to be methodologically biased toward recovery of Gram-negative bacterial sequences and may therefore have missed the importance of Gram-positive groups. The Phylochip (TM) data presented here provide a broader characterization of the bacterial community changes that occur within Orbicella annularis during the shift from a healthy to diseased state.	[Kellogg, Christina A.; Gray, Michael A.; Zawada, David G.] US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA; [Piceno, Yvette M.; Tom, Lauren M.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kellogg, CA (corresponding author), US Geol Survey, St Petersburg Coastal & Marine Sci Ctr, St Petersburg, FL USA.	ckellogg@usgs.gov	Tom, Lauren/E-9739-2015; Andersen, Gary/G-2792-2015; Piceno, Yvette/I-6738-2016	Andersen, Gary/0000-0002-1618-9827; Piceno, Yvette/0000-0002-7915-4699; Zawada, David/0000-0003-4547-4878	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy [DE-AC02-05CH11231]	Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program; United States Department of Energy(United States Department of Energy (DOE))	This project was supported by the Coral Reef Ecosystems Study (CREST) of the United States Geological Survey's Coastal and Marine Geology Program. A portion of this work was performed under the auspices of the United States Department of Energy under contract DE-AC02-05CH11231 to Lawrence Berkeley National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2007, APPL ENVIRON MICROB, V73, P981, DOI 10.1128/AEM.02172-06; Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Arotsker L, 2009, FEMS MICROBIOL ECOL, V70, P515, DOI 10.1111/j.1574-6941.2009.00770.x; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Brandt ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057164; Brandt ME, 2012, B MAR SCI, V88, P1035, DOI 10.5343/bms.2011.1104; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook GM, 2013, CORAL REEFS, V32, P375, DOI 10.1007/s00338-012-0989-6; Daniels CA, 2011, MAR ECOL PROG SER, V426, P29, DOI 10.3354/meps09024; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Francini R, 2010, LAT AM J AQUAT RES, V38, P292, DOI 10.3856/vol38-issue2-fulltext-16; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Gray MA, 2013, FEMS MICROBIOL ECOL, V83, P468, DOI 10.1111/1574-6941.12008; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kellogg CA, 2012, J MICROBIOL METH, V88, P103, DOI 10.1016/j.mimet.2011.10.019; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Nithyanand P, 2009, FEMS MICROBIOL ECOL, V69, P384, DOI 10.1111/j.1574-6941.2009.00723.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Penn K, 2006, APPL ENVIRON MICROB, V72, P1680, DOI 10.1128/AEM.72.2.1680-1683.2006; PoUock FJ, 2011, PLOS PATHOGENS, V7, DOI 10.1371/journal.ppat.1002183; Reis AMM, 2009, J APPL MICROBIOL, V106, P1378, DOI 10.1111/j.1365-2672.2008.04106.x; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roder C., 2013, ISME J; Rogers C, 2009, P R SOC B, V276, P197, DOI 10.1098/rspb.2008.0606; Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26; Rozycki H, 1999, APPL SOIL ECOL, V12, P239, DOI 10.1016/S0929-1393(99)00008-6; Sanchez JA, 2010, REV BIOL TROP, V58, P145; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Stackebrandt E, 1993, HDB NEW BACTERIAL SY, P152; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Zlotnikov AK, 2001, SOIL BIOL BIOCHEM, V33, P1525, DOI 10.1016/S0038-0717(01)00070-0	56	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79801	10.1371/journal.pone.0079801	http://dx.doi.org/10.1371/journal.pone.0079801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278181	Green Submitted, Green Published, gold			2022-12-27	WOS:000327313100048
J	Lai, YH; Liu, TC; Li, PC; Shih, WT; Young, ST				Lai, Ying-Hui; Liu, Tien-Chen; Li, Pei-Chun; Shih, Wan-Ting; Young, Shuenn-Tsong			Development and Preliminary Verification of a Mandarin-Based Hearing-Aid Fitting Strategy	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; COMPRESSION; RECOGNITION	Objective: The purpose of this study was to design and to verify a new hearing-aid fitting strategy (Aescu HRL-1) based on the acoustic features of Mandarin. The subjective and objective outcomes were compared to those fitted with NAL-NL1 (National Acoustic Laboratory Non-Linear, version1) in Mandarin-speaking hearing-aid users. Design: Fifteen subjects with sensorineural hearing loss participated in this preliminary study. Each subject wore a pair of four-channel hearing aids fitted with the Aescu HRL-1 and NAL-NL1 prescriptions alternatively for 1 month. Objective and subjective tests including the Mandarin Monosyllable Recognition Test (MMRT), Mandarin Hearing in Noise Test (MHINT), International Outcome Inventory for Hearing Aids (IOI-HA), and a sound-quality questionnaire were used to evaluate the performance of the two prescriptions. Results: The mean MMRT scores were 79.9% and 81.1% for NAL-NL1 and Aescu HRL-1 respectively. They are not statistically different. The corresponding MHINT signal-to-noise ratios were 0.87 and 0.85 dB, also, no significant difference was found between these two strategies. However, in subjective questionnaires, overall, the sound-quality and IOI-HA scores were higher for Aescu HRL-1. Conclusions: The speech recognition performance based on Aescu HRL-1 is as good as that of NAL-NL1 for Mandarin-speaking hearing-aid users. Moreover, the subjects generally responded that Aescu HRL-1 provides a more natural, richer, and better sound quality than does NAL-NL1.	[Lai, Ying-Hui] Acad Sinica, Res Ctr Informat Technol Innovat, Taipei 115, Taiwan; [Young, Shuenn-Tsong] Mackay Med Coll, Holist Educ Ctr, New Taipei City, Taiwan; [Li, Pei-Chun] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Liu, Tien-Chen; Shih, Wan-Ting] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan	Academia Sinica - Taiwan; Mackay Medical College; Mackay Medical College; National Taiwan University; National Taiwan University Hospital	Liu, TC (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	liuent@ntu.edu.tw; young0210@gmail.com		Shih, Wan-Ting/0000-0003-2069-3302	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audioscan, 2010, VER US GUID VERS 3 6; Barbara Lust JG, 1999, LEXICAL ANAPHORS PRO; Bench R, 1979, BKB A BAMFORD KOWAL; Byrne D, 2001, J Am Acad Audiol, V12, P37; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; Ching TYC, 1998, J ACOUST SOC AM, V103, P1128, DOI 10.1121/1.421224; Cole B, 2005, BRIEF HIST SPEECHMAP; CORLISS ELR, 1968, IEEE T ACOUST SPEECH, VAU16, P36, DOI 10.1109/TAU.1968.1161947; Cox RM, 2002, INT J AUDIOL, V41, P30, DOI 10.3109/14992020209101309; Cox RM, 1995, HEARING J, V48, P10, DOI [10.1097/00025572-199504000-00001., DOI 10.1097/00025572-199504000-00001]; Dillon H, 1996, EAR HEARING, V17, P287, DOI 10.1097/00003446-199608000-00001; Dillon H., 2001, HEARING AIDS; Geers A, 1989, VOLTA REV; Hawkins D B, 1993, J Am Acad Audiol, V4, P221; Jhou Y-M, 2007, THESIS NATL YANG MIN; Jing Chen TSQ, 2008, J ACOUST SOC AM, V123, P3323, DOI [10.1121/1.2933804, DOI 10.1121/1.2933804]; Keidser G, 2011, AUDIOL RES, V1, P88, DOI 10.4081/audiores.2011.e24; Keidser G, 2001, EAR HEARING, V22, P501, DOI 10.1097/00003446-200112000-00006; Keidser G, 1999, EVALUATION LOUDNESS; Keidser G, 2003, HEARING REV, V10, P14; Lee J, 2008, THESIS NATL YANG MIN; McCullough J A, 1993, J Am Acad Audiol, V4, P50; Mogford K, 1993, LANGUAGE DEV EXCEPTI, P110; Moore BCJ, 1997, AUDIT NEUROSCI, V3, P289; Moore BCJ, 2013, EAR HEARING, V34, P83, DOI 10.1097/AUD.0b013e3182650adf; Moore BCJ, 2010, EAR HEARING, V31, P657, DOI 10.1097/AUD.0b013e3181e1cd0d; Moore BCJ, 2010, J ACOUST SOC AM, V128, P360, DOI 10.1121/1.3436533; Moore BCJ, 2010, INT J AUDIOL, V49, P216, DOI 10.3109/14992020903296746; Preves D, 1989, HEAR J, V42, P19; Scollie SD, 2002, EAR HEARING, V23, P477, DOI 10.1097/00003446-200210000-00009; Seewald R, 1993, 2 HEAR HLTH CAR RES; Souza Pamela E, 2002, Trends Amplif, V6, P131, DOI 10.1177/108471380200600402; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; Takeshima H., 2003, Acoustical Science and Technology, V24, P61; Tsai KS, 2009, EAR HEARING, V30, P90, DOI 10.1097/AUD.0b013e31818f28a6; Valente M, 2007, AUDIOLOGY TREATMENT; Valente M., 2002, STRATEGIES SELECTING; van Buuren RA, 1999, J ACOUST SOC AM, V105, P2903, DOI 10.1121/1.426943; Wikipedia, 2011, LIST LANG NUMB NAT S; Wong LLN, 2007, EAR HEARING, V28, p70S, DOI 10.1097/AUD.0b013e31803154d0; Yeh Shiu-Huei S-TY, 2005, THESIS NATL YANG MIN	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80831	10.1371/journal.pone.0080831	http://dx.doi.org/10.1371/journal.pone.0080831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278326	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100116
J	Mattson, WI; Cohn, JF; Mahoor, MH; Gangi, DN; Messinger, DS				Mattson, Whitney I.; Cohn, Jeffrey F.; Mahoor, Mohammad H.; Gangi, Devon N.; Messinger, Daniel S.			Darwin's Duchenne: Eye Constriction during Infant Joy and Distress	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL EXPRESSION; PAIN; FACE; SMILES; FEAR; JUDGMENTS; PRETERM; ANGER	Darwin proposed that smiles with eye constriction (Duchenne smiles) index strong positive emotion in infants, while cry-faces with eye constriction index strong negative emotion. Research has supported Darwin's proposal with respect to smiling, but there has been little parallel research on cry-faces (open-mouth expressions with lateral lip stretching). To investigate the possibility that eye constriction indexes the affective intensity of positive and negative emotions, we first conducted the Face-to-Face/Still-Face (FFSF) procedure at 6 months. In the FFSF, three minutes of naturalistic infant-parent play interaction (which elicits more smiles than cry-faces) are followed by two minutes in which the parent holds an unresponsive still-face (which elicits more cry-faces than smiles). Consistent with Darwin's proposal, eye constriction was associated with stronger smiling and with stronger cry-faces. In addition, the proportion of smiles with eye constriction was higher during the positive-emotion eliciting play episode than during the still-face. In parallel, the proportion of cry-faces with eye constriction was higher during the negative-emotion eliciting still-face than during play. These results are consonant with the hypothesis that eye constriction indexes the affective intensity of both positive and negative facial configurations. A preponderance of eye constriction during cry-faces was observed in a second elicitor of intense negative emotion, vaccination injections, at both 6 and 12 months of age. The results support the existence of a Duchenne distress expression that parallels the more well-known Duchenne smile. This suggests that eye constriction-the Duchenne marker-has a systematic association with early facial expressions of intense negative and positive emotion.	[Mattson, Whitney I.; Gangi, Devon N.; Messinger, Daniel S.] Univ Miami, Dept Psychol, Miami, FL 33136 USA; [Cohn, Jeffrey F.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Cohn, Jeffrey F.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA; [Mahoor, Mohammad H.] Univ Denver, Dept Elect & Comp Engn, Denver, CO USA; [Messinger, Daniel S.] Univ Miami, Dept Pediat, Miami, FL 33152 USA; [Messinger, Daniel S.] Univ Miami, Dept Elect & Comp Engn, Miami, FL USA	University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; University of Denver; University of Miami; University of Miami	Mattson, WI (corresponding author), Univ Miami, Dept Psychol, Miami, FL 33136 USA.	w.mattson@umiami.edu		Gangi, Devon/0000-0003-2885-4641	National Institutes of Health [R01HD047417, R01HD057284, R01MH051435, 1R01GM105004]; National Science Foundation [INT-0808767, 1052736, BCS-1323927]; Autism Speaks; Direct For Social, Behav & Economic Scie [1052736] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1052603] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057284, T32HD007109] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051435] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Autism Speaks; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by grants from National Institutes of Health (R01HD047417, R01HD057284, R01MH051435, and 1R01GM105004) http://www.nih.gov/, National Science Foundation (INT-0808767, 1052736, and BCS-1323927) http://www.nsf.gov/, and Autism Speaks http://www.autismspeaks.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Baker S, 2004, IEEE T PATTERN ANAL, V26, P1380, DOI 10.1109/TPAMI.2004.77; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Camras LA, 2012, ASS PSYCH SCI 24 ANN; Camras LA, 2007, INFANCY, V11, P131, DOI 10.1111/j.1532-7078.2007.tb00219.x; Camras LA, 2011, EMOT REV, V3, P138, DOI 10.1177/1754073910387944; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; Darwin CR, 1872, EXPRESSION EMOTIONS, P33; Duchenne G.-B., 1990, MECH HUMAN FACIAL EX; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, FACIAL ACTION CODING; Fernandez-Dols JM, 2011, J NONVERBAL BEHAV, V35, P63, DOI 10.1007/s10919-010-0097-7; Fogel A, 2000, SOC DEV, V9, P497, DOI 10.1111/1467-9507.00140; FOX NA, 1988, DEV PSYCHOL, V24, P230, DOI 10.1037/0012-1649.24.2.230; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Fridlund A. J., 1997, PSYCHOL FACIAL EXPRE, P103, DOI [10.1017/CBO9780511659911.007, DOI 10.1017/CBO9780511659911.007]; GRUNAU RVE, 1987, PAIN, V28, P395, DOI 10.1016/0304-3959(87)90073-X; Izard, 1983, MAXIMALLY DISCRIMINA; Izard C. E., 1997, PSYCHOL FACIAL EXPRE, V2, P57, DOI DOI 10.1017/CBO9780511659911.005; IZARD CE, 1987, DEV PSYCHOL, V23, P105, DOI 10.1037/0012-1649.23.1.105; Kohut SA, 2012, PAIN, V153, P2458, DOI 10.1016/j.pain.2012.09.005; MATSUMOTO D, 1989, J NONVERBAL BEHAV, V13, P171, DOI 10.1007/BF00987048; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; Messinger DS, 2008, J NONVERBAL BEHAV, V32, P133, DOI 10.1007/s10919-008-0048-8; Messinger DS, 2012, EMOTION, V12, P430, DOI 10.1037/a0026498; Messinger DS, 2002, CURR DIR PSYCHOL SCI, V11, P1, DOI 10.1111/1467-8721.00156; Messinger DS, 2001, DEV PSYCHOL, V37, P642, DOI 10.1037/0012-1649.37.5.642; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Oster H, 2003, ANN NY ACAD SCI, V1000, P197, DOI 10.1196/annals.1280.024; OSTER H, 1992, DEV PSYCHOL, V28, P1115, DOI 10.1037/0012-1649.28.6.1115; Oster H, 2009, BABY FACS FACIAL ACT; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Scherer KR, 2007, EMOTION, V7, P113, DOI 10.1037/1528-3542.7.1.113; Segal LB, 1995, CHILD DEV, V66, P1829; SMITH CA, 1989, J PERS SOC PSYCHOL, V56, P339, DOI 10.1037/0022-3514.56.3.339; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	41	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80161	10.1371/journal.pone.0080161	http://dx.doi.org/10.1371/journal.pone.0080161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278255	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000327313100077
J	Smaldino, PE; Newson, L; Schank, JC; Richerson, PJ				Smaldino, Paul E.; Newson, Lesley; Schank, Jeffrey C.; Richerson, Peter J.			Simulating the Evolution of the Human Family: Cooperative Breeding Increases in Harsh Environments	PLOS ONE			English	Article							SOCIAL CATEGORIES; SEXUAL SELECTION; PARENTAL CHOICE; PREFERENCES; EMERGENCE; COMPETITION; DEMOGRAPHY; CONFLICT; ECOLOGY; HISTORY	Verbal and mathematical models that consider the costs and benefits of behavioral strategies have been useful in explaining animal behavior and are often used as the basis of evolutionary explanations of human behavior. In most cases, however, these models do not account for the effects that group structure and cultural traditions within a human population have on the costs and benefits of its members' decisions. Nor do they consider the likelihood that cultural as well as genetic traits will be subject to natural selection. In this paper, we present an agent-based model that incorporates some key aspects of human social structure and life history. We investigate the evolution of a population under conditions of different environmental harshness and in which selection can occur at the level of the group as well as the level of the individual. We focus on the evolution of a socially learned characteristic related to individuals' willingness to contribute to raising the offspring of others within their family group. We find that environmental harshness increases the frequency of individuals who make such contributions. However, under the conditions we stipulate, we also find that environmental variability can allow groups to survive with lower frequencies of helpers. The model presented here is inevitably a simplified representation of a human population, but it provides a basis for future modeling work toward evolutionary explanations of human behavior that consider the influence of both genetic and cultural transmission of behavior.	[Smaldino, Paul E.] Johns Hopkins Univ, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21218 USA; [Newson, Lesley; Richerson, Peter J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Schank, Jeffrey C.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Newson, Lesley] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Johns Hopkins University; University of California System; University of California Davis; University of California System; University of California Davis; University of Exeter	Smaldino, PE (corresponding author), Johns Hopkins Univ, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD 21218 USA.	paul.smaldino@gmail.com		Smaldino, Paul/0000-0002-7133-5620	National Institute of Health (NIH) [DP1OD003874]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	PES was supported, in part, by an National Institute of Health (NIH) Director's Pioneer Award, DP1OD003874, to Joshua M. Epstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou M, 2007, EVOL HUM BEHAV, V28, P403, DOI 10.1016/j.evolhumbehav.2007.05.007; Apostolou M, 2012, EVOL PSYCHOL-US, V10, P504; Apostolou M, 2010, EVOL HUM BEHAV, V31, P39, DOI 10.1016/j.evolhumbehav.2009.06.010; Axtell RL, 2002, P NATL ACAD SCI USA, V99, P7275, DOI 10.1073/pnas.092080799; Bentley GR, 1998, AM J HUM BIOL, V10, P151, DOI 10.1002/(SICI)1520-6300(1998)10:2<151::AID-AJHB2>3.0.CO;2-O; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bobe R, 2009, 1 HUMANS ORIGINS EAR; Boehm C., 1999, HIERARCHY FOREST EVO; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Buunk AP, 2008, REV GEN PSYCHOL, V12, P47, DOI 10.1037/1089-2680.12.1.47; Caspari R, 2006, AM J PHYS ANTHROPOL, V129, P512, DOI 10.1002/ajpa.20360; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Emlen ST., 1984, BEHAV ECOLOGY EVOLUT, V2, P305; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Gigerenzer G., 2012, ECOLOGICAL RATIONALI, DOI DOI 10.1093/ACPROF; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Hawkes K., 2006, EVOLUTION HUMAN LIFE; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hochberg ME, 2000, J EVOLUTION BIOL, V13, P213, DOI 10.1046/j.1420-9101.2000.00157.x; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Hrdy SB., 1999, ANIM BEHAV, DOI DOI 10.1006/ANBE.1999.1378; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jetz W, 2011, CURR BIOL, V21, P72, DOI 10.1016/j.cub.2010.11.075; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H, 1997, BETWEEN ZEUS AND THE SALMON, P175; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Kropotkin P., 1902, MUTUAL AID; LAFRENIERE P, 1984, CHILD DEV, V55, P1958; LEVINS R, 1966, AM SCI, V54, P421; Mace R, 2000, ANIM BEHAV, V59, P1, DOI 10.1006/anbe.1999.1287; Marlowe FW, 2001, CURR ANTHROPOL, V42, P755, DOI 10.1086/323820; Newson L, 2013, BUILDING BABIES PRIM; Pagel M, 2004, NATURE, V428, P275, DOI 10.1038/428275a; Perreault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045150; PIMM SL, 1988, NATURE, V334, P613, DOI 10.1038/334613a0; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Requejo RJ, 2011, J THEOR BIOL, V272, P35, DOI 10.1016/j.jtbi.2010.12.005; Richerson P., 2009, CLIODYNAMICS, DOI [10.2139/ssrn.1368756, DOI 10.21237/C7CLIO3112453]; Richerson Peter, 2013, CLIODYNAMICS, V4, P139; Richerson PJ, EVOLUTION MIND BRAIN, P263; Roberts SC, 2008, GENETICA, V134, P31, DOI 10.1007/s10709-008-9254-x; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Shutts K, 2013, J COGN DEV, V14, P35, DOI 10.1080/15248372.2011.638686; Shutts K, 2010, DEVELOPMENTAL SCI, V13, P599, DOI 10.1111/j.1467-7687.2009.00913.x; Smaldino P., 2013, BEHAV BRAIN IN PRESS; Smaldino PE, 2013, AM NAT, V181, P451, DOI 10.1086/669615; Smaldino PE, 2012, COMPLEXITY, V17, P11, DOI 10.1002/cplx.21382; Smaldino PE, 2014, HDB HUMAN COMPUTATIO; Solomon N. G., 1997, COOPERATIVE BREEDING; Stacey P.B., 1990, COOPERATIVE BREEDING; Stiver KA, 2009, ETHOLOGY, V115, P1101, DOI 10.1111/j.1439-0310.2009.01707.x; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Trivers RL., 1972, SEXUAL SELECTION DES; Tybur JM, 2011, PHILOS T R SOC B, V366, P3375, DOI 10.1098/rstb.2011.0136; Weiner J, 1994, BREAK FINCH; West SA, 2006, CURR BIOL, V16, P1103, DOI 10.1016/j.cub.2006.03.069; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Whitehead H, 2009, EVOL HUM BEHAV, V30, P261, DOI 10.1016/j.evolhumbehav.2009.02.003; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Winking J, 2011, EVOL HUM BEHAV, V32, P79, DOI 10.1016/j.evolhumbehav.2010.08.002; Wood BM, 2006, CURR ANTHROPOL, V47, P383, DOI 10.1086/503068; [No title captured]	78	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80753	10.1371/journal.pone.0080753	http://dx.doi.org/10.1371/journal.pone.0080753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LY	24278318	Green Published, gold			2022-12-27	WOS:000327313100110
J	Tanaka, M; Ishii, A; Watanabe, Y				Tanaka, Masaaki; Ishii, Akira; Watanabe, Yasuyoshi			Neural Mechanism of Facilitation System during Physical Fatigue	PLOS ONE			English	Article							HUMAN MUSCLE FATIGUE; MOTOR CORTEX; PREFRONTAL CORTEX; MENTAL FATIGUE; BRAIN; ACTIVATION; OUTPUT; MAGNETOENCEPHALOGRAPHY; SCALE	An enhanced facilitation system caused by motivational input plays an important role in supporting performance during physical fatigue. We tried to clarify the neural mechanisms of the facilitation system during physical fatigue using magnetoencephalography (MEG) and a classical conditioning technique. Twelve right-handed volunteers participated in this study. Participants underwent MEG recording during the imagery of maximum grips of the right hand guided by metronome sounds for 10 min. Thereafter, fatigue-inducing maximum handgrip trials were performed for 10 min; the metronome sounds were started 5 min after the beginning of the handgrip trials. The metronome sounds were used as conditioned stimuli and maximum handgrip trials as unconditioned stimuli. The next day, they were randomly assigned to two groups in a single-blinded, two-crossover fashion to undergo two types of MEG recordings, that is, for the control and motivation sessions, during the imagery of maximum grips of the right hand guided by metronome sounds for 10 min. The alpha-band event-related desynchronizations (ERDs) of the motivation session relative to the control session within the time windows of 500 to 700 and 800 to 900 ms after the onset of handgrip cue sounds were identified in the sensorimotor areas. In addition, the alpha-band ERD within the time window of 400 to 500 ms was identified in the right dorsolateral prefrontal cortex (Brodmann's area 46). The ERD level in the right dorsolateral prefrontal cortex was positively associated with that in the sensorimotor areas within the time window of 500 to 700 ms. These results suggest that the right dorsolateral prefrontal cortex is involved in the neural substrates of the facilitation system and activates the sensorimotor areas during physical fatigue.	[Tanaka, Masaaki; Ishii, Akira; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan; [Watanabe, Yasuyoshi] RIKEN Ctr Life Sci Technol, Kobe, Hyogo, Japan	Osaka Metropolitan University; RIKEN	Tanaka, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 558, Japan.	masa-t@msic.med.osaka-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [KAKENHI: 23300241]; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The authors thank Forte Science Communication for editorial assistance with the manuscript. This work was supported in part by the Grant-in-Aid for Scientific Research B (KAKENHI: 23300241) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the grant from Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Dettmers C, 1996, NEUROREPORT, V7, P2103, DOI 10.1097/00001756-199609020-00008; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; GOLDMANRAKIC PS, 1987, CIBA F SYMP, V132, P187; Hilty L, 2011, EUR J NEUROSCI, V34, P2035, DOI 10.1111/j.1460-9568.2011.07909.x; Ishii A, 2013, BRAIN RES, V1529, P105, DOI 10.1016/j.brainres.2013.07.022; KOLB B, 1983, CAN J PSYCHOL, V37, P211, DOI 10.1037/h0080724; Korotkov A, 2005, EXP BRAIN RES, V163, P65, DOI 10.1007/s00221-004-2141-5; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Liu JZ, 2007, NEUROIMAGE, V35, P299, DOI 10.1016/j.neuroimage.2006.09.050; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Schmidt L, 2009, J NEUROSCI, V29, P9450, DOI 10.1523/JNEUROSCI.1951-09.2009; Shigihara Y, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-2; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Tanaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070949; Tanaka M, 2012, INT J PSYCHIAT CLIN, V16, P312, DOI 10.3109/13651501.2011.653378; Tanaka M, 2012, NEUROSCI BIOBEHAV R, V36, P727, DOI 10.1016/j.neubiorev.2011.10.004; Tanaka M, 2011, BRAIN RES, V1412, P37, DOI 10.1016/j.brainres.2011.07.021; Tanaka M, 2011, BRAIN RES, V1395, P46, DOI 10.1016/j.brainres.2011.04.041; Tanaka M, 2010, MED HYPOTHESES, V75, P244, DOI 10.1016/j.mehy.2010.02.032; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550	29	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80731	10.1371/journal.pone.0080731	http://dx.doi.org/10.1371/journal.pone.0080731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278313	gold, Green Published, Green Submitted			2022-12-27	WOS:000327313100105
J	Zhou, SL; Ruan, YQ; Yu, HC; Chen, YZ; Yao, YJ; Ma, YH; Gao, Y				Zhou, Shanliang; Ruan, Yueqin; Yu, Hongchen; Chen, Yunzhi; Yao, Yongjun; Ma, Yanhui; Gao, Yan			Functional IL-23R rs10889677 Genetic Polymorphism and Risk of Multiple Solid Tumors: a Meta-Analysis	PLOS ONE			English	Article							REGULATORY T-CELLS; CANCER; INTERLEUKIN-23; VARIANTS; CHINESE; LUNG	Interleukin-23 receptor (IL23R) can interact with IL-23 and, thus, is involved in the T-helper 17 (Th17) cell-mediated inflammatory process as well as tumorigenesis. Recently, a functional single nucleotide polymorphism (SNP) rs10889677 has been identified in the 3'-untranslated region of IL-23R. It has been showed that the rs10889677AC SNP could increase the binding affinity of microRNA let-7f and downregulate IL-23R expression. Several case-control studies have examined the association between this SNP and genetic susceptibility of multiple solid tumors. However, the conclusions are conflicting. Therefore, we conducted this meta-analysis to systematically study the role of this functional IL-23R SNP in development of multiple solid tumors. There are a total of 5 studies are eligible (6731 cases and 7296 healthy controls). Either fixed-effect model or random-effect model was used to calculate pooled odds ratios (ORs) and the 95% confidence interval (95% CI). Significant association between this functional rs10889677 genetic variant and risk of multiple solid tumors were observed (CC genotype vs. AA genotype: OR = 0.59, 95% CI = 0.53-0.66, P < 0.001). These findings demonstrated that the IL-23R rs10889677 genetic variant might play an important part during malignant transformation of multiple solid tumors.	[Zhou, Shanliang] Canc Hosp Shandong Linyi, Clin Lab, Linyi, Shandong, Peoples R China; [Ruan, Yueqin] Binzhou Med Coll, Affiliated Hosp, Clin Lab, Binzhou, Shandong, Peoples R China; [Yu, Hongchen] Qingdao Orthoped & Traumatol Hosp, Qingdao, Shandong, Peoples R China; [Chen, Yunzhi] Peoples Hosp Chengwu Cty, Clin Lab, Heze, Shandong, Peoples R China; [Yao, Yongjun; Gao, Yan] Peoples Hosp Cangshan Cty, Dept Pathol, Linyi, Shandong, Peoples R China; [Ma, Yanhui] Shandong Univ, Qilu Childrens Hosp, Jinan 250100, Peoples R China	Binzhou Medical University; Shandong University	Ma, YH (corresponding author), Shandong Univ, Qilu Childrens Hosp, Jinan 250100, Peoples R China.	yanhui_mama@yeah.net; sd-cY-gY@163.com						Cai X, 2012, J CANCER RES CLIN, V138, P555, DOI 10.1007/s00432-011-1124-8; Chen B, 2011, CANCER EPIDEMIOL, V35, P165, DOI 10.1016/j.canep.2010.08.006; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P551, DOI 10.1002/hed.21779; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Liu L, 2013, EUR J CANCER, V49, P2143, DOI 10.1016/j.ejca.2013.01.028; MANTEL N, 1959, J NATL CANCER I, V22, P719; PETITTI DB, 1994, AM J EPIDEMIOL, V140, P779, DOI 10.1093/oxfordjournals.aje.a117325; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Yu DK, 2012, TUMOR BIOL, V33, P877, DOI 10.1007/s13277-011-0314-y; Zhang Z, 2010, CANCER GENET CYTOGEN, V196, P146, DOI 10.1016/j.cancergencyto.2009.09.006; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307	22	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80627	10.1371/journal.pone.0080627	http://dx.doi.org/10.1371/journal.pone.0080627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278297	Green Published, gold, Green Submitted			2022-12-27	WOS:000327313100097
J	Holliday, EG; Magee, CA; Kritharides, L; Banks, E; Attia, J				Holliday, Elizabeth G.; Magee, Christopher A.; Kritharides, Leonard; Banks, Emily; Attia, John			Short Sleep Duration Is Associated with Risk of Future Diabetes but Not Cardiovascular Disease: a Prospective Study and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; LEPTIN LEVELS; MORTALITY; QUALITY; POPULATION; MEN; COMPLAINTS; QUANTITY; WORKERS	Epidemiologic studies have observed association between short sleep duration and both cardiovascular disease (CVD) and type 2 diabetes, although these results may reflect confounding by pre-existing illness. This study aimed to determine whether short sleep duration predicts future CVD or type 2 diabetes after accounting for baseline health. Baseline data for 241,949 adults were collected through the 45 and Up Study, an Australian prospective cohort study, with health outcomes identified via electronic database linkage. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals. Compared to 7h sleep, <6h sleep was associated with incident CVD in participants reporting ill-health at baseline (HR=1.38 [95% CI: 1.12-1.70]), but not after excluding those with baseline illness and adjusting for baseline health status (1.03 [0.88-1.21]). In contrast, the risk of incident type 2 diabetes was significantly increased in those with <6h versus 7h sleep, even after excluding those with baseline illness and adjusting for baseline health (HR=1.29 [1.08-1.53], P=0.004). This suggests the association is valid and does not simply reflect confounding or reverse causation. Meta-analysis of ten prospective studies including 447,124 participants also confirmed an association between short sleep and incident diabetes (1.33 [1.20-1.48]). Obtaining less than 6 hours of sleep each night (compared to 7 hours) may increase type 2 diabetes risk by approximately 30%.	[Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Magee, Christopher A.] Univ Wollongong, Ctr Hlth Initiat, Wollongong, NSW, Australia; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW 2006, Australia; [Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Wollongong; Concord Repatriation General Hospital; University of Sydney; Australian National University; University of Sydney	Holliday, EG (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	Liz.Holliday@newcastle.edu.au	Smith, Albert Vernon/K-5150-2015; Scott, Rodney J/B-2827-2013; Liew, Gerald/AAB-6870-2022; Hewitt, Alex W/D-1936-2013; Brown, Matthew A/E-5749-2010; Jonasson, Fridbert/ABA-9889-2021; Kritharides, Leonard/AAQ-2720-2020; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Jankowski, Janusz/H-2706-2012; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Bellenguez, Céline/X-4004-2019; Tai, E Shyong/J-9831-2013; Belllenguez, Céline/Y-3183-2018; Attia, John R/F-5376-2013; Sim, Xueling/AAZ-6652-2020; Klaver, Caroline C.W./A-2013-2016; Cheng, Ching-Yu/K-7017-2013; Wang, Jie Jin/P-1499-2014; Rotter, Jerome/AAY-6598-2021; Cheng, Ching-Yu/Y-2229-2019; Aspelund, Thor/K-7022-2019; Blackwell, Jenefer M/H-3015-2015	Smith, Albert Vernon/0000-0003-1942-5845; Scott, Rodney J/0000-0001-7724-3404; Hewitt, Alex W/0000-0002-5123-5999; Brown, Matthew A/0000-0003-0538-8211; Wong, Tien Yin/0000-0002-8448-1264; Jankowski, Janusz/0000-0003-2130-9181; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Bellenguez, Céline/0000-0002-1240-7874; Belllenguez, Céline/0000-0002-1240-7874; Attia, John R/0000-0001-9800-1308; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Aspelund, Thor/0000-0002-7998-5433; Van Duijn, Cornelia/0000-0002-2374-9204; Klein, Ronald/0000-0002-4428-6237; Tai, E Shyong/0000-0003-2929-8966; Banks, Emily/0000-0002-4617-1302; Magee, Christopher/0000-0002-0465-6328; /0000-0001-6694-3587; Inouye, Michael/0000-0001-9413-6520; Klaver, Caroline/0000-0002-2355-5258; Plomin, Robert/0000-0002-0756-3629; Baird, Paul/0000-0002-1305-3502; Gillman, Matthew S./0000-0002-2340-6930; Cotch, Mary Frances/0000-0002-2046-4350	The Sax Institute; Cancer Council New South Wales; National Heart Foundation of Australia (New South Wales Division); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; Australian Red Cross Blood Service; Uniting Care Ageing; Australian National Health and Medical Research Council; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC085084, N01HC045133, N01HC085082, N01HC085080, N01HC035129, N01HC085081, N01HC055222, N01HC015103, N01HC085085, N01HC085086, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000426, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL080295, U01HL080295, R01HL105756, R01HL086694, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, R01AG015928, ZIAAG007380, R56AG020098, R01AG020098, R56AG023629, R01AG023629, ZIAAG007270, R01AG027058] Funding Source: NIH RePORTER	The Sax Institute(University of Sydney); Cancer Council New South Wales(Cancer Council New South Wales); National Heart Foundation of Australia (New South Wales Division)(National Heart Foundation of Australia); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; Australian Red Cross Blood Service; Uniting Care Ageing; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Sax Institute; Cancer Council New South Wales; the National Heart Foundation of Australia (New South Wales Division); The New South Wales Ministry of Health; Beyondblue: the National Depression Initiative; Ageing, Disability and Home Care, New South Wales Family and Community Services; the Australian Red Cross Blood Service; Uniting Care Ageing; the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Banks Emily, 2009, Aust New Zealand Health Policy, V6, P16, DOI 10.1186/1743-8462-6-16; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Ghanaat F, 2005, METABOLISM, V54, P604, DOI 10.1016/j.metabol.2004.12.003; Hayashino Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-129; HAYS RD, 1995, RAND USERS MANUAL ME; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hosmer D, 2008, APPL SURVIVAL ANAL R, P132; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Johansson I, 2010, EUR J CARDIOVASC NUR, V9, P175, DOI 10.1016/j.ejcnurse.2009.12.003; Kita T, 2012, DIABETES CARE, V35, P313, DOI 10.2337/dc11-1455; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Meisinger C, 2007, SLEEP, V30, P1121, DOI 10.1093/sleep/30.9.1121; *NAT CTR CLASS HLT, 2007, ICD10AM NAT CTR CLAS; Olafiranye O, 2012, SLEEP MED, V13, P728, DOI 10.1016/j.sleep.2012.01.015; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281; Shankar A, 2011, SLEEP, V34, P1173, DOI 10.5665/SLEEP.1232; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Suzuki E, 2009, PREV MED, V49, P135, DOI 10.1016/j.ypmed.2009.06.016; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; *WHO, 2008, ACT PLAN GLOB STRAT, P2008; Xu Q, 2010, DIABETES CARE, V33, P78, DOI 10.2337/dc09-1143; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879	40	193	198	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82305	10.1371/journal.pone.0082305	http://dx.doi.org/10.1371/journal.pone.0082305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282622	Green Published, Green Submitted, gold			2022-12-27	WOS:000327543500126
J	Zhu, ZW; Zhang, XH; Shen, ZJ; Zhong, S; Wang, XJ; Lu, YL; Xu, C				Zhu, Zhaowei; Zhang, Xiaohua; Shen, Zhoujun; Zhong, Shan; Wang, Xianjin; Lu, Yingli; Xu, Chen			Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							POPULATION-BASED COHORT; GROWTH-FACTOR-I; FOLLOW-UP; PROSTATE-CANCER; INCIDENT CANCER; PLASMA-LEVELS; US ADULTS; MORTALITY; ASSOCIATION; METFORMIN	Background: Increasing evidence suggests that diabetes mellitus (DM) may be associated with an increased risk of bladder cancer. To provide a quantitative assessment of this association, we evaluated the relation between DM and incidence and mortality of bladder cancer in an updated meta-analysis of cohort studies. Methods We identified cohort studies by searching the EMBASE and MEDLINE databases, through 31 March 2012. Summary relative risks (RRs) with 95% confidence intervals (CIs) were calculated with random-effects models. Results: A total of 29 cohort studies (27 articles) were included in this meta-analysis. DM was associated with an increased incidence of bladder cancer (RR 1.29, 95% CI: 1.08-1.54), with significant evidence of heterogeneity among these studies (p<0.001, I-2 = 94.9%). In stratified analysis, the RRs of bladder cancer were 1.36 (1.05-1.77) for diabetic men and 1.28 (0.75-2.19) for diabetic women, respectively. DM was also positively associated with bladder cancer mortality (RR 1.33, 95% CI: 1.14-1.55), with evident heterogeneity between studies (p = 0.002, I-2 = 63.3%). The positive association was observed for both men (RR 1.54, 95% CI: 1.30-1.82) and women (RR 1.50, 95% CI: 1.05-2.14). Conclusion: These findings suggest that compared to non-diabetic individuals, diabetic individuals have an increased incidence and mortality of bladder cancer.	[Zhu, Zhaowei; Zhang, Xiaohua; Shen, Zhoujun; Zhong, Shan; Wang, Xianjin] Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Lu, Yingli] Shanghai Jiao Tong Univ, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Xu, Chen] Shanghai Jiao Tong Univ, Dept Histol & Embryol, Sch Med, Shanghai 200030, Peoples R China; [Xu, Chen] Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Shen, ZJ (corresponding author), Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	shenzj6@sina.com; luy662003@yahoo.com.cn			National Natural Science Foundation of China [81072098]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]; Shanghai Basic Research Project [09DJ1400400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Basic Research Project	This work was supported by The National Natural Science Foundation of China (No. 81072098), Science and Technology Commission of Shanghai Municipality (No. 10DZ2270600), Shanghai Leading Academic Discipline Project (No. S30201) and Shanghai Basic Research Project (No. 09DJ1400400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Behrens T, 2009, J OCCUP ENVIRON HYG, V6, P555, DOI 10.1080/15459620903077682; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; BULBULYAN MA, 1995, INT J EPIDEMIOL, V24, P266, DOI 10.1093/ije/24.2.266; Chung H, 2009, UROLOGY, V74, pS36, DOI DOI 10.1016/J.UROLOGY.2009.07.1106; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Colmers IN, 2012, CAN MED ASSOC J, V184, pE675, DOI 10.1503/cmaj.112102; Corona G, 2011, INT J ANDROL, V34, P528, DOI 10.1111/j.1365-2605.2010.01117.x; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunn SE, 1997, CANCER RES, V57, P4667; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fernandez MI, 2012, J UROLOGY, V187, P856, DOI 10.1016/j.juro.2011.10.157; Ferrucci LM, 2010, CANCER-AM CANCER SOC, V116, P4345, DOI 10.1002/cncr.25463; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Guha N, 2010, OCCUP ENVIRON MED, V67, P568, DOI 10.1136/oem.2009.051565; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hwang EC, 2011, INT J UROL, V18, P769, DOI 10.1111/j.1442-2042.2011.02845.x; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KESSLER II, 1970, J NATL CANCER I, V44, P673; Kessler TM, 2008, EUR UROL, V53, P1040, DOI 10.1016/j.eururo.2007.09.044; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Lam EKK, 2011, ANN ONCOL, V22, P730, DOI 10.1093/annonc/mdq405; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lee MY, 2012, METABOLISM, V61, P242, DOI 10.1016/j.metabol.2011.06.020; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Li CY, 2011, DIABETES CARE, V34, P1365, DOI 10.2337/dc11-0020; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu XD, 2012, EUR J CANCER PREV, V21, P300, DOI 10.1097/CEJ.0b013e32834c9cd9; Liu XD, 2012, CANCER-AM CANCER SOC, V118, P1353, DOI 10.1002/cncr.26420; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Pira E, 2010, JNCI-J NATL CANCER I, V102, P1096, DOI 10.1093/jnci/djq214; RAGOZZINO M, 1982, J CHRON DIS, V35, P13, DOI 10.1016/0021-9681(82)90025-X; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shariat SF, 2003, UROLOGY, V61, P359, DOI 10.1016/S0090-4295(02)02253-7; Shu X, 2010, DIABETIC MED, V27, P791, DOI 10.1111/j.1464-5491.2010.03011.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swerdlow AJ, 2005, BRIT J CANCER, V92, P2070, DOI 10.1038/sj.bjc.6602611; Tripathi A, 2002, CANCER-AM CANCER SOC, V95, P2316, DOI 10.1002/cncr.10975; Tseng CH, 2011, DIABETOLOGIA, V54, P2009, DOI 10.1007/s00125-011-2171-z; Tseng CH, 2009, ANN MED, V41, P371, DOI 10.1080/07853890902729778; Verlato G, 2003, DIABETES CARE, V26, P1047, DOI 10.2337/diacare.26.4.1047; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vigneri R, 2009, NAT REV ENDOCRINOL, V5, P651, DOI 10.1038/nrendo.2009.219; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Woolcott CG, 2011, CANCER EPIDEMIOL, V35, P551, DOI 10.1016/j.canep.2011.02.014; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yood MU, 2009, DIABETES METAB SYND, V3, P12, DOI 10.1016/j.dsx.2008.10.003; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105; Zhang F, 2012, ACTA DIABETOL, V49, pS235, DOI 10.1007/s00592-012-0439-5; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512; Zhao H, 2003, J UROLOGY, V169, P714, DOI 10.1016/S0022-5347(05)63999-7; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	71	69	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56662	10.1371/journal.pone.0056662	http://dx.doi.org/10.1371/journal.pone.0056662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278234	Green Published, Green Submitted, gold			2022-12-27	WOS:000315184200134
J	Zhao, QB; Zhou, ZJ; Xu, HB; Chen, S; Xu, F; Fan, WL; Han, L				Zhao, Qingbai; Zhou, Zhijin; Xu, Haibo; Chen, Shi; Xu, Fang; Fan, Wenliang; Han, Lei			Dynamic Neural Network of Insight: A Functional Magnetic Resonance Imaging Study on Solving Chinese 'Chengyu' Riddles	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEFAULT MODE; AMYGDALA; BRAIN; AHA; CONFLICT; ACTIVATION; SYSTEM; TASK; EEG	The key components of insight include breaking mental sets and forming the novel, task-related associations. The majority of researchers have agreed that the anterior cingulate cortex may mediate processes of breaking ones mental set, while the exact neural correlates of forming novel associations are still debatable. In the present study, we used a paradigm of answer selection to explore brain activations of insight by using event-related functional magnetic resonance imaging during solving Chinese chengyu (in Chinese pinyin) riddles. Based on the participants choice, the trials were classified into the insight and non-insight conditions. Both stimulus-locked and response-locked analyses are conducted to detect the neural activity corresponding to the early and late periods of insight solution, respectively. Our data indicate that the early period of insight solution shows more activation in the middle temporal gyrus, the middle frontal gyrus and the anterior cingulate cortex. These activities might be associated to the extensive semantic processing, as well as detecting and resolving cognitive conflicts. In contrast, the late period of insight solution produced increased activities in the hippocampus and the amygdala, possibly reflecting the forming of novel association and the concomitant Aha feeling. Our study supports the key role of hippocampus in forming novel associations, and indicates a dynamic neural network during insight solution.	[Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China; [Zhao, Qingbai; Zhou, Zhijin; Chen, Shi; Xu, Fang] Cent China Normal Univ, Sch Psychol, Key Lab Human Dev & Mental Hlth Hubei Prov, Wuhan, Peoples R China; [Xu, Haibo; Fan, Wenliang] Huazhong Univ Sci & Technol, MRI Ctr Union Hosp, Wuhan 430074, Peoples R China; [Han, Lei] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China	Central China Normal University; Huazhong University of Science & Technology; Shandong Normal University	Zhou, ZJ (corresponding author), Minist Educ, Key Lab Adolescent Cyberpsychol & Behav CCNU, Wuhan, Peoples R China.	zhouzj@mail.ccnu.edu.cn; xuhaibo1120@hotmail.com		Fan, Wenliang/0000-0001-8949-6775	National Natural Science Foundation of China [81171386, 30770623]; Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china [10YJCXLX065]; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities [CCNU11C01005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china; Social Science Foundation of Hubei Province; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (grant 81171386 and 30770623), the Social Science and Humanitites Research Youth Foundation Project of the Educational Ministry of china (grant 10YJCXLX065), and the "Twelfth Five" Plan Project from Social Science Foundation of Hubei Province, as well as by the Fundamental Research Funds for Central Universities (grant CCNU11C01005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, BRAIN LANG, V100, P163, DOI 10.1016/j.bandl.2005.10.004; Aziz-Zadeh L, 2009, HUM BRAIN MAPP, V30, P908, DOI 10.1002/hbm.20554; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bink M.L., 2000, REV GEN PSYCHOL, V4, P59, DOI DOI 10.1037/1089-2680.4.1.59; Bowden EM, 2007, METHODS, V42, P87, DOI 10.1016/j.ymeth.2006.11.007; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Cranford EA, 2012, J PROBL SOLVING, V4, P128, DOI 10.7771/1932-6246.1129; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Huang FR, 2013, ACTA PSYCHOL SINICA, V45, P36; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; Johnson JD, 2008, HIPPOCAMPUS, V18, P975, DOI 10.1002/hipo.20456; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kershaw TC, 2004, J EXP PSYCHOL LEARN, V30, P3, DOI 10.1037/0278-7393.30.1.3; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Kohler W., 1925, MENTALITY APES; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Luo J, 2002, HIPPOCAMPUS, V12, P487, DOI 10.1002/hipo.10027; Luo J, 2006, BRAIN RES BULL, V70, P430, DOI 10.1016/j.brainresbull.2006.07.005; [罗劲 Luo Jing], 2004, [心理学报, Acta Psychologica Sinica], V36, P219; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mai XQ, 2004, HUM BRAIN MAPP, V22, P261, DOI 10.1002/hbm.20030; Mashal N, 2008, CORTEX, V44, P848, DOI 10.1016/j.cortex.2007.04.004; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Qiu J, 2008, BRAIN COGNITION, V68, P100, DOI 10.1016/j.bandc.2008.03.004; Qiu J, 2008, EXP BRAIN RES, V186, P629, DOI 10.1007/s00221-008-1270-7; Qiu J, 2006, NEUROREPORT, V17, P679, DOI 10.1097/00001756-200604240-00025; Qiu J, 2010, CORTEX, V46, P397, DOI 10.1016/j.cortex.2009.06.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Redish AD, 2001, BEHAV BRAIN RES, V127, P81, DOI 10.1016/S0166-4328(01)00356-4; Sandkuhler S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001459; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Weisberg RW, 1996, NATURE INSIGHT; Zhang M, 2011, BRAIN RES BULL, V84, P210, DOI 10.1016/j.brainresbull.2011.01.001	47	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59351	10.1371/journal.pone.0059351	http://dx.doi.org/10.1371/journal.pone.0059351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24282623	Green Submitted, gold, Green Published			2022-12-27	WOS:000316409800084
J	Holliday, EG; Smith, AV; Cornes, BK; Buitendijk, GHS; Jensen, RA; Sim, XL; Aspelund, T; Aung, T; Baird, PN; Boerwinkle, E; Cheng, CY; van Duijn, CM; Eiriksdottir, G; Gudnason, V; Harris, T; Hewitt, AW; Inouye, M; Jonasson, F; Klein, BEK; Launer, L; Li, XH; Liew, G; Lumley, T; McElduff, P; McKnight, B; Mitchell, P; Psaty, BM; Rochtchina, E; Rotter, JI; Scott, RJ; Tay, WT; Taylor, K; Teo, YY; Uitterlinden, AG; Viswanathan, A; Xie, S; Vingerling, JR; Klaver, CCW; Tai, ES; Siscovick, D; Klein, R; Cotch, MF; Wong, TY; Attia, J; Wang, JJ				Holliday, Elizabeth G.; Smith, Albert V.; Cornes, Belinda K.; Buitendijk, Gabrielle H. S.; Jensen, Richard A.; Sim, Xueling; Aspelund, Thor; Aung, Tin; Baird, Paul N.; Boerwinkle, Eric; Cheng, Ching Yu; van Duijn, Cornelia M.; Eiriksdottir, Gudny; Gudnason, Vilmundur; Harris, Tamara; Hewitt, Alex W.; Inouye, Michael; Jonasson, Fridbert; Klein, Barbara E. K.; Launer, Lenore; Li, Xiaohui; Liew, Gerald; Lumley, Thomas; McElduff, Patrick; McKnight, Barbara; Mitchell, Paul; Psaty, Bruce M.; Rochtchina, Elena; Rotter, Jerome I.; Scott, Rodney J.; Tay, Wanting; Taylor, Kent; Teo, Yik Ying; Uitterlinden, Andre G.; Viswanathan, Ananth; Xie, Sophia; Vingerling, Johannes R.; Klaver, Caroline C. W.; Tai, E. Shyong; Siscovick, David; Klein, Ronald; Cotch, Mary Frances; Wong, Tien Y.; Attia, John; Wang, Jie Jin		Wellcome Trust Case Control Consor	Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration: A Genome-Wide Association Study Meta-Analysis	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; SKIN PIGMENTATION; IDENTIFIES 3; RISK; PROGRESSION; POPULATION; EYE; VARIANTS	Genetic factors explain a majority of risk variance for age-related macular degeneration (AMD). While genome-wide association studies (GWAS) for late AMD implicate genes in complement, inflammatory and lipid pathways, the genetic architecture of early AMD has been relatively under studied. We conducted a GWAS meta-analysis of early AMD, including 4,089 individuals with prevalent signs of early AMD (soft drusen and/or retinal pigment epithelial changes) and 20,453 individuals without these signs. For various published late AMD risk loci, we also compared effect sizes between early and late AMD using an additional 484 individuals with prevalent late AMD. GWAS meta-analysis confirmed previously reported association of variants at the complement factor H (CFH) (peak P = 1.5x10(-31)) and age-related maculopathy susceptibility 2 (ARMS2) (P = 4.3x10(-24)) loci, and suggested Apolipoprotein E (ApoE) polymorphisms (rs2075650; P = 1.1x10(-6)) associated with early AMD. Other possible loci that did not reach GWAS significance included variants in the zinc finger protein gene GLI3 (rs2049622; P = 8.9x10(-6)) and upstream of GLI2 (rs6721654; P = 6.5x10(-6)), encoding retinal Sonic hedgehog signalling regulators, and in the tyrosinase (TYR) gene (rs621313; P = 3.5x10(-6)), involved in melanin biosynthesis. For a range of published, late AMD risk loci, estimated effect sizes were significantly lower for early than late AMD. This study confirms the involvement of multiple established AMD risk variants in early AMD, but suggests weaker genetic effects on the risk of early AMD relative to late AMD. Several biological processes were suggested to be potentially specific for early AMD, including pathways regulating RPE cell melanin content and signalling pathways potentially involved in retinal regeneration, generating hypotheses for further investigation.	[Holliday, Elizabeth G.; McElduff, Patrick; Attia, John] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Holliday, Elizabeth G.; McElduff, Patrick; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur; Wellcome Trust Case Control Consor] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur; Jonasson, Fridbert] Univ Iceland, Fac Med, Reykjavik, Iceland; [Cornes, Belinda K.; Aung, Tin; Cheng, Ching Yu; Tay, Wanting; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Buitendijk, Gabrielle H. S.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jensen, Richard A.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Siscovick, David] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Psaty, Bruce M.; Siscovick, David] Univ Washington, Dept Med, Seattle, WA USA; [Sim, Xueling] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Sim, Xueling] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Baird, Paul N.; Hewitt, Alex W.; Xie, Sophia; Wong, Tien Y.; Wang, Jie Jin] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Human Genome Sequencing Ctr, Houston, TX USA; [Cheng, Ching Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Cheng, Ching Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Cheng, Ching Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore; [Harris, Tamara; Launer, Lenore] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Inouye, Michael] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Jonasson, Fridbert] Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Li, Xiaohui; Rotter, Jerome I.; Taylor, Kent] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Liew, Gerald; Mitchell, Paul; Rochtchina, Elena; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Liew, Gerald; Mitchell, Paul; Rochtchina, Elena; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Scott, Rodney J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Scott, Rodney J.] Hunter Area Pathol Serv, Newcastle, NSW, Australia; [Teo, Yik Ying; Tai, E. Shyong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Viswanathan, Ananth] Moorfields Eye Hosp, London, England; [Tai, E. Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Attia, John] John Hunter Hosp, Dept Med, Newcastle, NSW, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; Icelandic Heart Association; University of Iceland; National University of Singapore; Singapore National Eye Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; University of Michigan System; University of Michigan; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; National University of Singapore; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Melbourne; Landspitali National University Hospital; University of Wisconsin System; University of Wisconsin Madison; Cedars Sinai Medical Center; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Auckland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; National University of Singapore; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle	Holliday, EG (corresponding author), Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia.	Liz.Holliday@newcastle.edu.au	Smith, Albert Vernon/K-5150-2015; Scott, Rodney J/B-2827-2013; Liew, Gerald/AAB-6870-2022; Hewitt, Alex W/D-1936-2013; Brown, Matthew A/E-5749-2010; Jonasson, Fridbert/ABA-9889-2021; Kritharides, Leonard/AAQ-2720-2020; Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020; wang, jie/GRS-0942-2022; Jankowski, Janusz/H-2706-2012; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Bellenguez, Céline/X-4004-2019; Tai, E Shyong/J-9831-2013; Belllenguez, Céline/Y-3183-2018; Attia, John R/F-5376-2013; Sim, Xueling/AAZ-6652-2020; Klaver, Caroline C.W./A-2013-2016; Cheng, Ching-Yu/K-7017-2013; Wang, Jie Jin/P-1499-2014; Rotter, Jerome/AAY-6598-2021; Cheng, Ching-Yu/Y-2229-2019; Aspelund, Thor/K-7022-2019; Blackwell, Jenefer M/H-3015-2015	Smith, Albert Vernon/0000-0003-1942-5845; Scott, Rodney J/0000-0001-7724-3404; Hewitt, Alex W/0000-0002-5123-5999; Brown, Matthew A/0000-0003-0538-8211; Wong, Tien Yin/0000-0002-8448-1264; Jankowski, Janusz/0000-0003-2130-9181; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Bellenguez, Céline/0000-0002-1240-7874; Belllenguez, Céline/0000-0002-1240-7874; Attia, John R/0000-0001-9800-1308; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Aspelund, Thor/0000-0002-7998-5433; Van Duijn, Cornelia/0000-0002-2374-9204; Klein, Ronald/0000-0002-4428-6237; Tai, E Shyong/0000-0003-2929-8966; Banks, Emily/0000-0002-4617-1302; Magee, Christopher/0000-0002-0465-6328; /0000-0001-6694-3587; Inouye, Michael/0000-0001-9413-6520; Klaver, Caroline/0000-0002-2355-5258; Plomin, Robert/0000-0002-0756-3629; Baird, Paul/0000-0002-1305-3502; Gillman, Matthew S./0000-0002-2340-6930; Cotch, Mary Frances/0000-0002-2046-4350	National Institutes of Health (NIH) [N01-AG-12100, HHSN268200625226C, UL1RR025005]; NIA; NEI Intramural Research Programs at the National Institutes of Health [ZIAAG007380, ZIAEY000401]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103]; National Human Genome Research Institute [U01HG004402]; NIH Roadmap for Medical Research; Australian National Health & Medical Research Council (NHMRC) [974159, 991407, 211069, 457349, 512423, 475604,529912, 590204]; Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye [529923]; Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2 [085475/B/08/Z, 085475/08/Z]; NHMRC [631096, APP1028444, 358702, 632909]; National Center of Advancing Translational Technologies CTSI [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics; Netherlands Organization of Scientific Research NWO [175.010.2005.011]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Lijf en Leven, Netherlands; Krimpen a/d Lek, Netherlands; MD Fonds, Utrecht, Netherlands; Oogfonds Nederland, Utrecht, Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam, Netherlands; Swart van Essen, Rotterdam, Netherlands; Netherlands Organisation for Scientific Research (NWO), Netherlands; Bevordering van Volkskracht, Rotterdam, Netherlands; Blindenhulp, The Hague, Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam, Netherlands; OOG, The Hague, Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn, Netherlands; Blinden-Penning, Amsterdam, Netherlands; Blindenhulp, 's Gravenzande, Netherlands; Henkes Stichting, Rotterdam, Netherlands; Topcon Europe BV, Netherlands; Capelle aan de IJssel, Netherlands; Medical Workshop BV, Groningen, Netherlands; Heidelberg Engineering, Dossenheim, Germany; Biomedical Research Council of Singapore [BMRC 08/1/35/19/550]; National Medical Research Council of Singapore [NMRC/STaR/0003/2008, CG/SERI/2010]; American Health Assistance Foundation, USA; National Medical Research Council [CG/SERI/2010, 0796/2003,, IRG07nov013, IRG09nov014, STaR/0003/2008]; Biomedical Research Council of Singapore, Singapore [09/1/35/19/616]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC085084, N01HC045133, N01HC085082, N01HC085080, N01HC035129, N01HC085081, N01HC055222, N01HC015103, N01HC085085, N01HC085086, N01HC085083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000426, ZIAEY000401] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL080295, U01HL080295, R01HL105756, R01HL086694, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, R01AG015928, ZIAAG007380, R56AG020098, R01AG020098, R56AG023629, R01AG023629, ZIAAG007270, R01AG027058] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NEI Intramural Research Programs at the National Institutes of Health; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye(German Research Foundation (DFG)); Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Center of Advancing Translational Technologies CTSI; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Lijf en Leven, Netherlands; Krimpen a/d Lek, Netherlands; MD Fonds, Utrecht, Netherlands; Oogfonds Nederland, Utrecht, Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam, Netherlands(Netherlands Government); Swart van Essen, Rotterdam, Netherlands; Netherlands Organisation for Scientific Research (NWO), Netherlands; Bevordering van Volkskracht, Rotterdam, Netherlands; Blindenhulp, The Hague, Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam, Netherlands; OOG, The Hague, Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn, Netherlands; Blinden-Penning, Amsterdam, Netherlands; Blindenhulp, 's Gravenzande, Netherlands(Netherlands Government); Henkes Stichting, Rotterdam, Netherlands; Topcon Europe BV, Netherlands(Netherlands Government); Capelle aan de IJssel, Netherlands(Netherlands Government); Medical Workshop BV, Groningen, Netherlands; Heidelberg Engineering, Dossenheim, Germany; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore); American Health Assistance Foundation, USA; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council of Singapore, Singapore(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Age, Gene/Environment Susceptibility-Reykjavik Study has been funded by National Institutes of Health (NIH) contract N01-AG-12100, the NIA and NEI Intramural Research Programs at the National Institutes of Health (ZIAAG007380 and ZIAEY000401), Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Blue Mountains Eye Study was supported by the Australian National Health & Medical Research Council (NHMRC) project grants (IDs 974159, 991407, 211069 and 457349) and Centre for Clinical Research Excellence (CCRE) in Translational Clinical Research in Eye Diseases, CCRE in TCR-Eye (ID 529923). The Blue Mountains Eye Study GWAS and genotyping costs were supported by Australian NHMRC project grants (IDs 512423, 475604,529912 and 590204), and the Wellcome Trust, United Kingdom, as part of Wellcome Trust Case Control Consortium 2 (grant IDs 085475/B/08/Z and 085475/08/Z). EGH (631096), PNB (APP1028444) and JJW (358702 and 632909) are supported by the NHMRC fellowship scheme. This CHS research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C and NHLBI grants HL080295, HL087652, HL105756 with additional contribution from NINDS. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the NIA. See also http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by National Center of Advancing Translational Technologies CTSI grant UL1TR000124 and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center and Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The GWA database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011). The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ophthalmologic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht.; Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research (NWO); Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, 's Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; all in the Netherlands; Heidelberg Engineering, Dossenheim, Germany. The Singapore Indian Eye Study (SINDI) was funded by grants from Biomedical Research Council of Singapore (BMRC 08/1/35/19/550), National Medical Research Council of Singapore (NMRC/STaR/0003/2008 and CG/SERI/2010), and American Health Assistance Foundation, USA. The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The Singapore Malay Eye Study (SiMES) is funded by National Medical Research Council (grants 0796/2003, IRG07nov013, IRG09nov014, STaR/0003/2008 and CG/SERI/2010) and Biomedical Research Council of Singapore (grants 09/1/35/19/616), Singapore and the American Health Assistance Foundation, USA. The Singapore Tissue Network and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Evans J, 2008, EYE, V22, P751, DOI 10.1038/eye.2008.100; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kinnunen K, 2011, ACTA OPHTHALMOL; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Ma L, 2012, BRIT J NUTR, V107, P350, DOI 10.1017/S0007114511004260; Memoli S, 1997, BBA-LIPID LIPID MET, V1346, P61, DOI 10.1016/S0005-2760(97)00018-0; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Naj AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001130; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Raymond P A, 1997, Adv Neurol, V72, P171; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Sallo FB, 2009, CURR EYE RES, V34, P238, DOI 10.1080/02713680802714058; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Sundelin SP, 2001, FREE RADICAL BIO MED, V30, P74, DOI 10.1016/S0891-5849(00)00444-5; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; WEITER JJ, 1985, AM J OPHTHALMOL, V99, P185, DOI 10.1016/0002-9394(85)90230-2; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zareparsi S, 2004, INVEST OPHTH VIS SCI, V45, P1306, DOI 10.1167/iovs.03-1253; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	67	193	198	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2013	8	1							e53830	10.1371/journal.pone.0053830	http://dx.doi.org/10.1371/journal.pone.0053830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086RY	24282622	Green Submitted, Green Published, gold			2022-12-27	WOS:000314705800079
J	Luo, JD; Lu, ZH; Lu, XJ; Chen, L; Cao, JP; Zhang, SY; Ling, Y; Zhou, XF				Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Cao, Jianping; Zhang, Shuyu; Ling, Yang; Zhou, Xifa			OTUD5 Regulates p53 Stability by Deubiquitinating p53	PLOS ONE			English	Article							HAUSP; MDM2; PATHWAY; DESTABILIZATION; STRESS; P300	Background: The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by its negative regulators ubiquitin ligase MDM2. Principal Findings: In this study, we have identified OTUD5 as a DUB that interacts with and deubiquitinates p53. OTUD5 forms a direct complex with p53 and controls level of ubiquitination. The function of OTUD5 is required to allow the rapid activation of p53-dependent transcription and a p53-dependent apoptosis in response to DNA damage stress. Conclusions: As a novel deubiquitinating enzyme for p53, OTUD5 is required for the stabilization and the activation of a p53 response.	[Luo, Judong; Lu, Zhonghua; Lu, Xujing; Chen, Ling; Ling, Yang; Zhou, Xifa] Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Luo, Judong; Cao, Jianping; Zhang, Shuyu] Soochow Univ, Jiangsu Prov Key Lab Radiat Med & Protect, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Ling, Y (corresponding author), Soochow Univ, Changzhou Tumor Hosp, Dept Radiotherapy, Changzhou, Peoples R China.	medilyn2001@yahoo.com.cn; 756035311@qq.com			National Natural Science Foundation of China [81102078, 81172597]; Natural Science Foundation of Jiangsu Province [BK2009102]; Innovative Project of Jiangsu Province [BL2012046]; Changzhou Social Development [CE20125026]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovative Project of Jiangsu Province; Changzhou Social Development; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work is supported by the National Natural Science Foundation of China (81102078 and 81172597), Natural Science Foundation of Jiangsu Province (BK2009102), Innovative Project of Jiangsu Province (BL2012046), Changzhou Social Development (CE20125026) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; COX RF, 1984, AM J HOSP PHARM, V41, P2410, DOI 10.1093/ajhp/41.11.2410; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hock AK, 2011, EMBO J, V30, P4921, DOI 10.1038/emboj.2011.419; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu JH, 2011, EMBO J, V30, P846, DOI 10.1038/emboj.2011.11; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	27	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77682	10.1371/journal.pone.0077682	http://dx.doi.org/10.1371/journal.pone.0077682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24143256	gold, Green Published, Green Submitted			2022-12-27	WOS:000325894100095
J	Zhao, Q; Wang, LX; Tao, T; Xu, B				Zhao, Qi; Wang, Lixia; Tao, Tao; Xu, Biao			Impacts of the "transport subsidy initiative on poor TB patients" in Rural China: A Patient-Cohort Based Longitudinal Study in Rural China	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; INCENTIVES; SERVICES; BARRIERS; ACCESS	Objective: To describe the financial burden on TB patients for transportation during treatment, and to evaluate the impacts of the "transportation subsidy initiative on poor TB patients" in rural China for improving poor patients' access to TB treatment. Methods: A Case-cohort of 429 TB patients was investigated through questionnaire interviews in four counties of two provinces in China. Information on the financial burden for transportation during TB diagnosis and treatment was collected. Qualitative in-depth interviews with 26 TB patients were carried out to understand their perceptions of transportation subsidy initiative. Results: The mean transportation cost of TB medical care was 97 CNY (70 CNY in median), varying from 0 to 700 CNY. About 51% of the patients spent more than 10 CNY per round trip to the TB dispensary. Of the 429 TB patients investigated, 139 had received transportation subsidies after getting TB diagnosis; 15/139 (10.9%) showed dissatisfaction, mainly because the subsidy amount being insufficient. The income of patients receiving transportation subsidies was significantly lower than those not receiving the subsidies (p<0.05). The impression that an appropriate transportation subsidy enables patients to complete the required visits during their TB treatment was obtained after observation of over 80% of the patients. Conclusion: The transportation subsidy plays an important role in reducing financial burden on poor TB patients for the completion of treatment. However, the coverage was limited and the amount of subsidy was not enough under the present policy. Considering the poverty of rural TB patients, a universal coverage and a rational amount of transportation subsidy should be proposed.	[Zhao, Qi; Tao, Tao; Xu, Biao] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Lixia] Natl Ctr TB Prevent & Control, Beijing, Peoples R China	Fudan University	Xu, B (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China.	bxu@shmu.edu.cn		Fan, Wenliang/0000-0001-8949-6775	WHO/CHN China [CHN/09/STB/000539, CHN/09/STB/000540]; Shanghai Leading Academic Discipline Project [12GWZX0101]; Distinguished Professorship Award by China Medical Board [G16916403]; Swedish International Development Cooperation Agency [EPI-4]	WHO/CHN China; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Distinguished Professorship Award by China Medical Board; Swedish International Development Cooperation Agency	This investigation received financial support from WHO/CHN China granted project (Grant No. CHN/09/STB/000539 & CHN/09/STB/000540). It also has been supported by the Shanghai Leading Academic Discipline Project (Project Number: 12GWZX0101), the Distinguished Professorship Award to the corresponding author granted by China Medical Board (No. G16916403), and the Swedish International Development Cooperation Agency granted project "Evidence for Policy and Implementation (EPI-4) Intensifying efforts to achieve the health-related MDGs in four countries with developing economies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beith A, 2007, PERFORMANCE BASED IN; Bowong S, 2010, COMMUN NONLINEAR SCI, V15, P3621, DOI 10.1016/j.cnsns.2010.01.007; Chen C, 2007, CHINESE J ANTITUBERC, V29, P293; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; Godfrey-Faussett R, 2002, INT J TUBERC LUNG D, V6, P796; Hu D, 2008, CHINESE J HLTH ED, V24, P436; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Liu XY, 2007, TROP MED INT HEALTH, V12, P1464, DOI 10.1111/j.1365-3156.2007.01953.x; Lonnroth K, 2001, SOC SCI MED, V52, P935, DOI 10.1016/S0277-9536(00)00195-7; MOH, 2002, CHIN TUB PREV CONTR; MOH, 2008, GUID PROV TRANSP SUB; Mookherj S, 2005, FOOD SUPPORT TUBERCU; Mookherji S, 2005, SUMMARY CURRENT EVID; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Squire SB, 2006, LANCET, V367, P955, DOI 10.1016/S0140-6736(06)68393-1; Wang Y, 2011, 5 NATL EPIDEMIOLOGY; Wares DF, 2001, INT J TUBERC LUNG D, V5, P732; Wei X, 2008, INT J TUBERC LUNG D, V12, P538; Weil D, 2004, MAPPING MOTIVATIONS; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2009, GLOB TUB CONTR EP ST; World Health Organization (WHO), 2005, ADDR POV TB CONTR; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Yao H, 2008, INT J TUBERC LUNG D, V12, P1166; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19; Zhao J, 2008, CHINESE J ANTITUBERC, V30, P452	28	11	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2013	8	11							e82503	10.1371/journal.pone.0082503	http://dx.doi.org/10.1371/journal.pone.0082503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259RH	24282623	gold, Green Submitted, Green Published			2022-12-27	WOS:000327543500127
J	O'Connor, JW; Gomez, EW				O'Connor, Joseph W.; Gomez, Esther W.			Cell Adhesion and Shape Regulate TGF-Beta1-Induced Epithelial-Myofibroblast Transition via MRTF-A Signaling	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; SERUM RESPONSE FACTOR; MESENCHYMAL STEM-CELLS; TGF-BETA; MESSENGER-RNA; TRANSCRIPTION FACTORS; HISTONE ACETYLATION; GRANULATION-TISSUE; TRACTIONAL FORCES; GENE-EXPRESSION	Myofibroblasts, specialized cells that play important roles in wound healing and fibrosis, can develop from epithelial cells through an epithelial-mesenchymal transition (EMT). During EMT, epithelial cells detach from neighboring cells and acquire an elongated, mesenchymal-like morphology. These phenotypic changes are accompanied by changes in gene expression patterns including upregulation of a variety of cytoskeletal associated proteins which contribute to the ability of myofibroblasts to exert large contractile forces. Here, the relationship between cell shape and cytoskeletal tension and the expression of cytoskeletal proteins in transforming growth factor (TGF)-beta 1-induced EMT is determined. We find that culturing cells in conditions which permit cell spreading and increased contractility promotes the increased expression of myofibroblast markers and cytoskeletal associated proteins. In contrast, blocking cell spreading prevents transdifferentiation to the myofibroblast phenotype. Furthermore, we find that cell shape regulates the expression of cytoskeletal proteins by controlling the subcellular localization of myocardin related transcription factor (MRTF)-A. Pharmacological inhibition of cytoskeletal tension or MRTF-A signaling blocks the acquisition of a myofibroblast phenotype in spread cells while overexpression of MRTF-A promotes the expression of cytoskeletal proteins for all cell shapes. These data suggest that cell shape is a critical determinant of myofibroblast development from epithelial cells.	[O'Connor, Joseph W.; Gomez, Esther W.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Gomez, Esther W.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gomez, EW (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	ewgomez@engr.psu.edu		Gomez, Esther/0000-0003-2082-013X; Perry, Ivan/0000-0002-4965-9792; Kearney, Patricia/0000-0001-9599-3540	Pennsylvania State University	Pennsylvania State University	Funding provided by The Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; BENZEEV A, 1984, J CELL BIOL, V99, P1424, DOI 10.1083/jcb.99.4.1424; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Condeelis J, 2005, BIOL CELL, V97, P97; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Desai RA, 2011, INTEGR BIOL-UK, V3, P560, DOI 10.1039/c0ib00129e; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Neira RE, 2012, INT J BIOCHEM CELL B, V44, P2194, DOI 10.1016/j.biocel.2012.08.018; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gabbiani G, 1981, Prog Clin Biol Res, V54, P183; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gomez EW, 2011, METHODS MOL BIOL, V671, P107, DOI 10.1007/978-1-59745-551-0_5; Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; HESKETH JE, 1991, BIOCHEM J, V277, P1; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jung J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074598; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; Lin JJC, 2009, INT REV CEL MOL BIO, V274, P1, DOI 10.1016/S1937-6448(08)02001-7; Maeda M, 2006, J BIOL CHEM, V281, P59, DOI 10.1074/jbc.M503304200; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	73	72	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83188	10.1371/journal.pone.0083188	http://dx.doi.org/10.1371/journal.pone.0083188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24282548	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400126
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-27	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-27	WOS:000315184200085
